Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 67.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Extravillous trophoblasts: 71.3;Hepatocytes: 29.3;Spermatogonia: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.3	2.8	6.2	1.9	6.8	0.3	4.7	3.8	9.8	9.8	11.3	6.2	1.6	10.5	5.9	2.6	6.3	3.9	2.7	6.5	6.7	6.8	67.1	4.9	0.7	5.8	5.6	4.7	5.6	6.0	6.1	1.9	6.5	14.4	5.0	11.8	1.7	5.3	4.0	1.4	2.3	7.3	4.8	1.7	3.6	8.2	6.1	1.5	7.5	2.4	0.8	6.4	5.7	8.7	3.5	8.5	25.0	0.0	4.9	18.9	9.0	8.7	4.2	4.9	5.0	8.4	1.0	0.1	1.4	9.8	6.5	2.9	11.3	4.1	3.4	0.0	9.7	0.0	10.0	14.0	3.9	0.1	3.8	7.7	2.5	4.0	5.1	13.5	4.7	11.4	1.5	0.1	19.0	8.9	4.3	0.1	19.0	9.6	7.6	0.0	7.8	0.0	4.4	15.3	20.1	23.5	7.0	1.7	8.5	8.0	0.1	1.7	3.2	12.5	13.4	14.3	13.9	0.1	0.0	0.1	12.5	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	6.8	3.8	9.8	6.5	6.7	5.8	5.6	6.5	4.8	6.1	8.7	0.9	0.0	5.9	22.2	0.3	0.9	2.8	0.9	6.2	6.0	3.9	1.0	1.2	1.5	2.1	0.0	2.1	2.8	0.0	0.7	0.0	1.6	0.5	3.7	7.4	0.7	6.7	0.0	15.4	2.2	71.3	3.2	3.1	6.0	0.0	6.2	0.7	29.3	1.6	0.0	13.6	2.8	0.0	0.3	0.9	1.4	1.2	0.4	1.8	5.6	0.0	2.7	0.0	17.6	14.0	1.1	1.6	2.2	0.0	4.0	0.2	8.4	8.5	9.1	6.6	3.9	4.2	14.5	27.1	3.0	0.4	5.6	0.3	3.3	3.1	1.8
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 89.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 777.7;Rod photoreceptor cells: 640.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebral cortex: 31.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	9.1	12.6	0.3	8.1	0.6	12.0	8.1	0.9	31.0	7.1	0.0	7.0	4.6	9.9	9.9	7.4	7.5	5.4	20.4	2.9	0.0	10.5	5.1	10.3	9.0	4.7	2.9	5.5	13.1	89.7	13.7	9.9	3.5	8.6	6.3	28.2	6.7	8.2	13.0	6.3	8.5	7.6	0.0	8.6	12.6	6.7	4.8	13.2	23.4	6.7	7.7	7.8	7.1	4.8	25.1	15.3	14.6	12.3	13.7	14.3	41.0	19.4	16.8	12.0	11.3	15.6	10.0	0.9	4.6	27.6	16.5	11.4	11.7	11.4	27.1	20.6	4.4	13.3	9.0	10.0	11.7	9.5	31.3	12.9	9.6	23.7	30.9	10.2	27.4	12.3	3.2	14.1	22.5	3.7	8.8	5.6	6.4	4.9	8.3	5.8	13.8	2.2	10.0	51.0	4.2	6.6	12.0	8.8	10.2	9.9	5.3	12.9	25.6	26.4	17.5	19.7	19.4	12.9	3.9	1.5	23.0	16.0	19.1	1.4	0.5	0.2	1.4	0.2	1.4	0.1	1.3	1.0	0.3	0.3	1.7	1.5	1.5	1.1	2.2	0.2	1.0	0.5	0.3	0.6	0.9	31.0	2.9	0.0	4.7	2.9	3.5	0.0	4.8	4.8	54.6	35.3	34.2	77.7	13.4	15.9	20.8	15.9	32.5	254.4	42.2	40.9	86.7	102.9	19.3	143.5	777.7	81.6	149.1	130.6	43.0	46.0	23.9	36.6	67.4	56.0	72.1	35.3	265.8	67.4	56.3	29.5	44.9	65.7	21.0	24.4	118.2	38.2	62.4	306.2	327.7	31.6	12.2	128.8	23.5	32.7	38.2	67.1	10.6	156.4	72.7	53.2	252.4	147.8	113.9	55.9	76.3	46.6	57.4	42.1	56.0	90.0	10.7	640.8	19.7	26.7	45.5	46.9	59.3	23.3	9.9	213.3	158.1	33.6	21.7	49.0
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138626	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 5.7;skin 1: 20.7"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 12.9;Suprabasal keratinocytes: 38.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"hTCEpi: 38.7;SK-BR-3: 18.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 1.0;hippocampal formation: 1.1"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	5.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.3	0.2	0.2	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	2.8	0.3	3.9	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	38.7	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.5	0.1	2.7	0.0	18.3	0.0	0.2	9.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	12.9	0.9	6.0	0.0	0.2	1.0	0.5	0.5	0.0	5.1	0.0	0.0	1.1	0.0	3.0	0.0	0.1	2.2	2.6	0.3	0.1	0.0	0.0	1.4	0.0	2.7	0.1	1.5	3.7	0.0	0.5	0.0	0.0	0.4	1.7	2.9	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.6	1.9	0.0	0.7	0.0	1.0	0.0	0.1	3.1	0.2	0.0	0.0	0.2	0.7	0.4	2.2	38.6	3.4	0.0	0.1	0.9	2.7
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503017-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 101.7;intestine: 70.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 95.8;Distal enterocytes: 109.9;Microglial cells: 570.6;Paneth cells: 106.2;Proximal enterocytes: 204.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 27.2;NK-cell: 17.9"	"Group enriched"	"Detected in many"	9	"NK-cells: 17.9;T-cells: 27.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 67.3;HEK 293: 20.4;HEL: 37.7;Hep G2: 18.5;RPTEC TERT1: 24.2;SH-SY5Y: 78.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	101.7	14.1	3.9	13.6	1.9	3.6	13.7	17.6	6.4	5.3	16.6	26.4	11.0	3.6	3.1	5.0	15.5	1.9	15.3	15.6	33.7	28.0	6.4	3.2	17.6	14.4	2.2	2.0	1.4	0.5	2.3	19.7	4.2	18.2	2.2	1.2	3.1	0.2	1.5	70.7	9.8	15.1	4.2	2.1	0.9	19.3	2.7	1.9	1.4	3.5	3.6	1.7	14.3	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.1	4.3	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	20.4	37.7	4.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	24.2	0.2	0.9	78.9	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	4.0	0.0	0.9	7.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	11.1	0.0	27.2	0.8	2.7	6.8	0.0	2.5	1.7	6.6	0.2	17.9	0.0	0.1	0.0	2.5	14.1	13.6	13.7	17.6	15.3	15.6	17.6	14.4	19.7	15.1	19.3	14.3	17.1	0.0	3.0	3.9	9.9	0.8	0.1	0.0	1.2	1.9	0.4	3.9	3.0	95.8	0.6	49.7	0.0	5.8	24.7	109.9	5.9	13.8	27.3	0.6	0.6	52.9	0.0	7.8	16.1	1.9	0.2	3.7	0.0	0.7	3.8	0.3	2.5	38.4	0.4	0.0	11.4	15.8	0.0	0.6	1.2	3.8	0.9	1.6	0.0	570.6	0.2	0.2	32.0	6.0	3.2	8.1	106.2	0.0	4.6	0.2	204.6	57.7	0.7	1.1	0.0	0.4	1.3	0.4	0.9	0.2	0.6	9.9	24.5	0.1	19.9	0.3
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184017939	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 167.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 196.0;Inhibitory neurons: 122.8;Rod photoreceptor cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	15.4	23.2	42.5	16.3	44.2	22.4	13.1	48.4	50.0	30.9	167.1	24.4	10.8	21.6	10.4	44.5	16.1	17.9	47.2	45.5	43.6	41.6	7.9	15.6	13.1	44.0	39.5	23.4	13.0	24.0	41.7	17.2	44.7	27.8	22.1	126.2	18.4	13.7	117.5	24.1	23.2	16.1	34.0	37.1	82.3	16.5	46.3	15.3	13.8	40.3	11.8	34.8	35.2	43.2	21.5	11.5	25.9	30.8	25.7	28.3	40.0	16.8	13.3	14.8	16.2	17.9	15.8	22.5	38.6	16.2	22.6	83.3	32.1	18.6	19.3	24.4	31.1	48.1	32.5	18.0	10.3	14.8	36.5	45.6	18.3	15.9	10.6	30.3	17.8	65.6	45.6	30.8	25.7	56.7	40.7	17.1	26.7	38.4	21.7	28.1	8.7	13.4	54.4	136.4	46.6	27.8	17.1	93.5	29.3	33.3	56.6	4.9	20.4	17.4	16.6	22.3	23.8	11.7	24.3	21.1	12.5	29.2	17.9	11.7	4.6	8.3	6.9	2.2	4.4	3.1	3.8	3.1	3.6	4.5	4.3	6.0	16.4	5.6	4.2	1.3	5.7	4.5	42.5	44.2	48.4	50.0	45.5	43.6	44.0	39.5	44.7	34.0	46.3	43.2	8.3	9.6	5.3	39.2	6.4	8.9	14.4	18.3	35.3	39.1	10.5	11.3	37.2	2.8	37.2	44.1	196.0	3.2	7.7	23.3	7.9	5.7	6.0	10.4	18.0	9.5	59.3	21.2	101.3	4.5	5.0	12.5	91.3	20.8	5.1	31.0	6.8	3.3	49.7	33.7	122.8	6.4	20.3	32.7	6.5	3.5	8.1	29.3	12.4	32.8	8.3	13.8	9.2	82.4	62.7	7.9	20.2	7.9	7.5	9.3	5.1	4.8	44.9	121.1	0.0	27.4	15.4	6.8	18.8	41.3	12.1	4.5	8.6	14.9	7.5	61.5
ABHD3	LABH3	ENSG00000158201	"Abhydrolase domain containing 3, phospholipase"	Q8WU67	18	21650901-21704780	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 187.7;Paneth cells: 126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 209.6;RPMI-8226: 233.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010729	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA010729: AB_1844449"	"unprognostic (1.46e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.58e-2)"	17.1	7.3	13.3	25.2	13.8	17.6	15.7	16.8	21.9	12.6	23.2	63.5	44.1	8.1	9.1	18.1	12.0	20.8	7.5	13.2	14.0	14.5	39.3	15.7	29.8	14.2	15.6	12.5	12.3	16.0	11.4	19.8	16.2	11.1	65.7	5.8	14.5	6.2	14.4	6.3	56.3	9.7	13.2	24.0	35.6	6.3	16.2	21.4	22.9	7.9	25.8	15.3	12.8	15.9	29.0	20.6	19.8	12.7	12.3	8.2	0.1	18.6	7.6	13.1	17.6	21.6	29.1	82.3	33.2	6.2	58.6	93.6	32.5	15.3	18.1	52.1	21.9	9.0	35.7	37.5	18.7	39.6	28.9	7.3	17.7	19.2	8.8	6.5	8.7	28.0	23.4	47.9	11.6	11.7	38.5	43.6	9.7	92.1	47.8	209.6	15.0	233.5	36.4	27.6	16.6	7.5	42.5	37.6	11.2	21.3	11.7	68.9	6.9	12.7	18.2	22.6	29.3	53.1	37.5	84.9	16.1	50.9	29.4	89.3	24.7	29.3	25.3	44.4	19.8	16.2	22.7	24.8	15.2	12.6	18.2	23.2	81.6	18.6	61.8	10.2	44.9	24.3	13.3	13.8	16.8	21.9	13.2	14.0	14.2	15.6	16.2	13.2	16.2	15.9	8.4	9.6	9.3	42.4	22.8	33.4	40.8	21.6	18.2	14.3	12.9	6.2	4.6	40.0	25.4	3.7	47.9	30.6	24.4	187.7	1.9	52.9	4.1	32.6	9.9	9.5	36.4	10.3	27.2	27.5	22.7	10.6	32.1	49.4	11.4	1.2	10.4	31.6	68.5	0.0	30.9	57.9	52.9	31.9	47.2	1.5	7.5	26.4	32.0	33.7	29.6	7.8	26.8	17.1	10.7	51.1	126.6	6.4	45.5	32.0	93.8	8.8	40.8	15.7	13.1	6.8	13.2	4.1	9.7	22.4	15.2	94.3	38.3	5.4	36.8	36.8
ABI1	"ABI-1, E3B1, SSH3BP1"	ENSG00000136754	"Abl interactor 1"	Q8IZP0	10	26746593-26861087	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 278.2;Suprabasal keratinocytes: 270.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008375, HPA068407"	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA		440000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cell Junctions"		"CAB008375: AB_592744, HPA068407: AB_2685983"	"unprognostic (2.83e-3)"	"unprognostic (8.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	28.9	16.2	28.5	35.0	29.2	83.8	29.8	28.3	38.9	30.4	20.9	32.0	32.4	23.6	19.2	53.0	23.8	24.9	16.3	37.4	28.8	27.6	24.9	28.1	48.1	24.7	26.8	26.6	19.9	20.1	12.9	28.3	25.4	20.8	33.0	18.9	32.9	19.1	20.0	42.9	34.1	23.8	26.2	32.3	31.8	14.2	28.0	44.5	22.6	19.6	53.7	34.7	36.5	27.1	55.0	28.6	21.1	21.9	34.4	39.5	34.1	50.9	31.2	35.0	37.5	33.7	61.7	101.1	23.2	51.7	23.0	57.7	28.0	37.0	41.0	65.2	24.2	44.5	18.0	29.0	23.6	23.2	43.9	28.1	54.6	35.3	21.8	41.5	43.7	33.5	30.7	67.2	40.5	25.4	49.8	26.0	18.8	37.5	13.5	51.4	41.2	69.2	48.0	22.9	17.1	18.5	41.3	44.5	46.8	29.4	27.7	35.5	50.6	27.3	33.2	34.4	25.5	15.0	24.0	108.7	38.7	61.1	17.4	77.3	35.5	91.4	42.1	43.2	40.8	57.2	40.9	48.5	39.4	47.7	37.7	41.7	64.3	35.8	45.4	34.1	76.5	57.2	28.5	29.2	28.3	38.9	37.4	28.8	24.7	26.8	25.4	26.2	28.0	27.1	44.4	41.7	37.7	278.2	89.3	246.2	127.9	74.0	123.5	9.6	40.5	26.5	23.2	38.6	73.5	25.8	2.1	36.4	75.7	69.7	13.7	56.3	11.3	72.1	41.3	41.9	44.9	43.8	81.6	52.1	46.9	45.9	42.3	111.5	57.7	22.3	32.9	25.6	75.8	16.8	133.7	54.9	83.4	80.5	116.3	5.7	22.1	92.1	92.5	106.8	89.8	48.2	73.2	128.7	47.4	82.2	52.1	22.2	56.8	132.5	52.7	39.0	86.2	10.0	32.9	29.8	40.3	14.7	10.8	109.6	270.6	77.2	71.0	27.2	41.3	195.4
ABITRAM	"C9orf6, CG-8, FAM206A, FLJ20457, Simiate"	ENSG00000119328	"Actin binding transcription modulator"	Q9NX38	9	108934400-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.7;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 10.6;Fibroblasts: 4.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035917, HPA035918"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	14.2	11.9	17.2	10.0	18.7	15.6	17.2	16.8	21.9	12.5	18.7	14.9	14.4	13.6	25.1	16.4	21.5	10.9	15.8	17.7	17.3	13.6	14.6	12.7	9.0	16.8	17.1	13.5	13.3	23.2	13.9	12.5	17.2	12.1	16.2	24.7	15.3	14.2	13.2	24.5	13.1	12.5	17.5	8.5	14.5	20.2	17.5	11.9	19.0	11.8	12.0	11.9	11.4	18.3	18.5	19.8	19.5	23.4	36.2	44.6	28.1	17.1	20.0	17.0	13.9	29.5	9.7	17.0	9.8	16.6	22.3	41.3	17.2	18.3	16.0	10.4	17.6	10.5	25.8	27.0	30.7	40.4	13.3	25.3	33.6	20.7	47.6	20.9	23.7	26.1	39.7	16.6	20.3	53.0	28.9	16.3	22.6	55.9	28.7	13.9	33.9	18.9	22.5	19.2	26.7	13.7	27.0	23.3	30.1	20.0	31.6	21.4	14.9	9.2	16.9	39.3	21.7	14.7	38.5	12.6	30.1	15.6	13.4	38.8	31.2	31.0	14.8	33.4	22.6	16.5	23.1	19.6	35.5	10.8	22.9	17.6	37.4	21.1	34.6	37.0	21.1	20.1	17.2	18.7	16.8	21.9	17.7	17.3	16.8	17.1	17.2	17.5	17.5	18.3	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 197.6;Cardiomyocytes: 61.7;Hepatocytes: 116.0;Oligodendrocyte precursor cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 75.3;HHSteC: 77.6;HSkMC: 89.4;hTERT-HME1: 90.9;hTERT-RPE1: 76.2;TIME: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		30000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	68.4	7.4	19.2	3.8	18.0	0.5	57.6	49.7	19.1	12.5	6.8	11.1	2.7	10.4	6.3	33.2	14.4	7.1	87.8	20.4	26.7	19.8	115.8	20.0	5.3	37.2	25.2	3.9	2.7	59.6	6.8	34.4	28.7	9.1	5.0	28.6	6.5	8.2	45.8	8.3	7.8	10.6	34.0	8.7	5.4	2.0	29.9	2.2	9.2	38.7	4.5	14.1	17.7	30.2	23.6	4.8	0.0	0.2	39.6	75.3	0.1	16.1	44.8	9.1	15.8	0.1	16.2	0.0	2.7	20.5	47.9	0.5	0.1	18.9	17.7	0.1	0.2	0.0	1.4	0.6	77.6	0.0	0.1	89.4	5.1	32.5	90.9	76.2	41.1	0.0	0.0	7.2	54.8	9.2	0.0	0.0	0.2	1.5	63.0	0.0	0.1	0.0	50.3	16.0	6.3	0.1	3.3	1.1	8.7	1.2	1.5	0.1	103.9	18.9	4.2	19.9	27.7	0.1	0.0	0.0	33.5	0.0	55.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	2.7	19.2	18.0	49.7	19.1	20.4	26.7	37.2	25.2	28.7	34.0	29.9	30.2	197.6	0.0	3.7	21.5	1.3	1.5	1.2	2.6	0.6	2.5	7.6	3.9	61.7	18.6	5.3	0.0	0.0	0.2	0.3	0.0	5.9	8.7	3.0	0.5	2.5	39.6	0.0	0.0	31.0	3.5	0.7	9.4	3.6	2.5	1.3	0.0	34.2	116.0	12.3	28.6	33.7	0.0	8.2	13.5	1.1	0.5	0.3	8.5	5.4	21.5	0.9	19.3	0.0	63.8	25.6	22.5	0.0	0.7	0.1	2.5	0.0	23.5	4.9	25.1	0.0	7.4	7.7	1.7	2.7	2.0	1.6	0.4	0.7	0.5	0.0	22.2
AC004691.2		ENSG00000250424	"Novel protein, MINDY4 and AQP1 readthrough"		7	30852273-30923812	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019206, HPA030130"	Approved		Approved	"Plasma membrane"		NA	NA							"Plasma membrane"		"HPA019206: AB_1844965, HPA030130: AB_10601565"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"			"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.72e-4)"		"unprognostic (5.13e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.76e-1)"		"unprognostic (2.49e-1)"	"unprognostic (3.71e-2)"	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.3	0.0	0.5	0.4	0.4	0.4	0.2	0.6	0.9	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC005324.2		ENSG00000251537	"Novel tripartite motif-containing 16 (TRIM16) and CMT1A duplicated region transcript 1 (CDRT1) protein"		17	15571491-15651653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;CAPAN-2: 1.1;HaCaT: 2.1;HeLa: 1.1"									"HPA023623, HPA066431"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"		Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (3.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.80e-11)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.09e-1)"	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC005726.1		ENSG00000258472	"Novel protein"		17	28455752-28614185	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 13.2;Club cells: 5.6;granulocytes: 6.3;Proximal tubular cells: 20.4;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA					"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: AB_2679710"	"unprognostic (1.26e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (7.25e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.58e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.49e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	9.6	13.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.3	2.4	0.0	0.0	5.6	3.7	0.0	1.7	0.5	0.0	1.9	1.2	0.0	1.7	2.4	1.4	0.0	0.0	0.0	2.0	0.8	1.6	0.0	3.2	6.3	2.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	20.4	5.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.3	1.1	1.2	0.0	0.0
AC020907.6		ENSG00000285526	"Novel protein"		19	35106510-35124297	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 3.3;choroid plexus: 3.1;salivary gland: 7.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 3.9;Club cells: 1.3;Respiratory ciliated cells: 2.9"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"SCLC-21H: 6.2;WM-115: 8.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"spinal cord: 3.8"	HPA010856	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA					"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"																		0.0	0.0	2.4	0.0	3.1	0.0	0.4	2.7	3.2	1.4	3.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	2.4	0.0	0.1	0.0	0.0	2.9	2.7	0.0	1.8	0.0		0.2	2.6	0.3	0.0	0.2	7.3	0.1	0.0	1.6	0.0	0.0	2.3	0.0	0.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0		3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.1	2.7	3.2	2.2	2.4	2.9	2.7	2.6	2.3	2.6	3.3	0.0	6.4	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC127029.3		ENSG00000285947	"Novel protein"		17	63917203-63931385	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 14.0;naive B-cell: 18.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 18.4"	"Cell line enhanced"	"Detected in single"		"U-698: 2.2"									"HPA009178, HPA043715"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"		"Cluster 27: U-698-M & Daudi - Adaptive immune response"		"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA009178: AB_1078483, HPA043715: AB_2678632"																		0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	2.2	0.4	14.0	0.7	0.3	0.5	18.4	0.4	0.2	0.0	0.5	3.8	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC138696.1		ENSG00000264668	"Novel protein"		8	143247110-143276403	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.7;MOLT-4: 1.2"									"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"		"Cluster 34: Mesenchymal cell lines - ECM organization"		"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (2.24e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-3)"		"unprognostic (1.87e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.06e-1)"	0.3	0.3	0.2	0.0	0.3	0.0	0.2	0.1	0.5	0.3	0.0	0.4	0.1	0.6	0.0	0.1	0.7	0.0	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.2	0.4	0.4	0.6	0.1	0.2	0.0	0.3	0.3	0.0	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.3	1.7	0.1	0.1	0.5	1.1	0.6	0.2	0.0	0.7	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	1.0	0.4	0.0	0.3	0.2	0.3	0.4	0.0	0.0	0.0	0.0	1.2	0.0	1.1	0.1	0.3	0.6	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.2	1.1	0.0	0.8	0.2	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACOT9	"ACATE2, CGI-16, MT-ACT48"	ENSG00000123130	"Acyl-CoA thioesterase 9"	Q9Y305	X	23701055-23766475	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035533	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		7600	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035533: AB_10696506"	"unprognostic (5.69e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	24.1	18.8	8.0	19.5	7.5	15.8	19.8	7.5	9.5	17.7	10.3	22.0	15.5	22.5	8.4	12.1	17.3	13.6	49.3	7.2	9.1	15.5	14.5	26.1	12.7	8.0	7.5	15.1	14.0	11.7	8.8	17.8	8.6	16.1	16.4	9.6	18.6	22.1	27.6	12.5	15.8	32.3	6.9	18.4	17.7	6.2	8.5	6.3	17.4	14.2	12.5	21.3	14.7	7.5	81.5	54.0	23.1	51.4	37.2	42.0	11.7	62.7	54.3	60.7	58.4	48.5	71.4	4.1	39.1	70.5	81.8	48.3	29.6	79.9	84.2	18.8	44.6	27.4	55.0	35.6	49.9	10.8	33.3	37.5	53.6	71.5	80.5	39.6	90.3	0.6	17.7	26.7	66.7	28.4	15.2	26.1	33.9	31.8	65.3	15.7	87.6	34.4	72.8	29.8	4.5	22.1	68.4	28.3	41.6	85.5	31.9	14.0	84.7	50.7	33.8	73.3	34.7	6.4	16.1	0.5	37.4	10.5	43.6	24.7	30.2	22.2	10.2	43.5	14.1	11.1	12.6	11.3	32.4	9.9	4.0	9.4	15.8	12.3	56.2	5.4	20.8	18.6	8.0	7.5	7.5	9.5	7.2	9.1	8.0	7.5	8.6	6.9	8.5	7.5	34.6	48.1	27.3	12.1	23.0	20.1	45.9	51.8	7.4	5.3	5.6	6.7	44.3	18.6	36.8	16.5	25.0	4.0	21.5	9.7	5.9	59.6	0.8	20.8	22.9	38.7	2.4	11.2	6.1	52.5	11.4	33.4	16.8	21.6	37.3	14.8	32.9	11.8	42.4	5.0	8.6	10.3	16.2	37.1	95.4	0.4	18.0	57.3	33.8	13.1	192.3	11.9	19.6	4.5	3.1	83.4	15.0	25.6	27.7	52.4	14.6	30.3	38.0	9.9	26.3	35.2	65.1	1.6	10.4	3.5	10.7	3.0	21.2	30.4	11.2	38.2
ACTN1		ENSG00000072110	"Actinin alpha 1"	P12814	14	68874128-68979440	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 524.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 351.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 364.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004303, HPA006035"	Approved		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		210000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB004303: AB_626633, HPA006035: AB_1078095"	"unprognostic (4.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (9.08e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (8.00e-4)"	117.4	40.7	27.3	149.5	55.8	149.3	103.5	0.1	32.0	118.4	20.1	449.8	49.8	313.1	60.3	154.4	152.1	143.9	121.4	29.7	14.7	46.7	61.8	100.0	47.5	24.5	11.0	61.8	46.8	9.1	27.3	96.1	7.3	174.3	109.0	28.2	116.4	295.1	21.7	59.3	106.9	524.5	4.2	55.9	171.7	21.2	32.9	32.6	35.0	13.3	50.7	305.9	83.3	28.8	871.9	262.3	158.6	121.4	275.2	180.5	592.4	749.3	712.0	770.0	571.1	211.8	196.6	0.7	256.5	744.7	310.4	370.9	126.8	790.3	965.2	4.6	38.5	118.2	133.5	179.0	494.0	85.4	14.3	231.7	152.1	479.8	540.3	551.6	428.6	48.2	56.9	1.4	612.0	246.9	10.1	181.1	124.7	217.9	198.1	59.3	294.1	32.6	292.0	225.6	57.0	68.7	649.9	96.8	177.1	474.8	146.0	170.9	546.0	1085.2	432.8	126.9	662.5	113.8	47.8	3.9	314.4	115.7	584.4	64.6	67.5	137.1	5.7	28.8	7.1	0.1	22.7	12.4	45.5	0.2	103.9	92.2	364.2	4.5	8.9	2.0	9.6	89.2	27.3	55.8	0.1	32.0	29.7	14.7	24.5	11.0	7.3	4.2	32.9	28.8	44.7	38.5	25.1	19.6	4.0	119.3	154.9	137.4	82.0	74.7	88.6	157.6	60.3	51.5	36.0	42.3	246.0	155.3	3.0	17.2	3.9	186.8	34.0	65.8	112.8	135.5	38.5	21.9	102.7	144.9	351.8	88.9	34.1	90.2	7.6	15.9	129.5	96.6	79.5	18.5	29.7	57.3	59.0	100.9	82.1	10.7	35.8	96.4	30.2	34.7	105.1	6.0	4.1	9.0	4.3	203.7	28.0	245.6	0.6	132.6	2.4	15.3	47.8	80.8	177.5	30.0	270.6	19.4	18.4	51.8	59.8	66.9	22.7	20.9	47.0	67.1
ACTR10	"ACTR11, Arp10, Arp11, HARP11"	ENSG00000131966	"Actin related protein 10"	Q9NZ32	14	58200080-58235636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000699			Approved	"Vesicles,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane, Focal adhesion sites"		"HPA000699: "	"prognostic unfavorable (3.24e-4)"	"unprognostic (4.61e-2)"	"unprognostic (6.22e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (3.20e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (8.48e-8)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.48e-2)"	12.6	18.0	22.4	3.1	22.4	5.4	12.5	23.4	41.5	15.9	24.5	13.5	2.7	10.2	5.0	16.4	12.7	4.2	22.9	22.2	22.9	18.0	18.5	10.8	4.2	22.3	22.4	15.8	17.4	8.7	20.3	6.4	22.5	14.5	4.4	5.5	10.3	4.7	10.2	13.2	11.3	6.1	22.1	14.7	13.2	10.8	23.0	5.3	13.6	4.1	4.3	12.0	13.9	22.9	4.1	2.6	4.6	1.8	15.3	7.3	2.3	3.1	3.6	4.9	6.1	3.5	4.8	6.3	4.5	6.7	3.0	4.2	6.2	4.5	7.2	3.3	15.3	2.4	4.6	6.9	13.0	4.3	3.4	9.7	6.8	4.5	8.5	4.3	6.7	3.6	2.1	5.0	10.3	11.3	5.7	16.2	2.3	4.0	20.8	4.0	8.0	3.7	9.1	5.2	2.6	2.9	5.9	4.9	16.9	5.2	8.4	7.1	5.4	5.3	11.3	4.9	2.8	2.9	2.0	7.1	5.8	3.3	3.2	15.7	5.4	8.6	6.2	7.3	9.2	6.1	7.0	6.2	4.3	4.1	7.2	7.5	7.8	5.9	8.5	4.8	5.5	4.0	22.4	22.4	23.4	41.5	22.2	22.9	22.3	22.4	22.5	22.1	23.0	22.9	68.3	60.9	44.2	28.7	39.9	53.3	66.4	125.7	34.1	71.4	35.8	43.3	77.0	42.9	75.1	51.5	29.2	110.1	46.4	59.6	125.2	81.2	8.7	40.3	46.7	54.4	33.6	60.0	48.6	59.6	76.9	73.4	32.1	29.7	43.7	49.6	47.8	31.8	77.8	57.2	47.3	48.1	105.8	32.0	38.4	11.6	88.3	47.2	74.7	23.4	52.8	101.4	35.0	40.2	54.6	75.0	29.1	80.1	34.7	59.1	56.3	111.7	67.7	72.0	78.9	54.5	96.6	116.4	60.4	45.7	64.4	156.0	46.1	81.3	41.3	54.6
ACTR6	"ARP6, FLJ13433"	ENSG00000075089	"Actin related protein 6"	Q9GZN1	12	100199122-100241865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038587, HPA038588"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA038587: AB_10670781, HPA038588: AB_10672719"	"unprognostic (1.24e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (7.70e-9)"	"unprognostic (4.11e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.40e-2)"	15.0	16.7	17.6	12.8	17.7	7.4	28.9	18.2	24.5	13.9	17.9	14.6	15.2	15.2	18.1	13.8	14.2	10.3	17.5	18.2	19.8	22.1	19.6	12.2	20.8	18.0	18.6	17.9	5.0	20.8	4.5	17.0	19.1	16.8	15.3	20.6	15.3	15.9	14.3	13.6	14.4	14.4	18.3	16.1	10.6	21.3	17.7	20.4	16.3	15.8	19.2	17.1	4.5	20.8	60.2	23.5	27.1	35.9	22.4	28.3	63.3	26.0	22.6	25.0	18.2	15.2	17.8	32.9	24.7	19.5	18.8	23.0	36.5	22.5	34.3	48.9	33.8	22.8	22.2	17.7	23.6	33.7	17.7	17.4	27.7	20.2	25.8	38.5	28.9	38.0	36.9	10.5	29.2	15.5	33.7	50.8	31.6	22.5	34.2	27.0	27.3	41.4	27.3	35.8	24.8	47.0	35.3	62.5	36.5	22.4	40.6	39.5	18.8	18.4	12.3	20.5	23.7	23.6	55.6	42.8	12.1	21.2	21.7	5.7	6.4	10.0	15.2	11.5	19.3	12.6	17.9	20.3	8.2	12.1	19.4	19.6	3.0	19.4	13.2	12.0	20.5	12.1	17.6	17.7	18.2	24.5	18.2	19.8	18.0	18.6	19.1	18.3	17.7	20.8	33.5	16.0	17.7	6.5	25.8	22.9	36.2	72.4	29.6	32.7	26.5	23.9	34.8	8.6	38.1	23.9	18.8	55.6	36.9	9.9	46.9	21.4	135.2	56.8	27.7	20.7	12.5	21.7	20.9	12.0	68.4	25.0	12.2	28.9	33.0	19.1	16.1	16.4	23.7	33.7	23.2	11.3	73.2	19.1	13.4	34.3	20.2	17.5	32.0	13.1	19.5	27.0	25.7	17.1	17.4	13.2	10.0	22.6	19.7	24.7	11.7	67.9	67.9	32.8	32.9	27.8	36.8	80.8	19.9	23.8	19.7	96.0	36.6	23.8	13.3	33.8
ADAM33	"C20orf153, dJ964F7.1, DKFZp434K0521"	ENSG00000149451	"ADAM metallopeptidase domain 33"	Q9BZ11	20	3667965-3682246	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 280.4"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 40.8;Fibroblasts: 45.2;Leydig cells: 22.7;Microglial cells: 18.7;Smooth muscle cells: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 82.4;ASC TERT1: 104.9;BJ: 38.5;BJ hTERT+: 64.7;fHDF/TERT166: 38.9;U-2197: 50.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low region specificity"	"Detected in all"			"HPA067152, HPA071758"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear speckles"	"HPA067152: AB_2685791, HPA071758: "	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.43e-4)"	"unprognostic (7.14e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.75e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-5)"	"unprognostic (3.10e-3)"	53.3	3.8	7.8	10.5	8.5	0.1	47.4	5.8	12.3	280.4	8.4	157.2	11.0	151.8	19.0	31.6	106.9	32.8	26.7	6.7	9.3	3.9	2.0	18.0	6.2	16.0	8.0	58.7	6.0	0.5	6.9	12.7	16.4	87.0	12.1	1.0	19.6	57.5	9.1	22.0	43.4	53.0	5.9	8.3	44.8	22.5	6.9	0.9	18.4	14.1	2.2	125.4	159.0	6.2	0.0	0.0	0.2	0.0	82.4	104.9	0.2	38.5	64.7	11.2	21.3	0.1	0.0	0.0	0.2	38.9	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.0	13.0	0.0	0.0	18.2	0.0	4.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	2.8	0.2	2.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.1	0.0	0.2	0.0	50.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	8.5	5.8	12.3	6.7	9.3	16.0	8.0	16.4	5.9	6.9	6.2	3.9	0.0	0.0	7.2	0.1	5.5	0.1	0.0	0.6	0.0	0.3	0.3	3.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.5	1.8	40.8	2.4	0.0	0.0	1.3	0.0	0.1	45.2	2.6	1.2	0.0	3.1	1.8	0.0	0.5	0.0	11.4	0.0	0.0	0.3	8.8	0.8	22.7	0.8	3.6	18.7	0.0	2.2	0.0	8.0	0.1	0.0	0.0	10.1	0.0	0.2	0.0	0.9	0.0	0.1	6.6	6.8	17.1	0.7	0.5	0.3	3.1	0.5	0.7	0.0	0.0	0.1
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835755-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 314.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 365.2;Endometrial stromal cells: 235.3;Endothelial cells: 275.9;Extravillous trophoblasts: 240.8;Fibroblasts: 243.9;Sertoli cells: 210.4;Smooth muscle cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"gdT-cell: 4.5;NK-cell: 6.6"	"Group enriched"	"Detected in many"	56	"NK-cells: 6.6;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 382.0;BJ: 451.4;hTEC/SVTERT24-B: 250.0;hTERT-HME1: 248.2;LHCN-M2: 295.3;RPTEC TERT1: 343.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 35.6"	"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4100000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	234.6	46.4	22.2	71.3	24.9	1.4	94.1	20.8	28.9	87.4	22.3	54.6	8.7	97.1	9.0	82.6	161.2	111.8	95.9	21.5	23.5	76.0	39.0	79.7	10.1	24.8	25.5	314.4	29.4	18.5	25.5	245.1	25.2	88.2	59.3	15.6	19.2	13.9	48.9	21.9	44.6	162.6	25.3	13.9	56.0	8.2	26.4	12.2	50.1	40.3	5.4	143.1	50.6	30.5	0.1	0.0	6.8	0.1	382.0	104.9	21.8	451.4	199.6	90.4	61.1	0.0	0.0	0.0	29.5	120.1	2.0	9.2	4.6	23.6	150.0	0.4	120.3	0.0	29.7	0.1	85.6	15.5	0.0	103.0	0.3	250.0	248.2	15.1	35.4	3.7	7.3	0.0	295.3	0.0	1.7	0.3	21.9	0.0	14.5	0.0	151.6	0.6	343.9	25.1	0.2	32.7	21.4	0.0	2.2	16.0	0.2	3.8	34.9	99.6	4.3	156.0	63.1	0.5	0.0	0.0	80.8	0.5	29.7	0.0	0.0	0.0	4.5	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.0	6.6	0.0	0.0	0.0	0.8	22.2	24.9	20.8	28.9	21.5	23.5	24.8	25.5	25.2	25.3	26.4	30.5	365.2	6.4	22.4	2.9	0.5	121.2	32.5	10.4	53.5	0.6	13.9	54.9	179.5	12.8	9.6	57.0	0.0	71.1	13.1	0.2	1.9	47.4	1.4	86.5	235.3	275.9	0.0	0.4	3.2	22.3	240.8	243.9	11.7	148.2	2.5	0.3	157.8	2.2	16.5	0.0	3.3	0.2	2.0	5.0	38.5	4.4	109.0	5.8	53.4	7.5	0.6	52.2	20.6	2.0	19.9	20.6	0.0	41.8	3.6	26.3	0.0	6.3	3.3	3.3	210.4	91.0	452.4	0.4	1.0	22.8	41.6	54.9	10.1	8.8	0.0	16.8
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110853-179345461	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 32.2;Excitatory neurons: 17.9;Fibroblasts: 30.7;Hepatic stellate cells: 17.2;Kupffer cells: 71.4;Sertoli cells: 26.3;Smooth muscle cells: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 35.8;BJ: 31.4;fHDF/TERT166: 39.3;HHSteC: 115.5;HSkMC: 94.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2000000		"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	36.9	10.9	0.8	2.4	4.2	0.3	22.7	0.9	3.5	20.6	0.9	10.5	1.4	21.7	0.5	5.5	15.5	6.1	22.3	0.5	0.9	7.5	15.8	29.6	1.8	4.5	3.3	12.1	5.8	0.4	15.1	9.7	4.2	9.0	1.4	0.2	5.3	1.8	2.9	9.4	11.6	9.1	0.2	38.4	9.3	3.9	2.5	0.4	6.8	0.8	0.6	15.0	16.7	2.2	0.0	0.0	0.1	0.7	36.0	35.8	0.0	31.4	5.4	11.5	12.4	0.1	0.0	0.0	0.2	39.3	0.7	0.1	1.8	0.0	5.1	0.0	1.5	0.0	0.1	2.3	115.5	0.0	0.0	94.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.8	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.9	1.2	0.1	0.0	0.4	1.9	0.0	10.7	0.0	19.1	3.0	24.5	0.0	0.3	0.0	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.8	4.2	0.9	3.5	0.5	0.9	4.5	3.3	4.2	0.2	2.5	2.2	3.3	0.0	1.1	1.6	0.1	2.2	0.4	0.0	2.2	0.3	0.2	5.2	1.5	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.3	0.9	32.2	1.4	0.0	0.0	17.9	0.0	0.3	30.7	0.0	0.8	1.3	6.5	17.2	0.5	5.1	0.0	8.5	0.0	0.0	71.4	4.4	3.4	5.0	10.4	0.0	4.7	0.3	0.1	0.0	3.0	2.4	0.5	0.0	12.8	0.1	0.4	0.0	0.2	0.0	0.0	26.3	4.7	20.4	2.1	4.8	0.2	2.7	0.0	0.4	0.6	0.0	0.1
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 146.7;Endometrial stromal cells: 36.9;Extravillous trophoblasts: 46.4;Fibroblasts: 34.5;Hofbauer cells: 34.0;Syncytiotrophoblasts: 99.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 11.1"	"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 92.0;BEWO: 200.3;HSkMC: 43.8;K-562: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	32.0	5.1	1.1	14.9	1.0	4.2	24.7	0.8	11.1	22.9	7.9	19.3	3.6	20.0	1.6	33.3	29.2	7.7	22.3	0.8	1.4	6.4	17.3	26.1	1.8	4.4	2.8	17.1	3.0	0.5	3.0	62.9	2.9	9.0	3.8	0.6	11.8	3.4	37.7	11.8	13.7	11.4	1.2	5.4	17.2	2.4	3.6	0.8	6.1	47.9	1.2	32.8	23.3	1.5	22.0	0.6	0.3	3.9	19.1	92.0	200.3	20.8	18.0	12.1	7.0	1.8	8.5	0.2	4.3	14.4	0.2	11.0	0.8	3.2	4.9	1.7	0.4	6.2	2.6	8.9	15.3	0.3	3.0	43.8	0.9	3.0	6.8	10.3	0.1	0.0	67.7	0.7	2.2	0.5	0.0	1.1	3.5	0.6	0.7	0.0	0.0	0.1	2.1	0.8	0.1	0.6	6.7	15.9	0.1	10.0	4.5	11.5	3.8	0.7	5.5	8.6	0.3	1.9	0.6	4.5	0.8	4.0	0.5	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.3	1.1	1.0	0.8	11.1	0.8	1.4	4.4	2.8	2.9	1.2	3.6	1.5	2.8	0.0	1.5	1.0	0.5	2.4	2.3	0.2	0.6	1.7	1.3	1.8	2.2	10.0	0.6	0.0	0.0	146.7	1.0	0.2	0.0	1.7	0.6	2.6	36.9	5.3	0.0	0.0	0.3	0.6	46.4	34.5	0.0	5.4	2.5	0.9	1.8	10.6	34.0	0.0	0.1	0.2	0.0	24.0	12.5	0.7	30.1	20.0	3.6	0.0	23.1	1.4	1.0	0.0	0.0	12.3	0.1	3.4	3.2	2.2	0.0	0.2	0.9	2.2	0.0	14.3	3.8	0.1	1.6	5.5	2.8	99.5	1.7	0.5	0.3	2.5
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897900-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;intestine: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 97.7;Intestinal goblet cells: 42.5;Oligodendrocytes: 43.6;Paneth cells: 64.4;Proximal enterocytes: 48.5;Undifferentiated cells: 50.6"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 15.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 108.1;CAPAN-2: 74.1;HMC-1: 71.0;OE19: 191.5;THP-1: 122.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	4.9	3.8	51.2	11.2	55.8	9.8	3.4	57.3	73.6	4.1	11.2	43.2	19.7	6.0	0.6	9.0	8.8	6.0	8.1	59.4	42.9	22.3	3.6	10.4	3.8	63.5	63.1	1.5	13.3	6.1	4.7	2.7	56.9	6.6	22.8	1.6	4.6	2.9	0.7	3.9	26.8	8.3	48.7	17.2	19.6	1.1	55.4	0.9	7.6	0.5	2.1	8.9	3.8	85.9	108.1	4.0	0.1	3.7	1.4	0.2	1.1	3.6	0.1	0.7	0.1	43.1	74.1	0.2	10.3	0.5	0.2	44.5	5.9	8.1	0.5	0.6	4.7	0.0	6.0	25.4	1.7	0.7	71.0	1.8	21.4	0.2	0.0	0.1	0.0	3.1	0.4	0.0	0.0	33.2	0.1	30.1	3.2	191.5	0.0	14.4	0.2	0.4	4.7	25.0	3.1	1.0	3.3	1.3	0.5	0.4	25.9	122.6	0.6	0.8	2.8	0.1	0.3	0.0	0.2	0.0	0.2	22.3	3.3	1.0	6.5	3.3	6.0	7.3	2.8	1.1	1.6	5.5	5.1	0.9	0.5	2.6	3.1	1.6	11.7	0.3	0.8	4.0	51.2	55.8	57.3	73.6	59.4	42.9	63.5	63.1	56.9	48.7	55.4	85.9	0.4	0.0	10.3	2.9	3.6	1.0	2.9	3.3	2.8	4.7	2.5	1.5	8.5	7.2	2.9	7.3	0.0	0.3	19.4	97.7	9.8	3.9	0.2	8.6	0.9	0.5	16.2	0.0	13.2	4.6	0.9	1.5	17.9	7.6	7.0	1.3	0.0	0.6	12.2	0.0	12.6	42.5	4.1	23.0	15.7	0.4	0.0	22.1	10.6	2.8	13.2	1.3	15.5	3.0	43.6	17.5	64.4	0.0	2.6	3.0	48.5	7.1	8.2	1.1	0.0	0.1	1.9	0.3	1.2	1.1	1.3	0.7	9.0	0.0	50.6	5.5
ADCK5	FLJ35454	ENSG00000173137	"AarF domain containing kinase 5"	Q3MIX3	8	144373101-144393242	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 61.7;Theca cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025692, HPA028679"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA025692: AB_10599486, HPA028679: AB_10600226"	"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.31e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.90e-2)"	3.1	9.1	1.3	1.5	1.3	0.9	3.4	1.1	2.6	4.5	0.9	6.7	4.8	3.7	0.2	6.4	3.7	0.5	4.1	1.4	1.1	4.3	6.4	2.8	1.1	1.4	1.1	4.5	5.0	0.8	3.5	0.6	1.3	4.1	0.7	0.5	4.1	0.8	4.0	5.2	8.4	0.4	0.9	5.7	4.4	6.7	1.2	1.1	3.6	0.7	0.5	4.0	4.2	1.2	2.5	3.1	0.7	2.1	0.5	0.5	3.7	2.2	1.2	1.8	0.7	3.6	2.7	1.1	1.5	0.5	0.6	3.2	0.1	2.2	0.1	2.8	1.0	2.9	2.6	3.9	1.6	0.7	2.2	1.0	1.4	0.6	0.7	0.9	1.2	2.1	1.9	1.9	0.9	6.9	2.2	2.9	0.4	2.3	2.3	2.8	1.0	2.0	1.2	2.3	0.4	1.1	3.1	2.4	1.8	0.5	2.1	1.9	0.8	0.8	3.2	2.2	1.5	0.9	0.3	1.0	1.9	2.5	1.3	0.9	2.0	1.2	1.1	2.7	1.3	0.9	1.3	0.8	3.2	2.7	1.3	0.7	0.4	1.0	2.7	2.0	2.1	1.3	1.3	1.3	1.1	2.6	1.4	1.1	1.4	1.1	1.3	0.9	1.2	1.2	5.8	3.2	1.7	4.9	6.5	4.1	3.3	10.2	2.2	10.3	5.0	6.1	2.3	7.2	6.9	5.5	16.7	4.3	6.6	33.5	3.9	9.3	8.2	3.7	4.2	5.0	8.4	3.0	7.6	7.1	11.2	4.5	20.4	4.8	8.9	16.2	2.5	8.2	8.0	3.3	8.3	31.2	12.2	5.5	4.3	11.3	5.9	5.0	3.6	2.8	9.1	6.4	7.2	4.0	2.4	9.5	16.8	7.2	3.7	2.7	61.7	6.9	9.5	16.3	13.1	2.5	4.4	26.5	19.2	4.7	5.1	2.5	4.8	42.3	25.4	3.1
ADGRG7	"FLJ14454, GPR128"	ENSG00000144820	"Adhesion G protein-coupled receptor G7"	Q96K78	3	100609601-100695479	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 42.9;liver: 24.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 23.9;Paneth cells: 14.0;Proximal enterocytes: 39.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056451			Approved	"Plasma membrane"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA056451: "		"unprognostic (1.65e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.79e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"			"unprognostic (9.37e-3)"		"unprognostic (2.84e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"		"unprognostic (6.77e-2)"	0.1	0.1	0.0	0.9	0.0	2.2	0.1	0.2	0.1	0.5	0.0	5.2	42.9	0.3	0.0	0.2	0.6	0.7	0.2	0.0	0.0	0.1	24.7	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.2	2.9	0.2	0.1	0.0	0.1	0.2	39.3	1.5	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.2	5.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0
ADGRL2	"KIAA0786, LEC1, LPHH1, LPHN2"	ENSG00000117114	"Adhesion G protein-coupled receptor L2"	O95490	1	81306147-81992436	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"Excitatory neurons: 902.7;Inhibitory neurons: 646.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 252.8;hTEC/SVTERT24-B: 130.3;NTERA-2: 100.0;SH-SY5Y: 168.3;U-2197: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043447			Approved	"Plasma membrane"		NA	NA		700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA043447: AB_2678486"	"unprognostic (2.54e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.81e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.76e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.41e-2)"	19.8	19.9	11.0	8.2	13.4	0.0	17.8	6.5	26.3	16.4	5.0	15.3	5.8	12.4	15.0	23.6	23.1	23.1	28.5	13.9	14.6	21.4	38.5	64.9	8.9	8.6	10.7	36.3	9.7	27.5	20.5	48.8	7.6	30.0	10.9	25.2	36.7	19.4	4.4	12.9	13.4	12.7	7.0	19.9	15.5	4.2	15.5	10.4	43.2	19.7	8.7	13.2	23.4	15.0	18.2	9.9	252.8	0.0	30.3	35.3	3.4	6.4	14.8	2.5	2.9	0.0	0.0	0.1	69.6	34.6	7.1	10.1	20.3	28.0	2.3	0.5	41.5	0.0	7.0	16.6	11.8	0.0	0.4	32.5	1.8	130.3	12.9	17.8	42.9	0.0	0.0	0.0	3.4	0.2	0.0	0.1	100.0	0.0	7.1	0.0	34.9	0.0	56.9	3.8	11.7	168.3	0.0	6.3	0.0	73.5	0.4	74.7	27.5	26.0	28.9	118.9	9.3	0.0	0.0	0.2	14.9	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	13.4	6.5	26.3	13.9	14.6	8.6	10.7	7.6	7.0	15.5	15.0	25.3	3.2	2.2	23.8	0.2	0.0	7.0	0.0	2.2	48.5	6.6	11.2	44.1	10.0	3.1	5.5	6.2	0.4	0.1	2.1	0.0	4.7	1.4	11.7	10.3	36.9	0.0	0.0	902.7	1.6	0.4	19.6	0.5	25.4	0.0	32.3	30.0	39.3	0.9	33.7	646.8	2.0	0.0	3.1	0.0	1.4	23.3	1.1	0.0	69.3	0.0	19.0	0.0	11.1	13.0	0.8	3.6	17.7	0.0	10.4	0.0	7.8	0.0	3.9	19.7	2.5	19.8	1.5	3.5	4.1	0.0	0.4	0.5	43.1	3.5	3.0
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	306	"liver: 2739.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	8.9	0.3	0.5	0.1	0.5	6.6	0.3	0.0	0.0	0.7	2739.1	0.8	0.0	0.1	0.1	0.1	1.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1501.5;liver: 5858.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1501.5	140.2	2.2	36.4	3.4	0.1	924.6	1.9	9.0	41.0	13.5	202.2	38.5	161.4	74.8	105.8	385.0	145.1	215.3	2.0	1.9	66.7	5858.7	373.2	25.8	4.7	2.2	117.7	49.1	7.8	24.2	6.8	3.2	26.7	114.7	0.1	67.9	26.7	66.6	159.2	237.1	73.4	4.4	72.7	141.1	2.8	2.2	19.8	94.5	228.2	16.0	287.9	118.7	2.4	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	1.9	9.0	2.0	1.9	4.7	2.2	3.2	4.4	2.2	2.4	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 196.3"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 89.0;Club cells: 64.1;Squamous epithelial cells: 209.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 1.0;HaCaT: 1.2"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	196.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.2	0.0	0.0	38.1	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	89.0	21.1	0.0	0.0	0.0	0.2	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	18.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.6	0.0	0.0	26.2	0.0	0.0	0.0	2.3	0.0	0.0	209.1	0.0	0.0	0.0	0.0	0.0	1.0
ADSS2	ADSS	ENSG00000035687	"Adenylosuccinate synthase 2"	P30520	1	244408494-244451909	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.4;Cytotrophoblasts: 49.3;dendritic cells: 59.6;Extravillous trophoblasts: 97.2;Hofbauer cells: 35.8;Syncytiotrophoblasts: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		690000	"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.8	20.5	17.8	28.1	22.0	43.9	34.6	21.7	26.7	25.9	17.0	28.7	28.7	23.4	29.8	32.6	23.9	21.0	8.9	19.2	21.1	32.9	24.3	25.3	31.9	21.9	19.6	21.7	19.8	27.6	14.5	28.6	23.1	25.3	29.8	11.4	22.8	25.6	10.8	33.2	27.1	25.2	19.6	23.7	35.0	70.3	20.9	33.8	34.9	8.4	34.9	36.2	21.5	28.7	89.9	48.6	41.6	36.9	47.6	67.8	76.2	88.5	74.4	62.3	47.0	64.6	84.5	79.7	57.1	68.9	26.6	66.1	45.9	58.0	69.5	59.6	81.0	53.1	47.8	49.3	57.1	127.1	65.6	46.8	68.5	58.1	58.3	72.1	225.6	43.3	94.0	57.7	62.7	21.6	82.3	85.0	110.5	85.0	53.1	74.9	39.4	86.5	103.8	55.2	56.2	49.2	75.2	69.0	91.4	43.9	48.0	66.7	99.4	57.1	31.3	67.0	93.7	69.1	97.2	60.0	47.2	146.8	86.3	48.3	22.8	20.0	20.4	29.9	22.0	15.3	18.6	17.8	20.1	12.3	15.6	17.9	17.5	23.6	33.6	7.9	22.3	18.8	17.8	22.0	21.7	26.7	19.2	21.1	21.9	19.6	23.1	19.6	20.9	28.7	26.4	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	49.3	59.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	97.2	9.3	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	54.0	11.0	0.0	0.0	0.0
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294991-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 6.4;Distal tubular cells: 9.8;Hofbauer cells: 5.7;Proximal tubular cells: 6.3;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	1.8	2.1	2.2	1.3	2.7	2.1	2.2	2.0	3.3	1.7	2.7	2.6	4.2	1.5	1.9	1.6	2.2	1.5	4.6	1.7	1.9	5.0	3.7	1.7	1.8	1.8	2.0	1.7	2.1	5.4	1.5	2.2	2.0	1.6	3.1	3.1	1.8	1.7	3.7	1.2	3.0	1.7	1.7	2.0	2.8	10.7	2.7	2.3	3.0	4.0	2.1	1.7	1.1	3.2	2.7	1.4	3.4	6.1	3.5	5.1	3.3	3.0	4.4	4.8	4.7	5.7	3.3	4.8	3.8	4.7	5.8	1.5	4.4	4.5	5.4	2.8	2.6	5.7	1.8	6.6	3.5	5.3	2.7	4.7	3.6	3.6	5.8	3.1	2.6	3.5	5.9	2.2	4.5	2.6	0.9	4.8	2.2	4.6	2.8	3.3	4.6	2.8	6.1	2.9	3.7	3.2	2.4	3.5	6.4	4.5	2.8	9.8	3.2	2.9	0.7	2.6	3.4	1.5	2.6	3.7	3.6	6.0	4.5	0.0	1.6	2.8	1.0	1.2	1.3	2.5	1.5	1.9	1.4	3.4	2.1	1.4	0.4	2.4	4.3	1.6	2.3	0.7	2.2	2.7	2.0	3.3	1.7	1.9	1.8	2.0	2.0	1.7	2.7	3.2	2.4	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	5.0	3.7	0.0	6.4	1.1	0.0	9.8	3.1	0.0	2.6	2.6	2.2	0.0	0.0	0.0	3.8	4.6	1.2	0.0	1.8	2.5	5.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	6.3	5.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	0.9	4.5	0.0	0.0
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020120-1056118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		20000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	11.4	2.7	8.7	4.3	5.5	2.0	14.7	0.1	13.9	14.4	8.9	10.9	7.9	13.7	1.8	15.6	14.6	7.3	9.9	5.8	0.0	44.0	13.3	19.8	1.6	16.0	1.4	5.5	28.0	3.9	8.3	5.1	6.1	14.4	1.5	0.8	24.8	8.2	4.2	16.5	9.6	2.9	2.2	6.3	13.4	9.7	7.9	2.6	34.7	2.0	1.6	16.2	11.6	9.9	124.3	75.1	11.1	42.7	2.4	3.0	122.1	61.4	19.6	39.7	24.5	60.6	205.3	2.3	236.9	9.6	19.3	210.1	4.1	75.6	4.7	4.4	28.6	0.2	102.1	54.2	17.1	1.8	23.1	10.5	32.2	12.6	27.7	55.9	7.2	1.7	25.7	0.7	3.5	93.0	0.8	17.6	28.4	39.7	54.5	20.1	27.0	18.5	70.0	51.4	2.4	25.9	124.8	129.1	121.9	12.7	114.8	7.4	107.8	47.7	169.0	6.4	50.6	1.2	0.6	3.5	30.4	10.8	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	5.5	0.1	13.9	5.8	0.0	16.0	1.4	6.1	2.2	7.9	9.9	27.4	25.6	8.8	15.0	2.2	15.0	9.2	94.5	19.9	1.4	32.7	39.2	3.1	61.5	42.0	156.3	8.4	1.6	0.9	29.9	1.9	91.2	0.4	37.2	14.0	29.0	6.7	1.7	23.1	16.9	4.8	8.7	17.9	62.7	2.5	7.2	21.8	13.1	4.1	5.0	7.8	11.6	36.7	2.9	10.1	1.0	5.6	4.3	24.9	12.2	15.6	10.5	0.0	15.1	29.6	87.3	17.7	2.6	0.6	22.3	18.1	16.0	33.0	5.3	6.6	3.3	23.3	0.8	11.4	11.7	6.0	1.2	2.9	2.3	18.3	21.2
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 173.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Plasma membrane, Cytosol"	"HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.92e-4)"	39.6	13.5	7.5	6.3	8.1	1.9	31.2	7.3	8.0	6.9	8.6	12.9	9.3	7.8	9.0	13.3	6.8	5.0	17.0	6.9	7.7	10.4	21.9	9.3	5.1	8.2	7.3	7.9	5.0	3.2	5.6	4.1	6.9	9.9	7.1	2.4	7.6	7.7	9.8	5.6	11.5	5.0	6.2	7.7	9.9	3.9	8.3	2.4	14.6	7.3	3.6	12.0	6.3	6.5	26.5	45.2	1.1	11.3	26.2	9.8	0.3	10.4	25.5	21.0	23.6	35.3	49.8	3.8	25.8	14.5	27.5	27.9	12.7	3.8	5.9	50.8	1.9	0.2	27.3	173.3	56.1	0.3	6.4	13.3	8.4	33.8	7.2	13.2	9.5	1.7	20.5	21.9	11.0	33.5	1.2	1.3	4.5	21.2	14.6	0.8	4.2	12.4	11.4	19.2	3.6	0.8	19.1	16.6	29.8	1.8	0.7	7.2	12.0	0.5	25.3	15.6	30.8	16.2	32.7	7.3	14.0	0.9	13.9	1.0	0.5	0.5	1.8	0.5	1.5	1.7	0.6	1.5	0.4	1.5	0.8	1.3	0.5	4.0	0.5	0.2	1.3	0.7	7.5	8.1	7.3	8.0	6.9	7.7	8.2	7.3	6.9	6.2	8.3	6.5	11.6	6.4	14.1	7.2	5.0	2.3	15.0	8.4	2.8	5.7	5.5	4.7	13.8	8.6	10.5	18.4	0.0	13.9	1.4	53.1	3.9	40.7	24.1	6.0	7.7	4.8	12.0	7.0	8.2	21.9	3.0	11.2	14.3	6.2	11.4	22.3	1.8	25.0	10.2	1.7	5.2	7.1	14.2	3.3	3.3	47.0	5.3	6.7	8.8	4.7	34.4	4.8	1.0	5.5	3.5	40.8	22.7	4.5	17.0	14.6	28.7	22.6	9.5	2.1	19.7	11.8	12.8	6.2	3.9	5.1	1.4	18.6	3.8	8.8	13.7	20.4
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 84.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	11.4	13.3	10.5	12.3	12.4	10.6	12.3	11.4	13.6	11.5	15.1	11.4	9.5	12.4	8.8	10.6	10.4	10.7	7.4	11.3	11.6	13.1	8.1	11.0	16.0	9.9	10.7	13.5	8.4	15.1	7.5	12.2	10.6	10.9	11.6	15.3	9.8	11.7	7.2	9.5	10.1	13.3	10.4	14.9	11.1	14.2	13.8	14.1	15.1	9.4	12.5	11.3	10.2	14.7	18.1	21.3	13.9	9.7	18.0	22.5	25.7	20.6	21.9	22.4	26.7	23.2	10.6	15.4	13.6	16.4	19.4	18.8	18.1	17.2	30.4	12.8	15.4	13.2	20.2	11.4	17.0	9.7	20.7	19.1	21.1	20.5	25.1	25.0	18.3	18.5	8.6	7.5	23.6	13.1	18.1	14.3	9.1	25.1	7.2	11.8	45.5	8.1	18.7	11.3	4.7	14.1	23.6	11.0	19.7	84.8	26.7	10.7	16.1	17.2	14.2	14.8	19.3	9.3	10.7	18.8	22.8	11.5	17.0	4.9	9.7	12.6	8.6	14.4	8.0	8.4	8.4	9.4	8.5	9.2	10.0	8.9	33.8	7.6	13.9	6.3	7.1	4.3	10.5	12.4	11.4	13.6	11.3	11.6	9.9	10.7	10.6	10.4	13.8	14.7	13.4	3.2	12.3	71.2	24.4	7.0	9.7	8.9	10.2	24.6	11.1	9.0	8.4	21.5	11.9	5.5	16.7	14.9	16.8	15.8	1.9	9.9	12.8	11.0	14.8	12.6	7.2	15.2	55.1	7.2	11.1	11.7	14.8	10.8	10.1	18.0	16.8	13.6	16.5	33.7	54.6	9.9	12.2	35.1	10.5	13.9	15.2	21.4	5.4	61.8	32.3	11.7	25.7	51.8	78.5	7.9	15.2	13.9	11.2	15.6	14.6	5.7	15.3	23.2	19.7	10.5	11.2	23.1	23.6	11.0	7.7	14.0	19.0	15.6	11.8	12.1
AL139300.1		ENSG00000256500	"Novel protein"		14	103562962-103685924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.7;tongue: 16.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;granulocytes: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA044617, HPA052450"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044617: AB_2679024, HPA052450: AB_2681838"					"unprognostic (1.56e-1)"													4.3	2.6	0.9	2.9	1.0	0.8	1.3	0.9	5.2	1.2	0.2	1.4	0.0	0.8	0.2	1.6	0.9	0.1	12.8	1.4	1.6	0.5	0.5	1.0	1.6	1.0	1.7	1.0	2.5	7.5	3.8	0.1	1.6	1.4	0.0	3.5	1.6	1.1	31.7	0.6	0.7	3.1	0.7	0.4	0.7	9.4	1.1	2.9	0.1	16.5	1.7	3.4	0.5	1.2	8.1	15.9	18.5	0.6	8.2	7.8	5.6	25.7	19.7	29.3	17.0	9.5	12.1	22.0	17.2	19.2	19.3	5.5	12.4	13.3	17.4	6.7	0.0	8.7	6.1	8.7	9.7	10.8	3.4	8.6	0.6	13.5	11.0	14.5	15.2	13.7	11.6	3.4	21.4	15.4	18.9	1.2	12.1	19.5	13.9	7.7	12.1	11.4	13.6	9.0	22.1	12.2	14.6	5.7	12.1	6.2	13.0	6.6	8.4	11.3	9.2	16.9	10.4	6.4	8.6	25.6	19.6	3.4	9.8	0.2	0.8	1.1	0.5	1.3	0.7	0.3	0.7	0.9	0.4	1.3	1.0	0.4	0.7	0.6	1.6	1.5	1.4	0.3	0.9	1.0	0.9	5.2	1.4	1.6	1.0	1.7	1.6	0.7	1.1	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL353671.1		ENSG00000288684	"Novel protein"		9	32455323-32552603	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.4"	"Low cell line specificity"	"Detected in some"											"HPA047193, HPA073217"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 36: HEL - Hemostasis"		"Plasma membrane, Cytosol"		"HPA047193: AB_2679978, HPA073217: "																		0.7	0.1	0.5	0.3	0.5	0.2	0.2	0.4	0.5	0.4	0.5	0.3	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.3	0.6	0.3	0.5	0.2	0.0	0.9	0.9	0.1	0.0	0.8		0.1	0.9	0.2	0.2	0.0	0.2	0.4	0.4	0.2	0.3	0.2	0.5	0.2	0.2	0.1	0.8	0.5	0.1	0.5	0.1	0.2		0.9	0.3	0.5	0.6	0.1	0.8	0.7	0.2	1.4	0.7	0.7	1.4	0.7	0.0	0.4	0.2	0.6	0.9	0.1	0.2	0.7	0.0	1.3	0.4	1.8	0.7	0.0	0.4	0.8	0.1	0.7	0.5	0.6	1.0	0.8	1.1	1.3	0.2	0.1	0.7	0.0	0.3	0.7	0.3	0.9	0.1	1.4	0.3	0.1	0.3	0.7	0.6	1.4	0.5	0.2	0.2	0.1	0.1	0.0	0.5	0.6	0.5	0.6	0.4	0.3	0.5	0.4	0.4	0.2	0.0	1.7	0.4	1.6	0.5	0.4	0.3	0.5	0.5	0.6	0.3	0.3	0.6	0.5	5.4	0.4	0.3	0.1	0.8	0.3	0.5	0.5	0.4	0.5	0.3	0.6	0.9	0.9	0.9	0.5	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL357075.4		ENSG00000288520	"Novel protein"	G9CGD6	6	154159828-154510114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;HMC-1: 1.0"									"HPA028708, HPA028710, HPA049651"	Uncertain		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA					"Cluster 3: HMC-1 - Innate immune response"		"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442, HPA049651: AB_2680841"																		0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.4	0.5	0.5	0.3	0.5	0.7	0.1	1.0	0.4	0.3	0.2	0.0	0.2	0.8	0.6	0.2	0.0	0.3	0.2	0.5	1.4	0.0		0.5	0.3	0.4	0.3	0.1	0.0	0.3	0.0	0.0	0.6	0.6	0.3	0.5	0.3	0.6	0.2	0.0	0.2	0.0	0.4	0.5		0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL358113.1		ENSG00000285130	"Novel protein"		9	69035747-69255187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.6;Endometrial ciliated cells: 3.8;Glandular and luminal cells: 3.8;Respiratory ciliated cells: 1.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"									"HPA001813, HPA068304, HPA070714"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"		"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161"																		0.0	0.3	0.1	0.4	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.6	0.0		0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0		0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.7	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.8	0.5	0.1	0.1	0.1	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	3.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.8	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 496.1;salivary gland: 128.0;stomach 1: 224.8"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 389.5;Basal squamous epithelial cells: 274.3;Club cells: 150.1;Gastric mucus-secreting cells: 437.9;Respiratory ciliated cells: 412.7;Squamous epithelial cells: 342.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.4;lung cancer: 60.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"A549: 5094.7;OE19: 6071.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		52000	"Cluster 22: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	1.7	1.0	0.4	1.3	0.7	0.1	3.2	0.3	0.4	6.7	17.5	4.5	6.2	0.3	0.2	496.1	5.5	10.3	0.3	1.0	0.4	1.3	1.9	10.9	0.5	0.6	2.1	0.4	0.5	0.0	0.9	0.0	0.5	1.9	3.3	0.1	128.0	1.5	1.3	72.6	3.5	0.4	0.9	0.9	224.8	1.6	1.3	0.6	0.5	0.3	33.7	6.2	22.3	0.9	0.1	5094.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	10.7	246.5	0.0	2.7	0.5	2.0	29.3	0.7	12.8	0.0	0.0	0.8	0.1	116.6	1.0	0.3	0.1	0.5	0.0	14.9	0.5	0.4	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.1	0.3	0.4	6071.6	19.8	0.0	0.0	0.0	0.0	87.0	0.2	0.6	24.8	0.0	0.0	0.2	0.2	0.9	0.6	0.3	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.4	1.0	0.4	0.6	2.1	0.5	0.9	1.3	0.9	0.7	3.2	5.5	0.0	0.7	44.1	46.8	389.5	274.3	0.0	0.1	1.5	0.4	2.8	150.1	0.0	0.0	0.0	0.0	5.1	0.0	1.4	1.5	12.4	0.2	1.3	1.8	0.0	0.1	0.5	0.0	1.6	437.9	0.8	2.5	0.3	1.4	3.2	0.2	0.0	0.0	4.8	83.4	0.3	1.8	5.2	0.9	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	9.5	4.7	1.9	3.2	5.8	3.4	5.0	412.7	0.2	0.0	1.7	20.1	1.7	8.6	342.2	32.0	0.0	0.5	0.2	8.4	64.3
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"skin 1: 56.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.1;Pancreatic endocrine cells: 6.3;Prostatic glandular cells: 1.8;Spermatocytes: 1.8;Spermatogonia: 1.7;Suprabasal keratinocytes: 1.8"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 3.9;melanoma: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.4;HBEC3-KT: 10.1;hTCEpi: 7.3;hTERT-HME1: 13.7;T-47d: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.0	0.0	0.5	0.0	0.3	0.0	1.6	1.9	2.1	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.4	0.2	0.1	0.7	0.1	0.0	0.1	0.3	0.0	0.1	56.2	0.0	0.0	0.1	0.0	0.0	0.8	1.0	0.0	0.0	0.0	1.2	0.0	1.8	0.5	6.4	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.1	0.5	0.2	0.2	0.1	2.9	0.4	0.8	10.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.3	0.1	13.7	0.0	0.0	0.9	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	0.0	4.4	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.9	2.1	0.7	0.4	0.8	0.7	0.7	0.1	1.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	2.1	1.2	0.0	0.0	0.6	0.5	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.4	0.1	0.1	0.2	0.0	0.0	1.2	0.9	1.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	1.7	0.3	1.8	1.1	0.0	0.0	0.0	0.6
ALPG	"ALPPL2, GCAP"	ENSG00000163286	"Alkaline phosphatase, germ cell"	P10696	2	232406844-232410714	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 33.9;HaCaT: 24.9;SuSa: 38.3"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.7	33.9	0.0	0.0	0.0	0.0	24.9	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ALPI	IAP	ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456125-232460753	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	138	"intestine: 141.2"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 290.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"CACO-2: 4.8"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		130000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	141.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	128.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	290.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0
ALPP	"PALP, PLAP"	ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378724-232382889	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix: 17.8;placenta: 34.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 12.8;Glandular and luminal cells: 5.0;Syncytiotrophoblasts: 6.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 381.0;SiHa: 103.6"									"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	17.8	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	34.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	42.9	0.0	0.1	0.0	0.1	381.0	0.0	0.0	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	103.6	35.3	0.0	3.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	6.7	0.1	0.2	0.0	0.0
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986165-34008104	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 134.3;liver: 180.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5"	"Group enriched"	"Detected in all"	4	"liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 175.4;U-266/84: 98.0"	"Low region specificity"	"Detected in all"							"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		70000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	8.6	15.0	5.9	5.0	5.5	3.0	6.4	4.6	6.0	6.5	4.6	40.0	18.0	4.7	9.6	15.6	6.2	20.5	10.1	5.4	7.8	134.3	180.6	9.2	3.6	5.9	6.4	7.8	13.8	13.0	5.7	7.7	6.6	39.3	42.9	12.0	60.7	12.5	19.2	4.9	15.9	7.0	5.8	5.4	34.8	4.3	8.4	4.8	8.3	14.9	5.6	8.8	8.5	5.8	12.7	20.2	11.1	14.3	7.7	11.9	19.1	16.6	12.2	7.6	5.7	66.1	15.1	4.1	8.7	23.6	28.6	5.8	2.8	12.0	7.7	12.7	10.9	9.8	13.7	19.0	5.4	6.0	3.0	18.1	6.0	9.7	3.6	10.7	8.5	8.3	3.8	14.7	22.4	9.6	5.0	7.6	10.0	9.4	32.9	6.0	18.6	6.5	33.2	62.4	6.1	8.7	27.6	19.3	16.9	9.1	14.9	5.9	15.6	24.6	5.4	6.2	13.6	175.4	98.0	7.4	7.0	12.1	18.8	0.3	6.0	9.3	8.3	8.0	7.0	7.1	7.2	6.4	8.9	5.2	6.6	4.8	10.0	8.7	14.2	4.6	7.9	6.0	5.9	5.5	4.6	6.0	5.4	7.8	5.9	6.4	6.6	5.8	8.4	5.8	0.8	3.2	4.1	0.0	2.2	0.4	0.4	0.9	1.8	4.3	1.4	0.9	1.1	8.6	3.7	1.8	0.0	1.0	2.2	19.7	5.9	0.8	8.9	2.3	1.2	3.0	4.2	2.1	0.0	3.8	1.0	2.9	4.1	1.5	0.0	1.2	1.1	21.6	1.1	5.0	0.0	5.1	4.1	0.9	0.2	21.6	0.6	1.2	0.0	0.0	1.5	9.3	3.1	0.0	0.0	2.6	4.5	2.2	1.6	0.6	4.7	38.5	3.1	0.9	0.0	1.7	3.7	0.7	0.7	3.4	0.6	0.3	1.5	1.2	4.4	0.4
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7;skeletal muscle: 27.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.7	8.2	6.5	11.2	6.1	0.4	5.5	11.8	0.3	6.9	1.4	5.1	3.0	0.4	2.6	0.7	1.7	1.7	7.6	6.9	5.8	60.7	2.3	4.4	15.5	8.6	1.4	3.3	0.7	0.5	2.0	9.5	2.8	0.2	1.8	2.0	0.2	27.3	5.8	5.0	0.6	2.7	5.9	4.8	13.1	8.0	0.6	0.9	0.9	0.4	0.3	0.2	15.4	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.2	11.2	5.5	11.8	7.6	6.9	15.5	8.6	9.5	2.7	8.0	15.4	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
AMIGO2	"ALI1, DEGA"	ENSG00000139211	"Adhesion molecule with Ig like domain 2"	Q86SJ2	12	47075707-47079959	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 62.6;Enteroendocrine cells: 60.4;Glandular and luminal cells: 72.8;Granulosa cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 192.0;fHDF/TERT166: 183.2;hTERT-RPE1: 312.2;LHCN-M2: 179.2;RT4: 251.9;U-2 OS: 149.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054004, HPA059601"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	Yes		390000	"Cluster 32: T-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA054004: AB_2682339, HPA059601: AB_2684078"	"unprognostic (2.63e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.29e-3)"	10.8	19.8	4.5	7.0	4.9	3.5	22.8	3.6	5.4	20.3	2.3	39.4	3.3	30.7	7.9	4.0	36.4	19.3	5.6	3.2	8.8	7.7	4.6	20.0	12.4	9.1	37.9	28.7	3.6	6.4	5.3	13.2	19.6	11.3	9.0	25.7	4.5	11.0	1.1	4.4	12.6	34.3	4.3	17.4	5.5	10.7	13.1	2.8	4.2	2.2	7.6	22.6	14.3	3.9	44.4	105.5	6.3	0.2	2.5	0.2	17.2	14.8	39.3	4.7	3.8	0.3	192.0	0.0	47.6	183.2	117.0	64.8	0.0	117.6	5.5	8.6	0.7	0.0	11.0	0.1	3.8	1.2	1.7	0.9	20.1	122.6	59.5	312.2	15.0	0.9	8.5	0.0	179.2	2.1	3.6	0.1	4.5	21.2	27.1	0.3	46.5	0.1	52.3	251.9	18.8	0.0	76.2	9.0	0.5	3.4	11.2	1.0	4.1	2.6	149.9	1.7	121.3	1.9	0.4	0.2	10.0	3.4	2.8	0.0	0.1	0.0	4.4	0.2	6.0	3.7	6.8	6.9	0.7	1.6	15.3	12.1	0.1	8.6	0.0	8.8	4.4	4.7	4.5	4.9	3.6	5.4	3.2	8.8	9.1	37.9	19.6	4.3	13.1	3.9	7.2	9.6	3.1	1.0	3.6	2.4	13.1	39.4	15.4	62.6	10.8	37.7	1.6	1.5	4.9	1.8	0.0	1.0	12.4	0.4	1.9	5.3	1.4	31.5	6.0	12.7	60.4	5.7	2.6	19.3	28.1	11.1	0.5	72.8	7.0	76.8	32.2	1.2	4.8	0.0	0.2	3.1	2.0	3.5	1.1	2.3	2.5	7.2	1.8	1.9	5.3	15.6	2.1	0.0	0.1	40.4	1.5	0.7	3.8	10.7	0.0	0.1	2.9	4.9	0.0	3.2	27.7	0.7	2.4	2.5	0.4	8.5	7.6	12.8	0.3	33.9
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631420	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 48.9;pituitary gland: 21.3;retina: 65.9"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 72.2;Cone photoreceptor cells: 87.6;Excitatory neurons: 228.2;Inhibitory neurons: 198.4;Oligodendrocyte precursor cells: 96.5;Rod photoreceptor cells: 59.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 64.6;ASC TERT1: 37.8;BJ hTERT+ SV40 Large T+: 25.4;BJ hTERT+ SV40 Large T+ RasG12V: 29.9;GAMG: 44.8;HBF TERT88: 23.1;U-138 MG: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	6.5	1.3	19.2	1.5	21.9	0.0	5.9	7.2	48.9	5.8	0.0	3.7	0.5	4.0	3.4	3.2	4.7	3.0	5.4	27.3	28.8	2.6	0.4	1.0	0.4	11.2	0.8	0.9	1.8	0.3	21.3	0.0	10.9	1.4	1.4	65.9	2.5	2.9	3.6	1.3	1.8	3.8	7.9	1.9	2.8	2.5	5.4	0.7	1.7	9.6	0.2	2.4	2.9	17.5	0.0	0.0	16.7	0.0	64.6	37.8	0.0	2.4	0.0	25.4	29.9	0.0	0.0	0.0	0.0	4.8	44.8	0.0	0.0	0.0	23.1	0.0	2.0	0.2	0.0	0.0	0.0	0.3	0.1	22.4	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.5	0.1	0.3	0.0	0.3	8.5	0.0	0.0	0.0	0.0	1.9	0.0	0.1	4.9	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0	24.6	17.1	8.8	9.8	0.1	0.3	0.0	16.8	0.3	22.6	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.4	0.0	0.0	19.2	21.9	7.2	48.9	27.3	28.8	11.2	0.8	10.9	7.9	5.4	17.5	0.8	0.0	0.0	22.5	0.6	0.3	0.1	0.0	0.0	72.2	3.1	2.2	7.9	0.0	0.0	0.0	87.6	0.0	0.3	0.0	1.9	0.3	9.9	0.4	3.2	1.1	0.0	0.0	228.2	0.0	0.0	8.6	0.0	0.3	0.0	0.2	3.9	0.1	0.1	1.7	198.4	0.0	0.0	13.0	1.1	15.0	2.8	0.7	0.0	22.5	0.5	7.6	3.1	96.5	5.5	0.1	0.0	4.9	0.1	0.0	0.0	0.0	0.0	59.4	6.6	8.3	8.4	4.7	2.8	0.0	0.3	0.0	0.6	2.0	0.0	0.0
ANKEF1	"ANKRD5, dJ839B4.6, FLJ21669"	ENSG00000132623	"Ankyrin repeat and EF-hand domain containing 1"	Q9NU02	20	9986126-10058303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.0;testis: 14.6"	"Group enriched"	"Detected in many"	21	"Early spermatids: 323.1;Late spermatids: 383.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041151	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center, Plasma membrane, Cytosol"		"HPA041151: AB_10796569"	"unprognostic (4.72e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.38e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.73e-2)"	"prognostic favorable (4.44e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (3.11e-1)"	2.4	1.4	1.1	1.5	1.1	0.6	3.1	2.7	1.4	2.2	2.8	2.5	2.5	1.0	1.0	2.5	4.0	2.2	1.0	0.9	1.7	2.5	4.0	1.7	1.2	1.4	1.3	2.2	14.0	4.3	2.2	0.7	1.4	1.9	2.3	5.3	2.6	2.1	0.6	2.8	2.4	0.7	0.9	1.2	3.7	14.6	1.6	1.7	5.7	0.6	1.8	1.6	1.3	0.9	9.0	8.7	0.9	2.1	2.2	1.5	5.9	1.3	0.1	1.6	0.8	5.1	7.2	0.1	2.4	0.3	9.7	7.1	2.3	9.0	1.9	0.0	1.4	1.1	2.2	5.3	1.0	0.9	0.2	3.9	9.8	1.5	1.4	4.0	1.4	3.2	3.4	6.1	0.4	2.4	1.4	0.0	4.4	11.2	2.4	0.0	0.1	5.6	5.3	5.5	6.5	3.1	3.8	8.7	0.0	3.2	7.2	0.8	0.9	1.1	1.4	0.1	1.4	7.0	14.2	1.3	2.4	0.4	1.2	0.0	0.0	0.0	0.7	0.0	1.1	0.5	0.7	0.5	0.0	0.4	1.0	0.6	0.1	0.5	0.0	0.5	0.7	0.2	1.1	1.1	2.7	1.4	0.9	1.7	1.4	1.3	1.4	0.9	1.6	0.9	0.5	3.2	6.7	1.3	2.0	0.3	2.3	1.6	3.4	1.7	3.4	1.8	1.8	2.8	2.0	7.3	0.0	2.2	1.2	2.7	1.9	4.5	323.1	6.7	1.0	1.8	5.3	0.4	1.1	6.3	2.0	0.9	10.7	2.8	1.3	0.7	0.7	9.1	1.3	3.3	2.8	3.8	2.0	0.3	0.6	383.0	3.4	1.4	0.0	1.0	0.0	0.8	3.1	0.5	0.4	5.3	4.2	4.1	4.8	1.9	3.3	2.8	16.2	4.9	0.0	0.7	0.3	5.1	3.4	8.6	0.3	1.5	2.6	1.1	3.7	1.5
ANKFN1	FLJ38335	ENSG00000153930	"Ankyrin repeat and fibronectin type III domain containing 1"	Q8N957	17	55882301-56511659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.3;cervix: 9.2;fallopian tube: 5.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 138.4;Excitatory neurons: 27.2;Inhibitory neurons: 86.6;Oligodendrocyte precursor cells: 70.9;Respiratory ciliated cells: 31.0"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.8;MOLT-4: 15.4;T-47d: 5.0;U-2197: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021566, HPA022538, HPA048953"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane"	"HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: "	"unprognostic (6.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.38e-5)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.44e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-2)"	0.7	0.2	5.3	0.0	3.6	0.0	0.3	3.6	1.8	9.2	0.6	0.1	0.1	0.1	0.9	0.2	5.3	0.2	0.0	3.1	8.4	0.1	0.0	0.7	0.0	7.5	11.3	0.0	0.0	0.0	0.3	0.8	6.2	0.2	0.1	0.2	0.2	0.1	0.0	2.2	0.1	0.0	7.7	0.0	0.3	1.7	9.7	0.6	0.1	0.0	0.0	1.0	0.9	3.0	0.0	0.0	0.1	0.0	1.1	0.1	0.3	0.0	2.5	0.1	0.2	0.0	0.0	0.2	0.2	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.1	0.4	15.4	0.0	0.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.5	0.0	0.2	0.0	5.0	0.0	0.0	0.0	0.3	4.8	0.0	1.3	0.2	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.6	3.6	1.8	3.1	8.4	7.5	11.3	6.2	7.7	9.7	3.0	0.0	0.0	1.1	138.4	0.0	0.5	0.1	0.6	0.0	0.0	0.3	0.1	0.6	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	18.7	16.9	1.2	0.3	0.0	0.0	27.2	0.0	0.9	1.1	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	86.6	2.4	0.0	0.0	0.7	8.6	0.6	0.0	1.8	11.2	0.0	0.3	0.0	70.9	3.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	31.0	0.1	6.6	0.0	0.5	6.4	2.7	0.0	0.4	2.9	0.0	0.0	0.1	1.4
ANKLE2	"KIAA0692, Lem4, LEMD7"	ENSG00000176915	"Ankyrin repeat and LEM domain containing 2"	Q86XL3	12	132725503-132761832	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 215.7;Urothelial cells: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003602, HPA074838"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Plasma membrane"		"HPA003602: AB_1858349, HPA074838: "	"unprognostic (4.43e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.97e-6)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.90e-8)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.92e-3)"	"unprognostic (2.09e-1)"	30.0	37.6	12.4	27.0	13.3	38.4	27.8	15.2	16.6	25.4	21.9	23.8	17.8	24.9	19.0	33.6	25.2	17.4	22.0	13.8	14.1	21.8	22.9	31.3	31.6	12.3	12.4	27.1	24.6	17.9	23.1	20.4	12.3	23.9	16.1	12.3	26.1	15.6	29.3	36.9	33.3	21.9	12.0	37.9	24.1	55.7	14.3	26.2	23.3	18.3	31.2	25.0	27.6	13.2	50.7	46.4	47.3	29.5	26.9	42.1	59.1	60.2	44.7	59.0	45.0	53.2	33.6	39.5	30.7	53.1	39.5	59.2	41.8	54.8	56.2	17.0	51.6	50.1	84.0	25.2	29.9	54.6	34.0	39.1	54.9	56.2	41.3	108.8	42.8	32.0	46.1	15.1	61.2	36.4	51.1	89.4	40.1	24.8	43.9	58.0	31.1	16.7	42.6	64.9	57.9	35.6	77.7	32.4	27.1	44.1	56.9	39.1	61.5	70.5	50.9	38.0	68.1	27.9	29.5	47.9	54.7	35.8	40.5	0.9	1.2	4.4	1.8	1.1	2.4	2.7	2.6	2.8	1.7	2.8	2.4	2.0	0.7	2.7	1.3	1.7	2.6	0.7	12.4	13.3	15.2	16.6	13.8	14.1	12.3	12.4	12.3	12.0	14.3	13.2	38.0	73.7	31.2	18.3	43.2	67.3	92.0	38.2	32.5	32.3	31.2	27.1	24.6	27.1	51.3	31.3	45.9	29.2	41.1	33.8	1.9	33.2	109.1	58.6	52.4	36.3	20.8	23.1	21.0	32.7	35.5	35.7	35.2	119.2	18.4	38.3	22.9	12.9	20.1	32.0	17.8	18.0	24.4	19.7	47.6	24.5	25.1	35.5	33.8	16.9	40.6	21.9	47.4	18.1	18.4	101.9	24.8	28.2	47.6	116.9	18.8	8.5	32.3	39.7	26.3	39.2	40.5	215.7	61.8	44.8	72.9	36.5	44.7	31.6	24.0	168.7
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 60.8"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 56.4;Fibroblasts: 31.2;Leydig cells: 36.4;Muller glia cells: 57.7;Peritubular cells: 50.8;Skeletal myocytes: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.6;THP-1: 6.8;TIME: 8.4;U-87 MG: 8.3;U-937: 7.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favorable (9.35e-4)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	4.0	1.3	8.2	1.1	7.9	0.3	4.6	7.6	9.7	20.6	6.4	6.0	0.5	5.8	1.4	24.7	6.6	1.3	2.9	7.5	8.6	0.8	2.5	2.3	0.4	8.7	9.5	4.4	0.7	0.0	2.0	0.1	8.5	6.6	0.8	1.3	11.4	2.7	8.2	60.8	2.5	2.1	8.4	0.5	3.9	1.6	9.0	0.5	1.7	3.8	6.7	7.3	20.6	7.6	0.1	0.0	0.0	0.0	2.2	9.6	0.2	1.4	3.6	0.4	1.2	0.4	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.1	2.9	0.1	3.3	0.4	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.2	0.0	0.0	3.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.5	0.0	0.0	2.1	0.0	0.7	0.8	0.1	0.0	0.3	1.1	0.3	0.0	0.2	0.7	0.1	0.7	0.2	0.5	0.7	0.7	8.2	7.9	7.6	9.7	7.5	8.6	8.7	9.5	8.5	8.4	9.0	7.6	1.6	0.0	0.0	6.8	0.3	4.6	16.8	10.2	0.0	1.1	6.3	13.5	1.5	2.8	9.5	1.8	0.0	0.1	2.2	0.0	0.0	0.0	3.5	56.4	10.9	1.3	0.0	2.7	5.6	0.4	0.1	31.2	0.5	17.2	19.1	0.0	2.2	13.9	11.0	0.0	2.1	0.0	14.2	1.2	4.6	5.9	36.4	1.1	5.4	1.0	1.1	57.7	5.2	3.0	0.6	0.1	0.0	50.8	0.4	5.3	0.0	0.1	9.8	2.7	0.0	29.5	6.4	0.1	1.0	10.4	12.4	0.3	5.5	1.1	0.0	13.6
ANKRD42	"FLJ37874, PPP1R79, SARP"	ENSG00000137494	"Ankyrin repeat domain 42"	Q8N9B4	11	83193712-83260694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 170.5;Late spermatids: 63.2;Respiratory ciliated cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039917	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039917: AB_10672894"	"unprognostic (6.59e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.90e-1)"	5.2	13.3	8.0	5.2	8.9	9.0	6.0	4.3	11.8	7.4	15.8	5.8	5.2	6.0	19.7	4.8	15.8	7.6	5.3	11.6	14.3	11.1	4.7	6.6	3.8	10.0	9.2	8.7	5.9	12.3	13.1	3.9	7.9	7.2	4.2	17.8	6.0	7.4	2.7	5.5	4.9	5.3	7.6	4.5	6.2	37.2	10.7	2.8	11.8	2.2	4.1	7.3	5.5	8.2	5.6	9.7	4.7	9.5	14.3	15.0	4.1	11.4	8.8	6.7	4.1	5.9	6.8	2.2	14.1	10.3	13.4	11.9	5.0	7.8	5.5	3.2	3.7	4.0	14.5	4.0	10.0	11.6	9.0	8.9	8.8	17.0	8.9	12.3	7.0	4.0	12.0	2.0	9.8	7.9	1.7	12.2	3.9	8.8	6.1	2.7	6.5	2.8	21.8	6.6	3.7	4.9	14.9	9.2	2.9	6.1	13.9	6.2	10.2	10.2	7.1	37.1	5.4	2.9	7.1	4.5	7.9	6.7	4.3	5.7	2.6	3.2	2.9	3.0	1.9	5.0	2.5	2.9	3.5	3.8	1.2	2.0	2.0	4.4	8.0	1.4	1.1	1.7	8.0	8.9	4.3	11.8	11.6	14.3	10.0	9.2	7.9	7.6	10.7	8.2	7.6	9.6	16.0	7.5	8.5	11.2	21.5	6.5	4.0	3.9	11.9	9.8	7.8	8.6	8.0	7.3	39.6	3.1	7.1	5.2	9.8	7.7	170.5	53.1	21.9	8.5	3.0	2.1	33.3	6.7	3.3	13.0	7.7	15.4	13.9	7.8	9.3	4.8	5.0	1.7	27.3	3.1	12.2	7.2	9.9	63.2	8.7	8.8	7.2	7.5	7.3	7.4	2.1	4.5	2.9	5.7	4.9	10.5	4.7	10.6	5.8	14.8	61.6	22.4	13.1	16.6	9.0	55.5	17.3	4.7	15.3	5.5	9.1	14.5	3.9	11.5
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173608336-173669851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 6.7;choroid plexus: 14.3;fallopian tube: 12.7;parathyroid gland: 9.3;testis: 11.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Early spermatids: 48.8;Endometrial ciliated cells: 23.7;Late spermatids: 16.8;Respiratory ciliated cells: 31.8;Spermatocytes: 54.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.5;BJ hTERT+: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;GAMG: 1.9;HBF TERT88: 1.9;SH-SY5Y: 5.7"									"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.2	0.6	2.8	0.0	5.4	0.2	0.1	1.9	2.5	1.3	14.3	0.2	0.0	1.6	0.7	0.0	12.7	0.3	0.4	4.3	2.8	1.3	0.0	1.2	0.0	5.2	6.7	0.7	0.3	9.3	1.8	0.0	3.9	0.8	0.1	2.6	0.0	0.3	0.2	0.0	0.0	1.1	3.3	0.4	0.1	11.0	3.8	0.2	0.5	0.0	0.0	0.1	0.1	4.0	0.0	0.0	5.5	0.0	0.0	0.3	0.1	0.0	2.0	1.7	2.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	5.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	5.4	1.9	2.5	4.3	2.8	5.2	6.7	3.9	3.3	3.8	4.0	0.2	0.0	1.7	12.4	0.0	0.3	0.3	1.1	0.0	0.7	0.1	0.4	0.9	0.0	1.5	5.5	37.5	0.2	0.0	0.3	1.9	0.6	48.8	23.7	1.3	1.3	0.0	0.0	4.6	0.5	0.3	0.4	0.0	0.6	0.0	1.1	3.3	0.0	0.1	0.0	4.1	0.0	6.1	0.0	0.0	16.8	1.8	0.2	0.0	2.8	0.0	3.3	0.0	0.5	3.2	0.1	0.0	0.4	0.0	0.2	0.0	0.4	31.8	1.7	0.0	0.1	0.8	54.9	7.9	0.0	0.0	0.1	0.0	5.5	0.4	0.1
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2185.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5755.6;Pancreatic endocrine cells: 5217.8;Prostatic glandular cells: 4575.5;Urothelial cells: 4326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 4429.7;classical monocyte: 2762.3;intermediate monocyte: 2401.9;myeloid DC: 4018.8;non-classical monocyte: 2686.5;T-reg: 1681.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 174.7"	"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		19000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	975.6	370.5	49.0	461.9	50.5	151.7	708.5	49.6	96.9	806.3	95.6	631.2	502.0	296.2	267.2	2185.3	388.4	453.9	393.0	47.6	79.4	358.3	185.5	878.3	200.7	90.0	83.6	187.0	324.3	344.0	163.9	650.4	84.9	399.3	606.1	30.2	933.4	386.4	304.8	1140.8	487.5	425.4	73.3	301.6	379.0	116.1	120.9	188.7	351.2	205.8	541.1	842.2	1256.7	80.1	4183.3	4421.4	223.6	105.5	2962.4	4744.2	971.0	4703.6	2968.4	2868.4	2534.9	2083.5	1903.6	10.0	3907.2	5983.6	2185.1	4304.9	992.9	8695.5	3113.5	846.8	103.9	78.2	1918.7	882.7	1782.0	4.5	59.9	2324.4	2278.6	2013.2	4335.0	3477.2	5455.0	58.4	320.9	447.9	6271.8	468.4	18.5	239.1	508.2	3444.1	3283.5	48.9	1198.8	226.6	5172.4	2410.7	295.1	171.9	1774.5	424.8	1942.8	2305.1	922.7	173.6	6336.8	2534.1	3406.8	8668.0	4807.4	172.6	616.3	83.8	2449.2	47.9	5206.0	4429.7	2762.3	355.0	603.8	2401.9	668.5	657.9	686.4	701.7	4018.8	412.1	77.0	313.9	73.6	287.1	2686.5	609.4	1681.4	3754.4	49.0	50.5	49.6	96.9	47.6	79.4	90.0	83.6	84.9	73.3	120.9	80.1	673.9	2141.0	414.8	0.3	101.3	2512.2	3396.9	5755.6	246.4	2.5	395.9	337.4	28.2	773.5	3086.6	560.9	0.0	1874.5	135.9	933.6	13.7	3941.4	93.0	855.9	457.1	772.0	103.4	38.7	0.2	2411.4	2714.4	1076.7	328.7	1376.3	105.7	97.5	474.0	64.2	1537.2	0.0	1.3	689.0	1668.2	429.6	1992.1	126.6	771.1	715.1	1417.6	15.9	1284.0	19.4	138.0	1.5	0.1	5217.8	920.9	638.7	144.5	4575.5	845.8	51.8	2446.8	8.1	184.1	437.7	831.1	13.0	29.3	789.7	2325.1	1150.1	224.1	8.6	749.9	4326.1
APC	"DP2, DP2.5, DP3, PPP1R46"	ENSG00000134982	"APC regulator of WNT signaling pathway"	P25054	5	112707498-112846239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 536.4;Bipolar cells: 196.9;Excitatory neurons: 165.8;Inhibitory neurons: 236.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013349, HPA013362"	Supported		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA013349: AB_1844913, HPA013362: "	"unprognostic (4.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	6.9	4.6	28.4	6.2	26.0	9.1	5.7	23.1	31.0	5.7	0.1	6.7	6.2	5.6	3.3	7.7	4.3	4.9	7.2	52.8	27.4	6.2	5.7	6.2	5.6	32.1	30.7	6.6	4.1	8.5	3.9	5.1	39.0	5.2	6.2	20.0	3.8	4.1	8.5	5.7	8.5	7.5	16.0	6.1	5.0	5.1	37.9	8.5	5.9	11.8	5.9	5.4	3.6	20.9	11.3	10.1	16.8	12.2	13.4	11.3	6.7	17.9	8.5	9.7	11.5	8.2	8.9	22.0	17.0	23.1	15.5	9.0	17.4	14.6	15.9	13.2	12.2	16.8	14.9	6.2	6.6	8.4	8.6	9.3	9.8	16.6	10.8	6.8	13.6	10.2	20.9	7.2	14.3	7.8	9.6	4.2	6.0	6.1	3.6	8.1	20.8	10.7	8.9	14.1	17.0	10.1	16.9	6.5	7.1	6.8	9.1	6.7	22.8	19.6	9.5	19.5	13.6	5.6	9.5	8.2	10.8	15.3	11.2	11.8	2.5	4.9	2.9	1.3	2.4	2.8	1.5	1.9	2.1	3.1	2.4	2.4	11.4	2.9	2.4	2.7	1.5	1.0	28.4	26.0	23.1	31.0	52.8	27.4	32.1	30.7	39.0	16.0	37.9	20.9	40.6	51.3	23.6	536.4	21.9	11.2	8.9	10.1	19.9	196.9	13.1	14.9	56.6	18.6	20.1	0.0	66.7	5.4	28.9	28.6	0.0	18.7	10.5	20.1	27.6	31.2	27.5	17.4	165.8	19.5	6.5	25.9	19.4	29.7	19.0	28.7	26.7	13.9	16.3	79.1	236.4	17.2	2.0	18.9	12.4	5.5	17.7	27.8	17.8	85.3	30.7	23.4	23.7	196.6	150.8	20.3	34.7	19.5	22.9	10.4	37.2	5.1	18.0	41.5	39.5	44.1	34.0	19.2	30.4	26.5	11.6	2.9	22.4	27.1	16.0	8.9
APLP1	APLP	ENSG00000105290	"Amyloid beta precursor like protein 1"	P51693	19	35867899-35879792	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Endocytosis"	Heparin-binding	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 1201.6"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 147.1;Horizontal cells: 161.5;Oligodendrocytes: 461.3"	"Cancer enhanced"	"Detected in many"		"glioma: 63.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.6;AN3-CA: 162.9;HMC-1: 76.0;SCLC-21H: 87.2;SH-SY5Y: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028970, HPA028971"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		6400000	"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA028970: AB_2672847, HPA028971: AB_10601334"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.36e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (7.32e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-11)"	"unprognostic (1.38e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (2.65e-5)"	3.0	31.5	417.1	3.1	718.0	0.4	1.4	680.9	552.4	3.1	218.6	4.4	1.8	3.1	1.3	1.5	2.7	5.5	10.8	438.3	465.8	4.9	0.6	1.9	1.4	783.2	627.4	1.4	75.0	22.3	151.4	0.9	710.7	2.1	2.2	56.3	1.8	1.9	0.5	1.1	2.1	3.2	605.9	0.5	28.1	13.1	598.3	0.8	1.5	0.5	1.5	1.2	2.1	1201.6	4.4	40.0	81.6	162.9	7.1	3.2	10.4	5.6	3.5	7.8	1.1	7.3	6.3	0.8	66.5	21.0	27.7	2.2	26.1	2.6	5.2	48.9	3.7	0.3	10.6	5.2	2.0	0.2	76.0	3.6	1.8	3.2	0.1	28.8	3.1	6.1	2.7	1.2	25.0	8.3	0.2	0.3	3.9	16.5	16.5	7.2	0.4	1.1	1.4	1.1	87.2	89.3	23.1	3.8	0.8	23.9	20.8	4.3	1.3	61.3	28.8	32.9	4.3	2.4	1.6	0.3	42.3	1.1	33.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	417.1	718.0	680.9	552.4	438.3	465.8	783.2	627.4	710.7	605.9	598.3	1201.6	2.5	6.4	0.0	12.4	0.6	1.3	2.6	0.7	1.2	147.1	0.4	1.1	6.2	1.5	0.2	0.0	12.5	0.3	0.3	0.4	0.0	2.0	27.6	1.3	1.2	2.8	34.9	0.0	55.5	4.2	6.4	2.8	10.2	3.2	0.0	0.1	0.7	0.4	0.4	161.5	46.8	1.1	2.0	0.3	1.6	15.8	1.2	1.1	5.4	12.2	0.0	14.6	0.0	19.1	461.3	3.1	0.1	0.0	0.4	1.9	0.0	0.1	0.2	38.6	0.0	1.9	1.8	14.5	28.7	0.1	0.6	0.4	0.5	0.1	0.2	1.3
APMAP	"BSCv, C20orf3"	ENSG00000101474	"Adipocyte plasma membrane associated protein"	Q9HDC9	20	24962925-24992751	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 314.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 325.4;Hepatocytes: 251.1;Syncytiotrophoblasts: 751.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 680.7;NK-cells: 343.8;T-cells: 367.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012863, HPA064700"	Approved		Approved	"Plasma membrane"		NA	NA		130000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA012863: AB_1845683, HPA064700: AB_2685328"	"unprognostic (4.07e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.99e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.51e-2)"	168.0	44.6	59.2	47.2	60.1	187.4	84.6	76.0	65.4	41.8	62.2	46.5	32.7	46.8	106.3	26.7	46.0	43.1	37.5	64.1	72.6	50.5	314.0	53.2	44.0	61.4	62.8	40.8	45.2	83.4	78.7	80.2	68.6	44.2	42.9	32.0	40.1	47.9	39.5	55.8	34.7	49.2	60.5	66.6	38.5	54.2	69.7	42.4	209.1	24.4	34.1	51.8	29.5	68.8	110.6	191.3	90.0	139.5	175.3	97.5	94.4	141.8	153.4	133.3	137.4	113.7	189.3	45.9	161.1	170.6	232.1	198.1	85.0	165.1	149.1	62.3	69.7	51.2	66.0	226.9	140.9	99.5	115.4	134.3	226.9	154.9	107.0	173.8	192.5	73.4	61.5	195.8	128.6	168.1	68.9	108.2	59.3	166.6	172.1	56.3	312.8	96.3	140.2	98.9	150.6	59.4	146.9	240.5	157.1	92.0	87.6	78.8	173.7	156.9	140.6	134.7	209.5	113.0	134.3	50.9	83.1	148.0	151.9	61.8	99.3	198.9	367.9	98.6	228.8	36.4	100.8	268.2	102.1	37.4	78.6	202.2	680.7	343.8	71.3	50.7	75.0	363.3	59.2	60.1	76.0	65.4	64.1	72.6	61.4	62.8	68.6	60.5	69.7	68.8	28.5	19.2	32.7	25.8	22.2	24.3	46.7	77.6	17.1	51.4	48.1	32.1	17.5	34.3	39.7	49.7	10.4	325.4	163.2	18.9	17.6	72.0	22.9	18.0	26.3	42.4	18.0	33.6	24.0	45.4	50.6	40.6	15.3	23.8	36.1	68.6	41.4	251.1	95.9	16.8	25.4	19.4	85.5	50.0	94.8	32.5	65.0	59.5	46.2	42.2	105.1	35.0	222.5	19.6	15.9	40.8	25.4	82.0	54.9	34.1	20.8	13.2	24.5	22.5	39.5	36.9	33.2	97.1	90.1	16.7	20.0	751.1	96.7	38.3	28.0	28.1
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568705-195584033	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 5037.8"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 4485.3;Leydig cells: 2077.4;Melanocytes: 1028.1;Peritubular cells: 994.5"	"Cancer enriched"	"Detected in all"	4	"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"memory B-cell: 5.0"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.0"	"Group enriched"	"Detected in many"	6	"ASC diff: 3507.4;ASC TERT1: 1918.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	98900000000	90000000000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA040520: AB_2677020"	"prognostic favorable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.71e-3)"	2071.8	84.8	949.6	13.9	1157.3	0.9	5037.8	1174.9	1364.1	620.2	1370.1	144.7	56.0	496.7	155.7	160.0	750.6	213.3	1007.8	952.8	1010.4	49.7	7.1	183.5	24.6	1148.3	1040.5	131.2	212.4	61.9	192.2	350.5	1122.0	419.8	57.2	0.8	1272.3	183.8	1154.9	970.1	88.4	96.2	1027.5	8.2	402.6	75.7	1070.2	113.5	828.8	625.3	20.8	434.4	591.7	1347.6	0.0	2.2	0.5	0.7	3507.4	1918.1	6.1	31.3	7.6	0.1	0.2	222.4	0.4	0.4	0.9	1.8	0.0	0.9	0.4	10.5	0.3	0.3	2.4	0.3	0.2	0.1	12.5	0.3	0.5	91.4	21.0	0.2	17.0	0.3	4.3	0.2	0.2	0.9	5.3	1.3	0.1	0.7	0.5	38.9	0.5	0.1	0.0	0.6	0.0	2.8	0.7	0.5	0.0	34.8	31.8	1.3	67.2	0.1	0.4	0.5	1.4	0.4	0.1	0.2	0.3	9.2	1.0	0.4	420.3	0.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	949.6	1157.3	1174.9	1364.1	952.8	1010.4	1148.3	1040.5	1122.0	1027.5	1070.2	1347.6	543.2	0.0	11.0	2.9	7.5	145.0	16.0	25.4	46.7	0.0	121.6	138.7	26.9	1.5	81.8	5.5	0.0	5.4	15.9	1.4	0.0	0.4	9.7	16.3	393.7	114.1	46.3	0.0	3.3	0.0	4.2	4485.3	7.7	7.0	0.0	0.0	21.4	0.0	13.3	0.0	2.1	0.7	10.2	0.3	193.2	51.0	2077.4	31.8	1028.1	279.2	1.0	0.0	0.0	300.6	221.5	2.3	0.3	994.5	19.2	25.7	0.0	0.2	128.9	0.0	19.7	100.3	210.7	10.5	4.0	24.1	102.6	5.9	23.5	7.0	0.6	47.3
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 124.5"	"Cell type enriched"	"Detected in many"	4	"Adipocytes: 781.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 24.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 36.7;HDLM-2: 19.3;hTERT-RPE1: 15.1"	"Group enriched"	"Detected in all"	4	"basal ganglia: 5.7;olfactory bulb: 20.1"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Approved	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA052462: AB_2681841, HPA058882: AB_2683844"	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	124.5	15.6	35.2	15.4	28.7	0.3	90.6	29.8	41.8	43.8	22.5	12.4	3.9	15.7	2.3	35.3	30.5	34.4	55.8	26.9	30.7	20.0	17.7	17.1	5.6	37.6	34.0	6.9	24.0	28.0	10.5	86.6	38.1	12.8	12.0	5.8	10.3	5.6	34.3	18.4	10.7	52.5	30.3	6.1	12.1	3.0	43.6	10.6	64.8	28.8	3.3	28.3	18.1	29.3	6.4	0.2	36.7	1.2	1.1	2.1	0.3	6.0	9.9	6.0	8.7	2.4	6.5	2.0	0.5	2.3	2.1	2.0	1.4	0.3	10.1	19.3	1.4	0.5	2.0	0.0	2.2	1.0	0.6	1.4	1.7	2.1	4.7	15.1	4.6	3.5	0.5	2.5	3.1	1.3	1.0	1.1	0.2	1.5	1.1	2.9	0.8	0.9	0.7	0.6	3.1	3.4	5.7	0.5	13.6	0.6	0.2	3.1	5.6	1.3	2.0	8.1	5.5	1.8	0.9	1.4	2.0	4.0	6.9	2.2	0.3	0.2	0.3	0.1	0.4	1.0	0.7	0.5	0.2	0.8	0.5	0.3	1.6	0.3	0.2	0.6	1.1	0.1	35.2	28.7	29.8	41.8	26.9	30.7	37.6	34.0	38.1	30.3	43.6	29.3	781.6	6.4	5.3	17.3	15.9	18.1	2.5	1.4	6.8	4.4	5.4	5.8	11.9	4.3	5.9	0.0	4.2	2.9	13.3	5.3	0.0	1.1	2.9	0.7	7.2	169.4	3.6	18.9	5.3	0.4	1.4	25.0	1.1	1.3	7.6	5.8	62.4	3.8	6.6	3.3	7.0	6.3	2.0	14.2	27.1	2.1	4.4	6.6	28.4	32.8	5.9	39.6	29.9	5.0	28.5	1.2	0.6	0.4	5.7	2.9	2.3	0.5	5.4	4.8	111.7	17.5	193.5	5.5	1.0	2.3	15.5	1.0	18.3	1.1	9.3	3.7
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961872-49965682	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 622.6;testis: 222.0"	"Group enriched"	"Detected in many"	7	"Early spermatids: 1542.9;Late spermatids: 4265.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 223.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065008	Enhanced		Approved	"Plasma membrane"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favorable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	2.9	0.8	2.7	0.1	3.7	0.2	17.1	3.3	2.7	12.9	1.5	0.4	15.3	2.7	0.2	16.5	0.7	2.8	4.0	2.4	2.9	1.9	0.1	7.6	0.0	3.3	3.9	0.2	2.0	3.0	1.2	0.0	3.1	1.3	0.0	1.0	622.6	1.0	0.2	112.7	0.1	0.3	2.6	0.4	52.3	222.0	3.8	0.0	1.6	0.0	0.1	0.3	0.4	2.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.7	223.2	0.0	10.1	0.0	0.0	0.3	0.0	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.7	3.3	2.7	2.4	2.9	3.3	3.9	3.1	2.6	3.8	2.6	0.5	57.7	3.1	0.0	0.1	1.3	0.5	18.3	0.0	0.8	53.9	48.0	0.3	0.0	56.4	7.3	0.0	0.0	0.1	0.0	0.0	0.1	1542.9	1.5	0.1	1.8	0.0	0.0	0.0	0.2	0.0	1.4	34.7	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.4	0.0	1.6	4265.6	28.6	1.7	295.3	0.0	0.0	53.7	0.0	3.0	0.1	7.2	0.0	19.2	0.3	1.6	0.0	0.0	9.7	1.7	19.7	0.0	1.8	403.9	15.9	1.3	0.9	0.0	0.6	18.7	0.0	0.6
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		36000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: AB_2686262"	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.41e-4)"	"unprognostic (7.56e-3)"	41.5	63.5	40.0	58.6	48.6	97.5	33.4	37.9	50.4	44.1	62.9	35.5	29.6	38.9	14.0	37.7	48.3	44.2	42.9	42.2	38.5	47.8	40.2	71.8	53.4	50.6	42.3	49.4	37.1	20.4	48.9	35.5	45.9	44.9	18.2	8.6	33.3	25.7	20.1	47.1	43.3	28.7	40.1	117.5	31.3	16.4	50.8	32.2	46.6	20.1	25.2	39.7	37.5	56.8	19.7	41.9	15.2	18.5	63.4	42.9	23.1	26.2	46.5	29.8	29.3	56.0	50.8	42.9	51.3	44.4	40.7	64.5	23.2	64.4	12.5	50.9	28.4	36.6	40.3	81.9	43.7	25.1	98.7	47.5	65.4	48.7	23.4	36.2	33.2	31.3	31.5	17.4	13.9	40.3	38.9	89.3	9.5	35.1	25.9	36.8	23.2	21.3	27.5	61.1	15.7	32.0	19.1	27.9	84.8	19.5	25.1	56.8	37.5	41.0	28.5	42.8	16.4	27.4	14.3	23.0	21.8	37.4	22.3	19.3	24.8	30.7	8.9	39.4	5.2	6.6	5.9	6.8	15.9	4.7	4.5	5.4	50.8	13.4	51.3	5.3	6.7	17.6	40.0	48.6	37.9	50.4	42.2	38.5	50.6	42.3	45.9	40.1	50.8	56.8	8.9	28.9	32.3	33.6	16.1	7.4	7.5	14.3	15.4	4.3	8.7	7.9	2.6	7.2	9.0	16.5	33.3	9.2	18.3	16.5	9.8	13.5	50.1	14.1	11.7	7.8	23.3	9.9	7.7	7.5	8.9	22.4	16.3	9.1	10.8	36.9	9.7	10.8	43.0	0.0	7.0	12.8	12.2	45.6	25.1	6.4	20.8	57.3	8.8	30.0	29.0	7.4	21.6	17.6	31.5	12.1	10.9	15.1	12.3	4.8	20.9	5.3	20.2	2.8	0.0	8.6	8.8	0.4	2.8	10.8	5.4	4.9	12.4	10.5	15.1	7.4
ARF1		ENSG00000143761	"ADP ribosylation factor 1"	P84077	1	228082660-228099212	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007742	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB007742: AB_562043"	"unprognostic (9.54e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.73e-1)"	"unprognostic (8.95e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.94e-1)"	268.3	282.5	213.8	176.7	222.5	426.9	241.9	188.1	261.9	249.1	215.1	259.8	242.6	266.6	193.1	304.7	247.5	189.2	340.0	242.7	231.3	257.0	324.7	298.2	185.0	200.6	201.6	237.3	327.6	296.9	299.1	276.9	207.6	244.0	177.3	96.7	355.2	203.9	330.9	237.3	240.8	176.2	196.6	251.4	265.6	193.9	218.9	184.4	240.3	206.4	154.7	229.0	233.1	206.4	476.6	321.6	257.4	257.9	289.9	362.6	425.7	409.5	433.0	444.3	386.8	383.6	442.7	239.9	428.8	438.3	204.6	298.8	316.4	399.4	219.4	355.3	506.8	234.3	209.8	386.6	559.5	342.1	333.8	350.4	476.7	408.6	427.0	374.1	443.3	267.0	456.0	533.3	431.4	341.8	350.0	495.9	331.7	656.7	643.0	279.0	228.1	750.6	315.1	242.1	362.6	320.0	265.9	790.0	466.8	87.8	543.9	681.0	406.0	324.6	256.5	479.4	626.8	498.5	301.0	331.1	445.9	285.0	670.6	1003.7	556.5	625.5	387.3	527.8	472.4	276.7	328.0	359.8	423.6	261.3	253.2	280.8	863.6	345.5	528.2	571.4	417.9	1082.4	213.8	222.5	188.1	261.9	242.7	231.3	200.6	201.6	207.6	196.6	218.9	206.4	276.9	173.1	185.2	25.8	205.1	262.6	281.7	248.0	104.2	114.3	209.1	172.0	139.8	125.8	208.1	115.8	45.9	373.7	267.8	487.8	230.9	422.7	236.3	164.6	218.7	247.2	230.1	173.8	42.3	404.5	565.8	227.3	142.8	240.8	198.3	128.8	152.4	124.8	409.4	158.2	41.1	436.9	213.6	198.8	256.2	429.9	229.2	300.1	300.6	35.6	356.0	162.2	214.2	30.7	40.7	400.2	407.2	227.2	282.8	344.6	370.1	173.3	180.7	80.2	230.1	149.6	416.0	321.1	155.7	158.3	286.0	676.7	224.9	174.6	335.2	370.0
ARHGAP23	KIAA1501	ENSG00000275832	"Rho GTPase activating protein 23"	Q9P227	17	38419280-38512385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.4;Hepatic stellate cells: 46.1;Oligodendrocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 296.7;RT4: 115.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019818, HPA047291"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA019818: AB_1844993, HPA047291: AB_2680012"	"unprognostic (3.35e-1)"	"unprognostic (5.11e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.50e-3)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.38e-5)"	"unprognostic (8.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.25e-1)"	25.6	13.8	36.2	8.3	66.2	10.7	18.8	47.2	54.6	25.9	5.5	22.8	3.0	28.4	3.7	60.8	18.4	7.8	27.3	34.4	37.5	11.8	2.9	28.0	4.1	63.7	59.6	18.1	3.5	3.1	6.2	19.4	54.1	19.9	2.8	8.5	12.8	12.5	10.6	61.1	10.4	11.6	43.0	30.7	13.4	16.1	66.1	5.4	9.5	5.8	11.0	36.3	29.5	97.8	32.5	17.2	15.2	5.1	9.5	31.1	19.6	44.8	49.5	37.7	21.8	56.8	55.1	0.7	35.2	102.5	18.7	296.7	1.7	62.3	26.6	3.5	3.3	0.0	55.1	0.4	47.2	3.0	0.3	18.8	11.8	27.7	17.3	31.0	39.4	6.0	0.6	8.3	21.6	0.0	10.2	6.3	9.0	1.2	6.3	17.0	33.0	10.4	16.0	115.7	3.7	8.8	26.9	0.1	0.3	21.2	6.7	7.9	57.7	62.6	22.9	12.9	12.1	6.5	7.3	1.9	16.3	8.1	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	66.2	47.2	54.6	34.4	37.5	63.7	59.6	54.1	43.0	66.1	97.8	27.2	12.8	1.5	23.8	0.7	9.9	17.5	10.6	9.1	59.4	1.7	3.9	20.4	1.5	13.2	3.7	0.0	27.0	0.2	0.1	0.0	2.9	7.6	8.5	10.0	34.9	0.0	4.0	9.3	1.4	3.1	11.6	3.1	5.7	0.0	4.9	46.1	0.5	5.1	26.9	16.2	0.4	2.0	2.5	4.2	21.0	9.0	1.2	1.8	9.4	0.2	9.6	0.0	20.1	129.2	7.0	0.1	7.2	1.7	15.4	0.0	0.2	8.3	3.4	0.0	10.9	7.6	13.5	2.7	27.5	25.9	16.6	1.8	1.3	0.3	42.2
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475150-86002668	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 99.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1364.3;Microglial cells: 905.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.9;memory B-cell: 47.3;naive B-cell: 36.8;plasmacytoid DC: 12.7"	"Group enriched"	"Detected in many"	5	"B-cells: 47.3;dendritic cells: 12.7;monocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 109.0;ASC TERT1: 65.5;HHSteC: 63.6;HUVEC TERT2: 121.9;RPTEC TERT1: 67.2;TIME: 87.0;U-138 MG: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	14.6	2.2	6.5	7.5	5.1	18.7	9.2	6.2	5.8	5.5	3.9	7.4	7.3	9.4	4.6	6.1	4.1	10.9	27.3	5.7	6.6	99.8	9.5	15.7	10.5	15.7	11.5	5.5	30.1	8.1	5.4	22.4	17.2	5.4	6.1	8.4	10.6	7.2	10.2	7.0	10.3	14.1	12.1	16.4	26.0	3.4	10.4	7.5	27.8	7.7	15.5	9.1	5.6	19.1	3.0	6.2	4.4	0.1	109.0	65.5	4.8	21.5	28.5	5.2	8.4	0.1	0.0	2.8	7.4	48.8	6.4	0.0	0.2	9.0	11.0	0.0	1.2	3.6	0.6	0.2	63.6	0.4	0.0	48.4	0.9	10.3	4.7	23.9	121.9	0.0	6.6	0.4	46.1	0.0	0.1	0.0	0.3	1.5	11.3	0.6	22.4	11.8	67.2	0.0	2.3	2.3	2.5	3.5	7.8	4.7	0.4	0.2	87.0	59.9	1.2	4.4	0.3	0.3	0.0	3.9	10.1	2.2	19.9	0.0	15.9	0.0	0.0	3.0	0.0	47.3	0.0	0.0	3.8	36.8	0.0	0.0	5.5	0.0	2.3	12.7	0.0	3.1	6.5	5.1	6.2	5.8	5.7	6.6	15.7	11.5	17.2	12.1	10.4	19.1	14.0	57.7	28.8	1364.3	142.1	8.2	3.9	35.6	10.2	6.6	1.2	4.7	26.4	47.1	18.3	46.0	6.2	54.8	9.9	1.0	226.9	9.4	30.5	1.2	12.9	9.5	2.4	0.0	12.2	11.8	26.2	24.7	25.0	1.4	1.3	6.7	4.2	9.5	10.5	111.0	51.3	3.3	6.1	33.7	21.3	8.8	16.8	26.3	19.6	905.0	34.0	27.7	0.0	27.2	21.8	7.4	2.9	12.4	2.0	2.3	0.2	205.9	24.8	6.6	6.6	50.0	21.3	8.1	5.9	4.0	6.3	232.9	4.1	18.4	5.0	1.9
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 440.8;Endothelial cells: 298.6;Prostatic glandular cells: 593.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A-431: 118.8;hTERT-HME1: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	32.9	3.7	7.0	2.8	5.5	0.1	30.3	22.5	8.0	8.8	7.3	9.4	2.1	7.4	5.3	4.5	10.2	6.5	19.2	4.6	5.5	23.7	16.8	27.1	4.9	6.8	6.1	10.2	7.4	6.5	6.2	17.4	7.1	11.2	3.2	14.9	12.1	7.0	11.6	14.7	6.4	5.6	6.4	21.7	10.4	5.8	8.6	3.0	22.8	12.7	2.8	8.0	9.3	5.1	118.8	4.8	7.0	0.1	26.7	57.5	24.5	38.6	62.9	31.0	45.1	13.7	5.4	0.0	85.2	76.5	36.3	24.8	0.2	27.4	63.9	0.1	4.1	0.4	6.6	7.6	2.7	0.0	0.0	11.7	5.4	23.7	100.9	36.4	88.0	0.1	0.0	0.0	32.1	4.7	2.2	0.1	9.0	0.6	82.1	1.4	5.6	0.0	82.7	10.8	0.1	1.5	24.1	20.5	2.0	26.5	5.6	0.4	84.2	20.0	26.2	29.7	32.3	0.1	0.1	0.2	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	5.5	22.5	8.0	4.6	5.5	6.8	6.1	7.1	6.4	8.6	5.1	440.8	51.3	18.4	26.4	2.9	23.5	239.2	31.7	4.6	16.0	87.3	46.1	26.0	31.5	39.6	130.6	18.8	29.5	2.0	0.9	54.8	83.5	94.1	36.9	11.4	298.6	0.0	3.2	11.3	17.2	102.6	63.6	20.9	106.2	3.8	13.8	177.1	56.1	3.0	92.5	24.1	1.0	6.1	13.6	17.9	24.4	24.5	6.2	26.6	208.9	2.5	94.2	0.0	2.0	3.5	55.7	0.1	21.8	0.1	593.9	0.1	78.1	12.5	81.2	190.7	58.2	127.8	80.3	116.5	1.7	17.2	14.1	4.1	11.1	1.6	146.9
ARHGAP33	"FLJ39019, SNX26, TCGAP"	ENSG00000004777	"Rho GTPase activating protein 33"	O14559	19	35774532-35788822	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.4;Cone photoreceptor cells: 25.0;Horizontal cells: 20.2;Oligodendrocytes: 22.7;Rod photoreceptor cells: 33.7;Spermatocytes: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030117, HPA030118"	Supported		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA030117: AB_10599306, HPA030118: AB_10601238"	"unprognostic (1.44e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.61e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (3.09e-8)"	"unprognostic (5.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-2)"	7.7	8.7	24.3	4.2	28.8	20.5	10.9	14.3	39.1	20.4	8.2	11.2	4.0	13.9	1.3	8.1	17.1	2.8	6.9	30.0	21.0	10.1	5.6	6.8	5.8	19.9	16.5	26.9	11.9	4.2	33.6	1.6	18.0	12.5	1.3	9.9	7.4	3.3	3.4	9.8	9.2	2.0	15.2	11.1	10.4	39.6	19.5	11.7	18.0	1.3	2.2	9.4	13.7	22.1	9.0	5.6	15.5	11.7	0.6	1.5	1.2	7.2	0.9	2.7	1.9	2.3	6.6	5.2	2.6	2.1	2.3	2.4	1.9	2.0	1.0	16.4	3.6	7.6	8.6	2.1	0.7	2.7	58.1	2.2	0.4	2.1	0.8	2.2	1.6	20.4	3.7	22.1	2.4	6.8	18.8	7.4	3.5	3.4	2.5	25.4	2.5	2.5	1.2	1.4	15.4	9.4	3.2	5.7	1.1	1.9	8.3	7.5	3.1	11.0	10.6	5.8	8.5	19.5	4.0	5.2	4.0	8.9	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	28.8	14.3	39.1	30.0	21.0	19.9	16.5	18.0	15.2	19.5	22.1	2.7	0.0	1.1	7.8	1.0	1.7	1.0	1.0	4.6	27.4	4.8	4.7	2.3	2.8	2.7	1.8	25.0	0.7	5.1	1.4	0.0	0.4	11.4	6.1	4.8	1.6	3.5	6.5	12.1	0.7	1.0	3.5	3.6	2.5	5.1	7.3	1.1	1.5	1.2	20.2	11.3	2.3	2.0	0.8	1.9	8.9	4.1	0.7	0.0	1.9	0.2	7.3	0.0	19.1	22.7	0.7	0.6	3.0	2.2	0.6	0.3	0.2	4.2	33.7	0.0	4.6	3.1	22.2	6.2	4.2	1.7	0.4	3.6	7.2	2.8	0.6
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058346-131089885	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"adrenal gland: 105.4;brain: 144.3;pituitary gland: 176.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast glandular cells: 2.7;Oligodendrocyte precursor cells: 1.0;Skeletal myocytes: 1.5"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	161	"SH-SY5Y: 176.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 89.4"	"Low region specificity"	"Detected in many"			"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		0.2	105.4	20.1	0.0	3.7	0.0	1.4	0.8	3.2	1.6	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	13.5	132.5	0.0	0.0	0.0	0.0	35.0	46.1	0.0	0.0	0.0	176.9	0.1	144.3	0.2	0.1	0.0	0.2	0.0	6.6	0.1	0.0	0.0	4.7	0.0	0.1	0.8	52.1	0.4	0.1	1.1	0.0	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	176.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	3.7	0.8	3.2	13.5	132.5	35.0	46.1	144.3	4.7	52.1	10.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472264-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 119.7;lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 171.0;Early spermatids: 96.8;NK-cells: 123.6;Spermatocytes: 89.0;T-cells: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 388.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 27.6;HMC-1: 116.2;MOLT-4: 22.5;NB-4: 22.1;THP-1: 34.9;U-937: 27.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	10.8	4.2	4.2	34.3	6.1	119.7	4.1	8.1	11.1	2.6	4.7	7.7	8.2	3.4	1.6	4.6	7.4	10.5	3.9	4.4	5.3	5.1	7.5	22.0	56.9	7.8	5.8	1.6	3.5	0.6	2.2	5.2	8.8	4.3	10.7	0.5	4.7	1.8	1.3	2.2	37.6	5.9	5.6	100.7	8.8	19.3	6.1	34.9	4.5	6.4	60.7	9.5	3.6	6.4	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.4	0.5	0.1	0.2	0.1	0.0	14.3	0.3	0.3	0.0	0.2	0.4	0.0	0.0	0.7	0.0	27.6	0.1	0.0	1.1	16.4	116.2	0.7	0.0	0.0	0.3	0.2	0.0	14.3	0.5	7.9	0.0	0.0	22.5	22.1	1.0	0.0	0.0	9.1	10.2	4.6	0.0	0.1	3.9	3.0	0.0	0.0	0.4	0.5	0.0	34.9	0.9	0.2	0.3	0.1	0.1	9.2	7.2	13.3	0.3	27.3	0.5	51.9	86.1	243.4	43.3	89.2	30.0	35.9	47.3	39.6	72.1	44.0	61.9	46.0	388.9	68.2	71.0	97.4	63.6	70.8	4.2	6.1	8.1	11.1	4.4	5.3	7.8	5.8	8.8	5.6	6.1	6.4	2.2	0.0	14.2	1.0	49.1	1.5	0.2	0.0	1.8	0.2	1.6	2.9	2.1	1.5	1.3	0.0	2.1	0.4	171.0	0.6	0.0	0.2	96.8	0.6	0.8	1.5	0.0	11.6	3.7	0.0	0.6	2.4	4.6	0.8	12.0	0.0	3.6	1.2	43.5	0.0	1.9	0.5	0.0	39.0	19.7	44.8	1.8	35.1	0.0	8.4	34.8	0.0	123.6	0.0	0.2	0.2	0.1	0.0	50.8	0.2	0.0	0.3	2.2	0.7	0.0	0.6	1.2	89.0	17.5	0.4	1.4	0.3	108.2	0.3	0.4	0.1
ARHGEF12	"KIAA0382, LARG"	ENSG00000196914	"Rho guanine nucleotide exchange factor 12"	Q9NZN5	11	120336413-120489937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018911, CAB025581"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB025581: , HPA018911: AB_1845003"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.91e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (5.43e-6)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	25.6	30.6	27.2	14.3	26.9	11.4	31.9	26.8	32.1	32.9	26.4	27.6	25.0	27.8	25.4	27.6	29.3	28.4	40.3	30.9	23.0	67.4	66.4	36.7	11.9	17.8	25.6	25.2	26.1	68.4	14.6	42.9	17.3	26.5	29.1	47.7	25.0	30.9	32.2	49.5	25.5	30.3	20.1	21.5	32.2	9.7	35.9	13.5	51.5	31.8	18.7	28.7	22.0	19.3	38.1	31.6	41.9	39.8	55.0	54.5	16.7	43.8	49.8	26.1	33.1	37.5	27.2	3.2	51.7	79.8	46.6	27.5	54.1	56.0	51.3	31.1	25.8	61.8	34.0	29.2	49.2	0.1	43.7	52.4	39.7	57.8	63.8	58.0	80.7	32.7	52.4	122.5	67.0	26.6	0.1	0.1	11.4	49.3	26.1	13.4	47.4	11.9	65.1	66.1	30.0	36.4	61.5	51.0	16.2	25.0	43.1	5.1	80.1	57.2	24.2	37.6	32.4	35.1	15.4	20.2	23.6	7.9	44.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	27.2	26.9	26.8	32.1	30.9	23.0	17.8	25.6	17.3	20.1	35.9	19.3	86.2	73.7	88.4	274.9	8.6	90.5	69.1	47.2	42.1	134.6	55.1	26.9	87.6	68.6	57.8	97.5	185.6	16.7	11.5	59.7	35.2	45.6	6.4	61.4	55.7	94.0	37.8	69.7	239.0	50.9	10.4	44.0	34.7	140.3	11.4	44.9	85.6	118.3	7.3	90.9	192.4	39.6	18.3	31.2	25.6	14.8	29.8	18.2	51.6	118.0	8.7	41.0	13.4	143.2	55.0	53.5	52.1	33.4	9.3	85.6	48.1	76.3	48.7	80.9	26.3	58.4	60.3	16.3	13.8	55.3	85.1	28.7	16.1	43.1	41.3	99.1
ARHGEF28	"p190RhoGEF, RGNEF, RIP2"	ENSG00000214944	"Rho guanine nucleotide exchange factor 28"	Q8N1W1	5	73626158-73941993	"Predicted intracellular proteins"	Differentiation	"Guanine-nucleotide releasing factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.1;Granulosa cells: 83.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 97.8;LHCN-M2: 92.2;TIME: 59.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037602	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytosol"	"Plasma membrane"	"HPA037602: AB_10672282"	"unprognostic (1.97e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.91e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.98e-4)"	4.8	23.9	4.5	1.1	4.7	0.0	7.5	0.4	5.1	3.9	0.0	3.3	3.2	4.1	2.5	6.4	9.8	5.3	1.9	5.0	4.3	31.5	6.4	7.3	0.4	1.6	2.0	19.0	20.7	1.2	6.0	0.5	3.2	5.0	3.7	6.0	19.2	3.6	0.9	14.8	2.5	3.5	1.4	2.8	21.8	1.5	3.2	4.0	13.6	0.9	2.9	3.7	6.6	2.8	30.1	21.0	0.1	2.6	2.6	3.6	0.0	10.8	21.5	13.5	13.3	6.3	12.8	0.1	22.5	3.7	30.4	10.0	1.4	17.4	20.2	0.2	3.1	0.6	3.3	27.2	20.9	0.0	0.0	3.3	7.0	21.0	97.8	25.2	44.4	0.6	0.0	0.0	92.2	2.8	0.0	0.0	0.2	7.9	8.5	0.0	5.5	3.7	36.4	18.0	2.0	3.9	5.3	0.8	0.6	0.0	4.6	0.1	59.8	6.6	9.2	0.5	10.3	1.1	0.0	0.2	10.1	1.4	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	4.7	0.4	5.1	5.0	4.3	1.6	2.0	3.2	1.4	3.2	2.8	9.1	28.9	16.4	3.9	0.2	25.7	14.1	14.1	40.5	4.9	7.5	11.0	2.0	24.3	15.5	31.3	0.0	0.3	2.1	3.7	15.6	13.0	9.6	32.7	1.7	12.8	11.4	2.7	73.1	11.3	0.3	3.1	35.7	12.6	1.3	83.2	2.2	7.3	0.3	13.5	34.5	10.7	40.7	0.3	0.9	2.6	10.2	3.3	1.8	32.8	0.6	26.8	1.0	34.7	15.2	26.3	4.6	5.7	1.2	16.0	3.9	26.7	50.4	1.6	6.6	0.5	7.0	1.0	1.3	20.4	25.6	0.1	1.2	32.3	6.7	17.3
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298504-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	9.8	6.9	8.6	11.1	9.2	34.7	9.1	14.8	10.0	8.6	8.9	7.7	8.8	9.5	6.8	7.4	6.8	9.0	8.7	8.0	11.7	9.4	18.7	10.3	14.9	7.9	7.7	12.5	7.4	9.8	5.4	9.8	7.6	8.6	8.8	14.0	6.7	7.6	5.4	8.7	9.1	8.2	6.8	14.0	8.9	6.9	12.3	14.5	10.6	6.3	11.2	8.4	7.5	10.7	8.5	7.0	19.2	9.5	9.3	11.2	9.7	9.9	8.4	6.6	10.4	8.3	13.1	20.4	10.3	8.4	6.3	9.6	8.6	4.8	9.6	14.3	5.5	9.2	8.2	8.0	5.6	19.7	12.8	8.4	5.2	6.4	6.6	10.5	10.6	11.6	10.7	16.3	7.1	11.5	14.3	17.7	3.8	8.2	8.7	14.5	16.6	6.1	7.1	14.9	16.5	14.3	16.9	8.4	12.0	9.4	14.3	17.8	15.3	11.2	8.7	9.1	4.6	5.3	4.2	18.3	6.7	12.3	5.8	65.8	19.5	59.1	20.6	20.1	23.3	31.5	25.3	22.1	14.9	42.3	27.0	26.5	109.4	29.1	40.8	19.8	19.8	10.1	8.6	9.2	14.8	10.0	8.0	11.7	7.9	7.7	7.6	6.8	12.3	10.7	57.7	83.3	100.9	68.9	73.5	38.4	21.2	22.1	64.3	111.0	29.5	35.8	55.0	24.3	32.3	27.6	52.1	19.9	74.0	33.0	19.6	23.3	18.2	40.5	37.6	47.1	22.8	45.8	94.2	21.7	21.3	40.1	26.0	52.6	65.2	39.9	37.5	41.9	34.7	112.7	78.6	35.5	20.3	47.7	49.5	8.8	36.4	59.3	26.6	63.7	75.8	63.9	49.4	86.5	91.4	24.9	38.6	36.1	55.1	20.9	43.4	14.9	11.2	64.2	19.7	40.0	43.0	38.6	33.8	55.4	33.4	20.4	77.0	34.1	32.9	17.7
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901684-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 968.2;Syncytiotrophoblasts: 920.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 115.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	50.0	8.1	2.9	21.2	5.8	6.9	34.3	3.2	11.3	37.2	20.7	17.5	10.2	39.0	4.6	20.2	20.6	39.3	18.3	4.4	1.6	21.4	8.3	18.3	18.8	7.8	6.9	17.5	6.2	13.3	10.0	21.0	11.4	18.3	11.7	4.1	15.8	10.2	87.2	18.1	14.2	42.5	0.9	16.9	11.5	6.9	9.0	13.1	7.8	11.9	16.7	30.9	19.6	9.7	2.2	0.9	6.0	14.7	13.0	34.0	1.2	42.9	115.2	29.9	23.3	52.7	2.3	3.9	10.1	41.4	4.3	14.3	20.6	6.5	36.0	13.7	6.1	2.1	10.4	13.5	23.9	0.6	25.2	43.3	3.4	17.6	20.2	26.2	3.9	7.5	1.9	5.7	9.9	7.7	14.4	1.1	1.1	10.2	13.5	17.7	9.8	1.1	20.1	23.9	3.3	4.4	19.2	10.6	12.8	13.1	8.7	0.7	3.3	16.5	22.0	25.1	10.9	0.4	0.0	11.4	14.3	0.8	5.4	9.6	1.2	0.8	13.3	2.8	1.8	37.5	19.7	11.8	2.2	41.2	12.8	8.4	2.2	12.3	8.2	1.0	30.9	5.4	2.9	5.8	3.2	11.3	4.4	1.6	7.8	6.9	11.4	0.9	9.0	9.7	86.2	131.4	70.7	54.5	199.8	968.2	453.9	111.3	105.9	54.4	112.8	96.6	72.8	27.1	96.3	51.5	0.0	187.8	89.1	7.5	99.7	56.1	31.7	164.7	231.0	134.1	36.4	5.2	167.8	14.6	150.7	343.6	21.4	457.7	24.6	37.6	119.2	7.4	51.0	74.0	181.9	18.7	22.4	44.1	162.4	20.1	151.6	43.6	138.7	34.7	39.0	17.2	58.7	74.4	155.8	41.1	25.2	60.5	234.5	193.7	5.4	304.8	38.4	3.6	131.5	496.3	463.9	8.2	5.8	65.7	477.8	920.4	178.2	24.3	41.7	233.9
ARL13A	ARL13	ENSG00000174225	"ADP ribosylation factor like GTPase 13A"	Q5H913	X	100969708-100990831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 5.1"	"Group enriched"	"Detected in some"	29	"Early spermatids: 69.8;Late spermatids: 55.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037377, HPA037378"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA037377: AB_2675442, HPA037378: AB_10670932"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.37e-4)"	"unprognostic (2.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.1	5.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	55.5	0.6	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARL15	"ARFRP2, FLJ20051"	ENSG00000185305	"ADP ribosylation factor like GTPase 15"	Q9NXU5	5	53883942-54310582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 441.6;Inhibitory neurons: 285.2;Microglial cells: 408.5;Oligodendrocyte precursor cells: 184.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044604, HPA063820"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Plasma membrane, Cell Junctions"	"HPA044604: AB_10960542, HPA063820: AB_2685131"	"unprognostic (2.18e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.35e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.08e-1)"	14.0	12.5	6.6	5.6	7.5	1.9	13.0	5.6	10.0	17.7	7.2	10.6	11.9	16.0	7.6	9.8	8.2	14.5	14.0	8.5	7.1	17.9	9.8	7.6	6.3	5.8	6.2	5.7	5.0	3.2	8.5	22.3	6.0	10.0	10.9	7.6	10.5	6.8	3.3	11.3	9.9	16.6	6.1	8.2	8.3	9.3	6.8	10.6	8.4	11.7	8.0	13.6	8.8	6.2	3.2	5.5	8.5	15.6	7.0	7.8	11.8	10.2	15.1	9.4	20.7	21.1	8.0	32.0	14.9	9.1	11.0	7.7	13.2	14.1	12.4	3.2	13.9	36.9	7.1	2.8	2.5	4.5	43.8	10.0	10.1	15.8	9.5	14.2	20.8	7.0	32.4	5.3	6.5	7.7	7.5	4.3	3.0	1.6	3.9	6.2	10.4	0.8	12.8	30.3	11.3	7.1	13.1	6.7	7.9	15.6	8.6	4.7	11.4	5.7	9.6	5.4	6.7	1.8	1.7	34.8	9.9	10.6	9.5	1.1	1.8	2.2	1.3	1.4	0.7	1.0	0.9	0.9	2.4	0.7	0.9	0.7	3.5	0.7	1.2	0.3	2.3	1.2	6.6	7.5	5.6	10.0	8.5	7.1	5.8	6.2	6.0	6.1	6.8	6.2	44.5	3.2	7.7	33.6	6.5	9.7	7.9	5.8	8.0	5.1	4.8	5.8	7.5	5.7	4.5	12.9	14.6	52.5	5.2	7.5	21.5	3.2	3.4	4.1	6.9	35.1	20.9	8.6	441.6	4.9	4.9	8.5	6.6	5.1	2.5	3.2	26.0	4.9	8.4	1.7	285.2	7.6	18.3	8.7	8.7	1.5	4.4	12.5	1.8	408.5	5.0	3.2	6.2	184.5	104.7	6.9	7.6	3.8	4.7	5.4	5.7	10.0	3.9	3.0	6.6	3.6	5.3	1.0	3.5	5.9	10.1	42.7	8.9	24.4	7.1	8.4
ARMC12	"C6orf81, FLJ25390"	ENSG00000157343	"Armadillo repeat containing 12"	Q5T9G4	6	35737032-35749079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 64.2"	"Group enriched"	"Detected in some"	96	"Early spermatids: 503.3;Late spermatids: 1116.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.9;HSkMC: 6.1;MOLT-4: 4.8;U-698: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030895, HPA075457, HPA075777"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA030895: AB_10602114, HPA075457: , HPA075777: "	"unprognostic (1.94e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.52e-2)"	"unprognostic (6.36e-4)"	"unprognostic (8.99e-2)"	"unprognostic (1.17e-12)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.09e-1)"	1.6	1.7	4.4	0.6	4.4	0.9	1.5	4.0	5.3	2.5	5.1	1.5	0.0	1.7	5.8	0.8	2.8	0.7	0.7	4.3	4.5	1.5	4.5	1.2	1.3	4.6	5.1	3.0	1.3	0.5	11.2	0.2	4.6	3.6	0.3	1.3	0.6	0.8	1.9	1.1	1.7	0.7	4.3	2.8	1.2	64.2	4.3	3.0	2.4	0.5	0.7	1.1	1.7	4.5	0.0	0.3	2.1	2.7	4.9	2.3	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.5	0.1	0.1	0.8	0.1	0.6	0.1	0.1	1.2	0.6	0.3	0.1	0.0	2.4	0.0	0.0	6.1	1.5	0.1	0.9	2.5	0.5	2.0	0.0	3.2	0.8	0.3	4.8	0.6	0.4	0.0	0.1	2.2	0.0	0.0	0.5	0.0	0.6	2.0	0.0	0.0	0.4	1.0	1.4	0.2	0.0	0.4	0.2	0.1	0.0	0.7	0.2	5.4	0.2	2.8	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.2	0.9	0.0	0.0	0.0	0.8	0.0	0.1	4.4	4.4	4.0	5.3	4.3	4.5	4.6	5.1	4.6	4.3	4.3	4.5	0.8	0.0	0.0	4.6	0.1	0.9	1.9	0.2	1.2	0.0	0.3	0.4	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	503.3	0.4	0.4	0.8	0.0	0.4	0.3	0.0	0.0	0.6	0.0	0.3	0.0	2.4	0.4	2.8	0.0	0.0	0.5	0.2	0.0	1.2	0.8	1116.3	8.4	1.3	0.0	0.0	0.1	0.8	0.0	0.5	0.3	0.0	0.0	4.1	0.0	0.7	0.2	0.3	0.2	0.2	0.0	0.5	0.4	8.1	6.0	0.7	0.1	0.0	0.3	0.2	0.2	0.4
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 88.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.2	11.0	10.4	8.8	10.6	10.3	17.8	10.0	11.5	13.7	6.9	12.8	10.8	15.2	15.5	11.0	15.0	10.0	10.7	11.4	9.3	12.6	11.3	11.2	10.4	7.7	7.0	20.3	14.7	19.9	7.2	8.4	7.6	20.6	15.3	10.6	15.7	13.5	9.3	11.2	12.3	13.9	7.3	8.0	13.5	5.4	9.6	16.2	19.5	10.1	13.3	11.2	6.5	11.4	17.8	15.7	36.4	19.4	15.9	17.8	20.4	17.1	13.1	19.5	34.5	18.7	21.5	0.0	20.3	17.2	22.3	15.1	32.8	16.3	22.1	0.0	13.1	17.9	19.2	15.6	20.6	32.7	20.0	22.3	20.7	16.9	20.3	15.5	20.0	0.0	17.6	0.1	26.3	15.8	23.3	3.9	16.4	30.3	29.5	22.7	88.9	0.1	14.5	24.2	17.1	15.4	30.5	15.7	24.7	10.4	10.8	15.4	20.3	14.5	12.8	16.5	12.3	0.0	13.0	0.0	11.4	32.7	37.8	0.1	11.8	3.2	13.9	12.3	13.3	12.5	12.8	10.9	11.3	6.4	17.8	14.0	1.0	9.3	7.8	10.0	9.7	11.1	10.4	10.6	10.0	11.5	11.4	9.3	7.7	7.0	7.6	7.3	9.6	11.4	6.9	6.4	6.9	0.0	9.0	5.6	11.7	8.0	19.4	16.5	8.9	7.7	4.4	7.2	10.3	9.2	20.9	5.7	9.2	6.8	21.5	10.0	0.3	5.9	8.3	9.6	9.6	3.4	0.0	9.7	2.6	9.9	10.7	5.7	1.3	7.8	5.7	9.6	6.0	1.7	0.0	9.8	4.1	7.2	3.5	0.5	8.4	6.6	8.8	0.0	4.6	6.5	10.3	0.0	0.0	9.3	3.8	6.0	12.0	9.3	9.6	10.6	13.7	20.8	0.0	6.7	7.8	3.0	5.3	14.5	5.7	3.7	9.5	7.5	9.7	11.1
ARMH4	"C14orf37, UT2"	ENSG00000139971	"Armadillo like helical domain containing 4"	Q86TY3	14	57999735-58298139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8;kidney: 8.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 15.8;Collecting duct cells: 12.9;Endometrial ciliated cells: 10.2;Endometrial stromal cells: 7.7;Granulosa cells: 26.0;Theca cells: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.7;AN3-CA: 6.1;fHDF/TERT166: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001580, HPA001789"	Enhanced		Approved	"Plasma membrane"		NA	NA		1800000		"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"		"HPA001580: AB_2666366, HPA001789: AB_1078328"	"unprognostic (2.56e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.87e-8)"	"unprognostic (5.22e-6)"	"unprognostic (4.93e-2)"	"unprognostic (8.74e-4)"	"unprognostic (3.01e-4)"	1.2	2.5	2.3	0.6	3.6	0.7	0.8	8.5	3.5	1.8	0.0	0.7	0.5	3.0	1.8	0.8	2.1	1.8	3.1	2.6	2.1	8.3	0.8	0.7	0.4	11.5	5.1	4.3	1.0	3.6	1.3	0.4	12.8	1.6	1.0	1.2	0.7	1.4	0.2	1.0	0.7	2.3	1.0	0.5	1.4	2.2	1.6	0.2	1.5	1.9	0.3	1.2	0.9	0.7	0.0	0.0	9.7	6.1	4.7	1.7	0.0	1.9	1.5	0.3	0.3	0.5	0.1	0.0	0.6	10.8	1.2	0.0	2.9	0.0	0.4	0.1	1.0	0.0	0.0	0.5	0.2	0.0	4.8	1.8	0.0	0.2	0.2	2.7	0.5	0.8	0.1	0.3	1.2	0.3	0.0	0.0	4.5	0.0	2.0	1.4	0.3	2.5	3.9	0.3	1.1	0.0	0.1	0.0	0.3	2.7	0.2	0.2	0.1	1.3	3.5	0.5	2.6	0.3	0.2	0.0	3.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.6	8.5	3.5	2.6	2.1	11.5	5.1	12.8	1.0	1.6	0.7	15.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	12.9	0.0	0.2	0.7	0.0	0.0	2.1	0.0	10.2	7.7	2.3	0.0	0.0	0.0	1.3	0.4	3.0	0.0	2.4	0.0	26.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.3	44.5	0.0	0.0
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635783	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	86.1	49.2	17.4	148.2	22.5	69.1	48.8	23.7	23.8	46.5	13.0	104.7	99.5	69.5	15.7	77.8	52.0	52.9	35.7	20.0	22.3	39.0	64.3	103.1	158.9	35.2	22.8	30.6	51.7	29.9	19.7	108.2	29.7	46.0	68.9	8.0	45.9	35.9	18.7	42.6	117.4	78.9	24.0	120.8	88.6	38.4	24.1	130.5	46.0	22.5	131.3	75.9	51.8	37.8	313.4	167.7	141.0	98.1	114.0	161.5	338.7	419.7	317.9	176.3	143.0	150.9	215.9	284.9	463.9	241.7	114.6	211.2	101.1	141.6	93.9	413.6	87.1	172.9	212.6	132.6	185.2	254.8	325.0	197.6	148.2	215.7	170.3	201.2	213.7	196.1	133.3	229.1	233.9	125.6	238.5	67.9	133.7	238.5	63.0	219.2	126.3	278.6	97.3	158.7	61.1	164.7	435.8	186.1	167.3	147.1	185.2	222.5	480.9	259.0	134.5	293.8	410.1	270.1	321.8	196.2	204.5	179.6	204.6	1221.0	987.7	1563.7	395.7	1110.1	315.7	338.3	382.3	407.1	838.9	339.7	409.4	415.4	1852.1	392.6	1267.7	394.3	512.4	1913.3	17.4	22.5	23.7	23.8	20.0	22.3	35.2	22.8	29.7	24.0	24.1	37.8	148.7	375.0	188.9	8.1	163.3	249.1	178.3	275.9	91.0	34.2	79.9	118.9	30.2	150.2	197.6	82.8	14.6	475.1	227.4	283.5	166.3	344.3	35.5	78.8	211.4	186.7	202.0	90.0	21.6	280.2	734.2	166.2	87.1	119.8	258.8	147.7	181.7	87.4	608.5	38.7	13.8	146.6	238.0	556.3	740.8	24.2	125.9	558.5	254.3	20.6	635.1	56.7	423.3	7.5	51.5	381.6	234.5	183.6	132.1	182.6	213.6	152.0	95.2	25.4	243.3	83.9	286.8	151.9	137.3	161.5	244.9	199.5	234.4	144.4	155.4	234.6
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443674	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 345.8;Late spermatids: 460.2;Oligodendrocyte precursor cells: 622.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 11.6;monocytes: 6.7"	"Cell line enhanced"	"Detected in all"		"TIME: 167.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		31000	"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.63e-8)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	35.1	22.2	13.5	12.2	15.1	47.8	24.0	7.6	22.0	17.6	3.9	13.4	5.5	19.0	12.2	10.7	17.2	14.6	24.7	14.7	10.5	11.9	9.3	30.1	18.0	14.2	20.9	18.2	7.8	18.1	10.5	27.8	16.5	12.7	8.9	8.6	8.5	11.4	13.4	17.3	12.2	17.9	9.4	30.0	10.6	28.5	29.1	16.3	16.4	10.4	19.0	15.9	15.6	17.1	48.9	31.5	41.1	27.4	46.7	61.9	37.1	44.2	83.8	57.2	62.3	17.5	18.2	14.4	31.8	67.7	38.6	13.2	24.7	41.4	86.3	20.6	15.9	22.6	20.7	23.6	119.9	10.4	6.7	61.7	15.3	33.6	50.3	66.9	60.2	7.7	13.0	45.7	54.0	15.1	13.3	9.8	13.1	24.1	30.5	13.6	9.6	7.0	18.1	25.2	14.6	44.4	32.4	20.5	26.5	42.5	17.0	22.4	167.5	45.9	28.9	20.6	69.8	42.2	12.0	9.7	34.6	14.6	50.3	0.0	2.2	1.5	0.5	2.1	0.3	1.3	1.0	0.9	3.7	1.0	1.3	0.8	11.6	0.6	6.7	0.4	0.8	1.1	13.5	15.1	7.6	22.0	14.7	10.5	14.2	20.9	16.5	9.4	29.1	17.1	97.2	3.2	6.3	206.6	22.7	47.7	21.9	12.0	29.6	25.0	12.4	14.7	33.7	27.1	11.5	3.7	16.7	42.2	14.6	3.6	3.9	10.5	159.7	14.3	34.2	109.1	13.1	98.9	345.8	8.7	37.6	43.7	4.6	27.7	9.5	30.1	103.9	8.2	64.0	62.2	225.8	4.3	8.2	56.1	168.8	460.2	39.1	73.1	44.4	181.8	71.4	9.5	15.5	622.3	245.9	12.5	4.7	54.9	13.7	37.9	5.8	4.3	4.2	7.8	78.9	28.5	90.1	61.4	95.5	25.2	44.9	46.7	23.1	58.9	4.8	22.0
ASB5		ENSG00000164122	"Ankyrin repeat and SOCS box containing 5"	Q8WWX0	4	176213673-176277571	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 217.2;tongue: 67.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 52.7;Late spermatids: 293.6;Skeletal myocytes: 79.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.5;prostate cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 1184.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028870			Approved	"Plasma membrane"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA028870: AB_10611679"					"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-4)"		"unprognostic (1.90e-1)"			"unprognostic (7.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"		"unprognostic (6.80e-3)"	0.1	0.0	0.4	0.9	0.5	0.0	0.0	1.3	1.0	1.0	0.2	11.1	0.3	0.6	0.1	10.5	0.1	1.2	3.9	0.5	0.4	0.7	0.0	0.2	0.0	0.9	1.5	0.0	0.0	0.1	0.4	0.0	0.8	12.9	3.3	0.0	23.9	0.3	217.2	0.2	1.2	2.5	0.8	0.0	4.7	7.3	0.5	0.1	0.0	67.0	0.0	19.2	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	29.1	0.0	25.9	54.7	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	61.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1184.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.3	1.0	0.5	0.4	0.9	1.5	0.8	0.8	0.5	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.7	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	293.6	1.2	0.3	0.0	0.0	0.0	0.0	0.0	11.6	0.8	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	79.6	0.6	0.9	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Assembly factor for spindle microtubules"	Q8IZT6	1	197084121-197146694	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 10.1;lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.5;Granulosa cells: 121.1;Plasma cells: 44.8;Spermatocytes: 43.8;Spermatogonia: 44.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017816			Approved	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.2	0.1	0.0	3.0	0.0	10.1	0.4	0.0	0.1	0.2	0.0	1.6	2.1	0.3	0.0	1.5	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.3	5.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	1.9	0.0	0.2	0.0	0.0	2.7	1.9	0.7	0.0	0.9	1.1	3.2	0.1	17.0	0.1	0.0	5.1	0.6	0.4	0.2	44.6	22.9	39.1	23.2	1.9	5.5	14.7	35.1	23.2	32.6	25.6	16.7	31.1	45.4	12.5	27.5	13.8	40.2	33.6	12.1	39.1	41.8	25.4	33.1	56.1	12.8	0.4	51.9	20.5	0.6	1.0	26.1	15.2	7.3	31.5	32.9	41.8	50.7	29.0	16.0	40.6	10.3	17.8	24.8	6.4	30.2	55.5	31.7	7.4	11.4	20.4	29.5	50.6	20.6	9.5	20.8	26.9	12.7	28.9	20.9	20.0	34.9	61.2	13.9	21.6	26.8	14.9	11.0	42.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	1.1	1.3	5.8	6.1	1.5	4.0	2.2	0.1	2.4	2.4	1.1	0.0	1.3	1.8	0.0	20.0	7.8	7.7	0.0	0.3	3.9	2.9	6.2	4.3	0.0	99.5	2.0	0.0	14.8	9.8	13.3	8.1	1.3	121.1	6.4	2.2	11.6	0.0	4.8	6.8	4.1	6.4	2.4	4.5	0.6	6.4	0.0	0.0	0.9	0.7	4.1	0.0	1.0	0.5	0.2	1.5	44.8	2.0	0.4	0.4	0.8	0.3	0.0	0.6	7.0	43.8	44.7	27.1	3.4	3.7	9.1	5.7	16.9	2.1
ATG13	KIAA0652	ENSG00000175224	"Autophagy related 13"	O75143	11	46617527-46674818	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039350			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039350: AB_10673142"	"unprognostic (3.66e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.47e-1)"	32.3	39.7	55.9	26.1	67.6	60.5	30.1	49.4	63.7	30.6	46.1	26.5	29.3	28.2	32.2	32.0	32.1	29.6	36.8	55.2	51.8	28.7	43.9	25.3	31.5	60.2	59.4	29.7	44.6	37.5	57.7	21.9	61.8	31.1	24.1	48.4	35.9	25.5	34.5	39.6	28.0	24.8	51.8	36.4	36.4	82.0	59.6	40.6	36.8	33.4	33.6	27.4	29.1	87.9	32.8	58.5	44.1	26.1	60.2	70.0	44.5	37.5	65.4	45.0	57.0	40.2	31.7	30.2	25.6	56.5	58.1	38.8	42.7	50.3	45.2	57.9	81.1	32.8	39.7	71.2	67.4	44.1	54.1	84.9	59.0	31.0	67.9	63.9	45.0	69.4	57.8	66.8	40.8	48.8	44.0	65.1	55.0	59.5	49.9	41.4	57.0	53.7	29.9	34.5	41.6	42.1	51.2	40.6	55.4	42.1	58.0	89.5	44.6	54.7	33.3	51.1	41.2	61.1	73.8	38.6	67.8	39.3	40.9	41.7	36.1	48.5	35.1	42.6	27.9	27.1	31.2	27.8	35.0	21.7	26.4	29.2	67.7	31.5	35.1	25.6	44.7	39.9	55.9	67.6	49.4	63.7	55.2	51.8	60.2	59.4	61.8	51.8	59.6	87.9	10.6	16.0	16.2	14.7	16.9	9.3	12.0	9.0	13.1	22.7	16.7	12.3	13.2	8.6	12.0	12.9	39.6	9.9	25.4	24.5	7.9	18.9	42.7	30.0	17.3	12.7	18.0	28.2	23.4	32.3	22.4	14.8	20.9	46.1	8.8	22.5	13.2	22.5	15.1	33.7	25.7	22.6	14.2	19.1	9.8	46.8	11.5	15.7	12.4	15.0	22.8	16.3	19.6	25.1	61.0	30.4	12.9	11.3	36.6	19.9	19.5	13.5	9.4	32.2	13.1	16.9	19.9	46.3	16.3	15.8	11.5	26.4	18.0	9.8	11.9	24.3
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Excitatory neurons: 178.7;Inhibitory neurons: 176.4;Late spermatids: 119.1;Microglial cells: 132.1;Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 60.1;classical monocyte: 136.6;eosinophil: 88.4;intermediate monocyte: 79.4;myeloid DC: 82.4;neutrophil: 107.4;non-classical monocyte: 60.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 82.4;granulocytes: 107.4;monocytes: 136.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		33000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	16.8	13.5	11.2	25.0	13.1	47.6	18.0	7.3	21.8	14.5	17.0	17.3	13.0	14.9	16.7	16.7	18.7	16.6	10.8	12.4	9.5	13.7	13.2	20.9	23.9	15.0	15.0	12.2	10.9	21.2	7.5	21.0	13.1	11.6	19.2	10.3	12.2	11.9	13.0	18.0	13.8	20.0	12.4	16.4	14.4	22.5	15.4	13.1	13.0	13.5	25.0	20.3	12.0	21.3	48.5	37.1	16.7	9.2	28.0	36.7	80.4	44.5	56.8	43.1	49.9	16.0	42.5	22.1	26.5	39.2	45.1	14.5	18.3	62.0	73.8	19.8	23.5	16.0	33.6	19.6	36.9	46.8	50.8	38.0	28.2	83.6	52.0	45.4	60.5	14.0	24.1	17.9	60.6	31.3	13.7	21.3	13.0	22.2	47.9	17.1	19.6	19.9	32.5	34.2	14.6	14.5	31.6	26.4	17.5	20.1	28.8	44.7	42.5	36.0	25.7	23.6	63.2	11.1	31.8	38.1	57.8	43.1	49.9	60.1	136.6	88.4	15.9	79.4	12.3	13.0	12.9	15.1	82.4	12.3	11.7	13.7	107.4	21.3	60.8	14.7	12.4	56.8	11.2	13.1	7.3	21.8	12.4	9.5	15.0	15.0	13.1	12.4	15.4	21.3	6.4	0.0	9.8	160.0	11.4	11.1	7.3	21.6	9.6	18.1	7.4	3.6	4.2	4.3	12.5	7.3	18.8	16.5	7.9	8.3	7.9	12.3	44.2	10.6	9.5	14.6	11.4	9.5	178.7	12.9	16.8	11.0	10.7	13.2	14.7	12.4	19.6	9.0	57.6	20.2	176.4	7.6	22.4	25.8	12.1	119.1	10.2	28.8	3.6	132.1	30.6	8.1	13.4	99.0	137.2	17.4	7.3	9.8	10.8	6.4	8.4	6.8	16.5	12.5	6.6	11.7	10.6	22.4	11.9	9.8	7.7	19.2	10.1	9.9	7.6	7.4
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311956-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 171.4;Extravillous trophoblasts: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		3900000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	24.8	26.0	19.8	31.7	23.4	26.4	33.9	21.4	23.5	22.2	18.8	36.4	32.0	30.0	20.3	19.4	29.4	20.4	21.3	19.6	21.5	32.7	34.6	18.0	44.9	20.5	21.5	32.0	26.2	29.6	18.6	37.3	23.3	28.7	47.5	19.1	18.8	38.4	43.2	23.8	27.2	37.0	21.0	27.6	24.5	20.1	22.9	41.8	22.5	25.4	51.8	29.1	17.6	27.5	102.2	133.8	85.1	144.0	112.5	113.2	40.6	105.4	91.9	117.4	134.9	278.6	157.3	149.6	122.8	110.0	164.5	106.7	187.8	157.0	169.5	113.4	189.3	179.1	108.7	271.5	145.4	226.1	92.0	98.4	119.8	154.7	188.5	82.0	79.7	144.5	237.0	124.4	166.3	178.7	203.4	112.1	330.3	167.4	84.9	185.8	117.3	133.4	126.4	146.5	129.3	87.8	84.3	103.1	124.3	189.2	169.7	82.9	70.2	96.0	101.2	127.3	65.8	160.3	195.7	300.1	85.6	124.5	146.8	12.6	16.4	0.4	34.6	23.5	59.1	56.6	49.0	53.8	36.3	39.9	50.0	46.9	1.8	55.4	21.1	31.7	50.2	29.0	19.8	23.4	21.4	23.5	19.6	21.5	20.5	21.5	23.3	21.0	22.9	27.5	7.2	12.8	19.3	18.6	34.7	15.0	28.2	55.0	30.7	10.0	18.2	16.1	21.1	28.6	33.3	23.9	4.2	171.4	23.3	17.6	27.4	45.2	1.1	20.7	28.2	6.1	19.2	32.2	15.4	49.3	166.3	25.3	22.4	20.8	25.3	32.9	5.3	22.2	52.4	10.1	15.4	33.8	26.4	14.4	10.8	1.7	23.9	20.2	30.2	2.8	26.1	21.3	26.8	16.6	25.7	32.4	28.5	34.3	36.3	24.0	18.8	52.7	27.3	14.7	26.3	19.2	29.0	3.3	43.8	24.6	8.5	95.4	29.8	40.7	58.4	18.1
ATOX1	HAH1	ENSG00000177556	"Antioxidant 1 copper chaperone"	O00244	5	151742316-151772532	"Predicted intracellular proteins"	"Copper transport, Ion transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 932.7;Proximal tubular cells: 1449.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055036			Approved	"Nucleoplasm,Plasma membrane"		NA	NA		790000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane"	"HPA055036: "	"unprognostic (5.55e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.53e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-1)"	102.0	136.9	173.3	65.9	183.6	73.8	100.1	180.8	201.1	84.4	181.9	84.7	81.8	73.7	98.0	112.1	64.6	63.6	107.4	170.0	189.7	217.1	260.9	80.3	142.9	181.9	184.7	57.8	57.1	180.6	81.2	69.8	183.6	100.2	64.3	24.9	93.0	74.6	53.6	102.8	83.0	75.9	184.9	124.4	76.1	72.9	185.6	82.6	119.3	39.5	128.2	91.7	84.2	192.8	112.0	181.9	104.4	73.1	275.1	224.2	136.6	197.7	225.8	197.2	267.3	248.2	235.8	224.9	233.3	345.7	437.1	102.4	129.2	502.5	161.3	143.9	220.3	98.7	118.4	255.1	254.1	137.5	108.5	291.3	105.0	246.0	161.1	144.7	295.3	138.5	83.4	642.7	305.1	276.6	102.3	304.0	59.8	249.8	382.3	61.4	120.0	350.0	190.6	98.1	136.2	80.0	169.3	476.6	763.4	117.2	234.2	165.3	328.5	201.0	159.4	246.9	345.9	522.6	513.4	136.2	271.7	92.3	846.1	154.6	207.9	199.4	75.1	247.6	69.0	98.6	67.3	66.2	171.3	68.3	53.0	58.0	155.3	97.0	177.2	217.8	103.5	117.3	173.3	183.6	180.8	201.1	170.0	189.7	181.9	184.7	183.6	184.9	185.6	192.8	209.1	57.7	56.6	8.1	93.2	67.7	79.8	204.5	70.0	22.7	250.1	246.5	112.1	165.8	102.2	211.5	14.6	146.0	65.6	213.6	541.9	207.6	178.9	121.1	171.1	183.2	150.7	104.1	6.4	159.1	218.7	127.3	96.8	135.3	73.0	117.8	236.7	932.7	671.2	25.2	9.1	171.1	164.8	221.4	166.0	321.1	83.0	230.4	238.3	4.7	436.7	185.7	88.6	5.5	22.7	318.1	238.7	103.4	170.4	124.2	727.0	1449.1	108.5	24.9	92.1	69.0	235.2	81.9	156.0	153.1	106.4	118.8	55.4	96.6	152.7	122.2
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	38.0	22.5	8.5	32.0	9.3	36.9	22.8	12.2	14.8	17.0	18.4	21.2	20.2	18.9	17.0	18.0	17.4	24.2	55.7	10.4	9.3	36.2	87.0	35.5	20.8	9.7	8.4	15.9	16.4	50.3	15.3	54.8	9.1	15.5	22.0	11.6	21.8	15.2	17.0	11.5	16.6	16.9	9.5	16.9	24.4	9.6	12.8	16.3	46.0	14.4	19.4	40.1	16.3	10.1	184.6	19.3	33.0	35.2	49.7	64.9	96.8	62.7	75.4	74.9	132.5	114.1	45.2	74.2	161.1	89.4	197.9	64.2	37.5	66.9	171.4	175.5	31.4	43.1	24.8	31.7	77.1	139.7	91.6	32.6	36.8	127.8	89.0	105.0	38.0	34.9	46.2	139.1	90.7	41.0	53.9	34.8	41.1	64.5	33.5	40.0	77.1	48.8	71.6	53.4	52.4	30.5	64.1	77.9	52.9	31.2	127.7	92.4	37.1	81.2	64.2	162.1	116.5	93.4	141.2	116.6	149.3	80.6	55.7	0.2	0.4	0.4	0.4	0.6	0.5	0.4	0.4	0.7	0.6	0.2	0.5	0.5	0.0	0.6	0.2	0.3	1.0	0.2	8.5	9.3	12.2	14.8	10.4	9.3	9.7	8.4	9.1	9.5	12.8	10.1	56.6	51.3	34.1	51.6	22.3	82.5	49.1	42.1	21.1	25.9	32.1	16.6	50.0	78.6	35.9	49.7	20.9	29.6	26.6	43.7	3.9	66.6	2.0	52.3	65.4	50.5	30.6	23.5	61.8	71.4	19.0	53.2	42.8	181.8	8.8	27.9	68.9	153.2	37.2	15.2	80.6	24.1	26.4	31.1	384.4	2.3	10.2	110.1	62.2	76.8	27.0	8.4	18.6	64.3	49.6	87.8	23.7	13.2	37.8	94.3	11.6	41.4	31.7	13.6	13.1	35.8	42.4	15.2	6.8	36.5	71.2	64.6	24.4	14.1	24.7	69.9
ATP13A5	FLJ16025	ENSG00000187527	"ATPase 13A5"	Q4VNC0	3	193274789-193378820	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"breast: 17.3;choroid plexus: 38.5;salivary gland: 11.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 37.9;Oligodendrocyte precursor cells: 26.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA031771, HPA031772, HPA031774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	Nucleoplasm	"HPA031771: AB_2674038, HPA031772: , HPA031774: AB_2674039"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-4)"		"unprognostic (2.06e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.93e-1)"		"unprognostic (1.67e-4)"	"unprognostic (3.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.14e-2)"		"unprognostic (1.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.10e-2)"		0.0	0.1	2.3	0.0	1.9	0.2	17.3	1.5	2.7	0.0	38.5	0.0	0.0	0.1	0.8	0.7	0.1	0.0	0.2	3.1	1.8	0.2	0.0	0.5	0.1	1.6	2.3	0.2	0.1	0.2	0.3	0.0	1.5	0.0	0.0	0.8	11.7	0.0	1.3	3.9	0.0	0.0	0.8	0.0	1.6	0.4	2.4	0.0	1.3	0.1	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	2.3	1.9	1.5	2.7	3.1	1.8	1.6	2.3	1.5	0.8	2.4	1.8	0.1	0.0	0.5	37.9	0.0	0.0	0.0	0.3	0.0	0.0	5.8	5.8	0.7	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.4	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.9	0.0	0.0	0.0	26.2	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.4;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 56.2;Club cells: 50.0;Intestinal goblet cells: 82.3;Oligodendrocyte precursor cells: 58.8;Respiratory ciliated cells: 78.2;Undifferentiated cells: 77.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 24.5;OE19: 44.4;RT4: 19.3;SK-BR-3: 33.0;T-47d: 11.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.0	0.0	1.4	2.4	1.4	11.0	2.5	0.5	1.3	6.4	0.5	30.1	27.3	1.0	0.1	4.7	6.8	4.6	0.0	1.3	1.1	1.8	0.1	10.5	0.0	1.0	0.9	0.0	0.7	3.3	1.0	0.9	1.0	12.5	37.4	0.9	19.6	0.2	0.1	26.0	20.3	0.6	0.6	0.4	5.9	0.4	1.1	0.0	8.9	0.0	0.5	4.0	4.6	0.8	6.2	0.4	0.9	0.1	0.0	0.0	6.4	0.2	0.0	0.0	0.0	5.8	5.2	0.0	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	44.4	0.1	0.0	0.0	0.2	0.0	19.3	4.9	0.0	0.0	33.0	0.2	0.9	11.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	1.4	0.5	1.3	1.3	1.1	1.0	0.9	1.0	0.6	1.1	0.8	0.0	32.1	56.2	4.2	0.0	0.6	14.3	39.9	0.6	1.3	20.8	3.2	0.8	5.7	50.0	0.0	0.0	2.0	0.1	44.4	0.0	9.0	3.2	26.8	2.5	0.7	34.2	0.0	8.3	2.5	2.4	0.5	22.4	28.0	8.9	0.0	0.0	0.1	0.3	0.0	1.8	82.3	8.2	0.0	1.2	1.9	0.0	0.6	1.8	1.0	0.0	1.9	0.0	58.8	2.4	4.7	29.2	0.0	0.0	13.8	10.2	1.8	78.2	5.2	0.0	0.1	1.8	0.8	1.0	1.5	1.1	24.1	0.9	0.2	77.1	9.9
ATP6V1H	"CGI-11, SFD, SFDalpha, SFDbeta, VMA13"	ENSG00000047249	"ATPase H+ transporting V1 subunit H"	Q9UI12	8	53715543-53843558	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009532, HPA023421"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		8300	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB009532: AB_667834, HPA023421: AB_1845202"	"unprognostic (1.67e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.30e-2)"	"prognostic favorable (1.46e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	24.1	44.6	42.5	15.9	46.7	25.6	26.0	27.5	58.8	23.9	30.2	31.6	12.9	25.4	32.9	34.1	22.6	20.7	31.2	57.4	38.0	60.5	19.1	24.2	21.4	30.5	30.2	24.1	17.4	47.7	42.4	23.9	32.7	30.2	20.4	37.4	28.7	27.4	37.8	35.2	19.1	24.1	29.4	20.3	31.8	18.5	31.0	26.6	52.4	27.3	22.0	28.5	26.4	37.9	42.8	35.6	29.8	31.8	50.9	32.9	23.4	40.5	44.5	54.8	56.7	33.5	54.1	27.2	38.7	40.9	69.7	67.8	52.6	58.9	56.1	39.9	35.8	28.8	34.3	40.9	69.1	19.6	31.8	46.5	82.3	37.2	66.4	52.5	37.8	28.9	39.4	14.0	81.6	36.0	30.6	32.5	27.4	37.0	17.4	28.2	10.6	18.6	88.4	67.4	23.5	34.9	28.7	54.6	79.5	34.4	64.0	16.3	43.2	24.4	19.7	54.6	25.5	25.9	30.4	32.3	57.8	27.4	27.5	25.7	14.8	36.2	13.2	16.6	14.9	13.6	14.3	15.4	20.2	12.0	14.4	16.0	14.5	22.6	23.4	15.9	20.7	11.8	42.5	46.7	27.5	58.8	57.4	38.0	30.5	30.2	32.7	29.4	31.0	37.9	18.2	38.5	27.4	84.2	39.0	29.6	40.1	55.5	42.1	72.8	27.8	21.0	28.9	38.6	50.3	58.8	112.6	76.0	35.9	39.0	105.7	49.1	8.3	94.1	27.7	25.4	35.3	27.0	154.7	31.1	43.6	23.6	26.0	145.7	15.8	22.0	28.9	21.9	64.7	62.2	105.8	17.4	75.3	43.0	103.6	8.5	43.2	52.9	30.2	42.2	35.1	48.4	37.0	58.3	57.7	44.1	30.1	48.2	20.9	32.5	31.4	64.9	39.6	76.4	19.7	16.8	24.6	28.5	52.9	37.6	31.4	100.0	38.1	36.4	21.8	41.4
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106621	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124"	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	9.0	5.9	3.8	5.7	4.2	9.9	6.8	4.9	5.0	7.5	3.3	7.3	3.7	6.4	4.3	10.3	6.0	6.5	5.3	3.6	5.0	5.6	9.6	6.8	7.7	6.2	5.7	7.1	4.5	6.4	4.0	7.0	6.2	6.0	6.8	3.9	5.8	5.5	3.3	12.9	4.8	8.6	4.3	5.6	5.2	9.3	4.3	8.0	5.9	5.9	9.8	9.0	8.0	4.9	8.6	16.7	14.6	13.6	20.9	20.1	28.4	9.7	15.4	11.9	16.5	12.3	23.2	17.6	18.5	15.8	14.1	14.6	11.6	21.0	26.3	20.0	3.5	7.4	8.0	18.2	17.3	13.5	12.6	16.5	18.1	20.9	21.8	15.9	18.7	19.4	10.1	12.5	18.2	33.1	14.0	11.9	10.4	28.5	13.6	11.0	27.0	9.9	15.3	19.4	5.3	8.8	23.1	9.5	13.3	19.6	18.1	9.1	10.0	11.7	17.0	7.5	5.2	10.8	19.8	16.2	8.3	12.9	6.9	13.5	14.3	10.8	6.1	16.5	7.4	7.7	7.0	6.9	16.2	10.6	7.8	8.8	12.2	8.7	23.0	9.3	8.1	6.3	3.8	4.2	4.9	5.0	3.6	5.0	6.2	5.7	6.2	4.3	4.3	4.9	55.0	16.0	12.4	33.6	27.6	25.4	28.6	29.8	19.4	35.4	16.9	18.4	19.3	15.7	20.0	42.3	50.1	20.3	31.5	13.8	15.6	25.8	19.8	20.3	34.9	53.0	16.1	30.3	36.1	17.3	29.8	34.6	18.3	22.5	24.6	25.9	49.6	21.1	22.4	26.9	28.6	16.4	12.2	35.1	27.2	26.8	67.7	30.0	23.2	28.1	48.0	20.4	29.9	39.2	51.5	19.6	16.1	65.1	20.1	31.9	16.6	17.7	16.0	46.7	46.0	51.9	38.2	39.1	57.2	21.6	30.3	25.3	28.8	24.8	18.9	28.2
ATXN7L3	DKFZp761G2113	ENSG00000087152	"Ataxin 7 like 3"	Q14CW9	17	44191805-44200113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064316	Supported		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Plasma membrane"	"HPA064316: AB_2685243"	"unprognostic (2.37e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (2.86e-3)"	"unprognostic (6.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.40e-1)"	23.3	24.6	51.0	32.6	58.1	45.0	21.3	28.0	76.6	28.4	12.0	26.8	31.2	28.3	25.9	40.1	26.5	24.1	24.9	58.5	35.9	29.2	28.0	25.2	37.2	58.3	42.4	25.5	24.2	24.5	35.1	30.7	60.6	26.9	24.3	21.5	27.9	27.7	25.3	31.2	29.6	25.8	33.0	36.3	28.3	36.9	48.3	42.1	29.1	22.6	35.5	28.7	28.1	54.1	40.9	67.7	73.3	47.8	50.1	49.5	39.8	49.1	54.3	61.4	57.7	52.0	45.1	71.3	38.6	55.5	56.6	43.9	57.7	46.1	51.2	83.6	57.2	48.5	58.9	58.5	49.3	76.3	94.3	56.1	69.0	51.7	54.1	65.0	60.3	54.2	66.1	43.5	40.8	30.7	92.3	58.0	55.1	36.7	52.5	62.8	70.9	54.1	49.8	57.9	46.5	59.0	29.0	25.4	50.5	101.4	62.0	67.1	52.2	61.5	63.8	32.3	46.5	52.1	73.8	86.4	40.6	32.6	36.8	0.4	1.2	1.5	1.7	0.7	1.0	1.4	1.4	1.1	1.0	2.4	1.0	1.3	2.5	0.5	0.9	1.6	0.8	1.1	51.0	58.1	28.0	76.6	58.5	35.9	58.3	42.4	60.6	33.0	48.3	54.1	14.3	3.2	3.7	5.5	9.4	7.1	5.6	8.0	8.6	17.4	13.7	9.1	6.2	5.7	6.6	18.4	16.7	6.3	11.3	22.2	3.9	7.1	14.7	14.0	16.9	10.5	14.4	4.0	9.1	13.1	6.7	7.2	8.6	20.7	2.5	9.9	10.4	8.1	8.4	28.6	8.6	11.0	4.1	11.1	10.9	40.0	9.0	10.0	5.4	8.4	12.7	8.6	5.2	3.0	5.3	15.0	13.6	5.7	5.5	8.6	14.1	4.6	7.6	13.9	6.6	6.7	9.3	6.3	8.5	11.0	10.5	13.7	10.0	10.4	11.2	9.1
AVEN	PDCD12	ENSG00000169857	"Apoptosis and caspase activation inhibitor"	Q9NQS1	15	33858782-34075155	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 44.0;Oligodendrocytes: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020863	Approved		Approved	"Plasma membrane,Actin filaments,Centrosome"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Actin filaments"	Centrosome	"HPA020863: AB_1845219"	"unprognostic (1.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.77e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (5.29e-10)"	"unprognostic (7.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-3)"	13.7	11.4	8.5	7.2	8.6	4.4	10.8	8.9	10.1	11.4	10.5	15.2	7.4	12.5	5.2	12.3	11.3	6.4	28.5	8.2	9.2	5.5	16.9	7.2	4.8	9.2	9.0	10.5	20.8	3.0	5.8	12.4	9.4	9.4	9.4	2.5	7.9	9.1	31.1	11.2	7.5	12.5	8.8	6.5	12.3	10.7	9.0	6.9	5.6	13.6	7.9	16.2	10.8	9.1	16.4	26.3	26.0	8.6	21.4	24.1	14.7	41.1	36.2	31.9	19.9	7.2	11.3	15.2	24.8	34.8	24.2	10.4	12.2	26.9	25.7	14.6	7.7	26.1	15.9	20.5	31.5	26.6	18.2	19.8	50.9	18.4	45.8	38.6	35.2	7.6	26.6	21.1	45.6	17.3	10.5	46.1	11.9	22.2	8.5	15.7	14.6	32.2	26.4	21.0	13.4	16.8	22.6	11.6	11.4	10.7	12.6	29.4	24.5	27.7	9.5	12.0	34.6	21.2	17.7	31.1	13.3	31.0	15.2	0.0	0.2	0.0	0.5	0.6	0.6	0.4	0.5	0.2	0.2	0.1	0.2	0.3	0.0	0.5	0.2	2.3	0.9	0.1	8.5	8.6	8.9	10.1	8.2	9.2	9.2	9.0	9.4	8.8	9.0	9.1	9.0	3.2	5.3	16.6	5.6	5.7	8.7	1.8	3.4	5.6	7.5	9.0	32.7	2.8	0.8	0.0	6.2	11.0	10.5	7.4	0.0	2.9	13.8	4.4	14.3	10.2	4.8	9.5	21.8	8.6	44.0	8.5	5.6	5.6	0.0	14.7	8.6	19.1	7.4	8.4	24.1	7.7	0.0	4.1	4.4	6.5	7.5	5.0	3.6	22.5	3.5	10.9	7.2	26.7	86.6	7.0	5.2	10.5	15.6	21.5	9.4	4.6	1.5	5.3	6.6	4.9	9.7	6.2	7.4	12.9	9.7	9.4	6.5	23.1	6.0	14.7
AVPI1	"PP5395, VIP32, VIT32"	ENSG00000119986	"Arginine vasopressin induced 1"	Q5T686	10	97677424-97687241	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 100.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 246.7;Granulosa cells: 385.5;Langerhans cells: 326.1;Late spermatids: 278.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 119.7;HHSteC: 119.1;hTCEpi: 230.5;SK-MEL-30: 194.5;U-2197: 134.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037649	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA037649: AB_10671879"	"unprognostic (4.57e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-2)"	"unprognostic (7.34e-3)"	"unprognostic (8.56e-3)"	"unprognostic (2.29e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.83e-3)"	32.1	41.5	18.5	6.5	25.4	5.0	21.2	21.9	23.2	38.1	16.2	24.6	14.0	11.2	4.7	26.2	18.9	10.4	22.4	18.3	19.8	12.1	46.9	22.5	2.4	23.7	20.2	85.6	9.4	5.6	19.2	16.9	21.9	26.3	18.9	25.5	22.7	16.6	12.5	100.7	15.6	5.3	22.4	20.8	30.5	16.0	20.8	2.0	9.1	3.9	4.4	25.5	46.0	29.5	38.8	99.8	0.5	14.3	20.2	9.1	20.0	18.5	100.7	25.0	37.5	18.8	47.2	0.8	13.0	10.5	18.0	40.0	7.6	32.3	9.4	1.0	8.9	2.6	119.7	52.6	119.1	2.6	3.0	14.6	230.5	18.7	49.1	22.8	3.4	3.6	5.7	2.0	14.0	33.4	1.7	3.1	3.5	10.6	9.3	1.3	11.3	1.5	24.9	20.9	1.7	4.0	63.9	22.7	194.5	3.2	17.2	3.1	5.5	5.9	11.7	134.4	4.6	4.4	3.3	0.8	22.2	8.1	3.8	0.0	6.2	2.3	4.2	5.7	2.0	2.8	2.8	3.1	11.1	2.0	3.0	3.7	0.5	2.0	0.5	2.3	2.6	2.9	18.5	25.4	21.9	23.2	18.3	19.8	23.7	20.2	21.9	22.4	20.8	29.5	6.3	19.2	19.0	0.7	8.0	96.0	87.6	246.7	145.1	9.6	13.6	16.8	9.7	52.9	63.4	38.6	6.2	149.6	15.4	137.5	43.0	18.8	60.9	33.2	17.1	11.4	31.8	2.1	3.6	24.1	64.8	23.4	58.1	57.9	6.3	385.5	34.2	42.4	41.8	13.5	4.3	70.4	48.8	21.7	326.1	278.5	10.2	49.6	83.6	0.0	6.4	128.2	2.1	0.5	4.4	43.3	100.6	14.7	5.9	55.2	109.0	11.2	16.7	14.6	6.6	10.2	19.3	3.5	4.9	68.0	108.4	194.7	19.0	10.9	100.6	106.3
B3GALT2	beta3Gal-T2	ENSG00000162630	"Beta-1,3-galactosyltransferase 2"	O43825	1	193178730-193186613	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.2;gallbladder: 15.0;heart muscle: 21.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 46.6;Cardiomyocytes: 34.4;Excitatory neurons: 27.6;Inhibitory neurons: 28.3;Leydig cells: 31.7;Peritubular cells: 21.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"MAIT T-cell: 8.4"	"Lineage enriched"	"Detected in single"	53	"T-cells: 8.4"	"Group enriched"	"Detected in some"	4	"AF22: 18.3;ASC TERT1: 8.1;LHCN-M2: 12.6;WM-115: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078659			Approved	"Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA078659: AB_2686887"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.34e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.14e-4)"	"unprognostic (4.41e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-3)"	0.3	1.2	13.4	0.7	15.3	0.2	0.3	4.9	17.1	0.2	2.3	1.0	0.9	0.1	1.0	0.6	0.2	15.0	21.0	17.2	7.1	0.9	0.2	1.8	0.2	5.8	7.4	10.4	0.2	0.0	0.5	0.3	5.8	4.7	1.2	6.6	0.1	5.1	0.1	0.2	3.0	0.1	7.0	0.8	1.3	0.7	8.5	0.0	1.0	0.3	0.9	1.4	0.3	15.9	0.0	0.0	18.3	0.0	0.5	8.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.6	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.2	0.0	8.4	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	13.4	15.3	4.9	17.1	17.2	7.1	5.8	7.4	5.8	7.0	8.5	15.9	0.6	0.0	0.5	1.6	0.9	0.3	0.1	0.0	0.6	46.6	0.0	0.1	34.4	11.5	0.0	1.8	4.2	0.0	0.2	0.1	0.0	0.1	0.0	0.3	1.3	1.1	3.0	0.8	27.6	0.0	0.0	2.0	0.0	0.9	2.5	0.4	0.7	0.1	0.3	8.4	28.3	0.7	0.0	0.6	0.3	0.7	31.7	0.7	0.0	4.7	0.0	2.4	0.0	12.1	9.3	0.5	0.1	21.1	0.4	0.1	3.4	0.1	2.2	6.2	0.0	0.3	1.2	0.0	0.0	0.3	0.3	0.0	4.9	0.3	0.5	0.0
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.2;lymphoid tissue: 96.4"	"Cell type enriched"	"Detected in many"	10	"B-cells: 455.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"memory B-cell: 310.4;naive B-cell: 253.0"	"Lineage enriched"	"Detected in many"	16	"B-cells: 310.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.6;HEL: 10.6;HL-60: 9.6;U-266/70: 31.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	8.5	3.6	0.6	35.1	0.6	6.2	2.2	1.5	0.9	2.3	0.2	2.8	2.4	0.8	3.2	0.8	2.3	3.0	0.7	0.5	0.7	3.2	0.3	8.1	82.2	0.8	0.8	0.1	0.5	0.4	1.5	0.8	0.9	5.8	3.3	0.2	2.4	4.7	0.1	0.7	24.2	1.0	0.9	56.1	7.4	3.0	1.0	9.7	12.9	0.2	96.4	7.6	0.7	0.6	0.0	3.0	0.0	0.0	3.4	1.4	0.1	0.1	0.1	0.4	0.6	0.1	4.6	13.6	1.2	0.0	0.0	0.2	0.1	1.5	0.4	0.0	0.0	10.6	2.6	0.0	0.1	9.6	0.0	0.6	0.4	0.0	0.0	1.2	0.1	0.0	0.1	4.0	0.6	0.5	0.0	0.6	0.0	0.4	5.7	0.2	0.6	0.0	0.4	6.1	2.6	0.0	0.3	0.2	0.0	0.1	0.5	2.5	1.3	0.0	0.6	0.0	0.0	31.0	0.0	2.2	0.1	5.3	0.0	10.8	1.7	19.7	0.4	0.5	0.1	310.4	0.1	0.2	10.5	253.0	0.1	0.1	0.9	1.5	0.2	5.2	0.2	11.3	0.6	0.6	1.5	0.9	0.5	0.7	0.8	0.8	0.9	0.9	1.0	0.6	3.5	44.8	27.1	6.8	455.9	0.1	2.2	0.5	0.0	0.2	1.7	0.4	0.5	0.0	10.0	3.7	0.0	2.1	5.8	0.0	0.0	0.2	2.8	13.1	1.0	1.3	0.0	6.1	7.3	0.2	0.6	1.4	6.1	15.2	1.3	0.1	0.0	0.1	1.5	0.0	1.6	0.4	2.0	2.9	25.1	2.0	0.0	13.0	5.4	4.7	2.8	1.8	1.0	1.0	1.3	4.1	1.3	0.4	13.7	4.4	0.2	4.2	2.2	0.1	0.0	0.1	0.8	1.9	5.6	0.8	1.1	0.3	12.9	2.1	1.1	4.3
BBOF1	"C14orf45, CCDC176, FBB10"	ENSG00000119636	"Basal body orientation factor 1"	Q8ND07	14	74019349-74082863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 239.3;Endometrial ciliated cells: 166.4;Late spermatids: 111.3;Respiratory ciliated cells: 177.8;Spermatocytes: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003090, HPA003136, HPA075108"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: "	"unprognostic (1.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.04e-3)"	4.9	2.8	5.8	2.3	6.3	6.5	7.3	5.5	9.0	6.5	15.9	7.1	2.0	7.1	14.6	5.2	22.5	5.7	4.4	6.3	5.8	9.7	2.2	6.8	1.7	9.7	9.8	5.1	2.8	5.0	10.7	2.4	8.3	5.5	3.5	24.3	3.8	7.1	2.3	3.1	2.4	5.5	8.0	1.4	3.4	38.6	6.2	2.8	13.2	3.3	2.1	5.0	3.1	6.6	5.4	3.1	1.3	8.7	5.7	12.5	1.1	4.6	6.5	4.6	4.3	1.1	3.7	5.3	1.2	5.7	2.0	1.3	1.8	0.8	5.2	0.8	1.0	0.6	3.1	1.2	4.8	2.7	0.3	6.1	4.2	10.3	1.3	7.3	1.7	9.7	2.9	0.9	3.4	4.3	8.5	1.3	0.4	0.5	2.1	3.0	3.4	0.9	7.9	1.4	5.2	3.3	9.0	3.6	2.6	1.3	9.2	0.2	3.8	5.7	4.0	7.6	1.3	1.9	4.9	3.3	16.7	0.3	1.6	1.1	0.0	0.1	1.5	0.0	1.8	0.5	1.4	1.0	0.1	0.6	1.9	1.5	1.0	1.1	0.0	2.4	0.3	1.2	5.8	6.3	5.5	9.0	6.3	5.8	9.7	9.8	8.3	8.0	6.2	6.6	3.8	12.8	8.1	0.0	1.4	0.0	3.8	0.0	4.0	7.8	15.8	8.0	0.0	7.2	30.3	3.7	29.2	1.8	3.9	1.8	15.6	9.0	239.3	166.4	15.1	3.1	2.4	39.6	0.0	3.5	2.6	7.4	2.0	18.2	1.3	4.3	3.6	4.5	2.3	6.7	0.0	2.7	0.0	1.6	0.0	111.3	10.8	3.9	0.0	0.0	0.8	5.7	4.1	0.0	0.0	3.0	0.2	6.0	0.7	2.5	1.0	23.5	177.8	29.9	0.0	4.3	4.0	149.2	14.7	1.3	0.0	1.0	2.3	4.1	0.9	3.4
BCAR1	"CAS, CASS1, Crkas, P130Cas"	ENSG00000050820	"BCAR1 scaffold protein, Cas family member"	P56945	16	75228181-75268053	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000443, HPA042282"	Approved	Approved	Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB000443: , HPA042282: AB_2677929"	"unprognostic (5.44e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.43e-3)"	"prognostic unfavorable (9.11e-5)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.20e-1)"	34.7	22.3	3.5	4.2	5.8	0.0	27.9	16.9	6.6	37.7	6.3	34.4	15.8	39.2	2.6	22.5	25.3	9.4	47.1	2.3	7.9	47.3	34.2	38.8	2.1	3.9	1.9	19.7	32.4	5.9	29.5	14.1	2.3	25.6	3.5	1.3	25.5	5.7	93.8	18.2	33.1	3.8	0.0	33.7	44.6	34.3	4.2	0.9	26.8	6.8	1.1	24.9	26.2	15.8	21.8	36.8	17.5	6.0	6.7	6.3	34.1	29.5	17.1	20.9	16.4	46.5	32.1	1.9	38.2	33.3	23.6	18.2	6.1	34.0	6.0	0.1	20.0	0.0	23.7	37.2	16.7	0.1	15.1	19.1	16.3	25.3	12.5	12.3	57.9	0.0	20.0	1.0	12.6	48.9	0.1	1.3	23.4	16.1	24.0	0.8	7.9	8.2	19.1	27.9	21.4	31.5	28.7	6.6	11.2	8.4	15.0	5.4	53.6	34.4	29.5	8.8	44.2	8.0	4.7	0.7	22.2	0.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	16.9	6.6	2.3	7.9	3.9	1.9	2.3	0.0	4.2	15.8	30.1	22.4	6.9	9.4	1.2	28.0	59.7	36.8	12.0	26.5	20.3	14.4	22.9	31.5	21.8	22.0	6.2	46.8	0.7	75.7	27.4	51.9	19.0	13.7	27.9	49.2	34.8	0.0	13.1	61.8	25.7	21.1	71.9	22.5	8.9	15.0	46.8	21.0	6.0	13.5	11.7	42.1	12.2	1.4	6.3	26.8	16.4	2.1	32.0	10.3	0.6	12.9	0.0	19.1	31.2	68.5	59.6	33.4	1.4	58.4	57.4	38.9	13.1	6.8	19.7	8.5	38.5	20.6	17.1	12.5	17.6	36.1	2.2	10.9	33.7	62.7
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3 adaptor protein, NSP family member"	O75815	1	93561741-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.5;Basal prostatic cells: 149.0;Extravillous trophoblasts: 75.0;Urothelial cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0;memory B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 159.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavorable (8.41e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic unfavorable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	31.0	10.6	17.7	6.6	20.9	1.0	18.5	19.3	15.3	10.0	21.1	15.3	13.4	5.7	3.6	8.1	9.5	7.5	13.1	14.8	18.7	15.9	11.9	14.2	13.8	21.1	20.6	11.4	4.2	4.0	4.6	17.0	18.9	8.9	16.6	1.5	21.9	9.5	24.4	15.6	12.9	8.0	19.0	4.8	16.2	6.3	21.7	4.3	10.4	21.1	13.0	13.6	9.8	17.8	56.0	23.4	43.5	3.4	18.4	14.4	37.1	56.9	98.3	45.9	28.1	4.0	40.9	9.0	18.9	88.1	59.4	34.0	1.3	73.5	39.7	4.0	1.3	0.0	16.2	10.3	33.1	0.4	0.2	17.3	79.5	47.5	159.7	44.1	51.1	1.1	1.6	0.3	125.7	8.6	1.0	0.2	13.6	24.5	79.7	3.7	62.7	1.3	120.4	70.1	1.5	3.6	27.4	29.1	36.1	16.8	32.9	2.2	60.8	67.3	17.5	29.2	76.0	4.5	2.1	1.2	10.1	0.2	25.2	2.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.3	1.6	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	17.7	20.9	19.3	15.3	14.8	18.7	21.1	20.6	18.9	19.0	21.7	17.8	26.9	3.2	7.2	72.5	10.2	9.8	149.0	11.3	2.8	0.9	7.9	13.5	7.1	11.5	11.7	14.7	0.0	27.5	2.5	30.8	27.4	11.3	11.3	13.3	2.6	17.9	14.9	0.4	5.2	6.3	75.0	6.3	15.8	16.6	3.8	33.7	5.7	10.3	11.9	21.9	11.2	20.7	8.2	5.3	12.7	12.8	10.2	8.3	19.6	64.6	9.4	4.0	0.0	3.0	2.1	28.0	22.0	1.2	8.9	36.3	25.8	23.7	18.1	0.4	72.3	23.8	19.9	4.2	3.7	4.8	10.2	18.9	3.7	8.3	10.3	106.1
BCL2L12		ENSG00000126453	"BCL2 like 12"	Q9HB09	19	49665142-49673916	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020856	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane"	"HPA020856: AB_1845320"	"unprognostic (2.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.87e-3)"	"unprognostic (6.12e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (8.75e-5)"	"unprognostic (8.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.56e-1)"	8.5	8.5	3.8	14.7	3.9	18.2	9.5	3.9	5.1	8.3	5.0	11.9	10.5	9.9	3.2	13.4	9.5	6.5	9.4	3.6	3.8	7.8	16.6	9.6	20.6	4.4	4.2	9.7	15.5	4.5	2.7	10.3	4.1	11.3	7.3	1.7	11.7	5.0	14.0	8.5	11.9	6.8	4.1	16.7	11.7	10.1	4.1	17.3	7.6	13.5	15.8	9.6	8.7	4.3	105.2	63.7	49.8	94.8	12.6	12.6	56.9	58.2	23.3	57.2	60.6	89.2	55.4	58.4	26.7	20.2	32.4	49.7	46.3	39.4	30.7	74.1	97.4	53.1	43.5	62.0	11.4	56.6	62.2	15.5	19.0	64.3	18.2	11.5	38.7	79.2	138.8	73.3	30.8	59.1	67.6	91.8	62.4	61.8	77.4	86.6	54.3	62.7	24.8	52.0	0.9	29.4	59.5	79.0	41.8	35.6	33.0	70.3	22.8	64.1	75.2	45.5	96.4	61.2	102.4	114.3	27.2	78.0	64.3	11.0	7.4	17.0	12.5	12.2	14.6	14.8	13.2	12.3	6.5	14.6	12.8	13.1	10.9	15.8	8.6	25.9	14.4	6.3	3.8	3.9	3.9	5.1	3.6	3.8	4.4	4.2	4.1	4.1	4.1	4.3	10.2	9.6	13.1	3.3	22.1	32.2	37.4	23.3	14.2	1.0	35.2	34.2	5.0	10.0	16.5	5.5	0.0	70.3	18.2	14.6	7.9	25.7	8.3	17.0	11.5	13.2	6.7	18.5	0.2	25.8	126.3	16.2	9.2	20.1	9.5	18.9	11.0	13.1	37.6	0.0	0.2	15.7	18.3	12.6	16.1	6.4	6.5	15.5	26.6	1.0	22.1	3.5	24.7	0.0	1.6	34.5	16.6	6.0	44.3	20.5	6.5	10.4	12.6	1.2	13.1	14.0	15.1	11.6	22.3	19.7	19.5	55.7	15.7	11.7	23.3	27.7
BCL6B	"BAZF, ZBTB28, ZNF62"	ENSG00000161940	"BCL6B transcription repressor"	Q8N143	17	7023050-7030290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 37.8;Endothelial cells: 45.0;Hepatic stellate cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 53.2;HUVEC TERT2: 96.2;TIME: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059147, HPA075112"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA059147: AB_2683928, HPA075112: AB_2732279"	"unprognostic (5.61e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (8.56e-5)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.26e-2)"	29.8	5.6	8.1	5.7	7.0	0.1	15.4	6.2	9.2	5.7	4.4	4.4	3.2	7.7	0.7	3.8	5.1	13.4	23.3	6.5	6.9	13.4	4.0	28.9	5.5	7.8	7.1	2.9	3.8	3.1	5.5	19.9	7.3	4.5	2.2	0.6	4.0	3.5	11.5	4.4	4.9	7.7	6.6	13.0	4.3	2.0	10.1	2.0	12.0	14.7	2.1	7.9	4.8	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	18.2	0.0	0.0	0.5	0.0	53.2	0.0	0.0	0.0	0.1	0.0	96.2	0.2	3.4	0.4	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	38.2	0.8	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.2	9.2	6.5	6.9	7.8	7.1	7.3	6.6	10.1	6.7	37.8	3.2	4.2	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	45.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	23.6	0.2	0.1	0.0	0.0	0.2	0.0	1.9	2.3	0.0	0.0	0.3	3.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.2	0.0	0.9	0.8	0.6	1.5	0.4	1.3	0.1	0.2	0.9	0.0	0.5
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR activator of RhoGEF and GTPase"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	19.4	11.1	34.3	11.0	65.7	34.6	17.4	15.9	30.7	14.3	10.6	11.7	10.0	12.3	16.1	24.5	12.1	9.3	12.2	45.0	22.2	21.1	13.8	18.6	13.7	27.1	26.5	9.4	14.6	20.6	25.0	10.3	24.1	11.8	7.6	7.4	18.3	10.1	5.8	23.5	10.2	8.8	20.9	11.4	16.1	11.0	35.0	14.7	19.7	5.7	10.8	15.3	14.3	14.1	47.6	20.1	30.3	31.2	17.7	12.1	45.6	16.8	15.7	15.2	12.2	35.6	18.7	32.9	30.5	14.4	14.7	47.6	3.6	46.8	4.3	63.3	32.3	28.8	27.7	28.6	22.9	26.9	14.6	10.2	31.1	22.8	19.8	27.0	53.6	23.3	112.5	15.1	7.0	31.3	25.4	21.4	25.8	37.4	19.5	32.9	12.4	21.7	23.7	29.6	27.7	26.3	30.7	26.1	12.6	19.3	16.6	21.7	61.4	9.1	1.0	14.9	14.0	3.4	14.8	11.7	23.4	20.1	14.3	0.0	0.5	0.0	3.1	0.2	1.1	0.6	1.5	1.6	0.4	0.6	1.3	1.7	0.5	1.5	0.5	0.4	0.8	1.4	34.3	65.7	15.9	30.7	45.0	22.2	27.1	26.5	24.1	20.9	35.0	14.1	19.3	9.6	11.5	51.2	4.5	15.4	11.9	18.2	6.2	22.9	17.1	9.9	7.5	17.2	20.9	18.4	22.9	14.0	23.9	17.7	9.8	14.4	5.6	22.1	8.0	27.8	19.9	5.5	24.6	16.6	6.8	7.1	11.7	31.4	10.8	9.9	70.6	22.1	7.2	23.5	20.7	13.9	12.2	9.3	11.1	13.5	8.7	9.2	5.4	18.7	6.6	13.2	15.5	32.2	7.0	27.7	8.1	5.7	10.7	11.8	10.7	18.2	12.5	9.4	0.0	4.0	6.8	2.7	7.3	9.3	15.8	10.8	10.3	10.0	13.7	13.3
BEND6	"bA203B9.1, C6orf65, FLJ30162"	ENSG00000151917	"BEN domain containing 6"	Q5SZJ8	6	56955107-57027346	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.9;retina: 11.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.6;Excitatory neurons: 87.3;Horizontal cells: 42.1;Inhibitory neurons: 118.6;Oligodendrocyte precursor cells: 49.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 8.8"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 8.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 28.8;fHDF/TERT166: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031605, HPA052973"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA031605: AB_10602395, HPA052973: AB_2682002"	"unprognostic (4.27e-1)"	"unprognostic (7.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.18e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.84e-6)"	"unprognostic (9.27e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.98e-3)"	1.2	2.1	12.1	1.5	14.2	0.7	0.6	30.5	30.9	4.0	2.9	1.4	0.5	2.8	0.7	1.2	1.0	3.8	2.4	12.6	16.0	0.6	0.2	0.6	0.9	19.5	16.0	2.0	0.4	0.7	1.7	2.0	20.4	2.4	1.5	11.8	0.5	2.4	3.9	1.0	0.7	3.6	12.1	0.8	0.8	1.0	15.7	1.1	0.8	0.6	0.8	2.8	1.7	21.7	5.4	2.2	1.3	0.6	17.6	28.8	4.9	16.1	15.6	7.1	8.2	0.2	2.4	0.1	5.2	28.7	9.9	0.7	1.8	0.8	8.7	2.4	1.0	3.6	7.5	0.4	4.7	10.3	0.2	12.7	4.5	9.8	4.3	11.9	4.7	13.3	4.6	9.2	14.3	5.5	6.2	2.5	4.4	0.3	1.3	0.1	0.2	2.6	2.6	5.4	6.1	6.2	10.8	1.3	1.4	6.1	0.3	5.9	6.1	21.5	0.7	14.5	3.6	12.6	15.2	4.3	12.6	6.5	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	8.8	0.0	0.1	12.1	14.2	30.5	30.9	12.6	16.0	19.5	16.0	20.4	12.1	15.7	21.7	0.4	0.0	0.0	16.6	0.3	0.9	0.2	0.2	0.0	82.6	0.2	1.1	3.6	0.0	0.7	0.0	4.2	0.5	10.8	0.0	0.0	0.2	0.6	0.5	11.9	0.2	0.0	0.0	87.3	0.4	1.6	5.6	0.0	0.5	0.0	13.5	1.1	0.0	0.1	42.1	118.6	0.0	0.0	0.0	4.0	0.8	1.8	1.1	3.6	13.1	0.3	4.9	0.0	49.8	22.9	0.6	0.0	3.0	0.0	0.4	0.0	1.0	0.0	4.8	0.0	8.7	2.7	0.7	5.8	0.2	1.0	0.0	0.1	4.4	0.0	0.1
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465764	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 625.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 3131.8;Hofbauer cells: 1099.2;Proximal enterocytes: 864.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 465.2"	"Group enriched"	"Detected in all"	7	"dendritic cells: 343.3;monocytes: 465.2"	"Cell line enhanced"	"Detected in many"		"A549: 506.6;K-562: 506.8;OE19: 451.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	115.7	76.8	46.6	48.2	46.9	625.2	93.8	49.4	61.0	86.2	52.1	78.5	75.1	59.0	20.5	188.8	69.3	50.9	125.6	44.5	48.0	103.1	266.2	102.8	58.9	56.0	48.6	66.7	73.2	46.1	25.2	52.1	58.5	74.3	30.3	5.5	89.4	42.2	210.4	83.9	72.2	31.7	49.8	166.7	138.4	10.2	52.3	27.5	64.5	94.1	25.3	81.0	96.5	53.4	227.9	506.6	7.3	77.7	73.7	70.2	57.3	28.0	88.7	39.3	75.4	103.4	203.8	74.3	212.3	56.3	126.8	73.1	30.4	64.6	10.5	123.8	20.0	114.9	73.4	62.4	169.8	1.6	32.2	69.2	119.4	52.4	34.2	40.1	41.8	27.4	506.8	137.0	51.0	359.2	6.1	7.2	1.9	451.4	133.8	54.0	23.4	120.3	50.9	146.5	0.4	10.5	84.5	224.5	84.4	13.2	221.5	17.6	39.2	99.4	103.9	156.4	15.9	71.7	92.1	28.5	259.1	46.2	39.0	45.5	465.2	18.0	29.2	220.9	27.0	58.2	24.3	24.5	343.3	37.5	24.7	19.3	58.4	27.4	117.7	75.8	37.3	259.4	46.6	46.9	49.4	61.0	44.5	48.0	56.0	48.6	58.5	49.8	52.3	53.4	74.6	221.2	164.5	9.4	34.4	129.4	348.5	337.9	103.6	11.2	93.8	143.0	130.5	164.5	184.2	97.5	6.2	84.9	39.5	343.6	266.1	234.2	10.0	56.5	46.3	51.1	44.9	3131.8	5.2	267.3	94.7	112.5	280.3	83.1	43.1	31.0	57.1	680.8	1099.2	10.1	5.1	223.5	158.7	627.7	165.4	23.6	124.2	286.7	144.1	13.1	219.8	88.0	32.0	2.0	5.6	260.4	464.0	94.0	25.7	229.7	864.3	488.3	139.1	13.5	32.9	65.4	146.0	2.6	4.0	160.3	130.4	74.7	34.5	34.7	191.0	260.5
BSDC1	"FLJ10276, RP4-811H24.7"	ENSG00000160058	"BSD domain containing 1"	Q9NW68	1	32364633-32394731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 37.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031358, HPA031360"	Approved		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA031358: AB_2673841, HPA031360: AB_10601120"	"unprognostic (1.42e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.82e-5)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.07e-1)"	36.8	63.0	28.0	17.4	29.4	77.1	37.8	31.7	30.6	38.7	27.3	35.9	25.4	35.3	24.9	36.7	35.3	23.3	35.9	28.9	27.2	38.7	73.2	33.7	22.4	32.5	27.8	54.5	56.0	42.3	46.5	22.1	28.8	41.0	22.5	21.7	45.0	24.3	36.7	47.5	34.8	20.7	28.1	35.8	41.0	51.3	28.4	19.5	37.9	16.3	21.8	33.2	36.5	35.9	24.3	16.2	32.8	25.2	38.6	29.6	25.6	23.0	43.9	39.8	41.0	18.1	19.9	17.8	27.0	41.3	22.6	26.1	23.4	21.6	25.6	33.4	33.3	14.2	35.5	22.1	33.2	17.6	24.7	35.5	46.4	30.7	23.2	47.8	24.8	28.0	36.4	30.8	22.3	10.7	18.7	10.3	20.8	14.1	19.0	18.8	18.8	24.7	22.6	19.5	34.6	25.0	22.1	22.7	25.2	37.7	21.4	13.9	30.1	22.1	19.8	28.3	22.6	42.2	41.6	15.9	25.8	22.3	13.5	37.4	5.1	18.3	6.2	5.9	6.1	7.0	5.5	5.2	4.9	8.3	6.0	5.6	8.4	6.1	5.0	6.5	7.3	6.2	28.0	29.4	31.7	30.6	28.9	27.2	32.5	27.8	28.8	28.1	28.4	35.9	24.6	32.1	18.6	23.5	42.8	28.4	56.6	31.5	25.6	53.6	38.9	26.7	19.4	55.8	21.9	25.8	83.4	51.1	38.8	59.3	19.6	37.8	88.9	23.7	26.3	35.2	40.1	76.0	25.6	44.1	31.0	32.7	27.0	34.4	21.0	36.1	50.0	56.7	20.0	85.8	31.6	47.8	28.5	25.8	13.1	100.7	54.7	20.1	32.0	25.3	28.0	30.3	57.7	29.1	35.0	45.6	40.0	47.4	32.1	58.4	63.9	28.0	18.4	69.8	39.5	33.1	38.1	42.9	45.9	21.2	25.9	96.5	34.6	60.5	39.3	57.2
BTBD18		ENSG00000233436	"BTB domain containing 18"	B2RXH4	11	57743514-57751781	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 3.1;testis: 2.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.7;Cone photoreceptor cells: 4.2;Rod photoreceptor cells: 1.6;Spermatocytes: 5.5;Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049325	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA049325: AB_2680713"	"unprognostic (6.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.69e-3)"	"unprognostic (4.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.17e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.88e-1)"	0.0	0.0	0.1	0.0	0.3	0.4	0.0	3.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.3	3.1	0.9	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.4	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	5.5	3.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
BTN2A1	"BT2.1, BTF1, BTN2.1"	ENSG00000112763	"Butyrophilin subfamily 2 member A1"	Q7KYR7	6	26457904-26476621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019208	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA019208: AB_1845492"	"unprognostic (1.86e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.90e-3)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (4.52e-5)"	16.1	17.3	10.8	11.4	10.7	16.8	13.3	19.9	13.1	15.5	11.4	17.7	9.8	16.7	8.3	8.9	16.1	10.2	16.0	11.1	15.2	13.6	9.1	18.4	13.9	12.1	13.2	15.2	8.9	4.8	11.9	19.0	13.7	13.3	11.0	4.5	9.5	14.4	11.7	8.2	15.0	16.9	12.0	25.7	12.2	11.7	13.5	10.6	10.5	10.1	11.4	17.3	13.3	12.2	16.4	14.5	28.9	18.3	12.7	10.2	1.4	36.1	30.1	42.3	38.7	13.5	11.0	13.3	47.3	24.5	54.9	7.0	22.1	8.9	40.2	18.4	21.6	7.9	15.3	16.0	19.9	11.8	21.2	13.9	8.2	47.1	15.2	25.1	15.3	25.4	13.5	20.6	35.7	6.7	19.9	18.2	9.7	4.8	11.9	17.0	27.3	13.6	16.5	7.3	28.9	16.4	11.2	14.8	26.4	17.8	4.3	9.9	21.3	32.1	16.6	28.1	40.8	16.1	40.4	11.1	12.8	22.0	52.1	43.6	9.0	30.2	11.1	5.2	9.8	8.6	9.3	12.4	8.4	6.2	8.6	11.0	51.7	9.9	8.8	8.9	16.0	7.2	10.8	10.7	19.9	13.1	11.1	15.2	12.1	13.2	13.7	12.0	13.5	12.2	21.2	16.0	14.7	7.5	20.0	8.0	8.0	8.5	9.1	8.0	11.8	10.9	17.6	7.2	11.7	9.2	6.2	6.1	35.4	16.0	3.9	10.9	3.2	18.1	17.7	22.1	9.0	4.6	8.9	12.8	11.2	14.7	18.8	20.8	24.6	13.3	21.8	6.2	11.6	3.3	10.2	14.8	12.2	17.9	16.7	6.2	12.8	18.4	10.6	10.3	21.9	6.0	25.7	10.6	7.8	16.4	10.2	12.8	18.9	13.1	11.4	4.7	26.9	2.3	39.5	12.4	24.4	8.7	12.9	7.3	8.1	11.8	25.0	14.9	12.9	17.9
BTRC	"beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1"	ENSG00000166167	"Beta-transducin repeat containing E3 ubiquitin protein ligase"	Q9Y297	10	101354033-101557321	"Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 109.7;Excitatory neurons: 154.0;Inhibitory neurons: 144.4;Oligodendrocyte precursor cells: 183.5;Oligodendrocytes: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031156, CAB032986"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB032986: AB_2243598, HPA031156: AB_2673764"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.23e-1)"	5.2	9.2	16.3	3.8	19.3	2.8	8.5	8.9	17.4	6.8	7.8	6.3	3.9	6.1	10.5	8.4	7.7	5.8	14.6	18.9	16.3	8.0	6.4	4.9	4.2	10.7	12.6	11.0	6.5	13.1	9.4	7.9	13.7	8.8	4.7	21.6	6.9	5.9	12.2	6.8	4.7	7.1	10.0	6.5	5.7	13.8	16.3	6.4	8.5	12.1	5.6	6.4	6.7	13.7	8.7	13.0	17.2	20.0	16.1	14.1	6.3	12.0	18.4	11.8	10.0	9.0	6.5	13.8	11.8	9.9	12.3	12.9	14.1	13.0	11.7	9.5	11.5	10.1	8.0	11.5	8.9	14.9	5.7	9.0	14.7	10.4	18.4	22.4	15.3	12.7	11.0	4.5	12.0	7.2	9.8	7.5	7.8	9.0	9.9	12.4	24.6	2.8	10.3	5.4	12.9	11.2	8.1	3.5	11.3	19.2	9.2	5.1	12.7	6.1	10.3	8.6	8.5	7.5	18.2	8.7	6.4	7.3	3.9	1.8	1.7	1.8	2.9	1.5	2.8	2.5	3.0	2.5	2.3	2.1	3.4	2.8	1.1	2.5	1.6	1.1	2.8	1.6	16.3	19.3	8.9	17.4	18.9	16.3	10.7	12.6	13.7	10.0	16.3	13.7	8.6	3.2	9.4	109.7	6.9	5.6	4.1	6.9	12.5	32.5	10.0	7.4	28.0	8.6	10.6	3.7	29.2	11.5	6.1	5.0	7.9	9.7	41.9	11.7	12.4	9.0	3.0	20.6	154.0	7.2	7.2	10.3	3.6	10.6	13.9	10.1	6.4	6.7	5.9	16.8	144.4	4.9	6.1	3.5	2.5	21.6	9.0	5.0	1.8	69.3	4.6	13.6	8.2	183.5	148.0	7.9	3.2	10.5	6.3	6.6	5.5	9.4	13.0	26.0	6.6	8.3	7.6	33.8	18.3	7.4	7.1	12.4	8.2	5.9	4.8	6.2
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 265.5;skeletal muscle: 367.7;tongue: 258.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 278.2;Extravillous trophoblasts: 875.6;Syncytiotrophoblasts: 762.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Cytosol"		"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavorable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	26.1	18.1	8.5	26.8	10.1	45.7	49.7	6.9	14.3	19.1	9.7	51.2	28.9	18.4	9.9	42.6	20.2	17.2	265.5	10.2	6.3	37.8	18.4	20.0	30.0	5.2	6.3	16.0	30.0	6.7	10.4	80.4	6.5	19.3	56.8	88.0	23.8	34.3	367.7	55.5	30.0	39.0	5.6	16.5	50.2	11.6	6.9	33.0	36.5	258.9	38.4	59.5	26.2	8.8	91.7	81.3	138.2	201.7	67.5	118.3	125.7	126.0	156.3	117.6	124.9	201.8	129.7	208.0	143.7	96.9	87.6	181.6	164.8	141.5	152.0	27.8	99.8	129.6	84.4	117.0	70.5	180.3	79.1	90.6	74.6	104.0	187.7	92.4	171.6	149.7	251.9	43.5	96.9	105.0	90.0	210.4	143.9	259.5	174.1	111.0	91.2	216.6	113.4	152.6	179.9	106.8	50.8	419.9	67.7	156.7	187.8	149.5	97.6	93.1	119.1	141.5	136.3	89.5	92.8	288.1	45.5	220.6	340.3	2.6	46.0	5.0	27.3	55.2	44.6	44.6	39.8	36.9	98.8	42.9	56.8	47.1	2.1	56.8	41.6	38.5	31.8	44.0	8.5	10.1	6.9	14.3	10.2	6.3	5.2	6.3	6.5	5.6	6.9	8.8	32.8	22.4	60.5	3.9	30.0	57.6	69.9	60.5	82.6	55.9	52.3	57.0	278.2	17.2	53.9	47.8	64.6	214.3	26.8	42.4	58.7	47.5	9.8	31.9	43.2	42.9	30.5	63.5	48.6	65.6	875.6	43.5	110.1	40.6	21.0	33.3	8.9	13.7	65.0	6.7	32.0	49.5	61.1	33.4	46.0	6.4	12.2	30.7	24.9	12.2	47.5	19.7	19.6	19.1	17.9	47.0	42.9	9.8	31.9	52.0	19.2	20.8	32.6	106.4	6.6	30.2	54.2	11.3	4.1	99.6	51.6	762.9	29.3	52.6	90.6	79.0
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126798708	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 112.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 819.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 118.8;U-2197: 36.1;U-266/84: 27.2;U-87 MG: 37.0;WM-115: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	0.7	0.0	30.4	0.1	74.4	0.0	4.7	41.9	47.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	29.9	37.4	0.3	0.1	0.0	0.0	60.4	53.8	0.1	0.2	0.0	0.3	0.3	57.0	0.0	0.1	0.0	10.6	0.0	0.1	1.1	0.1	0.0	29.8	0.0	0.0	6.5	68.0	1.1	0.3	0.4	0.7	0.0	0.0	112.1	0.3	0.1	0.0	0.0	0.8	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	2.3	0.0	1.6	0.0	0.9	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	118.8	0.0	0.0	0.2	0.0	4.7	0.0	36.1	0.7	0.0	27.2	0.0	37.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	74.4	41.9	47.7	29.9	37.4	60.4	53.8	57.0	29.8	68.0	112.1	0.2	0.0	0.0	24.5	0.1	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	120.5	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	142.7	0.3	0.0	0.0	3.7	0.0	0.0	0.0	181.0	819.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	1.3	0.5	0.0	0.0	4.2	0.1	0.0	0.0	0.0
C11orf42	MGC34805	ENSG00000180878	"Chromosome 11 open reading frame 42"	Q8N5U0	11	6205557-6211135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 25.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 818.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;HeLa: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063404	Enhanced		Approved	"Nuclear membrane,Vesicles,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Nuclear membrane, Vesicles"	"HPA063404: AB_2685006"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.49e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.30e-2)"	"unprognostic (6.47e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-2)"	0.0	0.1	0.5	0.2	0.5	0.1	0.1	1.4	0.7	0.1	0.0	0.3	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.4	0.2	0.0	0.1	1.5	0.7	0.0	0.0	0.2	0.3	25.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.8	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	1.3	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.0	0.2	0.3	0.1	0.4	0.1	0.4	0.2	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.1	0.3	0.1	0.3	0.1	0.6	0.1	0.1	0.3	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.4	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.5	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	818.5	1.5	0.2	0.0	1.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C12orf73	"BRAWNIN, DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103940763-103965708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 42.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favorable (1.61e-4)"	6.0	11.4	15.6	7.7	15.4	4.4	7.9	17.1	16.1	8.5	13.3	7.2	7.0	8.2	10.3	6.4	7.3	4.6	12.3	15.5	16.7	10.3	8.3	5.8	9.2	14.7	15.0	10.1	7.7	10.0	10.8	6.1	15.2	8.7	7.6	13.2	7.2	7.3	42.5	8.3	6.8	6.5	14.4	6.9	8.9	10.9	15.3	8.3	12.9	27.6	8.9	7.3	6.9	17.3	11.8	21.2	31.8	19.4	8.9	11.6	20.7	12.6	7.4	13.4	10.8	23.2	9.9	13.7	15.9	7.5	11.7	18.3	19.1	15.6	10.1	19.7	38.4	20.9	32.9	29.1	13.1	30.8	18.2	10.3	17.6	6.9	11.9	32.5	12.5	39.5	27.0	9.2	12.5	13.2	34.5	46.1	15.6	11.0	35.9	19.7	11.9	13.7	17.8	16.6	51.8	18.5	13.0	21.9	29.7	14.1	36.4	16.7	6.5	16.4	9.3	12.4	12.8	24.5	40.6	28.8	22.4	17.4	14.5	10.1	5.6	10.6	11.7	5.0	11.4	14.6	10.6	11.1	8.6	11.3	15.7	14.8	1.7	14.5	4.5	13.3	17.0	4.2	15.6	15.4	17.1	16.1	15.5	16.7	14.7	15.0	15.2	14.4	15.3	17.3	6.8	6.4	6.8	7.5	7.8	6.0	9.4	16.3	18.8	16.3	9.0	11.0	16.5	7.2	10.0	9.2	0.0	11.6	8.6	7.1	27.4	20.3	87.1	8.7	10.3	8.3	11.4	18.5	5.0	12.1	11.7	7.9	15.3	9.1	9.5	13.8	8.9	15.5	17.5	8.4	6.0	13.2	20.3	7.9	5.1	36.6	8.7	8.7	1.8	2.8	12.4	17.1	22.6	7.5	9.0	19.9	5.6	8.6	13.7	13.7	16.0	25.9	10.9	15.2	6.6	5.6	11.7	31.1	25.6	16.0	5.3	8.9	8.8	6.4	12.3	8.6
C12orf76	FLJ40142	ENSG00000174456	"Chromosome 12 open reading frame 76"		12	110027028-110073634	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"brain: 77.2;choroid plexus: 44.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 174.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 60.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA039713	Uncertain		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 51: Myeloid cells - Hemostasis"	"Actin filaments"	"Plasma membrane"	"HPA039713: AB_2676640"	"unprognostic (9.20e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"prognostic favorable (6.44e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (2.09e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	4.0	5.0	58.2	5.4	61.5	2.4	7.4	67.2	76.0	6.8	44.0	6.2	3.5	5.6	9.9	3.9	10.3	3.7	4.0	59.5	61.6	8.4	10.1	8.0	8.5	64.9	63.6	8.4	6.4	3.9	10.2	8.0	67.3	6.7	4.7	16.6	5.0	5.1	6.7	4.6	5.7	3.4	60.0	9.2	4.6	8.3	61.3	7.1	9.6	4.1	6.1	5.5	5.4	77.2	3.8	7.5	10.7	8.8	5.2	12.2	10.9	3.4	3.0	7.3	5.0	4.8	4.3	8.1	4.6	1.8	5.0	8.8	4.2	5.4	5.0	9.8	9.9	8.5	7.2	13.3	7.2	13.6	16.2	13.7	14.9	4.7	11.3	19.7	10.7	13.4	13.0	3.0	5.4	4.1	4.3	25.2	9.4	5.1	6.1	10.5	7.0	12.5	11.2	4.1	26.4	12.5	5.3	2.8	11.1	13.3	8.4	6.2	6.2	3.5	4.9	3.4	1.5	8.4	12.8	4.4	8.2	6.3	3.5	60.0	10.2	11.0	6.4	7.8	9.2	18.6	12.7	7.1	10.9	11.6	17.4	10.2	5.8	18.8	5.2	9.7	12.8	12.0	58.2	61.5	67.2	76.0	59.5	61.6	64.9	63.6	67.3	60.0	61.3	77.2	22.5	32.1	17.0	13.4	15.2	7.9	16.2	18.7	13.6	26.4	24.9	39.8	7.1	18.6	10.5	16.5	2.1	30.2	13.3	6.4	35.2	11.6	31.0	42.3	18.7	18.3	6.1	14.5	32.0	15.1	10.5	17.7	6.6	17.4	5.1	22.8	21.8	22.4	26.4	32.0	28.5	10.7	16.2	24.2	13.1	13.5	26.1	35.9	19.6	15.0	25.3	39.4	24.7	53.3	174.6	11.8	7.5	33.8	10.2	11.7	13.3	38.6	33.9	20.9	6.6	16.4	16.5	25.2	11.3	9.0	8.5	12.0	21.8	15.4	9.5	9.8
C14orf93	"FLJ12154, RTFC"	ENSG00000100802	"Chromosome 14 open reading frame 93"	Q9H972	14	22985894-23010166	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002569	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"HPA002569: AB_1078334"	"prognostic favorable (5.05e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.11e-2)"	8.3	4.8	6.5	5.7	7.7	12.6	8.2	6.7	7.0	11.2	8.5	8.8	7.4	8.7	11.4	7.4	9.5	9.2	5.6	6.2	7.3	11.1	8.9	6.7	10.1	7.7	7.2	10.3	9.6	8.3	6.5	5.0	7.5	9.6	9.6	4.4	8.0	5.7	6.7	18.3	8.1	6.8	6.7	10.6	8.3	4.0	7.2	15.7	11.5	7.9	10.5	8.6	8.3	9.5	5.7	10.5	8.8	12.3	13.9	30.8	12.2	6.6	10.2	5.1	6.7	6.6	16.5	16.0	6.1	6.0	7.2	11.8	5.4	16.6	4.7	6.3	3.8	10.1	14.0	15.3	12.1	7.4	8.3	22.4	12.8	7.6	9.6	18.5	9.6	10.1	11.1	3.4	5.3	16.3	9.5	13.6	3.0	12.3	7.3	15.1	8.4	9.8	6.7	8.6	31.8	13.8	8.8	8.4	9.0	9.4	13.0	12.8	5.5	9.6	12.7	4.3	6.7	11.9	3.6	11.0	6.6	9.1	10.0	12.2	7.7	22.9	8.1	7.4	7.2	10.4	6.5	8.5	9.1	10.0	9.8	9.4	11.2	10.4	13.0	6.3	13.4	7.1	6.5	7.7	6.7	7.0	6.2	7.3	7.7	7.2	7.5	6.7	7.2	9.5	3.1	9.6	1.1	14.7	8.7	3.1	4.1	4.6	10.2	1.4	4.0	4.1	3.3	1.5	2.6	0.0	4.2	4.3	7.8	3.7	7.9	3.9	0.8	3.3	2.6	3.3	15.7	6.5	3.4	3.0	5.7	3.9	7.7	3.0	7.0	4.7	1.4	1.5	3.8	0.0	3.4	6.3	4.1	5.5	2.5	1.5	4.4	3.4	5.4	9.4	1.9	4.1	7.2	7.1	9.9	3.1	7.3	4.1	5.2	1.9	4.6	3.6	4.6	2.0	6.6	3.8	3.7	2.9	8.2	5.3	1.6	3.0	5.2	4.1	5.1	2.5
C16orf74	MGC17624	ENSG00000154102	"Chromosome 16 open reading frame 74"	Q96GX8	16	85690084-85751129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 47.4;Basal prostatic cells: 56.7;Bipolar cells: 55.8;Cone photoreceptor cells: 58.4;Rod photoreceptor cells: 87.8;Syncytiotrophoblasts: 74.3;Urothelial cells: 55.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 96.1;hTCEpi: 80.8;T-47d: 84.5"									HPA049367	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Centrosome	"HPA049367: AB_2680730"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.15e-3)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.08e-3)"	"unprognostic (4.22e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.40e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.07e-3)"	3.6	0.7	8.4	4.3	8.5	8.9	6.5	6.8	12.0	9.5	7.8	3.1	1.4	1.5	2.0	9.4	1.5	2.2	2.2	12.2	7.4	2.5	1.1	2.2	8.4	7.5	7.4	0.8	1.8	7.5	1.3	6.7	7.0	9.2	1.1	27.7	4.2	7.3	0.5	9.0	5.6	0.9	6.7	16.0	2.9	2.1	7.6	1.4	5.0	0.3	6.4	17.2	14.5	7.4	35.3	11.5	0.4	4.7	5.1	5.6	14.1	4.2	5.6	13.1	3.7	8.9	32.1	0.3	47.2	3.3	5.5	49.4	2.0	96.1	7.4	0.0	7.6	0.0	5.3	0.9	13.9	1.0	0.0	12.2	80.8	12.6	54.7	9.8	43.4	5.8	0.0	0.2	0.4	29.6	0.0	54.0	2.9	37.7	32.6	1.4	0.0	2.8	0.1	39.5	10.7	2.8	17.5	8.9	9.1	3.6	84.5	14.9	44.8	8.4	22.0	3.8	12.7	11.7	9.3	40.0	0.0	12.6	1.7	0.1	16.8	21.8	1.3	6.3	4.4	46.7	8.8	7.0	18.3	49.4	14.5	9.3	6.6	7.8	2.0	0.3	18.0	10.8	8.4	8.5	6.8	12.0	12.2	7.4	7.5	7.4	7.0	6.7	7.6	7.4	10.1	3.2	1.1	6.5	47.4	9.3	56.7	23.8	8.0	55.8	19.0	20.3	1.8	1.5	9.8	1.8	58.4	45.8	3.4	0.1	3.9	3.0	1.7	4.4	4.6	7.2	0.0	0.8	0.4	1.1	19.7	5.7	1.5	4.1	0.0	0.5	2.5	0.0	5.0	15.2	0.4	0.0	8.2	1.2	2.9	0.4	3.4	2.5	19.6	1.0	5.2	18.8	4.1	1.5	0.8	3.2	0.0	3.4	44.2	36.5	0.0	2.4	3.9	87.8	0.0	0.3	2.5	0.9	8.4	8.5	7.0	74.3	3.7	1.5	0.2	55.7
C17orf58		ENSG00000186665	"Chromosome 17 open reading frame 58"	Q2M2W7	17	67991099-67996469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 35.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 55.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 37.3"	HPA023036	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA023036: AB_10601144"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (1.31e-10)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.01e-1)"	11.9	5.4	5.2	2.8	5.5	3.9	16.9	5.4	10.0	26.8	4.8	8.4	4.0	15.1	6.9	5.1	7.8	4.7	5.9	5.7	5.3	6.1	9.4	3.4	3.2	5.4	5.3	4.8	4.8	3.2	2.0	35.6	5.1	5.8	7.3	8.9	4.3	3.6	3.5	3.5	4.6	10.9	5.5	2.3	6.8	3.0	5.2	2.1	6.8	7.3	7.1	8.8	7.6	5.5	9.8	9.5	9.3	11.6	6.6	16.6	7.3	4.0	11.4	6.9	11.2	5.6	12.4	13.0	8.9	3.3	12.1	4.9	21.3	8.6	16.6	23.5	21.5	8.4	3.2	17.8	10.4	7.2	14.9	9.2	10.2	6.7	15.4	7.7	32.7	11.2	18.2	19.6	6.7	13.1	1.3	9.5	10.7	23.6	10.0	3.1	10.2	17.4	8.7	6.5	6.9	12.5	6.0	55.5	20.8	11.4	15.8	8.2	6.1	5.8	5.9	4.2	8.5	38.9	30.9	11.6	14.8	12.6	10.5	8.6	2.8	5.0	2.2	2.9	0.7	3.0	0.8	1.7	3.9	0.5	0.3	0.8	1.1	2.7	5.0	0.1	0.4	1.8	5.2	5.5	5.4	10.0	5.7	5.3	5.4	5.3	5.1	5.5	5.2	5.5	21.6	0.0	1.7	6.2	3.5	4.8	5.5	5.6	7.4	8.9	31.0	21.8	4.7	12.8	6.1	11.0	10.4	28.6	4.1	10.5	23.5	10.1	0.9	21.0	40.5	16.3	3.6	8.4	5.0	9.3	21.7	51.6	19.9	19.4	12.7	3.8	14.3	18.5	16.9	5.0	4.6	15.0	10.2	9.7	21.5	2.8	3.7	7.3	8.8	2.8	18.4	31.9	12.3	3.0	4.6	10.7	10.0	5.3	7.0	11.6	10.9	19.7	16.5	15.6	6.6	36.2	14.1	7.3	6.0	20.7	8.4	15.3	4.1	8.3	10.1	7.6
C18orf21	"HsT3108, PNAS-124, PNAS-131"	ENSG00000141428	"Chromosome 18 open reading frame 21"	Q32NC0	18	35972625-35979286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 145.2;Late spermatids: 76.3;Spermatocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065505, HPA067322"	Uncertain		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Plasma membrane"		"HPA065505: AB_2685498, HPA067322: AB_2685822"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.88e-2)"	"unprognostic (8.66e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (2.53e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.97e-2)"	16.4	18.2	15.2	12.8	15.7	71.9	20.5	18.6	19.7	13.6	14.2	15.1	16.2	15.3	18.4	14.7	14.9	12.3	18.3	15.4	15.2	15.1	16.9	12.2	21.8	15.0	15.0	17.0	23.2	17.9	12.9	14.6	15.0	14.4	13.1	19.2	19.3	12.9	34.1	16.3	15.2	13.0	15.6	18.1	19.8	35.8	15.4	21.9	14.0	26.4	18.8	16.3	12.3	16.5	24.9	17.2	35.3	27.0	25.4	36.2	25.9	34.3	34.9	42.3	44.7	15.8	17.8	22.4	33.7	27.4	26.9	26.2	28.2	28.8	45.7	33.4	30.4	22.5	21.2	35.5	35.3	65.4	26.3	37.9	46.7	38.2	39.3	36.8	37.0	30.6	39.7	34.0	29.4	29.5	42.4	48.0	30.4	11.6	18.9	28.0	30.7	43.0	29.2	29.5	25.5	36.0	25.4	18.8	58.3	32.7	28.2	31.2	24.3	43.3	19.1	15.8	31.0	43.2	41.4	46.0	21.4	37.3	22.1	97.5	28.8	34.2	24.5	30.7	24.2	34.7	25.9	23.2	27.1	30.9	19.8	25.9	28.0	28.8	30.0	26.6	41.5	19.8	15.2	15.7	18.6	19.7	15.4	15.2	15.0	15.0	15.0	15.6	15.4	16.5	9.6	19.2	6.1	3.9	13.7	11.9	8.9	17.4	18.2	9.6	13.1	16.5	12.7	10.0	12.1	1.8	6.2	19.0	23.0	10.4	11.7	20.2	145.2	13.7	14.7	10.8	7.2	12.4	5.5	28.8	32.0	12.4	8.6	14.4	14.0	12.9	10.0	9.6	21.3	8.4	6.0	12.9	16.2	20.1	10.3	76.3	22.4	14.4	12.4	5.6	24.4	13.1	20.6	4.5	5.1	20.0	14.0	17.0	13.5	11.7	17.8	20.1	5.1	12.1	0.0	14.1	11.3	124.0	35.9	12.8	12.4	13.1	13.6	17.3	15.9	9.3
C19orf71	LOC100128569	ENSG00000183397	"Chromosome 19 open reading frame 71"	A6NCJ1	19	3539154-3544030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 53.7"	"Group enriched"	"Detected in some"	69	"Early spermatids: 566.4;Late spermatids: 357.0"	"Cancer enriched"	"Detected in all"	5	"melanoma: 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HeLa: 92.7;SK-MEL-30: 48.2;WM-115: 170.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048654	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Endoplasmic reticulum"	"HPA048654: AB_2680480"	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.74e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (2.02e-5)"	"unprognostic (5.52e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-3)"	2.6	4.5	3.7	8.1	3.5	10.5	2.2	15.0	5.6	3.4	0.0	2.7	8.5	4.9	0.8	3.5	4.5	3.8	2.5	4.4	5.6	6.3	3.5	4.4	9.5	4.6	3.1	4.7	7.6	0.7	7.5	3.2	3.8	4.1	0.6	3.3	12.3	2.3	2.5	13.0	7.3	0.9	1.4	9.8	6.0	53.7	4.6	1.9	11.0	0.5	1.2	2.6	2.5	10.9	15.9	12.8	4.1	5.5	0.1	0.1	8.3	9.8	0.0	0.0	0.0	8.1	4.7	2.8	7.2	0.1	20.8	13.8	0.1	0.7	0.0	16.0	7.5	2.1	92.7	2.4	0.0	2.1	9.7	0.1	0.2	0.3	0.1	4.5	0.1	7.3	11.1	13.9	0.0	11.1	3.5	5.2	3.5	0.5	3.9	5.3	6.1	14.9	0.0	6.2	9.7	8.9	17.0	8.5	48.2	1.9	9.6	5.2	13.2	7.6	9.9	23.2	9.3	11.0	3.1	4.1	22.7	9.4	170.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.5	15.0	5.6	4.4	5.6	4.6	3.1	3.8	1.4	4.6	10.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	566.4	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	357.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	2.7	1.6	0.0	0.0	0.1	0.1	0.2	0.0	0.1
C1orf189		ENSG00000163263	"Chromosome 1 open reading frame 189"	Q5VU69	1	154199085-154206333	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 30.5;testis: 19.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 88.7;Endometrial ciliated cells: 30.7;Late spermatids: 19.6;Respiratory ciliated cells: 25.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045779			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Golgi apparatus, Plasma membrane"		"HPA045779: AB_2679448"	"unprognostic (8.23e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.01e-3)"	"unprognostic (2.50e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.36e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.05e-2)"	0.1	0.0	0.2	0.1	0.3	0.5	0.1	0.4	0.4	1.6	0.6	0.0	0.0	0.5	0.3	0.1	30.5	0.0	0.1	0.3	0.4	0.1	0.3	1.8	0.1	1.6	3.4	0.1	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.1	0.0	0.9	0.0	0.1	19.7	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.4	0.2	0.3	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.4	0.2	0.4	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.5	0.1	0.1	0.5	0.2	0.5	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.3	0.0	0.4	0.2	0.2	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.4	0.4	0.3	0.4	1.6	3.4	1.2	0.9	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.7	30.7	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	19.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	25.1	0.0	0.0	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	11.3	12.5	20.6	6.3	20.4	14.3	11.7	19.5	24.4	15.5	18.2	13.4	7.9	13.4	5.5	18.8	13.0	4.0	9.4	20.5	20.3	11.2	11.6	8.6	9.0	20.8	19.7	16.1	12.9	7.4	9.9	7.1	20.6	14.2	3.9	2.7	12.5	8.5	9.6	19.6	10.5	5.0	19.2	10.8	12.3	7.5	20.3	9.2	12.1	3.5	7.3	14.4	14.7	21.0	22.2	24.3	17.0	10.9	8.2	8.3	40.0	16.8	7.4	14.6	10.9	24.1	22.2	22.7	35.6	6.6	10.3	25.4	16.0	16.6	5.3	24.6	76.7	13.9	20.1	23.1	13.3	32.0	16.7	7.6	19.5	14.3	13.1	9.2	16.1	26.1	35.2	13.3	10.7	27.8	42.0	44.4	34.4	28.5	55.6	32.1	24.2	36.4	13.6	18.2	28.1	27.2	16.0	29.4	23.3	4.5	31.0	29.2	15.1	11.8	18.1	32.7	37.2	23.9	12.7	21.6	14.2	18.3	19.2	14.9	29.0	43.3	28.2	35.9	35.2	37.2	31.1	30.7	37.6	29.9	36.1	30.2	4.7	35.9	34.9	49.3	34.7	17.5	20.6	20.4	19.5	24.4	20.5	20.3	20.8	19.7	20.6	19.2	20.3	21.0	37.7	22.4	22.4	10.4	29.8	66.8	35.5	58.5	47.3	51.4	41.1	50.9	18.1	28.6	31.0	38.6	18.8	76.2	49.8	61.6	45.0	38.0	4.4	28.2	31.7	33.9	26.3	57.4	12.9	39.5	59.3	34.3	25.0	43.7	24.7	36.9	32.2	24.4	40.4	47.1	10.1	58.8	54.9	24.2	72.7	5.5	51.3	29.8	32.0	2.8	32.4	42.5	30.9	9.5	14.3	37.5	43.5	46.6	28.1	37.4	47.8	38.3	25.1	54.5	65.7	31.6	44.7	44.0	50.0	54.1	80.6	28.3	47.2	28.0	56.6	25.8
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Endothelial cells: 101.3;Kupffer cells: 145.7;Langerhans cells: 282.7;Leydig cells: 95.1;Peritubular cells: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"myeloid DC: 103.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 103.5"	"Cell line enhanced"	"Detected in many"		"AF22: 77.8;AN3-CA: 110.5;ASC diff: 86.1;ASC TERT1: 141.3;HSkMC: 102.1;HUVEC TERT2: 108.4;U-87 MG: 68.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: AB_2732511"	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	37.6	19.1	59.8	26.4	60.7	11.9	30.7	62.0	96.2	27.6	56.2	25.9	13.3	30.1	39.1	17.9	33.2	46.4	34.6	57.6	62.2	28.4	29.7	29.2	62.6	61.9	61.8	7.9	5.1	14.5	10.5	59.2	62.0	28.7	25.9	16.2	8.4	75.6	24.6	11.1	15.0	60.3	63.5	69.4	12.7	13.9	64.2	30.8	13.9	48.3	27.9	36.2	18.2	62.4	1.6	0.3	77.8	110.5	86.1	141.3	2.2	14.0	20.5	3.8	12.0	0.9	1.9	0.6	4.1	12.3	1.5	2.7	0.2	0.5	5.6	1.4	12.2	1.9	2.0	1.3	17.7	3.9	2.6	102.1	5.9	24.8	1.9	13.2	108.4	1.8	1.8	12.2	15.0	4.2	0.7	24.0	5.7	0.1	3.9	18.8	1.7	1.4	1.1	6.1	1.5	1.3	1.4	0.8	7.5	16.4	1.4	58.0	0.7	28.1	2.1	0.8	0.9	5.0	4.8	1.2	68.3	3.1	0.7	0.1	21.2	0.8	0.6	20.8	2.5	0.9	3.8	1.7	103.5	0.7	3.5	2.0	1.0	0.8	5.6	2.1	1.9	6.4	59.8	60.7	62.0	96.2	57.6	62.2	61.9	61.8	62.0	63.5	64.2	62.4	115.7	3.2	4.5	19.6	3.3	6.4	2.2	2.4	1.8	0.8	2.3	3.7	10.6	2.8	2.5	22.0	0.0	1.3	1.5	2.0	76.3	0.7	9.4	3.1	37.6	101.3	1.2	0.4	4.1	2.3	0.8	29.3	5.1	3.1	1.3	0.7	51.8	1.3	45.3	0.0	3.8	1.3	0.0	145.7	282.7	19.6	95.1	65.6	12.4	16.9	24.9	23.4	1.0	0.5	0.3	2.0	1.5	104.2	3.0	4.9	2.7	4.9	0.5	1.6	32.9	7.5	70.4	16.6	1.9	7.5	5.1	3.6	3.3	5.2	1.4	8.4
C1orf68	"LEP7, XP32"	ENSG00000198854	"Chromosome 1 open reading frame 68"	Q5T750	1	152719522-152720470	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"skin 1: 678.3"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 78.3"	"Group enriched"	"Detected in some"	13	"head and neck cancer: 2.4;melanoma: 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HaCaT: 1.8"	"Not detected"	"Not detected"							HPA057942			Approved	"Plasma membrane,Cytosol"		NA	NA		220000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"	Cytosol	"HPA057942: "		"unprognostic (1.73e-1)"				"unprognostic (7.46e-2)"			"unprognostic (9.34e-2)"									0.4	0.0	0.0	0.0	0.0	0.2	42.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	678.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.8	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	78.3	0.0	0.1	0.0	0.0	0.0
C1orf74	"FLJ25078, URLC4"	ENSG00000162757	"Chromosome 1 open reading frame 74"	Q96LT6	1	209779208-209784559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 6.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 14.9;Glandular and luminal cells: 28.4;Squamous epithelial cells: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028496	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA028496: AB_10602698"	"unprognostic (3.25e-1)"	"prognostic unfavorable (8.52e-6)"	"unprognostic (8.41e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.40e-2)"	0.6	0.9	0.7	2.4	0.7	1.1	2.2	1.8	0.7	0.9	0.2	1.6	1.3	0.8	2.0	4.0	1.1	0.9	1.5	0.7	0.9	1.9	1.7	0.9	4.3	0.8	0.8	0.9	0.8	1.2	0.8	1.1	0.8	1.6	2.0	0.9	1.9	0.9	1.0	6.7	2.8	0.6	0.7	4.2	1.7	1.3	1.1	2.1	1.2	0.9	2.4	1.9	1.7	0.8	4.7	2.4	1.5	0.8	2.0	2.3	3.5	2.6	3.4	3.1	3.2	4.9	3.5	4.9	1.5	1.7	1.9	9.3	0.9	7.6	3.6	4.9	3.1	3.2	1.7	0.4	2.8	4.6	1.4	1.4	6.6	3.9	6.3	2.6	1.8	6.6	6.5	3.5	2.7	2.4	3.9	4.7	6.4	3.2	4.1	4.0	7.2	6.9	2.7	4.0	6.0	6.5	3.5	2.7	4.0	3.4	4.2	2.4	1.7	2.6	3.1	2.7	4.2	3.2	3.4	5.4	2.3	3.7	3.8	4.7	0.8	0.7	1.3	0.9	0.9	1.8	0.6	1.0	1.6	3.7	1.1	1.2	0.5	1.5	0.5	2.7	0.6	0.9	0.7	0.7	1.8	0.7	0.7	0.9	0.8	0.8	0.8	0.7	1.1	0.8	0.6	3.2	2.2	0.0	1.1	2.2	6.1	4.6	6.8	1.6	3.7	2.8	2.0	0.0	1.8	0.0	0.0	3.9	1.5	3.5	7.9	1.9	0.1	14.9	1.8	0.8	3.6	2.1	0.5	2.0	5.0	0.9	2.6	28.4	1.3	2.2	1.4	2.3	2.8	1.7	0.6	5.9	0.0	1.3	0.3	0.6	2.5	1.6	0.0	1.0	1.3	2.2	0.0	0.0	0.3	4.1	3.5	0.0	0.6	5.1	2.4	7.4	1.8	1.3	0.0	0.4	1.0	3.6	4.7	25.0	4.8	4.0	1.1	2.8	3.4	12.1
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA		410000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	79.3	135.4	85.5	84.1	85.7	121.2	108.7	91.5	118.3	58.4	119.6	140.3	95.9	66.4	68.3	138.6	74.5	48.7	126.3	89.5	94.3	136.4	134.5	54.7	115.7	89.6	92.3	52.7	72.9	127.7	81.3	75.8	93.2	63.9	141.6	86.7	66.2	73.1	174.2	81.3	78.4	80.9	93.1	73.5	74.3	62.5	90.7	98.5	65.1	160.1	135.6	108.4	73.9	97.3	443.8	671.0	233.0	378.0	169.8	207.7	313.7	330.4	268.5	751.4	458.8	646.8	143.7	941.8	317.8	251.3	271.3	385.8	756.7	448.9	689.8	216.6	1300.5	433.9	312.4	762.2	269.9	535.6	331.0	231.4	404.1	414.6	593.1	181.1	390.0	548.2	526.1	234.4	296.1	308.6	766.4	385.6	525.9	497.2	396.7	601.2	329.1	515.0	440.5	328.7	186.0	348.0	271.4	344.4	483.6	232.1	218.1	267.1	231.1	240.1	219.7	275.9	729.9	122.0	201.2	415.0	229.3	506.2	376.8	68.1	197.6	49.9	217.1	212.0	283.5	330.1	239.0	215.4	389.5	289.8	289.7	245.7	15.5	240.7	166.4	325.4	203.6	432.6	85.5	85.7	91.5	118.3	89.5	94.3	89.6	92.3	93.2	93.1	90.7	97.3	101.6	28.9	30.5	10.7	153.1	243.1	229.0	283.3	165.0	70.5	157.3	209.4	84.8	102.9	107.8	82.8	27.1	323.8	115.0	105.6	313.1	248.0	75.1	106.7	149.9	108.2	79.2	183.1	10.8	205.1	457.9	101.0	94.8	85.9	62.2	131.6	75.3	128.5	202.7	60.6	11.6	190.2	154.6	85.3	129.8	89.5	119.6	101.8	156.5	10.3	170.3	105.2	93.7	11.1	16.1	199.3	128.5	98.6	197.4	255.1	78.9	444.1	65.1	79.9	85.5	101.6	189.1	79.3	237.3	284.4	255.3	179.0	105.5	354.3	364.0	253.8
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037523-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.6;liver: 18.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Cholangiocytes: 47.1;Hepatocytes: 129.1;Oligodendrocyte precursor cells: 45.8;Paneth cells: 51.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;CACO-2: 2.2;EFO-21: 3.3;OE19: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	6.7	0.0	8.2	0.0	0.3	4.3	8.8	0.0	0.0	3.0	0.6	0.0	0.1	0.0	0.0	0.4	0.0	8.7	6.2	0.2	18.7	0.1	0.0	8.4	12.1	0.0	1.4	0.2	1.1	0.9	6.0	0.5	0.7	0.0	0.1	0.0	0.0	0.1	1.1	0.0	5.8	0.0	1.5	0.1	14.6	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.5	0.4	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	4.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.1	1.0	0.5	0.5	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.2	4.3	8.8	8.7	6.2	8.4	12.1	6.0	5.8	14.6	6.1	0.0	0.0	0.0	163.2	0.5	0.1	0.1	0.0	0.0	1.9	5.9	6.0	0.5	47.1	0.0	0.0	0.0	1.8	0.2	32.8	1.9	3.9	13.6	0.1	0.2	0.2	4.9	10.7	33.4	2.0	11.9	0.2	4.6	0.1	0.0	0.1	3.6	129.1	0.6	0.0	15.0	14.8	0.0	2.9	0.0	30.8	0.3	0.2	1.8	6.5	0.0	15.7	0.0	45.8	20.1	0.8	51.3	4.1	0.2	0.7	10.7	1.8	0.0	0.3	0.0	0.0	0.1	0.5	0.9	0.0	0.0	5.2	0.3	0.0	28.8	0.3
C3orf14	HT021	ENSG00000114405	"Chromosome 3 open reading frame 14"	Q9HBI5	3	62319015-62336213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 159.7;Spermatocytes: 173.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 28.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 408.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048286	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA048286: AB_2680340"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.69e-3)"	"unprognostic (6.91e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.76e-5)"	"unprognostic (1.57e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.33e-5)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	7.6	15.9	35.4	5.9	37.3	1.3	35.6	32.3	44.5	6.7	23.0	8.3	3.5	7.8	8.1	18.8	4.2	6.5	10.2	37.6	36.7	15.0	3.4	6.9	5.8	32.2	31.4	9.1	12.6	3.8	31.0	5.0	33.0	17.9	4.3	27.2	12.4	5.5	1.3	17.3	4.8	7.1	33.5	4.3	6.2	32.8	33.8	3.7	9.1	1.3	9.2	12.7	9.3	33.0	0.1	22.1	27.2	0.0	18.9	24.8	19.3	33.6	21.2	41.7	41.0	0.3	36.8	0.0	0.1	20.4	84.6	6.7	0.0	21.4	32.1	0.0	14.5	20.5	0.0	0.0	12.0	0.3	45.2	11.3	28.9	47.8	39.6	0.9	21.0	0.0	2.4	0.3	43.0	408.7	0.0	0.0	33.4	31.9	41.9	0.1	0.0	11.8	37.0	64.3	45.9	40.8	21.3	90.0	38.7	20.5	34.0	25.1	0.5	22.2	0.2	105.1	34.8	24.1	0.0	0.0	22.1	0.0	78.4	9.2	4.7	0.7	0.2	17.9	0.0	4.1	3.9	3.3	5.4	1.4	1.1	0.8	0.5	0.9	28.1	7.6	7.9	2.4	35.4	37.3	32.3	44.5	37.6	36.7	32.2	31.4	33.0	33.5	33.8	33.0	8.7	22.4	11.8	11.8	3.3	36.8	23.6	41.5	31.3	34.7	90.2	77.0	7.7	11.5	38.1	22.0	4.2	21.4	8.0	2.6	60.7	35.7	159.7	11.3	14.8	12.1	87.4	2.1	34.8	55.1	19.6	20.9	4.1	12.6	1.3	7.9	5.7	3.1	32.0	37.0	33.4	3.8	44.7	10.0	27.2	62.9	14.0	13.4	46.2	3.7	56.6	35.4	0.0	13.0	15.8	35.8	0.8	10.5	0.5	21.8	2.7	41.5	12.3	28.0	0.0	15.8	21.6	173.2	53.5	30.8	28.7	9.9	5.0	20.6	3.9	23.3
C3orf38	MGC26717	ENSG00000179021	"Chromosome 3 open reading frame 38"	Q5JPI3	3	88149959-88168729	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 341.2;Late spermatids: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 147.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034736, HPA034737"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034736: AB_2674307, HPA034737: AB_10671505"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (9.28e-3)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.67e-2)"	10.2	8.8	7.1	11.1	9.2	42.1	12.4	11.2	11.5	10.7	6.8	11.1	9.7	9.1	10.9	12.1	10.6	9.7	9.9	7.8	8.6	10.4	14.1	10.1	17.7	8.0	7.5	11.6	7.8	10.7	4.8	12.4	8.6	10.1	11.0	7.7	8.8	9.5	8.0	8.2	10.0	10.9	8.7	13.2	10.4	32.8	7.8	20.9	12.0	10.8	18.4	12.5	5.2	12.8	16.6	17.4	32.5	17.7	22.5	19.8	15.0	26.3	31.5	38.6	51.9	19.5	22.5	22.8	23.1	24.5	18.4	11.8	23.7	19.2	33.1	40.1	11.7	27.1	12.3	16.9	30.8	37.9	22.5	27.7	20.1	26.1	21.8	25.2	23.1	23.7	18.0	25.1	43.4	19.4	38.3	16.9	40.0	31.0	18.8	23.9	11.4	21.5	25.7	22.6	10.1	14.6	24.1	14.2	42.2	26.2	25.5	30.0	20.6	24.2	25.7	147.7	29.8	22.6	36.2	33.0	18.8	29.8	23.0	47.8	22.3	24.1	16.8	32.4	21.4	26.0	15.3	17.2	23.5	22.3	15.1	15.6	9.7	23.4	27.4	16.2	20.5	21.6	7.1	9.2	11.2	11.5	7.8	8.6	8.0	7.5	8.6	8.7	7.8	12.8	13.3	19.2	7.5	5.9	30.9	11.7	18.8	19.9	14.2	21.6	11.0	9.5	6.9	8.6	16.7	5.5	22.9	21.6	24.4	13.9	19.6	16.7	341.2	14.4	13.3	10.8	16.2	23.5	9.7	13.7	22.7	17.3	11.7	10.2	14.0	14.2	11.4	7.5	26.7	6.7	9.1	13.3	14.2	23.9	25.1	312.0	16.4	24.0	16.0	6.5	28.0	23.2	23.7	10.1	15.0	15.3	19.3	15.1	17.5	18.6	16.1	14.5	21.2	24.8	13.1	14.9	16.6	75.7	12.2	14.9	14.1	25.6	24.6	18.1	11.1	22.5
C8orf37	"BBS21, CORD16, FAP418, FLJ30600, MOT25, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244913-95269201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease variant, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	1.7	1.8	1.7	1.2	1.9	0.9	2.3	2.3	2.2	2.3	3.2	1.0	0.9	2.4	3.1	1.0	3.9	1.4	2.7	1.7	1.8	2.4	1.8	1.5	2.2	2.3	2.9	4.8	1.2	3.5	2.3	1.8	2.2	2.0	0.9	5.0	1.5	1.7	1.1	1.5	1.0	2.3	2.7	1.7	1.1	1.7	1.8	2.4	2.4	1.8	1.9	1.2	1.4	2.9	2.8	4.5	3.6	1.9	1.2	3.3	1.0	1.2	2.7	1.5	2.0	0.7	6.0	5.6	2.8	2.0	3.8	2.3	1.5	3.1	3.3	1.8	1.4	4.4	2.7	2.0	1.4	0.9	2.3	3.3	1.4	1.8	5.0	3.9	2.3	3.3	2.3	3.2	2.0	2.1	4.8	1.1	1.1	5.6	3.0	2.5	1.9	1.4	3.4	1.2	3.5	3.4	2.5	0.5	2.1	2.7	4.2	0.8	2.0	1.9	2.4	1.6	1.2	2.9	3.0	3.8	3.6	2.1	2.4	0.3	0.3	0.1	0.2	0.2	0.5	0.4	0.3	0.3	0.5	0.8	0.3	0.5	0.4	0.7	0.1	0.2	0.1	0.2	1.7	1.9	2.3	2.2	1.7	1.8	2.3	2.9	2.2	2.7	1.8	2.9	2.4	3.2	2.6	6.8	2.5	0.9	3.7	2.9	4.0	2.7	1.3	2.4	5.3	0.0	3.3	7.3	2.1	2.5	1.8	0.1	7.9	1.8	10.2	3.4	1.3	1.5	0.0	0.4	6.8	2.7	2.9	2.8	1.1	1.0	0.0	1.9	1.1	3.8	1.3	3.3	5.2	0.1	2.0	1.6	1.2	8.7	3.1	0.8	1.8	1.9	1.8	5.3	0.0	8.5	5.7	1.2	0.2	3.0	0.7	1.9	0.1	4.7	7.9	4.1	0.0	2.5	4.2	6.0	3.5	0.9	1.8	0.8	1.1	3.0	0.5	1.8
C9orf153	bA507D14.1	ENSG00000187753	"Chromosome 9 open reading frame 153"	Q5TBE3	9	86220265-86259657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 20.8"	"Group enriched"	"Detected in some"	26	"Early spermatids: 268.6;Late spermatids: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.3"	"Not detected"	"Not detected"							HPA079466			Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies, Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA079466: "	"unprognostic (2.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.30e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-6)"	"unprognostic (9.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.10e-1)"	0.1	0.4	0.3	0.4	0.2	2.6	0.2	1.4	0.9	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.5	0.5	0.6	0.2	0.1	0.1	0.0	0.9	0.6	0.1	0.1	0.6	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.2	0.3	20.8	0.5	0.1	0.2	0.1	0.0	0.0	0.0	1.3	0.2	0.8	0.0	0.4	0.0	0.4	0.3	0.2	0.0	0.0	0.2	0.0	0.6	0.8	0.2	0.2	0.5	0.2	0.0	0.0	0.1	0.1	0.3	0.0	1.3	0.2	0.1	0.2	0.2	0.1	0.6	0.1	0.0	0.0	0.3	0.9	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.7	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.6	0.1	0.2	0.4	0.1	0.3	0.0	0.1	0.4	0.8	1.6	0.2	0.3	0.6	0.1	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.5	0.3	0.2	0.2	0.1	1.5	0.3	0.2	1.4	0.9	0.2	0.2	0.5	0.6	0.6	0.0	0.5	1.3	0.3	0.0	0.0	9.8	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	268.6	0.4	0.5	0.7	0.0	0.0	4.8	0.0	0.1	0.4	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.4	244.8	2.8	0.1	1.8	1.0	0.1	0.4	2.1	6.6	9.7	0.1	0.0	0.7	0.4	0.3	0.0	0.1	0.0	0.1	0.0	1.3	0.7	1.8	1.9	0.0	0.1	0.1	0.2	0.3	0.1	0.2
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257251-150265078	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 33.3;retina: 39.4;skeletal muscle: 33.7;tongue: 47.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 69.5;Melanocytes: 53.4;Muller glia cells: 164.5;Oligodendrocytes: 25.7"	"Cancer enriched"	"Detected in many"	5	"melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 102.2;AN3-CA: 65.9;NTERA-2: 83.9;SK-MEL-30: 217.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.0	0.2	8.6	0.2	14.4	1.2	0.3	15.9	27.6	0.1	33.3	3.8	0.4	0.1	0.4	1.9	1.7	0.6	7.6	8.7	11.3	0.3	8.7	0.2	0.1	14.3	14.0	1.4	0.2	3.4	0.5	0.3	14.6	4.0	0.7	39.4	0.4	20.3	33.7	5.4	1.3	0.5	12.5	0.2	1.2	0.5	13.3	0.0	1.0	47.4	0.0	0.6	0.1	20.6	0.9	0.2	102.2	65.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.5	0.0	0.1	0.3	0.2	0.1	0.0	0.2	1.1	0.3	0.3	6.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.1	0.6	0.0	0.9	0.3	0.3	83.9	0.4	1.1	0.1	0.3	0.3	0.0	0.2	3.2	1.8	0.0	0.3	217.9	14.6	0.8	0.4	0.1	0.1	0.2	0.2	0.4	0.9	4.9	0.4	0.7	0.5	0.2	0.0	0.2	0.4	0.4	0.5	0.1	0.5	0.2	0.3	0.0	0.6	0.3	0.3	0.5	0.0	0.1	0.6	0.0	0.0	8.6	14.4	15.9	27.6	8.7	11.3	14.3	14.0	14.6	12.5	13.3	20.6	0.1	3.2	0.5	0.3	0.2	2.2	0.3	0.3	0.0	1.3	0.1	0.0	69.5	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.0	0.8	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.7	0.1	3.4	0.0	0.2	0.0	0.0	0.0	6.1	0.1	0.0	0.1	0.3	0.0	0.3	0.9	0.2	0.9	0.1	53.4	0.0	0.0	164.5	0.0	0.0	25.7	1.9	0.3	3.4	0.0	0.3	0.0	0.1	0.1	4.9	0.0	0.6	0.5	0.0	0.2	0.0	0.4	0.3	0.1	0.0	0.2	0.5
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 42.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 188.7;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 34.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;NB-4: 1.0;NTERA-2: 1.1;U-266/70: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.0	1.0	33.5	0.6	30.5	1.2	0.0	0.0	34.6	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.7	0.0	0.3	42.8	3.4	1.3	0.0	0.1	0.4	4.6	6.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.2	9.7	0.4	0.1	1.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	33.5	30.5	0.0	34.6	42.8	3.4	4.6	6.2	0.9	9.7	3.8	1.1	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.4	0.0	0.0	188.7	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	116.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.5	0.0	0.2	0.0	73.9	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 23.1"	"Group enriched"	"Detected in some"	24	"Cytotrophoblasts: 28.2;Syncytiotrophoblasts: 54.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048014			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA048014: "										"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.2	0.0	0.0
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499570	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 3060.6"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 172.1;Breast myoepithelial cells: 156.1;Suprabasal keratinocytes: 390.7"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"A-431: 400.3"					"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favorable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	3.9	0.5	0.0	0.0	0.0	0.1	41.2	0.0	0.0	94.0	0.0	0.8	0.0	0.3	0.7	67.5	0.1	0.0	1.3	0.0	0.0	0.3	1.7	0.8	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	554.0	0.0	11.7	3060.6	0.6	0.0	0.0	0.4	0.8	1.0	0.0	9.2	0.6	0.0	13.4	0.1	306.6	0.0	400.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	27.3	0.3	2.2	0.0	0.0	172.1	156.1	0.2	0.0	1.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	11.1	0.0	0.0	0.4	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.2	0.3	6.8	390.7	0.0	1.2	0.0	0.0	3.3
CAMK2A	"CAMKA, CaMKIIα, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 662.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 245.8"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 662.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 1071.1"	"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		66000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	0.2	0.9	161.7	0.2	230.9	0.1	0.1	0.0	662.9	1.2	0.0	1.0	0.1	2.8	0.3	1.3	1.5	0.3	4.8	453.1	0.0	0.7	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.0	3.5	0.3	0.0	0.8	0.2	1.9	0.7	0.4	95.0	0.7	0.4	2.4	0.0	0.3	0.5	0.1	0.0	0.0	0.1	34.7	0.0	2.0	0.7	99.6	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	230.9	0.0	662.9	453.1	0.0	0.0	0.0	0.0	0.0	0.0	99.6	0.0	0.0	0.0	12.1	0.0	3.4	0.0	0.0	0.0	5.1	0.0	0.0	14.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.0	245.8	0.0	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	55.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	3.6	9.4	0.0	0.4	0.0	8.5	8.1	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	3.6	1.8	0.0	0.3	0.0	1.4	0.3	0.2	0.0	0.0	0.0
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 159.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 272.9;Excitatory neurons: 182.9;Inhibitory neurons: 200.0;Microglial cells: 187.4;Oligodendrocyte precursor cells: 203.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 272.6"					"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		240000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	28.6	25.6	52.7	26.6	45.1	5.7	21.0	45.8	52.0	18.9	1.6	36.4	28.8	23.5	9.8	29.7	18.8	30.7	159.3	60.2	23.9	19.3	37.3	22.9	35.2	11.8	33.9	25.4	15.2	56.5	9.1	19.8	12.6	32.2	39.1	79.2	13.4	41.7	105.1	15.8	34.1	24.9	21.0	18.4	37.1	19.8	46.7	16.3	23.7	60.0	31.4	27.4	19.7	22.9	4.8	62.5	67.5	22.8	144.0	272.6	24.0	145.4	96.3	56.0	48.0	42.3	17.6	91.2	20.7	102.3	70.7	2.1	42.6	22.8	56.6	35.1	10.8	0.0	22.0	49.2	73.0	0.1	0.2	176.3	30.5	43.5	107.1	88.5	50.6	11.3	3.6	39.4	106.8	17.1	9.3	3.6	9.8	60.3	22.8	17.9	79.0	0.4	57.3	42.7	18.2	18.3	20.0	29.3	19.5	55.9	0.6	23.7	30.7	146.9	34.8	63.6	29.1	30.4	16.5	76.7	75.7	5.5	70.8	0.0	12.7	0.0	6.7	7.0	12.7	11.2	6.6	7.5	15.7	22.6	7.4	6.5	0.9	9.7	2.5	0.1	13.2	7.7	52.7	45.1	45.8	52.0	60.2	23.9	11.8	33.9	12.6	21.0	46.7	22.9	43.7	41.7	37.6	128.3	55.1	18.4	16.6	8.3	22.8	83.3	14.0	17.1	272.9	62.9	24.7	29.5	87.6	0.5	19.0	70.9	5.9	8.4	3.2	18.2	35.2	27.2	103.8	3.6	182.9	20.1	0.4	50.1	71.9	47.0	10.1	13.0	24.3	57.2	18.6	72.3	200.0	88.1	14.2	17.3	22.3	6.2	20.2	31.5	5.4	187.4	16.0	35.9	28.8	203.1	128.0	11.6	57.3	19.9	20.4	36.2	52.4	23.1	21.7	74.0	6.6	32.8	44.4	3.1	3.4	37.1	31.8	1.1	27.8	12.3	48.6	27.5
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393505-17557790	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 577.1;tongue: 313.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Excitatory neurons: 158.1;Inhibitory neurons: 137.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 26.1;basal ganglia: 40.9;cerebral cortex: 87.2;hippocampal formation: 50.2;white matter: 32.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 101.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	17.8	11.6	26.1	7.6	40.9	0.0	10.7	0.9	87.2	15.4	2.9	32.6	4.1	28.5	17.8	21.7	16.8	11.4	113.6	50.2	11.1	8.7	4.5	4.7	1.7	3.2	3.8	4.5	4.2	7.5	5.1	8.8	2.7	25.1	9.6	9.1	7.7	30.7	577.1	2.6	8.9	42.7	0.0	3.1	9.8	1.5	9.1	3.1	5.5	313.0	2.3	14.5	6.4	32.3	15.5	24.6	44.4	55.1	0.3	0.1	10.4	52.3	42.7	46.6	43.0	8.1	6.9	0.0	48.9	62.1	60.5	8.2	21.3	20.9	66.8	0.1	7.9	0.0	15.4	26.5	4.3	0.0	0.0	3.5	9.9	23.1	10.3	72.3	2.2	0.0	0.0	0.1	101.6	25.2	0.0	0.0	17.0	0.8	15.6	5.2	59.1	1.1	23.6	6.4	6.1	10.9	19.0	59.2	31.3	82.8	65.0	11.2	0.2	36.6	31.6	1.0	47.6	0.0	0.0	0.2	11.7	0.1	48.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	40.9	0.9	87.2	50.2	11.1	3.2	3.8	2.7	0.0	9.1	32.3	2.0	3.2	1.5	9.8	0.0	1.9	4.3	6.2	5.7	16.4	10.2	8.4	126.5	4.3	5.4	1.8	4.2	16.5	0.0	1.9	3.9	2.7	0.1	13.9	13.7	2.7	6.0	0.0	158.1	0.7	12.2	7.9	0.0	5.8	0.0	22.8	3.9	2.4	2.2	8.4	137.2	1.3	2.0	0.0	2.2	0.0	0.6	0.3	0.0	10.3	0.0	6.3	0.0	16.6	7.2	3.7	1.9	4.9	0.0	1.9	0.0	16.7	33.9	2.2	32.9	25.5	43.4	0.1	3.2	2.1	0.9	37.5	0.3	0.3	1.6	0.6
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine	Q13938	19	5912339-5916211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 334.8"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8"					"Low region specificity"	"Detected in all"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favorable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	12.2	25.9	37.5	10.9	35.1	10.0	11.6	55.0	30.1	47.2	55.4	16.1	6.9	21.7	4.6	12.9	334.8	11.2	13.5	40.2	69.6	38.3	21.5	49.5	12.2	72.6	105.3	13.8	24.0	3.3	27.9	9.3	85.7	40.4	2.8	2.2	24.9	30.9	4.3	16.2	18.7	2.3	60.9	25.2	37.5	6.4	50.0	5.7	30.8	1.1	4.2	44.2	13.7	66.1	2.2	2.3	0.9	6.3	2.1	3.2	4.0	0.7	0.7	0.3	0.6	1.5	13.8	0.9	4.0	1.5	0.7	2.3	0.1	0.6	0.0	4.7	1.9	0.8	4.8	4.7	2.5	0.8	3.5	4.1	4.2	0.4	0.8	4.0	1.0	4.7	0.7	5.4	0.7	4.4	2.4	4.0	0.7	19.4	12.6	3.1	0.3	4.7	1.8	6.2	1.0	4.9	1.0	65.1	6.6	2.0	4.3	4.7	1.5	0.6	0.4	4.6	17.1	19.8	6.5	1.1	7.7	1.8	2.8	0.4	0.7	0.3	1.7	0.6	0.9	0.9	1.0	1.3	0.8	1.8	0.8	0.7	0.7	1.8	0.4	1.5	1.0	0.8	37.5	35.1	55.0	30.1	40.2	69.6	72.6	105.3	85.7	60.9	50.0	66.1	5.3	12.8	16.5	11.1	3.3	4.8	32.1	122.8	1.8	2.5	8.9	8.8	2.2	0.0	161.5	121.4	4.2	24.3	7.4	5.3	35.2	34.7	6.5	2622.9	48.3	5.5	19.2	0.4	2.6	5.9	22.8	12.9	33.6	330.8	6.3	8.1	0.0	0.0	5.2	6.7	3.2	25.1	197.4	0.0	5.9	5.7	4.7	6.6	10.6	6.5	3.0	7.7	9.2	3.5	12.9	36.9	3.3	4.9	3.8	20.4	4.2	4.5	1557.4	4.2	6.6	3.5	42.7	0.4	0.6	0.9	4.1	20.5	9.2	3.3	9.3	128.6
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969366	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	45.7	21.7	7.0	69.4	7.2	48.5	44.4	7.4	12.4	26.4	8.6	27.6	62.4	18.4	33.1	47.7	34.9	50.1	17.8	7.5	8.0	33.3	54.1	61.3	80.2	9.7	8.1	43.2	52.5	4.7	11.0	70.2	8.7	21.7	30.7	2.0	55.2	15.5	7.5	46.7	58.8	32.2	8.3	71.1	42.4	4.9	9.0	57.2	15.6	18.1	82.1	76.5	30.5	8.7	33.8	9.5	0.0	12.9	58.2	140.4	27.8	68.0	103.2	80.5	117.0	22.4	128.5	22.3	123.1	71.5	110.4	52.7	0.0	94.3	78.8	22.4	0.4	53.1	7.4	55.8	158.2	48.5	19.2	122.6	127.0	97.9	144.4	104.7	143.8	0.5	1.3	0.0	64.4	2.8	26.1	46.7	0.0	71.6	28.2	21.4	21.5	14.2	64.9	46.2	0.6	0.4	60.8	31.6	49.3	0.7	11.9	62.5	93.2	84.4	30.4	80.8	40.5	0.0	0.0	0.3	42.2	105.5	63.4	136.4	292.0	50.6	208.9	312.9	224.8	141.9	155.6	193.9	205.5	144.4	93.4	138.5	667.2	226.2	255.4	35.4	257.9	410.9	7.0	7.2	7.4	12.4	7.5	8.0	9.7	8.1	8.7	8.3	9.0	8.7	78.1	60.9	60.8	0.3	87.4	55.8	63.3	130.1	21.1	0.0	40.8	48.4	5.6	47.1	107.0	22.0	0.0	129.1	80.4	12.4	15.6	157.5	0.6	35.9	27.7	73.0	20.9	12.4	0.0	189.9	103.0	53.6	33.1	45.7	34.8	32.6	82.1	34.7	116.7	0.0	0.2	37.8	73.2	168.0	81.2	2.1	29.2	105.2	30.2	23.4	141.5	1.9	177.1	1.5	0.2	148.5	8.6	20.7	50.5	31.1	85.4	41.1	86.1	0.4	6.6	38.1	34.2	0.2	0.5	25.8	45.9	115.9	102.1	36.8	32.9	80.0
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733802-8841808	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 182.7;tongue: 72.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	5.7	0.1	0.1	27.4	0.1	0.1	0.0	0.0	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	2.5	0.2	182.7	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.1	72.8	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	11.0	2.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0
CAVIN3	"cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC"	ENSG00000170955	"Caveolae associated protein 3"	Q969G5	11	6318946-6320532	"Predicted intracellular proteins"	"Biological rhythms"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 140.5;Exocrine glandular cells: 252.2;Extravillous trophoblasts: 88.9;Fibroblasts: 88.7;Pancreatic endocrine cells: 219.0;Smooth muscle cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 16.2;myeloid DC: 42.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 42.8;monocytes: 16.2"	"Cell line enhanced"	"Detected in many"		"A-431: 120.7;BJ: 111.6;HaCaT: 91.7;TIME: 133.6;U-87 MG: 125.9;WM-115: 137.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055136, HPA073327"	Supported		Approved	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA055136: AB_2682711, HPA073327: AB_2686595"	"unprognostic (7.92e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (3.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.96e-2)"	69.3	20.3	5.0	16.4	5.3	0.5	51.7	4.9	7.3	73.5	10.3	69.8	5.8	106.5	1.3	19.2	48.8	1.3	57.9	4.3	4.3	24.9	8.3	37.8	2.5	5.1	4.3	37.0	21.4	1.3	8.1	11.7	5.4	43.6	4.0	0.0	20.3	13.1	17.1	28.3	29.6	22.9	4.9	25.0	37.3	12.1	5.7	1.1	22.6	5.6	1.4	79.3	58.2	4.1	120.7	12.1	0.1	0.4	5.4	24.7	0.0	111.6	45.1	18.5	20.5	0.0	0.1	0.0	36.6	26.1	1.9	91.7	0.0	9.0	3.4	30.1	0.0	0.0	14.0	0.0	14.6	0.0	0.5	16.6	12.4	6.9	9.0	0.0	35.7	0.0	0.0	0.7	19.8	0.0	0.0	0.1	74.6	0.9	2.0	0.0	0.0	0.2	25.6	0.0	0.0	0.1	40.9	0.2	27.0	0.7	0.2	0.5	133.6	0.0	0.4	46.0	0.4	0.2	1.0	0.2	125.9	0.0	137.7	0.0	16.2	0.0	0.0	1.1	0.0	0.0	0.8	0.0	42.8	0.0	0.0	0.0	0.2	0.4	0.0	0.0	6.1	5.9	5.0	5.3	4.9	7.3	4.3	4.3	5.1	4.3	5.4	4.9	5.7	4.1	140.5	12.8	6.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.7	36.2	0.0	0.0	8.1	16.5	0.0	3.6	1.0	0.0	39.2	6.0	0.0	6.9	59.7	70.3	0.0	0.0	0.0	252.2	88.9	88.7	0.0	8.0	0.0	2.6	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	30.5	0.0	0.0	0.0	0.0	219.0	0.0	0.0	0.5	0.0	0.0	47.6	10.2	0.0	0.0	0.0	146.0	0.0	0.0	0.0	0.0	8.5	1.6	45.7	0.0	0.0
CBWD1		ENSG00000172785	"COBW domain containing 1"	Q9BRT8	9	121038-179147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 185.1"									"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (3.75e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.80e-7)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.98e-3)"	18.6	34.4	8.7	15.3	9.2	13.0	19.9	10.6	11.1	14.3	13.0	16.9	13.3	13.7	20.8	26.8	14.6	10.6	20.7	9.0	10.2	40.1	26.8	16.1	13.4	9.0	9.0	15.4	30.0	38.3	19.4	22.2	9.2	19.9	15.2	27.5	23.7	12.2	21.8	22.3	14.1	12.2	9.0	16.9	19.1	16.4	9.1	13.2	25.4	17.6	20.1	23.4	17.1	9.9	43.3	16.1	22.7	12.2	29.1	26.2	50.3	22.2	14.6	30.4	23.0	23.4	16.1	39.4	28.3	8.2	18.4	7.3	11.3	21.1	32.4	67.8	38.9	0.4	39.1	72.6	31.5	115.1	17.2	23.5	9.9	7.3	59.0	19.5	32.9	19.7	13.6	84.3	25.2	52.1	25.1	185.1	22.9	37.6	34.6	47.7	34.6	75.8	39.4	120.7	40.8	24.8	45.8	16.8	17.8	55.5	35.6	109.2	34.4	16.0	22.9	20.8	19.7	10.1	14.6	44.6	39.6	60.6	19.2	3.6	65.7	19.3	10.3	75.6	16.9	21.1	18.6	16.8	74.1	15.7	16.2	17.7	10.2	12.8	60.8	19.6	18.1	48.3	8.7	9.2	10.6	11.1	9.0	10.2	9.0	9.0	9.2	9.0	9.1	9.9	19.5	54.5	50.1	8.1	41.2	47.7	29.9	47.6	97.9	50.8	49.4	37.6	51.8	30.0	49.8	35.0	108.4	96.3	17.7	20.4	35.2	79.9	51.7	14.9	10.1	23.0	31.2	44.6	17.0	118.5	41.2	23.0	34.7	11.9	32.8	26.7	20.7	19.0	32.0	38.7	17.1	39.0	50.8	25.1	38.0	16.4	18.0	37.9	32.0	18.7	81.5	32.2	18.6	5.5	16.7	66.9	38.2	13.2	90.0	32.0	49.5	73.6	31.0	63.5	32.9	20.2	27.8	48.6	28.1	83.8	50.6	124.8	23.5	24.1	62.3	24.9
CBWD2		ENSG00000136682	"COBW domain containing 2"	Q8IUF1	2	113437691-113496204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 110.3;Suprabasal keratinocytes: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (7.69e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (7.57e-3)"	4.7	8.3	5.8	5.3	6.3	1.5	7.0	7.0	7.2	8.2	7.1	8.4	2.2	7.0	7.1	9.4	4.5	4.5	15.9	6.3	6.7	13.8	10.5	4.0	3.2	6.0	6.2	5.4	5.6	16.2	8.8	5.9	6.1	6.4	5.9	6.3	8.1	7.4	26.0	4.3	4.6	8.1	5.5	4.9	6.5	2.0	6.0	6.8	9.6	23.9	4.6	8.7	5.4	6.4	16.1	9.7	9.8	11.2	25.7	11.8	19.2	11.9	7.4	9.1	12.0	16.0	9.6	20.7	36.2	12.8	42.1	13.2	10.8	13.2	12.0	7.5	28.9	17.4	16.8	29.8	8.6	8.1	7.8	11.1	8.1	13.4	8.1	17.7	17.1	11.1	10.1	22.2	13.4	17.1	23.3	24.2	11.9	30.2	20.7	10.9	26.6	54.6	24.6	25.1	28.0	8.0	31.4	4.6	5.1	33.7	14.5	21.6	20.8	7.7	10.7	4.8	11.9	8.5	38.2	10.5	12.8	44.5	19.3	15.6	67.7	35.6	12.1	68.4	13.2	17.9	18.2	14.3	65.3	22.7	15.3	14.1	18.5	20.2	56.2	16.2	27.0	52.9	5.8	6.3	7.0	7.2	6.3	6.7	6.0	6.2	6.1	5.5	6.0	6.4	5.6	9.6	20.5	11.8	32.5	110.3	12.8	24.5	62.6	10.5	15.9	14.9	49.6	18.6	20.0	14.7	16.7	17.6	7.1	7.2	39.2	29.6	18.6	10.3	7.1	11.9	2.4	23.7	27.3	14.3	13.2	16.4	23.0	11.1	15.8	9.5	6.1	11.4	9.0	13.5	25.8	11.4	16.2	9.4	62.5	18.4	10.8	20.0	26.6	21.5	53.8	10.9	2.1	15.6	24.9	12.7	14.1	17.3	78.7	14.9	13.7	33.9	26.4	14.0	0.0	9.6	17.1	21.7	13.6	61.0	120.0	25.9	18.4	11.6	17.3	12.2
CBWD3	bA561O23.1	ENSG00000196873	"COBW domain containing 3"	Q5JTY5	9	68232003-68300035	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.71e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.16e-4)"	12.2	19.4	7.5	18.8	7.5	13.5	17.3	9.8	9.5	9.8	5.3	14.0	13.0	9.9	7.3	17.2	9.7	6.6	13.0	8.1	8.9	21.2	28.4	10.2	16.9	8.4	7.7	12.0	27.2	8.6	18.4	15.6	8.8	10.5	9.8	18.0	13.5	10.2	17.5	13.1	20.6	8.9	4.4	12.7	17.5	12.3	6.9	12.7	14.3	13.3	13.0	18.8	12.2	10.6	73.0	52.6	25.1	41.2	18.9	6.7	34.3	35.6	14.1	15.2	17.4	15.0	69.4	84.1	33.9	26.1	67.5	86.7	48.0	70.5	39.8	128.2	31.0	31.9	137.8	73.6	24.8	60.9	38.3	15.6	21.3	27.0	35.3	30.5	35.6	93.1	60.4	66.1	22.3	47.4	71.8	81.9	38.5	86.4	88.7	32.6	78.7	94.0	17.3	32.8	40.3	25.7	58.0	36.2	46.3	46.6	26.7	71.5	16.6	22.6	58.1	38.4	70.1	38.3	165.4	102.3	68.8	92.3	41.6	29.8	86.1	66.2	27.8	71.5	24.0	52.5	25.2	28.7	62.0	52.3	27.6	25.5	86.5	16.1	52.0	46.5	37.9	59.8	7.5	7.5	9.8	9.5	8.1	8.9	8.4	7.7	8.8	4.4	6.9	10.6	4.3	25.6	30.0	2.0	15.9	14.5	16.2	6.0	12.0	25.2	14.5	9.7	28.7	7.2	21.0	11.0	29.2	13.2	5.6	9.7	1.9	7.1	4.7	4.0	2.4	9.0	4.2	5.2	10.8	11.6	7.9	8.9	8.6	3.8	12.6	12.4	6.1	8.2	5.0	11.8	8.9	9.1	2.0	11.0	10.1	2.4	5.0	6.8	5.4	6.5	19.7	5.9	8.2	10.1	5.6	8.8	17.4	3.0	20.3	12.6	28.9	7.1	24.1	36.2	6.6	5.3	6.3	16.7	7.8	7.3	21.5	15.5	10.6	7.6	10.7	12.9
CBWD5		ENSG00000147996	"COBW domain containing 5"	Q5RIA9	9	65668805-65734041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 178.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.23e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.02e-3)"	"unprognostic (5.32e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.87e-1)"	9.8	15.2	20.7	8.4	21.1	7.0	17.0	21.7	25.8	11.2	20.6	11.4	11.0	6.5	9.0	15.5	10.9	5.2	12.5	21.1	22.3	26.0	41.9	9.6	6.6	21.1	21.3	10.6	19.4	7.8	16.8	6.7	21.5	17.4	10.5	8.7	9.6	7.7	8.4	11.0	13.9	5.9	20.7	21.2	11.4	11.4	21.0	4.6	15.6	4.2	9.7	12.7	9.8	21.8	37.7	40.1	14.0	17.3	20.8	9.5	16.4	26.0	17.6	20.2	20.6	5.2	33.6	51.2	16.2	15.3	29.1	27.2	64.1	21.3	38.2	8.4	15.4	14.4	69.3	91.0	16.2	32.8	8.9	16.9	23.9	18.7	14.8	25.0	37.3	19.4	20.5	36.9	21.1	45.8	16.4	34.2	16.3	64.4	42.4	28.1	19.2	49.9	32.4	23.9	18.1	18.3	21.2	16.1	8.0	24.5	76.4	21.3	10.6	9.1	33.6	27.7	30.2	12.0	34.8	11.8	37.4	35.9	35.3	1.7	11.8	8.8	3.2	15.0	3.7	5.3	5.3	4.6	12.4	3.0	4.8	4.0	7.8	2.8	9.8	5.2	4.4	10.6	20.7	21.1	21.7	25.8	21.1	22.3	21.1	21.3	21.5	20.7	21.0	21.8	17.8	41.7	51.8	13.4	58.4	65.1	31.8	24.6	178.7	37.7	59.4	36.7	33.6	25.8	38.5	20.2	68.8	44.0	10.6	33.2	21.5	33.1	10.5	17.4	8.4	22.8	16.8	25.9	60.6	39.0	23.0	20.1	49.5	15.4	10.1	16.3	16.4	48.0	15.9	35.3	60.8	32.6	12.2	25.1	36.6	4.6	21.1	27.5	30.2	20.6	45.2	13.5	7.2	37.2	32.2	33.7	51.1	17.3	143.5	32.3	76.9	42.7	27.8	62.4	6.6	10.4	18.8	35.2	25.5	119.4	85.5	50.5	29.6	12.3	34.2	30.5
CBWD6	CBWD7	ENSG00000215126	"COBW domain containing 6"	Q4V339	9	41131306-41199261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 39.4;Excitatory neurons: 24.9;Inhibitory neurons: 20.2;Langerhans cells: 30.0;Oligodendrocyte precursor cells: 18.6;Suprabasal keratinocytes: 42.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 17.3;PC-3: 26.8;TIME: 16.6"									"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (9.48e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.28e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.94e-4)"	2.0	5.3	1.8	0.7	1.8	2.2	2.1	1.8	3.4	1.0	2.5	1.9	1.1	1.2	0.2	2.9	0.9	1.5	3.4	1.8	2.1	3.4	7.2	2.0	0.3	1.9	1.9	1.6	3.4	0.1	2.7	0.2	2.2	1.7	0.1	0.9	2.5	1.9	3.6	1.5	1.9	0.3	1.9	2.1	2.2	1.9	2.0	0.1	2.2	0.0	0.5	1.1	1.9	1.8	2.0	0.5	0.9	0.2	0.9	2.4	1.6	11.0	12.4	12.6	0.0	4.3	1.2	2.7	0.5	9.0	0.5	1.8	15.9	0.3	0.4	2.8	10.6	0.7	6.4	2.9	0.1	3.4	1.0	0.2	1.5	8.4	10.1	0.9	9.7	0.8	1.4	1.5	17.3	1.8	5.1	0.7	2.3	4.5	26.8	1.2	10.8	3.6	11.5	0.5	0.7	1.2	2.7	0.8	1.1	2.2	0.9	1.5	16.6	0.2	1.0	0.3	1.2	4.9	0.8	13.5	1.5	1.0	1.2	1.6	4.1	1.7	0.6	5.0	0.9	3.5	2.9	2.3	2.3	1.2	1.8	2.2	0.6	0.4	7.0	2.7	1.3	2.4	1.8	1.8	1.8	3.4	1.8	2.1	1.9	1.9	2.2	1.9	2.0	1.8	2.0	3.2	8.9	5.2	1.3	39.4	0.0	11.0	0.0	0.0	5.1	2.7	0.0	0.0	7.5	5.5	0.0	5.2	1.4	0.0	3.9	4.3	0.0	1.5	0.9	1.4	0.0	0.0	24.9	4.9	5.2	1.4	0.0	1.4	8.8	2.2	0.0	0.0	3.0	0.0	20.2	0.0	8.2	0.0	30.0	0.0	0.0	1.4	14.2	5.6	1.6	0.0	0.0	18.6	8.1	4.4	0.0	0.0	1.4	0.0	0.0	8.8	7.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	42.9	6.3	2.8	1.4	0.0	0.0
CBY2	"NURIT, SPERT"	ENSG00000174015	"Chibby family member 2"	Q8NA61	13	45702320-45714559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	441	"testis: 99.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039359, HPA040046"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 36: Testis - Spermatogenesis"		"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cell Junctions"		"HPA039359: AB_10794088, HPA040046: AB_10796117"	"unprognostic (2.86e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.19e-4)"		"unprognostic (8.52e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-1)"		"unprognostic (2.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.15e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	99.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC107	MGC31967	ENSG00000159884	"Coiled-coil domain containing 107"	Q8WV48	9	35658290-35661511	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016857, HPA050442"			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA016857: AB_10669751, HPA050442: AB_2681128"	"unprognostic (3.70e-3)"	"unprognostic (7.07e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.75e-2)"	91.6	61.0	35.1	19.1	34.6	7.8	75.3	37.4	40.6	48.5	36.0	117.8	19.2	74.2	31.1	25.1	60.6	15.3	90.3	34.5	35.3	37.7	50.3	43.6	15.4	35.5	35.7	32.3	62.7	12.8	33.0	13.9	36.0	55.9	16.8	13.9	26.6	29.2	64.4	32.5	47.1	28.2	34.7	41.2	74.4	17.1	37.3	26.0	31.4	22.4	14.4	76.6	39.1	35.0	17.9	15.7	12.8	16.3	63.3	40.3	7.4	29.5	26.4	18.5	17.2	7.2	5.2	11.5	12.8	38.9	47.6	5.9	9.6	14.2	13.6	34.4	15.3	5.5	25.1	18.3	15.0	8.5	20.1	24.1	16.6	19.8	15.3	34.4	13.1	19.2	7.2	21.7	23.4	11.6	9.5	12.6	9.5	12.6	48.2	13.7	2.9	9.3	62.8	9.6	8.4	14.0	15.2	21.1	15.4	9.5	11.1	10.4	16.7	29.5	16.3	21.6	27.3	9.6	15.4	23.1	54.6	13.5	26.2	33.3	39.3	20.1	128.7	43.2	168.8	79.5	111.6	113.8	45.0	79.5	53.2	74.2	7.8	69.3	25.9	123.8	140.8	75.1	35.1	34.6	37.4	40.6	34.5	35.3	35.5	35.7	36.0	34.7	37.3	35.0	68.7	67.3	25.0	11.1	104.8	70.2	38.0	76.9	8.6	31.9	39.2	65.3	0.7	60.1	48.4	82.8	8.4	15.0	175.2	143.9	17.6	74.1	7.6	33.5	34.1	36.1	88.1	15.8	8.6	140.2	66.2	60.0	121.8	30.5	34.3	24.4	53.9	77.3	90.9	32.0	10.2	100.5	69.2	46.9	185.9	28.3	59.4	82.0	113.8	13.1	43.5	57.2	133.9	7.5	10.8	86.7	108.6	102.3	53.3	45.3	146.7	66.9	48.2	34.1	118.3	33.7	135.3	37.9	63.1	17.8	66.9	13.8	132.7	44.9	51.7	29.5
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267190-115296693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045120, HPA050621"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: AB_2679222, HPA050621: AB_2681191"	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	4.3	3.6	5.7	5.3	6.3	7.3	6.0	7.4	7.3	4.5	2.6	9.1	7.2	5.6	6.2	4.5	4.1	3.1	6.0	5.8	6.6	2.8	1.2	5.5	4.6	6.4	5.5	2.1	10.2	4.5	4.6	2.4	6.3	6.7	9.3	7.9	6.5	5.0	4.3	4.9	6.3	5.4	5.7	4.6	6.4	40.7	5.9	3.7	4.0	2.5	4.2	3.8	3.6	7.8	12.0	5.9	11.5	18.5	7.1	14.0	2.9	10.5	5.3	7.7	8.7	2.6	6.7	14.8	8.9	7.2	11.4	7.5	12.1	6.0	16.0	12.0	10.1	9.8	8.8	3.8	9.7	12.9	4.8	6.4	7.2	9.8	13.0	8.8	12.1	13.1	4.1	11.6	10.8	9.3	19.2	11.4	13.1	11.0	11.0	20.6	14.5	113.7	7.7	4.2	17.9	23.5	11.5	7.2	32.8	7.8	12.2	18.9	12.6	10.1	6.9	19.7	14.8	13.2	13.2	3.0	6.7	9.9	6.0	0.3	5.0	11.0	2.9	4.0	3.3	2.8	2.2	2.5	5.4	4.0	2.8	1.9	3.2	3.0	4.9	10.2	0.1	2.1	5.7	6.3	7.4	7.3	5.8	6.6	6.4	5.5	6.3	5.7	5.9	7.8	15.7	16.0	14.0	16.0	19.2	14.1	5.0	6.0	8.0	29.2	19.4	18.4	17.6	8.6	8.4	5.5	10.4	0.7	19.5	23.6	5.9	28.2	8.5	23.0	21.4	12.4	40.6	20.8	26.4	25.9	2.0	11.5	14.3	12.3	9.5	15.0	7.9	3.1	32.7	10.1	15.2	33.4	6.1	28.6	31.5	18.5	4.1	31.5	14.2	15.0	36.6	11.0	11.3	21.1	54.7	27.1	18.7	4.1	27.3	8.0	11.8	4.4	11.7	24.9	13.1	18.5	18.2	201.8	73.3	13.8	22.6	0.5	9.2	5.5	32.8	3.4
CCDC136	"DKFZP434G156, KIAA1793, NAG6"	ENSG00000128596	"Coiled-coil domain containing 136"	Q96JN2	7	128790757-128822132	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 87.6;retina: 52.5;testis: 185.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 780.2;Late spermatids: 2032.0"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 30.5;U-937: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010646, HPA071015"	Enhanced	Approved	Approved	"Nuclear membrane,Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	"Nuclear membrane, Plasma membrane"	"HPA010646: , HPA071015: AB_2686334"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-4)"	"unprognostic (2.58e-2)"	"unprognostic (8.44e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.18e-4)"	"unprognostic (5.27e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	1.8	3.7	37.2	1.9	24.4	0.8	1.7	42.7	39.9	5.2	6.2	20.1	1.6	9.3	2.2	1.7	3.3	2.2	5.7	24.2	34.7	0.7	0.3	1.1	2.7	30.5	54.2	2.8	0.8	1.6	6.4	1.4	26.3	12.1	3.1	52.5	1.6	13.6	4.4	0.9	4.8	11.6	34.9	1.5	4.6	185.7	87.6	5.2	1.3	4.0	1.7	13.1	3.9	30.6	1.1	1.5	11.7	7.9	6.3	5.4	2.0	4.7	6.0	4.6	4.3	1.8	1.0	6.5	0.5	6.2	18.4	2.5	7.8	0.9	4.3	17.2	7.7	10.7	3.1	0.0	2.2	1.5	22.2	6.0	0.8	5.0	0.4	4.1	2.7	10.0	4.0	6.0	1.9	2.3	8.0	3.4	16.3	0.1	5.1	19.5	2.3	2.9	0.3	2.4	7.4	20.4	2.9	3.3	5.1	4.1	0.3	3.1	2.4	7.4	4.2	3.7	3.5	3.4	1.6	6.1	30.5	46.2	1.9	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	37.2	24.4	42.7	39.9	24.2	34.7	30.5	54.2	26.3	34.9	87.6	30.6	1.6	0.0	0.5	11.4	1.1	0.5	0.9	0.1	1.8	306.0	0.6	3.8	7.5	1.5	0.7	0.0	98.0	0.1	2.2	0.0	0.0	0.7	780.2	0.3	2.2	2.0	0.0	0.4	23.3	1.5	0.3	2.6	1.5	0.1	0.0	1.9	1.1	0.0	6.8	40.4	48.0	0.1	0.0	0.6	1.6	2032.0	18.0	2.3	0.0	10.3	0.7	22.5	2.1	28.6	13.3	0.6	0.1	7.5	1.1	0.9	0.0	0.2	2.0	20.7	6.6	1.6	6.1	321.9	17.2	0.1	0.4	0.4	3.4	0.3	0.0	0.3
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 42.8;Erythroid cells: 26.3;Late spermatids: 25.8;Spermatocytes: 99.7;Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	0.7	0.3	0.5	0.9	0.8	2.1	2.8	0.5	0.6	0.6	0.3	0.8	0.7	0.6	1.5	0.8	1.1	0.5	0.2	0.6	0.5	0.6	1.3	0.7	1.2	0.9	0.6	0.8	0.8	0.6	0.5	0.7	0.6	1.6	0.8	1.7	3.9	0.5	0.1	2.1	0.7	0.6	0.7	0.8	0.6	10.5	0.7	2.8	0.7	0.2	1.4	0.5	0.6	1.2	5.4	1.0	6.9	0.0	0.5	1.9	0.0	5.7	6.9	5.3	6.5	0.1	4.4	6.3	4.9	2.0	10.5	4.2	2.9	3.8	9.4	5.3	1.1	7.7	0.8	1.6	0.2	2.3	4.3	0.5	2.7	11.0	5.5	1.0	4.0	7.8	5.2	6.3	11.2	1.2	4.9	2.6	1.6	4.6	6.3	5.9	12.6	2.0	0.8	2.1	3.9	3.4	3.3	0.4	1.5	3.3	7.9	2.0	2.9	10.8	2.4	4.8	7.2	1.5	1.8	5.3	1.5	12.6	7.3	4.0	0.5	0.8	1.0	0.7	1.1	0.3	0.9	1.7	0.1	0.7	1.2	1.4	0.4	1.1	0.8	0.5	1.7	0.5	0.5	0.8	0.5	0.6	0.6	0.5	0.9	0.6	0.6	0.7	0.7	1.2	2.4	3.2	1.1	5.2	2.3	5.0	2.1	2.2	2.2	6.4	4.2	2.8	0.6	0.0	2.9	0.0	0.0	0.9	2.9	1.1	0.0	2.3	42.8	2.6	2.0	3.4	1.2	26.3	1.2	3.5	0.4	2.5	3.6	1.4	8.9	4.4	1.4	1.4	3.2	3.3	2.0	2.1	0.0	2.6	3.3	25.8	4.4	2.6	3.6	1.0	0.7	3.6	8.2	5.0	6.1	1.8	0.5	2.2	1.2	1.1	0.2	1.0	5.3	2.8	6.6	2.2	2.3	99.7	34.5	3.2	3.8	0.1	3.4	0.9	1.7	1.2
CCDC154	"C16orf29, LOC645811"	ENSG00000197599	"Coiled-coil domain containing 154"		16	1434383-1444556	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 11.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 51.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.5;NB-4: 4.7;SCLC-21H: 33.2;U-266/70: 5.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.9"	"HPA041158, HPA043535, HPA048237"	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"	"Golgi apparatus"	"HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323"	"unprognostic (2.40e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.35e-2)"	"unprognostic (8.02e-6)"	"unprognostic (9.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.35e-5)"	0.6	0.8	1.5	0.9	1.7	1.0	0.8	1.7	2.2	1.9	0.5	1.2	1.4	1.0	0.3	0.4	1.9	0.5	0.7	1.4	1.3	2.3	0.7	0.8	1.4	1.8	1.4	1.5	1.2	0.1	3.8	0.4	1.6	1.5	0.1	0.8	0.7	0.4	0.8	1.5	1.2	0.2	0.9	2.2	2.0	11.6	1.5	0.4	2.8	0.1	0.4	0.8	0.9	2.4	9.5	0.4	0.3	0.6	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.4	0.3	0.1	0.5	0.1	0.3	0.1	0.0	0.1	0.0	0.1	1.2	0.5	0.0	0.7	0.0	4.7	0.2	0.0	0.1	2.8	0.1	0.2	0.0	0.2	33.2	0.5	0.1	0.2	1.4	0.1	1.0	2.4	0.0	0.4	0.1	0.4	0.0	5.8	1.6	0.1	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.7	2.2	1.4	1.3	1.8	1.4	1.6	0.9	1.5	2.4	0.2	0.0	0.0	9.8	1.4	0.0	0.5	0.2	0.0	3.2	0.5	0.6	0.6	1.5	0.1	3.7	8.4	0.0	0.4	0.1	0.0	0.1	51.6	0.3	0.3	0.1	0.0	0.0	3.9	0.4	0.0	0.3	1.1	0.3	1.3	1.5	0.4	0.2	0.8	6.7	4.8	0.5	0.0	0.3	0.8	11.1	1.5	0.6	1.8	7.5	0.8	2.4	0.0	2.0	3.8	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.8	4.2	0.0	0.3	0.6	10.1	1.2	0.0	0.4	0.0	0.7	0.4	0.0	0.2
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 36.4;Respiratory ciliated cells: 57.6;Spermatocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.0;intermediate monocyte: 2.2;memory B-cell: 3.5;naive B-cell: 2.2;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.5;granulocytes: 1.0;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: AB_2684591"	"prognostic favorable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (3.18e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.6	4.8	11.8	1.3	11.9	0.4	3.3	11.3	15.9	5.9	12.3	3.8	1.9	3.2	1.9	2.1	11.2	3.1	1.3	11.8	12.0	11.8	3.6	2.9	1.4	11.6	11.8	2.4	5.6	6.2	12.9	1.0	11.7	7.2	2.1	6.6	4.4	5.0	0.8	1.1	2.4	1.3	11.8	2.4	3.8	19.1	12.3	0.9	9.1	0.2	1.0	4.1	2.4	11.5	4.7	2.8	1.2	1.4	1.2	0.8	2.7	0.2	1.9	1.4	2.4	1.8	13.4	3.8	5.0	0.5	4.0	4.7	0.7	6.5	1.3	3.9	1.6	1.9	1.7	0.5	1.3	0.6	3.2	0.3	0.6	4.5	0.4	4.3	1.1	1.4	0.8	1.4	2.0	4.0	0.2	1.4	2.7	4.2	2.2	1.3	0.0	0.7	5.5	1.8	2.9	2.6	4.0	2.3	2.6	2.5	6.7	0.1	0.3	2.1	5.9	1.5	0.7	0.5	1.8	0.8	5.3	0.5	1.7	0.0	0.4	1.0	0.3	2.2	0.2	3.5	0.1	0.1	0.4	2.2	0.0	0.0	0.4	0.3	1.8	0.3	0.0	0.2	11.8	11.9	11.3	15.9	11.8	12.0	11.6	11.8	11.7	11.8	12.3	11.5	1.7	3.2	7.2	17.0	2.3	1.1	7.9	26.5	9.1	8.9	13.3	12.1	1.0	12.8	22.0	9.2	6.2	5.6	0.9	11.3	21.5	9.4	20.7	30.9	2.4	2.1	36.4	1.3	17.7	7.2	2.2	2.5	21.9	6.9	2.5	1.6	2.5	2.6	3.3	3.3	10.0	13.6	14.2	2.0	2.2	11.7	2.1	3.6	3.6	1.9	2.7	10.2	0.0	5.0	2.4	6.5	8.3	3.0	1.8	5.7	6.3	11.5	57.6	15.4	0.0	2.9	3.8	50.6	19.9	3.9	0.9	2.5	1.3	3.9	10.2	11.4
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"		6	138773769-138793319	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Nucleoplasm	"HPA055125: AB_2682705"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	21.8	48.4	41.8	19.6	42.5	40.1	28.1	38.4	48.7	23.8	47.1	23.8	30.4	16.7	38.1	16.4	35.8	23.8	19.1	43.8	43.2	59.9	67.8	26.2	35.4	38.5	38.8	21.8	35.5	53.0	29.5	32.1	39.3	25.0	24.3	25.6	52.3	20.2	15.7	18.0	30.7	15.9	37.8	29.8	29.3	23.8	41.1	46.5	54.2	21.3	33.6	26.2	17.2	39.0	7.2	12.9	9.5	17.4	17.5	24.4	19.4	11.7	20.3	15.2	24.6	11.1	14.1	31.1	22.3	11.8	21.3	12.3	15.6	16.2	24.4	35.9	35.7	25.3	16.3	22.1	27.6	43.8	25.6	15.7	20.2	10.9	32.0	31.0	25.1	43.1	25.8	42.2	17.1	15.9	36.3	58.0	8.9	28.9	13.2	21.7	9.5	29.2	18.3	10.6	11.8	18.4	15.6	13.8	34.9	18.6	6.7	47.6	19.5	11.9	13.5	22.3	18.0	55.8	53.0	23.1	12.7	27.1	10.6	137.8	91.6	120.6	84.5	96.5	76.4	107.1	88.4	92.8	102.1	106.6	101.5	93.3	249.6	115.8	85.0	90.0	159.8	93.6	41.8	42.5	38.4	48.7	43.8	43.2	38.5	38.8	39.3	37.8	41.1	39.0	24.5	32.1	35.4	12.7	36.5	13.4	25.0	36.9	29.0	16.0	24.6	25.1	11.0	24.3	31.6	36.8	18.8	82.7	42.7	31.7	123.3	19.3	146.8	83.5	11.4	20.7	24.7	39.2	25.6	31.6	49.2	23.2	16.3	15.6	43.1	25.3	29.3	50.8	38.0	10.1	22.3	30.6	38.7	41.5	31.5	99.9	16.8	36.1	32.0	3.7	39.5	24.6	42.2	5.5	17.9	16.8	35.9	15.1	29.7	31.2	81.0	130.9	89.0	14.2	13.1	14.0	15.8	48.6	27.2	15.5	14.9	108.9	35.4	18.1	23.1	36.2
CCDC59	"BR22, HSPC128, TAP26"	ENSG00000133773	"Coiled-coil domain containing 59"	Q9P031	12	82223681-82358805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038555	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA038555: AB_10669543"	"unprognostic (1.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-2)"	12.9	6.3	7.1	5.2	7.4	40.3	10.9	7.8	10.3	9.2	3.7	10.0	4.2	9.2	10.9	10.6	10.0	7.0	9.0	7.1	6.5	6.5	9.7	8.0	8.8	7.4	6.1	11.3	7.8	9.6	6.7	9.6	7.0	7.0	7.5	4.7	6.7	6.7	16.0	8.5	6.0	8.0	6.1	6.3	7.4	12.3	6.9	12.5	8.6	19.3	11.1	11.1	8.7	10.2	27.2	22.9	18.9	16.0	22.5	20.1	33.1	24.0	28.5	43.4	35.3	52.9	16.0	31.0	12.0	26.0	29.9	18.3	95.3	46.7	36.4	35.7	51.3	34.3	15.1	34.6	66.7	40.3	15.7	36.1	39.0	43.5	55.9	34.6	35.9	55.8	62.8	17.1	26.9	50.6	39.6	57.1	30.4	25.6	54.4	28.4	31.9	27.6	23.4	28.4	33.8	16.4	27.4	15.6	34.6	23.1	32.3	55.0	17.6	18.0	16.3	15.1	45.7	22.7	30.2	66.2	15.7	32.8	29.0	25.9	9.2	18.3	10.7	12.6	22.0	16.4	19.0	20.9	9.9	24.1	22.2	18.7	22.3	14.9	19.0	21.4	29.5	5.9	7.1	7.4	7.8	10.3	7.1	6.5	7.4	6.1	7.0	6.1	6.9	10.2	76.6	67.3	56.3	10.1	81.7	85.8	129.9	84.9	65.4	33.7	57.3	80.1	44.3	40.0	66.5	44.1	22.9	80.0	88.2	33.1	129.1	48.7	125.8	63.1	71.5	62.0	35.8	41.2	9.4	57.5	88.3	61.5	29.6	85.0	78.6	45.8	64.2	53.9	56.8	43.7	9.9	62.5	50.8	70.9	53.8	28.4	53.4	62.0	48.0	5.6	66.9	47.2	64.9	12.1	17.2	54.8	44.0	53.8	54.7	88.1	56.1	93.0	51.5	40.6	19.7	118.1	57.8	204.9	135.2	57.6	89.9	146.8	95.6	43.5	56.7	100.6
CCDC62	"CT109, ERAP75, FLJ40344, TSP-NY"	ENSG00000130783	"Coiled-coil domain containing 62"	Q6P9F0	12	122774526-122827528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 70.0"	"Group enriched"	"Detected in some"	13	"Early spermatids: 259.2;Late spermatids: 75.0;Spermatocytes: 188.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039021, HPA058741"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"HPA039021: AB_10673604, HPA058741: AB_2683805"	"unprognostic (3.39e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-4)"	"unprognostic (5.23e-1)"	"unprognostic (6.39e-6)"	"unprognostic (2.78e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.25e-4)"	0.2	0.3	1.2	0.2	1.3	0.2	0.1	0.7	1.8	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	1.3	0.5	0.1	0.1	0.1	0.3	0.6	0.4	0.1	0.1	0.3	0.7	0.0	0.7	0.1	0.1	1.4	0.1	0.1	0.7	0.4	0.2	0.1	0.2	0.5	0.1	70.0	0.5	0.2	0.1	0.3	0.3	0.1	0.1	2.0	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.3	0.9	0.1	0.0	0.0	0.6	0.8	0.1	0.3	0.4	0.1	0.1	0.0	0.7	0.3	0.2	0.4	0.1	0.0	1.2	0.1	0.0	0.5	0.8	0.2	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.6	0.1	0.2	2.9	0.1	0.1	0.3	0.3	0.2	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.0	1.2	1.3	0.7	1.8	1.3	0.5	0.6	0.4	0.7	0.2	0.5	2.0	0.5	0.0	0.0	9.1	2.1	0.5	0.2	0.1	0.6	1.4	0.4	0.5	1.0	0.0	0.0	0.0	4.2	0.1	0.6	0.1	0.0	0.3	259.2	0.5	0.4	0.4	0.0	0.0	11.7	0.2	0.6	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.1	1.7	8.1	0.2	0.0	0.3	1.7	75.0	3.1	1.3	1.8	3.7	0.2	0.5	1.0	5.0	8.0	0.1	0.0	2.6	0.3	0.5	0.1	0.0	0.0	1.3	13.1	0.5	0.2	188.2	2.9	0.4	0.9	0.0	0.3	0.2	0.3	0.2
CCDC69	"DKFZP434C171, FLJ13705"	ENSG00000198624	"Coiled-coil domain containing 69"	A6NI79	5	151181052-151224093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 351.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 124.5;dendritic cells: 106.9;Granulosa cells: 138.2;NK-cells: 197.8;Plasma cells: 133.6;Theca cells: 132.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 129.2;Daudi: 199.9;U-266/70: 120.5;U-698: 119.1"	"Region enhanced"	"Detected in some"		"cerebellum: 4.8"	"Low region specificity"	"Detected in all"			"HPA043648, HPA052896"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"	"Golgi apparatus, Actin filaments"	"HPA043648: AB_10795877, HPA052896: AB_2681983"	"prognostic favorable (3.21e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	108.9	89.6	6.7	45.8	8.4	46.3	60.5	12.2	7.9	15.2	13.4	138.5	19.6	32.9	13.3	54.1	37.1	19.3	96.9	5.9	8.9	10.7	24.0	39.0	70.4	13.3	13.8	27.1	47.5	32.1	8.5	14.8	13.6	23.0	20.5	1.8	14.4	29.4	351.9	13.3	44.7	45.6	11.3	55.4	37.0	13.2	9.2	37.8	11.6	163.8	66.8	87.7	21.9	7.2	8.0	1.6	0.4	6.4	129.2	13.1	4.2	1.5	13.1	2.6	2.4	2.1	1.1	199.9	6.3	0.5	3.3	1.0	3.0	2.8	0.9	0.1	2.7	27.0	0.0	17.5	21.1	9.9	34.4	33.0	0.2	1.0	0.0	2.5	13.1	0.0	23.7	44.0	0.1	0.6	43.8	23.3	7.5	0.1	15.2	36.0	1.0	12.1	0.5	5.9	0.2	0.8	2.4	3.2	1.7	3.2	2.0	24.0	32.0	1.0	6.1	0.6	1.5	120.5	60.1	119.1	1.4	22.2	0.0	30.9	12.4	13.5	11.3	10.9	10.3	5.4	8.8	10.8	10.0	10.4	6.1	6.6	9.6	14.3	10.3	19.3	8.5	11.5	6.7	8.4	12.2	7.9	5.9	8.9	13.3	13.8	13.6	11.3	9.2	7.2	51.0	12.8	78.4	0.7	68.8	2.5	3.0	3.5	1.2	0.4	4.8	2.4	124.5	1.5	13.5	1.8	0.0	7.3	106.9	0.2	0.0	2.9	0.5	26.8	2.7	58.9	1.8	32.2	1.8	20.0	9.6	18.4	7.1	1.3	34.8	138.2	28.2	39.7	7.3	6.7	2.7	0.0	4.1	64.0	12.2	2.4	5.6	46.5	10.6	11.2	73.5	4.9	197.8	1.0	0.6	8.8	0.1	7.9	133.6	3.6	4.5	3.2	51.3	1.4	13.1	4.7	14.8	1.2	1.0	0.7	1.3	35.4	65.7	132.1	0.9	23.5
CCDC8	"3M3, DKFZp564K0322, PPP1R20"	ENSG00000169515	"Coiled-coil domain containing 8"	Q9H0W5	19	46410329-46413564	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 36.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 27.0;Distal tubular cells: 39.2;Granulosa cells: 25.7;Leydig cells: 70.8;Peritubular cells: 57.9;Theca cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.5;AN3-CA: 22.2;HSkMC: 19.6;K-562: 20.3;RH-30: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041993	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041993: AB_10795388"	"unprognostic (3.05e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (5.43e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.18e-3)"	4.1	16.3	4.1	2.7	3.8	0.7	8.8	3.9	2.6	13.9	7.5	3.3	0.9	13.9	10.5	1.3	22.9	4.2	24.7	3.6	3.9	11.2	0.7	4.4	0.9	5.2	7.4	36.8	13.6	9.1	12.9	6.7	5.3	6.4	1.2	1.3	10.8	7.5	2.1	3.1	2.2	6.5	4.8	2.3	2.2	5.9	4.2	5.6	9.0	2.4	0.8	7.5	7.3	4.4	1.9	0.1	18.5	22.2	4.8	6.0	8.9	9.6	0.0	2.1	0.9	0.1	0.1	0.2	12.5	7.6	0.4	0.2	0.1	15.0	1.0	0.0	9.4	0.0	0.2	1.0	16.0	0.1	0.1	19.6	0.0	5.2	15.2	0.3	0.1	0.1	20.3	0.0	6.8	0.0	0.0	1.3	13.3	0.0	0.0	0.7	24.8	0.0	16.1	0.1	2.9	0.1	0.1	0.1	0.1	14.2	0.1	4.7	1.7	1.2	4.9	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.1	3.8	3.9	2.6	3.6	3.9	5.2	7.4	5.3	4.8	4.2	4.4	0.7	0.0	1.1	1.3	0.0	0.9	6.5	1.5	0.0	0.4	1.8	19.3	27.0	7.2	4.0	11.0	0.0	7.5	0.1	0.0	39.2	14.8	0.4	15.0	13.9	1.2	0.0	0.0	0.0	1.1	10.0	17.3	0.0	3.9	1.3	25.7	1.1	0.0	1.7	0.0	0.0	0.0	2.0	0.0	0.9	2.9	70.8	0.6	1.8	1.0	0.0	14.6	0.0	1.5	0.1	3.6	0.0	57.9	0.0	3.7	0.0	1.2	2.4	0.5	13.1	12.3	8.3	0.4	5.5	0.0	0.1	2.1	0.2	32.7	0.0	0.8
CCDC97	"FLJ40267, MGC20255"	ENSG00000142039	"Coiled-coil domain containing 97"	Q96F63	19	41310172-41324873	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043320, HPA043572"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043320: AB_10964344, HPA043572: AB_10962488"	"unprognostic (9.25e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"	14.6	12.9	19.0	17.8	21.3	23.0	14.3	17.7	17.7	20.3	14.4	14.0	14.2	17.3	23.4	20.2	21.9	12.3	15.6	16.5	18.2	12.0	11.8	14.3	23.8	23.5	20.2	24.0	17.7	15.8	13.7	10.5	19.9	16.2	11.2	10.7	18.0	14.6	30.6	20.2	16.6	14.2	18.1	20.0	15.7	32.1	20.4	21.9	16.3	20.5	22.2	14.8	17.2	20.5	25.2	54.1	28.2	32.9	36.2	28.7	20.3	16.6	13.4	25.7	21.9	32.4	23.6	23.9	17.4	13.9	17.3	16.7	38.8	33.1	19.5	44.1	37.6	21.9	25.5	21.5	27.5	36.6	45.3	28.1	41.7	30.0	25.0	21.1	18.0	25.8	28.5	44.4	24.9	18.3	33.6	8.9	13.2	30.5	19.3	37.5	22.4	17.5	23.7	47.3	25.1	22.2	37.0	40.3	16.5	18.6	27.5	27.6	21.6	22.1	22.0	11.5	27.8	45.3	42.2	22.7	21.0	26.7	30.0	9.4	7.2	8.5	12.0	7.6	13.4	9.1	8.1	8.7	5.8	10.0	8.7	7.8	11.9	10.4	12.6	6.3	7.2	8.1	19.0	21.3	17.7	17.7	16.5	18.2	23.5	20.2	19.9	18.1	20.4	20.5	7.3	12.8	6.7	5.2	22.3	4.6	11.4	11.3	6.2	11.8	11.2	8.8	6.7	7.2	8.9	9.2	12.5	11.1	23.9	13.5	7.9	13.1	3.7	9.3	8.6	8.4	11.5	7.8	4.1	26.1	4.5	10.0	15.3	9.8	16.5	11.2	9.7	6.5	15.3	10.1	4.7	12.1	18.3	10.0	7.9	8.4	12.8	12.3	1.8	3.7	16.1	7.1	25.7	1.0	6.6	20.5	5.9	11.3	18.6	10.0	16.7	9.3	12.2	8.5	0.0	13.1	8.5	22.5	12.9	10.8	5.8	18.3	20.1	7.2	10.7	13.3
CCNT2		ENSG00000082258	"Cyclin T2"	O60583	2	134918235-134959342	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005559	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA005559: AB_1078608"	"unprognostic (2.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.44e-4)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (3.28e-4)"	13.4	12.1	10.1	12.2	10.2	29.0	15.6	13.7	12.4	16.4	10.6	13.0	13.4	13.5	14.8	12.8	14.0	9.4	11.7	9.9	10.8	10.9	18.3	14.9	15.5	10.4	10.0	17.4	19.8	15.0	15.1	12.0	10.8	13.5	12.1	19.0	13.0	10.7	10.3	15.4	14.4	8.5	11.1	15.6	14.8	12.3	10.5	14.4	14.5	9.7	14.1	15.0	16.3	14.4	9.0	4.4	28.0	10.5	13.6	13.7	21.3	12.2	9.9	11.2	13.9	11.9	10.1	14.6	8.9	10.0	5.4	11.4	17.0	9.1	16.3	7.9	11.5	15.8	11.9	16.9	13.3	14.3	13.4	12.6	17.6	11.1	13.5	14.4	16.8	10.8	13.4	14.6	13.2	6.1	16.0	21.2	22.8	7.4	9.0	15.2	10.0	11.7	17.4	24.4	19.1	15.8	8.9	10.3	14.2	20.3	10.8	17.3	15.3	14.4	15.9	6.2	9.0	10.2	6.7	15.1	9.0	11.2	12.5	3.8	1.6	2.0	1.7	2.0	2.1	1.6	1.9	2.1	2.1	1.2	3.3	2.6	2.1	2.8	1.0	1.9	2.6	1.3	10.1	10.2	13.7	12.4	9.9	10.8	10.4	10.0	10.8	11.1	10.5	14.4	27.1	25.6	26.0	49.6	38.0	15.0	28.8	17.9	26.7	34.7	21.6	15.4	23.5	14.3	21.8	14.7	33.3	11.9	35.3	22.4	7.9	16.2	5.5	20.2	30.2	21.5	18.5	20.0	73.6	14.9	9.6	23.7	46.9	33.1	11.4	31.1	18.9	20.9	10.1	42.1	70.1	16.4	6.1	15.7	22.1	14.6	14.0	25.2	8.8	52.5	23.6	12.9	19.6	76.9	81.8	14.2	19.0	22.2	26.5	35.4	19.1	7.0	12.4	34.5	19.7	17.7	24.2	17.7	23.6	25.3	18.2	13.7	29.0	25.2	17.1	50.5
CCNYL1	FLJ40432	ENSG00000163249	"Cyclin Y like 1"	Q8N7R7	2	207711540-207761839	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 62.7;Paneth cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046825	Approved		Approved	"Plasma membrane"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA046825: AB_10963934"	"unprognostic (2.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.12e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.96e-3)"	12.8	4.7	3.8	10.6	4.9	9.9	7.1	2.8	5.3	8.2	3.7	15.3	11.7	5.0	5.2	17.8	4.2	7.9	6.1	5.2	5.1	10.9	12.4	11.8	8.6	4.8	4.2	3.4	13.7	4.2	4.5	13.6	5.1	4.8	13.3	9.0	6.9	4.8	7.8	3.9	11.3	8.7	4.2	8.1	11.0	16.2	4.5	6.1	11.4	4.4	9.3	10.4	9.5	6.8	25.7	11.0	14.5	20.4	18.6	21.2	83.3	15.6	25.8	15.7	17.7	51.1	23.7	9.9	14.2	28.6	38.5	17.4	17.7	29.4	15.2	3.7	13.5	13.3	12.8	41.6	18.7	11.9	15.2	10.7	12.0	20.0	20.9	13.8	52.5	11.5	6.8	9.4	21.9	13.6	10.5	11.2	28.1	10.3	12.2	9.4	12.4	8.0	16.2	19.5	3.5	10.8	18.5	8.0	23.5	33.6	7.2	31.5	27.3	17.7	16.6	23.2	10.5	5.6	8.4	13.4	18.5	13.5	15.4	0.7	1.1	0.5	0.3	0.6	0.4	0.3	0.5	0.5	0.5	1.1	0.4	0.8	1.3	0.6	0.5	0.5	0.4	0.3	3.8	4.9	2.8	5.3	5.2	5.1	4.8	4.2	5.1	4.2	4.5	6.8	31.8	3.2	19.1	10.1	14.1	12.2	13.8	7.6	5.7	6.2	10.0	10.0	9.0	2.8	8.5	23.9	10.4	12.6	13.2	62.7	1.9	5.8	13.7	13.6	7.7	17.0	9.6	6.5	34.1	14.7	42.9	11.4	25.0	20.4	5.7	5.8	23.9	12.5	16.2	5.0	11.6	13.1	8.2	17.5	29.9	10.9	2.8	18.7	8.8	7.5	20.8	10.2	7.2	14.6	28.7	13.9	121.3	3.8	7.7	16.1	10.1	12.6	6.3	12.3	0.0	16.0	10.4	23.9	9.5	7.6	10.5	7.7	10.9	4.3	17.0	18.0
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	85.3	122.3	121.4	103.0	125.8	79.5	119.4	132.2	176.7	77.1	139.0	95.3	87.2	93.6	77.1	106.9	119.9	67.4	100.8	125.3	135.5	114.5	108.3	60.1	123.9	129.4	126.1	113.5	82.3	120.4	65.3	93.3	129.5	86.6	112.9	135.7	74.9	89.8	134.8	93.8	83.3	137.3	132.4	67.1	80.7	120.3	130.2	129.1	87.6	120.8	148.5	136.7	70.6	143.8	432.3	562.3	324.3	311.9	352.5	261.2	419.7	388.8	315.9	617.9	378.0	611.1	396.3	689.5	442.3	337.9	392.5	395.5	1045.2	519.9	519.1	384.3	660.6	437.6	438.6	579.2	261.9	547.7	357.2	333.7	312.4	556.6	514.7	303.3	531.6	425.3	795.2	250.1	375.5	603.5	688.2	372.1	656.4	859.5	702.1	587.3	314.5	771.1	496.9	349.9	434.9	448.1	347.0	635.0	388.7	531.0	560.2	707.3	366.1	249.0	373.0	263.3	717.1	457.5	808.2	975.7	288.1	349.1	408.1	75.1	107.1	49.0	129.0	137.0	171.2	142.1	144.3	138.8	171.7	156.8	177.0	156.7	14.9	145.8	146.8	120.8	164.3	222.3	121.4	125.8	132.2	176.7	125.3	135.5	129.4	126.1	129.5	132.4	130.2	143.8	82.8	54.5	62.5	18.3	104.8	144.9	241.1	247.4	119.5	124.5	133.2	118.5	121.1	98.7	132.3	90.1	106.3	226.7	100.5	71.7	113.5	208.6	111.9	118.4	137.4	122.4	125.3	134.0	29.7	183.2	217.8	113.9	70.8	86.6	73.0	180.1	74.6	88.4	162.6	74.0	34.6	93.8	193.3	83.0	96.5	226.7	83.6	78.1	112.1	22.5	153.6	158.1	105.0	37.2	41.9	199.1	78.8	88.0	95.8	169.0	115.9	212.3	137.6	244.3	118.3	110.3	145.4	410.0	232.4	123.1	159.8	184.6	112.1	347.9	149.8	157.9
CD164L2		ENSG00000174950	"CD164 molecule like 2"	Q6UWJ8	1	27379176-27383333	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 19.9;fallopian tube: 30.0;salivary gland: 13.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 28.5;Endometrial ciliated cells: 53.6;Respiratory ciliated cells: 146.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.2;CAPAN-2: 4.1;HaCaT: 1.9;HBEC3-KT: 2.2;hTCEpi: 2.8;SK-BR-3: 2.6;T-47d: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062915	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA062915: AB_2684903"	"unprognostic (8.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.64e-5)"		"unprognostic (7.81e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.91e-6)"	"unprognostic (1.33e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.71e-2)"	0.1	0.1	0.3	0.0	0.3	0.0	2.5	0.2	0.4	4.9	1.0	0.2	0.0	0.3	0.5	19.9	30.0	0.1	0.0	0.4	0.3	0.9	0.2	5.1	0.0	2.0	1.5	0.0	0.8	0.8	3.4	0.0	0.6	4.1	0.2	0.0	13.5	0.3	0.0	11.1	0.1	0.0	0.8	0.0	0.7	0.5	0.2	0.9	0.4	0.0	1.8	0.0	9.3	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.9	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.1	0.1	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	2.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.4	0.3	2.0	1.5	0.6	0.8	0.2	0.4	0.2	0.0	3.7	0.0	0.2	2.9	9.6	12.9	28.5	0.0	5.7	14.4	0.9	0.0	10.1	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.2	53.6	0.5	1.5	0.0	0.0	0.2	0.2	0.1	0.5	0.0	1.0	0.0	0.0	1.1	0.0	0.1	0.0	0.3	0.5	12.2	0.0	0.4	1.6	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.2	3.4	0.0	0.1	146.1	0.0	0.0	0.1	2.8	0.1	1.0	9.3	2.8	0.0	0.4	0.0	0.5	4.4
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314494-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 237.3;breast: 155.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 155.4;Fibroblasts: 166.9;Leydig cells: 74.9;Smooth muscle cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive CD8 T-cell: 21.8"	"Lineage enriched"	"Detected in single"	144	"T-cells: 21.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 492.4;ASC TERT1: 481.9;BJ: 222.2;BJ hTERT+: 330.1;fHDF/TERT166: 451.1;HSkMC: 516.8;U-2197: 794.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		43000000	"Cluster 32: T-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA051856: AB_2681640"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	237.3	12.9	2.3	39.3	2.4	0.4	155.5	2.2	4.0	87.2	1.5	31.7	7.8	52.2	6.9	19.6	60.8	32.3	30.3	2.2	2.2	18.7	3.6	36.5	6.2	2.4	2.6	23.9	11.7	3.3	8.8	67.4	2.2	17.8	7.4	0.4	18.2	19.4	15.8	51.0	27.2	26.5	2.0	7.2	26.3	5.0	3.9	5.3	35.0	6.5	2.6	63.4	61.5	2.0	0.0	0.0	4.9	0.0	492.4	481.9	0.3	222.2	330.1	16.3	15.1	0.1	0.0	0.0	5.8	451.1	0.0	0.0	0.2	0.2	3.5	0.0	0.0	0.0	0.1	3.3	97.5	0.0	0.0	516.8	0.0	21.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.4	3.2	2.5	0.0	1.4	9.5	0.0	0.2	0.0	0.0	2.8	7.6	0.0	1.2	0.0	13.4	0.5	0.4	0.1	0.0	0.8	794.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	2.6	0.0	0.1	3.1	21.8	0.0	0.0	0.0	0.0	0.0	2.5	2.3	2.4	2.2	4.0	2.2	2.2	2.4	2.6	2.2	2.0	3.9	2.0	15.0	0.0	0.0	1.3	1.3	12.5	0.0	0.0	0.6	0.1	1.2	1.5	2.2	0.0	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.2	0.3	5.3	155.4	5.8	0.0	0.0	0.0	0.0	2.5	166.9	13.3	3.1	0.0	0.0	2.5	0.0	6.0	0.0	0.0	0.0	0.0	0.3	14.4	2.3	74.9	1.6	12.4	1.9	0.6	2.9	1.0	0.0	0.0	0.3	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.1	32.9	5.5	59.3	0.1	0.1	0.8	8.2	4.4	6.9	1.1	0.0	0.1
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466399-74484794	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 95.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 103.5;granulocytes: 59.5;Hofbauer cells: 114.0;Kupffer cells: 97.6;Macrophages: 90.9;NK-cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 104.4;NB-4: 45.9;RPMI-8226: 88.7"									"HPA010971, HPA011645"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010971: , HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	10.6	7.5	6.7	31.1	7.1	24.4	4.6	7.1	31.1	2.8	7.5	9.2	11.3	3.5	1.8	3.5	3.1	14.2	4.7	6.9	7.8	3.5	14.6	18.1	27.0	11.4	8.6	1.5	3.2	1.4	3.6	13.9	13.2	4.0	8.6	1.0	4.0	2.5	1.6	4.5	13.5	11.7	9.2	95.2	4.9	1.2	12.1	14.1	2.3	2.7	11.7	9.5	2.6	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	5.5	104.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.5	45.9	0.0	0.0	0.0	0.2	0.0	88.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	17.1	0.0	845.6	170.3	481.9	226.4	374.2	48.3	18.9	45.5	67.5	159.2	6.4	16.7	52.5	560.5	456.5	387.6	149.7	3.1	197.0	6.7	7.1	7.1	31.1	6.9	7.8	11.4	8.6	13.2	9.2	12.1	12.5	1.0	0.0	7.4	0.3	7.8	0.9	0.1	0.2	0.0	0.0	0.6	1.8	0.6	1.5	0.7	0.0	0.0	0.7	103.5	0.1	0.0	0.1	0.0	0.6	0.2	2.5	0.0	5.7	0.1	0.0	1.2	0.8	0.5	0.7	59.5	0.0	2.2	1.3	114.0	0.0	0.3	0.2	0.0	97.6	24.0	0.4	0.0	90.9	3.6	5.6	36.6	0.0	225.6	1.0	0.0	0.0	0.1	0.0	14.5	0.1	0.0	0.4	0.6	0.1	6.6	0.6	0.5	0.0	0.4	0.2	0.6	1.5	33.2	0.0	0.2	0.2
CD300LB	"CLM7, TREM5"	ENSG00000178789	"CD300 molecule like family member b"	A8K4G0	17	74521174-74531475	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 7.8;brain: 16.3;lymphoid tissue: 8.2"	"Group enriched"	"Detected in some"	4	"dendritic cells: 7.1;Hofbauer cells: 6.2;Kupffer cells: 8.7;Langerhans cells: 6.5;Macrophages: 16.6;monocytes: 13.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	5	"cerebral cortex: 16.3"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 75.9"	"Group enriched"	"Detected in many"	53	"dendritic cells: 25.0;granulocytes: 75.9;monocytes: 31.7"	"Group enriched"	"Detected in some"	6	"HL-60: 1.7;NB-4: 2.4;THP-1: 1.9;U-937: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060449			Approved	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA060449: "	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.49e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.01e-2)"	1.7	0.4	0.1	8.2	0.2	7.8	0.7	0.1	16.3	0.4	0.6	0.7	0.7	0.3	0.0	0.3	0.3	2.1	0.2	0.1	0.2	0.2	0.8	1.7	0.8	0.3	0.3	0.1	0.9	0.1	0.2	0.9	3.1	0.4	0.9	0.0	0.3	0.1	0.3	0.1	1.6	1.8	0.2	3.7	0.6	0.3	1.3	0.6	0.2	0.1	0.9	2.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	1.1	0.0	1.5	31.7	75.9	0.1	13.6	0.3	0.0	0.0	0.0	25.0	0.0	0.0	0.2	33.3	0.8	1.9	15.6	0.0	11.8	0.1	0.2	0.1	16.3	0.1	0.2	0.3	0.3	3.1	0.2	1.3	0.4	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.6	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.4	0.2	6.2	0.0	0.0	0.0	0.0	8.7	6.5	0.2	0.0	16.6	0.0	0.0	13.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0
CD34		ENSG00000174059	"CD34 molecule"	P28906	1	207880972-207911402	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Adipocytes: 298.7;Endothelial cells: 292.4;Fibroblasts: 121.9;Hepatic stellate cells: 136.0;Leydig cells: 146.3;Peritubular cells: 123.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 64.3;MOLT-4: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000018, HPA036722, HPA036723"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		93000000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272"	"unprognostic (3.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (1.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.01e-2)"	202.7	28.5	29.2	13.9	28.8	5.7	122.3	27.3	34.2	95.4	21.0	54.2	13.5	71.6	42.3	28.9	82.8	54.3	153.2	25.1	27.5	49.4	5.6	69.1	18.1	29.8	29.5	35.4	18.9	21.8	10.1	219.5	30.8	36.2	19.3	2.3	37.4	33.2	58.5	67.5	39.3	75.5	24.8	21.7	34.4	20.2	32.9	19.0	79.5	68.2	17.1	74.0	61.6	28.0	0.0	0.0	0.2	0.0	3.2	0.3	0.2	0.4	2.4	0.7	1.7	0.0	0.0	0.0	6.2	0.7	0.2	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.7	64.3	1.1	0.0	0.0	1.7	0.0	66.5	0.3	0.5	0.0	0.0	0.1	3.7	0.0	0.3	0.0	0.1	0.2	0.0	0.6	0.1	0.4	2.3	0.0	9.9	0.2	2.8	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	29.2	28.8	27.3	34.2	25.1	27.5	29.8	29.5	30.8	24.8	32.9	28.0	298.7	3.2	7.8	1.6	1.0	16.7	0.2	0.3	4.6	0.6	2.1	3.0	21.9	2.8	0.1	3.7	2.1	0.2	1.5	0.0	0.0	0.5	11.6	1.0	5.2	292.4	0.0	22.3	0.2	0.2	0.3	121.9	0.5	1.0	1.3	0.1	136.0	0.6	0.4	0.0	0.1	0.0	0.0	1.2	21.8	5.0	146.3	2.4	17.8	33.7	0.3	0.2	0.0	0.5	0.3	0.2	0.0	123.0	1.6	0.3	0.0	0.1	0.0	0.2	6.6	7.7	15.2	1.0	2.0	1.5	12.9	0.1	2.2	4.0	0.0	0.3
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"	16.6	7.0	7.5	100.2	7.4	155.2	6.5	9.4	13.7	4.2	5.9	13.9	8.2	3.7	0.7	7.3	5.8	13.9	5.2	6.3	11.4	7.6	6.4	46.9	215.0	17.0	12.0	1.7	3.2	1.8	3.4	15.1	16.5	6.9	3.8	0.3	11.5	2.8	1.9	4.1	116.3	3.9	16.7	235.7	14.8	7.4	15.6	57.5	8.3	2.4	88.0	19.1	5.2	28.7	0.2	0.6	1.5	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	306.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	49.5	0.2	53.1	0.0	0.5	0.0	9.4	290.0	0.0	0.0	0.0	0.0	0.2	0.0	18.5	2.6	16.3	0.0	0.0	0.4	5.8	0.2	0.0	0.0	2.9	0.3	110.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	109.0	0.8	0.3	1.0	0.2	0.0	0.3	0.1	69.4	0.2	81.4	0.1	550.2	658.2	829.6	353.2	601.6	357.4	1511.6	426.3	376.2	449.7	1722.2	435.3	368.6	903.8	321.8	747.8	586.3	467.1	816.2	7.5	7.4	9.4	13.7	6.3	11.4	17.0	12.0	16.5	16.7	15.6	28.7	7.1	9.6	14.3	0.3	1643.9	11.7	1.3	0.1	4.6	12.1	4.6	12.1	1.6	2.8	2.5	1.8	6.2	1.9	489.6	2.2	0.0	0.5	94.2	1.2	1.9	9.7	1.2	67.7	0.1	0.0	2.3	6.9	11.7	1.5	264.6	0.3	11.4	4.1	345.3	0.0	0.2	1.7	0.0	272.0	358.4	221.3	2.8	319.7	28.4	21.5	365.0	1.1	394.4	0.0	0.1	0.0	8.0	0.7	119.8	1.1	0.6	2.9	0.9	6.3	0.0	3.2	5.7	1.1	1.3	2.6	11.8	2.9	390.3	0.9	1.9	1.1
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820799	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.9;lymphoid tissue: 219.3;parathyroid gland: 173.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 278.8;Hofbauer cells: 139.3;Kupffer cells: 247.1;Langerhans cells: 80.1;Macrophages: 109.0;monocytes: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"classical monocyte: 247.3;intermediate monocyte: 241.4;memory CD4 T-cell: 153.4;myeloid DC: 166.3;naive CD4 T-cell: 128.1;non-classical monocyte: 204.2;plasmacytoid DC: 263.8;T-reg: 154.5"	"Group enriched"	"Detected in many"	20	"dendritic cells: 263.8;monocytes: 247.3;T-cells: 154.5"	"Group enriched"	"Detected in some"	6	"HEL: 103.2;HL-60: 42.1;NB-4: 60.0;THP-1: 116.2;U-937: 109.7"	"Region enriched"	"Detected in many"	14	"basal ganglia: 46.2"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	45.5	16.2	15.0	82.1	15.4	26.5	14.7	15.5	17.4	20.4	15.8	26.0	18.7	7.9	7.0	15.1	21.3	35.3	10.0	15.1	16.7	10.1	152.9	72.1	119.0	22.9	20.2	8.6	7.6	173.8	6.1	47.4	21.0	7.3	31.0	10.5	8.5	10.3	2.9	12.6	27.4	26.5	19.6	164.4	21.0	7.5	19.6	219.3	8.8	5.7	75.7	41.0	5.8	25.7	0.0	0.0	3.6	0.1	0.1	0.2	0.3	0.1	2.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	103.2	0.0	0.6	10.5	42.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	15.4	60.0	1.0	0.0	0.0	0.0	0.2	12.8	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.7	0.1	116.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	109.7	0.0	0.8	247.3	1.9	2.0	241.4	6.3	0.5	153.4	0.8	166.3	0.5	128.1	0.7	11.1	2.0	204.2	263.8	154.5	240.6	15.0	15.4	15.5	17.4	15.1	16.7	22.9	20.2	21.0	19.6	19.6	25.7	4.5	0.0	5.2	1.6	5.2	3.4	0.3	0.4	0.0	1.5	2.9	5.8	2.1	8.6	2.1	3.7	0.0	0.9	61.9	0.0	5.9	0.0	0.1	3.5	8.7	9.6	0.0	7.8	0.9	0.4	1.2	3.7	0.0	0.4	7.6	0.4	278.8	34.3	139.3	5.0	0.7	0.0	0.0	247.1	80.1	0.5	16.8	109.0	5.4	29.0	104.5	22.0	6.2	0.5	0.2	0.0	0.0	15.1	2.5	0.2	0.0	3.3	20.3	0.2	13.1	0.7	13.5	0.0	0.2	0.4	2.3	1.2	34.0	0.0	0.0	0.4
CD46	"MCP, MGC26544, MIC10, TLX, TRA2.10"	ENSG00000117335	"CD46 molecule"	P15529	1	207752054-207795513	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 296.7;eosinophil: 382.4;neutrophil: 401.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 401.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB010401, HPA016903"	Enhanced		Approved	"Plasma membrane"		NA	NA		1000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB010401: AB_2291289, HPA016903: AB_1846309"	"unprognostic (1.42e-2)"	"prognostic unfavorable (8.54e-5)"	"unprognostic (3.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.78e-3)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.76e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.49e-2)"	98.6	237.4	30.0	64.0	35.0	80.5	128.4	33.5	39.5	74.0	61.4	103.1	124.6	62.1	77.1	102.2	110.0	73.8	64.9	30.2	34.4	173.2	133.9	129.1	58.2	37.4	33.6	61.2	112.5	310.6	41.8	221.5	38.1	167.4	103.2	72.6	166.9	107.4	47.4	47.7	98.6	67.1	34.8	79.6	117.4	40.5	36.3	44.4	86.8	58.1	66.6	97.2	68.2	41.5	130.0	71.7	66.1	30.8	202.9	199.2	99.9	95.0	137.3	61.3	82.5	71.3	335.4	19.8	94.3	95.3	84.5	170.7	50.0	130.5	93.0	99.9	70.9	42.9	73.8	128.6	128.8	94.8	142.8	172.9	189.6	92.9	72.5	144.4	174.2	76.8	91.8	83.4	95.7	61.3	45.4	82.8	75.6	76.9	70.9	30.2	104.7	123.0	251.4	252.6	66.5	45.4	120.5	266.8	160.1	130.8	210.2	79.8	150.9	65.6	57.7	139.2	109.9	111.2	144.3	60.1	95.8	61.2	63.0	296.7	79.8	382.4	50.1	82.4	68.9	43.5	63.3	55.8	47.3	34.1	71.1	60.5	401.8	46.9	87.5	24.9	60.5	102.4	30.0	35.0	33.5	39.5	30.2	34.4	37.4	33.6	38.1	34.8	36.3	41.5	186.0	201.9	241.1	59.7	60.3	52.9	89.3	87.2	108.1	63.0	144.3	85.7	61.4	75.8	177.8	145.3	66.7	247.3	94.0	105.2	15.6	77.4	227.7	206.1	67.0	106.7	72.8	46.9	61.0	79.9	76.2	70.5	97.9	231.3	114.5	78.1	77.8	120.9	59.9	40.4	73.6	91.1	87.5	78.9	63.1	36.9	47.2	91.6	62.2	82.4	88.7	25.3	39.1	112.1	153.9	72.8	117.7	44.0	76.0	144.5	92.6	54.4	208.8	87.3	52.6	69.7	89.3	17.1	20.2	104.5	45.9	343.7	89.9	99.4	115.9	165.7
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711831	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 148.4;lymphoid tissue: 283.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 336.1;dendritic cells: 251.2;Kupffer cells: 245.8;Macrophages: 218.3;monocytes: 366.6;NK-cells: 454.2;T-cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 220.9;HMC-1: 236.9;U-266/70: 501.4;U-266/84: 360.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002497, HPA055146"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	11.8	5.9	1.4	115.3	1.5	148.4	18.8	1.5	4.7	10.2	2.3	24.9	20.5	6.7	5.0	8.4	5.7	26.6	4.3	1.3	1.7	4.4	19.9	31.0	283.9	2.6	1.8	3.1	2.0	1.6	1.6	5.8	2.7	8.1	32.5	0.1	14.0	4.4	2.9	3.5	48.3	12.5	2.1	160.0	32.5	2.9	3.2	138.9	5.2	3.4	256.8	41.8	4.5	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	220.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	6.0	0.0	2.1	0.0	0.0	0.0	27.1	236.9	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.4	78.6	0.0	0.0	78.9	38.4	0.1	0.0	0.0	4.7	0.1	34.3	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.1	0.0	0.3	0.2	0.4	501.4	360.3	89.9	0.2	66.7	0.1	218.1	327.1	230.8	242.8	470.2	335.8	206.2	275.2	283.4	329.7	161.2	277.9	301.6	82.1	160.7	487.4	57.0	229.9	603.5	1.4	1.5	1.5	4.7	1.3	1.7	2.6	1.8	2.7	2.1	3.2	4.1	3.7	0.0	9.6	0.7	336.1	5.5	0.8	0.0	1.8	0.0	2.0	1.7	1.1	2.8	1.3	3.7	0.0	0.6	251.2	0.1	1.9	0.2	0.1	0.7	0.5	2.8	1.2	21.5	0.1	0.2	0.8	2.4	6.6	0.6	90.7	0.1	7.1	2.0	86.4	0.0	0.1	0.1	0.0	245.8	106.5	0.5	1.8	218.3	39.2	1.0	366.6	0.0	454.2	0.5	0.0	0.1	0.0	0.4	127.4	0.4	0.0	4.9	2.2	0.0	0.0	1.7	2.1	0.5	0.3	0.7	3.0	0.4	376.2	0.0	1.2	0.5
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 137.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		550000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	81.4	11.9	2.7	43.5	2.6	16.4	41.0	2.8	6.5	23.9	6.5	13.8	9.8	17.8	6.1	19.0	23.4	39.7	34.3	2.7	3.5	25.6	16.3	64.6	14.0	5.4	4.3	6.2	13.2	10.8	6.6	137.6	5.4	11.3	12.1	1.4	9.7	10.9	24.2	12.2	14.5	43.5	4.0	23.4	13.0	4.6	7.1	9.3	21.4	34.4	10.6	41.3	12.8	3.5	0.2	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	346.0	0.0	0.9	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.9	0.2	27.8	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	105.3	442.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	593.5	0.1	0.0	25.8	0.4	0.3	16.8	0.0	0.0	0.2	0.1	9.1	0.0	0.0	0.0	27.8	0.1	7.5	1.2	0.5	9.9	2.7	2.6	2.8	6.5	2.7	3.5	5.4	4.3	5.4	4.0	7.1	3.5	321.5	3.2	7.4	0.0	2.4	15.0	1.0	0.0	6.2	0.0	1.0	1.8	14.3	5.7	3.7	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.4	0.4	0.7	309.2	0.0	1.3	0.0	0.0	0.5	9.8	0.5	0.4	5.1	0.0	162.8	1.9	19.9	0.0	0.2	0.0	0.0	156.4	52.5	0.8	1.8	102.4	8.8	4.7	131.8	0.2	6.2	0.0	0.1	0.1	0.0	27.8	2.1	4.1	0.0	0.3	3.0	0.1	19.7	5.7	8.0	0.0	0.2	1.6	10.1	0.4	2.4	3.0	0.0	4.0
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 64.2;Cytotrophoblasts: 84.5;Extravillous trophoblasts: 154.5;Spermatogonia: 69.9;Suprabasal keratinocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064971			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA064971: AB_2685395"	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (4.19e-4)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	3.9	2.6	1.9	7.4	2.0	55.8	4.2	3.0	2.1	8.7	2.1	4.6	4.7	5.4	1.8	18.6	4.1	2.6	2.7	1.7	1.8	3.4	2.7	3.6	11.6	2.1	1.9	4.1	3.2	1.8	1.7	9.2	2.1	3.8	2.9	1.3	5.5	2.2	1.4	24.7	4.9	3.5	1.9	6.6	3.8	11.6	2.0	14.6	3.3	1.5	8.5	4.2	10.2	2.0	40.6	41.3	46.7	35.6	7.9	13.2	61.1	59.0	18.0	45.2	39.7	50.9	50.2	52.9	31.5	20.9	34.5	63.5	32.9	68.0	27.1	58.2	26.1	33.4	33.9	43.2	9.7	59.8	27.0	9.4	20.8	35.2	32.7	15.1	31.4	45.0	37.5	53.0	32.1	98.8	56.2	40.1	34.8	35.1	94.0	53.6	68.1	19.7	15.9	46.2	27.2	33.5	56.6	22.3	46.8	20.5	44.0	39.8	48.8	39.9	50.5	55.3	79.5	19.5	25.9	54.4	33.5	30.2	67.5	1.1	4.3	10.6	11.9	4.9	14.8	8.4	12.7	16.7	4.7	5.4	7.4	8.9	1.6	12.9	5.6	5.1	11.1	7.0	1.9	2.0	3.0	2.1	1.7	1.8	2.1	1.9	2.1	1.9	2.0	2.0	5.4	0.0	2.2	0.7	7.4	64.2	26.5	36.6	13.1	3.4	8.7	8.3	0.6	0.0	9.0	1.8	0.0	84.5	11.5	4.3	3.9	12.7	8.1	9.0	9.0	10.9	3.0	53.0	1.8	7.0	154.5	10.2	3.1	12.5	28.6	15.1	7.9	2.2	24.3	13.5	1.3	6.6	6.1	5.9	22.6	6.8	8.4	8.4	17.8	2.8	9.3	4.6	9.2	1.0	1.8	12.3	3.3	6.0	11.8	16.1	1.9	1.8	7.7	2.6	6.6	4.6	12.5	43.0	69.9	21.3	67.1	25.9	17.7	3.6	9.5	43.2
CDH8		ENSG00000150394	"Cadherin 8"	P55286	16	61647242-62037035	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 22.4"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 220.8;Inhibitory neurons: 236.4;Oligodendrocytes: 145.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.0;fHDF/TERT166: 6.3;HaCaT: 14.4;LHCN-M2: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014908, HPA076441"	Approved		Approved	"Plasma membrane"		NA	NA		870000		"Cluster 65: Brain - Ion transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014908: AB_1845908, HPA076441: "	"unprognostic (1.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.91e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	0.1	0.1	7.2	0.0	9.9	0.0	0.3	0.0	22.4	0.4	0.0	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.2	16.3	5.7	0.0	0.0	0.1	0.0	6.4	9.8	1.7	0.0	0.1	0.7	0.3	18.4	0.4	0.1	2.2	0.4	5.0	0.4	0.1	0.2	0.4	7.6	0.0	0.1	0.3	9.1	0.5	0.1	0.9	0.0	0.4	0.1	2.5	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.3	0.0	14.4	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	17.3	0.0	0.0	0.0	1.3	0.0	1.3	0.0	0.0	1.1	0.0	1.9	0.1	0.1	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.9	0.0	22.4	16.3	5.7	6.4	9.8	18.4	7.6	9.1	2.5	0.4	0.0	0.5	3.9	0.0	0.1	0.8	1.3	1.2	15.1	0.1	0.9	1.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.9	0.1	0.1	0.5	0.0	0.0	220.8	0.0	0.2	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	236.4	0.0	2.0	0.0	0.0	1.3	0.0	0.1	0.0	8.4	0.0	0.7	0.0	7.5	145.7	0.0	0.0	0.4	0.0	0.3	0.0	0.2	2.7	0.7	0.0	0.7	4.7	1.3	2.5	0.5	0.1	0.3	0.1	0.1	0.0	0.8
CDIPT	"PIS, PIS1"	ENSG00000103502	"CDP-diacylglycerol--inositol 3-phosphatidyltransferase"	O14735	16	29858357-29863414	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056597	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane, Plasma membrane"		"HPA056597: AB_2683182"	"unprognostic (7.81e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (1.93e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.48e-1)"	93.8	101.7	75.1	32.1	73.8	26.8	81.0	79.0	86.2	84.5	64.2	104.7	39.0	91.1	31.1	61.1	76.2	51.7	105.4	73.6	76.2	80.6	114.5	65.1	36.1	78.4	74.6	109.6	86.8	87.9	68.7	42.3	78.9	78.1	24.4	34.0	67.2	55.5	49.7	82.8	69.6	38.9	69.1	66.3	89.1	43.9	73.6	40.6	69.1	43.9	24.8	89.7	73.6	70.1	40.0	85.6	23.7	47.3	125.8	86.3	70.5	71.0	76.6	47.9	47.4	50.5	75.1	26.9	125.2	80.3	42.2	62.0	38.7	44.5	21.3	67.5	85.3	19.5	61.4	74.1	87.7	28.5	47.2	148.0	77.2	64.3	29.7	75.8	60.9	49.9	29.5	67.1	44.0	127.7	40.3	56.2	55.5	42.2	65.7	74.8	29.5	78.7	63.7	38.1	96.4	53.8	36.9	76.1	55.7	41.2	57.5	74.8	52.8	70.3	22.1	58.0	35.8	51.4	62.1	19.3	77.2	46.0	43.4	11.7	8.2	28.9	8.5	6.2	5.7	6.5	7.9	9.1	3.8	6.4	7.7	7.2	20.6	11.4	7.9	8.1	12.0	3.8	75.1	73.8	79.0	86.2	73.6	76.2	78.4	74.6	78.9	69.1	73.6	70.1	54.7	25.6	28.3	10.4	25.1	41.3	41.4	22.9	30.1	53.4	42.1	49.7	57.9	41.5	15.4	46.0	45.9	120.6	31.9	57.5	41.1	72.0	54.0	18.1	30.4	48.0	37.3	22.7	16.4	71.8	127.3	59.3	19.4	29.6	13.4	30.7	46.1	41.7	65.0	58.9	19.3	30.6	10.2	41.8	21.3	12.8	76.7	33.3	23.2	11.2	45.2	57.7	36.0	9.0	11.5	44.9	37.9	61.7	31.7	38.9	87.9	34.5	15.1	56.3	46.0	24.4	44.6	10.2	14.7	32.3	50.7	73.2	30.5	34.1	34.8	39.3
CDRT15		ENSG00000223510	"CMT1A duplicated region transcript 15"	Q96T59	17	14235673-14236862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 20.9"	"Group enriched"	"Detected in some"	24	"Early spermatids: 117.5;Late spermatids: 88.5;Spermatocytes: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 3.8"									HPA055952	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"		"HPA055952: AB_2682983"	"unprognostic (3.27e-2)"	"unprognostic (1.77e-2)"	"unprognostic (8.61e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.38e-2)"	0.1	0.4	0.1	1.2	0.2	0.6	0.1	1.4	0.5	0.2	0.4	0.2	0.7	0.2	0.2	0.3	0.1	0.4	0.3	0.3	0.0	0.1	0.4	0.3	2.7	0.6	0.1	0.4	0.2	0.0	0.1	0.1	0.6	0.2	0.0	0.4	0.7	0.0	0.1	3.3	0.8	0.0	0.1	0.9	0.4	20.9	0.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.7	1.3	0.9	2.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	2.5	0.3	2.1	0.4	0.0	0.3	0.9	0.0	0.0	0.0	2.1	3.8	1.2	2.6	1.8	0.0	1.0	1.5	0.0	0.0	0.0	0.0	0.7	0.0	1.0	1.0	0.4	0.0	0.5	1.0	1.6	0.8	1.5	1.2	0.8	0.3	0.8	0.0	1.0	1.0	1.8	0.2	0.5	0.3	2.7	0.4	0.5	1.1	3.2	0.4	0.8	0.9	0.7	0.8	0.9	0.5	1.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	1.4	0.5	0.3	0.0	0.6	0.1	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.5	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573686-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 559.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 1103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	117.0	68.6	39.1	113.7	42.0	161.3	73.0	40.6	42.9	59.3	48.3	80.0	57.5	60.6	54.9	78.7	51.6	76.4	74.5	37.0	47.1	64.4	112.9	83.6	159.3	46.0	41.8	57.9	84.3	85.8	43.0	108.5	46.0	43.2	70.8	49.2	52.7	47.7	250.9	55.0	65.5	75.7	44.6	121.6	89.0	95.9	45.8	194.5	97.4	155.9	165.6	104.3	49.3	47.8	376.2	85.5	147.6	98.0	166.7	203.6	174.5	201.6	261.1	197.6	194.7	213.4	147.0	473.9	298.0	227.4	229.2	158.2	213.5	202.0	366.4	306.1	80.1	282.3	93.2	130.9	258.2	318.7	173.4	194.7	206.7	178.2	473.4	139.6	254.5	137.9	205.7	309.9	289.5	107.1	260.9	180.9	148.9	161.6	108.2	156.8	197.6	382.2	206.9	150.7	116.5	87.8	192.0	140.4	246.0	210.0	456.3	190.8	316.4	209.4	198.5	168.5	202.7	446.9	363.2	1103.9	117.0	187.8	124.7	14.3	10.5	17.6	13.0	12.3	13.5	11.1	12.2	13.2	9.7	7.0	9.7	15.2	9.7	6.4	13.7	15.9	24.0	5.7	39.1	42.0	40.6	42.9	37.0	47.1	46.0	41.8	46.0	44.6	45.8	47.8	116.3	57.7	69.8	7.2	114.9	145.9	217.3	19.5	63.7	22.6	97.6	77.2	86.2	74.4	34.4	84.6	10.4	51.6	169.7	158.0	37.2	42.1	324.7	174.0	160.5	99.5	47.2	59.5	13.2	87.6	82.0	93.7	88.7	314.4	45.0	63.0	91.1	97.2	118.5	23.5	12.3	102.4	10.2	146.8	117.7	559.5	34.2	145.0	55.2	17.8	100.4	109.5	90.6	8.0	14.5	88.1	101.2	35.7	239.4	320.2	26.9	74.4	27.4	29.9	26.3	120.9	92.5	21.2	30.9	94.0	128.3	35.2	126.5	124.4	90.1	219.5
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109174418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 50.3;Spermatocytes: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	10.5	7.6	5.1	7.8	5.9	10.2	10.2	10.8	7.8	8.2	4.6	8.5	8.7	9.3	10.5	6.2	6.0	9.4	7.7	5.8	4.1	8.0	10.0	6.6	8.9	4.9	4.2	6.5	7.5	16.9	5.6	10.1	5.5	6.4	10.9	12.0	5.2	6.3	6.1	6.8	7.8	10.8	3.9	7.7	7.3	26.2	5.5	14.4	8.7	6.6	7.4	6.4	6.5	7.9	17.9	7.9	23.1	22.9	21.2	35.2	18.1	40.3	22.1	35.8	39.8	11.9	15.3	16.0	18.4	20.9	30.8	9.1	16.1	15.4	56.1	20.3	16.1	34.8	18.9	12.3	19.6	28.5	14.5	21.2	11.0	30.3	29.9	19.2	32.4	52.5	63.9	52.5	32.4	11.8	32.0	24.6	7.6	14.7	14.6	25.7	17.4	15.7	17.0	7.4	17.4	14.4	19.8	14.7	12.9	15.0	18.2	43.9	14.7	23.1	13.6	24.4	42.9	15.4	19.1	25.3	21.8	43.1	18.9	15.9	5.2	6.6	4.7	6.1	5.1	3.3	4.8	6.7	5.7	6.3	4.5	6.7	3.6	11.6	9.6	6.0	6.9	4.6	5.1	5.9	10.8	7.8	5.8	4.1	4.9	4.2	5.5	3.9	5.5	7.9	12.9	6.4	5.3	12.4	6.3	3.3	7.6	7.4	7.4	6.6	6.8	7.2	10.3	2.8	6.8	5.5	20.9	9.8	9.7	4.2	7.9	7.0	50.3	12.8	18.5	10.6	5.4	18.1	31.9	5.4	13.2	15.5	8.2	6.9	5.1	20.5	8.2	6.3	10.2	5.0	31.1	3.1	8.2	4.1	6.8	39.3	17.4	7.7	8.8	27.2	7.7	10.4	8.2	26.2	36.1	6.0	4.5	12.4	13.2	4.4	5.7	13.4	9.8	12.3	13.1	21.8	14.1	75.7	13.0	5.8	4.4	8.5	6.7	13.6	6.1	5.0
CFAP251	"CaM-IP4, MGC33630, WDR66"	ENSG00000158023	"Cilia and flagella associated protein 251"	Q8TBY9	12	121918592-122003927	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.3;testis: 19.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.7;Fibroblasts: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 31.8;hTCEpi: 30.8;hTERT-HME1: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039902, HPA040005"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA039902: AB_10795236, HPA040005: AB_10795160"	"unprognostic (4.92e-3)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (5.58e-3)"	"unprognostic (6.89e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.8	1.6	0.3	2.4	0.1	1.3	1.3	1.7	3.5	13.2	0.2	0.1	1.9	4.7	0.3	22.3	1.2	1.3	2.4	3.9	2.7	1.4	3.0	0.6	5.5	6.6	2.2	1.7	2.9	6.5	0.9	3.6	0.7	0.1	4.6	1.1	1.6	0.3	1.5	0.2	0.6	2.7	1.7	0.4	19.9	4.1	0.5	4.7	0.4	0.9	0.3	1.3	1.6	4.7	0.4	0.4	0.2	0.5	0.5	0.5	0.3	2.5	1.2	3.0	0.3	1.4	0.2	3.7	0.2	0.7	0.9	0.3	31.8	4.4	0.2	0.5	0.2	0.6	0.3	3.7	0.1	8.6	1.8	30.8	2.4	19.9	0.7	1.3	0.5	7.5	0.1	1.9	0.9	0.3	0.6	0.4	0.4	0.2	0.4	0.8	0.0	5.4	0.5	2.5	0.1	0.2	0.1	0.2	0.8	0.9	0.1	1.0	2.5	3.9	0.5	0.5	0.5	0.2	3.8	2.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	1.6	2.4	1.3	1.7	2.4	3.9	5.5	6.6	3.6	2.7	4.1	1.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
CFAP299	C4orf22	ENSG00000197826	"Cilia and flagella associated protein 299"	Q6V702	4	80335730-80963750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 19.8;testis: 27.4"	"Cell type enriched"	"Detected in some"	54	"Endometrial ciliated cells: 54.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;BJ: 1.6;hTERT-RPE1: 2.5;LHCN-M2: 1.0;SCLC-21H: 1.1;U-251 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043383	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.0	0.9	0.0	1.0	0.0	0.1	1.4	0.5	0.7	2.6	0.1	0.1	0.2	0.0	0.0	19.8	0.1	0.0	1.0	1.0	0.3	0.0	1.4	0.1	5.3	3.7	0.1	0.0	0.0	0.1	0.0	2.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	27.4	1.2	0.1	0.6	0.0	0.0	0.0	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.7	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.0	1.4	0.5	1.0	1.0	5.3	3.7	2.3	3.5	1.2	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	54.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
CFAP58	"bA554P13.1, C10orf80, CCDC147, FLJ35908"	ENSG00000120051	"Cilia and flagella associated protein 58"	Q5T655	10	104353833-104455102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.4;testis: 13.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 73.3;Endometrial ciliated cells: 25.1;Late spermatids: 58.9;Respiratory ciliated cells: 56.9;Spermatocytes: 34.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;U-2 OS: 6.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.9"	"HPA036555, HPA071938"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	"Plasma membrane, Cytosol"	"HPA036555: AB_10673622, HPA071938: "	"unprognostic (5.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.57e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.62e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.59e-1)"	0.4	0.6	1.0	0.5	1.3	0.4	0.4	0.4	0.7	2.2	2.4	0.5	0.1	1.8	0.2	0.2	8.4	0.2	2.5	0.8	1.2	0.7	0.1	1.3	0.3	2.9	3.7	0.5	0.3	0.7	1.5	0.4	2.2	0.5	0.0	0.6	0.2	0.4	1.3	0.3	0.2	0.6	2.0	0.3	0.3	13.4	1.0	0.1	0.8	0.8	0.4	0.3	0.6	1.1	0.1	0.0	0.7	0.1	0.1	0.3	0.1	1.0	3.1	0.6	1.6	0.0	0.0	2.4	0.2	0.4	1.7	0.2	0.0	0.2	1.8	0.3	0.1	0.5	0.9	0.0	0.3	0.3	0.4	0.3	1.3	0.5	1.6	1.3	1.0	0.1	0.7	0.7	0.8	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.2	0.3	0.3	0.0	0.4	0.2	0.0	0.1	0.5	0.7	0.1	0.4	2.0	0.6	6.5	0.3	1.8	0.2	0.0	0.1	0.7	0.8	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.4	0.7	0.8	1.2	2.9	3.7	2.2	2.0	1.0	1.1	0.4	0.0	0.5	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	10.0	0.0	9.3	0.0	0.0	0.1	0.1	0.0	0.0	0.6	73.3	25.1	0.3	0.4	0.0	0.0	4.0	0.2	0.4	0.7	0.0	0.4	0.0	0.3	1.8	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.0	58.9	0.6	0.2	0.0	1.9	0.1	0.7	1.0	1.0	0.0	0.3	0.0	1.2	0.0	0.2	0.0	0.0	56.9	0.3	0.0	0.8	1.0	34.4	4.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2
CFAP65	"CCDC108, DKFZp434O0527, MGC35338"	ENSG00000181378	"Cilia and flagella associated protein 65"	Q6ZU64	2	219002846-219041527	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.1;choroid plexus: 13.5;fallopian tube: 25.7;testis: 9.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 204.5;Late spermatids: 164.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 10.8"	"HPA055156, HPA063406"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA055156: AB_2682720, HPA063406: "	"unprognostic (3.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (6.08e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.60e-2)"	0.0	0.1	2.3	0.0	2.1	0.0	0.1	1.0	1.0	1.3	13.5	0.1	0.0	0.5	1.8	0.0	25.7	0.4	0.0	2.6	2.8	0.4	0.0	2.7	0.0	8.4	12.1	0.0	0.3	0.1	3.5	0.0	6.2	0.1	0.2	9.2	0.1	0.1	0.0	0.0	0.4	0.0	6.1	0.0	0.3	9.4	2.4	0.0	0.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.1	1.0	1.0	2.6	2.8	8.4	12.1	6.2	6.1	2.4	3.2	0.1	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.8	7.7	8.8	0.0	4.3	6.8	0.0	12.5	0.0	0.1	1.1	0.0	0.6	204.5	45.1	0.5	0.2	29.1	0.0	0.0	1.5	0.0	0.2	2.0	1.8	0.0	0.2	0.0	0.1	0.1	0.0	0.0	25.2	0.0	0.0	0.0	164.3	0.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	1.8	0.7	0.0	1.1	1.9	1.1	29.2	19.5	0.0	0.1	0.0	14.4	5.7	0.0	0.0	0.0	0.2	0.1	5.1	0.1
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34709113-34714823	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 372.8;skeletal muscle: 719.9;tongue: 686.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 522.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		47000000	"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	48.7	52.5	71.7	28.6	98.7	18.1	24.6	90.3	116.1	39.8	53.9	92.5	14.3	73.4	19.5	69.0	42.6	24.1	372.8	69.4	85.0	31.4	125.9	24.9	10.7	85.7	83.6	41.2	9.4	24.4	10.9	35.3	88.7	75.4	28.1	41.0	17.1	107.3	719.9	8.2	24.0	115.0	74.7	12.7	36.1	21.7	81.2	10.4	29.4	686.4	9.9	56.8	24.3	130.5	87.1	77.7	49.5	32.0	51.1	185.6	27.9	146.6	170.5	145.6	151.4	61.9	38.5	30.6	58.5	245.2	104.9	17.1	107.4	32.5	268.6	4.2	45.0	6.6	87.4	144.5	81.6	8.2	5.3	139.3	12.4	122.2	67.7	96.8	145.9	4.5	9.9	26.8	186.9	25.5	6.3	4.3	16.3	15.4	118.9	5.4	158.1	4.7	55.1	17.7	10.3	41.7	96.6	21.5	51.2	36.2	47.8	7.5	124.6	140.9	93.0	66.1	72.9	34.3	22.8	11.7	51.7	11.4	34.5	1.8	1.0	1.3	1.9	1.0	3.1	4.9	2.2	2.1	1.6	3.0	1.7	1.8	0.3	1.8	0.4	1.6	2.1	0.9	71.7	98.7	90.3	116.1	69.4	85.0	85.7	83.6	88.7	74.7	81.2	130.5	39.6	105.8	41.6	6.2	17.0	20.0	88.6	31.3	23.9	62.8	19.6	16.6	522.2	22.8	26.3	22.0	20.9	32.2	11.5	0.9	60.7	45.2	2.6	40.3	60.5	45.1	9.5	11.4	9.6	39.7	60.5	69.9	6.1	56.2	5.7	25.8	47.2	112.0	15.6	77.4	14.2	2.4	57.0	15.7	14.4	10.1	57.2	10.6	30.2	11.2	5.7	112.9	15.5	8.0	93.8	24.7	4.0	98.6	60.4	84.0	1.0	101.9	24.7	57.8	32.9	83.9	115.8	49.3	51.9	16.1	19.5	21.3	21.1	47.9	4.6	58.5
CHMP2A	"BC-2, CHMP2, VPS2, VPS2A"	ENSG00000130724	"Charged multivesicular body protein 2A"	O43633	19	58551566-58555105	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041153, HPA042031"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		230000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041153: AB_10964358, HPA042031: AB_10961727"	"unprognostic (1.80e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.71e-2)"	131.8	185.9	144.9	86.8	149.6	162.3	125.1	153.7	171.9	108.9	143.5	141.3	113.4	111.7	150.1	154.9	104.6	83.1	182.6	144.4	147.8	163.3	161.3	116.9	81.9	151.1	147.0	101.9	125.0	147.8	118.7	95.8	151.3	112.5	124.1	75.2	137.2	97.1	222.9	158.4	121.9	83.6	149.0	121.2	143.8	73.9	146.8	82.6	123.2	151.7	95.1	114.3	113.7	157.4	110.4	290.9	91.4	85.0	138.9	172.9	112.9	100.0	204.3	52.0	56.0	86.3	160.1	29.3	143.2	168.1	149.2	87.7	76.1	190.4	43.7	98.8	628.2	71.8	214.0	134.7	266.6	121.1	108.0	201.5	266.0	81.5	257.8	175.3	153.1	135.5	86.8	135.6	159.5	187.1	153.7	111.3	38.3	304.2	220.3	65.2	78.6	222.0	230.1	246.8	107.3	181.2	162.0	213.7	123.4	57.3	164.3	121.5	174.4	262.0	37.7	77.2	117.3	339.0	404.9	95.2	185.0	141.0	176.6	278.9	247.4	351.1	134.9	232.7	114.5	127.0	148.0	153.1	216.2	123.0	102.0	116.3	820.6	131.6	243.9	197.1	215.5	208.4	144.9	149.6	153.7	171.9	144.4	147.8	151.1	147.0	151.3	149.0	146.8	157.4	166.1	99.3	119.8	9.4	72.9	165.6	261.4	287.7	69.4	73.9	124.7	120.6	118.7	154.4	207.2	165.5	16.7	288.8	76.5	555.2	442.2	332.6	121.9	194.0	109.2	143.6	155.4	142.5	5.3	522.5	296.8	113.5	115.7	198.8	121.5	102.1	142.5	214.0	269.1	52.2	5.6	296.6	217.7	142.0	145.8	90.9	145.1	134.5	215.3	6.5	203.6	217.6	147.2	3.0	13.4	479.8	615.3	133.2	77.3	258.5	607.0	599.8	242.1	94.3	85.5	103.9	169.7	116.8	89.7	109.5	198.5	460.0	89.2	149.3	226.3	372.7
CIAO3	"FLJ21988, HPRN, IOP1, NAR1, NARFL, PRN"	ENSG00000103245	"Cytosolic iron-sulfur assembly component 3"	Q9H6Q4	16	729760-741329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 11.6;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 10.9;Hofbauer cells: 16.0;Syncytiotrophoblasts: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 142.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040851	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA040851: AB_10794427"	"unprognostic (6.31e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (7.61e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (9.83e-5)"	"unprognostic (2.49e-2)"	"unprognostic (8.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.33e-3)"	10.4	13.8	16.8	7.5	18.0	10.7	12.3	17.2	27.2	11.6	14.1	16.1	13.3	12.1	11.5	18.5	12.2	6.7	23.1	17.6	16.0	19.5	22.4	9.4	11.7	17.6	17.1	10.1	15.7	12.1	14.9	5.8	17.8	18.9	4.9	4.5	16.8	9.2	20.5	18.1	16.5	4.8	16.3	17.3	16.1	11.3	16.6	12.0	13.0	13.2	7.9	13.1	13.7	17.5	9.1	26.1	10.1	14.9	10.3	7.3	24.6	12.7	9.4	17.2	15.0	18.8	22.0	12.9	19.2	8.0	12.7	20.3	10.0	15.4	6.1	24.1	22.8	10.9	14.7	15.5	13.2	19.3	15.0	9.2	19.1	10.2	8.5	11.4	12.9	50.7	20.3	12.0	8.5	33.9	17.5	9.0	8.6	18.4	16.5	142.5	15.3	23.7	10.6	9.0	11.8	16.1	15.3	36.0	13.4	6.0	33.0	19.7	14.0	14.5	13.6	16.1	11.5	15.8	12.1	35.7	9.9	11.0	19.0	2.7	11.1	8.9	10.9	9.9	8.3	14.8	11.0	8.9	11.9	9.2	8.6	12.4	2.3	15.5	11.6	9.4	11.7	9.9	16.8	18.0	17.2	27.2	17.6	16.0	17.6	17.1	17.8	16.3	16.6	17.5	3.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	20.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	10.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	14.2	0.5	0.0	0.0	0.0
CIB3	KIP3	ENSG00000141977	"Calcium and integrin binding family member 3"	Q96Q77	19	16161368-16173525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"bone marrow: 1.2"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 30.2;Late spermatids: 9.5"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.5;MCF7: 2.2;NB-4: 1.4;THP-1: 1.3;U-937: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043553, HPA043995"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane, Cytosol"		"HPA043553: AB_10964566, HPA043995: "	"unprognostic (8.43e-2)"	"unprognostic (7.26e-5)"		"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.14e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.05e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	1.4	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.7	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	30.2	0.0	0.1	0.0	0.0	0.2	0.1	1.8	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CIP2A	KIAA1524	ENSG00000163507	"Cellular inhibitor of PP2A"	Q8TCG1	3	108549864-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.5;lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 8.0;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 12.9;Granulosa cells: 25.3;Hofbauer cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	1.1	1.1	0.3	3.4	0.6	7.5	1.4	0.9	0.8	0.9	0.1	1.9	1.2	1.8	0.6	1.7	0.9	1.2	0.7	0.6	0.5	1.0	0.7	1.4	6.7	0.2	0.9	1.9	0.4	0.6	0.7	2.1	0.2	1.8	2.7	2.6	0.6	0.8	0.6	1.2	1.7	1.5	0.0	2.3	1.2	5.7	0.1	6.9	1.2	0.7	5.2	2.0	0.9	0.4	42.2	12.2	33.9	21.8	1.4	3.2	13.8	31.1	14.7	36.2	41.9	15.0	18.5	27.6	10.4	11.4	27.7	20.9	11.7	11.0	65.8	8.8	11.3	33.9	17.4	11.3	0.5	21.8	23.2	1.4	2.3	28.4	11.5	5.9	16.3	12.7	21.1	44.5	36.1	8.7	26.7	19.2	35.0	15.8	20.8	30.1	31.2	15.3	11.0	11.5	16.4	21.6	22.9	9.0	12.7	19.7	15.3	15.6	12.2	37.0	41.7	11.3	38.3	10.2	12.1	46.1	16.4	23.2	38.6	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.6	0.9	0.8	0.6	0.5	0.2	0.9	0.2	0.0	0.1	0.4	1.2	9.6	1.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	2.5	3.7	0.0	8.0	1.8	0.0	1.9	2.8	0.0	2.5	2.8	2.6	0.0	0.0	0.0	7.3	12.9	3.0	0.0	2.7	3.8	25.3	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	2.4	1.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.4	1.7	5.4	0.0	0.0
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 373.9;intestine: 257.8"	"Group enriched"	"Detected in many"	6	"Distal enterocytes: 597.0;Paneth cells: 183.2;Squamous epithelial cells: 158.7;Urothelial cells: 176.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4;urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	1368	"RT4: 430.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	NA	NA		150000		"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.6	0.0	6.3	13.9	9.4	0.0	2.2	6.7	8.0	44.6	3.2	257.8	0.1	0.1	0.1	373.9	0.2	0.2	0.1	6.2	6.6	0.1	0.1	0.0	0.0	10.9	7.0	0.0	0.1	0.0	0.5	0.0	8.7	2.5	143.5	0.0	23.1	0.2	0.1	17.1	29.1	2.9	7.1	0.1	0.6	0.3	8.0	0.1	0.0	0.0	30.1	99.3	66.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	430.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.4	6.7	8.0	6.2	6.6	10.9	7.0	8.7	7.1	8.0	12.7	0.1	0.0	0.0	0.0	2.9	3.3	40.3	6.5	2.8	0.0	1.9	1.8	0.4	0.0	17.5	1.8	0.0	0.0	0.2	597.0	0.0	0.0	0.4	7.3	0.1	0.3	8.3	0.0	0.1	0.0	0.0	0.4	0.0	3.5	8.9	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	183.2	0.0	1.2	9.7	4.7	0.0	1.9	0.0	0.0	0.0	0.4	0.1	0.0	158.7	11.9	0.0	1.5	0.0	12.0	176.9
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11848079	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	13.6	14.8	19.1	7.5	19.1	7.7	11.9	17.3	21.3	14.8	8.2	13.7	6.3	12.6	8.7	7.4	12.6	4.9	13.2	18.0	23.5	11.8	13.7	13.8	7.4	29.6	29.5	18.6	9.2	6.0	20.2	6.4	32.1	12.5	4.8	15.2	7.8	5.5	11.6	9.8	13.0	7.3	15.4	12.0	10.5	17.1	22.5	5.3	14.4	8.1	6.1	11.5	11.1	19.4	5.1	6.4	13.9	11.1	15.2	15.4	3.8	4.1	11.1	7.1	11.7	8.6	15.9	7.9	4.4	5.5	19.3	8.8	9.0	8.8	6.7	3.6	4.5	9.4	13.8	12.1	20.1	3.9	7.6	10.1	6.2	12.7	7.7	9.4	6.9	9.6	10.6	11.7	7.8	3.1	5.7	13.4	5.7	3.3	4.5	7.0	7.4	8.6	9.7	4.4	5.7	9.6	3.9	5.1	13.0	9.5	5.0	10.6	7.4	6.5	7.0	10.1	3.3	7.2	4.0	17.6	8.5	10.2	5.3	0.0	0.8	0.0	0.4	0.6	0.3	0.6	0.2	0.3	0.6	0.9	0.2	0.3	0.0	0.1	1.6	0.6	0.0	0.4	19.1	19.1	17.3	21.3	18.0	23.5	29.6	29.5	32.1	15.4	22.5	19.4	6.4	19.2	23.6	6.8	12.5	3.4	3.7	5.1	6.2	21.7	5.6	4.7	23.5	8.6	7.0	3.7	14.6	3.7	2.5	5.8	0.0	4.5	15.0	7.7	6.6	6.5	6.6	8.2	9.0	4.6	2.9	8.5	12.2	9.8	2.5	12.6	7.1	7.9	7.5	26.9	9.4	2.9	4.1	10.8	7.8	9.0	7.5	10.2	1.8	9.4	7.4	7.7	3.1	9.0	8.8	5.6	4.4	7.2	3.9	4.7	6.3	3.9	8.9	17.0	0.0	8.9	6.4	9.3	9.8	4.8	3.1	4.1	3.8	8.0	3.2	4.5
CLDN23	CLDNL	ENSG00000253958	"Claudin 23"	Q96B33	8	8701937-8704096	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.4;stomach 1: 15.6"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 418.8;Paneth cells: 449.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.3;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;Daudi: 6.4;RT4: 6.7;SK-BR-3: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061306			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Plasma membrane, Cell Junctions"	"HPA061306: "	"unprognostic (1.86e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-2)"	"unprognostic (8.25e-3)"	"prognostic favorable (9.65e-8)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.33e-3)"	6.2	1.1	0.3	2.3	0.4	0.1	5.7	0.2	0.3	2.4	2.3	16.4	4.1	1.0	1.9	3.3	1.4	1.2	0.7	0.3	0.3	4.5	10.4	4.7	0.3	0.5	0.4	1.6	4.0	2.1	0.9	1.5	0.4	1.3	6.8	0.1	6.8	1.3	0.5	13.5	10.1	0.3	0.4	1.8	15.6	0.5	0.5	0.1	4.9	0.3	0.3	5.0	2.7	0.6	0.1	2.6	0.0	0.1	0.7	0.1	7.7	1.9	1.5	2.0	3.1	1.5	4.2	6.4	0.0	0.1	0.7	2.5	0.0	0.0	0.2	1.3	0.0	0.0	0.7	0.1	3.5	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.3	0.0	0.2	1.9	0.3	1.3	0.0	0.0	0.0	0.9	6.7	0.3	0.9	2.6	6.8	0.1	0.7	0.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.9	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.5	0.4	0.4	0.4	0.5	0.6	13.0	9.6	3.1	0.3	1.1	0.1	6.6	4.2	2.2	0.1	6.8	3.4	0.7	30.0	6.9	1.8	0.0	19.1	2.8	418.8	7.9	26.9	0.0	6.0	2.5	3.4	7.7	0.0	0.0	10.7	14.9	3.3	59.7	6.7	4.5	0.8	8.2	10.6	16.8	0.0	0.0	49.9	26.4	2.4	1.4	0.0	0.3	4.6	3.6	1.9	1.4	1.1	0.0	0.0	0.0	28.1	449.9	0.4	0.1	3.3	99.1	4.7	10.3	1.1	6.6	1.5	3.2	0.0	0.0	3.9	0.6	9.4	1.3	0.3	55.2	12.2
CLEC4F	"CLECSF13, FLJ39110, KCLR"	ENSG00000152672	"C-type lectin domain family 4 member F"	Q8N1N0	2	70808643-70820599	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 17.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 10.4;Horizontal cells: 5.0;Macrophages: 4.5;monocytes: 4.0;Rod photoreceptor cells: 6.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.0;non-classical monocyte: 4.4"	"Lineage enriched"	"Detected in single"	12	"monocytes: 6.0"	"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056101			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"HPA056101: "	"unprognostic (8.14e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.68e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.44e-1)"	1.5	0.0	0.1	0.6	0.0	0.0	1.1	0.1	0.2	2.7	0.1	0.7	1.6	1.6	0.8	0.7	1.4	1.0	0.7	0.1	0.1	0.6	0.7	0.9	1.2	0.0	0.0	0.6	0.3	0.0	0.6	0.1	0.1	1.5	0.8	17.2	1.7	0.9	1.0	1.3	4.5	1.2	0.0	3.4	0.6	1.0	0.1	0.2	0.3	0.6	0.8	0.7	1.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.6	0.4	0.2	0.3	0.3	0.0	0.0	0.0	10.4	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.1	0.0	0.0	1.0	2.3	1.4	0.0	4.5	0.0	0.0	4.0	0.8	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745382-24844321	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 346.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 13.4;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA		5800000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Centrosome"		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	154.0	58.6	51.8	97.7	70.2	32.3	88.1	61.8	82.7	165.4	39.4	136.3	32.4	201.5	84.6	119.3	103.0	106.5	197.2	50.8	66.5	256.8	72.3	114.6	51.0	73.6	68.0	46.0	49.7	29.3	14.1	120.6	67.0	112.8	66.8	53.1	49.4	152.8	30.7	33.6	54.2	280.4	62.4	43.1	80.0	34.2	88.9	59.6	47.6	53.2	56.4	156.1	73.4	91.4	219.3	25.3	222.7	176.8	299.1	645.6	116.7	561.0	571.4	253.9	304.2	48.3	114.1	129.8	320.1	799.2	77.0	76.8	155.0	151.5	635.7	33.3	64.9	50.0	60.8	88.3	417.3	17.5	6.3	299.3	256.8	363.0	365.1	417.3	427.0	76.0	40.4	138.2	739.0	38.4	34.8	28.5	212.6	50.4	101.8	83.5	247.3	51.5	260.0	58.4	38.9	101.3	144.7	68.4	453.7	228.3	60.0	116.1	601.0	452.2	168.8	199.4	230.1	75.4	111.7	108.6	333.8	151.1	140.5	0.8	5.4	2.5	0.4	4.4	0.0	13.4	0.3	0.2	5.6	11.9	0.1	0.2	1.2	0.0	4.0	1.7	0.0	3.5	51.8	70.2	61.8	82.7	50.8	66.5	73.6	68.0	67.0	62.4	88.9	91.4	178.7	16.0	30.5	24.8	50.8	61.6	50.4	79.8	37.0	3.7	49.9	33.0	172.5	21.5	35.2	14.7	10.4	71.5	2.2	18.1	41.1	39.2	44.9	20.9	103.0	177.1	9.6	40.8	1.5	43.1	211.4	120.5	21.4	53.6	40.0	10.2	88.5	34.4	39.3	1.7	4.2	22.6	20.3	28.2	100.2	27.3	28.6	52.6	129.9	75.9	50.8	13.0	4.1	41.7	196.9	54.7	10.6	87.6	171.2	114.5	0.1	346.1	16.7	26.5	46.0	87.9	162.5	44.0	29.1	29.3	52.0	177.0	8.1	46.5	2.6	49.1
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	31	"retina: 297.9"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 407.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.3"					"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"	NA	NA		11000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: AB_2732286"	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.4	1.0	2.7	0.5	6.1	3.9	2.3	2.0	4.0	1.5	7.2	0.9	0.5	1.4	0.5	1.2	1.8	2.0	0.3	3.1	4.2	5.3	0.5	1.4	0.7	3.0	3.4	4.9	1.3	3.6	3.9	0.6	3.1	8.5	0.1	297.9	2.3	1.1	0.2	0.7	1.4	0.1	3.1	0.1	3.1	2.6	4.3	1.7	6.8	0.0	0.0	0.8	0.1	9.5	3.6	5.4	10.1	6.8	0.0	0.0	6.1	3.9	0.3	0.0	0.0	4.2	2.1	4.3	1.0	0.0	3.6	1.5	0.0	0.6	0.0	3.6	9.3	7.3	2.9	34.3	0.0	2.5	1.3	0.3	0.0	0.0	0.0	1.7	0.4	10.5	10.5	12.3	0.0	1.2	4.4	7.8	0.7	4.4	2.4	8.8	4.8	15.5	1.1	1.1	8.8	6.2	4.0	2.5	3.4	8.0	3.3	1.0	0.8	4.0	5.7	2.8	2.0	6.9	13.3	9.7	3.2	4.7	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	0.0	2.7	6.1	2.0	4.0	3.1	4.2	3.0	3.4	3.1	3.1	4.3	9.5	0.1	0.0	2.6	0.3	0.1	0.0	3.8	1.5	2.8	29.6	2.8	5.0	0.2	0.0	1.7	0.0	20.9	0.8	0.0	0.1	1.9	0.4	0.7	2.5	0.3	2.0	0.0	0.0	5.2	0.2	0.1	0.4	0.0	3.2	0.0	3.5	0.0	0.0	0.2	16.8	3.8	0.0	0.0	0.0	0.3	0.8	0.9	0.2	0.0	1.0	0.0	58.1	0.0	0.0	4.9	0.0	0.0	1.2	0.0	5.5	0.0	0.5	2.4	407.5	6.6	0.0	0.3	10.6	8.6	0.2	0.1	0.4	0.1	17.3	0.1	1.6
CMTM4	CKLFSF4	ENSG00000183723	"CKLF like MARVEL transmembrane domain containing 4"	Q8IZR5	16	66614750-66696743	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 68.0;Granulosa cells: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014704, HPA023890"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA014704: AB_1847005, HPA023890: AB_1847007"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.43e-1)"	"unprognostic (5.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.06e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	4.5	5.0	36.4	2.7	34.1	2.5	5.7	32.8	34.5	3.9	28.3	16.1	11.9	4.4	20.1	6.0	10.6	2.9	4.1	43.1	37.1	26.3	4.1	8.4	0.6	42.1	41.7	3.4	19.2	32.7	14.4	2.1	35.4	7.7	12.6	7.8	11.1	3.8	3.3	7.7	12.9	3.4	41.8	2.0	31.4	6.9	45.5	0.5	38.6	2.1	1.1	3.2	4.1	41.6	16.0	12.9	7.8	19.1	2.6	4.2	31.7	6.6	5.9	3.5	5.6	24.2	17.7	0.7	10.8	3.9	4.8	20.0	19.7	7.8	5.2	1.3	17.2	1.7	5.3	15.2	5.6	1.4	3.0	6.7	13.4	4.2	8.1	11.9	2.0	2.3	8.0	4.1	5.1	18.5	0.1	3.2	8.7	28.6	8.6	3.5	10.6	4.9	15.2	14.2	17.9	7.1	27.4	14.6	9.3	5.6	15.3	3.4	4.3	6.5	7.0	1.8	6.6	1.4	3.3	0.7	8.1	3.2	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	36.4	34.1	32.8	34.5	43.1	37.1	42.1	41.7	35.4	41.8	45.5	41.6	2.6	22.4	11.1	32.7	0.8	5.2	8.8	21.9	4.6	9.5	23.5	10.8	7.1	15.7	19.3	23.9	8.4	5.0	1.6	51.7	13.7	15.9	1.9	20.7	2.7	4.3	39.0	0.8	68.0	24.0	29.6	3.5	27.5	12.3	4.5	67.6	1.8	6.1	2.4	30.3	37.7	24.1	20.3	2.8	0.9	3.0	2.5	1.9	3.6	7.5	4.4	24.2	0.0	37.7	51.3	30.8	19.5	3.0	0.6	29.0	30.7	19.9	40.0	11.1	6.6	3.1	8.8	6.4	7.7	7.5	5.5	2.9	0.9	2.5	43.4	19.4
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391698-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 102.3;Ductal cells: 105.6;Hofbauer cells: 120.3;Kupffer cells: 110.7;Langerhans cells: 102.8;monocytes: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 135.4;hTERT-RPE1: 135.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077409			Approved	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA077409: AB_2686838"	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	22.8	10.4	7.5	20.7	7.7	43.7	32.6	8.6	12.9	15.2	8.7	8.4	5.3	11.1	10.9	3.9	38.7	16.0	10.1	7.3	8.2	22.1	10.1	33.0	32.2	8.9	8.3	5.5	19.9	4.0	3.7	19.2	9.2	12.1	9.3	0.6	13.1	19.9	4.0	10.1	18.3	10.5	8.7	49.3	13.4	8.6	9.5	46.1	20.5	3.1	31.4	24.1	7.2	10.8	0.4	15.8	32.8	40.2	29.8	29.0	93.4	15.5	18.0	26.5	24.3	18.0	135.4	0.1	46.7	18.1	33.0	17.4	40.6	69.1	23.2	0.0	32.8	18.5	0.1	40.6	120.8	4.7	29.0	31.0	9.0	27.2	42.6	135.1	60.0	0.2	15.8	40.9	19.6	0.4	0.2	42.9	39.7	7.0	71.7	90.5	12.3	85.0	37.7	30.9	1.6	33.9	2.0	2.6	80.8	13.9	21.3	48.7	36.2	25.3	25.5	27.9	54.4	11.6	4.6	0.2	9.3	57.9	54.2	32.4	198.7	110.8	21.3	196.8	12.7	44.2	72.1	44.2	106.8	34.7	76.5	54.1	77.3	21.6	173.6	45.0	164.1	112.6	7.5	7.7	8.6	12.9	7.3	8.2	8.9	8.3	9.2	8.7	9.5	10.8	10.3	25.6	16.7	1.0	65.5	9.8	20.2	102.3	1.8	0.5	63.4	86.0	2.1	28.6	51.9	18.4	0.0	22.2	25.0	2.0	0.0	105.6	0.2	17.4	12.8	24.2	17.3	11.6	0.5	15.5	10.0	15.2	26.0	33.1	29.8	29.0	20.7	1.3	120.3	1.7	1.4	4.4	40.7	110.7	102.8	1.2	1.5	77.2	24.9	20.6	108.1	1.4	12.3	1.0	0.3	91.8	8.1	1.2	62.9	42.0	1.2	27.5	23.3	0.2	6.6	1.2	13.5	1.2	10.4	0.9	5.5	6.8	57.4	6.1	2.8	16.3
CMYA5	"C5orf10, DKFZp451G223, SPRYD2, TRIM76"	ENSG00000164309	"Cardiomyopathy associated 5"	Q8N3K9	5	79689836-79800240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 623.5;tongue: 799.5"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 3425.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.3;RT4: 1.5;THP-1: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA074081, HPA077831"	Enhanced		Approved	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles, Cytosol"	"Vesicles, Plasma membrane"	"HPA074081: , HPA077831: "	"unprognostic (5.53e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.01e-4)"	"unprognostic (7.00e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.69e-2)"	"unprognostic (9.74e-2)"	0.9	0.1	1.4	0.2	1.4	0.0	3.9	1.2	2.1	1.7	3.1	1.3	0.1	5.9	4.6	6.6	2.1	0.9	155.8	0.6	0.6	2.5	1.2	0.5	0.0	1.6	2.0	14.6	0.3	3.6	2.0	1.1	1.1	6.1	0.2	1.7	6.1	2.1	623.5	2.2	0.4	4.6	1.1	0.0	0.6	0.5	1.7	0.9	2.3	799.5	0.1	2.1	1.2	0.8	0.0	0.0	0.0	0.1	0.5	0.4	0.6	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	5.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	1.2	2.1	0.6	0.6	1.6	2.0	1.1	1.1	1.7	0.8	2.7	9.6	2.8	69.5	0.4	1.3	17.9	2.9	4.6	2.0	24.4	46.6	3425.2	5.7	12.2	25.8	0.0	21.4	1.3	0.4	17.6	0.7	0.3	29.3	7.2	19.7	1.8	0.0	32.9	0.4	2.9	113.7	3.6	55.2	1.3	2.5	0.4	2.3	2.1	217.0	10.7	0.2	8.2	0.6	1.6	2.3	14.9	1.4	0.0	6.5	0.1	8.8	2.1	156.3	2.9	0.6	0.2	13.5	0.6	4.8	0.0	15.4	6.2	3.0	0.0	165.6	23.1	2.5	2.0	2.2	5.4	32.8	1.2	1.7	0.2	18.1
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel subunit alpha 1"	P29973	4	47935977-48016681	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 264.4"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 1139.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.2;RT4: 7.2;U-2 OS: 3.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 79: Retina - Phototransduction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	3.3	0.4	0.5	0.8	1.4	0.3	1.5	1.6	0.9	1.0	0.6	3.6	2.2	0.4	9.3	9.0	4.1	1.1	0.4	0.7	0.8	2.4	23.5	0.3	0.1	0.4	0.3	0.1	0.8	4.1	0.3	1.0	0.4	2.6	2.4	264.4	4.3	1.7	5.0	5.1	6.3	0.3	0.1	3.4	2.8	0.4	0.7	0.3	0.7	1.3	0.5	3.7	1.9	0.6	2.3	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	2.0	9.2	0.1	0.5	0.0	2.7	1.4	0.2	0.3	0.1	0.0	0.6	0.0	0.2	0.8	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.9	0.0	0.8	0.7	0.5	0.2	0.9	0.0	0.1	0.4	1.1	2.2	0.1	0.0	0.1	0.4	7.2	0.3	0.0	0.2	0.5	0.1	0.2	0.9	0.0	0.3	0.2	3.0	0.1	0.1	0.7	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	0.5	1.4	1.6	0.9	0.7	0.8	0.4	0.3	0.4	0.1	0.7	0.6	7.3	0.0	0.0	0.7	0.1	0.1	1.8	0.5	0.6	97.7	8.7	1.8	0.7	5.7	3.4	62.5	91.8	0.0	0.0	10.6	0.0	10.1	0.4	2.5	0.4	8.7	0.0	2.7	1.2	6.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	38.0	1.7	45.4	1.1	4.0	0.0	0.8	0.0	0.1	0.3	0.5	0.0	7.5	0.0	163.9	0.0	0.0	0.2	2.1	16.4	0.0	0.0	3.7	24.5	0.4	0.8	1139.7	0.0	0.6	17.1	0.6	1.3	10.3	2.7	0.3	0.2	0.1	4.7	35.1
CNGA4	"CNCA2, CNG5, CNGB2, OCNC2, OCNCb"	ENSG00000132259	"Cyclic nucleotide gated channel subunit alpha 4"	Q8IV77	11	6234765-6244479	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Ion channel, Ligand-gated ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 17.3;testis: 6.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.1;Early spermatids: 5.0;Endometrial ciliated cells: 2.7;Excitatory neurons: 3.0;Inhibitory neurons: 2.5;Late spermatids: 3.6;Oligodendrocytes: 3.1;Respiratory ciliated cells: 3.5"	"Cancer enriched"	"Detected in single"	6	"endometrial cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA074128			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"		"HPA074128: "	"unprognostic (1.11e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.69e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.55e-3)"	0.1	0.2	1.2	0.2	1.3	0.4	0.2	1.3	1.2	0.7	0.7	0.2	0.3	0.6	0.2	0.2	17.3	0.2	0.1	1.4	1.4	0.4	0.2	1.4	0.2	2.8	3.8	0.4	0.4	0.0	0.7	0.0	2.5	0.2	0.1	1.1	0.1	0.5	0.0	0.3	0.2	0.1	1.8	0.3	0.2	6.1	1.2	0.3	0.2	0.0	0.2	0.2	0.2	1.9	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	1.3	1.2	1.4	1.4	2.8	3.8	2.5	1.8	1.2	1.9	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CNKSR2	"CNK2, KIAA0902, KSR2"	ENSG00000149970	"Connector enhancer of kinase suppressor of Ras 2"	Q8WXI2	X	21372801-21654695	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 22.6;retina: 17.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.7;Excitatory neurons: 497.7;Inhibitory neurons: 143.6;Oligodendrocyte precursor cells: 93.5;Rod photoreceptor cells: 86.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.9;AF22: 4.0;NTERA-2: 8.9;PC-3: 4.8;RH-30: 8.2;U-251 MG: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001502			Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Plasma membrane"		"HPA001502: AB_1078542"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.13e-2)"	1.5	2.6	8.4	0.3	12.2	0.2	1.4	22.6	16.4	1.0	0.0	0.7	0.1	0.3	0.5	0.0	1.3	0.1	0.8	20.3	0.0	0.1	0.7	1.2	0.9	0.0	0.0	0.6	2.5	0.0	1.6	0.1	0.0	0.7	0.0	17.9	0.5	0.1	4.7	0.8	0.6	0.1	0.0	0.5	1.2	0.6	0.0	0.9	0.9	1.3	1.0	0.6	0.9	5.3	0.0	5.9	4.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	2.0	0.0	8.9	0.0	4.8	0.0	8.2	0.0	0.0	0.0	3.9	1.6	0.0	0.1	0.3	2.1	0.0	0.6	0.0	0.1	1.9	0.0	5.3	3.1	0.0	3.4	0.8	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.9	0.8	0.2	0.0	0.0	0.0	0.0	0.2	0.1	8.4	12.2	22.6	16.4	20.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.3	16.0	1.3	111.7	9.0	1.3	0.5	0.0	1.2	17.8	0.3	0.6	5.7	1.5	5.6	0.0	20.9	0.1	2.1	0.4	0.0	0.3	0.3	1.0	13.6	0.3	0.0	0.8	497.7	2.3	0.0	6.7	0.0	1.3	1.3	1.0	0.0	2.1	0.1	23.5	143.6	0.5	0.0	0.0	2.6	0.0	0.6	0.2	0.0	15.9	0.2	12.7	0.0	93.5	10.6	0.6	0.1	1.5	3.1	2.0	1.3	0.3	0.0	86.1	0.0	0.6	0.9	6.0	7.7	0.1	1.8	0.0	2.9	1.5	0.4	0.0
CNNM1	ACDP1	ENSG00000119946	"Cyclin and CBS domain divalent metal cation transport mediator 1"	Q9NRU3	10	99329356-99394330	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;testis: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.1;Excitatory neurons: 69.9;Horizontal cells: 50.5;Inhibitory neurons: 89.5;Late spermatids: 88.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.6;BJ hTERT+: 7.4;BJ hTERT+ SV40 Large T+ RasG12V: 11.3;HAP1: 8.7;OE19: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040408	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA040408: AB_10793963"	"unprognostic (9.04e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.60e-4)"	"unprognostic (4.08e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.03e-1)"	0.2	1.1	9.9	0.2	9.9	0.0	0.5	5.4	16.7	1.8	0.0	0.7	0.4	0.9	1.7	0.8	1.0	0.3	0.1	7.3	7.3	1.7	0.2	0.1	0.0	3.6	2.9	2.6	1.1	0.6	3.6	0.0	3.5	1.7	0.4	5.2	0.8	0.8	0.0	1.2	0.6	0.4	2.0	0.1	0.6	9.8	4.7	0.1	0.1	0.1	0.1	1.7	1.4	10.1	0.0	19.6	0.0	0.0	0.0	0.0	0.0	2.8	7.4	6.7	11.3	0.0	4.4	0.0	0.0	1.4	0.1	1.7	8.7	0.0	4.8	0.0	0.9	1.9	2.8	3.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.4	2.7	0.3	0.0	0.9	7.7	0.8	0.0	0.0	0.0	0.9	0.0	2.2	6.1	2.0	0.4	1.0	0.5	0.0	0.0	0.0	0.6	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	9.9	5.4	16.7	7.3	7.3	3.6	2.9	3.5	2.0	4.7	10.1	0.6	0.0	0.0	4.6	0.0	2.3	3.3	0.1	5.2	25.3	0.7	2.8	1.4	0.0	0.2	1.8	14.6	0.0	0.0	0.0	0.0	0.6	103.1	0.5	1.0	0.4	0.0	0.8	69.9	1.5	0.0	1.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	50.5	89.5	0.1	0.0	0.0	0.8	88.0	2.1	0.3	1.8	4.7	0.1	1.3	0.0	10.6	2.2	2.0	0.3	2.6	0.0	5.9	0.1	0.7	0.6	3.4	0.0	2.0	0.5	1.9	1.6	1.5	1.0	0.0	0.2	1.2	0.1	2.4
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.2;skeletal muscle: 131.6;tongue: 107.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 198.7;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 548.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.7;HeLa: 57.0;OE19: 53.4;RPMI-8226: 45.5;SuSa: 32.6;U-266/84: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	3.0	1.0	83.8	1.4	96.7	0.0	14.8	62.0	91.1	4.8	41.6	13.3	18.9	2.2	2.1	13.6	19.1	5.8	54.8	81.8	67.9	12.9	19.6	13.8	0.2	76.6	88.3	2.8	18.4	31.5	12.8	4.7	69.2	14.4	10.9	23.3	47.3	4.2	131.6	27.5	21.5	2.7	66.6	0.3	17.6	3.0	89.8	1.3	8.3	107.9	1.0	1.8	5.8	118.2	12.4	8.8	0.2	0.3	0.0	0.0	33.7	0.0	0.0	0.0	0.0	24.1	18.2	0.0	0.9	0.0	1.4	21.1	12.0	0.0	0.0	0.0	9.6	0.0	57.0	4.7	0.0	0.0	0.1	1.5	2.3	0.0	0.0	0.0	0.0	1.6	6.5	0.2	0.2	7.9	0.1	0.1	9.0	53.4	8.0	0.1	0.5	45.5	17.4	0.0	11.0	0.2	3.2	26.2	3.9	32.6	16.6	0.1	0.0	0.0	9.8	0.3	0.9	0.0	34.1	0.1	0.1	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	83.8	96.7	62.0	91.1	81.8	67.9	76.6	88.3	69.2	66.6	89.8	118.2	1.4	38.5	19.6	48.0	1.0	17.8	3.4	1.2	4.0	2.3	38.0	34.7	76.2	28.6	13.2	9.2	58.4	23.3	4.6	59.4	0.0	21.5	3.8	65.9	3.3	2.2	18.6	0.0	198.7	9.7	9.2	7.7	35.7	74.6	10.1	4.6	0.4	29.7	2.2	0.0	96.6	35.2	4.1	0.8	1.7	3.1	0.6	0.9	16.0	10.3	1.1	94.4	0.0	353.9	548.8	23.2	35.0	0.4	0.2	25.3	76.8	18.6	31.4	73.6	0.0	10.5	1.5	0.7	8.8	6.8	35.7	40.2	1.7	11.2	14.4	7.3
COL4A5	"ASLN, ATS"	ENSG00000188153	"Collagen type IV alpha 5 chain"	P29400	X	108439838-108697545	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 102.9"	"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 713.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 87.7;HHSteC: 95.0;HUVEC TERT2: 92.8;TIME: 88.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077177			Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Vesicles	"HPA077177: "	"unprognostic (2.58e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.97e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.06e-1)"	7.4	5.6	25.2	2.3	57.4	0.0	8.1	38.2	40.8	38.1	20.0	5.8	3.8	59.2	25.4	9.6	37.5	18.2	10.9	27.0	33.7	16.9	2.4	8.5	1.2	47.7	43.1	23.0	3.8	16.8	19.7	14.5	47.4	37.0	5.6	6.1	7.4	32.9	7.6	26.4	6.3	47.2	36.4	5.5	34.5	6.0	45.3	2.7	10.5	4.4	1.0	47.6	22.7	102.9	4.5	26.7	47.2	14.9	18.0	10.6	0.3	2.8	11.7	14.2	23.2	24.0	1.9	4.2	0.0	2.0	8.6	21.7	13.2	45.2	17.8	6.7	11.7	3.4	87.7	2.9	95.0	0.0	13.5	49.2	53.6	17.4	37.2	45.2	92.8	0.0	0.2	0.1	13.9	2.0	0.1	0.5	14.0	0.0	16.0	0.1	0.0	0.2	35.9	26.7	0.0	0.0	70.2	2.2	6.0	65.6	12.9	0.0	88.8	9.5	2.8	6.4	4.0	1.9	0.0	0.0	8.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	57.4	38.2	40.8	27.0	33.7	47.7	43.1	47.4	36.4	45.3	102.9	1.0	6.4	7.3	72.5	0.0	26.9	29.7	29.4	17.1	0.5	14.8	14.7	10.0	2.8	14.2	20.2	0.0	0.7	0.0	0.0	0.0	0.4	0.1	7.4	45.4	4.6	0.0	0.0	1.1	0.9	0.4	12.3	3.1	5.7	1.3	2.0	4.2	0.5	0.4	0.0	1.5	0.2	6.1	0.3	2.1	1.7	20.2	0.6	1.8	20.6	0.0	11.1	0.0	3.5	713.9	0.4	0.0	36.9	0.0	18.1	0.0	0.1	8.2	0.6	6.6	2.4	18.3	0.4	0.9	4.2	15.9	0.7	1.1	21.5	0.1	24.7
COL5A3		ENSG00000080573	"Collagen type V alpha 3 chain"	P25940	19	9959561-10010504	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Astrocytes: 510.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 38.9;BJ: 23.6;BJ hTERT+: 26.2;BJ hTERT+ SV40 Large T+: 14.4;HSkMC: 28.2;WM-115: 26.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA041695, HPA048256"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		330000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA041695: , HPA048256: AB_2680330"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.84e-3)"	"unprognostic (3.01e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.17e-8)"	"unprognostic (3.25e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (6.87e-5)"	47.4	5.0	33.2	9.9	33.2	0.1	32.3	30.6	45.9	44.9	43.6	19.3	3.7	27.3	1.9	9.0	22.8	4.1	33.5	33.3	26.4	7.9	13.4	14.2	3.2	35.2	30.2	6.3	5.2	3.0	3.5	32.8	32.3	16.6	2.0	21.1	7.3	8.9	15.3	21.7	11.7	10.3	31.0	1.7	9.9	4.7	30.2	4.5	12.7	6.0	3.9	12.6	26.4	28.4	0.0	0.0	0.5	0.0	12.4	38.9	0.0	23.6	26.2	14.4	5.7	0.0	0.0	0.0	0.2	4.4	0.3	2.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	28.2	0.6	5.2	5.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.1	0.0	0.0	0.0	11.6	5.5	0.5	0.0	0.0	0.0	0.0	1.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	33.2	30.6	45.9	33.3	26.4	35.2	30.2	32.3	31.0	30.2	28.4	13.7	0.0	0.0	510.3	0.0	4.2	0.1	0.2	2.2	65.1	0.3	0.9	6.4	0.0	0.1	0.0	6.2	0.1	0.3	1.3	0.0	0.2	6.9	0.4	12.0	8.1	0.0	0.0	15.6	0.0	0.2	17.5	0.5	0.4	0.0	0.0	3.9	22.9	0.6	3.3	3.4	0.0	0.0	0.0	3.2	2.1	17.4	0.4	14.2	36.5	0.1	2.6	0.0	73.9	2.5	0.3	0.1	8.2	0.0	0.3	0.2	0.1	0.9	28.3	92.1	8.5	58.0	0.3	0.3	3.2	7.1	0.1	1.9	0.9	0.0	0.3
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098112-46132848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 453.2;Fibroblasts: 1455.4;Leydig cells: 605.5;Peritubular cells: 472.1;Smooth muscle cells: 555.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 4.5;MAIT T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1155.7;ASC TERT1: 2116.9;BJ: 1073.7;BJ hTERT+: 982.8;fHDF/TERT166: 775.0;HHSteC: 1129.2;HSkMC: 1524.4;U-138 MG: 1128.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 49.6"	"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		8200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	732.4	96.2	10.1	219.9	10.8	4.5	455.0	8.7	14.4	873.3	21.6	1287.5	97.7	1001.7	36.5	178.8	675.1	283.8	484.3	10.0	14.9	96.5	97.6	394.2	55.7	14.0	19.4	723.6	78.6	24.0	112.2	335.3	11.2	569.9	60.2	0.9	156.2	274.6	123.4	390.6	402.2	275.4	9.8	175.1	441.6	77.0	11.7	35.6	201.3	67.2	25.6	918.6	595.9	12.3	9.4	12.5	34.8	31.2	1155.7	2116.9	10.0	1073.7	982.8	265.5	121.5	2.3	42.4	0.2	79.2	775.0	170.8	0.9	8.1	0.7	21.7	0.8	12.3	0.2	0.2	0.2	1129.2	0.5	4.8	1524.4	0.2	503.6	10.2	0.1	0.6	0.6	0.6	0.8	108.7	5.2	0.4	2.4	19.3	0.0	130.5	0.4	66.9	1.8	0.0	0.1	1.1	54.2	41.6	0.6	0.7	19.4	1.2	6.6	0.2	1128.1	131.5	421.5	270.3	0.7	0.4	0.9	578.1	0.5	164.8	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.4	2.4	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.1	0.5	10.1	10.8	8.7	14.4	10.0	14.9	14.0	19.4	11.2	9.8	11.7	12.3	127.3	3.2	0.6	2.0	3.1	164.4	4.3	0.6	9.1	0.7	12.7	33.5	8.7	4.3	0.6	7.3	0.0	17.6	41.2	0.4	0.0	15.1	4.0	13.2	453.2	101.4	0.0	2.7	0.1	0.4	25.1	1455.4	13.3	10.3	0.0	36.1	123.1	1.4	35.3	0.0	0.8	0.1	0.0	3.1	219.7	23.7	605.5	11.7	181.5	44.0	2.4	3.1	32.0	0.0	0.1	5.9	1.0	472.1	12.1	11.2	0.0	0.4	0.1	0.5	295.9	284.8	555.2	3.7	11.5	4.6	140.4	40.4	32.7	125.3	0.4	3.9
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Neurotransmitter degradation"		"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 17.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.3;Excitatory neurons: 45.1;Inhibitory neurons: 46.3;Late spermatids: 16.6;NK-cells: 15.5;Oligodendrocyte precursor cells: 18.1;Oligodendrocytes: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"MAIT T-cell: 60.9"	"Lineage enriched"	"Detected in many"	34	"T-cells: 60.9"	"Group enriched"	"Detected in some"	6	"BEWO: 11.5;HDLM-2: 3.8;U-937: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Cell Junctions"	"HPA045876: AB_2679479"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.5	2.3	3.1	0.7	3.2	0.8	2.2	3.9	4.6	4.6	11.9	3.7	1.0	3.4	1.6	0.9	8.8	1.1	17.9	3.7	2.7	2.9	3.4	2.5	3.9	4.8	3.2	3.6	1.7	3.6	5.7	0.3	2.8	4.6	0.5	0.6	1.5	0.8	10.8	1.6	2.6	0.7	2.6	7.2	2.4	5.0	2.3	2.6	2.6	5.1	3.0	2.2	2.4	2.9	0.1	0.0	0.7	0.0	0.0	0.3	11.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	3.8	0.4	0.2	0.5	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.1	0.2	0.3	0.5	0.0	0.3	0.2	0.2	0.1	0.3	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.0	0.2	1.0	0.0	0.0	0.2	0.5	0.6	0.0	0.0	0.1	0.2	0.2	0.1	0.8	0.4	0.0	0.0	5.2	0.1	0.0	0.6	0.0	9.9	0.0	60.9	0.0	5.3	7.4	0.0	0.0	0.5	0.6	0.0	1.8	0.0	0.4	0.3	3.5	3.1	3.2	3.9	4.6	3.7	2.7	4.8	3.2	2.8	2.6	2.3	2.9	0.6	0.0	0.6	17.3	0.5	0.3	0.2	0.1	0.0	0.3	0.4	0.6	0.7	0.0	1.4	0.0	0.0	0.3	7.7	0.0	0.0	0.1	4.1	6.5	1.4	0.4	1.2	0.4	45.1	0.0	0.2	0.6	1.1	0.8	0.0	3.3	1.8	0.8	0.2	6.7	46.3	0.2	2.0	0.6	0.0	16.6	1.8	0.4	0.0	7.5	0.4	0.3	15.5	18.1	18.3	0.2	0.1	4.5	2.0	0.2	0.0	0.2	4.3	0.7	0.0	0.5	0.7	1.5	0.5	0.0	0.1	2.3	4.1	1.4	0.3	0.1
COMTD1	FLJ23841	ENSG00000165644	"Catechol-O-methyltransferase domain containing 1"	Q86VU5	10	75233641-75236030	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 128.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 334.8;Exocrine glandular cells: 249.5;Paneth cells: 272.5;Proximal enterocytes: 435.9;Squamous epithelial cells: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.2;PC-3: 38.3;RPMI-8226: 24.5;U-266/70: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042165	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA042165: AB_10794042"	"unprognostic (2.53e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.08e-3)"	"unprognostic (9.35e-2)"	"unprognostic (6.74e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.35e-1)"	11.0	17.9	1.1	1.0	1.5	1.5	9.8	1.2	1.8	18.3	5.8	23.3	7.4	7.5	0.4	70.6	7.2	0.4	33.5	1.3	1.7	29.1	37.5	11.7	0.6	1.7	2.0	8.0	128.6	3.4	17.1	0.9	1.7	11.8	1.0	1.1	23.9	1.0	28.2	25.3	25.2	0.5	1.1	12.4	27.8	3.4	1.6	0.5	18.5	0.7	0.7	8.3	29.0	0.9	6.9	2.2	0.5	1.3	0.1	0.7	19.0	2.1	1.0	0.3	0.6	1.6	6.0	20.0	3.5	0.4	1.1	9.0	0.9	1.9	0.1	3.2	30.2	0.8	4.8	3.3	1.1	3.5	3.3	0.6	3.2	0.1	2.9	1.3	0.3	3.6	7.8	4.7	0.1	6.2	5.3	11.0	1.2	5.1	38.3	10.6	1.3	24.5	1.8	0.6	8.4	2.3	2.4	16.0	4.8	0.5	8.9	0.5	1.4	0.6	5.9	1.2	2.1	21.5	4.5	9.8	0.7	3.4	0.6	0.0	7.1	3.9	10.6	10.0	11.6	7.1	10.6	11.0	8.5	5.6	3.5	6.1	1.4	7.3	9.4	15.3	8.9	6.8	1.1	1.5	1.2	1.8	1.3	1.7	1.7	2.0	1.7	1.1	1.6	0.9	23.6	19.2	11.5	1.6	18.2	29.4	40.5	54.1	133.1	6.0	29.3	37.1	31.1	57.2	33.8	53.3	10.4	33.4	30.8	334.8	144.8	162.8	1.6	10.5	7.7	13.5	40.2	16.0	3.4	249.5	79.1	13.4	148.8	33.4	12.7	10.3	25.4	84.0	35.1	1.7	3.9	206.0	42.7	24.2	21.3	3.5	9.6	21.8	37.4	6.5	31.8	10.7	24.7	1.5	0.5	109.2	272.5	7.2	50.8	38.7	435.9	140.3	11.3	34.5	32.9	6.2	25.6	2.6	3.4	285.3	38.2	30.4	29.2	10.7	143.8	56.7
COPRS	"C17orf79, COPR5, HSA272196, TTP1"	ENSG00000172301	"Coordinator of PRMT5 and differentiation stimulator"	Q9NQ92	17	31851871-31859291	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.2;Late spermatids: 288.9;Spermatocytes: 575.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052552	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA052552: AB_2681868"	"unprognostic (1.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.11e-2)"	51.1	46.5	127.4	20.1	130.0	14.2	49.8	124.6	172.8	42.8	129.5	99.0	16.0	43.4	117.6	26.4	51.7	32.0	66.1	128.7	136.2	55.8	68.1	33.9	21.0	123.6	126.7	51.7	41.9	49.0	67.4	19.7	128.8	60.2	27.4	56.0	35.4	46.3	53.5	30.3	31.1	44.4	123.3	25.1	51.6	241.4	131.2	13.2	63.2	53.3	27.8	57.1	33.3	124.1	101.5	132.9	64.4	66.6	104.3	99.5	45.2	109.7	140.3	125.8	127.8	83.4	27.0	53.0	58.8	135.1	245.0	58.5	116.0	67.6	142.3	18.7	153.8	15.4	79.7	99.5	105.5	53.2	43.4	64.2	87.4	169.3	92.4	135.7	68.6	75.2	75.0	46.9	139.6	89.9	79.6	170.7	49.1	65.2	62.8	61.8	120.8	104.4	74.5	62.8	58.4	44.2	65.9	32.6	107.1	56.1	104.4	57.9	37.0	327.8	85.9	116.6	156.3	76.2	77.2	58.3	170.8	50.1	44.9	1.8	2.0	0.0	0.6	2.0	1.6	1.9	0.5	0.1	2.6	3.6	0.3	0.3	0.6	0.0	0.9	1.0	0.8	0.3	127.4	130.0	124.6	172.8	128.7	136.2	123.6	126.7	128.8	123.3	131.2	124.1	54.2	22.4	8.3	13.7	20.9	34.4	69.0	15.3	29.6	43.1	79.2	88.4	78.9	68.6	13.4	86.5	10.4	31.9	10.7	12.1	225.0	99.6	253.2	142.2	38.5	53.5	19.7	18.7	14.6	80.8	54.9	65.7	14.3	40.5	3.8	39.9	62.4	95.4	87.6	26.9	14.8	15.9	40.7	30.3	34.7	288.9	62.4	36.5	58.7	7.5	47.9	136.3	9.2	3.5	9.2	70.7	8.4	65.1	27.4	127.4	6.4	212.0	55.8	43.0	19.7	46.9	63.5	575.6	63.8	21.4	31.7	27.4	11.2	49.6	21.3	39.6
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067614-19080095	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubiquinone biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 40.4;neutrophil: 126.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 126.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"HPA067252: AB_2685813, HPA071922: AB_2686473"	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	10.2	13.6	10.7	7.0	11.2	4.8	13.4	10.9	11.6	10.8	12.5	14.1	12.4	15.6	12.3	12.4	15.5	10.7	23.4	11.0	10.8	14.1	12.3	10.0	8.3	10.6	11.3	20.0	10.3	24.4	9.7	10.0	11.1	17.7	13.2	14.0	10.4	14.7	45.8	7.9	11.8	11.6	10.4	10.0	12.8	20.9	11.3	10.3	16.2	44.9	8.4	10.3	8.8	13.1	23.5	24.8	21.1	12.4	11.6	12.2	17.7	13.5	11.0	18.0	18.5	15.9	19.1	17.8	63.9	10.4	19.4	24.5	29.6	16.9	13.0	15.2	29.9	9.5	22.8	49.3	14.4	22.9	20.1	10.3	14.6	16.8	12.2	14.8	14.8	20.9	26.4	16.2	12.9	42.4	24.0	18.4	16.1	9.1	13.1	29.0	23.3	22.8	15.7	15.5	30.4	17.4	12.6	27.4	16.2	10.2	25.2	30.7	16.3	19.0	10.9	14.1	19.7	15.0	26.2	19.7	20.4	13.1	12.5	40.4	11.4	17.8	9.9	10.6	9.4	16.3	8.9	8.7	12.6	15.3	12.2	10.8	126.5	12.9	12.3	15.6	6.2	5.6	10.7	11.2	10.9	11.6	11.0	10.8	10.6	11.3	11.1	10.4	11.3	13.1	13.3	16.0	12.6	6.2	35.5	11.0	26.3	20.9	13.6	31.2	18.3	21.1	21.8	31.5	14.9	16.5	39.6	21.2	28.7	38.1	45.0	25.2	14.8	23.7	16.2	16.1	24.0	4.8	6.0	18.0	17.9	14.9	32.1	23.2	25.4	31.1	20.7	11.1	23.3	20.2	8.8	39.0	30.5	29.4	12.9	8.5	18.6	18.8	10.6	4.7	11.6	39.5	8.2	5.0	9.4	13.2	30.4	13.9	11.6	17.8	71.5	23.7	24.4	53.9	19.7	20.0	20.2	81.3	53.1	12.8	12.4	32.2	23.9	38.2	39.8	24.0
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 56.9"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.4	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.4	4.5	56.9	0.0	0.3	1.0	0.1	1.9	0.0	0.7	0.6	0.5	0.2	1.1	1.9	0.4	0.1	2.3	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.3	0.1	0.1	0.1	0.1	1.2	3.9	0.1	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.7	0.6	0.1	0.1	0.3	0.1	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
CORO2A	"IR10, WDR2"	ENSG00000106789	"Coronin 2A"	Q92828	9	98120975-98192637	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.2;Proximal enterocytes: 93.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 11.4;monocytes: 7.8;T-cells: 11.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 66.6;OE19: 56.4;SK-BR-3: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041161, HPA041302"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA041161: AB_10795537, HPA041302: AB_10794195"	"unprognostic (4.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.40e-3)"	1.9	1.7	1.9	4.9	1.5	14.8	4.7	4.9	3.2	6.1	0.0	17.5	34.3	1.6	0.7	15.2	4.7	18.2	0.3	1.2	2.9	1.1	3.3	7.4	2.9	3.7	3.4	0.3	0.4	2.5	4.0	2.1	4.9	14.3	12.9	1.2	6.1	1.4	0.3	9.3	35.1	2.2	0.8	3.0	11.1	9.2	4.5	5.7	1.2	0.3	5.9	12.8	7.7	1.8	8.4	2.9	0.6	2.0	1.2	1.3	66.6	0.6	0.7	2.1	3.2	19.1	1.4	0.1	9.4	1.2	3.2	23.1	7.7	12.7	1.3	6.9	1.8	0.2	11.6	17.1	2.7	7.9	0.7	0.4	15.4	1.0	18.6	0.7	0.7	10.0	6.8	3.8	0.3	6.3	1.5	7.8	8.6	56.4	2.2	6.1	0.1	0.2	1.3	23.5	1.7	2.4	4.4	45.3	1.6	15.0	5.3	12.8	0.6	0.2	9.7	0.2	2.4	0.7	4.0	0.7	0.5	2.5	2.8	11.2	1.4	11.4	2.4	2.9	5.2	0.6	3.9	3.7	0.5	0.5	2.5	3.3	1.0	1.7	7.8	0.7	11.9	1.5	1.9	1.5	4.9	3.2	1.2	2.9	3.7	3.4	4.9	0.8	4.5	1.8	2.8	12.8	27.8	0.7	3.1	6.6	18.9	47.2	14.8	2.1	8.5	4.3	1.9	28.6	46.4	0.0	4.2	10.5	2.1	76.2	0.0	4.5	2.6	15.6	11.6	6.0	7.2	0.8	11.6	5.1	42.2	2.2	36.2	19.9	0.0	38.1	0.7	3.8	6.0	1.7	10.5	15.7	20.3	12.0	2.6	3.9	0.0	10.6	0.0	1.0	1.8	0.7	2.1	0.5	0.8	22.6	19.7	0.4	1.4	15.7	93.0	1.7	35.8	1.7	0.0	1.5	3.7	0.5	3.3	29.4	9.9	15.9	10.7	0.2	36.3	30.4
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578993-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.4;retina: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Bipolar cells: 43.2;Cone photoreceptor cells: 37.5;Excitatory neurons: 96.6;Inhibitory neurons: 50.0;Oligodendrocytes: 146.4"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;ASC TERT1: 57.5;HSkMC: 41.6;hTEC/SVTERT24-B: 34.6;U-87 MG: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced	Supported	Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	3.5	44.1	2.0	60.9	0.7	7.2	62.1	66.5	7.2	28.2	5.9	1.2	7.5	2.2	1.4	27.5	4.7	16.4	48.1	43.5	9.2	1.3	5.1	1.8	62.4	62.7	14.9	2.2	0.5	3.5	3.2	58.0	4.3	1.5	45.2	2.7	4.9	2.6	4.1	2.8	6.3	51.9	3.9	3.1	1.0	66.5	1.3	6.1	4.5	0.8	4.1	3.7	83.4	0.6	0.8	26.2	2.2	26.8	57.5	0.0	13.7	15.0	2.3	3.2	0.3	3.0	3.5	1.6	2.3	3.7	0.2	1.0	0.3	9.5	0.0	1.2	0.0	0.0	1.2	9.8	0.0	0.4	41.6	0.3	34.6	2.0	20.4	1.0	0.0	0.0	0.1	24.4	0.1	0.0	0.1	6.5	0.0	0.1	2.2	0.1	1.2	3.7	0.0	15.3	0.3	0.2	0.0	7.8	4.8	0.0	3.1	0.2	7.8	8.9	1.7	18.3	0.0	0.0	3.5	59.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.1	60.9	62.1	66.5	48.1	43.5	62.4	62.7	58.0	51.9	66.5	83.4	2.8	0.0	0.0	57.1	1.1	1.0	0.4	0.0	0.0	43.2	0.1	1.0	1.5	0.0	0.0	7.3	37.5	0.0	0.0	0.0	0.0	3.8	0.4	2.1	11.6	3.0	3.6	0.0	96.6	0.6	0.0	8.0	0.0	0.3	0.0	0.9	6.4	0.0	0.2	0.0	50.0	0.3	0.0	0.3	0.7	0.7	7.8	0.3	7.2	11.2	0.1	12.5	0.0	17.1	146.4	0.6	0.0	0.4	0.0	0.1	0.0	0.1	8.1	21.4	6.6	1.4	2.1	0.2	0.5	0.1	0.9	0.0	0.1	7.5	0.0	0.1
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354719	"Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 90.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Late spermatids: 27.4;Respiratory ciliated cells: 12.6;Spermatocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 24.9;SCLC-21H: 10.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.7	0.1	0.3	1.0	0.2	1.1	0.9	1.0	0.5	0.4	0.4	6.7	0.2	0.2	1.2	1.2	0.7	0.2	0.1	0.3	0.3	0.8	0.1	0.3	0.2	0.3	0.5	0.5	0.2	0.0	0.9	0.2	0.4	0.7	4.8	0.4	1.4	0.2	0.3	2.5	0.3	0.2	0.1	0.3	0.2	90.5	0.3	3.3	0.1	0.0	1.9	0.5	0.9	0.6	3.1	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.2	24.9	0.1	0.2	0.3	0.3	1.8	0.7	0.2	0.2	0.9	0.7	0.0	2.0	0.1	0.3	0.2	1.8	0.2	2.7	0.5	0.6	1.7	0.0	0.1	0.4	0.2	0.0	0.6	0.1	0.2	0.6	2.6	0.5	0.1	0.0	0.2	0.1	0.4	10.1	0.3	0.4	0.1	0.0	0.6	0.4	0.0	0.5	0.2	0.5	0.1	0.3	1.6	1.4	0.1	0.1	0.3	0.1	0.8	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.2	0.2	1.5	0.5	0.2	0.4	0.2	0.3	0.3	0.2	1.0	0.5	0.3	0.3	0.3	0.5	0.4	0.1	0.3	0.6	0.2	0.0	0.5	0.0	0.0	0.5	0.7	3.5	1.2	2.4	0.9	1.3	0.6	0.0	2.1	0.0	4.2	0.5	1.8	8.0	0.0	0.5	36.0	1.3	0.5	0.2	1.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.0	0.2	0.0	0.0	0.1	3.3	0.1	1.3	4.1	0.0	0.0	27.4	0.6	0.3	0.0	0.0	0.0	1.4	2.1	0.0	0.1	9.6	4.1	0.0	0.3	0.7	3.4	0.1	12.6	5.4	0.0	0.4	0.5	61.1	1.7	0.3	0.4	0.4	0.6	0.1	6.5	2.3
CPEB3	KIAA0940	ENSG00000107864	"Cytoplasmic polyadenylation element binding protein 3"	Q8NE35	10	92046692-92291078	"Predicted intracellular proteins"	"Translation regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 32.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 176.0;Early spermatids: 226.2;Excitatory neurons: 233.7;Inhibitory neurons: 286.9;Late spermatids: 408.9;Oligodendrocyte precursor cells: 148.8;Oligodendrocytes: 128.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.1;U-266/70: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070942			Approved	"Nucleoplasm,Plasma membrane,Midbody,Cytosol"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane, Midbody"	"HPA070942: "	"unprognostic (4.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.95e-5)"	"prognostic favorable (5.06e-5)"	"unprognostic (4.09e-4)"	"unprognostic (2.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.84e-9)"	"unprognostic (3.33e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.40e-1)"	1.9	3.9	6.1	1.8	7.2	1.7	3.2	6.2	17.3	2.5	2.1	2.3	3.1	1.9	4.5	4.6	1.8	2.0	5.1	6.4	4.3	4.6	32.2	2.2	1.9	10.4	5.6	3.5	3.5	3.2	4.0	1.6	11.0	4.2	2.6	7.1	7.5	2.4	19.7	4.0	3.0	2.0	1.4	2.6	2.8	12.9	4.4	1.5	6.5	9.5	2.1	1.9	3.1	7.0	0.9	0.2	0.3	1.9	0.5	0.5	0.7	0.8	0.6	1.2	0.9	0.6	1.9	1.1	1.0	0.3	0.5	2.5	0.9	0.6	0.7	1.1	0.9	1.4	1.3	0.8	1.4	0.6	1.4	0.4	1.5	0.6	2.4	1.0	1.1	1.3	0.9	12.1	0.5	0.7	0.9	0.8	0.2	1.3	0.9	1.1	1.6	2.1	1.2	0.4	1.4	0.5	0.8	2.2	1.6	1.0	2.7	1.6	0.8	0.6	0.6	0.4	0.7	6.3	1.7	1.1	0.3	2.2	0.1	2.6	0.4	0.8	0.2	0.5	0.2	0.7	0.1	0.3	0.3	0.1	0.1	0.1	0.5	0.2	0.6	0.2	0.1	0.2	6.1	7.2	6.2	17.3	6.4	4.3	10.4	5.6	11.0	1.4	4.4	7.0	6.1	6.4	7.0	176.0	6.2	8.8	4.0	4.0	7.4	26.0	20.5	10.7	25.3	5.7	4.4	12.9	50.1	2.1	3.0	11.3	5.9	3.2	226.2	9.0	3.0	7.1	19.8	3.6	233.7	2.6	1.6	5.5	4.1	10.8	3.8	4.1	12.5	75.2	4.8	30.3	286.9	9.9	8.2	23.9	3.4	408.9	5.9	10.3	5.4	87.1	8.9	3.2	4.1	148.8	128.6	3.2	4.0	7.9	4.2	10.7	10.1	5.0	8.7	24.7	0.0	4.4	4.1	13.2	7.2	22.0	13.9	1.2	3.3	3.4	5.9	6.5
CPNE9	KIAA4217	ENSG00000144550	"Copine family member 9"	Q8IYJ1	3	9703826-9729908	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 69.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 12.9;Excitatory neurons: 28.2;Inhibitory neurons: 8.0;Late spermatids: 61.3"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.0"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.3;U-937: 2.0"	"Low region specificity"	"Detected in all"							HPA060813			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA060813: "	"unprognostic (2.96e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-4)"	"unprognostic (1.47e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.48e-2)"	0.1	2.1	10.9	0.2	7.1	1.2	0.1	12.1	23.6	0.1	0.0	0.4	0.3	0.1	0.0	0.1	0.1	0.1	0.1	5.8	19.6	0.2	0.0	0.3	0.2	69.2	19.8	0.1	0.1	0.1	5.3	0.1	65.0	0.1	0.1	1.1	0.1	0.2	0.0	1.7	0.3	0.2	4.2	0.2	0.3	1.3	39.6	0.1	0.1	0.0	0.1	0.1	0.1	12.9	0.0	0.3	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.2	0.3	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.5	0.0	0.0	0.2	0.4	0.7	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.4	0.3	2.0	0.1	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	10.9	7.1	12.1	23.6	5.8	19.6	69.2	19.8	65.0	4.2	39.6	12.9	0.1	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.6	0.8	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.9	0.1	0.1	0.1	0.0	0.0	28.2	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	1.9	0.0	8.0	0.0	0.0	0.8	0.3	61.3	0.0	0.8	0.0	3.7	0.0	0.7	0.0	2.0	2.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.9	0.7	0.2	0.4	0.0	0.1	0.0	0.1	0.0
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 144.3"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 1.5;Fibroblasts: 8.5;Microglial cells: 2.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 73.6;BJ: 39.7;BJ hTERT+: 51.7;hTERT-RPE1: 30.6;RH-30: 57.6;U-2197: 46.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	11.1	1.8	0.3	2.7	1.0	0.0	11.8	0.5	2.9	33.3	2.3	4.6	0.8	14.6	9.1	7.4	19.9	30.7	2.8	0.8	0.4	2.0	1.4	7.1	2.8	0.7	0.5	144.3	3.2	1.8	5.2	42.1	0.8	5.9	1.8	0.1	1.5	24.2	0.2	13.8	2.6	8.4	1.2	1.4	3.3	3.1	0.3	1.5	7.8	0.0	1.0	23.0	25.1	0.9	26.1	0.4	0.0	1.6	5.0	0.5	73.6	39.7	51.7	14.5	5.8	1.7	0.7	0.0	3.7	21.3	0.3	0.0	0.0	0.0	5.4	0.0	2.9	0.0	0.3	0.7	4.4	0.0	0.0	9.2	0.0	0.0	0.0	30.6	0.0	0.0	1.2	0.0	0.9	6.1	0.0	0.1	9.2	0.2	22.0	0.1	57.6	0.0	0.0	1.1	0.1	0.1	1.4	0.5	0.1	8.3	0.3	0.0	0.0	2.0	2.6	46.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.5	2.9	0.8	0.4	0.7	0.5	0.8	1.2	0.3	0.9	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.0	0.6	8.5	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0
CRCP	"C17, CGRP-RCP, POLR3I, RCP, RCP9"	ENSG00000241258	"CGRP receptor component"	O75575	7	66114604-66154568	"Metabolic proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006883, HPA007216"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA006883: , HPA007216: AB_1856160"	"unprognostic (2.36e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.67e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.49e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.87e-2)"	"unprognostic (4.81e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.06e-1)"	13.5	15.3	10.8	13.8	11.4	37.5	17.6	12.7	14.1	14.7	11.2	18.3	16.8	14.7	11.3	20.0	17.3	13.1	17.5	11.3	13.7	16.5	26.5	14.5	16.4	11.6	12.2	16.9	20.6	21.2	11.1	13.7	14.1	17.3	19.6	14.2	16.1	15.8	14.8	16.1	14.7	18.2	11.3	17.4	17.9	8.3	13.9	15.2	20.0	13.6	16.6	16.6	14.4	12.4	44.0	26.9	19.5	26.4	27.0	33.7	19.0	29.9	31.9	43.7	33.7	43.5	34.6	40.6	35.7	29.0	37.0	32.4	26.7	35.9	46.1	26.0	27.3	23.1	19.1	20.9	19.4	47.6	32.6	27.0	30.9	38.3	71.6	27.8	23.7	23.1	49.3	28.8	30.0	35.0	36.7	37.7	39.8	58.7	33.6	38.4	30.1	37.8	27.8	40.5	46.1	60.3	34.3	95.2	29.2	22.8	73.6	24.0	27.6	63.4	33.6	36.5	56.3	35.4	70.0	54.3	35.9	36.8	51.6	25.9	12.0	20.4	17.6	11.1	17.1	14.4	15.4	14.9	9.1	13.4	14.5	17.3	20.9	10.9	17.0	12.0	16.0	12.0	10.8	11.4	12.7	14.1	11.3	13.7	11.6	12.2	14.1	11.3	13.9	12.4	24.8	28.9	32.5	12.1	30.4	13.4	22.2	13.9	24.5	29.9	19.7	19.2	25.7	12.8	23.0	16.5	22.9	12.6	47.8	15.5	35.2	21.3	4.4	27.7	30.3	18.1	16.1	12.2	19.5	24.8	11.8	20.5	27.5	29.4	34.1	22.8	9.7	25.2	12.1	30.3	20.5	15.4	8.2	13.6	9.2	4.3	18.6	17.7	16.0	12.2	20.6	23.0	22.6	12.5	17.2	29.8	10.2	22.2	26.5	26.2	10.5	17.6	32.8	25.8	6.6	27.2	18.5	24.5	16.7	20.9	14.8	11.5	27.3	28.6	14.7	32.1
CREB5	"CRE-BPA, H_GS165L15.1"	ENSG00000146592	"CAMP responsive element binding protein 5"	Q02930	7	28299321-28825894	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 165.7;Basal prostatic cells: 192.2;monocytes: 163.9;Oligodendrocyte precursor cells: 229.7;Oligodendrocytes: 734.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 198.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 198.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 62.5;Karpas-707: 25.0;U-2 OS: 25.7;U-2197: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050020, HPA061622"			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA050020: AB_2680993, HPA061622: AB_2684569"	"unprognostic (3.59e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	10.5	1.3	6.3	7.9	20.5	6.1	5.0	6.8	12.7	1.7	0.0	3.5	0.9	8.4	2.8	3.5	2.2	11.4	5.3	9.6	19.9	3.0	1.8	6.1	0.9	19.7	14.6	0.7	3.2	0.2	1.1	3.7	15.8	1.2	1.7	1.3	3.5	1.0	3.2	2.9	2.2	4.7	2.9	7.4	1.4	0.7	23.0	0.7	1.8	4.0	0.8	4.4	2.2	35.0	0.1	0.6	7.3	0.4	0.4	10.3	0.3	0.7	1.6	4.4	6.6	4.2	2.7	18.9	1.3	1.8	4.5	0.7	0.2	6.4	13.8	0.0	5.0	20.4	4.2	0.4	0.4	62.5	0.7	1.3	1.2	18.9	20.1	0.9	3.0	0.1	2.4	25.0	1.5	0.1	0.1	0.0	9.1	0.1	7.4	0.5	6.8	0.5	9.0	2.0	0.7	5.2	0.3	0.4	2.2	10.0	0.2	1.5	0.8	8.6	25.7	28.7	8.5	1.5	4.5	0.2	9.4	0.3	14.8	0.1	29.9	0.0	0.0	9.7	0.0	1.9	0.0	0.0	18.2	0.1	0.0	0.0	198.8	0.0	3.9	0.3	0.0	7.0	6.3	20.5	6.8	12.7	9.6	19.9	19.7	14.6	15.8	2.9	23.0	35.0	165.7	6.4	7.2	10.7	3.2	21.9	192.2	8.2	13.1	1.3	10.7	8.9	16.8	17.2	6.3	12.9	0.0	4.0	0.8	0.0	1.9	74.2	0.4	41.0	56.3	31.3	0.0	0.4	17.0	27.4	13.4	108.0	3.1	69.7	14.0	0.6	14.3	0.5	8.3	5.0	22.2	0.0	6.1	47.4	118.2	1.6	5.9	75.8	30.2	22.5	163.9	14.3	4.1	229.7	734.9	22.5	0.0	0.4	3.2	44.9	0.0	25.6	4.7	0.9	19.7	143.5	31.8	12.6	7.3	12.0	13.2	24.8	3.1	2.6	0.0	35.1
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 980.8;Endometrial ciliated cells: 1761.1;Proximal enterocytes: 2548.8;Respiratory ciliated cells: 1702.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 699.8;CAPAN-2: 415.5;HaCaT: 464.1;HDLM-2: 329.5;OE19: 1305.8;T-47d: 586.0"									HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"		NA	NA		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	265.2	21.7	19.2	61.1	19.7	29.4	180.8	20.0	36.4	147.4	20.3	133.9	121.7	108.0	206.6	118.7	118.2	28.1	262.6	18.5	20.3	109.7	17.8	254.6	83.9	26.9	29.1	49.8	18.3	21.2	41.5	28.3	24.6	49.6	55.4	0.2	135.7	87.9	44.7	301.1	312.5	42.4	24.7	94.5	94.2	14.3	21.0	79.6	182.1	50.2	135.7	113.7	98.9	20.3	0.0	699.8	4.8	0.6	12.1	8.3	66.8	1.3	0.4	9.0	0.1	21.0	415.5	228.0	2.4	191.0	2.6	464.1	0.1	0.0	0.0	329.5	0.0	17.7	294.7	116.3	1.8	0.1	0.2	3.8	0.0	23.1	0.0	0.9	0.5	64.6	0.5	0.9	0.0	3.7	8.1	1.6	7.4	1305.8	36.4	181.3	0.0	45.5	0.0	0.0	18.5	1.3	2.6	1.2	0.0	0.5	586.0	106.4	1.5	0.4	0.4	5.5	0.0	0.3	0.2	17.9	0.0	0.0	0.6	121.8	218.6	313.1	209.2	214.4	135.1	697.0	442.0	222.1	442.9	384.2	85.4	100.2	13.9	323.5	283.9	291.3	694.8	465.6	19.2	19.7	20.0	36.4	18.5	20.3	26.9	29.1	24.6	24.7	21.0	20.3	50.2	980.8	256.2	0.3	350.7	186.5	1.2	79.5	67.2	0.0	88.1	18.3	1.0	2.8	501.3	51.5	0.0	2.1	287.8	360.4	1.9	20.5	3.6	1761.1	124.5	86.4	76.5	27.3	0.0	3.1	4.3	313.3	210.0	491.9	521.5	0.1	24.7	1.3	52.2	0.0	0.0	243.1	30.5	168.0	577.3	26.2	25.1	523.7	370.0	1.9	461.4	0.2	83.4	0.0	0.1	34.2	659.2	9.4	584.3	0.7	2548.8	2.5	1702.1	0.0	223.5	8.2	448.0	1.0	11.4	29.4	251.6	1.5	524.7	0.1	190.7	3.0
CRIP2	"CRP2, ESP1"	ENSG00000182809	"Cysteine rich protein 2"	P52943	14	105472962-105480162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"heart muscle: 1113.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 459.4;Cardiomyocytes: 863.3;Endothelial cells: 510.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 52.1;memory CD4 T-cell: 80.4;naive B-cell: 109.9;T-reg: 115.6"	"Group enriched"	"Detected in all"	30	"B-cells: 109.9;T-cells: 115.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 321.9;MCF7: 306.5;SK-BR-3: 303.7;T-47d: 266.4;TIME: 259.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042664	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA		160000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA042664: AB_10797017"	"unprognostic (2.68e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.68e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.26e-3)"	177.6	44.7	160.4	31.3	172.0	1.5	162.5	137.7	259.5	101.6	124.2	101.9	27.0	138.1	36.4	127.3	130.0	47.9	1113.7	172.7	186.4	205.1	52.7	185.7	30.0	157.3	158.7	51.2	46.1	19.2	175.0	49.6	158.6	89.0	8.3	4.1	100.0	72.9	52.5	128.9	82.8	32.0	145.0	104.1	66.1	92.8	191.9	10.4	155.6	42.7	16.5	121.4	100.4	140.8	2.5	201.2	37.9	98.3	4.3	19.9	10.0	17.5	1.9	2.8	1.0	7.1	44.2	0.2	321.9	73.8	4.5	166.8	3.6	50.8	0.1	2.3	1.9	0.2	132.5	73.8	24.3	0.0	25.5	10.5	4.4	5.2	26.2	38.4	192.7	0.2	0.5	1.4	26.8	306.5	0.5	0.6	10.0	45.7	143.4	0.4	7.7	9.9	140.1	0.6	61.6	175.3	30.0	303.7	1.9	4.9	266.4	0.1	259.3	82.7	38.8	2.3	50.5	0.7	0.6	0.9	24.3	0.3	179.3	0.2	1.9	0.0	7.5	0.9	6.8	52.1	80.4	17.2	3.6	109.9	17.8	4.5	1.0	3.7	0.5	0.5	115.6	10.4	160.4	172.0	137.7	259.5	172.7	186.4	157.3	158.7	158.6	145.0	191.9	140.8	459.4	157.0	33.7	17.9	15.0	153.2	96.7	206.4	29.0	2.7	110.0	140.7	863.3	107.2	127.1	189.4	4.2	2.6	8.2	0.9	154.6	106.8	37.9	125.1	28.8	510.4	25.2	9.7	16.4	87.6	30.5	132.9	32.1	126.6	7.6	0.4	346.3	30.4	3.0	94.2	3.0	0.3	81.4	11.8	92.6	84.0	28.0	9.3	156.5	27.2	2.5	57.2	1.0	4.5	3.1	48.9	0.1	14.7	7.0	37.4	0.2	17.0	155.7	4.0	276.1	108.1	339.5	27.8	46.1	20.1	196.8	32.0	32.5	5.9	0.2	103.2
CRK		ENSG00000167193	"CRK proto-oncogene, adaptor protein"	P46108	17	1420689-1463162	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010485, HPA068087"	Approved		Approved	"Plasma membrane"		NA	NA		400000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"CAB010485: AB_2085043, HPA068087: AB_2685950"	"unprognostic (6.82e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.70e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.93e-2)"	48.2	23.2	27.9	20.8	28.3	5.7	30.6	28.1	27.8	26.4	25.2	34.1	26.8	28.2	32.1	26.9	21.0	29.7	27.7	28.2	28.5	31.5	50.1	30.2	17.3	29.6	29.7	24.8	27.3	25.3	11.2	42.2	29.4	23.9	34.4	22.6	23.8	27.0	32.0	20.4	24.2	35.6	30.1	20.4	26.1	20.5	31.2	17.6	36.7	37.9	20.1	31.6	21.8	29.3	45.9	69.8	50.8	54.6	83.7	70.2	47.5	77.3	64.8	59.7	55.3	90.7	26.3	22.0	37.6	89.1	41.7	69.1	68.2	55.8	87.2	11.1	46.6	24.5	43.7	50.2	77.9	10.6	20.9	68.3	64.7	61.9	77.1	45.8	74.3	20.2	42.1	20.3	84.4	46.3	11.5	12.1	46.3	50.4	34.6	24.3	25.7	20.1	78.4	48.4	18.8	49.2	73.5	45.2	54.6	47.7	44.5	17.7	79.8	59.7	33.9	63.8	77.3	9.6	15.8	13.5	50.4	20.6	66.6	6.2	3.9	5.3	3.0	4.2	3.0	3.6	3.2	2.7	4.4	5.2	2.4	3.5	13.9	2.7	4.4	3.9	2.6	1.7	27.9	28.3	28.1	27.8	28.2	28.5	29.6	29.7	29.4	30.1	31.2	29.3	89.5	67.3	51.5	12.7	34.6	149.5	68.8	29.6	50.7	43.8	62.7	45.5	35.2	48.6	33.8	33.1	27.1	63.3	22.1	92.6	41.1	62.1	4.3	55.2	64.5	89.7	49.8	39.5	17.5	65.3	61.6	52.7	47.4	94.1	7.6	33.0	92.8	65.6	45.3	53.8	17.6	61.9	22.4	47.1	91.6	8.3	43.8	46.3	53.4	19.7	45.3	43.5	24.7	12.5	13.6	76.7	60.5	44.0	25.7	77.9	58.3	39.7	32.6	38.9	46.0	59.6	72.9	29.0	58.6	62.8	167.8	85.0	29.9	35.4	66.4	92.2
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972964	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	7.6	7.6	5.2	2.3	5.5	1.6	8.0	10.1	7.2	13.5	29.0	10.2	1.7	10.4	0.7	10.0	22.7	1.4	6.2	5.8	6.2	8.3	3.3	8.4	2.4	9.5	11.5	13.3	10.7	1.7	10.2	1.3	6.1	10.4	0.4	11.3	7.6	1.8	6.2	14.3	7.9	1.1	6.2	10.2	8.9	5.3	6.6	2.8	8.1	1.2	0.7	9.2	11.4	6.9	4.1	1.7	3.1	3.1	2.1	1.9	1.2	2.9	0.9	0.9	1.0	0.2	1.8	10.9	2.7	1.3	0.3	4.9	0.7	2.2	0.1	0.9	5.6	5.0	6.1	0.8	3.7	0.3	4.9	1.7	5.0	0.9	0.8	1.7	1.5	7.7	0.7	2.7	0.3	3.5	3.4	1.2	11.1	0.9	2.6	3.1	4.1	3.8	0.7	1.1	9.4	10.2	3.1	2.0	9.7	0.9	4.1	1.4	4.3	2.6	3.4	6.8	2.3	4.7	3.7	2.2	2.6	0.7	3.3	0.0	0.0	0.3	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	0.1	5.2	5.5	10.1	7.2	5.8	6.2	9.5	11.5	6.1	6.2	6.6	6.9	9.0	0.0	4.6	14.0	5.4	6.2	4.1	4.4	17.1	26.3	7.9	7.7	5.8	5.7	4.1	5.5	27.1	1.3	8.2	2.3	0.0	4.7	5.5	35.2	6.3	7.1	3.6	2.5	27.9	2.3	6.5	11.3	6.1	5.9	1.3	28.2	6.4	1.8	2.4	3.3	24.0	4.3	4.1	1.6	5.3	2.6	19.3	3.4	5.4	11.2	3.1	11.7	12.3	13.0	19.9	2.4	1.9	12.8	2.1	2.0	0.8	1.5	34.0	109.7	0.0	12.8	9.4	1.2	12.8	13.1	5.1	1.1	8.0	3.5	2.7	2.2
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683678-18782333	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 37.4;Horizontal cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	203	"amygdala: 14.2;basal ganglia: 11.4;cerebellum: 27.1;cerebral cortex: 24.3;hippocampal formation: 24.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022035, HPA063619"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255, HPA063619: "	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favorable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.8	11.3	14.2	5.2	11.4	2.1	8.2	27.1	24.3	11.3	0.0	8.9	4.0	9.3	3.4	5.2	10.3	3.2	10.5	24.5	0.0	12.8	10.4	7.9	4.1	0.0	0.0	9.4	9.8	4.7	23.7	3.9	0.0	11.6	1.5	4.4	7.3	5.1	14.4	7.4	8.5	2.5	0.0	9.6	9.9	11.3	0.0	3.6	14.4	3.6	2.2	9.7	7.4	0.0	5.2	7.9	6.7	10.7	6.3	4.5	18.6	5.4	3.6	5.3	4.8	5.1	6.6	7.1	11.6	5.2	3.9	5.5	2.1	3.5	1.3	3.1	15.1	6.0	7.8	9.3	5.5	8.3	16.3	7.8	2.9	4.4	1.3	6.8	3.1	7.2	4.8	6.3	3.0	15.2	5.7	10.0	8.8	2.7	13.1	8.7	2.9	8.1	3.2	8.0	12.1	10.7	6.0	5.8	7.0	2.2	6.6	5.2	5.4	6.0	9.1	10.8	6.4	4.4	3.6	4.6	6.9	8.6	4.6	0.3	0.6	0.4	0.4	0.2	0.3	0.5	0.5	0.6	0.7	0.7	0.5	0.3	0.2	0.3	0.4	0.8	0.4	0.4	14.2	11.4	27.1	24.3	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	5.3	31.0	6.9	2.7	8.9	7.8	5.7	29.1	5.8	6.1	17.7	10.0	3.5	18.4	27.1	9.7	7.9	6.8	11.7	4.6	1.1	9.6	14.0	5.6	19.2	3.6	37.4	6.0	2.7	7.5	8.6	9.8	2.5	14.7	3.9	4.7	8.8	43.7	26.7	7.1	12.2	6.0	4.0	3.2	9.3	6.3	3.6	10.3	5.5	9.1	8.2	12.1	20.2	3.5	9.6	4.9	2.0	3.0	6.1	5.0	4.8	14.7	0.0	14.2	6.6	2.9	8.8	2.4	2.0	10.4	5.1	8.3	5.2	3.6
CRYBG3	DKFZp667G2110	ENSG00000080200	"Crystallin beta-gamma domain containing 3"	Q68DQ2	3	97822011-97944984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 122.6;Bipolar cells: 123.6;Early spermatids: 121.4;Late spermatids: 131.8;Oligodendrocytes: 128.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.6;granulocytes: 1.5;monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075635			Approved	"Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA075635: "	"unprognostic (1.88e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.10e-2)"	"unprognostic (3.41e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.86e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (1.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.38e-3)"	10.6	2.8	5.3	5.5	12.6	0.8	7.7	9.2	8.0	8.0	3.4	7.0	3.6	6.6	2.7	8.9	5.6	5.3	6.5	5.3	10.6	4.9	3.2	5.7	3.4	15.5	10.0	3.5	5.4	3.7	1.2	10.7	16.0	5.0	7.6	7.8	6.3	4.1	7.5	12.9	4.5	6.4	11.3	4.0	5.3	14.0	10.0	2.8	26.6	9.9	4.5	7.5	4.6	17.2	16.5	6.1	3.5	4.2	11.1	11.8	6.2	5.8	5.3	4.2	6.3	0.4	5.4	0.1	1.9	10.1	6.2	10.5	7.0	4.9	8.0	20.4	3.8	4.1	2.7	2.1	5.8	6.1	1.0	7.7	4.9	5.3	5.8	6.9	8.2	1.3	0.3	3.0	7.4	0.2	2.2	0.7	3.0	4.5	5.5	0.0	12.3	2.1	6.1	10.9	39.2	3.0	12.2	4.8	3.9	2.2	4.2	6.8	10.9	8.9	6.9	5.2	7.1	5.0	0.1	3.7	9.3	3.5	5.8	1.5	1.4	0.0	0.1	0.9	0.2	0.1	0.2	0.2	1.4	0.2	0.1	0.1	0.0	0.0	1.0	3.6	0.0	0.3	5.3	12.6	9.2	8.0	5.3	10.6	15.5	10.0	16.0	11.3	10.0	17.2	122.6	32.1	19.6	48.0	4.2	5.1	7.0	3.7	23.9	123.6	13.7	9.3	37.6	1.5	16.9	18.4	6.2	4.0	13.8	6.0	1.9	8.8	121.4	32.6	48.9	52.1	12.7	2.5	37.5	13.1	11.3	38.0	18.3	22.7	0.0	68.0	15.0	5.1	6.6	13.5	23.0	8.3	2.0	17.4	3.0	131.8	8.4	18.9	8.8	37.5	22.1	29.4	1.0	10.6	128.3	13.2	8.7	4.5	12.0	7.1	2.5	2.8	21.3	9.6	39.5	29.2	18.2	49.6	9.5	24.5	6.1	2.3	3.0	14.0	5.2	7.0
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 329.8;liver: 254.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040403, HPA058848"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632, HPA058848: "	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	33.7	31.8	69.5	15.4	81.3	11.2	27.1	75.4	78.1	33.0	65.6	62.1	190.2	30.5	51.7	24.7	26.5	30.0	30.4	65.2	79.0	329.8	254.1	19.9	19.4	76.3	71.9	19.8	46.9	31.4	38.1	16.1	76.1	32.2	49.3	20.7	41.6	36.5	17.0	16.3	131.6	22.8	77.2	23.3	45.2	4.9	71.9	18.0	35.0	20.7	16.3	20.9	23.6	89.8	8.1	6.9	6.4	42.7	31.6	36.1	5.8	11.1	20.0	4.8	3.9	2.6	7.8	0.1	20.6	15.5	10.9	1.9	5.7	9.9	4.9	19.4	4.7	14.2	0.8	55.1	18.1	4.6	12.2	21.5	6.4	3.9	22.0	17.1	51.7	20.3	1.0	5.8	12.7	29.2	12.7	7.2	0.4	68.7	10.2	6.4	3.8	1.0	40.8	16.9	4.2	5.0	6.6	3.1	51.0	3.0	21.2	18.0	50.1	5.8	2.6	14.3	7.1	7.6	1.6	0.0	11.1	7.9	24.5	5.8	50.7	3.2	23.2	59.6	18.9	20.5	30.6	22.1	60.5	23.1	23.5	22.2	1.7	15.6	50.6	6.4	37.5	43.8	69.5	81.3	75.4	78.1	65.2	79.0	76.3	71.9	76.1	77.2	71.9	89.8	29.2	6.4	10.3	57.8	17.7	10.3	15.9	29.7	6.2	6.1	22.0	11.6	10.5	35.8	25.6	77.3	12.5	22.0	10.0	138.5	485.2	26.1	3.6	32.5	8.8	29.1	9.1	6.9	54.5	31.6	11.2	29.8	34.1	27.2	25.3	8.8	50.7	306.1	71.4	1.7	35.3	89.0	32.6	91.6	34.3	4.3	26.1	51.3	37.4	13.1	19.3	112.2	9.2	33.7	114.1	43.2	219.1	24.0	14.3	23.0	509.9	1033.9	20.9	12.6	19.7	23.4	14.7	1.0	2.7	13.0	9.2	20.8	20.1	20.7	105.2	15.0
CSMD3		ENSG00000164796	"CUB and Sushi multiple domains 3"	Q7Z407	8	112222928-113436939	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 6.8"	"Group enriched"	"Detected in some"	12	"Excitatory neurons: 915.9;Inhibitory neurons: 867.9;Oligodendrocyte precursor cells: 1761.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029007, HPA029008"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA029007: AB_10601802, HPA029008: "	"unprognostic (2.26e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.26e-2)"		"unprognostic (3.54e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.03e-10)"	"unprognostic (1.95e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-3)"	0.0	0.0	6.8	0.0	4.3	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	4.8	0.0	0.0	0.0	0.0	1.9	2.7	0.0	0.2	0.0	0.1	0.0	1.6	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	4.3	0.0	6.0	5.7	4.8	1.9	2.7	1.6	0.8	5.0	0.7	0.0	0.0	3.0	21.5	0.2	0.3	0.1	0.0	0.0	7.3	0.0	0.0	1.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.5	0.1	0.4	0.0	0.0	915.9	0.0	0.0	0.9	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	867.9	0.0	0.0	0.0	0.8	6.3	0.0	0.3	0.0	19.7	0.0	0.5	0.0	1761.3	92.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.9	0.0	0.4	0.2	17.1	8.2	0.0	0.6	0.0	0.0	0.0	0.0	0.3
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66012008-66013505	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"skin 1: 761.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Club cells: 115.2;Pancreatic endocrine cells: 368.1;Respiratory ciliated cells: 404.0"	"Group enriched"	"Detected in many"	5	"thyroid cancer: 171.0;urothelial cancer: 43.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 130.2;CAPAN-2: 364.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		82000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: AB_2679158"	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	3.2	0.3	0.1	0.3	0.1	0.2	28.5	0.8	0.4	7.4	0.8	0.4	0.0	0.3	0.6	34.6	14.9	0.5	2.8	0.1	0.3	2.6	0.3	18.3	0.0	0.2	0.2	0.7	0.7	2.1	1.6	8.1	0.1	0.9	0.0	0.0	7.4	4.9	2.0	761.4	0.3	0.1	0.1	0.2	0.6	1.8	0.4	2.7	21.4	0.0	2.2	1.2	22.5	0.2	130.2	0.0	0.0	0.6	0.0	0.0	37.6	1.4	0.0	0.3	0.2	1.0	364.6	0.0	1.8	5.1	0.1	4.5	0.0	32.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.6	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.8	0.2	0.7	0.0	0.0	35.8	0.4	0.1	0.8	0.1	0.0	0.2	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.4	0.1	0.3	0.2	0.2	0.1	0.1	0.4	0.2	0.1	93.0	6.1	0.0	0.6	1.1	1.7	41.4	0.6	0.0	5.3	7.1	1.2	0.0	115.2	58.8	0.0	33.3	0.0	0.1	0.0	57.4	0.2	7.7	0.1	0.9	0.0	0.0	0.0	21.6	24.4	2.0	0.0	0.6	21.6	0.1	0.4	0.1	41.1	0.0	0.0	0.0	24.4	1.4	10.0	0.8	0.0	5.3	5.4	0.0	1.1	1.3	0.0	0.0	0.0	368.1	1.1	0.4	9.8	1.9	0.0	0.5	404.0	0.1	0.0	0.3	16.0	5.2	17.6	1.0	27.6	64.2	0.7	0.0	0.4	6.1
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029677-97156556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 643.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 63.7;Cytotrophoblasts: 122.3;Extravillous trophoblasts: 153.0;Granulosa cells: 54.2;Syncytiotrophoblasts: 67.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.1"	"Group enriched"	"Detected in many"	8	"BEWO: 592.6;SuSa: 739.0"					"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.2	0.2	0.6	0.3	0.7	0.3	5.8	0.8	1.6	43.1	0.8	2.9	1.1	2.8	1.7	19.8	1.3	0.5	0.1	0.6	0.5	21.3	0.2	0.9	0.1	0.7	0.6	0.2	2.1	1.4	1.5	16.8	0.6	0.7	3.2	17.2	9.4	0.1	0.7	52.5	0.4	0.8	0.5	0.2	2.8	65.8	0.6	643.6	1.3	0.1	6.0	0.4	20.1	1.0	37.1	5.2	12.1	33.1	0.6	0.0	592.6	0.5	0.0	7.1	4.7	81.0	37.7	0.3	2.8	0.5	50.5	67.2	58.8	43.9	9.7	0.1	4.4	0.8	1.9	3.1	0.2	0.1	3.3	0.0	9.2	1.5	0.8	0.9	2.4	8.5	0.5	0.2	14.4	15.2	0.9	0.3	76.2	78.9	10.7	0.0	27.3	0.1	11.4	3.7	2.4	3.6	39.1	13.1	13.2	739.0	21.1	3.2	0.0	1.0	23.6	0.2	3.5	5.7	20.6	0.8	1.6	0.4	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.2	3.3	0.0	15.1	0.0	0.1	0.6	0.7	0.8	1.6	0.6	0.5	0.7	0.6	0.6	0.5	0.6	1.0	0.9	0.0	1.1	0.3	0.9	30.3	13.0	63.7	19.9	4.6	13.1	9.9	1.3	0.0	17.4	1.8	10.4	122.3	6.9	4.7	1.9	1.8	2.6	15.0	2.9	1.8	1.8	0.0	0.6	0.8	153.0	3.2	0.0	24.0	0.0	54.2	0.4	0.0	13.6	0.0	0.9	1.5	10.2	0.8	3.0	8.2	4.1	2.4	0.0	0.0	0.2	6.5	0.0	0.0	3.5	0.5	10.5	1.2	0.0	8.1	0.1	22.1	4.2	36.6	6.6	1.4	3.6	46.7	33.7	8.2	11.9	67.3	0.5	0.7	4.2	8.4
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924491-7926135	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 275.1;endometrium 1: 85.7"	"Cell type enriched"	"Detected in many"	4	"Endometrial ciliated cells: 127.7"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 69.5;glioma: 56.3;ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 96.4;HEK 293: 67.5;NTERA-2: 72.4;REH: 57.3;SCLC-21H: 56.2;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	6.5	12.5	176.3	0.9	275.1	0.1	3.2	0.0	173.0	36.9	0.0	61.3	0.9	85.7	2.9	2.6	43.0	0.2	1.0	199.1	58.0	11.7	0.4	7.0	0.0	0.0	21.3	6.2	2.2	1.1	57.0	0.3	1.0	16.3	0.4	0.2	6.4	12.4	0.5	4.1	4.7	4.9	0.0	1.4	8.8	27.8	85.5	0.3	2.8	0.1	0.0	21.2	13.2	40.7	33.5	8.1	20.5	96.4	0.0	0.3	4.8	8.5	2.3	4.1	2.4	2.4	5.0	0.2	16.2	2.0	2.2	35.9	4.7	0.9	0.2	3.0	67.5	0.7	5.3	1.5	0.9	1.8	1.9	0.0	2.7	1.4	0.9	9.8	5.4	9.1	21.3	0.3	0.5	40.5	18.5	13.6	72.4	2.4	34.1	57.3	0.0	6.4	15.0	1.4	56.2	94.5	5.2	2.8	9.9	1.7	21.2	0.6	8.3	2.1	33.1	3.9	4.8	0.7	1.0	4.8	8.0	3.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.3	275.1	0.0	173.0	199.1	58.0	0.0	21.3	1.0	0.0	85.5	40.7	0.6	0.0	0.0	3.3	0.7	1.1	4.1	1.5	2.2	0.3	15.3	6.7	0.4	1.5	1.0	9.2	4.2	0.2	0.2	0.5	3.9	7.8	9.5	127.7	22.4	1.6	9.1	0.0	20.6	0.4	0.4	3.0	0.0	7.9	0.0	13.3	0.7	0.1	0.3	0.0	3.5	0.5	2.0	0.3	0.5	27.1	1.2	0.5	1.8	4.7	0.0	0.6	0.0	1.5	2.9	1.7	1.2	1.9	0.0	19.9	0.0	11.9	21.0	0.4	0.0	0.2	17.7	6.0	16.0	0.3	2.0	0.3	0.6	3.2	0.2	6.4
CUEDC1		ENSG00000180891	"CUE domain containing 1"	Q9NWM3	17	57861243-57955412	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Oligodendrocytes: 117.9;Rod photoreceptor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 21.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 21.7"	"Cell line enhanced"	"Detected in many"		"T-47d: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023050, HPA024836"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Centrosome	"HPA023050: AB_1847332, HPA024836: AB_1847333"	"unprognostic (4.46e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.77e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.04e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-2)"	20.5	19.2	19.1	13.9	29.5	8.6	17.2	23.2	22.8	31.5	20.6	40.9	7.6	24.7	7.9	32.4	32.4	19.7	38.8	16.6	22.5	25.1	6.1	21.2	7.5	29.5	27.5	9.5	19.0	11.3	21.6	11.9	24.0	24.4	10.6	30.4	30.9	26.3	86.6	11.7	13.2	25.6	21.9	10.6	23.2	3.2	27.8	5.5	18.2	39.7	5.5	31.3	21.2	33.8	27.1	81.7	83.7	15.1	13.5	24.4	2.8	18.8	37.6	38.5	27.7	15.1	100.9	0.4	74.3	36.2	32.6	21.2	9.3	40.1	13.7	52.8	15.8	0.9	58.4	12.6	32.1	0.3	6.3	25.2	23.7	22.5	18.9	33.8	18.8	0.5	1.1	0.4	35.8	15.2	1.4	0.6	2.9	30.7	22.5	2.8	21.6	4.0	25.8	17.5	34.5	18.9	7.9	8.4	32.0	14.2	116.8	2.9	24.2	101.9	63.4	28.2	42.4	0.0	0.4	0.4	44.3	3.7	83.3	0.7	0.5	2.5	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.2	1.9	21.7	0.0	0.2	19.1	29.5	23.2	22.8	16.6	22.5	29.5	27.5	24.0	21.9	27.8	33.8	14.1	19.2	5.9	22.5	0.9	4.1	15.6	6.5	13.1	47.1	11.5	11.6	16.1	17.2	10.4	22.0	64.6	0.7	30.9	6.2	7.9	20.3	0.4	24.6	6.3	10.7	3.5	0.0	4.8	26.3	0.4	15.8	10.2	22.9	0.0	10.0	3.9	3.4	17.3	10.1	13.0	4.5	18.3	11.3	7.3	2.9	6.8	12.9	5.4	30.9	4.3	31.8	0.0	31.2	117.9	27.7	2.1	5.3	0.1	21.8	0.7	8.6	17.6	64.8	6.6	26.6	15.3	0.0	1.3	19.0	2.4	0.7	0.7	1.6	4.2	17.3
CUTA	"ACHAP, C6orf82"	ENSG00000112514	"CutA divalent cation tolerance homolog"	O60888	6	33416442-33418317	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016787, HPA064369"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA		26000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Focal adhesion sites"		"CAB016787: , HPA064369: AB_2685248"	"unprognostic (7.03e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.98e-2)"	"prognostic favorable (8.50e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.55e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.74e-1)"	129.0	268.0	155.3	60.3	165.9	93.9	132.4	166.2	177.1	159.6	196.0	156.7	104.5	158.7	184.8	106.4	144.4	95.1	151.1	159.6	169.9	200.3	217.8	118.3	99.0	166.1	158.3	193.8	186.3	177.2	346.6	81.5	169.6	153.8	71.2	60.3	179.2	113.0	142.8	149.5	129.1	80.1	161.9	147.1	177.5	74.2	160.9	82.7	201.6	89.2	82.5	128.2	121.9	173.0	244.5	142.0	242.7	293.8	177.6	173.9	109.7	224.0	430.1	433.1	462.7	147.5	154.1	166.1	162.2	269.1	316.0	152.4	154.5	231.3	248.9	153.2	295.1	171.8	228.9	397.0	226.3	134.2	135.9	224.7	195.8	209.8	179.8	303.7	118.8	180.9	212.9	348.7	325.1	187.2	222.0	305.1	213.8	222.6	187.5	235.9	141.8	456.4	310.1	112.3	451.7	225.4	136.2	231.3	425.8	135.5	170.8	308.7	121.3	222.6	190.0	166.5	229.8	341.7	363.9	189.5	202.9	304.9	189.3	207.8	179.2	103.6	225.8	138.1	335.1	315.7	360.7	274.6	163.6	266.5	366.5	279.2	25.6	306.9	97.2	120.0	421.9	400.4	155.3	165.9	166.2	177.1	159.6	169.9	166.1	158.3	169.6	161.9	160.9	173.0	109.5	131.4	119.3	14.0	209.5	230.6	287.9	424.5	266.9	92.6	401.0	488.6	138.2	237.4	239.7	316.3	68.8	361.6	186.2	154.0	283.7	188.3	85.4	181.8	177.9	114.7	292.1	111.7	13.0	141.0	235.5	181.4	105.5	156.8	169.9	122.6	134.2	340.1	328.6	77.4	17.4	320.1	360.1	167.1	197.1	345.2	200.0	139.2	316.6	10.3	140.0	179.7	216.3	14.1	31.2	113.3	223.9	191.5	375.7	243.3	306.6	559.1	229.5	85.9	92.1	131.1	226.7	111.0	106.4	203.5	230.4	242.9	242.4	217.8	341.3	268.4
CX3CR1	"CCRL1, CMKBRL1, CMKDR1, GPR13, V28"	ENSG00000168329	"C-X3-C motif chemokine receptor 1"	P49238	3	39263495-39281735	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"	"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.4"	"Group enriched"	"Detected in some"	5	"Microglial cells: 177.1;NK-cells: 350.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 449.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	21	"RPMI-8226: 589.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032478, HPA046587"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB032478: AB_638830, HPA046587: AB_2679708"	"unprognostic (2.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.12e-1)"	2.3	3.8	6.2	6.9	6.4	1.1	5.1	8.6	6.0	2.7	1.7	1.1	1.2	2.7	4.2	0.8	6.1	2.6	2.4	7.7	8.4	2.5	2.0	9.9	2.1	17.3	14.8	1.6	0.7	4.5	1.0	4.6	18.9	3.5	1.1	0.5	7.6	7.2	6.5	2.3	0.9	3.5	21.5	11.9	1.4	1.8	17.4	2.0	2.4	2.2	5.3	2.4	0.3	26.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.2	6.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	24.5	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.2	0.1	589.8	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.2	0.1	16.5	0.0	0.0	0.1	0.1	0.0	0.5	1.0	0.1	0.0	28.6	0.0	7.7	99.6	1.8	264.0	261.2	3.4	0.8	55.9	145.2	94.4	0.7	19.0	122.4	20.8	39.7	449.2	7.1	1.5	232.7	6.2	6.4	8.6	6.0	7.7	8.4	17.3	14.8	18.9	21.5	17.4	26.4	0.8	0.0	0.5	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.8	3.8	0.4	0.0	0.6	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.2	0.2	0.1	3.5	0.0	2.1	0.3	0.0	0.0	0.3	0.0	0.0	5.1	0.1	0.7	0.3	4.1	0.0	0.6	0.0	0.0	15.0	28.0	0.3	0.3	43.2	0.0	177.1	50.3	0.1	350.1	2.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.7	0.2	6.6	0.4	1.3	0.7	0.2	0.0	0.6	0.0	22.6	0.1	0.1	0.0
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011032, HPA042299"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum, Plasma membrane"		"HPA011032: , HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favorable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favorable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	19.0	21.7	17.4	6.1	17.3	4.3	18.2	17.4	20.1	15.9	14.2	10.7	15.2	15.6	28.5	10.9	18.7	16.3	14.0	16.7	19.6	25.5	29.0	9.7	9.3	18.1	17.6	20.8	19.7	30.9	24.1	10.8	17.8	13.5	7.4	9.2	20.0	17.6	16.2	14.4	12.1	8.4	17.6	9.6	16.0	29.3	17.9	10.2	22.7	14.9	7.2	12.9	11.7	18.7	16.2	21.6	11.8	12.7	74.7	22.5	5.2	15.7	31.5	11.0	10.9	6.3	10.3	5.3	13.6	17.4	9.2	22.5	4.9	7.1	4.4	17.9	25.7	5.0	13.5	10.5	13.7	2.1	9.5	28.8	17.0	6.2	11.7	22.3	20.1	11.5	5.1	31.2	8.3	20.6	7.8	3.4	4.3	13.7	11.5	9.2	10.6	12.5	25.1	8.5	9.3	8.1	17.2	9.9	23.5	13.1	25.6	3.2	28.5	15.7	4.0	14.5	8.0	5.8	4.9	3.9	19.9	4.5	6.2	0.6	10.8	13.6	5.9	9.2	6.7	8.1	9.3	7.4	10.5	7.1	8.6	8.0	9.5	5.5	8.7	11.3	11.2	8.2	17.4	17.3	17.4	20.1	16.7	19.6	18.1	17.6	17.8	17.6	17.9	18.7	57.4	12.8	10.3	9.1	17.2	53.7	18.4	36.0	12.5	26.9	35.4	36.7	9.8	45.8	21.8	31.3	58.4	55.7	11.4	18.5	52.8	34.3	28.5	36.6	20.0	34.4	13.8	33.3	7.6	27.0	29.1	23.8	19.4	23.4	11.4	22.3	41.0	32.9	21.4	40.4	10.4	16.0	36.7	24.0	23.8	30.6	28.9	17.3	14.2	4.7	15.4	37.6	15.5	8.5	10.0	26.9	18.9	28.6	17.6	8.3	39.7	55.7	38.5	30.4	0.0	15.2	20.1	130.3	29.2	9.5	42.9	38.6	15.8	39.3	16.6	15.8
CYBC1	"C17orf62, Eros, FLJ90469, MGC4368"	ENSG00000178927	"Cytochrome b-245 chaperone 1"	Q9BQA9	17	82442586-82450829	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Chaperone	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 47.4;Ductal cells: 39.7;Granulosa cells: 56.1;Hofbauer cells: 80.2;monocytes: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045696	Uncertain		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Cell Junctions"	"HPA045696: AB_2679421"	"unprognostic (1.87e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.81e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.83e-11)"	"unprognostic (1.47e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.14e-3)"	39.2	35.7	34.4	70.1	36.1	37.2	37.4	36.7	42.6	40.9	36.3	33.8	24.6	33.7	23.7	34.1	34.9	46.0	30.7	33.2	35.6	51.2	64.9	41.4	110.5	41.8	37.8	33.8	45.0	24.5	25.9	30.7	37.7	43.4	27.7	9.9	30.8	23.2	14.9	29.4	49.3	40.7	37.1	117.4	36.9	17.8	36.7	63.3	28.9	13.6	72.1	49.7	28.2	40.6	48.5	67.4	37.1	61.4	57.9	60.6	35.0	42.2	51.6	61.8	73.1	26.2	47.8	122.4	37.8	60.6	75.4	48.3	25.7	32.4	42.6	87.4	21.1	33.4	19.2	30.6	59.3	38.1	94.4	68.5	45.7	53.1	29.3	59.0	81.5	90.3	28.4	88.2	52.9	50.8	160.2	33.0	27.5	65.0	35.3	120.1	22.7	93.1	44.8	60.7	31.7	60.7	77.0	88.1	55.7	66.3	91.4	148.3	27.9	46.7	46.0	79.3	45.9	157.8	58.3	93.1	61.2	61.0	42.5	223.8	136.7	182.9	96.3	181.3	74.7	114.8	88.2	93.6	125.2	115.9	73.0	71.1	300.6	104.5	169.4	130.9	101.1	161.4	34.4	36.1	36.7	42.6	33.2	35.6	41.8	37.8	37.7	37.1	36.7	40.6	35.6	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	19.0	17.1	0.0	0.0	0.0	22.0	0.0	27.6	47.4	0.0	9.8	39.7	0.0	11.9	21.9	12.9	0.0	0.0	0.0	33.6	36.1	10.9	0.0	12.4	0.0	56.1	0.0	0.0	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	54.8	0.0	0.0	0.0	0.0	34.9	0.0	0.0	11.1	0.0	0.0	19.6	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	27.6	19.5	23.8	0.0	0.0
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153446-54173986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 18.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"A549: 411.5;Hep G2: 122.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022261, HPA063771"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.0	0.0	0.2	0.4	0.4	0.0	3.7	0.0	0.3	1.7	0.0	0.0	0.1	14.9	0.2	3.8	0.2	0.0	0.0	0.1	1.8	35.3	0.4	0.7	0.2	0.4	2.0	0.0	0.0	0.0	0.2	10.0	0.3	2.9	0.0	0.0	0.3	2.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.2	1.3	0.0	10.5	28.7	1.3	0.2	0.5	411.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.6	0.0	3.2	0.0	0.9	15.8	0.0	0.1	0.1	0.0	0.0	0.0	6.5	122.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	7.0	1.3	0.0	2.6	0.6	0.0	0.1	0.1	0.0	0.0	0.0	16.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.1	1.8	0.4	2.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	1.3	22.8	48.3	142.7	74.0	0.0	11.0	8.6	0.4	0.0	47.0	0.0	0.0	0.1	0.1	0.1	5.9	0.1	0.0	0.7	0.5	0.3	0.0	0.0	0.2	0.0	0.1	2.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	9.8	0.0	61.3	13.1	0.0	0.0	0.0	0.6	0.0	0.0	3.3	19.6	0.1	0.1	0.0	0.2	36.7
DAAM1	KIAA0666	ENSG00000100592	"Dishevelled associated activator of morphogenesis 1"	Q9Y4D1	14	59188646-59371405	"Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 467.3;Suprabasal keratinocytes: 332.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026605, HPA064789"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA		9700	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA026605: AB_1847464, HPA064789: AB_2685352"	"unprognostic (2.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	14.5	6.2	13.0	6.8	13.6	5.4	10.4	12.6	12.8	13.6	22.8	13.5	4.8	13.5	5.6	19.0	7.7	5.9	19.3	11.8	14.8	6.9	12.6	10.5	11.1	7.9	8.1	8.0	9.3	20.6	5.3	9.1	8.3	11.9	8.5	24.9	9.4	11.0	5.6	30.9	7.2	10.9	7.8	13.1	7.0	6.9	11.2	4.8	7.4	4.7	15.6	9.5	15.1	10.7	18.2	1.9	13.1	3.5	7.8	5.8	17.1	2.5	2.3	4.7	4.8	9.4	16.6	20.4	4.4	5.6	9.6	39.7	11.8	10.0	4.0	9.0	4.1	6.8	4.8	11.8	4.8	7.9	3.8	3.9	10.6	3.9	4.7	10.8	11.3	10.2	11.9	9.9	2.8	17.0	6.9	4.9	7.5	12.9	5.6	6.3	11.1	2.0	6.8	13.5	20.3	4.8	15.8	23.1	16.1	8.7	30.5	2.1	10.8	3.9	7.4	8.4	2.2	2.2	2.7	22.1	5.0	1.5	8.7	7.7	2.0	2.6	2.3	2.4	3.0	10.8	3.0	2.3	2.2	4.6	2.4	2.6	2.8	6.7	3.5	18.3	4.0	1.9	13.0	13.6	12.6	12.8	11.8	14.8	7.9	8.1	8.3	7.8	11.2	10.7	62.2	35.3	27.0	160.6	37.8	467.3	172.4	128.6	30.7	110.7	56.8	40.6	149.3	38.6	82.3	29.5	308.6	33.0	66.9	47.0	23.5	63.8	40.0	68.4	142.9	71.9	87.7	140.0	143.7	93.1	27.6	67.3	21.9	54.6	26.0	155.2	102.4	47.2	32.8	195.2	202.0	56.7	73.2	16.3	55.8	16.6	60.3	36.1	90.7	66.5	25.2	96.5	16.5	74.9	24.3	191.4	45.1	74.1	30.8	104.2	24.7	12.8	102.4	168.7	32.9	84.6	66.3	51.3	46.3	52.8	332.0	34.2	25.1	25.1	38.1	84.2
DAW1	"FLJ25955, ODA16, WDR69"	ENSG00000123977	"Dynein assembly factor with WD repeats 1"	Q8N136	2	227871054-227924344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 25.7;fallopian tube: 32.6;testis: 51.3"	"Group enriched"	"Detected in some"	13	"Early spermatids: 106.7;Late spermatids: 215.3;Respiratory ciliated cells: 113.9;Spermatocytes: 177.1"	"Cancer enhanced"	"Detected in some"		"lung cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HUVEC TERT2: 21.8;U-2197: 40.7"	"Low region specificity"	"Detected in many"							HPA046118	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Plasma membrane"	"HPA046118: AB_10961428"		"unprognostic (1.23e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.37e-1)"		"unprognostic (1.23e-1)"	"unprognostic (5.63e-3)"	"unprognostic (2.90e-2)"	"unprognostic (9.92e-3)"		"unprognostic (1.54e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-1)"	0.6	0.0	4.3	0.1	5.3	0.3	0.4	2.9	4.7	0.7	25.7	0.2	0.0	0.1	0.3	0.5	32.6	0.3	0.5	4.5	4.5	0.2	0.4	3.0	0.2	7.3	8.8	0.1	0.0	0.2	0.2	0.8	5.5	0.0	0.0	0.7	0.1	0.0	3.6	0.2	0.0	0.1	6.8	0.2	0.1	51.3	5.4	0.4	0.1	0.0	0.2	0.1	0.0	5.4	0.8	0.0	0.1	0.0	0.3	1.2	0.6	0.8	0.4	0.9	0.6	5.4	0.5	0.2	0.0	0.2	8.8	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.7	0.0	1.0	0.7	5.8	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.1	0.3	0.1	0.2	0.4	0.1	0.8	0.0	0.0	0.2	0.0	0.5	2.2	0.2	2.0	40.7	0.0	0.0	0.1	0.3	3.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.3	2.9	4.7	4.5	4.5	7.3	8.8	5.5	6.8	5.4	5.4	0.0	0.0	1.1	0.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.7	0.0	11.5	0.0	4.2	0.2	0.0	0.0	0.0	0.2	106.7	11.2	0.0	0.2	0.0	0.0	6.2	0.0	2.8	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	8.2	0.0	0.0	215.3	3.4	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.1	3.0	0.2	2.6	0.0	0.1	0.0	0.1	113.9	0.3	0.0	0.7	2.1	177.1	4.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0
DBN1	D0S117E	ENSG00000113758	"Drebrin 1"	Q16643	5	177456608-177474401	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 87.1;Pancreatic endocrine cells: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 5.8;granulocytes: 9.4;T-cells: 14.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051452, HPA056940"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA		2000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Actin filaments"		"HPA051452: AB_2681489, HPA056940: AB_2683279"	"unprognostic (3.81e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.57e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (8.28e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-3)"	59.4	9.3	44.8	17.6	52.5	6.4	36.5	19.3	71.7	59.7	18.6	67.6	9.5	84.4	10.2	30.9	44.7	24.4	39.7	70.1	45.4	52.0	4.0	24.7	9.0	33.8	25.4	34.8	16.9	17.1	45.8	7.1	32.3	29.7	5.9	5.5	33.1	23.9	27.6	36.6	25.0	28.6	24.0	14.2	47.4	27.0	39.7	14.6	33.4	9.0	4.4	61.0	33.1	35.5	17.4	56.1	182.0	319.1	42.4	66.2	56.5	198.6	50.3	113.4	94.5	193.9	59.0	0.3	139.5	155.1	39.0	27.0	80.9	144.0	53.6	5.2	70.4	111.6	72.9	82.0	149.3	43.0	20.5	87.1	37.1	127.3	38.0	113.3	189.4	131.4	54.0	26.0	84.2	25.1	115.1	63.8	264.1	5.7	123.4	338.1	197.2	34.5	85.3	23.7	213.7	289.8	67.0	28.8	111.5	58.4	78.7	42.6	298.6	126.7	169.3	28.2	94.9	6.3	3.1	177.5	53.2	40.5	80.5	9.4	1.4	1.1	10.3	0.8	14.0	0.3	0.3	7.2	1.8	0.4	0.4	5.2	3.2	0.3	0.8	5.8	0.2	2.2	44.8	52.5	19.3	71.7	70.1	45.4	33.8	25.4	32.3	24.0	39.7	35.5	44.2	3.2	1.5	8.1	1.2	10.3	13.7	24.6	9.1	7.0	7.6	9.1	5.1	2.8	11.1	9.2	4.2	1.0	4.5	1.4	1.9	87.1	16.9	8.4	44.0	43.2	40.7	4.8	15.7	43.4	2.8	56.1	11.7	18.4	10.8	49.4	20.7	0.0	1.7	42.1	13.0	2.4	40.7	1.8	8.9	41.6	50.1	6.1	8.8	2.8	2.4	13.4	1.0	5.0	1.0	64.5	0.6	41.0	4.0	16.9	0.6	6.3	5.2	4.5	19.7	10.8	43.4	6.5	26.7	20.1	7.2	0.8	10.4	8.1	3.9	7.5
DCAF16	"C4orf30, FLJ20280"	ENSG00000163257	"DDB1 and CUL4 associated factor 16"	Q9NXF7	4	17800655-17810758	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042487	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA042487: AB_10795505"	"unprognostic (2.23e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.40e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-3)"	"prognostic favorable (7.67e-4)"	9.6	8.2	4.5	8.0	7.0	18.1	13.0	6.4	6.7	12.8	2.9	10.4	7.9	13.8	10.2	7.9	11.9	6.6	8.4	4.2	7.4	9.2	4.8	9.1	11.9	6.1	5.8	19.4	11.3	12.3	13.3	9.8	5.7	10.6	9.5	13.3	10.9	7.9	8.2	15.0	10.2	8.9	4.5	8.9	8.8	10.9	7.8	12.0	10.1	4.4	11.4	10.0	10.2	9.4	21.7	4.6	24.3	25.5	6.8	11.9	13.2	13.9	16.3	16.2	19.1	13.1	17.2	24.2	10.8	12.9	13.1	10.7	14.4	14.7	23.9	8.3	13.2	34.2	16.0	21.5	16.3	30.4	13.4	15.5	11.8	20.6	20.3	10.8	11.3	23.6	37.4	39.3	9.4	8.2	33.4	29.0	20.0	6.3	13.1	35.0	27.8	15.7	7.1	16.9	36.0	28.9	14.8	3.9	16.9	12.2	14.3	8.1	14.5	18.7	14.7	20.8	17.8	17.3	7.4	29.4	15.4	20.6	12.8	7.8	1.4	2.1	2.5	1.6	3.3	2.0	2.7	2.8	0.9	2.9	3.4	3.2	1.0	2.1	1.1	1.8	2.1	1.3	4.5	7.0	6.4	6.7	4.2	7.4	6.1	5.8	5.7	4.5	7.8	9.4	11.6	19.2	24.8	13.1	17.6	25.4	24.3	9.4	25.6	12.2	16.3	16.9	21.9	12.8	14.4	9.2	6.2	17.6	27.0	8.6	13.7	9.9	19.6	12.9	18.4	13.0	17.5	21.7	20.2	7.7	10.0	15.9	14.3	13.3	17.1	24.8	11.4	6.4	7.7	15.2	20.2	12.5	14.2	11.9	11.3	11.5	21.1	9.4	10.6	15.0	10.2	27.5	7.2	29.1	36.7	11.8	7.6	22.2	27.6	14.6	9.2	5.1	17.1	14.6	13.1	21.7	16.2	28.8	17.3	19.5	21.2	12.3	20.3	19.0	13.9	19.2
DCBLD2	"CLCP1, ESDN"	ENSG00000057019	"Discoidin, CUB and LCCL domain containing 2"	Q96PD2	3	98795941-98901695	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 83.8;Oligodendrocyte precursor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 455.0;hTERT-RPE1: 648.9;LHCN-M2: 776.8;RPTEC TERT1: 479.0;U-87 MG: 581.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016909	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		2200000		"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA016909: AB_1847510"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-3)"	"unprognostic (9.29e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.32e-5)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.59e-3)"	12.2	13.3	4.0	4.5	3.8	1.2	8.2	8.1	5.8	8.3	6.6	11.5	2.8	14.6	8.0	6.4	14.5	12.5	27.6	3.4	5.9	11.0	9.8	11.5	3.6	6.5	6.9	17.8	5.8	13.2	6.6	8.0	26.7	11.5	7.0	22.4	10.1	14.9	5.2	8.3	4.1	16.3	4.8	1.6	6.5	23.8	7.3	6.9	15.7	8.4	3.9	7.8	5.1	5.0	55.3	397.0	52.3	41.2	67.8	160.1	22.7	122.0	57.9	81.4	91.9	33.9	171.6	0.1	373.7	211.5	249.0	50.3	24.1	198.8	186.2	0.8	8.4	19.4	12.1	51.5	41.6	9.3	8.7	63.8	30.3	234.3	455.0	648.9	54.6	7.1	4.0	5.0	776.8	14.6	7.7	5.5	36.5	0.4	135.6	8.1	98.2	4.8	479.0	14.4	14.0	24.3	33.5	6.9	145.9	35.2	26.4	7.3	90.4	208.0	166.6	53.8	433.0	6.3	9.7	7.4	581.3	3.4	92.8	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.0	3.8	8.1	5.8	3.4	5.9	6.5	6.9	26.7	4.8	7.3	5.0	5.9	32.1	52.8	18.3	2.7	22.8	15.5	18.2	17.1	12.9	15.5	16.3	83.8	17.2	19.0	18.4	77.2	12.4	1.6	4.3	0.0	30.5	3.1	32.2	39.5	7.7	3.6	5.9	51.6	8.0	9.7	33.8	6.1	38.3	38.0	52.2	6.8	20.5	4.0	13.5	51.3	8.0	20.3	3.2	6.2	5.8	22.1	4.0	8.8	25.3	1.4	40.9	2.1	88.4	38.9	26.3	4.6	50.4	1.6	11.9	0.7	7.9	22.8	48.9	0.0	12.3	31.3	15.8	24.2	14.1	15.6	4.0	1.8	34.4	8.2	7.1
DCHS1	"CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16"	ENSG00000166341	"Dachsous cadherin-related 1"	Q96JQ0	11	6621330-6655809	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 34.8;Endometrial stromal cells: 17.3;Endothelial cells: 29.0;Fibroblasts: 17.0;Granulosa cells: 19.3;Hepatic stellate cells: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 33.5;HUVEC TERT2: 47.1;REH: 23.5;SH-SY5Y: 32.4;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017970, HPA050246"	Approved		Approved	"Plasma membrane"		NA	NA		4000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA017970: AB_2669718, HPA050246: AB_2681062"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.52e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (5.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-3)"	9.4	2.5	7.4	8.4	6.8	0.7	9.3	6.1	6.3	19.5	0.9	19.0	4.1	28.9	2.4	5.0	13.2	8.3	9.2	6.6	10.1	4.6	2.0	10.1	4.0	7.6	6.3	11.6	3.3	2.0	3.2	10.1	5.7	9.3	3.4	0.6	3.5	11.5	4.2	3.7	8.3	16.2	4.7	12.9	8.2	3.0	8.7	3.8	4.1	4.6	2.2	14.8	9.3	3.8	0.0	0.1	33.5	0.1	0.0	0.1	0.3	1.2	8.7	5.4	6.0	0.3	0.0	0.1	5.1	9.9	0.4	0.0	2.7	0.1	3.7	0.1	0.9	0.7	0.0	0.0	0.3	0.2	0.0	1.0	0.1	2.5	0.0	0.0	47.1	0.1	0.2	0.0	2.0	0.0	1.2	0.6	5.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	2.4	32.4	0.0	0.3	0.2	3.5	0.0	1.3	20.4	0.1	10.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	7.4	6.8	6.1	6.3	6.6	10.1	7.6	6.3	5.7	4.7	8.7	3.8	34.8	0.0	0.5	12.1	0.2	2.9	0.3	0.0	0.0	1.5	1.7	3.0	3.8	4.3	0.0	0.0	0.0	0.2	1.4	0.2	0.0	1.0	3.1	0.8	17.3	29.0	0.0	2.7	2.0	0.4	0.3	17.0	1.1	0.7	0.0	19.3	61.1	0.2	2.2	0.0	7.4	0.7	0.0	4.7	4.2	3.4	1.2	2.4	16.0	4.7	0.2	0.9	0.0	10.1	1.4	0.1	0.1	1.9	0.2	0.3	0.1	0.1	0.0	0.5	0.0	7.4	4.9	4.9	0.6	0.5	1.7	0.3	1.2	4.6	1.1	0.1
DCHS2	"CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ"	ENSG00000197410	"Dachsous cadherin-related 2"	Q6V1P9	4	154231742-154491799	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 63.0;Early spermatids: 20.7;Excitatory neurons: 30.3;Horizontal cells: 25.2;Inhibitory neurons: 13.2;Late spermatids: 19.4;Microglial cells: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"U-2 OS: 4.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA064159	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Plasma membrane"		"HPA064159: AB_2685201"	"unprognostic (1.38e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-3)"	0.0	0.1	0.6	0.0	0.8	0.0	0.1	0.3	0.5	0.9	0.0	1.7	0.0	1.4	0.0	0.0	0.9	0.1	0.0	0.4	0.8	0.1	0.0	0.1	0.0	0.5	1.3	0.7	0.0	0.0	0.6	0.0	0.3	0.4	0.0	0.1	0.1	0.2	0.0	0.2	0.3	0.1	0.7	0.0	1.2	1.1	1.1	0.0	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.5	0.4	0.8	0.5	1.3	0.3	0.7	1.1	1.4	0.0	0.0	0.0	63.0	0.0	0.4	0.2	0.8	0.0	0.4	0.8	0.6	1.9	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.7	0.1	0.5	0.3	6.7	0.0	30.3	0.0	0.0	1.8	3.6	0.0	0.0	1.2	0.0	0.0	0.1	25.2	13.2	0.1	0.0	0.0	0.7	19.4	0.6	0.0	0.0	13.1	0.0	0.2	0.0	6.6	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.2	0.0	0.3	0.5	1.7	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0
DCUN1D2	"C13orf17, FLJ10704, FLJ20092"	ENSG00000150401	"Defective in cullin neddylation 1 domain containing 2"	Q6PH85	13	113455819-113490951	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.6;skeletal muscle: 108.7;tongue: 69.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 79.6;Excitatory neurons: 43.9;Inhibitory neurons: 37.9;Oligodendrocytes: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 11.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 11.3"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 54.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039349	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA039349: AB_10673240"	"unprognostic (3.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.43e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.21e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.25e-2)"	8.1	8.4	9.7	4.4	8.8	14.0	7.6	23.4	14.6	8.9	30.1	9.2	4.6	9.4	9.4	6.4	7.7	5.4	98.6	8.5	9.7	8.3	8.5	7.7	7.2	12.6	9.9	8.1	7.1	5.9	10.5	7.4	13.4	7.5	6.4	16.8	9.0	4.8	108.7	14.4	8.3	7.4	8.5	9.4	8.3	9.0	10.2	8.1	4.5	69.1	7.3	7.0	7.4	15.3	13.3	7.5	13.0	9.5	9.8	8.3	10.6	10.0	11.4	9.0	10.8	27.4	7.3	9.8	3.4	11.3	13.9	17.2	13.8	7.1	12.5	6.7	23.4	15.6	40.9	7.5	6.0	24.5	11.2	12.0	11.6	9.8	9.0	6.2	8.3	12.9	9.2	8.4	8.6	9.0	16.6	38.1	8.9	9.7	11.8	16.9	20.8	11.2	6.4	8.3	54.7	12.2	6.9	24.6	7.0	8.8	14.1	10.6	12.7	11.3	16.4	9.0	14.3	25.5	11.4	19.2	25.3	10.4	7.7	11.3	1.5	2.2	2.0	1.0	2.5	1.9	1.8	1.4	1.6	0.9	1.8	0.9	0.8	1.9	1.5	0.2	2.0	1.5	9.7	8.8	23.4	14.6	8.5	9.7	12.6	9.9	13.4	8.5	10.2	15.3	7.6	16.0	15.6	27.4	2.4	5.9	2.0	2.3	1.8	9.0	6.7	4.3	79.6	0.0	8.4	3.7	16.7	2.4	2.5	4.8	1.9	1.7	5.9	5.0	6.5	7.1	6.6	3.0	43.9	1.3	1.4	6.6	8.2	6.0	5.1	4.6	5.7	3.9	1.4	18.5	37.9	4.4	0.0	3.5	4.4	8.3	7.2	4.2	5.4	18.7	2.2	4.8	3.1	30.2	42.8	2.1	1.3	5.7	2.0	3.7	3.4	2.5	4.6	9.6	0.0	3.5	3.7	3.8	4.2	4.3	7.4	2.6	3.5	5.2	3.9	3.2
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 131.8;kidney: 124.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 364.4;Excitatory neurons: 197.4;Oligodendrocyte precursor cells: 182.4;Proximal tubular cells: 283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 239.4;LHCN-M2: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		350000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	10.3	28.6	95.9	12.8	100.9	0.6	18.8	61.5	131.8	22.4	73.4	45.1	40.1	10.8	76.5	12.6	36.5	25.5	17.4	102.0	77.3	124.8	79.5	26.4	2.6	58.6	84.8	2.9	27.5	21.1	6.3	11.6	62.6	28.5	45.3	34.6	17.7	18.6	30.4	5.6	39.7	16.5	59.5	10.6	29.7	19.1	106.6	1.0	28.9	14.0	2.0	19.2	2.6	80.3	63.1	7.6	36.0	6.9	84.1	78.0	9.2	155.9	120.0	63.6	75.6	89.9	16.5	0.1	39.2	239.4	38.3	17.8	79.7	15.0	93.0	0.3	29.5	0.2	22.3	31.8	40.9	57.6	3.2	60.5	2.0	50.4	24.9	85.5	75.9	0.0	0.1	6.0	179.7	7.5	3.0	0.3	25.5	124.6	22.6	0.0	63.1	0.9	113.4	46.3	59.2	115.0	18.0	56.3	9.1	38.7	29.6	4.9	107.7	31.6	27.0	11.7	57.8	0.0	0.1	0.2	1.6	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	100.9	61.5	131.8	102.0	77.3	58.6	84.8	62.6	59.5	106.6	80.3	14.1	35.3	43.4	364.4	2.6	13.8	4.6	6.8	5.7	4.5	31.2	13.8	11.8	61.5	13.6	69.9	4.2	2.7	0.4	75.3	125.2	15.9	22.5	36.9	9.8	7.5	34.2	2.7	197.4	31.2	0.9	13.9	47.9	24.2	0.0	59.3	8.2	102.8	1.1	0.0	51.0	86.9	8.2	2.2	5.5	25.6	15.8	2.4	12.4	23.4	0.6	68.4	0.0	182.4	9.6	44.5	69.4	74.9	0.0	33.6	68.7	283.3	36.5	9.4	13.1	15.3	18.6	4.6	5.4	32.6	14.3	0.8	2.5	13.5	106.7	8.3
DDIAS	"C11orf82, FLJ25416, FLJ38838, noxin"	ENSG00000165490	"DNA damage induced apoptosis suppressor"	Q8IXT1	11	82899975-82958277	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.9;testis: 10.8"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 8.2;Spermatocytes: 17.2;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038540, HPA038541"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA038540: AB_10672648, HPA038541: AB_2676071"	"unprognostic (2.53e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.86e-6)"	"unprognostic (4.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.04e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.11e-16)"	"unprognostic (7.17e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.13e-2)"	0.9	0.4	0.6	3.3	0.9	7.9	2.1	0.9	1.0	0.7	0.4	1.8	1.6	1.2	1.0	2.9	0.5	0.7	0.5	0.8	0.4	0.4	1.2	3.4	4.4	0.8	0.8	0.5	0.9	0.1	0.1	1.9	0.7	0.5	2.2	0.5	0.8	0.4	1.0	2.2	1.5	1.8	0.5	2.9	0.9	10.8	0.8	5.3	0.4	0.9	6.2	3.5	0.9	1.8	13.6	22.6	21.0	15.2	1.9	3.1	15.3	25.4	10.5	26.8	31.0	22.4	16.2	16.1	36.1	5.7	21.6	24.7	36.0	15.5	36.8	30.7	19.7	23.1	10.6	9.1	0.2	28.6	19.7	0.7	1.4	33.8	15.6	2.3	12.8	20.5	23.9	27.0	23.9	19.6	27.0	23.2	25.1	36.5	24.4	20.0	40.5	20.6	5.7	23.3	15.6	21.5	15.2	15.6	5.7	20.2	16.5	11.7	6.0	26.7	35.9	71.1	30.4	15.4	44.3	56.4	8.4	20.2	26.3	0.7	10.3	4.1	0.5	7.9	0.2	1.1	0.3	0.7	4.5	1.7	0.6	0.4	5.5	2.2	8.5	1.4	0.5	3.2	0.6	0.9	0.9	1.0	0.8	0.4	0.8	0.8	0.7	0.5	0.8	1.8	0.3	0.0	0.0	0.0	4.3	0.0	0.6	0.0	1.8	0.0	1.1	1.1	0.9	1.5	0.0	0.0	0.0	2.7	1.0	0.6	0.0	0.9	4.2	1.0	0.6	0.8	0.0	6.5	0.6	0.6	5.5	0.8	1.1	1.2	0.0	2.5	0.7	0.7	2.5	0.0	0.3	0.7	0.0	6.4	0.0	1.9	0.3	3.5	0.0	1.9	4.5	0.0	4.1	0.5	0.6	0.5	0.1	0.7	8.2	0.7	0.3	0.3	0.0	0.0	0.0	0.8	1.1	17.2	18.2	5.4	0.0	0.3	1.5	0.5	1.6	0.9
DDX4	VASA	ENSG00000152670	"DEAD-box helicase 4"	Q9NQI0	5	55738017-55817157	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"testis: 149.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 565.1;Late spermatids: 184.1;Spermatocytes: 320.9"	"Cancer enriched"	"Detected in single"	37	"testis cancer: 3.0"	"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;PC-3: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026170, HPA037763, HPA037764"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.54e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.43e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.55e-1)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	149.7	0.3	0.3	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.2	0.1	0.3	0.1	0.2	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	565.1	0.0	0.0	0.4	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	12.2	0.0	0.0	184.1	5.6	0.5	0.0	1.0	0.0	0.0	0.0	1.5	8.7	0.1	0.0	3.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	320.9	83.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX58	"DKFZp434J1111, FLJ13599, RIG-1, RIG-I, RIG1"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455302-32526208	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 79.0;BJ hTERT+ SV40 Large T+ RasG12V: 76.0;GAMG: 22.8"									"CAB012643, HPA047193, HPA073217"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB012643: , HPA047193: AB_2679978, HPA073217: "	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	6.3	4.9	3.5	7.5	2.9	1.3	6.0	3.0	4.3	7.1	3.1	6.3	2.9	5.6	4.7	6.4	4.4	6.0	4.1	2.7	3.6	5.5	6.3	7.1	7.4	5.2	3.7	4.6	5.7	2.5	5.2	5.7	4.0	4.2	5.3	2.3	10.0	3.5	4.8	7.8	7.1	5.7	6.5	9.2	4.8	2.8	3.6	15.6	4.3	1.7	5.2	5.1	5.3	2.9	4.3	2.4	2.5	2.2	7.5	6.4	2.7	2.1	14.6	79.0	76.0	2.4	1.4	0.4	2.7	2.7	22.8	2.8	2.3	1.3	11.4	7.4	0.9	1.1	2.4	3.5	5.0	1.4	4.5	4.9	1.3	6.9	1.3	4.2	14.3	1.5	1.8	1.0	6.6	0.6	3.8	12.4	1.8	0.6	2.0	2.4	3.1	0.0	11.6	0.6	2.0	0.3	1.7	1.7	12.6	1.7	3.5	0.9	13.4	1.5	0.9	1.7	1.1	0.0	0.3	0.9	2.6	3.3	2.1	0.0	0.1	0.3	0.2	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.2	0.2	1.3	0.4	0.2	0.0	0.2	0.0	3.5	2.9	3.0	4.3	2.7	3.6	5.2	3.7	4.0	6.5	3.6	2.9	41.7	22.4	8.8	20.5	13.9	4.2	5.1	7.2	13.6	4.1	5.8	5.1	5.1	5.7	6.7	1.8	2.1	5.6	13.9	13.8	0.0	19.5	2.7	12.9	8.7	23.6	3.0	5.7	10.4	12.2	7.6	13.9	21.9	20.3	5.1	16.8	9.3	6.7	5.6	6.7	13.2	4.6	4.1	7.3	4.6	0.4	6.5	11.6	0.0	39.4	12.3	6.4	21.6	31.2	17.5	16.2	7.7	6.0	9.1	4.9	16.9	7.2	7.3	2.5	6.6	16.8	13.1	0.5	2.3	10.9	5.4	2.5	17.8	10.4	2.6	5.3
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 32.8;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 44.0"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	6.9	2.8	2.9	15.8	3.1	51.1	5.8	2.4	4.4	6.6	3.5	9.1	8.7	6.7	2.1	3.2	5.4	9.2	3.5	2.4	5.0	2.2	8.2	10.1	9.6	9.6	3.9	5.3	3.1	3.0	0.4	20.7	5.5	3.8	9.0	6.3	9.0	3.2	1.0	3.0	11.0	7.4	9.3	12.8	13.5	2.2	7.8	15.5	3.5	3.6	7.3	5.9	0.7	5.7	12.3	7.1	2.7	1.1	6.9	19.9	13.3	12.0	25.3	44.0	30.4	0.1	28.0	0.2	0.6	12.2	23.9	4.7	1.2	7.3	12.8	7.0	1.0	27.0	8.1	0.7	8.4	11.1	6.5	5.6	2.1	15.9	1.4	9.2	31.5	6.0	0.5	0.3	28.6	0.3	10.0	7.0	0.6	1.1	5.9	5.4	6.1	0.0	4.2	7.1	0.5	3.6	21.4	2.6	12.2	0.5	1.9	15.3	34.1	2.4	15.6	5.6	4.2	11.2	1.9	0.1	7.8	32.2	3.4	2.4	5.9	5.4	3.7	9.1	5.1	1.2	3.7	3.8	3.6	2.0	2.9	3.3	32.8	2.7	13.1	0.0	5.5	2.5	2.9	3.1	2.4	4.4	2.4	5.0	9.6	3.9	5.5	9.3	7.8	5.7	29.0	9.6	6.7	11.4	14.7	1.0	2.6	3.9	3.4	1.7	11.2	3.3	8.3	2.8	5.1	3.7	22.9	6.1	16.0	24.0	0.0	7.6	15.7	8.5	15.6	18.9	0.0	5.9	1.5	10.1	39.4	13.0	44.4	7.1	8.8	20.3	6.1	6.6	26.1	0.0	5.5	14.1	10.2	23.8	6.0	4.4	3.4	46.2	0.0	33.7	35.6	2.9	24.7	28.6	2.4	26.4	31.5	4.1	6.0	2.1	13.2	3.7	11.5	19.4	6.6	7.1	5.7	0.7	1.4	4.3	2.4	7.1	24.1	12.2	4.5	2.0
DENND10	FAM45A	ENSG00000119979	"DENN domain containing 10"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 36.5;Cytotrophoblasts: 53.8;Extravillous trophoblasts: 27.7;Hofbauer cells: 56.0;Syncytiotrophoblasts: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	16.7	14.3	18.7	14.0	20.2	32.4	14.0	18.7	23.6	14.2	17.4	17.9	12.6	13.3	16.7	20.5	11.4	12.7	15.5	18.8	19.2	26.1	31.1	12.6	13.1	19.8	18.9	20.9	9.4	18.0	2.9	15.6	19.8	13.4	14.4	10.6	10.9	10.6	17.6	18.7	15.2	13.2	19.8	14.1	14.2	7.3	19.3	13.1	19.9	11.1	14.6	14.8	9.3	21.7	23.7	24.9	38.6	45.5	75.9	59.1	15.9	32.3	85.9	29.4	30.1	23.7	35.8	16.1	12.8	41.4	33.8	42.2	25.7	28.0	27.0	29.2	24.1	3.8	11.5	32.9	75.4	11.0	10.3	63.7	31.5	20.9	32.6	75.0	36.1	16.8	7.8	22.9	42.0	20.0	17.2	48.5	23.6	22.1	14.6	17.0	40.6	14.3	38.6	25.9	6.9	27.7	21.7	30.2	67.5	36.1	24.9	48.5	36.6	23.3	12.3	28.9	19.4	23.0	10.0	17.7	35.9	54.7	11.2	44.9	26.6	55.6	6.9	31.8	6.6	3.9	10.9	10.0	16.6	3.6	5.7	7.1	40.0	6.1	36.4	5.0	20.4	11.6	18.7	20.2	18.7	23.6	18.8	19.2	19.8	18.9	19.8	19.8	19.3	21.7	9.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	53.8	11.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	27.7	9.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	45.3	1.7	0.0	0.0	0.0
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472529	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		8700	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	13.3	12.6	15.0	12.0	18.0	6.5	12.6	19.7	16.5	11.1	14.2	11.3	12.1	11.7	9.8	16.7	13.0	10.8	12.1	14.9	17.2	16.8	13.2	11.3	12.4	17.4	18.7	15.3	11.4	18.0	9.2	20.1	17.5	11.8	12.2	12.2	10.9	12.3	12.3	10.9	11.1	16.1	16.1	10.7	12.1	9.8	18.3	13.3	12.3	13.9	16.2	14.4	10.1	18.3	37.8	36.8	31.0	35.4	25.7	24.3	15.1	52.5	33.6	53.4	39.6	88.4	48.4	79.9	33.1	44.5	29.7	30.3	60.5	62.2	53.7	31.9	41.8	39.9	37.6	35.8	41.8	49.3	25.4	30.5	30.6	84.4	67.4	29.1	41.3	39.3	72.6	17.6	38.4	48.0	48.8	22.2	27.2	28.3	42.4	41.3	37.1	40.1	48.5	28.6	36.5	35.6	48.9	42.1	58.0	26.6	27.0	17.0	43.4	24.9	34.0	46.4	35.0	21.6	32.5	114.3	26.5	45.7	38.5	1.8	11.2	8.6	15.2	9.1	11.7	16.6	10.3	13.5	10.6	15.8	10.7	13.0	1.4	17.5	12.3	12.4	16.2	10.5	15.0	18.0	19.7	16.5	14.9	17.2	17.4	18.7	17.5	16.1	18.3	18.3	26.9	44.8	34.3	3.3	23.5	34.4	39.0	43.8	30.1	21.1	20.5	25.0	23.7	32.9	36.6	18.4	108.4	91.1	22.8	12.6	37.2	46.5	32.0	22.4	31.6	34.0	34.2	15.6	6.5	39.1	64.9	25.1	20.9	23.8	24.7	35.6	31.4	31.0	41.8	20.2	8.3	17.3	28.5	22.9	13.8	73.2	30.1	17.0	10.6	3.7	37.4	23.3	28.8	5.0	6.9	49.1	10.6	32.4	19.3	48.1	25.0	57.8	26.0	34.0	19.7	29.9	26.9	35.7	28.4	32.0	40.6	66.4	18.5	43.9	27.9	38.9
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	19.0	18.8	18.5	8.1	18.6	2.9	19.2	19.6	28.3	17.8	19.9	15.1	15.6	11.4	25.7	12.8	15.9	11.9	22.2	18.6	19.2	22.8	20.2	13.4	7.7	19.3	19.2	8.4	20.2	32.9	7.9	13.2	19.4	15.1	15.8	10.8	18.3	10.2	30.8	18.7	14.5	9.6	19.3	9.2	18.1	24.0	18.3	6.8	16.6	19.5	9.0	12.4	11.1	20.7	17.2	19.9	7.1	15.6	18.5	12.7	12.4	16.0	8.9	11.4	20.7	25.2	17.6	7.2	23.8	13.7	9.0	23.7	10.6	26.2	16.1	13.8	33.9	9.9	13.8	21.8	10.2	5.5	7.0	10.0	17.0	14.6	22.1	5.6	11.3	12.5	6.0	8.6	13.5	35.2	6.0	21.6	9.9	55.4	8.5	10.0	18.8	12.7	39.1	20.5	3.9	8.3	19.8	17.4	17.9	56.8	11.7	11.2	5.6	9.4	6.4	28.7	18.3	4.7	7.9	13.6	14.9	20.3	14.4	19.2	34.3	29.3	6.7	33.9	6.0	7.6	6.5	4.6	21.6	5.9	7.0	6.1	25.0	8.4	40.8	9.4	10.9	14.4	18.5	18.6	19.6	28.3	18.6	19.2	19.3	19.2	19.4	19.3	18.3	20.7	31.1	16.0	18.1	29.4	11.9	16.3	26.7	59.0	11.4	21.3	19.8	17.4	14.1	25.8	38.5	29.5	31.3	52.9	11.3	25.9	17.6	47.2	69.5	38.1	13.6	23.7	7.2	21.9	32.9	39.0	31.8	18.9	14.3	22.2	8.8	13.8	27.5	20.5	29.4	18.5	37.3	28.5	48.8	17.9	15.5	24.4	22.4	14.3	19.6	14.0	20.8	27.6	22.6	36.7	36.2	30.0	24.8	35.0	10.5	29.0	44.4	25.2	50.7	40.1	6.6	15.1	18.2	71.5	22.3	10.7	18.6	51.6	11.2	27.3	22.2	25.1
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197526-80387757	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 163.9;thyroid gland: 355.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 150.7;Endometrial stromal cells: 158.3;Extravillous trophoblasts: 523.3;Muller glia cells: 246.4"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 80.8;fHDF/TERT166: 41.8;HeLa: 95.4;HHSteC: 44.2;SiHa: 168.1;SK-BR-3: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048002			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA048002: AB_2680230"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.67e-4)"	"prognostic favorable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.5	3.0	18.0	0.6	15.3	0.1	15.3	15.0	24.6	163.9	5.9	1.3	1.3	40.2	0.5	58.9	0.7	5.1	11.9	17.1	13.0	5.0	0.1	1.6	0.8	13.6	19.2	0.2	1.8	6.6	31.6	14.5	17.4	9.0	1.7	7.4	33.3	30.4	6.5	7.1	1.5	4.5	5.5	0.6	5.3	4.7	13.3	1.2	355.8	70.7	33.1	6.0	25.0	16.6	0.2	9.5	0.0	0.0	0.5	1.4	0.3	80.8	16.6	6.2	0.9	0.0	0.3	0.2	0.2	41.8	0.3	1.7	2.9	0.0	6.1	0.0	0.2	0.0	95.4	0.0	44.2	0.0	0.2	5.1	0.0	1.2	0.0	3.9	1.4	0.0	0.0	0.8	0.5	1.9	0.1	0.1	1.7	0.0	0.5	0.8	3.9	0.1	0.0	0.8	0.0	0.2	168.1	35.3	0.3	7.1	0.1	0.0	0.8	0.3	7.0	17.4	20.1	2.8	0.0	0.0	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	15.3	15.0	24.6	17.1	13.0	13.6	19.2	17.4	5.5	13.3	16.6	0.1	0.0	0.5	52.9	0.3	2.9	0.1	0.0	2.2	3.3	150.7	34.4	1.9	0.0	0.0	0.0	0.0	4.8	0.5	0.2	0.0	0.0	29.5	14.2	158.3	2.3	0.0	0.0	1.0	0.0	523.3	24.6	0.0	15.6	0.0	0.1	0.7	0.2	9.2	1.7	1.0	0.5	0.0	1.3	5.7	12.5	3.4	1.3	5.4	4.7	0.0	246.4	0.0	8.5	1.4	1.0	0.0	4.1	0.3	0.3	0.0	0.0	0.0	7.8	0.0	69.1	6.5	9.7	0.7	8.9	3.0	28.2	1.7	0.9	0.1	0.1
DIRAS1	"Di-Ras1, GBTS1, RIG"	ENSG00000176490	"DIRAS family GTPase 1"	O95057	19	2714567-2721372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.8;heart muscle: 105.0;tongue: 51.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Distal tubular cells: 31.3;Excitatory neurons: 20.4;Horizontal cells: 89.2;Inhibitory neurons: 25.9"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4;melanoma: 13.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.4;REH: 49.2;SH-SY5Y: 27.8;THP-1: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050164			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA050164: "	"unprognostic (7.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.60e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-4)"	1.8	2.5	10.5	1.2	20.7	0.7	1.9	16.1	84.8	7.0	0.0	1.4	1.2	12.7	2.5	5.4	6.6	0.7	105.0	19.8	16.9	4.8	0.1	0.6	0.6	17.1	17.4	2.7	6.7	17.0	22.4	0.3	14.5	3.3	1.1	11.5	6.7	1.8	2.7	1.9	2.2	7.4	0.0	4.2	3.5	6.0	45.2	0.1	0.5	51.8	0.7	4.0	2.4	34.8	0.1	2.2	7.0	24.1	0.9	3.1	0.1	8.2	2.8	0.4	0.1	1.4	0.4	0.0	1.0	21.9	12.2	0.1	10.1	0.0	0.0	0.0	15.6	0.5	0.8	0.9	1.0	0.0	43.4	1.4	5.1	0.1	0.1	4.6	0.0	0.2	15.0	7.2	2.8	3.6	0.2	0.4	15.2	0.0	3.3	49.2	0.0	11.7	0.0	0.0	3.1	27.8	0.3	1.1	15.6	1.2	1.1	34.2	0.0	5.3	6.6	0.2	2.6	16.4	12.4	8.9	11.8	0.5	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	20.7	16.1	84.8	19.8	16.9	17.1	17.4	14.5	0.0	45.2	34.8	0.0	0.0	0.0	1.6	6.9	1.1	0.8	0.2	2.2	7.9	2.6	2.8	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	31.3	1.4	0.4	0.1	2.2	0.3	0.0	1.3	20.4	2.0	0.5	0.9	0.0	0.3	0.0	2.3	0.0	0.0	5.7	89.2	25.9	0.0	0.0	0.0	3.6	1.1	1.2	0.5	3.6	4.7	0.1	4.6	0.0	2.0	3.4	1.5	0.0	0.0	0.6	0.9	0.0	0.1	0.0	6.1	0.0	0.7	2.1	0.7	0.4	0.3	0.4	0.3	0.1	0.0	0.0	0.2
DIS3L	"DIS3L1, FLJ38088, KIAA1955, MGC4562"	ENSG00000166938	"DIS3 like exosome 3'-5' exoribonuclease"	Q8TF46	15	66293217-66333898	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041805	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Centrosome	"HPA041805: AB_10796783"	"unprognostic (2.57e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.40e-1)"	11.0	11.8	7.9	6.2	9.8	7.6	9.3	8.9	8.6	10.3	7.7	11.1	5.1	11.1	9.5	7.5	9.6	5.5	12.7	8.0	9.1	8.3	11.0	5.9	7.6	8.7	9.4	11.1	12.8	15.8	10.0	5.4	9.6	8.7	6.0	11.4	8.9	9.0	23.2	7.4	7.7	8.8	8.8	8.7	9.0	9.8	8.9	7.8	11.0	28.3	7.2	9.6	8.1	12.2	14.0	32.6	10.6	14.1	12.2	16.4	12.4	9.5	11.1	14.3	13.2	17.6	10.1	51.6	10.3	13.4	14.9	23.3	25.7	9.2	9.2	12.0	24.1	26.7	25.1	20.1	9.5	27.7	10.1	6.9	9.7	4.5	14.8	9.7	13.1	17.7	18.6	12.6	14.4	12.3	13.8	17.3	15.4	12.7	20.0	18.3	42.1	30.0	5.7	18.9	17.1	15.7	22.3	7.6	11.4	10.0	10.6	21.8	14.4	18.7	16.8	7.4	18.7	10.1	36.9	24.0	6.4	35.9	7.8	8.5	5.1	4.3	7.6	6.1	10.2	6.5	7.7	10.0	8.5	7.8	8.8	7.3	0.6	11.7	13.2	6.7	8.0	6.7	7.9	9.8	8.9	8.6	8.0	9.1	8.7	9.4	9.6	8.8	8.9	12.2	7.1	6.4	16.2	22.5	14.6	4.2	5.5	4.0	17.1	15.6	9.4	7.6	30.3	15.7	7.1	3.7	4.2	17.0	9.6	5.0	5.9	6.5	7.1	8.3	14.6	10.2	3.0	24.2	11.4	3.5	4.5	12.4	10.7	7.3	16.5	25.1	7.1	19.2	9.6	10.1	17.2	10.6	8.2	12.3	7.8	9.9	19.9	10.1	1.8	13.1	14.4	17.7	12.3	22.6	23.1	3.3	5.1	20.3	18.4	4.8	5.4	9.8	8.1	23.2	19.7	9.5	10.1	28.5	17.2	12.1	5.4	3.7	16.0	16.5	14.0	3.8
DLG2	"chapsyn-110, PPP1R58, PSD-93, PSD93"	ENSG00000150672	"Discs large MAGUK scaffold protein 2"	Q15700	11	83455012-85627922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 3292.3;Inhibitory neurons: 2602.7;Oligodendrocyte precursor cells: 2331.8;Oligodendrocytes: 4213.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.2;SH-SY5Y: 8.1;T-47d: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021307, HPA023896, CAB072341"	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Vesicles	"CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353"	"unprognostic (2.61e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.44e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.61e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.84e-1)"	"unprognostic (7.66e-6)"	"unprognostic (2.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.89e-2)"	1.6	11.0	29.5	1.1	48.7	0.3	2.1	3.6	55.8	1.8	0.0	2.3	1.2	2.9	4.1	7.5	5.7	2.1	3.0	64.4	18.1	3.6	2.8	1.7	1.1	13.5	8.2	5.7	3.3	7.3	10.0	2.4	10.3	4.0	1.4	25.4	3.1	4.6	0.8	20.2	1.2	2.2	11.9	2.5	1.5	8.1	10.5	7.3	15.5	0.7	2.9	1.7	2.6	88.4	0.6	0.3	0.9	0.5	0.6	0.7	8.2	0.2	0.5	0.4	0.3	7.4	1.1	1.3	1.3	0.4	0.5	0.8	2.3	0.7	0.4	0.8	0.9	1.3	5.0	0.2	0.1	0.4	1.1	0.5	0.5	1.0	1.0	0.4	0.5	1.9	1.2	3.5	0.7	0.9	0.6	1.3	6.0	0.8	1.3	1.4	2.0	0.9	0.4	0.3	5.9	8.1	0.8	5.1	0.4	7.2	21.2	0.0	0.3	2.2	1.8	2.1	0.3	0.8	2.9	5.6	0.8	0.7	0.2	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.1	0.2	0.0	0.6	0.6	0.2	0.0	0.0	0.1	0.5	0.0	0.0	29.5	48.7	3.6	55.8	64.4	18.1	13.5	8.2	10.3	11.9	10.5	88.4	7.0	3.2	10.4	742.8	1.3	3.3	3.6	0.3	9.1	298.1	4.4	5.2	8.3	2.8	1.8	7.3	275.2	7.9	1.8	1.5	9.8	0.7	21.5	1.3	2.7	3.6	4.2	0.0	3292.3	0.4	0.5	7.4	1.1	2.4	0.0	1.6	2.2	4.6	4.0	23.5	2602.7	1.1	0.0	0.3	0.0	16.4	7.8	0.8	1.8	487.2	0.6	11.0	0.0	2331.8	4213.8	0.4	0.1	6.4	0.1	2.0	0.6	2.7	0.9	48.2	6.6	7.1	4.1	11.3	3.2	6.2	8.5	2.1	1.7	12.1	0.9	0.8
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 51.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.9;Excitatory neurons: 39.1;Horizontal cells: 21.9;Inhibitory neurons: 27.9;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;NTERA-2: 4.2;SCLC-21H: 12.5;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	0.3	0.4	46.9	0.5	41.2	1.1	0.2	0.0	48.2	0.2	0.0	0.3	0.2	0.3	0.0	0.1	0.3	0.1	0.1	36.0	19.1	1.3	0.1	0.2	0.3	0.0	17.8	0.1	1.1	0.2	4.8	0.0	0.0	0.2	0.0	1.8	0.2	0.2	0.1	0.2	0.5	0.0	0.0	1.9	0.3	7.5	51.6	0.3	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	8.0	0.1	0.0	1.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.3	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	12.5	2.4	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	46.9	41.2	0.0	48.2	36.0	19.1	0.0	17.8	0.0	0.0	51.6	0.0	0.2	0.0	0.0	1.0	1.8	0.3	0.9	0.8	1.8	4.1	0.7	0.8	1.0	0.0	0.1	1.8	4.2	0.1	0.9	0.8	3.9	0.4	18.9	0.2	0.1	0.4	1.2	0.0	39.1	0.6	0.2	0.4	0.0	0.1	0.0	0.3	0.4	0.1	10.1	21.9	27.9	0.4	0.0	7.1	0.6	19.3	0.9	4.1	0.0	1.9	0.7	1.5	1.0	8.0	0.7	0.2	0.0	0.0	0.8	0.2	1.3	0.8	0.0	2.2	0.0	0.7	0.4	3.4	4.9	1.1	0.3	0.0	1.3	0.1	0.9	0.6
DLL1		ENSG00000198719	"Delta like canonical Notch ligand 1"	O00548	6	170282206-170306565	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 88.8;Basal keratinocytes: 66.9;Basal squamous epithelial cells: 82.0;Enteroendocrine cells: 51.9;Intestinal goblet cells: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 3.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.8;HBEC3-KT: 4.5;NB-4: 14.2;THP-1: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001255			Approved	"Plasma membrane"		NA	NA		690000	"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"		"HPA001255: "	"unprognostic (1.03e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.66e-1)"	20.9	8.6	2.8	2.1	6.9	0.7	19.2	3.3	4.5	21.1	0.2	15.4	3.9	10.1	0.3	21.9	11.5	0.8	15.9	2.2	2.9	12.5	6.4	13.1	1.9	6.0	5.1	4.2	16.9	0.3	6.2	1.2	4.8	28.7	0.9	0.4	17.7	1.1	5.3	26.2	19.3	0.8	2.0	53.9	10.9	1.6	4.0	0.2	12.4	0.7	0.4	9.6	22.9	11.0	0.7	0.1	3.3	2.0	0.1	0.1	1.5	0.3	0.2	0.2	0.3	1.0	0.1	0.0	0.3	0.1	0.6	6.8	1.4	4.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.6	0.0	0.4	0.1	0.7	0.0	0.0	0.0	0.1	0.8	0.0	14.2	0.2	0.1	0.0	1.1	2.8	0.0	0.0	0.4	1.6	0.2	0.1	0.0	0.0	1.1	0.4	14.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.0	0.0	0.1	2.8	6.9	3.3	4.5	2.2	2.9	6.0	5.1	4.8	2.0	4.0	11.0	88.8	0.0	0.5	26.1	2.7	66.9	14.9	31.2	82.0	1.4	5.4	14.7	11.8	0.0	7.2	1.8	22.9	3.1	3.0	3.0	0.0	0.3	0.4	5.1	10.1	28.5	51.9	0.4	6.9	1.8	5.9	19.2	1.5	5.3	5.7	0.2	21.4	0.2	1.3	0.0	6.4	80.3	16.2	4.8	6.6	1.9	0.3	2.7	7.2	4.7	0.2	1.1	0.0	28.6	26.7	0.7	2.5	1.2	0.3	4.8	2.5	0.1	9.0	0.6	13.1	12.3	8.2	0.5	2.0	8.5	12.8	3.7	4.7	0.1	3.6	1.1
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 5.7;choroid plexus: 2.3;pituitary gland: 3.4;testis: 1.4"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 24.6;Spermatogonia: 39.5"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.6;naive CD8 T-cell: 1.4"	"Group enriched"	"Detected in many"	13	"B-cells: 2.6;T-cells: 1.4"	"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 83.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024559, HPA056533"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA024559: , HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.0	0.0	5.1	0.1	5.7	0.0	0.0	3.1	5.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	4.7	0.0	0.0	0.0	0.1	4.9	4.7	0.2	0.0	0.5	3.4	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.1	0.0	1.4	4.6	0.0	0.1	0.0	0.1	0.0	0.0	5.4	0.1	3.9	0.9	2.0	0.0	0.0	0.6	1.1	0.0	0.7	0.2	0.5	0.9	0.1	3.7	0.0	1.5	0.1	2.3	1.0	0.2	1.2	6.0	0.2	0.1	0.3	0.3	1.0	4.6	0.0	0.0	0.1	0.1	0.1	0.1	4.3	1.1	0.1	0.3	0.0	0.2	0.0	0.7	0.0	6.2	0.6	0.2	0.2	0.2	0.2	13.6	14.1	2.9	0.1	83.7	0.3	0.0	0.2	0.0	0.0	2.6	0.1	1.0	1.4	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.5	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	5.1	5.7	3.1	5.6	4.7	4.7	4.9	4.7	4.2	4.4	4.6	5.4	0.3	0.0	0.0	0.3	1.1	0.3	0.3	0.4	0.0	0.5	1.3	4.7	0.5	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.7	0.6	0.1	0.7	0.2	3.0	0.0	1.7	0.6	0.6	1.0	0.5	0.3	0.0	1.7	0.0	0.0	0.3	0.0	3.4	0.3	0.0	0.0	0.0	2.2	1.2	0.1	1.8	0.0	0.0	0.9	0.0	24.6	0.5	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.7	6.6	0.0	0.6	6.5	39.5	0.2	0.1	0.3	0.5	1.7	0.0	0.1
DMWD	"D19S593E, DMR-N9, gene59"	ENSG00000185800	"DM1 locus, WD repeat containing"	Q09019	19	45782947-45792845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068172, HPA069843"	Approved		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Actin filaments"		"HPA068172: AB_2685964, HPA069843: AB_2686212"	"unprognostic (6.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (5.11e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.59e-2)"	24.6	19.1	27.7	12.3	23.4	7.3	23.0	10.5	31.7	29.1	10.8	40.3	9.7	39.6	6.7	18.2	29.4	11.8	43.1	30.0	18.6	18.7	10.2	22.6	11.2	17.5	19.9	29.1	18.1	10.3	29.6	15.0	15.1	25.2	7.4	11.9	17.1	12.2	44.0	15.5	18.3	14.8	8.9	17.0	25.0	36.5	20.2	10.3	23.1	20.1	7.1	30.6	23.2	14.5	31.6	34.3	30.4	21.2	18.1	22.9	23.3	26.9	18.8	23.5	21.2	20.6	17.1	13.2	15.4	30.4	28.8	23.4	16.1	13.4	12.3	38.6	30.0	11.4	37.3	18.2	22.4	1.4	17.6	21.5	16.2	22.0	31.2	26.7	20.3	8.3	28.2	28.9	18.6	25.8	16.0	9.0	13.8	20.6	22.2	16.3	11.0	14.5	14.6	29.7	30.4	33.6	28.9	22.2	19.5	13.4	19.4	7.7	43.3	27.0	26.6	18.1	40.7	41.1	27.4	15.0	28.1	2.1	31.8	0.6	0.2	0.2	1.4	0.6	1.1	0.6	1.2	1.1	0.2	1.4	0.4	0.8	0.6	1.8	0.8	0.2	0.7	0.3	27.7	23.4	10.5	31.7	30.0	18.6	17.5	19.9	15.1	8.9	20.2	14.5	18.8	6.4	4.7	8.1	6.9	8.4	13.9	4.5	2.2	34.5	11.8	9.8	28.5	10.0	4.4	9.2	60.5	7.3	10.6	10.4	5.9	7.3	17.2	12.4	18.9	16.2	26.3	9.3	8.1	10.6	9.6	15.3	6.1	11.2	11.4	23.3	20.0	4.6	2.0	52.2	7.5	7.9	10.2	4.8	11.4	57.7	17.1	2.6	5.4	5.6	0.9	23.3	14.4	10.1	5.8	13.8	7.2	17.0	6.8	11.5	5.6	7.1	8.9	41.2	13.1	24.5	19.0	10.8	15.7	4.6	7.0	5.5	9.0	20.6	8.1	11.5
DNAAF1	"CILD13, DAU1, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 22.7;testis: 45.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 116.2;Endometrial ciliated cells: 311.3;Plasma cells: 225.4;Respiratory ciliated cells: 494.5;Spermatocytes: 116.2"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 3.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.3;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7;Karpas-707: 4.9;PC-3: 1.4;SK-BR-3: 1.4;U-266/70: 4.0;U-266/84: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA041166: AB_10794190, HPA074239: AB_2732250"	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.3	0.7	1.4	0.1	1.2	1.2	0.3	1.1	1.9	2.2	9.7	0.3	0.0	0.5	1.4	0.4	22.7	0.0	0.4	1.6	1.5	1.0	0.8	3.5	0.0	4.1	7.3	0.4	0.3	0.3	2.4	0.2	4.3	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	3.0	0.7	0.2	45.3	1.6	0.0	1.6	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	4.0	2.8	0.4	0.1	0.0	0.0	1.3	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.3	0.3	0.1	0.4	1.0	0.3	1.4	1.2	1.1	1.9	1.6	1.5	4.1	7.3	4.3	3.0	1.6	1.3	1.1	0.0	12.4	1.6	5.7	0.6	1.5	9.6	0.0	1.4	4.5	1.5	0.7	1.5	67.2	3.7	54.2	0.2	0.5	0.1	0.0	1.3	116.2	311.3	4.4	1.9	0.0	0.0	9.6	0.4	0.4	2.4	0.5	14.6	3.8	2.6	2.2	0.6	1.9	0.0	5.2	0.0	18.3	7.0	1.5	26.7	1.2	21.6	87.2	0.0	0.8	2.4	1.0	0.5	0.6	0.9	0.0	0.4	225.4	1.4	0.0	1.7	494.5	51.0	0.0	1.6	7.3	116.2	17.0	0.2	0.3	0.4	4.5	1.2	0.3	0.9
DNAAF4	"CILD25, DYX1C1, EKN1, FLJ37882"	ENSG00000256061	"Dynein axonemal assembly factor 4"	Q8WXU2	15	55410525-55508234	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 171.5;Proximal tubular cells: 34.4;Respiratory ciliated cells: 102.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051048	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA051048: AB_2681325"	"unprognostic (5.97e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.30e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	1.0	2.0	4.7	1.1	4.7	1.2	3.3	3.6	6.8	2.8	8.4	0.9	0.6	3.7	10.6	1.2	11.1	2.2	1.0	4.8	5.8	5.0	0.5	4.3	1.1	5.1	5.0	2.6	2.1	8.5	3.5	0.7	3.8	2.0	0.9	27.5	1.5	2.0	0.8	1.7	0.8	2.0	3.6	1.3	1.0	11.3	6.7	0.7	8.6	0.5	0.9	1.4	0.7	3.7	7.0	4.8	4.9	10.4	2.0	3.5	1.5	1.0	2.6	3.2	3.6	1.0	2.9	0.6	4.4	2.1	5.2	2.1	1.9	2.7	3.7	2.4	2.5	2.6	3.2	1.7	1.8	5.4	4.2	2.2	5.7	7.6	2.9	5.1	7.2	2.2	0.8	0.3	4.8	2.9	1.3	4.7	2.9	11.0	3.7	1.1	2.3	0.9	17.6	2.3	4.9	10.7	4.3	1.3	6.5	4.2	6.2	1.4	2.5	5.0	2.5	4.4	5.2	2.1	5.4	1.7	8.3	1.3	1.5	0.1	0.7	0.5	0.3	0.5	0.3	1.4	0.5	0.5	0.6	1.3	0.7	0.5	1.4	0.4	0.5	1.9	0.7	0.3	4.7	4.7	3.6	6.8	4.8	5.8	5.1	5.0	3.8	3.6	6.7	3.7	4.1	12.8	15.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	7.9	9.8	0.0	0.0	15.5	12.9	0.0	2.0	0.4	0.0	5.9	13.6	0.0	171.5	9.0	2.8	0.0	0.0	0.0	5.1	1.5	3.4	0.0	13.3	2.5	9.7	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.4	0.0	0.0	34.4	102.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.7	7.2	0.0	0.0
DNAH17	"DNAHL1, DNEL2, FLJ40457"	ENSG00000187775	"Dynein axonemal heavy chain 17"	Q9UFH2	17	78423697-78577396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 2.1;retina: 2.5;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 56.4;Cone photoreceptor cells: 87.6;Early spermatids: 43.7;Late spermatids: 36.6;Oligodendrocytes: 52.5"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 2.9;lung cancer: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 5.7;MOLT-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA024354, HPA076261"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA024354: AB_1847911, HPA076261: AB_2732305"	"unprognostic (4.98e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.70e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.35e-3)"	"unprognostic (1.58e-10)"	"unprognostic (5.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.12e-1)"	"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.2	1.6	0.8	1.3	0.9	0.6	2.1	0.4	6.4	0.5	0.7	0.6	0.6	0.3	0.1	0.0	56.4	0.1	0.0	2.5	0.0	0.0	0.0	87.6	0.0	0.1	0.0	0.0	0.0	43.7	1.4	0.5	1.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.8	1.7	36.6	0.6	2.9	0.0	1.0	0.1	1.5	0.0	1.0	52.5	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	7.8	0.0	0.6	0.5	17.4	0.6	0.0	0.1	0.0	0.3	0.4	0.0	0.1
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 138.4;tongue: 144.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 673.9;Late spermatids: 1608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 33.6;CAPAN-2: 43.3;HeLa: 47.3;MCF7: 33.6;RT4: 85.2;SCLC-21H: 53.3;SiHa: 42.7;THP-1: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"CAB004646: AB_426011, HPA041790: AB_2677674"	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	16.5	20.0	60.6	14.0	67.7	63.7	12.6	62.6	138.4	14.1	45.6	18.0	13.8	8.3	20.2	15.8	38.9	11.2	123.3	68.6	93.1	26.7	3.3	19.7	11.3	65.7	73.3	12.1	6.6	7.4	30.9	9.5	89.8	26.7	18.5	33.0	15.6	15.6	123.2	28.6	16.3	19.6	59.8	13.5	24.2	78.3	73.5	9.4	9.6	144.6	12.4	29.6	13.6	71.3	33.6	0.2	0.0	0.0	0.0	0.0	0.1	4.1	0.0	1.1	0.5	0.0	43.3	0.0	0.3	3.2	0.0	31.3	0.0	0.0	0.1	0.1	0.0	19.9	47.3	0.0	9.4	0.0	20.6	3.6	4.1	2.6	0.0	0.0	6.6	0.0	0.0	0.0	0.4	33.6	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.1	85.2	53.3	0.0	42.7	8.6	3.6	2.3	32.4	39.8	0.5	0.0	8.7	4.0	0.4	0.6	2.4	0.0	0.1	4.2	0.0	0.0	0.3	1.1	0.6	0.3	1.0	0.7	0.9	0.9	0.4	0.1	1.7	1.4	0.0	0.1	0.4	0.2	0.5	0.6	60.6	67.7	62.6	138.4	68.6	93.1	65.7	73.3	89.8	59.8	73.5	71.3	41.9	6.4	4.8	12.7	10.0	28.8	209.9	14.0	2.2	19.6	44.6	29.2	43.6	2.8	33.5	7.3	81.3	1.9	6.7	55.5	1.9	1.3	673.9	124.0	11.4	18.9	100.3	92.8	16.6	2.4	3.8	18.3	21.4	41.8	36.9	7.5	6.8	0.2	16.5	6.7	24.0	34.9	10.2	9.5	81.7	1608.0	10.2	51.7	51.6	6.5	3.5	10.3	6.2	15.1	19.0	5.1	55.3	11.3	3.7	115.8	15.8	7.2	138.9	22.6	6.6	17.4	20.2	33.8	27.7	16.9	46.7	6.8	37.1	6.9	42.1	190.1
DNAJB13	"RSPH16A, TSARG6"	ENSG00000187726	"DnaJ heat shock protein family (Hsp40) member B13"	P59910	11	73951026-73970366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Chaperone	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 53.2;testis: 18.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 90.6;Endometrial ciliated cells: 114.8;Late spermatids: 62.9;Respiratory ciliated cells: 104.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;Karpas-707: 2.6;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052465, HPA061330"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA052465: AB_2681842, HPA061330: AB_2732659"	"unprognostic (1.07e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.72e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.40e-2)"	0.1	0.1	1.5	1.2	1.5	4.4	0.2	1.0	1.4	5.5	12.2	0.1	0.6	2.0	5.2	0.1	53.2	2.2	0.1	2.0	1.9	1.0	0.1	3.1	2.1	4.8	5.7	0.3	0.8	0.1	1.1	0.5	3.6	0.9	0.0	0.4	0.6	2.9	0.3	0.1	2.9	0.1	4.0	1.3	0.2	18.9	2.4	0.0	0.2	0.0	0.0	0.2	0.1	1.8	0.0	0.4	0.3	0.7	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.7	0.2	0.9	2.1	0.2	0.3	0.5	0.1	0.0	0.0	2.7	0.3	1.0	0.9	0.3	0.0	0.2	0.6	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.2	2.6	0.4	0.3	0.6	0.9	0.2	0.2	1.5	0.4	1.2	1.1	4.5	0.5	0.3	1.0	0.5	2.2	0.2	0.4	0.3	0.7	0.0	0.0	0.6	0.6	0.0	2.2	2.0	1.9	0.0	0.3	0.1	0.7	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.1	1.5	1.5	1.0	1.4	2.0	1.9	4.8	5.7	3.6	4.0	2.4	1.8	0.2	3.2	0.0	2.0	0.0	0.0	1.9	11.1	0.0	0.2	0.1	0.3	0.2	0.0	7.6	1.8	0.0	0.1	0.0	0.1	0.0	1.7	90.6	114.8	2.4	0.2	0.0	0.0	0.4	0.0	0.1	0.5	0.0	13.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	10.2	0.0	0.0	62.9	1.2	0.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	1.2	0.0	1.3	1.4	1.0	104.2	0.9	0.0	1.1	3.3	19.5	1.5	0.0	0.0	0.0	0.3	0.0	0.0	1.2
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415871	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.5;retina: 52.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1038.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.1;HEL: 165.8;K-562: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	1.5	11.1	34.7	0.9	43.3	4.7	1.1	33.7	46.9	0.8	0.0	2.1	1.0	0.6	0.4	0.3	1.1	1.0	8.9	42.1	48.0	7.7	0.4	1.5	0.2	60.2	51.3	0.5	2.1	1.0	12.6	7.4	67.6	1.1	1.7	52.8	0.7	0.7	0.4	1.1	1.0	0.9	27.2	2.1	1.7	2.2	42.0	0.8	1.7	0.8	0.3	1.1	0.9	81.5	10.4	2.8	0.1	4.4	2.1	0.5	23.4	20.1	33.1	32.6	31.7	2.7	0.5	9.9	1.7	8.3	8.0	2.5	14.6	3.3	25.8	62.1	6.9	165.8	5.1	0.6	0.2	5.6	3.9	2.7	2.2	3.3	13.8	6.0	0.7	8.0	65.5	1.2	6.6	1.9	2.1	0.0	6.5	0.0	2.2	0.0	4.9	0.4	23.7	0.0	39.4	27.0	11.9	15.5	5.4	37.4	7.5	0.3	6.5	4.8	3.3	0.6	5.9	6.0	4.1	3.0	13.4	4.1	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	43.3	33.7	46.9	42.1	48.0	60.2	51.3	67.6	27.2	42.0	81.5	0.8	0.0	0.5	49.3	0.5	1.3	0.4	0.5	0.0	30.4	0.6	0.3	28.0	2.8	0.2	0.0	14.6	8.9	1.5	0.4	1.9	0.8	2.0	1.8	0.5	3.7	7.2	19.4	237.4	0.7	2.1	5.8	1.5	3.0	0.0	0.6	0.4	0.1	1.2	52.2	237.6	1.9	2.0	0.0	0.8	1.9	0.0	0.7	7.2	18.7	1.1	4.1	0.0	136.7	1038.1	0.4	0.2	0.0	0.9	1.7	0.0	7.2	1.2	21.6	0.0	0.2	8.5	1.7	2.5	0.0	0.3	7.4	0.6	6.9	0.6	0.2
DPY19L4		ENSG00000156162	"Dpy-19 like 4"	Q7Z388	8	94719703-94793836	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024339, HPA024780"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA024339: , HPA024780: AB_10600869"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.28e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	11.5	12.3	7.3	6.6	10.5	5.1	12.5	9.7	9.4	13.6	8.0	8.6	6.7	12.3	10.5	7.6	11.2	10.0	15.4	6.5	10.1	14.5	15.8	9.1	6.9	9.9	9.0	16.7	9.4	26.4	6.4	12.6	10.3	11.6	9.0	13.0	10.2	9.0	7.2	9.4	7.9	9.5	9.6	11.1	13.1	9.6	8.9	7.0	16.1	9.3	5.8	8.6	8.5	14.4	24.4	15.5	26.1	16.4	25.9	33.3	14.4	21.5	20.3	19.8	19.4	7.3	35.0	5.4	25.8	20.8	13.3	25.0	16.0	16.9	32.7	12.2	12.8	25.3	15.1	12.2	30.1	10.9	5.1	22.2	14.0	16.8	16.2	23.2	24.3	16.0	18.0	9.0	23.3	15.3	20.9	20.5	10.2	27.9	17.2	14.8	17.9	10.9	19.1	18.9	12.8	28.7	17.2	3.6	16.8	15.9	22.8	13.6	24.0	20.5	12.6	23.1	18.1	9.9	13.1	14.8	15.4	18.7	29.6	0.7	0.5	0.0	1.0	0.6	1.4	1.2	1.0	1.6	1.0	0.3	1.1	1.4	0.4	1.4	0.6	1.2	0.4	0.7	7.3	10.5	9.7	9.4	6.5	10.1	9.9	9.0	10.3	9.6	8.9	14.4	21.1	16.0	16.3	20.5	6.3	9.8	14.1	11.6	15.9	19.6	16.2	12.1	26.0	11.5	13.0	40.5	4.2	16.7	3.7	8.5	1.9	8.9	2.1	13.7	20.3	19.0	7.3	9.7	13.2	10.0	11.9	20.4	12.2	13.7	3.8	23.1	65.0	27.5	9.6	13.5	18.3	11.5	10.2	14.8	11.9	5.0	17.4	8.3	10.6	25.3	5.5	11.9	9.2	23.6	39.7	13.0	6.4	18.4	7.9	15.6	10.7	10.7	18.8	17.6	6.6	13.4	14.9	11.9	9.8	16.6	12.1	9.2	7.8	32.6	12.0	14.1
DRD1		ENSG00000184845	"Dopamine receptor D1"	P21728	5	175440036-175444182	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 21.3;retina: 8.4"	"Group enriched"	"Detected in some"	12	"Bipolar cells: 40.1;Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 26.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 164.4"	"Region enriched"	"Detected in many"	13	"basal ganglia: 86.7"	"HPA013393, HPA017304"		Supported	Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA013393: AB_1847833, HPA017304: "	"unprognostic (2.74e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.15e-6)"	"unprognostic (6.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.60e-4)"	"unprognostic (5.86e-2)"	"unprognostic (5.43e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	0.4	0.6	4.7	0.0	21.3	0.0	0.2	0.0	8.5	0.4	0.1	0.2	0.1	0.1	0.2	0.3	0.2	0.4	0.0	3.1	0.4	0.7	1.1	0.7	0.0	0.3	0.9	0.1	0.0	0.0	0.1	1.1	0.0	1.1	0.3	8.4	0.0	0.4	0.0	0.0	0.3	0.1	0.7	0.1	0.2	0.0	1.8	0.3	0.1	0.6	0.1	0.7	0.4	2.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	26.4	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	21.3	0.0	8.5	3.1	0.4	0.3	0.9	0.0	0.7	1.8	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	40.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	33.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DRP2		ENSG00000102385	"Dystrophin related protein 2"	Q13474	X	101219769-101264502	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.8;lymphoid tissue: 4.7"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 35.6;Inhibitory neurons: 24.5;Oligodendrocyte precursor cells: 11.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 10.7;TIME: 18.5;U-87 MG: 4.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 56.0"	HPA002949			Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Plasma membrane"		"HPA002949: AB_1078706"	"unprognostic (8.47e-4)"	"unprognostic (3.56e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.58e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.27e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.44e-16)"	"unprognostic (3.71e-4)"	"unprognostic (4.22e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.25e-1)"	0.7	0.3	4.0	0.2	5.9	0.2	0.4	0.0	8.8	0.6	0.0	3.2	0.2	0.7	0.7	0.2	0.2	0.2	0.2	6.2	0.7	0.0	0.0	0.0	0.0	0.1	2.6	1.4	0.0	0.0	2.3	0.0	0.6	1.3	0.4	1.0	0.6	0.9	0.2	0.3	0.8	0.6	0.0	0.0	0.3	0.5	0.7	4.7	0.0	1.1	0.0	0.6	1.1	4.8	0.0	0.6	2.2	0.1	0.1	0.2	0.1	0.4	0.1	0.3	0.9	0.0	0.4	0.3	0.2	0.1	0.6	0.0	0.3	0.0	0.7	0.1	0.2	0.2	0.6	0.0	0.2	0.1	0.4	1.4	0.0	0.7	0.0	0.0	1.4	0.5	0.0	0.9	1.5	0.0	1.3	0.5	0.1	0.1	0.1	0.3	10.7	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.4	0.0	0.1	18.5	0.2	0.7	0.2	0.4	0.0	0.1	0.0	4.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.9	0.0	8.8	6.2	0.7	0.1	2.6	0.6	0.0	0.7	4.8	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	1.8	0.0	35.6	0.0	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	24.5	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.3	0.0	11.1	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
DSEL	"C18orf4, DE-epi2, FLJ11477, NCAG1"	ENSG00000171451	"Dermatan sulfate epimerase like"	Q8IZU8	18	67506587-67516720	"Predicted membrane proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 86.4;Extravillous trophoblasts: 72.5;Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 104.2;Theca cells: 83.9"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 70.7;BJ hTERT+: 43.0;fHDF/TERT166: 38.9;LHCN-M2: 92.1;U-138 MG: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060942			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane"	Nucleoplasm	"HPA060942: AB_2684392"	"unprognostic (2.49e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.91e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.16e-4)"	4.0	1.3	5.1	1.3	8.5	0.3	2.6	7.3	4.7	5.1	0.7	2.2	0.6	2.6	1.6	1.1	3.3	4.0	2.2	5.1	6.4	4.3	3.5	2.7	0.5	9.5	7.4	3.6	1.5	3.2	0.3	6.1	8.8	2.0	1.3	0.8	0.8	2.1	0.7	1.2	1.1	3.6	5.9	2.0	1.2	1.3	7.0	0.8	1.0	1.8	0.3	1.7	1.4	11.7	0.0	0.3	8.7	0.1	16.5	24.3	0.9	70.7	43.0	19.2	8.3	0.1	0.2	0.0	0.1	38.9	4.7	0.4	1.7	3.5	18.5	0.0	0.1	0.0	8.5	0.1	14.6	0.0	0.1	25.3	5.1	11.7	26.0	6.8	3.8	0.0	0.0	1.1	92.1	0.0	0.0	0.0	1.3	0.0	3.7	0.8	19.3	0.1	8.7	0.1	3.1	4.0	4.8	0.2	0.0	3.7	0.1	0.0	6.2	95.6	2.4	6.2	8.6	0.3	0.0	0.0	20.0	0.0	8.1	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	5.1	8.5	7.3	4.7	5.1	6.4	9.5	7.4	8.8	5.9	7.0	11.7	15.9	6.4	16.2	3.3	2.6	11.6	9.9	8.6	19.4	10.1	14.5	12.3	13.3	47.1	5.2	11.0	4.2	2.8	1.4	1.0	0.0	9.7	1.8	3.9	86.4	10.9	6.6	0.0	10.3	2.3	72.5	44.3	8.2	4.2	4.5	9.5	13.2	15.6	2.6	3.3	25.5	1.1	0.0	2.2	9.3	1.7	24.5	3.5	7.2	2.8	0.0	12.6	1.0	112.6	104.2	6.6	0.1	36.9	0.3	8.5	0.4	26.4	1.3	4.2	13.1	43.3	20.9	31.6	21.9	7.1	13.2	8.9	4.9	83.9	0.7	5.2
DUS1L	"DUS1, PP3111"	ENSG00000169718	"Dihydrouridine synthase 1 like"	Q6P1R4	17	82057506-82065887	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023384	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA023384: AB_1847879"	"unprognostic (4.42e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (4.17e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.70e-3)"	83.3	86.7	38.2	51.1	38.0	94.2	89.0	35.2	49.7	85.3	40.6	101.3	66.6	74.0	23.0	117.8	81.8	27.0	93.1	38.4	34.9	90.4	174.3	80.5	64.8	40.4	36.4	82.3	148.3	32.0	99.7	27.0	37.0	118.8	29.8	16.9	105.8	30.4	144.3	127.1	107.2	18.9	35.2	131.3	119.4	93.6	38.5	37.7	93.6	27.3	33.3	87.9	85.0	38.6	169.4	109.0	37.7	44.3	28.9	28.4	115.0	57.5	26.8	56.5	40.2	99.7	77.9	133.7	65.3	33.0	39.8	112.0	46.1	60.9	21.9	54.6	263.1	89.2	167.3	178.8	65.3	138.8	101.0	43.1	75.1	37.3	46.4	27.0	64.1	124.8	147.1	69.4	28.5	268.6	192.9	114.9	43.7	87.6	151.7	143.7	43.1	151.7	42.3	114.3	193.9	118.7	45.2	192.6	127.1	35.8	112.3	133.1	49.1	91.7	89.0	79.3	150.1	164.5	48.9	113.0	58.8	102.2	65.0	3.0	3.5	5.0	4.0	3.9	6.0	3.9	4.0	5.0	3.6	3.3	6.5	5.6	1.2	5.9	5.3	7.9	7.6	2.0	38.2	38.0	35.2	49.7	38.4	34.9	40.4	36.4	37.0	35.2	38.5	38.6	36.8	28.9	19.1	17.6	30.0	22.0	20.0	10.0	10.8	28.3	78.3	69.8	21.3	24.3	15.0	11.0	29.2	16.1	60.1	65.2	7.9	12.1	87.2	30.5	28.4	21.0	43.2	21.7	15.9	39.1	19.1	19.1	37.2	37.6	3.8	46.3	13.9	77.8	21.0	18.5	15.8	58.1	8.2	26.8	14.3	146.2	14.3	27.0	10.6	10.3	19.2	17.8	27.8	10.1	18.2	32.0	32.2	13.5	33.7	40.9	32.4	24.5	15.3	47.8	13.1	18.0	23.9	43.3	9.6	23.3	28.4	15.6	28.4	52.2	75.4	37.5
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 210.5"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 273.9;Early spermatids: 288.8;Late spermatids: 979.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.8;REH: 16.0;SH-SY5Y: 4.3;SK-MEL-30: 4.0;U-2 OS: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA076649: AB_2686811"	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favorable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.7	5.9	5.3	0.2	7.6	0.1	3.4	10.7	7.5	5.9	4.9	1.8	0.5	3.4	9.0	1.0	1.5	0.7	7.8	4.8	7.7	50.0	0.7	1.6	0.6	17.1	8.7	5.2	2.4	13.0	8.7	0.7	8.1	6.6	0.1	0.6	2.1	3.0	0.9	1.2	1.5	0.3	7.8	2.7	2.3	210.5	7.6	0.3	9.6	0.3	0.2	2.5	2.7	8.8	0.2	0.2	0.1	1.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	4.8	0.1	1.0	1.9	0.2	2.6	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	3.4	0.6	0.0	0.0	16.0	1.8	0.1	0.0	0.0	2.1	4.3	2.6	0.0	4.0	0.1	1.1	0.9	0.0	0.0	3.6	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.6	10.7	7.5	4.8	7.7	17.1	8.7	8.1	7.8	7.6	8.8	2.9	0.0	0.0	1.3	0.8	0.6	1.3	0.0	0.0	0.6	3.6	4.4	2.5	1.5	0.0	18.4	4.2	0.0	0.4	0.1	273.9	2.4	288.8	0.6	4.0	2.2	1.8	0.0	1.7	1.0	0.1	2.9	1.5	0.6	0.0	7.0	1.8	0.1	0.6	6.7	2.6	0.4	0.0	0.6	1.9	979.4	8.7	1.2	7.2	0.0	0.6	2.9	0.0	3.0	4.7	0.6	0.0	10.9	0.0	0.9	0.0	55.3	0.1	0.3	0.0	2.5	3.3	121.5	6.0	0.3	0.1	0.1	0.3	7.5	0.7	0.4
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972290	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 467.9;Late spermatids: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	6.6	17.8	8.2	3.9	8.1	1.4	6.9	8.2	8.5	10.7	9.6	7.1	4.5	8.1	5.8	5.7	8.5	4.2	9.6	8.1	8.4	12.3	13.0	6.4	4.6	9.3	8.6	13.4	10.8	11.8	13.0	4.4	8.7	10.3	3.9	4.8	6.7	6.0	5.3	4.9	5.8	4.8	8.6	9.7	8.6	31.3	8.3	7.0	11.5	7.1	3.0	7.9	7.4	8.5	12.9	6.3	5.8	23.1	9.5	6.4	6.7	7.5	12.0	16.2	15.5	7.6	5.9	5.2	8.5	16.6	5.2	8.7	10.1	16.8	9.4	9.6	12.9	9.3	15.8	16.4	18.7	0.0	4.6	9.7	16.3	10.5	13.5	9.9	21.3	6.6	8.3	11.9	9.8	14.7	1.5	11.1	4.4	8.4	1.3	4.0	4.1	8.2	21.2	4.5	30.1	17.0	6.6	7.3	16.9	4.1	0.0	14.8	7.0	4.7	12.6	4.6	12.3	9.1	9.4	10.2	4.6	14.4	5.2	0.0	1.9	1.0	2.2	1.6	3.9	2.4	2.3	1.4	4.3	2.1	1.6	2.3	0.3	2.1	1.4	1.3	1.6	1.8	8.2	8.1	8.2	8.5	8.1	8.4	9.3	8.6	8.7	8.6	8.3	8.5	11.2	6.4	9.6	11.8	16.8	8.5	15.3	14.3	19.9	13.3	13.6	11.4	7.1	11.5	10.5	3.7	16.7	14.5	14.1	5.0	19.6	8.4	467.9	9.3	10.6	9.8	16.2	4.4	4.4	12.6	9.5	10.9	15.8	8.7	6.3	12.1	8.6	10.9	6.6	5.0	6.2	9.0	12.2	5.9	4.9	242.8	17.7	6.9	12.4	1.9	4.3	16.0	11.3	7.5	6.6	6.9	10.5	12.4	14.7	10.8	10.6	13.3	8.9	15.6	13.1	7.1	14.3	78.4	16.1	11.8	5.5	20.1	15.4	22.6	8.3	11.5
EEF1AKMT1	N6AMT2	ENSG00000150456	"EEF1A lysine methyltransferase 1"	Q8WVE0	13	20728731-20773961	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Breast myoepithelial cells: 19.9;Cytotrophoblasts: 19.8;Distal tubular cells: 27.4;Endometrial ciliated cells: 20.9;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040417, HPA042543"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA040417: AB_2676973, HPA042543: AB_2678045"	"unprognostic (4.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.31e-2)"	9.6	10.3	11.1	5.3	11.6	3.4	9.8	11.8	16.8	11.2	10.5	9.5	4.5	10.8	14.3	5.8	11.1	6.3	9.9	11.2	12.6	9.5	13.5	6.4	6.8	11.1	11.6	10.4	6.3	9.5	9.9	6.5	11.8	10.2	6.0	10.2	7.9	8.9	11.1	5.9	5.6	9.2	12.0	5.8	7.1	4.3	12.0	9.2	9.5	12.2	6.8	8.8	7.5	12.3	11.1	8.5	6.9	11.4	28.3	29.2	16.9	14.4	11.0	12.4	6.4	11.9	12.1	18.0	10.5	15.8	5.8	9.0	9.4	12.2	12.8	11.7	8.4	23.3	3.8	22.8	15.6	46.3	4.6	20.1	10.7	9.2	20.4	13.8	22.4	15.7	13.6	2.4	35.5	30.7	15.6	41.0	12.0	20.2	6.2	19.2	7.6	3.5	17.8	12.7	15.8	9.4	12.5	6.1	16.5	5.9	6.4	42.4	13.3	8.5	0.0	19.1	6.4	3.3	6.7	19.9	7.3	31.4	6.1	0.0	5.2	0.9	8.6	4.1	9.6	13.1	10.3	9.0	8.9	5.4	13.0	11.3	0.7	16.3	4.4	10.8	12.0	6.7	11.1	11.6	11.8	16.8	11.2	12.6	11.1	11.6	11.8	12.0	12.0	12.3	15.0	22.4	9.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.3	19.9	0.0	0.0	8.1	7.3	0.0	19.8	3.1	0.0	27.4	12.6	0.0	20.9	16.2	6.0	0.0	0.0	0.0	10.4	15.2	8.9	0.0	7.0	3.8	13.2	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	36.5	7.3	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	15.7	2.2	9.9	0.0	0.0
EFCAB1	FLJ11767	ENSG00000034239	"EF-hand calcium binding domain 1"	Q9HAE3	8	48710789-48735311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 91.6;testis: 37.5"	"Group enriched"	"Detected in many"	19	"Early spermatids: 538.8;Endometrial ciliated cells: 159.1;Late spermatids: 552.0;Respiratory ciliated cells: 310.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 6.5;ASC diff: 2.6;ASC TERT1: 6.2;CAPAN-2: 3.1;hTEC/SVTERT24-B: 2.6;SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023527, HPA069955"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA023527: AB_2231065, HPA069955: AB_2686220"	"unprognostic (5.29e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.94e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.47e-3)"	0.3	1.5	3.1	0.1	4.7	0.7	3.0	1.9	2.5	11.4	22.4	0.5	0.6	12.4	2.5	0.7	91.6	0.6	0.2	3.7	4.9	0.5	0.7	10.6	0.1	13.5	12.1	19.3	3.2	0.0	3.1	0.5	7.0	5.4	0.4	0.0	2.0	5.9	0.0	4.7	1.0	2.9	9.1	0.3	0.6	37.5	5.7	0.4	0.1	0.2	0.2	2.3	3.4	8.5	6.5	0.0	0.8	0.0	2.6	6.2	0.0	0.1	0.6	0.0	0.2	0.0	3.1	0.0	0.0	0.1	0.0	1.7	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.2	2.6	1.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.5	4.9	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.0	1.2	0.3	0.0	0.0	0.1	0.0	3.1	4.7	1.9	2.5	3.7	4.9	13.5	12.1	7.0	9.1	5.7	8.5	0.4	0.0	5.9	0.0	0.0	6.8	9.7	14.7	4.0	0.0	0.4	9.1	0.4	0.0	20.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	538.8	159.1	4.7	1.2	0.0	0.0	0.7	1.5	0.1	2.2	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.2	0.0	0.3	552.0	4.7	0.8	1.8	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	5.7	0.0	3.4	0.0	0.3	310.7	0.0	0.0	0.7	6.2	16.9	4.5	0.1	1.8	0.3	0.4	3.9	0.0	2.5
EFCAB2	"CFAP200, DRC8, MGC12458"	ENSG00000203666	"EF-hand calcium binding domain 2"	Q5VUJ9	1	244969705-245127164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.3;Endometrial ciliated cells: 103.1;Late spermatids: 132.5;Respiratory ciliated cells: 177.2;Spermatocytes: 115.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.1;THP-1: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031206, HPA031207"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA031206: AB_10599710, HPA031207: AB_10599946"	"unprognostic (1.36e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (4.88e-2)"	13.0	10.6	11.5	6.7	13.8	14.4	16.0	14.4	21.9	8.7	26.7	6.8	3.3	21.2	17.5	10.5	36.1	14.7	15.0	11.4	14.4	11.1	5.6	12.6	9.6	18.1	16.9	11.3	9.0	15.4	8.5	16.8	13.9	8.9	12.4	17.7	8.8	13.1	19.7	6.9	7.4	11.4	14.9	7.5	12.4	28.0	12.9	7.4	26.8	7.5	10.7	8.2	4.9	16.3	7.3	9.1	20.3	5.2	7.2	16.7	24.7	9.2	9.7	11.5	10.6	23.5	19.5	25.3	19.2	11.6	12.2	5.7	8.2	5.3	7.1	2.7	5.0	12.4	41.3	10.7	15.2	12.8	77.1	14.6	11.0	15.5	14.4	13.7	18.0	0.7	48.0	20.1	10.0	7.6	2.6	34.6	26.0	10.4	6.9	48.4	3.1	6.8	29.0	12.3	15.9	21.4	16.0	6.1	13.6	22.7	5.9	70.5	2.8	14.1	5.3	7.9	33.7	6.9	12.4	17.2	11.2	35.9	11.7	0.9	1.3	2.3	0.4	1.4	0.5	3.1	0.5	0.3	4.3	3.3	0.4	0.4	3.8	2.3	1.1	8.7	0.6	1.0	11.5	13.8	14.4	21.9	11.4	14.4	18.1	16.9	13.9	14.9	12.9	16.3	13.3	3.2	14.5	76.0	11.5	5.1	11.8	17.2	10.2	12.6	11.6	11.0	58.6	8.6	23.0	23.9	14.6	16.3	9.3	5.4	50.9	8.2	112.3	103.1	18.5	11.7	18.8	17.2	54.6	10.8	46.3	15.5	11.2	11.1	0.0	13.6	12.5	7.3	11.2	5.0	90.3	6.5	22.4	21.3	6.5	132.5	9.0	13.2	7.2	42.2	6.6	19.2	1.0	74.9	75.9	5.6	6.6	6.4	12.0	7.1	2.7	35.6	177.2	19.1	6.6	15.5	15.8	115.9	30.6	5.4	3.0	34.2	7.5	8.3	6.9	10.6
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.3;Excitatory neurons: 58.9;Inhibitory neurons: 47.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	2.7	5.3	7.3	2.2	7.6	2.0	6.0	8.9	10.3	5.8	10.1	3.4	2.0	6.1	6.2	2.9	8.1	4.6	6.5	7.4	9.3	5.6	1.7	4.0	3.6	6.8	7.2	8.0	2.9	10.4	5.9	3.2	7.0	5.4	3.0	8.9	3.1	5.0	6.7	3.1	2.1	4.7	6.5	2.7	3.2	14.6	8.2	7.3	5.9	3.9	3.3	3.7	2.8	8.3	6.5	5.7	7.1	4.5	7.5	11.0	3.6	4.1	4.6	7.2	8.8	1.7	5.0	4.4	9.6	2.5	14.5	6.0	6.1	4.1	8.5	8.6	4.3	3.6	10.4	3.9	4.6	5.1	3.2	6.1	9.9	8.6	5.6	11.4	6.1	8.2	4.8	7.3	4.7	1.5	9.9	3.5	3.1	4.6	5.6	6.2	10.7	4.6	11.1	3.6	15.2	5.8	8.1	4.5	10.5	9.6	4.5	3.8	1.7	4.1	3.5	12.1	4.0	4.7	8.7	5.0	7.4	3.5	6.0	10.1	0.4	0.1	1.2	0.3	1.6	1.8	1.4	1.4	0.8	1.9	1.4	1.3	0.0	1.3	2.6	1.0	1.6	0.6	7.3	7.6	8.9	10.3	7.4	9.3	6.8	7.2	7.0	6.5	8.2	8.3	3.1	12.8	4.1	23.2	6.0	3.1	5.6	7.0	5.7	7.7	2.6	3.9	7.8	2.8	5.6	5.5	4.2	3.7	2.1	0.6	7.9	3.8	55.3	19.9	8.0	3.2	1.8	1.3	58.9	0.7	2.0	5.6	3.6	3.4	2.5	7.9	2.2	1.2	2.6	0.0	47.7	1.3	8.2	2.5	1.6	8.8	10.8	1.8	1.8	14.0	1.9	5.2	2.1	41.7	21.9	1.4	0.3	13.5	6.0	1.4	0.5	5.5	27.5	11.3	26.3	11.8	5.3	73.4	22.7	3.8	2.3	1.2	3.4	5.8	2.1	1.6
EFHC2	"FLJ22843, MRX74"	ENSG00000183690	"EF-hand domain containing 2"	Q5JST6	X	44147872-44343672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 17.1;fallopian tube: 14.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Early spermatids: 78.6;Endometrial ciliated cells: 55.3;Respiratory ciliated cells: 79.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 16.4;NK-cell: 5.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.4;NK-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.7;HEL: 3.7;HMC-1: 12.0;NB-4: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034492	Approved	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli fibrillar center"	"Plasma membrane"	"HPA034492: AB_10671227"	"unprognostic (1.93e-1)"	"unprognostic (7.80e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.07e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.13e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.97e-2)"	0.4	0.3	1.5	0.3	1.9	1.4	0.7	1.0	1.4	2.7	17.1	1.1	0.3	3.7	3.4	1.8	14.7	1.4	3.7	1.5	2.1	1.8	0.0	2.0	0.2	5.2	3.9	1.7	0.1	0.2	3.1	0.8	2.8	1.9	0.3	2.0	8.2	3.6	0.0	3.5	0.5	1.6	2.7	0.3	0.9	6.7	2.5	0.5	2.3	0.1	0.4	0.5	0.9	2.6	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.7	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.1	3.7	0.0	0.0	0.0	0.0	12.0	0.2	0.2	0.1	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	1.5	0.0	0.6	0.1	0.6	0.1	0.3	0.1	0.5	0.7	1.5	5.8	0.0	0.0	0.0	0.9	1.5	1.9	1.0	1.4	1.5	2.1	5.2	3.9	2.8	2.7	2.5	2.6	0.1	0.0	3.9	32.0	0.0	3.1	6.0	9.6	1.2	0.2	0.4	0.5	10.8	4.3	5.1	0.0	2.1	0.0	1.6	1.2	1.9	0.9	78.6	55.3	6.0	0.3	0.0	1.7	7.2	5.9	0.1	0.8	0.0	17.1	16.4	3.8	0.4	0.0	0.3	0.0	1.7	1.5	4.1	0.0	0.4	19.0	6.8	4.9	0.0	0.0	0.4	5.3	3.1	1.5	0.2	1.0	0.0	7.2	0.2	1.0	3.8	0.7	79.6	0.1	6.6	0.1	3.7	11.3	10.5	7.3	2.8	0.3	1.6	0.4	5.2	6.0
EHBP1L1	"DKFZp762C186, TANGERIN"	ENSG00000173442	"EH domain binding protein 1 like 1"	Q8N3D4	11	65576046-65592650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 255.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 79.1;Kupffer cells: 79.7;Macrophages: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039479, HPA073476"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		110000		"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Plasma membrane"		"HPA039479: AB_10795678, HPA073476: "	"unprognostic (1.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.10e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.10e-1)"	27.2	9.9	7.5	51.9	6.2	59.7	21.5	5.9	9.4	35.9	7.3	108.1	26.0	56.1	5.7	45.4	48.0	18.0	45.6	7.1	6.3	17.7	10.8	39.6	30.7	9.8	8.1	19.6	8.1	4.1	9.8	16.3	7.7	45.2	12.2	0.4	22.9	39.5	255.7	22.6	46.6	32.8	8.0	73.3	41.0	7.3	9.4	14.5	13.0	70.7	16.6	71.3	40.8	9.0	40.6	41.0	1.3	21.8	10.5	26.4	8.2	31.4	22.9	14.8	7.8	13.7	34.9	14.0	52.4	45.8	41.2	55.9	7.6	29.7	3.4	39.3	1.2	32.4	51.0	12.0	10.0	7.1	30.1	22.7	19.8	37.2	6.8	26.9	15.2	20.8	50.5	55.9	13.8	34.5	12.4	27.5	1.8	15.1	34.8	33.6	0.2	46.8	13.7	20.0	0.9	17.2	17.4	15.2	32.9	3.0	21.9	33.7	26.3	40.3	42.9	57.3	0.6	98.5	66.6	7.3	60.2	18.8	23.9	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	7.5	6.2	5.9	9.4	7.1	6.3	9.8	8.1	7.7	8.0	9.4	9.0	33.1	0.0	6.9	6.2	23.9	10.1	8.5	2.9	15.9	1.4	12.2	14.2	22.0	7.2	7.4	1.8	0.0	3.4	27.3	79.1	0.0	3.6	0.2	11.9	12.2	26.0	4.2	61.6	4.4	5.1	1.4	13.8	61.2	14.2	2.5	5.3	18.9	5.7	32.6	0.0	2.2	16.3	2.0	79.7	33.9	1.7	11.5	67.6	7.2	15.0	49.1	0.7	20.6	1.5	1.3	27.8	53.0	38.0	19.5	11.6	19.5	0.4	8.6	1.1	26.3	27.3	30.7	2.7	5.9	15.3	14.8	2.6	23.2	23.0	21.9	17.0
EHD3	PAST3	ENSG00000013016	"EH domain containing 3"	Q9NZN3	2	31234152-31269451	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.7;esophagus: 43.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 24.3;Hepatic stellate cells: 120.3;Syncytiotrophoblasts: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 20.8;naive B-cell: 5.6"	"Lineage enriched"	"Detected in many"	7	"B-cells: 20.8"	"Cell line enhanced"	"Detected in many"		"BJ: 79.7;BJ hTERT+: 192.2;HEL: 77.4;U-266/70: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		15000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (3.44e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.88e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (4.92e-3)"	2.5	9.1	20.5	5.9	29.5	1.9	3.2	10.5	38.7	5.5	1.1	2.5	1.6	4.4	3.0	43.9	4.5	3.4	15.9	29.5	18.5	20.0	11.0	5.7	6.8	11.7	17.8	2.5	1.3	21.1	9.1	11.7	13.9	5.5	1.7	9.0	5.9	4.4	2.3	3.1	3.7	4.6	9.6	7.3	2.2	1.3	31.1	2.7	3.2	5.1	11.1	6.6	6.0	26.2	1.8	8.4	4.5	3.9	7.5	11.3	0.7	79.7	192.2	7.5	6.9	0.0	0.9	0.6	2.9	26.0	6.5	0.8	0.2	5.2	5.3	3.2	7.1	77.4	0.4	0.0	25.7	0.0	0.2	18.1	2.3	7.3	3.0	20.0	0.1	0.2	0.3	0.4	5.6	12.6	1.0	0.1	17.7	0.0	4.3	2.8	0.3	1.8	5.8	8.9	2.2	12.1	0.8	1.3	0.0	14.1	1.2	0.0	0.0	5.8	5.4	0.3	6.5	48.7	6.5	0.1	14.8	0.0	12.4	0.6	0.5	0.5	2.1	1.0	1.1	20.8	1.0	1.4	0.5	5.6	0.9	0.5	1.2	0.8	2.8	0.0	0.5	10.2	20.5	29.5	10.5	38.7	29.5	18.5	11.7	17.8	13.9	9.6	31.1	26.2	1.9	0.0	0.0	2.6	16.2	0.8	1.8	1.7	10.2	9.7	0.6	6.2	24.3	5.7	0.9	0.0	0.0	4.1	0.6	0.0	0.0	0.5	0.1	0.7	2.3	8.4	1.8	6.1	17.1	0.2	8.4	3.3	1.1	0.5	0.0	0.4	120.3	5.0	1.7	0.0	11.1	0.1	0.0	16.1	0.4	0.0	1.2	5.9	0.0	4.7	1.1	9.0	0.0	22.6	5.4	0.2	0.1	3.0	5.8	2.6	0.0	0.2	0.4	5.9	19.7	3.0	7.0	0.6	2.7	10.7	0.9	43.9	1.4	0.7	0.1	4.7
EHD4	PAST4	ENSG00000103966	"EH domain containing 4"	Q9H223	15	41895933-41972557	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 189.5;Urothelial cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 103.8;TIME: 172.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA052729, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		440000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.72e-1)"	21.6	4.6	3.1	11.8	3.2	10.9	16.4	7.5	3.5	9.4	5.3	12.1	5.5	9.6	10.5	15.0	9.8	15.2	27.8	3.3	3.8	14.3	9.6	15.0	12.8	4.8	4.0	5.6	14.3	12.8	5.8	8.3	4.8	9.5	10.2	6.1	10.4	9.7	4.4	14.3	12.4	12.9	5.2	7.4	9.9	2.8	4.0	5.3	18.4	4.7	8.8	23.8	9.0	6.6	28.7	9.8	9.3	9.6	4.6	6.5	8.1	14.9	31.4	25.9	36.1	41.4	16.1	5.9	39.2	18.8	51.6	28.4	13.9	32.6	19.0	35.7	11.7	8.7	13.5	7.1	11.3	4.0	24.4	5.5	12.6	26.3	28.8	9.9	103.8	8.7	9.2	6.6	21.1	12.2	4.2	4.5	7.1	27.8	33.5	0.1	24.5	9.4	23.4	57.0	15.4	6.5	10.9	23.2	17.0	9.0	22.9	5.6	172.8	8.1	15.7	30.5	73.1	18.1	30.9	12.4	10.3	9.4	71.6	1.1	14.0	9.0	4.0	12.4	6.1	2.1	6.2	5.0	14.9	2.6	2.6	3.8	2.3	4.4	5.2	2.5	7.9	8.0	3.1	3.2	7.5	3.5	3.3	3.8	4.8	4.0	4.8	5.2	4.0	6.6	94.9	6.4	44.2	3.9	20.0	81.6	189.5	68.1	34.1	4.9	31.4	20.1	36.6	30.0	69.0	44.1	31.3	10.1	22.2	96.0	7.9	71.3	16.1	66.1	9.7	114.9	22.6	5.7	1.2	62.6	20.4	21.3	25.5	72.4	61.6	16.2	54.7	8.7	89.0	1.7	0.7	22.5	28.5	35.6	52.7	34.7	7.5	46.3	19.6	12.2	53.5	37.5	4.1	26.7	2.7	75.1	70.9	4.9	31.5	49.9	71.4	4.6	60.8	27.8	13.1	8.0	29.0	5.4	8.2	29.3	79.8	17.4	27.8	21.2	37.3	200.1
EIF2B2	"EIF-2Bbeta, EIF2B"	ENSG00000119718	"Eukaryotic translation initiation factor 2B subunit beta"	P49770	14	75002921-75012366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005841, CAB037105, HPA048028"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		12000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	2.7	5.3	4.0	2.9	4.5	3.2	3.6	8.7	4.8	3.9	2.2	3.0	3.0	3.6	4.9	3.8	3.1	4.0	3.9	3.6	6.1	4.9	3.3	2.7	4.0	4.5	4.2	2.9	4.0	8.5	3.5	4.8	4.5	4.1	3.8	6.8	2.8	4.5	5.5	4.0	2.8	3.4	2.9	2.7	2.6	3.9	4.8	3.9	11.5	7.1	4.2	4.0	2.6	6.9	5.9	7.0	5.6	6.4	6.3	5.2	7.4	3.7	6.1	7.1	8.2	9.0	5.9	5.2	2.3	5.8	4.5	4.4	8.8	8.7	10.6	3.2	6.5	4.6	6.3	6.2	8.2	3.4	5.3	4.8	8.2	9.1	9.3	6.1	24.8	4.5	4.2	4.9	15.5	17.4	5.5	4.3	4.0	7.3	10.3	3.4	6.6	4.3	10.1	7.0	6.0	4.8	3.9	5.5	8.4	6.9	9.0	3.2	6.4	5.4	5.2	2.4	4.8	8.4	7.5	6.2	5.9	4.3	4.2	4.2	1.8	1.4	3.0	1.9	2.5	2.1	2.6	2.5	2.4	2.0	1.9	2.0	1.0	3.3	1.8	2.0	4.0	2.5	4.0	4.5	8.7	4.8	3.6	6.1	4.5	4.2	4.5	2.9	4.8	6.9	18.9	19.2	11.5	6.2	14.1	17.7	19.5	28.9	18.2	28.2	15.4	17.0	18.2	22.8	21.5	25.8	45.9	51.5	16.1	15.3	41.1	36.2	12.1	17.0	14.5	32.1	15.6	20.8	5.3	33.1	56.5	18.3	12.8	12.8	21.5	17.5	13.2	11.9	33.7	28.6	5.4	9.0	20.3	19.1	11.9	12.7	15.8	18.8	14.2	1.9	28.0	27.3	28.8	2.5	8.5	28.1	11.7	16.1	11.3	17.5	19.0	50.8	17.2	29.4	26.3	16.9	27.9	84.2	27.4	27.3	21.9	165.5	14.9	30.5	19.7	19.2
EIF5AL1	"bA342M3.3, EIF5AP1"	ENSG00000253626	"Eukaryotic translation initiation factor 5A like 1"	Q6IS14	10	79512533-79516440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 10.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 79.2;Intestinal goblet cells: 96.7;Spermatocytes: 76.5;Undifferentiated cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"U-251 MG: 2.2"									HPA074052			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA074052: "	"unprognostic (2.16e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.55e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.81e-1)"	0.8	0.8	0.1	0.2	0.1	0.2	0.6	0.5	0.3	0.4	0.0	0.6	0.2	0.5	0.2	1.4	0.4	0.0	0.9	0.1	0.0	0.5	1.3	0.6	0.3	0.0	0.0	0.3	0.7	0.2	0.4	0.0	0.0	0.5	0.2	0.8	0.5	0.0	1.5	1.0	0.5	0.0	0.0	0.5	0.5	10.6	0.0	0.0	0.5	0.0	0.3	0.5	0.7	0.1	0.4	0.8	0.3	1.7	0.0	0.2	0.3	0.3	0.1	0.3	0.2	0.6	0.3	0.9	0.3	0.0	0.2	0.5	0.1	0.0	0.2	0.2	0.7	0.2	1.0	0.4	0.1	0.3	0.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.6	1.0	0.9	1.2	0.1	0.1	0.3	0.7	0.6	0.5	0.8	0.2	0.5	0.5	0.4	0.6	0.1	0.8	0.7	0.2	0.4	1.0	1.1	2.2	0.4	0.5	0.8	0.7	0.2	0.6	1.1	0.8	0.6	1.2	2.0	1.4	1.3	1.2	1.3	1.6	1.3	0.9	1.3	0.7	1.7	1.3	2.5	1.0	0.8	0.1	0.1	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	16.0	30.0	1.3	10.4	33.8	3.0	7.8	0.0	0.6	5.1	2.4	43.1	2.8	16.1	0.0	0.0	20.8	2.4	79.2	11.7	64.5	14.7	2.9	4.4	12.9	60.0	10.7	0.6	47.8	35.1	15.5	0.0	3.2	48.2	0.9	4.2	5.1	17.5	1.7	0.6	96.7	8.2	8.7	27.9	8.7	5.0	7.2	19.6	0.0	41.9	1.2	13.4	0.0	1.0	65.6	61.2	3.0	0.5	10.3	66.5	11.1	6.1	0.5	0.0	6.9	25.9	76.5	4.3	0.0	34.5	27.6	8.9	3.3	121.3	5.0
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337371-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 769.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		210000	"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: AB_2676843"	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	39.4	31.6	50.3	32.8	53.5	20.8	33.9	50.8	88.8	31.3	51.1	56.3	23.1	35.2	41.7	44.4	29.6	18.5	89.6	48.8	55.3	50.9	38.4	30.9	32.6	54.1	52.5	27.0	48.6	32.1	28.2	29.6	55.0	44.0	30.0	23.8	36.5	33.5	102.9	39.4	29.1	28.7	52.8	30.7	42.1	48.6	53.6	26.2	29.3	56.2	36.6	47.8	33.7	53.0	117.0	57.2	63.8	83.5	75.5	88.7	105.4	100.4	62.9	65.3	64.6	132.5	80.9	132.5	84.6	75.2	77.4	64.9	112.6	97.3	114.6	80.8	67.4	159.6	57.7	175.9	59.7	158.0	94.3	60.2	66.8	91.0	92.1	55.9	96.6	80.0	179.6	64.4	95.2	94.9	100.8	145.7	99.5	76.2	83.0	86.8	94.7	108.2	134.9	96.2	53.8	50.9	54.6	123.8	85.3	120.4	50.5	103.0	106.9	100.7	99.3	53.2	90.7	47.4	72.0	106.0	73.3	172.0	75.9	19.8	11.0	13.7	15.5	12.5	18.2	20.9	16.3	15.5	8.4	19.8	15.9	17.0	2.9	18.3	17.3	26.2	12.5	6.4	50.3	53.5	50.8	88.8	48.8	55.3	54.1	52.5	55.0	52.8	53.6	53.0	121.7	109.0	219.6	23.8	152.4	321.3	200.4	209.0	84.8	103.8	159.1	112.1	579.1	135.8	198.6	343.9	50.1	143.7	142.9	135.0	144.8	210.5	769.9	143.1	175.0	153.2	157.9	154.2	27.4	235.1	205.3	130.4	82.0	157.5	172.7	90.0	146.3	480.9	134.7	77.4	28.3	206.7	144.5	123.5	128.9	144.0	124.5	95.7	142.3	18.7	157.7	91.8	145.2	21.6	36.7	282.6	93.8	175.7	183.2	253.9	102.7	226.2	165.4	111.3	276.1	167.3	157.7	575.3	505.0	99.1	324.8	181.4	133.4	101.7	185.1	244.7
ELMO3	"CED-12, CED12, ELMO-3, FLJ13824"	ENSG00000102890	"Engulfment and cell motility 3"	Q96BJ8	16	67199111-67204029	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 63.9;Paneth cells: 50.3;Proximal enterocytes: 100.3;Undifferentiated cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.1;CAPAN-2: 49.3;HaCaT: 46.9;T-47d: 45.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021484	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"		"HPA021484: AB_1848129"	"unprognostic (4.49e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.14e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (6.95e-3)"	"prognostic favorable (2.77e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-2)"	2.8	1.8	1.5	4.3	1.4	5.6	8.8	2.4	2.6	6.4	0.3	24.3	33.1	2.0	4.1	25.8	8.5	8.6	1.9	1.1	1.7	21.4	8.1	8.3	2.9	2.1	1.0	1.8	41.0	8.5	29.8	7.1	2.8	19.3	9.1	0.7	20.3	9.6	1.2	33.5	26.3	0.8	0.4	5.6	26.0	13.0	1.3	2.1	19.3	0.3	2.6	8.5	13.2	1.5	22.1	2.5	2.4	3.0	0.4	0.6	33.1	1.3	0.7	1.6	1.4	14.2	49.3	3.0	1.5	0.7	0.7	46.9	2.2	21.6	0.3	1.4	2.9	3.2	4.8	4.7	1.0	1.9	7.5	0.5	15.6	1.2	1.1	1.6	1.7	2.6	3.1	1.5	0.9	18.4	2.0	9.3	3.2	20.7	1.9	4.6	2.3	4.9	2.0	2.9	16.2	3.6	3.2	14.4	1.5	1.3	45.8	3.4	2.8	3.7	4.5	2.3	2.3	4.9	1.7	5.8	1.9	4.4	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	1.5	1.4	2.4	2.6	1.1	1.7	2.1	1.0	2.8	0.4	1.3	1.5	1.8	0.0	13.1	0.0	2.0	8.8	11.9	21.9	13.1	0.9	20.6	16.3	1.2	15.7	12.6	20.2	0.0	33.8	1.0	63.9	17.6	20.1	22.9	8.8	1.7	1.6	13.1	6.9	0.4	24.0	15.0	1.7	47.4	12.2	4.5	1.3	1.4	3.6	3.6	0.0	0.3	33.8	22.4	1.6	3.1	36.3	0.9	2.6	3.6	1.9	2.8	0.4	0.0	0.0	1.0	24.8	50.3	0.7	1.4	7.9	100.3	28.6	12.3	1.5	0.0	0.4	1.6	14.5	5.9	14.4	13.5	16.8	2.3	5.0	52.3	13.0
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 70.4;Fibroblasts: 115.9;Leydig cells: 110.6;Peritubular cells: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 97.6;BJ: 143.7;fHDF/TERT166: 205.6;U-2197: 817.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2900000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280"	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.62e-3)"	147.2	21.6	11.6	40.8	14.3	0.1	94.2	19.9	17.6	100.2	24.3	57.6	8.8	73.6	18.4	53.0	70.7	76.7	184.1	13.1	15.3	12.8	13.4	214.1	14.5	15.4	20.1	37.0	90.9	2.8	24.9	58.9	13.8	106.4	11.3	2.8	66.9	35.1	17.9	91.3	40.6	90.0	14.9	40.9	63.2	13.1	14.0	5.1	48.4	16.9	4.5	85.3	84.3	17.9	0.0	2.0	0.8	0.0	97.6	0.6	0.6	143.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	205.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.5	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.6	0.6	8.3	0.8	0.8	0.4	58.0	1.0	0.0	0.0	28.0	68.9	0.0	1.2	0.1	10.0	0.6	0.0	0.0	0.2	0.3	817.9	0.0	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	14.3	19.9	17.6	13.1	15.3	15.4	20.1	13.8	14.9	14.0	17.9	34.6	0.0	6.4	34.9	0.1	11.0	13.5	33.9	4.0	2.8	0.9	1.1	9.7	2.8	4.3	7.3	2.1	0.1	0.3	0.2	0.0	0.3	3.5	3.5	70.4	28.4	1.8	0.0	4.6	3.9	0.3	115.9	7.1	2.3	0.0	0.2	47.2	4.2	0.5	6.7	8.1	1.3	0.0	0.6	20.4	7.5	110.6	1.2	14.2	23.4	0.0	15.9	0.0	14.1	18.5	1.1	0.2	148.2	0.4	1.4	0.0	0.1	3.0	0.8	0.0	12.2	34.1	1.1	1.2	2.1	10.9	0.1	1.2	0.6	0.2	1.1
EMP3	YMP	ENSG00000142227	"Epithelial membrane protein 3"	P54852	19	48321509-48330553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 2037.4;Macrophages: 699.2;Melanocytes: 1117.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 195.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 1472.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062030			Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Plasma membrane"		"HPA062030: "	"unprognostic (5.06e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.31e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.31e-7)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-3)"	107.7	85.6	37.6	115.8	37.4	325.1	68.8	37.9	41.0	149.6	36.9	166.7	36.9	143.9	60.7	37.1	96.2	72.5	100.9	38.6	53.8	51.8	29.1	141.0	86.1	52.1	43.9	110.8	18.4	17.1	21.4	67.1	46.9	61.3	65.5	9.2	41.8	90.1	21.7	61.6	81.6	202.9	44.2	91.8	65.3	33.5	43.7	45.2	43.2	43.7	94.7	132.8	106.9	48.4	73.8	739.3	44.9	127.1	691.3	1081.5	1.2	490.7	898.0	627.6	560.7	73.5	265.0	6.9	107.5	1101.0	296.4	12.1	45.5	54.6	390.4	241.3	20.5	335.0	192.0	43.3	572.4	160.2	338.9	586.1	12.2	635.3	436.3	455.5	277.9	66.1	237.4	616.1	1019.5	10.1	25.1	1472.4	55.4	12.1	196.9	22.1	150.1	355.7	554.6	0.4	1.8	2.0	225.2	1.2	131.2	77.2	2.7	253.1	456.6	574.7	236.5	435.8	388.1	287.6	426.6	20.1	339.2	232.5	402.5	2401.3	980.4	1402.3	1324.0	1173.0	1117.1	570.1	1425.3	1327.0	688.7	467.9	818.8	948.4	1094.0	854.5	1148.4	516.9	1631.4	1971.4	37.6	37.4	37.9	41.0	38.6	53.8	52.1	43.9	46.9	44.2	43.7	48.4	66.5	0.0	4.5	5.5	338.0	278.0	75.4	161.0	48.3	2.3	14.7	22.9	5.4	21.5	21.8	33.1	0.0	14.9	375.9	1.5	5.9	72.0	6.5	18.9	255.1	118.6	6.0	94.8	0.2	11.2	26.0	371.3	23.0	15.1	257.0	8.5	128.2	7.2	589.0	0.0	0.3	4.1	42.7	458.8	2037.4	21.3	335.5	699.2	1117.1	6.5	444.5	64.6	565.4	0.0	0.7	114.3	28.2	217.0	334.9	285.5	1.7	9.3	14.6	5.0	105.2	193.0	278.7	16.2	6.7	10.6	189.9	20.2	441.4	29.1	4.9	44.4
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815013-127854658	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 528.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 407.5;Endothelial cells: 514.4;Extravillous trophoblasts: 294.4;Hepatic stellate cells: 579.0;Leydig cells: 487.1;Peritubular cells: 1421.8;Syncytiotrophoblasts: 376.4;Theca cells: 308.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 19.9;intermediate monocyte: 28.2;myeloid DC: 10.3;NK-cell: 7.6;non-classical monocyte: 22.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 10.3;monocytes: 28.2;NK-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 263.8;HUVEC TERT2: 487.4;TIME: 1027.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"		NA	NA		280000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (6.61e-4)"	"prognostic favorable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	234.5	92.6	44.4	80.2	41.5	18.8	164.8	45.2	44.5	129.7	50.4	62.4	33.2	111.1	35.1	43.1	122.4	58.7	528.7	36.7	43.1	211.6	60.7	260.7	43.4	50.0	47.1	220.9	47.1	29.7	56.1	93.6	52.8	93.9	17.5	2.1	46.2	73.5	72.3	51.3	76.8	65.7	43.1	226.5	57.6	98.9	59.4	17.3	169.2	54.8	17.7	93.0	95.8	43.6	1.3	1.0	7.1	0.4	117.8	81.0	217.8	147.1	102.0	74.4	43.4	0.5	1.3	1.0	70.2	263.8	56.8	2.4	0.0	23.2	24.5	0.7	0.3	42.3	76.7	4.6	91.7	20.2	0.5	137.6	5.4	97.7	34.9	1.0	487.4	1.4	0.7	1.4	88.1	0.9	0.6	1.8	1.7	0.3	4.2	66.9	12.5	1.4	0.0	0.4	0.8	1.8	78.0	65.3	20.1	4.7	13.8	29.8	1027.5	248.1	13.7	164.7	0.7	5.2	1.2	0.9	67.1	52.0	83.2	0.0	19.9	0.5	1.8	28.2	0.6	0.6	3.0	3.4	10.3	1.4	1.9	3.0	0.5	7.6	22.1	3.8	1.2	8.4	44.4	41.5	45.2	44.5	36.7	43.1	50.0	47.1	52.8	43.1	59.4	43.6	407.5	3.2	16.0	2.0	9.2	12.0	2.3	2.1	2.8	2.8	9.5	9.8	28.4	18.6	2.3	3.7	4.2	30.0	8.6	0.4	0.0	10.2	8.6	7.7	67.9	514.4	2.4	49.2	0.6	1.1	294.4	85.7	3.1	8.1	15.2	0.8	579.0	9.8	132.0	0.0	0.7	1.6	0.0	65.4	29.7	51.4	487.1	56.6	24.9	78.7	36.2	2.0	4.1	1.5	1.1	1.4	0.0	1421.8	2.1	2.0	0.0	0.3	5.1	4.6	72.3	44.0	57.5	4.4	5.2	1.3	8.4	376.4	9.6	308.1	0.5	1.4
ENKD1	"C16orf48, DKFZP434A1319, FBB11"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.2;Endometrial ciliated cells: 38.3;Respiratory ciliated cells: 42.5;Spermatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Centrosome"	Cytosol	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favorable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	12.8	12.8	8.4	4.6	8.3	3.5	14.9	22.0	11.5	23.2	13.6	28.6	3.9	21.2	5.6	8.6	30.7	3.6	13.2	8.2	8.6	26.6	11.6	14.7	2.2	9.9	10.9	21.2	67.2	16.0	25.6	3.3	8.4	20.6	2.7	8.5	13.7	9.2	9.5	12.1	11.1	4.4	10.0	11.9	15.9	41.1	9.1	4.7	22.3	1.6	2.5	21.5	14.2	8.5	11.1	7.5	17.2	8.0	5.6	5.8	8.5	8.5	5.1	6.7	8.1	5.5	16.5	4.1	14.3	5.3	0.0	12.7	4.5	10.2	8.2	6.5	10.2	4.1	25.7	13.1	9.1	7.4	5.4	5.1	7.3	9.1	8.2	15.4	5.5	13.3	6.9	2.5	3.5	5.7	8.2	30.9	8.2	11.5	3.0	28.5	1.8	31.3	7.2	1.1	17.4	18.9	18.2	1.8	9.7	3.9	15.8	10.5	14.3	8.1	11.4	15.2	0.1	19.1	9.2	4.5	12.3	10.8	2.5	0.0	0.4	0.0	0.1	0.1	0.4	0.2	0.3	0.2	0.1	0.0	0.2	0.3	0.9	0.2	0.2	1.3	0.0	0.1	8.4	8.3	22.0	11.5	8.2	8.6	9.9	10.9	8.4	10.0	9.1	8.5	8.8	22.4	14.4	8.8	1.7	6.9	5.9	6.2	4.0	3.6	10.4	11.2	5.5	10.0	4.0	9.2	4.2	3.1	1.5	4.4	1.9	13.1	34.2	38.3	10.5	8.6	13.2	2.1	2.1	10.7	2.4	7.5	1.5	9.5	1.3	7.4	10.4	26.4	4.7	3.3	2.2	6.0	2.0	3.2	4.3	20.6	13.1	2.6	5.4	0.0	3.0	8.8	0.0	2.5	1.7	9.5	1.4	14.3	2.6	6.0	1.8	7.3	42.5	10.5	6.6	9.1	8.0	37.0	7.9	1.2	5.3	3.4	1.9	11.6	4.9	4.4
EPB41L4A	NBL4	ENSG00000129595	"Erythrocyte membrane protein band 4.1 like 4A"	Q9HCS5	5	112142441-112419313	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 64.3;Oligodendrocyte precursor cells: 164.4;Oligodendrocytes: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 30.1;HeLa: 36.5;RT4: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036580	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Nucleoplasm	"HPA036580: AB_10669908"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.40e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.65e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-1)"	8.7	4.5	4.8	3.2	5.7	3.6	5.3	4.1	4.8	4.1	9.0	4.0	2.6	4.3	12.7	10.1	7.4	13.8	9.2	6.0	5.1	11.7	3.3	7.7	3.3	5.7	4.6	5.7	4.9	8.0	0.5	9.3	4.8	5.8	4.8	16.0	7.2	5.4	4.2	8.8	3.4	2.7	4.9	4.7	5.6	6.1	4.8	3.6	13.5	4.2	3.6	5.1	2.3	4.8	0.8	5.5	14.3	1.5	0.0	0.0	2.9	2.1	0.0	0.0	0.0	3.0	12.3	6.2	30.1	0.0	0.8	7.4	1.1	6.9	0.0	1.0	5.0	9.8	36.5	2.0	0.1	2.6	3.1	0.0	3.0	0.0	0.0	1.6	9.2	1.7	1.9	5.6	0.0	1.8	4.6	3.5	2.7	1.2	1.1	2.3	10.7	1.3	8.4	21.6	11.8	6.1	10.7	5.2	4.5	9.8	15.9	1.4	15.7	0.7	2.4	1.9	4.4	5.6	1.3	4.6	1.4	5.2	0.8	0.5	0.2	0.1	2.0	0.3	1.1	1.4	0.6	0.6	0.2	1.6	0.9	1.8	0.2	0.1	0.5	0.1	0.6	0.5	4.8	5.7	4.1	4.8	6.0	5.1	5.7	4.6	4.8	4.9	4.8	4.8	55.9	28.9	7.7	17.3	4.7	6.0	16.8	11.2	13.6	5.0	11.2	4.7	8.3	64.3	24.2	14.7	4.2	7.4	4.5	8.5	11.7	15.0	20.8	19.7	3.1	35.2	1.2	2.1	28.6	7.5	0.7	8.4	7.1	17.1	8.8	11.9	34.6	1.7	2.7	1.7	31.8	6.3	16.2	4.6	2.1	23.0	1.8	1.8	3.6	56.2	3.2	8.2	14.4	164.4	65.4	14.1	10.9	1.9	6.5	13.7	1.9	30.4	39.5	32.1	0.0	8.7	6.0	1.8	9.1	16.0	8.1	2.5	3.7	2.2	7.5	19.1
EPB41L4B	"EHM2, LULU2"	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171974-109321059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.9;pancreas: 149.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 134.8;Excitatory neurons: 79.7;Hepatocytes: 125.2;Proximal enterocytes: 79.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.7;hTCEpi: 49.8;OE19: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavorable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	21.0	9.7	6.0	4.5	8.7	0.0	15.3	2.0	12.2	4.1	11.8	57.6	47.6	1.2	17.9	1.5	10.8	4.2	8.8	10.7	6.4	6.4	88.9	6.3	0.2	2.7	5.3	13.8	149.1	11.1	1.6	2.5	3.7	7.6	56.7	3.0	26.9	9.1	6.1	15.5	51.9	1.9	7.2	0.1	30.6	7.5	10.9	0.6	44.7	0.7	1.6	2.2	3.4	4.3	8.7	10.8	0.7	0.8	0.8	0.0	31.7	1.1	0.4	3.7	1.9	18.5	8.5	0.0	2.3	1.0	8.9	13.9	21.5	11.5	3.9	9.2	5.1	0.0	3.4	26.5	2.2	0.4	0.0	0.3	49.8	1.5	17.0	1.1	0.2	8.0	0.3	0.0	5.2	22.3	0.4	0.2	13.8	62.8	15.7	0.0	0.0	0.6	12.9	13.1	13.1	1.4	3.4	22.2	0.0	6.3	5.2	0.1	0.5	7.5	7.6	2.5	3.1	0.1	0.1	0.0	5.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	8.7	2.0	12.2	10.7	6.4	2.7	5.3	3.7	7.2	10.9	4.3	0.2	6.4	5.1	2.6	0.4	11.5	5.4	6.0	1.2	7.5	22.7	10.4	18.5	20.0	9.6	7.3	0.0	4.1	0.0	134.8	0.0	3.5	11.7	23.8	2.3	0.8	51.6	0.0	79.7	20.8	2.1	2.5	26.0	20.7	0.0	6.2	5.0	125.2	0.6	38.7	58.9	51.4	12.2	1.6	1.5	1.9	13.4	0.4	1.8	3.7	0.0	1.9	0.0	12.1	3.8	10.2	54.4	2.6	0.0	7.2	79.2	0.8	39.2	1.1	0.0	0.8	1.0	1.4	17.2	0.9	24.0	1.9	0.5	6.8	46.5	6.5
EQTN	"AFAF, C9orf11, equatorin, SPACA8"	ENSG00000120160	Equatorin	Q9NQ60	9	27284654-27297150	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 37.8"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 739.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA015089, HPA015504"	Enhanced		Approved	"Plasma membrane,Actin filaments"	"Secreted in male reproductive system"	NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane, Actin filaments"		"HPA015089: AB_1845795, HPA015504: AB_2067598"	"unprognostic (7.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-3)"	"unprognostic (4.41e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.67e-2)"		"unprognostic (1.14e-1)"	"unprognostic (4.59e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	0.2	0.0	0.4	0.0	1.2	0.0	0.2	0.8	0.6	0.2	0.2	0.3	0.4	0.2	0.5	0.0	0.2	0.0	0.0	0.2	0.4	0.2	0.0	0.3	0.2	1.5	0.9	0.5	0.4	0.0	0.0	0.0	1.3	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.8	0.2	0.2	37.8	1.6	0.0	0.2	0.1	0.0	0.1	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.8	0.6	0.2	0.4	1.5	0.9	1.3	0.8	1.6	2.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	739.3	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	67.8	5.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.7	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	16.2	2.4	0.0	0.3	0.1	0.0	0.1	0.2	0.1
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 72.8;Inhibitory neurons: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		30000000	"Cluster 34: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: AB_2677946"	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	51.5	15.8	3.7	37.0	4.3	27.9	25.5	3.1	5.6	21.8	2.3	37.9	63.4	22.0	14.4	13.2	25.5	23.7	17.1	3.4	5.2	16.4	32.9	31.2	38.2	8.4	5.7	20.7	13.7	19.1	8.2	47.0	7.0	18.6	43.7	12.4	19.3	22.0	20.9	36.5	55.1	21.7	5.0	30.8	33.7	9.1	6.6	63.7	17.5	19.6	36.8	27.3	11.7	6.8	25.9	14.1	21.3	20.0	114.7	111.5	61.4	18.3	59.6	44.0	76.2	17.6	91.1	75.3	37.6	36.0	61.8	25.7	17.8	38.1	27.3	139.8	7.5	24.7	10.0	13.9	130.9	12.0	44.1	46.8	16.2	50.6	15.5	64.3	61.1	48.8	12.9	74.7	26.7	11.6	113.2	12.4	10.6	3.1	10.4	82.4	28.8	38.4	32.8	39.0	7.8	5.5	29.6	19.8	28.6	14.6	17.1	57.0	48.8	37.4	12.6	6.2	31.1	26.9	53.9	57.8	40.2	40.2	22.5	28.8	15.2	18.0	22.6	12.3	20.2	14.8	19.2	19.1	10.5	18.3	22.3	18.1	15.8	23.1	20.6	16.7	13.9	13.7	3.7	4.3	3.1	5.6	3.4	5.2	8.4	5.7	7.0	5.0	6.6	6.8	11.1	9.6	16.3	34.0	15.3	25.0	14.2	19.2	8.6	13.6	6.6	3.9	10.6	10.0	16.9	9.2	2.1	9.6	21.1	24.4	0.0	12.4	27.0	12.7	15.0	16.3	10.3	14.1	72.8	15.5	11.9	18.4	16.3	19.8	15.2	13.9	16.8	28.0	17.6	3.3	79.3	23.9	4.1	29.9	16.1	7.3	9.9	22.9	7.2	24.4	32.5	9.0	20.6	32.6	70.1	12.3	14.1	16.1	32.3	13.5	47.3	6.9	23.1	7.6	0.0	10.3	22.6	1.4	1.8	9.8	11.1	9.2	21.8	5.7	27.3	14.9
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318631-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 498.6;choroid plexus: 136.2"	"Cell type enriched"	"Detected in some"	51	"Oligodendrocytes: 290.9"	"Cancer enriched"	"Detected in some"	4	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HAP1: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	0.7	0.2	212.4	2.3	342.3	18.8	0.5	312.8	386.9	0.5	136.2	0.7	0.5	0.4	0.1	0.4	0.4	0.8	0.3	208.7	266.4	0.5	0.5	2.4	3.3	408.3	313.2	0.2	0.3	0.0	0.4	0.1	391.8	0.3	0.9	0.6	1.7	0.3	0.4	0.7	3.8	0.3	266.5	4.7	1.3	0.5	300.8	1.6	0.4	0.0	3.0	0.7	0.3	498.6	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.3	0.0	1.9	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	3.5	0.4	0.2	0.7	2.3	0.2	0.1	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.5	0.0	0.1	0.0	0.3	0.6	1.2	0.0	0.2	0.1	0.3	0.6	3.4	2.5	0.6	1.7	0.9	0.9	0.5	0.3	0.3	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.3	0.3	0.6	0.5	0.2	0.3	0.2	0.1	212.4	342.3	312.8	386.9	208.7	266.4	408.3	313.2	391.8	266.5	300.8	498.6	0.1	0.0	1.3	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.8	0.2	0.0	1.2	0.9	0.1	0.0	2.2	0.0	1.9	1.1	0.0	3.1	2.0	290.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0
ETNK1	"EKI, EKI1"	ENSG00000139163	"Ethanolamine kinase 1"	Q9HBU6	12	22625075-22690665	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 299.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010712, HPA029407"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA010712: AB_2668349, HPA029407: AB_2673026"	"unprognostic (2.06e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.98e-3)"	"unprognostic (8.30e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.53e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.75e-4)"	10.1	14.4	13.7	14.5	15.2	12.2	13.7	9.0	15.9	10.8	16.4	27.2	23.3	10.2	19.6	10.8	10.1	14.0	7.3	14.7	28.1	18.4	18.2	12.6	17.4	12.0	14.2	11.7	10.7	10.8	13.7	11.3	15.8	10.9	15.3	18.2	12.4	6.2	6.2	15.3	15.5	7.6	11.1	16.7	45.0	17.8	19.3	23.1	14.5	5.6	14.3	10.8	9.5	17.5	14.8	27.9	30.4	27.5	21.2	21.3	21.7	15.6	12.2	17.4	16.0	20.6	33.3	41.1	14.7	11.6	16.5	10.7	27.1	7.6	28.2	36.8	23.7	34.7	11.5	18.9	20.6	33.9	29.4	13.7	7.2	21.9	17.4	25.8	20.3	15.7	41.8	17.2	22.3	7.7	38.8	67.1	59.3	17.9	20.1	32.7	28.1	32.9	25.6	16.5	9.8	17.8	18.9	13.9	27.1	41.1	24.1	32.1	17.5	12.2	19.9	18.6	25.0	12.9	18.1	46.8	16.2	21.0	23.9	44.0	14.3	15.9	15.4	22.0	15.2	22.2	16.4	14.4	14.1	15.3	17.7	17.7	14.6	17.7	23.4	12.6	20.5	19.2	13.7	15.2	9.0	15.9	14.7	28.1	12.0	14.2	15.8	11.1	19.3	17.5	33.6	48.1	32.2	48.0	55.9	144.3	75.7	34.7	64.9	41.0	56.8	42.2	10.1	45.8	43.8	44.1	50.1	30.1	57.6	116.1	27.4	30.7	299.0	64.2	49.1	34.8	108.3	48.8	104.4	44.5	24.2	38.2	230.4	51.4	34.8	40.9	28.2	41.5	42.9	26.9	104.3	60.7	46.8	88.3	60.0	43.5	24.2	57.0	67.6	84.3	39.1	17.7	43.3	121.2	152.9	39.5	62.9	21.4	63.7	73.8	57.7	33.2	81.6	39.5	39.5	23.3	38.9	49.1	18.5	51.9	170.2	75.4	49.0	41.5	47.8	90.3
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 191.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Cytotrophoblasts: 43.3;Hepatocytes: 78.1;Proximal tubular cells: 77.3;Syncytiotrophoblasts: 124.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 85.7;U-138 MG: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"		NA	Yes				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	1.1	0.5	0.2	1.1	0.9	0.1	3.4	0.6	0.5	9.8	0.2	0.7	1.7	2.8	9.6	0.4	3.7	1.2	1.6	0.2	0.3	20.0	191.6	20.7	0.4	1.1	0.5	0.5	23.8	7.6	1.1	17.3	0.9	0.9	0.7	0.5	8.9	2.2	1.2	2.7	1.8	2.0	0.7	10.8	0.6	2.9	0.8	5.1	1.8	1.6	0.3	0.8	0.8	0.8	1.0	14.5	1.5	0.4	3.1	21.2	1.4	68.0	45.3	59.2	30.1	0.5	1.2	0.1	6.3	85.7	54.2	9.4	1.7	14.4	36.8	0.0	1.1	0.0	2.5	45.7	2.2	0.0	0.1	15.0	8.3	73.2	33.3	59.0	37.2	0.0	0.0	0.0	46.1	0.0	0.1	0.0	3.3	0.2	23.5	7.9	0.1	0.0	32.5	0.5	0.9	1.6	6.2	0.4	53.7	2.2	0.2	0.3	31.0	110.3	46.3	2.0	71.9	0.7	0.1	0.3	62.5	0.0	59.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.5	0.2	0.3	1.1	0.5	0.9	0.7	0.8	0.8	6.1	41.7	35.4	1.0	0.9	2.8	13.7	14.3	3.4	1.2	11.7	12.3	0.3	1.5	23.0	11.0	0.0	43.3	0.4	0.1	27.4	30.5	12.2	13.3	1.4	4.8	1.8	0.0	1.1	16.1	25.9	4.7	0.0	11.4	0.0	0.0	2.2	78.1	3.5	0.0	0.9	1.1	4.1	0.8	1.2	9.4	0.3	0.6	28.4	2.8	0.1	0.0	0.0	1.5	0.9	9.7	0.0	0.7	0.0	12.3	0.5	77.3	1.7	0.1	0.0	2.2	9.0	2.2	0.9	1.1	0.9	124.8	1.1	0.0	1.6	10.5
EVI2B	"CD361, D17S376, EVDB"	ENSG00000185862	"Ecotropic viral integration site 2B"	P34910	17	31303770-31314105	"CD markers, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 189.0;lymphoid tissue: 169.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 233.2;Kupffer cells: 522.3;Langerhans cells: 169.8;Macrophages: 271.9;monocytes: 426.4;T-cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1366.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1366.0;monocytes: 381.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 87.9;HL-60: 99.9;HMC-1: 133.3;Karpas-707: 96.4;NB-4: 79.4;RPMI-8226: 147.7;THP-1: 124.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007346, HPA053383"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA007346: , HPA053383: "	"unprognostic (1.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.73e-2)"	24.6	11.0	6.4	100.9	7.3	189.0	13.8	7.3	11.6	13.1	8.7	27.9	23.7	7.4	4.3	11.8	7.8	30.5	6.7	6.3	8.4	5.1	24.9	61.1	159.5	13.3	10.3	5.5	3.0	3.8	1.8	15.4	10.8	7.4	30.5	1.2	11.8	6.1	2.0	5.1	39.2	17.0	7.7	158.8	33.7	3.7	8.5	76.4	5.3	12.2	169.8	38.5	4.1	11.1	0.6	0.7	0.0	0.0	6.5	8.3	0.1	0.8	5.8	6.7	12.4	0.0	3.4	87.9	0.1	5.5	26.4	0.6	0.0	1.2	7.5	0.1	0.0	2.1	0.0	0.0	66.0	99.9	133.3	15.3	0.0	3.9	5.3	2.2	6.9	7.3	1.4	96.4	19.8	0.0	29.4	79.4	0.1	0.0	0.0	51.0	0.4	147.7	0.3	0.2	0.0	0.1	0.4	0.2	0.5	0.0	0.0	124.8	7.2	1.9	0.2	0.7	7.0	18.4	0.9	18.9	8.6	34.0	2.2	1005.3	328.9	798.7	79.2	240.1	76.8	183.6	120.8	102.8	149.9	146.2	91.9	87.5	1366.0	44.2	381.9	86.3	173.6	251.4	6.4	7.3	7.3	11.6	6.3	8.4	13.3	10.3	10.8	7.7	8.5	11.1	2.1	0.0	14.8	0.7	233.2	5.4	0.7	0.7	1.8	0.2	1.5	1.7	1.0	2.8	6.7	1.8	0.0	0.6	129.0	1.3	0.0	0.3	8.3	0.1	0.3	5.6	0.0	6.5	2.7	0.0	0.8	4.0	1.5	0.4	82.2	0.0	7.5	2.3	89.1	0.0	3.1	0.1	2.0	522.3	169.8	9.0	0.0	271.9	37.4	11.2	426.4	0.0	117.4	4.0	31.7	1.0	0.0	0.4	110.4	0.4	0.1	1.1	2.4	0.8	19.7	1.2	1.9	0.4	0.4	0.4	3.7	0.3	170.9	0.0	1.3	1.1
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853648-55905086	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: AB_2679125"	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (5.50e-5)"	19.7	16.5	18.1	17.3	20.4	12.7	20.0	20.4	20.0	18.9	18.7	18.0	16.8	16.6	20.4	29.3	16.5	15.5	16.5	18.3	20.0	15.9	10.2	17.4	18.3	21.1	19.2	15.1	12.9	20.5	14.5	20.8	20.3	14.3	19.1	18.5	17.4	12.8	13.6	28.1	16.2	15.7	20.4	20.8	15.6	16.9	20.1	13.9	16.3	13.5	20.0	16.2	20.1	25.1	21.8	12.4	21.9	25.3	36.9	45.9	14.6	30.2	30.1	24.1	25.1	8.6	37.1	20.9	20.6	32.6	29.1	25.4	18.0	23.9	34.5	11.1	12.4	19.4	14.8	10.1	34.7	21.3	26.4	37.4	32.1	25.1	27.6	31.2	39.9	16.0	28.3	20.1	53.0	13.8	15.6	21.5	13.9	31.2	23.4	18.0	16.4	17.1	26.9	23.6	16.2	28.7	18.0	29.2	25.5	18.5	18.6	22.6	48.5	29.7	24.2	25.8	26.3	23.9	12.7	18.4	38.6	23.4	28.8	21.3	14.6	13.1	6.5	19.0	8.8	8.4	9.2	9.5	14.3	8.3	8.3	6.0	19.5	12.5	23.6	6.4	11.6	7.9	18.1	20.4	20.4	20.0	18.3	20.0	21.1	19.2	20.3	20.4	20.1	25.1	44.7	41.7	38.0	77.4	24.5	34.8	14.8	34.0	22.2	48.8	26.4	21.2	29.1	17.2	35.6	22.0	31.3	60.8	21.4	38.3	19.6	23.6	45.3	41.0	47.5	39.0	22.2	19.6	72.6	20.0	31.6	28.9	22.4	37.2	36.7	35.5	40.0	12.3	40.9	28.6	86.5	28.8	24.4	37.7	47.4	16.7	21.5	37.8	40.9	56.2	38.7	40.3	22.6	73.4	138.0	36.2	32.4	23.7	19.0	17.4	37.6	21.9	44.7	32.5	32.9	25.9	27.9	47.6	31.6	42.5	39.9	51.2	27.8	44.6	28.7	26.8
EXOC3L1	"EXOC3L, FLJ35539, FLJ35587"	ENSG00000179044	"Exocyst complex component 3 like 1"	Q86VI1	16	67184379-67190185	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 44.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.4;Endothelial cells: 19.6;Granulosa cells: 20.8;Hepatic stellate cells: 28.9;Leydig cells: 15.5;Peritubular cells: 18.4;Theca cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;HUVEC TERT2: 3.5;SCLC-21H: 6.4;SuSa: 2.1;TIME: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029574	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA029574: AB_10602495"	"unprognostic (1.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.64e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.35e-1)"	6.4	4.6	0.5	1.8	0.5	0.0	4.1	1.0	0.8	2.6	0.0	1.6	0.9	2.8	0.1	1.3	1.8	1.1	5.4	0.5	0.5	7.3	2.1	10.0	1.4	0.8	0.2	3.6	1.6	0.8	2.0	5.9	1.1	2.4	0.4	0.2	1.6	0.6	2.1	1.2	1.7	0.9	0.1	44.7	1.5	2.1	0.4	0.1	7.1	0.8	0.2	1.7	1.3	0.1	0.1	0.0	0.7	0.2	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.8	0.1	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	3.5	0.4	0.3	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.4	0.8	0.7	0.1	0.0	0.1	6.4	0.8	0.8	0.1	0.0	2.1	0.6	0.0	2.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.5	1.0	0.8	0.5	0.5	0.8	0.2	1.1	0.1	0.4	0.1	26.4	0.0	0.0	0.3	0.3	0.9	2.1	2.8	5.7	1.5	3.0	5.2	1.6	0.0	0.4	3.7	0.0	0.6	0.2	4.6	7.9	1.0	2.0	0.1	0.3	19.6	1.2	2.7	0.1	3.7	4.3	2.6	1.5	0.4	0.0	20.8	28.9	1.4	0.8	3.3	0.3	3.4	2.0	1.9	0.2	5.5	15.5	1.8	0.0	1.0	4.0	0.3	0.0	1.0	0.0	0.6	3.1	18.4	0.0	0.4	8.9	0.2	0.3	0.9	0.0	0.3	1.1	4.0	8.6	1.2	2.0	0.8	0.2	32.5	2.7	1.6
EXOC7	"BLOM4, EXO70, Exo70p, KIAA1067, YJL085W"	ENSG00000182473	"Exocyst complex component 7"	Q9UPT5	17	76081016-76121576	"Human disease related genes, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022840, HPA022842"	Supported		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Vesicles, Plasma membrane"	"HPA022840: AB_1848316, HPA022842: AB_1848317"	"unprognostic (5.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-1)"	40.4	31.4	36.0	32.7	37.0	53.2	31.2	31.4	36.7	39.3	34.1	40.1	32.5	40.1	33.1	52.3	52.3	35.4	47.2	36.8	35.5	31.9	30.2	35.9	32.7	35.4	34.3	49.6	41.1	61.2	41.0	35.3	36.5	48.1	27.9	24.7	50.6	43.1	43.0	37.0	34.7	43.5	31.9	32.4	30.3	24.9	36.4	43.5	43.0	41.4	32.3	44.3	30.1	34.8	65.6	79.4	71.9	58.5	66.6	47.0	74.5	58.9	77.6	103.9	74.7	67.5	43.0	33.7	42.0	103.0	65.6	52.7	43.9	57.1	69.0	29.3	59.1	55.8	64.0	72.3	46.4	62.9	55.7	66.1	44.3	80.5	39.2	73.5	116.9	59.8	38.1	33.7	65.6	59.8	102.1	27.8	37.8	49.5	83.4	54.0	123.3	34.6	59.7	133.6	38.9	91.4	66.5	48.6	44.6	68.8	79.7	51.0	77.5	111.3	66.3	74.1	65.8	46.0	18.2	31.2	66.4	28.0	59.0	55.1	41.1	66.1	35.5	57.4	24.4	26.7	26.9	30.4	28.9	26.9	27.7	23.9	46.2	36.4	79.7	12.3	32.0	44.9	36.0	37.0	31.4	36.7	36.8	35.5	35.4	34.3	36.5	31.9	36.4	34.8	31.0	19.2	35.0	36.6	37.7	19.8	40.1	40.8	31.3	87.6	30.2	28.8	7.5	28.6	41.4	40.5	143.9	51.5	37.5	47.6	33.2	38.3	22.4	35.1	25.8	27.1	48.9	48.6	26.2	37.1	29.0	31.6	27.0	34.4	41.1	65.0	30.7	27.0	37.7	67.3	31.1	43.8	54.9	29.6	21.3	52.2	37.3	26.9	24.9	15.0	36.8	52.1	56.7	44.2	35.0	44.6	41.4	38.4	15.7	41.5	62.8	35.3	43.7	108.8	46.0	27.8	49.5	32.1	16.6	20.3	19.9	71.1	35.8	56.6	29.8	44.8
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 59.4;stomach 1: 44.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.9;Distal enterocytes: 124.7;Gastric mucus-secreting cells: 74.5;Glandular and luminal cells: 74.7;Paneth cells: 86.1;Suprabasal keratinocytes: 168.4;Urothelial cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 42.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 126.0;RPTEC TERT1: 205.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	1.0	1.3	0.8	6.2	0.9	1.7	8.0	0.5	0.8	3.6	8.9	59.4	45.8	2.9	4.8	8.2	8.2	29.9	4.6	0.5	0.8	31.8	7.1	4.1	1.4	1.7	2.2	0.5	23.6	5.2	1.5	3.9	1.4	5.0	53.0	2.6	8.9	11.5	0.3	37.5	41.0	2.7	1.0	3.8	44.0	0.6	0.9	1.1	8.3	0.2	1.6	27.5	5.8	0.8	32.7	52.1	4.3	0.2	1.5	4.0	33.1	1.6	17.1	0.9	2.7	45.0	81.8	0.0	69.5	3.7	78.1	54.4	27.1	24.0	1.5	0.1	26.8	0.8	1.0	32.8	10.6	0.0	0.3	5.5	67.3	8.0	49.8	8.0	84.9	7.8	0.4	0.0	0.1	17.6	3.8	0.1	5.7	17.9	126.0	0.1	0.0	0.8	205.9	58.5	2.1	0.4	12.3	12.6	0.3	48.5	5.3	0.3	57.1	0.1	31.8	0.1	0.3	4.8	1.0	0.1	18.7	0.0	1.4	11.9	10.0	1.8	0.4	3.2	2.1	0.5	3.8	1.9	4.7	0.1	3.4	2.1	42.0	0.7	0.5	0.5	1.0	4.0	0.8	0.9	0.5	0.8	0.5	0.8	1.7	2.2	1.4	1.0	0.9	0.8	0.3	9.6	3.7	0.0	0.9	109.9	17.8	4.5	10.8	0.5	10.5	6.3	0.3	32.9	12.7	31.3	0.0	5.4	0.2	124.7	1.9	28.0	0.0	40.9	5.1	1.2	13.1	2.5	0.2	15.0	7.9	2.9	74.5	74.7	2.5	1.0	1.1	9.6	0.9	0.0	1.4	50.8	4.1	1.9	3.8	0.0	0.0	2.1	1.8	1.0	2.6	0.0	0.0	0.0	0.0	44.7	86.1	0.0	0.1	34.1	62.9	19.3	25.0	2.0	0.0	0.4	2.8	0.9	1.3	37.0	168.4	2.1	2.1	0.1	50.7	116.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322138	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"intestine: 550.0"	"Cell type enriched"	"Detected in some"	10	"Proximal enterocytes: 5965.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 1.6;neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		61000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.2	0.1	0.1	3.1	0.1	0.9	0.0	0.6	0.2	0.0	0.4	28.2	291.0	0.3	0.1	0.1	0.2	0.1	0.6	0.2	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.3	0.0	0.0	0.1	0.4	550.0	1.9	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.3	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.6	0.4	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.2	4.2	0.4	0.1	0.3	0.3	0.0	0.1	0.1	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.8	0.0	0.0	0.0	242.0	0.0	0.0	0.0	1.4	0.1	0.1	1.2	0.0	0.0	0.2	0.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	570.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	383.1	0.0	0.0	0.0	5965.8	17.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	222.5	0.0
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280536-81284777	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 3691.0;vagina: 2600.3"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 2511.2;Alveolar cells type 2: 1891.0;Hofbauer cells: 2385.2;Squamous epithelial cells: 9211.0"	"Group enriched"	"Detected in all"	4	"cervical cancer: 268.3;head and neck cancer: 288.8;urothelial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 1167.2;MOLT-4: 1213.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		14000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	379.8	15.5	107.9	137.8	112.9	111.8	241.8	112.3	146.5	1340.4	307.4	256.7	83.3	62.7	4.8	3691.0	22.4	87.7	343.4	116.6	130.7	34.0	27.5	272.5	191.4	162.8	120.5	12.1	73.1	443.0	32.7	338.8	155.7	22.9	210.6	33.3	514.9	17.1	119.1	692.7	122.3	52.4	133.1	127.4	181.2	45.1	118.2	137.6	74.9	306.1	292.9	362.3	2600.3	138.9	76.9	215.9	133.1	0.3	615.7	59.0	0.3	158.0	8.9	123.2	153.3	2.2	100.3	1167.2	86.7	38.3	1.1	69.2	328.9	254.8	103.7	597.6	603.2	449.0	136.2	345.0	54.2	421.6	107.9	45.0	507.0	146.8	306.1	121.3	708.9	328.6	125.9	124.1	73.7	69.3	1213.7	199.9	170.5	785.1	732.1	526.0	0.4	127.7	198.9	951.4	514.4	190.7	74.1	24.7	61.0	230.2	1.2	201.6	97.0	0.1	331.3	1.6	1.4	155.6	70.1	902.2	52.2	396.8	184.9	8.1	14.3	0.9	6.1	16.6	9.3	17.2	6.9	13.7	55.9	10.4	3.1	11.9	5.2	22.3	5.5	54.8	9.8	13.4	107.9	112.9	112.3	146.5	116.6	130.7	162.8	120.5	155.7	133.1	118.2	138.9	2511.2	288.4	1891.0	30.7	93.0	121.0	90.0	881.2	727.3	23.7	22.3	48.6	5.7	2.8	649.8	22.0	45.9	28.0	97.5	420.3	3.9	35.4	29.5	55.7	579.5	662.2	197.2	74.4	7.7	23.8	272.4	140.6	278.8	29.6	55.8	70.1	35.3	1.4	2385.2	21.9	10.9	216.3	175.0	182.2	764.3	46.0	6.2	405.5	206.3	4.7	697.1	273.0	15.5	6.0	16.3	43.3	561.0	5.3	132.9	71.3	10.4	2.3	115.7	43.5	361.6	140.0	336.8	179.4	182.5	9211.0	168.6	27.0	102.3	68.8	419.2	232.6
FAIM	"FAIM1, FLJ10582"	ENSG00000158234	"Fas apoptotic inhibitory molecule"	Q9NVQ4	3	138608606-138633376	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"retina: 235.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 173.3;Rod photoreceptor cells: 228.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 135.7"					"Low region specificity"	"Detected in all"			"HPA042440, HPA052209"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA042440: AB_2677999, HPA052209: AB_2681761"	"unprognostic (6.45e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (3.96e-5)"	"unprognostic (4.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.63e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.98e-2)"	18.3	8.6	16.8	6.9	17.9	4.1	15.6	17.5	21.3	31.7	14.9	9.3	6.4	12.6	19.5	12.2	38.2	12.1	6.4	16.2	18.6	15.3	8.2	10.5	10.8	18.9	17.7	10.8	38.1	8.5	10.4	8.4	19.4	14.9	7.9	235.0	9.6	21.7	5.4	8.5	6.1	9.7	19.2	4.9	9.8	7.3	17.1	19.8	20.3	5.5	13.7	13.5	10.4	19.9	80.8	15.5	1.7	13.9	14.7	27.2	55.4	24.4	14.7	25.2	21.5	26.8	23.2	0.2	21.0	32.0	29.0	20.9	66.8	13.9	28.2	66.2	69.8	15.1	42.9	39.1	16.3	0.0	4.8	38.4	26.5	9.4	14.4	15.4	27.5	5.7	10.0	20.0	15.8	30.7	0.4	68.3	30.1	2.5	15.3	81.4	18.0	2.1	40.4	39.5	26.0	22.1	43.2	23.8	64.6	16.4	40.1	20.0	16.9	5.1	11.9	25.9	12.0	0.0	0.4	135.7	20.8	0.2	21.0	16.8	2.9	2.2	10.5	3.3	9.6	17.0	5.8	8.4	6.3	12.0	3.8	9.8	0.4	18.8	2.2	4.3	6.9	4.3	16.8	17.9	17.5	21.3	16.2	18.6	18.9	17.7	19.4	19.2	17.1	19.9	16.4	19.2	22.9	9.1	12.7	10.8	30.3	35.2	14.2	31.9	14.3	21.5	5.3	68.6	32.4	25.8	66.7	42.0	14.7	5.9	31.3	63.1	12.0	173.3	29.8	14.5	21.1	7.2	7.7	50.0	33.3	16.8	8.2	41.3	41.2	17.2	8.9	9.4	25.2	15.2	6.1	8.8	14.2	3.2	5.7	16.5	17.4	6.5	16.0	1.9	15.6	45.3	21.6	11.1	16.5	31.3	4.4	19.9	14.2	22.1	2.2	28.1	77.5	228.3	0.0	25.0	22.6	14.1	4.2	16.6	13.1	14.6	10.8	14.6	11.7	21.6
FAM161B	"C14orf44, FLJ31697"	ENSG00000156050	"FAM161 centrosomal protein B"	Q96MY7	14	73931501-73950414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 62.9;Late spermatids: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019125	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA019125: AB_1845570"	"unprognostic (1.50e-1)"	"unprognostic (9.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (6.78e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.60e-1)"	2.7	8.7	6.6	1.7	6.6	1.2	4.8	5.8	8.2	5.3	3.4	3.9	3.3	5.2	4.3	4.1	5.5	2.7	5.4	6.4	5.9	7.2	5.1	2.8	1.8	6.8	5.7	12.8	2.2	4.3	7.6	2.4	7.1	6.0	2.7	10.1	2.8	5.2	7.9	2.1	3.3	3.4	5.5	3.1	3.3	18.8	6.1	1.9	4.2	4.8	1.8	5.5	3.8	6.6	2.1	1.6	2.2	3.4	4.7	3.5	2.0	3.6	2.8	6.0	5.8	1.5	2.6	3.3	2.3	4.2	2.5	3.9	0.9	1.7	4.1	9.2	1.8	1.6	1.6	1.7	4.0	1.1	2.3	2.6	3.4	6.1	2.2	4.4	2.7	3.4	1.0	1.6	4.3	3.3	3.1	4.2	0.5	1.4	3.5	2.1	2.9	1.3	3.1	3.1	2.7	2.5	5.1	2.3	3.1	1.6	8.1	1.5	2.9	12.4	5.6	3.1	2.2	3.3	2.2	2.1	6.3	1.9	2.2	3.2	1.3	1.9	1.1	0.3	1.3	0.7	1.2	1.7	0.2	0.9	0.6	0.4	0.4	1.3	0.4	0.3	0.7	0.9	6.6	6.6	5.8	8.2	6.4	5.9	6.8	5.7	7.1	5.5	6.1	6.6	3.5	3.2	4.8	4.9	3.0	0.6	2.1	1.0	3.4	8.9	3.7	3.8	3.4	0.0	3.2	1.8	4.2	1.5	1.9	3.5	0.0	1.0	62.9	5.9	3.9	2.2	0.0	1.7	7.3	1.6	1.1	4.6	7.1	4.5	0.0	5.0	2.5	0.7	2.9	3.3	8.6	4.1	2.0	1.2	0.7	142.7	3.4	1.4	1.8	2.8	2.2	8.0	6.2	5.5	2.9	1.2	0.8	9.4	1.4	0.8	4.3	4.2	9.4	16.7	6.6	5.2	4.2	11.0	6.1	0.6	0.9	2.2	3.3	9.6	1.4	0.9
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133577081-133609389	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 60.1"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 24.8;Inhibitory neurons: 17.8;Late spermatids: 17.3"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"	"Group enriched"	"Detected in many"	6	"amygdala: 26.5;basal ganglia: 44.4;cerebral cortex: 60.1;hippocampal formation: 38.2;white matter: 32.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"SH-SY5Y: 50.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067336	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: AB_2685825"	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	10.0	26.5	0.0	44.4	0.0	0.0	0.0	60.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.1	0.4	5.2	38.2	0.0	0.8	8.7	0.3	1.7	0.0	0.0	0.4	0.1	0.0	0.5	0.8	7.3	0.2	0.5	0.2	0.3	0.8	0.0	0.0	0.0	0.0	6.0	0.2	0.4	2.4	0.0	0.2	0.2	0.0	0.0	1.1	0.1	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.7	0.2	0.1	0.0	0.0	2.4	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	44.4	0.0	60.1	38.2	0.0	0.0	0.0	7.3	6.0	0.0	32.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM171A1	"APCN, C10orf38, FLJ12884"	ENSG00000148468	"Family with sequence similarity 171 member A1"	Q5VUB5	10	15211643-15371289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 263.8;Cholangiocytes: 98.7;Excitatory neurons: 166.9;Oligodendrocytes: 214.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 1.7;MAIT T-cell: 4.4;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"TIME: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051345	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	Nucleoplasm	"HPA051345: AB_2681449"	"unprognostic (3.60e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.71e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (4.90e-6)"	"unprognostic (3.28e-2)"	11.0	5.0	60.1	7.5	73.2	0.5	8.8	69.8	56.4	11.8	22.7	21.6	19.1	12.8	6.4	6.4	15.6	12.9	10.6	68.5	49.5	31.9	15.4	7.4	6.0	79.6	64.8	14.2	22.4	10.9	3.7	4.1	75.6	11.2	17.6	2.6	14.1	11.9	7.6	4.2	13.0	12.3	59.3	12.4	13.3	3.5	68.7	3.9	6.9	6.1	6.6	9.0	6.3	86.7	0.0	16.2	33.3	12.6	13.2	24.9	0.4	19.5	3.9	10.2	8.8	3.0	19.2	0.1	21.5	53.4	22.7	1.4	24.0	0.2	11.5	5.9	33.4	46.7	5.2	48.1	14.3	0.0	36.0	19.7	4.9	27.8	4.0	36.8	51.4	6.8	17.5	0.2	32.8	1.4	7.7	0.1	30.4	9.3	7.8	30.4	17.0	5.1	12.7	0.0	22.4	27.6	10.9	0.2	0.1	35.0	0.2	0.6	105.6	13.9	53.6	50.4	20.8	6.3	2.1	0.1	30.3	0.0	10.8	0.0	0.0	0.0	1.7	0.0	4.4	0.0	2.5	2.2	0.0	0.0	4.7	2.4	0.0	0.2	0.0	0.0	0.5	0.9	60.1	73.2	69.8	56.4	68.5	49.5	79.6	64.8	75.6	59.3	68.7	86.7	11.1	0.0	0.0	263.8	1.0	1.3	4.0	3.1	8.0	4.0	7.6	5.7	6.8	98.7	1.7	14.7	0.0	0.1	0.2	25.4	3.9	21.1	0.7	5.9	12.5	43.7	21.0	6.5	166.9	12.2	0.2	12.3	35.7	14.6	1.3	14.4	49.2	24.7	0.4	6.7	76.6	23.7	4.1	2.8	1.7	1.1	5.3	0.3	1.8	33.7	0.7	1.5	0.0	44.2	214.4	17.5	16.1	5.7	5.2	16.5	7.3	4.5	2.4	1.1	0.0	7.5	5.9	2.3	5.7	8.0	1.8	0.1	2.0	11.4	38.8	3.6
FAM186A	LOC121006	ENSG00000185958	"Family with sequence similarity 186 member A"	A6NE01	12	50326230-50396622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 14.2"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 521.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047128, HPA064735"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA047128: AB_10967726, HPA064735: "	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.65e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.22e-3)"	0.1	0.3	0.2	0.2	0.4	0.5	0.1	0.6	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.2	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.2	0.3	0.0	0.9	0.0	0.1	0.3	0.1	0.7	0.2	0.0	1.1	0.3	0.2	0.0	0.0	0.3	0.1	14.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	521.1	0.1	0.2	0.1	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	64.7	0.6	0.1	0.0	2.8	0.0	0.6	0.0	1.5	3.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM193A	"C4orf8, RES4-22"	ENSG00000125386	"Family with sequence similarity 193 member A"	P78312	4	2536647-2732573	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043116	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA043116: AB_10795767"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.84e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.96e-3)"	14.3	11.7	9.7	7.6	9.3	13.0	13.2	15.1	11.5	14.8	9.6	13.4	7.9	13.8	6.8	9.6	12.9	6.0	9.7	9.5	9.7	11.9	11.6	10.1	9.6	9.8	9.0	15.0	11.1	9.2	15.5	7.6	9.3	12.1	6.0	8.9	10.1	7.0	15.1	13.2	12.3	8.0	6.9	12.0	10.5	21.1	10.5	12.4	12.2	8.7	6.7	11.5	11.2	11.8	8.7	10.7	20.0	11.3	12.0	12.2	10.5	13.1	11.3	12.7	10.8	10.9	13.9	17.1	7.7	14.7	15.7	7.4	14.0	9.4	10.8	10.3	8.9	25.7	14.3	11.5	14.4	15.8	17.2	13.3	9.8	12.7	13.0	11.6	12.8	10.0	18.2	18.5	10.8	9.4	25.5	25.6	15.9	8.9	11.8	24.7	10.3	8.4	8.7	11.1	17.1	14.6	11.2	7.8	11.3	10.9	14.3	15.9	17.4	19.2	11.3	10.5	17.5	18.0	14.5	16.1	10.7	12.8	13.8	3.3	0.9	0.8	0.8	0.6	0.6	0.6	0.7	1.2	0.6	0.9	0.7	1.1	1.8	1.3	3.1	1.7	0.6	0.5	9.7	9.3	15.1	11.5	9.5	9.7	9.8	9.0	9.3	6.9	10.5	11.8	21.8	12.8	18.2	62.7	11.2	9.4	6.7	6.5	9.1	25.7	10.5	9.0	14.7	4.3	15.6	1.8	47.9	7.3	20.0	12.9	1.9	9.4	8.9	19.8	21.8	19.4	14.4	17.9	62.4	7.5	7.1	13.2	15.8	27.1	8.8	30.2	11.0	6.3	8.7	15.2	70.8	11.1	8.2	7.6	11.6	13.4	17.1	15.9	14.2	51.5	11.1	15.8	11.3	45.8	58.3	10.1	11.0	14.7	12.4	11.3	11.4	2.8	5.6	26.2	6.6	20.5	17.5	36.2	32.4	9.6	9.9	5.6	14.4	13.6	9.6	9.2
FAM210B	"C20orf108, dJ1167H4.1, DKFZP434A1114"	ENSG00000124098	"Family with sequence similarity 210 member B"	Q96KR6	20	56358974-56368663	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 449.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 299.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042652	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"		"HPA042652: AB_2678098"	"unprognostic (3.29e-1)"	"prognostic favorable (5.44e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.34e-2)"	"unprognostic (9.45e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (1.44e-10)"	"unprognostic (1.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.00e-1)"	38.2	87.6	32.1	13.9	34.1	85.2	62.0	30.0	33.6	43.7	37.7	39.8	24.7	36.5	45.7	31.1	40.1	40.6	43.9	33.9	32.6	34.6	100.3	28.2	13.9	29.6	33.8	108.9	41.5	32.7	28.1	36.7	29.9	66.8	30.6	30.0	54.9	58.7	75.2	36.5	23.3	34.2	29.6	19.6	34.2	14.1	35.9	20.6	28.4	102.2	20.0	32.5	32.7	29.1	19.9	7.5	29.3	71.6	83.2	93.4	57.1	23.8	53.4	42.6	48.7	13.9	9.6	1.6	12.1	40.9	24.6	56.2	15.9	68.7	71.0	2.9	24.9	12.2	16.9	132.0	54.4	1.3	7.4	80.2	75.2	24.1	34.0	49.3	69.4	10.2	93.6	12.7	52.7	20.6	10.4	5.4	24.9	29.0	46.7	0.1	60.4	15.9	21.9	22.9	40.4	72.9	57.9	124.6	299.1	62.3	55.0	11.1	48.4	37.8	25.2	61.0	14.7	9.9	10.9	0.4	30.0	7.7	25.2	2.3	2.3	6.9	1.7	3.3	1.3	1.1	1.9	2.3	1.7	1.3	2.0	1.9	1.0	1.4	1.5	1.5	2.3	1.0	32.1	34.1	30.0	33.6	33.9	32.6	29.6	33.8	29.9	29.6	35.9	29.1	30.3	16.0	29.3	4.2	7.4	24.9	85.4	28.2	70.6	10.3	57.5	98.8	56.8	54.3	19.3	16.5	39.6	77.7	13.5	23.8	64.6	27.9	1.0	41.4	49.0	28.8	50.9	449.3	5.7	19.5	26.3	46.1	44.9	37.4	19.1	47.5	46.1	154.5	28.0	1.7	6.6	28.6	20.3	44.1	21.2	4.7	66.8	26.2	37.4	5.6	36.6	27.8	14.4	4.0	8.4	35.7	15.3	155.7	9.4	48.7	34.1	46.1	15.6	19.2	19.7	28.1	37.1	1.1	9.4	68.6	32.5	41.9	14.6	123.4	33.4	56.3
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283783	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 47.3;Endometrial ciliated cells: 34.0;Respiratory ciliated cells: 91.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"OE19: 28.0"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	6.2	4.9	7.6	0.4	8.3	1.0	6.8	7.5	8.8	2.9	7.9	2.6	3.2	1.7	11.0	1.3	19.6	4.0	1.9	8.0	8.4	7.3	9.1	4.0	0.5	8.1	8.5	0.8	9.1	7.6	8.5	1.5	7.8	4.2	2.9	8.8	4.4	2.7	6.4	1.3	3.5	1.1	7.8	1.2	5.1	8.0	9.5	0.7	9.7	3.2	0.4	1.9	0.7	9.1	0.6	2.1	2.1	0.6	1.6	0.2	0.5	0.2	2.0	0.4	0.4	2.6	2.2	0.1	0.6	0.7	4.5	0.6	0.9	0.5	0.7	2.1	0.1	0.1	1.3	3.6	0.9	0.5	0.3	1.0	0.5	0.6	0.5	0.9	0.2	0.3	0.2	1.5	0.6	3.1	0.2	0.2	0.4	28.0	1.0	0.3	0.5	0.3	3.4	1.8	3.7	2.9	1.0	1.6	0.3	0.5	1.7	0.2	0.5	0.4	0.5	1.2	0.5	5.5	1.2	0.1	1.6	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	7.6	8.3	7.5	8.8	8.0	8.4	8.1	8.5	7.8	7.8	9.5	9.1	1.6	9.6	2.6	4.2	0.4	0.6	2.5	5.1	0.0	12.9	7.7	9.1	7.9	8.6	8.4	0.0	12.5	3.3	0.1	6.2	9.8	7.5	47.3	34.0	0.6	1.8	7.7	0.8	1.0	7.8	1.6	1.5	3.1	2.0	0.0	1.5	1.8	3.6	0.8	1.7	1.1	5.7	14.2	1.0	0.0	6.2	0.6	0.7	1.8	1.0	0.0	4.7	0.0	0.0	2.9	5.8	3.0	0.4	0.4	2.8	13.0	10.3	91.4	7.4	0.0	2.0	2.2	8.8	4.3	0.3	0.3	3.4	0.2	0.8	3.1	1.9
FAM72A	"LMPIP, MGC57827, p17, RP11-312O7.1, UGENE"	ENSG00000196550	"Family with sequence similarity 72 member A"	Q5TYM5	1	206186179-206204414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.5;Kupffer cells: 18.2;Late spermatids: 30.2;Spermatocytes: 28.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (3.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.20e-5)"	"unprognostic (3.61e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.01e-5)"	"unprognostic (7.70e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-16)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.89e-1)"	4.0	3.1	2.6	5.9	2.9	8.4	3.6	9.1	3.1	1.3	1.0	2.2	3.1	0.9	0.4	2.5	1.8	2.7	1.2	3.1	4.0	1.3	2.0	2.6	10.9	5.4	4.4	1.1	1.4	1.6	0.8	3.5	5.8	1.1	2.3	0.2	1.0	0.7	0.6	5.9	2.9	2.0	4.1	6.3	1.5	7.1	4.8	8.6	0.9	1.0	7.5	1.5	1.5	4.7	21.1	16.4	17.7	7.7	2.6	3.1	21.1	14.6	6.3	17.1	12.7	9.9	31.1	54.2	12.3	3.8	18.8	24.7	20.9	8.1	20.2	29.5	16.3	24.3	16.4	13.9	1.8	42.9	27.0	4.4	1.4	15.1	26.7	5.1	10.7	45.7	50.1	36.7	10.7	12.9	26.9	38.3	32.1	15.1	22.1	29.5	30.6	41.4	9.8	3.2	17.7	10.2	10.6	9.7	9.3	20.1	20.5	23.2	5.5	13.5	15.5	17.7	24.9	29.1	44.8	48.4	11.1	34.9	18.8	0.0	5.9	0.0	0.7	8.0	0.2	1.7	1.4	1.4	4.6	0.5	0.1	0.3	1.0	0.6	4.8	1.9	2.9	2.1	2.6	2.9	9.1	3.1	3.1	4.0	5.4	4.4	5.8	4.1	4.8	4.7	5.9	0.0	1.5	0.0	2.4	1.8	0.4	1.2	1.2	0.3	0.8	0.6	1.5	0.0	0.9	0.0	0.0	0.8	3.7	4.9	0.0	1.0	29.5	1.5	1.5	8.4	0.0	0.4	0.1	0.8	3.8	1.8	0.5	0.7	0.0	0.3	7.1	0.4	9.4	0.0	0.2	3.6	0.0	18.2	5.8	30.2	0.0	6.9	3.6	0.0	9.6	0.6	2.1	0.0	0.1	0.6	0.0	0.0	1.6	0.4	1.3	0.3	2.1	0.2	0.0	0.9	2.2	28.0	4.1	2.0	1.0	0.7	1.4	0.8	1.6	0.8
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.2;lymphoid tissue: 10.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7.3;Early spermatids: 11.3;Erythroid cells: 5.9;Hepatic stellate cells: 6.4;Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	0.8	0.6	1.2	3.7	1.0	6.2	0.8	2.0	1.1	0.5	1.3	1.1	1.3	0.5	0.4	1.6	0.4	1.0	0.3	1.2	1.2	0.4	0.4	0.6	8.1	1.6	1.4	0.4	0.2	0.7	0.2	1.4	1.6	0.2	1.2	0.1	0.4	0.2	0.1	1.9	1.1	0.7	1.3	2.0	1.0	2.3	1.3	10.3	0.3	0.2	6.6	0.8	0.7	1.4	28.6	10.3	16.5	8.2	1.6	2.4	13.3	14.7	6.2	16.8	14.1	0.1	14.5	62.9	19.9	2.7	16.4	17.1	23.1	8.3	25.9	41.1	17.3	27.2	12.0	12.5	1.0	47.7	23.2	1.3	0.9	13.0	26.5	4.2	10.3	51.0	36.1	37.3	12.4	12.1	24.1	39.1	31.6	14.9	20.6	35.8	35.8	28.7	6.7	3.2	18.0	10.4	11.1	8.6	8.6	16.9	11.4	36.5	3.6	13.8	23.5	27.3	26.6	32.6	44.1	61.3	12.4	50.8	32.6	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.4	0.3	1.2	1.0	2.0	1.1	1.2	1.2	1.6	1.4	1.6	1.3	1.3	1.4	1.3	0.0	0.0	0.0	1.6	1.0	0.1	0.2	0.0	0.0	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.8	0.1	7.3	0.0	0.2	11.3	0.2	0.4	2.5	0.0	5.9	0.1	0.2	2.3	0.6	1.1	0.2	0.0	0.5	6.4	0.0	1.1	0.0	0.3	4.9	0.0	1.9	2.8	3.0	0.6	1.6	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.1	2.3	0.0	2.5	0.0	2.1	0.0	0.7	0.0	0.0	0.3	0.9	17.0	3.1	3.5	1.0	0.1	1.2	0.2	3.6	0.0
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.9;lymphoid tissue: 5.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 7.8;Extravillous trophoblasts: 4.5;Sertoli cells: 6.6;Spermatocytes: 9.4;Spermatogonia: 3.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 64.9"									"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.4	0.2	0.1	1.5	0.1	2.9	0.3	0.2	0.2	0.2	0.0	0.4	0.6	0.2	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	4.5	0.1	0.1	0.1	0.2	0.0	0.0	0.5	0.1	0.1	0.6	0.0	0.2	0.0	0.0	1.2	0.4	0.3	0.1	1.2	0.3	1.6	0.1	5.4	0.1	0.1	4.5	0.4	0.4	0.2	18.7	10.6	12.5	5.7	0.6	1.7	12.1	8.9	2.8	12.0	9.0	1.6	21.7	44.4	11.6	1.0	11.0	17.4	17.2	5.5	13.0	15.3	10.0	19.1	9.4	3.3	0.4	39.5	16.6	0.3	0.1	9.1	24.3	2.5	5.1	34.7	34.0	20.5	0.8	1.4	23.2	30.4	10.2	20.8	6.6	29.7	9.0	31.5	2.1	2.3	6.3	11.5	8.7	5.0	4.9	13.0	12.5	33.4	3.7	9.4	15.4	12.5	20.3	41.9	64.9	26.0	5.1	24.1	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.8	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.6	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	2.3	0.3	0.2	1.3	0.0	7.8	0.2	0.2	4.5	0.3	0.0	0.1	0.0	0.5	1.8	0.1	1.7	0.0	0.3	0.6	0.0	2.2	1.4	0.5	0.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	6.6	0.3	0.7	9.4	3.5	1.3	0.3	0.3	0.7	0.3	0.5	0.0
FAM72D		ENSG00000215784	"Family with sequence similarity 72 member D"	Q6L9T8	1	145095974-145112696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.0;lymphoid tissue: 6.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.3;Erythroid cells: 9.7;Extravillous trophoblasts: 5.5;Spermatocytes: 15.4;Spermatogonia: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.70e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-3)"	"unprognostic (5.88e-5)"	"unprognostic (7.65e-4)"	"unprognostic (6.72e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (6.63e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.74e-2)"	"unprognostic (6.50e-2)"	0.7	0.3	0.4	3.0	0.4	4.0	0.5	0.7	0.5	0.3	0.2	0.8	1.0	0.3	0.1	1.1	0.2	0.5	0.2	0.4	0.8	0.2	0.3	0.5	4.8	0.6	0.7	0.2	0.1	0.2	0.1	1.1	0.6	0.1	1.0	0.1	0.2	0.1	0.0	1.9	1.3	0.5	0.4	1.2	0.6	2.1	0.7	6.7	0.2	0.1	4.5	0.6	0.4	0.5	16.6	10.4	11.7	4.5	0.5	1.0	12.4	9.8	3.0	11.1	7.1	7.5	14.7	26.6	9.3	1.5	11.1	17.3	13.6	3.0	12.8	22.6	14.1	13.6	5.8	9.7	0.6	24.0	14.2	0.8	1.1	9.4	16.9	2.0	5.6	33.0	26.8	34.9	7.2	12.4	16.6	22.5	21.1	20.3	14.4	13.9	14.3	30.7	4.0	2.2	10.9	9.1	7.3	6.3	4.4	13.9	17.2	15.7	2.7	8.3	9.6	7.3	16.7	27.0	46.5	39.3	0.2	18.7	10.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.4	0.7	0.5	0.4	0.8	0.6	0.7	0.6	0.4	0.7	0.5	2.0	0.0	0.0	0.0	0.8	1.0	0.0	0.2	1.2	0.0	0.2	0.4	1.1	0.0	0.2	0.0	0.0	1.2	0.1	0.8	0.0	0.1	7.3	0.2	0.3	2.1	0.0	9.7	0.3	0.0	5.5	0.8	0.0	0.2	0.0	0.3	0.4	0.1	1.5	0.0	0.5	0.8	0.0	1.0	1.0	0.6	0.0	1.8	1.8	1.0	0.8	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.8	0.2	0.3	0.1	0.3	0.0	0.0	0.5	0.8	15.4	4.5	1.6	1.0	0.3	0.4	0.1	1.4	0.1
FBLN7	"FLJ37440, TM14"	ENSG00000144152	"Fibulin 7"	Q53RD9	2	112138385-112188218	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 14.4;Fibroblasts: 16.6;Inhibitory neurons: 30.7;Melanocytes: 17.8;Skeletal myocytes: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	26	"memory CD4 T-cell: 34.4;naive CD4 T-cell: 29.5;T-reg: 36.5"	"Lineage enriched"	"Detected in many"	35	"T-cells: 36.5"	"Cell line enhanced"	"Detected in many"		"AF22: 24.5;BJ hTERT+: 17.7;hTERT-RPE1: 12.8;SCLC-21H: 15.8;SH-SY5Y: 12.6;U-2197: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034992			Approved	"Plasma membrane,Cell Junctions"	"Secreted to extracellular matrix"	NA	NA		310000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Cell Junctions"	"HPA034992: AB_10601469"	"unprognostic (1.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.33e-2)"	6.5	4.0	0.8	4.3	0.6	0.7	7.8	4.0	6.4	10.3	0.4	1.8	1.1	4.8	2.8	1.9	7.1	3.4	2.5	2.1	3.8	1.5	5.2	2.7	9.8	9.2	4.4	1.4	2.4	6.9	12.2	3.2	9.7	3.3	1.3	2.5	2.5	3.1	1.4	5.5	2.9	2.2	2.2	5.6	3.0	0.5	4.1	8.6	10.7	2.5	6.0	2.5	7.5	1.1	0.0	0.1	24.5	0.0	2.6	1.9	0.1	5.5	17.7	5.9	9.2	0.0	0.2	0.0	0.1	8.3	1.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.9	1.1	1.2	0.0	0.0	1.9	0.1	9.9	0.0	12.8	1.4	0.3	0.0	0.0	2.1	0.0	0.7	0.1	0.6	0.0	0.5	0.0	0.0	6.6	0.3	0.0	15.8	12.6	0.1	0.1	0.7	0.1	0.7	0.2	5.2	0.8	0.7	25.4	0.8	0.0	0.0	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.4	0.0	1.3	0.0	34.4	0.4	0.0	0.0	29.5	1.0	0.0	0.0	0.0	1.0	36.5	6.2	0.8	0.6	4.0	6.4	2.1	3.8	9.2	4.4	9.7	2.2	4.1	1.1	1.4	3.2	0.5	0.3	0.7	4.5	1.0	0.3	0.0	3.8	1.0	2.4	1.1	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.0	0.3	1.7	1.2	5.9	2.6	0.0	0.0	14.4	0.2	10.1	16.6	0.0	1.2	1.3	0.7	0.4	2.2	0.5	3.3	30.7	0.0	0.0	0.0	4.0	3.6	0.3	0.4	17.8	1.9	0.0	2.3	0.0	6.6	0.9	0.6	0.0	5.3	0.1	0.4	0.1	0.5	0.3	7.6	6.6	19.3	7.8	0.1	0.4	0.1	3.8	1.5	7.7	0.2	0.0	0.3
FBRSL1	KIAA1545	ENSG00000112787	"Fibrosin like 1"	Q9HCM7	12	132489551-132585188	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 90.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049880	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA049880: AB_2680930"	"unprognostic (2.02e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (9.82e-4)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (7.21e-4)"	12.3	19.2	16.3	8.7	13.1	10.1	13.2	20.7	21.2	17.8	7.2	20.5	11.2	18.6	7.7	15.6	18.7	4.1	31.1	16.2	6.7	19.3	26.8	16.2	8.5	10.0	7.7	22.3	39.2	7.3	28.7	5.7	8.0	22.0	3.6	5.9	14.7	7.2	31.9	19.4	23.3	4.1	4.7	28.3	21.4	29.1	9.6	6.2	15.7	9.4	4.7	17.8	15.7	10.2	11.7	18.5	8.7	14.8	3.7	4.5	64.4	10.9	3.1	7.1	4.3	32.7	6.9	19.0	18.4	3.6	6.1	22.6	9.3	6.1	2.3	14.7	47.6	23.2	11.0	25.0	8.0	24.7	23.4	4.1	10.7	6.6	4.8	6.5	7.0	15.9	49.9	3.8	3.1	29.8	33.7	90.0	22.7	8.4	33.4	50.9	9.3	13.2	6.2	11.2	33.4	28.0	10.2	15.8	14.1	3.6	18.6	23.7	11.1	7.6	18.5	13.7	13.9	24.6	13.0	12.0	8.8	23.8	9.4	1.2	0.4	1.2	0.3	0.3	0.3	0.8	0.3	0.3	0.3	0.6	0.3	0.4	0.5	0.2	0.7	1.0	0.6	0.3	16.3	13.1	20.7	21.2	16.2	6.7	10.0	7.7	8.0	4.7	9.6	10.2	14.9	3.2	5.2	24.2	12.8	9.2	7.1	3.3	11.4	28.9	20.7	18.5	13.7	4.3	4.0	11.0	41.7	6.9	19.8	24.0	7.9	6.2	1.4	16.8	17.9	8.8	31.0	12.0	17.0	7.6	5.8	11.8	15.3	22.0	1.3	22.6	7.5	22.2	6.9	11.8	17.1	21.7	0.0	11.6	11.1	2.0	16.1	16.4	5.4	15.0	7.7	9.3	6.2	12.5	16.8	9.0	15.0	15.4	11.9	16.0	13.3	6.4	6.4	22.7	6.6	12.7	11.5	5.7	8.0	10.8	10.4	11.5	10.9	12.7	18.7	10.4
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490278	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 18.4;pituitary gland: 17.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5;Excitatory neurons: 44.4;Inhibitory neurons: 43.6;Rod photoreceptor cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 9.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 9.6"	"Cell line enhanced"	"Detected in many"		"AF22: 20.3;Karpas-707: 22.4"	"Low region specificity"	"Detected in all"							"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: AB_2683795, HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favorable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.5	1.8	3.9	0.9	5.0	2.2	2.6	6.8	7.0	4.1	2.9	1.6	2.0	1.1	18.4	0.7	4.4	1.4	1.4	4.6	3.9	3.2	6.0	1.5	1.4	1.1	1.7	0.7	4.7	7.1	17.3	0.6	2.0	3.5	2.0	14.3	3.4	5.1	1.1	0.4	2.9	0.7	0.3	1.2	2.2	4.2	3.5	0.6	7.0	0.9	2.8	1.2	0.7	4.3	16.5	2.9	20.3	7.5	0.5	0.0	0.3	0.2	0.5	3.0	5.5	3.1	4.6	5.8	7.2	0.1	8.1	5.1	2.3	3.5	3.0	2.6	3.6	2.7	0.3	1.7	0.0	3.5	1.9	0.2	10.8	0.7	3.2	1.5	0.0	5.6	1.1	22.4	1.0	5.7	0.5	5.0	3.9	2.2	4.5	0.2	4.5	8.2	3.9	2.4	13.1	5.4	0.4	3.3	9.5	3.5	13.8	5.9	0.6	1.6	5.8	3.2	3.0	5.2	5.0	5.2	6.8	0.7	3.5	0.3	0.1	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.2	0.1	0.2	0.9	0.0	0.1	9.6	0.2	0.1	3.9	5.0	6.8	7.0	4.6	3.9	1.1	1.7	2.0	0.3	3.5	4.3	0.0	3.2	4.1	7.5	1.7	0.1	3.0	10.9	5.2	8.2	3.9	3.4	2.1	8.6	7.9	3.7	35.5	0.6	0.0	0.5	7.9	5.3	12.1	13.5	1.3	0.2	10.2	0.0	44.4	4.6	0.4	0.9	1.5	6.4	0.0	1.9	0.4	1.9	2.7	5.0	43.6	3.9	4.1	0.8	2.3	12.4	1.2	0.4	0.0	2.8	0.0	9.3	0.0	23.6	3.2	3.1	0.4	0.7	11.1	1.7	0.2	4.7	23.4	48.6	0.0	0.5	1.8	10.5	5.6	1.2	0.0	0.0	0.5	4.2	1.0	1.7
FBXO41	"Fbx41, KIAA1940"	ENSG00000163013	"F-box protein 41"	Q8TF61	2	73254682-73284478	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.9;Enteroendocrine cells: 12.0;Excitatory neurons: 28.8;Inhibitory neurons: 22.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 21.2;basal ganglia: 31.0;cerebral cortex: 42.3;hippocampal formation: 29.6;white matter: 24.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055246, HPA058386"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA055246: AB_2682758, HPA058386: AB_2683701"	"unprognostic (1.15e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.74e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (7.97e-3)"	"unprognostic (7.55e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-2)"	1.3	3.0	21.2	4.6	31.0	3.3	1.5	7.2	42.3	1.7	0.0	1.8	1.4	1.6	2.3	1.3	1.7	1.7	1.0	29.6	4.6	1.1	0.4	1.5	7.7	4.2	3.8	2.5	3.7	5.5	13.9	0.5	4.6	2.6	1.4	3.1	2.6	2.0	0.1	2.3	5.3	1.2	1.1	9.1	1.8	2.3	5.4	5.5	1.2	0.1	6.9	1.5	1.4	24.8	6.4	3.1	1.0	0.0	0.3	0.2	1.4	1.2	1.0	2.0	2.5	7.2	3.6	46.6	0.2	0.2	4.5	5.1	6.5	4.1	2.0	19.4	0.6	14.5	8.0	3.0	1.5	22.2	10.4	2.5	1.6	0.1	1.6	5.6	0.3	12.7	2.9	7.6	2.1	1.7	7.7	20.4	4.7	2.4	2.7	25.4	11.7	23.2	1.3	2.2	15.7	5.8	8.0	3.3	5.0	0.3	4.5	9.2	0.4	7.0	5.9	6.4	1.2	8.5	3.9	22.1	1.8	23.7	3.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	21.2	31.0	7.2	42.3	29.6	4.6	4.2	3.8	4.6	1.1	5.4	24.8	0.3	0.0	0.6	2.6	5.1	0.3	0.3	1.0	1.2	13.9	1.8	1.4	2.1	1.5	0.3	1.8	0.0	0.0	3.4	0.5	0.0	0.5	0.2	0.3	2.5	0.4	12.0	0.0	28.8	2.5	0.1	2.1	0.0	1.1	2.5	2.1	0.7	0.0	1.9	6.7	22.4	0.4	2.0	4.7	1.1	1.5	0.3	3.2	1.8	7.5	2.6	0.9	2.1	5.5	0.9	1.1	0.3	0.7	3.6	0.8	0.1	0.3	1.1	2.3	0.0	0.3	0.7	1.3	2.4	0.5	0.3	0.0	3.1	5.4	0.8	0.2
FBXW11	"BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696"	ENSG00000072803	"F-box and WD repeat domain containing 11"	Q9UKB1	5	171861549-172006873	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072204	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA072204: AB_2686493"	"unprognostic (4.04e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.76e-1)"	19.5	20.4	33.3	13.6	38.2	8.2	17.0	34.7	41.6	19.9	27.4	14.6	12.6	22.9	12.4	24.2	27.0	17.5	36.1	38.0	35.5	23.0	20.7	17.6	16.7	33.3	34.4	25.6	29.1	33.1	14.2	13.9	33.1	19.0	16.0	37.2	13.5	20.3	34.5	13.7	13.2	26.1	34.4	18.1	20.0	14.3	37.7	17.3	21.1	35.6	22.0	19.2	15.8	42.4	35.4	35.6	52.0	45.2	39.9	40.2	26.4	37.1	51.7	45.0	54.9	36.7	23.1	32.5	44.3	46.4	72.0	22.8	37.6	56.3	74.6	42.7	37.3	26.2	35.0	28.5	35.4	29.8	36.0	28.5	38.2	36.8	59.8	48.5	38.6	27.3	16.6	31.7	55.7	26.5	20.7	15.3	19.8	20.8	39.5	30.1	43.7	22.0	34.8	29.2	21.6	37.2	32.9	27.3	70.8	38.7	34.2	31.0	33.8	44.3	22.0	27.4	37.2	31.8	38.9	22.2	31.3	27.8	34.6	25.4	7.3	7.2	5.8	5.1	6.1	8.5	4.8	5.7	7.3	8.4	4.3	5.7	7.1	14.1	5.7	8.6	5.7	6.6	33.3	38.2	34.7	41.6	38.0	35.5	33.3	34.4	33.1	34.4	37.7	42.4	35.4	25.6	21.2	75.4	52.7	19.1	15.6	21.8	32.5	43.5	26.4	22.1	59.1	42.9	20.8	27.6	8.4	8.5	49.8	25.1	43.0	33.7	32.9	42.0	47.9	26.3	28.8	27.4	86.5	36.9	7.8	24.7	38.2	51.0	20.8	25.8	29.3	43.1	12.8	35.3	85.3	21.6	20.3	29.6	25.3	34.3	29.5	26.6	12.4	62.8	24.6	63.6	16.5	75.9	94.4	54.1	14.9	28.6	36.5	30.2	21.5	52.4	17.1	34.3	46.0	28.2	33.5	34.5	16.0	28.7	23.7	12.0	28.8	17.2	15.0	32.9
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 206.9;salivary gland: 85.4;stomach 1: 85.5;thyroid gland: 99.9"	"Cell type enriched"	"Detected in many"	9	"Intestinal goblet cells: 6081.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 63.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.6;Daudi: 1.8;JURKAT: 1.7;MOLT-4: 1.8;RH-30: 7.1"									"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Golgi apparatus, Cytokinetic bridge"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.28e-5)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.08e-1)"	5.9	10.0	5.1	14.0	7.2	0.4	3.2	4.0	8.4	56.4	15.0	206.9	68.7	1.2	0.6	4.6	9.8	49.2	2.9	5.6	6.8	11.3	1.0	1.9	0.9	20.1	10.6	3.7	4.9	0.5	3.4	2.9	11.1	3.8	67.7	0.6	85.4	1.4	0.4	14.8	148.7	2.6	5.9	1.5	85.5	2.9	14.0	1.5	99.9	0.0	0.7	3.4	1.6	12.0	0.0	4.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.1	1.8	0.6	0.1	1.5	0.3	0.1	7.1	1.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.0	0.1	5.1	7.2	4.0	8.4	5.6	6.8	20.1	10.6	11.1	5.9	14.0	12.0	0.6	3.2	5.1	2.6	4.6	3.7	1.9	15.8	1.2	1.1	1.3	3.4	2.8	70.1	60.0	25.8	0.0	0.7	1.8	622.2	0.0	5.2	7.2	4.2	0.3	26.7	81.1	0.0	0.6	0.9	0.4	1.9	552.0	4.0	15.9	0.4	0.7	1.3	44.0	0.0	0.4	6081.9	2.0	30.2	12.6	9.2	0.9	21.6	8.8	15.9	0.9	0.4	1.0	0.5	0.2	3.9	253.6	0.0	2.1	13.8	413.5	1.2	11.0	2.0	59.2	0.5	1.1	0.5	2.4	0.4	6.8	0.4	5.6	0.9	191.4	164.1
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 16.1;Granulosa cells: 12.6;Inhibitory neurons: 15.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000911, HPA076516"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA000911: AB_1078853, HPA076516: "	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	3.9	5.1	8.2	1.6	6.2	0.0	3.6	5.3	7.6	7.0	2.4	5.6	1.0	7.1	1.6	5.8	5.1	2.2	5.0	8.3	5.2	3.5	1.1	2.8	0.5	3.8	4.1	7.4	3.2	3.6	3.6	3.4	3.7	4.3	1.6	1.6	3.4	3.3	1.3	5.4	2.8	5.4	3.5	2.4	3.5	2.4	4.9	0.4	3.3	1.0	1.0	4.8	5.4	4.6	18.5	6.9	13.2	19.3	7.8	13.8	6.2	10.4	12.8	10.6	8.5	0.6	0.4	0.0	8.2	19.9	9.6	5.3	14.6	9.0	5.8	1.0	8.9	0.0	5.0	2.2	8.3	0.0	0.0	11.3	5.6	16.1	7.6	9.4	9.7	2.3	2.0	0.0	8.4	2.4	0.7	0.0	12.6	0.0	10.2	9.4	6.7	0.0	9.1	0.3	13.1	11.9	10.3	0.2	16.6	21.0	10.3	0.4	6.9	10.5	8.7	23.0	9.4	0.1	0.2	0.1	11.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.2	5.3	7.6	8.3	5.2	3.8	4.1	3.7	3.5	4.9	4.6	3.2	0.0	0.0	4.6	0.0	2.9	1.2	2.0	5.2	2.5	3.2	3.9	3.4	0.0	0.7	0.0	0.0	0.5	0.1	0.2	0.0	1.6	0.4	1.3	7.0	4.2	1.2	0.0	16.1	1.1	1.0	5.1	1.5	2.1	0.0	12.6	2.9	0.3	0.4	1.7	15.2	1.0	0.0	0.0	1.0	0.6	2.8	0.1	7.2	5.6	0.0	2.3	0.0	7.1	1.8	0.5	0.5	4.1	0.1	1.6	0.1	1.4	0.3	3.5	0.0	2.3	4.0	0.3	2.2	5.5	4.1	0.3	0.1	2.9	2.8	1.0
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 207.8;lung: 86.5;lymphoid tissue: 141.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 182.2;Langerhans cells: 63.8;Macrophages: 155.9;monocytes: 159.7;NK-cells: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 86.0;U-266/70: 153.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	25.0	6.8	12.8	62.2	11.9	207.8	16.0	11.9	19.1	7.6	11.5	6.0	3.9	8.1	1.7	5.2	15.6	12.7	8.7	11.4	12.3	7.5	10.8	86.5	27.5	13.6	12.7	2.9	5.8	1.6	2.7	7.9	14.5	7.2	4.0	0.7	6.6	2.4	3.2	4.5	10.1	16.3	12.5	141.1	5.9	2.5	17.2	8.4	7.4	6.5	20.0	17.8	7.3	12.6	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.7	29.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	3.8	5.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	153.1	2.1	6.5	0.0	19.5	0.0	30.8	381.4	229.4	189.5	469.1	11.3	54.0	15.8	89.1	196.1	84.0	8.0	78.4	272.9	264.5	405.2	9.0	1.2	494.1	12.8	11.9	11.9	19.1	11.4	12.3	13.6	12.7	14.5	12.5	17.2	12.6	8.6	6.4	20.0	0.0	24.9	2.8	0.6	0.2	0.0	0.0	0.4	0.6	1.6	1.5	5.7	1.8	0.0	0.5	55.2	0.0	0.0	0.0	0.3	0.1	0.2	14.9	0.0	7.4	0.2	0.2	0.7	2.7	1.5	0.1	13.3	0.1	6.8	1.9	56.8	0.0	0.1	0.0	0.0	182.2	63.8	0.7	0.3	155.9	1.8	6.5	159.7	0.1	259.5	1.0	0.4	0.0	1.2	0.0	4.2	0.4	0.0	0.7	1.5	0.0	0.0	0.7	0.6	0.2	0.5	0.5	1.1	1.0	28.0	0.0	0.0	2.5
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad diadenosine triphosphatase"	P49789	3	59747277-61251459	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 94.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 609.8;Inhibitory neurons: 450.5;Microglial cells: 337.3;Oligodendrocyte precursor cells: 1086.7;Oligodendrocytes: 1111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"naive CD4 T-cell: 87.6"	"Lineage enriched"	"Detected in all"	12	"T-cells: 87.6"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 17.5;U-266/70: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		12000	"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	5.6	24.4	13.7	6.2	18.3	8.0	9.0	13.0	17.3	5.4	94.0	6.9	6.4	3.5	6.9	5.0	6.6	9.8	15.8	19.7	16.4	24.9	9.6	4.7	7.6	18.9	17.0	6.8	13.0	18.1	7.9	3.0	18.9	5.3	5.8	7.6	8.5	4.7	10.6	8.1	5.3	4.7	15.0	5.0	8.6	5.5	15.9	12.1	11.7	7.2	5.3	6.7	4.2	19.8	0.1	0.0	1.4	0.0	0.6	0.1	2.5	0.1	0.2	0.1	0.0	2.7	4.2	4.0	0.7	0.1	3.0	0.0	12.7	3.2	0.0	2.2	5.0	3.3	2.0	6.4	3.3	8.7	0.1	9.1	5.2	0.2	6.9	0.3	0.0	3.7	2.5	11.9	0.2	3.6	15.2	6.7	1.2	12.2	0.9	11.3	0.0	17.5	15.3	2.0	2.9	4.3	1.5	9.9	10.1	5.3	0.4	0.2	0.0	1.7	0.4	0.1	2.4	34.6	11.3	0.0	4.0	0.1	1.9	6.8	4.6	0.5	2.2	2.9	1.4	4.1	17.2	1.8	5.7	3.1	87.6	15.6	0.8	7.2	1.3	5.8	20.5	11.9	13.7	18.3	13.0	17.3	19.7	16.4	18.9	17.0	18.9	15.0	15.9	19.8	4.1	6.4	10.6	609.8	19.7	7.6	20.7	30.0	46.7	12.6	41.2	31.2	10.0	38.6	17.5	27.6	58.4	42.0	12.4	6.9	78.2	19.1	45.8	14.6	7.9	7.0	7.7	17.7	276.6	4.7	8.5	10.1	18.3	19.0	5.7	25.7	14.6	23.4	20.9	30.3	450.5	12.9	22.4	10.2	7.1	163.0	19.3	12.9	12.4	337.3	8.6	19.7	6.2	1086.7	1111.0	9.7	15.0	9.8	23.8	12.0	20.7	126.6	12.4	20.7	0.0	10.7	6.2	19.1	7.5	33.7	11.2	32.7	11.5	23.0	20.1	18.8
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 11467.1;tongue: 9770.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1145.1;Early spermatids: 373.8;Late spermatids: 1206.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 88.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 36.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 36.1;T-cells: 18.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 303.7;fHDF/TERT166: 258.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavorable (2.11e-4)"	938.4	65.8	120.8	75.5	117.2	11.7	441.8	95.9	126.3	315.5	85.8	672.0	83.2	464.6	107.7	538.1	281.6	127.6	1462.3	130.8	144.9	45.2	43.1	285.6	41.7	103.9	125.4	102.8	39.4	196.5	92.9	106.6	115.9	408.8	161.4	76.2	161.3	541.1	11467.1	101.3	235.5	486.5	114.8	43.0	368.4	60.2	130.1	25.1	310.1	9770.8	32.1	469.6	253.1	102.9	0.4	44.3	60.7	57.8	127.2	52.3	1.5	183.7	303.7	34.8	81.3	0.3	12.7	0.7	55.8	258.8	95.0	0.5	119.2	148.0	28.2	0.4	136.7	0.7	34.4	0.0	121.6	0.3	26.8	96.6	24.4	41.2	128.7	14.1	36.6	34.5	0.1	26.0	81.9	2.5	26.1	1.6	19.1	0.2	52.2	69.8	2.6	38.2	1.1	0.1	43.5	63.8	6.6	0.2	12.4	24.1	0.3	2.4	102.5	150.2	71.0	5.9	44.7	6.8	16.0	1.1	11.9	1.4	18.2	0.1	0.7	0.0	5.2	0.1	13.8	5.8	18.2	7.2	3.1	3.6	12.0	4.0	1.2	36.1	0.0	19.4	2.2	11.1	120.8	117.2	95.9	126.3	130.8	144.9	103.9	125.4	115.9	114.8	130.1	102.9	203.0	48.1	11.7	32.0	8.1	56.5	26.9	15.1	14.2	36.2	1.4	8.3	1145.1	0.0	4.9	11.0	8.4	0.6	8.6	0.5	1.9	3.0	373.8	4.3	32.3	61.1	13.8	17.9	70.2	0.2	1.1	236.0	2.0	2.0	15.8	41.0	113.6	6.1	4.3	99.3	55.6	0.8	0.0	5.1	47.0	1206.9	123.9	35.6	32.0	16.9	7.4	209.6	2.1	35.2	8.2	0.6	7.6	152.4	15.5	20.1	0.6	11.6	4.8	19.4	105.2	248.1	235.7	7.4	88.6	2.7	44.8	2.7	15.5	9.6	2.0	2.6
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 161.3;Inhibitory neurons: 82.9;Oligodendrocyte precursor cells: 309.6;Oligodendrocytes: 129.4;Sertoli cells: 72.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	34	"basophil: 3.3"	"Lineage enriched"	"Detected in single"	34	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"AF22: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	3.1	2.0	3.9	0.4	5.0	0.8	2.0	2.3	4.4	2.4	0.0	2.6	0.4	1.1	1.2	0.6	1.9	1.1	3.3	2.5	5.4	1.9	3.2	1.4	0.6	3.0	4.2	4.6	2.9	0.4	2.6	1.1	3.9	1.6	0.7	1.4	2.6	2.7	1.0	1.0	1.4	0.9	1.8	3.0	1.8	1.1	4.6	0.2	1.1	1.7	0.2	1.7	2.4	5.1	6.4	2.3	18.6	0.0	0.0	0.0	6.8	2.4	1.6	1.7	3.2	0.0	2.2	0.0	6.6	2.6	3.4	0.9	6.2	2.6	1.3	0.0	4.6	0.0	4.7	4.6	1.5	0.0	0.0	0.8	2.2	3.3	9.0	2.6	4.0	0.0	0.0	0.0	5.1	1.6	0.0	0.0	7.9	0.4	2.9	0.0	6.3	0.0	4.2	2.1	2.9	2.5	0.0	1.8	1.7	10.3	2.0	0.0	0.4	7.6	6.8	0.0	5.1	1.1	0.0	0.0	2.3	0.0	4.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.0	2.3	4.4	2.5	5.4	3.0	4.2	3.9	1.8	4.6	5.1	2.9	6.4	7.3	161.3	0.7	1.9	0.1	2.8	1.8	24.4	5.7	2.7	19.4	20.0	3.0	12.9	0.0	21.2	0.2	0.1	1.9	3.7	3.8	0.7	0.7	2.1	0.0	0.0	53.4	1.5	7.4	11.6	4.1	1.6	0.0	23.6	7.9	13.5	1.4	6.7	82.9	0.0	4.1	0.0	1.6	6.4	51.9	0.6	17.8	28.1	0.0	4.3	0.0	309.6	129.4	1.1	0.0	34.3	0.0	1.8	0.0	8.1	4.0	2.1	72.3	16.6	17.8	1.1	1.2	1.0	0.4	16.8	0.2	7.0	0.0	0.0
FILIP1L	"DOC-1, GIP130"	ENSG00000168386	"Filamin A interacting protein 1 like"	Q4L180	3	99830141-100114513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 210.1;Early spermatids: 376.7;Sertoli cells: 256.4;Skeletal myocytes: 184.2;Smooth muscle cells: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.1;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 84.2;HDLM-2: 79.9;TIME: 145.8"	"Region enriched"	"Detected in many"	7	"olfactory bulb: 18.0"	"Low region specificity"	"Detected in all"			HPA043133	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA043133: AB_10793991"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (2.46e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.82e-3)"	77.1	21.7	4.9	52.4	6.3	0.8	32.6	4.8	6.6	63.8	4.0	57.7	28.4	117.6	23.8	56.0	31.2	90.9	54.8	6.2	4.4	24.0	28.1	30.7	30.1	9.6	4.2	76.4	35.5	17.5	3.9	43.9	9.7	67.9	29.8	4.7	9.3	54.3	140.4	16.8	41.2	151.7	3.7	42.9	46.7	22.0	3.6	11.9	20.1	161.5	22.3	101.5	21.9	4.0	59.0	0.0	22.3	0.1	35.8	30.2	2.0	29.4	58.8	50.2	56.5	17.8	0.2	0.2	5.0	84.2	13.2	7.1	0.0	14.4	59.0	79.9	0.6	4.8	0.2	23.3	17.8	1.4	0.0	24.2	5.1	5.6	0.0	32.0	22.8	0.0	3.8	0.5	7.7	0.1	5.2	1.2	1.3	3.1	0.0	0.1	26.1	0.7	33.5	1.0	2.0	3.7	0.4	0.4	0.1	11.7	0.0	10.5	145.8	8.8	0.2	1.9	15.5	4.2	0.2	0.3	6.5	0.4	0.0	0.2	0.4	0.0	0.1	1.0	0.0	0.6	0.1	0.1	2.1	0.6	0.0	0.1	0.2	0.4	2.9	0.4	0.1	0.3	4.9	6.3	4.8	6.6	6.2	4.4	9.6	4.2	9.7	3.7	3.6	4.0	92.9	16.0	23.1	9.4	4.1	27.8	56.7	7.9	2.2	11.8	12.3	6.5	145.7	35.8	2.3	5.5	8.4	1.1	1.8	2.1	1.9	210.1	376.7	2.3	60.5	77.2	3.0	0.0	42.0	109.3	0.7	145.2	21.9	2.4	34.8	16.3	41.0	0.7	3.2	106.0	25.8	5.7	6.1	36.3	98.9	180.2	83.0	86.1	17.8	25.3	17.7	0.9	0.0	22.1	21.6	43.7	0.2	104.2	3.0	5.1	5.4	2.6	1.9	6.0	256.4	184.2	351.9	40.1	2.5	1.5	22.7	3.1	8.8	41.8	3.2	3.5
FKBP2	"FKBP-13, FKBP13, PPIase"	ENSG00000173486	"FKBP prolyl isomerase 2"	P26885	11	64241003-64244132	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 929.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB025561, HPA049405"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	No	No		510000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"CAB025561: , HPA049405: AB_2680749"	"unprognostic (4.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.66e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.57e-2)"	64.7	127.6	185.1	77.5	187.6	50.1	58.3	192.7	234.7	113.1	210.8	105.7	136.3	81.1	397.7	68.4	94.4	77.2	117.4	185.0	196.9	122.7	197.3	62.7	70.7	199.9	199.6	75.3	280.1	160.4	200.9	73.1	197.7	92.5	84.2	37.1	208.9	146.7	33.3	60.9	107.3	72.6	183.4	67.5	113.4	74.7	194.3	59.0	187.6	48.4	70.4	85.7	61.6	196.0	101.2	144.8	82.8	165.9	178.5	98.2	94.6	132.9	146.4	108.8	101.4	148.1	257.0	80.8	195.4	186.5	148.2	134.7	70.5	121.0	51.3	101.4	54.5	90.0	196.5	158.3	231.6	74.5	125.5	116.0	169.3	145.4	163.5	156.9	86.9	76.6	61.0	253.6	138.1	186.7	85.1	112.6	92.6	211.1	130.0	70.8	70.9	299.2	198.9	120.7	110.0	91.3	85.4	263.2	147.9	59.5	98.1	69.5	68.9	123.8	100.9	182.8	72.6	128.5	48.6	69.0	156.7	80.6	142.8	276.8	173.1	25.9	178.9	191.2	230.8	170.1	139.2	176.4	172.2	165.0	90.4	131.5	68.6	162.9	162.7	929.1	55.9	126.7	185.1	187.6	192.7	234.7	185.0	196.9	199.9	199.6	197.7	183.4	194.3	196.0	129.5	147.4	168.0	20.9	179.7	164.4	251.0	447.2	125.2	86.4	205.0	185.4	134.7	275.9	270.6	389.9	22.9	279.8	174.4	534.1	412.8	270.8	126.4	212.5	206.3	138.6	342.6	41.4	11.3	254.2	386.9	167.0	179.4	258.5	144.0	146.5	148.5	754.4	228.4	32.0	14.8	508.2	305.2	100.1	201.7	99.0	230.2	140.7	300.6	16.9	151.7	181.7	111.2	11.1	20.6	292.2	424.7	255.1	765.2	315.5	594.7	792.2	241.9	83.3	184.1	138.4	221.3	327.1	282.1	136.6	168.1	620.5	123.6	138.8	339.4	312.0
FLACC1	ALS2CR12	ENSG00000155749	"Flagellum associated containing coiled-coil domains 1"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.8;testis: 17.1"	"Cell type enriched"	"Detected in single"	8	"Cardiomyocytes: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.4;U-2197: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035793			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane, Cytosol"		"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.9	1.1	3.9	1.0	4.3	5.0	0.5	2.8	3.9	0.7	9.8	0.8	0.5	0.7	1.1	1.2	8.3	1.1	4.5	5.0	3.2	1.3	0.7	2.5	1.6	5.8	6.4	0.3	0.9	0.7	1.1	0.8	3.7	0.5	1.0	3.3	1.1	0.8	1.8	1.2	1.0	0.6	4.2	0.8	0.5	17.1	3.0	0.7	1.6	0.4	0.5	0.6	0.4	3.7	0.1	0.2	1.1	0.7	2.7	1.1	0.0	0.8	0.3	0.7	0.4	0.0	0.3	0.2	0.6	1.2	0.4	1.1	0.4	0.1	0.3	0.7	0.1	0.1	1.7	0.4	0.6	1.2	1.0	0.5	0.3	0.7	0.1	0.8	0.1	1.2	0.5	1.6	0.6	0.0	0.6	1.0	0.3	0.4	0.6	0.3	0.5	0.7	0.4	0.2	0.2	0.7	0.7	0.0	3.4	1.0	0.4	1.4	0.9	1.5	0.7	5.9	0.5	0.8	1.8	0.5	1.2	0.6	0.7	3.1	0.4	0.4	0.7	0.3	0.3	0.3	0.4	0.4	0.2	0.7	0.6	0.7	3.6	1.3	0.3	0.2	0.3	0.2	3.9	4.3	2.8	3.9	5.0	3.2	5.8	6.4	3.7	4.2	3.0	3.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	21.9	21.1	19.2	17.0	20.5	14.2	23.5	20.2	20.7	20.4	19.7	22.8	20.1	19.8	20.5	26.1	19.1	11.8	28.7	20.1	19.5	21.7	32.8	17.7	22.8	20.2	20.3	15.5	18.9	18.0	15.1	14.3	20.6	24.3	18.9	9.8	21.0	13.7	34.1	32.9	24.9	17.7	19.6	30.1	22.0	19.0	20.6	16.0	22.5	32.0	23.0	22.6	21.1	21.0	33.4	52.4	32.8	56.1	27.9	20.5	62.1	24.7	20.5	35.2	30.2	46.9	40.1	38.5	48.8	23.0	18.3	42.6	63.4	51.3	23.0	40.6	47.5	31.4	42.8	33.7	38.1	46.0	39.1	29.5	65.9	40.2	42.8	17.0	41.5	40.4	51.4	30.3	30.2	71.8	31.9	32.0	71.7	72.2	53.8	52.8	16.2	88.7	33.9	45.8	54.9	75.6	38.7	86.2	50.0	63.0	74.0	68.6	26.4	21.9	30.1	28.6	39.6	47.5	63.7	66.9	26.4	36.8	36.1	29.8	35.3	23.7	34.5	33.0	38.9	39.0	31.9	33.8	37.7	34.2	29.1	28.9	7.8	26.1	41.4	38.3	37.9	37.6	19.2	20.5	20.2	20.7	20.1	19.5	20.2	20.3	20.6	19.6	20.6	21.0	12.2	9.6	10.6	9.8	19.3	26.5	18.1	37.1	23.3	15.7	16.4	15.9	39.4	20.0	22.6	25.8	6.2	42.5	16.9	22.1	31.3	24.4	25.3	15.4	12.0	14.1	12.0	19.0	8.2	28.2	42.6	12.1	25.0	12.6	8.8	21.2	11.7	27.0	27.6	15.2	6.3	20.8	28.5	18.1	11.1	77.6	10.2	14.8	14.2	5.6	34.7	23.3	32.0	4.5	8.2	25.4	14.9	9.8	18.3	26.1	30.3	32.9	19.3	17.2	6.6	9.7	18.3	22.9	20.6	25.7	27.6	36.0	20.2	23.1	25.4	20.0
FMN2		ENSG00000155816	"Formin 2"	Q9NZ56	1	240014348-240475187	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, Protein transport, Stress response, Transport"	"Actin-binding, Developmental protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.0;parathyroid gland: 19.7;retina: 16.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 758.1;Excitatory neurons: 537.5;Horizontal cells: 124.5;Inhibitory neurons: 366.7;Oligodendrocyte precursor cells: 154.3"	"Group enriched"	"Detected in some"	8	"glioma: 5.9;testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 70.8;BJ hTERT+: 39.4;fHDF/TERT166: 73.8;LHCN-M2: 87.9;U-138 MG: 48.9;WM-115: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050649			Approved	"Plasma membrane,Actin filaments"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Actin filaments"		"HPA050649: AB_2681202"	"unprognostic (1.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.11e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.40e-3)"	1.2	5.1	27.6	0.2	29.6	0.0	0.5	11.8	46.0	0.4	0.0	6.8	0.2	1.4	0.9	0.7	1.9	1.2	0.1	28.4	20.9	3.6	0.0	0.3	0.0	21.2	29.7	2.4	1.0	19.7	9.0	0.2	14.4	1.6	1.6	16.7	0.3	2.6	0.1	0.2	0.9	1.7	16.0	0.2	0.7	2.2	39.0	0.0	0.5	0.2	0.1	0.3	0.3	30.9	0.0	2.1	6.6	0.0	20.2	15.3	0.0	70.8	39.4	31.0	16.3	0.0	0.0	0.0	0.0	73.8	1.2	0.0	1.3	0.0	28.8	0.0	5.8	0.0	0.7	0.0	0.1	0.0	0.0	1.7	0.0	8.5	1.9	17.0	0.0	0.0	0.0	0.0	87.9	0.0	0.0	0.1	2.3	0.0	2.2	0.0	0.2	0.0	0.0	0.0	12.0	10.6	0.0	0.1	0.3	0.2	2.1	0.1	0.3	48.9	0.2	16.0	18.2	0.0	0.0	0.0	10.4	0.0	69.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	29.6	11.8	46.0	28.4	20.9	21.2	29.7	14.4	16.0	39.0	30.9	0.0	0.0	0.0	758.1	0.0	0.1	0.0	0.0	0.0	30.6	0.2	0.3	1.6	0.0	0.0	1.8	50.1	0.1	0.0	4.7	0.0	0.0	15.2	4.3	0.7	0.5	12.1	0.0	537.5	0.0	0.1	1.4	0.0	1.1	0.0	0.8	2.9	0.1	0.1	124.5	366.7	0.5	0.0	0.6	0.6	3.0	0.3	0.1	1.8	31.9	0.0	2.3	0.0	154.3	17.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.3	1.8	4.4	0.0	0.0	0.5	0.0	3.1	1.6	0.0
FMNL2	"FHOD2, KIAA1902"	ENSG00000157827	"Formin like 2"	Q96PY5	2	152335174-152649826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 223.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 668.0;Excitatory neurons: 574.9;Inhibitory neurons: 321.9;Oligodendrocyte precursor cells: 371.0;Oligodendrocytes: 2442.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 191.4;hTERT-HME1: 123.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005464	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA005464: AB_1848965"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.58e-1)"	26.4	25.2	88.9	11.1	152.3	0.7	20.8	135.2	119.3	18.1	73.6	15.2	8.9	20.7	14.9	8.5	15.3	16.8	12.0	92.9	102.6	22.2	8.1	32.2	14.2	172.3	136.3	54.0	18.1	23.1	28.4	58.2	165.5	15.2	12.3	10.6	32.1	11.7	24.1	11.3	11.6	16.3	121.6	19.8	17.3	9.0	128.5	14.8	33.1	19.3	8.4	19.3	18.3	223.5	14.5	15.1	45.9	25.5	54.5	58.3	191.4	14.4	29.4	24.9	34.8	16.3	0.9	0.3	29.8	12.6	53.7	16.2	22.4	45.8	39.6	0.1	23.4	0.2	10.0	70.2	15.7	4.0	0.8	38.4	27.8	48.2	123.5	48.3	44.7	6.6	0.6	0.3	13.9	4.0	0.8	4.5	29.5	12.4	30.0	25.9	9.9	20.9	72.9	9.9	46.6	38.0	12.2	4.5	51.4	38.7	1.1	1.5	49.9	37.4	1.0	12.7	25.0	1.3	0.5	0.1	34.7	3.3	77.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	88.9	152.3	135.2	119.3	92.9	102.6	172.3	136.3	165.5	121.6	128.5	223.5	21.5	25.6	25.9	668.0	2.7	26.4	23.0	14.0	19.4	23.8	11.4	10.0	3.8	1.5	16.4	11.0	0.0	36.1	4.5	2.6	13.7	20.4	24.5	14.1	10.8	29.1	8.3	0.4	574.9	6.9	17.8	36.2	8.2	27.0	1.3	36.0	20.0	1.3	40.6	0.0	321.9	3.3	10.2	64.8	53.0	10.5	35.1	31.5	7.2	245.4	4.4	3.9	1.0	371.0	2442.0	10.0	2.1	41.3	5.6	33.5	0.7	8.9	8.5	2.0	6.6	18.7	13.2	6.7	8.0	6.3	16.9	27.0	2.1	13.0	6.1	13.2
FOXN3	"C14orf116, CHES1"	ENSG00000053254	"Forkhead box N3"	O00409	14	89124871-89619149	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 517.2;Oligodendrocyte precursor cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.2;U-266/84: 112.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059209	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA059209: AB_2683949"	"unprognostic (1.69e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.58e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.11e-1)"	46.5	27.0	17.8	23.6	17.9	83.7	22.8	76.2	15.1	24.9	33.4	28.8	36.7	26.5	9.2	39.4	23.2	22.9	38.2	12.2	15.8	12.8	30.8	23.9	29.1	20.5	18.3	50.6	24.8	46.9	5.1	22.7	21.5	20.2	21.8	16.5	18.4	22.1	79.6	41.4	35.2	35.1	19.3	21.6	29.0	16.8	21.5	41.6	9.5	72.6	30.9	25.5	20.6	18.3	0.5	7.7	19.7	11.3	78.1	24.8	14.2	15.7	15.4	13.8	22.7	7.8	6.3	24.0	7.8	25.0	9.5	5.6	33.5	22.3	20.4	109.2	6.2	8.3	14.6	25.0	25.3	16.6	14.1	59.4	12.6	1.3	9.4	16.6	30.2	34.1	10.0	69.0	22.9	9.4	32.2	16.6	21.2	14.2	13.8	51.4	67.0	22.8	1.7	26.6	10.7	35.1	23.0	21.9	6.4	64.8	12.8	45.3	55.0	23.5	32.1	23.6	23.6	58.4	112.6	44.6	8.5	28.2	13.8	48.8	23.8	35.8	41.9	25.7	33.3	13.5	27.8	35.9	35.2	16.4	35.8	34.6	9.6	32.2	17.3	7.9	35.9	31.2	17.8	17.9	76.2	15.1	12.2	15.8	20.5	18.3	21.5	19.3	21.5	18.3	108.7	32.1	33.9	229.5	65.4	89.3	22.4	27.4	41.5	123.2	21.0	21.7	103.2	47.1	53.4	9.2	0.0	36.9	105.9	37.2	21.5	11.5	86.2	38.8	36.3	67.3	59.3	52.5	125.6	20.9	21.3	75.2	45.9	36.4	12.7	112.4	55.6	92.9	43.5	79.1	195.2	37.5	30.5	100.3	174.9	38.5	96.3	87.9	32.0	517.2	65.3	38.6	94.7	291.6	143.8	15.5	32.1	85.4	71.3	16.8	77.4	12.2	16.0	9.9	39.5	133.6	57.9	4.3	11.6	51.4	147.6	29.6	85.0	37.2	46.6	29.1
FP565260.3		ENSG00000277117	"ICOS ligand"		21	5022493-5040666	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 17.4"	"Cell type enriched"	"Detected in single"	6	"monocytes: 4.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;REH: 18.5;SiHa: 15.6"									HPA029179			Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane, Cytoplasmic bodies"		"HPA029179: AB_2732445"	"unprognostic (3.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.58e-4)"	"unprognostic (6.66e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-1)"	2.8	1.5	6.1	4.7	12.8	3.7	2.4	8.5	8.8	2.8	1.4	2.9	4.8	1.4	0.6	3.4	2.5	3.2	4.2	6.2	7.5	5.0	2.9	1.9	5.5	11.8	10.6	0.3	1.3	0.4	1.2	2.5	11.0	2.1	2.1	0.0	2.2	1.5	0.7	3.8	3.5	1.3	7.0	3.2	4.8	0.8	11.5	1.9	2.1	1.1	6.3	3.0	2.6	17.4	0.3	0.8	0.0	1.5	0.4	0.9	22.8	1.8	1.4	0.2	0.1	5.5	0.9	12.7	3.8	0.1	2.8	4.2	1.4	1.9	0.3	0.4	1.3	0.0	0.6	2.9	0.2	9.7	8.8	0.2	2.2	1.2	1.1	0.0	1.2	0.0	1.5	0.5	0.1	3.1	0.0	5.6	0.9	15.1	7.6	18.5	0.6	12.7	0.5	7.6	1.0	0.0	15.6	12.9	0.3	0.8	4.4	12.5	0.4	0.0	3.4	0.0	0.3	8.9	9.5	8.2	9.0	5.6	2.0	0.0	0.3	0.0	0.0	1.2	0.1	1.2	0.2	0.0	0.3	2.1	0.0	0.2	0.0	0.0	0.2	0.4	0.5	0.5	6.1	12.8	8.5	8.8	6.2	7.5	11.8	10.6	11.0	7.0	11.5	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.0;skeletal muscle: 81.2;tongue: 74.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.6;Cardiomyocytes: 73.7;Cone photoreceptor cells: 79.2;Early spermatids: 121.9;Horizontal cells: 101.0;Late spermatids: 122.8;Sertoli cells: 72.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.0;intermediate monocyte: 3.4;neutrophil: 2.5;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.5;monocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.0;OE19: 49.2;RPMI-8226: 79.6;SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.68e-3)"	9.4	7.3	6.6	2.0	5.5	5.4	6.7	4.3	6.8	3.0	12.0	5.5	2.9	2.7	15.7	2.5	2.2	2.5	85.0	6.3	7.7	14.9	0.7	4.0	1.3	10.1	8.5	1.4	1.6	20.6	4.2	14.8	7.3	2.8	6.6	21.6	2.9	7.8	81.2	2.1	6.7	3.5	7.6	7.2	2.8	9.9	9.9	1.1	7.1	74.7	0.5	4.6	2.6	5.4	0.0	4.3	3.8	0.3	0.7	0.2	0.3	4.1	0.3	0.1	0.0	0.5	5.2	0.9	4.7	1.9	0.9	0.2	0.2	0.0	0.0	0.2	0.2	24.0	4.8	2.8	0.2	0.0	0.3	1.0	0.1	0.0	0.2	0.2	2.7	0.1	0.1	0.1	4.9	0.7	0.0	0.1	0.4	49.2	7.2	0.1	3.0	79.6	6.2	10.1	28.4	13.8	1.4	0.3	0.9	0.6	1.7	0.8	4.4	0.2	0.6	0.1	2.9	0.4	0.3	0.0	0.9	7.6	2.8	0.0	2.0	0.0	0.2	3.4	0.4	0.3	0.1	0.0	0.2	0.4	0.0	0.0	2.5	0.3	1.5	0.4	0.0	6.0	6.6	5.5	4.3	6.8	6.3	7.7	10.1	8.5	7.3	7.6	9.9	5.4	38.4	22.4	1.1	6.2	0.4	1.0	1.0	0.6	0.6	108.6	2.6	1.9	73.7	15.7	1.8	1.8	79.2	0.4	0.2	28.9	17.6	2.8	121.9	2.8	1.4	25.8	1.2	0.8	37.9	2.0	1.2	8.8	2.0	3.9	0.0	0.4	4.2	0.3	0.8	101.0	70.0	38.3	0.0	4.4	0.6	122.8	2.1	8.3	0.0	27.2	4.2	3.9	1.0	10.1	16.0	2.3	10.0	4.9	0.0	1.6	43.6	12.4	3.2	7.0	72.3	66.6	50.7	4.1	1.4	0.2	1.3	0.1	0.9	29.8	2.4	2.3
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.7;smooth muscle: 2.2"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.7	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FSD1L	"CCDC10, CSDUFD1, FSD1CL, FSD1NL"	ENSG00000106701	"Fibronectin type III and SPRY domain containing 1 like"	Q9BXM9	9	105447796-105552433	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 43.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 423.3;Early spermatids: 97.2;Excitatory neurons: 79.0;Rod photoreceptor cells: 121.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035138	Approved		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA035138: AB_10601324"	"unprognostic (9.28e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.17e-5)"	"unprognostic (4.20e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.22e-3)"	1.2	3.5	8.4	2.1	9.4	2.4	1.6	7.8	10.0	1.7	6.3	2.6	4.5	2.1	3.3	0.9	7.1	1.4	4.1	8.9	12.3	2.1	0.7	2.2	1.4	13.2	11.4	1.4	1.4	2.0	3.3	0.9	11.5	1.6	2.4	43.2	1.1	1.6	7.3	1.1	3.7	1.5	11.7	1.4	2.2	5.8	12.5	1.6	2.0	13.3	1.5	1.1	0.9	12.0	3.3	3.8	5.6	3.9	1.6	3.2	2.0	3.1	1.8	2.5	2.5	1.7	1.4	8.3	1.2	2.7	3.0	1.3	3.6	1.6	3.5	11.1	1.3	1.4	5.3	2.3	2.5	4.9	3.4	1.5	1.6	3.6	5.5	3.2	2.4	3.9	1.8	5.1	2.5	1.1	8.4	3.1	3.5	0.4	2.2	10.6	3.8	0.7	2.6	0.7	12.3	5.9	3.5	0.9	3.0	2.3	3.7	1.7	3.2	4.4	2.7	3.7	4.2	2.6	9.9	2.2	3.1	3.0	1.6	0.4	0.9	0.0	0.5	0.6	0.2	1.8	0.7	0.5	0.6	0.6	0.0	0.3	0.2	0.5	0.4	0.6	0.2	0.2	8.4	9.4	7.8	10.0	8.9	12.3	13.2	11.4	11.5	11.7	12.5	12.0	2.9	3.2	1.1	23.8	4.2	1.0	2.0	2.5	0.0	23.1	2.3	2.0	6.0	1.5	3.5	7.3	423.3	0.3	3.4	3.0	1.9	22.7	97.2	47.5	5.7	3.3	10.7	1.7	79.0	3.8	1.3	5.2	2.6	15.1	14.0	10.4	1.1	1.3	3.8	52.2	59.2	6.3	2.0	1.2	3.5	68.2	5.0	5.3	10.6	16.9	21.0	12.7	1.0	21.6	66.9	5.2	7.1	6.8	3.0	1.1	7.8	2.4	44.9	121.1	13.1	6.3	4.1	26.0	26.1	0.3	0.9	0.0	2.8	2.2	6.8	0.2
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 939.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 131.5;Early spermatids: 104.7;Hepatocytes: 444.9;Late spermatids: 124.3;Proximal tubular cells: 395.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 92.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		1600000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.4	1.7	5.4	0.2	6.8	0.0	0.4	3.6	8.4	1.3	3.0	1.3	1.3	1.2	0.4	0.3	0.9	0.1	1.6	4.9	4.7	155.7	939.8	0.2	0.2	4.6	3.9	3.0	4.0	0.0	3.4	0.0	5.6	4.2	0.0	0.0	0.2	0.6	0.4	0.3	1.7	0.0	3.5	0.5	0.5	13.9	4.4	0.0	0.9	0.0	0.0	1.3	1.0	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.0	92.9	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.5	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.4	6.8	3.6	8.4	4.9	4.7	4.6	3.9	5.6	3.5	4.4	5.5	0.0	0.0	0.0	1.0	8.1	0.1	0.0	0.0	0.0	1.3	0.2	0.5	1.5	131.5	0.0	9.2	0.0	0.0	0.1	0.0	46.9	0.0	104.7	0.1	0.4	1.8	0.0	61.5	10.5	0.0	0.0	0.6	0.0	0.2	0.0	0.6	30.4	444.9	0.1	3.3	5.9	0.1	0.0	28.9	0.0	124.3	3.1	1.6	0.0	1.0	0.0	0.2	0.0	1.0	18.5	0.0	0.1	2.6	0.0	0.5	0.3	395.1	0.0	0.4	0.0	0.2	0.5	39.2	17.9	0.2	0.4	0.0	3.6	0.1	0.2	0.1
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1800.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1870.8;Distal enterocytes: 5605.4;Intestinal goblet cells: 2165.8;Paneth cells: 3324.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 896.3;hTCEpi: 1603.2;OE19: 3112.0;RT4: 860.2;SK-BR-3: 830.8;WM-115: 589.7"									HPA010856	Supported		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	5.1	1.1	7.3	59.5	7.4	1.3	225.2	7.1	7.9	168.0	7.5	1466.2	102.7	13.2	15.2	685.3	104.3	100.5	5.8	7.1	6.5	12.0	2.0	150.2	0.8	8.0	7.3	1.8	64.3	0.1	24.7	84.9	6.8	512.1	1800.0	45.4	569.1	33.3	2.1	568.3	308.9	35.7	6.7	0.6	572.4	0.6	7.0	18.7	1.5	0.1	163.3	295.6	395.8	7.4	166.3	0.0	0.0	0.4	0.6	0.4	150.5	0.0	0.0	0.0	0.0	6.0	235.3	0.3	0.5	0.0	1.3	896.3	0.1	339.5	0.0	0.1	0.3	1.0	7.7	0.6	0.1	0.1	0.6	0.0	1603.2	0.0	0.7	0.1	0.1	0.1	0.1	1.1	0.0	304.5	0.8	2.2	0.8	3112.0	1.4	0.8	0.4	1.2	0.0	860.2	190.2	2.1	1.0	830.8	61.8	2.3	155.9	0.2	0.0	0.3	0.6	0.9	0.7	0.1	0.4	0.7	1.0	0.3	589.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	7.3	7.4	7.1	7.9	7.1	6.5	8.0	7.3	6.8	6.7	7.0	7.4	3.1	762.8	262.6	0.3	11.1	576.9	792.9	1870.8	340.4	2.9	557.5	515.7	1.3	201.6	1026.4	134.3	0.0	883.5	8.3	5605.4	1.9	35.6	0.4	180.1	29.5	19.7	974.3	2.7	0.1	708.4	138.1	20.3	356.8	194.1	22.3	0.0	0.0	0.9	81.4	1.7	0.0	2165.8	587.9	0.0	68.3	0.0	0.0	15.6	412.6	0.0	1.6	422.1	0.0	0.0	0.6	556.5	3324.0	0.0	6.5	1041.7	1693.0	0.5	1627.1	13.3	0.0	0.5	66.5	0.2	0.2	541.1	865.5	1512.1	17.9	0.0	1499.3	1509.9
FYB1	"ADAP, FYB, FYB-120/130, SLAP-130"	ENSG00000082074	"FYN binding protein 1"	O15117	5	39105252-39274528	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.0;lymphoid tissue: 112.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 142.9;Extravillous trophoblasts: 88.7;Hofbauer cells: 157.0;Macrophages: 104.2;T-cells: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1670.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HEL: 61.5;JURKAT: 211.9;MOLT-4: 212.9;REH: 61.3;U-937: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025336, HPA026796, HPA067427"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6200000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Nucleoplasm	"CAB025336: , HPA026796: AB_10964126, HPA067427: "	"unprognostic (5.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-1)"	10.2	5.8	5.7	82.5	5.5	53.0	5.1	6.3	9.3	6.6	7.4	10.0	9.1	3.8	10.5	5.7	3.6	16.8	2.4	5.4	7.9	5.0	13.6	17.6	85.8	16.7	19.1	2.7	1.8	2.1	1.5	17.9	15.8	4.2	11.0	0.5	7.4	3.0	1.2	2.0	15.0	11.6	9.3	73.0	12.2	3.3	13.3	112.8	2.6	2.7	63.0	17.1	1.8	13.9	0.2	4.2	0.0	0.0	0.5	0.0	21.1	0.1	1.2	0.3	0.4	0.4	0.3	0.3	0.0	0.0	8.0	16.4	0.0	0.3	0.1	0.3	0.0	61.5	0.0	0.1	0.0	23.3	18.6	0.3	0.4	0.0	0.4	0.1	0.0	211.9	0.0	0.0	0.0	0.0	212.9	13.5	0.2	0.1	0.1	61.3	0.0	0.3	1.0	3.5	0.1	0.0	0.1	0.5	6.5	1.4	0.0	5.2	0.0	0.0	0.2	0.2	0.2	0.4	0.0	4.5	0.0	81.4	0.2	151.3	359.0	354.6	76.3	406.5	52.9	1.8	216.7	134.5	127.6	1.3	271.7	169.8	1670.8	89.9	483.9	30.8	231.5	400.1	5.7	5.5	6.3	9.3	5.4	7.9	16.7	19.1	15.8	9.3	13.3	13.9	4.4	16.0	24.7	0.0	6.2	0.0	0.0	0.0	0.0	0.0	3.2	7.6	0.0	0.0	5.6	14.7	0.0	28.8	142.9	0.0	9.8	0.4	0.0	0.7	1.1	4.3	0.0	0.0	0.0	0.0	88.7	3.8	0.0	1.0	15.2	0.1	0.0	0.0	157.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	35.9	3.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	40.2	119.3	0.1	0.0	0.0
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955395	"CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 120.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.0;Collecting duct cells: 36.8;Endothelial cells: 51.2;Hepatic stellate cells: 99.6;Sertoli cells: 32.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 63.6;Hep G2: 85.2;HSkMC: 46.0;HUVEC TERT2: 93.6;TIME: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042328, HPA074833"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"HPA042328: AB_10962494, HPA074833: AB_2686716"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.97e-1)"	120.1	9.5	6.7	5.8	6.2	0.3	55.6	5.1	7.3	12.5	7.8	14.9	2.8	12.2	7.6	6.5	16.3	11.5	27.4	5.6	5.9	27.1	14.6	32.9	6.2	6.5	6.3	12.9	9.5	6.4	8.7	11.7	7.0	12.5	6.3	1.1	12.2	30.2	31.5	5.9	8.8	13.4	5.6	14.1	14.1	5.1	8.5	3.9	18.1	40.6	4.6	10.5	9.5	5.9	1.3	1.1	2.7	5.2	63.6	16.5	3.7	8.4	7.6	3.2	3.3	7.1	0.9	0.0	1.8	2.6	4.4	2.8	3.1	1.3	2.5	0.2	2.1	2.8	2.3	85.2	18.9	0.0	0.1	46.0	0.5	2.8	0.5	7.5	93.6	0.1	3.9	0.4	2.2	2.2	0.0	0.0	3.9	7.5	18.8	0.1	4.8	0.2	9.0	13.7	0.6	0.8	3.5	1.0	1.4	5.6	12.0	0.0	46.3	7.8	5.1	9.2	1.7	0.4	1.3	0.0	1.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	6.2	5.1	7.3	5.6	5.9	6.5	6.3	7.0	5.6	8.5	5.9	83.0	0.0	1.3	9.8	0.5	1.5	0.5	1.3	2.2	0.7	5.5	3.2	8.3	7.2	2.0	36.8	10.4	0.2	0.5	1.0	3.9	0.5	0.7	0.4	2.7	51.2	0.0	2.7	8.1	1.6	0.2	17.7	4.1	0.5	0.0	9.1	99.6	14.1	0.2	0.0	3.4	1.3	0.0	6.7	1.8	2.2	9.3	0.6	0.0	10.3	0.0	0.2	2.1	3.0	0.7	1.0	0.1	6.8	0.3	1.4	0.7	9.4	2.1	0.2	32.9	14.4	26.6	0.3	3.2	1.3	0.6	0.3	0.4	16.6	1.1	0.2
GAB1	DFNB26	ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 162.7;Microglial cells: 192.0;Oligodendrocyte precursor cells: 288.0;Oligodendrocytes: 1013.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center, Plasma membrane"	Cytosol	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	7.9	8.6	23.3	6.7	69.9	11.5	9.9	35.5	30.0	10.6	2.5	19.7	12.1	18.1	14.2	20.4	9.2	12.5	30.5	20.4	34.6	13.9	9.1	17.9	6.1	57.3	45.4	19.5	8.1	11.3	4.3	21.0	47.9	8.5	22.8	6.9	8.9	14.7	13.4	10.7	12.3	17.7	26.4	7.5	11.3	9.2	45.7	5.4	7.5	16.5	8.7	7.1	9.7	114.8	6.7	1.4	16.7	12.1	8.3	7.9	22.0	4.6	15.2	5.4	9.4	12.8	11.2	0.2	1.4	6.5	3.7	3.8	16.2	5.3	6.2	1.0	3.9	12.2	3.7	6.1	5.7	1.6	2.3	9.7	9.5	6.6	4.3	11.5	7.2	0.2	4.1	21.7	3.8	9.7	0.9	0.0	4.8	3.5	5.3	74.6	8.2	8.8	8.4	8.0	3.9	11.8	3.1	13.3	5.6	11.2	8.5	1.6	5.5	6.9	5.4	3.4	3.5	34.6	18.2	26.3	4.7	4.8	5.7	4.1	0.4	0.5	0.0	0.5	0.2	0.9	0.0	0.0	0.5	1.8	0.0	0.0	2.6	5.0	1.7	2.2	0.0	0.3	23.3	69.9	35.5	30.0	20.4	34.6	57.3	45.4	47.9	26.4	45.7	114.8	13.4	28.9	19.0	89.5	13.1	20.3	8.8	3.3	12.0	2.1	11.6	8.9	34.0	8.6	5.3	12.9	0.0	23.5	10.9	26.2	0.0	6.6	0.9	8.8	9.3	16.3	22.2	40.8	162.7	2.6	10.6	14.4	11.2	21.6	2.5	9.6	13.9	7.0	6.1	3.3	62.2	27.8	4.1	11.6	10.2	3.8	20.8	8.8	16.0	192.0	5.6	15.4	1.0	288.0	1013.6	4.9	10.7	18.8	94.4	7.2	9.3	5.4	3.4	0.8	13.1	7.0	14.3	2.0	5.3	19.9	24.9	10.4	2.7	4.4	13.6	13.5
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor subunit alpha1"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 55.1;retina: 17.8"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 198.0;Excitatory neurons: 220.5;Inhibitory neurons: 215.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA029363, HPA055746"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"CAB022502: , HPA029363: , HPA055746: AB_2682904"					"unprognostic (2.58e-2)"						"unprognostic (4.78e-3)"	"unprognostic (1.84e-1)"		"unprognostic (3.31e-1)"		"unprognostic (2.43e-1)"		0.0	1.2	6.7	0.0	11.1	0.0	0.0	24.8	55.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	14.3	0.6	0.0	0.0	0.2	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	11.1	24.8	55.1	7.7	21.7	0.0	0.0	0.0	0.0	14.3	24.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	198.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	220.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	215.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	17.8	0.0	3.5	0.0	8.0	16.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA5		ENSG00000186297	"Gamma-aminobutyric acid type A receptor subunit alpha5"	P31644	15	26866911-26949208	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 111.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 27.6;Inhibitory neurons: 14.1"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Group enriched"	"Detected in many"	4	"amygdala: 52.0;basal ganglia: 73.5;cerebral cortex: 98.6;hippocampal formation: 111.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A549: 35.3;HAP1: 12.0;NTERA-2: 16.2;U-2 OS: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029363, HPA077031, CAB079022"		Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"CAB079022: , HPA029363: , HPA077031: AB_2686825"	"unprognostic (6.33e-2)"			"unprognostic (8.94e-3)"	"unprognostic (1.04e-1)"			"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.57e-1)"		"unprognostic (7.63e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	52.0	0.1	73.5	0.0	0.0	0.0	98.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.5	111.0	7.2	0.1	0.1	0.0	0.0	0.0	3.0	0.0	0.1	0.7	0.5	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.7	12.0	9.0	0.1	0.1	0.3	0.0	0.0	19.6	0.0	35.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	12.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.1	0.2	1.8	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	73.5	0.0	98.6	111.0	7.2	0.0	3.0	0.0	0.0	12.0	19.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.8	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 98.5;parathyroid gland: 46.3;retina: 29.7"	"Group enriched"	"Detected in many"	8	"Inhibitory neurons: 392.8;Oligodendrocyte precursor cells: 146.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 20.1;HEL: 64.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 547.6"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	0.2	3.0	22.1	0.0	29.9	3.3	0.1	15.5	33.0	1.0	0.0	0.0	0.0	1.6	4.3	0.4	0.2	0.1	0.0	17.1	98.5	4.8	0.1	0.2	0.1	12.4	41.6	0.2	0.2	46.3	5.0	0.4	17.6	0.8	0.1	29.7	0.1	0.3	0.0	0.2	0.1	0.0	12.7	0.1	0.0	3.2	31.1	0.8	0.1	0.0	0.2	0.6	0.4	14.2	18.2	0.7	0.0	7.3	0.0	0.0	0.1	0.4	0.0	2.6	1.7	4.6	6.7	0.0	0.9	0.5	2.9	20.1	2.3	0.6	1.6	2.8	13.4	64.5	6.0	0.2	0.0	0.3	1.1	0.0	5.5	0.0	2.3	0.6	0.1	0.5	17.0	0.3	0.8	1.5	0.0	0.0	8.1	9.7	6.7	1.0	4.6	0.4	8.5	9.4	6.7	2.1	12.6	0.0	3.5	0.6	0.2	0.0	0.0	12.0	1.7	2.4	7.0	0.0	0.0	0.1	11.5	3.2	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	29.9	15.5	33.0	17.1	98.5	12.4	41.6	17.6	12.7	31.1	14.2	0.0	0.0	0.0	14.7	0.0	0.3	2.1	7.7	2.2	32.5	0.1	0.1	1.3	0.0	3.6	0.0	10.4	0.0	0.0	0.2	7.9	4.5	5.6	4.4	0.4	0.4	3.0	5.5	2.6	5.6	0.1	0.2	0.0	2.9	0.0	5.5	0.0	0.0	4.0	5.0	392.8	0.3	2.0	0.8	0.4	6.2	0.6	0.5	0.0	7.5	0.0	4.9	0.0	146.8	7.6	2.9	0.0	0.0	0.1	0.9	0.0	0.0	4.7	6.0	0.0	0.0	1.2	4.4	7.7	0.6	0.1	0.5	0.0	0.1	0.1	0.4
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 25.8;tongue: 11.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.4;Club cells: 1.3;Collecting duct cells: 1.8;Fibroblasts: 5.9;Late spermatids: 1.8;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;TIME: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.3	0.4	2.2	0.4	2.1	1.2	0.4	2.6	2.5	0.1	0.1	0.2	0.2	0.3	0.6	0.6	0.2	0.3	0.6	1.8	0.8	0.7	0.3	0.3	0.4	0.9	0.5	0.6	0.4	0.2	0.2	0.3	0.9	0.6	0.2	1.7	0.4	0.1	25.8	0.9	0.2	0.2	0.1	0.6	0.3	0.5	1.0	0.1	0.9	11.3	0.3	0.2	0.0	2.3	0.4	0.0	0.2	0.4	0.3	0.1	0.5	0.2	0.1	0.0	0.0	0.5	0.5	0.4	0.2	0.0	0.2	0.3	4.7	0.1	0.1	0.6	0.1	0.5	0.8	0.2	0.0	0.3	1.3	0.1	0.1	0.2	0.1	0.4	0.1	0.3	0.5	1.7	0.2	0.3	0.2	0.5	0.5	0.1	0.1	0.7	0.9	0.4	0.2	0.6	0.5	0.3	0.2	0.3	1.3	0.3	0.4	0.3	2.4	0.6	0.5	0.8	0.2	0.6	0.3	0.3	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	2.2	2.1	2.6	2.5	1.8	0.8	0.9	0.5	0.9	0.1	1.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	1.8	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0
GAGE1	CT4.1	ENSG00000205777	"G antigen 1"	P0DTW1	X	49599025-49608536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 9.1"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 113.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 739.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	739.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	24.4	113.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12C		ENSG00000237671	"G antigen 12C"	A1L429	X	49532211-49539538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	271	"testis: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/84: 37.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	9.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12D		ENSG00000227488	"G antigen 12D"	A1L429	X	49541767-49549094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	271	"testis: 27.0"	"Cell type enriched"	"Detected in single"	10	"Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/84: 37.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	9.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12F		ENSG00000236362	"G antigen 12F"	"P0CL80, O76087, P0CL82"	X	49551278-49568218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 178.7"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"AN3-CA: 1630.3;K-562: 1415.3"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.7	178.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.9	0.0	0.0	1630.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.1	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1415.3	30.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	360.9	0.0	5.1	56.9	7.5	0.3	1.0	0.6	72.0	0.0	0.2	0.0	171.2	1.3	11.5	4.6	4.8	12.1	3.4	8.4	12.6	8.7	0.0	7.8	9.7	8.6	1.4	14.7	10.5	12.4	20.2	11.5	0.4	0.6	0.2	0.3	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12G		ENSG00000215269	"G antigen 12G"	"P0CL81, O76087, P0CL82"	X	49570434-49577754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"retina: 1.6;stomach 1: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 439.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 23: AN3-CA - Transcription regulation"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	439.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	54.7	0.0	0.0	8.4	0.5	0.1	0.2	0.0	0.0	0.0	0.2	0.0	20.8	0.2	1.5	0.9	0.5	1.6	0.8	0.8	2.0	0.2	0.0	1.5	0.3	1.7	0.0	0.3	1.4	0.9	4.7	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12H		ENSG00000224902	"G antigen 12H"	A6NDE8	X	49579983-49587301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	230	"testis: 22.9"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 1.4;Spermatogonia: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"A-431: 53.9;U-266/84: 164.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.3	1.4	0.0	0.0	0.0	164.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12J	GAGE11	ENSG00000224659	"G antigen 12J"	A6NER3	X	49322057-49329384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 35.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"AN3-CA: 1145.9;K-562: 290.3"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	35.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1145.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	2.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	290.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	32.4	0.0	0.0	0.0	0.2	0.5	0.0	2.5	32.2	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE13	GAGE12A	ENSG00000274274	"G antigen 13"	Q4V321	X	49331616-49338952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 36.1"	"Group enriched"	"Detected in some"	22	"Spermatocytes: 4.2;Spermatogonia: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 303.6;T-47d: 165.3;WM-115: 83.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	303.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	3.6	0.0	2.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	165.3	0.0	0.7	3.4	1.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE2A	"CT4.2, GAGE2"	ENSG00000189064	"G antigen 2A"	Q6NT46	X	49589529-49596827	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	108	"testis: 92.5"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 108.0;Spermatogonia: 358.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 86.8;T-47d: 289.7;WM-115: 325.3"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"															"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	86.8	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	289.7	0.0	0.0	47.3	10.6	0.1	0.0	1.2	13.8	0.0	2.9	0.0	325.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	108.0	358.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE2E	GAGE8	ENSG00000275113	"G antigen 2E"	Q4V326	X	49341192-49345922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"stomach 1: 12.8;testis: 26.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AN3-CA: 2587.1;K-562: 674.0"									HPA043232	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.2	12.8	26.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2587.1	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	4.3	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	674.0	12.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.0	5.0	0.3	0.3	364.7	0.1	3.3	61.8	2.4	0.2	0.2	0.8	20.9	0.0	0.7	0.2	138.5	0.4	0.6	0.1	0.5	0.0	0.0	0.6	0.1	1.0	0.0	1.2	2.1	0.0	0.4	0.4	0.0	1.5	2.9	0.1	0.1	0.3	0.0	0.3	0.2	0.0	0.1	0.5	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 65.8"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 74.0;Oligodendrocyte precursor cells: 156.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 284.9;TIME: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	12.1	15.6	10.7	14.4	14.5	19.3	13.5	12.1	10.0	24.1	33.0	16.1	14.4	6.3	6.0	4.9	14.6	16.7	9.0	9.5	12.5	9.7	4.4	15.5	9.9	16.1	13.9	65.8	9.8	13.6	11.5	4.7	12.3	9.1	14.7	7.8	13.5	3.7	5.4	6.0	12.6	11.6	9.9	15.8	22.0	4.5	13.9	7.8	16.6	8.2	9.4	11.1	5.2	12.6	25.6	85.3	20.3	17.8	42.2	37.3	15.6	71.7	39.9	27.9	26.7	12.1	56.7	16.6	49.3	121.4	49.9	4.4	9.4	56.0	25.4	43.2	6.7	45.4	16.0	16.5	32.4	9.9	42.3	46.7	12.9	22.7	33.2	284.9	54.4	12.5	10.5	50.9	48.4	26.4	1.1	6.8	8.0	71.1	17.3	5.1	10.7	16.6	38.6	17.1	2.7	6.6	31.8	117.0	9.4	29.6	45.6	7.4	161.2	67.5	15.9	16.8	77.7	14.5	15.0	8.7	44.2	19.3	21.1	2.0	1.2	2.4	3.1	1.6	2.8	1.9	1.8	2.0	1.4	2.1	0.8	2.1	2.5	1.9	1.8	1.1	1.6	1.0	10.7	14.5	12.1	10.0	9.5	12.5	16.1	13.9	12.3	9.9	13.9	12.6	17.4	9.6	46.4	32.7	17.4	4.8	3.9	5.6	1.8	4.6	12.4	8.6	5.0	5.7	8.7	14.7	4.2	0.7	27.7	23.0	9.8	9.1	10.3	12.4	7.4	14.1	3.0	21.4	14.3	30.1	1.5	13.7	30.5	22.3	10.2	10.5	23.9	5.3	8.5	0.0	15.9	20.4	6.1	19.5	7.8	22.5	38.2	12.4	0.0	74.0	11.9	17.4	44.3	156.9	66.9	36.8	13.6	50.0	15.4	8.2	15.3	2.7	0.7	10.5	6.6	5.6	7.8	2.0	4.0	1.2	3.7	0.8	21.7	27.3	12.2	4.2
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807670-98850081	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 74.7;intestine: 55.8;stomach 1: 54.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 101.2;Intestinal goblet cells: 142.4;Undifferentiated cells: 42.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 128.4;U-2197: 160.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA048292, HPA071076"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA048292: AB_2680343, HPA071076: "	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	5.0	2.0	1.2	7.7	1.3	2.2	3.4	6.5	1.8	8.7	4.3	55.3	34.2	3.7	74.7	19.6	7.5	10.5	1.2	1.1	1.4	4.8	0.4	11.7	3.2	2.6	1.4	0.4	13.6	6.3	3.4	2.6	2.7	4.6	55.8	0.6	25.5	4.3	1.3	3.4	27.1	14.0	1.1	2.2	54.8	4.6	1.5	3.3	14.7	0.6	6.1	11.9	4.6	1.6	5.4	4.1	3.4	13.5	10.0	7.8	0.0	1.4	2.1	2.0	4.6	0.8	21.6	0.0	5.0	0.9	12.2	38.0	2.9	1.3	1.6	26.2	1.7	2.4	0.2	0.0	0.5	1.6	0.5	3.8	0.9	6.4	0.0	2.7	2.3	19.3	30.2	0.0	0.6	13.9	2.6	4.7	16.7	128.4	5.6	6.5	0.3	0.1	2.3	7.7	12.4	1.1	0.5	30.6	3.0	7.7	4.5	4.5	4.3	0.0	0.3	160.9	0.0	2.1	4.8	2.3	37.1	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.6	0.0	0.4	0.2	0.0	0.1	0.6	0.3	0.0	0.6	0.0	0.1	0.0	0.1	1.2	1.3	6.5	1.8	1.1	1.4	2.6	1.4	2.7	1.1	1.5	1.6	1.3	3.2	25.7	2.0	2.3	2.4	1.3	8.3	1.2	2.4	0.4	0.1	1.0	18.6	16.9	11.0	16.7	1.0	2.6	101.2	0.0	11.2	1.8	4.8	1.6	1.6	19.9	1.3	7.4	25.4	1.7	12.5	32.1	8.7	2.5	2.4	0.0	0.0	2.3	0.0	5.7	142.4	2.0	0.3	3.9	1.4	2.1	3.9	0.0	3.7	0.2	0.8	3.1	3.5	7.0	32.0	36.5	7.5	1.7	7.4	21.9	2.7	16.9	0.2	0.0	0.7	1.5	5.9	10.5	9.9	1.3	1.1	4.5	5.1	42.5	11.1
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625509-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 39.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 39.8;Excitatory neurons: 114.9;Inhibitory neurons: 141.9;Oligodendrocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Hep G2: 43.2;JURKAT: 24.0;Karpas-707: 85.2;SCLC-21H: 24.8;U-266/84: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favorable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.4	0.8	2.1	0.3	1.9	0.1	0.8	4.5	5.4	0.9	0.0	0.7	1.8	0.8	0.0	0.7	1.2	1.6	3.5	0.7	2.2	5.4	39.7	1.0	1.0	6.2	7.5	2.0	9.6	0.1	2.5	0.4	6.3	1.0	0.4	2.2	1.5	0.6	4.6	0.8	1.6	0.3	3.3	1.3	2.6	0.8	6.1	8.2	0.8	1.8	0.7	1.0	0.7	6.1	0.0	0.1	1.7	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.7	0.4	0.2	0.0	43.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.3	0.0	24.0	1.6	85.2	0.0	0.4	0.3	0.1	0.3	2.4	0.0	0.9	0.5	4.4	0.0	1.1	24.8	1.3	0.0	0.0	0.5	0.2	0.1	0.0	1.8	0.0	0.4	1.1	0.0	1.1	30.7	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	1.9	4.5	5.4	0.7	2.2	6.2	7.5	6.3	3.3	6.1	6.1	0.1	0.0	0.0	39.8	0.4	0.1	0.4	0.1	0.6	1.9	0.4	0.1	12.7	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.3	1.3	0.1	0.4	0.0	0.0	114.9	3.3	0.0	1.0	3.1	0.7	0.0	0.2	0.7	22.9	0.0	0.0	141.9	0.6	0.0	0.0	0.0	5.4	0.6	0.0	0.0	9.4	0.2	0.2	0.0	18.6	83.9	1.6	1.4	0.0	0.5	0.1	0.1	3.2	4.0	1.2	0.0	0.3	0.8	0.4	1.1	0.6	0.0	0.0	0.4	0.1	0.9	0.3
GAS2L1	GAR22	ENSG00000185340	"Growth arrest specific 2 like 1"	Q99501	22	29306582-29312785	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 84.6;Late spermatids: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 77.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019858	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	"Cell Junctions"	"HPA019858: AB_1849486"	"unprognostic (3.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (4.23e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-2)"	22.6	36.3	46.7	5.5	41.8	6.5	22.4	39.4	58.5	16.2	30.4	25.8	18.1	18.4	5.3	34.3	16.5	4.2	33.5	45.4	37.8	21.0	18.6	19.3	2.3	50.0	43.3	8.9	14.4	6.6	22.1	4.1	42.2	22.2	2.0	4.0	24.7	16.9	6.5	52.8	17.8	4.4	41.8	29.1	27.4	51.3	47.3	1.1	15.6	3.9	1.8	17.6	19.6	37.4	20.4	23.1	3.5	14.5	5.5	5.2	22.6	29.7	8.9	12.3	6.4	10.6	14.2	0.1	13.1	15.9	12.9	60.5	6.0	16.8	2.2	27.6	2.9	26.5	19.9	7.5	7.0	0.2	17.8	5.6	11.5	11.9	4.7	8.9	16.5	26.2	12.8	4.1	9.0	17.2	0.5	14.8	5.3	13.5	51.6	0.6	10.3	1.7	7.5	12.8	1.2	19.0	23.0	30.3	17.0	4.4	30.2	4.1	35.5	77.0	53.0	34.6	30.3	0.3	0.4	0.3	34.1	1.0	19.3	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	46.7	41.8	39.4	58.5	45.4	37.8	50.0	43.3	42.2	41.8	47.3	37.4	34.5	6.4	1.7	28.1	0.4	28.2	7.0	12.3	21.6	3.6	24.0	18.4	5.6	14.3	8.3	1.8	6.2	24.8	0.8	13.4	7.9	12.2	33.8	19.2	9.2	26.2	1.8	19.6	14.8	6.7	14.3	12.0	9.2	10.0	1.3	28.9	84.6	12.0	14.1	13.5	11.4	5.1	20.3	14.5	23.0	89.7	9.6	37.6	12.4	7.5	7.6	5.4	0.0	4.0	4.0	10.2	7.2	11.7	0.2	6.1	41.7	10.1	4.3	20.9	39.5	35.3	23.5	5.4	12.4	27.9	32.4	6.7	2.2	17.8	11.8	4.6
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910606-10198606	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.6;Fibroblasts: 79.6;Inhibitory neurons: 76.6;Late spermatids: 73.4;Oligodendrocytes: 163.3"	"Group enriched"	"Detected in all"	4	"glioma: 15.7;melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 26.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 17.1;monocytes: 26.2"	"Cell line enriched"	"Detected in many"	9	"WM-115: 533.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: AB_2685319"	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (6.89e-4)"	27.3	8.5	34.9	23.7	68.9	31.1	15.3	75.4	79.8	29.9	0.0	26.3	7.3	13.3	4.3	23.8	17.8	16.3	46.1	61.9	8.4	1.7	2.3	17.1	9.1	23.4	24.1	7.8	3.4	1.1	2.6	16.2	15.8	8.5	12.0	30.1	7.8	10.8	5.8	33.7	11.9	24.0	14.3	16.1	8.9	17.4	32.9	9.3	4.6	6.8	10.3	18.3	19.5	85.3	0.1	0.5	0.6	1.0	16.5	22.5	0.3	0.8	0.0	2.6	1.1	0.1	0.2	6.6	1.9	6.6	0.3	0.3	0.0	0.0	1.6	0.0	1.5	0.0	1.3	0.7	5.3	1.8	48.7	4.3	0.3	5.1	0.1	0.0	0.0	42.7	0.0	0.6	0.0	0.0	54.3	15.4	2.6	2.1	0.0	14.3	0.1	49.6	0.0	0.2	0.1	3.0	0.2	0.2	60.1	21.0	2.8	24.7	0.0	0.2	3.4	0.1	0.1	0.4	0.0	0.0	0.4	35.1	533.8	0.6	26.2	17.1	2.8	6.9	0.9	0.5	0.3	1.4	5.3	0.6	0.2	1.4	16.4	4.5	4.9	1.0	0.0	7.7	34.9	68.9	75.4	79.8	61.9	8.4	23.4	24.1	15.8	14.3	32.9	85.3	2.9	0.0	4.2	6.8	3.3	8.3	4.5	1.5	1.2	34.6	1.6	2.3	13.3	0.0	1.1	5.5	27.1	1.0	14.5	0.0	0.0	1.0	62.3	17.7	12.8	5.7	0.0	0.4	133.6	0.0	1.8	79.6	0.0	26.3	17.2	7.9	5.0	0.9	39.2	0.0	76.6	0.0	0.0	66.7	32.2	73.4	10.2	54.3	33.8	52.5	57.2	9.5	18.6	11.1	163.3	0.2	0.0	1.9	5.5	2.0	0.0	0.1	16.3	31.7	0.0	67.0	7.1	1.6	6.7	1.0	16.6	1.9	7.4	0.2	0.0	4.9
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 198.3;Late spermatids: 277.8;Respiratory ciliated cells: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Plasma membrane"	"HPA041311: AB_2677402, HPA048238: AB_2680324"	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favorable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favorable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	5.2	10.3	9.5	2.8	9.7	1.4	6.3	10.0	14.3	7.8	12.3	7.7	2.6	6.5	10.1	8.4	18.9	6.1	15.4	9.5	9.9	13.8	5.5	7.1	2.8	10.3	10.0	8.9	10.5	16.3	14.1	2.1	10.1	7.3	3.0	5.0	11.4	8.6	15.1	4.5	3.9	4.4	10.3	3.4	8.2	16.8	10.9	2.5	12.5	10.0	2.0	6.3	5.8	10.2	17.9	14.5	1.8	8.5	7.8	6.2	14.3	3.6	8.8	13.9	4.1	14.1	13.0	1.0	9.1	7.1	8.4	17.8	5.9	9.9	3.3	0.0	10.7	3.7	9.0	16.2	8.7	2.2	2.8	7.9	6.0	10.4	4.7	6.3	8.3	5.8	14.3	2.1	6.1	41.9	2.5	9.9	11.6	11.3	7.4	0.7	15.7	1.0	17.4	8.5	14.6	10.7	18.4	9.7	21.0	1.6	19.6	8.4	6.2	8.6	10.3	4.7	8.3	3.4	5.4	0.0	21.3	2.7	15.1	1.7	1.2	1.4	0.7	2.0	0.7	0.4	1.0	1.4	1.7	0.8	0.8	0.7	1.5	0.0	1.3	1.9	1.6	0.8	9.5	9.7	10.0	14.3	9.5	9.9	10.3	10.0	10.1	10.3	10.9	10.2	5.9	22.4	11.3	20.5	3.1	1.1	4.7	7.0	5.7	11.9	14.1	10.8	7.9	25.8	13.4	22.0	20.9	3.0	0.7	5.9	13.7	17.1	198.3	45.5	7.1	5.8	6.0	3.0	27.5	10.9	3.6	5.5	12.2	10.0	2.5	16.1	7.1	4.8	4.1	26.9	24.6	6.3	8.2	0.8	1.4	277.8	14.0	2.3	5.4	1.9	1.3	12.4	0.0	13.0	6.0	10.0	4.6	7.5	1.1	5.8	5.3	30.9	82.3	28.0	6.6	6.7	9.5	28.7	11.9	7.2	2.6	1.6	1.6	25.2	5.3	5.8
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580628-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 102.7;Late spermatids: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	6.6	6.6	5.4	7.8	6.3	13.5	9.2	6.4	5.7	7.0	6.2	6.9	6.5	6.1	6.5	7.0	5.9	6.3	4.8	5.2	5.9	6.2	10.6	6.9	8.6	6.3	6.3	8.0	6.9	9.4	4.5	7.5	6.1	7.3	6.2	3.6	8.2	6.7	6.6	7.8	6.5	5.1	6.2	8.3	7.7	11.0	6.1	8.3	7.7	6.7	9.9	7.1	4.7	7.2	15.7	20.8	9.0	19.5	19.7	13.5	12.4	13.4	15.5	13.2	16.5	17.5	10.5	14.4	8.0	12.6	29.7	17.0	13.1	14.7	14.1	20.3	11.9	10.6	11.4	9.2	29.2	18.5	16.9	12.7	39.7	14.1	27.8	12.4	12.6	14.2	17.6	16.1	15.0	15.6	18.0	16.0	18.8	17.2	16.1	12.7	9.8	16.5	11.4	12.0	14.2	20.6	14.4	67.9	27.5	16.1	11.6	13.2	16.4	19.5	6.3	17.0	15.6	43.6	20.6	9.1	19.3	18.6	20.2	5.3	7.1	13.2	7.1	6.9	9.1	6.6	6.4	7.0	6.6	6.3	5.1	5.2	13.1	8.7	8.2	3.8	6.5	8.1	5.4	6.3	6.4	5.7	5.2	5.9	6.3	6.3	6.1	6.2	6.1	7.2	4.8	12.8	7.7	0.0	9.6	10.6	5.0	2.7	12.0	4.1	11.5	6.1	3.6	4.3	3.7	3.7	4.2	7.2	7.3	10.0	5.9	5.1	102.7	4.3	5.5	6.7	7.2	8.2	0.0	6.4	4.6	5.0	8.6	6.8	1.3	5.9	5.0	7.4	5.2	11.8	0.0	8.2	2.0	10.1	8.3	131.7	5.3	7.6	12.4	0.0	6.9	4.9	5.2	0.0	0.0	5.9	6.6	3.8	6.3	5.4	6.0	4.5	2.4	5.9	6.6	5.9	6.5	7.8	4.6	6.3	10.4	10.4	8.8	5.8	5.8	5.4
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885199-93909456	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 48.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 207.9;Erythroid cells: 301.9;Prostatic glandular cells: 762.3;Urothelial cells: 374.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	12.2	13.1	5.4	6.6	4.7	15.0	6.6	5.1	5.4	4.5	5.6	6.2	19.2	3.6	4.0	6.6	14.3	14.1	4.7	4.7	7.5	11.3	48.5	5.9	4.6	6.4	6.9	2.8	7.7	6.7	3.4	10.3	7.1	5.6	5.5	3.6	4.5	5.9	16.0	3.0	12.7	3.6	5.1	6.8	5.7	3.2	5.7	5.0	16.8	11.8	10.1	6.9	3.7	6.1	37.7	58.6	6.4	12.6	20.9	13.0	24.4	43.7	27.3	32.8	24.3	9.9	21.7	14.2	84.8	28.8	106.7	37.3	9.6	18.0	26.2	38.6	12.7	98.9	37.4	42.8	39.1	36.8	15.2	16.1	6.7	67.0	10.7	13.2	36.4	16.0	40.0	20.5	24.0	7.3	26.8	8.5	21.5	36.0	27.4	12.3	19.0	20.9	23.6	43.4	14.8	6.1	41.3	32.2	15.4	71.8	7.2	22.7	38.4	34.1	20.1	64.5	66.7	18.1	25.0	14.7	28.2	20.4	12.2	2.1	0.3	0.7	2.6	0.2	1.5	1.3	2.5	3.4	0.3	2.0	1.5	1.6	1.5	2.3	0.3	1.0	0.7	0.7	5.4	4.7	5.1	5.4	4.7	7.5	6.4	6.9	7.1	5.1	5.7	6.1	28.7	41.7	19.1	16.0	14.6	11.5	207.9	33.2	24.5	24.8	24.2	34.2	16.4	61.5	29.0	29.5	6.2	63.5	39.3	21.7	25.4	25.1	3.9	66.3	27.6	55.5	52.5	301.9	32.0	12.3	19.6	44.5	15.8	50.1	19.7	17.3	31.4	102.4	19.9	33.7	30.7	19.9	22.4	20.7	51.4	4.0	21.5	32.0	8.8	15.0	9.3	21.2	34.0	11.1	11.6	24.2	8.0	12.4	21.6	762.3	47.2	65.1	64.3	13.1	0.0	48.4	37.1	32.0	36.7	33.5	9.2	45.0	34.1	26.5	17.8	374.9
GDE1	MIR16	ENSG00000006007	"Glycerophosphodiester phosphodiesterase 1"	Q9NZC3	16	19501693-19522123	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 270.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077420			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA077420: "	"unprognostic (1.69e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (7.52e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.60e-3)"	"unprognostic (9.92e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (8.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	28.9	25.9	42.9	15.6	46.3	27.8	21.1	42.9	49.9	21.9	40.4	44.9	30.0	20.0	27.5	22.4	16.9	18.4	52.8	45.7	45.5	27.6	25.4	29.3	11.7	44.5	47.7	12.8	28.5	76.8	19.2	20.5	43.3	26.7	41.6	19.8	28.3	30.3	62.9	26.4	27.7	26.5	42.8	13.5	34.3	14.1	48.8	16.8	20.3	64.4	15.3	30.2	16.6	47.4	38.6	46.2	25.0	29.4	115.3	43.3	34.7	38.3	66.9	30.0	37.1	26.6	67.4	29.2	48.1	57.2	32.8	31.8	35.2	46.6	36.9	31.7	52.8	24.2	41.4	57.2	69.1	32.7	21.5	44.9	73.1	32.2	37.4	54.5	40.6	36.3	13.7	29.1	33.2	70.3	28.3	29.1	29.1	59.9	34.2	40.2	45.7	41.7	72.9	59.7	28.9	25.8	37.0	44.5	37.9	38.5	45.8	37.8	42.7	25.3	22.3	33.9	24.6	27.0	27.4	19.9	38.5	47.2	23.1	52.0	19.3	11.2	8.9	17.7	11.5	7.2	10.4	10.4	12.4	6.1	5.5	8.5	34.0	6.6	22.7	7.5	12.7	8.2	42.9	46.3	42.9	49.9	45.7	45.5	44.5	47.7	43.3	42.8	48.8	47.4	12.2	38.5	86.8	7.2	18.9	23.5	30.3	56.2	22.8	15.4	38.3	22.4	66.8	34.3	56.0	9.2	27.1	80.4	23.2	123.1	23.5	97.0	35.1	26.9	23.8	17.7	33.5	100.8	12.0	163.9	78.6	27.3	24.5	21.5	3.8	36.4	20.7	23.9	60.8	32.0	15.9	57.5	61.1	48.2	22.9	61.2	28.6	32.3	24.9	8.4	38.2	22.3	24.7	9.5	25.0	77.4	97.6	38.0	19.6	100.5	101.7	45.9	39.7	29.6	13.1	16.7	24.9	87.1	59.6	31.9	29.5	270.4	22.0	45.9	85.3	79.2
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.9;Cardiomyocytes: 108.2;Excitatory neurons: 133.2;Inhibitory neurons: 106.2;NK-cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.5;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.5;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEL: 30.5;HMC-1: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	10.5	2.0	14.3	2.8	21.6	12.7	9.6	11.2	26.1	5.0	0.0	6.2	1.8	3.6	0.8	8.6	4.4	4.3	16.7	24.5	3.7	2.3	7.2	9.7	4.3	3.0	1.5	1.5	1.5	1.7	3.5	3.9	2.3	4.0	2.8	2.1	3.6	1.4	12.0	5.5	6.5	4.9	0.6	8.8	7.9	0.6	2.5	3.0	2.7	9.7	4.2	6.2	5.8	16.9	12.5	1.3	1.0	2.1	1.7	1.8	1.3	1.0	0.5	0.7	0.4	0.4	0.9	16.8	16.6	1.2	1.0	10.9	3.4	5.4	0.7	1.2	6.0	30.5	7.2	6.6	2.4	9.0	46.3	0.9	4.1	1.6	4.5	2.6	9.5	4.5	0.9	1.5	1.3	4.1	2.0	5.2	1.8	4.3	3.3	6.9	2.1	8.8	0.6	2.4	5.5	1.0	4.0	0.7	4.0	2.1	0.9	0.9	12.2	1.6	3.2	3.5	5.6	13.4	8.3	19.8	1.4	5.3	0.4	0.2	0.4	15.5	1.5	0.9	0.2	2.7	0.2	0.7	0.2	1.9	0.1	0.5	0.3	13.1	0.9	0.1	0.1	1.0	14.3	21.6	11.2	26.1	24.5	3.7	3.0	1.5	2.3	0.6	2.5	16.9	100.9	0.0	1.8	33.0	14.3	20.3	4.9	14.5	19.9	43.8	7.4	3.7	108.2	10.0	14.4	0.0	0.0	1.5	46.1	18.2	0.0	5.3	0.1	3.8	1.0	49.0	8.4	31.2	133.2	3.1	34.7	9.1	2.0	8.0	4.5	0.2	51.4	19.5	2.5	1.7	106.2	11.2	8.2	15.7	31.3	0.3	2.5	21.4	12.4	42.2	4.7	2.1	142.2	58.8	56.6	30.5	31.7	1.2	14.5	3.1	10.6	0.3	13.6	2.7	13.1	19.9	17.5	0.0	3.3	34.6	22.4	0.7	23.4	1.0	4.4	4.7
GINM1	"C6orf72, dJ12G14.2"	ENSG00000055211	"Glycoprotein integral membrane 1"	Q9NU53	6	149566294-149591748	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 369.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017210, HPA041679"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		35000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center, Plasma membrane"		"HPA017210: AB_1845743, HPA041679: AB_2677611"	"unprognostic (6.09e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.79e-3)"	56.0	44.0	25.7	24.0	31.4	41.2	45.0	33.9	36.1	47.8	38.5	43.0	25.9	46.4	44.6	32.2	39.2	38.2	58.6	25.0	28.9	92.7	45.7	36.0	26.1	30.6	29.0	50.5	36.8	55.3	24.7	62.6	30.6	40.3	34.8	21.9	32.2	47.4	47.1	36.4	28.1	50.5	29.3	35.1	34.1	48.0	26.9	21.7	73.9	42.3	24.7	42.2	34.0	38.9	27.2	19.5	30.5	41.4	162.6	96.1	48.3	89.0	107.5	68.1	85.1	25.4	35.7	19.4	46.9	87.6	62.9	53.8	20.1	46.0	89.0	33.6	39.6	18.9	17.5	30.5	62.0	37.2	17.2	107.8	39.1	58.0	39.6	74.7	74.7	27.0	24.6	31.8	65.1	35.3	22.9	27.9	10.1	40.2	20.1	25.2	54.0	15.1	97.7	23.9	19.2	18.1	90.1	53.2	18.9	33.5	32.9	38.4	51.3	35.9	37.0	92.9	60.9	30.6	38.6	24.5	67.4	33.1	34.3	21.0	18.5	25.1	8.8	17.8	10.5	22.8	10.2	9.7	13.9	17.0	9.8	8.0	32.1	11.4	23.4	16.9	10.7	10.6	25.7	31.4	33.9	36.1	25.0	28.9	30.6	29.0	30.6	29.3	26.9	38.9	120.5	80.1	53.7	10.1	44.6	46.8	58.6	75.1	46.7	21.3	50.1	50.3	54.1	38.6	53.4	66.2	29.2	81.1	31.4	64.5	39.2	92.7	191.0	42.2	77.3	78.9	26.8	32.2	11.9	80.7	77.1	103.4	18.3	60.7	29.1	48.2	104.6	41.9	45.6	16.8	13.9	23.1	46.8	56.0	47.7	369.6	129.5	46.6	42.7	5.6	75.7	86.5	18.6	17.1	25.0	67.8	33.5	112.8	45.3	65.0	49.8	132.1	33.8	22.6	98.6	85.9	71.1	166.5	82.8	48.7	47.0	122.7	32.0	65.7	22.4	64.0
GIPC1	"C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2"	ENSG00000123159	"GIPC PDZ domain containing family member 1"	O14908	19	14477760-14496149	"Human disease related genes, Predicted intracellular proteins"			"Congenital muscular dystrophy, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 345.8"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 501.1;Pancreatic endocrine cells: 296.7;Paneth cells: 285.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043958, HPA061786"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		11000	"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA043958: AB_10963436, HPA061786: AB_2756319"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	51.0	54.8	80.0	22.4	91.5	3.3	54.3	88.7	94.4	99.8	64.7	120.2	24.7	53.7	17.6	345.8	48.9	23.4	66.1	74.5	82.1	104.1	58.4	76.3	15.9	89.4	91.4	34.4	43.5	20.8	56.0	28.7	88.1	63.6	41.1	17.9	100.9	31.0	65.1	150.2	45.5	17.5	82.0	37.7	78.7	24.9	91.1	18.6	55.8	23.3	21.0	74.1	140.1	92.3	328.1	148.6	44.7	70.6	40.6	40.7	35.2	119.7	59.8	96.7	87.3	80.3	120.6	4.7	220.3	85.2	64.6	183.8	38.7	100.6	32.6	33.8	69.0	63.9	100.7	79.7	123.7	6.9	75.3	46.7	98.5	58.8	51.3	57.4	66.0	47.2	30.1	54.4	49.9	243.8	21.3	13.3	48.6	182.1	147.8	21.7	37.4	43.7	121.6	281.6	41.8	46.2	67.1	163.2	157.0	23.1	102.5	35.1	115.4	135.7	74.6	191.7	130.1	50.5	70.5	17.3	113.9	51.9	146.2	3.0	0.7	0.1	5.1	1.1	4.7	1.9	5.1	5.1	1.1	0.8	4.2	3.3	0.3	1.5	0.5	3.6	12.0	1.7	80.0	91.5	88.7	94.4	74.5	82.1	89.4	91.4	88.1	82.0	91.1	92.3	30.6	28.9	15.2	22.9	8.3	113.9	77.4	52.1	35.9	69.8	73.6	31.6	14.8	37.1	62.8	82.8	35.5	36.3	19.3	501.1	52.8	167.9	1.1	92.2	30.5	32.4	43.1	1.7	28.8	164.3	77.1	32.6	69.3	76.8	10.2	37.3	23.2	18.0	55.9	75.7	32.2	87.8	42.7	10.8	29.8	2.4	20.5	16.1	58.7	10.3	23.4	73.3	18.6	17.1	71.6	296.7	285.4	25.2	6.8	120.4	36.0	52.7	38.0	46.0	19.7	18.1	44.5	6.4	20.4	107.0	169.8	25.7	22.9	47.7	138.1	199.7
GJB7	"bA136M9.1, CX25"	ENSG00000164411	"Gap junction protein beta 7"	Q6PEY0	6	87282980-87329278	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 7.0;pituitary gland: 5.5;placenta: 2.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 10.4;Endometrial ciliated cells: 12.8;Ionocytes: 22.4;Respiratory ciliated cells: 18.4;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;HDLM-2: 7.6;MCF7: 4.1;OE19: 4.8;RT4: 3.6;SuSa: 2.4"					"Not detected"	"Not detected"			HPA014392			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA014392: "	"unprognostic (8.30e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-3)"		"unprognostic (2.61e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.10e-2)"	0.0	0.0	0.2	0.0	0.1	0.3	0.0	1.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.1	5.5	2.6	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.2	1.5	0.0	0.1	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	4.1	0.0	0.1	1.2	4.8	0.0	0.1	0.0	0.0	0.0	3.6	0.1	0.0	0.8	0.0	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.6	0.1	0.1	0.4	0.1	0.5	0.0	0.1	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	1.3	0.0	2.5	0.6	0.3	0.2	0.0	0.5	0.0	0.0	10.4	0.5	0.1	0.0	0.2	1.1	12.8	0.8	0.3	0.0	0.0	0.7	0.2	4.4	0.6	0.0	3.0	0.0	0.1	0.4	0.0	0.5	0.0	1.1	0.0	22.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.0	0.0	0.0	0.0	18.4	0.6	0.0	1.7	0.3	0.3	0.3	0.0	0.0	7.3	0.5	0.2	0.3	0.2
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95822726	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 777.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 723.9;Extravillous trophoblasts: 751.2;Proximal enterocytes: 968.3;Proximal tubular cells: 1165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 569.0;RPTEC TERT1: 462.1;U-87 MG: 441.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008634, HPA046431, CAB069419"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		6300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	82.1	101.4	32.5	80.0	34.9	173.7	37.2	46.3	52.4	28.2	29.0	57.2	194.7	12.7	10.1	13.6	17.2	50.8	102.7	47.3	37.1	247.4	143.6	71.9	61.5	52.0	42.1	10.9	10.9	82.4	23.7	102.0	39.8	28.5	47.4	6.9	59.2	25.6	777.4	38.3	170.3	25.7	34.3	64.9	40.2	4.9	43.6	75.6	18.9	55.9	80.4	53.1	20.9	37.9	22.2	97.1	8.4	18.0	211.3	310.4	1.6	326.5	569.0	35.9	62.9	31.2	10.2	86.2	45.7	99.0	83.0	9.7	12.9	156.4	100.5	75.7	24.1	62.8	63.5	248.1	386.6	67.2	182.8	184.4	23.2	219.7	21.3	81.1	75.3	179.3	8.2	51.3	262.3	7.9	121.4	133.0	22.2	3.3	111.6	186.1	66.8	107.9	462.1	16.8	23.6	12.5	85.3	47.8	39.4	22.0	13.0	66.0	78.0	91.9	101.9	74.6	14.4	37.1	202.0	70.4	441.3	170.6	19.7	48.9	727.2	901.6	222.9	483.8	313.6	142.9	205.0	166.7	459.8	107.8	201.4	186.1	783.8	113.4	411.2	166.6	457.7	781.7	32.5	34.9	46.3	52.4	47.3	37.1	52.0	42.1	39.8	34.3	43.6	37.9	77.5	22.4	28.4	3.6	74.1	17.2	62.9	330.5	8.6	2.2	57.9	31.5	154.9	65.8	183.6	93.8	0.0	47.4	130.0	173.8	723.9	60.4	0.3	83.4	49.0	47.1	31.7	63.1	8.7	96.0	751.2	63.1	35.7	118.0	31.6	3.5	46.4	206.9	271.5	0.0	8.0	89.9	65.1	304.9	276.1	2.3	19.0	232.3	69.4	12.2	340.0	7.8	302.8	2.0	2.4	113.5	291.3	13.9	200.2	89.5	968.3	1165.9	124.1	3.9	19.7	22.1	67.0	0.6	1.6	4.1	20.6	285.3	97.7	11.7	85.4	214.6
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643657	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.6;Gastric mucus-secreting cells: 24.5;Hofbauer cells: 22.7;Kupffer cells: 33.3;Macrophages: 26.7;monocytes: 27.6;T-cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: AB_2678018, HPA045481: AB_2679343"	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.97e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.15e-4)"	7.5	3.3	2.9	32.0	2.4	50.9	5.4	2.5	6.1	3.7	2.5	9.6	10.4	3.3	1.4	8.6	5.4	6.0	2.9	3.8	4.0	4.3	4.7	16.9	29.4	6.5	4.4	2.6	6.0	8.9	3.6	4.6	5.7	5.4	6.5	0.4	6.9	2.8	1.1	6.9	22.6	4.3	4.5	54.3	16.7	2.9	6.6	19.1	8.5	1.9	22.9	8.3	5.3	7.4	9.9	4.5	5.9	6.5	6.4	3.3	23.5	6.1	5.2	3.6	3.4	3.6	13.0	24.1	12.1	4.3	4.7	11.5	3.9	6.7	2.3	8.3	6.1	7.6	7.1	4.0	1.9	21.7	92.0	4.2	4.5	3.9	2.0	4.2	8.2	21.1	5.3	8.5	3.9	14.6	13.7	35.8	3.5	12.7	8.1	23.3	2.6	14.0	6.9	23.3	5.1	15.2	8.4	8.7	3.7	4.5	8.0	30.7	15.0	6.6	3.8	7.6	4.6	4.3	1.9	19.8	4.2	28.0	4.6	7.0	19.5	51.9	13.2	23.7	12.3	12.6	8.4	11.9	15.1	12.8	8.9	9.7	71.8	9.7	33.1	13.5	10.0	12.5	2.9	2.4	2.5	6.1	3.8	4.0	6.5	4.4	5.7	4.5	6.6	7.4	1.7	0.0	10.2	0.3	26.6	1.1	1.7	2.5	1.2	0.0	1.9	1.3	0.9	2.8	3.1	0.0	0.0	0.6	14.9	21.2	0.0	4.1	0.1	1.4	0.9	1.8	0.0	1.3	2.1	4.7	5.3	0.9	24.5	4.0	7.0	3.5	2.5	1.6	22.7	0.0	2.1	6.6	0.0	33.3	6.6	0.4	0.6	26.7	1.8	6.5	27.6	0.4	20.6	0.5	0.2	12.9	20.2	0.7	13.9	2.0	9.3	0.7	1.5	0.1	0.0	0.4	1.6	0.6	1.3	3.5	1.1	0.8	25.8	0.9	6.0	4.1
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716097-78031811	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 556.6;Excitatory neurons: 405.6;Microglial cells: 394.4;Oligodendrocyte precursor cells: 338.3;Oligodendrocytes: 495.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 27.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 27.0"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		800000	"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: AB_2680544"	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	23.5	21.3	37.2	18.8	42.2	43.8	20.1	35.8	51.3	21.1	19.3	30.3	14.5	23.7	18.7	23.2	16.9	20.1	8.6	51.0	38.5	20.9	22.0	31.1	9.9	40.5	42.7	22.4	14.6	16.3	12.5	21.7	39.9	21.2	27.2	10.4	16.8	25.7	10.5	8.9	16.8	27.4	42.4	11.3	27.9	11.5	45.5	19.7	23.1	11.8	9.1	23.5	13.8	48.5	30.6	34.1	29.8	32.0	34.9	35.5	42.8	40.7	29.7	16.6	20.6	10.5	24.1	0.1	32.0	35.5	24.5	48.5	22.5	23.4	20.6	1.1	12.5	83.0	29.0	21.4	31.4	51.8	30.0	24.3	28.0	33.9	32.5	34.3	42.7	70.3	14.8	0.2	29.5	38.5	58.8	31.0	24.0	46.5	4.7	22.0	36.5	0.3	37.8	64.5	33.1	49.6	29.3	23.3	30.5	27.5	22.2	18.3	55.0	29.2	1.9	41.9	24.0	0.2	0.1	0.3	20.3	28.9	32.0	27.0	2.5	5.7	0.8	2.2	1.7	0.9	2.0	1.1	2.8	0.9	2.1	1.7	8.9	3.6	4.5	3.2	2.2	1.5	37.2	42.2	35.8	51.3	51.0	38.5	40.5	42.7	39.9	42.4	45.5	48.5	117.7	176.3	97.5	556.6	4.8	47.3	38.4	42.7	39.3	34.0	75.6	54.5	6.0	58.6	48.3	77.3	16.7	47.4	33.4	137.0	7.9	36.2	18.9	57.5	64.2	107.3	92.3	58.0	405.6	39.7	53.2	51.7	70.8	76.0	50.7	40.2	98.6	64.0	53.7	82.4	242.0	92.5	30.5	139.5	173.9	11.1	39.4	128.8	48.0	394.4	114.6	40.5	8.2	338.3	495.2	54.2	60.7	52.3	6.2	70.5	52.9	45.4	67.0	5.0	26.3	62.3	40.8	5.6	13.2	46.3	21.6	29.0	25.0	45.2	75.4	70.1
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"retina: 2629.0"	"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 1373.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	178.1	123.8	167.9	179.9	212.3	147.6	119.7	147.8	234.4	124.3	87.1	165.7	173.7	127.1	90.8	126.7	114.4	110.9	119.6	228.3	172.0	125.1	103.3	146.7	160.0	159.5	153.2	130.2	105.9	148.2	106.8	141.1	169.5	118.3	123.1	2629.0	120.6	118.9	66.8	111.8	208.2	156.1	131.6	142.6	129.7	99.0	168.9	167.3	113.6	97.1	145.6	152.6	102.7	203.9	373.2	344.2	400.2	280.4	222.4	242.4	154.4	515.4	339.9	456.2	355.2	282.8	361.8	385.5	369.3	522.5	258.6	192.0	405.5	373.5	411.4	595.9	199.2	375.0	308.2	325.6	279.1	227.7	394.4	216.4	256.6	437.2	402.9	306.1	376.8	298.8	236.8	337.8	440.0	230.3	501.9	177.4	230.8	190.0	275.0	482.9	308.7	306.4	310.8	227.5	489.9	556.5	477.1	306.6	420.5	272.8	214.8	305.9	579.4	399.3	267.5	314.8	379.1	227.1	432.8	888.7	341.4	470.1	230.5	11.4	13.3	21.9	9.9	16.4	9.1	9.0	9.9	11.2	13.3	9.6	6.7	7.2	22.1	12.8	17.5	22.7	12.5	8.2	167.9	212.3	147.8	234.4	228.3	172.0	159.5	153.2	169.5	131.6	168.9	203.9	172.0	70.5	42.6	57.5	67.9	86.3	51.6	47.4	33.0	149.8	65.3	57.8	60.6	52.9	42.4	75.4	175.2	44.2	124.4	140.9	46.9	88.0	29.1	93.3	112.9	131.6	122.9	40.3	102.4	100.5	99.4	77.8	52.0	121.6	53.8	101.9	95.3	60.3	100.8	180.0	101.9	95.5	40.7	152.7	114.6	33.8	76.1	128.0	53.4	115.2	119.5	250.3	73.2	70.9	110.1	175.4	91.0	88.0	75.3	100.5	167.6	67.4	41.1	1373.7	78.9	71.0	105.9	68.8	67.1	51.6	101.7	36.4	74.5	83.7	83.0	94.1
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"retina: 426.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 471.3;Cone photoreceptor cells: 932.0;Rod photoreceptor cells: 462.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;NTERA-2: 17.0;U-698: 40.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 5.1"	HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.9	1.4	6.3	1.6	6.0	1.0	0.6	6.7	9.5	2.3	6.7	1.4	1.7	2.2	0.7	0.4	1.6	1.1	4.4	5.9	6.6	2.0	0.2	0.7	1.6	5.7	5.3	2.8	0.7	1.5	36.2	0.4	5.6	2.1	0.6	426.5	2.1	1.4	1.3	0.7	1.5	3.2	5.2	0.9	1.0	0.6	5.7	0.3	1.6	0.3	1.6	1.6	1.1	6.4	0.4	1.2	9.4	3.1	1.3	2.0	0.9	4.8	0.8	2.5	2.1	1.9	0.5	14.1	0.1	5.1	0.1	0.5	9.2	0.3	2.3	1.2	2.1	3.4	6.8	1.5	0.9	1.1	2.3	2.4	0.5	2.4	2.7	9.6	2.5	1.8	1.5	1.3	1.2	0.7	0.7	0.8	17.0	0.1	0.5	0.7	2.8	0.9	0.5	0.4	1.1	2.2	0.4	0.1	1.0	2.5	0.1	0.6	4.0	3.2	3.8	4.8	6.7	1.4	1.0	40.9	1.3	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	6.0	6.7	9.5	5.9	6.6	5.7	5.3	5.6	5.2	5.7	6.4	0.3	0.0	0.0	5.2	1.3	0.4	0.4	0.2	1.2	471.3	0.8	1.3	6.1	0.0	0.1	0.0	932.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	3.3	0.0	1.3	12.3	0.0	0.0	2.3	2.0	0.1	0.0	0.1	1.1	0.0	0.1	74.0	12.4	0.0	4.1	0.3	0.4	0.0	3.7	0.1	1.8	3.7	0.1	86.7	0.0	6.0	1.2	0.1	0.0	3.4	3.2	0.8	0.0	0.1	0.6	462.8	0.0	0.3	1.4	0.1	0.5	0.0	0.0	0.0	0.4	0.2	0.1	0.2
GNG2		ENSG00000186469	"G protein subunit gamma 2"	P59768	14	51826195-51979342	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 113.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 251.8;Early spermatids: 714.4;Late spermatids: 1146.4;NK-cells: 246.1"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 77.2;fHDF/TERT166: 140.2;MOLT-4: 112.5;SH-SY5Y: 89.2;WM-115: 249.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003534, CAB018380"	Uncertain	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Vesicles	"CAB018380: AB_631547, HPA003534: AB_1079004"	"unprognostic (6.11e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.90e-6)"	"unprognostic (9.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.59e-2)"	51.3	22.0	38.5	41.1	44.8	64.0	21.0	0.8	55.4	11.9	10.9	24.1	15.2	12.2	5.1	14.1	5.8	17.3	13.5	54.1	75.2	7.5	12.7	19.0	47.7	10.6	20.5	14.4	7.3	3.5	14.9	19.5	27.2	10.6	19.6	15.0	8.1	9.0	5.6	7.8	21.2	19.8	13.6	61.7	15.9	113.4	46.4	62.0	5.7	13.1	45.4	22.2	5.3	22.2	0.0	3.1	77.2	48.6	11.6	15.0	1.2	12.9	15.9	6.1	4.9	6.4	0.2	0.2	1.8	140.2	8.9	0.3	10.4	0.0	4.2	36.4	1.2	0.0	0.7	0.0	6.0	7.4	0.3	25.1	0.0	6.2	0.5	32.2	0.0	67.9	0.0	6.5	39.7	0.0	112.5	12.0	41.1	0.0	9.5	39.4	6.1	2.0	6.4	0.0	11.5	89.2	0.3	0.1	34.5	2.7	0.0	0.3	0.0	18.7	3.1	0.3	9.9	0.2	0.0	5.5	15.5	39.2	249.0	379.4	64.0	177.1	162.8	111.9	110.5	38.1	88.9	134.2	65.8	36.2	55.5	98.5	185.2	25.2	177.3	28.0	143.2	158.6	38.5	44.8	0.8	55.4	54.1	75.2	10.6	20.5	27.2	13.6	46.4	22.2	11.6	6.4	7.2	3.3	101.3	11.5	0.4	0.0	2.2	18.7	1.5	1.9	1.0	1.5	0.0	3.7	2.1	0.6	251.8	0.8	1.9	0.2	714.4	0.5	2.7	11.7	175.8	20.4	66.2	0.0	0.6	23.9	11.7	0.8	32.3	0.2	11.0	0.9	51.1	0.0	59.6	2.4	0.0	94.1	60.0	1146.4	9.9	84.0	55.2	24.4	33.3	0.7	246.1	96.0	3.2	0.5	0.1	6.0	62.7	0.2	0.1	0.9	0.0	2.2	39.5	10.2	12.2	11.2	4.6	1.3	6.7	0.7	191.5	2.2	0.5	0.2
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060779-129062406	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.1;lung: 3.2;lymphoid tissue: 8.9"	"Cell type enriched"	"Detected in some"	8	"Macrophages: 151.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 29.5;neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	14	"HEL: 85.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2600000	"Cluster 34: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.1	1.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	1.2	0.2	0.2	0.7	0.3	0.0	0.0	0.3	0.6	0.1	0.1	0.0	13.9	0.0	0.2	3.0	0.0	51.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	14.4	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	2.9	0.1	1.7	0.0	0.0	0.6	0.0	1.3	0.0	18.3	0.0	151.9	0.0	0.0	4.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.3	0.0
GPATCH1	"ECGP, FLJ10206, FLJ38686, GPATC1"	ENSG00000076650	"G-patch domain containing 1"	Q9BRR8	19	33080899-33130542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043430, HPA043604, HPA074327"	Approved		Approved	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Cell Junctions"	"HPA043430: AB_10960493, HPA043604: AB_10960499, HPA074327: "	"unprognostic (2.38e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.95e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.56e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-3)"	3.5	3.1	3.0	3.5	3.2	3.7	4.4	5.1	4.0	4.0	2.0	4.8	5.4	4.5	4.4	4.3	3.9	2.8	3.8	3.1	2.9	4.4	3.4	3.4	4.9	2.8	3.0	7.2	3.8	6.3	2.6	4.2	3.0	4.2	4.5	3.9	4.6	3.4	4.2	5.6	4.6	4.4	2.7	4.3	4.9	4.4	3.3	5.9	4.7	3.2	5.0	3.6	3.6	3.4	8.8	18.2	8.4	9.1	5.5	6.2	7.1	7.8	5.4	11.6	9.7	12.9	7.9	12.3	9.7	6.2	5.5	7.7	10.6	6.4	10.1	21.4	6.6	11.7	6.8	9.8	7.2	20.3	7.6	5.3	7.4	7.9	7.2	5.6	6.6	9.6	12.5	7.7	5.8	11.2	11.8	7.1	5.9	11.5	7.5	11.9	10.6	5.5	5.4	5.4	9.3	6.2	12.3	7.6	4.6	7.2	6.4	14.5	7.5	10.2	7.6	5.6	11.3	6.4	11.1	10.6	6.3	10.3	9.5	23.1	6.4	7.4	6.0	6.6	4.1	6.2	5.6	7.7	6.0	7.0	9.6	6.0	4.7	3.5	3.7	5.3	9.2	5.0	3.0	3.2	5.1	4.0	3.1	2.9	2.8	3.0	3.0	2.7	3.3	3.4	6.5	9.6	7.9	5.9	9.1	6.1	5.0	6.0	10.8	9.7	5.2	4.6	11.8	1.5	9.8	7.3	14.6	10.5	10.7	12.0	15.6	6.8	3.2	5.2	9.4	6.4	4.2	4.2	7.2	4.5	5.2	7.5	10.2	6.8	16.5	10.1	7.9	4.6	4.1	3.3	7.0	7.7	8.2	6.0	5.2	2.1	10.2	5.8	8.8	2.8	5.8	7.1	16.5	5.5	7.0	9.0	8.7	8.2	5.5	3.3	6.8	6.6	10.3	11.9	0.0	8.0	7.3	19.5	14.8	6.5	3.7	5.5	9.1	7.0	6.5	3.4
GPBP1	DKFZp761C169	ENSG00000062194	"GC-rich promoter binding protein 1"	Q86WP2	5	57173948-57264679	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 622.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037773	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA037773: AB_10671721"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (3.70e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (4.15e-5)"	39.2	48.6	67.6	37.8	72.0	66.0	55.7	87.7	87.8	46.5	63.6	38.9	31.2	42.6	48.0	36.9	47.0	36.6	39.8	66.0	67.8	48.0	44.0	43.5	57.8	66.2	68.0	65.1	35.7	50.1	41.7	43.3	66.8	42.1	36.9	83.7	42.6	36.5	59.0	38.2	40.3	32.7	68.5	48.1	37.6	75.2	67.3	69.0	51.5	56.5	53.0	43.9	38.0	85.4	56.4	45.3	83.7	70.1	53.8	51.6	75.9	42.9	72.4	68.6	88.4	73.0	63.2	74.2	48.0	44.0	84.9	37.5	71.9	48.6	86.8	41.7	48.1	61.9	49.6	61.5	62.9	45.2	60.8	43.6	74.8	56.1	78.1	65.8	56.7	59.5	62.3	117.6	56.4	72.3	70.3	78.6	51.2	28.2	31.3	75.4	68.5	72.7	53.7	58.7	72.7	56.0	62.1	53.4	69.6	54.3	104.9	75.8	37.3	25.0	50.2	35.1	62.0	90.0	79.6	81.6	40.7	66.7	46.9	93.8	38.2	76.4	59.6	41.0	76.3	71.5	72.1	72.6	43.7	61.9	78.5	73.8	73.2	79.5	45.5	29.8	84.9	68.8	67.6	72.0	87.7	87.8	66.0	67.8	66.2	68.0	66.8	68.5	67.3	85.4	132.9	60.9	88.3	129.3	272.2	227.5	241.1	102.6	206.1	139.8	146.1	87.9	89.0	65.8	121.9	84.6	148.0	99.0	246.9	149.6	99.7	76.5	249.9	246.6	134.0	123.1	107.7	82.7	106.4	55.9	74.3	143.2	115.2	267.8	142.8	119.0	68.2	47.0	56.2	134.6	96.4	103.3	118.0	70.3	622.0	102.4	133.9	162.8	188.5	112.4	160.7	95.7	178.2	168.9	221.6	70.5	176.3	91.4	261.6	246.5	87.9	72.6	154.6	199.0	52.6	129.7	139.9	379.3	279.6	195.6	237.7	161.7	285.2	107.0	102.0	304.1
GPBP1L1	SP192	ENSG00000159592	"GC-rich promoter binding protein 1 like 1"	Q9HC44	1	45627304-45688113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028593	Approved		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites, Cytosol"	"HPA028593: AB_10602906"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.42e-3)"	"unprognostic (9.79e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.51e-1)"	"unprognostic (7.56e-3)"	"unprognostic (6.13e-2)"	28.7	26.7	25.2	31.0	29.4	49.3	40.9	27.3	28.0	35.0	26.1	57.3	54.0	35.6	37.6	45.0	36.2	30.3	41.7	23.6	27.1	47.0	66.3	39.2	39.9	27.7	28.3	30.6	39.3	41.7	25.5	34.1	28.2	35.8	61.2	27.4	42.4	36.1	46.2	47.2	56.7	36.3	26.8	36.9	42.6	57.9	27.4	54.7	48.7	54.9	49.5	35.6	36.7	32.8	41.1	24.7	42.1	44.9	48.4	47.1	57.5	31.9	52.2	44.8	56.1	25.2	44.8	56.3	40.5	43.7	46.9	42.0	46.6	47.8	56.3	64.4	33.4	73.7	28.9	39.2	66.7	74.2	65.1	34.6	102.0	35.3	99.4	60.2	57.7	71.0	63.7	48.7	51.6	22.0	66.2	65.8	60.4	54.8	27.7	43.0	55.1	41.9	51.5	40.2	51.9	34.7	52.6	76.6	83.5	81.6	35.1	86.2	49.8	32.0	33.6	35.2	48.9	47.2	46.9	41.3	34.0	60.6	34.5	24.0	21.6	40.3	21.6	27.3	22.9	16.5	20.9	21.1	23.0	14.1	22.6	22.4	22.6	26.6	30.6	13.1	26.4	21.1	25.2	29.4	27.3	28.0	23.6	27.1	27.7	28.3	28.2	26.8	27.4	32.8	43.3	60.9	24.4	54.5	45.1	64.9	41.2	28.3	59.2	23.5	51.3	33.5	46.9	41.5	34.3	60.7	35.5	26.2	47.5	96.8	50.9	33.0	23.4	38.1	32.2	38.6	38.3	62.1	48.5	38.9	33.7	25.4	44.9	47.5	59.6	24.3	37.5	81.3	25.0	37.0	49.0	67.2	32.6	49.9	51.6	17.6	20.5	46.1	23.2	70.3	41.3	18.2	45.3	50.8	93.8	51.2	57.0	21.4	36.6	62.8	75.5	58.7	33.0	32.9	19.7	22.4	42.0	78.9	75.3	71.7	67.8	45.4	47.1	27.7	68.6	78.2
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415489	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Alveolar cells type 2: 29.2;Astrocytes: 54.5;Extravillous trophoblasts: 36.2;Granulosa cells: 30.6;Proximal tubular cells: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 209.7;HAP1: 121.8;NTERA-2: 110.3;RPTEC TERT1: 276.6;SuSa: 242.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		190000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	9.6	9.8	5.9	4.9	6.4	0.1	5.6	5.0	5.8	12.0	4.6	22.5	10.6	10.8	16.4	7.4	11.2	9.0	7.9	6.3	7.5	20.6	1.8	17.4	2.5	7.2	6.9	12.3	10.8	5.6	16.6	29.0	6.0	8.0	10.9	1.2	13.0	11.4	24.3	3.8	10.8	17.7	6.6	5.7	16.9	7.8	4.9	8.4	5.9	20.0	2.0	10.3	5.2	8.5	0.0	0.0	209.7	8.3	8.9	1.3	26.0	1.6	0.0	0.0	0.0	0.1	0.5	0.3	71.7	1.2	0.0	0.1	121.8	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.2	0.0	0.0	37.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	6.0	0.1	0.1	110.3	0.0	3.2	0.6	19.2	0.0	276.6	8.4	0.1	1.5	0.8	0.1	0.1	242.0	3.2	3.2	0.0	21.3	24.8	0.0	13.6	0.0	0.0	0.1	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.4	5.0	5.8	6.3	7.5	7.2	6.9	6.0	6.6	4.9	8.5	1.7	51.3	29.2	54.5	0.2	1.5	3.7	14.7	14.2	0.0	2.9	2.0	4.4	5.7	8.7	23.9	0.0	0.5	0.2	2.5	3.9	7.0	0.6	5.9	1.7	1.2	2.4	0.0	4.7	12.7	36.2	14.4	6.6	10.0	0.0	30.6	0.0	0.0	2.5	0.0	1.4	11.1	4.1	0.6	3.9	2.1	2.1	2.0	1.8	14.0	1.1	1.0	0.0	4.5	4.3	16.5	4.3	0.4	0.1	1.4	4.6	30.3	12.8	0.1	0.0	6.3	13.6	2.4	23.6	2.3	0.4	3.1	1.0	1.4	11.3	0.6
GPR173	SREB3	ENSG00000184194	"G protein-coupled receptor 173"	Q9NS66	X	53048789-53080615	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 43.4;Excitatory neurons: 19.7;Inhibitory neurons: 14.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003905			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Plasma membrane"	"HPA003905: AB_1078922"	"unprognostic (2.68e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.95e-3)"	"prognostic unfavorable (2.88e-6)"	"unprognostic (3.87e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.08e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.95e-2)"	2.2	2.7	12.6	1.4	11.7	1.0	2.0	14.5	12.5	6.6	4.6	4.2	0.6	5.5	2.1	1.0	6.4	1.4	4.0	12.3	14.2	2.9	0.4	2.6	1.0	10.9	13.6	12.0	0.8	1.1	18.4	2.1	13.3	4.0	1.1	7.0	1.3	2.3	2.4	1.7	2.1	1.9	9.3	3.3	1.9	1.5	14.5	1.5	1.8	1.0	0.4	3.2	3.6	12.0	0.0	0.0	7.8	0.8	4.1	2.4	0.3	1.4	2.7	2.0	2.3	0.8	0.1	0.2	1.9	2.6	5.9	0.8	9.5	0.0	1.7	0.9	1.3	0.6	9.3	0.3	6.0	0.5	0.2	5.8	0.0	3.0	4.1	6.6	3.2	0.2	0.0	5.4	2.9	4.6	0.2	0.1	6.2	0.4	3.5	0.2	2.6	0.7	0.4	0.4	5.8	7.9	0.0	0.8	0.0	4.7	1.2	0.2	5.7	3.4	5.0	2.6	1.1	0.2	0.7	0.8	2.5	0.0	1.8	3.3	0.1	0.2	0.4	0.1	0.2	0.2	0.2	0.1	0.0	0.4	0.2	0.2	0.6	0.8	0.2	0.3	0.1	0.0	12.6	11.7	14.5	12.5	12.3	14.2	10.9	13.6	13.3	9.3	14.5	12.0	0.5	0.0	0.0	43.4	0.2	0.3	0.4	0.6	0.0	6.6	0.1	0.3	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	5.2	1.1	3.5	0.0	19.7	0.0	0.0	1.5	0.0	0.3	0.0	7.1	1.8	0.1	0.2	6.7	14.1	0.4	0.0	0.3	0.7	0.0	3.1	0.2	1.8	11.2	0.0	3.2	0.0	49.3	42.3	0.1	0.0	4.5	0.0	0.3	0.0	0.1	0.1	3.1	0.0	2.0	2.5	0.1	0.2	0.0	0.0	0.1	0.1	2.8	0.1	0.2
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71753855-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 10.3;Breast myoepithelial cells: 7.5;Collecting duct cells: 12.9;Glandular and luminal cells: 8.1;monocytes: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.8;neutrophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 17.9;HL-60: 17.5;MCF7: 14.6;NTERA-2: 28.9;RPTEC TERT1: 13.6;SH-SY5Y: 10.9;T-47d: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favorable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.4	4.0	21.3	1.5	22.9	15.7	3.9	13.0	19.7	3.5	7.4	1.6	0.3	5.0	2.8	3.7	6.8	1.0	3.4	19.9	20.6	3.2	0.1	1.4	0.2	18.0	18.3	4.4	3.1	17.3	9.2	1.2	16.2	5.1	0.5	1.8	1.4	4.3	0.7	2.1	0.7	2.9	19.7	3.3	2.0	4.7	22.9	0.5	6.2	1.9	0.2	2.0	2.3	18.9	0.0	1.1	1.9	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	17.9	0.0	0.8	0.1	4.3	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	17.5	0.9	0.0	2.9	0.0	1.2	0.0	0.0	3.7	0.0	0.0	0.0	14.6	1.2	0.2	28.9	0.0	0.0	0.0	0.0	0.0	13.6	7.8	3.0	10.9	3.8	0.0	0.0	3.6	9.9	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	7.2	0.0	0.1	0.0	0.0	0.1	21.3	22.9	13.0	19.7	19.9	20.6	18.0	18.3	16.2	19.7	22.9	18.9	0.2	0.0	1.1	0.0	0.1	1.9	4.2	0.0	4.0	10.3	6.5	7.5	3.5	2.8	1.3	12.9	4.2	1.4	0.4	0.2	1.9	0.7	0.2	2.1	4.9	0.4	1.2	1.7	0.0	0.0	1.3	1.2	1.1	8.1	0.0	2.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.9	3.2	0.0	0.0	8.6	0.5	1.0	0.0	0.0	0.3	0.1	1.2	0.0	5.6	0.0	0.1	1.5	0.4	0.0	2.3	1.7	0.2	4.8	4.7	1.7	0.3	0.7	0.5	0.3	2.0
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794125-96837477	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.4;Excitatory neurons: 46.2;Granulosa cells: 31.2;Inhibitory neurons: 20.3;Late spermatids: 35.2;Spermatocytes: 24.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.8;HHSteC: 13.5;Karpas-707: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	0.5	0.9	1.4	0.7	3.5	0.1	0.4	0.7	2.7	1.5	2.7	1.2	1.5	0.5	0.3	0.5	0.7	0.7	0.5	1.5	0.1	0.3	0.0	0.3	0.1	1.6	0.6	1.0	1.4	1.0	0.9	0.7	2.0	0.9	1.8	0.2	0.4	0.5	0.2	0.4	1.1	0.6	0.0	0.3	1.1	2.4	0.9	0.6	0.6	0.1	0.2	0.8	1.4	1.8	0.0	0.1	1.6	0.4	2.3	0.8	0.4	1.0	0.0	0.0	0.2	0.2	1.2	0.1	0.0	0.1	1.3	1.2	5.4	2.5	0.0	8.8	4.1	5.2	0.4	0.0	13.5	3.3	0.6	2.5	0.4	0.0	3.7	0.3	0.0	7.6	3.8	20.8	0.5	0.4	2.5	0.0	5.4	0.0	0.7	0.0	1.9	4.3	0.3	0.2	2.4	1.5	0.3	3.3	0.6	1.7	1.3	0.7	0.0	1.4	2.1	0.2	2.0	1.6	0.9	0.1	0.8	2.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	1.4	3.5	0.7	2.7	1.5	0.1	1.6	0.6	2.0	0.0	0.9	1.8	0.6	0.0	0.0	2.3	0.2	1.9	0.7	0.3	4.0	1.5	0.6	0.9	0.7	2.8	0.1	1.8	0.0	0.2	0.3	0.1	0.0	0.4	31.4	0.1	0.5	0.7	3.0	0.4	46.2	0.9	0.7	2.5	1.1	0.1	0.0	31.2	1.1	0.0	0.2	0.0	20.3	0.5	0.0	0.0	8.9	35.2	3.4	0.4	1.8	9.4	0.1	0.2	0.0	11.6	4.8	0.4	0.1	4.9	1.0	1.1	0.1	0.2	0.0	0.2	0.0	0.4	2.2	24.6	10.5	1.9	0.3	0.1	0.4	2.1	0.5	0.3
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 10.5;skin 1: 17.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0"	"Low region specificity"	"Detected in many"							"HPA038129, HPA070760"	Approved		Approved	"Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA038129: AB_2675846, HPA070760: "	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.1	0.0	1.7	0.6	1.6	0.0	0.9	5.9	2.1	0.9	0.4	6.2	3.6	0.0	0.0	4.4	0.3	0.2	0.0	0.6	6.7	5.7	0.3	10.5	0.0	5.5	4.9	0.1	5.7	2.1	4.2	0.0	5.7	1.9	3.4	0.1	2.8	1.1	0.1	17.4	8.0	0.1	1.8	0.0	5.1	3.0	9.7	0.0	3.4	0.0	0.5	0.6	2.0	1.0	10.2	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.7	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.0	1.7	0.3	0.3	0.1	3.7	12.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.9	2.1	0.6	6.7	5.5	4.9	5.7	1.8	9.7	1.0	0.0	19.2	3.7	0.0	0.0	1.7	2.8	1.9	2.8	0.3	1.4	1.0	0.2	7.2	2.1	3.7	0.0	0.0	0.0	30.4	0.0	11.3	9.3	0.0	0.0	0.1	6.6	0.0	0.7	20.2	0.0	0.1	3.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	30.8	0.0	0.0	0.3	20.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	13.1	0.4	0.0	2.1	21.7	4.0	1.8	0.1	0.0	0.0	0.2	2.9	0.8	2.4	6.1	0.0	0.1	0.0	7.3	1.3
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160167-55167297	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 62.7;Extravillous trophoblasts: 218.9;Fibroblasts: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 254.4;fHDF/TERT166: 246.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036720	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA036720: AB_2675269"	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (5.13e-9)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	13.3	6.1	1.2	12.5	1.2	0.1	12.6	1.2	1.6	37.1	6.9	7.3	2.9	21.1	21.9	6.2	14.3	17.0	11.2	1.0	1.7	6.5	2.2	6.9	3.8	1.5	1.1	27.3	4.6	9.3	2.4	39.7	1.4	10.2	8.4	1.3	7.2	15.8	1.5	5.0	4.1	27.2	1.5	4.0	5.6	5.6	1.2	1.3	22.3	6.3	3.0	17.8	9.8	3.6	37.2	39.0	75.3	77.0	180.7	223.9	36.6	179.8	254.4	97.0	192.7	3.2	82.1	0.0	199.0	246.4	86.5	28.2	46.0	51.5	131.5	0.5	17.3	2.1	49.1	6.9	64.4	0.0	0.0	157.5	60.8	68.3	35.5	126.5	122.7	0.0	1.1	0.1	137.4	14.4	0.0	0.0	32.6	1.0	42.8	0.1	40.2	0.0	65.9	1.3	0.1	1.4	56.6	4.6	68.0	80.8	56.6	3.4	102.7	63.6	65.6	84.5	102.3	0.1	0.5	0.5	103.0	0.1	118.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.2	1.6	1.0	1.7	1.5	1.1	1.4	1.5	1.2	3.6	10.9	0.0	1.1	0.3	0.3	7.1	6.0	38.3	9.1	0.2	8.9	6.1	4.3	0.0	33.3	25.8	0.0	49.5	0.2	0.5	5.9	13.7	0.4	6.5	62.7	18.6	0.0	0.0	0.1	38.8	218.9	76.6	2.6	4.9	4.5	30.9	19.2	0.2	10.2	0.0	0.1	4.7	4.1	0.0	6.9	0.6	51.3	1.1	24.9	5.6	1.1	7.9	0.0	0.0	0.1	15.8	0.3	39.9	1.4	2.6	0.1	0.5	36.5	0.3	13.1	20.1	38.2	0.1	0.4	3.1	6.1	13.3	1.8	29.9	0.9	2.4
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2 related adaptor protein 2"	O75791	22	39901084-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 184.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 32.6;granulocytes: 146.9;Macrophages: 82.0;NK-cells: 59.8;T-cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 58.2"	"Group enriched"	"Detected in some"	4	"HEL: 45.7;JURKAT: 175.8;K-562: 44.8;MOLT-4: 122.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.2	0.7	0.2	7.9	0.2	10.3	2.0	0.2	0.3	1.5	0.5	2.2	3.6	0.8	0.5	1.2	0.7	2.6	1.1	0.2	0.3	0.6	1.2	4.4	15.7	0.6	0.3	0.2	0.4	0.1	0.3	0.6	0.5	1.6	2.3	0.3	1.7	0.7	0.4	1.1	4.5	0.9	0.5	9.3	3.8	1.9	0.4	184.8	0.8	0.5	12.9	3.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	45.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.2	0.3	0.0	175.8	44.8	0.0	0.0	0.0	122.8	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	6.3	0.7	0.1	51.4	0.3	38.2	3.1	37.5	56.2	1.2	5.2	31.3	58.2	6.6	5.4	0.3	0.8	35.0	74.9	0.2	0.2	0.2	0.3	0.2	0.3	0.6	0.3	0.5	0.5	0.4	0.7	1.1	0.0	6.7	0.3	8.2	1.7	0.0	0.0	0.0	0.6	1.1	0.8	1.0	2.8	0.0	0.0	0.0	0.0	18.3	0.1	0.0	0.4	4.8	0.3	0.1	0.8	1.2	32.6	1.3	0.2	0.0	0.6	0.0	0.1	146.9	0.2	2.5	2.3	0.2	0.0	1.2	0.6	0.0	1.9	4.6	2.9	0.3	82.0	1.8	1.0	6.8	0.3	59.8	2.5	1.0	0.0	0.3	0.4	6.3	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.9	4.4	2.1	0.1	1.1	0.1	57.1	0.0	0.1	0.3
GRID2IP		ENSG00000215045	"Grid2 interacting protein"	A4D2P6	7	6497462-6551436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"brain: 31.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.8;Inhibitory neurons: 2.9;Oligodendrocyte precursor cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"thalamus: 31.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"REH: 3.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 22.4;thalamus: 7.2"	"Low region specificity"	"Detected in all"			HPA045381			Approved	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA045381: AB_10962495"	"unprognostic (1.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.19e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.17e-1)"	0.0	0.4	6.7	0.1	6.2	0.2	0.2	10.7	1.4	0.1	0.0	0.3	0.4	0.1	0.0	0.3	0.2	0.1	0.1	0.1	7.9	0.2	0.0	0.2	0.1	2.4	9.8	0.1	0.5	0.5	0.9	0.0	1.9	0.5	0.1	0.5	0.4	0.3	0.0	0.7	0.3	0.0	0.0	0.3	0.4	0.3	31.9	0.2	0.3	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.3	0.0	3.6	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	6.2	10.7	1.4	0.1	7.9	2.4	9.8	1.9	0.0	31.9	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.6	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.5	0.1	0.0	0.1	0.0	0.4	2.8	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.5	1.3	0.1	0.0	0.0	0.3	0.2	0.4	0.1	0.0	1.0	0.0	0.0	0.1	0.8	0.2	1.2	0.0	0.0	0.1	0.9	0.1	0.2
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564675-25729294	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.2;Club cells: 16.7;Extravillous trophoblasts: 29.2;granulocytes: 18.9;Hofbauer cells: 29.3;Macrophages: 26.4;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.1;eosinophil: 5.2;intermediate monocyte: 7.2;memory B-cell: 4.1;myeloid DC: 3.2;naive B-cell: 5.0;non-classical monocyte: 6.8;plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.6;JURKAT: 69.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	30.2	5.4	6.5	12.9	8.9	7.8	9.4	2.3	14.7	4.0	0.0	3.1	2.8	5.3	1.3	2.4	8.7	4.7	4.3	18.9	2.6	2.4	3.2	9.4	15.1	5.4	6.2	2.9	7.1	4.2	3.2	4.4	2.5	7.5	3.9	4.8	3.2	1.6	0.9	3.3	4.7	5.9	2.9	18.8	3.8	15.7	7.6	10.2	4.1	1.2	15.6	6.2	1.5	6.0	0.1	3.9	11.9	3.9	8.1	1.0	17.3	1.3	3.8	3.8	6.5	6.4	6.8	22.5	0.3	0.3	10.5	0.2	11.9	9.1	11.1	43.6	7.6	10.3	1.3	14.3	0.3	33.8	16.8	2.0	6.2	2.6	4.6	0.6	0.7	69.4	1.1	0.1	4.4	5.6	24.4	2.4	8.5	12.1	0.0	10.8	18.9	3.8	0.0	6.6	27.6	37.5	2.2	0.1	9.0	10.9	3.3	13.4	0.3	0.1	23.6	0.2	4.9	2.6	9.1	17.4	15.8	11.8	3.7	0.5	4.1	5.2	0.0	7.2	0.2	4.1	0.0	0.2	3.2	5.0	0.1	0.1	0.2	0.0	6.8	2.7	0.3	1.5	6.5	8.9	2.3	14.7	18.9	2.6	5.4	6.2	2.5	2.9	7.6	6.0	3.9	16.0	32.2	0.0	10.2	0.0	0.0	0.0	0.0	0.0	11.7	9.5	0.0	0.0	16.7	0.0	0.0	2.0	1.1	0.0	1.9	9.4	0.0	12.7	5.8	2.4	0.0	0.0	0.0	1.8	29.2	4.1	0.0	2.2	18.9	3.7	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	27.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	2.1	0.0	0.0	1.8	6.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	3.3	1.1	5.0	0.0	0.0
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296870-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 52.2;Extravillous trophoblasts: 31.2;Granulosa cells: 27.1;Spermatocytes: 73.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"		Yes	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.90e-10)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	0.6	0.6	0.2	5.1	0.2	11.2	0.5	0.5	0.3	0.7	0.2	2.4	4.1	0.8	0.0	3.6	0.2	0.5	0.3	0.2	0.3	0.3	0.4	0.6	9.2	0.4	0.3	0.2	0.2	0.1	0.1	2.6	0.4	0.2	2.6	0.1	0.7	0.1	0.1	2.5	2.9	1.2	0.1	2.4	1.9	7.2	0.5	19.6	0.2	0.2	8.7	1.0	1.2	0.4	59.5	27.6	53.2	42.2	1.1	3.0	25.5	50.3	23.5	71.7	58.8	29.3	21.9	55.7	13.0	19.4	32.8	30.3	48.0	12.7	45.7	33.7	52.0	37.4	38.9	22.8	0.1	67.5	43.8	0.6	1.0	30.9	15.6	7.5	31.2	39.7	29.0	67.8	43.4	33.1	60.9	33.0	37.2	24.2	30.7	59.6	59.7	36.3	11.7	10.7	27.5	37.5	48.1	30.7	21.5	23.8	26.2	25.8	25.1	40.6	75.8	33.4	53.7	38.6	19.7	56.3	25.8	32.2	60.5	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.4	0.3	0.2	0.2	0.2	0.5	0.3	0.2	0.3	0.4	0.3	0.4	0.1	0.5	0.4	1.1	0.0	0.0	0.7	7.0	2.8	1.1	2.1	0.6	0.7	2.8	3.4	1.6	0.0	0.5	0.0	0.0	19.2	6.8	7.6	0.0	0.9	5.6	2.1	4.7	3.9	1.2	52.2	0.3	0.2	31.2	5.1	16.8	4.3	0.0	27.1	6.4	1.2	19.9	0.0	0.5	9.4	2.0	7.5	4.0	3.9	0.3	4.7	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.8	0.2	0.7	19.1	1.8	0.5	0.5	0.2	0.3	6.6	2.6	5.4	73.6	27.8	11.7	2.6	1.5	5.0	1.2	13.8	1.6
GUCA1A	"C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1"	ENSG00000048545	"Guanylate cyclase activator 1A"	P43080	6	42155406-42181338	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	91	"retina: 804.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 667.2;Late spermatids: 432.4;Muller glia cells: 219.9;Rod photoreceptor cells: 1191.6"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.5"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Group enriched"	"Detected in some"	8	"NTERA-2: 3.8;SH-SY5Y: 4.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA005561, HPA075056"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA005561: AB_2667361, HPA075056: "	"unprognostic (1.91e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (9.70e-2)"		"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.79e-1)"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (1.16e-1)"	0.0	0.0	1.5	0.1	3.5	0.1	0.0	0.9	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	5.4	0.0	0.0	0.0	0.1	1.5	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	804.8	0.0	0.0	0.1	0.1	0.1	0.1	0.8	0.0	0.0	8.8	6.2	0.0	0.0	0.0	0.2	0.0	0.1	1.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.0	0.0	4.9	0.0	0.0	1.5	3.5	0.9	1.8	1.3	5.4	1.5	1.4	1.4	0.8	6.2	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	140.7	0.0	0.0	0.3	0.0	0.0	0.0	667.2	0.6	1.3	0.0	0.0	0.0	106.5	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	65.6	1.0	0.0	4.1	0.0	0.0	432.4	1.8	0.1	0.0	0.0	5.2	219.9	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	1191.6	0.0	0.0	1.2	3.2	3.9	0.0	0.0	0.3	0.0	0.1	0.0	0.1
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877294-88895597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 966.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 50.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 50.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.7;U-2 OS: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	10.3	1.9	2.1	11.5	2.0	3.1	8.6	1.9	2.7	5.1	2.1	3.2	0.6	4.3	0.1	6.1	6.2	2.7	4.6	2.1	2.0	6.1	0.9	9.7	11.7	2.4	2.1	2.7	1.4	0.5	2.2	1.4	2.5	5.7	0.4	4.2	6.0	0.7	3.6	6.2	4.6	2.7	2.3	5.7	3.5	1.0	2.4	2.9	4.6	0.6	3.2	6.9	5.6	2.1	2.0	7.0	1.3	15.4	4.4	4.2	4.7	4.4	1.0	1.6	2.0	4.4	6.4	0.0	11.9	5.4	2.5	1.7	14.7	1.9	0.0	34.7	12.9	4.9	0.3	0.0	0.6	0.0	0.1	1.6	0.8	3.0	0.2	0.2	7.1	0.6	0.1	9.3	0.8	0.2	0.1	0.0	11.2	0.0	0.2	0.0	0.6	11.5	2.9	0.1	0.1	4.2	0.9	0.7	6.1	1.9	0.0	0.6	1.3	10.8	31.2	8.1	0.7	1.1	0.1	0.1	3.8	0.0	9.3	1.4	1.1	0.0	1.2	0.8	5.4	0.2	18.3	7.4	2.2	1.5	18.3	8.6	0.3	10.1	0.2	0.8	50.9	5.9	2.1	2.0	1.9	2.7	2.1	2.0	2.4	2.1	2.5	2.3	2.4	2.1	16.0	0.0	3.4	1.3	4.0	32.0	10.8	13.5	4.6	2.5	47.1	42.4	9.3	1.5	10.4	1.8	10.4	5.8	3.2	0.5	0.0	5.3	0.0	6.3	3.7	29.4	0.0	0.0	1.3	2.0	966.2	8.5	1.5	12.1	1.3	2.5	3.3	0.1	19.3	0.0	0.1	0.9	6.1	0.3	22.0	0.2	0.9	3.0	17.8	2.8	9.7	3.8	3.1	0.5	0.1	9.9	0.1	0.7	0.5	10.4	0.0	0.2	2.7	103.8	13.1	7.2	24.5	0.3	2.1	6.3	24.2	20.4	9.4	0.2	0.5	7.8
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064531-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 250.3;Spermatocytes: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	6.3	6.7	3.8	3.6	5.2	2.7	5.1	4.4	5.4	7.4	2.0	9.2	5.2	7.9	5.0	6.2	5.3	5.7	5.1	3.7	4.2	5.7	7.3	4.7	4.6	4.9	5.0	7.8	6.0	6.7	4.1	6.4	4.8	7.2	4.3	8.0	4.5	9.4	9.7	4.4	5.0	7.2	4.7	5.1	5.2	9.5	4.6	5.2	6.9	11.2	3.7	5.9	6.0	6.6	2.0	2.3	2.3	2.0	12.7	12.5	1.7	9.1	4.1	6.8	3.9	1.1	0.9	2.1	3.1	7.1	2.5	2.2	2.9	1.6	7.3	3.5	2.8	2.1	2.3	1.0	8.5	1.7	3.3	7.8	4.3	4.2	3.5	9.8	5.3	3.1	2.5	4.2	12.3	1.8	3.1	4.0	0.5	1.3	4.7	2.5	7.6	1.3	3.1	1.4	3.3	2.5	4.4	3.2	3.5	1.5	5.0	1.9	8.0	10.7	1.4	5.6	3.1	5.3	1.7	1.8	5.1	2.3	4.4	0.4	0.6	0.9	0.8	1.1	0.9	0.5	0.7	0.9	0.7	0.5	0.8	0.9	0.1	0.8	1.8	0.4	0.9	0.5	3.8	5.2	4.4	5.4	3.7	4.2	4.9	5.0	4.8	4.7	4.6	6.6	19.3	12.8	14.1	18.9	10.0	8.0	6.6	5.4	8.6	19.6	6.1	5.0	12.5	1.5	9.6	5.5	20.9	5.0	8.8	7.4	9.8	6.2	250.3	7.9	18.5	14.4	8.4	7.4	31.8	3.3	5.0	16.0	6.6	6.5	17.1	9.8	15.7	11.5	7.4	23.5	33.9	4.7	8.2	11.4	5.7	59.4	21.8	8.6	7.2	16.9	9.3	13.7	7.2	30.7	45.6	3.1	6.0	27.8	12.2	2.7	7.7	8.6	10.4	22.2	13.1	18.7	17.4	130.9	16.4	8.5	7.2	10.8	11.3	17.9	3.8	3.3
HEG1	"HEG, KIAA1237"	ENSG00000173706	"Heart development protein with EGF like domains 1"	Q9ULI3	3	124965710-125055997	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 90.1;Cardiomyocytes: 90.5;Cone photoreceptor cells: 264.8;Endothelial cells: 121.5;Hepatic stellate cells: 130.3;Microglial cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 174.1;HHSteC: 241.5;hTERT-RPE1: 351.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010952, HPA011559"	Approved		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		510000000	"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA010952: AB_2668389, HPA011559: AB_1850580"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.11e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.16e-4)"	30.1	9.9	19.3	19.2	23.2	1.9	14.8	27.0	15.0	20.8	28.3	11.9	8.0	19.2	6.2	16.1	13.2	38.9	67.3	14.3	22.7	15.2	7.5	55.1	16.5	32.0	28.1	12.4	31.6	16.1	3.6	33.4	28.6	13.9	12.2	46.8	7.7	14.6	14.3	5.2	9.4	25.4	27.3	17.9	9.8	13.5	30.3	8.6	52.2	24.2	15.7	30.0	10.1	30.6	7.0	7.1	54.7	4.2	73.2	58.7	21.1	64.9	90.1	72.6	83.5	58.5	1.0	2.8	43.8	174.1	52.3	15.3	7.4	31.6	97.9	6.5	3.7	1.3	42.3	8.4	241.5	1.8	80.6	77.8	10.1	87.4	21.5	351.3	69.3	5.0	0.1	1.0	25.7	1.3	2.8	0.1	10.1	0.1	5.5	4.8	41.0	0.2	14.6	1.2	1.0	5.6	134.8	10.6	6.4	55.1	24.2	4.3	93.9	37.7	41.3	150.5	29.1	6.9	19.7	0.4	76.8	6.5	82.4	1.1	0.1	0.0	1.9	1.7	1.1	0.5	0.6	1.7	0.4	0.3	1.2	0.8	0.0	3.9	1.9	0.4	0.2	0.5	19.3	23.2	27.0	15.0	14.3	22.7	32.0	28.1	28.6	27.3	30.3	30.6	90.1	86.6	5.8	28.7	4.9	5.0	8.0	25.4	6.8	6.1	2.4	5.7	90.5	7.2	6.5	27.6	264.8	1.8	19.2	0.5	0.0	32.0	7.0	4.0	20.1	121.5	0.0	6.1	0.9	6.4	65.3	44.8	1.1	2.2	26.6	24.9	130.3	3.5	6.8	1.7	14.9	0.5	4.1	18.4	7.3	9.4	5.0	7.1	7.2	92.8	4.0	6.0	35.0	13.0	57.6	6.4	0.1	13.9	8.6	5.2	0.8	1.3	1.0	66.8	0.0	24.0	28.7	1.0	1.1	2.7	4.4	3.3	14.2	3.1	0.1	1.3
HELZ	"DHRC, HUMORF5, KIAA0054"	ENSG00000198265	"Helicase with zinc finger"	P42694	17	67070444-67245989	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028276	Approved		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli, Nucleoli rim"	"Plasma membrane, Actin filaments"	"HPA028276: AB_10601814"	"unprognostic (3.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	6.3	6.6	3.8	8.5	4.9	12.5	6.6	12.0	5.7	7.6	8.4	5.8	4.8	7.4	6.1	4.7	6.1	7.1	6.1	3.6	6.9	6.9	10.9	6.8	9.8	4.1	5.2	12.3	7.8	12.0	6.1	11.2	4.0	6.1	6.6	14.3	6.2	6.2	9.1	4.4	5.9	7.5	3.3	9.1	6.5	10.8	5.5	15.4	8.7	14.0	8.9	6.6	5.0	3.3	10.3	10.0	12.3	12.3	14.8	8.4	18.7	9.0	8.8	11.8	12.4	14.7	7.9	21.2	7.2	12.0	7.4	10.5	23.3	11.3	18.4	8.2	7.3	27.2	10.7	12.5	7.1	22.3	15.6	9.8	10.5	11.4	14.1	8.8	18.1	15.6	19.1	12.9	9.8	13.0	29.0	7.6	7.4	9.2	9.7	19.3	21.6	9.2	9.1	14.3	12.0	11.0	14.3	11.5	15.2	16.9	13.7	13.7	16.1	14.5	16.6	8.0	8.1	10.7	13.4	15.5	7.2	13.7	15.5	2.3	3.3	2.8	5.1	2.8	6.3	1.7	3.1	3.2	2.8	2.8	1.9	2.6	2.3	2.6	1.9	2.2	3.0	2.3	3.8	4.9	12.0	5.7	3.6	6.9	4.1	5.2	4.0	3.3	5.5	3.3	42.9	19.2	37.1	89.1	44.3	32.1	24.6	30.2	29.6	50.8	32.8	23.6	31.1	24.3	30.2	27.6	93.8	32.9	95.8	29.4	7.9	19.1	5.2	49.4	55.8	32.3	38.3	48.8	93.1	14.2	42.8	30.9	38.7	118.5	33.7	51.9	61.8	52.1	31.9	67.3	112.1	30.2	16.2	79.4	28.8	10.5	38.8	55.4	14.2	107.7	62.0	24.0	104.0	134.2	72.6	19.2	23.1	42.9	67.1	29.3	27.7	14.6	26.1	54.9	13.1	45.9	34.0	36.0	26.0	33.6	20.2	18.3	71.0	32.6	26.3	45.8
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 72.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 58.7;Spermatocytes: 178.5;Spermatogonia: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 71.4;MOLT-4: 68.2;NB-4: 75.3;U-937: 98.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"cerebellum: 9.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favorable (2.56e-4)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	5.4	2.9	8.6	8.0	8.9	13.3	8.0	6.8	9.2	8.5	4.9	6.5	5.0	3.9	4.7	2.7	2.3	6.5	1.8	8.9	9.6	3.4	2.0	4.7	13.5	8.0	8.1	5.2	2.1	0.9	5.3	5.6	8.9	3.7	9.5	3.0	3.0	3.4	3.2	3.8	7.6	3.6	7.8	11.1	4.7	72.0	10.6	18.7	2.2	6.2	11.3	6.2	2.0	8.6	16.9	8.5	0.7	0.0	0.7	0.5	0.1	4.0	1.5	9.4	1.5	24.7	26.0	0.0	8.9	7.5	0.0	0.1	0.0	0.2	5.9	5.5	0.0	42.4	31.7	0.0	8.1	25.4	36.4	7.8	0.5	2.1	0.0	0.0	1.9	71.4	0.0	18.5	0.4	42.8	68.2	75.3	24.0	13.5	3.7	29.3	0.0	1.5	0.0	18.0	40.1	0.0	35.3	9.8	0.1	2.4	0.0	55.7	0.5	0.0	31.4	17.5	0.1	11.2	15.0	0.1	0.0	98.6	0.3	43.3	19.7	43.2	61.8	24.0	55.6	12.6	30.0	56.4	24.6	7.1	24.7	45.1	19.6	55.6	29.8	19.5	31.2	39.9	8.6	8.9	6.8	9.2	8.9	9.6	8.0	8.1	8.9	7.8	10.6	8.6	2.4	0.0	1.1	2.3	5.4	1.7	1.4	6.6	1.2	5.2	8.1	7.1	1.8	14.3	4.0	5.5	0.0	12.8	28.0	4.0	3.9	3.0	12.2	2.2	3.6	3.0	4.9	13.9	5.2	1.3	21.5	5.2	2.6	2.4	7.0	2.9	6.1	0.5	15.8	0.0	3.7	4.0	4.1	11.7	3.3	20.1	5.0	7.5	1.8	3.7	11.2	3.6	58.7	4.0	2.7	2.8	7.4	3.0	8.0	1.2	5.5	0.8	2.8	2.4	6.6	3.0	3.5	178.5	107.7	2.9	1.6	5.2	23.0	8.5	6.1	3.3
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: AB_2680382, HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favorable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	5.3	5.7	2.5	2.3	2.9	4.0	4.9	1.5	3.1	5.5	3.0	9.3	2.6	7.6	1.7	5.2	6.1	2.2	7.4	2.3	1.1	3.7	3.7	5.1	2.3	2.0	1.8	8.3	6.1	5.4	6.3	2.7	2.7	4.4	2.8	5.3	4.8	2.9	14.2	5.3	6.1	3.7	0.4	4.3	6.3	4.8	2.7	4.4	5.8	9.3	2.4	5.6	5.0	6.2	8.5	16.5	11.2	4.7	9.2	6.9	3.2	6.0	7.1	7.6	7.3	8.6	1.1	8.5	7.2	10.4	11.5	8.5	12.0	5.9	5.6	5.2	7.8	54.0	20.2	2.9	3.5	12.8	4.1	5.7	4.5	9.0	11.2	4.9	10.2	7.0	21.2	3.4	7.3	3.9	2.9	4.3	3.4	6.4	7.1	10.2	16.0	0.7	2.6	18.2	12.3	7.1	14.6	4.1	4.5	5.8	4.8	14.8	15.3	14.0	9.2	5.5	9.1	2.2	3.3	7.7	6.5	5.9	7.6	0.1	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.6	0.2	0.1	2.5	2.9	1.5	3.1	2.3	1.1	2.0	1.8	2.7	0.4	2.7	6.2	56.2	22.4	23.5	68.9	34.3	16.4	15.3	18.1	27.9	107.9	39.1	31.2	66.6	21.5	23.6	64.4	148.0	25.9	28.5	31.8	1.9	28.7	13.0	35.0	55.8	73.3	28.1	67.9	88.9	30.4	15.5	34.3	43.3	29.6	3.8	135.0	38.9	36.7	19.0	122.8	82.9	32.1	16.2	22.3	20.7	15.8	56.2	22.1	69.4	84.3	26.9	41.0	45.3	65.9	89.7	36.6	30.8	52.3	56.6	20.5	31.1	19.8	19.6	142.9	65.7	46.0	43.2	72.5	66.4	38.3	21.0	17.8	30.0	62.7	35.5	11.5
HIP1R	"FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655"	ENSG00000130787	"Huntingtin interacting protein 1 related"	O75146	12	122834453-122862961	"Cancer-related genes, Predicted intracellular proteins"	Endocytosis	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 103.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.5;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 9.3;naive B-cell: 10.6"	"Group enriched"	"Detected in many"	8	"B-cells: 10.6;granulocytes: 2.9;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017187, HPA038135, HPA038136"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Cytosol"	Vesicles	"CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852"	"unprognostic (4.52e-1)"	"unprognostic (6.39e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.72e-2)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.54e-3)"	"prognostic favorable (7.26e-4)"	18.5	24.0	68.6	10.4	95.5	13.3	22.6	78.8	80.3	16.0	33.5	16.3	31.8	9.0	3.8	18.0	9.0	7.7	18.9	68.0	67.8	50.2	25.6	15.4	17.5	87.3	83.8	5.6	50.2	8.9	42.0	4.7	75.6	21.0	4.9	5.5	58.7	10.5	7.2	51.7	36.0	2.2	65.3	20.9	66.7	8.5	85.7	12.6	21.5	4.4	11.7	11.4	19.7	103.4	38.1	10.8	8.0	33.1	2.3	6.1	39.2	5.9	9.5	5.9	4.6	16.8	11.1	36.0	19.0	4.3	8.9	32.4	9.7	21.4	0.5	5.8	14.0	0.8	13.8	17.8	7.1	2.8	24.5	3.8	14.9	8.0	13.4	8.1	40.5	16.5	9.6	2.0	3.4	54.4	17.4	8.8	7.4	32.8	12.8	9.0	10.2	12.5	19.6	45.4	8.1	17.9	7.1	18.0	9.5	4.3	36.6	1.5	32.8	3.7	27.5	11.7	5.7	24.8	14.2	21.8	6.0	6.0	3.1	0.0	0.0	2.9	2.7	0.0	1.5	9.3	1.7	2.1	0.0	10.6	3.0	1.9	0.2	0.7	0.0	0.0	0.4	2.0	68.6	95.5	78.8	80.3	68.0	67.8	87.3	83.8	75.6	65.3	85.7	103.4	57.0	0.0	13.4	134.5	38.0	13.3	16.8	8.4	6.8	16.4	21.2	18.2	4.2	60.1	11.1	60.7	29.2	3.7	18.2	28.4	0.0	40.1	3.1	21.9	4.7	18.2	7.8	1.3	11.2	28.7	13.1	2.3	80.5	37.5	5.7	25.3	19.2	24.4	0.6	18.5	9.7	29.9	22.4	1.2	4.2	2.9	1.5	2.2	10.6	9.4	0.1	12.5	7.2	168.9	117.8	22.7	25.3	1.2	17.2	20.2	47.5	17.9	14.2	16.6	0.0	2.5	4.1	6.5	13.3	11.5	21.0	1.9	15.0	1.3	23.9	28.4
HPS3	"BLOC2S1, SUTAL"	ENSG00000163755	"HPS3 biogenesis of lysosomal organelles complex 2 subunit 1"	Q969F9	3	149129638-149173732	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 115.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046281, HPA052778"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Plasma membrane"		"HPA046281: AB_10961641, HPA052778: AB_2681943"	"unprognostic (1.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.06e-2)"	7.6	9.2	4.2	11.4	4.7	5.6	7.9	4.8	4.2	7.5	8.3	7.5	11.0	9.9	4.9	5.6	8.6	9.0	5.0	3.7	6.0	12.0	8.0	9.7	17.6	6.7	5.6	14.0	6.7	5.7	3.7	10.6	6.8	9.3	9.1	9.6	6.6	8.5	2.8	4.7	10.8	10.3	5.6	16.0	9.2	6.9	5.2	16.8	8.8	3.9	16.4	8.4	5.2	8.5	49.1	26.5	15.7	16.3	21.4	27.4	11.7	19.7	38.4	25.3	32.4	9.1	31.8	12.4	23.8	23.7	115.3	16.5	17.4	13.4	32.4	30.6	13.9	5.8	11.8	9.9	19.1	15.7	9.1	18.0	13.5	24.4	10.0	51.6	26.2	20.2	6.5	29.4	32.5	30.3	11.3	22.1	37.7	26.3	21.1	13.4	10.3	33.7	13.9	24.1	4.7	12.4	16.8	17.7	35.9	33.4	19.2	20.5	13.2	25.2	4.5	26.0	29.0	24.0	10.0	30.6	37.7	30.1	6.3	20.7	12.5	12.1	12.0	15.2	14.5	15.4	10.9	12.9	19.5	12.2	8.4	10.9	5.7	9.8	10.3	11.0	10.7	10.9	4.2	4.7	4.8	4.2	3.7	6.0	6.7	5.6	6.8	5.6	5.2	8.5	9.9	12.8	19.5	17.6	28.6	3.7	3.9	11.5	6.8	6.7	9.1	7.4	2.5	5.7	22.9	7.3	2.1	21.0	24.3	8.0	5.9	10.7	3.0	10.6	11.6	9.9	9.0	7.4	13.3	18.1	14.6	10.8	16.8	10.4	15.2	18.0	17.5	6.9	19.8	3.3	16.5	8.8	14.2	29.3	23.8	4.8	11.5	33.1	14.2	38.4	14.4	25.1	19.6	19.1	27.3	12.9	4.9	30.1	15.4	6.8	13.6	22.8	20.7	5.2	0.0	7.4	8.4	4.4	8.4	8.7	5.3	14.1	18.9	5.4	7.5	5.1
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090107-96839562	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5"	"Group enriched"	"Detected in some"	27	"Excitatory neurons: 1308.8;Inhibitory neurons: 893.1;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RT4: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA		24000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: AB_2732374"	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	1.4	4.2	1.4	0.2	3.5	0.0	0.3	0.0	9.0	1.8	0.0	0.2	0.4	2.1	2.1	0.4	0.5	0.2	0.9	12.5	7.3	0.8	0.0	0.0	0.0	0.1	5.2	0.1	2.2	2.1	1.9	0.0	0.3	0.2	0.1	2.2	0.0	0.2	1.1	0.5	0.4	1.5	0.3	0.0	0.9	0.3	6.1	0.0	2.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	17.3	0.9	0.7	0.1	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.5	0.0	9.0	12.5	7.3	0.1	5.2	0.3	0.3	6.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.6	0.1	0.0	0.0	1308.8	0.6	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	3.3	893.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	38.4	0.0	0.9	0.0	968.6	16.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	1.8	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.0;lymphoid tissue: 37.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 78.5;dendritic cells: 101.3;Gastric mucus-secreting cells: 40.2;NK-cells: 82.4;Plasma cells: 134.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 232.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.0;HL-60: 43.5;HMC-1: 56.4;NB-4: 140.1;RPMI-8226: 63.2;U-266/84: 41.9;U-937: 137.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (3.47e-5)"	1.6	0.7	0.5	16.8	1.1	47.0	3.3	1.1	1.1	3.0	1.2	9.8	12.7	1.3	1.8	1.7	3.2	5.4	0.4	0.5	0.4	1.5	2.2	5.6	27.2	1.5	0.7	0.5	4.3	2.3	4.0	1.5	1.1	5.1	9.3	0.3	9.5	2.9	0.4	0.4	20.5	1.0	0.7	37.7	12.7	0.4	1.0	8.7	2.6	1.2	35.7	7.5	0.7	2.8	15.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	2.2	21.3	41.0	0.6	0.0	0.8	0.7	0.0	0.6	0.0	2.3	0.1	0.6	0.5	2.6	0.0	43.5	56.4	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	37.4	0.0	9.0	0.1	140.1	0.0	5.5	0.0	3.0	0.0	63.2	0.4	5.6	0.1	0.1	0.0	1.3	0.3	0.0	0.3	15.9	0.2	0.1	0.1	0.2	0.2	5.7	41.9	23.6	0.2	137.3	0.0	232.1	15.5	100.9	17.1	22.0	15.8	56.4	7.6	11.2	25.5	35.8	6.9	9.2	182.6	85.2	38.8	7.6	13.0	16.7	0.5	1.1	1.1	1.1	0.5	0.4	1.5	0.7	1.1	0.7	1.0	2.8	1.0	3.2	8.9	0.0	78.5	0.3	1.2	3.0	0.6	0.0	3.6	1.9	0.6	5.7	11.3	5.5	0.0	2.6	101.3	18.9	0.0	6.7	0.0	4.5	1.5	0.8	8.4	32.2	0.5	5.1	4.1	0.7	40.2	7.9	6.3	0.1	1.4	0.6	1.1	0.0	0.4	19.1	2.0	3.4	2.4	0.1	0.0	7.3	10.6	1.0	10.7	0.0	82.4	1.0	0.3	9.7	18.0	0.0	134.0	2.6	17.9	0.3	7.9	0.0	0.0	1.1	0.7	0.1	0.5	0.1	0.1	3.4	31.0	0.2	9.3	4.1
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822244-21937310	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.8;Endothelial cells: 322.9;Granulosa cells: 776.0;Hepatic stellate cells: 600.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 293.0;HUVEC TERT2: 620.8;TIME: 504.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1400000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	140.7	54.7	3.8	36.1	5.2	1.7	96.2	3.7	4.8	65.9	18.8	153.1	18.3	151.9	6.6	44.1	85.0	53.4	156.6	3.6	2.9	37.6	10.6	49.0	14.2	5.6	4.6	31.3	31.7	13.1	11.8	30.3	5.7	60.3	8.6	0.3	45.0	56.5	65.1	41.0	54.9	96.2	4.0	37.4	76.1	9.0	7.6	6.7	69.1	40.8	3.5	110.2	59.7	4.7	44.0	40.7	13.8	45.9	131.0	99.4	51.5	70.2	17.8	21.1	18.7	50.5	86.7	3.3	293.0	112.9	0.8	26.9	3.1	31.9	5.4	0.6	4.3	15.7	46.0	35.7	27.0	0.0	4.1	61.6	9.4	19.9	6.0	28.1	620.8	0.3	21.4	5.7	32.4	11.8	0.0	20.0	11.7	19.6	17.9	6.3	87.8	6.1	35.1	6.5	1.3	4.1	51.4	20.0	28.7	14.0	8.1	7.2	504.3	41.1	51.8	29.7	2.3	0.5	7.3	2.6	9.7	0.1	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	5.2	3.7	4.8	3.6	2.9	5.6	4.6	5.7	4.0	7.6	4.7	366.8	70.5	28.6	3.6	3.9	26.4	13.5	81.1	21.1	0.6	6.2	21.5	5.8	38.6	30.3	92.0	0.0	11.0	3.4	52.9	0.0	76.1	1.4	24.2	47.7	322.9	2.4	22.9	0.8	25.0	89.0	141.3	62.2	39.8	23.4	776.0	600.4	6.6	6.8	3.3	0.8	12.6	16.2	22.1	19.2	5.8	75.2	4.6	60.5	15.9	1.8	1.6	0.0	2.5	4.3	87.5	29.9	69.2	4.6	19.3	19.2	0.9	28.7	0.6	32.9	82.5	69.8	0.3	4.8	10.0	17.8	9.3	5.0	83.3	20.1	11.8
HUNK		ENSG00000142149	"Hormonally up-regulated Neu-associated kinase"	P57058	21	31873020-32044633	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.8"	"Cell type enriched"	"Detected in many"	5	"Inhibitory neurons: 109.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;BEWO: 16.3;RH-30: 18.1;SCLC-21H: 14.8;SiHa: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA027295: AB_2672203, HPA027372: AB_2672239"	"unprognostic (9.09e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.00e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.48e-5)"	"unprognostic (8.84e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.69e-2)"	0.7	1.0	0.8	1.3	1.3	0.2	1.2	0.4	4.7	0.4	0.0	3.6	1.4	4.1	1.9	0.4	1.9	0.5	0.4	4.2	2.6	3.7	0.5	0.9	0.4	0.4	0.1	0.6	9.8	0.1	1.1	4.6	0.1	0.9	3.7	3.0	0.6	2.1	0.3	3.0	2.7	2.4	0.0	0.1	1.3	0.9	0.2	0.7	0.6	0.2	0.6	1.5	0.7	1.6	0.0	3.9	13.2	0.1	0.0	0.0	16.3	1.3	0.0	0.2	0.0	5.3	0.1	0.0	0.5	6.2	0.2	0.0	7.7	0.0	0.1	0.1	3.9	0.0	3.7	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	1.1	0.2	1.1	10.2	0.1	0.1	0.1	18.1	0.1	1.3	0.0	14.8	9.8	13.2	1.0	0.5	9.3	5.5	1.4	0.0	0.1	9.3	0.1	0.0	0.1	0.0	1.8	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.4	4.7	4.2	2.6	0.4	0.1	0.1	0.0	0.2	1.6	0.2	6.4	9.1	7.5	0.0	5.1	2.6	0.2	0.6	8.1	0.5	2.8	3.5	14.3	3.0	7.3	2.1	9.2	0.0	4.6	0.0	5.3	0.2	1.2	1.3	0.8	4.9	0.0	19.0	3.3	13.9	7.9	0.5	3.4	0.0	4.3	0.4	1.0	2.7	3.3	109.6	5.1	0.0	0.0	4.2	0.1	0.3	0.4	3.6	1.0	0.1	8.1	0.0	10.1	1.5	1.6	4.4	0.0	0.0	2.1	1.8	1.9	0.8	1.2	0.0	6.3	2.2	0.7	1.1	0.7	5.8	6.2	0.5	0.0	10.6	0.9
HYDIN	"CILD5, DKFZp434D0513, KIAA1864, PPP1R31"	ENSG00000157423	"HYDIN axonemal central pair apparatus protein"	Q4G0P3	16	70802084-71230722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.9;choroid plexus: 23.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;Endometrial ciliated cells: 150.6;Excitatory neurons: 49.2;Respiratory ciliated cells: 153.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;RPTEC TERT1: 2.8;SiHa: 5.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA067155, HPA074129"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA067155: AB_2685792, HPA074129: AB_2686665"	"unprognostic (8.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.88e-4)"	"unprognostic (4.25e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.52e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.97e-2)"	0.3	0.3	2.2	0.3	3.2	0.5	0.5	1.2	1.4	1.2	23.9	0.6	0.2	0.9	2.0	0.1	5.3	0.5	0.5	3.4	3.5	1.3	0.5	1.4	0.3	8.9	9.9	1.1	0.7	2.5	4.4	0.1	5.8	0.8	0.1	6.4	0.3	0.3	0.1	0.5	0.2	0.1	8.0	0.4	0.2	4.7	4.3	0.0	1.9	0.0	0.0	0.5	0.4	4.4	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.1	1.8	0.3	0.1	0.1	0.6	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.0	1.1	0.2	0.0	0.0	0.0	0.4	0.4	0.7	0.0	0.4	0.1	0.1	0.4	2.8	0.4	1.1	0.2	5.3	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.4	0.0	0.1	0.9	0.0	0.5	0.4	0.1	0.3	0.5	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.7	0.1	0.3	0.2	0.1	0.0	2.2	3.2	1.2	1.4	3.4	3.5	8.9	9.9	5.8	8.0	4.3	4.4	0.1	3.2	2.6	35.3	0.0	0.0	0.2	2.6	0.0	17.0	1.5	1.1	2.5	0.0	18.3	9.2	52.1	0.0	0.4	0.0	1.9	2.5	35.4	150.6	6.5	0.7	3.5	0.0	49.2	0.6	0.0	1.4	0.0	4.0	0.0	5.0	0.0	0.0	0.1	0.0	25.9	0.1	4.1	0.0	0.0	31.5	2.5	0.3	3.6	3.7	0.0	9.3	0.0	26.2	21.8	0.3	0.1	4.5	0.1	0.6	0.0	1.8	153.2	30.5	0.0	2.0	1.7	17.7	7.5	0.0	0.0	0.0	0.5	1.6	0.1	0.2
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43450989-43453989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 232.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 97.7;HUVEC TERT2: 106.7;U-251 MG: 99.2;WM-115: 105.5"					"Low region specificity"	"Detected in all"			HPA040092	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favorable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.72e-5)"	31.7	22.8	28.1	9.3	29.2	12.1	19.3	29.6	36.3	23.4	27.9	21.3	44.1	23.3	15.4	15.0	24.2	18.7	20.8	27.0	31.2	29.5	44.6	23.0	11.3	30.9	28.9	42.1	53.7	25.2	14.6	10.5	30.9	19.8	12.3	4.1	35.3	47.0	20.8	16.2	34.4	13.2	30.0	12.2	23.9	3.9	28.4	8.8	19.1	10.2	9.2	17.4	15.3	32.4	58.7	7.3	2.2	3.5	9.8	15.1	0.2	48.4	35.7	52.6	34.3	24.2	97.7	0.0	4.1	29.7	25.1	10.9	0.0	45.8	21.6	15.2	20.5	10.2	25.0	0.0	58.8	0.0	0.0	9.4	12.4	64.0	0.0	56.3	106.7	0.5	1.2	0.0	34.5	1.2	9.6	8.8	11.1	5.6	15.5	46.0	0.0	0.3	37.5	2.2	27.2	20.3	56.0	30.4	13.2	8.7	9.2	72.0	59.5	3.7	0.0	12.4	99.2	0.0	0.0	0.0	4.1	13.4	105.5	10.6	1.7	3.7	4.2	1.3	5.5	4.3	7.1	3.3	5.8	5.3	6.6	2.0	0.1	7.5	1.8	29.9	0.7	4.0	28.1	29.2	29.6	36.3	27.0	31.2	30.9	28.9	30.9	30.0	28.4	32.4	29.8	19.2	64.4	5.9	16.1	28.0	45.2	22.8	51.8	16.9	41.0	65.3	0.4	65.8	23.0	57.0	10.4	18.6	19.2	56.6	45.0	106.7	1.2	9.9	23.6	23.2	69.5	21.5	1.4	86.1	115.9	45.7	25.5	18.7	43.2	33.5	25.0	59.0	29.8	8.4	1.9	89.1	16.2	8.5	31.0	4.5	31.7	23.5	40.9	1.9	15.8	45.0	8.2	4.5	4.8	109.6	97.0	30.5	41.7	33.7	232.5	146.9	12.4	16.7	26.3	31.3	58.2	1.4	3.0	27.3	22.0	12.0	12.3	49.8	47.6	38.4
HYLS1	FLJ32915	ENSG00000198331	"HYLS1 centriolar and ciliogenesis associated"	Q96M11	11	125883614-125900646	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 80.8;Late spermatids: 54.9;Spermatocytes: 92.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041210	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA041210: AB_10794987"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.28e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.56e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	2.9	2.4	5.7	3.0	5.3	2.4	4.3	8.0	8.5	4.2	4.9	4.7	6.0	3.8	6.7	3.7	4.2	2.6	5.0	5.4	5.3	5.5	5.8	2.5	6.2	5.0	4.7	3.9	2.2	2.7	2.3	4.4	5.0	5.0	5.0	4.3	3.1	6.1	2.7	4.8	3.3	6.4	4.5	3.6	5.4	26.5	6.0	5.2	2.5	4.3	9.0	3.8	2.3	5.2	11.2	23.9	8.4	5.9	16.5	11.6	14.8	27.3	10.9	24.8	16.9	0.3	17.2	5.0	11.3	25.4	8.4	15.8	12.2	10.0	28.7	27.1	9.2	3.5	2.3	4.9	12.9	12.4	16.9	7.2	11.0	25.2	28.3	5.1	18.4	11.0	6.1	27.3	33.6	18.6	9.1	36.2	18.4	46.2	40.8	19.0	0.1	16.5	27.3	17.9	11.6	7.2	29.6	22.2	11.0	10.5	53.6	26.9	16.7	1.8	20.9	19.4	4.6	10.1	11.4	11.4	5.1	26.7	22.2	5.7	7.6	1.5	10.6	8.7	10.2	16.1	13.8	12.6	10.0	16.1	13.2	9.7	1.1	6.8	6.3	20.4	15.5	7.1	5.7	5.3	8.0	8.5	5.4	5.3	5.0	4.7	5.0	4.5	6.0	5.2	3.9	0.0	0.5	2.6	9.3	4.2	2.8	8.0	4.6	7.1	4.1	5.3	5.5	1.5	2.2	1.8	4.2	18.6	11.5	4.0	11.7	5.5	80.8	5.8	3.4	3.7	4.9	9.1	14.3	4.2	13.0	5.9	8.6	2.1	0.0	7.1	6.8	5.4	7.6	0.0	13.8	3.2	8.2	3.2	4.0	54.9	8.4	2.5	7.2	6.5	11.9	5.8	12.3	6.0	5.8	3.6	5.8	6.0	4.2	3.3	5.2	12.1	4.8	6.5	6.6	2.3	5.7	92.1	32.3	6.2	4.3	4.4	4.9	7.5	5.5	1.5
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 219.3;urinary bladder: 215.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 612.2;Alveolar cells type 2: 561.6;Endothelial cells: 240.8;Langerhans cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 158.3;Karpas-707: 459.7;RPMI-8226: 148.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA	87900000	2200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favorable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	87.9	23.6	9.1	44.6	9.6	117.1	32.4	7.9	12.0	11.2	9.9	17.7	16.8	23.9	3.5	11.0	26.2	56.4	39.1	8.8	9.9	43.9	67.1	219.3	38.3	12.3	8.7	13.0	11.1	8.3	9.3	27.8	10.2	22.2	18.1	10.5	18.0	6.3	15.1	17.9	22.6	23.4	10.0	55.9	21.5	5.6	15.4	28.4	30.8	12.8	32.9	215.3	12.5	10.2	46.3	0.5	7.9	0.2	2.0	4.4	9.7	8.6	91.6	21.8	62.0	14.0	49.8	39.6	130.3	3.8	99.3	8.9	1.7	0.4	45.6	123.8	0.1	3.8	1.4	62.0	158.3	1.3	23.9	55.7	4.0	13.7	20.3	2.0	10.7	4.9	15.0	459.7	1.5	3.3	0.5	34.9	3.1	0.5	24.7	1.0	0.2	148.5	36.8	0.3	0.3	1.1	61.2	3.3	94.5	3.7	6.9	2.8	34.3	22.3	1.9	12.3	0.8	137.4	142.7	25.5	35.1	26.3	32.6	5.0	28.3	5.2	5.3	25.8	9.8	3.8	4.0	6.3	24.7	1.5	1.9	3.8	40.8	15.2	17.0	14.1	6.1	20.8	9.1	9.6	7.9	12.0	8.8	9.9	12.3	8.7	10.2	10.0	15.4	10.2	150.3	612.2	561.6	0.3	31.7	85.3	22.2	62.6	28.5	0.0	50.2	24.9	1.1	21.5	133.5	3.7	0.0	1.1	28.9	2.9	0.0	176.8	2.0	14.1	15.5	240.8	2.4	1.3	0.5	98.7	3.3	136.6	13.7	29.8	139.8	0.1	48.2	12.1	86.7	0.0	0.4	0.7	32.6	53.6	232.6	1.3	4.7	168.3	76.5	7.5	101.9	4.6	5.2	0.5	0.2	113.7	0.3	1.5	57.6	27.1	0.3	15.0	83.2	0.4	6.6	38.2	57.6	0.8	1.6	4.3	69.3	1.2	28.8	0.5	1.6	14.1
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 341.8;Endothelial cells: 180.8;Hepatic stellate cells: 128.5;NK-cells: 106.1;Plasma cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 1260.8;TIME: 319.0"	"Low region specificity"	"Detected in all"							HPA071155			Approved	"Plasma membrane,Cytosol"		NA	NA		730000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	97.4	11.3	39.6	30.4	39.6	20.7	78.7	40.3	48.3	20.3	34.6	26.3	14.1	24.4	6.7	12.1	22.2	18.8	99.7	38.2	40.5	44.3	14.6	84.5	60.5	42.1	40.9	12.7	15.4	9.0	12.4	79.3	42.9	16.1	18.2	1.2	16.0	8.6	37.9	16.3	34.2	29.5	41.4	168.1	18.8	3.5	44.6	31.5	33.6	55.9	41.8	33.0	21.4	40.6	0.0	0.0	0.0	0.0	11.3	10.8	3.2	1.1	0.7	0.3	1.1	2.7	52.2	92.9	16.6	0.0	0.3	0.4	1.2	0.0	1.7	22.3	0.0	82.9	4.4	10.0	1.8	14.2	0.3	0.4	0.0	0.8	0.2	0.0	1260.8	78.8	67.7	50.5	0.3	0.0	101.8	11.8	0.1	0.7	0.0	60.3	0.2	128.7	6.7	12.8	0.0	0.8	0.0	0.2	0.0	0.1	0.0	10.3	319.0	0.2	0.8	6.2	0.0	47.6	18.7	83.4	0.1	17.7	0.0	444.8	191.8	62.1	282.8	464.6	326.0	265.6	371.2	270.7	203.6	328.9	400.3	253.3	23.1	188.5	525.8	67.2	450.8	502.0	39.6	39.6	40.3	48.3	38.2	40.5	42.1	40.9	42.9	41.4	44.6	40.6	341.8	0.0	8.4	0.0	47.8	7.4	4.0	5.2	0.6	0.1	6.1	11.3	0.5	1.5	4.5	7.3	0.0	0.5	41.7	1.7	0.0	1.2	0.6	1.2	2.4	180.8	1.2	28.2	0.1	1.4	0.3	13.8	1.1	0.8	12.0	0.7	128.5	1.9	20.0	0.0	0.0	2.2	2.0	55.6	13.4	1.3	0.3	56.9	28.4	21.5	25.7	0.4	106.1	0.5	0.2	6.8	4.7	1.9	114.4	3.8	0.6	0.5	4.1	0.5	6.6	7.4	11.6	0.2	0.3	0.7	5.4	1.0	60.1	6.5	4.2	2.8
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936763-203961577	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 16.5;lymphoid tissue: 20.2"	"Cell type enriched"	"Detected in some"	12	"T-cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 29.1"	"Lineage enriched"	"Detected in single"	54	"T-cells: 29.1"	"Group enriched"	"Detected in some"	8	"HEL: 4.6;MOLT-4: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	0.5	0.1	0.0	7.7	0.0	16.5	0.3	0.0	0.0	0.2	0.0	0.7	0.7	0.2	0.1	0.5	0.3	1.4	0.2	0.0	0.0	0.2	0.4	2.6	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.2	2.3	0.4	0.0	3.3	1.3	0.2	0.0	20.2	0.4	0.0	16.2	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.2	0.0	15.1	6.8	0.0	0.0	15.7	7.2	0.1	0.5	0.0	0.0	29.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	3.1	2.9	0.0	0.0	0.0	0.0	1.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.2	6.3	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.8	4.7	0.1	0.0	3.1	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	1.8	0.1	81.2	0.0	0.0	0.1
IFFO2		ENSG00000169991	"Intermediate filament family orphan 2"	Q5TF58	1	18904280-18956676	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 43.0;skin 1: 169.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 121.0;Basal prostatic cells: 83.0;Suprabasal keratinocytes: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	18	"basophil: 12.6"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 139.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015987, HPA064603"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA015987: AB_2121678, HPA064603: AB_2685296"	"unprognostic (1.43e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.27e-3)"	"unprognostic (3.24e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.36e-1)"	5.3	9.2	7.4	8.2	6.6	10.4	12.6	19.6	10.6	12.3	0.6	9.0	2.0	7.4	2.4	43.0	5.2	7.0	4.2	6.4	7.9	6.8	5.8	7.5	8.6	11.2	9.3	3.3	19.1	10.7	6.5	7.2	9.7	9.4	2.8	4.3	14.4	9.1	7.9	169.9	3.9	7.1	6.8	6.3	4.4	1.8	9.6	6.2	6.4	4.2	14.0	8.5	21.6	8.8	23.3	37.2	9.9	27.4	6.2	4.9	16.0	17.2	11.4	9.2	6.4	51.5	26.6	0.3	21.6	13.1	10.6	57.6	7.6	36.6	7.4	139.3	6.7	0.4	7.1	20.4	4.5	4.0	21.3	3.2	36.3	12.4	15.7	15.2	19.9	1.2	1.4	4.6	6.1	4.9	3.9	3.7	4.2	23.9	8.8	13.1	6.1	9.8	5.4	14.9	31.6	1.7	13.1	18.2	12.6	10.1	4.9	2.1	54.6	12.4	17.2	7.3	50.5	9.7	11.3	0.8	8.3	5.7	14.8	12.6	0.2	0.0	0.4	0.3	0.5	0.5	0.3	0.4	0.1	0.2	0.3	0.6	0.0	0.2	0.0	0.4	0.3	0.1	7.4	6.6	19.6	10.6	6.4	7.9	11.2	9.3	9.7	6.8	9.6	8.8	4.1	3.2	5.4	5.5	6.0	121.0	83.0	24.1	40.5	6.8	11.5	13.5	6.8	12.8	9.7	1.8	0.0	5.1	20.9	4.9	1.9	17.3	1.3	23.3	5.9	7.7	2.4	3.2	8.5	17.6	5.4	4.7	3.1	10.2	3.8	0.8	4.6	3.4	2.4	25.2	9.6	1.3	2.0	1.6	17.1	4.5	1.2	6.8	14.2	1.0	3.5	4.4	8.2	11.6	8.8	14.6	3.3	3.0	15.5	15.0	0.8	9.3	23.1	1.8	0.0	3.5	7.5	0.8	0.4	32.4	100.3	4.0	13.9	0.4	1.3	44.2
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422887-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 64.2;neutrophil: 112.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 112.3"	"Low cell line specificity"	"Detected in all"											"HPA024122, HPA072413"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA024122: AB_1851452, HPA072413: "	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	35.2	24.6	11.2	6.5	14.4	57.7	32.3	13.2	16.2	23.0	31.7	30.3	8.1	20.8	4.8	24.0	25.4	4.6	30.9	13.9	19.0	21.3	27.3	40.1	3.9	11.0	13.2	31.3	102.9	9.8	31.2	7.9	13.0	28.1	5.5	13.4	25.7	6.4	58.9	21.9	22.2	10.2	11.7	19.9	38.3	24.5	13.1	4.5	25.6	3.1	3.9	24.1	25.8	19.6	22.1	26.8	25.9	21.7	44.4	28.2	25.0	23.8	26.6	36.0	29.6	42.7	21.1	12.2	52.9	18.8	64.6	15.0	21.5	29.2	46.9	17.1	31.7	13.8	46.1	37.9	61.5	19.9	9.5	24.7	43.4	39.7	47.1	18.9	18.3	22.2	46.5	17.4	14.2	35.7	24.1	20.1	51.8	26.9	30.1	24.6	9.2	22.9	6.0	6.1	37.9	18.9	28.0	15.5	61.2	57.7	9.8	15.2	12.6	45.8	10.4	35.0	68.5	27.2	34.8	37.1	12.9	43.6	63.8	19.8	7.6	64.2	7.2	6.5	6.2	8.7	7.7	7.9	6.6	7.2	6.8	7.0	112.3	8.0	6.4	4.6	8.6	5.2	11.2	14.4	13.2	16.2	13.9	19.0	11.0	13.2	13.0	11.7	13.1	19.6	179.3	32.1	31.4	39.2	110.6	197.3	159.3	55.6	259.6	50.3	141.7	142.6	60.6	37.1	55.0	18.4	89.6	66.5	130.9	276.0	17.6	49.6	43.9	123.2	159.7	96.8	138.2	24.6	36.1	56.5	84.2	135.5	162.6	190.1	74.4	51.3	52.8	21.7	126.1	21.9	24.4	183.5	54.9	96.9	153.4	10.1	36.7	141.8	103.2	44.0	55.8	32.4	20.6	24.1	42.6	55.1	287.8	41.0	104.6	143.9	226.9	13.3	34.1	86.8	39.5	138.9	172.7	25.5	14.5	135.1	126.0	151.7	129.8	53.4	180.0	154.4
IFT52	"C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5"	ENSG00000101052	"Intraflagellar transport 52"	Q9Y366	20	43590937-43647299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063367, HPA067423"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA063367: , HPA067423: AB_2685837"	"unprognostic (2.88e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.18e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.30e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	23.5	15.1	12.2	11.7	12.6	29.1	26.1	12.4	15.2	29.3	14.3	16.3	9.2	27.4	29.0	14.8	38.0	19.0	11.8	12.5	13.5	20.5	7.8	16.9	18.3	12.3	12.8	39.2	15.7	22.5	16.5	17.5	12.8	17.5	17.8	15.1	13.6	23.8	4.7	15.5	11.2	24.3	13.3	15.7	12.2	31.8	14.1	22.8	31.3	9.0	18.9	19.5	18.0	14.2	33.9	25.4	50.3	35.8	41.9	46.4	23.9	20.8	46.1	53.6	51.6	70.5	33.7	18.8	32.8	42.6	43.4	27.7	21.3	37.3	58.6	15.6	20.0	24.8	16.2	65.9	51.4	33.4	16.4	37.8	40.2	34.9	27.0	39.0	42.7	41.4	21.3	26.1	39.9	34.0	46.4	51.5	28.4	22.2	24.9	48.6	57.5	27.8	41.8	32.9	38.8	45.3	63.6	46.7	52.2	25.3	21.8	45.1	26.9	47.3	35.1	26.3	31.1	25.3	26.9	32.8	56.8	24.0	34.8	8.0	22.0	16.8	18.4	20.9	15.0	17.5	14.7	17.5	28.4	15.3	15.4	16.0	6.3	17.4	26.2	21.5	18.6	17.3	12.2	12.6	12.4	15.2	12.5	13.5	12.3	12.8	12.8	13.3	14.1	14.2	21.1	6.4	13.1	11.4	13.7	13.0	12.8	22.4	12.0	11.5	14.1	19.2	2.9	11.5	13.2	7.3	0.0	19.9	16.0	14.8	19.6	26.1	78.4	32.1	19.4	18.1	9.5	23.4	20.5	22.2	19.7	25.3	8.2	10.5	14.5	26.7	23.2	2.6	19.4	8.4	22.5	11.0	14.2	18.2	13.9	20.9	28.6	13.3	17.8	12.2	21.3	22.6	18.6	14.6	25.7	14.8	10.1	38.4	13.5	5.9	5.5	18.3	49.0	12.8	13.1	23.9	24.8	57.3	18.5	12.2	14.9	9.6	12.1	30.4	10.3	10.5
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 41.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Excitatory neurons: 27.1;Inhibitory neurons: 29.3;Oligodendrocytes: 38.5;Spermatocytes: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"CACO-2: 82.4;OE19: 166.9"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Plasma membrane"	"HPA059137: AB_2683920"	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	2.4	0.0	0.2	0.0	0.2	0.0	2.0	0.0	0.8	0.1	0.0	0.5	0.0	0.2	0.5	1.5	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.3	2.0	0.7	0.3	0.0	0.0	1.5	0.3	0.9	0.8	0.0	0.8	0.4	1.0	0.0	0.0	41.6	0.1	0.2	0.2	0.0	0.0	4.1	0.3	1.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	1.7	0.5	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.0	0.0	1.6	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	166.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.4	0.7	0.3	0.8	0.2	0.3	2.1	0.0	0.0	0.0	17.9	0.0	2.2	0.0	1.1	0.0	1.7	2.0	1.5	0.6	0.0	0.7	0.0	0.0	4.3	0.0	0.7	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.0	27.1	0.2	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	29.3	0.4	0.0	0.0	0.3	5.4	0.0	0.0	1.8	0.0	0.0	0.2	0.0	6.0	38.5	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	1.9	0.0	0.0	0.7	9.8	8.7	0.0	4.7	2.6	0.2	0.0	1.4	0.0
IL12RB1	"CD212, IL12RB"	ENSG00000096996	"Interleukin 12 receptor subunit beta 1"	P42701	19	18058995-18098944	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 35.1;Kupffer cells: 13.9;NK-cells: 69.0;Plasma cells: 15.3;T-cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 18.8;HDLM-2: 35.2;Karpas-707: 57.8;U-698: 15.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA074414			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA074414: AB_2686687"	"unprognostic (7.70e-3)"	"prognostic favorable (3.41e-4)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.93e-2)"	2.1	1.2	1.0	15.2	1.8	9.3	0.9	1.0	2.1	1.0	1.7	3.1	4.5	0.7	0.8	1.6	0.8	3.5	0.7	1.1	1.1	0.9	2.2	5.8	24.6	2.5	1.5	0.6	0.5	1.3	0.5	1.6	2.3	0.8	2.9	0.5	1.7	0.6	0.7	1.6	7.0	1.9	1.1	16.2	4.1	0.8	2.3	6.6	0.7	0.2	14.1	4.0	0.5	3.7	0.3	0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.1	0.5	1.0	0.3	2.2	18.8	0.1	0.2	0.7	0.3	0.0	0.0	0.0	35.2	0.2	2.2	0.6	0.3	1.0	0.9	3.1	0.1	0.0	0.5	0.0	0.2	0.1	5.1	0.3	57.8	0.0	0.2	9.7	0.3	0.1	0.1	0.0	6.7	0.1	0.8	0.0	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.4	9.7	0.4	0.5	0.4	0.2	0.2	6.6	11.0	15.2	0.6	12.1	1.1	8.5	12.5	9.2	50.9	34.7	64.0	11.5	34.8	41.7	14.7	9.1	19.3	34.0	14.7	40.9	34.0	8.1	53.0	24.3	1.0	1.8	1.0	2.1	1.1	1.1	2.5	1.5	2.3	1.1	2.3	3.7	0.5	0.0	3.0	0.3	9.6	0.3	2.1	0.1	0.6	0.0	0.3	0.5	1.0	1.5	0.6	0.0	0.0	0.2	35.1	0.1	0.0	0.0	0.5	0.5	0.2	0.5	0.0	5.2	0.8	0.0	0.8	0.7	3.1	0.7	4.5	0.0	0.4	0.1	6.4	0.0	0.4	0.0	0.0	13.9	4.0	0.0	0.0	11.7	0.0	3.7	11.9	0.0	69.0	0.0	2.6	0.1	0.0	0.0	15.3	0.5	0.4	0.2	0.2	0.0	0.0	0.7	0.3	0.4	0.1	0.0	0.9	0.1	31.5	0.0	0.2	1.3
IL12RB2		ENSG00000081985	"Interleukin 12 receptor subunit beta 2"	Q99665	1	67307364-67398724	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5;placenta: 7.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.4;Excitatory neurons: 22.5;Inhibitory neurons: 16.6;T-cells: 12.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 2.5;melanoma: 5.6;renal cancer: 1.7"	"Region enhanced"	"Detected in many"		"hippocampal formation: 4.5"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 21.3"	"Group enriched"	"Detected in many"	35	"NK-cells: 21.3;T-cells: 6.0"	"Group enriched"	"Detected in some"	9	"HMC-1: 4.6;SCLC-21H: 6.8;SK-MEL-30: 18.4;THP-1: 13.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"Low region specificity"	"Detected in all"			HPA024168	Uncertain		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA024168: AB_1851629"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.90e-1)"	1.9	0.3	1.2	1.2	1.6	0.8	0.4	0.0	2.3	0.6	0.0	0.4	0.3	0.2	0.3	0.8	0.1	0.5	0.2	4.5	0.0	0.3	0.8	0.4	1.8	0.0	0.7	0.2	2.6	0.8	0.0	7.0	0.0	0.1	0.4	0.1	1.3	0.7	3.5	1.4	0.4	0.4	0.0	1.4	0.3	1.0	0.3	1.0	0.1	0.7	0.9	0.7	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.1	18.4	0.0	0.0	13.4	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	6.0	0.0	3.2	0.0	1.6	1.0	0.0	0.0	0.0	0.1	0.3	21.3	0.0	0.0	3.9	1.2	1.2	1.6	0.0	2.3	4.5	0.0	0.0	0.7	0.0	0.0	0.3	0.7	0.2	0.0	2.3	1.0	0.6	0.5	0.2	0.1	0.6	0.0	0.1	0.3	0.7	0.0	0.7	0.0	0.0	0.0	8.4	0.0	0.0	0.0	1.5	0.3	0.3	0.1	0.0	0.8	22.5	0.0	0.0	0.9	2.6	0.7	0.0	1.5	0.0	0.0	3.8	0.0	16.6	0.0	0.0	0.8	0.9	0.9	0.0	0.5	1.8	2.8	0.0	0.0	4.1	1.0	1.6	0.2	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.0	0.6	0.0	12.8	0.0	0.0	0.1
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 24.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 96.7;Late spermatids: 200.7;Spermatocytes: 44.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	187	"HDLM-2: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042421			Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	40000			"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA042421: AB_10795504"	"unprognostic (2.17e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-1)"	0.3	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.2	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	96.7	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	200.7	2.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.5	44.4	1.2	0.0	0.6	0.0	14.7	0.0	0.0	0.0
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.0;testis: 30.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 322.4"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"PC-3: 133.0;U-2197: 425.6;U-251 MG: 297.4;U-87 MG: 167.9"	"Region enhanced"	"Detected in many"		"olfactory bulb: 7.0"	"Low region specificity"	"Detected in some"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.8	4.8	1.3	4.0	1.9	0.0	0.4	0.1	1.1	1.1	1.6	0.4	0.3	0.8	4.4	0.6	0.1	0.8	0.7	1.5	10.6	3.6	10.0	1.4	0.1	3.1	3.7	0.1	0.1	0.5	12.0	0.4	1.8	4.1	0.7	0.0	0.9	3.5	0.0	0.2	0.3	0.3	0.7	0.2	0.1	30.0	6.1	2.1	1.2	0.1	0.1	4.4	0.2	0.8	0.4	0.0	4.6	0.1	0.7	3.6	0.0	29.2	28.0	0.1	0.1	0.0	0.0	0.0	0.5	14.6	46.6	0.1	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.1	4.8	0.8	4.6	26.9	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	133.0	0.0	0.0	0.0	2.4	0.2	0.0	6.8	2.1	0.3	0.4	0.0	0.1	0.4	0.0	14.7	0.4	425.6	297.4	0.0	0.2	0.1	167.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.9	0.1	1.1	1.5	10.6	3.1	3.7	1.8	0.7	6.1	0.8	0.3	0.0	0.0	0.0	0.1	0.1	4.7	0.3	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	322.4	0.4	0.3	1.3	4.2	0.0	0.4	0.0	0.0	10.3	0.0	0.4	0.0	0.0	46.4	0.4	0.0	0.0	0.6	0.0	0.0	2.8	0.3	58.6	2.8	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	8.5	0.0	4.9	0.1	10.9	0.0	0.0	2.9	0.0	0.0	0.0	3.4	63.1	4.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 135.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 57.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1"	"Group enriched"	"Detected in all"	11	"cerebellum: 54.5;hippocampal formation: 27.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 48.8"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	208000	7300	"Cluster 5: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	18.9	6.3	3.5	63.3	3.0	62.1	15.5	57.3	4.1	9.6	13.8	14.4	11.3	9.9	7.7	7.4	17.8	16.2	5.9	2.9	5.7	3.2	9.7	23.7	132.6	5.9	5.7	6.1	2.6	2.3	2.1	9.0	10.5	5.8	16.8	0.5	11.2	4.5	3.3	12.0	39.9	9.8	5.8	86.2	15.6	4.2	5.2	130.4	6.9	8.5	135.3	18.9	10.4	7.6	0.0	0.0	0.0	0.1	17.5	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	29.4	0.0	0.0	0.9	21.0	50.6	0.9	0.0	0.1	0.6	0.0	0.4	3.5	3.2	10.7	0.1	0.0	1.7	22.2	0.0	0.1	0.0	0.1	0.1	51.0	0.0	0.2	0.1	0.1	0.1	0.0	9.9	0.0	0.0	4.6	0.2	0.3	0.2	1.0	0.0	60.3	5.5	25.8	1.8	35.1	1.5	252.8	116.2	321.3	164.5	142.7	185.9	166.0	170.6	180.6	150.9	157.2	224.9	185.6	282.5	213.2	149.1	113.7	197.0	338.0	3.5	3.0	57.3	4.1	2.9	5.7	5.9	5.7	10.5	5.8	5.2	7.6	9.4	3.2	6.6	0.0	135.3	8.2	0.2	0.8	1.2	0.2	0.8	1.4	2.7	8.6	1.9	1.8	0.0	0.3	78.1	0.3	0.0	0.1	1.4	3.1	6.6	7.5	0.0	20.2	3.4	0.2	0.3	15.9	1.1	0.7	27.1	0.0	26.7	9.2	19.0	0.0	4.9	0.3	0.0	59.2	94.4	1.4	10.8	33.1	28.4	18.7	30.2	0.3	121.5	0.0	0.3	0.0	1.2	18.0	55.6	0.1	0.1	0.4	7.7	0.7	6.6	1.1	3.2	2.1	7.5	1.2	3.7	0.4	76.3	0.2	0.7	0.2
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 127.1;Endometrial stromal cells: 280.2;Glandular and luminal cells: 315.4;Hepatic stellate cells: 146.7;Langerhans cells: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 624.9;ASC TERT1: 276.8;HHSteC: 196.3;HSkMC: 770.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1400000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	137.3	68.0	7.1	69.5	8.3	18.0	77.5	7.5	11.0	161.1	16.2	39.3	20.7	33.5	105.2	32.1	52.0	92.0	58.3	7.6	9.0	45.7	75.5	115.5	17.1	16.2	8.4	31.1	43.3	126.7	13.1	120.8	8.9	66.7	30.5	8.5	34.2	47.4	18.6	40.1	40.3	49.9	10.0	41.0	43.9	20.6	14.9	21.7	52.5	16.0	19.7	87.4	40.2	7.7	2.0	12.8	0.3	10.8	624.9	276.8	4.4	27.4	123.8	19.2	28.7	5.7	3.4	0.0	19.8	55.0	33.9	5.5	0.2	2.2	16.1	55.5	0.1	0.7	2.9	31.3	196.3	0.1	0.3	770.6	2.3	21.7	5.2	8.4	8.7	0.0	3.5	1.1	28.1	5.6	0.0	1.2	0.7	5.6	0.9	0.3	2.0	0.4	18.3	13.4	0.1	0.3	12.5	7.7	0.0	3.6	11.1	0.8	0.3	54.7	3.6	92.1	2.2	0.1	0.0	0.1	21.3	0.6	3.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	7.1	8.3	7.5	11.0	7.6	9.0	16.2	8.4	8.9	10.0	14.9	7.7	99.3	25.6	73.2	1.3	1.8	31.1	46.8	8.2	5.2	0.1	19.4	13.7	5.2	28.6	68.6	5.5	0.0	6.1	2.5	0.7	3.9	31.7	7.0	127.1	280.2	103.6	1.2	14.3	0.5	21.8	82.8	79.1	2.0	315.4	1.3	0.3	146.7	47.1	5.4	0.0	3.0	0.5	10.2	12.0	188.2	12.6	28.0	26.0	19.6	23.4	7.0	9.0	0.0	0.5	0.5	12.0	0.3	1.5	1.8	65.9	0.0	8.3	28.6	1.0	6.6	37.7	34.3	1.3	1.2	4.5	38.6	23.9	8.5	4.0	0.8	23.6
ILDR2	C1orf32	ENSG00000143195	"Immunoglobulin like domain containing receptor 2"	Q71H61	1	166895711-166975540	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;retina: 10.6;testis: 8.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.9;Excitatory neurons: 45.0;Muller glia cells: 89.1;Oligodendrocyte precursor cells: 96.0"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.8;JURKAT: 5.7;MOLT-4: 4.3;U-2 OS: 9.6;U-251 MG: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012545, HPA012815"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA012545: AB_2126894, HPA012815: "	"unprognostic (9.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.89e-5)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	0.3	0.3	7.0	0.2	6.7	0.5	0.0	0.0	8.0	0.1	0.0	1.6	0.1	0.1	0.4	0.1	0.2	0.3	1.4	8.7	4.4	2.8	0.4	0.4	0.2	0.0	4.8	0.1	0.1	0.0	1.4	0.1	0.2	0.8	0.3	10.6	0.1	1.1	0.1	0.0	0.2	0.7	0.0	0.1	0.1	8.8	12.8	1.1	0.1	0.2	0.2	0.3	0.1	1.5	0.0	0.0	7.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.8	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.2	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	4.3	0.0	2.7	0.1	0.0	0.0	0.2	0.5	0.5	0.1	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	9.6	0.0	5.4	1.8	0.0	0.4	1.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	6.7	0.0	8.0	8.7	4.4	0.0	4.8	0.2	0.0	12.8	1.5	0.0	0.0	0.0	22.9	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	4.3	0.0	0.6	0.0	6.2	0.0	2.0	0.2	0.0	0.1	12.7	0.0	0.1	0.2	1.2	0.0	45.0	0.2	0.3	0.6	0.0	0.1	0.0	1.7	0.4	1.6	0.1	1.7	17.6	0.0	0.0	0.0	0.0	18.8	0.6	0.2	0.0	5.6	0.6	89.1	0.0	96.0	16.5	0.1	0.2	0.0	0.9	0.0	0.0	4.9	0.0	8.8	0.0	8.8	0.5	4.8	2.0	0.0	0.0	0.3	0.5	0.1	0.3	0.0
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537787-132783480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 6.7"	"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 250.8"	"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	22.5	16.9	26.8	12.0	85.5	9.5	17.3	56.9	30.4	29.6	10.9	54.2	19.2	49.5	19.5	29.6	30.7	15.2	75.0	20.4	21.3	14.1	14.6	25.1	8.4	20.5	37.7	19.5	12.8	12.2	14.7	28.8	20.4	24.5	16.7	16.9	13.5	23.6	75.4	22.9	23.4	42.1	17.5	13.9	27.6	22.9	50.5	6.8	14.1	50.3	7.3	35.5	22.7	27.0	35.4	13.7	22.6	21.9	33.8	23.7	18.4	36.4	27.9	23.3	15.4	32.6	14.0	3.1	13.7	38.8	15.1	19.5	24.8	15.2	27.9	10.8	14.4	5.1	17.3	44.7	24.3	12.9	11.9	16.0	14.9	15.0	28.2	18.6	16.3	6.6	7.6	18.2	12.6	28.3	3.6	40.9	10.5	21.0	24.3	7.6	14.9	5.6	19.4	19.9	5.4	18.5	18.3	26.5	22.6	20.5	17.2	30.4	13.7	14.9	17.2	20.1	21.6	3.6	18.4	11.0	14.4	8.6	6.5	6.7	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.3	26.8	85.5	56.9	30.4	20.4	21.3	20.5	37.7	20.4	17.5	50.5	27.0	14.7	9.6	19.7	14.7	4.5	5.4	4.4	1.9	0.0	10.5	7.1	5.3	10.1	4.3	6.4	7.3	0.0	3.9	5.0	24.8	0.0	6.5	12.3	2.8	22.8	10.0	6.1	3.2	33.5	9.2	3.7	5.6	6.6	5.9	8.8	8.6	15.0	17.9	2.9	8.4	25.2	9.9	2.0	7.2	12.0	17.0	7.2	6.9	1.8	19.7	4.1	9.6	0.0	18.1	29.2	12.1	11.5	11.7	2.5	6.5	13.8	4.3	2.5	5.2	6.6	6.5	24.3	6.3	7.3	2.8	5.8	2.5	2.7	10.7	13.9	8.6
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 17.7;brain: 13.6;lymphoid tissue: 13.5;thyroid gland: 39.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 46.1;Excitatory neurons: 120.0;Microglial cells: 252.9;T-cells: 65.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 71.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HMC-1: 19.8;THP-1: 10.5;U-937: 11.0"	"Low region specificity"	"Detected in all"							"HPA028708, HPA028710"	Supported		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	0.7	0.2	8.4	7.9	5.4	17.7	1.5	4.1	13.6	2.7	0.0	1.3	0.7	1.1	1.4	1.4	2.1	2.9	0.6	5.4	3.2	2.8	2.0	1.5	13.5	0.0	7.4	0.6	0.7	0.1	0.6	1.6	0.0	0.8	1.2	0.2	1.2	0.4	0.2	0.5	2.3	0.9	0.0	6.8	2.4	0.9	12.2	10.6	39.1	0.2	12.8	2.1	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	19.8	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	3.1	1.2	0.8	0.0	0.5	0.1	0.1	0.3	0.7	2.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	3.2	14.5	71.6	13.0	6.5	27.6	0.0	16.3	12.5	16.2	0.1	27.9	16.8	42.7	14.3	8.5	0.4	22.6	12.6	8.4	5.4	4.1	13.6	5.4	3.2	0.0	7.4	0.0	0.0	12.2	5.4	1.1	0.0	1.7	7.8	3.5	0.6	0.5	0.4	12.0	0.6	1.8	1.0	1.1	1.5	1.7	1.8	0.0	1.7	46.1	0.0	7.9	2.1	1.3	2.0	1.2	2.3	0.0	3.2	120.0	0.0	0.1	1.0	3.1	2.5	0.0	0.1	3.3	1.1	2.8	3.3	9.8	0.5	2.0	23.4	15.2	0.3	0.3	15.2	0.0	252.9	17.9	0.2	27.8	9.0	14.6	0.0	0.1	0.4	20.7	0.6	0.1	2.0	1.3	0.2	0.0	3.4	0.4	0.2	1.1	4.0	0.6	2.7	65.5	2.0	0.3	1.3
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403285-76708132	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1011.9;Late spermatids: 351.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 74.2;Hep G2: 61.7;HMC-1: 211.8;RPMI-8226: 81.6;U-937: 57.0"	"Region enhanced"	"Detected in many"		"hippocampal formation: 30.5"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		3700000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460"	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	7.9	12.2	0.8	11.7	0.6	25.0	27.1	0.5	0.7	19.6	2.4	25.7	56.5	3.3	9.5	2.8	3.4	18.6	2.9	0.4	0.9	35.2	113.1	9.9	14.4	2.2	2.5	8.9	25.7	44.3	1.1	30.7	1.9	15.2	23.0	23.9	34.6	15.4	0.3	2.7	31.4	4.3	1.4	13.2	39.1	51.1	2.4	7.3	28.6	1.3	8.2	6.5	1.5	2.4	0.0	9.6	31.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	74.2	0.1	0.7	2.7	0.0	2.7	0.2	12.1	0.0	0.1	8.6	12.0	27.6	6.8	61.7	0.2	15.7	211.8	0.0	0.0	0.0	0.0	0.0	1.2	14.9	24.6	21.4	0.0	0.0	13.5	42.4	14.8	25.4	0.3	4.9	0.1	81.6	0.0	0.1	0.6	3.2	17.3	0.9	0.1	31.4	0.0	9.3	0.4	0.0	0.5	0.0	0.3	19.8	0.0	18.7	0.1	57.0	3.0	21.3	3.1	1.9	4.5	2.5	3.7	0.5	4.7	3.9	2.9	0.2	1.8	3.3	6.0	4.3	3.4	7.7	6.2	1.4	0.8	0.6	0.5	0.7	0.4	0.9	2.2	2.5	1.9	1.4	2.4	2.4	9.1	12.8	12.2	0.7	27.3	4.7	21.5	2.4	0.0	6.7	68.9	34.5	3.5	107.2	9.1	35.0	108.4	14.2	230.3	96.2	7.9	44.5	1011.9	43.8	3.3	7.7	9.1	76.3	2.3	66.7	1.2	22.0	99.4	37.5	94.9	8.7	18.5	235.7	65.9	1.7	19.0	52.9	61.1	132.6	63.3	351.0	7.5	141.3	16.0	47.8	63.4	14.0	114.4	0.5	1.1	18.7	37.5	5.3	148.3	21.5	87.1	65.2	16.1	121.8	0.0	3.9	3.5	25.5	11.4	1.2	3.8	7.3	112.1	82.7	43.7	6.5
IRAG2	"JAW1, LRMP"	ENSG00000118308	"Inositol 1,4,5-triphosphate receptor associated 2"	Q12912	12	25004342-25108334	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fertilization, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 60.3;lymphoid tissue: 202.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.1;B-cells: 6.2;dendritic cells: 42.9;Hofbauer cells: 14.1;Plasma cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 210.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Daudi: 634.3;REH: 221.9;U-698: 722.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA002967, HPA007356, HPA018505"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA		6700	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum, Plasma membrane"		"HPA002967: AB_1079161, HPA007356: , HPA018505: AB_1851988"	"unprognostic (3.78e-2)"	"unprognostic (2.59e-3)"	"unprognostic (7.54e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.97e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.59e-2)"	9.6	1.9	8.5	47.2	5.4	60.3	6.5	2.3	5.6	2.4	3.2	10.1	8.7	2.5	2.8	5.2	5.1	7.8	2.4	6.6	2.6	9.4	6.2	7.7	171.7	6.0	4.4	5.7	30.7	1.5	2.4	4.4	6.1	3.4	9.2	1.1	3.6	4.4	1.1	5.8	19.1	4.5	3.6	37.5	10.1	1.0	2.8	95.1	4.9	1.6	202.8	14.5	8.3	4.6	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	634.3	0.3	0.0	0.0	0.2	0.0	2.4	0.0	22.1	0.0	37.8	0.0	0.1	0.0	49.7	54.2	0.0	0.0	0.7	0.0	0.1	0.0	31.5	7.8	40.6	0.0	0.0	54.5	91.2	0.1	0.0	0.0	221.9	0.3	63.8	0.7	29.7	0.2	0.1	0.2	0.3	0.2	0.1	0.0	36.7	0.5	0.0	1.5	0.0	0.1	40.4	7.8	722.4	0.2	21.8	0.0	80.2	21.0	210.1	23.6	40.8	20.2	66.1	14.9	24.2	22.4	51.0	25.5	25.4	151.3	49.0	51.5	20.8	2.7	20.2	8.5	5.4	2.3	5.6	6.6	2.6	6.0	4.4	6.1	3.6	2.8	4.6	13.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173710-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 118.0"	"Region enriched"	"Detected in all"	5	"spinal cord: 124.7"	"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		130000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	89.3	17.5	4.4	5.5	11.8	0.0	66.9	1.7	10.4	216.2	5.4	75.1	5.7	181.4	18.9	17.1	78.7	38.6	63.3	4.6	5.2	20.9	8.2	37.7	9.9	2.8	3.2	170.9	10.1	2.1	44.6	10.2	2.8	51.4	5.2	0.3	33.6	22.9	18.5	46.7	31.3	26.3	2.3	33.0	32.5	14.9	4.5	3.3	63.4	19.7	5.3	63.5	111.9	5.0	0.0	1.5	0.1	0.0	62.7	33.5	0.2	10.2	0.1	0.0	0.0	0.0	4.0	0.0	0.6	148.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	25.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.5	5.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.4	7.6	0.1	0.1	1.1	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.8	1.7	10.4	4.6	5.2	2.8	3.2	2.8	2.3	4.5	5.0	10.3	0.0	1.3	0.7	0.1	11.7	0.1	0.2	0.0	0.1	4.8	3.9	3.9	1.5	0.7	0.0	0.0	1.3	0.8	0.0	0.0	0.2	2.4	7.2	193.5	14.0	0.0	0.0	1.9	0.2	1.4	154.5	2.0	4.2	0.0	0.0	7.5	0.0	3.8	0.0	0.2	0.0	0.0	0.0	16.2	6.1	214.9	2.6	12.4	34.7	0.0	0.2	0.0	0.5	0.7	0.8	0.0	159.9	0.0	0.1	0.0	0.1	1.5	0.5	26.3	7.0	49.8	0.7	0.7	1.3	8.8	1.0	2.6	7.0	0.0	0.2
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389649	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.6;epididymis: 10.7;lymphoid tissue: 11.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 16.1;Erythroid cells: 43.5;granulocytes: 17.8;Late spermatids: 24.8;Macrophages: 23.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"basophil: 64.5"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 64.5"	"Group enriched"	"Detected in some"	14	"HEL: 404.6;HMC-1: 631.7"	"Not detected"	"Not detected"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		NA	NA		90000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.8	0.2	3.7	0.2	3.6	16.6	0.4	4.0	4.8	1.5	3.8	0.3	0.0	0.9	10.7	0.3	1.5	0.8	1.4	3.5	3.6	1.0	0.5	5.1	0.2	3.6	3.5	1.5	0.1	1.3	1.9	1.1	3.6	0.6	0.1	1.6	0.1	0.8	0.6	0.1	0.3	0.2	3.3	11.2	0.3	2.9	3.5	0.1	3.1	1.1	0.1	0.2	0.7	3.7	0.5	0.7	2.2	0.3	0.1	0.3	18.4	0.3	0.1	0.8	0.6	0.0	0.2	0.0	0.3	0.0	0.2	0.6	1.8	0.0	0.4	0.4	1.1	404.6	0.3	1.3	0.0	0.2	631.7	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.7	1.1	0.0	0.7	0.5	36.4	0.8	0.0	0.7	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.5	0.5	0.1	1.5	4.5	0.9	0.3	0.2	0.7	0.0	0.0	0.4	0.2	0.3	0.4	0.3	0.8	64.5	0.3	4.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	4.5	0.0	0.0	0.8	0.0	19.3	3.7	3.6	4.0	4.8	3.5	3.6	3.6	3.5	3.6	3.3	3.5	3.7	0.3	0.0	1.5	1.0	0.4	0.3	0.4	0.1	1.8	5.1	0.2	1.1	1.5	1.5	1.3	5.5	8.4	1.3	0.1	0.6	0.0	0.0	16.1	1.0	0.7	2.1	0.0	43.5	4.1	0.0	1.4	1.1	0.0	3.2	17.8	0.1	3.6	0.0	0.2	3.3	2.8	0.0	0.0	3.1	0.7	24.8	1.8	23.0	0.0	1.0	2.9	1.3	0.0	9.5	4.6	0.1	0.0	1.9	0.1	0.3	0.0	0.0	0.0	3.0	0.0	1.8	0.7	3.4	7.4	0.5	0.0	0.7	0.6	0.1	0.3	0.3
ITGA4	CD49D	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181538940	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 47.1;lymphoid tissue: 74.1"	"Group enriched"	"Detected in many"	4	"B-cells: 86.3;dendritic cells: 151.5;Erythroid cells: 169.3;Macrophages: 72.0;monocytes: 73.8;NK-cells: 126.7;Plasma cells: 141.6;T-cells: 129.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.0;HEL: 308.1;JURKAT: 142.3;MOLT-4: 373.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 12.9"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA074961: AB_2732273"	"unprognostic (5.31e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.76e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (2.26e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.57e-2)"	3.3	2.3	1.2	31.5	0.5	47.1	3.8	4.1	1.5	12.7	3.0	8.7	8.7	3.3	1.4	2.3	1.5	9.8	1.5	4.1	1.3	2.7	5.7	12.7	37.2	1.4	1.6	1.4	1.5	0.9	0.4	14.7	2.9	3.5	10.3	8.6	2.9	2.5	0.6	1.2	11.7	5.2	0.9	45.5	10.4	0.8	2.4	74.1	2.0	0.9	26.1	9.5	1.4	1.3	0.3	1.3	4.6	0.1	38.9	55.0	0.0	42.3	46.7	19.5	42.0	0.0	0.0	32.4	0.2	164.0	17.4	23.4	14.0	0.7	22.3	0.0	3.4	308.1	1.1	0.0	4.0	123.4	6.8	39.2	0.0	1.2	0.0	20.5	2.3	142.3	0.1	45.5	12.7	0.0	373.6	117.9	3.7	0.0	0.2	78.1	20.3	5.1	0.0	0.0	8.2	2.6	0.1	0.4	1.4	1.6	0.0	82.9	23.2	6.5	4.1	0.7	8.5	90.9	77.5	18.6	3.7	59.5	90.3	29.5	55.0	137.4	42.0	131.3	32.1	37.3	46.9	52.4	66.0	33.0	26.5	33.1	7.1	32.2	139.6	17.5	13.4	65.2	1.2	0.5	4.1	1.5	4.1	1.3	1.4	1.6	2.9	0.9	2.4	1.3	2.8	0.0	6.7	0.0	86.3	0.3	0.2	1.2	0.0	2.3	1.1	1.4	1.2	2.8	1.8	0.0	6.2	0.1	151.5	0.1	0.0	0.0	0.0	4.4	6.5	1.4	0.0	169.3	9.4	0.0	0.3	6.3	7.1	6.4	18.9	0.3	1.8	0.2	5.9	0.0	0.5	0.1	0.0	24.5	4.4	0.0	0.6	72.0	0.0	7.5	73.8	0.2	126.7	15.6	0.3	0.0	0.4	0.0	141.6	0.3	0.0	0.2	0.8	6.4	0.0	0.7	8.3	0.7	1.2	0.3	0.6	0.4	129.9	0.4	0.2	0.2
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 262.3"	"Group enriched"	"Detected in many"	6	"Astrocytes: 87.5;Cardiomyocytes: 124.5;Sertoli cells: 164.3;Skeletal myocytes: 65.8;Smooth muscle cells: 110.6"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 309.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA		1200000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (9.59e-5)"	133.4	8.2	18.5	18.5	21.2	1.8	69.0	15.9	30.2	28.7	16.1	97.8	17.7	45.5	12.3	23.9	56.1	30.8	157.9	34.5	17.8	11.5	10.2	15.5	6.4	21.2	21.1	19.1	5.1	6.1	12.6	1.9	20.3	33.9	8.9	2.4	14.9	37.3	262.3	16.0	27.4	95.2	16.4	10.2	35.2	8.9	23.8	3.4	26.1	154.1	3.3	46.5	25.5	21.0	0.2	4.1	7.5	12.3	66.5	13.4	0.7	5.4	8.7	11.7	11.8	8.4	6.5	2.3	7.4	3.4	0.9	1.1	5.1	0.3	10.0	0.2	3.8	0.8	2.8	3.2	0.5	0.3	2.7	19.1	0.2	64.2	0.3	309.1	0.2	2.2	0.9	1.6	37.8	5.3	0.3	3.1	20.9	1.7	0.4	0.1	28.7	0.6	0.2	0.2	0.9	2.8	0.6	0.2	48.0	4.0	0.9	13.9	0.0	1.3	12.4	0.8	8.4	3.2	2.2	0.9	57.8	8.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.5	21.2	15.9	30.2	34.5	17.8	21.2	21.1	20.3	16.4	23.8	21.0	11.9	0.0	0.0	87.5	0.3	1.9	0.5	0.1	0.6	2.4	1.2	3.4	124.5	2.8	0.0	1.8	4.2	0.0	0.3	0.7	0.0	0.3	0.3	1.1	1.2	9.5	7.7	0.4	17.6	0.0	0.1	5.0	0.5	1.1	0.0	6.2	0.7	1.4	0.6	0.0	9.4	1.8	0.0	1.9	2.7	0.1	6.5	2.2	3.6	9.4	0.0	3.4	0.0	6.6	3.7	0.3	0.1	6.4	0.1	0.8	2.6	0.8	0.1	0.6	164.3	65.8	110.6	4.1	2.9	0.7	2.3	0.1	0.5	0.3	0.9	0.3
ITGA8		ENSG00000077943	"Integrin subunit alpha 8"	P53708	10	15513954-15719922	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 37.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.8;Inhibitory neurons: 56.1;Microglial cells: 34.7;Oligodendrocyte precursor cells: 64.8;Plasma cells: 25.5;Sertoli cells: 52.6;Smooth muscle cells: 57.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.4;HMC-1: 19.8;HSkMC: 8.7;U-266/84: 9.7"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 14.1"	HPA003432	Approved		Approved	"Plasma membrane"		NA	NA		200000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA003432: AB_1851825"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.03e-2)"	8.6	10.5	1.6	2.1	2.1	0.1	2.7	1.9	5.0	23.8	8.0	6.1	6.7	9.7	5.5	9.8	8.8	6.7	7.7	7.0	0.9	10.0	0.7	20.8	3.2	1.5	2.8	5.7	0.8	4.7	3.2	0.2	1.1	37.4	6.1	1.6	1.8	30.8	2.9	3.3	6.8	9.1	1.5	19.9	19.3	0.6	1.5	1.0	5.6	6.9	4.4	15.7	9.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	8.4	2.5	0.0	0.0	0.0	0.0	19.8	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.7	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	1.9	5.0	7.0	0.9	1.5	2.8	1.1	1.5	1.5	2.2	1.2	0.0	1.3	0.7	2.4	1.0	1.9	0.0	0.6	6.3	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.0	11.4	0.0	0.0	82.8	0.0	0.0	10.1	0.0	0.2	0.0	0.0	4.2	0.0	0.1	0.0	56.1	0.0	0.0	0.0	1.8	0.1	0.9	0.5	1.8	34.7	0.0	13.6	0.0	64.8	4.0	0.0	0.0	0.0	25.5	1.5	0.0	0.0	0.0	0.3	52.6	11.3	57.6	0.0	0.2	0.4	1.1	0.0	1.2	0.1	0.1	1.4
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823507	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.0;Hepatic stellate cells: 54.3;Inhibitory neurons: 61.0;Leydig cells: 41.3;Microglial cells: 53.4;Oligodendrocyte precursor cells: 93.5;Peritubular cells: 74.9"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 23.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.1;HEL: 8.1;SH-SY5Y: 11.8;SuSa: 16.9;WM-115: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		500000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.8	15.5	1.9	4.5	1.8	8.5	5.9	0.0	6.2	21.8	3.6	9.6	6.3	10.6	4.0	15.5	5.4	9.4	20.1	7.8	0.7	4.0	14.8	8.9	4.1	0.9	1.3	5.0	1.8	2.6	1.7	9.8	0.4	12.5	6.8	0.7	4.2	10.8	2.8	3.0	9.1	15.8	0.7	22.6	7.5	6.9	5.0	1.8	20.7	9.8	2.4	6.5	4.5	1.2	0.2	0.0	4.3	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	10.1	0.0	3.2	1.4	0.0	0.1	0.2	3.8	0.0	0.0	0.1	0.6	8.1	0.1	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.4	0.3	0.0	0.2	0.5	11.8	0.1	0.5	0.7	16.9	0.0	3.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.8	0.0	6.2	7.8	0.7	0.9	1.3	0.4	0.7	5.0	1.2	20.8	0.0	14.7	16.0	0.1	2.5	1.1	0.1	1.2	1.2	1.1	2.9	12.9	2.8	3.1	1.8	0.0	0.2	0.0	0.0	0.0	0.1	1.5	1.4	4.9	21.6	0.0	3.0	82.0	0.0	0.5	7.5	0.0	0.9	6.3	36.2	54.3	1.3	2.8	0.0	61.0	0.1	0.0	31.9	2.2	4.2	41.3	5.7	3.6	53.4	0.1	0.6	0.0	93.5	6.2	0.0	0.0	74.9	0.4	0.2	0.0	0.1	0.0	0.0	0.0	3.2	3.3	0.6	0.9	0.0	1.7	0.3	1.8	25.9	0.4	0.3
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 459.9;hTERT-RPE1: 508.7;WM-115: 477.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"		NA	NA		64000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	102.7	32.5	24.4	26.0	33.4	3.3	71.3	32.6	20.3	84.7	71.0	48.1	33.1	75.9	16.4	54.9	33.2	71.7	68.8	24.6	28.7	48.6	51.4	53.9	6.0	38.2	32.9	28.0	23.1	21.8	20.5	82.3	35.4	37.3	24.9	14.3	49.6	46.9	30.0	88.9	32.5	60.1	32.3	41.0	29.7	13.5	32.5	12.2	34.3	33.7	9.9	40.3	70.0	35.8	189.1	459.9	32.4	82.7	296.6	84.2	166.3	197.5	120.0	35.9	57.6	92.6	240.3	0.8	93.5	336.3	177.0	148.0	29.5	102.7	31.2	2.0	20.1	66.3	69.5	98.0	51.0	0.4	116.8	51.2	23.2	91.1	46.9	508.7	121.2	0.2	60.7	98.1	122.7	190.0	0.8	1.1	145.8	105.1	50.4	0.4	52.2	71.8	98.8	41.2	0.9	67.5	146.6	214.5	165.7	56.4	121.9	4.2	318.2	134.9	200.7	118.5	103.7	16.6	18.4	1.3	141.3	0.8	477.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	2.5	24.4	33.4	32.6	20.3	24.6	28.7	38.2	32.9	35.4	32.3	32.5	35.8	50.4	6.4	6.7	55.5	1.0	17.2	23.1	18.8	6.2	8.1	20.6	27.2	28.9	42.9	10.0	29.5	4.2	68.5	0.6	34.9	11.7	38.3	10.7	22.0	21.4	27.5	3.5	2.7	0.9	18.8	7.4	52.1	11.2	13.4	0.0	135.9	31.1	39.1	72.3	35.3	18.1	12.9	2.0	36.8	17.5	4.1	20.2	28.5	10.6	60.9	0.4	50.2	0.0	16.6	12.5	70.4	27.0	16.6	0.6	24.9	21.0	10.7	6.2	14.9	39.5	31.3	52.1	2.6	7.0	15.6	22.3	55.1	1.7	1.0	16.3	14.8
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191323-53207282	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 45.1;dendritic cells: 62.3;NK-cells: 134.9;Plasma cells: 115.9;T-cells: 62.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	99	"Karpas-707: 4821.4;RPMI-8226: 3980.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042277			Approved	"Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"	1.6	1.4	1.7	20.0	1.8	15.5	1.9	1.7	2.2	2.7	2.0	9.7	11.7	1.6	2.8	6.4	2.9	3.9	0.8	1.5	2.0	4.7	5.3	6.6	29.2	2.3	1.8	0.7	1.2	0.7	1.3	0.5	2.0	1.7	9.5	1.0	4.1	2.3	0.7	11.9	17.3	2.4	1.9	30.0	8.2	0.6	2.8	8.6	3.1	0.6	26.5	6.2	2.9	2.1	0.1	0.0	0.0	0.3	0.1	0.7	1.4	0.5	0.0	0.0	0.5	0.0	2.1	44.5	0.8	0.0	0.0	9.4	0.0	0.3	0.0	16.5	0.0	1.5	0.0	0.0	0.0	1.0	18.5	1.0	1.8	0.2	0.1	0.6	0.0	2.2	0.4	4821.4	0.0	1.6	0.9	7.0	0.3	41.7	0.1	1.8	0.0	3980.8	0.0	1.2	1.9	0.6	0.1	1.8	0.5	0.0	0.8	10.4	0.0	0.3	0.6	0.9	0.0	8.9	17.9	3.8	3.8	2.6	1.6	80.7	5.6	97.7	52.0	1.4	38.2	28.1	51.8	63.0	44.5	29.8	44.5	44.4	1.5	23.7	0.4	11.9	71.8	17.3	1.7	1.8	1.7	2.2	1.5	2.0	2.3	1.8	2.0	1.9	2.8	2.1	1.0	3.2	5.5	1.3	45.1	2.2	0.3	1.7	3.4	0.1	1.3	1.0	0.5	2.8	1.3	7.3	4.2	0.1	62.3	0.6	7.9	0.3	0.0	1.2	0.4	0.9	0.0	2.1	0.0	0.5	0.1	1.3	2.6	2.4	29.2	0.1	0.4	2.2	13.3	0.0	0.1	0.5	0.0	3.7	10.3	0.3	0.0	17.3	7.2	1.9	13.3	7.0	134.9	0.0	0.5	0.9	1.7	0.0	115.9	0.2	0.0	7.6	0.2	0.8	0.0	1.0	8.2	0.2	1.4	3.3	3.7	0.1	62.5	0.1	1.2	1.4
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.9;choroid plexus: 39.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 376.2;Glandular and luminal cells: 551.9;Oligodendrocyte precursor cells: 192.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	133	"basophil: 16.5"	"Lineage enriched"	"Detected in single"	133	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"AF22: 44.3;EFO-21: 54.6;RPTEC TERT1: 88.1;WM-115: 127.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	3.8	2.6	25.7	4.2	41.8	0.3	9.6	53.9	19.2	15.4	39.4	3.7	3.2	7.7	14.0	6.4	7.5	8.7	2.9	19.5	37.5	21.6	0.8	2.4	0.5	38.9	48.4	4.7	13.3	5.1	5.4	5.2	42.7	6.7	2.8	4.6	13.6	9.0	0.2	6.3	4.2	3.0	39.7	0.0	4.2	6.5	35.6	0.8	2.1	0.9	6.9	7.2	9.0	48.6	28.2	1.1	44.3	5.6	3.7	15.2	0.0	0.1	0.5	0.2	1.5	0.3	6.9	0.0	54.6	2.0	1.7	30.1	1.9	4.5	0.5	0.0	0.7	0.0	23.1	0.0	1.8	0.0	0.1	1.8	12.6	0.5	2.4	27.1	2.4	0.0	0.0	8.3	0.8	0.1	0.0	0.0	3.3	0.4	4.8	0.0	3.7	0.0	88.1	2.5	0.7	1.9	8.6	0.2	23.5	0.8	0.7	0.1	3.0	11.2	7.1	3.2	5.8	10.2	0.1	0.0	2.7	0.0	127.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	25.7	41.8	53.9	19.2	19.5	37.5	38.9	48.4	42.7	39.7	35.6	48.6	0.7	12.8	4.8	106.4	2.5	33.1	117.2	39.4	34.7	13.3	26.3	18.7	3.0	38.6	57.9	38.6	0.0	20.0	0.4	5.0	7.9	26.3	3.0	376.2	150.6	5.2	34.0	0.0	28.1	17.4	1.2	15.5	7.7	551.9	1.3	0.9	1.4	0.2	3.3	1.7	8.2	7.4	34.6	1.0	4.7	6.5	44.1	9.8	3.6	4.7	31.6	24.3	0.0	192.0	119.2	35.8	6.1	44.8	2.0	149.7	14.5	76.7	100.1	1.4	0.0	4.8	7.0	1.4	1.1	34.6	12.4	4.9	5.5	1.9	9.6	150.7
ITM2A	"BRICD2A, E25A"	ENSG00000078596	"Integral membrane protein 2A"	O43736	X	79360384-79367667	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 322.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 390.0;Endothelial cells: 368.4;Fibroblasts: 302.1;granulocytes: 194.6;Leydig cells: 335.5;Muller glia cells: 188.9;T-cells: 239.2"	"Cancer enhanced"	"Detected in all"		"glioma: 51.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 172.6;eosinophil: 88.5;gdT-cell: 107.1;MAIT T-cell: 79.3;memory CD4 T-cell: 204.7;memory CD8 T-cell: 170.5;naive CD4 T-cell: 216.7;naive CD8 T-cell: 101.6;NK-cell: 130.3;T-reg: 168.1"	"Group enriched"	"Detected in all"	7	"granulocytes: 172.6;NK-cells: 130.3;T-cells: 216.7"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 1749.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000296			Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA000296: "	"unprognostic (1.05e-2)"	"unprognostic (5.22e-3)"	"unprognostic (2.77e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-3)"	"prognostic favorable (3.66e-6)"	"unprognostic (1.57e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.30e-1)"	80.2	10.8	103.4	26.8	95.2	45.8	74.5	99.4	172.0	55.3	75.5	30.5	15.1	44.4	18.8	40.1	42.8	28.8	115.3	92.1	105.4	20.6	6.3	52.2	87.2	101.5	102.2	181.4	10.0	14.9	21.0	29.7	102.0	22.8	32.2	11.9	74.9	22.4	41.2	25.0	22.1	56.6	95.2	24.5	24.2	15.9	109.8	322.9	83.1	75.2	46.9	42.3	26.0	95.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	216.6	2.5	0.0	4.4	0.0	69.9	0.0	0.0	0.0	113.1	124.2	19.5	0.0	0.0	0.0	0.1	0.0	333.3	80.2	0.0	0.0	0.0	1749.0	77.6	25.0	0.0	0.0	0.7	0.1	0.3	64.6	0.0	0.2	19.0	0.0	0.9	0.0	17.6	2.2	2.5	3.0	0.0	1.8	0.4	1.1	208.1	0.0	0.0	0.2	0.0	8.7	172.6	0.8	88.5	107.1	1.3	79.3	23.4	204.7	170.5	0.8	23.5	216.7	101.6	3.9	130.3	1.1	6.1	168.1	115.3	103.4	95.2	99.4	172.0	92.1	105.4	101.5	102.2	102.0	95.2	109.8	95.8	390.0	3.2	14.8	1.0	28.0	67.4	13.2	2.1	50.1	3.1	21.1	81.9	29.3	2.8	4.4	1.8	0.0	0.4	64.8	2.1	5.9	0.4	3.1	0.4	2.6	368.4	2.4	42.7	3.5	50.9	0.2	302.1	29.6	0.6	194.6	1.4	135.0	1.0	1.3	1.7	2.3	85.6	0.0	9.5	39.5	7.1	335.5	8.6	62.2	114.3	3.2	188.9	65.9	18.1	60.2	1.0	1.4	117.8	81.8	12.3	0.2	1.4	0.7	12.1	0.0	31.8	22.5	0.5	2.6	24.3	47.0	0.3	239.2	2.0	2.9	2.5
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;intestine: 18.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 51.4;Early spermatids: 45.4;Gastric mucus-secreting cells: 34.1;Late spermatids: 166.4;Proximal enterocytes: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.6;OE19: 18.2"	"Low region specificity"	"Detected in all"							HPA040454	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Plasma membrane"	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.2	7.3	21.4	0.7	26.7	0.4	0.2	13.8	36.5	1.3	10.9	10.7	17.6	0.3	0.1	0.3	0.5	0.2	2.6	28.7	12.4	0.2	1.7	0.5	0.1	10.9	12.0	0.3	1.9	2.0	0.4	0.3	11.6	0.8	2.7	0.3	1.4	0.3	4.4	0.4	18.1	0.3	11.3	0.2	10.9	10.4	12.1	0.0	0.2	0.0	0.0	0.6	0.9	20.4	7.1	1.9	0.3	7.9	0.0	2.5	14.3	4.3	3.4	2.8	2.9	16.3	0.3	0.0	3.5	0.4	6.3	0.8	3.4	0.3	0.2	6.6	4.3	9.9	4.7	33.6	12.6	3.4	0.5	0.2	0.2	2.7	0.8	1.6	0.2	1.3	12.9	1.9	1.0	4.7	0.3	6.5	0.9	18.2	5.6	1.7	1.4	0.6	0.3	0.4	0.7	1.5	3.2	0.0	0.3	0.0	0.9	5.0	0.3	6.9	7.1	7.7	11.8	1.0	10.8	0.0	12.6	13.2	2.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.4	26.7	13.8	36.5	28.7	12.4	10.9	12.0	11.6	11.3	12.1	20.4	0.1	0.0	0.0	3.3	0.5	0.1	0.3	0.1	0.0	0.0	0.3	0.0	1.4	0.0	0.1	0.0	0.0	0.6	0.1	51.4	0.0	0.1	45.4	0.3	2.4	0.5	0.0	0.8	23.7	0.7	0.5	0.3	34.1	0.3	0.0	1.0	0.4	0.3	0.2	0.0	0.8	12.0	0.0	0.0	0.0	166.4	2.5	0.4	0.0	1.9	0.0	7.9	0.0	1.5	2.9	0.8	16.1	1.5	0.1	0.1	35.8	0.1	0.1	0.2	6.6	0.3	0.5	14.4	4.9	0.0	0.0	0.1	0.4	0.1	18.7	0.2
ITPRID2	"CS-1, KIAA1927, KRAP, SPAG13, SSFA2"	ENSG00000138434	"ITPR interacting domain containing 2"	P28290	2	181891730-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 175.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 30.7;Cardiomyocytes: 30.0;Cytotrophoblasts: 25.7;Extravillous trophoblasts: 26.8;Hofbauer cells: 20.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 6.1;monocytes: 5.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: AB_2674271, HPA039989: AB_2676788"	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (5.79e-5)"	30.8	20.7	55.0	20.6	62.9	42.4	32.1	57.2	66.2	30.9	50.3	50.4	36.4	25.8	18.4	22.8	20.3	37.7	24.4	45.5	61.5	48.4	79.3	44.9	17.6	65.2	60.5	13.6	175.8	20.9	18.3	34.7	63.3	34.0	44.2	16.9	69.9	17.1	31.9	112.9	34.0	25.6	57.3	32.4	56.1	37.4	62.6	24.1	36.5	23.4	16.0	31.3	29.5	61.1	56.0	25.8	71.6	12.6	53.8	41.3	21.7	94.6	82.6	29.1	37.0	25.9	56.0	1.2	30.7	59.7	31.5	46.2	14.5	41.6	56.6	25.2	20.3	52.5	106.6	23.5	45.7	28.5	48.9	30.0	64.4	51.3	57.7	66.7	145.8	22.3	25.0	29.5	82.9	28.7	25.4	41.0	5.0	47.0	62.5	18.7	29.3	19.2	87.0	16.3	13.7	12.1	55.7	19.7	91.0	27.6	14.2	61.6	68.1	73.1	37.0	27.5	50.3	20.9	9.4	21.9	34.0	17.1	57.2	6.1	2.8	4.2	0.9	2.7	0.6	0.4	0.6	0.6	2.7	0.9	0.8	0.7	4.7	0.8	5.1	2.1	0.4	1.3	55.0	62.9	57.2	66.2	45.5	61.5	65.2	60.5	63.3	57.3	62.6	61.1	30.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	25.7	5.8	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	26.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	33.4	1.1	0.0	0.0	0.0
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged canonical Notch ligand 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 211.1;Endometrial ciliated cells: 197.4;Smooth muscle cells: 190.1;Squamous epithelial cells: 343.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 219.2;hTERT-HME1: 131.1;U-251 MG: 187.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		25000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-3)"	44.2	10.1	10.3	13.0	9.5	21.8	30.3	8.4	12.0	44.0	8.9	23.7	13.8	27.3	19.5	52.4	27.0	21.6	20.7	12.8	9.8	21.7	6.2	23.9	8.4	12.4	14.2	20.3	22.0	20.9	8.2	67.9	10.0	25.9	23.0	22.1	15.8	26.7	9.8	57.2	13.6	23.6	9.7	23.3	25.1	4.5	12.1	9.3	19.9	22.8	15.6	28.5	50.0	8.5	4.1	20.6	63.1	78.1	11.8	11.3	2.3	2.4	11.9	3.3	1.8	18.5	11.2	0.7	59.0	2.4	17.7	85.8	9.4	219.2	2.7	0.2	4.5	7.0	2.2	87.9	5.8	28.4	0.5	4.6	63.7	10.6	131.1	12.5	21.1	0.3	0.1	8.8	6.0	0.2	0.0	20.2	18.2	68.7	20.3	5.3	3.9	13.1	29.9	25.6	2.8	2.1	6.3	4.4	26.2	49.8	0.3	3.3	80.5	14.2	9.9	11.8	187.9	3.6	0.6	0.9	9.1	10.3	11.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	10.3	9.5	8.4	12.0	12.8	9.8	12.4	14.2	10.0	9.7	12.1	8.5	73.0	41.7	15.4	5.9	1.1	104.6	54.9	76.3	211.1	9.7	13.2	29.1	20.6	30.0	34.4	16.5	43.8	16.9	6.8	64.3	1.9	31.6	5.0	197.4	22.2	102.5	5.3	0.0	6.9	30.4	1.0	41.9	76.0	96.4	7.0	2.7	60.0	1.8	4.2	21.9	9.2	12.8	20.3	5.9	33.9	9.6	21.5	9.1	14.2	22.5	2.8	11.9	2.1	24.6	1.3	97.3	18.3	33.8	4.3	24.5	7.8	2.3	30.2	69.1	85.5	46.7	190.1	0.9	3.2	343.9	106.8	2.2	4.3	107.2	39.1	33.7
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.4;Inhibitory neurons: 122.3;Microglial cells: 106.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 132.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 132.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 42.2;HDLM-2: 75.0;HEL: 154.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	15.6	7.6	3.2	19.2	3.7	21.7	8.9	6.3	9.1	8.5	1.1	6.7	6.5	11.3	8.6	8.8	8.0	10.5	24.5	2.7	3.1	6.8	4.5	10.9	18.2	3.3	1.8	11.5	3.8	6.5	2.9	11.0	2.0	6.8	6.5	12.8	4.0	6.2	9.8	11.2	7.7	9.5	3.5	17.6	13.4	9.8	1.7	7.5	4.8	8.9	12.7	11.7	9.1	3.9	6.8	3.7	3.7	6.3	42.2	12.4	1.1	9.1	8.6	7.2	4.6	1.2	2.0	0.3	2.1	5.4	5.4	2.3	4.4	5.1	4.9	75.0	1.4	154.7	7.6	1.7	10.0	10.5	7.1	9.5	2.1	2.8	4.5	7.6	6.6	5.1	10.9	17.4	11.6	2.2	2.9	12.8	3.3	3.3	4.3	5.1	8.2	2.2	4.7	3.5	4.2	2.4	2.6	3.5	2.8	3.6	2.0	15.4	13.1	10.2	3.6	10.7	6.4	3.1	6.4	1.5	13.6	4.7	5.3	132.5	20.5	38.2	5.6	20.1	4.5	5.6	4.1	3.1	26.5	4.9	2.2	2.8	19.2	9.6	16.4	9.7	4.5	7.7	3.2	3.7	6.3	9.1	2.7	3.1	3.3	1.8	2.0	3.5	1.7	3.9	14.3	16.0	7.9	31.6	12.9	9.7	3.3	4.9	10.8	8.0	5.2	3.4	30.0	0.0	6.7	7.3	8.4	1.9	13.9	11.7	1.9	3.3	8.6	5.1	11.2	9.4	3.0	19.8	93.4	3.9	0.9	8.9	38.7	5.6	14.0	11.4	4.6	1.9	14.2	8.4	122.3	4.5	0.0	33.6	28.8	7.1	23.6	38.9	5.4	106.8	49.5	12.6	8.2	69.9	42.3	7.0	20.9	33.4	10.7	3.0	3.9	3.3	7.1	11.2	0.0	9.7	12.5	15.0	5.5	11.6	8.4	3.4	10.4	5.1	4.1	4.5
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.8;dendritic cells: 20.1;Macrophages: 17.9;NK-cells: 18.6;Plasma cells: 18.4;T-cells: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 35.7;HEL: 15.9;HMC-1: 15.5;Karpas-707: 40.2;U-266/70: 15.4;U-266/84: 24.7;U-937: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane, Cytosol"		"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favorable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.7	2.5	4.0	36.3	4.4	18.6	4.0	3.9	5.6	3.3	3.7	4.0	3.0	2.2	2.4	2.8	5.3	4.8	3.2	4.1	6.7	6.2	2.9	13.1	40.5	7.3	6.1	15.5	1.8	1.9	3.1	5.7	6.4	4.4	3.1	0.6	3.5	1.9	0.7	1.7	15.4	3.5	5.5	55.1	4.6	2.6	6.6	11.3	4.9	0.9	29.7	7.4	3.1	6.1	0.2	0.6	0.5	1.8	0.6	2.4	0.4	0.8	0.0	0.1	0.1	0.0	1.6	0.7	3.3	0.7	0.4	0.2	0.0	0.4	0.0	35.7	0.0	15.9	0.1	1.5	1.2	0.0	15.5	8.4	0.5	0.1	0.0	0.1	0.3	3.6	0.1	40.2	0.0	0.7	6.5	0.0	0.3	0.9	1.3	8.2	0.0	0.7	0.8	0.0	0.0	0.6	0.2	0.4	0.1	0.2	3.5	2.4	0.7	0.0	0.7	0.0	0.0	15.4	24.7	4.3	0.1	24.2	0.3	2.0	7.5	0.3	17.8	14.6	20.2	9.4	21.1	18.6	6.8	10.3	20.2	18.5	25.1	13.4	14.2	5.5	18.0	12.4	4.0	4.4	3.9	5.6	4.1	6.7	7.3	6.1	6.4	5.5	6.6	6.1	5.5	0.0	4.6	2.3	27.8	0.8	0.6	0.5	0.6	0.6	0.5	0.8	1.9	0.0	1.0	1.8	0.0	1.1	20.1	0.0	0.0	0.5	1.0	0.3	2.1	8.0	0.0	6.1	4.3	0.4	0.8	4.6	2.0	0.4	5.1	0.8	9.7	0.4	14.5	0.0	2.6	0.0	0.0	9.2	1.9	2.0	12.5	17.9	3.6	4.7	16.6	0.9	18.6	0.0	0.4	0.5	0.0	14.7	18.4	0.5	0.0	0.3	0.9	0.7	6.6	0.3	2.9	0.3	0.7	0.3	1.0	1.4	37.7	14.8	0.1	0.6
KANK3	"ANKRD47, FLJ46061"	ENSG00000186994	"KN motif and ankyrin repeat domains 3"	Q6NY19	19	8322584-8343262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 196.2;Endothelial cells: 83.8;Hepatic stellate cells: 55.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 7.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.1;TIME: 14.8;U-266/70: 5.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"olfactory bulb: 16.2"	HPA051153	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA051153: AB_2681365"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-4)"	"unprognostic (1.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.77e-1)"	"prognostic favorable (1.69e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.24e-1)"	25.6	7.6	12.0	2.3	9.7	0.6	26.1	9.6	12.2	8.2	5.8	6.2	2.9	10.2	0.7	5.1	11.2	2.5	32.9	8.7	8.9	22.2	4.2	33.4	2.8	12.5	11.5	3.6	3.9	1.5	6.9	14.6	11.5	7.6	0.5	0.3	4.1	1.8	13.7	6.7	7.3	2.4	9.7	35.5	6.2	2.4	13.2	0.7	15.5	6.0	0.8	7.9	6.8	8.9	0.1	0.6	0.2	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.0	2.3	0.0	0.0	0.1	0.5	2.6	0.0	0.7	1.4	0.3	0.3	0.4	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	8.1	0.6	0.0	0.3	0.0	0.4	0.0	0.4	0.5	0.5	0.2	1.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.5	0.0	14.8	0.0	1.3	0.3	0.1	5.9	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	1.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.2	0.4	0.2	1.2	0.0	0.0	0.4	0.2	12.0	9.7	9.6	12.2	8.7	8.9	12.5	11.5	11.5	9.7	13.2	8.9	196.2	6.4	3.2	2.0	0.3	2.5	0.4	0.6	0.6	0.3	1.5	2.5	2.2	0.0	0.8	0.0	4.2	0.4	3.8	0.1	5.9	0.1	6.6	0.5	0.7	83.8	0.0	2.7	0.6	1.8	0.3	6.4	1.5	0.8	0.0	0.2	55.3	1.0	0.5	0.0	0.9	0.0	0.0	1.3	2.1	8.1	0.6	0.9	5.4	18.7	0.0	0.4	12.3	0.5	1.6	0.6	0.1	0.4	0.4	1.0	0.0	0.4	0.7	0.7	19.7	8.3	12.9	6.5	3.6	1.1	1.3	0.3	2.8	4.0	0.1	0.8
KATNB1		ENSG00000140854	"Katanin regulatory subunit B1"	Q9BVA0	16	57735739-57757244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041165, HPA041839"	Enhanced		Supported	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"	Microtubules	"HPA041165: AB_10795584, HPA041839: AB_10795598"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (2.89e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.54e-1)"	9.9	13.3	16.0	10.8	18.4	23.0	10.6	5.5	24.7	10.1	11.8	9.9	10.6	11.2	4.1	15.9	19.2	6.2	11.7	18.2	11.7	10.3	9.5	11.9	10.5	10.4	9.1	9.6	14.0	10.7	13.7	7.2	10.1	10.2	5.5	5.9	13.1	7.7	10.4	29.0	10.1	6.5	6.6	12.9	10.3	37.1	13.2	12.8	11.0	7.9	8.2	8.7	11.9	16.3	20.8	35.7	19.2	25.0	10.4	9.2	35.2	13.9	18.5	35.2	19.6	30.2	18.3	16.1	28.0	8.8	13.2	27.0	25.8	27.9	16.2	11.1	74.8	21.0	20.4	42.5	11.5	47.6	77.6	9.5	17.3	28.7	16.1	14.8	21.2	58.8	42.8	8.2	15.0	21.6	67.6	60.1	34.0	14.7	61.4	53.7	23.8	59.6	10.6	9.9	97.0	29.2	23.8	27.1	16.8	7.6	10.2	23.9	16.0	24.5	21.9	22.9	31.0	18.5	16.1	19.9	35.2	36.6	15.7	50.8	18.9	46.1	21.0	20.8	20.4	9.3	17.5	16.3	17.8	9.3	16.0	15.5	27.9	16.1	22.7	11.9	20.1	21.7	16.0	18.4	5.5	24.7	18.2	11.7	10.4	9.1	10.1	6.6	13.2	16.3	5.5	3.2	5.5	3.3	5.2	9.1	8.0	11.5	9.6	10.2	8.4	7.1	2.6	4.3	7.7	5.5	6.2	17.3	8.5	13.2	11.7	13.7	115.4	18.8	4.4	6.0	4.8	8.8	14.8	13.6	11.7	6.6	12.8	4.7	5.1	7.6	6.8	4.7	9.9	18.5	11.2	9.2	6.1	5.1	2.5	36.6	7.8	7.6	7.2	3.7	6.1	10.0	11.3	2.5	4.9	10.1	5.1	4.9	13.3	7.3	10.5	8.0	26.2	10.9	6.6	4.9	6.3	41.8	8.3	11.9	13.8	7.7	10.9	8.2	11.8	7.8
KATNIP	"JBTS26, KIAA0556"	ENSG00000047578	"Katanin interacting protein"	O60303	16	27550133-27780369	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.7;Cardiomyocytes: 4.5;Cytotrophoblasts: 3.0;dendritic cells: 1.4;Extravillous trophoblasts: 2.6;Hofbauer cells: 2.6;Syncytiotrophoblasts: 2.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 14.3;eosinophil: 3.6;neutrophil: 9.9;NK-cell: 5.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 14.3;NK-cells: 5.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035089, HPA035090"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Plasma membrane"	"HPA035089: AB_10671509, HPA035090: AB_10601129"	"unprognostic (1.81e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.76e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.72e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.45e-1)"	4.4	4.8	5.2	4.7	5.9	6.7	5.4	3.9	6.9	6.3	22.7	6.5	4.8	6.3	6.2	9.7	29.7	5.1	5.4	5.4	4.1	7.8	4.0	6.3	4.4	6.7	7.8	5.1	9.0	7.7	11.5	4.4	4.9	8.8	7.2	31.3	7.9	5.7	3.3	8.9	6.0	5.5	4.9	6.2	9.3	9.9	6.3	5.6	15.9	1.7	4.0	5.3	5.8	6.6	6.7	13.5	7.5	7.0	11.1	10.1	12.4	8.9	9.6	7.7	10.4	12.0	10.9	5.7	12.4	12.8	15.0	11.0	9.7	11.5	15.4	26.5	6.7	4.5	14.9	7.0	6.6	6.1	11.0	10.8	9.9	17.1	18.2	10.0	15.5	6.3	7.3	4.7	11.1	15.3	6.7	7.5	4.6	8.6	5.5	9.6	9.1	6.2	14.5	9.2	9.5	6.1	8.9	7.9	5.0	10.3	17.8	5.3	13.5	9.8	6.2	7.7	7.9	6.3	5.7	6.4	11.3	5.9	8.9	14.3	1.8	3.6	0.7	1.2	0.7	0.8	0.4	1.2	1.2	1.1	1.6	0.3	9.9	5.0	0.4	1.4	1.6	0.3	5.2	5.9	3.9	6.9	5.4	4.1	6.7	7.8	4.9	4.9	6.3	6.6	2.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	3.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537225-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;lymphoid tissue: 2.3;retina: 4.6"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 264.8;Excitatory neurons: 279.1;Inhibitory neurons: 241.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;HDLM-2: 1.4;HEK 293: 3.4;SCLC-21H: 2.7"					"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.1	0.4	1.7	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	2.4	2.2	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.5	0.0	1.1	0.0	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.3	0.0	1.3	2.3	0.4	0.3	1.5	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.0	1.4	2.4	2.2	1.0	2.6	0.4	1.3	1.5	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	17.4	0.0	0.0	0.3	0.0	0.0	1.8	264.8	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	17.9	0.0	279.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	241.2	0.6	0.0	0.0	0.0	6.8	1.2	0.0	0.0	3.7	0.0	0.7	0.0	11.6	4.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.1	0.1	0.4	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium inwardly rectifying channel subfamily J member 15"	Q99712	21	38155549-38307357	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 241.6;thyroid gland: 129.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 197.9;Cholangiocytes: 88.6;Proximal tubular cells: 236.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	20	"neutrophil: 395.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 395.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 68.7;GAMG: 103.6;HBEC3-KT: 69.6;RPTEC TERT1: 67.5;RT4: 80.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (1.95e-4)"	8.7	0.5	0.8	20.7	0.7	14.1	2.8	0.9	6.7	12.7	0.5	0.9	1.5	0.5	11.0	8.5	1.2	30.4	0.8	0.8	0.6	241.6	2.8	42.2	1.2	0.9	0.6	0.3	57.8	0.7	0.4	4.6	1.8	2.6	0.4	0.5	25.5	14.6	0.5	3.0	0.7	2.4	0.3	11.7	40.5	1.8	5.4	1.9	129.5	3.0	1.9	25.1	8.1	1.1	1.6	0.0	0.3	0.6	13.7	68.7	0.6	1.0	4.8	0.0	0.0	0.0	0.6	0.2	0.0	7.5	103.6	23.5	0.0	69.6	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.1	21.0	7.2	17.8	3.8	1.5	3.2	0.1	0.2	0.7	31.6	0.0	0.1	0.2	0.0	0.1	0.7	1.5	0.3	0.7	67.5	80.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.4	3.5	0.2	1.7	0.4	0.1	5.6	4.3	0.4	0.3	19.3	0.1	0.0	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.3	395.3	0.0	0.0	0.4	0.0	4.6	0.8	0.7	0.9	6.7	0.8	0.6	0.9	0.6	1.8	0.3	5.4	1.1	2.9	60.9	197.9	0.0	1.1	2.8	10.4	20.7	13.6	0.0	0.5	0.0	1.6	88.6	33.1	31.3	0.0	0.1	0.0	0.0	17.6	27.8	1.9	0.0	0.0	4.6	0.0	0.0	0.3	8.6	0.8	1.5	15.8	0.1	6.3	0.0	0.7	0.4	0.4	0.0	0.1	0.0	2.0	2.9	3.0	2.2	0.6	5.9	1.8	0.0	2.1	0.0	0.0	0.0	0.1	44.7	0.0	0.0	0.1	0.7	0.0	236.9	7.0	0.0	0.0	1.5	0.8	1.1	1.1	16.8	1.6	0.1	1.7	0.1	0.0	9.0
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium inwardly rectifying channel subfamily J member 3"	P48549	2	154697855-154858354	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 309.6;Horizontal cells: 124.5;Inhibitory neurons: 431.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;SH-SY5Y: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024231, HPA064138"	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Plasma membrane"	"HPA024231: AB_1855558, HPA064138: "	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.5	1.4	5.7	0.1	8.7	0.1	0.3	32.7	17.0	1.6	4.7	0.8	10.7	0.1	1.1	0.1	0.4	1.3	15.1	14.6	3.7	10.5	3.1	0.2	0.0	2.2	4.3	0.1	2.1	10.4	6.8	0.0	2.4	6.5	0.8	5.0	0.0	11.3	5.3	0.1	9.5	0.2	1.6	0.4	0.7	0.4	4.1	0.0	0.1	0.2	0.0	0.4	0.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.1	5.7	8.7	32.7	17.0	14.6	3.7	2.2	4.3	2.4	1.6	4.1	6.4	0.3	0.0	0.0	38.8	0.0	0.8	5.3	0.0	0.0	10.9	3.7	1.7	49.0	5.7	0.0	20.2	14.6	0.0	0.0	0.1	5.9	0.1	0.3	0.0	0.0	1.3	31.1	0.0	309.6	3.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.3	0.1	124.5	431.3	7.0	0.0	0.0	2.1	0.0	6.2	0.6	1.8	5.6	0.0	0.7	0.0	32.6	6.8	0.0	1.2	4.1	0.0	6.1	16.2	8.7	0.0	3.9	0.0	8.0	1.6	0.4	0.3	0.0	1.8	0.0	0.8	1.9	8.4	4.7
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319845-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 151.3;Urothelial cells: 131.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 26.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.4;granulocytes: 26.2;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HEL: 37.6;HMC-1: 40.3;T-47d: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.9	2.4	2.9	7.5	2.4	3.9	5.6	3.0	3.3	29.9	2.7	15.4	4.6	24.0	1.5	30.5	15.7	4.5	6.7	2.7	2.2	3.1	3.0	9.4	5.6	2.9	2.3	9.5	12.5	0.6	1.9	7.0	2.9	6.2	9.4	0.8	14.5	2.4	1.5	19.1	6.8	14.3	2.1	15.6	9.5	2.1	2.8	2.5	1.4	0.7	7.9	13.3	18.2	3.7	9.2	3.3	0.5	0.5	5.1	3.3	0.7	7.8	3.8	2.0	2.7	2.6	9.8	0.6	3.5	11.2	2.1	11.7	4.2	17.7	1.3	0.4	0.3	37.6	1.9	0.4	4.7	2.7	40.3	0.8	15.6	2.5	4.8	10.5	5.3	5.8	0.5	2.8	5.7	20.2	2.4	2.3	0.4	19.4	2.1	3.9	0.5	2.7	7.1	0.8	0.5	0.8	0.8	0.8	0.3	1.8	22.8	10.5	5.8	0.5	4.4	4.1	0.4	1.0	0.2	1.0	0.6	13.4	0.3	26.2	6.9	15.8	1.4	6.2	1.2	1.4	2.0	1.9	11.4	1.1	1.7	1.2	5.0	0.6	7.2	3.1	2.6	2.3	2.9	2.4	3.0	3.3	2.7	2.2	2.9	2.3	2.9	2.1	2.8	3.7	8.7	0.0	10.5	0.0	16.0	43.1	50.6	20.6	20.5	3.3	61.2	32.9	12.1	17.2	15.1	7.3	6.2	2.0	18.5	62.4	0.0	19.1	2.8	32.5	58.8	28.3	12.6	17.9	1.1	47.7	4.0	19.2	28.1	84.8	22.2	72.7	151.3	4.3	39.2	0.0	1.7	64.5	2.0	75.7	61.5	1.2	25.7	47.0	5.4	2.8	62.1	1.2	11.3	0.0	0.9	67.2	39.2	20.3	45.6	41.1	37.6	0.4	7.7	5.9	26.3	3.1	9.3	14.8	3.3	48.0	67.2	2.5	14.8	1.5	26.7	131.5
KCNK7	K2p7.1	ENSG00000173338	"Potassium two pore domain channel subfamily K member 7"	Q9Y2U2	11	65592836-65595996	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 90.0"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 103.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 2.1;naive B-cell: 2.2;neutrophil: 1.5"	"Group enriched"	"Detected in many"	16	"B-cells: 2.2;granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA077577			Approved	"Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA077577: AB_2686845"	"unprognostic (1.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.08e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.11e-2)"	2.0	0.7	2.7	0.2	2.9	5.4	2.9	3.4	5.7	4.6	1.7	2.1	0.4	1.4	0.1	18.0	2.3	0.3	1.6	2.7	2.4	0.7	0.9	1.7	0.3	2.8	2.8	1.8	0.4	0.0	1.3	0.4	3.0	1.4	0.0	0.7	2.5	0.3	2.6	90.0	1.2	0.2	2.7	2.0	1.2	1.1	2.7	0.4	0.6	0.5	1.0	1.7	9.5	3.4	0.3	1.6	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	1.0	0.4	0.4	0.1	0.2	2.2	0.0	0.0	0.0	0.5	1.1	0.5	0.9	0.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.6	1.3	0.4	1.0	0.5	0.4	0.6	0.6	0.6	0.9	0.0	0.2	0.6	0.1	6.8	1.5	0.3	0.4	0.7	0.0	0.4	1.1	0.0	0.3	1.1	1.0	0.1	0.9	0.7	0.2	0.5	0.6	0.6	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	2.7	2.9	3.4	5.7	2.7	2.4	2.8	2.8	3.0	2.7	2.7	3.4	1.1	0.0	0.5	0.3	0.8	19.1	0.4	0.7	0.6	2.1	0.7	1.8	0.2	0.0	0.7	0.0	0.0	0.1	1.6	1.0	0.0	0.1	0.7	0.7	0.3	1.2	1.2	0.0	0.9	0.0	0.1	0.4	0.0	1.7	0.0	0.2	0.7	0.3	0.5	0.0	0.9	0.4	0.0	1.3	4.0	1.8	0.6	0.7	3.6	0.0	0.4	0.1	0.0	1.0	1.8	0.1	4.8	0.0	0.0	0.3	0.3	0.1	1.1	1.1	6.6	0.4	0.8	0.1	1.3	16.3	103.7	0.0	0.6	0.1	0.8	1.3
KCNK9	"K2p9.1, TASK-3, TASK3"	ENSG00000169427	"Potassium two pore domain channel subfamily K member 9"	Q9NPC2	8	139600838-139704109	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 7.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 16.0;Inhibitory neurons: 8.0;Late spermatids: 9.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	4	"cerebellum: 7.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075842			Approved	"Plasma membrane"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA075842: "	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.96e-8)"	"unprognostic (1.91e-1)"	"unprognostic (8.17e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.12e-6)"	"unprognostic (2.94e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.76e-1)"	0.0	1.6	0.0	0.1	0.0	0.0	0.0	7.8	1.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	1.9	0.2	0.1	0.8	0.3	0.9	0.0	0.4	0.3	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.9	0.3	2.1	0.0	0.0	0.0	0.0	0.0	16.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KDF1	"C1orf172, FLJ34633, RP11-344H11.3"	ENSG00000175707	"Keratinocyte differentiation factor 1"	Q8NAX2	1	26949562-26960468	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 32.6;Ductal cells: 29.4;Syncytiotrophoblasts: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	36	"B-cells: 3.4;T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"A-431: 24.9;BEWO: 20.8;CAPAN-2: 22.7;HaCaT: 21.4;HBEC3-KT: 30.3;hTCEpi: 38.5;OE19: 39.3;SK-BR-3: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA028634, HPA028639"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Cytosol	"HPA028634: , HPA028639: AB_10599191"	"unprognostic (2.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (3.04e-13)"	"unprognostic (1.38e-3)"	"unprognostic (7.83e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.40e-4)"	0.1	1.1	0.4	1.3	0.3	0.1	10.3	1.6	1.3	4.0	0.3	8.9	12.4	0.9	19.7	20.2	7.4	2.9	0.4	0.4	0.2	11.0	4.7	4.4	0.8	0.3	0.3	0.1	16.2	12.5	10.4	3.9	0.4	7.2	7.1	1.3	12.8	4.6	0.0	17.7	10.5	0.3	0.2	0.6	10.6	2.6	0.3	2.3	10.0	0.0	3.4	4.8	8.3	0.7	24.9	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	12.1	22.7	0.0	0.9	0.0	0.0	21.4	0.0	30.3	0.0	0.1	0.4	0.0	0.0	4.4	0.3	0.0	0.0	0.1	38.5	0.0	3.1	0.0	0.0	0.0	1.4	0.0	0.0	14.7	0.0	0.1	1.7	39.3	0.1	0.0	0.0	3.7	5.5	11.7	14.9	0.0	0.2	25.2	0.1	2.7	16.1	0.4	0.2	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.2	2.5	4.3	3.0	0.1	3.4	6.2	3.8	0.0	0.0	0.0	0.0	0.2	1.7	0.4	0.3	1.6	1.3	0.4	0.2	0.3	0.3	0.4	0.2	0.3	0.7	0.2	12.8	8.8	0.0	0.8	0.0	14.3	0.0	10.8	0.6	15.1	16.3	0.3	12.8	2.5	14.7	0.0	32.6	1.5	17.2	25.4	29.4	0.4	7.3	0.8	0.7	7.8	0.0	0.2	23.2	26.5	0.6	13.7	8.0	0.0	0.1	0.0	4.4	2.7	0.0	0.1	13.1	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.2	1.1	0.0	0.0	0.1	21.8	25.2	0.0	0.4	16.8	26.2	10.1	5.1	2.5	0.0	0.0	0.3	6.3	7.5	14.4	0.0	29.7	1.2	0.0	16.9	19.0
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324152-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.9;Endometrial ciliated cells: 41.8;Late spermatids: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: AB_2670571, HPA061066: AB_2684423"	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.1	8.1	5.3	0.7	5.8	2.4	3.7	14.2	5.2	2.3	10.5	2.5	1.8	3.0	6.2	2.3	5.8	3.1	1.7	5.3	8.7	9.2	5.5	3.0	0.2	4.1	5.0	8.6	9.1	11.6	6.3	1.2	3.9	2.9	1.3	15.0	2.8	2.6	1.5	5.8	1.1	2.9	3.7	0.6	11.1	22.3	6.0	3.2	3.6	1.4	0.4	1.3	1.1	5.0	10.7	6.3	13.2	12.4	0.4	0.3	2.9	2.8	3.3	6.5	7.5	2.8	5.5	0.1	3.0	0.7	11.0	6.1	18.1	5.6	5.4	0.9	10.1	0.2	9.7	2.5	2.3	1.9	0.4	1.5	9.5	6.0	7.0	7.7	0.2	5.8	4.4	0.2	0.6	3.8	6.0	4.0	0.6	2.6	1.5	2.2	0.5	0.0	13.8	1.3	38.1	13.6	4.8	12.5	4.0	9.0	11.8	1.5	0.0	0.8	3.2	1.8	4.2	6.2	14.6	0.1	2.4	0.5	2.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	5.8	14.2	5.2	5.3	8.7	4.1	5.0	3.9	3.7	6.0	5.0	1.5	6.4	2.7	7.5	1.4	9.7	5.1	3.5	17.6	17.8	13.3	8.1	3.7	5.7	3.7	3.7	27.1	2.3	0.9	0.9	5.9	5.0	87.9	41.8	2.2	1.6	8.4	0.8	22.4	2.9	1.2	2.1	11.2	13.3	1.3	8.3	0.4	5.6	0.5	11.8	25.9	1.5	0.0	0.0	0.4	65.4	2.8	0.4	3.6	1.0	0.1	5.7	0.0	12.1	13.1	3.9	1.7	0.4	3.2	3.0	0.2	10.0	25.9	16.3	6.6	5.7	2.1	28.8	11.9	4.7	8.7	0.7	1.2	7.6	1.6	2.0
KIAA1958	FLJ39294	ENSG00000165185	KIAA1958	Q8N8K9	9	112486827-112669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 169.8;Excitatory neurons: 64.2;Inhibitory neurons: 55.1;Oligodendrocyte precursor cells: 127.6;Oligodendrocytes: 166.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020625	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA020625: AB_1852451"	"unprognostic (3.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.58e-1)"	1.1	6.6	5.5	1.1	10.5	4.9	2.2	9.3	6.9	5.1	4.4	1.4	1.7	3.4	0.9	1.5	3.0	1.3	1.3	3.9	6.6	5.8	3.4	2.1	1.3	8.2	8.9	9.9	2.6	1.4	1.8	0.7	7.0	1.5	1.5	10.0	3.0	2.4	0.9	1.6	1.9	3.1	7.5	1.5	4.8	5.8	10.7	3.9	2.4	0.8	1.3	1.4	1.9	14.5	3.7	5.2	20.7	6.0	1.4	0.3	9.9	2.7	0.9	3.2	3.6	9.5	2.4	11.8	3.1	8.9	2.2	3.2	15.3	1.5	4.5	3.6	6.2	4.6	7.3	6.7	0.8	7.0	5.6	0.6	1.2	4.2	2.0	2.9	2.6	11.0	11.0	2.9	1.0	4.2	11.0	4.0	11.4	8.6	2.4	8.8	11.8	3.3	4.3	5.1	10.6	11.2	4.5	4.7	2.7	11.4	4.3	7.1	0.5	1.1	6.1	0.7	3.3	5.3	10.4	6.9	1.4	4.8	0.8	0.4	0.7	0.0	0.5	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.4	0.6	0.6	0.6	0.2	0.6	0.1	0.4	5.5	10.5	9.3	6.9	3.9	6.6	8.2	8.9	7.0	7.5	10.7	14.5	0.5	3.2	19.3	169.8	3.7	4.7	3.4	1.5	6.8	20.6	7.9	4.2	4.3	4.3	6.2	1.8	14.6	1.2	3.0	4.6	7.9	3.2	4.1	12.1	8.1	1.4	4.8	3.8	64.2	6.7	1.0	3.3	8.2	8.0	0.0	20.3	0.4	8.0	1.0	6.7	55.1	4.4	12.2	7.5	4.6	2.5	6.5	4.2	1.8	15.9	2.5	8.3	3.1	127.6	166.4	3.3	6.2	5.3	5.0	6.5	5.0	11.0	5.9	12.1	6.6	2.5	4.1	1.5	8.0	5.3	4.7	0.8	1.6	29.9	5.2	5.7
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 18.9;Early spermatids: 44.0;Hepatic stellate cells: 15.4;Late spermatids: 88.7;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;hTERT-HME1: 3.7;U-2 OS: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.0	0.2	2.3	0.0	2.2	0.0	0.0	0.0	3.3	0.3	1.8	0.2	0.1	0.4	0.0	0.0	1.8	0.0	0.0	2.3	4.9	0.4	0.1	0.2	0.0	0.6	1.4	0.2	0.0	0.0	0.6	0.0	0.4	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.5	0.3	0.0	0.0	23.2	3.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.8	0.7	0.4	0.0	0.0	0.0	0.1	1.2	1.6	0.6	0.4	0.2	0.4	0.0	0.5	0.9	0.3	0.0	0.6	0.4	0.4	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.3	0.5	3.7	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.3	0.6	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.2	2.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.2	0.0	3.3	2.3	4.9	0.6	1.4	0.4	0.3	3.1	0.0	18.9	0.0	0.0	0.7	0.2	1.7	0.0	0.1	0.6	0.0	0.2	0.3	2.8	0.0	0.2	1.8	4.2	0.1	2.8	0.1	0.0	0.0	44.0	2.8	0.3	15.2	0.0	0.0	11.0	0.0	0.1	0.9	0.0	0.2	0.0	0.0	15.4	0.5	5.1	0.0	2.8	0.0	0.0	1.6	9.8	88.7	1.2	3.2	1.8	1.9	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.8	0.1	0.1	0.1	0.3	3.5	0.3	19.7	0.5	2.7	3.2	4.3	0.1	1.3	1.6	0.2	5.2	0.1	0.2
KIF19	"FLJ37300, KIF19A"	ENSG00000196169	"Kinesin family member 19"	Q2TAC6	17	74326210-74355820	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.7;fallopian tube: 12.0;lymphoid tissue: 13.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 44.4;Enteroendocrine cells: 23.8;Hepatic stellate cells: 15.4;Intestinal goblet cells: 14.1;Plasma cells: 15.6;Respiratory ciliated cells: 57.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043638, HPA073303"	Enhanced		Approved	"Plasma membrane,Actin filaments,Centrosome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Actin filaments, Centrosome"	"HPA043638: AB_10962579, HPA073303: AB_2686593"	"unprognostic (1.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-9)"	"unprognostic (5.16e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.53e-1)"	1.4	0.1	7.5	0.4	10.3	0.2	1.2	4.0	11.4	2.2	3.5	1.7	3.0	0.3	0.0	0.5	12.0	0.4	0.3	7.2	7.4	0.2	0.9	1.9	0.1	7.5	8.0	0.2	1.1	0.0	0.3	0.0	5.9	0.9	0.6	0.1	1.0	0.2	0.4	0.6	2.3	0.4	6.2	13.5	0.7	0.6	7.7	1.0	1.9	0.6	0.1	1.6	1.5	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.4	7.5	10.3	4.0	11.4	7.2	7.4	7.5	8.0	5.9	6.2	7.7	16.7	1.3	0.0	0.0	2.0	1.3	0.0	0.4	2.5	0.0	1.1	0.1	0.0	1.6	0.0	6.3	0.0	0.0	0.0	3.5	0.8	0.0	0.0	0.5	44.4	0.2	4.2	23.8	0.4	0.0	0.0	3.1	1.0	1.1	0.7	0.0	0.0	15.4	0.1	0.1	0.0	0.1	14.1	4.1	0.6	1.6	0.3	0.0	0.3	3.6	0.0	0.1	5.7	3.1	4.0	3.7	0.0	0.1	0.0	15.6	0.3	0.2	0.0	57.6	0.3	0.0	1.8	1.3	0.2	1.6	0.0	0.1	0.0	2.5	0.2	1.9	0.2
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	1.6	0.8	16.1	9.4	16.4	34.1	1.3	0.0	16.5	0.9	0.0	2.4	2.0	0.7	0.4	0.8	1.2	2.1	0.7	21.6	8.3	0.9	1.5	4.8	12.9	5.9	5.7	0.7	0.8	6.0	0.6	0.9	6.5	0.8	1.8	21.4	1.4	0.7	0.3	0.7	6.7	0.8	1.5	12.3	2.5	13.7	9.5	11.8	1.0	0.4	8.0	2.3	0.8	7.9	1.3	1.5	11.8	0.5	0.0	0.0	3.0	0.1	0.0	0.3	0.1	0.7	0.4	39.1	0.5	0.0	3.4	0.3	1.2	0.3	0.4	1.9	0.4	9.7	0.2	0.2	1.0	29.4	41.0	1.0	4.1	0.4	0.7	0.0	1.5	78.8	4.6	49.6	0.0	0.2	24.5	11.2	5.2	3.9	0.0	8.4	0.1	43.8	0.2	0.0	7.2	1.0	0.6	0.5	0.6	2.1	0.2	8.9	2.8	0.0	3.3	0.0	0.2	90.2	44.7	19.3	3.9	12.8	0.3	6.0	0.0	0.6	0.8	0.2	0.9	0.4	0.6	0.8	0.1	0.3	0.5	0.6	1.0	1.3	0.3	0.1	0.6	0.4	16.1	16.4	0.0	16.5	21.6	8.3	5.9	5.7	6.5	1.5	9.5	7.9	1.5	0.0	3.8	22.5	11.0	1.0	0.5	0.2	0.0	25.7	0.4	0.8	1.5	0.0	0.1	1.8	58.4	0.0	17.4	1.2	0.0	0.5	20.4	0.1	0.2	1.8	0.0	4.8	15.6	1.6	0.1	0.6	1.1	0.4	6.3	0.5	1.4	0.3	1.7	1.7	11.8	1.4	0.0	4.4	3.1	82.1	0.9	5.3	0.0	8.4	2.7	20.0	13.4	14.6	4.0	2.4	0.3	0.0	12.0	0.4	0.2	0.0	0.1	26.1	6.6	0.6	1.1	1.9	3.7	0.1	1.0	0.0	18.0	0.1	1.1	2.0
KIF26A	"DKFZP434N178, KIAA1236"	ENSG00000066735	"Kinesin family member 26A"	Q9ULI4	14	104138723-104180894	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1"	"Group enriched"	"Detected in many"	5	"stomach cancer: 3.8;testis cancer: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046882, HPA060346"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046882: AB_2679856, HPA060346: AB_2684259"	"unprognostic (3.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.24e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.68e-3)"	5.0	2.3	2.1	0.7	1.3	2.0	4.6	0.5	1.5	5.0	3.0	2.6	0.4	2.4	0.2	1.4	2.6	0.4	5.7	0.8	1.4	3.8	0.6	2.2	0.3	1.3	1.3	4.1	5.7	0.3	2.9	1.8	1.4	0.8	0.4	0.1	1.0	0.8	2.9	2.8	1.9	0.4	0.9	4.2	1.8	2.8	1.8	0.2	1.5	1.0	0.1	2.0	2.1	0.5	0.0	1.7	1.0	3.9	0.0	0.0	6.7	0.3	0.0	0.0	0.0	3.1	0.0	0.0	5.3	0.0	0.7	2.5	3.1	0.0	0.0	0.0	4.9	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	6.7	0.0	0.0	0.0	24.9	0.0	0.0	20.8	0.2	2.0	18.8	7.9	2.0	0.0	0.0	19.2	39.3	4.4	0.6	0.0	2.5	0.4	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.5	1.5	0.8	1.4	1.3	1.3	1.4	0.9	1.8	0.5	22.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.3	0.1	3.2	0.0	0.0	1.8	0.0	1.0	0.0	1.3	1.9	0.7	0.4	0.2	4.4	11.9	7.7	4.8	0.5	0.2	0.8	2.1	0.0	0.2	0.0	0.4	13.9	0.2	2.6	18.5	0.7	2.6	0.0	0.3	1.1	0.1	0.0	0.1	1.8	3.7	0.0	0.2	0.0	0.0	0.1	0.2	1.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.2	8.1	1.2	1.7	0.4	0.1	0.3	2.8	0.0
KIF26B	FLJ10157	ENSG00000162849	"Kinesin family member 26B"	Q2KJY2	1	245154985-245709432	"Predicted intracellular proteins"		"Developmental protein, Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.2"	"Group enriched"	"Detected in many"	4	"Inhibitory neurons: 282.0;Oligodendrocyte precursor cells: 378.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	18	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 1.8"	"Cell line enhanced"	"Detected in some"		"HSkMC: 16.5;REH: 15.2;SH-SY5Y: 14.4;U-937: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027709, HPA028478, HPA028561, HPA028562"	Enhanced		Approved	"Plasma membrane,Microtubules"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Microtubules"		"HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417"	"unprognostic (3.66e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.30e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-4)"	"unprognostic (7.22e-3)"	0.1	0.7	2.4	0.3	2.1	0.0	0.4	4.1	3.3	1.1	0.0	0.7	0.1	0.7	0.2	0.2	0.4	0.8	0.5	2.1	3.7	1.0	0.2	1.1	0.2	2.8	6.2	0.1	0.2	0.4	0.4	1.7	3.1	0.8	0.0	0.1	0.4	0.8	0.0	1.2	0.3	0.5	3.2	0.3	0.5	0.5	2.6	0.3	1.0	0.0	0.2	0.4	0.2	1.8	0.0	0.0	2.2	3.9	1.1	1.3	1.5	1.9	2.4	0.1	0.0	2.2	0.0	0.0	3.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.1	0.3	16.5	0.7	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	15.2	0.2	0.0	2.0	0.0	4.0	14.4	0.0	0.0	0.0	2.8	0.0	0.9	0.2	3.3	0.0	0.0	1.1	0.0	0.0	0.0	0.7	7.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.4	2.1	4.1	3.3	2.1	3.7	2.8	6.2	3.1	3.2	2.6	1.8	0.1	0.0	0.5	9.8	0.0	0.9	0.1	0.8	0.6	1.0	0.8	1.7	2.3	0.0	1.1	7.3	4.2	2.4	2.8	0.0	0.0	2.0	2.1	4.3	17.7	0.6	0.0	0.0	34.6	4.8	2.8	2.1	1.5	1.1	0.0	1.4	0.0	0.0	0.8	0.0	282.0	0.0	0.0	0.0	0.4	5.6	0.6	0.6	3.6	66.5	0.8	0.5	0.0	378.0	9.8	9.2	0.0	0.0	0.0	0.2	0.2	0.5	2.0	0.4	0.0	0.8	1.5	1.1	2.0	0.5	1.3	2.5	0.3	0.1	0.5	0.0
KLC1	"hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A"	ENSG00000126214	"Kinesin light chain 1"	Q07866	14	103561896-103714249	"Predicted intracellular proteins"	"Host-virus interaction"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 397.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009798, HPA044617, HPA052450"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		14000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838"	"unprognostic (6.93e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.17e-4)"	"unprognostic (6.58e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.49e-1)"	70.8	49.4	282.9	42.2	302.0	50.3	63.0	273.5	358.7	74.8	220.4	89.9	26.2	71.5	43.9	66.0	65.0	38.4	100.0	310.6	299.8	35.6	29.9	66.0	44.2	378.9	305.0	62.8	43.0	48.5	86.7	45.9	397.0	47.1	34.3	158.6	54.2	47.1	123.4	68.2	48.7	58.0	300.0	49.0	53.9	45.6	301.7	40.2	48.6	71.5	47.4	66.5	69.8	304.0	57.0	74.2	138.6	76.3	92.6	102.8	65.5	129.5	105.4	118.6	81.7	64.0	60.8	75.8	65.2	139.3	53.2	93.0	85.8	69.6	112.0	89.9	43.9	41.6	92.8	66.1	106.8	83.4	79.5	73.4	109.3	89.6	112.1	126.5	104.2	52.8	63.5	83.7	104.4	94.6	56.9	74.0	45.6	90.1	140.4	53.0	60.6	38.2	74.7	122.5	165.1	93.5	105.7	52.7	90.2	85.9	47.9	40.1	152.7	88.4	43.5	123.1	74.1	65.9	50.0	83.3	101.7	47.7	97.0	5.5	4.6	9.8	7.3	4.6	6.6	5.0	6.5	7.8	5.1	6.8	5.7	5.0	5.0	3.1	6.5	7.6	7.0	2.9	282.9	302.0	273.5	358.7	310.6	299.8	378.9	305.0	397.0	300.0	301.7	304.0	45.2	44.8	32.6	92.4	24.3	26.0	45.1	30.1	13.6	140.8	18.7	19.7	39.3	15.7	21.5	20.2	52.1	22.6	29.5	17.9	9.8	42.9	8.0	30.8	41.8	45.5	44.9	13.2	84.1	30.7	30.6	37.4	27.0	43.2	33.6	31.5	39.3	18.9	30.5	138.0	80.8	24.3	28.5	19.9	23.8	17.0	38.5	24.4	39.2	73.1	36.3	45.4	20.6	57.3	89.8	71.2	17.3	48.2	26.2	46.6	15.8	5.1	23.8	106.1	26.3	46.4	46.8	64.8	83.3	20.1	17.6	42.1	30.8	17.1	17.5	38.4
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50545899-50551023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.2;parathyroid gland: 13.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.2;Collecting duct cells: 5.5;granulocytes: 5.7;Kupffer cells: 5.2;monocytes: 21.1;NK-cells: 10.3;T-cells: 5.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.3;head and neck cancer: 11.4;urothelial cancer: 40.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 97.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA000518: AB_1079213, HPA076540: "	"prognostic favorable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.2	0.2	0.2	2.1	0.1	1.0	0.3	0.1	0.2	0.5	0.1	0.3	0.4	0.2	0.3	0.4	0.1	0.3	0.0	0.1	0.2	3.7	0.4	0.7	2.3	0.5	0.2	0.0	0.1	13.7	1.0	0.1	0.3	0.4	0.1	0.0	1.3	0.2	0.0	0.3	1.1	0.1	0.2	2.7	0.5	0.2	0.4	5.2	2.0	0.0	1.3	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.8	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.0	0.2	97.7	0.1	1.2	0.0	0.2	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.3	0.0	0.1	1.1	1.1	0.1	2.0	1.9	1.4	1.9	2.1	2.6	0.9	1.3	2.3	2.0	0.2	0.7	1.4	0.3	2.0	1.5	0.2	0.1	0.1	0.2	0.1	0.2	0.5	0.2	0.3	0.2	0.4	0.2	0.0	0.0	0.6	0.0	5.2	0.1	0.0	1.6	0.0	0.0	3.0	1.4	0.5	0.0	1.6	5.5	0.0	0.0	2.5	0.1	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.7	0.1	0.2	0.5	0.3	5.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	5.2	1.2	0.0	0.0	2.7	0.0	0.0	21.1	0.0	10.3	0.0	0.0	1.3	0.0	0.0	2.8	0.1	0.0	0.3	1.6	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.2
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487551-183555706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 31.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 35.7;Endometrial ciliated cells: 28.3;granulocytes: 51.1;Hofbauer cells: 24.1;Macrophages: 33.3;Plasma cells: 63.6;Respiratory ciliated cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.3;HEL: 26.6;HMC-1: 26.7;U-266/70: 82.1;U-266/84: 45.5;U-698: 121.3"	"Low region specificity"	"Detected in all"							HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	1.5	0.7	0.7	11.8	0.8	3.5	0.9	1.0	1.0	0.8	0.7	2.5	2.5	0.6	0.2	0.6	4.8	2.1	0.7	0.6	1.4	0.4	1.0	4.2	29.3	2.6	1.4	0.3	0.6	0.2	0.2	1.9	2.0	0.5	2.3	0.1	1.3	0.1	0.2	0.1	4.8	0.7	1.5	6.3	4.1	0.2	3.1	10.0	0.6	0.3	31.0	1.8	0.3	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	26.6	0.0	0.0	0.0	7.3	26.7	0.0	0.0	0.0	0.0	0.0	4.6	0.5	0.4	18.4	0.0	0.0	8.8	4.1	0.0	0.0	0.0	14.8	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.5	0.0	0.1	0.0	0.1	82.1	45.5	121.3	0.0	8.0	0.0	7.8	2.8	11.8	0.6	2.2	0.7	3.6	2.4	1.0	2.0	2.4	2.9	1.8	2.4	2.2	2.7	4.6	4.2	2.6	0.7	0.8	1.0	1.0	0.6	1.4	2.6	1.4	2.0	1.5	3.1	3.7	4.0	6.4	6.5	0.7	35.7	1.1	1.7	0.6	0.6	0.6	0.3	0.4	4.8	0.0	5.4	0.0	2.1	0.2	16.6	0.2	0.0	0.1	2.0	28.3	0.5	4.6	0.0	7.6	0.3	0.0	0.3	1.7	2.0	0.8	51.1	8.1	1.1	0.2	24.1	0.0	0.3	0.0	0.0	20.7	22.4	0.8	0.3	33.3	8.8	14.0	10.1	0.3	5.2	1.0	0.3	0.0	0.1	0.0	63.6	1.2	0.0	0.4	24.4	0.7	0.0	1.8	1.5	0.3	0.4	0.1	0.6	0.5	16.8	0.0	0.2	1.2
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 560.6;Late spermatids: 242.7;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	9.5	18.8	12.8	7.0	13.3	12.4	13.0	16.3	15.9	10.5	12.1	9.2	7.8	11.5	12.2	9.0	9.7	9.7	50.8	12.5	13.1	11.9	10.4	7.7	8.3	12.6	12.7	11.8	7.7	10.8	7.3	8.6	12.3	10.1	7.9	14.9	8.5	8.1	9.1	10.9	6.9	10.5	12.2	8.0	6.3	42.2	13.4	12.4	9.2	9.7	9.1	8.7	9.4	14.7	24.7	20.7	55.7	66.3	26.8	23.2	20.3	21.3	31.5	30.7	35.6	25.3	17.5	24.1	16.8	26.2	50.5	26.2	21.5	15.0	25.8	6.4	15.5	15.9	16.7	32.9	20.0	32.5	12.0	20.7	19.1	35.2	28.8	24.2	39.6	29.4	28.3	25.5	50.7	28.4	27.3	51.3	77.0	16.7	24.5	23.7	31.2	22.2	29.2	21.0	33.5	32.5	46.2	22.7	23.3	33.9	18.9	16.9	17.0	25.7	26.6	56.9	25.7	39.9	35.3	58.6	17.0	33.8	31.5	44.1	15.3	67.2	13.0	17.9	13.7	9.2	13.8	12.3	11.1	11.9	10.1	10.0	14.4	9.5	15.8	8.0	16.7	12.6	12.8	13.3	16.3	15.9	12.5	13.1	12.6	12.7	12.3	12.2	13.4	14.7	12.1	22.4	5.5	45.7	13.0	23.6	18.2	13.0	18.2	23.7	12.3	13.5	101.2	8.6	11.3	9.2	29.2	20.7	14.4	5.7	11.7	17.7	560.6	18.3	16.7	15.8	10.8	25.6	74.5	17.6	27.1	19.8	10.2	13.2	21.5	16.3	13.2	7.0	19.7	37.0	75.2	7.6	14.2	16.0	17.2	242.7	16.8	12.6	12.4	35.6	13.4	30.3	8.2	168.9	45.6	19.4	1.9	20.7	12.3	11.5	7.4	13.5	18.8	16.3	6.6	14.3	17.9	83.7	19.7	24.6	33.8	23.7	17.2	12.1	7.0	24.0
KLRC1	"CD159a, NKG2, NKG2-A, NKG2-B"	ENSG00000134545	"Killer cell lectin like receptor C1"	P26715	12	10442264-10454685	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.7"	"Group enriched"	"Detected in some"	8	"dendritic cells: 104.2;NK-cells: 254.3;T-cells: 100.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 229.2;NK-cell: 367.6"	"Group enriched"	"Detected in many"	46	"NK-cells: 367.6;T-cells: 229.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 5.6;Karpas-707: 1.9"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (8.17e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.58e-7)"	"unprognostic (3.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-3)"	0.7	0.5	0.8	2.2	0.8	5.3	2.0	0.6	1.4	0.7	0.4	1.8	1.4	3.1	1.5	1.4	0.9	2.0	0.7	1.0	1.6	0.3	1.8	3.3	3.1	1.4	1.4	0.7	0.8	0.3	0.3	2.2	1.0	0.7	2.0	1.2	1.2	0.4	0.4	1.0	2.6	0.9	1.2	6.7	4.3	0.9	1.8	1.1	0.7	0.0	2.5	1.0	0.6	2.0	0.2	0.8	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.4	0.8	0.0	0.6	0.1	0.0	0.2	1.6	0.1	0.3	1.4	0.5	0.4	0.2	1.0	5.6	0.0	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	0.4	0.3	0.6	1.9	0.4	0.0	0.1	1.4	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.4	0.0	0.1	1.7	0.1	0.0	1.3	0.2	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.4	0.0	1.9	0.3	0.2	229.2	0.3	29.1	0.6	0.1	40.1	0.3	0.2	0.3	33.2	6.4	367.6	0.6	0.4	0.1	28.6	0.8	0.8	0.6	1.4	1.0	1.6	1.4	1.4	1.0	1.2	1.8	2.0	1.2	0.0	0.6	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.9	1.3	0.5	1.5	0.0	0.0	0.0	0.1	104.2	0.8	0.0	0.1	1.3	0.3	0.4	0.4	1.8	11.2	0.2	0.0	0.0	0.6	3.1	0.4	0.0	0.0	3.9	0.9	0.1	1.7	0.1	2.8	0.0	4.0	0.4	0.4	0.6	2.0	5.4	0.0	1.4	0.0	254.3	1.0	0.0	0.0	1.2	1.2	17.6	0.1	0.6	0.6	0.0	2.0	0.0	0.1	0.8	1.1	0.6	0.5	0.1	0.1	100.2	0.0	0.5	0.4
KLRC2	"CD159c, NKG2-C"	ENSG00000205809	"Killer cell lectin like receptor C2"	P26717	12	10426854-10442300	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.4;lymphoid tissue: 5.8"	"Group enriched"	"Detected in some"	6	"dendritic cells: 111.5;Oligodendrocyte precursor cells: 32.6;T-cells: 49.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 24.6;NK-cell: 84.5"	"Group enriched"	"Detected in many"	103	"NK-cells: 84.5;T-cells: 24.6"	"Cell line enhanced"	"Detected in some"		"GAMG: 19.1;HEL: 5.8;HeLa: 17.5;HSkMC: 4.1"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (9.05e-4)"	"unprognostic (2.54e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-9)"	"unprognostic (8.10e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.31e-3)"	0.4	0.1	3.9	0.4	3.8	2.2	0.8	3.6	9.4	0.3	2.8	1.3	0.7	0.9	0.0	0.5	0.5	1.1	0.1	3.7	4.1	0.1	0.8	1.0	1.1	4.2	4.2	1.0	0.2	0.0	0.1	0.4	4.1	0.3	0.8	0.3	0.3	0.2	0.0	0.1	1.1	0.0	4.2	5.8	2.3	0.4	3.9	0.3	0.3	0.0	1.3	0.4	0.3	4.7	0.0	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	19.1	0.0	0.0	2.2	0.0	0.0	0.0	5.8	17.5	0.3	0.0	0.6	0.0	4.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.1	1.2	0.1	0.4	0.0	0.0	0.0	0.0	0.6	2.8	0.1	0.1	0.0	0.0	0.0	24.6	0.0	0.6	0.0	0.0	11.0	0.0	0.0	0.1	9.2	0.5	84.5	0.1	0.0	0.0	4.6	3.9	3.8	3.6	9.4	3.7	4.1	4.2	4.2	4.1	4.2	3.9	4.7	0.5	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.3	1.2	0.0	0.6	0.0	0.0	0.0	111.5	0.2	0.0	0.2	0.0	0.1	0.1	0.1	9.6	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	9.2	32.6	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	49.9	1.7	0.3	0.2
KLRF1	"CLEC5C, NKp80"	ENSG00000150045	"Killer cell lectin like receptor F1"	Q9NZS2	12	9827481-9845007	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.8;lymphoid tissue: 18.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 302.0;NK-cells: 963.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 664.4"	"Lineage enriched"	"Detected in all"	7	"NK-cells: 664.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.5;HAP1: 1.5;U-937: 4.4"									HPA054038			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA054038: "	"unprognostic (2.96e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.95e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.43e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.89e-3)"	1.5	0.1	0.6	1.4	0.6	12.8	0.8	0.6	1.4	0.7	0.6	0.7	0.3	0.9	3.8	0.6	1.5	1.4	0.6	0.6	0.6	1.2	4.5	4.4	3.4	0.8	0.6	0.1	1.3	0.3	0.5	1.0	0.6	0.5	1.0	0.1	1.4	1.1	1.2	0.5	0.8	0.8	0.6	18.0	1.2	0.6	0.6	0.4	0.8	0.4	3.5	0.9	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.4	0.6	0.4	0.8	0.9	71.5	1.5	94.4	3.4	3.6	35.2	1.5	1.5	1.4	35.4	5.8	664.4	1.1	2.3	1.2	83.0	0.6	0.6	0.6	1.4	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.6	3.2	0.0	2.2	0.0	2.3	1.5	1.1	0.2	0.6	0.0	1.3	0.1	0.3	5.7	1.3	0.0	0.0	0.9	302.0	0.1	9.8	0.5	0.5	0.5	0.5	2.2	0.0	24.0	0.1	0.2	0.7	1.2	0.0	1.0	1.3	0.1	8.9	1.8	1.4	0.0	0.2	0.1	0.0	9.1	6.6	1.1	0.0	2.1	12.4	2.8	3.9	0.4	963.0	0.0	0.3	0.4	0.0	0.0	12.7	0.9	0.0	0.8	0.2	0.0	0.0	0.1	0.2	0.2	2.0	0.2	1.1	0.5	80.6	0.0	0.3	3.1
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018978-49060794	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	19.9	21.9	14.0	17.0	14.4	62.1	20.3	14.7	18.1	20.2	3.8	21.3	13.2	26.9	14.4	25.5	24.1	11.7	23.7	12.1	9.1	18.2	20.5	25.1	17.5	9.3	8.2	25.3	33.2	22.9	25.4	16.2	8.6	19.2	14.7	48.0	22.1	16.2	44.9	30.4	27.9	15.5	3.1	36.6	25.5	23.6	12.7	29.0	26.5	21.9	17.2	19.4	19.4	13.4	32.3	31.9	31.0	24.7	29.3	20.4	32.6	17.3	17.1	20.3	10.9	54.8	14.1	33.4	21.2	23.9	14.0	21.5	38.1	19.9	17.7	22.4	26.7	47.2	37.7	29.9	20.5	59.1	43.2	18.4	25.8	30.7	32.0	27.3	31.8	33.2	55.1	19.2	23.7	37.4	26.8	48.0	29.9	45.4	25.0	37.4	22.4	12.0	18.1	37.2	24.6	21.2	28.1	25.5	19.5	26.1	24.0	44.1	49.8	15.5	30.7	14.5	30.5	24.8	20.9	31.7	17.1	28.0	12.5	0.5	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.5	0.5	0.0	0.2	0.0	0.1	14.0	14.4	14.7	18.1	12.1	9.1	9.3	8.2	8.6	3.1	12.7	13.4	12.9	9.6	19.1	17.6	13.3	14.0	7.8	8.1	14.2	26.8	12.1	7.1	7.8	12.8	10.9	18.4	52.1	8.2	15.3	12.3	1.9	6.3	2.8	10.7	12.7	13.2	13.1	16.0	17.4	6.0	6.0	8.8	24.5	13.1	8.2	23.3	17.9	13.0	9.8	21.9	16.5	10.0	6.1	15.7	18.4	2.4	9.6	15.4	10.6	15.0	14.9	6.4	17.5	12.5	19.8	8.8	9.5	10.9	10.1	11.0	13.3	4.5	9.0	38.4	6.6	14.4	12.5	6.5	3.8	18.9	17.6	11.4	15.3	10.8	10.3	9.6
KNDC1	"bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND"	ENSG00000171798	"Kinase non-catalytic C-lobe domain containing 1"	Q76NI1	10	133160219-133226412	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;pituitary gland: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Excitatory neurons: 41.9;Inhibitory neurons: 36.3;Respiratory ciliated cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;EFO-21: 1.2;MCF7: 1.1;NTERA-2: 1.4;RPMI-8226: 2.1;SuSa: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039624, HPA056143"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"	Vesicles	"HPA039624: AB_10671045, HPA056143: "	"unprognostic (2.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (1.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.41e-2)"	1.5	13.7	31.1	0.1	17.9	0.0	0.2	8.4	44.0	2.3	0.0	0.3	0.0	2.8	0.7	0.2	9.0	0.2	0.3	19.8	9.1	0.8	6.5	2.8	0.0	17.3	13.3	8.5	0.5	0.4	27.5	0.4	10.3	1.1	0.0	0.9	0.6	0.9	0.0	0.2	0.2	0.4	3.0	0.5	0.3	1.8	22.7	0.0	2.5	0.0	0.0	0.2	0.9	13.1	0.2	0.3	0.2	1.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.2	0.0	1.2	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	31.1	17.9	8.4	44.0	19.8	9.1	17.3	13.3	10.3	3.0	22.7	13.1	0.0	0.0	9.0	93.4	0.2	0.0	0.1	0.4	0.0	1.6	0.2	0.0	2.4	1.5	4.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	1.5	0.2	3.0	0.0	41.9	0.0	0.1	1.4	0.0	0.3	0.0	1.5	0.4	4.6	0.2	1.7	36.3	0.0	0.0	1.0	0.4	1.0	3.7	1.2	0.0	5.6	0.3	4.5	0.0	6.6	2.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	25.9	1.0	0.0	0.1	0.5	0.0	1.7	0.0	0.3	0.1	0.4	1.2	0.0	0.0
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin (SPAG5) binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.6;thyroid gland: 53.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 328.2;Late spermatids: 600.1;Spermatocytes: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	8.0	6.2	6.3	8.1	7.1	14.1	14.3	7.7	8.6	5.1	4.5	7.9	9.2	6.4	12.3	9.1	5.7	4.4	7.4	7.2	6.2	7.2	12.0	5.8	14.5	6.2	6.2	5.1	5.0	8.4	5.6	10.7	6.5	6.8	10.4	9.0	10.3	7.2	12.2	6.7	6.2	10.2	5.9	7.1	10.2	63.6	6.1	25.6	53.1	12.4	16.1	5.6	5.6	7.7	103.4	47.5	92.7	61.0	20.1	30.9	48.1	69.9	54.0	141.0	123.3	102.6	44.2	39.7	34.8	47.3	112.1	115.7	100.0	64.8	126.5	70.8	48.8	117.7	107.4	65.2	18.9	63.8	58.6	16.1	36.5	71.3	70.6	34.5	80.3	97.6	86.3	66.8	120.0	52.2	55.6	51.2	58.6	87.7	71.2	56.4	69.7	45.7	49.7	42.3	89.9	62.5	58.3	63.3	15.1	55.8	66.5	45.3	41.6	67.5	68.8	69.7	98.3	56.5	98.6	70.5	41.8	84.0	56.5	13.2	17.6	17.4	7.9	24.3	6.8	9.5	5.7	7.0	18.4	11.2	5.4	5.5	9.7	9.8	47.8	12.7	9.4	7.1	6.3	7.1	7.7	8.6	7.2	6.2	6.2	6.2	6.5	5.9	6.1	7.7	2.4	9.6	1.1	2.6	4.1	2.2	2.9	7.6	3.4	8.2	4.2	3.4	7.3	1.5	5.4	0.0	8.4	25.2	2.5	1.9	3.9	8.5	328.2	5.9	4.9	3.7	2.4	34.3	5.1	9.3	40.8	5.2	5.6	4.4	1.3	16.9	3.6	8.0	21.6	5.0	4.9	5.3	14.2	9.8	2.0	600.1	9.0	8.2	3.6	4.7	8.0	8.5	6.2	2.0	4.3	12.3	0.5	7.2	12.6	4.9	2.8	5.8	7.2	8.5	0.0	3.7	6.5	145.7	19.2	7.0	1.4	21.1	5.1	8.5	6.4	3.0
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.4;Erythroid cells: 29.5;Plasma cells: 28.7;Spermatocytes: 40.7;Spermatogonia: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favorable (8.69e-4)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	7.1	7.6	3.7	11.7	3.6	42.3	7.6	4.9	5.3	9.1	3.5	9.8	9.0	5.3	5.2	12.2	6.8	3.4	4.1	3.6	3.4	6.7	6.4	8.0	16.4	3.8	3.4	8.2	6.6	2.9	5.7	5.8	3.9	7.3	11.9	5.5	7.7	2.9	2.5	15.1	14.5	4.6	3.1	18.2	7.2	28.2	4.0	17.8	5.4	1.4	17.4	6.2	8.9	5.0	33.8	27.6	77.8	17.9	5.9	10.8	35.0	30.6	19.8	29.7	27.9	26.2	27.6	40.2	15.6	14.9	19.5	45.4	34.1	19.1	39.1	28.8	23.7	49.7	57.1	27.1	2.0	49.3	32.8	5.8	4.3	30.7	20.2	15.5	20.5	50.5	50.4	29.4	22.6	25.0	40.9	113.0	39.4	16.3	34.5	55.4	37.8	44.8	17.8	35.6	24.1	31.0	55.7	11.7	16.7	46.2	44.4	28.1	15.1	33.7	32.3	33.3	36.3	39.3	42.3	61.0	20.1	31.3	39.6	2.5	0.5	1.8	0.7	0.7	0.6	1.6	1.1	1.3	0.5	0.9	0.8	1.0	1.6	0.9	1.0	0.8	0.5	0.3	3.7	3.6	4.9	5.3	3.6	3.4	3.8	3.4	3.9	3.1	4.0	5.0	4.3	0.0	2.6	3.3	8.1	4.2	1.9	1.9	2.2	2.2	3.1	3.4	1.8	0.0	1.9	5.5	4.2	7.0	3.8	3.0	0.0	1.5	30.4	3.3	3.9	2.9	0.0	29.5	6.2	0.4	5.9	2.9	10.2	5.2	1.3	14.7	2.2	1.3	4.8	0.0	4.5	2.3	0.0	2.2	4.7	17.7	4.7	4.0	1.8	4.7	1.6	1.1	2.1	2.5	4.4	0.8	1.0	3.0	28.7	1.0	1.5	0.5	5.0	5.0	6.6	3.1	2.9	40.7	39.9	4.9	2.3	2.9	5.3	2.1	5.8	1.6
KPTN	2E4	ENSG00000118162	"Kaptin, actin binding protein"	Q9Y664	19	47475150-47484265	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 23.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 23.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041710, HPA041796"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA041710: AB_10961904, HPA041796: AB_10962832"	"unprognostic (4.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.54e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (9.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (1.40e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-1)"	5.2	6.6	5.1	3.0	5.5	5.6	4.7	5.9	8.4	7.2	3.6	6.2	3.4	5.3	1.4	7.7	4.4	2.4	5.8	5.6	5.1	6.3	8.6	4.5	3.4	5.6	5.1	3.2	5.5	4.0	10.0	2.8	5.0	8.0	2.2	1.6	10.1	2.0	6.9	4.8	4.5	2.6	4.6	6.1	4.7	5.4	5.1	8.2	4.8	6.7	2.1	5.1	5.8	5.4	9.7	16.8	12.9	8.6	12.9	10.0	9.3	5.4	9.9	28.4	17.5	12.6	11.3	12.3	4.1	9.5	10.1	11.1	11.0	19.1	7.9	11.4	17.2	5.2	12.2	11.4	11.5	10.1	13.8	11.5	12.3	9.5	8.7	7.2	11.0	15.2	10.1	10.9	8.3	7.8	17.7	44.8	11.6	10.5	10.3	12.6	6.3	4.8	8.8	15.0	27.8	21.1	9.1	10.3	6.8	6.4	8.5	14.5	6.6	6.9	7.6	3.7	12.2	2.8	4.8	5.3	6.1	6.4	10.4	0.0	3.9	1.7	1.4	3.4	0.4	1.5	1.0	1.2	4.6	1.6	1.3	1.1	3.2	1.2	5.3	23.9	1.7	2.2	5.1	5.5	5.9	8.4	5.6	5.1	5.6	5.1	5.0	4.6	5.1	5.4	2.6	3.2	2.7	4.6	4.8	2.8	8.5	13.8	2.8	5.8	5.8	3.9	3.7	4.3	8.9	5.5	6.2	14.5	12.1	3.4	9.8	9.6	0.8	3.1	3.3	3.0	3.0	0.8	4.7	4.2	13.3	5.0	5.1	3.4	2.5	4.9	3.3	6.2	8.5	10.1	3.5	2.5	8.2	5.6	2.8	2.5	1.2	5.8	1.8	1.9	2.5	6.9	5.2	3.0	4.3	5.0	1.8	0.7	6.5	4.4	4.3	8.3	2.9	4.0	0.0	3.5	3.5	4.9	18.9	4.5	3.1	15.3	1.7	8.2	4.0	5.8
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434371	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 27.5"	"Cell type enriched"	"Detected in some"	7	"Ductal cells: 20.4"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"PC-3: 38.5;U-2 OS: 50.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		1500000000		"Cluster 61: Skin - Cornification"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	"Plasma membrane"	"HPA019367: AB_1852239, HPA076201: AB_2686786"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	50.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.6	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703524	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 273.0"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 20.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"HaCaT: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"		NA	NA		1200000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Nuclear membrane, Plasma membrane"		"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.6	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	273.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.2	0.0	0.0	0.0	0.0	0.0
KRTAP25-1	KAP25.1	ENSG00000232263	"Keratin associated protein 25-1"	Q3LHN0	21	30289145-30289514	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031438	Uncertain		Approved	"Nuclear membrane,Plasma membrane,Cytosol"		NA	NA							"Nuclear membrane"	"Plasma membrane, Cytosol"	"HPA031438: AB_10610000"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112107931-112254939	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Early spermatids: 114.7;Extravillous trophoblasts: 119.1;Fibroblasts: 149.2;Leydig cells: 166.5;Microglial cells: 124.6;Oligodendrocyte precursor cells: 160.4;Theca cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 330.5;ASC TERT1: 512.5;HSkMC: 405.5;hTERT-RPE1: 256.0;HUVEC TERT2: 441.3;TIME: 404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		320000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	116.2	9.4	17.6	34.0	17.1	0.5	59.9	11.7	12.9	77.0	12.6	82.6	17.2	77.5	18.5	35.6	115.2	37.3	51.2	12.3	17.9	9.9	4.4	80.8	11.5	12.7	16.3	23.2	4.9	8.6	13.6	68.0	14.7	35.4	34.0	1.3	38.4	40.7	10.6	17.7	34.5	107.8	11.4	1.5	36.7	18.7	22.6	5.0	23.2	18.6	8.9	65.1	40.3	11.4	0.3	0.1	18.8	0.6	330.5	512.5	0.3	91.4	55.8	8.9	1.4	0.0	36.1	0.0	58.0	154.9	19.8	0.3	4.0	0.6	1.5	0.3	46.4	0.0	44.4	0.0	69.6	0.1	0.3	405.5	0.1	64.9	0.2	256.0	441.3	0.0	0.4	0.4	1.7	0.0	0.1	0.3	1.1	0.0	15.1	0.2	0.2	0.3	134.0	2.8	0.4	2.1	14.2	0.4	68.5	1.5	0.4	0.2	404.9	145.1	7.6	160.6	29.1	0.0	0.3	0.3	33.5	0.2	191.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	17.1	11.7	12.9	12.3	17.9	12.7	16.3	14.7	11.4	22.6	11.4	115.7	3.2	4.5	45.4	0.1	22.7	1.4	2.9	8.6	1.6	5.4	9.4	53.3	2.8	10.4	3.7	0.0	1.0	0.6	0.0	3.9	0.7	114.7	6.2	24.8	103.5	0.0	2.7	27.4	0.7	119.1	149.2	3.6	10.5	1.3	3.5	36.0	35.3	3.0	0.0	6.3	0.8	20.3	1.6	20.8	47.0	166.5	2.0	56.9	124.6	0.6	0.0	0.0	160.4	2.0	0.7	0.0	81.3	1.5	1.5	0.0	0.1	1.7	0.5	65.7	5.4	98.2	1.3	1.2	5.0	18.6	3.0	2.7	117.4	0.0	12.9
LAMC1	LAMB2	ENSG00000135862	"Laminin subunit gamma 1"	P11047	1	183023420-183145592	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 231.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 187.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1582.4;ASC TERT1: 863.5;HSkMC: 980.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001908, HPA001909, CAB004486, CAB078163"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		100000000	"Cluster 37: B-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Plasma membrane"		"CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.30e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.85e-5)"	117.2	16.4	6.3	34.9	7.2	1.1	79.3	9.2	7.1	55.1	13.8	78.3	16.0	63.2	19.3	44.5	63.8	54.7	61.7	7.2	8.7	19.4	13.8	58.7	15.3	6.9	7.7	36.1	19.2	20.0	9.5	231.7	6.0	31.3	34.3	3.7	28.1	50.9	50.5	40.8	48.9	102.3	6.4	8.4	51.1	18.7	8.6	14.7	40.3	60.1	12.0	66.9	47.7	5.4	52.5	83.5	268.4	76.7	1582.4	863.5	405.0	374.8	373.0	147.8	87.1	249.4	58.2	18.8	168.6	180.8	87.9	127.4	51.7	99.2	112.7	0.6	52.6	0.9	71.1	91.3	248.1	16.6	8.9	980.4	52.2	177.0	138.7	262.7	261.0	0.2	0.6	55.5	182.5	22.8	0.2	17.4	109.3	96.0	15.7	13.5	226.2	9.9	237.6	137.0	17.6	50.1	98.9	0.7	95.6	459.0	21.2	43.6	486.5	179.1	70.0	168.2	95.4	21.6	0.3	12.4	148.7	12.3	177.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	7.2	9.2	7.1	7.2	8.7	6.9	7.7	6.0	6.4	8.6	5.4	81.2	35.3	21.6	32.7	8.1	31.4	46.1	44.4	35.9	3.1	7.1	17.4	57.5	27.1	21.0	36.8	4.2	101.9	0.2	1.6	1.9	59.2	5.7	32.5	58.5	80.9	1.2	0.0	69.2	23.3	69.0	187.8	8.6	78.5	2.5	53.0	26.7	19.1	18.7	1.7	50.0	2.4	18.3	10.7	20.6	6.8	120.9	4.5	33.8	106.8	6.0	2.2	1.0	35.2	2.5	44.7	2.6	62.4	11.0	59.9	0.5	12.4	14.8	0.7	72.3	73.9	102.1	17.6	36.8	17.0	16.9	72.1	2.8	74.4	3.5	25.8
LAPTM4A	"HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp"	ENSG00000068697	"Lysosomal protein transmembrane 4 alpha"	Q15012	2	20032650-20051628	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 1393.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031402, HPA031404, HPA068554"	Approved		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Vesicles"	"Plasma membrane"	"HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: AB_2686003"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.73e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (8.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (7.98e-3)"	"unprognostic (2.36e-1)"	360.5	451.0	116.8	177.1	114.9	199.5	338.5	120.7	146.8	469.8	150.8	256.2	219.6	507.6	339.7	315.4	370.1	383.7	322.5	112.7	130.2	460.9	409.2	308.0	160.1	123.3	122.2	460.3	290.8	289.2	155.6	397.6	128.1	306.3	233.9	59.1	306.0	611.8	204.4	247.2	227.7	412.2	130.1	190.9	240.5	389.3	125.5	122.8	365.8	234.8	178.5	342.1	248.7	128.0	417.7	228.8	136.4	283.2	1393.4	1031.8	509.1	514.3	651.8	349.3	393.6	180.5	398.4	73.2	116.2	637.9	356.9	400.7	115.0	250.6	317.8	181.2	183.2	112.4	244.3	520.1	534.8	86.7	294.9	691.7	501.2	338.7	386.4	481.9	367.6	62.2	86.6	135.8	527.5	243.3	53.8	114.0	299.2	353.1	207.1	89.3	397.5	139.7	858.6	347.7	214.8	207.3	480.4	390.5	335.9	492.9	169.6	70.1	467.5	575.7	203.8	500.3	336.5	221.7	349.2	118.3	455.3	172.8	234.4	737.8	382.3	289.3	94.6	324.9	116.4	197.4	112.9	106.9	269.2	192.3	126.7	113.7	200.1	124.3	393.4	226.9	119.3	427.0	116.8	114.9	120.7	146.8	112.7	130.2	123.3	122.2	128.1	130.1	125.5	128.0	351.7	195.5	203.1	39.2	156.5	659.0	601.1	1210.5	339.2	24.4	330.3	306.1	211.7	380.3	727.7	553.6	12.5	224.4	109.8	174.8	162.4	539.4	1235.7	195.7	407.1	384.0	138.1	65.0	15.0	347.6	1035.3	896.8	111.6	286.0	521.9	445.7	331.3	519.4	311.3	20.2	14.3	203.6	767.0	299.3	716.0	1080.9	835.3	254.4	588.7	39.4	278.0	315.3	48.4	34.7	18.7	289.4	246.2	600.7	156.8	331.2	171.5	940.9	506.7	24.7	532.5	389.4	583.0	356.3	173.5	268.2	709.8	302.9	146.4	579.1	224.8	500.9
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 709.0;epididymis: 402.7;lymphoid tissue: 605.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.4;granulocytes: 309.1;Hofbauer cells: 264.4;Kupffer cells: 401.2;Langerhans cells: 337.6;Late spermatids: 290.9;Macrophages: 466.1;monocytes: 535.7;NK-cells: 471.7;T-cells: 375.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 875.8;HDLM-2: 799.3;HL-60: 850.7;HMC-1: 861.7;JURKAT: 792.7;NB-4: 789.2;THP-1: 840.5;U-698: 1105.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		1800000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	85.9	31.1	11.3	396.9	13.1	709.0	43.9	13.9	30.9	28.5	16.8	54.7	42.4	27.4	402.7	29.5	21.5	76.4	14.5	11.3	14.2	13.1	89.0	173.8	563.5	19.7	18.9	10.0	12.2	12.6	4.3	67.2	21.3	184.5	71.2	4.9	44.4	24.3	7.1	40.6	62.3	60.4	18.6	375.2	53.2	33.2	24.8	499.8	23.6	17.8	605.1	133.0	7.7	29.9	36.1	0.2	1.9	0.0	0.0	0.0	409.8	0.1	1.2	3.9	2.9	237.4	1.4	875.8	179.5	0.0	249.1	1.7	0.1	0.6	3.9	799.3	202.9	187.6	0.4	1.1	0.9	850.7	861.7	2.3	0.1	1.4	1.2	0.3	0.0	792.7	100.4	569.7	0.0	2.8	624.8	789.2	1.0	0.4	8.2	451.6	1.6	638.2	0.0	233.8	2.8	7.5	1.9	91.8	6.4	25.0	6.4	840.5	3.1	22.0	13.6	1.5	25.5	135.3	292.5	1105.7	17.0	530.9	3.6	1007.3	1559.5	810.8	915.7	1806.2	822.0	342.3	539.6	761.2	1134.5	251.6	330.2	560.5	1908.6	650.6	1826.1	297.5	598.1	3644.2	11.3	13.1	13.9	30.9	11.3	14.2	19.7	18.9	21.3	18.6	24.8	29.9	7.4	32.1	73.2	0.3	185.2	12.0	1.2	0.0	1.8	0.4	10.3	11.7	4.2	5.7	18.0	3.7	0.0	9.8	438.4	0.2	0.0	16.9	113.1	4.7	42.8	9.6	1.2	63.9	0.5	16.3	68.3	10.9	19.9	7.0	309.1	0.7	12.5	24.0	264.4	0.0	0.5	0.5	0.0	401.2	337.6	290.9	1.2	466.1	23.2	17.8	535.7	23.7	471.7	0.5	1.5	6.8	2.4	1.9	102.4	42.0	0.1	1.5	13.8	1.2	0.0	3.1	6.2	2.7	1.6	2.2	11.8	13.5	375.3	0.5	0.4	4.0
LCTL	"FLJ33279, KLG, KLPH"	ENSG00000188501	"Lactase like"	Q6UWM7	15	66547179-66565979	"Cancer-related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.9;Early spermatids: 5.8;Late spermatids: 9.0"	"Group enriched"	"Detected in some"	5	"glioma: 1.5;melanoma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.6;hTERT-RPE1: 6.7;NTERA-2: 5.2;SuSa: 6.0;U-2 OS: 14.3;U-251 MG: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071640			Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	"Endoplasmic reticulum"	"HPA071640: AB_2686428"	"unprognostic (4.60e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.51e-3)"	"unprognostic (4.44e-16)"	"unprognostic (6.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	0.1	0.1	1.4	0.2	1.5	0.4	0.1	1.2	1.5	0.1	1.0	0.2	0.2	0.1	0.1	0.1	0.0	0.2	0.0	1.3	1.3	0.1	0.1	0.0	0.2	2.1	1.4	0.1	0.1	0.0	0.1	0.0	1.8	0.1	0.0	0.3	0.1	0.0	0.7	0.5	0.1	0.0	1.5	0.1	0.1	0.3	1.6	0.0	0.1	0.0	0.0	0.0	0.1	3.0	0.3	0.2	2.8	0.2	0.1	0.1	0.7	0.7	0.0	0.0	0.3	0.3	0.4	0.4	5.6	0.2	0.5	0.6	0.0	0.0	0.1	0.2	0.1	0.7	0.9	1.4	0.0	0.2	0.3	0.3	0.0	0.3	0.0	6.7	0.0	0.2	0.3	0.3	0.1	0.1	0.2	0.4	5.2	0.4	0.1	0.2	3.1	0.3	0.0	0.3	0.3	0.2	0.1	0.3	1.6	6.0	0.4	0.5	0.2	1.4	14.3	0.5	6.4	0.1	0.2	0.2	1.9	0.6	2.7	0.5	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.1	0.1	0.1	0.0	1.4	1.5	1.2	1.5	1.3	1.3	2.1	1.4	1.8	1.5	1.6	3.0	0.0	0.0	0.0	2.9	0.7	0.4	0.6	0.0	0.0	0.6	0.1	0.1	0.3	1.5	0.1	0.0	0.0	0.1	0.6	0.2	0.0	0.1	5.8	0.2	0.3	0.2	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.3	9.0	0.6	0.1	0.0	0.0	0.0	1.4	2.1	0.5	1.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.4	0.0	0.6	0.4	1.6	2.1	0.0	0.3	0.3	0.9	0.3	0.1	0.4
LENG1		ENSG00000105617	"Leukocyte receptor cluster member 1"	Q96BZ8	19	54155161-54159721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 98.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;HaCaT: 5.7;HDLM-2: 3.6;HSkMC: 2.1;LHCN-M2: 3.1;U-87 MG: 4.1;WM-115: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043541	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"	Nucleoplasm	"HPA043541: AB_10961190"	"unprognostic (8.75e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.73e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.22e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-2)"	8.2	8.9	0.2	0.0	0.3	0.1	8.1	0.5	0.3	9.3	0.0	9.4	0.0	8.8	0.2	6.6	9.5	0.0	12.0	0.1	0.2	9.1	8.3	7.1	0.0	0.3	0.3	10.3	10.1	0.1	8.6	0.0	0.9	8.8	0.2	0.2	7.2	0.1	15.2	7.4	8.4	0.0	0.3	11.2	10.0	14.7	0.3	0.1	8.3	0.0	0.1	9.5	7.5	0.5	0.0	0.0	4.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	3.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	2.2	0.0	0.6	1.1	0.4	0.5	0.6	0.4	0.9	0.7	0.5	0.6	0.6	0.5	0.8	0.7	0.0	0.4	0.4	0.1	0.2	0.3	0.5	0.3	0.1	0.2	0.3	0.3	0.9	0.3	0.3	0.5	28.8	19.2	8.8	2.3	31.4	20.6	22.1	28.6	11.4	10.1	15.2	14.5	7.8	17.2	17.6	18.4	0.0	27.5	30.9	33.7	23.5	21.5	98.8	23.6	18.6	24.2	27.0	17.7	1.1	28.4	14.6	18.3	10.7	17.6	54.6	15.3	29.3	17.0	30.6	6.7	1.2	27.2	34.6	21.8	23.9	15.6	22.4	22.3	21.4	0.0	26.9	19.4	51.5	1.5	4.7	26.1	28.0	15.1	18.0	15.6	35.9	38.2	26.4	15.6	39.5	14.5	24.8	37.3	31.2	10.8	21.5	42.8	38.7	21.3	18.8	16.7
LGALS8	PCTA-1	ENSG00000116977	"Galectin 8"	O00214	1	236518000-236552981	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 322.8;Late spermatids: 222.6;Syncytiotrophoblasts: 176.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 118.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012734, HPA030491"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"HPA012734: AB_2668720, HPA030491: AB_10602345"	"unprognostic (2.03e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.93e-7)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.21e-2)"	28.6	14.3	10.8	26.5	11.3	44.4	23.3	12.4	14.1	17.2	11.5	19.9	21.6	16.7	19.6	21.2	13.8	24.8	55.0	12.5	12.6	23.4	49.5	27.0	24.0	12.9	10.9	21.6	21.8	35.0	12.7	41.0	13.5	22.2	19.9	22.9	22.1	21.3	6.8	32.4	24.1	21.8	11.7	42.6	18.9	57.1	11.4	26.3	17.2	9.4	22.8	32.8	15.3	11.7	52.3	27.5	3.6	20.8	46.6	39.0	55.6	38.0	45.4	49.0	59.3	37.6	63.3	1.5	34.8	33.7	26.8	60.3	11.0	54.7	43.2	31.1	7.3	35.5	20.7	68.1	56.9	46.9	78.9	39.6	45.6	41.0	13.8	42.4	52.5	26.4	40.7	25.1	35.7	33.3	23.2	8.4	12.5	4.1	18.5	27.2	0.8	3.0	35.4	80.8	13.1	25.7	24.4	82.3	13.7	2.1	59.0	33.7	39.1	1.0	22.0	29.9	47.7	10.0	7.4	1.0	50.4	65.7	30.9	118.5	37.4	18.7	12.5	32.9	17.8	10.7	18.4	14.1	31.7	6.8	12.2	12.7	16.1	14.2	24.0	14.2	22.5	24.8	10.8	11.3	12.4	14.1	12.5	12.6	12.9	10.9	13.5	11.7	11.4	11.7	44.0	76.9	54.7	12.1	19.3	32.5	28.5	64.9	44.9	28.1	31.7	22.7	55.2	34.3	68.1	14.7	25.0	64.4	33.9	25.3	5.9	61.8	322.8	18.7	21.9	39.9	18.1	19.0	31.5	39.2	53.5	35.2	23.0	20.8	109.4	38.0	46.1	27.1	57.5	38.7	37.0	18.8	57.0	100.5	23.6	222.6	23.6	45.1	7.2	24.4	38.7	6.5	17.5	18.1	16.7	44.0	36.0	13.9	15.1	20.6	26.4	14.5	53.1	19.4	26.3	22.5	19.6	46.8	8.7	21.3	37.1	176.2	34.4	22.8	17.1	24.4
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193799-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 9.0;Cardiomyocytes: 10.5;dendritic cells: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 15.4;memory CD8 T-cell: 9.1;naive CD8 T-cell: 4.8"	"Lineage enriched"	"Detected in single"	37	"T-cells: 15.4"	"Cell line enhanced"	"Detected in some"		"A549: 17.4;CAPAN-2: 15.4;HaCaT: 8.3;HeLa: 3.9"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 24.4"	"Low region specificity"	"Detected in many"			HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.2	2.3	0.4	5.4	1.4	5.1	8.2	1.5	3.7	0.3	1.4	0.1	1.2	2.2	5.0	8.8	6.2	14.7	1.0	7.2	0.8	2.1	3.4	0.8	14.7	7.6	1.8	0.2	0.0	17.5	0.3	8.0	5.9	0.7	0.0	5.3	1.4	0.3	4.1	1.3	0.3	6.1	6.7	0.6	7.2	9.8	0.3	5.1	0.5	0.3	2.9	3.8	2.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.6	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.0	0.0	1.7	9.1	0.0	0.0	0.7	4.8	0.0	0.4	0.0	0.0	0.5	3.4	2.3	5.4	8.2	1.5	1.0	7.2	14.7	7.6	8.0	6.1	9.8	2.0	0.1	0.0	0.0	2.6	0.2	1.3	3.6	0.5	23.3	0.0	1.5	9.0	10.5	0.0	0.6	0.0	0.0	0.9	6.0	0.8	0.0	0.0	3.1	0.0	0.0	0.2	0.0	0.4	1.0	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.8	1.6	0.0	0.6	0.3	4.1	0.0	0.2	0.0	1.9	0.0	0.0	4.1	0.0	0.2	0.0	0.7	0.0	2.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	5.6	5.5	3.3	0.3	0.1	0.8	4.3	0.0	2.7	0.9
LHFPL2	KIAA0206	ENSG00000145685	"LHFPL tetraspan subfamily member 2"	Q6ZUX7	5	78485215-78770021	"Predicted membrane proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 121.9;Microglial cells: 209.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.9;plasmacytoid DC: 6.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.3;granulocytes: 7.9;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 116.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042402, HPA076743"	Uncertain		Approved	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA042402: AB_10794276, HPA076743: "	"unprognostic (2.19e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (3.40e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.85e-2)"	18.2	18.8	10.9	19.6	11.5	18.4	20.5	12.0	13.4	14.0	15.3	17.7	23.8	18.0	18.9	6.3	9.1	22.6	12.2	10.1	11.1	3.1	6.4	19.7	15.2	17.2	13.7	18.5	11.4	10.4	5.7	14.8	14.9	11.4	17.5	5.5	19.3	24.7	2.7	5.7	21.2	22.0	14.6	4.3	14.8	9.1	18.5	14.8	9.1	4.1	14.4	36.3	10.3	18.7	9.8	36.1	10.6	14.1	63.0	18.0	32.7	11.0	28.0	18.7	32.5	12.8	28.4	24.4	4.8	21.7	116.4	16.6	10.2	11.8	30.6	0.2	9.1	24.3	7.2	21.6	46.5	0.1	0.2	20.7	46.6	57.3	88.4	29.6	44.8	0.9	0.2	17.8	42.9	5.2	0.1	1.4	11.8	7.9	10.3	4.7	15.0	6.8	7.1	42.6	2.0	14.4	17.9	6.6	62.5	22.3	3.9	3.0	29.8	21.7	11.8	60.1	33.2	0.7	0.1	34.1	57.5	0.2	39.7	7.9	3.9	4.0	0.0	1.4	0.1	0.6	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	0.5	6.3	0.1	1.3	10.9	11.5	12.0	13.4	10.1	11.1	17.2	13.7	14.9	14.6	18.5	18.7	13.5	3.2	3.4	20.2	5.7	8.7	7.3	5.2	0.6	6.6	18.2	15.6	3.7	1.5	7.6	7.3	0.0	4.0	20.3	34.8	0.0	9.1	1.5	7.5	26.3	21.4	2.4	10.7	15.8	12.9	2.6	38.1	10.7	14.6	0.0	121.9	35.3	1.4	60.1	3.3	7.9	16.3	6.1	40.4	14.7	1.7	19.3	36.3	10.6	209.9	5.5	5.4	0.0	55.3	4.6	17.0	16.1	33.4	3.3	10.4	29.8	0.7	3.9	2.2	6.6	19.1	13.1	0.7	1.7	1.4	4.8	7.3	1.3	22.1	10.0	12.4
LILRA6	"CD85b, ILT8, LILRB6"	ENSG00000244482	"Leukocyte immunoglobulin like receptor A6"	Q6PI73	19	54236592-54242791	"Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 9.0;lymphoid tissue: 16.9"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 13.8;Kupffer cells: 31.7;Macrophages: 30.6;monocytes: 19.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.4;intermediate monocyte: 3.9;neutrophil: 8.2"	"Group enriched"	"Detected in many"	26	"granulocytes: 8.2;monocytes: 3.9"	"Not detected"	"Not detected"											HPA026985			Approved	"Plasma membrane,Cytosol"		NA	NA		21000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"HPA026985: "	"unprognostic (1.00e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.47e-5)"	"unprognostic (7.76e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-2)"	3.3	1.1	0.0	1.3	0.0	1.6	1.1	0.0	0.1	0.4	0.0	1.0	0.1	0.5	0.0	0.3	2.2	0.2	1.1	0.0	0.0	0.7	1.3	9.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.9	0.0	0.4	0.3	0.8	1.4	0.0	16.9	0.8	0.2	0.1	0.0	0.5	0.0	0.0	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.2	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	5.3	0.0	0.0	0.2	0.4	0.0	0.1	3.8	0.0	0.7	0.9	13.8	0.0	0.0	0.0	0.0	31.7	5.2	0.0	0.0	30.6	0.0	1.0	19.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1
LILRB3	"CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB"	ENSG00000204577	"Leukocyte immunoglobulin like receptor B3"	O75022	19	54216278-54223506	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.0;lymphoid tissue: 49.9"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 63.4;Kupffer cells: 88.6;Macrophages: 88.8;monocytes: 71.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 44.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 44.8;monocytes: 15.4"	"Not detected"	"Not detected"											HPA026985			Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"HPA026985: "	"unprognostic (7.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.83e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.92e-8)"	"unprognostic (2.18e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-1)"	9.9	3.4	0.4	8.3	0.4	14.6	2.9	0.4	2.1	1.2	0.9	2.7	0.3	1.2	0.3	1.3	5.4	0.1	3.4	0.4	0.4	2.3	4.1	27.0	0.3	1.2	0.8	1.0	1.9	0.0	1.3	1.2	1.3	1.7	0.0	0.2	2.4	0.0	1.1	0.8	2.6	0.1	0.6	49.9	2.3	0.5	1.8	0.6	1.6	0.0	0.2	3.2	1.6	1.4	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	15.4	0.6	0.1	14.3	0.2	0.1	0.3	0.0	7.2	0.1	0.0	0.1	44.8	0.0	5.6	0.5	0.0	11.6	0.4	0.4	0.4	2.1	0.4	0.4	1.2	0.8	1.3	0.6	1.8	1.4	1.5	9.6	13.0	0.3	2.2	2.4	1.2	6.5	0.0	0.7	1.6	2.2	0.4	4.3	8.3	1.8	0.0	1.5	2.1	0.6	0.0	0.3	1.3	0.8	1.9	3.0	0.0	0.8	0.2	0.6	6.7	2.9	0.0	2.2	7.6	0.5	1.8	3.2	63.4	0.0	0.1	1.9	0.0	88.6	8.4	4.1	0.3	88.8	1.8	1.9	71.2	0.9	3.1	0.0	0.1	0.2	1.3	0.7	2.1	1.6	0.4	0.4	5.2	2.9	6.6	4.3	1.3	0.8	1.5	0.1	3.0	1.2	3.8	2.6	2.0	0.4
LIPJ	"bA425M17.2, LIPL1"	ENSG00000204022	"Lipase family member J"	Q5W064	10	88586753-88606976	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"testis: 7.0"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 67.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048594	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"		"HPA048594: AB_2680456"	"unprognostic (4.79e-3)"	"unprognostic (6.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.90e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.21e-4)"	"unprognostic (9.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.88e-1)"	0.2	0.0	0.2	0.1	0.2	0.0	0.2	1.0	0.3	0.1	0.3	0.1	0.3	0.1	0.9	0.0	0.7	0.1	0.1	0.3	0.3	0.2	0.5	0.1	0.3	1.2	0.5	0.1	0.4	0.0	0.1	0.0	0.5	0.3	0.2	0.1	0.3	0.1	0.3	0.1	0.1	0.2	0.4	0.1	0.2	7.0	0.3	0.4	0.6	0.0	0.3	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.0	0.3	0.3	0.3	1.2	0.5	0.5	0.4	0.3	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.1	67.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.0	0.6	0.0	9.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501807-8574668	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 573.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 20.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 20.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No		6600	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	131.4	14.3	9.5	45.6	9.5	0.1	97.5	13.5	10.8	27.2	38.8	18.1	9.0	90.3	18.4	36.1	57.8	67.2	90.6	14.0	9.7	33.0	9.7	131.7	17.3	14.0	11.0	65.8	37.7	30.0	8.7	54.5	12.1	34.8	7.0	15.2	42.2	16.8	573.4	28.8	20.1	63.3	13.2	55.6	46.4	11.3	12.6	4.7	18.5	260.9	10.2	110.6	31.5	14.8	9.4	52.0	8.6	6.6	62.0	34.6	8.9	37.9	19.4	20.5	50.0	38.8	11.5	0.0	4.2	44.2	8.8	0.8	4.9	9.9	8.4	16.0	3.6	11.6	3.5	7.6	88.9	0.0	1.1	124.9	0.2	93.8	0.7	11.9	10.1	0.0	0.0	0.0	26.8	6.7	0.0	0.1	16.8	12.0	2.3	0.2	28.2	0.1	19.1	3.6	0.3	21.3	6.4	31.1	20.6	23.9	40.7	0.1	5.0	20.4	40.3	83.0	25.9	5.1	6.2	2.6	4.1	2.9	27.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	2.9	0.6	3.3	0.3	0.0	0.1	0.0	0.0	0.0	1.0	20.5	0.3	9.5	9.5	13.5	10.8	14.0	9.7	14.0	11.0	12.1	13.2	12.6	14.8	287.6	9.6	10.7	2.0	2.1	31.6	42.1	7.4	9.6	13.0	20.4	17.0	14.7	14.3	13.5	5.5	10.4	3.9	1.7	1.4	3.9	122.0	1.1	9.6	77.7	161.9	12.1	0.0	0.8	48.5	4.2	64.5	7.1	4.8	10.2	44.2	30.7	12.6	3.4	97.6	1.2	2.4	4.1	0.8	47.0	2.3	11.5	3.2	53.4	29.0	9.0	38.9	1.0	4.0	8.7	114.1	0.9	32.4	8.0	8.4	0.3	45.5	12.0	8.0	0.0	57.0	112.9	6.4	9.1	29.0	27.1	4.4	5.3	21.5	4.7	7.5
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106862-98209638	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 50.7;Excitatory neurons: 114.9;Inhibitory neurons: 69.0;Oligodendrocyte precursor cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.2"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: AB_2677698"	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	3.5	7.0	4.2	3.9	6.2	13.8	3.6	0.0	25.2	4.9	0.0	9.7	8.8	3.9	3.9	9.5	4.1	4.2	12.4	6.0	0.0	6.6	6.2	6.6	3.6	2.1	0.5	5.0	14.8	10.7	7.0	3.1	1.8	5.1	8.0	8.2	7.9	4.0	11.1	9.0	9.8	3.7	0.0	4.6	6.5	5.2	1.2	4.9	5.8	7.0	4.8	5.8	6.2	8.7	12.5	14.5	11.0	11.4	5.8	4.6	10.2	5.1	5.5	4.9	5.9	11.5	11.1	6.5	14.3	6.5	18.6	13.4	12.8	7.8	7.6	9.4	9.0	4.4	13.0	11.6	7.0	8.0	7.6	3.2	10.5	10.1	13.6	4.9	7.4	7.4	11.8	13.4	4.5	16.9	8.5	4.8	13.4	17.1	7.0	9.2	7.5	13.0	8.2	21.7	7.8	15.7	10.2	18.4	7.4	11.0	5.1	3.2	9.2	10.2	16.6	20.5	11.7	5.9	11.2	12.8	6.8	6.2	12.3	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.4	1.4	0.1	0.3	0.2	0.2	0.1	4.2	6.2	0.0	25.2	6.0	0.0	2.1	0.5	1.8	0.0	1.2	8.7	6.0	28.9	17.0	28.7	7.8	9.7	4.3	6.2	14.8	14.2	5.5	3.9	22.4	15.7	11.8	1.8	14.6	2.8	7.5	50.7	1.9	6.1	1.1	13.2	7.6	5.7	12.0	8.4	114.9	9.1	1.9	5.4	21.4	26.4	2.5	5.3	2.5	8.4	2.2	6.7	69.0	14.7	4.1	1.6	2.3	2.0	1.8	3.2	1.8	16.9	2.8	6.1	7.2	52.3	29.6	10.3	23.8	4.5	12.9	8.8	14.0	3.0	15.8	10.6	0.0	8.6	5.7	6.9	6.3	15.5	10.9	3.0	8.6	2.7	14.7	20.5
LNX2	"MGC46315, PDZRN1"	ENSG00000139517	"Ligand of numb-protein X 2"	Q8N448	13	27545913-27620529	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040698	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	"Plasma membrane, Cytosol"	"HPA040698: AB_10673138"	"unprognostic (4.97e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.79e-2)"	"prognostic favorable (7.09e-13)"	"unprognostic (4.18e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-2)"	3.2	6.7	2.0	3.7	2.3	3.8	6.9	5.1	3.0	4.0	6.5	10.7	14.2	3.0	4.8	10.6	4.6	7.9	8.7	2.4	2.8	7.9	20.5	11.5	4.0	1.7	1.8	4.3	19.6	7.1	3.2	3.7	1.7	6.4	10.5	8.0	9.4	4.8	5.9	6.6	13.4	3.8	1.9	3.1	9.9	12.3	2.4	7.8	9.9	5.9	5.1	6.2	6.7	1.9	6.4	3.5	6.5	7.2	6.7	3.1	6.8	5.6	4.9	5.4	4.9	12.7	12.5	9.6	4.7	4.9	9.8	12.0	11.8	15.0	7.0	6.0	4.9	12.3	7.2	9.3	10.5	6.6	7.6	2.6	22.8	3.8	14.7	15.4	9.9	9.9	3.8	3.6	7.9	7.9	10.0	4.4	7.2	29.0	3.9	9.2	12.7	5.0	11.9	11.1	16.7	3.5	7.6	15.4	10.1	8.0	10.7	5.2	12.6	3.1	4.3	3.1	4.6	3.5	6.3	9.9	2.0	6.3	4.4	2.0	0.3	0.9	0.5	0.1	0.7	0.5	0.6	0.7	0.3	0.5	0.6	0.6	0.3	1.1	0.2	0.1	1.0	0.2	2.0	2.3	5.1	3.0	2.4	2.8	1.7	1.8	1.7	1.9	2.4	1.9	4.5	32.1	27.6	9.8	5.6	25.4	27.7	15.8	23.9	8.9	13.3	7.6	11.4	25.8	11.4	20.2	2.1	1.5	5.5	27.8	3.9	10.2	16.4	11.0	2.7	7.2	10.2	18.9	23.2	14.2	8.1	3.2	11.7	14.7	1.3	10.8	9.3	59.2	2.3	5.0	8.0	17.0	8.2	5.0	7.7	7.3	2.8	2.8	10.6	21.5	2.3	4.4	5.2	3.0	6.7	11.0	23.5	3.4	5.4	16.8	17.8	7.8	15.9	16.3	0.0	3.1	3.5	15.6	17.5	14.8	22.0	3.0	5.5	11.1	11.9	20.9
LONRF1	"FLJ23749, RNF191"	ENSG00000154359	"LON peptidase N-terminal domain and ring finger 1"	Q17RB8	8	12721906-12756073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023584, HPA024814"	Uncertain		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	Centrosome	"HPA023584: AB_1853233, HPA024814: AB_1853235"	"unprognostic (2.59e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.15e-1)"	16.2	5.8	2.8	4.5	2.7	5.9	10.5	3.4	3.7	11.4	1.3	7.7	2.3	11.3	9.6	13.0	10.5	9.5	4.9	3.0	2.3	6.3	9.9	7.3	7.1	2.2	2.1	15.2	7.5	8.0	3.8	10.1	1.9	10.7	4.3	7.9	8.0	10.6	17.2	28.7	4.5	9.2	2.3	8.4	5.4	15.8	2.6	6.8	8.7	11.3	8.1	7.9	8.3	3.0	1.2	3.0	15.0	4.6	15.6	7.4	10.0	3.8	6.3	4.1	5.7	0.9	3.9	24.0	0.9	6.7	12.9	1.8	12.0	4.7	4.6	3.7	6.8	7.9	0.5	6.2	14.4	2.1	3.0	7.0	8.2	2.6	8.9	3.8	6.4	9.7	1.1	56.6	2.7	4.2	10.4	7.0	15.5	4.8	0.9	5.8	10.2	4.3	3.5	10.2	31.2	3.6	2.2	5.1	29.8	10.7	1.0	10.4	2.9	2.2	3.7	8.9	3.0	4.3	20.7	12.4	12.0	7.2	7.0	0.0	0.1	0.6	0.1	0.5	0.3	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	2.8	2.7	3.4	3.7	3.0	2.3	2.2	2.1	1.9	2.3	2.6	3.0	18.9	9.6	16.3	23.2	25.2	60.8	32.8	7.8	52.3	25.1	15.1	10.3	9.7	10.0	13.1	11.0	16.7	3.6	6.3	4.3	7.9	5.3	57.4	12.1	27.9	15.1	2.4	4.6	67.0	4.0	8.2	24.2	5.6	28.3	6.3	27.8	6.1	14.7	5.6	8.4	43.6	6.4	4.1	9.5	27.6	53.5	29.2	17.2	44.4	21.5	3.6	8.3	0.0	42.7	14.9	4.3	6.4	19.9	16.3	26.4	3.8	6.0	8.7	13.0	19.7	36.7	32.7	8.2	19.7	26.4	73.6	7.3	9.7	3.4	5.8	30.1
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 16.9;Gastric mucus-secreting cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 12.2;K-562: 13.8;OE19: 15.2;PC-3: 16.0;SiHa: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA050422: AB_2681122, HPA061162: AB_2732658"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.3	3.3	1.2	1.9	1.1	4.5	1.4	6.6	2.8	1.5	0.0	3.5	2.3	1.9	1.2	1.4	2.0	2.4	2.3	3.3	1.0	2.8	12.7	6.4	0.8	0.9	1.9	1.6	7.0	0.7	0.9	0.8	1.0	1.9	4.3	2.8	4.8	2.4	8.8	0.7	2.0	1.5	1.5	0.6	4.0	1.7	2.0	0.3	8.2	3.9	1.0	3.6	0.7	1.1	5.0	6.9	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	6.0	0.0	3.5	0.0	12.2	0.0	1.3	0.0	0.1	0.1	3.7	6.6	11.8	6.9	3.7	5.7	0.7	0.0	0.0	0.0	0.0	2.1	1.7	0.5	13.8	0.0	0.9	5.5	0.0	2.3	0.0	15.2	16.0	0.0	3.1	0.0	4.2	2.1	0.2	0.0	14.5	0.4	11.8	0.1	0.0	4.5	0.3	0.1	0.2	0.0	7.9	1.4	6.3	0.0	3.2	5.4	3.4	0.0	0.4	0.0	2.4	0.0	3.8	0.0	1.1	0.8	0.0	0.0	0.5	0.8	0.5	0.0	0.0	0.0	0.4	0.3	1.2	1.1	6.6	2.8	3.3	1.0	0.9	1.9	1.0	1.5	2.0	1.1	2.2	6.4	13.4	7.8	0.4	1.5	16.9	0.2	1.8	3.3	0.8	1.9	4.4	0.0	6.1	1.8	0.0	0.5	5.3	11.2	1.9	3.0	1.6	4.4	6.4	3.3	1.2	0.4	1.8	4.3	0.0	8.0	17.3	13.0	6.3	0.1	2.2	4.1	2.7	1.7	6.0	4.6	0.0	4.7	7.7	1.0	0.9	9.5	3.6	9.4	0.5	3.7	2.1	3.5	0.2	5.2	8.8	1.5	1.3	7.2	1.6	1.5	0.3	0.3	0.0	9.9	2.0	2.4	4.6	1.6	0.1	0.4	2.7	0.2	3.7	12.5
LOXHD1	"DFNB77, FLJ32670, LH2D1"	ENSG00000167210	"Lipoxygenase homology domains 1"	Q8IVV2	18	46476972-46657220	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 7.2;kidney: 6.9;testis: 23.0"	"Group enriched"	"Detected in some"	70	"Early spermatids: 199.3;Late spermatids: 439.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077128			Approved	"Plasma membrane"		NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA077128: "	"unprognostic (6.95e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.75e-4)"	"unprognostic (9.53e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.48e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.66e-3)"	2.3	0.0	0.5	0.0	3.4	2.8	0.6	0.0	2.1	0.0	0.1	0.1	0.0	0.1	7.2	0.0	1.7	0.2	0.9	0.3	0.0	6.9	0.0	1.0	0.0	0.0	0.1	0.1	0.2	0.2	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.1	0.0	0.0	0.8	0.1	23.0	0.3	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	3.4	0.0	2.1	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.9	1.2	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	199.3	0.0	0.1	0.9	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	439.4	1.8	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	4.5	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.5;tongue: 137.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.2	15.0	29.0	14.9	30.6	8.6	36.7	24.2	24.9	25.1	21.9	16.7	11.9	16.6	19.0	40.5	15.6	13.0	20.1	21.0	32.1	14.9	27.0	16.1	22.3	31.8	38.2	31.5	9.9	23.1	34.2	11.7	35.3	13.7	8.5	14.8	27.3	14.1	193.5	13.4	19.7	13.0	14.1	14.8	14.9	57.4	35.0	16.1	14.6	137.2	26.3	19.9	23.1	18.8	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.0	30.6	24.2	24.9	21.0	32.1	31.8	38.2	35.3	14.1	35.0	18.8	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013144	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 154.4;Granulosa cells: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	9.7	9.3	17.9	21.2	19.9	19.8	9.8	14.6	17.4	9.7	16.6	13.9	62.8	9.8	6.7	10.0	9.5	25.7	7.2	16.1	24.2	26.4	165.8	21.2	24.3	22.7	22.0	13.2	16.4	13.5	10.9	15.7	24.2	9.0	12.5	10.7	7.4	8.0	2.7	3.6	39.9	9.6	15.6	20.3	28.1	22.0	28.8	18.9	12.1	3.0	19.2	9.9	6.0	14.3	8.7	12.0	17.1	6.6	31.7	27.4	10.5	17.4	22.8	18.9	16.9	16.7	7.1	5.4	10.8	30.2	30.2	0.2	13.8	6.3	13.2	11.2	2.7	13.3	10.0	19.4	27.2	11.2	17.0	27.4	4.6	18.5	17.2	28.2	23.4	14.8	12.8	3.5	28.2	7.2	15.0	12.0	5.7	13.7	13.1	26.7	14.0	23.2	17.6	20.0	14.4	10.2	18.4	9.1	6.8	10.7	0.0	18.0	31.2	25.3	28.7	31.7	14.6	5.0	7.9	12.3	22.1	12.2	8.1	8.7	2.4	7.8	11.8	1.5	12.1	1.0	9.2	7.2	1.0	1.7	9.1	6.3	23.4	12.5	0.8	1.5	9.2	3.2	17.9	19.9	14.6	17.4	16.1	24.2	22.7	22.0	24.2	15.6	28.8	14.3	17.7	67.3	44.0	55.2	20.4	5.6	9.8	8.5	5.7	35.7	12.1	11.2	11.2	154.4	23.9	38.6	14.6	25.2	41.9	45.3	17.6	11.8	3.3	48.2	33.3	18.9	14.9	138.1	26.3	19.0	11.3	25.4	103.0	64.4	12.6	323.0	19.2	131.1	23.1	116.1	65.6	36.8	16.2	26.8	8.9	11.0	22.7	31.1	8.8	79.6	31.2	16.7	59.8	37.7	21.0	22.2	21.6	31.2	16.1	21.2	92.4	54.9	17.1	16.7	6.6	16.6	20.1	26.5	73.0	0.6	2.0	49.5	58.9	20.3	14.0	14.1
LRCH2	KIAA1495	ENSG00000130224	"Leucine rich repeats and calponin homology domain containing 2"	Q5VUJ6	X	115110616-115234096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.8;Excitatory neurons: 24.4;Inhibitory neurons: 38.0;Oligodendrocyte precursor cells: 48.2;Oligodendrocytes: 32.0;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 21.4;U-266/70: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003233, HPA076892"	Approved		Approved	"Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA003233: AB_2265929, HPA076892: "	"unprognostic (9.74e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.09e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.16e-2)"	2.7	4.4	3.9	1.4	4.1	0.0	2.0	4.2	4.7	5.2	0.6	8.2	0.5	5.1	2.1	1.6	3.4	2.6	2.6	4.0	6.8	1.1	0.2	2.8	0.7	3.3	3.8	7.0	0.5	0.3	4.4	7.5	3.5	8.3	1.9	3.6	0.5	7.3	0.5	0.5	2.0	5.1	3.9	1.8	2.0	2.1	6.2	0.5	2.3	1.5	0.2	4.9	3.3	4.3	0.0	0.0	6.4	4.7	6.4	5.3	0.0	4.3	9.2	4.1	9.3	0.0	0.0	0.1	0.1	5.7	3.2	0.3	21.4	0.0	6.2	0.0	5.8	0.0	0.0	0.0	5.1	0.0	0.1	3.1	0.0	1.6	0.3	10.8	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	6.2	0.0	4.6	0.0	5.1	0.6	0.0	8.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	2.5	0.1	6.0	14.0	2.5	0.0	1.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.1	4.2	4.7	4.0	6.8	3.3	3.8	3.5	3.9	6.2	4.3	9.3	3.2	12.3	23.8	0.0	0.6	0.1	0.0	0.6	6.9	0.1	0.3	7.5	0.0	0.0	1.8	0.0	0.1	0.0	0.0	1.9	0.0	9.1	0.1	5.9	6.7	0.0	0.0	24.4	0.0	0.2	6.3	0.0	0.1	0.0	8.4	2.9	0.0	0.6	1.7	38.0	0.0	0.0	0.0	1.0	2.9	8.7	0.1	1.8	9.4	0.0	6.4	0.0	48.2	32.0	0.0	0.0	6.4	0.0	1.2	0.0	0.0	0.0	2.5	26.3	3.6	7.8	5.4	2.9	0.0	0.1	0.3	0.2	5.7	0.0	0.1
LRP11	"bA350J20.3, MANSC3"	ENSG00000120256	"LDL receptor related protein 11"	Q86VZ4	6	149818757-149864359	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 61.3;Respiratory ciliated cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017267			Approved	"Vesicles,Plasma membrane"		NA	NA		1500000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Vesicles	"HPA017267: "	"prognostic unfavorable (2.31e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.23e-2)"	14.5	18.0	25.2	5.3	25.8	1.4	11.8	18.7	31.5	17.2	13.8	13.1	11.7	11.4	16.4	28.6	22.3	11.3	10.8	26.7	23.3	20.3	10.0	13.6	2.9	23.6	24.9	16.5	19.8	42.8	17.6	12.5	25.0	25.5	12.3	13.5	20.1	13.0	5.2	20.6	9.1	12.0	19.7	4.1	16.3	8.0	26.0	2.4	22.9	4.8	5.9	18.0	20.8	25.0	26.5	22.9	17.2	15.0	37.8	67.2	3.5	27.7	52.1	18.5	22.4	7.3	52.9	0.2	36.7	43.3	79.4	69.4	19.2	47.1	13.3	43.7	19.4	13.3	74.3	30.4	22.6	13.2	0.8	42.8	93.1	23.0	46.5	52.5	28.9	11.8	26.8	11.0	22.3	45.4	0.5	1.3	10.4	52.0	19.6	14.5	25.5	6.4	33.9	53.8	22.4	15.6	86.7	46.3	17.0	8.5	38.8	26.4	21.1	22.6	4.8	48.4	21.3	0.1	8.7	6.3	40.9	12.9	13.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	25.2	25.8	18.7	31.5	26.7	23.3	23.6	24.9	25.0	19.7	26.0	25.0	7.3	6.4	2.8	17.6	0.5	11.3	14.3	17.9	5.7	12.2	10.2	6.0	8.8	12.8	18.3	20.2	2.1	2.1	0.5	7.7	5.9	6.5	27.0	61.3	6.4	7.4	29.4	5.5	42.5	22.7	1.8	20.5	15.3	16.5	0.0	12.4	9.3	9.5	3.6	8.4	44.3	5.0	16.2	1.9	6.2	31.7	16.4	1.7	14.2	11.2	0.1	6.0	0.0	17.6	40.1	19.7	4.2	14.7	0.6	22.2	4.0	7.0	107.7	5.5	0.0	10.0	11.7	14.7	10.4	14.9	14.3	5.6	1.8	15.7	13.2	23.6
LRP12	"FLJ12929, ST7"	ENSG00000147650	"LDL receptor related protein 12"	Q9Y561	8	104489231-104589258	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 42.7;Excitatory neurons: 78.7;Inhibitory neurons: 53.7;Oligodendrocyte precursor cells: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"basophil: 47.0"	"Lineage enriched"	"Detected in many"	32	"granulocytes: 47.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017245	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane,Mitochondria"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center, Plasma membrane, Mitochondria"		"HPA017245: AB_1857532"	"unprognostic (2.17e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.87e-4)"	"unprognostic (2.96e-2)"	"unprognostic (3.96e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	5.7	4.7	5.1	3.9	8.8	2.2	4.3	4.7	9.4	6.4	3.1	4.8	3.1	16.5	4.0	4.1	5.8	7.5	13.6	13.8	5.3	6.5	1.5	4.6	1.6	1.8	2.3	6.1	4.5	10.0	3.1	5.3	1.1	6.5	4.8	6.1	3.8	5.9	9.3	3.1	3.0	18.5	2.4	3.7	2.8	4.9	3.1	12.9	6.8	17.2	2.3	7.6	3.2	3.9	18.5	10.6	21.1	37.1	23.4	18.4	4.7	51.5	51.3	17.6	24.6	2.4	17.7	0.0	20.2	49.0	21.2	8.1	8.6	22.0	37.7	34.3	8.2	28.7	4.7	0.8	14.4	0.4	22.1	24.8	15.4	29.5	23.7	63.4	9.1	21.9	6.2	0.0	63.9	3.0	26.5	0.6	5.3	1.6	18.2	2.1	20.5	4.0	13.9	0.8	27.0	16.4	16.4	0.7	44.6	15.8	5.0	5.6	25.7	48.1	31.0	15.7	33.6	23.8	20.2	0.2	25.9	0.0	53.9	47.0	0.3	5.8	0.2	0.8	1.4	0.0	1.0	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.5	0.4	0.1	0.4	5.1	8.8	4.7	9.4	13.8	5.3	1.8	2.3	1.1	2.4	3.1	3.9	4.4	16.0	2.2	42.7	0.2	11.5	6.3	12.3	10.8	17.5	3.9	4.3	11.7	7.2	5.2	14.7	6.2	0.2	1.7	2.0	0.0	4.6	4.3	4.4	16.4	5.9	14.4	2.5	78.7	4.5	0.5	12.6	1.5	5.5	8.2	10.9	4.2	0.8	5.3	28.6	53.7	2.5	10.2	7.9	14.3	2.7	8.7	8.2	7.2	9.4	6.1	3.1	1.0	64.3	25.2	5.1	0.3	9.1	0.1	7.7	1.5	3.8	5.3	8.3	6.6	8.2	11.3	8.5	12.0	3.2	10.9	0.3	3.9	4.5	2.3	5.2
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355249-194369743	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.9;skin 1: 7.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"fHDF/TERT166: 120.6;U-87 MG: 62.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		1700000		"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	1.1	0.1	0.0	1.3	0.0	0.0	3.7	0.0	0.0	2.9	0.0	1.7	0.5	1.9	0.0	0.5	1.1	1.6	0.2	0.0	0.0	0.0	0.1	2.0	0.8	0.0	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.1	3.0	0.0	1.0	0.0	0.1	7.3	0.4	0.6	0.0	1.3	1.5	0.0	0.1	0.2	1.3	0.2	4.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.7	0.1	0.1	0.4	0.0	0.0	1.0	120.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	22.5	3.7	3.0	0.0	0.0	0.0	0.0	62.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023305-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.0	6.1	2.3	3.8	2.2	7.0	5.8	7.5	5.4	6.1	2.2	8.7	5.7	5.4	0.9	10.3	9.0	1.6	5.0	2.5	1.9	7.5	18.0	6.4	3.2	3.0	2.8	4.5	10.1	2.0	5.9	2.4	3.0	8.4	1.7	0.6	9.6	2.2	2.5	8.7	8.6	1.2	2.1	9.5	10.5	4.0	2.2	3.1	8.9	0.5	1.5	6.1	6.9	2.3	18.6	20.7	6.2	12.7	2.5	3.3	24.0	12.7	5.2	7.5	6.3	18.6	12.4	13.9	11.2	2.5	7.8	21.3	6.0	7.6	1.7	8.5	38.6	8.8	43.1	25.5	2.1	10.4	21.2	3.3	3.1	4.5	1.2	3.1	11.1	13.0	6.3	6.0	2.0	31.6	23.5	34.5	6.4	15.0	27.4	19.0	12.2	7.8	4.8	16.9	19.1	18.6	5.8	29.9	11.2	3.0	24.4	12.0	6.5	13.1	16.3	20.8	21.9	11.5	3.1	2.1	7.0	8.9	13.9	2.3	1.2	1.5	1.4	0.9	1.4	0.6	1.6	1.6	0.8	0.7	0.8	1.1	0.0	1.1	0.4	1.3	1.4	1.4	2.3	2.2	7.5	5.4	2.5	1.9	3.0	2.8	3.0	2.1	2.2	2.3	3.9	6.4	2.2	4.2	4.1	4.5	5.0	2.9	1.8	5.2	8.5	8.6	2.7	14.3	7.0	3.7	0.0	12.7	7.8	18.1	5.9	7.3	1.5	19.0	3.4	3.7	4.8	10.3	2.5	4.7	27.9	4.8	13.3	5.0	4.5	13.3	7.1	12.6	8.7	5.0	2.9	12.2	4.1	6.3	3.2	4.4	7.2	4.2	8.8	0.0	4.3	5.6	7.2	1.0	1.8	5.8	9.4	6.4	8.5	2.4	10.9	10.2	24.4	4.1	0.0	2.8	5.2	2.3	11.9	6.3	2.4	3.0	7.0	4.9	18.4	3.7
LRRC69		ENSG00000214954	"Leucine rich repeat containing 69"	Q6ZNQ3	8	91101832-91219236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 77.3;Late spermatids: 18.0;Microglial cells: 27.2;Oligodendrocytes: 27.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.3;SuSa: 5.2;U-266/70: 16.0;U-266/84: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046337	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"		"HPA046337: AB_2679626"	"unprognostic (1.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.69e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-6)"	"unprognostic (6.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.68e-5)"	0.3	0.5	0.2	0.9	0.6	0.1	0.6	0.6	0.4	0.3	0.8	0.3	0.2	0.2	0.9	0.3	0.2	0.4	0.5	0.2	0.4	0.5	0.3	0.4	1.1	0.8	0.5	0.2	0.3	0.9	0.2	0.4	0.8	0.5	0.7	0.6	0.7	0.3	0.5	1.7	0.4	0.8	0.5	0.7	0.4	2.9	0.5	0.8	0.5	0.4	0.7	0.7	0.3	1.0	0.6	0.6	0.1	0.4	0.6	1.3	1.0	0.3	0.1	0.2	0.3	0.9	0.8	0.9	0.4	0.2	0.1	0.6	0.7	1.1	0.3	0.3	6.3	1.4	1.8	0.4	0.2	0.5	1.0	0.4	1.0	0.4	0.7	0.4	0.1	1.1	1.0	0.5	0.4	0.2	0.3	0.4	0.6	1.0	0.4	0.8	0.0	0.7	0.2	0.7	0.0	0.2	0.0	0.4	1.0	5.2	1.4	1.0	0.5	0.2	0.6	0.1	0.8	16.0	9.5	3.8	0.1	2.1	0.8	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.3	0.1	0.0	0.4	0.4	0.2	0.0	0.1	0.1	0.4	0.5	0.0	0.2	0.6	0.6	0.4	0.2	0.4	0.8	0.5	0.8	0.5	0.5	1.0	1.1	0.0	1.1	16.0	1.5	4.7	2.9	1.3	0.6	1.9	1.6	0.6	2.9	0.0	1.5	3.7	4.2	2.3	2.0	1.1	3.9	1.5	77.3	1.2	0.4	2.7	2.4	0.8	5.3	1.2	1.9	1.7	0.0	0.6	0.0	1.0	4.2	0.6	0.9	0.0	6.4	2.2	6.1	1.3	7.0	18.0	2.8	1.6	7.2	27.2	4.2	1.1	2.1	7.5	27.9	1.8	1.6	1.2	0.2	5.3	0.4	0.9	6.1	3.2	0.0	4.7	2.7	4.2	4.0	0.7	5.3	1.0	2.2	0.9	1.7	2.3
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"		1	69567922-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	9	"brain: 20.2"	"Group enriched"	"Detected in many"	20	"Excitatory neurons: 1132.4;Inhibitory neurons: 996.9;Oligodendrocyte precursor cells: 1038.0;Oligodendrocytes: 408.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 6.9;basal ganglia: 17.0;cerebral cortex: 20.2;hippocampal formation: 17.7;thalamus: 11.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 12.6;HEL: 44.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	0.1	0.2	6.9	0.1	17.0	0.2	0.0	0.0	20.2	0.2	0.0	0.4	0.1	0.2	0.1	0.2	0.0	1.0	1.4	17.7	1.7	0.8	0.2	0.0	0.1	0.0	2.2	0.1	0.8	0.1	0.0	0.2	0.0	0.3	0.6	1.5	0.0	0.1	1.0	0.2	0.2	0.2	0.0	0.0	0.2	1.6	11.4	0.0	2.2	0.0	0.0	0.1	0.1	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	4.4	0.0	0.0	12.6	0.3	0.0	0.0	0.0	0.6	44.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	4.7	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	6.9	17.0	0.0	20.2	17.7	1.7	0.0	2.2	0.0	0.0	11.4	2.9	0.8	0.0	0.0	41.4	2.5	0.8	0.6	0.4	1.8	44.4	0.3	0.3	6.2	2.8	0.2	0.0	2.1	0.4	2.4	0.0	0.0	0.0	29.4	0.5	1.4	1.2	0.0	3.2	1132.4	0.0	0.5	1.8	0.0	1.4	0.0	0.6	2.9	6.5	0.3	6.7	996.9	0.0	0.0	2.8	3.6	6.3	0.6	0.5	5.4	17.8	1.7	1.0	2.1	1038.0	408.2	0.0	0.0	3.0	1.3	0.9	0.0	1.6	0.1	8.3	0.0	1.4	1.5	9.2	3.0	0.5	1.3	0.1	2.3	0.1	0.0	0.1
LRRC9	FLJ46156	ENSG00000131951	"Leucine rich repeat containing 9"	Q6ZRR7	14	59919713-60063559	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;choroid plexus: 12.4;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 112.6;Excitatory neurons: 28.0;Inhibitory neurons: 18.0;Late spermatids: 75.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040965, HPA041381, HPA077675"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Nuclear bodies"	"HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: "	"unprognostic (1.01e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.62e-3)"	"unprognostic (8.54e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-2)"	0.3	0.1	0.9	0.0	1.6	0.1	0.0	1.0	0.6	0.0	12.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	5.2	5.4	0.0	0.0	0.7	0.5	0.0	3.7	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	4.3	0.0	0.0	8.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.0	0.6	1.0	1.7	5.2	5.4	3.7	4.3	1.9	5.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.6	1.5	0.1	0.1	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.7	18.0	0.0	0.0	0.0	0.0	75.8	0.9	0.1	0.0	1.9	0.0	0.8	0.0	5.5	2.0	0.0	0.0	0.7	0.0	0.7	0.4	0.0	2.9	0.2	0.0	0.0	0.0	10.3	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
LRRFIP2	HUFI-2	ENSG00000093167	"LRR binding FLII interacting protein 2"	Q9Y608	3	37052626-37183689	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 516.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035956, HPA042023"	Uncertain		Approved	"Plasma membrane,Actin filaments"		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Actin filaments"		"HPA035956: AB_10671238, HPA042023: AB_2677802"	"unprognostic (2.03e-3)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.16e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.84e-3)"	"unprognostic (3.76e-2)"	23.4	24.0	43.7	20.1	46.9	44.3	22.3	43.6	49.0	46.0	33.6	38.3	35.4	31.8	19.7	52.6	25.8	22.0	75.8	38.8	44.4	24.0	48.5	27.0	18.1	43.4	42.0	27.4	19.2	33.3	18.6	20.8	44.8	41.0	34.2	36.0	28.5	24.3	97.9	37.0	36.2	31.5	41.0	45.0	26.5	71.8	46.4	18.8	27.5	45.3	23.2	24.2	40.9	60.9	56.6	30.8	34.9	27.7	45.5	69.3	30.5	149.9	148.2	82.6	94.3	29.0	25.3	22.2	24.0	145.4	40.8	28.8	25.8	74.2	134.3	49.7	20.2	39.8	44.0	28.6	64.8	31.9	23.3	31.1	52.1	107.8	110.4	45.8	58.2	34.0	32.3	37.8	69.5	14.4	27.2	17.0	23.0	23.0	39.2	13.0	99.2	22.6	58.4	21.7	12.6	19.9	57.9	53.0	49.4	28.0	30.6	32.6	56.5	63.1	42.6	93.4	71.5	29.1	57.1	33.9	37.1	28.1	91.4	20.5	21.4	33.8	8.8	14.9	11.3	9.7	9.3	9.5	14.1	8.5	6.8	8.3	19.2	16.9	26.9	7.9	13.0	11.7	43.7	46.9	43.6	49.0	38.8	44.4	43.4	42.0	44.8	41.0	46.4	60.9	47.8	28.9	36.5	98.6	29.1	136.1	143.0	41.3	113.8	36.3	64.7	53.2	123.1	38.6	53.7	23.9	29.2	29.2	28.7	117.2	64.6	89.8	516.2	78.9	44.0	59.9	54.0	60.0	169.8	94.3	46.1	57.4	37.8	127.3	52.6	29.4	56.7	58.8	24.9	122.8	197.7	45.6	28.5	35.6	128.3	330.7	42.3	48.2	74.7	62.8	67.7	51.9	30.9	130.7	309.0	109.9	90.1	57.6	45.8	325.6	125.8	46.1	36.2	51.9	39.5	32.4	72.8	159.9	73.4	139.3	170.5	39.3	34.1	90.0	66.0	303.2
LRRIQ3	"LRRC44, MGC22773"	ENSG00000162620	"Leucine rich repeats and IQ motif containing 3"	A6PVS8	1	74026015-74198187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 20.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 258.5;Late spermatids: 103.6;Spermatocytes: 204.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.9;JURKAT: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030799	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA030799: AB_10601337"	"unprognostic (5.94e-3)"	"unprognostic (6.00e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.65e-2)"	1.6	0.7	0.5	0.7	0.5	0.1	0.7	0.6	0.7	0.2	1.2	0.3	0.2	0.2	0.3	0.1	2.1	0.4	0.3	0.4	0.6	2.0	0.9	0.3	0.7	0.7	0.8	0.3	0.2	1.2	0.5	0.2	0.7	0.4	0.2	0.5	0.7	0.4	0.1	0.1	0.2	0.0	0.6	0.4	0.3	20.4	0.7	1.0	1.5	0.5	0.6	0.2	0.1	0.7	0.2	1.0	0.1	0.4	1.0	0.4	0.6	0.6	0.4	0.8	0.9	0.1	1.4	1.4	1.2	0.1	7.9	0.1	2.1	2.0	1.0	3.5	0.0	1.3	0.3	0.7	0.1	2.3	0.7	0.7	1.0	1.4	0.5	0.3	0.4	4.8	1.1	1.9	1.4	0.0	0.9	0.3	1.1	2.5	0.6	1.1	0.8	1.4	1.2	0.1	1.0	0.7	0.1	0.1	3.1	0.2	0.9	1.3	0.1	0.1	0.7	0.5	1.2	2.0	0.7	1.1	1.5	0.2	1.1	0.0	0.0	0.8	0.9	0.5	1.1	1.6	1.0	1.1	0.1	0.7	0.9	1.3	0.0	0.4	0.1	0.4	1.6	0.3	0.5	0.5	0.6	0.7	0.4	0.6	0.7	0.8	0.7	0.6	0.7	0.7	1.0	0.0	1.5	2.0	2.8	1.1	1.2	4.0	0.0	1.0	2.0	2.8	1.2	2.8	2.6	0.0	4.2	1.7	0.5	0.3	13.7	1.5	258.5	21.6	0.8	0.8	3.0	0.4	4.1	1.7	1.5	0.3	0.0	1.5	0.0	3.2	0.7	1.8	1.3	0.0	3.9	0.6	0.0	0.6	0.2	103.6	1.8	0.5	0.0	1.9	0.8	1.2	2.1	2.0	4.0	0.9	0.1	1.5	0.6	0.9	0.1	6.3	36.0	0.7	0.0	0.2	1.5	204.8	31.3	0.0	0.1	0.3	1.5	3.6	0.7	1.2
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279087-50288114	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.9;skeletal muscle: 16.5"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 283.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079523			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA079523: "	"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.4	0.4	2.9	0.1	4.8	0.4	0.3	3.1	3.7	1.3	1.8	0.5	0.3	0.7	0.2	0.5	0.7	0.2	23.9	3.2	3.2	0.8	0.2	0.4	0.0	3.7	3.7	1.2	0.2	0.0	0.1	0.1	3.4	0.4	0.1	0.3	0.2	0.4	16.5	0.2	0.3	0.4	2.7	0.2	0.3	3.9	3.8	0.0	0.2	5.5	0.0	0.4	0.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.8	3.1	3.7	3.2	3.2	3.7	3.7	3.4	2.7	3.8	6.0	1.0	0.0	0.6	0.7	0.3	1.0	0.2	0.2	0.0	0.2	1.5	0.9	4.4	0.0	0.8	1.8	0.0	0.1	0.3	0.9	0.0	0.1	40.5	3.3	0.6	0.8	0.0	0.0	0.2	0.2	0.1	0.4	0.0	10.1	5.1	0.2	0.0	0.3	0.1	0.0	0.2	0.3	0.0	0.3	0.4	283.1	1.2	0.3	1.8	0.0	0.0	0.5	0.0	0.0	2.8	0.2	0.0	0.7	0.0	0.4	1.5	0.1	0.2	0.2	0.0	1.4	4.7	1.8	1.1	0.4	1.3	0.1	0.2	0.1	0.7	0.1
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082638	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 30.6"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 1890.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.9;HAP1: 4.4;HeLa: 1.9;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: AB_2676307, HPA046161: AB_2679564"	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	0.3	6.5	8.6	0.1	8.5	0.1	0.5	11.8	8.0	0.1	1.1	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	6.3	15.1	0.2	0.9	0.2	0.0	10.8	30.6	0.0	0.0	0.0	0.6	0.0	17.2	2.4	0.6	1.1	0.1	0.1	0.0	0.1	0.2	0.3	17.6	0.1	0.1	0.5	15.3	0.0	0.0	0.6	0.0	0.3	0.1	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.9	4.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	11.8	8.0	6.3	15.1	10.8	30.6	17.2	17.6	15.3	16.5	0.3	0.0	0.0	11.4	0.0	0.6	0.1	0.0	1.8	6.9	0.3	1.7	0.6	0.0	0.0	3.7	0.0	0.0	0.1	1.2	0.0	0.0	33.7	0.6	0.7	0.1	0.0	0.0	149.4	0.0	0.1	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	371.4	1.7	0.0	0.0	0.0	6.4	0.9	0.1	0.0	4.7	0.0	0.3	0.0	1890.0	9.1	0.2	23.9	0.0	0.0	4.5	0.0	0.7	0.0	0.8	0.0	0.4	0.3	0.3	0.6	0.9	0.3	0.1	0.0	2.4	1.5	1.6
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.5;testis: 36.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 186.7;Prostatic glandular cells: 105.2;Spermatocytes: 404.4;Spermatogonia: 105.8;Urothelial cells: 131.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 11.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 125.2;BJ: 131.9;HeLa: 142.4;SiHa: 206.3;U-2197: 273.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017770, CAB075742, CAB075743, CAB079929"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB075742: AB_2665748, CAB075743: AB_2665749, CAB079929: , HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	5.4	0.2	0.6	0.2	0.6	0.3	4.4	0.9	1.7	3.3	0.0	0.5	0.3	0.5	0.2	12.5	1.2	0.4	1.5	0.8	1.0	3.0	0.2	0.8	0.2	1.7	0.8	0.7	0.3	0.0	0.4	2.4	2.0	1.1	0.0	2.4	1.7	0.8	5.4	6.8	0.3	0.1	1.1	0.2	1.1	36.0	0.7	0.6	1.0	1.3	0.6	1.0	5.1	1.1	125.2	2.0	0.0	6.3	2.4	7.9	1.5	131.9	15.3	39.9	24.0	0.2	0.5	0.0	10.9	15.0	14.3	10.8	0.0	7.5	33.5	1.2	0.2	0.1	142.4	0.3	1.9	0.0	0.0	11.7	21.1	29.7	38.0	0.1	3.7	0.0	0.0	0.6	76.2	1.0	0.2	0.3	4.2	4.1	2.0	0.3	0.5	0.2	6.7	1.7	3.7	0.5	206.3	2.7	41.3	6.6	0.5	0.2	5.4	1.9	11.8	273.2	0.2	0.2	0.1	0.3	0.6	0.1	13.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.9	1.7	0.8	1.0	1.7	0.8	2.0	1.1	0.7	1.1	25.6	3.2	0.5	0.0	0.4	38.9	54.2	4.3	21.6	0.6	15.1	49.8	0.2	5.7	9.8	25.8	0.0	13.5	0.3	0.0	0.0	0.8	7.7	3.1	8.5	9.2	0.0	0.0	0.0	0.0	186.7	8.0	0.0	9.0	0.0	0.0	3.3	0.1	6.0	0.0	0.0	0.0	6.1	0.3	28.7	14.8	4.1	4.6	12.4	0.0	0.0	0.5	0.0	0.0	0.1	6.7	1.1	3.0	0.0	105.2	0.0	0.2	3.6	0.6	0.0	17.8	13.1	404.4	105.8	32.2	44.9	25.3	0.7	0.1	0.0	131.4
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 244.0;dendritic cells: 36.2;Melanocytes: 71.2;Plasma cells: 102.5;T-cells: 44.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.3;JURKAT: 14.1;Karpas-707: 28.0;U-266/70: 70.7;U-266/84: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050917	Approved		Approved	"Plasma membrane,Centriolar satellite"		NA	NA		43000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Centriolar satellite"	"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"	2.4	0.9	0.1	13.7	0.2	11.5	2.0	0.1	0.2	0.8	0.2	3.9	4.0	0.6	0.4	0.9	0.9	2.5	0.5	0.1	0.2	1.1	2.3	3.8	30.2	0.3	0.2	0.6	0.2	0.0	0.2	0.3	0.2	1.1	3.8	0.0	7.1	0.4	0.3	0.8	12.0	0.5	0.3	26.7	6.0	0.2	0.2	25.5	1.4	0.2	31.1	3.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	28.0	0.0	0.0	2.3	0.5	0.1	0.8	0.0	1.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	70.7	29.3	0.3	0.0	4.0	0.0	1.2	0.8	0.4	112.9	1.1	113.5	56.1	97.6	109.8	5.2	52.8	109.6	112.3	2.4	22.2	0.8	72.8	80.3	53.5	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.0	1.8	0.3	244.0	1.0	0.5	0.1	0.0	0.0	0.4	0.8	0.9	0.0	0.0	0.0	0.0	0.1	36.2	0.1	0.0	0.0	0.1	0.1	0.1	0.7	1.2	28.0	0.1	0.2	0.0	1.4	0.5	0.1	0.0	0.0	1.8	0.4	1.9	0.0	0.1	0.0	0.0	3.2	31.9	0.0	0.0	6.3	71.2	1.9	2.1	0.0	22.6	0.0	0.1	0.1	0.0	0.0	102.5	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.1	0.5	1.0	0.1	44.8	0.0	0.3	0.3
LYPD1	"LYPDC1, MGC29643"	ENSG00000150551	"LY6/PLAUR domain containing 1"	Q8N2G4	2	132643286-132671579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.2;choroid plexus: 15.4;fallopian tube: 53.5;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 73.8;Exocrine glandular cells: 74.5;monocytes: 62.0;Oligodendrocyte precursor cells: 28.1;Pancreatic endocrine cells: 43.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 57.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 41.6;HUVEC TERT2: 32.7;SK-MEL-30: 36.5;U-251 MG: 65.9;WM-115: 140.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068333			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA068333: "	"unprognostic (9.25e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.40e-3)"	"unprognostic (5.60e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	0.6	0.8	24.8	0.3	27.1	0.4	0.8	19.5	25.5	0.3	15.4	8.1	0.1	0.9	0.1	1.5	53.5	1.2	0.8	24.2	29.2	5.9	1.0	1.0	0.6	29.9	30.0	1.3	5.1	0.3	33.7	0.0	27.7	0.7	0.2	1.6	5.5	0.1	0.3	0.3	1.6	0.6	27.3	0.3	0.9	0.7	31.2	2.2	0.9	0.1	1.0	0.8	0.6	21.5	0.4	8.6	11.6	0.2	0.0	0.0	0.0	1.9	1.5	6.3	1.4	0.6	1.1	0.0	18.3	5.1	3.0	7.2	0.0	0.0	2.9	0.1	1.8	0.0	4.0	0.0	0.0	0.0	0.2	0.0	0.1	41.6	0.0	1.7	32.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	11.1	0.2	3.3	0.0	0.0	0.0	15.1	0.2	1.1	2.3	1.8	0.2	36.5	26.8	0.1	0.3	1.5	0.7	17.4	5.9	65.9	0.1	0.0	0.1	10.0	0.0	140.5	0.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	27.1	19.5	25.5	24.2	29.2	29.9	30.0	27.7	27.3	31.2	21.5	0.7	0.0	0.0	8.1	0.2	0.1	0.1	0.4	0.0	1.6	2.0	0.9	0.2	2.8	0.2	5.5	0.0	0.0	0.0	0.5	1.9	73.8	5.6	1.4	0.1	0.2	1.8	0.0	0.8	74.5	0.0	2.2	0.0	0.9	0.0	0.1	0.4	0.0	0.1	15.2	4.7	0.0	0.0	0.8	0.7	9.3	4.1	0.1	0.0	0.0	62.0	1.4	0.0	28.1	4.4	43.4	0.0	0.0	0.0	0.1	0.1	4.8	0.3	0.8	0.0	0.2	3.9	2.6	2.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Phagocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.3;retina: 27.9"	"Cell type enhanced"	"Detected in all"		"monocytes: 277.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;SK-MEL-30: 27.1;THP-1: 99.5;U-937: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: AB_2682129, HPA055725: AB_2682898"	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	5.2	2.7	2.0	8.5	2.7	31.3	6.4	10.1	3.3	7.1	9.1	4.5	3.0	4.3	2.7	4.2	3.9	5.1	2.2	2.0	2.5	3.6	5.5	5.5	7.5	2.2	2.6	4.5	2.2	6.2	1.8	4.6	2.5	3.4	4.3	27.9	4.3	3.3	1.7	9.7	3.3	4.4	1.1	10.8	7.7	6.1	3.3	25.7	6.4	3.8	6.5	5.7	5.2	3.4	8.6	1.9	0.9	2.0	12.7	14.4	1.3	3.1	12.5	3.3	3.1	0.0	2.3	1.1	1.2	6.8	7.7	4.1	1.2	1.6	2.9	30.8	2.7	2.8	1.9	0.6	2.3	4.2	3.7	4.8	7.8	4.0	10.0	4.8	2.8	1.3	0.2	1.7	2.6	0.4	5.3	8.7	0.2	1.6	0.9	0.4	1.2	0.0	9.2	9.2	5.4	1.1	3.4	0.2	27.1	1.0	1.2	99.5	5.8	2.4	1.1	2.8	2.8	2.1	0.1	0.2	4.1	38.0	7.0	0.4	2.9	5.7	0.6	3.4	0.8	1.0	0.2	0.7	1.7	1.4	0.2	0.4	12.2	1.7	6.1	0.2	0.2	0.7	2.0	2.7	10.1	3.3	2.0	2.5	2.2	2.6	2.5	1.1	3.3	3.4	66.3	19.2	41.1	71.2	70.9	71.0	89.8	14.6	18.8	67.4	17.6	15.6	11.6	15.7	28.4	11.0	93.8	6.7	77.3	25.0	11.7	6.6	24.6	22.6	23.8	51.2	9.6	21.0	151.5	12.3	5.0	27.0	41.3	22.4	112.5	9.4	26.0	15.4	31.9	52.2	155.9	14.3	28.5	65.6	81.3	17.7	28.0	111.4	120.9	159.3	277.4	25.6	88.6	112.1	81.6	39.6	24.2	21.8	37.3	56.0	12.7	10.9	26.7	162.5	13.1	31.2	22.7	93.3	28.0	18.7	65.1	8.8	71.3	13.6	7.6	98.5
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.8;parathyroid gland: 54.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 17.6;Excitatory neurons: 26.2;Horizontal cells: 20.2;Melanocytes: 19.6;Rod photoreceptor cells: 18.5;Sertoli cells: 65.7;Smooth muscle cells: 15.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.1;basal ganglia: 11.6;cerebral cortex: 14.8;hippocampal formation: 14.5;white matter: 9.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 19.7;SK-MEL-30: 75.0;U-698: 23.2;WM-115: 50.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 23.2;basal ganglia: 66.8;cerebral cortex: 45.5;hippocampal formation: 36.3;olfactory bulb: 26.7"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	3.7	1.7	13.1	1.5	11.6	0.1	3.0	0.0	14.8	2.0	0.0	1.3	0.5	2.9	0.9	5.3	1.6	3.5	5.0	14.5	0.6	4.7	0.7	7.0	1.1	0.0	0.1	1.2	1.5	54.2	2.2	6.5	0.3	2.8	0.4	3.5	1.4	1.1	1.9	4.6	0.9	2.5	0.0	0.5	1.4	7.5	2.3	1.9	2.7	2.0	0.5	2.3	1.7	9.2	0.1	0.0	9.7	8.3	0.0	0.0	1.2	5.0	0.1	4.3	3.7	0.3	0.1	11.1	3.5	3.1	1.6	0.2	0.5	0.2	2.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	1.7	0.9	0.1	1.8	0.0	0.6	0.0	11.7	0.0	0.1	14.4	0.0	19.7	0.1	12.2	0.0	0.0	0.0	15.6	0.0	2.7	0.4	14.8	12.9	0.0	0.0	75.0	8.2	0.1	0.4	0.0	5.1	3.5	0.1	1.5	0.1	0.1	23.2	0.1	1.1	50.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.1	11.6	0.0	14.8	14.5	0.6	0.0	0.1	0.3	0.0	2.3	9.2	3.9	0.0	0.0	1.6	0.0	1.3	0.8	1.0	17.6	1.8	0.3	11.3	4.6	0.0	0.1	0.0	4.2	7.1	0.4	0.0	1.9	0.0	0.5	0.6	1.3	3.2	0.0	0.0	26.2	0.0	2.3	2.4	0.0	0.5	0.0	3.5	0.0	0.0	0.9	20.2	2.9	0.0	2.0	0.0	0.0	0.8	1.2	0.2	19.6	1.9	0.0	0.9	0.0	6.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	18.5	65.7	1.1	15.4	0.2	1.1	7.3	0.1	0.8	1.4	2.5	0.0	0.0
MADD	"DENN, KIAA0358, RAB3GEP"	ENSG00000110514	"MAP kinase activating death domain"	Q8WXG6	11	47269161-47330031	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Guanine-nucleotide releasing factor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 133.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 80.9;Cone photoreceptor cells: 125.1;Horizontal cells: 132.9;Rod photoreceptor cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 33.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 33.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038568	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA038568: AB_10795030"	"unprognostic (3.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (6.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.36e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.25e-4)"	15.1	24.6	32.4	17.7	32.2	28.4	14.8	46.7	44.5	16.1	0.3	17.9	12.4	15.1	12.0	11.1	14.0	12.2	24.6	40.5	21.2	17.1	13.0	19.0	20.9	18.2	18.8	18.8	17.5	18.4	65.7	16.0	22.1	20.7	16.6	133.2	16.6	17.1	30.1	22.8	19.0	14.6	7.0	22.0	18.8	28.5	16.7	23.6	14.4	23.4	17.9	18.7	15.0	32.1	14.0	28.7	30.8	27.6	20.6	14.3	6.9	19.3	25.8	24.2	25.9	21.0	12.9	29.6	6.0	21.3	31.1	27.2	25.2	13.6	20.8	33.1	25.6	52.7	55.0	18.3	14.8	36.1	69.4	13.9	14.3	12.7	15.9	16.4	22.4	18.7	34.5	21.1	21.5	19.7	17.2	38.6	18.4	32.8	19.6	23.2	49.5	19.7	12.4	66.0	48.4	31.5	24.9	29.0	17.6	18.1	22.8	27.0	19.2	22.4	14.1	32.3	13.2	24.9	27.9	16.6	20.9	25.1	21.5	33.3	3.4	6.5	5.6	5.6	5.0	4.0	3.9	4.6	5.2	4.2	4.5	3.6	0.9	5.7	7.9	2.7	7.5	6.2	32.4	32.2	46.7	44.5	40.5	21.2	18.2	18.8	22.1	7.0	16.7	32.1	10.6	12.8	9.2	21.5	11.7	10.7	4.1	6.1	6.8	80.9	11.3	10.2	23.4	7.2	5.8	7.3	125.1	4.6	29.0	21.2	0.0	7.5	14.6	5.3	7.0	11.5	16.3	8.6	37.4	4.9	2.3	7.8	23.4	8.3	26.6	13.9	14.6	7.0	11.5	132.9	33.7	17.7	4.1	19.4	14.9	4.9	7.2	14.9	10.6	21.5	11.1	14.4	23.7	14.1	22.4	12.0	12.2	12.8	17.7	8.0	12.2	5.1	6.2	106.8	6.6	8.7	7.7	14.9	23.2	6.7	8.2	4.4	15.4	16.2	13.7	5.9
MAMDC2	MGC21981	ENSG00000165072	"MAM domain containing 2"	Q7Z304	9	70043848-70226972	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 74.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 42.5;Excitatory neurons: 37.0;Fibroblasts: 38.7;Inhibitory neurons: 42.9;Leydig cells: 96.6;Microglial cells: 45.9;Peritubular cells: 82.0;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.7;HHSteC: 57.2;LHCN-M2: 75.0;TIME: 71.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021814, HPA022249"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles, Plasma membrane"		"HPA021814: AB_1853508, HPA022249: AB_2139157"	"unprognostic (1.88e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (2.79e-3)"	17.2	8.2	1.0	1.2	1.2	0.2	15.6	0.8	1.6	30.4	2.3	45.5	8.4	74.5	19.1	21.2	58.5	13.0	15.4	0.7	1.5	2.6	1.2	37.2	0.5	0.7	1.2	49.1	3.7	1.8	0.8	4.3	0.7	7.7	12.3	5.7	9.9	10.8	6.6	9.2	21.6	25.3	0.7	16.1	19.1	7.5	1.8	1.6	8.0	17.1	3.1	32.3	18.5	1.1	0.3	0.0	0.7	0.0	55.7	18.8	1.7	11.1	5.0	2.7	4.6	0.0	1.2	0.0	0.7	2.1	1.5	9.1	0.1	0.8	2.3	0.0	0.0	0.0	15.6	0.1	57.2	0.0	0.0	3.6	0.7	1.7	0.9	19.9	4.9	0.0	0.0	0.5	75.0	0.0	0.0	0.1	7.7	0.1	0.0	0.0	8.8	7.3	24.6	0.0	0.7	0.0	0.1	0.1	0.0	20.8	0.0	0.0	71.0	0.0	1.8	0.1	2.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.6	0.7	1.5	0.7	1.2	0.7	0.7	1.8	1.1	2.0	0.0	1.5	20.2	0.5	6.1	0.5	0.4	0.6	0.8	0.5	10.8	4.3	0.0	0.1	3.7	4.2	0.2	0.2	0.2	0.0	0.1	42.5	0.7	13.7	3.9	0.0	0.0	37.0	0.2	6.6	38.7	0.5	0.5	1.3	0.3	0.4	0.0	3.3	0.0	42.9	0.1	0.0	0.0	17.5	11.4	96.6	13.6	10.6	45.9	0.0	13.8	0.0	11.6	23.3	0.4	0.2	82.0	0.0	0.1	0.0	0.5	0.1	0.5	39.5	4.8	22.4	0.4	0.4	1.1	4.8	0.3	0.8	0.1	0.1	0.1
MAP11	"C7orf43, FLJ10925, TRAPPC14"	ENSG00000146826	"Microtubule associated protein 11"	Q8WVR3	7	100154420-100158723	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 7.0;Extravillous trophoblasts: 7.2;Hofbauer cells: 7.7;Syncytiotrophoblasts: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019359, HPA029463, HPA029464"	Approved		Enhanced	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles	"Plasma membrane, Centriolar satellite"	"HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205"	"unprognostic (1.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.36e-3)"	"unprognostic (5.68e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.54e-3)"	7.5	13.3	9.4	16.7	9.6	11.9	8.4	9.6	10.7	9.7	7.4	20.0	14.2	11.8	6.4	15.9	9.5	7.1	7.3	10.4	12.1	16.6	17.2	10.7	20.7	11.5	11.4	6.7	13.8	17.6	17.9	7.3	12.3	12.8	11.5	4.9	15.3	8.4	5.6	25.0	22.5	5.7	7.0	32.2	17.8	30.3	12.0	13.9	15.5	3.8	12.4	9.4	10.9	9.4	7.6	9.7	11.1	18.8	6.8	3.7	12.5	13.9	10.8	9.4	6.8	7.6	8.8	9.6	12.4	10.5	14.6	14.4	5.3	11.0	3.6	18.1	10.6	7.3	13.5	6.7	8.1	9.0	32.1	7.5	7.4	9.1	7.0	6.8	8.3	9.7	15.9	16.9	12.4	23.6	20.7	19.3	12.4	14.0	13.9	12.3	5.1	10.7	8.2	8.6	14.0	14.8	12.5	35.7	7.6	7.3	7.2	10.7	11.5	18.6	15.7	24.7	10.9	24.8	25.4	9.7	10.5	12.3	20.2	0.6	0.3	1.4	0.6	0.6	0.5	0.2	0.8	0.6	0.2	0.6	0.4	0.7	1.9	0.2	0.6	0.2	0.0	0.2	9.4	9.6	9.6	10.7	10.4	12.1	11.5	11.4	12.3	7.0	12.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424058-209734118	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 253.3;retina: 411.0"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 875.7;Excitatory neurons: 883.3;Inhibitory neurons: 823.6;Oligodendrocyte precursor cells: 688.6;Rod photoreceptor cells: 514.5"	"Group enriched"	"Detected in many"	4	"glioma: 30.4;thyroid cancer: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 296.9;NTERA-2: 106.7;SCLC-21H: 148.6;SH-SY5Y: 82.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012558, HPA012828"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946"	"unprognostic (2.47e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (1.98e-6)"	"unprognostic (2.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.10e-5)"	5.5	11.6	89.2	1.2	115.9	0.3	5.5	2.7	253.3	4.3	0.0	2.9	0.9	2.3	3.9	6.5	2.5	7.6	8.4	135.2	215.6	5.4	3.8	13.5	1.8	37.7	52.2	7.4	10.7	15.5	33.8	0.8	75.3	7.6	1.7	411.0	7.8	4.9	1.7	16.9	1.6	2.8	14.5	1.7	3.3	6.5	123.9	3.5	16.7	4.6	2.4	1.6	5.3	88.2	2.6	0.6	296.9	0.0	3.9	2.2	0.1	1.9	2.1	0.7	2.2	0.0	16.1	0.0	1.7	3.8	14.0	4.1	23.4	1.8	1.0	0.1	1.4	1.2	8.9	0.1	36.7	0.3	0.2	3.1	9.6	0.1	5.8	17.3	7.8	0.1	0.0	3.1	0.3	1.1	0.1	0.0	106.7	0.5	0.5	0.0	0.6	0.3	3.8	0.1	148.6	82.7	6.3	0.9	3.7	34.8	8.2	0.0	0.2	0.3	1.7	0.1	4.1	1.9	0.0	0.0	15.5	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	89.2	115.9	2.7	253.3	135.2	215.6	37.7	52.2	75.3	14.5	123.9	88.2	16.8	96.1	3.2	127.3	1.8	5.9	3.3	12.0	4.6	144.7	6.2	8.0	4.9	27.1	3.7	5.5	875.7	0.4	0.1	0.0	3.9	26.8	22.1	2.2	1.1	15.7	32.4	2.7	883.3	11.0	0.1	5.3	3.6	4.4	1.3	1.6	18.5	0.4	0.5	33.7	823.6	0.2	6.1	1.4	1.5	10.7	28.6	1.4	19.6	74.0	0.0	129.7	0.0	688.6	53.8	10.0	0.0	15.4	0.1	12.3	0.0	0.4	3.4	514.5	32.9	5.1	26.1	6.6	22.7	2.3	6.5	0.3	0.3	6.6	0.0	0.7
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331"	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (1.56e-4)"	19.1	17.0	17.9	11.7	17.8	19.4	19.5	16.8	19.0	25.1	10.4	24.4	13.1	26.1	3.7	20.2	20.5	5.9	20.8	14.8	15.2	18.7	24.7	17.1	11.7	17.3	17.3	23.2	21.6	9.6	23.4	9.2	17.1	21.0	4.6	5.6	19.2	7.9	52.4	27.9	20.1	6.2	15.1	24.5	18.8	17.5	17.3	10.9	19.0	16.4	6.1	22.0	22.4	19.9	25.8	14.4	12.2	20.2	9.7	9.3	22.8	16.5	8.0	11.0	11.3	20.9	15.2	30.5	25.9	8.8	10.7	22.9	10.7	12.8	4.3	24.7	53.3	21.4	20.9	15.6	12.4	20.1	26.0	10.8	16.1	8.7	9.8	14.5	10.0	21.9	31.9	38.5	6.5	13.4	28.8	48.6	21.7	13.6	32.0	28.5	13.4	31.0	9.8	21.0	22.4	22.5	11.3	19.4	23.9	7.3	21.0	22.7	15.3	33.2	19.0	23.7	22.7	55.5	27.7	28.8	16.6	29.2	13.6	0.0	0.8	0.6	0.6	0.8	0.4	0.7	0.5	0.6	0.4	1.0	0.5	0.7	1.5	1.0	0.5	0.8	0.2	0.4	17.9	17.8	16.8	19.0	14.8	15.2	17.3	17.3	17.1	15.1	17.3	19.9	15.4	25.6	18.1	11.1	27.0	38.6	37.2	22.7	22.2	52.9	23.5	16.5	14.4	24.3	14.5	20.2	77.2	28.3	27.8	31.1	13.7	22.8	4.8	16.2	20.3	19.5	36.5	23.6	9.9	19.0	31.1	18.5	16.3	24.8	10.8	33.3	21.4	22.2	18.6	57.2	11.0	24.0	32.6	22.2	17.1	11.7	28.9	20.5	32.0	6.5	25.3	23.9	46.4	9.0	15.0	25.7	20.8	12.4	30.4	39.8	38.7	18.4	15.3	65.7	32.9	30.2	22.1	17.7	36.4	22.7	42.6	49.3	30.3	30.3	27.6	33.2
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 85.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.9;HHSteC: 53.7;HSkMC: 51.8;hTERT-RPE1: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	12.6	7.6	12.9	5.4	15.2	3.2	10.3	25.9	19.6	23.5	4.3	13.3	3.2	22.9	4.8	4.0	18.5	14.0	8.6	15.6	11.3	8.5	1.7	11.2	4.4	11.9	11.1	21.6	3.6	7.3	22.7	6.4	13.2	9.6	3.8	13.6	4.9	10.9	2.7	5.7	8.9	14.4	8.0	9.0	7.3	9.0	13.0	6.0	8.6	6.3	2.7	14.0	12.2	13.7	0.5	15.1	8.6	14.2	55.9	28.9	1.2	10.1	18.9	10.8	11.0	0.3	1.8	3.5	5.4	10.8	8.7	0.1	4.3	6.8	4.3	4.9	5.4	3.5	8.3	0.0	53.7	0.1	3.6	51.8	5.2	14.6	7.8	69.1	16.9	7.8	0.1	15.7	10.0	6.7	3.8	0.9	3.2	0.0	5.5	5.4	6.3	1.0	5.4	0.1	9.3	12.4	5.6	6.8	14.9	1.8	4.6	10.3	12.9	10.2	10.8	4.5	2.5	6.1	8.0	0.0	16.8	6.9	10.4	0.0	0.5	0.0	0.4	0.4	0.8	0.1	0.5	0.6	0.2	0.0	0.2	0.3	1.0	0.2	0.1	0.0	0.1	0.1	12.9	15.2	25.9	19.6	15.6	11.3	11.9	11.1	13.2	8.0	13.0	13.7	11.4	6.4	14.6	21.5	8.1	0.8	2.4	0.5	4.6	28.9	5.6	5.2	0.8	7.2	6.4	1.8	37.5	1.9	12.2	4.8	9.8	6.7	1.5	11.5	27.6	10.4	3.5	1.3	21.1	1.8	2.2	11.0	2.0	15.8	12.7	7.0	15.0	7.8	4.1	30.3	19.1	2.8	2.0	10.3	2.2	1.8	8.1	8.6	0.0	8.4	8.5	19.9	5.2	10.6	11.0	4.4	2.1	8.2	6.7	5.3	7.1	14.8	5.5	85.0	6.6	23.5	10.2	2.5	2.1	2.5	1.0	2.2	11.6	12.5	4.1	3.9
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327724-233385148	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 20.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 10.0;Collecting duct cells: 14.7;Ductal cells: 11.9;Exocrine glandular cells: 9.8;Glandular and luminal cells: 11.7;Proximal tubular cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 27.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.7	3.8	1.8	1.3	1.6	2.1	2.5	5.2	2.4	1.0	0.7	6.3	11.7	1.2	3.3	2.5	4.6	1.7	0.4	1.4	1.4	13.5	5.4	4.5	0.9	1.5	0.3	0.7	20.3	4.3	2.1	0.3	1.7	1.3	6.9	1.0	3.8	2.7	0.0	3.3	10.1	0.6	0.2	0.5	12.4	9.4	1.8	0.4	2.3	0.0	1.3	1.2	1.8	1.3	11.6	19.4	0.4	0.0	0.0	0.0	9.6	0.3	0.0	0.4	0.8	10.8	9.8	1.1	7.7	0.2	3.6	6.0	14.4	5.9	1.2	21.6	27.4	0.1	11.4	0.0	0.7	19.0	4.3	0.2	7.8	0.3	10.9	2.2	0.7	8.7	0.2	3.7	0.0	2.6	6.1	6.8	13.6	13.4	8.4	0.0	0.0	20.7	13.1	4.8	13.9	3.7	6.6	0.3	0.0	1.5	5.6	6.0	0.0	0.0	1.8	0.1	11.5	3.4	4.6	0.0	1.8	5.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.8	1.6	5.2	2.4	1.4	1.4	1.5	0.3	1.7	0.2	1.8	1.3	0.9	35.3	10.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.0	6.5	0.0	0.0	0.6	14.7	0.0	0.0	0.4	0.0	3.9	11.9	0.0	5.7	1.0	0.3	0.0	0.0	0.0	9.8	0.0	0.5	0.0	11.7	0.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27354067-27366961	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	42.9	17.8	17.2	5.5	17.0	0.6	42.6	17.4	20.7	50.2	16.8	25.4	1.8	30.9	4.1	70.0	38.8	4.7	61.8	16.6	17.4	37.3	10.4	54.2	4.7	18.4	17.5	15.6	15.2	5.2	18.0	5.1	17.6	41.3	4.5	1.4	30.3	7.3	15.2	65.7	17.7	12.1	17.3	22.3	23.6	8.3	18.4	2.8	30.3	11.3	7.9	39.8	53.4	16.6	7.2	7.2	6.9	4.4	9.9	12.5	1.4	9.0	5.3	7.2	4.4	2.0	9.4	0.1	8.4	16.4	3.2	10.1	2.0	6.4	3.6	6.5	7.1	0.3	16.0	4.7	2.7	0.5	0.4	10.2	17.6	7.8	2.3	8.8	4.0	0.7	2.0	2.7	10.2	25.1	0.2	9.0	2.2	8.7	8.1	2.3	3.2	1.7	12.9	9.1	2.0	3.0	8.5	7.1	6.3	3.1	4.4	5.0	11.6	13.2	7.2	16.6	5.2	3.5	4.1	0.0	12.1	5.8	4.3	0.9	0.6	3.3	2.8	2.0	3.7	1.5	2.5	3.1	1.3	2.0	1.8	1.6	1.2	0.7	4.5	0.0	3.0	1.2	17.2	17.0	17.4	20.7	16.6	17.4	18.4	17.5	17.6	17.3	18.4	16.6	45.8	19.2	17.8	6.2	3.9	12.5	11.9	8.8	17.1	1.1	8.1	8.9	12.2	5.7	10.3	3.7	0.0	1.2	4.3	8.4	3.9	2.8	0.4	2.3	6.0	27.7	0.0	0.8	1.5	4.4	2.5	10.3	8.6	5.2	2.5	1.2	28.9	0.9	2.8	5.0	1.7	6.1	4.1	8.5	7.1	1.2	16.1	6.4	5.4	5.6	9.3	5.4	8.2	0.0	0.2	12.8	1.9	15.1	3.1	9.5	1.1	1.7	6.2	0.8	6.6	10.8	11.1	13.5	7.7	14.7	14.8	0.1	8.2	0.3	8.8	14.9
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.1;lymphoid tissue: 56.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 42.6;dendritic cells: 42.6;Langerhans cells: 27.8;Plasma cells: 30.4;Rod photoreceptor cells: 77.9;T-cells: 43.6"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.2"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 45.2;HDLM-2: 46.4;Karpas-707: 46.9;REH: 25.5;RPMI-8226: 29.8;U-266/70: 36.0;U-266/84: 38.2;U-698: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	2.7	1.5	0.6	14.6	0.7	9.2	1.7	0.7	1.2	1.6	0.7	5.0	2.7	1.3	0.8	2.8	1.8	2.3	1.7	0.7	0.8	2.7	3.0	6.2	32.2	1.0	0.8	0.9	1.2	0.2	1.8	1.8	0.9	2.5	2.3	16.1	2.8	0.5	0.8	1.9	30.1	0.9	0.8	56.9	3.1	1.5	0.9	13.1	3.2	0.2	29.3	2.9	2.1	0.9	0.2	0.3	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	45.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	46.4	0.3	9.8	0.1	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	21.3	0.2	46.9	0.1	0.3	11.0	12.0	1.4	0.3	0.1	25.5	0.1	29.8	0.0	0.0	0.4	0.1	0.1	0.2	0.1	0.3	0.2	10.8	0.1	0.1	0.3	0.1	0.1	36.0	38.2	57.8	0.0	13.5	0.1	2.9	4.9	2.0	18.9	9.4	17.4	22.7	15.8	20.1	23.9	15.5	8.6	12.1	0.5	6.1	5.7	22.2	22.2	12.1	0.6	0.7	0.7	1.2	0.7	0.8	1.0	0.8	0.9	0.8	0.9	0.9	0.7	3.2	4.9	0.3	42.6	2.3	0.2	0.4	1.2	6.7	0.7	1.0	0.9	0.0	0.6	0.0	12.5	0.2	42.6	0.1	0.0	0.0	0.0	0.3	0.2	1.6	0.0	5.5	0.7	0.2	0.3	1.5	2.0	0.3	15.8	0.4	1.1	1.1	2.6	1.7	1.0	0.1	0.0	8.8	27.8	0.2	0.0	11.6	3.6	1.9	10.3	11.5	15.5	1.0	0.5	0.0	0.0	0.0	30.4	0.3	0.0	0.2	0.0	77.9	0.0	1.0	0.4	0.7	6.4	0.6	1.0	0.1	43.6	0.3	0.3	0.1
MAP4K5	"GCKR, KHS, KHS1"	ENSG00000012983	"Mitogen-activated protein kinase kinase kinase kinase 5"	Q9Y4K4	14	50418501-50561126	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 332.7;Oligodendrocytes: 707.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 66.7;eosinophil: 26.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 66.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036696, HPA078030"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane"	"HPA036696: AB_10672362, HPA078030: "	"unprognostic (1.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.58e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.53e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.02e-2)"	20.5	12.8	16.2	13.2	31.1	22.1	22.2	20.7	21.5	30.6	3.9	20.8	13.1	33.4	12.9	20.5	19.0	21.5	10.9	18.3	23.9	11.9	10.0	17.1	12.4	28.4	22.0	32.4	14.2	14.8	11.8	19.8	24.8	17.9	16.6	18.6	18.0	21.1	12.3	28.5	14.7	24.7	17.6	15.7	16.8	7.9	23.8	11.6	17.0	14.2	13.2	20.2	23.8	58.1	51.7	15.2	36.5	31.5	33.0	34.5	35.6	59.2	53.0	39.4	34.9	19.3	35.2	35.3	34.3	54.6	20.9	36.1	34.3	31.9	59.7	29.4	24.8	21.7	27.1	17.5	27.9	19.6	33.0	25.2	25.7	34.8	36.1	63.0	52.6	31.7	20.8	22.5	58.6	19.4	26.6	18.7	17.7	16.6	29.5	31.8	55.4	13.5	39.2	39.5	11.7	26.5	33.5	23.0	23.4	29.3	25.8	14.7	53.8	50.9	35.7	35.2	28.2	16.3	18.0	23.6	19.2	13.5	37.2	66.7	2.8	26.3	6.7	3.3	3.8	6.1	4.2	5.9	3.0	9.7	4.4	4.6	1.0	10.1	2.2	4.9	1.0	1.9	16.2	31.1	20.7	21.5	18.3	23.9	28.4	22.0	24.8	17.6	23.8	58.1	40.5	41.7	20.8	135.2	29.9	70.0	42.9	21.4	56.3	56.7	32.6	26.5	10.5	30.0	27.4	27.6	47.9	11.4	30.6	27.5	19.6	29.5	3.7	25.7	52.2	40.4	23.4	46.7	144.2	20.9	19.5	50.1	43.8	49.1	29.8	37.8	38.6	9.0	8.1	33.7	144.1	16.4	8.2	12.3	24.8	3.7	42.6	25.1	23.2	101.2	18.3	19.5	18.6	332.7	707.2	25.9	20.2	51.1	27.0	57.4	10.9	12.0	25.6	33.1	13.1	49.7	41.7	10.6	14.1	54.9	86.1	6.6	31.5	22.4	18.6	61.7
MARCHF10	"FLJ35757, MARCH-X, MARCH10, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 137.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;EFO-21: 4.7;HSkMC: 2.1;SCLC-21H: 8.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.1	0.2	1.3	0.2	1.6	0.0	0.1	1.2	0.9	1.4	10.5	1.1	0.0	0.4	7.5	0.1	12.8	0.1	0.1	1.1	1.3	1.5	0.0	2.7	0.0	3.6	5.0	0.1	0.2	0.3	12.7	0.0	2.6	0.6	0.0	0.1	0.3	0.1	0.0	0.2	0.4	0.0	3.6	0.1	0.4	137.6	1.3	0.2	0.1	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.1	0.0	0.0	0.1	2.5	1.1	0.1	0.8	0.2	0.0	0.0	0.0	4.7	0.3	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.8	0.6	0.0	1.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.0	8.3	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.1	1.3	1.6	1.2	0.9	1.1	1.3	3.6	5.0	2.6	3.6	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.1;epididymis: 1.9"	"Cell type enriched"	"Detected in single"	62	"granulocytes: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				0.4	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.7	0.3	0.7	1.9	1.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.2	0.0	0.3	0.7	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAT2B	"MATIIbeta, SDR23E1"	ENSG00000038274	"Methionine adenosyltransferase 2B"	Q9NZL9	5	163503114-163519354	"Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037721, HPA037722"	Uncertain		Approved	"Plasma membrane"		NA	NA		1100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA037721: AB_10672389, HPA037722: AB_10671718"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.19e-3)"	"unprognostic (3.57e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-3)"	36.6	54.6	31.1	64.7	32.4	31.1	50.5	35.3	39.8	46.9	37.5	61.5	86.9	45.4	59.4	40.9	66.7	42.1	75.3	32.8	33.7	104.8	82.7	56.1	102.6	32.2	35.3	73.3	23.9	69.2	22.0	48.9	33.3	46.1	66.5	47.8	64.3	53.2	57.8	34.6	84.4	44.4	34.6	84.5	57.2	31.7	33.3	89.6	81.4	63.7	92.7	60.9	33.2	34.0	72.4	60.0	100.6	55.1	73.4	72.9	62.2	61.8	68.5	67.7	99.4	41.5	128.5	74.8	127.6	66.0	99.5	56.6	84.8	125.4	89.1	254.5	69.6	67.3	63.3	62.1	95.9	71.0	44.7	60.4	101.1	86.1	66.4	81.8	149.5	76.6	54.8	90.8	84.0	40.7	99.2	85.9	38.6	43.9	40.0	112.4	49.2	123.4	111.7	76.6	40.4	57.9	82.8	58.2	93.8	44.1	76.5	95.1	121.2	73.6	48.5	51.8	107.7	78.4	82.3	68.3	54.1	129.1	51.3	619.4	227.5	477.4	321.5	274.3	355.8	359.1	351.2	349.3	204.6	345.3	352.7	341.4	357.8	401.5	302.4	167.2	528.3	689.9	31.1	32.4	35.3	39.8	32.8	33.7	32.2	35.3	33.3	34.6	33.3	34.0	24.9	48.1	43.3	8.8	90.1	42.7	35.1	75.6	129.1	23.2	26.0	20.7	57.7	41.5	48.1	44.1	8.4	61.3	62.8	49.2	62.6	38.8	39.0	63.5	36.2	38.9	15.0	79.3	15.0	26.2	29.7	34.6	36.2	44.2	28.4	28.1	35.7	58.3	45.3	18.5	12.8	40.8	61.1	83.3	55.3	13.3	34.5	48.5	42.7	18.7	70.6	41.7	80.3	9.0	16.2	28.9	38.1	31.2	65.7	46.8	53.4	103.7	72.6	17.6	46.0	21.7	35.6	23.6	30.5	69.8	36.2	37.6	84.2	23.3	51.3	45.7
MBP		ENSG00000197971	"Myelin basic protein"	P02686	18	76978827-77133683	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autoimmune encephalomyelitis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	142	"brain: 30812.9;choroid plexus: 9144.9"	"Cell type enriched"	"Detected in many"	11	"Oligodendrocytes: 2895.5"	"Group enriched"	"Detected in all"	9	"glioma: 47.5;melanoma: 20.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 99.3;SK-MEL-30: 204.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002300, HPA049222, HPA064368"	Enhanced	Supported	Approved	"Plasma membrane"		NA	NA		54000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247"	"unprognostic (9.36e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.48e-12)"	"unprognostic (2.90e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	27.3	7.1	15448.6	20.9	21296.6	43.0	20.9	19749.8	26916.8	17.3	9144.9	19.0	18.6	13.2	7.9	20.5	31.5	17.2	24.1	12696.6	16271.8	28.7	23.5	20.0	26.9	30812.9	22193.8	22.3	22.8	47.5	26.7	4.7	25986.2	15.3	16.9	7.5	22.0	13.0	140.8	28.7	20.7	8.7	23219.4	28.0	17.5	6.1	19406.0	12.5	22.2	81.6	27.8	19.0	20.2	30044.2	26.1	22.4	0.2	0.8	35.8	53.1	8.5	0.6	0.6	0.8	0.6	3.2	39.2	15.9	4.4	1.7	0.2	49.9	3.8	22.1	0.7	60.7	5.3	10.4	3.9	5.2	22.5	99.3	65.3	7.7	18.4	19.8	30.3	16.4	6.5	37.9	0.0	3.6	0.0	3.2	4.1	50.6	2.2	15.6	18.1	1.5	0.4	35.9	34.5	34.3	1.8	0.3	3.2	0.0	204.7	6.1	0.6	60.5	0.1	0.2	0.5	0.2	2.8	0.1	0.5	16.9	5.8	62.0	2.5	21.7	8.5	32.4	21.6	8.1	13.1	5.9	15.4	28.1	9.2	5.1	9.1	17.0	39.5	28.0	8.1	11.9	14.9	11.6	15448.6	21296.6	19749.8	26916.8	12696.6	16271.8	30812.9	22193.8	25986.2	23219.4	19406.0	30044.2	5.5	48.1	39.5	10.7	86.8	118.8	61.1	28.1	84.2	52.8	24.2	22.7	45.0	35.8	50.3	103.0	2.1	0.7	221.8	48.7	41.1	43.7	5.9	159.8	11.2	9.4	49.8	68.8	32.4	35.8	0.8	36.2	59.1	161.1	71.5	2.1	10.0	30.2	44.4	1.7	47.1	51.4	44.7	78.3	123.1	6.3	28.3	98.2	92.5	45.0	84.4	25.7	247.2	124.7	2895.5	60.4	25.5	14.3	45.3	117.6	37.5	36.0	54.0	6.1	0.0	88.7	8.4	7.7	1.1	75.6	154.7	0.7	151.6	0.0	42.1	103.7
MCAM	"CD146, HEMCAM, MelCAM, METCAM, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 128.5;Endothelial cells: 153.5;Muller glia cells: 89.8;Sertoli cells: 322.1;Smooth muscle cells: 384.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 83.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HUVEC TERT2: 1121.0;TIME: 1107.4;WM-115: 869.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Approved	"Plasma membrane"		NA	NA		1900000000	"Cluster 13: T-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (8.75e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.79e-3)"	332.7	30.0	36.6	68.4	46.1	1.2	180.6	45.7	45.3	96.6	25.3	166.3	29.2	175.8	47.0	89.2	136.4	66.8	118.0	35.3	44.7	42.0	10.5	116.4	19.6	59.4	43.1	60.9	22.0	93.9	17.8	168.0	52.2	78.1	32.2	12.2	39.5	148.0	40.7	50.9	73.0	160.9	36.2	35.4	97.7	9.7	50.2	15.5	58.7	37.4	15.4	174.5	79.8	44.8	0.7	5.1	4.7	0.3	21.5	0.3	23.2	3.2	0.3	29.9	13.3	17.9	0.9	1.2	94.5	10.7	44.7	3.2	38.3	8.1	15.0	56.9	14.5	1.2	102.4	19.8	51.0	0.1	0.4	15.2	0.3	40.8	18.7	1.1	1121.0	7.1	38.7	1.5	6.1	0.0	1.2	9.3	19.9	0.2	4.4	0.9	147.8	32.9	27.1	0.0	12.5	3.9	87.1	2.1	249.2	46.2	4.3	0.9	1107.4	3.1	156.7	0.2	89.1	2.4	2.3	0.6	43.1	0.1	869.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	36.6	46.1	45.7	45.3	35.3	44.7	59.4	43.1	52.2	36.2	50.2	44.8	128.5	0.0	2.3	1.3	1.4	4.7	0.6	11.1	8.0	1.2	9.9	19.7	65.8	18.6	1.1	0.0	22.9	0.5	2.5	0.1	0.0	17.3	1.7	7.8	14.0	153.5	0.0	0.0	1.4	0.4	38.7	14.1	1.5	10.3	0.0	18.2	60.0	0.6	0.8	0.0	3.5	0.0	0.0	1.3	7.0	0.7	0.9	2.4	21.4	14.0	0.6	89.8	1.0	18.6	45.2	1.6	0.0	25.2	3.1	1.7	0.0	0.9	1.3	4.0	322.1	9.9	384.6	2.1	1.6	1.7	3.3	0.4	9.3	4.9	0.1	1.8
MCTS2P	"MCTS2, psiMCT-1"	ENSG00000101898	"MCTS family member 2, pseudogene"		20	31547412-31548081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA001045			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"		Cytosol	"Plasma membrane"	"HPA001045: "	"unprognostic (1.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.17e-3)"	"unprognostic (6.04e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.90e-4)"	"unprognostic (6.59e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	0.9	0.6	0.2	1.6	0.3	1.5	2.2	0.7	1.3	1.0	0.3	1.6	1.0	1.0	0.5	1.3	1.4	0.6	0.6	0.3	0.4	1.0	0.7	0.8	1.8	0.2	0.5	2.5	0.7	1.7		1.5	0.4	1.2	1.1	1.4	0.8	0.9	0.6	0.6	0.5	1.4	0.1	0.8	1.3	1.3	0.4	2.3	1.6	0.7	2.7	2.1		0.4	8.8	0.0	7.6	7.2	2.2	5.4	0.0	3.2	5.1	10.3	4.3	0.2	4.1	13.3	0.1	4.4	3.8	11.1	0.1	15.0	12.4	0.2	10.1	20.2	2.4	2.3	3.1	17.4	10.7	3.8	7.2	4.1	7.4	3.3	4.2	8.0	9.7	4.6	3.8	3.2	16.0	2.8	0.2	23.1	7.9	8.4	25.4	4.7	3.4	1.0	10.9	10.4	3.4	9.1	3.0	5.6	4.9	7.2	5.5	5.2	11.4	4.0	8.2	3.4	4.7	10.0	6.2	11.9	6.5	0.0	0.3	0.1	0.3	0.2	0.7	0.4	0.4	0.5	0.8	0.5	0.7	0.6	0.0	0.8	0.1	0.4	0.1	0.3	0.2	0.3	0.7	1.3	0.3	0.4	0.2	0.5	0.4	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898607-112029561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.6;Kupffer cells: 119.8;Macrophages: 46.5;Microglial cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 8.6;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	50	"monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.1;Hep G2: 39.9;HUVEC TERT2: 38.4;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		Yes	NA		65000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	59.8	22.8	13.5	28.0	1.5	15.3	18.0	29.3	12.6	44.7	10.9	12.3	11.5	26.3	8.4	15.5	12.0	7.0	22.0	22.5	11.4	21.0	13.6	13.1	23.5	22.3	12.6	9.9	21.2	15.5	20.1	22.4	14.1	7.9	16.6	6.4	16.3	3.2	6.4	14.3	14.4	18.4	30.6	13.9	17.2	30.1	6.8	10.1	4.6	8.9	13.6	9.4	22.0	1.0	1.7	7.6	17.3	0.4	0.2	12.3	0.0	0.2	1.0	1.7	35.1	2.2	0.1	8.1	0.1	7.9	0.2	10.2	0.0	1.4	1.5	5.5	7.0	0.0	39.9	0.3	0.2	1.5	0.5	0.0	8.9	0.6	4.0	38.4	1.5	2.2	3.5	2.9	1.8	0.0	9.1	4.8	1.1	6.0	2.9	2.1	3.0	19.4	23.4	0.3	7.2	0.2	0.5	3.2	2.7	0.0	0.4	5.8	1.0	3.4	0.1	0.0	3.1	4.8	0.1	0.0	1.4	0.0	0.0	0.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.0	0.2	22.8	28.0	18.0	29.3	22.0	22.5	23.5	22.3	22.4	18.4	30.1	22.0	8.8	3.2	27.7	162.6	1.7	1.7	2.9	0.3	1.8	0.6	2.1	4.3	2.7	2.8	6.4	0.0	2.1	3.3	0.4	1.2	1.9	1.1	2.3	8.0	4.7	10.2	0.0	0.4	5.0	1.0	1.1	3.2	0.5	12.1	0.0	3.8	28.5	9.2	25.5	0.0	7.0	2.0	0.0	119.8	1.8	2.7	5.0	46.5	0.0	124.6	1.5	7.7	0.0	10.6	0.6	1.2	1.9	6.8	10.8	2.9	4.4	1.9	1.5	11.3	6.6	1.5	9.2	0.6	1.5	0.6	1.3	18.9	1.3	3.5	1.9	1.6
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672196-116798377	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.6;Club cells: 99.8;Glandular and luminal cells: 161.4;Pancreatic endocrine cells: 93.9;Prostatic glandular cells: 149.3;Urothelial cells: 128.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 7.5;hippocampal formation: 6.6;midbrain: 2.5;pons: 4.9;white matter: 7.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 203.8;CAPAN-2: 219.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	100000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	10.3	0.8	0.1	3.4	0.6	7.4	8.9	0.1	7.5	13.1	9.6	9.7	6.5	6.4	2.5	6.1	4.7	11.9	6.2	6.6	0.8	20.1	42.9	20.3	2.3	1.1	2.5	0.8	6.6	0.8	3.8	26.4	4.9	6.7	9.3	3.9	8.7	11.2	14.3	7.7	8.2	5.7	0.3	6.0	15.4	0.5	0.5	3.7	17.6	11.0	3.2	18.4	4.4	7.8	203.8	115.3	0.1	0.6	8.6	8.7	7.9	113.7	48.2	60.3	51.1	25.0	219.0	8.4	179.0	72.1	163.3	51.8	19.7	110.0	123.7	0.3	23.4	0.1	112.5	21.4	1.5	0.3	0.2	11.4	42.4	40.6	129.1	109.4	42.4	0.2	4.5	0.8	114.1	5.0	0.1	0.1	17.3	32.9	113.0	0.2	95.3	0.2	105.8	24.0	16.5	0.0	45.4	15.4	44.9	19.8	0.4	0.9	72.3	89.7	30.6	46.7	88.9	2.5	19.1	1.5	99.3	0.3	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	7.5	6.6	0.8	1.1	2.5	4.9	0.3	0.5	7.8	32.6	28.9	103.6	0.3	1.0	39.0	70.5	58.1	38.1	6.7	6.5	6.9	12.3	11.5	99.8	31.3	0.0	76.0	0.4	20.5	0.0	38.5	0.0	52.5	11.6	20.1	7.2	0.0	2.6	46.9	7.5	7.4	32.6	161.4	0.0	0.0	3.9	30.5	7.0	0.0	1.0	20.5	18.3	1.3	2.2	0.1	0.6	4.4	3.6	1.9	1.0	7.6	0.0	0.5	7.7	93.9	5.5	0.0	0.4	149.3	11.2	15.6	34.5	0.3	0.0	37.8	5.2	0.0	0.6	7.9	17.8	21.8	1.2	0.0	16.4	128.6
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.8	9.5	10.2	20.5	11.6	25.1	28.7	10.5	13.8	24.0	8.8	31.8	24.1	25.7	43.7	52.3	24.3	15.1	41.1	11.2	10.0	24.7	24.0	15.6	24.9	9.5	10.1	14.0	19.5	14.0	11.6	16.9	9.4	29.2	33.5	11.3	23.1	29.7	33.8	28.7	23.4	25.7	9.2	17.6	19.6	51.6	10.6	41.9	18.8	28.7	31.2	34.5	30.8	10.4	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	10.2	11.6	10.5	13.8	11.2	10.0	9.5	10.1	9.4	9.2	10.6	10.4	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		70000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	52.5	58.0	41.1	51.6	44.5	102.2	55.0	45.0	53.2	46.0	39.7	50.7	36.7	54.2	52.6	54.7	42.6	47.0	65.9	40.2	49.9	55.6	84.5	49.0	78.0	46.5	43.8	60.5	52.7	52.3	36.6	51.3	48.8	43.3	50.9	30.8	40.6	101.0	119.5	58.3	37.7	54.9	42.4	40.3	37.4	61.8	44.7	69.1	51.8	78.7	125.0	62.2	41.5	50.2	192.3	157.8	163.7	129.6	98.4	156.4	125.9	186.0	127.6	177.7	125.7	228.0	88.6	542.1	113.5	133.4	101.9	120.5	187.4	142.4	203.8	131.2	161.2	244.9	113.7	165.6	104.5	313.5	117.1	137.5	148.1	164.9	164.0	210.7	192.9	184.2	321.8	60.5	135.3	125.8	230.3	213.0	204.5	109.4	233.4	179.6	141.5	178.5	123.5	198.3	127.0	165.3	166.0	132.7	169.0	140.6	159.4	146.5	165.1	100.7	98.5	115.0	195.7	87.7	246.8	585.1	58.1	173.7	129.9	77.5	70.5	32.0	60.0	52.2	74.3	114.2	66.8	67.8	66.0	101.8	79.2	74.1	3.4	72.8	65.6	85.3	71.6	46.4	41.1	44.5	45.0	53.2	40.2	49.9	46.5	43.8	48.8	42.4	44.7	50.2	87.0	282.0	238.9	22.9	101.3	233.2	130.2	141.3	97.3	70.6	119.7	95.9	143.6	100.1	133.3	290.6	66.7	146.2	87.7	96.8	164.4	115.2	189.5	114.9	260.0	110.2	91.7	278.4	35.1	145.8	161.5	112.2	53.0	153.7	122.9	140.5	112.1	314.6	98.1	75.7	49.5	119.7	73.2	141.0	89.8	123.3	100.3	83.8	92.5	20.6	103.5	72.6	81.4	26.2	41.4	130.1	105.8	106.8	87.0	108.1	93.4	186.6	92.4	83.8	98.6	137.4	133.4	378.4	207.6	95.2	215.0	172.0	80.7	101.4	144.8	110.5
METTL15	"FLJ33979, METT5D1"	ENSG00000169519	"Methyltransferase like 15"	A6NJ78	11	28108248-28527041	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 130.2;Oligodendrocyte precursor cells: 132.7;Oligodendrocytes: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039885			Approved	"Golgi apparatus,Plasma membrane,Actin filaments"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"	"Actin filaments"	"HPA039885: AB_2676725"	"unprognostic (2.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.93e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.95e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.84e-3)"	4.3	8.1	4.8	4.1	4.5	2.3	6.2	5.5	5.4	6.1	6.1	7.0	5.1	5.0	5.7	4.6	5.7	4.5	7.7	4.9	5.4	7.7	9.3	4.3	5.3	4.9	4.8	5.9	4.4	7.0	4.2	5.1	5.2	6.3	6.9	7.0	4.5	5.6	8.7	5.1	5.1	4.5	4.5	4.3	5.4	3.3	5.2	5.2	7.6	11.2	5.3	4.4	3.3	6.2	8.8	9.2	9.3	7.1	11.3	18.0	6.5	10.6	8.1	10.6	10.9	6.3	5.9	20.2	6.2	8.8	6.7	7.3	12.3	10.9	20.2	12.5	10.8	6.4	6.5	7.3	12.6	12.1	5.6	10.2	16.0	5.9	15.1	11.5	10.3	6.7	13.7	8.9	12.6	6.0	8.4	7.4	7.2	9.2	6.8	4.5	20.2	7.4	15.8	5.0	8.2	6.7	8.8	7.8	12.7	8.9	15.4	7.4	7.8	9.6	7.4	12.3	9.4	6.0	7.6	11.7	13.5	12.0	10.6	2.1	1.4	3.7	2.2	1.0	2.7	3.6	2.6	2.9	1.7	1.8	2.8	3.6	0.6	4.4	1.2	1.8	3.1	1.5	4.8	4.5	5.5	5.4	4.9	5.4	4.9	4.8	5.2	4.5	5.2	6.2	16.5	12.8	24.3	130.2	21.3	44.0	38.1	37.1	23.9	13.6	21.6	15.0	14.3	14.3	20.3	11.0	18.8	11.3	28.7	18.2	11.7	10.6	34.5	19.6	24.7	15.7	9.6	17.0	96.8	11.8	14.1	23.5	16.3	28.2	5.1	18.1	12.8	15.0	10.4	13.5	93.9	17.6	10.2	14.2	50.7	12.6	10.8	17.9	14.2	105.9	6.1	8.7	19.6	132.7	146.1	9.9	13.3	8.2	21.0	57.2	13.0	14.9	18.9	16.1	6.6	60.7	23.2	17.9	10.0	17.4	35.7	8.5	35.5	21.3	16.2	53.1
MFSD1	"FLJ14153, Minerva, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 214.4;Kupffer cells: 289.7;Macrophages: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 254.5;granulocytes: 246.0;monocytes: 288.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065858	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Cytosol	"HPA065858: AB_2685569"	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	39.7	27.4	11.0	38.1	12.9	35.9	26.9	20.2	15.8	22.5	23.8	31.1	25.7	16.1	19.4	35.0	21.4	32.3	17.2	15.7	14.5	30.3	39.5	40.5	34.5	15.8	12.2	17.9	31.5	36.0	7.5	30.7	16.4	26.8	22.2	8.4	48.4	23.4	11.1	23.4	23.2	26.2	11.5	42.0	36.1	18.0	16.1	16.1	27.9	16.9	21.5	40.0	19.6	17.3	83.3	28.9	9.1	26.3	51.0	45.0	35.9	109.7	61.8	46.5	45.9	10.3	82.8	19.7	73.5	81.9	24.1	37.0	22.0	26.7	40.9	68.2	33.7	57.2	24.0	6.7	52.1	206.0	135.7	59.3	38.5	39.7	9.5	15.9	38.0	14.0	39.9	32.9	85.1	19.2	11.3	83.2	8.5	29.9	50.9	19.8	11.3	170.9	18.1	16.3	18.2	29.8	76.7	70.0	25.0	8.3	56.9	100.1	102.8	58.6	23.2	87.3	60.5	98.3	94.4	9.6	74.1	162.0	39.7	102.4	288.8	246.0	36.6	223.4	35.3	54.2	30.3	33.9	254.5	44.5	32.2	35.5	97.1	32.9	187.8	81.8	38.9	252.1	11.0	12.9	20.2	15.8	15.7	14.5	15.8	12.2	16.4	11.5	16.1	17.3	28.5	19.2	34.0	12.1	39.6	21.4	46.2	38.4	33.0	11.8	33.3	19.7	22.2	20.0	51.6	22.0	6.2	27.5	24.1	33.3	19.6	34.0	5.3	13.6	22.7	28.2	22.8	56.0	14.6	28.5	33.6	33.7	23.9	17.2	48.8	8.9	37.1	34.4	214.4	18.5	15.2	28.6	34.6	289.7	90.7	6.7	12.2	212.3	32.0	16.9	88.7	26.0	25.7	15.1	29.4	29.0	29.9	11.3	32.9	30.0	27.1	31.8	59.3	10.5	13.1	11.8	23.8	11.6	8.7	61.2	26.0	56.0	22.3	19.4	28.3	58.4
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.7;pituitary gland: 3.1;testis: 4.7;thyroid gland: 6.2"	"Group enriched"	"Detected in some"	8	"Astrocytes: 876.3;Excitatory neurons: 988.4;Inhibitory neurons: 1438.9"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 6.0;SCLC-21H: 2.5;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016418	Approved		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane"	"Centriolar satellite"	"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	0.3	0.8	1.7	0.0	2.0	0.1	0.0	0.2	1.4	0.1	0.0	0.4	0.0	0.0	3.7	0.0	0.1	0.1	1.7	1.0	1.8	0.0	0.1	0.1	0.0	1.0	2.4	0.0	0.1	0.0	3.1	0.0	1.6	0.2	0.1	0.5	0.0	0.6	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.7	2.3	0.0	6.2	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.2	1.4	1.0	1.8	1.0	2.4	1.6	1.1	2.3	0.7	0.1	6.4	1.1	876.3	0.0	0.1	0.2	1.5	0.0	11.2	0.0	0.0	10.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	123.9	0.1	0.1	4.2	0.0	0.0	988.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1438.9	0.0	4.1	0.0	0.0	98.9	16.1	0.3	0.0	34.7	0.2	0.5	0.0	32.2	17.2	0.4	0.0	4.1	0.0	0.3	0.0	0.1	0.0	1.8	0.0	0.4	0.2	3.8	1.5	0.0	0.1	0.0	0.5	6.2	0.0	0.3
MICB	PERB11.2	ENSG00000204516	"MHC class I polypeptide-related sequence B"	Q29980	6	31494881-31511124	"Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Cytolysis, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 10.3;Erythroid cells: 10.5;Hofbauer cells: 11.1;Kupffer cells: 17.8;monocytes: 13.2;T-cells: 11.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 15.2;U-266/84: 36.5"									HPA064618			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA064618: AB_2685301"	"unprognostic (3.63e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (7.04e-5)"	"unprognostic (2.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.94e-9)"	"unprognostic (1.91e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.21e-2)"	2.6	1.2	0.1	1.4	0.2	2.2	2.2	0.2	0.4	1.4	0.2	1.9	0.2	1.7	0.3	1.4	1.2	0.4	2.5	0.2	0.1	1.8	1.2	6.2	2.8	0.2	0.1	0.7	0.8	0.1	0.6	0.2	0.2	1.1	0.5	0.0	1.3	0.0	0.5	1.0	4.5	0.4	0.1	9.9	1.4	1.3	0.3	0.7	1.6	0.7	1.6	1.4	1.5	0.2	3.4	1.3	0.0	0.0	1.9	3.2	0.1	2.3	2.2	2.9	3.7	0.0	0.4	3.9	5.9	4.3	8.1	0.8	1.0	4.1	1.0	3.4	2.3	4.6	0.6	1.3	0.7	1.4	3.5	4.1	0.8	5.0	3.5	3.1	1.9	6.0	4.2	7.8	3.5	0.0	1.3	5.9	0.4	0.0	0.5	4.7	0.0	8.2	3.8	0.2	0.0	0.0	1.5	0.0	0.7	1.2	2.0	1.6	1.9	2.2	0.0	1.9	0.1	15.2	36.5	8.3	0.5	12.0	4.9	1.8	0.9	1.2	0.8	1.1	1.0	0.6	0.8	1.1	0.6	0.5	0.4	0.9	0.9	0.6	1.6	0.4	1.4	0.7	0.1	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.2	3.0	3.2	1.5	0.0	8.2	2.9	0.5	0.3	0.0	0.0	3.1	1.9	0.5	1.5	0.8	0.0	0.0	0.1	10.3	0.8	1.9	1.6	0.0	3.1	1.6	3.0	0.0	10.5	0.6	0.7	0.3	1.5	2.0	5.2	0.0	0.1	3.9	0.1	11.1	0.0	0.1	0.6	0.0	17.8	8.2	0.4	0.3	8.0	1.8	3.7	13.2	0.0	7.2	0.0	0.1	1.9	1.9	0.4	8.7	2.1	0.5	0.3	0.9	0.0	0.0	0.6	2.2	4.6	5.2	0.1	1.1	0.1	11.3	0.5	2.1	1.1
MKLN1	TWA2	ENSG00000128585	"Muskelin 1"	Q9UL63	7	131110096-131496632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 455.1;Excitatory neurons: 336.5;Inhibitory neurons: 256.4;Oligodendrocyte precursor cells: 369.5;Oligodendrocytes: 332.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022817, HPA041810"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Vesicles	"HPA022817: AB_1853974, HPA041810: AB_2677686"	"unprognostic (1.97e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.32e-1)"	12.6	12.1	20.0	6.9	22.3	9.1	13.6	23.1	17.8	10.8	19.1	7.5	9.0	10.1	11.8	7.5	11.9	7.1	8.9	17.1	22.3	13.8	14.7	7.6	8.8	19.4	24.7	13.8	7.7	10.0	4.6	11.6	22.8	16.0	7.3	22.0	11.3	13.4	10.5	9.6	8.4	9.0	18.8	8.7	8.4	9.5	21.4	8.6	11.3	13.5	7.7	7.2	5.4	21.5	14.1	16.0	13.6	13.8	32.8	29.6	8.5	13.3	30.7	14.8	18.8	7.3	11.9	14.6	9.0	16.7	29.3	9.5	14.4	13.1	24.2	14.5	7.0	6.2	13.1	8.5	15.7	10.4	8.7	17.7	8.8	20.6	10.0	15.9	13.7	8.8	23.3	10.2	18.6	5.2	12.3	11.1	15.5	11.4	8.3	7.7	16.0	10.1	16.4	8.1	7.0	15.2	25.7	25.7	12.9	14.1	5.0	12.9	14.1	11.5	6.5	21.1	11.0	24.7	10.0	24.6	39.6	12.3	17.2	1.2	0.7	1.4	1.1	0.9	0.8	0.9	1.1	0.9	0.8	1.6	1.7	1.4	9.5	0.7	1.3	1.2	0.7	0.5	20.0	22.3	23.1	17.8	17.1	22.3	19.4	24.7	22.8	18.8	21.4	21.5	54.4	51.3	43.7	455.1	42.6	44.1	29.3	22.9	31.9	49.7	34.6	21.5	24.9	38.6	27.4	46.0	70.9	17.3	37.6	33.2	7.9	23.0	5.7	30.5	60.4	50.5	37.1	38.9	336.5	23.7	17.4	46.3	36.7	46.9	34.2	42.9	64.2	78.3	21.7	53.8	256.4	29.4	28.5	41.9	52.1	7.8	68.0	35.1	35.6	210.8	44.9	44.1	26.8	369.5	332.5	27.1	36.5	84.2	40.2	49.3	38.7	31.4	25.9	64.9	85.5	64.3	56.9	41.1	28.0	28.9	45.9	14.8	37.9	35.9	28.4	39.1
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565674-23630075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;retina: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.8;Cone photoreceptor cells: 25.0;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 9.0;Rod photoreceptor cells: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"JURKAT: 26.3;K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	0.3	0.1	4.5	0.4	7.7	1.8	0.5	4.8	6.7	0.1	2.4	0.5	0.2	0.4	1.6	3.4	3.1	0.1	0.1	5.2	5.1	0.3	0.1	0.2	0.7	7.0	6.1	0.2	0.4	0.0	1.1	3.3	7.0	0.3	0.1	8.9	3.1	0.2	0.8	0.4	0.3	0.1	4.0	0.6	0.2	2.4	6.6	2.4	0.2	0.8	0.8	0.2	0.2	14.1	8.5	2.9	6.1	5.6	0.0	0.0	13.0	0.9	0.0	4.3	4.5	14.7	0.0	0.1	0.1	0.0	11.8	12.5	2.4	0.0	2.7	0.1	0.5	15.3	17.0	0.9	0.4	18.6	10.2	0.6	0.0	5.8	0.0	2.8	0.0	26.3	30.6	12.9	3.5	0.0	20.3	7.3	0.0	9.6	12.1	10.7	2.5	7.5	0.0	0.1	1.6	4.4	0.0	7.7	0.1	0.2	4.2	5.2	0.1	13.5	9.9	0.9	9.6	16.8	24.5	8.6	7.9	0.1	0.1	0.6	0.2	0.1	0.6	0.0	0.3	0.2	0.2	0.4	0.0	0.2	0.6	2.3	0.4	0.1	0.1	0.3	0.1	0.3	4.5	7.7	4.8	6.7	5.2	5.1	7.0	6.1	7.0	4.0	6.6	14.1	0.0	0.0	0.0	0.7	0.1	0.5	1.2	0.0	0.0	13.8	0.3	0.0	0.7	0.0	0.1	0.0	25.0	0.8	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.6	0.5	0.0	0.1	1.8	1.0	0.1	3.4	0.0	6.0	9.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	7.4	0.0	0.7	1.6	2.6	0.9	1.8	0.0	0.5	0.2	0.1	0.0	0.4
MLF2	NTN4	ENSG00000089693	"Myeloid leukemia factor 2"	Q15773	12	6747996-6767475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010811, HPA010859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA010811: AB_1079389, HPA010859: AB_1079388"	"unprognostic (1.65e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.42e-1)"	"unprognostic (9.88e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.63e-1)"	121.0	199.0	214.6	67.9	225.7	123.8	109.8	206.5	243.7	119.8	215.4	161.8	106.3	148.5	85.2	168.6	120.6	68.1	181.8	234.6	219.0	163.3	298.7	107.0	66.2	208.0	205.8	116.3	111.0	158.2	145.1	79.4	205.8	142.7	74.1	78.2	131.6	96.3	192.8	144.6	117.8	93.0	205.4	101.5	135.9	97.6	211.1	78.3	114.1	129.2	71.2	135.2	117.5	223.6	222.0	354.3	179.1	294.4	159.3	157.9	283.1	216.6	230.6	318.8	286.9	353.8	195.5	163.1	55.0	265.5	228.1	173.5	220.1	295.3	220.0	274.9	239.3	115.3	174.0	200.7	176.0	128.9	143.0	151.7	240.8	255.2	209.8	257.4	140.7	152.0	152.5	61.8	247.8	320.7	165.7	197.9	554.2	236.1	141.2	102.5	160.2	134.0	310.8	247.7	111.2	224.8	188.8	303.6	203.4	385.8	89.8	186.4	133.7	191.4	279.3	213.5	299.9	80.9	98.2	208.9	259.0	102.2	231.2	259.6	120.3	461.0	82.0	109.9	80.9	85.6	63.7	78.3	134.0	97.6	66.2	75.3	528.0	76.6	129.2	231.6	69.7	115.3	214.6	225.7	206.5	243.7	234.6	219.0	208.0	205.8	205.8	205.4	211.1	223.6	106.3	38.5	30.9	19.2	77.9	136.5	149.3	230.2	261.2	110.2	157.7	156.3	71.9	92.9	108.7	110.3	41.7	264.3	92.4	120.6	279.7	169.9	12.1	64.6	70.7	86.4	100.7	74.9	36.2	125.9	213.7	100.6	91.7	74.9	84.9	84.1	71.0	168.6	147.7	80.8	32.7	138.6	197.4	57.8	70.6	13.3	114.0	78.9	103.2	13.1	138.9	142.7	39.1	19.1	23.5	153.8	124.7	107.2	108.2	202.6	219.6	324.7	58.6	63.5	52.6	77.1	131.8	96.6	80.8	193.1	125.6	427.6	70.2	138.3	145.0	174.6
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Metabolism of cobalamin associated C"	Q9Y4U1	1	45500300-45513382	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 17.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	2.0	3.1	3.3	1.7	5.3	1.2	3.5	5.1	4.2	2.9	2.3	3.7	3.3	1.7	3.0	2.8	3.5	1.3	6.9	3.4	5.1	3.5	17.4	1.2	1.8	4.1	5.6	3.5	2.9	5.5	1.3	1.5	3.9	2.0	4.4	2.1	5.0	2.4	10.8	2.0	2.4	2.3	3.5	1.6	2.3	4.3	5.6	2.2	2.3	6.6	2.0	1.7	1.5	6.0	7.7	3.9	6.6	10.0	6.1	3.7	8.1	5.9	3.9	10.5	9.4	8.3	4.7	12.0	7.4	4.9	2.0	6.2	12.3	14.0	9.6	3.3	11.4	9.4	6.5	9.2	5.8	13.5	3.3	5.3	7.8	11.6	12.6	3.7	5.1	12.5	10.8	6.7	8.1	8.2	9.1	4.3	10.9	8.8	8.9	11.1	2.7	13.2	6.2	6.0	10.5	5.4	8.8	14.5	19.3	4.9	8.3	4.6	2.3	7.3	9.9	8.3	3.3	9.9	8.5	6.9	5.3	6.4	6.9	2.3	0.5	0.5	0.5	0.8	0.8	0.7	0.7	0.4	0.6	0.6	1.3	0.6	0.9	0.8	2.7	1.3	0.4	0.4	3.3	5.3	5.1	4.2	3.4	5.1	4.1	5.6	3.9	3.5	5.6	6.0	1.1	3.2	5.5	1.6	2.1	0.1	1.8	0.8	5.7	1.3	2.7	1.5	9.8	4.3	2.2	1.8	0.0	3.7	0.6	2.8	5.9	1.3	1.0	3.6	4.8	1.5	4.2	4.8	2.6	1.4	4.3	3.6	7.1	3.2	2.5	2.9	2.5	22.9	3.3	3.3	2.7	3.2	2.0	3.2	0.9	1.2	1.8	2.7	0.0	0.0	0.6	1.4	3.1	1.5	5.3	1.8	2.3	1.5	10.4	1.7	2.0	4.6	1.2	5.2	0.0	5.0	2.4	7.4	2.1	11.5	0.1	2.7	2.4	3.9	5.8	1.8
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770502-102780628	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"endometrium 1: 265.4"	"Cell type enriched"	"Detected in some"	38	"Basal respiratory cells: 3913.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 47.8;head and neck cancer: 102.2;lung cancer: 42.3"	"Region enhanced"	"Detected in single"		"thalamus: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 11.8;HUVEC TERT2: 15.1;SCLC-21H: 4.7"									CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.0	0.1	7.7	0.0	0.1	0.1	0.0	0.8	1.2	0.0	0.4	1.1	265.4	0.0	0.2	0.0	1.3	0.0	0.2	0.3	0.1	1.0	2.0	0.1	0.1	0.3	0.2	0.2	0.0	0.0	1.3	0.3	1.4	0.2	0.0	1.6	0.0	0.0	0.1	0.8	0.2	0.0	0.0	2.9	0.5	1.9	0.6	0.0	0.2	0.7	4.4	3.2	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	11.8	0.6	0.1	0.1	0.3	0.0	0.0	3.3	1.8	0.2	2.7	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.5	0.0	15.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	2.8	0.5	1.6	0.0	0.0	0.0	0.0	0.6	4.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.9	3.5	1.2	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.3	0.1	0.3	0.3	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	51.3	3913.2	0.0	0.0	0.7	0.0	0.1	0.0	85.4	29.5	0.0	0.0	0.0	0.4	0.0	34.0	6.1	6.4	2.5	9.0	0.0	0.0	0.0	14.6	0.0	6.3	0.0	12.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	9.5	1.3	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	102.5	0.1	0.0	0.0	42.5	0.0	0.1	29.3	0.0	0.0	0.0	11.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.2
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025754-58046901	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 55.8;Distal enterocytes: 109.3;Proximal enterocytes: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 93.6;Hep G2: 51.1;OE19: 44.6;SK-BR-3: 47.3;WM-115: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: AB_2676956"	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.08e-4)"	11.9	3.8	8.9	4.4	6.0	0.4	7.6	7.3	11.2	5.7	5.8	28.0	40.2	3.5	1.1	4.6	6.1	14.3	41.2	6.9	8.7	14.9	50.1	9.9	2.1	15.8	10.6	1.1	18.5	12.7	8.8	28.4	16.8	4.4	14.3	1.5	8.4	9.5	7.0	4.3	33.0	3.7	5.8	9.3	29.6	34.9	18.7	1.0	46.7	5.6	1.3	5.1	2.8	8.6	15.3	11.4	5.8	30.4	6.0	0.3	93.6	1.4	0.8	5.4	1.2	9.1	38.3	0.2	17.7	1.6	4.2	21.0	5.1	4.4	1.6	0.1	10.0	0.1	4.9	51.1	7.7	0.3	19.5	3.1	7.8	0.9	2.3	8.4	3.7	8.5	12.9	0.1	1.8	7.6	0.7	2.6	17.2	44.6	3.2	7.6	0.7	8.3	16.6	5.4	1.6	10.4	20.0	47.3	9.5	13.2	5.2	8.2	3.4	0.4	9.1	3.5	1.3	0.2	0.1	0.3	1.9	2.3	78.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.9	6.0	7.3	11.2	6.9	8.7	15.8	10.6	16.8	5.8	18.7	8.6	14.3	19.2	14.4	9.1	0.7	2.5	1.0	4.9	2.8	3.4	5.0	3.0	24.7	55.8	12.6	18.4	16.7	48.2	1.6	109.3	1.9	35.7	5.0	3.6	1.1	17.2	11.4	2.7	1.4	12.0	49.2	4.5	35.2	6.4	0.0	18.6	13.6	39.2	12.9	1.7	1.2	33.3	10.2	3.0	0.3	6.9	0.9	0.9	1.8	1.0	0.0	2.1	0.0	4.5	1.4	13.3	38.5	3.4	0.3	1.3	67.3	7.3	6.0	1.9	0.0	0.7	2.4	0.9	4.6	3.3	2.3	48.4	0.7	23.2	45.0	1.7
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226690-35276998	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Excitatory neurons: 24.6;Horizontal cells: 15.2;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.0;Proximal tubular cells: 11.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.4;testis cancer: 10.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 40.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.3;CACO-2: 56.0;EFO-21: 15.8;RPTEC TERT1: 24.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 51.5"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	3.4	1.0	6.1	0.5	5.8	0.7	0.5	40.0	8.1	0.7	3.5	0.7	2.1	1.3	0.1	0.3	2.2	0.6	0.6	6.0	5.6	7.8	0.5	4.7	0.4	4.4	5.6	0.4	5.8	0.3	3.8	0.2	5.4	1.7	0.2	2.5	0.5	4.2	0.3	1.2	1.4	2.0	2.7	0.4	0.6	0.4	7.2	0.0	0.7	0.1	0.0	0.4	0.3	4.8	0.6	36.3	0.1	0.2	0.2	0.0	1.0	1.9	2.3	3.8	2.0	56.0	9.7	0.0	15.8	2.5	1.2	0.6	8.5	0.0	1.6	0.2	0.3	1.9	1.2	0.6	0.0	0.1	0.4	0.2	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.5	0.4	0.5	0.1	0.2	13.6	0.1	2.4	0.1	0.2	0.0	24.6	0.1	14.1	9.7	2.5	0.7	0.3	2.9	0.5	0.3	0.6	7.4	17.7	1.8	0.7	0.3	0.2	0.1	1.6	0.2	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.1	5.8	40.0	8.1	6.0	5.6	4.4	5.6	5.4	2.7	7.2	4.8	0.3	16.0	1.5	5.2	0.0	0.1	0.2	0.0	0.0	3.9	0.2	0.8	0.5	8.6	1.3	1.8	0.0	0.1	0.1	0.7	5.9	8.5	0.6	0.8	0.3	1.4	0.0	0.0	24.6	0.9	0.1	0.6	0.0	0.5	0.0	0.1	0.4	0.4	0.0	15.2	38.4	0.1	0.0	0.6	0.0	0.0	0.3	0.1	1.8	10.3	0.0	0.2	0.0	12.5	12.0	1.9	0.1	0.0	0.0	0.4	2.3	11.4	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.1
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		350000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	18.9	50.5	45.4	16.7	47.3	11.7	20.1	52.2	49.2	23.9	41.1	31.8	45.6	23.6	35.3	27.7	27.8	16.0	44.8	46.6	47.9	31.2	39.1	14.9	20.9	55.5	50.1	30.6	31.8	31.1	22.9	16.2	56.2	27.5	31.4	33.6	23.7	22.9	52.2	16.5	33.0	22.5	45.7	23.0	20.9	26.2	50.0	23.2	23.2	70.9	24.2	24.2	19.5	47.1	27.2	36.9	29.8	34.0	66.7	32.2	26.0	22.8	37.2	38.4	53.4	36.7	35.0	38.3	48.6	33.6	30.6	65.9	60.0	66.7	36.2	29.4	74.9	68.8	35.3	39.9	47.5	32.0	19.4	43.1	16.9	36.2	64.4	58.1	52.9	45.2	23.4	30.7	50.1	23.2	34.6	14.2	16.4	40.9	31.0	35.0	28.0	94.9	45.5	30.4	55.7	24.4	26.7	47.5	28.7	43.5	65.3	21.9	24.1	22.9	19.4	17.3	22.6	75.0	48.4	25.1	47.9	45.8	17.1	2.3	16.2	5.7	28.2	17.0	37.0	27.4	38.3	32.6	23.0	31.9	56.0	40.8	2.7	43.1	15.5	19.1	53.1	29.0	45.4	47.3	52.2	49.2	46.6	47.9	55.5	50.1	56.2	45.7	50.0	47.1	5.6	6.4	15.0	7.8	10.8	1.9	7.6	16.4	5.2	23.4	9.2	10.7	54.1	7.2	10.9	14.7	4.2	31.8	9.1	28.3	15.6	19.6	18.9	5.6	9.2	9.6	10.8	4.2	4.9	8.8	11.4	10.9	6.1	8.5	15.2	13.3	6.1	18.8	23.9	35.3	6.1	19.0	8.2	7.2	2.2	31.3	11.1	6.6	3.6	3.7	9.7	20.7	12.3	2.0	6.9	12.2	33.2	8.6	11.8	7.2	70.1	31.4	7.8	16.7	6.6	8.2	10.1	34.5	9.0	9.1	2.7	16.3	11.1	21.0	16.4	6.2
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67240713-67336061	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.4	8.7	13.9	6.3	20.9	5.6	10.6	17.6	16.5	8.8	26.6	12.7	20.4	6.3	21.1	13.6	7.3	7.9	7.4	11.9	17.4	31.4	19.6	12.3	4.8	18.2	18.2	6.1	8.7	19.6	7.2	9.8	18.3	16.2	12.0	17.2	18.4	12.7	18.0	8.4	20.7	7.2	18.1	6.6	9.4	8.8	17.5	10.3	25.1	13.6	6.1	9.0	8.4	27.5	156.4	24.4	24.1	18.5	13.3	12.3	20.6	46.4	23.6	33.2	21.6	23.8	45.9	12.7	21.5	37.8	11.0	31.0	13.9	26.1	50.2	5.5	9.5	11.8	23.6	16.8	15.5	4.5	8.5	13.1	10.0	17.9	23.7	24.2	19.0	13.5	12.6	4.7	53.9	20.4	14.4	5.0	7.7	22.2	16.2	12.2	37.1	15.2	30.1	36.8	13.2	9.4	28.2	27.0	15.5	21.1	28.6	9.2	29.2	41.4	87.2	13.8	19.9	7.8	7.6	19.3	27.2	10.1	14.7	0.1	0.5	0.8	0.4	1.0	0.3	1.1	0.5	0.6	0.8	0.4	1.1	0.6	0.0	2.2	0.7	0.6	0.3	0.4	13.9	20.9	17.6	16.5	11.9	17.4	18.2	18.2	18.3	18.1	17.5	27.5	13.2	64.1	28.9	37.2	8.8	21.0	26.0	14.6	22.2	8.5	22.4	12.8	24.7	11.5	21.1	22.0	43.8	23.1	5.2	47.2	13.7	21.7	5.9	29.5	15.0	17.7	5.4	6.7	24.8	26.9	11.3	17.3	18.3	46.2	5.1	15.8	17.2	20.7	17.6	3.3	34.7	21.2	12.2	11.9	13.4	4.5	8.1	9.2	3.6	22.5	6.6	23.4	3.1	41.2	129.8	26.7	32.5	11.3	13.1	30.1	54.3	33.5	14.9	34.3	6.6	17.7	22.2	22.4	36.1	29.2	17.3	17.5	7.7	7.5	22.4	38.7
MRNIP	"C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537"	ENSG00000161010	"MRN complex interacting protein"	Q6NTE8	5	179835133-179862173	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Endometrial ciliated cells: 49.7;Glandular and luminal cells: 31.3;Respiratory ciliated cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043975	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA043975: AB_2678754"	"unprognostic (4.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-3)"	7.8	7.2	10.5	3.5	10.6	1.4	9.5	13.1	12.9	21.8	11.5	12.3	2.5	11.4	5.9	6.4	16.7	2.2	7.1	10.6	10.3	13.1	10.0	8.9	5.5	10.8	10.6	21.0	10.3	5.2	19.2	1.5	10.8	15.4	2.8	3.0	9.9	7.1	5.4	7.9	17.1	3.8	10.0	19.0	8.8	10.1	10.6	2.7	15.5	2.7	5.3	12.7	13.7	11.8	1.0	1.9	3.5	8.4	7.4	6.6	4.0	2.5	2.3	3.2	4.8	2.5	3.2	4.1	2.9	1.3	1.4	2.6	4.4	8.3	2.6	3.7	3.5	1.3	4.3	2.1	4.6	1.7	1.6	4.9	7.0	3.7	3.0	2.4	3.6	4.1	2.0	1.8	3.5	3.9	2.8	1.7	1.7	1.3	1.9	3.3	1.4	3.2	5.7	0.8	6.6	2.1	1.2	3.3	3.1	2.6	4.1	1.4	0.7	1.8	1.4	1.4	1.5	2.2	1.4	2.9	1.7	2.7	1.3	1.5	0.6	2.9	2.7	0.7	3.8	8.0	4.0	3.2	0.8	10.2	6.4	4.5	0.9	3.5	0.9	4.9	2.6	1.9	10.5	10.6	13.1	12.9	10.6	10.3	10.8	10.6	10.8	10.0	10.6	11.8	22.4	16.0	15.6	0.0	6.2	0.0	0.0	0.0	0.0	0.0	13.7	21.1	0.0	0.0	11.8	18.4	0.0	10.5	11.6	0.0	46.9	5.1	0.0	49.7	19.0	5.8	0.0	0.0	0.0	2.2	6.8	9.7	0.0	31.3	11.4	20.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.0	0.0	0.0	14.5	29.9	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	9.3	7.6	18.4	0.0	0.0
MRPL42	"HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31"	ENSG00000198015	"Mitochondrial ribosomal protein L42"	Q9Y6G3	12	93467514-93516214	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039398	Approved		Supported	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Mitochondria"		"HPA039398: AB_10673529"	"unprognostic (9.32e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (6.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.12e-4)"	15.7	26.7	6.8	8.8	8.3	13.9	14.9	11.6	9.0	15.7	9.9	16.9	13.5	14.5	10.9	19.3	14.2	8.1	17.2	7.9	9.8	21.4	20.4	12.8	12.2	7.5	8.3	14.3	13.8	23.4	15.4	11.3	8.6	15.9	16.8	6.1	14.0	10.5	12.0	14.9	13.5	13.8	6.3	10.8	15.9	14.4	7.7	19.2	14.0	14.4	14.9	16.6	16.6	11.7	30.5	42.3	53.5	33.8	25.5	36.8	36.5	43.0	33.0	45.4	32.9	51.8	11.6	49.9	16.3	32.1	29.8	22.4	61.5	48.0	74.3	50.6	40.5	45.0	26.8	61.9	41.9	74.0	21.3	31.0	44.4	48.4	60.5	42.2	46.5	53.0	61.3	19.0	54.0	36.1	67.2	49.3	65.1	52.8	55.9	48.1	25.5	40.4	49.2	77.0	39.8	32.0	36.0	39.3	41.3	42.0	35.5	33.4	29.1	26.5	22.1	21.3	49.6	31.2	49.0	46.1	12.2	45.7	41.5	21.0	14.4	20.4	14.7	21.2	18.9	25.9	19.4	16.6	16.4	23.7	21.3	21.8	8.3	27.0	20.4	11.2	28.1	16.3	6.8	8.3	11.6	9.0	7.9	9.8	7.5	8.3	8.6	6.3	7.7	11.7	55.0	28.9	35.5	13.4	59.9	67.3	97.6	131.6	50.1	34.9	48.7	38.1	82.6	42.9	82.5	46.0	60.5	96.7	41.4	38.2	213.2	86.2	397.6	87.5	61.3	48.7	93.2	66.7	16.2	77.4	133.1	54.5	48.9	48.6	58.4	50.7	32.9	48.4	54.0	47.1	22.1	66.8	107.8	34.1	47.9	165.0	51.6	32.6	60.5	6.5	35.2	22.1	54.6	20.1	20.3	89.8	49.9	56.1	59.8	109.8	44.9	146.5	96.7	41.6	52.6	42.3	59.8	230.5	66.6	59.7	75.0	95.5	51.7	100.1	82.1	115.4
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"intestine: 254.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 1139.3"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.2	0.0	0.0	10.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	234.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	254.3	0.0	0.0	0.5	0.0	0.0	0.3	4.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1139.3	0.0	0.0	0.4	0.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.6	0.1	27.8	0.0
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.0"	"Group enriched"	"Detected in some"	44	"Early spermatids: 262.3;Late spermatids: 672.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.5;non-classical monocyte: 8.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 8.0"	"Cell line enriched"	"Detected in single"	23	"THP-1: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058973	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	5.1	3.7	6.2	3.5	5.6	0.6	3.6	5.8	8.8	1.2	7.5	2.7	0.7	0.9	0.6	0.9	1.3	0.9	2.6	5.8	6.3	1.8	2.0	11.9	1.3	7.7	6.8	0.7	1.3	0.3	1.5	2.4	7.2	1.8	1.1	0.4	1.9	0.5	0.9	0.9	2.7	1.2	6.0	10.4	1.2	73.0	8.5	0.3	1.5	0.3	1.9	2.0	1.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.4	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.9	6.2	5.6	5.8	8.8	5.8	6.3	7.7	6.8	7.2	6.0	8.5	8.0	0.2	0.0	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	262.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.3	5.5	672.0	4.1	10.4	0.0	3.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.7	0.0	6.6	0.1	0.0	6.5	3.4	0.0	0.3	0.1	0.1	0.0	0.0	0.0
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756867-60776733	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lung: 43.9"	"Cell type enriched"	"Detected in some"	15	"Alveolar cells type 1: 96.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.2;HEL: 3.6;JURKAT: 1.6;MOLT-4: 1.6;U-266/70: 4.0;U-266/84: 2.1"	"Region enriched"	"Detected in some"	28	"olfactory bulb: 166.8"	"Region enriched"	"Detected in single"	26	"olfactory bulb: 20.2"	HPA054563			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 19: Lung - Lung function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.2	0.4	0.2	0.1	2.2	0.3	0.4	0.3	0.2	0.3	1.0	1.2	0.3	0.4	1.0	0.2	0.3	0.7	0.2	0.1	0.0	43.9	0.5	0.4	0.2	1.8	0.1	0.0	0.0	0.7	0.4	0.3	0.6	0.4	0.1	1.2	0.0	0.0	2.2	1.6	0.1	0.3	0.4	0.6	0.2	3.8	0.3	0.0	1.8	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.5	1.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	4.0	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	3.2	0.2	0.2	0.2	0.3	0.4	0.7	0.2	0.4	0.2	0.4	0.1	0.2	0.3	0.2	96.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	2.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0
MTCP1	"P13MTCP1, p8MTCP1, TCL1C"	ENSG00000214827	"Mature T cell proliferation 1"	P56278	X	155064034-155147937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.2;Respiratory ciliated cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA032040			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA032040: AB_2674122"	"unprognostic (2.42e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.29e-3)"	"unprognostic (8.30e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.40e-5)"	"unprognostic (9.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (4.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-2)"	1.0	2.1	0.8	1.9	1.1	2.8	1.8	1.7	1.4	1.3	1.1	1.6	2.0	1.7	2.7	1.2	1.4	1.3	1.4	0.8	1.0	1.8	2.5	1.2	2.5	1.1	0.9	2.3	2.6	1.0	1.7	1.0	1.0	1.7	2.0	2.5	1.6	1.4	1.2	4.2	1.8	1.4	0.9	1.9	2.0	5.3	1.0	1.9	1.9	0.7	2.5	1.4	0.9	1.2	1.2	3.9	1.9	3.1	1.2	1.0	2.1	2.4	1.2	1.5	3.7	3.5	6.0	2.2	2.4	0.5	2.4	3.9	2.6	2.8	1.9	1.5	2.5	1.0	13.6	1.9	1.1	2.4	2.5	1.9	1.3	2.5	2.4	1.8	1.4	3.8	0.9	3.9	1.1	1.7	3.2	5.1	0.9	1.5	0.6	3.4	2.0	5.1	2.0	1.7	0.9	1.4	1.7	1.0	1.7	1.3	1.8	1.1	1.5	1.8	3.0	1.7	1.9	8.6	4.1	4.4	3.4	2.9	2.6	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.8	1.1	1.7	1.4	0.8	1.0	1.1	0.9	1.0	0.9	1.0	1.2	0.5	0.0	1.5	0.0	0.5	0.3	0.3	0.7	0.6	0.0	0.6	0.5	1.4	1.5	1.4	0.0	0.0	0.2	0.8	0.6	0.0	0.8	0.0	0.7	0.3	0.5	1.8	3.2	0.0	1.2	0.4	0.6	0.0	0.6	0.0	2.2	0.4	2.0	0.4	0.0	0.0	0.0	0.0	1.0	0.3	0.6	1.2	0.8	1.8	0.0	1.0	0.0	1.0	0.0	0.0	1.0	0.2	0.4	0.9	0.3	0.3	0.3	2.4	0.0	0.0	0.6	0.4	0.6	0.2	0.4	0.9	0.3	0.7	0.8	0.5	0.1
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926760-135977359	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	68.9	49.5	66.7	65.1	75.5	151.1	50.7	41.6	79.4	67.1	45.6	50.5	40.2	65.1	50.9	125.5	62.2	50.5	77.1	79.5	65.0	58.5	49.7	57.8	89.4	77.7	60.0	49.2	23.8	75.9	34.0	61.7	54.0	52.9	55.4	39.9	36.8	51.3	47.6	46.8	46.6	66.1	56.3	79.7	41.2	56.6	65.2	72.5	88.2	48.0	107.8	67.2	58.5	53.3	126.0	90.6	111.5	170.4	160.3	187.2	55.8	189.5	208.0	129.3	137.7	104.5	139.4	229.7	132.7	255.6	188.6	78.9	107.1	161.1	246.1	153.1	84.2	152.9	94.6	77.2	127.3	211.5	213.5	136.5	158.5	152.9	147.7	180.1	205.5	163.6	182.3	138.1	253.2	94.3	208.4	163.0	155.9	121.9	118.9	120.0	83.8	187.7	144.5	103.1	140.6	248.3	157.1	105.8	158.4	102.8	75.4	130.7	215.2	193.5	85.0	192.3	189.7	103.8	160.2	325.9	307.5	185.0	420.2	117.4	75.4	85.2	54.7	105.7	46.0	107.9	33.5	41.7	89.3	125.0	21.5	31.7	180.3	46.0	169.4	82.8	32.6	70.5	66.7	75.5	41.6	79.4	79.5	65.0	77.7	60.0	54.0	56.3	65.2	53.3	110.6	48.1	40.6	0.0	149.8	119.2	58.9	86.8	72.8	0.0	68.6	72.8	82.0	70.1	61.9	69.9	0.0	63.4	131.6	67.1	90.1	69.6	77.8	83.8	153.3	108.5	33.0	91.9	0.0	51.3	73.1	92.4	45.9	131.9	98.6	64.8	87.4	59.2	100.5	0.0	0.0	46.9	46.8	247.5	232.7	28.6	86.3	214.0	101.4	0.0	234.2	0.0	125.7	0.0	0.0	99.9	67.0	123.8	59.2	96.2	52.6	88.3	50.0	0.0	92.1	99.8	79.8	65.8	123.8	143.3	149.0	68.8	86.1	106.5	52.4	106.9
MTSS1	"KIAA0429, MIM, MIMA, MIMB"	ENSG00000170873	"MTSS I-BAR domain containing 1"	O43312	8	124550784-124728473	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 208.2;Oligodendrocyte precursor cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 168.3"	"Group enriched"	"Detected in all"	5	"B-cells: 50.3;monocytes: 168.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 81.4;HDLM-2: 98.7;HEL: 337.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019613, HPA064003, HPA075540"	Approved	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA019613: , HPA064003: , HPA075540: AB_2686756"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.11e-7)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-3)"	24.5	36.2	16.8	13.2	23.2	12.5	14.0	46.1	23.4	12.5	22.3	11.0	6.4	8.4	9.9	45.2	12.5	9.2	17.1	16.3	27.7	24.2	72.9	16.5	16.0	27.5	20.6	10.4	28.5	3.7	11.0	35.7	25.3	10.1	9.1	15.0	13.9	6.3	32.3	30.8	7.9	9.6	20.5	34.5	12.0	22.3	26.4	18.4	6.0	24.4	17.2	15.5	24.3	39.5	3.6	1.1	51.6	1.0	81.4	41.7	0.1	2.1	14.2	1.1	0.5	4.8	0.4	1.6	4.9	0.2	0.4	0.8	0.4	29.2	1.1	98.7	1.2	337.8	0.9	27.0	18.4	0.0	34.5	66.4	65.4	15.9	41.0	2.1	31.5	0.3	0.5	0.3	5.6	2.7	0.8	4.0	1.8	54.8	0.4	0.4	0.1	0.5	11.6	11.3	36.3	2.8	7.9	6.3	26.6	2.5	1.3	1.1	16.7	2.7	1.0	0.2	0.7	0.5	0.3	5.4	29.1	0.4	10.7	3.1	13.1	0.1	22.7	88.1	2.6	44.9	4.8	8.7	11.8	50.3	2.2	6.8	2.2	2.2	168.3	0.2	0.5	29.2	16.8	23.2	46.1	23.4	16.3	27.7	27.5	20.6	25.3	20.5	26.4	39.5	33.0	0.0	26.9	15.7	92.0	35.8	81.4	41.2	9.6	0.0	8.0	19.9	34.9	22.8	30.9	66.2	0.0	36.0	51.4	10.7	21.5	17.6	54.2	25.5	0.9	32.2	44.2	17.2	40.4	5.2	2.3	30.5	26.5	9.7	46.3	0.9	70.3	78.1	74.2	0.0	208.2	17.1	61.1	167.1	116.2	62.1	3.7	96.7	26.6	114.3	90.2	0.0	78.2	360.4	178.4	32.6	15.9	4.5	12.6	71.9	1.2	19.9	42.0	0.0	39.5	25.2	17.3	2.5	10.7	86.1	63.4	94.4	22.7	1.8	15.8	59.2
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720884-195741123	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 58.5;kidney: 69.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.2;Ductal cells: 55.5;Ionocytes: 152.5;Respiratory ciliated cells: 66.5;Urothelial cells: 84.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		170000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	6.7	5.1	4.3	1.3	5.0	0.9	7.9	7.0	6.7	23.0	3.0	30.0	3.0	5.0	4.5	58.5	20.0	6.4	6.3	3.6	3.4	69.7	21.1	7.9	0.8	4.1	2.7	11.8	16.1	2.0	16.5	0.5	4.0	20.9	7.2	8.1	40.3	1.1	7.0	8.0	14.7	0.8	1.4	6.1	9.8	8.5	4.2	0.8	16.2	1.0	1.4	21.0	26.0	5.0	0.9	0.0	0.2	0.7	0.4	0.0	0.7	0.0	0.2	0.0	0.1	0.0	3.7	0.1	0.7	0.0	0.2	1.5	0.1	0.0	0.1	1.3	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.1	0.7	3.9	0.1	1.0	0.1	1.1	0.1	3.6	1.3	0.4	0.0	28.1	0.2	0.5	0.2	0.0	0.0	0.2	0.8	1.0	0.1	1.3	1.7	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.0	7.0	6.7	3.6	3.4	4.1	2.7	4.0	1.4	4.2	5.0	0.9	35.3	16.7	16.6	0.5	1.8	10.0	6.4	0.6	19.9	3.2	1.5	0.7	14.3	43.7	22.0	35.5	0.1	0.2	53.2	1.9	55.5	0.1	3.5	1.3	1.7	13.8	5.3	7.5	9.9	0.1	1.8	13.3	6.2	1.3	5.3	3.3	7.3	0.5	11.8	7.7	7.3	152.5	1.0	0.8	0.4	5.3	1.1	3.6	1.0	0.0	4.7	0.0	5.0	3.0	12.2	16.9	6.4	1.7	14.2	16.9	3.3	66.5	20.5	0.0	8.8	3.3	1.3	1.3	4.3	1.8	0.0	1.7	1.0	15.2	84.4
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281280-36387967	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 1343.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Nuclear bodies,Plasma membrane,Actin filaments,Cytosol"		No	No		410000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments"	"Nuclear bodies, Cytosol"	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	295.9	95.5	42.3	181.1	42.1	245.9	231.5	40.6	54.7	181.2	65.5	192.6	107.0	356.4	39.3	153.8	182.2	134.5	161.1	50.8	39.4	140.7	101.6	286.2	161.7	52.7	51.7	121.1	160.3	55.0	52.6	166.5	48.1	131.8	89.8	9.7	177.2	98.4	84.0	160.6	163.5	174.1	48.8	232.5	135.8	38.2	52.1	125.1	141.2	46.3	104.1	168.8	166.8	48.2	612.2	277.0	86.2	74.2	156.8	195.1	437.3	398.4	507.5	554.6	413.2	302.1	170.3	156.9	230.1	666.1	265.0	412.7	125.2	779.4	559.6	356.1	120.9	302.6	294.3	259.9	481.1	346.9	463.8	233.0	234.7	751.9	626.4	540.3	461.8	113.2	67.3	205.8	448.9	161.9	124.4	204.0	51.7	171.1	169.2	233.3	267.3	146.7	314.5	581.5	129.6	53.0	559.7	217.0	251.6	218.5	162.4	177.1	1343.7	1222.6	370.3	237.5	731.5	135.2	114.7	129.0	463.2	172.3	363.1	72.6	25.2	64.7	32.4	19.8	28.4	13.4	23.5	26.4	17.2	11.9	18.3	20.4	41.2	9.0	26.5	8.0	26.3	54.5	42.3	42.1	40.6	54.7	50.8	39.4	52.7	51.7	48.1	48.8	52.1	48.2	303.9	118.6	87.1	12.7	108.4	144.0	182.4	123.1	72.8	2.6	90.5	89.4	62.6	80.1	89.7	92.0	2.1	87.0	151.7	359.8	7.9	309.4	35.8	89.7	121.6	258.7	73.8	51.9	42.5	245.8	193.1	82.9	123.8	194.7	93.1	117.1	132.8	102.8	100.4	82.4	6.7	131.0	59.0	119.6	124.2	37.4	68.0	168.8	85.4	61.8	196.6	11.9	137.0	7.5	33.3	344.6	186.8	211.4	125.9	184.4	159.8	27.5	51.5	5.3	203.8	39.9	275.2	6.9	10.4	133.6	135.1	46.4	213.2	141.3	139.5	134.3
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"heart muscle: 6347.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2426.3"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 1.8"	"Cell line enriched"	"Detected in some"	4	"HEL: 552.8"	"Group enriched"	"Detected in all"	6	"amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9"	"Not detected"	"Not detected"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		NA	NA		3100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	2.1	0.5	0.2	0.4	0.3	134.6	2.7	0.2	0.4	0.4	0.4	0.8	0.8	0.8	0.0	0.6	0.5	1.0	6347.0	0.3	0.4	1.3	1.4	9.4	0.9	0.3	0.3	0.8	8.6	0.3	0.5	9.1	0.4	1.1	0.3	42.2	3.0	0.2	3.5	1.2	1.3	0.8	0.2	3.1	3.4	15.5	0.3	2.4	11.0	6.4	0.4	0.9	0.8	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.3	0.0	0.2	0.0	0.9	0.1	1.6	0.9	0.0	0.4	0.0	0.1	0.0	0.0	3.0	0.2	552.8	0.1	0.0	0.0	0.0	0.3	21.2	0.0	0.3	0.1	0.0	1.0	1.4	133.3	0.3	0.2	0.0	10.0	0.1	0.3	0.0	0.4	0.3	12.9	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	24.3	0.0	0.2	4.5	0.0	0.3	0.1	0.0	0.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.3	0.2	0.4	0.3	0.4	0.3	0.3	0.4	0.2	0.3	0.4	3.2	3.2	0.0	0.0	0.7	0.8	0.0	0.0	0.0	5.5	0.0	0.0	2426.3	0.0	0.0	0.0	64.6	0.5	2.7	0.1	0.0	0.1	23.3	0.1	0.0	23.2	0.0	412.8	0.1	0.0	3.9	150.7	1.5	0.1	0.0	0.3	1.8	0.5	1.9	1.7	0.0	0.8	0.0	0.6	0.6	54.6	3.4	34.0	12.4	0.0	1.5	7.9	4.1	0.0	0.1	0.1	0.0	1.5	0.8	0.0	10.9	0.2	0.0	24.4	0.0	0.6	36.5	9.9	0.5	0.0	0.9	1.4	0.3	0.2	1.0	0.0
MYO1E	"HuncM-IC, MGC104638, MYO1C"	ENSG00000157483	"Myosin IE"	Q12965	15	59132434-59372871	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 319.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 23.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 224.1;HaCaT: 208.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003003, HPA023886"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		13000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA003003: , HPA023886: AB_1854253"	"unprognostic (7.90e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (5.38e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	30.6	7.1	19.4	32.9	34.9	1.8	19.5	32.2	30.7	27.7	43.6	54.3	25.3	31.0	29.6	37.6	17.4	38.7	13.3	19.6	24.9	47.7	52.2	19.9	36.9	38.6	35.0	10.3	12.0	22.4	9.3	34.7	39.4	22.9	34.4	9.9	18.7	21.6	11.9	45.6	44.2	22.2	28.4	17.1	32.5	8.3	33.1	7.6	15.2	10.9	41.2	38.1	28.1	57.1	133.3	224.1	12.1	8.2	92.4	74.8	62.2	52.9	25.7	28.8	33.6	55.7	50.5	52.7	37.0	41.3	117.5	208.6	18.9	81.5	38.2	24.1	10.5	0.5	178.4	50.3	85.5	0.3	7.2	103.4	48.8	37.0	107.4	90.7	47.8	0.9	0.3	0.8	49.2	12.4	0.6	1.2	29.3	21.5	49.8	0.2	53.8	32.4	156.9	61.8	6.5	21.9	117.1	24.2	45.8	36.5	16.3	5.8	58.4	57.5	16.6	177.1	52.0	0.3	3.3	1.3	105.4	0.6	53.2	0.0	4.5	0.0	0.2	4.6	0.0	9.2	0.0	0.0	15.4	8.6	0.0	0.0	0.6	3.6	1.6	23.7	0.5	2.5	19.4	34.9	32.2	30.7	19.6	24.9	38.6	35.0	39.4	28.4	33.1	57.1	31.0	6.4	7.7	27.1	19.6	24.9	40.0	24.7	24.5	0.2	9.3	10.2	3.9	17.2	15.4	25.8	0.0	4.3	19.9	73.6	3.9	39.8	4.2	49.4	30.2	30.4	19.7	2.5	9.3	18.1	23.8	14.9	86.6	47.3	4.5	6.7	5.0	13.0	33.5	0.0	8.7	31.2	8.2	5.0	50.1	8.5	9.3	17.6	19.6	56.2	9.0	11.3	3.1	6.6	319.1	64.0	60.0	12.0	9.2	28.3	37.4	3.1	40.9	0.9	13.1	33.7	25.0	1.3	5.1	30.1	24.0	12.9	4.7	6.7	29.3	56.9
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934229-26212532	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 15.5;testis: 5.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3"	"Not detected"	"Not detected"							"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.4	0.0	1.8	0.1	0.1	0.0	0.8	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.6	0.3	0.0	0.1	0.0	0.6	0.5	0.0	0.7	0.0	0.5	0.0	0.5	0.1	0.3	15.5	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.2	5.2	0.3	0.2	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.8	0.1	0.6	0.6	0.5	0.5	0.2	0.3	0.3	0.2	0.0	0.5	2.0	0.1	1.8	0.3	0.0	0.0	0.9	0.6	0.3	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.9	0.8	156.6	0.6	0.1	0.3	1.8	0.0	2.2	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.4	0.0	0.0	0.0	58.2	1.2	0.1	0.0	1.9	0.0	74.8	0.0	1.0	0.4	0.2	0.0	1.2	0.0	0.3	0.0	1.0	0.0	3.9	0.0	0.0	2.4	31.7	14.2	2.4	1.0	0.0	0.0	0.0	0.4	0.3
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822789-50195147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 147.3;Inhibitory neurons: 90.5;Pancreatic endocrine cells: 106.6;Proximal enterocytes: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 65.5;HaCaT: 100.3;RH-30: 152.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	3.2	1.7	1.0	7.9	3.3	0.1	13.7	0.5	3.6	17.7	15.9	45.3	60.2	2.6	18.5	37.4	12.2	11.3	2.7	4.4	10.4	19.7	18.7	11.9	2.6	0.5	3.4	0.5	16.6	23.0	13.4	3.8	1.6	10.1	43.6	40.9	25.4	7.1	0.4	27.4	62.0	3.1	0.4	1.7	33.3	11.4	1.9	3.1	29.4	0.2	13.0	14.2	21.6	1.4	65.5	17.3	0.3	0.3	0.0	0.0	34.0	0.3	2.6	1.4	0.1	45.8	27.2	0.1	15.6	0.1	5.0	100.3	22.6	27.3	1.3	0.2	6.9	0.2	7.5	32.8	0.0	0.2	0.2	0.0	23.6	0.6	16.2	5.1	2.3	0.3	0.5	24.7	2.7	25.3	0.0	0.2	4.6	37.8	7.0	0.0	152.5	11.0	56.8	13.2	33.7	0.7	24.4	28.3	0.0	8.6	16.8	0.2	1.5	0.0	34.0	0.4	6.8	16.7	11.2	0.1	1.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	3.3	0.5	3.6	4.4	10.4	0.5	3.4	1.6	0.4	1.9	1.4	0.1	54.5	15.8	2.6	1.6	0.4	9.0	7.9	2.2	7.7	14.3	7.7	3.5	15.7	21.5	7.3	10.4	4.4	0.3	147.3	5.9	49.0	22.4	38.5	3.1	1.1	6.7	5.3	4.4	47.3	1.1	3.7	48.4	29.1	0.0	27.1	0.0	18.4	0.9	0.0	90.5	35.4	2.0	1.3	0.8	4.5	0.9	1.0	3.6	3.7	2.0	31.9	0.0	2.0	9.0	106.6	70.7	0.7	1.4	60.1	177.6	18.9	38.1	30.2	0.0	0.9	2.3	9.5	6.7	8.3	6.5	4.7	0.7	0.1	46.7	56.2
MYO9A	"FLJ11061, FLJ13244, MGC71859"	ENSG00000066933	"Myosin IXA"	B2RTY4	15	71822291-72118577	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, GTPase activation, Motor protein, Myosin"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 61.7"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 225.5;Inhibitory neurons: 192.9;Rod photoreceptor cells: 462.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039812, HPA040071"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA039812: AB_10961421, HPA040071: AB_10961117"	"unprognostic (7.53e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.44e-1)"	"unprognostic (4.41e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"	6.5	3.9	11.3	4.8	14.9	4.8	10.7	14.3	13.3	8.7	2.5	7.1	2.1	9.9	7.4	7.7	7.2	5.2	6.7	12.8	9.2	13.7	3.7	8.8	6.4	8.7	8.0	12.1	3.3	7.4	4.7	7.6	9.2	8.0	6.3	61.7	4.5	7.5	8.1	8.7	4.6	10.2	6.7	7.3	5.2	28.7	9.5	6.7	13.2	14.9	6.4	6.5	6.1	13.5	9.7	14.6	9.6	6.8	14.2	16.5	5.7	9.1	9.8	9.0	9.1	7.1	6.6	43.3	5.4	17.9	11.8	9.0	19.2	10.3	11.9	9.5	11.1	11.1	8.9	3.2	9.0	11.2	8.5	9.5	10.2	10.6	15.2	7.6	11.5	7.7	7.2	10.3	12.2	6.0	6.4	4.5	5.2	3.5	5.9	4.6	18.2	4.3	10.9	14.3	5.4	5.9	12.0	10.0	9.5	11.6	8.0	5.3	15.5	18.0	8.7	29.7	10.4	6.5	17.3	11.3	10.8	9.2	8.1	1.7	1.5	3.7	3.6	1.4	4.9	3.1	3.5	3.0	1.6	4.0	3.6	3.4	0.2	2.8	2.6	6.3	3.1	0.9	11.3	14.9	14.3	13.3	12.8	9.2	8.7	8.0	9.2	6.7	9.5	13.5	37.0	115.4	77.4	145.6	18.4	20.9	22.2	12.4	20.5	56.3	26.2	25.0	35.5	5.7	24.1	29.5	54.2	11.9	30.2	21.1	17.6	6.1	131.8	27.9	47.3	29.6	12.6	19.6	225.5	8.0	11.3	35.6	15.8	41.2	10.1	53.1	22.1	5.7	9.0	53.8	192.9	9.7	8.2	54.8	10.0	161.9	38.8	17.7	23.2	113.4	13.0	24.0	14.4	177.0	180.2	10.9	15.5	42.9	12.2	25.0	10.4	14.1	28.3	462.1	19.7	54.9	32.6	115.2	41.8	18.4	23.9	12.0	18.5	17.0	12.8	15.7
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056850-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	1.0	0.7	1.4	2.5	1.2	4.1	2.9	1.8	1.6	2.5	1.7	2.2	2.4	3.4	1.9	1.8	1.8	1.6	1.1	0.7	4.2	1.5	5.8	1.6	3.6	2.1	1.7	3.0	4.2	1.4	1.2	3.6	0.7	2.4	2.2	2.2	3.5	0.9	0.7	1.9	2.2	0.8	1.4	1.9	1.9	1.8	4.0	11.3	3.5	1.0	4.1	2.1	1.4	0.5	2.0	2.0	12.0	1.9	0.8	3.8	9.5	2.2	2.5	1.3	2.7	3.9	4.0	10.7	4.3	2.1	2.2	1.5	7.7	2.4	3.0	3.4	2.3	4.8	1.5	1.8	1.9	13.0	11.2	4.3	3.3	2.1	4.6	0.4	3.3	10.0	10.8	4.5	2.5	1.9	26.8	6.4	6.0	1.6	1.7	15.4	14.1	2.5	1.0	4.7	4.7	8.3	2.2	1.6	2.1	7.8	1.5	3.8	4.5	1.5	7.3	0.9	1.7	7.4	8.0	7.3	1.4	4.8	3.0	5.1	0.8	0.4	1.7	0.9	1.8	1.2	2.3	1.3	1.4	1.7	3.4	1.9	0.2	8.2	0.9	6.5	1.1	0.9	1.4	1.2	1.8	1.6	0.7	4.2	2.1	1.7	0.7	1.4	4.0	0.5	9.6	22.4	24.4	19.2	18.2	12.0	14.3	5.1	18.8	33.0	12.3	11.2	12.3	11.5	13.2	22.0	27.1	44.2	36.7	9.0	0.0	6.0	4.7	17.6	15.1	11.4	19.3	22.5	16.5	12.6	12.9	15.5	12.2	20.7	5.1	36.1	6.8	20.7	12.4	72.3	47.2	17.1	10.2	16.3	24.6	4.3	9.9	24.0	7.2	36.5	17.9	12.4	27.8	44.2	3.1	11.4	10.8	3.8	36.0	12.4	7.3	3.6	8.7	22.6	13.1	17.9	6.3	22.0	24.3	13.0	13.1	27.0	28.4	30.4	8.5	9.2
NAB1		ENSG00000138386	"NGFI-A binding protein 1"	Q13506	2	190646746-190692766	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 102.0;Suprabasal keratinocytes: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002738	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"HPA002738: AB_1079447"	"unprognostic (1.44e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.04e-3)"	"unprognostic (9.05e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.52e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.85e-2)"	29.3	20.3	19.4	23.5	16.7	18.6	34.8	50.4	23.5	28.1	7.4	22.8	15.8	32.3	50.1	36.3	27.5	28.0	28.5	18.7	9.7	19.9	37.8	22.8	26.8	13.4	13.2	26.0	17.9	23.5	21.1	26.4	14.9	18.5	25.6	41.4	20.7	20.9	8.0	66.7	17.1	25.2	14.9	19.8	37.9	26.0	13.8	21.2	37.9	17.2	26.3	31.2	24.2	25.9	35.5	25.8	65.0	22.6	24.5	42.7	111.0	35.5	55.7	26.4	29.8	62.8	38.4	39.6	40.6	28.3	48.9	88.4	37.4	45.9	51.8	126.1	31.0	46.7	96.3	30.2	15.8	19.8	22.4	24.6	70.4	55.9	17.1	37.4	41.5	23.9	46.3	33.2	40.6	17.4	28.7	20.0	22.8	38.4	35.2	35.0	46.7	15.9	19.3	34.5	57.9	46.9	41.8	13.9	37.3	82.8	11.4	30.6	29.0	54.5	43.0	31.0	21.6	25.7	30.3	29.5	57.3	17.6	43.7	0.0	1.3	0.6	1.3	1.1	1.9	0.7	1.3	1.7	0.9	0.4	1.4	1.5	2.9	2.6	3.7	0.8	3.3	0.8	19.4	16.7	50.4	23.5	18.7	9.7	13.4	13.2	14.9	14.9	13.8	25.9	24.1	6.4	21.2	14.0	5.9	102.0	23.1	24.6	31.3	26.1	19.7	19.7	18.2	11.5	29.8	12.9	12.5	4.3	9.2	11.4	3.9	10.3	1.4	17.5	10.8	30.1	14.4	12.0	37.2	8.0	11.1	25.2	21.4	23.4	20.3	14.2	44.6	25.7	6.7	6.7	21.2	17.5	14.2	17.3	77.4	3.2	13.4	20.7	39.2	24.4	10.6	12.4	11.3	29.1	28.3	10.2	26.3	14.7	14.9	30.5	4.8	5.1	22.3	15.5	46.0	24.6	39.2	1.7	27.3	55.7	138.9	1.2	16.7	7.3	16.0	29.9
NAIF1	"bA379C10.2, C9orf90, DKFZp762G199"	ENSG00000171169	"Nuclear apoptosis inducing factor 1"	Q69YI7	9	128061233-128068206	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054898, HPA064931"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054898: AB_2682633, HPA064931: AB_2732725"	"unprognostic (7.09e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.60e-1)"	"unprognostic (6.15e-2)"	"unprognostic (9.41e-2)"	"prognostic favorable (1.02e-5)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.30e-5)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.92e-2)"	2.0	2.4	1.2	1.8	1.4	4.3	1.8	1.2	1.6	2.1	1.3	2.0	2.0	2.2	0.7	2.6	1.8	1.0	2.0	1.2	1.2	1.7	2.6	1.6	2.6	1.4	1.2	1.7	2.4	1.8	1.5	1.6	1.3	1.5	1.2	0.7	2.2	1.4	2.7	2.3	2.3	1.4	1.1	3.2	2.1	3.4	1.6	2.4	1.7	1.9	2.2	1.6	1.8	1.2	5.1	4.4	2.7	7.0	2.5	2.2	6.1	3.8	2.3	3.2	2.6	3.5	4.0	6.2	3.3	2.4	4.5	3.8	2.8	2.9	2.6	19.1	3.8	4.6	5.4	2.0	4.1	6.4	12.5	2.0	3.4	2.5	4.0	2.6	2.9	6.9	11.0	3.9	3.0	5.9	6.2	7.7	3.0	6.9	7.4	5.9	4.3	5.7	2.5	3.1	3.9	4.5	3.8	5.2	4.0	2.0	4.0	6.3	2.0	3.8	11.8	3.2	4.5	6.3	14.0	4.1	3.6	4.1	5.1	0.0	0.7	1.2	0.5	0.6	0.4	0.3	1.1	0.7	0.7	0.9	0.7	0.6	1.5	0.5	1.0	0.5	0.3	0.5	1.2	1.4	1.2	1.6	1.2	1.2	1.4	1.2	1.3	1.1	1.6	1.2	5.6	0.0	3.0	2.0	5.4	4.8	4.6	3.9	4.6	4.0	3.9	2.8	4.2	4.3	3.4	5.5	0.0	5.8	6.6	6.3	3.9	3.5	8.7	2.6	3.5	6.4	5.4	0.8	1.0	6.6	5.7	3.1	1.5	3.2	8.2	3.7	7.1	2.4	5.7	10.1	0.9	4.0	0.0	7.0	3.6	10.9	6.2	3.1	0.0	0.0	5.1	4.6	7.2	2.0	0.7	3.7	5.1	3.0	3.4	3.3	7.3	4.2	1.8	5.0	0.0	4.2	3.5	15.1	7.8	5.0	3.8	4.7	4.0	4.4	3.6	2.9
NAPG		ENSG00000134265	"NSF attachment protein gamma"	Q99747	18	10525905-10552764	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008208, HPA011389"	Enhanced		Approved	"Plasma membrane"		NA	NA		8800	"Cluster 49: Eosinophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA008208: AB_1854305, HPA011389: AB_1854306"	"unprognostic (1.23e-1)"	"unprognostic (7.64e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.46e-3)"	"unprognostic (5.85e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.96e-2)"	11.3	14.8	18.4	9.7	18.6	7.2	11.8	21.1	25.3	10.5	13.9	11.9	9.3	10.7	12.0	12.1	11.0	13.4	19.9	25.9	20.8	16.4	13.6	9.7	9.6	30.3	20.1	7.5	12.6	12.4	9.9	13.9	32.6	13.7	13.7	12.6	11.7	10.7	10.2	9.9	10.7	11.8	19.4	9.4	13.7	7.4	20.1	9.0	14.5	14.6	11.2	14.3	10.1	21.7	9.4	5.6	9.6	8.3	27.1	18.4	14.0	19.8	28.1	19.0	24.0	12.4	14.1	12.3	15.5	27.3	17.4	9.0	12.7	17.7	26.9	11.0	7.8	9.2	9.8	12.8	25.9	26.0	16.6	20.3	20.6	21.8	16.2	12.4	18.0	16.0	15.1	29.0	28.2	13.2	20.0	11.1	7.7	72.3	8.3	8.7	15.8	21.2	22.5	22.0	38.3	10.1	16.1	16.9	23.1	15.5	7.7	17.2	20.5	29.8	14.4	27.8	21.2	18.8	20.4	13.6	20.1	17.7	14.2	12.5	4.9	14.1	5.1	6.1	4.7	7.5	4.1	5.2	3.8	3.3	5.6	4.8	8.1	5.8	6.1	4.1	4.4	3.1	18.4	18.6	21.1	25.3	25.9	20.8	30.3	20.1	32.6	19.4	20.1	21.7	32.2	28.9	34.7	33.6	29.1	24.3	31.1	26.9	21.6	62.0	21.8	17.4	35.1	21.5	27.5	27.6	12.5	23.6	32.9	30.8	41.1	53.3	18.1	27.9	33.2	23.4	23.4	33.2	68.5	42.5	30.3	25.3	28.5	49.5	45.0	13.6	20.0	21.7	25.4	45.4	53.8	22.3	28.5	22.1	16.1	4.6	7.8	24.5	26.6	30.9	22.4	31.3	22.6	34.7	52.9	77.7	34.1	21.1	36.2	34.8	20.8	39.5	20.8	34.0	26.3	30.5	29.6	26.6	39.9	30.8	21.2	45.1	26.2	28.4	19.0	56.5
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671788-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 34.8;lung: 11.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 262.8;Astrocytes: 478.6;Oligodendrocyte precursor cells: 774.6;Oligodendrocytes: 2156.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: AB_2679114"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	1.9	1.0	9.6	0.5	31.3	0.0	3.0	18.6	12.3	1.2	2.5	1.2	2.2	0.4	0.6	4.0	0.4	0.7	2.6	9.5	14.5	4.1	3.9	11.4	1.3	23.4	28.6	2.4	0.9	0.6	0.6	2.6	22.9	0.8	1.0	4.7	2.1	0.3	0.5	2.1	3.2	0.4	10.1	1.7	1.7	1.1	28.6	0.8	1.1	0.6	1.0	0.5	2.0	34.8	0.0	2.2	46.2	0.0	0.1	0.4	0.2	0.7	8.3	0.7	0.8	0.0	0.1	3.6	0.0	0.5	0.5	0.2	0.3	0.7	2.5	0.0	0.3	0.0	7.1	0.0	0.0	0.0	0.0	0.5	3.8	4.4	0.6	7.2	0.8	0.0	0.0	0.0	1.3	0.5	0.0	0.0	1.1	0.3	1.4	0.4	0.0	1.9	1.1	1.1	0.2	1.4	0.0	1.7	2.4	0.4	0.7	0.0	2.4	0.3	0.4	6.7	0.1	0.2	0.0	1.3	0.4	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	31.3	18.6	12.3	9.5	14.5	23.4	28.6	22.9	10.1	28.6	34.8	6.0	262.8	13.3	478.6	0.6	8.9	0.7	1.4	15.4	179.6	14.5	10.8	16.8	0.0	28.6	1.8	41.7	0.1	0.1	5.3	3.9	0.3	6.8	1.1	1.1	2.9	3.6	0.0	16.4	0.2	0.2	6.8	7.7	1.4	1.3	0.0	0.7	6.3	0.6	33.7	41.3	5.4	10.2	7.9	32.2	3.3	26.4	6.2	1.8	147.1	4.1	56.9	0.0	774.6	2156.8	1.0	5.2	7.5	0.0	0.5	20.7	14.0	1.2	7.8	6.6	8.7	24.7	0.1	1.3	15.5	2.8	0.0	0.7	0.0	1.6	1.5
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765478-53838463	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	5.4	5.2	3.4	9.5	3.5	8.4	11.1	3.6	4.1	5.7	3.6	11.9	8.9	6.5	7.4	7.7	7.5	4.6	4.5	3.6	3.4	6.9	7.8	4.7	15.7	3.2	3.3	5.9	4.7	9.5	1.7	8.0	3.3	4.8	14.2	6.0	4.2	5.2	4.3	7.3	8.2	7.1	3.5	5.6	6.4	7.5	3.5	14.2	6.8	5.2	18.4	7.1	4.2	3.9	61.6	31.2	42.8	43.7	15.5	15.5	49.3	40.9	31.0	63.8	51.1	47.5	40.4	119.0	26.2	18.6	51.2	72.0	73.2	43.3	89.8	29.8	50.9	58.5	42.9	40.5	14.3	95.3	31.9	9.4	17.0	62.9	37.5	18.6	39.1	44.2	67.7	16.9	35.6	22.2	47.2	38.2	101.0	52.2	49.9	52.0	68.4	66.0	29.8	41.7	25.4	32.2	36.5	71.5	35.9	45.3	55.3	50.2	22.7	32.9	32.6	45.5	74.9	17.9	48.8	84.7	27.3	71.6	42.2	0.0	2.3	1.5	3.0	5.0	4.7	3.6	2.8	2.7	2.6	2.8	5.3	4.1	0.1	3.1	3.3	2.3	3.4	2.4	3.4	3.5	3.6	4.1	3.6	3.4	3.2	3.3	3.3	3.5	3.5	3.9	4.4	6.4	6.3	12.4	8.7	10.1	6.4	9.0	12.0	4.5	10.1	6.3	8.1	4.3	5.4	5.5	2.1	11.5	5.9	7.9	0.0	8.5	2.3	5.0	5.6	6.1	0.0	19.4	13.8	9.1	20.2	6.3	8.6	4.6	7.6	21.5	5.3	7.1	11.8	3.3	11.0	10.3	16.2	8.2	8.9	2.1	2.8	7.1	7.2	13.1	4.7	3.3	3.1	11.6	19.4	7.0	5.8	3.4	20.1	8.9	2.9	4.5	5.5	2.9	6.6	6.3	15.7	11.8	14.3	18.2	8.5	6.8	6.7	4.3	18.2	6.5
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 323.2;Alveolar cells type 1: 471.1;Glandular and luminal cells: 337.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 137.3;HSkMC: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009689, CAB009720, HPA038768, HPA039270, HPA072955"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	94.7	8.6	8.3	23.3	8.1	8.6	64.2	6.4	12.3	26.6	14.4	30.7	15.5	19.2	17.5	14.5	22.7	31.4	32.7	7.7	6.4	33.8	20.7	91.9	25.8	8.3	7.3	8.3	17.1	9.5	8.1	69.2	8.5	22.4	30.2	9.8	26.7	29.8	27.2	20.6	38.1	25.8	7.4	25.2	23.5	6.9	9.7	22.2	25.6	12.0	22.2	34.5	15.3	7.9	4.4	29.0	26.4	0.4	17.7	2.3	27.7	6.6	8.2	12.2	22.4	9.3	1.9	9.2	137.3	14.7	1.5	12.6	36.0	13.5	15.8	4.1	1.0	0.8	4.4	62.3	8.3	10.1	0.4	67.7	4.0	7.9	1.3	4.4	21.0	0.8	0.1	7.6	27.7	1.3	5.8	4.0	4.1	34.6	2.9	1.6	0.7	5.4	6.1	39.8	0.6	4.8	1.1	31.2	55.5	29.3	2.3	7.7	53.8	8.2	14.3	0.8	16.5	7.8	34.8	11.4	0.2	7.9	36.6	24.2	13.3	37.3	18.3	28.5	14.7	10.9	12.2	17.5	14.1	12.3	6.4	9.9	80.9	12.3	50.6	8.7	12.1	17.1	8.3	8.1	6.4	12.3	7.7	6.4	8.3	7.3	8.5	7.4	9.7	7.9	323.2	471.1	135.1	11.1	34.9	60.5	235.6	83.5	98.4	4.7	43.1	38.0	14.2	50.1	89.0	44.1	25.0	56.3	45.9	103.4	9.8	62.0	8.2	244.8	24.8	148.1	108.3	2.5	18.2	19.8	42.6	37.2	107.6	337.0	64.5	15.7	86.7	21.6	14.7	10.1	11.3	108.4	12.2	29.8	28.9	4.3	7.5	51.4	24.9	34.7	15.4	84.1	64.9	8.0	4.9	69.1	43.6	29.0	34.8	66.1	100.5	26.7	64.4	12.4	26.3	8.8	30.0	2.1	1.1	11.4	20.6	42.8	59.4	37.2	46.6	90.3
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 404.8;skeletal muscle: 676.9;tongue: 548.9"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 152.2;LHCN-M2: 135.1;RH-30: 108.5"	"Region enhanced"	"Detected in all"		"basal ganglia: 40.4"	"Group enriched"	"Detected in all"	4	"basal ganglia: 9.0;midbrain: 13.4;pons: 10.0;thalamus: 25.2"	"HPA011185, HPA011904"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA		2900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	42.8	22.3	2.3	24.5	3.1	0.6	16.2	1.7	1.6	21.9	2.5	89.2	10.2	79.0	10.7	49.4	47.5	28.7	404.8	1.3	1.8	8.0	5.6	25.2	5.6	1.4	3.3	15.2	10.0	1.5	1.4	10.6	1.5	62.5	15.7	0.6	11.5	69.8	676.9	6.8	26.7	70.6	1.2	8.6	44.1	5.7	4.7	2.1	10.3	548.9	1.8	49.7	19.5	1.7	26.0	1.5	4.5	0.2	79.5	75.3	12.3	152.2	65.5	29.8	20.2	4.6	0.2	0.0	8.6	54.7	34.4	3.4	3.3	14.3	53.3	0.7	3.4	6.2	7.5	1.5	59.3	1.3	0.2	56.6	3.3	40.7	23.8	65.2	22.8	6.0	0.3	0.0	135.1	0.0	29.9	1.8	23.8	0.0	18.6	24.3	108.5	0.2	35.5	1.2	0.1	1.1	13.3	0.0	1.0	29.9	0.0	3.5	23.4	71.7	53.6	31.2	76.1	0.2	0.2	0.1	4.0	2.8	0.2	0.0	1.7	0.0	0.2	1.0	0.0	0.7	0.1	0.2	0.9	0.5	0.3	0.1	1.4	0.3	0.8	0.6	0.0	3.6	2.3	3.1	1.7	1.6	1.3	1.8	1.4	3.3	1.5	1.2	4.7	1.7	8.3	105.8	4.9	11.4	2.1	1.8	0.9	4.6	1.2	2.7	1.4	33.1	2329.6	0.0	5.4	0.0	4.2	0.8	4.1	0.4	1.9	15.3	24.0	2.6	24.2	17.4	0.0	1.7	26.6	32.4	4.0	93.2	1.1	3.2	1.3	29.7	38.6	1.5	1.2	1.7	27.6	0.5	0.0	4.4	2.2	9.0	73.3	44.9	0.0	16.9	5.8	0.7	0.0	24.6	27.3	21.8	0.1	346.1	0.3	1.3	5.3	0.7	0.4	3.8	216.9	70.4	177.2	0.7	3.6	0.8	0.9	0.3	2.3	13.0	2.1	0.4
NFAM1	CNAIP	ENSG00000235568	"NFAT activating protein with ITAM motif 1"	Q8NET5	22	42380407-42432403	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.9;lymphoid tissue: 19.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 11.4;Hofbauer cells: 17.0;Kupffer cells: 53.9;Macrophages: 27.2;monocytes: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 90.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 90.4;monocytes: 48.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 37.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031812	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA031812: AB_10603121"	"unprognostic (9.77e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	6.3	1.9	1.5	12.4	1.9	30.9	1.1	1.5	2.2	1.8	2.0	1.5	1.3	0.6	0.6	1.3	2.0	2.3	1.3	1.8	2.4	1.2	2.3	7.5	5.5	3.1	2.2	0.3	0.8	0.3	0.6	2.9	2.9	0.9	1.2	0.1	0.8	1.4	0.4	1.4	2.3	2.9	2.3	19.9	1.1	0.7	2.9	2.1	0.7	1.5	2.1	3.1	0.7	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	5.8	0.0	0.0	0.1	0.0	0.4	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.3	48.2	2.8	0.1	32.5	0.2	0.0	0.1	0.0	16.5	0.1	0.0	0.0	90.4	0.0	31.1	0.3	0.0	25.4	1.5	1.9	1.5	2.2	1.8	2.4	3.1	2.2	2.9	2.3	2.9	3.0	0.4	0.0	3.7	0.0	0.5	0.9	0.7	0.9	0.6	0.2	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.8	0.4	0.2	0.5	1.2	0.0	0.7	0.2	0.1	0.5	0.0	0.3	11.4	0.0	0.7	0.6	17.0	0.0	0.6	0.0	0.0	53.9	8.2	5.6	0.3	27.2	0.0	8.4	44.6	0.0	0.0	2.0	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.5	0.5	0.8	0.7	0.0	1.0	0.3	1.3	0.4	0.0	0.5
NGEF	ARHGEF27	ENSG00000066248	"Neuronal guanine nucleotide exchange factor"	Q8N5V2	2	232878701-233013256	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 56.2;brain: 129.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.0;Excitatory neurons: 105.9;Proximal enterocytes: 66.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 129.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 53.9;HDLM-2: 45.3;HeLa: 21.6;PC-3: 57.0;T-47d: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 167.6;cerebral cortex: 133.8;hippocampal formation: 73.0"	HPA008160	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA008160: AB_1854450"	"unprognostic (3.92e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.39e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.74e-1)"	1.1	56.2	16.3	2.2	129.6	0.1	1.9	0.0	59.4	4.1	0.0	14.2	42.7	5.0	4.1	10.3	4.8	3.1	2.2	19.8	0.0	7.0	35.5	0.7	0.2	0.0	0.0	2.0	6.0	11.9	2.7	0.3	0.0	1.8	10.5	1.4	2.0	0.7	0.9	30.3	31.3	6.7	0.0	0.4	10.7	3.7	0.2	0.0	0.9	0.7	0.3	1.8	5.2	29.4	53.9	15.4	0.6	0.2	0.2	8.2	0.9	0.9	0.1	0.4	0.0	0.7	5.2	0.0	15.2	10.9	5.5	6.9	11.6	3.0	0.4	45.3	3.8	0.1	21.6	16.7	0.2	0.0	0.3	0.0	0.2	3.5	0.6	0.2	1.9	0.2	0.2	0.2	0.5	4.0	0.0	0.1	1.3	0.2	57.0	0.0	0.0	0.1	1.0	1.4	1.9	0.4	6.6	3.3	0.1	2.0	32.2	0.4	0.0	0.5	4.5	0.3	1.0	0.5	0.2	0.0	3.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	129.6	0.0	59.4	19.8	0.0	0.0	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	10.4	0.0	9.9	1.2	1.2	2.8	0.3	2.1	1.4	2.4	4.3	0.5	0.0	0.0	0.1	0.0	38.0	0.0	3.9	0.7	9.1	0.9	0.4	4.9	0.0	105.9	10.5	0.3	0.7	17.3	2.0	0.0	0.3	0.4	20.4	0.1	1.7	12.8	14.6	0.0	0.3	0.6	2.0	0.0	0.3	1.8	6.5	0.0	5.5	0.0	4.5	6.0	12.1	23.5	1.2	0.1	0.5	66.7	9.8	2.5	0.2	0.0	0.2	0.3	1.1	0.8	3.8	7.5	0.0	0.2	0.5	20.2	1.1
NHSL2		ENSG00000204131	"NHS like 2"	Q5HYW2	X	71910818-72161750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 101.2;monocytes: 57.7;Prostatic glandular cells: 90.5;Urothelial cells: 80.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 14.3;neutrophil: 15.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.1;granulocytes: 15.6;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"AF22: 25.2;EFO-21: 29.5;HUVEC TERT2: 27.8;TIME: 16.3;U-937: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049771, HPA075115"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA049771: AB_2680872, HPA075115: "	"unprognostic (9.71e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.72e-4)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.37e-4)"	4.7	1.3	8.1	3.0	9.6	2.2	3.2	11.8	6.6	3.2	12.3	4.9	0.8	3.2	1.4	3.1	2.3	4.3	2.2	6.6	5.9	1.1	0.9	3.4	0.8	1.5	9.1	1.6	0.6	1.6	2.6	2.2	4.6	3.5	1.9	0.3	1.5	4.8	0.8	1.4	1.7	6.9	0.8	2.8	1.9	2.4	6.9	1.0	2.7	2.4	0.9	3.7	2.3	0.0	0.4	0.6	25.2	0.1	0.3	1.0	0.2	0.9	4.7	0.1	0.4	0.1	0.0	0.2	29.5	2.6	0.1	0.0	1.6	0.0	0.6	0.1	0.6	0.1	0.1	0.0	0.1	0.1	1.4	0.5	0.0	0.9	0.0	0.1	27.8	0.1	0.0	4.1	0.2	0.2	0.1	2.1	4.8	0.0	0.0	0.1	1.4	0.0	0.1	2.9	0.6	5.7	0.0	0.0	0.0	7.1	0.1	1.7	16.3	0.0	1.6	2.0	0.0	0.1	0.0	0.1	1.1	20.5	0.0	5.0	7.1	14.3	2.0	4.7	1.9	0.0	1.0	1.7	4.1	0.0	0.1	0.2	15.6	1.0	3.7	0.0	0.1	2.3	8.1	9.6	11.8	6.6	6.6	5.9	1.5	9.1	4.6	0.8	6.9	0.0	29.2	0.0	1.9	1.0	7.3	0.5	101.2	0.0	0.6	0.9	5.0	3.7	19.6	21.5	0.0	1.8	0.0	17.9	10.1	2.0	0.0	0.2	4.7	3.3	2.8	32.9	1.2	17.3	7.8	0.7	24.3	15.2	0.5	9.0	7.6	0.9	51.0	19.0	19.1	0.0	5.8	3.7	0.0	49.0	0.5	7.4	31.7	19.7	1.8	19.7	57.7	1.5	32.0	5.5	1.1	0.6	3.1	21.4	2.8	90.5	7.8	2.9	0.0	0.5	26.3	39.7	12.6	2.7	3.7	0.3	0.3	24.9	17.0	2.9	3.8	80.7
NIBAN1	"C1orf24, FAM129A, GIG39, NIBAN"	ENSG00000135842	"Niban apoptosis regulator 1"	Q9BZQ8	1	184790724-184974508	"Cancer-related genes, Predicted intracellular proteins"	"Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 164.1"	"Cell type enriched"	"Detected in some"	13	"Cardiomyocytes: 692.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 72.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 72.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.8;Karpas-707: 85.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		120000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.52e-4)"	18.2	7.8	1.4	38.9	1.6	8.8	24.0	1.5	1.9	14.8	3.1	104.7	8.5	24.2	6.2	61.2	22.1	27.7	164.1	1.5	2.0	3.3	2.7	18.1	11.3	3.9	2.4	4.9	85.7	4.2	2.1	6.2	3.1	59.6	15.9	0.8	100.6	43.1	60.9	8.8	18.5	41.0	2.8	12.3	58.9	1.9	2.2	12.2	15.3	41.2	17.3	105.8	14.6	3.2	42.0	0.5	0.2	0.1	28.0	42.2	1.6	21.1	42.9	17.7	22.3	0.0	17.3	0.0	13.6	54.2	4.6	46.0	2.4	1.5	28.4	83.8	3.2	17.5	8.2	0.0	65.2	57.2	19.1	39.1	65.3	52.1	62.4	12.6	0.1	6.3	4.2	85.5	0.5	0.2	1.9	10.0	11.1	0.0	4.3	13.3	9.9	0.8	24.5	0.8	2.3	2.1	0.4	0.1	29.9	7.0	9.0	17.9	3.3	35.0	0.1	6.3	43.5	71.1	30.2	8.7	68.8	23.4	35.3	20.4	3.6	10.9	5.1	2.1	4.4	1.0	4.7	5.0	5.2	0.3	0.4	1.8	72.1	5.7	0.8	0.5	11.9	2.2	1.4	1.6	1.5	1.9	1.5	2.0	3.9	2.4	3.1	2.8	2.2	3.2	20.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	692.7	0.0	0.0	0.0	0.0	0.4	52.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.2	24.7	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.4	27.4	0.0	0.0	0.0
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580004-36582614	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;esophagus: 2.6;testis: 7.9"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.3;Basal squamous epithelial cells: 6.8;Late spermatids: 2.1;Oligodendrocytes: 2.6;Prostatic glandular cells: 2.1;Squamous epithelial cells: 3.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;PC-3: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Plasma membrane"	"HPA062879: AB_2684892"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.0	0.0	0.4	0.0	1.1	0.0	0.0	1.2	0.5	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.3	0.0	2.3	1.3	0.0	0.0	0.1	1.1	0.0	2.4	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	7.9	2.1	0.0	1.4	0.0	0.0	0.0	0.0	4.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	3.6	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	1.2	0.5	0.2	2.1	2.3	1.3	2.4	2.0	2.1	4.4	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.9	6.8	0.0	1.0	1.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	3.4	0.4	0.0	0.0	0.0	0.0	0.4
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 15.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 15.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favorable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	8.1	10.7	4.9	4.7	5.0	6.5	7.0	4.7	5.5	10.5	6.4	10.8	4.8	10.1	3.4	43.2	9.8	5.2	17.0	4.7	4.6	8.8	9.1	5.5	5.0	5.3	5.1	4.0	9.6	6.0	4.8	4.2	5.4	8.3	3.4	2.7	10.3	6.8	24.1	21.5	6.4	5.8	5.1	8.1	7.3	3.5	5.1	4.7	7.9	13.7	10.5	9.6	16.5	5.2	5.3	15.6	1.6	12.2	5.1	5.9	2.4	7.0	8.0	3.4	5.9	0.9	13.0	9.5	21.0	8.9	5.1	13.1	4.7	4.0	1.1	12.5	5.0	12.6	5.5	8.6	7.7	4.4	7.0	6.6	16.4	4.5	8.7	6.9	7.0	12.5	0.1	6.2	3.6	14.2	7.5	10.7	7.5	6.9	8.6	14.6	2.1	3.1	8.2	6.8	2.3	7.9	10.4	5.5	4.5	2.4	17.7	13.0	8.2	6.8	6.0	6.1	3.6	2.2	2.6	3.3	1.0	13.4	4.9	2.8	3.5	15.4	0.8	1.5	1.0	0.5	0.8	1.2	2.1	0.4	0.9	1.0	8.1	1.4	1.4	0.9	1.4	2.3	4.9	5.0	4.7	5.5	4.7	4.6	5.3	5.1	5.4	5.1	5.1	5.2	3.0	0.0	7.9	5.9	3.2	2.5	1.7	4.5	2.8	1.3	4.1	4.2	12.8	2.8	4.2	7.3	2.1	3.6	1.4	7.3	1.9	7.1	2.0	8.7	2.8	3.8	2.4	3.8	5.9	3.8	2.2	3.5	8.2	4.1	0.0	5.7	5.3	10.2	6.5	0.0	4.0	3.7	2.0	6.0	1.8	4.7	1.2	4.0	1.8	2.8	6.2	6.1	5.2	5.5	2.8	5.5	7.6	1.2	1.8	1.6	3.9	5.3	7.2	3.2	0.0	2.9	2.7	1.9	2.0	10.8	4.7	0.5	2.8	2.1	5.5	1.2
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 68.3;brain: 58.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 319.5;Club cells: 164.2;Ductal cells: 123.9"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 90.1"	"Region enriched"	"Detected in all"	16	"olfactory bulb: 168.0"	"Group enriched"	"Detected in all"	5	"olfactory bulb: 43.3;pons: 14.1"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	68.3	24.0	19.9	4.1	17.9	6.0	30.7	18.2	23.5	8.3	16.3	5.3	3.1	7.5	4.9	6.9	8.6	4.8	5.4	21.4	58.9	10.7	3.1	6.2	5.7	29.3	22.7	7.1	8.4	4.5	9.8	1.9	26.2	5.0	2.9	3.0	7.4	2.5	2.5	4.9	4.1	4.7	22.4	4.8	5.5	11.9	21.4	4.5	17.7	3.1	3.0	8.5	6.5	44.7	90.1	35.3	6.1	1.3	17.1	7.7	0.8	4.7	10.5	12.5	16.6	12.9	23.5	3.4	12.9	14.7	0.1	15.0	34.0	7.0	7.4	30.3	36.7	12.4	13.2	59.7	4.4	8.2	13.6	7.6	2.8	18.2	7.2	7.6	17.9	23.3	0.2	1.4	6.9	55.2	8.8	30.0	22.9	18.0	8.9	25.7	0.1	38.7	11.5	7.3	3.1	34.6	8.2	5.1	40.5	6.0	5.9	33.8	4.0	2.4	10.3	10.3	7.9	0.7	9.9	8.2	26.3	52.9	14.1	0.0	1.0	7.8	7.9	0.7	2.9	5.9	5.9	7.7	4.5	11.3	5.8	4.1	1.6	1.8	0.5	13.4	7.6	3.4	19.9	17.9	18.2	23.5	21.4	58.9	29.3	22.7	26.2	22.4	21.4	44.7	39.0	3.2	2.7	5.5	13.6	15.6	29.5	319.5	21.6	1.9	30.7	37.6	3.5	20.0	164.2	31.3	0.0	2.4	25.3	5.3	13.7	123.9	33.7	21.3	7.3	19.6	18.6	7.4	0.6	58.2	14.1	19.7	11.2	15.6	5.7	12.0	7.5	3.7	32.3	5.0	1.2	6.5	18.3	8.8	86.4	29.0	4.4	26.0	33.8	1.9	18.5	6.5	25.7	2.0	1.0	45.2	5.1	3.8	32.5	39.3	0.8	32.0	57.8	4.1	13.1	22.5	28.6	24.0	21.6	29.5	12.8	3.1	19.7	8.2	9.1	60.6
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153559-51162428	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	63.6	84.4	79.3	74.7	81.6	77.0	63.1	78.7	102.2	38.2	79.0	60.1	38.8	49.7	46.8	91.0	48.6	20.8	37.7	88.0	92.0	65.4	83.2	41.3	73.9	83.9	78.4	33.6	67.8	52.8	47.4	39.2	82.4	38.7	77.6	218.4	50.7	30.4	35.6	57.5	33.1	66.3	76.5	48.5	41.8	25.3	81.0	61.1	41.3	20.9	95.8	72.2	48.9	80.1	483.6	833.1	285.9	444.8	118.6	183.7	479.7	355.3	227.3	652.2	489.7	656.9	288.1	754.2	372.4	304.1	272.4	252.1	542.5	553.3	553.4	398.4	729.3	504.9	605.8	975.9	237.1	575.8	243.8	177.8	341.7	493.1	458.6	120.6	404.6	247.8	739.0	270.0	392.8	720.4	715.2	647.1	390.7	957.5	739.3	446.9	587.6	751.3	511.5	320.2	418.6	461.1	188.1	521.0	385.3	246.2	554.0	419.6	279.5	476.9	452.2	307.0	774.4	374.0	840.9	956.3	286.2	480.4	385.8	1.1	55.0	2.1	47.2	77.1	69.3	96.4	50.3	53.8	134.0	67.6	54.3	60.4	1.7	69.6	48.6	84.8	49.1	68.4	79.3	81.6	78.7	102.2	88.0	92.0	83.9	78.4	82.4	76.5	81.0	80.1	53.1	32.1	30.5	0.0	71.3	132.4	97.5	198.8	88.8	283.3	98.8	118.1	34.2	65.8	92.3	71.7	285.7	180.0	25.4	54.2	150.6	211.3	34.2	40.2	107.2	85.1	89.7	81.8	0.0	201.5	269.7	85.0	64.2	37.2	45.7	113.5	27.8	123.3	207.1	40.4	0.0	107.4	101.7	25.7	88.9	93.7	61.2	48.9	129.9	0.0	47.2	105.6	27.8	0.0	0.0	194.0	50.5	58.6	113.8	170.6	12.2	195.2	42.0	323.7	13.1	83.0	182.9	22.7	98.8	139.4	133.1	88.5	38.0	215.5	157.7	98.2
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	44957992-45109016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 344.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		94000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane"	"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.3	31.8	36.2	22.3	37.7	19.5	25.8	30.3	43.4	24.7	27.9	27.8	23.6	26.4	15.7	28.8	27.7	20.3	28.3	38.8	36.4	27.3	39.5	26.5	33.6	35.4	33.7	26.3	22.2	37.8	23.3	36.6	35.0	24.5	29.2	25.7	32.1	27.6	44.6	23.9	26.4	32.9	33.9	28.4	24.5	24.9	37.2	35.2	30.7	47.6	39.5	33.0	23.5	34.9	51.5	88.8	53.7	42.3	82.9	75.0	60.6	41.4	87.6	115.9	101.0	83.9	57.0	54.0	86.2	80.4	78.4	51.5	94.5	92.3	132.9	117.9	73.3	49.0	60.7	84.4	53.7	71.0	62.6	66.4	64.1	79.1	69.2	64.1	87.1	60.9	81.8	38.1	63.1	49.2	76.2	31.7	42.4	151.5	87.8	57.5	67.2	52.2	73.6	78.8	39.2	32.9	33.0	30.2	38.0	112.8	73.1	46.0	50.1	69.9	49.5	55.8	68.1	41.4	61.0	69.9	64.5	44.5	56.4	34.9	49.4	20.0	23.8	33.3	19.9	42.3	19.9	20.1	26.2	31.0	23.7	18.8	26.5	21.1	27.6	115.5	25.7	11.8	36.2	37.7	30.3	43.4	38.8	36.4	35.4	33.7	35.0	33.9	37.2	34.9	50.1	38.5	29.5	49.3	53.8	13.9	15.4	48.8	24.5	97.8	74.1	57.1	46.5	97.2	33.6	69.9	116.7	73.7	87.5	48.7	78.2	69.4	31.1	51.5	63.1	46.4	50.9	72.0	30.3	71.2	61.9	39.6	21.9	62.3	22.8	28.1	85.3	344.4	47.6	129.5	30.7	43.0	28.5	86.5	15.9	12.2	55.0	34.6	10.6	18.7	97.9	41.5	59.8	20.1	19.3	67.9	52.0	51.1	31.0	15.3	84.1	108.1	24.0	123.5	59.2	16.1	46.3	67.6	35.5	20.5	14.1	81.8	40.1	25.4	68.6	18.6
NOXRED1	"C14orf148, FLJ32809"	ENSG00000165555	"NADP dependent oxidoreductase domain containing 1"	Q6NXP6	14	77394021-77423517	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 5.9;testis: 6.9"	"Group enriched"	"Detected in some"	25	"Early spermatids: 137.8;Late spermatids: 125.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA055658, HPA060408"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 34: Spermatids - Unknown function"	Vesicles	"Plasma membrane"	"HPA055658: AB_2682878, HPA060408: "	"unprognostic (1.92e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.49e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.07e-3)"	0.2	0.6	0.5	0.1	0.6	0.2	0.5	0.2	0.5	0.2	1.7	0.5	0.5	0.5	0.5	0.3	0.5	0.6	0.1	0.5	0.6	0.5	0.3	0.3	0.6	0.8	1.0	0.3	0.4	0.2	0.7	0.3	0.7	0.3	0.5	5.9	0.2	0.4	0.1	1.1	0.3	0.4	0.9	0.5	0.2	6.9	0.5	0.5	0.9	0.0	0.4	0.2	0.2	0.7	0.3	0.7	0.3	0.4	0.1	0.7	0.5	0.3	0.5	0.3	0.2	0.4	0.3	0.7	0.1	0.6	0.1	0.2	0.1	0.1	0.4	0.3	0.2	0.4	0.0	0.7	0.2	0.1	0.6	0.4	0.9	0.3	0.5	0.4	0.2	0.8	0.1	0.5	0.1	0.8	0.2	0.2	0.0	0.2	0.6	0.2	0.1	0.0	0.3	0.1	0.7	0.5	0.4	0.1	0.1	0.7	0.7	0.4	0.9	0.2	0.2	0.4	0.1	0.7	0.7	0.4	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.2	0.5	0.5	0.6	0.8	1.0	0.7	0.9	0.5	0.7	0.2	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.0	4.2	0.0	0.0	0.3	0.0	0.0	137.8	0.6	0.1	0.2	1.8	0.0	4.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.0	3.0	0.0	0.0	0.3	0.2	125.8	0.9	0.3	0.0	0.0	0.0	0.4	0.0	3.0	4.4	0.1	0.0	1.2	0.1	0.1	0.3	0.1	0.2	1.5	0.0	0.0	0.1	4.1	2.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1
NPL	"C1orf13, DHDPS1, NPL1"	ENSG00000135838	"N-acetylneuraminate pyruvate lyase"	Q9BXD5	1	182789293-182830384	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 52.3;placenta: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.1;Cytotrophoblasts: 123.1;Hofbauer cells: 481.5;Kupffer cells: 148.8;Microglial cells: 125.5;Proximal tubular cells: 141.0;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 423.2"	"Group enriched"	"Detected in many"	34	"granulocytes: 423.2;monocytes: 128.4"	"Cell line enhanced"	"Detected in many"		"HEL: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028345, HPA075808"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		190000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Plasma membrane"	"HPA028345: AB_10610145, HPA075808: "	"unprognostic (2.43e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (4.41e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.44e-2)"	12.7	5.8	16.7	19.2	20.8	18.9	5.5	19.3	22.9	4.3	11.1	6.9	2.8	1.7	29.9	10.0	3.3	13.0	2.6	12.7	15.6	52.3	20.8	14.5	32.5	19.6	20.1	1.4	2.8	3.3	1.7	45.2	18.9	2.3	9.1	1.9	4.2	6.2	1.7	8.4	4.4	7.5	15.8	28.7	5.0	5.1	27.0	6.2	2.6	2.8	14.7	15.5	5.1	22.0	3.4	0.6	1.0	0.0	2.8	2.8	0.9	1.1	2.1	1.2	0.6	0.0	1.4	9.0	1.5	0.0	0.0	1.3	1.9	2.4	0.3	0.0	1.5	14.2	0.4	0.1	1.5	5.4	8.1	2.2	9.1	0.2	0.0	0.1	0.1	10.1	10.9	13.8	2.1	1.1	0.3	3.5	11.0	7.0	1.1	1.4	0.7	11.0	0.2	7.4	3.1	4.6	5.0	0.3	4.7	1.1	2.9	8.7	0.2	1.1	2.4	0.7	0.1	9.8	12.7	9.0	2.4	9.5	3.6	25.5	128.4	104.1	5.5	118.2	4.8	1.8	4.5	4.9	7.6	6.3	3.5	4.9	423.2	0.3	96.6	1.5	8.1	65.4	16.7	20.8	19.3	22.9	12.7	15.6	19.6	20.1	18.9	15.8	27.0	22.0	2.9	0.0	5.5	170.1	4.9	6.1	4.0	8.6	1.8	7.6	1.5	4.4	2.9	2.8	4.8	7.3	2.1	123.1	2.2	2.3	19.6	1.2	19.1	0.4	0.6	3.5	1.8	45.5	7.5	2.4	6.1	2.5	3.1	0.2	5.7	0.5	72.8	3.9	481.5	6.7	13.5	1.4	6.1	148.8	11.5	27.0	0.9	91.7	10.6	125.5	40.1	2.8	5.2	22.1	21.0	1.3	0.3	0.4	0.7	1.6	0.9	141.0	1.7	2.8	0.0	1.7	1.7	16.5	8.9	16.5	7.1	107.4	3.1	3.4	1.6	4.3
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678688-153693992	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.1"	"Group enriched"	"Detected in many"	6	"Adipocytes: 99.6;Endothelial cells: 52.5;Hepatic stellate cells: 132.8"	"Group enriched"	"Detected in all"	4	"ovarian cancer: 39.2;renal cancer: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 158.5"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 18.7"	"Low region specificity"	"Detected in many"			HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	67.1	8.7	1.7	3.4	1.5	0.0	44.3	1.4	1.4	8.8	1.5	10.1	1.5	31.0	5.5	4.3	36.4	5.9	15.8	1.3	1.4	28.8	4.3	24.2	2.3	1.5	1.5	27.7	3.9	8.4	3.8	17.7	1.5	4.4	2.0	0.1	3.7	12.1	7.2	6.6	9.3	9.7	1.8	2.2	8.8	1.3	2.4	1.9	14.0	11.1	1.3	12.8	9.7	1.4	0.0	1.3	0.1	0.0	158.5	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	28.0	0.0	19.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	15.9	0.0	0.0	2.1	0.0	0.1	0.0	1.9	0.0	5.7	1.0	0.1	0.0	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	1.4	1.4	1.3	1.4	1.5	1.5	1.5	1.8	2.4	1.4	99.6	0.0	6.9	0.0	0.2	1.5	0.5	0.0	0.6	0.0	0.5	0.5	4.5	2.8	0.0	14.7	0.0	0.2	0.1	0.0	0.0	0.7	9.1	6.2	8.8	52.5	0.0	0.0	0.0	0.0	1.3	15.2	0.0	15.4	0.0	0.0	132.8	2.4	0.3	0.0	0.0	0.0	0.0	4.7	4.0	11.5	10.2	0.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.0	0.0	4.1	0.0	0.5	0.0	4.0	0.0	0.0	0.0	1.4	2.2	0.5	0.1	0.2	1.0	0.7	0.3	1.4	0.2	0.0
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	84.6	95.7	81.4	75.9	104.4	32.7	82.6	52.1	176.7	112.4	72.4	133.0	134.9	180.7	150.9	133.9	135.0	97.2	196.4	122.6	65.6	126.5	74.0	110.5	48.7	42.9	42.2	79.1	96.6	167.2	47.1	123.1	39.8	170.8	142.0	135.5	101.0	204.4	51.2	68.1	124.9	298.4	28.5	71.8	96.4	69.2	60.4	42.6	112.4	70.1	69.4	140.6	84.9	87.9	101.9	179.1	100.9	74.5	201.6	180.7	141.1	229.1	373.5	258.3	228.4	122.4	317.7	58.7	133.0	331.2	319.2	411.1	164.4	191.3	147.6	105.6	109.3	46.7	83.3	110.2	143.1	72.6	124.9	149.1	165.2	167.4	100.7	254.8	139.5	52.0	26.7	65.2	187.2	81.2	32.4	45.3	93.5	127.3	63.3	52.1	115.8	49.9	353.7	148.3	61.6	19.2	222.4	122.4	151.3	249.6	110.9	97.7	159.0	199.7	133.8	116.0	135.8	56.5	113.8	51.4	185.8	111.0	140.0	5.9	13.5	13.8	6.4	18.5	5.2	3.8	3.6	5.9	5.3	2.9	3.6	4.2	28.0	3.9	14.8	5.5	4.3	13.6	81.4	104.4	52.1	176.7	122.6	65.6	42.9	42.2	39.8	28.5	60.4	87.9	67.1	76.9	66.0	72.1	18.3	65.0	27.0	43.3	51.2	93.0	50.5	45.7	106.9	48.6	60.6	82.8	50.1	7.0	28.8	133.8	1.9	18.1	3.7	73.4	46.7	44.6	103.0	7.4	216.6	24.0	9.2	64.5	41.3	92.1	28.4	33.9	50.0	43.1	25.0	38.7	162.7	90.9	42.7	77.4	46.6	9.9	15.2	61.8	42.7	86.2	43.4	41.2	12.3	63.8	67.4	41.4	66.7	38.4	20.2	26.9	52.3	20.7	92.1	49.7	19.7	35.5	74.0	11.7	10.8	61.9	54.6	6.8	23.9	35.3	52.6	30.7
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38844028	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 280.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Excitatory neurons: 41.7;Inhibitory neurons: 50.4;Oligodendrocyte precursor cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 280.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 23.3;SCLC-21H: 30.8;SiHa: 23.6;U-87 MG: 87.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		420000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.7	5.0	91.6	1.9	75.4	0.3	2.8	0.3	145.7	8.7	0.0	9.5	1.3	10.9	3.8	3.0	7.9	2.0	15.7	280.2	17.0	1.6	1.9	1.9	1.6	4.1	15.2	8.1	5.2	7.0	6.8	0.4	0.7	8.1	1.5	5.3	4.8	7.0	0.6	1.1	3.3	7.6	3.1	2.5	5.0	1.8	58.0	0.7	2.7	2.5	1.5	7.3	4.8	46.0	1.0	6.2	0.2	1.8	12.2	1.2	0.0	4.1	0.9	7.9	2.7	6.2	1.3	0.0	7.2	1.1	23.3	0.8	1.7	0.2	2.6	0.6	2.0	0.0	0.2	9.6	1.2	0.1	0.3	3.9	0.4	7.2	0.1	11.4	0.3	0.1	7.7	0.3	0.3	9.7	0.0	0.5	7.3	3.0	2.2	1.6	0.0	15.3	2.0	17.1	30.8	2.0	23.6	0.1	0.7	1.7	9.9	2.5	0.4	14.1	8.4	0.0	0.7	2.1	0.0	0.0	87.9	18.5	7.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	91.6	75.4	0.3	145.7	280.2	17.0	4.1	15.2	0.7	3.1	58.0	46.0	4.7	0.0	0.0	9.4	0.3	1.1	2.7	0.9	0.0	6.6	3.3	1.5	18.0	4.3	3.0	3.7	2.1	0.0	2.3	0.0	0.0	7.3	1.7	1.7	3.2	4.2	1.8	0.0	41.7	3.8	0.0	1.5	0.5	3.0	0.0	1.5	5.0	0.4	0.2	0.0	50.4	0.2	6.1	0.3	0.9	0.8	1.8	0.3	1.8	1.9	0.0	4.8	6.2	19.1	10.5	2.0	0.0	2.2	0.9	3.8	0.1	0.5	2.2	3.3	0.0	2.4	2.8	0.2	1.3	0.1	1.0	0.0	1.7	0.3	0.0	3.4
NRCAM	"Bravo, KIAA0343"	ENSG00000091129	"Neuronal cell adhesion molecule"	Q92823	7	108147623-108456717	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 37.3;brain: 38.3;epididymis: 34.4;retina: 38.0"	"Group enriched"	"Detected in many"	7	"Astrocytes: 612.5;Excitatory neurons: 764.5;Inhibitory neurons: 392.4;Oligodendrocyte precursor cells: 1259.2"	"Cancer enriched"	"Detected in all"	7	"glioma: 57.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"A549: 99.6;AF22: 94.8;EFO-21: 175.4;HMC-1: 187.9;SH-SY5Y: 115.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012606	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in brain"	NA	NA		110000000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA012606: AB_1854636"	"unprognostic (2.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.42e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.28e-2)"	3.1	37.3	19.8	1.8	31.9	0.3	1.5	2.4	34.6	5.0	0.0	0.8	0.7	2.1	34.4	0.7	3.6	7.3	0.4	33.1	9.4	6.2	0.4	2.3	0.8	2.3	22.7	1.5	29.4	7.3	11.4	7.8	2.0	0.8	0.7	38.0	1.9	14.2	0.2	0.8	0.6	0.7	1.5	4.8	1.8	1.7	38.3	2.8	4.1	0.4	2.7	0.5	0.4	2.6	0.1	99.6	94.8	0.0	11.4	2.2	1.8	0.7	0.4	1.0	1.7	40.7	0.0	0.0	175.4	0.7	1.5	0.4	2.2	1.6	1.0	0.1	12.7	0.0	0.7	1.0	0.2	0.9	187.9	15.5	0.0	0.2	0.6	0.2	61.7	0.2	0.2	0.8	1.5	38.2	0.4	0.3	13.1	60.1	0.0	0.0	27.8	33.3	21.4	0.1	18.6	115.9	1.3	0.0	1.9	3.3	0.2	0.1	66.2	4.2	1.0	0.1	16.4	0.2	0.5	0.9	0.7	0.1	55.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.2	19.8	31.9	2.4	34.6	33.1	9.4	2.3	22.7	2.0	1.5	38.3	2.6	0.2	0.0	0.0	612.5	0.8	0.4	0.1	0.8	1.2	66.2	1.5	0.9	0.7	7.2	0.1	5.5	102.2	3.6	0.0	0.2	3.9	1.6	37.3	10.4	2.4	1.3	0.0	0.0	764.5	12.1	0.2	2.0	3.6	25.0	23.4	4.4	1.4	0.4	0.8	13.5	392.4	0.3	0.0	0.8	0.4	8.3	0.9	0.2	3.6	51.5	0.6	45.1	0.0	1259.2	21.9	3.7	0.0	0.4	2.6	1.2	0.0	3.3	0.1	8.8	0.0	1.0	2.6	1.1	2.7	0.2	0.1	4.4	1.1	34.2	0.0	0.0
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 78.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 134.4;Hepatic stellate cells: 137.8;Hofbauer cells: 141.3;Langerhans cells: 129.8;monocytes: 224.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 123.6;HUVEC TERT2: 105.7;TIME: 106.3;U-251 MG: 217.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039980, HPA054974"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA		29000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA039980: AB_10795517, HPA054974: AB_2682657"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (7.80e-5)"	18.8	22.2	18.0	17.8	13.8	4.6	12.6	9.3	11.7	18.8	7.0	78.7	5.3	51.8	3.7	13.3	21.1	31.1	6.3	21.7	42.5	4.9	9.6	24.3	8.2	30.4	23.9	46.8	1.9	2.5	9.6	47.0	19.6	13.0	10.5	3.6	3.3	30.9	2.3	4.8	14.9	54.8	13.2	7.5	25.9	1.4	33.9	6.1	10.8	3.4	4.5	38.3	15.9	12.4	2.5	50.4	32.2	0.2	30.1	9.6	9.3	8.5	14.8	10.0	9.5	48.0	123.6	0.0	11.9	25.3	20.5	19.2	1.5	15.9	16.8	0.1	6.8	0.5	2.4	0.4	80.7	0.0	2.1	68.5	12.2	14.4	12.3	64.5	105.7	0.2	0.2	0.1	6.8	0.2	0.0	0.0	41.5	0.1	9.2	0.2	2.0	12.0	21.7	0.0	29.0	1.0	1.1	0.3	75.4	84.9	0.1	0.8	106.3	43.1	0.4	11.3	217.0	0.0	0.2	3.2	96.9	0.3	88.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	13.8	9.3	11.7	21.7	42.5	30.4	23.9	19.6	13.2	33.9	12.4	88.7	89.8	57.5	2.0	3.8	19.4	19.5	30.8	97.9	36.5	1.3	11.3	4.5	5.7	53.2	1.8	0.0	89.7	0.1	0.6	0.0	6.4	6.3	8.8	8.1	134.4	1.2	2.7	4.1	3.8	8.7	47.0	1.5	13.2	3.8	2.7	137.8	1.8	141.3	0.0	9.4	1.1	4.1	28.0	129.8	18.9	2.8	53.7	19.6	53.4	224.8	4.8	0.0	4.0	8.1	53.2	0.0	4.9	0.2	9.1	0.0	0.6	48.1	2.7	0.0	4.6	32.2	1.4	1.4	17.8	12.6	25.7	2.4	48.1	0.4	51.5
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126186-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 542.9;choroid plexus: 474.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 139.1;Horizontal cells: 121.1;Inhibitory neurons: 111.9;Oligodendrocyte precursor cells: 69.9"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 11.2;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		0.0	4.9	276.8	0.4	315.2	0.2	0.0	108.9	281.1	0.1	474.7	1.2	0.4	0.2	0.0	0.1	0.0	0.2	0.0	138.2	466.8	0.1	0.0	0.0	0.1	263.2	332.8	0.0	1.2	0.0	23.5	0.0	468.0	0.0	0.4	22.6	0.1	0.0	0.7	0.1	0.3	0.3	194.7	0.1	0.4	0.3	459.9	0.0	0.1	0.0	0.1	0.0	0.1	542.9	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	11.2	9.2	0.0	0.0	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.2	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.8	315.2	108.9	281.1	138.2	466.8	263.2	332.8	468.0	194.7	459.9	542.9	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.1	0.0	0.0	139.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	121.1	111.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	23.7	0.0	69.9	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1900000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	22.8	37.7	38.3	13.5	39.5	27.8	21.5	37.0	45.9	23.2	41.6	23.0	14.9	22.5	26.8	28.5	26.1	13.5	29.1	39.7	38.6	21.4	26.3	18.0	15.2	39.0	39.0	25.7	15.5	23.9	14.1	21.1	39.8	20.9	18.4	22.6	19.3	26.4	69.0	36.6	17.6	22.9	36.4	19.8	18.0	14.8	38.6	21.0	20.0	43.3	18.6	22.4	21.6	39.7	55.6	64.4	35.9	32.0	30.5	31.4	28.7	21.0	41.8	57.7	41.3	53.9	43.1	31.6	16.6	47.8	47.2	50.4	25.9	70.3	40.8	12.3	25.1	29.8	10.3	61.4	33.8	30.7	16.4	23.5	33.3	55.3	20.3	30.8	46.8	23.4	42.5	26.5	36.2	29.1	31.4	54.7	40.7	42.5	65.4	14.7	41.1	29.8	68.6	37.1	20.5	23.4	29.6	59.8	26.7	18.8	36.5	22.0	37.8	38.7	29.4	23.9	40.2	21.9	41.8	24.7	28.9	43.0	29.3	31.4	21.3	80.3	20.0	26.6	19.7	35.0	21.2	19.5	29.7	36.0	23.4	20.7	69.1	16.7	28.1	23.1	28.2	25.5	38.3	39.5	37.0	45.9	39.7	38.6	39.0	39.0	39.8	36.4	38.6	39.7	34.6	22.4	23.2	17.3	36.1	89.2	63.5	106.3	44.3	60.2	28.6	26.0	35.4	24.3	57.8	31.3	22.9	150.7	29.7	68.2	56.7	104.7	23.0	51.0	29.6	44.3	43.6	41.0	24.0	94.5	146.0	41.1	30.5	54.9	40.5	49.1	31.1	42.2	81.1	70.7	24.8	42.5	61.1	43.7	43.6	38.8	39.1	43.8	42.7	14.0	52.9	61.7	32.0	17.6	31.2	123.4	65.7	46.3	41.8	76.0	66.4	73.8	43.2	44.5	78.9	44.2	64.7	106.1	103.2	55.1	75.7	151.6	31.6	48.9	44.0	88.5
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 35.5"	"Group enriched"	"Detected in some"	29	"Early spermatids: 159.5;Late spermatids: 300.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA056683	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA056683: AB_2683207"	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.5	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.1	2.6	0.1	0.7	0.1	0.0	1.0	0.1	0.7	0.6	0.1	0.1	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.4	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.2	0.0	0.1	0.2	0.8	35.5	0.4	0.0	0.7	0.0	0.0	0.3	0.1	0.2	1.2	0.2	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	1.2	0.5	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.4	0.1	0.0	1.0	0.0	0.1	0.2	0.2	0.6	0.1	0.2	0.3	0.0	1.1	0.8	0.4	0.9	0.1	0.5	0.1	0.2	0.2	0.6	0.5	0.3	1.0	0.1	0.3	0.2	0.7	0.9	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.4	0.4	0.1	0.3	0.8	0.7	0.0	0.2	0.0	1.2	0.1	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.3	0.5	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	159.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	300.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C1B-RDH14		ENSG00000250741	"NT5C1B-RDH14 readthrough"		2	18555545-18589564	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	126	"testis: 16.6"	"Group enriched"	"Detected in some"	97	"Early spermatids: 52.3;Late spermatids: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056683	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA056683: AB_2683207"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NUDCD3	"KIAA1068, NudCL"	ENSG00000015676	"NudC domain containing 3"	Q8IVD9	7	44379119-44490658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019136, HPA019528, HPA019529"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374"	"unprognostic (3.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.18e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.50e-2)"	2.9	2.8	6.8	1.3	9.0	2.8	2.8	3.2	7.2	2.5	0.0	2.4	1.2	2.2	2.4	2.7	3.5	2.2	7.5	6.6	5.1	2.2	1.8	2.4	2.2	4.4	5.5	3.1	3.3	3.7	1.8	1.7	5.6	2.8	1.8	4.8	2.4	3.3	8.2	3.1	2.0	3.0	3.9	1.9	2.7	3.9	5.6	2.1	2.7	5.7	2.2	2.3	1.8	6.3	2.6	4.9	3.4	6.3	4.2	3.4	1.3	4.1	4.0	4.8	4.9	3.3	1.8	8.1	3.0	5.5	6.6	3.0	4.8	5.6	2.8	4.8	4.9	2.2	2.9	2.3	3.8	3.9	1.3	3.1	3.7	3.6	4.1	2.8	5.9	2.4	6.1	2.6	3.6	2.3	1.6	3.7	4.3	2.5	6.3	2.3	3.7	3.0	2.7	4.0	3.6	10.6	2.4	4.5	1.8	3.4	3.4	5.7	5.7	3.3	3.4	2.2	3.3	7.3	8.1	4.0	3.6	4.5	5.9	0.6	0.8	0.9	1.0	0.8	1.1	1.0	0.9	0.9	0.7	1.0	0.9	0.9	0.5	0.8	1.0	0.6	1.0	0.9	6.8	9.0	3.2	7.2	6.6	5.1	4.4	5.5	5.6	3.9	5.6	6.3	30.5	12.8	19.2	35.9	26.4	11.3	13.0	16.5	20.5	40.9	29.3	25.3	44.5	17.2	16.0	38.6	54.2	19.6	21.9	22.7	23.5	29.6	87.7	27.4	34.4	25.3	17.4	22.3	59.6	21.6	18.1	23.9	23.9	30.9	9.5	35.8	22.5	32.8	18.3	48.8	58.8	25.1	26.4	17.9	9.5	98.3	30.4	13.9	16.0	46.9	21.2	24.8	34.0	36.2	61.2	27.4	18.8	28.2	14.3	15.9	27.2	26.8	21.9	40.2	32.9	17.8	25.2	106.6	21.1	25.5	16.2	14.4	26.2	18.9	27.8	13.3
NUDT16L1	"SDOS, TIRR"	ENSG00000168101	"Nudix hydrolase 16 like 1"	Q9BRJ7	16	4693694-4695859	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044186, HPA063605"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA044186: AB_10968571, HPA063605: AB_2685058"	"unprognostic (1.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (6.81e-2)"	"prognostic favorable (1.02e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.81e-3)"	19.7	46.4	43.1	12.0	44.8	22.2	21.5	43.6	52.5	23.1	45.6	28.5	21.7	21.4	15.3	28.9	23.4	8.4	58.2	44.1	42.0	43.4	64.1	17.2	17.9	45.3	43.2	22.7	24.6	20.4	39.9	8.0	41.9	34.8	11.9	14.5	26.6	14.7	25.0	25.2	29.2	8.5	43.3	33.7	30.1	22.8	44.3	18.2	30.8	16.9	13.1	22.7	21.8	45.7	14.7	23.8	21.2	28.7	15.7	12.1	19.4	17.2	12.9	20.4	12.8	26.9	11.6	15.2	24.4	20.7	10.3	16.8	23.1	23.4	9.5	22.6	38.9	16.8	21.1	32.8	17.0	24.4	19.2	18.7	21.3	17.2	10.7	13.9	15.1	22.6	31.2	18.5	20.1	57.3	36.8	36.0	33.6	24.4	27.0	50.9	22.4	24.2	24.8	18.0	41.8	31.5	25.1	25.9	11.7	16.5	38.4	56.4	20.0	16.7	25.3	39.8	15.9	32.1	20.5	26.1	10.4	32.3	34.8	56.6	54.3	96.2	52.6	48.2	63.1	60.7	63.4	62.8	50.2	65.3	74.0	63.5	68.2	63.9	53.5	83.6	78.3	98.1	43.1	44.8	43.6	52.5	44.1	42.0	45.3	43.2	41.9	43.3	44.3	45.7	23.3	16.0	22.4	14.4	32.6	14.0	19.7	37.4	27.9	52.1	36.0	36.2	52.6	24.3	28.0	42.3	10.4	53.8	43.6	47.7	109.5	28.7	5.2	28.7	33.6	21.4	43.1	23.1	10.2	30.9	31.8	24.0	30.5	29.0	27.9	31.7	17.9	41.8	40.9	47.1	11.8	51.7	89.5	18.3	18.7	8.7	31.4	20.8	30.2	3.7	43.3	83.5	34.0	9.5	15.0	30.0	48.5	50.0	33.0	17.9	77.8	98.2	20.1	58.3	46.0	14.2	22.8	14.8	34.7	24.9	16.6	49.1	43.6	58.0	51.4	17.6
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 151.6;Late spermatids: 424.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	7.7	8.9	5.9	6.9	7.3	4.6	13.1	8.9	7.8	8.5	5.0	7.6	6.3	8.1	7.7	8.7	8.9	6.9	6.2	6.1	5.9	10.2	14.4	5.9	9.1	5.5	5.9	10.4	10.2	8.9	6.3	7.8	5.5	7.8	9.1	9.0	8.4	7.0	7.4	9.0	6.5	8.9	6.6	5.7	7.2	24.2	5.5	10.4	8.2	8.7	11.0	9.2	8.0	6.4	19.7	19.7	32.5	20.5	11.8	11.5	23.2	23.0	18.8	35.3	33.5	37.6	24.7	34.6	22.0	12.4	40.9	17.4	45.4	26.7	57.8	29.6	27.8	32.6	16.4	43.9	8.2	23.6	21.8	8.2	13.8	29.9	28.9	7.9	20.8	20.5	28.7	25.3	27.8	23.7	28.7	29.1	57.9	31.6	61.9	34.3	25.2	25.0	34.0	24.7	29.4	20.3	21.6	26.6	26.0	24.4	17.0	16.2	10.6	28.6	19.7	23.3	26.5	16.4	38.3	37.9	19.3	16.8	39.2	0.0	4.1	1.4	4.9	5.5	8.6	7.2	6.3	6.0	3.2	6.5	7.5	6.7	0.2	5.6	6.6	3.1	6.7	4.1	5.9	7.3	8.9	7.8	6.1	5.9	5.5	5.9	5.5	6.6	5.5	6.4	9.6	9.6	6.8	6.5	10.3	26.0	20.7	17.5	12.5	10.8	9.3	8.9	4.7	14.3	13.8	16.5	18.8	23.6	8.5	3.3	11.7	15.5	151.6	5.3	8.1	10.2	3.6	12.6	11.5	12.7	20.2	10.8	5.1	6.4	8.2	8.1	12.8	12.6	8.4	6.7	12.0	7.5	16.2	4.4	9.9	424.7	9.6	3.6	21.4	2.8	5.0	11.4	7.2	17.1	12.8	11.1	5.1	8.2	7.5	12.8	4.2	14.5	6.9	19.1	13.1	18.7	11.6	39.8	21.1	11.3	27.4	9.4	11.5	9.0	9.6	11.2
NUS1	"C6orf68, MGC7199, NgBR, TANGO14"	ENSG00000153989	"NUS1 dehydrodolichyl diphosphate synthase subunit"	Q96E22	6	117675469-117710727	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Angiogenesis, Differentiation, Lipid metabolism"	"Developmental protein, Receptor, Transferase"	"Congenital disorder of glycosylation, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027504	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Plasma membrane"	"HPA027504: AB_10603124"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.26e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	17.8	20.0	12.1	22.2	13.0	19.4	22.2	11.4	15.5	60.3	16.1	19.8	16.5	20.6	28.4	15.7	18.4	16.1	11.7	12.9	13.8	28.4	31.6	18.2	21.4	10.8	12.5	16.5	20.4	29.8	11.9	21.6	11.9	20.6	20.3	12.5	30.5	17.6	10.0	11.1	17.6	18.7	11.7	17.8	24.2	12.6	13.5	18.5	35.4	12.6	20.6	23.5	11.7	12.4	27.1	19.5	41.3	46.4	40.7	52.9	101.0	48.3	50.1	39.5	45.1	44.6	29.5	63.4	51.1	44.7	50.0	24.0	62.1	47.2	73.0	47.9	57.0	72.8	31.5	80.2	62.6	92.8	41.2	46.6	52.5	43.3	87.7	40.3	41.3	46.5	88.4	54.9	59.7	30.5	43.9	58.8	48.0	36.9	35.3	41.7	29.7	45.7	79.0	26.6	48.7	38.5	29.1	37.4	36.9	45.6	23.8	95.9	36.4	24.3	30.1	39.2	70.5	75.6	60.8	66.8	57.6	70.0	49.7	1.9	1.3	0.8	1.3	1.4	1.9	1.1	1.6	1.8	1.5	1.0	1.3	1.7	0.1	1.9	2.5	3.8	1.7	1.0	12.1	13.0	11.4	15.5	12.9	13.8	10.8	12.5	11.9	11.7	13.5	12.4	18.7	0.0	22.3	30.3	28.5	60.5	41.9	32.6	19.4	15.3	26.6	13.7	6.3	15.7	24.0	25.8	10.4	26.8	38.1	26.4	27.4	23.4	16.0	15.7	28.9	24.3	13.1	19.1	33.4	30.2	63.6	22.8	38.2	21.4	31.1	15.8	28.2	39.7	35.3	15.2	37.1	29.3	20.3	37.0	42.2	14.0	18.0	30.2	32.0	20.6	28.4	8.3	24.7	35.7	36.5	37.4	22.7	20.3	57.5	73.1	18.6	33.6	23.1	9.6	6.6	21.3	25.9	24.9	25.4	25.7	56.1	57.9	26.2	14.5	26.1	77.5
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938051-112976460	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 15.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 202.5;BJ hTERT+ SV40 Large T+ RasG12V: 224.5;GAMG: 89.8;RT4: 62.6"	"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No		21000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	8.1	4.1	3.2	11.5	3.1	20.9	6.0	2.3	2.5	11.0	1.1	7.1	7.1	3.9	1.5	15.8	5.2	11.3	7.0	2.2	2.4	5.6	4.4	12.6	6.0	8.7	3.6	3.8	3.8	3.2	3.5	11.1	6.4	3.4	6.2	0.6	27.7	2.7	3.0	5.4	6.5	9.3	11.8	17.9	11.0	2.3	4.1	16.1	4.1	5.9	6.4	14.4	7.8	3.0	23.2	34.4	0.3	5.5	1.0	4.6	2.1	2.6	25.3	202.5	224.5	24.1	20.5	0.7	7.3	8.1	89.8	15.7	3.3	22.7	11.2	9.7	1.2	15.9	16.3	4.0	3.9	4.5	6.6	0.9	7.2	32.8	1.3	4.0	11.7	3.9	0.5	3.1	2.0	13.3	8.0	2.7	1.4	33.7	22.8	13.5	11.6	0.1	7.0	62.6	0.6	0.1	19.8	5.5	14.8	0.2	25.7	1.1	9.5	4.6	4.0	5.5	6.5	0.8	21.0	0.2	4.9	12.9	16.7	1.0	7.8	0.8	1.4	7.4	1.7	2.3	2.0	2.3	4.1	1.0	1.8	1.7	9.7	2.7	15.3	0.3	2.6	3.5	3.2	3.1	2.3	2.5	2.2	2.4	8.7	3.6	6.4	11.8	4.1	3.0	19.9	3.2	3.9	0.7	3.8	3.4	5.6	13.5	5.2	0.4	3.1	2.7	1.7	0.0	5.1	3.7	0.0	5.4	1.8	14.7	3.9	11.2	5.9	1.8	4.1	20.8	1.8	0.8	0.3	9.8	20.9	5.5	16.3	5.6	1.3	21.9	9.3	1.7	18.7	0.0	0.4	6.8	8.2	5.8	7.0	10.8	10.2	16.7	1.8	5.6	30.2	3.0	8.2	3.5	0.0	21.2	8.2	15.1	1.4	11.8	4.5	2.0	2.3	0.5	0.0	2.5	5.0	0.8	0.7	14.4	4.7	1.9	6.5	9.2	5.4	26.8
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208044-228378876	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 481.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 155.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		4500000	"Cluster 7: Monocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	3.5	2.5	2.4	1.4	18.4	1.6	3.7	10.4	4.4	8.1	18.1	5.2	0.7	3.7	1.8	4.6	5.1	1.1	78.5	0.9	2.7	6.6	1.3	8.9	2.1	4.3	2.7	8.6	5.4	1.1	13.6	0.9	2.4	9.9	0.5	0.8	9.4	1.7	481.3	4.7	5.4	0.5	1.0	9.3	5.2	1.9	6.3	4.9	7.5	112.8	1.3	3.2	7.4	0.1	1.7	2.8	3.6	3.7	0.2	0.2	4.6	1.6	0.7	1.7	1.4	2.1	1.3	3.2	5.4	0.7	0.7	2.1	1.3	2.2	0.3	2.0	3.4	1.7	10.5	0.1	1.2	2.4	2.2	1.4	0.6	0.4	0.5	5.1	0.5	7.0	3.2	0.0	0.3	1.8	3.3	3.5	4.9	0.6	2.1	4.4	0.0	1.9	1.8	1.4	1.7	6.3	0.6	3.9	1.0	0.8	3.4	4.0	1.0	0.0	5.1	0.3	0.5	2.5	0.5	4.7	0.0	0.8	2.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	2.4	18.4	10.4	4.4	0.9	2.7	4.3	2.7	2.4	1.0	6.3	0.1	1.5	0.0	5.5	1.6	2.4	2.2	6.6	7.7	23.9	4.2	7.3	11.9	155.8	4.3	4.5	5.5	10.4	0.1	1.9	0.7	11.7	3.6	4.9	3.9	3.7	3.1	0.0	3.0	3.9	0.5	0.5	5.7	3.1	11.3	7.0	1.8	1.4	0.5	0.1	0.0	5.3	2.7	4.1	0.3	1.0	4.5	3.1	1.1	1.8	5.6	0.5	7.9	4.1	1.5	1.7	0.8	1.1	4.5	1.5	3.8	0.6	4.1	1.3	3.2	0.0	22.9	6.1	1.0	4.1	9.4	1.7	1.2	5.4	6.2	1.2	3.6
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099315	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"choroid plexus: 28.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 30.9;Inhibitory neurons: 40.8;Melanocytes: 42.7;Peritubular cells: 14.7"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 24.6"	"Low region specificity"	"Detected in some"							HPA036402			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.3	0.0	1.8	0.1	1.8	0.0	0.3	0.1	1.8	1.2	28.1	0.1	0.0	0.2	0.3	2.2	1.1	0.0	0.3	1.4	1.8	0.3	0.1	0.6	1.8	0.5	0.9	0.3	0.0	0.0	0.8	1.5	0.6	0.6	0.0	0.0	0.8	1.0	0.2	6.4	0.2	0.0	0.0	1.1	0.1	1.9	2.4	0.4	4.2	0.0	0.7	0.2	2.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	5.6	0.0	0.0	24.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	0.1	1.8	1.4	1.8	0.5	0.9	0.6	0.0	2.4	1.0	0.0	0.0	0.0	0.7	0.0	2.0	0.1	0.1	0.6	0.0	0.0	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.4	5.6	0.2	0.1	0.0	0.0	30.9	0.0	0.1	1.4	0.0	2.8	0.0	2.3	0.0	0.0	0.1	0.0	40.8	0.1	0.0	0.0	0.9	3.0	9.3	0.1	42.7	0.0	0.0	0.0	0.0	2.5	0.8	0.0	1.2	14.7	0.0	0.0	0.0	0.1	2.0	0.0	0.0	1.0	0.8	4.2	4.9	6.1	0.9	0.1	0.1	0.4	0.1	0.2
OCM	OCM1	ENSG00000122543	Oncomodulin	P0CE72	7	5879827-5886363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 2.3;Excitatory neurons: 8.6;Inhibitory neurons: 7.0;Late spermatids: 2.4;Microglial cells: 4.7;Oligodendrocytes: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "	"unprognostic (1.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.90e-4)"	0.2	0.2	2.9	0.3	2.1	0.7	0.5	2.3	3.2	0.4	1.6	0.2	0.0	0.1	0.9	0.2	0.3	0.2	0.1	2.1	2.4	0.3	0.3	0.2	2.1	1.9	2.0	0.3	0.2	0.0	0.3	0.0	2.0	0.3	0.2	0.6	0.3	0.3	0.1	0.7	0.7	0.1	1.8	1.2	0.2	2.1	2.4	0.8	0.3	0.0	0.8	0.1	0.3	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.8	0.4	0.2	0.1	0.4	1.1	0.3	0.0	1.4	1.5	0.4	0.6	0.0	0.2	0.0	2.7	0.4	2.9	2.1	2.3	3.2	2.1	2.4	1.9	2.0	2.0	1.8	2.4	2.2	0.1	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	8.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	7.0	0.0	0.0	0.6	0.0	2.4	0.0	0.1	0.0	4.7	0.3	0.5	1.0	1.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
OCM2		ENSG00000135175	"Oncomodulin 2"	P0CE71	7	97984684-97991169	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA							"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448327	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 560.8;Late spermatids: 834.9;Prostatic glandular cells: 412.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	47.2	23.2	31.0	69.3	31.5	172.9	33.0	30.5	32.2	33.5	48.5	64.8	32.4	66.0	49.2	29.4	56.3	43.7	55.9	29.9	33.0	132.2	92.1	52.4	111.0	32.4	33.0	54.8	61.8	99.6	92.5	20.0	30.6	91.1	72.0	46.2	27.0	55.1	163.3	29.2	41.6	71.2	34.1	42.9	51.5	133.3	34.0	77.1	58.5	73.5	149.1	113.6	26.9	35.7	166.8	130.6	177.1	211.4	31.1	92.4	410.1	234.6	114.9	216.3	99.9	697.3	75.4	870.2	114.6	143.6	208.6	30.2	549.1	265.5	261.2	334.0	231.5	398.1	212.2	429.9	250.8	680.1	91.8	62.5	70.5	490.1	608.3	111.4	176.3	237.6	674.2	274.3	121.7	109.0	680.1	267.3	324.9	228.3	418.8	478.5	556.0	586.3	130.9	119.5	246.6	209.9	293.6	88.8	121.8	135.7	60.0	300.5	124.7	174.4	362.6	227.9	511.7	128.0	416.1	780.8	156.7	443.6	109.9	0.0	1.5	3.0	2.9	2.9	3.3	14.8	4.1	4.8	3.4	15.0	2.8	4.5	0.5	1.4	1.8	12.2	4.4	3.2	31.0	31.5	30.5	32.2	29.9	33.0	32.4	33.0	30.6	34.1	34.0	35.7	78.2	44.8	161.4	7.5	228.9	58.0	123.7	48.8	19.4	36.8	53.2	68.3	55.1	81.5	33.9	40.5	31.3	1.5	188.1	77.7	72.4	50.6	560.8	90.9	66.2	52.2	271.0	111.3	7.5	27.6	70.0	63.2	204.4	127.6	58.9	103.8	14.6	50.3	46.8	6.7	4.1	234.1	22.4	32.1	22.4	834.9	15.5	191.8	23.2	8.4	22.1	126.3	37.0	4.5	2.4	28.6	64.5	11.3	287.4	412.4	31.6	154.1	21.9	77.4	0.0	223.0	79.9	186.5	75.8	52.2	87.5	3.4	133.0	30.2	180.5	142.2
ODR4	"C1orf27, FLJ20505, odr-4, TTG1"	ENSG00000157181	"Odr-4 GPCR localization factor homolog"	Q5SWX8	1	186375838-186421378	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 37.8;Glandular and luminal cells: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015988, HPA031352"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Plasma membrane"		"HPA015988: AB_1845644, HPA031352: AB_2673838"	"unprognostic (1.19e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.20e-2)"	11.9	14.4	7.5	7.2	9.2	15.0	14.0	10.4	10.1	13.3	8.4	10.8	13.4	9.4	17.2	7.8	8.8	10.6	10.0	7.6	8.2	16.7	21.8	9.5	6.7	8.9	8.6	10.3	29.1	32.4	12.4	14.2	9.2	16.6	12.7	15.2	21.7	12.2	9.0	10.3	13.6	8.8	8.7	8.5	13.1	8.3	8.2	6.4	19.9	9.5	7.1	11.5	8.2	11.9	12.6	13.9	15.1	12.1	17.5	16.3	28.8	19.9	12.2	12.7	12.8	28.2	29.7	8.7	23.5	9.9	11.6	32.3	11.4	10.9	12.5	7.1	10.9	8.2	17.7	15.9	16.4	13.8	9.6	12.5	21.3	15.4	24.1	13.2	13.8	9.0	32.1	17.3	15.3	13.5	9.7	14.3	21.6	46.0	5.0	11.2	10.5	25.0	26.1	12.9	11.0	17.2	15.1	33.0	24.5	26.9	29.1	12.4	13.2	18.1	11.5	12.2	18.9	20.2	13.3	13.3	9.8	7.4	16.7	1.4	9.0	2.5	3.0	8.9	4.5	3.6	3.8	4.2	7.6	2.3	4.7	3.6	3.9	10.0	11.4	4.8	5.7	3.9	7.5	9.2	10.4	10.1	7.6	8.2	8.9	8.6	9.2	8.7	8.2	11.9	28.1	28.9	37.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	18.8	16.5	0.0	0.0	29.7	25.8	0.0	22.0	12.6	0.0	9.8	22.8	0.0	26.8	27.0	9.8	0.0	0.0	0.0	25.4	25.7	12.3	0.0	38.6	12.6	26.4	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	6.7	0.0	0.0	0.0	0.0	24.7	0.0	0.0	4.0	0.0	0.0	10.7	15.3	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	28.0	6.9	29.0	0.0	0.0
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	67949349-68433913	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 383.9;Oligodendrocyte precursor cells: 600.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	4.1	5.1	20.8	1.8	18.6	3.9	4.5	14.2	19.5	6.0	1.0	3.4	2.5	5.6	3.7	3.8	3.2	2.7	3.1	18.0	14.6	4.3	1.3	4.4	1.9	9.5	11.9	4.5	3.1	3.6	2.7	5.6	5.8	10.1	3.4	11.5	5.4	5.0	6.5	6.4	2.9	4.0	6.1	2.3	3.8	2.6	16.3	1.2	4.7	4.8	1.4	2.3	3.8	11.5	23.6	5.1	3.2	7.3	7.1	6.8	5.0	4.2	5.6	8.3	10.1	3.3	4.5	1.5	13.7	4.9	3.4	5.7	3.1	2.9	12.6	0.9	2.1	5.2	6.9	3.7	2.4	2.1	5.2	4.6	4.8	6.9	6.4	10.6	5.6	1.1	3.2	3.1	4.3	10.1	0.8	1.8	7.5	10.0	4.8	0.9	7.3	1.3	8.5	7.6	1.7	2.8	7.2	9.1	13.7	7.1	6.2	1.6	6.0	5.0	7.3	18.1	4.5	2.9	3.4	1.0	4.0	2.8	3.5	1.0	1.0	0.4	0.5	0.4	0.4	0.5	0.4	0.3	0.4	0.8	0.4	0.5	4.6	0.5	0.6	1.6	0.3	0.2	20.8	18.6	14.2	19.5	18.0	14.6	9.5	11.9	5.8	6.1	16.3	11.5	13.8	16.0	19.3	383.9	0.0	3.2	5.4	2.0	10.2	5.4	6.7	5.0	3.3	2.8	6.4	18.4	6.2	23.0	2.3	3.9	0.0	1.2	2.0	7.2	4.3	8.1	4.2	1.3	84.6	0.8	11.7	18.0	14.8	12.9	8.8	36.3	5.0	0.2	4.6	0.0	78.8	3.0	2.0	2.1	9.5	1.7	21.1	5.9	8.8	54.4	1.2	16.0	3.1	600.2	41.7	1.3	2.4	12.0	0.1	8.5	3.8	1.8	10.9	5.1	0.0	24.1	5.4	0.3	1.9	8.9	5.1	66.9	1.4	4.2	4.1	4.2
OR2C3	"OR2C4, OR2C5P, OST742"	ENSG00000196242	"Olfactory receptor family 2 subfamily C member 3"	Q8N628	1	247524677-247536440	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.4;granulocytes: 1.3;Late spermatids: 3.7;Spermatocytes: 2.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Immune cell enriched"	"Detected in single"	5	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA058578			Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"		"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA058578: AB_2683761"									"unprognostic (1.96e-1)"			"unprognostic (7.29e-2)"		"unprognostic (3.45e-2)"	"unprognostic (1.03e-1)"			0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.3	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	1.3	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	2.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0
OR6B2	OR6B2P	ENSG00000182083	"Olfactory receptor family 6 subfamily B member 2"	Q6IFH4	2	240028965-240030456	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047529	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA							"Plasma membrane"	Cytosol	"HPA047529: AB_2680077"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6B3	"OR6B3P, OR6B3Q"	ENSG00000178586	"Olfactory receptor family 6 subfamily B member 3"	Q8NGW1	2	240045077-240047027	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"retina: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047529	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"			"Plasma membrane"	Cytosol	"HPA047529: AB_2680077"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OSBPL10		ENSG00000144645	"Oxysterol binding protein like 10"	Q9BXB5	3	31657912-32077580	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 440.2;Late spermatids: 1206.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory B-cell: 11.5;naive B-cell: 6.7"	"Lineage enriched"	"Detected in single"	22	"B-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 93.3;RPTEC TERT1: 118.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003636			Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA003636: AB_1079529"	"unprognostic (5.28e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (5.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.85e-4)"	8.3	2.6	3.1	7.8	3.0	1.2	6.0	0.1	3.6	10.2	6.5	6.5	3.7	8.4	6.6	13.0	5.9	11.4	2.9	4.8	2.7	13.3	2.2	5.8	12.9	1.2	4.9	3.1	1.6	1.6	6.7	22.3	3.0	11.8	7.8	5.5	6.8	20.9	1.6	4.9	6.7	11.1	0.3	9.5	6.1	25.0	1.3	2.8	3.5	2.2	17.8	20.3	5.9	2.6	19.3	10.6	2.0	39.3	4.2	7.4	63.1	5.2	6.1	4.9	6.8	27.0	14.3	45.6	48.8	1.1	17.0	11.5	8.9	45.1	6.0	0.3	8.2	0.1	26.4	18.3	2.7	0.1	0.2	7.7	39.7	7.8	93.3	18.2	23.4	0.2	0.1	0.2	22.7	16.0	0.2	0.1	24.9	64.9	26.5	0.5	0.8	0.9	118.3	7.8	3.0	0.5	8.9	17.0	5.4	36.9	11.1	0.2	15.2	6.1	61.7	0.5	26.2	4.1	3.0	42.6	8.6	0.1	39.3	0.2	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	6.7	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3.1	3.0	0.1	3.6	4.8	2.7	1.2	4.9	3.0	0.3	1.3	2.6	20.5	9.6	3.9	2.9	50.6	10.8	7.5	10.1	4.6	7.3	13.8	6.6	2.3	4.3	7.3	7.3	0.0	15.3	2.4	7.9	9.8	1.8	440.2	11.0	26.5	21.1	15.0	5.7	70.5	4.9	25.9	10.4	6.1	26.4	0.0	1.3	18.2	0.6	2.5	0.0	129.9	4.6	6.1	0.9	6.3	1206.2	11.1	2.2	8.8	17.8	1.7	45.7	1.0	12.1	2.3	16.2	9.0	4.1	21.0	18.3	6.1	24.8	6.9	2.3	19.7	4.8	15.6	7.0	4.1	14.4	12.4	30.2	3.5	1.0	8.8	16.3
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402893	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.8;tongue: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 281.4;Excitatory neurons: 314.2;Inhibitory neurons: 404.2;Oligodendrocyte precursor cells: 134.2"	"Cancer enhanced"	"Detected in many"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.8;hTERT-HME1: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	1.3	1.5	4.1	1.0	6.1	0.2	1.7	3.7	16.3	1.1	0.0	1.0	0.7	0.8	0.7	2.4	1.0	1.1	3.8	6.1	8.0	2.7	5.6	4.0	1.1	5.7	6.9	1.4	1.2	0.8	6.7	0.6	5.3	3.1	1.0	8.4	2.2	1.5	33.8	8.7	3.5	1.4	1.7	1.0	0.8	1.3	7.5	1.6	2.3	20.3	0.8	1.0	1.5	8.3	0.0	1.1	8.3	16.9	6.8	7.5	6.3	13.9	7.2	12.0	14.6	1.4	0.2	0.0	0.5	12.9	6.6	0.3	19.6	11.4	20.2	0.2	10.2	48.8	2.9	0.0	4.4	8.0	0.3	5.0	17.6	26.4	50.8	4.3	5.8	6.2	0.9	5.8	15.9	7.0	0.1	0.0	10.0	0.0	10.2	0.0	16.9	3.2	0.9	0.0	6.3	3.8	6.2	1.8	13.7	9.2	2.4	0.1	11.4	13.7	8.5	9.3	16.3	31.8	13.4	0.0	16.3	0.0	6.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	4.1	6.1	3.7	16.3	6.1	8.0	5.7	6.9	5.3	1.7	7.5	8.3	0.7	0.0	7.2	281.4	0.0	13.3	2.1	1.3	7.4	59.4	2.1	1.7	15.2	4.3	6.5	0.0	25.0	0.2	0.0	0.1	1.9	0.6	1.0	4.4	1.0	1.7	1.8	0.0	314.2	0.8	4.9	4.3	0.0	0.4	7.0	2.0	0.0	6.2	3.9	1.7	404.2	6.0	4.1	3.5	1.0	1.1	0.0	0.7	5.4	62.8	0.0	10.6	0.0	134.2	10.3	0.2	0.0	1.5	1.5	2.2	9.5	6.2	78.2	6.9	0.0	25.4	5.8	0.1	2.1	6.4	20.9	0.1	0.9	14.5	1.4	0.5
OSCAR		ENSG00000170909	"Osteoclast associated Ig-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 13.6;lung: 28.4;lymphoid tissue: 29.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 35.6;Kupffer cells: 27.8;Macrophages: 42.9;monocytes: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	36	"classical monocyte: 43.0;eosinophil: 26.6;intermediate monocyte: 28.8;myeloid DC: 20.3;neutrophil: 40.0;non-classical monocyte: 27.0"	"Group enriched"	"Detected in many"	79	"dendritic cells: 20.3;granulocytes: 40.0;monocytes: 43.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.9;HHSteC: 9.4;hTERT-HME1: 5.0;NB-4: 5.9;U-937: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	3.7	1.8	0.9	2.3	0.7	13.6	1.8	0.1	1.6	2.2	0.0	1.5	0.0	1.3	0.0	1.5	3.2	1.3	1.9	0.1	0.7	1.5	2.4	28.4	0.3	1.3	0.7	1.1	1.3	0.1	1.0	0.6	0.9	1.7	0.3	0.0	2.2	0.3	0.5	2.1	1.6	1.7	0.7	29.8	1.2	0.9	0.8	0.2	1.1	0.6	0.6	2.2	2.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	13.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.4	0.6	0.0	0.0	0.2	0.6	5.0	0.8	0.0	0.0	0.0	0.4	0.1	0.1	0.0	5.9	0.3	0.1	1.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.5	17.9	0.0	0.0	43.0	26.6	0.3	28.8	0.1	0.0	0.2	0.4	20.3	0.0	0.1	0.0	40.0	0.0	27.0	0.8	0.2	16.8	0.9	0.7	0.1	1.6	0.1	0.7	1.3	0.7	0.9	0.7	0.8	1.7	0.2	3.2	5.9	0.3	0.3	0.8	0.6	0.7	0.6	0.0	0.7	0.4	0.3	1.5	2.1	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.1	0.3	0.9	0.0	1.7	1.9	0.0	0.4	0.6	0.0	0.1	1.3	0.3	0.0	0.0	35.6	0.0	1.0	0.3	0.0	27.8	11.6	0.2	0.0	42.9	0.0	1.0	66.4	0.0	1.0	0.0	0.3	0.4	0.0	0.0	0.4	0.3	0.1	0.2	3.7	0.4	0.0	0.2	0.1	0.6	0.5	0.4	0.1	0.3	0.7	0.4	0.1	0.3
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 58.0;testis: 76.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 453.5;Endometrial ciliated cells: 88.6;Respiratory ciliated cells: 199.1;Spermatocytes: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	6.8	8.2	9.7	2.4	10.4	2.0	9.4	7.4	10.5	9.5	31.3	7.3	2.9	10.0	22.0	5.0	58.0	8.8	7.9	11.1	13.0	19.1	2.8	11.0	1.9	11.3	14.7	9.1	8.2	30.2	23.1	5.6	10.9	9.9	3.9	23.1	8.7	8.9	4.9	6.8	2.7	7.9	9.9	1.4	6.3	76.1	13.5	3.6	17.9	5.2	1.5	5.9	4.8	8.3	6.7	6.3	7.6	8.9	8.9	8.6	1.4	4.0	9.7	9.7	6.6	0.1	5.8	1.5	7.3	7.3	7.1	5.1	0.2	7.5	6.2	1.1	5.9	0.1	3.9	0.7	10.9	0.8	1.2	9.8	12.0	13.7	5.9	14.1	6.7	6.3	0.1	1.7	7.7	4.8	3.6	2.5	7.8	2.6	2.6	3.8	3.1	1.2	16.0	2.3	20.4	9.0	7.5	3.5	5.4	7.2	7.6	1.1	5.8	7.0	2.6	12.7	6.9	2.8	3.1	0.8	13.4	0.2	4.7	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	0.2	0.6	0.2	0.6	1.0	0.1	0.1	0.0	1.2	0.7	0.2	9.7	10.4	7.4	10.5	11.1	13.0	11.3	14.7	10.9	9.9	13.5	8.3	3.0	9.6	10.9	4.6	0.4	1.5	5.5	21.3	3.4	5.4	7.9	7.5	5.5	5.7	21.3	12.9	16.7	12.2	0.0	2.0	23.5	15.1	453.5	88.6	5.8	3.3	4.9	1.7	8.1	9.3	3.4	6.4	6.1	7.7	0.0	4.8	2.2	2.3	4.2	5.0	6.9	2.3	32.6	0.8	1.2	66.8	12.5	1.4	3.6	1.0	0.1	12.9	0.0	5.0	2.6	7.2	4.0	9.1	0.4	3.5	0.5	26.1	199.1	21.3	0.0	4.7	7.7	163.7	20.6	3.6	3.1	20.1	0.7	13.9	2.3	5.2
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446401-20455089	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favorable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	5.7	6.3	6.1	3.8	6.2	6.1	7.0	6.4	7.3	6.8	6.8	7.6	3.8	6.4	8.5	6.0	6.1	6.6	8.1	6.0	6.3	5.8	11.1	6.2	9.3	6.4	6.1	5.3	5.6	7.4	5.2	6.7	6.4	4.9	7.0	4.1	5.3	8.3	10.5	4.7	6.2	5.6	6.5	8.4	6.4	2.4	6.3	9.9	7.6	9.9	10.1	8.2	4.9	6.9	10.3	17.2	5.6	16.2	9.9	6.6	17.6	8.0	11.3	21.1	20.1	21.5	12.3	21.1	10.3	11.0	9.0	8.6	17.9	17.6	14.1	16.8	19.1	14.8	12.2	32.1	7.4	24.3	19.7	5.3	5.2	26.1	14.0	4.6	14.3	18.8	14.0	12.1	17.6	21.0	25.0	11.8	9.1	31.5	31.8	35.3	10.3	12.4	12.8	11.7	21.3	4.2	15.4	16.0	11.9	3.3	9.7	23.7	6.1	8.7	21.2	11.3	10.7	3.4	18.0	31.7	5.0	36.1	11.0	9.3	29.2	38.5	18.8	27.9	17.4	28.7	19.7	17.2	44.5	38.1	15.9	17.4	13.8	20.9	23.3	16.9	19.2	24.6	6.1	6.2	6.4	7.3	6.0	6.3	6.4	6.1	6.4	6.5	6.3	6.9	27.1	35.3	34.9	16.3	46.0	11.5	20.9	26.2	14.2	37.8	24.0	25.1	17.2	15.7	29.1	23.9	37.5	66.3	31.8	22.5	35.2	24.7	3.1	19.2	18.3	24.1	26.9	19.6	23.0	29.8	47.0	23.4	28.1	16.3	25.9	24.6	25.7	19.3	65.8	10.1	24.1	24.2	22.4	30.7	32.8	3.0	19.3	34.2	21.4	7.5	28.4	31.0	32.0	16.6	17.0	20.0	30.6	21.4	26.2	10.9	42.2	39.7	25.5	51.5	13.1	24.6	23.9	7.8	16.9	22.0	11.5	46.1	26.8	37.3	31.6	17.4
OSR2	FLJ90037	ENSG00000164920	"Odd-skipped related transciption factor 2"	Q8N2R0	8	98944403-98952104	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 166.1;endometrium 1: 155.1;fallopian tube: 155.3"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 243.1;Leydig cells: 784.1;Peritubular cells: 758.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	16	"ASC diff: 542.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052425, HPA063486"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane"	Nucleoplasm	"HPA052425: AB_2681826, HPA063486: AB_2685022"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.73e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-7)"	"unprognostic (1.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.54e-3)"	45.0	9.9	0.0	2.4	0.0	0.6	26.0	0.2	0.2	166.1	0.0	9.2	0.6	155.1	53.7	15.1	155.3	12.9	4.2	0.0	0.0	1.3	0.3	3.6	2.4	0.0	0.0	93.2	4.2	3.0	2.7	8.2	0.0	40.2	3.8	0.0	6.8	72.2	5.6	27.9	24.9	47.1	0.0	0.2	5.1	35.6	0.0	0.8	5.6	5.1	1.1	27.2	83.8	0.0	32.3	4.5	0.0	4.4	542.4	17.2	4.3	17.6	33.1	13.7	13.6	3.4	3.9	0.0	2.9	26.7	0.8	12.4	2.7	4.7	6.7	1.5	13.0	0.6	3.3	1.6	8.9	0.9	0.6	17.0	9.8	2.3	1.6	0.8	0.0	4.8	4.0	0.4	0.6	14.6	2.9	5.7	0.0	2.6	2.8	13.8	1.6	1.1	1.1	2.7	1.4	0.1	1.9	7.5	0.4	0.3	4.3	7.5	0.2	2.1	0.1	13.9	1.0	0.7	0.5	0.3	0.9	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.9	14.1	6.6	3.4	1.2	0.0	7.9	5.3	0.7	0.0	3.3	0.0	0.0	17.2	0.9	0.7	0.0	0.0	5.8	7.8	243.1	3.7	0.0	0.0	0.0	0.0	138.4	71.7	0.5	5.9	0.0	0.2	0.0	0.0	9.3	0.0	0.0	18.4	10.2	1.9	21.9	24.1	784.1	2.7	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	758.3	4.6	3.6	103.9	0.1	1.7	0.0	32.9	8.8	21.3	5.1	4.5	0.3	9.1	24.2	2.3	95.6	22.3	2.2
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74922950-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 20.1"	"Cell type enriched"	"Detected in some"	20	"Paneth cells: 627.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"HDLM-2: 10.1"	"Region enriched"	"Detected in some"	12	"olfactory bulb: 12.7"	"Low region specificity"	"Detected in many"			"HPA024524, HPA053090"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.2	1.4	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	30.0	0.0	0.0	9.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	627.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	0.0
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828407-6839847	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.2;Cone photoreceptor cells: 100.1;Horizontal cells: 43.7;Leydig cells: 49.7;Peritubular cells: 38.4;Rod photoreceptor cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 39.6;hTERT-RPE1: 27.3;NTERA-2: 27.5;U-251 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		740000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.5	2.6	1.2	1.5	0.7	0.3	3.9	3.7	2.7	11.9	5.6	5.4	0.8	19.2	0.5	1.6	9.9	1.7	4.5	1.1	1.2	2.0	0.6	3.7	0.3	1.3	0.2	12.4	2.9	4.5	15.4	1.3	0.3	6.0	0.3	4.1	6.5	3.7	0.8	3.0	2.8	3.8	0.2	1.3	3.8	1.2	0.9	0.1	4.3	0.3	0.3	7.8	6.4	0.5	0.0	1.6	7.1	14.0	8.4	10.2	0.3	39.6	22.4	12.2	13.5	0.6	0.0	0.0	0.5	14.9	0.5	0.0	4.4	0.4	2.7	0.1	18.8	1.0	4.2	1.9	5.9	1.0	0.0	11.1	0.4	6.0	3.3	27.3	13.1	1.2	3.7	0.0	5.7	0.0	0.1	0.4	27.5	0.0	1.1	0.0	6.9	0.2	0.6	0.0	2.8	10.5	0.1	0.0	4.8	3.4	0.2	0.2	23.2	12.0	17.5	18.6	27.7	0.1	0.3	0.3	10.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	3.7	2.7	1.1	1.2	1.3	0.2	0.3	0.2	0.9	0.5	2.3	0.0	0.0	3.3	0.5	0.0	4.9	0.0	2.2	47.2	5.3	5.5	11.1	1.5	1.8	5.5	100.1	0.5	0.1	0.1	1.9	1.4	0.9	0.9	19.6	3.9	1.2	0.0	13.1	2.7	0.5	24.1	2.0	0.4	0.0	0.8	7.9	0.0	1.4	43.7	13.7	2.7	0.0	0.0	0.0	2.2	49.7	0.5	0.0	2.8	1.1	5.3	0.0	5.5	1.3	1.3	0.1	38.4	3.1	5.1	0.4	0.4	1.5	28.8	6.6	7.8	11.9	0.7	0.8	0.8	0.0	1.0	0.9	3.2	0.6	1.5
PALM2AKAP2	PALM2-AKAP2	ENSG00000157654	"PALM2 and AKAP2 fusion"	"Q8IXS6, Q9Y2D5"	9	109498325-110172512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 10.6;naive B-cell: 10.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	97.0	13.5	21.8	37.3	21.1	9.9	17.5	6.9	22.7	28.5	0.0	17.4	14.8	28.8	8.5	26.5	14.7	37.4	93.8	15.7	18.5	30.8	38.2	69.1	32.2	18.1	26.6	9.3	13.1	14.0	0.1	97.9	20.3	14.9	18.1	3.3	38.0	25.1	17.0	10.1	13.3	48.5	10.5	38.4	18.5	4.6	38.8	45.4	25.6	24.3	31.7	43.0	0.4	26.3	20.6	7.7	112.5	0.1	110.8	93.0	33.4	116.0	141.3	101.6	93.4	134.6	17.9	92.1	30.6	129.6	146.2	28.9	9.5	98.8	185.4	68.9	12.5	9.2	30.4	11.0	75.9	12.4	256.2	109.8	24.7	183.3	280.4	62.5	150.9	14.5	0.3	76.2	204.7	1.2	61.9	31.1	47.2	9.1	62.6	5.5	98.2	25.3	72.4	2.8	25.2	1.5	10.3	9.5	26.4	87.8	4.1	22.2	240.0	94.0	77.9	137.5	108.8	52.5	89.1	52.5	81.4	51.3	73.9	2.9	0.1	1.3	1.0	0.2	0.2	10.6	1.2	1.4	1.2	10.3	0.7	0.8	0.5	2.2	0.0	2.4	3.9	1.4	21.8	21.1	6.9	22.7	15.7	18.5	18.1	26.6	20.3	10.5	38.8	26.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PALM3		ENSG00000187867	"Paralemmin 3"	A6NDB9	19	14053363-14062076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 46.9;liver: 55.7;stomach 1: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 40.9;Cholangiocytes: 22.8;Collecting duct cells: 38.6;Exocrine glandular cells: 27.9;Hepatocytes: 40.5;Spermatogonia: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AN3-CA: 17.6;CACO-2: 20.2;GAMG: 5.5;HAP1: 15.8;NTERA-2: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052794, HPA056119"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA052794: AB_2681952, HPA056119: AB_2683042"	"unprognostic (3.67e-2)"	"unprognostic (9.08e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.72e-3)"	0.1	0.2	1.3	0.1	1.4	0.0	0.6	1.3	1.5	2.0	1.0	0.8	1.6	1.0	6.7	0.3	1.8	1.0	0.4	1.3	1.8	46.9	55.7	4.3	0.0	2.9	1.7	0.2	24.5	6.5	0.4	0.4	2.6	4.0	0.2	0.5	3.7	4.5	0.1	0.5	1.1	0.0	1.7	0.1	30.5	15.2	1.8	0.0	12.7	0.0	0.0	4.7	1.6	1.7	1.4	1.3	2.9	17.6	0.3	0.0	3.3	0.3	0.0	0.7	0.5	20.2	0.3	0.0	0.2	0.4	5.5	0.0	15.8	0.0	0.3	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.5	0.0	0.0	3.4	0.0	0.0	3.2	0.2	0.0	10.3	1.6	0.8	0.0	0.0	0.0	0.0	1.7	1.9	2.3	0.1	0.0	0.0	3.2	1.3	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	1.3	1.5	1.3	1.8	2.9	1.7	2.6	1.7	1.8	1.7	0.1	57.7	40.9	0.3	0.5	0.0	0.6	0.1	0.0	0.7	1.0	1.4	0.3	22.8	10.1	38.6	0.0	0.3	0.0	0.7	1.9	9.4	0.0	3.2	1.0	0.2	1.2	0.0	0.3	27.9	3.1	1.7	7.1	6.3	1.3	0.1	1.8	40.5	0.1	0.0	0.5	3.0	0.0	1.3	0.3	0.5	0.9	0.2	1.8	0.0	1.0	0.8	0.0	0.0	0.1	5.5	1.3	2.6	0.0	1.0	3.2	9.5	2.1	0.6	0.0	0.1	0.2	0.0	18.8	0.0	0.0	2.2	0.3	0.0	1.0	1.0
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99646113-99694541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 130.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 537.2;Cardiomyocytes: 157.6;Endothelial cells: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 155.2;LHCN-M2: 49.5;TIME: 220.5;U-87 MG: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Focal adhesion sites"	"HPA017959: AB_1854949, HPA030549: AB_2673518"	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favorable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	130.8	43.0	14.6	7.1	11.7	0.0	77.6	10.5	15.3	27.4	45.8	9.5	3.4	33.0	6.1	38.2	22.8	14.6	91.2	13.7	12.7	11.0	57.1	28.4	3.9	12.0	11.8	18.8	4.9	9.2	10.5	43.2	11.5	18.0	6.5	7.5	71.0	7.9	112.6	48.9	8.6	31.4	11.1	6.3	6.1	11.0	14.1	8.0	7.2	66.2	8.6	14.5	15.9	10.4	0.0	0.3	0.4	0.2	7.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	39.2	2.5	0.6	10.8	0.0	0.5	0.1	0.1	0.1	0.0	18.6	26.4	0.0	0.0	0.1	3.9	2.0	0.0	0.0	4.3	155.2	0.0	22.7	0.0	49.5	0.6	0.0	0.0	0.0	1.6	6.8	0.0	38.2	0.1	0.0	8.0	0.9	0.5	0.0	9.9	0.0	1.0	2.3	0.0	220.5	0.0	0.4	16.8	0.0	0.0	0.0	0.1	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	11.7	10.5	15.3	13.7	12.7	12.0	11.8	11.5	11.1	14.1	10.4	537.2	6.4	5.6	0.3	0.5	38.5	11.4	49.6	22.2	2.0	20.0	31.8	157.6	32.9	35.9	3.7	0.0	0.4	1.6	0.1	5.9	8.1	74.9	78.7	71.9	219.4	1.8	2.7	1.4	0.2	0.3	19.2	2.0	17.7	1.3	0.0	96.0	57.3	0.6	3.3	1.8	0.0	14.2	2.2	5.5	12.2	9.3	1.7	24.9	73.1	0.0	55.0	0.0	0.5	0.2	4.1	0.0	24.0	0.0	5.9	0.0	0.4	111.5	3.3	0.0	91.3	12.7	0.5	0.6	27.5	46.5	0.3	1.4	110.1	0.1	3.3
PARD6G	"PAR-6G, PAR6gamma"	ENSG00000178184	"Par-6 family cell polarity regulator gamma"	Q9BYG4	18	80157232-80247514	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 39.6;Oligodendrocyte precursor cells: 25.6;Squamous epithelial cells: 25.3;Suprabasal keratinocytes: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.4;hTCEpi: 34.0;RT4: 27.9;U-2 OS: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047017	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA047017: AB_2679904"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.80e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.85e-1)"	"unprognostic (2.72e-1)"	3.4	1.7	5.8	1.4	5.7	0.6	5.3	3.8	7.9	9.6	6.8	6.0	1.8	6.5	2.7	18.0	6.2	3.3	2.9	9.3	7.8	7.0	3.5	2.9	2.5	6.3	5.8	6.2	2.1	2.1	3.8	5.5	5.5	5.7	2.0	1.8	4.5	5.9	1.9	38.1	3.0	5.4	4.6	2.0	2.7	2.1	8.3	5.3	18.0	1.0	4.3	5.6	12.0	5.9	3.0	4.3	17.7	13.4	0.6	0.7	12.9	3.3	0.7	2.9	0.4	1.2	1.2	0.0	1.4	1.5	5.1	13.4	6.4	19.2	2.8	0.5	5.7	0.2	3.5	10.4	0.8	4.0	36.4	5.7	34.0	0.3	1.8	2.2	1.4	4.2	1.4	0.8	4.3	5.0	3.6	0.4	5.3	1.4	5.2	0.1	11.7	1.5	0.5	27.9	7.4	7.7	4.1	2.2	20.0	8.6	2.6	3.4	1.1	5.9	28.8	2.2	1.6	0.9	1.2	0.3	1.9	0.9	11.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	5.7	3.8	7.9	9.3	7.8	6.3	5.8	5.5	4.6	8.3	5.9	3.3	3.2	0.6	7.5	0.7	39.6	13.7	11.0	18.8	1.3	4.1	10.3	2.8	1.5	2.3	3.7	0.0	0.6	9.7	0.4	0.0	0.4	0.5	9.8	10.1	8.2	0.0	0.0	6.5	0.2	9.5	4.1	0.5	3.3	0.0	3.1	10.8	1.5	0.8	0.0	8.5	0.7	8.2	0.9	6.5	0.7	1.8	0.8	12.4	15.9	0.0	2.0	0.0	25.6	4.8	0.8	0.0	1.9	3.6	6.6	0.0	7.6	2.6	2.5	19.7	1.9	13.6	1.5	6.0	25.3	63.9	0.4	8.0	2.0	0.6	13.4
PARP6	"ARTD17, pART17"	ENSG00000137817	"Poly(ADP-ribose) polymerase family member 6"	Q2NL67	15	72241181-72272999	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026991	Approved		Approved	"Plasma membrane"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA026991: AB_1854989"	"unprognostic (3.88e-2)"	"prognostic favorable (3.17e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.36e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (8.02e-8)"	"unprognostic (6.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"	20.0	20.9	63.2	14.6	64.8	30.5	20.0	62.2	84.6	22.2	61.2	28.7	15.3	24.5	24.0	17.7	22.6	21.3	19.6	64.5	57.7	23.8	15.5	19.7	19.4	55.7	55.9	29.2	32.5	12.6	49.7	18.3	55.3	25.1	14.8	52.9	23.2	17.3	34.8	23.0	21.7	20.2	51.0	20.6	24.2	34.5	57.1	21.0	30.2	21.2	17.4	22.7	19.1	64.9	15.9	27.6	29.0	37.8	30.5	25.2	23.7	13.8	19.9	21.8	31.1	18.5	28.2	22.3	8.4	20.3	31.4	20.9	32.4	18.1	12.4	26.5	30.6	31.7	55.0	0.2	25.4	16.7	30.1	32.6	43.5	20.1	55.2	33.7	14.6	35.6	16.6	24.3	17.5	28.4	14.4	28.7	14.2	13.2	0.0	26.7	20.8	17.2	19.9	30.4	81.4	43.1	22.6	17.8	37.0	38.2	22.8	18.8	14.0	26.7	24.7	35.7	20.7	27.9	27.7	23.2	19.1	31.4	19.1	1.1	3.6	8.2	2.3	3.1	1.6	2.4	1.7	2.5	2.6	2.3	2.6	2.0	3.6	3.0	3.5	2.2	2.9	2.1	63.2	64.8	62.2	84.6	64.5	57.7	55.7	55.9	55.3	51.0	57.1	64.9	11.5	22.4	21.2	54.9	15.3	14.4	9.6	6.9	31.3	16.4	13.0	13.7	20.9	2.8	12.9	9.2	20.9	7.3	12.0	8.0	7.9	9.7	61.4	8.0	10.3	11.1	17.4	4.6	19.7	12.7	5.3	13.9	21.4	10.0	15.8	17.3	6.4	6.1	8.9	18.5	20.5	6.5	6.1	14.8	11.1	178.1	12.5	14.0	16.0	20.6	9.3	8.8	6.2	27.2	54.6	9.2	9.0	9.8	12.3	9.0	17.7	12.3	5.8	15.5	6.6	13.7	12.5	44.3	12.6	19.3	15.8	6.4	13.3	8.6	7.5	9.3
PCBD2	"DCOH2, DCOHM"	ENSG00000132570	"Pterin-4 alpha-carbinolamine dehydratase 2"	Q9H0N5	5	134905120-135007959	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 49.4;tongue: 42.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036428	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"		"HPA036428: AB_10670103"	"unprognostic (3.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.22e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.57e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.50e-1)"	5.3	7.7	7.3	4.8	8.5	7.6	6.0	7.8	7.6	4.3	11.0	6.1	9.5	4.2	4.1	8.3	5.7	4.6	17.1	6.4	7.5	10.2	11.9	4.9	5.9	8.7	7.7	5.1	8.0	13.0	3.8	3.5	8.0	5.4	7.0	9.9	9.6	3.8	49.4	9.2	8.1	3.6	6.8	5.8	8.2	3.2	8.1	5.5	9.6	42.7	6.1	4.5	4.9	10.8	7.5	7.2	9.4	6.9	5.7	5.2	5.2	6.0	5.2	3.8	3.8	12.0	17.5	8.7	8.8	4.4	6.1	6.5	5.6	5.9	3.4	12.3	3.1	6.0	9.5	7.1	5.4	7.1	3.6	3.4	7.1	3.6	7.6	5.1	4.3	7.7	7.7	12.2	6.9	13.0	7.5	12.3	5.1	11.5	6.9	10.9	8.4	9.7	8.1	7.4	7.2	9.2	10.4	6.0	9.1	7.1	13.0	9.4	5.9	6.4	4.3	7.1	8.1	10.6	15.7	5.5	7.8	8.8	4.8	5.7	5.1	5.4	3.6	4.5	2.9	4.5	4.0	3.4	4.4	4.2	3.8	4.3	2.8	4.0	4.6	7.7	3.9	2.7	7.3	8.5	7.8	7.6	6.4	7.5	8.7	7.7	8.0	6.8	8.1	10.8	4.2	9.6	10.3	28.7	8.8	3.6	6.4	15.8	7.4	13.5	11.7	8.4	32.5	20.0	12.5	16.5	12.5	13.6	10.1	13.6	21.5	17.1	8.4	7.9	6.1	6.9	4.2	31.5	10.6	18.2	24.4	5.8	13.3	8.7	6.3	22.4	7.1	23.1	24.6	23.5	12.9	9.5	20.3	10.0	9.6	3.5	7.2	10.2	5.4	17.8	26.9	14.8	7.2	13.0	20.6	17.8	6.2	2.2	13.1	7.1	26.5	26.3	11.9	45.9	0.0	9.0	7.4	5.2	11.5	13.8	6.0	10.1	7.8	9.5	15.9	8.7
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631744-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;lymphoid tissue: 25.1"	"Group enriched"	"Detected in many"	4	"Adipocytes: 57.6;Astrocytes: 77.1;Early spermatids: 60.7;Endothelial cells: 126.7;Excitatory neurons: 125.2;Hepatic stellate cells: 79.6;Inhibitory neurons: 67.9;Oligodendrocyte precursor cells: 193.0;Oligodendrocytes: 101.1;Spermatocytes: 68.3"	"Cancer enhanced"	"Detected in many"		"glioma: 9.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.7;HEK 293: 9.3;U-87 MG: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA		690000		"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	1.6	1.8	15.8	1.8	20.6	0.0	0.8	7.9	13.9	2.2	0.1	1.2	0.8	2.1	0.8	0.6	2.0	3.2	2.2	11.7	25.5	1.9	1.0	14.0	0.6	9.3	15.8	0.5	6.0	1.6	0.9	4.4	11.4	1.0	0.8	1.0	0.7	0.7	1.7	0.3	0.8	2.1	7.6	25.1	1.5	8.8	27.9	0.2	2.9	1.3	0.5	2.7	0.8	10.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	9.3	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.3	0.0	2.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	1.2	0.0	1.0	0.0	0.0	0.0	5.3	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	20.6	7.9	13.9	11.7	25.5	9.3	15.8	11.4	7.6	27.9	10.5	57.6	0.0	4.3	77.1	0.1	2.7	0.1	0.0	1.2	7.1	0.4	0.6	6.0	1.5	8.6	1.8	0.0	0.2	0.5	0.1	0.0	11.1	60.7	2.6	2.0	126.7	0.0	0.0	125.2	8.3	0.1	11.7	0.0	19.8	0.0	20.5	79.6	0.3	0.6	0.0	67.9	0.0	0.0	1.9	2.5	19.0	1.8	0.5	10.6	12.2	1.6	2.3	0.0	193.0	101.1	1.3	0.0	1.2	1.2	0.3	0.0	0.0	5.1	0.0	6.6	1.9	10.7	68.3	10.6	0.4	1.0	0.0	1.1	1.6	0.0	0.4
PCDHA1		ENSG00000204970	"Protocadherin alpha 1"	Q9Y5I3	5	140786136-141012347	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9;pituitary gland: 1.0;testis: 1.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;Hepatic stellate cells: 1.4;Sertoli cells: 6.6;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"T-47d: 9.1"	"Low region specificity"	"Detected in many"							HPA035969	Enhanced		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA035969: AB_10673492"	"unprognostic (2.76e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-4)"	"unprognostic (7.38e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.01e-5)"	"unprognostic (2.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.29e-1)"	0.0	0.2	0.2	0.0	0.5	0.0	0.1	1.5	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	0.0	0.0	1.5	0.7	0.0	0.1	0.0	1.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.1	1.1	0.1	9.1	0.3	0.0	1.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.5	1.0	0.7	0.4	1.5	0.7	1.1	0.9	0.5	1.9	0.0	3.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA12	PCDH-ALPHA12	ENSG00000251664	"Protocadherin alpha 12"	Q9UN75	5	140875302-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 28.9;Alveolar cells type 2: 5.1;Bipolar cells: 11.4;Cone photoreceptor cells: 6.2;Horizontal cells: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 3.9;cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.1;hTCEpi: 3.4;PC-3: 5.1;RT4: 5.2;SH-SY5Y: 2.1"									HPA035812	Approved		Approved	"Plasma membrane,Cytosol"		No	No				"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA035812: AB_2674796"	"unprognostic (3.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.74e-2)"			"unprognostic (2.24e-2)"		"unprognostic (2.08e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.18e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.97e-2)"	0.3	0.3	0.4	0.0	0.5	0.0	0.2	3.9	1.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.7	0.0	0.3	0.1	0.6	0.1	1.5	0.0	0.3	0.1	0.0	0.7	0.0	0.8	0.0	0.4	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	7.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.6	1.7	5.1	0.0	0.0	0.0	0.1	5.2	0.2	2.1	0.0	0.6	0.0	0.3	1.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	3.9	1.1	0.3	0.1	0.3	0.1	0.4	0.1	0.0	0.5	0.2	28.9	5.1	0.0	0.0	0.0	0.0	0.8	0.0	11.4	0.8	1.3	0.4	4.3	1.9	1.8	6.2	0.0	0.0	0.1	0.0	0.7	1.3	0.8	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.8	0.0	0.1	1.4	0.1	0.0	5.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.1	0.0	0.2	1.3	3.6	0.0	0.2	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PCDHA5	"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5"	ENSG00000204965	"Protocadherin alpha 5"	Q9Y5H7	5	140821604-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 3.3"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 6.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.3;EFO-21: 3.4;T-47d: 3.7;WM-115: 1.3"	"Low region specificity"	"Detected in many"							HPA044557	Approved		Approved	"Nuclear speckles,Plasma membrane,Mitochondria"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nuclear speckles, Mitochondria"	"HPA044557: AB_10970597"	"unprognostic (4.95e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (6.25e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-4)"	"unprognostic (9.30e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.17e-5)"	"unprognostic (2.11e-1)"	0.1	0.1	0.6	0.0	1.0	0.0	0.1	3.3	1.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.0	3.3	1.1	0.9	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHB1	PCDH-BETA1	ENSG00000171815	"Protocadherin beta 1"	Q9Y5F3	5	141051374-141059346	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cardiomyocytes: 2.7;Respiratory ciliated cells: 2.2;Skeletal myocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA053921	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"		"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"HPA053921: AB_2682310"	"unprognostic (5.54e-2)"	"unprognostic (1.60e-2)"		"unprognostic (9.01e-4)"	"unprognostic (8.65e-2)"			"unprognostic (8.00e-2)"		"unprognostic (7.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-5)"	"unprognostic (3.38e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-4)"	0.1	0.2	0.4	0.1	0.4	0.4	0.0	0.9	0.5	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.4	0.1	0.1	0.4	0.2	0.3	0.1	0.1	0.2	0.4	0.3	0.1	0.4	0.3	0.5	0.1	0.4	0.1	0.0	0.5	0.2	0.0	1.4	0.3	0.2	0.0	0.1	0.2	0.3	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.9	0.5	0.4	0.2	0.4	0.3	0.4	0.1	0.3	0.4	0.0	0.0	1.1	0.0	0.4	0.0	0.9	0.0	0.0	0.3	0.1	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.2	0.4	0.0	1.2	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7
PCDHB11	"ME2, PCDH-BETA11"	ENSG00000197479	"Protocadherin beta 11"	Q9Y5F2	5	141199610-141203779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 4.9;Endometrial stromal cells: 3.5;Fibroblasts: 4.8;Peritubular cells: 3.4;Sertoli cells: 6.6;Skeletal myocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.6;EFO-21: 8.9;U-2 OS: 3.0"									HPA045042	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA045042: AB_2679194"	"unprognostic (1.32e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.47e-3)"	1.3	0.6	0.2	0.5	0.5	0.2	0.9	0.9	1.2	1.2	0.0	1.0	0.2	1.5	0.5	0.7	0.9	0.9	0.8	0.5	0.0	0.7	0.2	0.8	0.1	0.3	0.3	1.6	2.6	2.6	0.7	0.6	0.1	0.9	0.3	0.6	0.8	1.0	0.4	0.8	0.4	1.2	0.4	0.6	0.6	0.4	0.0	0.3	0.6	0.6	0.1	0.9	0.6	0.4	0.0	0.1	1.8	5.6	0.1	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.9	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.8	0.0	0.1	0.0	1.4	0.3	0.1	0.0	0.1	0.2	0.0	0.3	0.0	2.2	0.0	0.0	0.2	2.2	0.3	1.3	0.1	0.7	0.3	1.3	0.0	0.3	0.1	3.0	2.4	0.0	0.1	0.0	0.0	1.4	0.1	1.5	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.5	0.9	1.2	0.5	0.0	0.3	0.3	0.1	0.4	0.0	0.4	1.9	3.2	0.5	0.0	0.0	0.0	0.7	0.0	0.0	4.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	3.5	1.9	2.4	0.0	0.0	1.8	0.0	4.8	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.1	1.8	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.0	3.4	0.1	0.9	0.0	0.9	0.0	0.2	6.6	4.1	1.7	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.7
PCDHB12	PCDH-BETA12	ENSG00000120328	"Protocadherin beta 12"	Q9Y5F1	5	141208697-141212571	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.0;Endometrial stromal cells: 2.8;Fibroblasts: 2.8;Melanocytes: 3.6;Peritubular cells: 2.6;Skeletal myocytes: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.7;ASC diff: 2.5;EFO-21: 3.0;RH-30: 3.2;U-2 OS: 2.3;U-2197: 2.4"									HPA045042	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA045042: AB_2679194"	"unprognostic (1.43e-2)"	"unprognostic (3.22e-3)"	"unprognostic (4.18e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.87e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.22e-3)"	"unprognostic (4.97e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.41e-3)"	1.3	0.6	0.1	0.4	0.7	0.0	1.2	0.9	1.1	1.9	0.0	1.3	0.2	2.7	0.8	0.4	1.9	1.0	1.4	0.8	0.1	0.6	0.3	1.4	0.1	0.3	0.3	2.2	1.3	1.0	2.0	0.4	0.0	0.9	0.4	0.8	0.6	0.9	0.7	0.5	0.6	1.8	0.1	0.7	0.6	1.1	0.1	0.1	0.6	0.9	0.1	1.2	1.1	0.7	0.0	0.0	0.7	2.7	2.5	1.4	0.4	0.0	1.9	0.1	0.2	0.0	0.0	0.0	3.0	0.3	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.7	0.2	0.0	0.0	0.6	0.7	0.1	0.0	0.0	0.1	0.0	0.5	0.5	3.2	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.6	0.2	2.1	0.4	0.2	0.4	2.3	2.4	0.0	0.0	0.0	0.0	1.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.9	1.1	0.8	0.1	0.3	0.3	0.0	0.1	0.1	0.7	1.9	0.0	1.1	0.0	0.0	0.4	0.0	0.2	0.0	4.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.8	0.1	2.8	1.3	1.8	0.0	0.0	0.9	0.0	2.8	0.5	0.1	0.0	0.1	1.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	3.6	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.1	0.0	0.2	0.0	0.3	0.0	2.2	1.6	1.2	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0
PCDHB16	"KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a"	ENSG00000272674	"Protocadherin beta 16"	Q9NRJ7	5	141182387-141186226	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 14.9;Endometrial stromal cells: 10.0;Fibroblasts: 7.3;Horizontal cells: 8.4;Skeletal myocytes: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 19.4;LHCN-M2: 10.5;U-138 MG: 39.3;U-2197: 11.1;U-87 MG: 9.9"	"Low region specificity"	"Detected in all"							HPA014668			Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"HPA014668: AB_1855055"	"unprognostic (3.44e-3)"	"unprognostic (4.03e-2)"	"unprognostic (8.14e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.49e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.83e-3)"	3.1	1.9	1.2	1.2	0.9	0.2	2.4	2.1	1.8	2.6	0.0	1.6	0.5	4.5	4.8	0.7	2.2	2.0	2.5	1.6	0.8	2.0	1.0	2.4	0.6	2.0	1.0	6.7	1.9	4.3	2.3	1.2	1.2	1.7	0.9	2.2	1.8	0.9	1.0	1.3	0.9	2.7	1.5	1.1	0.9	1.4	1.3	0.4	1.7	3.3	0.2	1.6	1.5	2.2	0.1	0.3	1.0	19.4	7.8	5.2	0.6	0.8	3.8	0.0	0.3	0.1	0.3	0.0	5.0	0.9	2.1	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	3.3	0.1	0.2	0.1	2.0	10.5	0.4	0.0	0.1	1.5	0.0	0.2	0.1	2.8	0.0	0.6	0.2	0.7	2.6	0.3	0.6	3.9	0.5	7.9	0.0	0.6	39.3	1.7	11.1	2.7	0.1	0.1	0.0	9.9	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.9	2.1	1.8	1.6	0.8	2.0	1.0	1.2	1.5	1.3	2.2	6.4	3.2	1.5	0.0	0.0	0.8	0.1	1.0	0.0	14.9	1.2	2.4	1.9	5.7	0.6	1.8	0.0	0.0	0.0	0.0	1.9	0.8	1.2	0.6	10.0	4.8	1.8	0.0	0.0	4.7	0.0	7.3	0.5	0.4	0.0	0.2	2.2	0.1	0.1	8.4	0.0	0.0	4.1	0.3	0.9	1.5	4.7	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.7	0.0	5.7	0.1	0.1	0.0	0.7	0.2	1.6	0.0	7.6	5.9	2.9	0.3	0.5	1.4	0.0	0.2	0.4	0.0	0.0
PCDHB5	"DKFZp586B0217, PCDH-BETA5"	ENSG00000113209	"Protocadherin beta 5"	Q9Y5E4	5	141135206-141138615	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.2;Early spermatids: 8.2;Muller glia cells: 5.0;Spermatocytes: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.7;GAMG: 13.9;NTERA-2: 17.7;RH-30: 14.0;SCLC-21H: 16.4;SuSa: 21.7;T-47d: 17.6;U-138 MG: 32.4;U-2 OS: 14.1;WM-115: 14.7"	"Low region specificity"	"Detected in many"							"HPA013191, HPA067473"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Vesicles	"HPA013191: AB_1855059, HPA067473: "	"unprognostic (2.21e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-3)"	1.4	1.6	2.2	0.4	1.7	0.0	1.6	1.1	3.2	3.4	0.0	1.4	0.2	4.2	3.5	0.7	2.8	1.8	1.9	2.8	0.6	2.4	0.7	1.7	0.2	2.5	1.6	5.9	4.7	2.7	3.2	0.4	1.3	2.9	0.3	2.4	2.2	2.1	1.1	0.6	0.6	2.1	1.7	0.7	1.0	3.1	1.8	0.4	2.5	0.6	0.1	1.6	1.3	2.3	0.0	1.0	18.7	0.3	1.3	0.8	0.2	0.4	0.1	0.3	0.3	0.0	0.0	0.0	9.6	0.0	13.9	0.0	9.8	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.0	0.7	0.0	0.0	0.1	3.8	0.9	0.0	0.7	0.1	0.0	0.0	0.1	0.0	17.7	0.0	0.0	0.0	14.0	0.0	0.0	0.0	16.4	0.5	0.0	0.2	6.1	21.7	17.6	4.3	0.0	32.4	14.1	5.3	0.0	0.0	0.0	0.0	1.7	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.7	1.1	3.2	2.8	0.6	2.5	1.6	1.3	1.7	1.8	2.3	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.6	5.2	0.9	2.2	1.1	1.5	1.8	1.8	0.0	0.0	0.0	0.0	0.0	2.5	8.2	0.5	4.3	1.1	0.0	0.0	0.0	3.6	0.0	1.5	0.0	0.2	0.0	0.5	0.4	0.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	3.8	3.1	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	2.2	0.0	4.5	0.0	1.1	0.0	0.5	0.1	0.7	0.0	2.1	2.7	13.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.6
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 2.4;Cardiomyocytes: 1.8;Horizontal cells: 3.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.5;T-47d: 7.3;WM-115: 3.3"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 37: Myocytes - Muscle contraction"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	0.3	0.2	1.1	0.2	2.3	0.2	0.2	3.2	2.0	0.5	0.0	0.5	0.2	0.6	0.9	0.2	0.4	0.1	1.2	2.2	0.9	0.2	0.1	0.3	0.1	1.5	1.4	0.6	0.5	0.5	0.9	0.5	0.9	0.3	0.2	1.0	0.2	0.2	0.7	0.3	0.1	0.4	1.7	0.2	0.1	0.7	1.4	0.1	0.2	0.4	0.1	0.4	0.3	1.3	0.0	0.2	0.3	1.1	0.7	1.3	0.1	1.1	0.7	0.3	0.6	0.3	0.1	0.2	1.8	0.7	0.5	0.1	0.1	0.2	0.7	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.1	1.1	0.3	0.0	0.4	2.1	0.0	0.1	0.1	0.5	4.5	0.0	0.1	0.5	0.1	0.0	0.2	2.0	1.6	0.2	0.2	0.2	1.0	1.3	0.1	0.6	1.1	0.3	7.3	0.2	0.5	2.0	0.3	1.0	0.2	0.1	0.6	0.1	2.4	0.1	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	2.3	3.2	2.0	2.2	0.9	1.5	1.4	0.9	1.7	1.4	1.3	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430507-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.2;Bipolar cells: 3.8;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.3;Endothelial cells: 2.2;Fibroblasts: 3.2;Skeletal myocytes: 2.0"	"Group enriched"	"Detected in many"	5	"glioma: 1.7;melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 9.3;BJ hTERT+: 15.4;fHDF/TERT166: 23.3;HHSteC: 7.2;HSkMC: 16.5;TIME: 7.5"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		21000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	3.0	4.3	5.3	0.8	6.8	0.0	1.5	5.5	3.7	2.0	0.8	1.3	0.2	2.6	0.4	1.0	1.9	3.9	4.2	5.1	8.4	1.0	0.7	3.1	0.4	10.0	4.2	1.9	1.1	0.3	1.4	2.2	4.5	1.0	0.3	1.4	0.9	1.5	1.3	1.7	0.8	1.7	5.5	1.2	1.0	0.3	5.2	0.9	1.6	1.1	0.4	1.2	2.0	4.6	0.0	0.0	0.1	1.9	0.8	1.4	0.1	9.3	15.4	0.0	0.0	0.0	0.0	0.5	0.0	23.3	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.0	16.5	0.0	4.5	0.0	0.0	5.4	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	2.6	7.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	6.8	5.5	3.7	5.1	8.4	10.0	4.2	4.5	5.5	5.2	4.6	2.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.8	0.2	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	2.2	0.0	0.0	0.0	0.2	0.0	3.2	1.1	0.1	0.0	0.1	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.7	0.0	2.0	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 3.2;Cardiomyocytes: 1.8;Fibroblasts: 1.5;Leydig cells: 1.2;Peritubular cells: 2.6;Skeletal myocytes: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;BJ: 3.9;fHDF/TERT166: 4.4;HSkMC: 3.4;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480"	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	2.2	1.6	1.8	0.7	1.4	0.0	1.9	2.7	2.5	3.0	0.7	1.5	0.1	2.9	1.9	0.8	3.1	1.4	4.9	2.9	1.5	1.1	0.7	2.0	0.2	3.8	3.2	6.3	1.8	3.8	2.6	0.7	2.6	1.9	0.3	2.3	1.2	2.2	1.0	1.0	0.6	2.1	3.5	0.6	0.9	2.3	2.6	0.8	1.6	1.1	0.2	1.4	1.7	2.2	0.0	0.7	0.3	0.2	2.8	6.4	0.0	3.9	1.3	0.3	0.5	0.0	0.0	0.1	0.4	4.4	0.5	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.4	0.1	0.0	0.2	3.9	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.5	0.0	0.2	0.5	0.0	2.3	0.1	0.3	0.4	0.0	2.3	0.6	0.3	0.2	0.0	0.0	0.3	0.0	1.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.4	2.7	2.5	2.9	1.5	3.8	3.2	2.6	3.5	2.6	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.2	0.3	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.1	0.9	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.5	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.4;Cardiomyocytes: 1.6;Endometrial stromal cells: 1.9;Fibroblasts: 1.3;Horizontal cells: 3.3;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 7.1;BJ: 2.3;EFO-21: 5.7"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	1.2	1.2	2.6	0.2	1.7	0.0	0.9	2.2	2.6	1.6	0.1	0.7	0.0	1.4	0.9	0.2	1.2	0.9	3.7	2.5	1.8	0.5	0.6	0.9	0.0	3.8	2.9	2.5	0.9	0.6	1.2	1.7	2.2	0.7	0.2	1.8	0.7	0.8	0.8	0.5	0.2	0.9	3.4	0.2	0.4	1.5	2.9	0.2	0.8	0.9	0.1	0.8	0.9	2.5	0.0	0.0	7.1	0.0	0.0	0.9	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	5.7	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.7	2.2	2.6	2.5	1.8	3.8	2.9	2.2	3.4	2.9	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.1	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.9	0.1	0.5	0.0	0.0	0.1	0.0	0.4	0.0	0.0
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355021-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Skeletal myocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.4;BJ: 4.3;HSkMC: 4.3;HUVEC TERT2: 4.3;U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	1.7	1.3	1.6	0.4	1.8	0.0	0.9	3.7	1.7	1.3	0.0	0.9	0.2	1.6	0.8	0.4	0.9	0.8	1.5	2.9	1.5	0.4	0.3	1.0	0.1	2.1	2.4	1.6	2.1	2.3	1.0	0.8	1.7	1.1	0.3	1.5	0.8	1.1	0.7	0.5	0.3	1.5	2.0	0.3	0.4	0.7	2.1	0.2	0.7	1.0	0.1	0.7	0.8	2.5	0.0	0.1	0.8	0.4	3.3	7.4	0.0	4.3	3.4	0.2	0.8	0.0	0.1	0.7	1.4	3.7	1.3	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.3	4.3	0.1	0.0	0.0	2.6	4.3	0.0	0.1	0.2	1.8	0.6	0.2	0.2	0.1	0.0	0.2	0.3	1.2	0.1	0.2	0.0	0.6	1.3	0.2	0.2	0.9	0.3	1.6	0.0	2.8	1.8	0.5	2.4	0.3	0.1	0.2	0.1	6.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.8	3.7	1.7	2.9	1.5	2.1	2.4	1.7	2.0	2.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 4.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.5;Endometrial stromal cells: 9.2;Horizontal cells: 10.1;Sertoli cells: 6.6;Skeletal myocytes: 5.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 15.8;ASC TERT1: 6.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	1.0	0.6	1.0	0.3	1.6	0.1	1.2	4.9	1.1	2.5	0.0	1.1	0.1	2.0	0.6	0.8	1.4	1.1	1.9	1.2	1.2	0.3	0.2	1.1	0.2	2.2	2.1	2.0	0.6	0.6	0.9	0.6	1.0	1.4	0.3	1.2	0.8	0.9	0.6	0.7	0.4	1.0	1.2	0.2	0.5	0.3	1.2	0.3	0.5	0.7	0.1	1.0	1.3	2.0	0.0	0.4	0.2	0.1	15.8	6.2	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.8	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.5	0.6	0.3	0.5	0.6	0.1	0.0	0.3	0.8	0.6	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.2	1.4	0.0	0.9	0.5	0.1	0.9	0.6	0.1	0.9	0.1	0.3	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	1.0	1.6	4.9	1.1	1.2	1.2	2.2	2.1	1.0	1.2	1.2	2.0	1.8	0.0	1.1	0.0	0.2	0.1	0.8	0.1	0.6	11.5	0.3	0.4	2.6	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.4	9.2	1.9	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.2	1.3	0.6	1.4	0.3	0.1	10.1	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.5	0.0	0.1	0.1	1.3	6.6	5.7	1.7	0.0	0.3	0.3	0.0	0.0	0.6	0.9	0.0	0.4
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373891-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.6;Cardiomyocytes: 5.0;Endometrial stromal cells: 4.6;Hepatic stellate cells: 3.6;Skeletal myocytes: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.6;T-47d: 5.6;WM-115: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	1.4	1.1	1.6	0.7	1.8	0.1	1.3	7.2	1.6	2.7	0.0	2.0	0.2	3.2	1.4	0.8	2.0	1.1	2.7	1.7	1.8	0.8	0.5	1.5	0.4	1.8	1.7	3.5	1.2	1.1	1.8	2.3	0.9	1.2	0.4	2.0	1.5	1.6	0.9	1.5	0.8	2.0	0.8	0.9	0.7	0.8	2.0	0.5	1.2	1.0	0.4	1.6	1.5	1.9	0.0	0.3	2.7	0.4	1.3	4.7	0.1	2.1	0.7	1.1	1.1	0.0	0.1	2.0	2.6	3.3	1.0	0.4	0.1	0.4	0.7	0.0	0.2	0.0	0.3	0.2	0.7	0.1	0.1	4.9	0.3	0.2	0.1	1.0	1.6	0.1	0.2	1.1	0.3	0.4	0.7	1.7	0.3	0.0	0.1	1.4	0.4	0.0	0.3	0.1	9.6	0.7	0.1	0.3	0.6	0.6	5.6	0.1	4.8	0.7	0.3	0.7	0.7	0.4	1.7	0.4	0.8	0.7	12.2	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.6	1.8	7.2	1.6	1.7	1.8	1.8	1.7	0.9	0.8	2.0	1.9	2.8	0.0	2.2	0.0	0.4	0.0	0.8	0.0	0.0	10.6	0.3	1.0	5.0	1.5	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.5	0.4	4.6	1.8	0.0	0.4	0.0	1.5	0.1	2.2	0.0	0.4	0.0	0.6	3.6	0.7	0.1	1.7	0.0	0.2	0.0	0.3	0.0	0.3	1.2	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.1	2.2	1.6	0.4	0.0	0.3	0.7	0.9	0.0	5.2	1.9	0.3	0.3	0.5	0.0	0.3	0.2	0.5	0.2	0.2
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.3;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.2;Skeletal myocytes: 2.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.3;BJ hTERT+: 20.8;hTERT-RPE1: 10.9;SH-SY5Y: 18.6;T-47d: 8.1"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	0.5	0.4	1.0	0.2	0.9	0.0	0.6	5.9	1.0	1.2	0.0	1.1	0.1	1.3	1.1	0.5	1.0	0.4	1.5	1.1	0.6	0.6	0.4	0.7	0.1	1.5	1.2	1.5	0.7	2.2	0.8	1.3	0.9	0.9	0.3	1.6	0.8	0.8	0.7	1.0	0.4	0.8	1.0	0.4	0.3	0.5	1.3	0.2	1.9	0.5	0.1	0.9	0.7	1.5	0.0	1.6	2.3	0.0	6.6	11.3	0.0	3.3	20.8	4.2	6.1	0.0	0.0	0.5	5.2	0.7	0.2	0.2	0.0	0.1	3.4	0.0	0.3	0.0	0.4	0.2	1.1	0.0	0.0	5.0	0.1	0.0	0.7	10.9	1.7	0.0	0.0	0.1	0.1	0.1	0.6	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.4	18.6	0.0	0.1	0.1	3.7	8.1	0.0	6.7	0.1	0.1	3.1	0.1	0.1	1.9	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	5.9	1.0	1.1	0.6	1.5	1.2	0.9	1.0	1.3	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.3	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.0	2.8	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.3
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.4;Cardiomyocytes: 3.5;Horizontal cells: 3.3;Skeletal myocytes: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.1	0.1	0.6	0.1	0.6	0.4	0.1	3.9	0.8	0.2	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.5	0.8	0.5	0.0	0.1	0.1	0.1	1.1	0.7	0.3	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.5	0.1	0.0	0.3	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.9	0.1	0.4	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.2	0.6	0.1	0.6	0.4	0.4	0.1	0.0	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.6	0.2	0.4	0.6	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.6	0.6	3.9	0.8	0.8	0.5	1.1	0.7	0.7	0.3	0.9	1.2	1.2	0.0	0.6	0.0	0.1	0.0	0.9	0.0	0.0	11.4	0.3	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	2.1	1.2	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.3	0.4	0.7	0.1	3.3	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.2	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.1	0.1	1.5	0.0	0.7	0.0	0.2	0.0	1.7	0.0	5.2	0.9	0.7	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.5
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.5;Cardiomyocytes: 1.3;Endometrial stromal cells: 1.5;Horizontal cells: 3.3;Skeletal myocytes: 2.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.6;HSkMC: 4.0;hTERT-RPE1: 16.9;TIME: 4.6;U-87 MG: 5.1"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	1.8	1.6	3.3	0.7	3.5	0.1	1.3	6.6	3.2	2.0	0.4	1.2	0.5	2.5	1.1	1.4	1.9	2.0	1.1	3.7	2.6	0.8	0.4	1.5	0.5	3.6	3.4	2.8	0.8	1.1	0.9	1.0	3.8	1.5	0.7	4.4	1.1	2.2	0.8	1.7	0.6	1.8	3.7	1.1	0.8	0.4	3.6	0.5	1.4	1.2	0.7	1.2	1.4	5.7	0.0	0.1	0.6	1.6	0.1	0.2	0.2	0.7	0.0	0.6	0.6	0.2	0.4	1.3	3.6	2.0	0.3	0.1	0.1	0.2	0.7	0.0	0.3	0.0	0.1	0.0	1.1	0.0	0.2	4.0	0.1	0.4	0.3	16.9	1.0	0.0	0.1	0.2	0.3	0.3	0.1	0.5	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.4	0.9	0.4	4.6	0.3	0.3	0.1	2.5	0.2	0.0	0.0	5.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.5	6.6	3.2	3.7	2.6	3.6	3.4	3.8	3.7	3.6	5.7	0.6	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.6	4.5	0.2	0.3	1.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.4	0.2	0.1	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	2.3	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.1
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.7;Late spermatids: 7.6;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.9;ASC TERT1: 6.6;hTERT-RPE1: 7.1;T-47d: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"		Yes	No				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	0.6	0.7	1.8	0.1	1.2	0.0	0.5	2.1	1.6	0.6	0.0	0.3	0.0	1.2	0.4	0.3	0.4	0.5	0.5	2.9	1.6	0.4	0.1	0.6	0.0	1.9	3.3	1.4	0.8	2.3	1.0	0.2	2.4	0.6	0.1	1.6	0.3	0.9	0.2	0.2	0.1	0.9	2.4	0.1	0.1	0.4	1.8	0.0	0.6	0.3	0.0	0.3	0.3	3.5	0.1	1.9	1.6	0.0	12.9	6.6	0.1	1.2	3.2	0.5	0.7	0.2	0.5	0.5	4.2	0.5	3.1	0.6	0.3	0.2	0.4	0.0	0.8	0.0	0.2	1.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	7.1	0.1	0.0	0.2	0.2	3.0	1.7	0.4	0.3	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.0	1.0	0.7	0.0	0.8	0.1	1.2	8.6	0.0	1.0	0.2	1.3	1.1	0.0	0.0	2.4	0.3	2.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.2	2.1	1.6	2.9	1.6	1.9	3.3	2.4	2.4	1.8	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370242-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.4;ASC TERT1: 8.4;fHDF/TERT166: 3.5;TIME: 5.5"									"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802"	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	0.7	0.3	0.4	0.2	0.8	0.0	0.5	3.8	0.8	0.8	0.0	0.8	0.0	1.0	0.6	0.3	0.7	0.4	1.2	0.9	0.5	0.3	0.2	0.5	0.2	1.3	1.4	1.2	0.7	1.1	0.7	0.4	0.6	0.4	0.3	0.8	0.8	0.4	0.5	0.6	0.3	0.7	0.6	0.4	0.4	0.4	0.8	0.3	0.6	0.5	0.2	0.6	0.6	1.4	0.0	0.6	0.4	0.3	10.4	8.4	0.2	1.2	2.0	0.7	0.8	0.0	0.0	1.8	0.3	3.5	0.6	0.5	0.0	0.2	0.5	0.0	0.2	0.0	0.2	0.1	0.4	0.1	0.0	2.1	0.4	0.2	0.1	0.2	1.0	0.0	0.2	0.8	0.2	0.4	0.6	0.9	0.1	0.0	0.1	1.5	0.6	0.0	0.2	0.1	2.4	0.5	0.0	0.0	0.2	0.3	0.6	0.0	5.5	0.5	0.1	0.5	0.6	0.2	1.8	0.2	0.4	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	3.8	0.8	0.9	0.5	1.3	1.4	0.6	0.6	0.8	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGC3	"PC-43, PC43, PCDH-GAMMA-C3, PCDH2"	ENSG00000240184	"Protocadherin gamma subfamily C, 3"	Q9UN70	5	141475947-141512977	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 308.1"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.0;Bipolar cells: 8.4;Endometrial stromal cells: 5.5;Fibroblasts: 10.2;Horizontal cells: 11.8;Skeletal myocytes: 6.6"	"Group enriched"	"Detected in all"	6	"glioma: 55.0;melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"plasmacytoid DC: 15.3"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 15.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 200.7;HSkMC: 186.2;U-138 MG: 244.1;WM-115: 382.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077289"	Approved		Approved	"Plasma membrane"		NA	NA		1200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832"	"unprognostic (2.52e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (3.72e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (6.00e-4)"	63.3	64.3	248.0	15.4	241.0	0.2	59.9	221.6	308.1	107.8	165.1	60.4	7.4	81.3	60.8	54.5	62.6	30.2	77.8	232.3	227.5	36.6	29.5	101.9	9.5	236.9	241.0	65.1	34.7	36.8	79.0	37.1	216.6	66.0	20.4	36.3	46.4	40.7	27.6	64.7	32.0	39.5	216.5	22.2	38.7	22.0	263.5	15.7	45.7	26.3	14.8	60.6	80.0	220.8	12.8	7.7	48.1	14.0	200.7	178.3	0.6	58.6	162.6	30.9	32.5	0.0	12.7	43.5	39.7	108.0	111.7	46.2	6.1	20.7	28.2	0.2	20.0	0.1	1.2	1.2	62.6	0.5	1.5	186.2	31.6	46.9	37.2	104.2	19.7	0.0	0.2	1.6	79.2	24.8	1.0	5.4	2.3	0.8	0.1	30.0	97.1	0.4	17.9	13.7	16.6	69.8	17.3	0.6	115.9	16.8	40.0	66.9	22.1	244.1	12.2	46.7	72.2	0.1	0.6	0.7	60.3	0.1	382.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	15.3	0.0	0.1	248.0	241.0	221.6	308.1	232.3	227.5	236.9	241.0	216.6	216.5	263.5	220.8	2.5	0.0	0.0	0.0	0.3	0.3	0.5	0.3	8.0	8.4	0.2	1.1	0.8	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.2	1.4	0.3	5.5	1.9	0.0	0.0	0.0	0.2	0.2	10.2	0.0	0.5	0.0	0.2	1.1	0.0	0.3	11.8	0.0	0.2	0.0	0.3	0.3	0.7	1.2	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.6	0.0	0.1	0.0	1.0	0.0	6.6	1.7	1.6	0.0	3.9	0.1	0.7	0.1	3.5	0.0	0.5
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489081-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 28.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 4.6;SuSa: 7.4;U-138 MG: 14.4;U-251 MG: 6.5;U-87 MG: 8.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA076140"	Supported		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"		"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	0.3	0.5	5.6	0.1	8.6	0.0	0.3	0.0	11.7	0.8	0.0	1.3	0.0	1.2	0.2	0.3	0.7	0.2	5.3	28.4	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.7	0.4	0.0	1.2	0.1	0.0	0.5	0.0	1.2	0.4	0.5	1.2	0.5	0.2	0.7	0.0	0.1	0.3	0.6	0.3	0.1	0.2	0.2	0.0	0.5	0.6	0.0	0.0	0.0	0.3	0.3	0.3	1.5	0.1	0.8	0.5	0.4	0.5	0.0	0.0	0.4	1.4	2.2	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	4.6	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	7.4	0.1	0.2	0.1	14.4	0.2	0.2	6.5	0.0	0.0	0.0	8.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.6	0.0	11.7	28.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCLO	"ACZ, DKFZp779G1236, KIAA0559"	ENSG00000186472	"Piccolo presynaptic cytomatrix protein"	Q9Y6V0	7	82754012-83162930	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 25.6;pituitary gland: 11.1;retina: 21.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 655.4;Inhibitory neurons: 746.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 25.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	28	"REH: 263.3;U-2 OS: 284.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015858, HPA029579, CAB079012"	Approved	Supported	Approved	"Nuclear speckles,Plasma membrane"		NA	NA		6000000		"Cluster 58: Brain - Synaptic function"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles, Plasma membrane"		"CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044"	"unprognostic (1.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.79e-6)"	"unprognostic (5.15e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-5)"	"unprognostic (6.62e-5)"	1.8	4.2	4.0	0.2	5.5	0.0	2.4	25.6	22.4	1.5	0.0	2.1	1.5	0.3	3.8	2.3	1.0	0.9	1.4	7.8	1.7	4.4	0.1	0.8	0.1	0.0	0.0	0.8	3.9	4.4	11.1	0.3	0.0	2.5	1.7	21.7	2.5	2.5	0.1	2.0	1.7	0.1	0.0	0.5	1.5	3.7	1.3	1.2	4.6	0.1	0.2	0.6	2.6	4.2	1.2	1.6	1.9	0.0	0.8	0.1	0.0	0.7	0.7	0.5	1.0	0.3	0.7	0.0	0.0	0.8	7.7	0.6	5.7	2.4	2.4	0.3	0.8	0.0	1.2	0.1	0.0	0.8	0.2	0.4	1.8	0.0	9.6	0.5	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.0	2.0	1.0	4.7	263.3	4.2	0.0	1.9	0.9	4.9	3.4	0.2	2.7	0.6	1.2	3.4	0.6	0.0	0.0	284.5	1.2	0.6	0.2	0.0	0.5	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.5	25.6	22.4	7.8	1.7	0.0	0.0	0.0	0.0	1.3	4.2	0.6	9.6	17.9	40.5	0.0	2.5	9.0	3.2	13.6	121.9	11.0	9.7	31.2	22.8	12.6	1.8	131.3	1.9	0.0	22.9	7.9	6.4	13.0	7.4	6.7	2.5	60.1	0.0	655.4	4.9	0.4	2.4	20.4	13.5	0.0	24.2	0.0	0.2	1.7	85.8	746.4	15.0	2.0	0.0	0.0	7.9	2.8	0.4	0.0	50.6	0.0	16.2	0.0	73.9	73.7	2.5	21.9	6.4	0.0	3.9	13.5	23.0	7.7	86.9	0.0	0.3	3.2	5.0	19.5	19.3	3.4	0.7	0.3	37.5	9.3	6.0
PCMTD1	FLJ10883	ENSG00000168300	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1"	Q96MG8	8	51817575-51899186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025696, HPA061444"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA025696: AB_1855077, HPA061444: AB_2684519"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.11e-3)"	36.5	35.2	18.2	23.3	20.2	16.8	38.2	25.2	21.9	33.8	23.2	38.8	25.9	35.3	47.5	28.0	30.8	29.0	35.5	16.4	19.9	38.3	30.4	28.3	28.8	19.1	19.2	42.6	73.9	77.9	25.5	26.3	19.9	36.1	25.8	25.4	57.6	32.0	83.4	33.5	26.8	28.3	18.9	46.3	29.5	14.9	18.9	35.1	53.3	67.1	27.3	32.6	31.0	21.6	11.7	5.7	24.3	5.4	34.1	28.4	14.0	13.4	22.8	5.5	9.0	3.1	23.6	12.0	18.0	17.3	8.4	27.2	4.7	15.8	9.3	11.9	8.5	12.6	11.7	8.3	43.9	5.2	12.4	30.4	31.7	6.9	17.4	35.8	24.4	16.0	9.5	36.0	12.0	4.2	24.5	13.7	8.9	16.7	3.0	8.0	4.5	13.8	24.7	21.7	16.2	15.0	10.9	14.8	17.1	18.5	14.2	7.6	22.2	6.8	5.9	8.8	5.2	21.6	15.6	3.9	16.4	11.4	7.0	18.7	8.4	23.2	8.6	11.0	10.4	13.1	11.5	9.4	8.1	13.0	13.5	12.4	29.4	21.6	12.7	14.7	13.2	9.1	18.2	20.2	25.2	21.9	16.4	19.9	19.1	19.2	19.9	18.9	18.9	21.6	98.4	115.4	68.1	78.7	78.1	54.0	66.0	49.7	58.6	80.7	66.7	61.0	92.7	48.6	52.0	84.6	10.4	38.1	80.7	28.7	64.6	32.9	4.7	66.6	63.9	79.3	46.7	51.4	144.7	39.8	37.2	79.2	45.9	92.2	53.0	107.2	76.4	37.1	25.1	58.9	159.7	39.0	61.1	51.8	56.8	10.4	104.1	62.7	71.2	144.3	52.5	120.8	55.6	106.1	122.3	43.8	32.2	120.0	101.8	98.0	45.5	92.8	56.7	24.0	39.5	73.2	68.2	16.4	24.2	38.3	59.2	68.5	62.1	87.6	30.9	94.6
PDCD7	"ES18, HES18"	ENSG00000090470	"Programmed cell death 7"	Q8N8D1	15	65117379-65133808	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 176.1;Cone photoreceptor cells: 221.0;Rod photoreceptor cells: 176.3;Spermatocytes: 164.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049388	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoli	"HPA049388: AB_2680741"	"unprognostic (7.71e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (8.18e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.29e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.62e-2)"	12.0	12.4	13.8	11.9	14.3	10.0	11.9	18.0	18.2	16.2	12.2	15.8	9.9	16.5	12.7	17.8	13.6	8.4	11.4	14.2	13.3	10.3	12.5	10.2	14.5	14.2	13.5	16.8	11.2	11.6	10.9	11.9	14.6	13.0	9.3	10.8	10.0	11.9	13.1	11.1	11.3	13.3	12.0	13.4	11.0	18.9	14.2	15.7	12.5	8.7	15.1	14.8	14.0	16.7	18.2	14.9	24.8	25.7	24.4	34.2	15.0	20.4	22.6	24.7	18.8	18.2	19.7	34.9	21.7	16.5	18.5	33.5	63.9	14.7	17.7	21.3	17.0	33.9	12.8	15.9	22.5	46.6	21.8	20.0	22.0	13.6	25.4	23.7	19.8	25.6	44.0	27.6	21.7	13.9	48.7	33.2	30.1	21.1	13.3	42.7	31.8	39.0	15.2	28.5	20.4	24.3	22.8	19.1	31.3	27.0	15.4	37.7	20.0	25.2	24.6	14.8	31.9	49.1	60.4	24.9	22.7	50.5	13.2	2.1	1.4	0.9	2.0	1.2	1.7	2.3	1.9	1.8	1.3	2.4	2.0	1.9	0.3	3.3	1.2	1.8	1.5	0.7	13.8	14.3	18.0	18.2	14.2	13.3	14.2	13.5	14.6	12.0	14.2	16.7	33.6	0.0	14.3	10.1	46.3	38.0	67.8	6.0	89.4	176.1	33.1	40.9	17.7	21.5	11.1	29.5	221.0	55.3	55.8	17.2	29.4	9.0	5.9	26.8	51.8	36.5	14.4	27.5	31.0	8.2	32.6	38.4	20.4	28.2	19.7	49.0	31.1	19.4	23.6	75.7	32.9	26.9	6.1	23.2	22.8	8.9	58.1	24.7	12.4	9.4	14.5	47.2	45.3	15.1	28.9	7.3	11.6	48.2	37.9	56.8	14.2	22.7	8.5	176.3	46.0	45.5	38.8	164.6	107.3	48.8	39.9	71.4	49.5	60.3	26.1	51.5
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20368537-20688583	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.2;Bipolar cells: 38.4;Cardiomyocytes: 131.3;Horizontal cells: 52.2;Inhibitory neurons: 78.8;Smooth muscle cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.6;HEL: 15.3;HeLa: 42.5;HUVEC TERT2: 7.4;SH-SY5Y: 17.9;U-138 MG: 11.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 18.8"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"		NA	NA		37000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	6.5	1.0	1.6	3.1	1.3	0.2	3.8	3.1	1.3	6.7	1.8	15.0	1.9	4.2	1.4	2.2	4.1	4.7	43.4	1.3	1.5	3.3	1.3	3.9	1.0	1.9	2.3	3.4	6.2	0.6	2.1	11.3	1.2	5.4	7.6	5.7	2.7	3.5	2.2	1.3	9.6	5.2	1.6	2.2	5.1	0.4	2.5	0.6	2.8	1.8	0.5	2.5	3.1	1.4	0.0	0.2	8.6	0.0	1.9	1.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.3	42.5	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.1	0.0	0.0	0.0	2.7	0.0	0.1	17.9	0.0	0.0	0.1	3.3	0.0	0.0	0.3	11.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	3.1	1.3	1.3	1.5	1.9	2.3	1.2	1.6	2.5	1.4	2.7	0.0	0.0	98.2	0.0	0.3	0.2	0.0	0.6	38.4	0.2	0.3	131.3	4.3	0.6	0.0	0.0	0.0	0.0	28.4	0.0	5.8	0.7	0.5	1.6	3.9	4.2	0.0	4.1	0.5	0.0	11.3	0.0	1.4	17.1	0.0	2.2	0.0	0.7	52.2	78.8	7.0	0.0	0.0	0.7	0.6	1.5	3.1	1.8	27.2	0.5	4.4	0.0	27.6	3.9	0.4	26.9	0.7	0.0	0.5	33.4	3.1	0.0	2.8	6.6	3.6	49.9	0.3	0.9	0.9	0.3	0.0	0.6	0.5	16.4	0.2
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.6;tongue: 125.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	23.5	21.6	16.5	12.2	19.9	7.4	16.6	21.6	21.9	13.3	9.4	22.8	20.1	14.2	13.3	17.2	10.0	12.3	77.8	21.1	14.5	21.5	31.0	12.7	11.9	16.6	17.2	11.7	21.5	21.0	15.4	24.4	16.5	18.9	20.6	27.1	20.4	16.0	138.6	14.6	15.0	17.8	13.4	11.1	23.1	27.8	19.7	13.2	14.3	125.2	14.8	15.0	11.7	21.1	20.4	54.3	29.9	11.9	20.7	25.5	28.5	38.9	30.1	40.3	38.9	69.3	18.8	27.2	24.7	31.4	49.1	39.4	58.9	31.9	41.1	25.8	47.2	26.9	54.6	82.3	45.0	50.7	30.7	25.6	37.9	23.2	31.5	23.8	31.1	23.9	57.9	25.4	33.1	35.7	32.2	29.9	25.2	54.2	30.5	27.0	53.5	23.8	62.1	54.7	32.0	23.3	33.8	48.1	52.2	29.3	54.8	29.9	21.0	30.4	35.5	32.3	42.7	24.4	53.3	35.7	23.9	24.2	32.5	14.0	19.4	17.5	15.4	21.4	14.3	18.8	14.4	12.7	27.5	16.0	17.2	12.6	3.9	22.1	34.6	7.4	22.1	14.7	16.5	19.9	21.6	21.9	21.1	14.5	16.6	17.2	16.5	13.4	19.7	21.1	9.0	35.3	24.6	34.3	14.5	26.0	21.4	26.7	15.4	25.8	15.1	11.4	115.3	20.0	26.0	5.5	29.2	62.9	9.0	14.4	64.6	21.4	52.6	15.1	12.2	13.0	9.0	13.5	85.4	14.3	34.9	20.6	16.3	16.6	5.7	16.5	11.7	23.6	26.4	20.2	80.3	17.2	42.7	18.6	13.6	54.0	10.8	14.7	21.4	24.4	23.2	21.0	9.2	40.2	53.4	16.7	15.9	13.5	14.1	22.4	15.0	30.7	19.8	26.7	0.0	14.5	18.8	57.2	36.1	17.9	25.4	83.0	13.4	27.5	20.0	19.7
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 629.5;skeletal muscle: 1163.5;tongue: 576.0"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 1844.2"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 219.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		1200000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	41.7	26.0	20.5	25.6	25.2	59.7	39.5	22.4	22.4	27.4	84.9	34.1	33.3	94.8	11.3	72.3	40.5	47.5	629.5	21.4	27.7	34.9	82.7	22.0	16.2	30.9	30.1	27.2	30.2	12.2	17.5	67.7	25.0	88.5	30.8	18.2	40.2	68.9	1163.5	21.5	34.4	105.9	22.7	24.1	31.0	12.7	26.3	10.9	25.5	576.0	21.1	45.8	27.6	21.0	31.4	87.2	33.6	13.0	71.7	51.3	13.0	71.6	59.9	40.1	32.6	80.8	66.3	12.0	72.0	72.3	21.0	31.8	46.5	68.2	65.9	24.1	19.3	43.7	53.8	32.2	103.7	14.6	38.3	66.4	58.4	96.1	74.0	177.9	93.5	13.2	19.2	12.5	86.2	29.8	15.0	4.8	11.4	66.7	36.6	7.2	24.7	11.1	45.0	94.6	16.5	21.8	38.9	88.7	20.3	26.7	10.3	5.2	113.7	103.7	17.3	46.1	44.1	9.5	13.0	12.7	56.5	10.3	24.9	219.7	23.4	21.0	12.1	40.6	9.7	10.5	12.0	12.8	19.5	7.6	7.9	10.4	22.6	9.2	44.6	6.6	11.8	15.2	20.5	25.2	22.4	22.4	21.4	27.7	30.9	30.1	25.0	22.7	26.3	21.0	107.4	44.8	23.6	184.1	22.1	194.4	380.3	92.1	63.7	4.7	90.2	67.4	1844.2	62.9	82.9	49.7	31.3	13.7	18.5	180.0	13.7	95.0	19.2	68.7	11.8	117.2	109.4	27.6	4.9	95.1	96.5	97.8	84.6	108.7	52.0	29.1	137.8	207.0	38.8	1.7	20.7	107.4	36.7	60.6	75.3	9.1	41.3	59.8	62.2	104.0	41.6	86.2	12.3	181.5	43.1	139.2	166.8	66.5	23.2	300.7	117.5	73.6	70.0	35.8	78.9	96.7	134.7	23.8	34.4	107.3	157.0	23.8	31.1	6.8	74.0	217.5
PDZD8	"bA129M16.2, FLJ34427, PDZK8"	ENSG00000165650	"PDZ domain containing 8"	Q8NEN9	10	117277274-117375440	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 73.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 208.7;Late spermatids: 477.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015716, HPA051610"	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	"Plasma membrane"	"HPA015716: AB_1855162, HPA051610: AB_2681549"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.01e-2)"	7.1	7.0	8.9	4.7	12.1	73.0	4.7	15.7	8.6	7.9	17.9	9.3	14.0	9.1	14.1	10.8	6.8	9.7	5.1	8.1	11.8	13.1	15.8	6.0	3.2	11.9	13.8	8.9	14.1	28.3	4.2	5.4	12.2	6.4	11.2	14.1	12.9	10.6	4.9	5.5	10.6	6.9	11.3	3.7	10.4	13.2	12.5	5.8	6.8	5.8	3.6	6.6	5.8	13.2	12.6	21.1	7.6	14.7	12.8	11.4	4.3	11.9	10.2	5.2	4.2	10.7	16.4	14.7	10.5	18.1	6.0	18.4	13.4	12.6	10.3	9.4	11.8	124.3	8.6	10.6	9.4	52.4	11.2	11.2	14.7	9.5	27.9	19.3	9.3	12.1	11.5	15.0	13.0	5.1	10.2	6.7	6.0	6.6	18.8	8.2	29.2	6.4	15.5	9.0	6.0	9.6	12.6	5.4	9.7	6.9	3.7	7.6	15.1	8.6	9.4	15.8	20.5	8.0	7.2	10.5	10.8	23.6	7.7	1.4	0.5	2.6	0.9	0.5	0.9	0.3	0.7	0.7	0.7	0.4	0.5	0.7	2.3	1.2	0.9	0.5	0.3	0.2	8.9	12.1	15.7	8.6	8.1	11.8	11.9	13.8	12.2	11.3	12.5	13.2	22.1	12.8	30.7	32.3	13.7	29.7	24.4	10.3	24.5	31.9	16.4	17.0	19.8	40.0	21.0	18.4	22.9	9.8	36.1	26.9	9.8	31.9	208.7	78.3	46.7	24.0	33.7	82.0	49.2	81.9	7.2	27.3	48.4	111.2	44.2	14.6	18.9	58.6	7.5	32.0	61.0	38.8	10.2	16.0	31.8	477.6	23.6	25.2	23.2	30.0	15.5	29.0	23.7	51.8	56.4	57.6	23.1	28.6	28.1	41.1	27.0	26.5	28.5	45.0	26.3	46.3	24.5	25.8	29.1	36.3	32.4	6.7	28.4	90.8	50.2	44.6
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118136124-118145584	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2083.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 3705.6;Hepatocytes: 2242.4;Proximal enterocytes: 2177.7;Proximal tubular cells: 4542.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA008819, CAB009906, CAB013493, HPA063904"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		51000000	"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708"	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	217.9	1754.1	941.2	84.0	966.0	121.8	235.5	987.9	1049.0	258.0	958.4	208.9	601.4	186.6	383.7	219.5	218.4	154.8	463.8	932.6	951.5	1046.1	2083.1	176.4	122.7	959.0	965.9	335.9	357.5	1162.7	292.3	128.8	982.6	261.6	191.2	336.1	344.5	233.2	580.3	190.3	510.6	167.6	1006.6	121.2	201.7	152.2	1025.0	138.1	739.7	546.8	160.2	200.8	179.0	1081.7	289.2	241.6	340.0	348.8	493.5	250.2	500.0	214.5	262.3	347.7	177.1	151.6	96.4	439.6	221.3	336.2	139.9	194.4	495.0	202.8	257.7	115.1	454.2	220.0	274.7	1021.7	289.2	403.6	94.5	240.8	334.7	203.9	140.0	396.1	162.7	240.9	375.8	169.2	356.4	346.3	226.8	813.7	319.7	243.1	273.9	446.1	235.6	829.7	428.7	277.2	397.5	306.9	439.9	306.2	446.0	200.4	443.6	293.0	168.9	253.7	147.0	254.0	237.3	161.6	315.1	234.1	301.1	303.2	280.9	5.0	67.5	20.0	155.2	76.4	247.0	271.7	258.9	193.1	205.1	210.0	244.6	201.2	8.0	138.1	68.6	231.6	259.7	258.4	941.2	966.0	987.9	1049.0	932.6	951.5	959.0	965.9	982.6	1006.6	1025.0	1081.7	193.7	403.8	433.3	101.5	230.9	318.1	449.3	367.6	288.5	539.4	538.4	590.7	697.3	713.4	243.2	783.5	95.9	999.6	144.6	207.1	3705.6	507.9	44.3	499.3	319.0	186.5	320.6	218.1	93.7	244.6	862.3	347.9	169.2	369.8	371.8	419.7	213.8	2242.4	591.6	721.8	99.6	378.8	335.7	201.4	239.0	84.4	543.1	195.3	743.5	53.4	296.8	1792.2	101.0	39.2	199.8	184.2	313.3	731.6	279.3	517.4	2177.7	4542.6	291.6	411.6	368.1	337.5	347.8	330.6	145.7	367.7	325.2	615.5	216.7	921.6	631.3	399.5
PECAM1	CD31	ENSG00000261371	"Platelet and endothelial cell adhesion molecule 1"	P16284	17	64319415-64413776	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 455.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 672.9;Endothelial cells: 468.2;Hepatic stellate cells: 275.3;Macrophages: 143.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 702.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 773.0;TIME: 537.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004690, HPA004871"	Enhanced		Approved	"Nucleoli,Plasma membrane"		NA	NA		110000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoli	"HPA004690: AB_1078462, HPA004871: "	"unprognostic (2.79e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.68e-2)"	"prognostic unfavorable (8.98e-5)"	"unprognostic (9.72e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.16e-2)"	195.6	21.4	20.3	78.9	21.4	35.5	128.5	21.9	25.3	54.9	21.7	37.9	29.7	51.1	9.2	54.3	45.1	88.6	70.3	18.0	22.2	43.6	22.4	204.9	68.0	24.7	23.1	10.7	21.3	29.9	9.7	455.1	24.1	23.5	37.7	4.0	33.4	24.5	35.7	36.2	39.4	83.5	26.3	94.9	30.9	5.0	28.1	62.4	69.8	97.0	60.4	84.0	35.7	22.2	0.1	0.3	1.3	0.1	1.1	1.5	0.4	0.2	0.3	0.0	0.1	4.7	0.1	4.2	121.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	95.0	1.8	2.2	3.7	0.5	0.3	0.3	0.0	0.8	0.2	1.6	773.0	34.1	2.3	57.8	0.1	0.4	33.3	8.1	0.1	0.0	9.1	1.4	15.3	3.8	0.0	0.1	0.4	0.3	1.8	0.0	0.1	0.2	0.0	48.5	537.8	0.8	0.5	0.9	0.2	3.4	6.3	6.8	1.6	6.7	0.1	54.8	263.9	219.2	19.8	419.6	18.9	26.7	2.2	46.6	154.0	32.7	36.3	68.6	392.0	40.3	702.3	88.6	2.1	224.2	20.3	21.4	21.9	25.3	18.0	22.2	24.7	23.1	24.1	26.3	28.1	22.2	672.9	16.0	37.9	0.7	24.4	0.0	0.5	0.0	4.0	0.0	4.8	4.6	23.3	1.5	3.1	9.2	0.0	0.5	50.1	0.0	0.0	0.8	0.9	1.1	1.1	468.2	0.0	17.9	1.2	0.2	4.0	22.0	0.0	1.6	8.8	0.0	275.3	3.0	45.8	0.0	1.2	0.0	0.0	110.4	0.0	1.1	2.5	143.9	0.0	47.8	93.8	0.3	26.8	0.5	1.3	0.1	0.0	1.9	109.1	1.3	0.0	0.5	7.3	1.2	0.0	6.9	15.8	0.1	0.5	1.6	0.0	0.8	21.2	4.3	0.1	1.0
PFDN1	PFD1	ENSG00000113068	"Prefoldin subunit 1"	O60925	5	140245035-140303113	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006499	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006499: AB_1079596"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.66e-3)"	"prognostic unfavorable (8.81e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.00e-1)"	74.1	50.9	73.9	37.7	75.6	60.2	50.0	82.2	88.4	41.4	70.8	59.2	40.2	50.8	54.3	52.3	41.9	35.7	93.3	77.2	79.7	61.6	38.5	46.9	46.1	82.9	77.2	37.2	34.7	52.8	39.4	50.8	80.5	44.8	42.9	35.1	45.4	43.7	149.0	46.2	39.8	61.4	79.1	36.6	40.7	29.9	79.3	51.5	42.4	86.4	51.6	45.9	40.9	81.2	172.4	79.6	137.7	80.9	89.7	91.8	133.8	229.6	114.9	174.6	192.6	172.1	107.9	114.9	224.1	124.3	180.0	62.6	102.0	228.7	204.2	122.6	102.9	102.4	76.5	113.0	105.1	213.5	76.4	98.2	119.8	148.5	156.3	112.6	196.0	132.8	93.7	73.1	149.8	78.5	146.0	147.6	92.0	70.3	119.2	101.3	195.9	86.3	197.1	77.9	78.2	81.8	172.1	148.6	136.8	128.5	102.1	122.3	249.1	121.8	119.6	71.9	208.0	70.3	198.6	299.2	122.5	138.5	144.1	149.5	84.7	130.3	86.2	131.1	91.8	106.0	98.6	100.4	100.5	97.9	97.3	88.4	14.0	114.7	130.3	93.0	129.3	115.5	73.9	75.6	82.2	88.4	77.2	79.7	82.9	77.2	80.5	79.1	79.3	81.2	87.9	67.3	33.0	16.3	57.4	38.0	65.9	96.2	30.7	42.5	50.1	57.3	81.3	52.9	62.1	66.2	45.9	116.1	53.1	56.6	123.3	121.9	3.9	58.0	56.6	73.8	46.6	62.9	31.2	101.7	86.6	55.4	35.2	70.9	54.4	53.6	72.1	56.9	85.4	25.2	29.3	43.6	48.8	61.1	37.7	12.9	52.2	63.4	74.7	37.5	90.4	84.9	71.1	24.1	39.3	128.9	55.1	52.3	35.5	45.4	80.9	147.3	45.3	42.9	65.7	39.6	63.7	23.7	61.8	40.8	34.9	85.6	45.2	42.9	47.3	63.6
PGAP3	"CAB2, MGC9753, PER1, PERLD1, PP1498"	ENSG00000161395	"Post-GPI attachment to proteins phospholipase 3"	Q96FM1	17	39671122-39696797	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"OE19: 800.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016591	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA016591: AB_1855203"	"unprognostic (1.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.57e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.94e-2)"	10.5	11.9	17.0	5.6	17.2	5.0	12.9	14.0	19.6	14.6	16.2	18.6	14.9	11.3	18.3	25.8	15.9	13.4	14.8	17.5	16.7	20.6	35.6	12.1	7.4	14.9	15.4	13.5	27.1	22.7	14.9	11.8	14.6	18.5	13.7	7.1	25.1	11.7	8.3	21.0	17.1	6.1	14.7	12.3	16.6	9.1	16.5	4.8	27.1	4.5	7.5	12.2	13.7	15.5	3.7	9.6	7.7	7.0	7.9	8.1	7.9	4.3	10.1	6.7	6.1	5.4	23.8	4.2	19.7	8.3	2.2	12.6	2.4	2.9	3.1	8.6	7.7	5.2	6.0	9.3	10.6	12.9	12.8	14.9	15.0	3.1	6.8	7.6	2.2	1.9	4.9	9.6	6.1	8.7	2.9	11.7	7.6	800.4	2.1	3.2	4.7	12.1	10.7	12.0	7.1	4.7	11.9	134.0	6.9	0.8	11.4	12.4	3.4	7.2	7.6	3.5	3.3	8.5	2.0	1.4	8.1	4.9	8.1	2.6	7.2	4.6	15.2	11.6	8.3	8.1	10.6	12.5	5.7	7.7	10.1	10.1	2.0	10.4	4.3	3.9	5.4	7.3	17.0	17.2	14.0	19.6	17.5	16.7	14.9	15.4	14.6	14.7	16.5	15.5	6.5	3.2	14.9	7.8	3.7	3.8	3.3	5.6	3.4	12.6	9.1	7.0	7.7	14.3	10.1	14.7	8.4	8.1	5.3	20.3	1.9	7.6	0.1	3.5	4.5	5.0	8.4	3.0	9.0	11.1	6.5	5.1	9.2	5.7	8.9	6.8	4.6	9.0	4.4	13.5	6.3	15.3	8.2	5.1	2.8	0.1	3.1	3.7	1.8	2.8	1.9	7.5	4.1	9.0	6.1	6.3	13.9	1.5	2.8	3.7	22.9	3.4	4.9	22.1	0.0	5.0	3.3	0.7	2.4	8.1	2.8	10.4	4.9	5.8	13.3	3.1
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348841	"Metabolic proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 8.5;esophagus: 8.2;skin 1: 15.1;vagina: 10.3"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 30.1;Club cells: 9.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.7;HDLM-2: 2.2;Karpas-707: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB025879			Approved	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"		"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	15.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	2.3	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	30.1	0.6	0.0	0.0	0.1	0.3	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.0	1.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	2.0	0.0	0.3	0.3	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	4.0	3.4	0.3	0.0	0.0	0.2	0.2
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	107.3	51.9	23.8	38.1	25.6	41.7	76.6	25.8	29.8	58.4	34.1	68.1	127.3	52.3	51.3	57.5	44.2	53.4	50.7	25.0	30.2	96.0	173.8	42.7	30.6	25.6	29.6	57.9	74.2	80.5	49.0	85.3	27.7	53.0	65.2	55.1	55.3	73.2	54.4	98.2	121.9	67.4	26.6	32.5	95.8	39.5	28.5	28.0	65.6	44.0	40.8	56.3	51.0	29.8	123.3	44.4	80.3	64.9	339.8	177.6	80.5	164.6	182.7	119.4	158.3	46.4	123.6	86.3	187.8	213.4	138.8	70.1	74.3	81.6	149.3	49.7	42.7	58.0	111.3	88.3	429.1	84.7	41.7	140.9	161.3	100.3	123.3	277.0	109.1	55.0	98.2	105.6	173.7	38.2	78.9	39.2	63.1	148.5	39.7	62.5	64.2	59.8	176.8	42.9	63.3	59.7	92.4	103.1	97.3	131.2	79.7	38.0	203.5	100.0	81.4	103.8	77.3	121.0	106.0	91.3	109.9	74.4	70.1	2.2	1.0	2.0	1.5	0.9	0.7	1.2	1.8	1.5	0.6	0.9	1.6	1.5	0.9	1.1	0.7	2.4	2.0	0.6	23.8	25.6	25.8	29.8	25.0	30.2	25.6	29.6	27.7	26.6	28.5	29.8	95.9	54.5	41.0	16.6	27.0	100.1	49.7	27.8	54.1	22.4	49.2	32.8	60.7	58.6	35.9	44.1	10.4	85.4	41.2	68.2	29.4	57.3	80.9	42.2	59.1	50.0	35.5	104.2	20.4	74.2	146.6	69.9	53.0	64.2	12.0	31.0	47.2	125.1	35.3	11.8	19.1	67.8	40.7	15.7	39.5	49.5	46.3	22.1	67.6	13.1	19.0	98.6	21.6	13.6	25.0	69.7	50.6	37.6	48.9	58.0	177.3	111.0	27.4	41.1	13.1	63.3	53.1	33.3	27.3	51.9	111.8	274.9	32.4	39.4	58.8	34.4
PHACTR2	"C6orf56, KIAA0680"	ENSG00000112419	"Phosphatase and actin regulator 2"	O75167	6	143536845-143831185	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 164.2;placenta: 83.8"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 214.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031719, HPA031720, HPA031725"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279"	"unprognostic (3.25e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.99e-4)"	"unprognostic (3.60e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	11.6	25.4	7.0	7.8	9.0	7.6	5.5	4.3	5.7	8.1	164.2	8.5	7.5	9.9	3.6	22.0	5.7	8.4	12.4	10.0	4.9	5.9	7.9	15.7	7.8	12.3	10.3	6.5	4.9	13.1	4.0	83.8	15.1	10.3	8.5	2.7	6.0	6.9	4.5	2.7	6.1	9.8	3.5	13.5	12.0	6.5	16.5	2.7	15.5	7.3	6.7	7.6	6.4	4.5	21.9	13.5	3.6	26.6	3.7	8.0	15.3	18.0	27.2	7.7	9.6	23.9	9.5	1.2	47.5	51.7	5.4	6.5	2.0	17.9	9.1	18.1	8.5	35.5	14.7	14.0	6.1	9.1	10.5	11.2	9.8	7.7	24.9	11.8	47.0	6.7	10.2	0.1	12.4	24.0	1.3	2.1	26.8	7.7	3.8	3.3	26.3	0.2	9.3	19.2	5.2	5.2	20.0	26.1	0.3	13.4	9.8	13.1	82.2	34.9	18.2	15.2	11.8	0.2	0.1	0.3	8.6	9.5	3.2	6.0	3.5	6.7	3.3	2.5	12.3	0.4	4.0	4.4	3.3	0.2	2.4	1.6	1.8	3.5	2.7	3.2	5.5	1.9	7.0	9.0	4.3	5.7	10.0	4.9	12.3	10.3	15.1	3.5	16.5	4.5	160.9	214.7	94.5	41.4	11.7	24.2	16.0	19.5	47.3	37.0	14.2	13.8	71.8	32.9	73.2	22.0	2.1	84.7	27.5	58.9	13.7	30.5	10.1	49.6	43.7	158.6	21.6	32.8	55.2	22.5	49.8	144.8	54.6	64.7	38.7	34.9	157.1	27.6	35.4	101.0	133.8	19.2	24.4	121.1	40.2	23.2	103.2	52.5	24.9	77.8	71.7	10.3	15.5	5.5	20.9	49.4	22.3	120.0	10.6	63.3	20.2	24.8	51.1	3.0	98.6	95.9	83.5	3.1	2.3	33.0	17.2	52.5	51.3	127.9	26.3	30.9
PHACTR4	"FLJ13171, PPP1R124"	ENSG00000204138	"Phosphatase and actin regulator 4"	Q8IZ21	1	28369582-28500364	"Predicted intracellular proteins"	Neurogenesis	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 212.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028985	Approved		Approved	"Plasma membrane,Intermediate filaments,Cytosol"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA028985: AB_10602142"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (9.65e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.26e-2)"	7.2	6.5	6.3	8.6	8.1	11.8	10.1	8.2	6.8	13.6	10.2	12.9	9.1	13.7	7.1	33.0	13.2	8.9	8.9	5.8	8.5	14.1	16.3	12.4	7.8	9.1	6.8	13.1	11.7	15.1	4.0	10.4	7.2	11.8	14.1	5.1	11.3	8.2	11.9	16.2	10.3	13.8	5.5	12.0	10.7	8.6	8.0	11.9	12.4	18.3	12.2	9.4	14.8	9.3	26.0	17.2	37.8	27.5	9.6	10.2	5.8	18.1	18.3	38.5	40.0	16.4	28.1	24.5	15.9	21.6	24.3	17.7	26.3	17.4	33.9	18.1	14.9	51.6	28.2	26.5	14.3	31.2	56.7	9.9	16.4	24.7	42.7	14.0	52.0	19.5	26.0	16.9	24.5	8.0	22.3	7.8	28.3	14.0	11.8	23.2	35.7	18.5	20.2	22.8	20.1	26.0	41.0	16.9	20.9	14.9	22.5	11.1	33.3	18.8	34.6	13.4	35.8	12.4	19.7	20.1	18.4	26.2	20.3	1.9	2.0	2.0	3.3	2.0	2.9	1.4	2.6	3.3	2.2	2.2	1.8	2.6	1.4	2.4	3.3	2.6	1.2	1.5	6.3	8.1	8.2	6.8	5.8	8.5	9.1	6.8	7.2	5.5	8.0	9.3	65.9	70.5	49.8	60.7	38.9	38.6	23.6	24.1	46.7	34.6	37.0	35.8	38.5	40.0	53.7	23.9	20.9	17.6	36.7	59.9	17.6	32.4	6.1	125.6	58.6	56.2	49.3	32.2	65.8	36.5	17.3	29.1	35.2	212.6	48.0	38.8	42.5	63.3	22.8	23.5	82.6	57.0	24.4	33.6	32.3	8.5	19.3	40.3	17.8	92.8	33.7	19.8	51.5	117.1	148.1	48.2	33.5	29.7	30.8	24.4	40.0	45.5	63.3	39.8	39.5	45.6	31.0	47.1	39.4	62.1	54.1	15.2	35.7	15.3	50.6	30.9
PHF20L1	"CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B"	ENSG00000129292	"PHD finger protein 20 like 1"	A8MW92	8	132775358-132848807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025060, HPA028417"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"HPA025060: AB_10599822, HPA028417: AB_10602278"	"unprognostic (9.12e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.83e-2)"	12.1	14.0	8.0	13.5	9.6	24.9	10.9	10.4	11.3	11.6	9.9	9.2	9.4	11.4	10.0	11.6	7.9	10.7	17.5	8.0	6.4	10.7	13.4	10.3	11.8	6.5	6.7	11.3	8.9	15.7	8.7	12.4	6.7	9.9	10.1	12.5	9.6	8.0	16.7	7.7	9.9	11.5	5.7	11.5	9.3	13.5	7.2	25.6	22.7	18.5	12.4	12.8	8.9	9.8	20.9	20.6	33.1	19.1	25.3	29.9	11.9	30.1	23.4	20.2	19.7	11.5	14.0	23.8	25.6	30.3	17.4	12.0	22.5	16.0	24.9	40.4	16.1	25.5	24.3	8.2	26.6	20.7	17.6	22.5	19.4	21.1	31.1	19.5	22.6	37.2	32.1	36.4	30.4	21.0	67.6	9.2	14.7	23.8	27.1	32.6	22.1	20.6	16.5	17.8	81.4	23.8	19.1	13.5	24.5	13.8	26.5	23.0	29.6	32.6	25.9	21.5	29.1	21.5	29.9	30.3	28.8	35.8	29.6	3.5	3.8	7.0	2.1	2.4	2.1	2.1	1.9	2.5	3.6	2.2	2.8	2.2	12.6	3.0	3.6	2.9	2.5	1.5	8.0	9.6	10.4	11.3	8.0	6.4	6.5	6.7	6.7	5.7	7.2	9.8	65.9	25.6	51.6	74.4	51.1	33.6	52.6	48.2	40.9	55.7	40.5	38.0	88.5	25.8	57.2	36.8	43.8	29.7	92.9	35.1	23.5	37.3	81.2	39.8	73.4	55.2	43.7	37.9	133.9	31.3	32.0	51.6	41.8	48.9	60.2	60.1	36.0	33.4	36.6	53.8	192.2	29.0	44.7	39.6	49.3	49.5	40.0	84.2	23.2	83.4	67.5	50.9	78.2	104.5	117.5	40.6	26.4	42.9	66.6	40.4	41.5	25.7	30.8	54.1	46.0	68.1	58.9	115.1	45.9	44.9	36.2	45.0	65.8	61.4	30.9	66.7
PHLDB1	"FLJ00141, KIAA0638, LL5a"	ENSG00000019144	"Pleckstrin homology like domain family B member 1"	Q86UU1	11	118606440-118658031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 87.2;Late spermatids: 87.7;Oligodendrocytes: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.2;ASC TERT1: 105.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037959, HPA038448"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA037959: AB_10673651, HPA038448: AB_10697390"	"unprognostic (7.81e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.36e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.36e-6)"	"unprognostic (7.09e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.44e-1)"	52.6	8.1	39.2	11.5	79.7	0.5	38.9	42.5	66.0	39.1	3.8	23.8	9.2	38.4	2.6	9.1	30.2	21.6	33.0	42.3	49.2	15.8	3.2	26.8	4.6	64.3	64.6	31.9	22.2	4.5	8.8	24.6	56.0	16.7	6.4	1.6	11.1	15.8	13.3	15.1	15.3	18.6	33.4	12.5	14.3	12.0	75.3	3.1	20.3	13.6	2.3	21.9	22.9	133.7	4.8	7.5	28.9	14.2	105.2	105.9	10.1	21.9	26.6	12.7	7.4	11.2	31.8	0.0	40.2	44.3	17.2	18.6	6.6	44.8	2.0	0.7	4.2	8.6	5.7	5.5	27.2	0.0	15.8	55.8	9.6	17.8	12.5	28.3	36.6	0.7	7.5	0.3	16.7	3.4	0.1	0.5	10.2	0.4	3.8	1.1	7.5	0.7	12.5	6.8	6.5	14.5	55.8	4.7	15.6	11.3	20.1	2.7	45.4	25.9	22.9	13.2	18.3	0.2	0.0	0.1	7.5	1.5	29.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	39.2	79.7	42.5	66.0	42.3	49.2	64.3	64.6	56.0	33.4	75.3	133.7	34.4	6.4	13.7	53.2	1.6	18.4	9.2	13.7	14.2	4.0	7.2	19.6	5.6	1.5	6.3	31.3	0.0	1.0	2.5	34.2	0.0	9.4	78.3	11.6	87.2	32.1	8.4	0.0	4.1	4.4	1.5	54.9	11.7	8.6	1.3	25.6	26.4	0.9	5.9	3.3	8.3	20.4	0.0	2.5	34.4	87.7	67.1	8.2	12.4	23.4	2.2	7.6	0.0	67.3	244.5	24.3	29.8	44.4	0.7	4.2	10.7	7.8	0.5	2.3	39.5	42.9	53.8	21.9	10.1	1.9	9.1	1.5	5.4	11.0	16.8	2.4
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.0;skin 1: 43.5"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 58.0;Urothelial cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (4.11e-5)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	3.7	9.2	6.3	5.6	5.5	3.5	6.4	3.9	6.4	14.4	8.9	6.1	5.0	5.3	1.1	42.0	8.0	6.1	5.7	5.1	7.8	8.1	13.9	5.6	7.7	4.5	3.8	12.7	8.0	4.2	10.5	3.1	5.8	14.8	1.7	0.8	15.6	3.7	3.7	43.5	6.6	1.9	2.8	6.6	6.3	30.1	4.5	6.2	5.0	1.0	6.8	8.2	22.4	11.3	6.9	7.2	3.0	7.4	2.6	5.3	19.1	4.9	4.3	4.8	3.3	7.3	7.2	4.1	15.2	3.0	3.8	8.0	2.1	8.6	0.9	9.9	6.8	4.6	7.4	8.8	6.5	1.8	8.5	4.5	10.7	5.1	3.1	3.7	4.3	10.2	8.3	6.1	2.4	11.0	7.2	0.4	1.8	16.6	5.8	8.3	3.9	2.8	2.3	23.3	0.1	6.4	6.3	13.5	6.2	1.8	9.7	5.8	5.4	3.1	8.2	3.8	4.7	15.8	18.8	4.7	2.9	3.4	5.3	0.2	2.3	0.3	2.4	1.4	1.8	2.2	2.2	1.8	4.4	2.4	3.2	3.0	0.5	1.8	0.1	5.1	2.3	1.7	6.3	5.5	3.9	6.4	5.1	7.8	4.5	3.8	5.8	2.8	4.5	11.3	2.7	0.0	1.7	2.6	17.1	29.1	27.2	11.6	31.9	1.0	10.0	8.0	1.9	8.6	7.6	9.2	0.0	18.5	7.6	7.1	1.9	5.5	11.3	12.9	9.6	4.6	3.0	1.7	5.1	2.4	4.5	7.3	4.6	9.8	5.7	3.2	4.6	12.6	3.6	0.0	7.0	4.3	8.2	2.8	34.7	8.9	3.7	11.2	5.4	11.2	6.7	4.1	7.2	4.0	2.0	2.1	4.7	3.4	11.6	22.0	10.5	8.5	12.7	1.9	6.6	8.6	10.9	28.2	4.8	37.7	38.4	58.0	14.3	4.6	3.7	45.1
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase 1"	Q8TCT1	17	49223366-49230787	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 103.0"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1499.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	160	"eosinophil: 171.1;neutrophil: 426.7"	"Lineage enriched"	"Detected in many"	228	"granulocytes: 426.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;EFO-21: 3.2;HDLM-2: 4.1;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065025			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	1.5	3.4	3.4	19.0	0.5	6.3	3.9	0.4	0.6	0.7	2.9	0.7	0.2	1.0	1.3	2.2	1.8	1.8	7.3	1.3	1.0	2.3	1.6	8.8	6.2	0.3	1.2	0.2	0.6	6.4	7.4	0.8	0.0	0.7	1.2	0.3	3.4	1.3	3.0	0.4	6.9	14.2	0.9	103.0	5.5	0.3	0.7	3.2	0.2	0.9	0.5	6.1	0.0	1.0	0.0	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.1	1.5	0.0	5.7	3.2	0.0	2.1	0.0	0.9	0.3	0.1	4.1	0.1	0.7	0.7	0.2	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.7	1.2	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.1	0.1	2.2	0.3	1.7	1.1	0.0	0.1	0.2	0.3	1.5	2.0	0.1	0.2	0.6	171.1	0.4	1.5	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.2	426.7	0.5	1.8	0.0	0.1	1.1	1.5	3.4	6.3	3.9	1.8	7.3	8.8	6.2	7.4	6.9	5.5	6.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	205.8	0.0	0.0	1.4	0.0	8.6	0.7	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.4	0.0	2.6	0.0	1.4	0.0	0.0	0.3	0.0	1499.6	7.8	0.6	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	11.2	4.5	0.0	0.0	237.6	0.1	0.0	0.1	0.1
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 953.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		590000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	71.5	109.2	196.7	54.5	200.5	64.6	62.4	206.2	245.6	76.0	192.2	74.0	54.0	44.7	103.0	70.6	99.3	62.0	267.2	192.3	203.3	82.6	47.9	57.3	57.4	199.3	191.9	65.0	153.4	160.9	85.2	49.8	200.3	89.2	50.5	26.3	144.0	86.6	432.6	45.8	62.9	78.1	198.8	41.6	61.5	56.9	199.1	68.5	86.7	441.5	40.0	71.8	41.4	216.2	53.6	452.5	225.6	199.1	153.4	266.0	412.8	147.6	170.8	158.8	138.6	165.7	138.0	145.1	142.8	168.6	180.0	155.0	51.2	293.9	50.2	116.9	132.5	45.4	276.8	380.3	177.5	82.6	176.4	322.8	248.7	91.8	109.5	145.8	218.8	93.1	102.9	129.7	257.2	328.2	156.9	176.7	216.0	372.5	206.6	106.5	106.6	196.7	255.6	113.3	137.6	132.8	146.7	155.8	75.1	107.0	127.2	226.4	177.0	390.6	130.8	91.5	166.5	60.5	93.4	94.0	174.3	59.7	235.8	38.2	290.0	31.0	197.6	318.4	170.7	241.3	173.9	184.6	321.8	178.9	126.0	175.8	13.7	196.7	231.7	425.4	223.6	324.1	196.7	200.5	206.2	245.6	192.3	203.3	199.3	191.9	200.3	198.8	199.1	216.2	125.7	96.1	159.8	24.8	111.8	150.3	187.7	659.2	204.9	43.9	223.1	317.7	384.8	178.7	326.5	217.0	22.9	322.1	111.8	337.1	747.4	196.1	271.3	122.2	168.1	111.9	265.1	80.2	8.1	252.4	489.5	213.1	140.6	170.3	123.5	367.4	83.6	201.9	286.5	67.3	12.5	370.9	309.3	97.2	197.1	953.5	205.0	133.6	334.4	5.6	273.2	194.7	146.2	10.6	25.0	185.3	359.8	223.4	187.8	257.5	540.1	817.4	250.6	77.7	85.5	137.1	249.6	141.8	143.8	140.3	161.8	264.1	106.4	352.5	336.0	199.5
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174902-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2267.8;lymphoid tissue: 2103.1;vagina: 1595.8"	"Group enriched"	"Detected in many"	10	"Basal respiratory cells: 5354.5;Club cells: 2170.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Group enriched"	"Detected in some"	22	"cerebral cortex: 12.0;pons: 7.3;thalamus: 19.0"	"Immune cell enriched"	"Detected in some"	1021	"neutrophil: 1763.3"	"Lineage enriched"	"Detected in single"	4377	"granulocytes: 1763.3"	"Group enriched"	"Detected in many"	5	"EFO-21: 89.3;HaCaT: 109.8;OE19: 103.7;PC-3: 189.9"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA		1400000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favorable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.84e-6)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavorable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	6.1	0.7	0.2	101.9	0.5	1.8	8.8	0.2	12.0	180.1	1.2	124.3	1.9	2.3	1.1	2267.8	4.8	56.6	1.7	0.2	0.4	1.5	3.3	32.5	0.4	0.3	0.3	0.7	1.6	0.2	2.8	1.1	7.3	11.7	43.3	0.0	460.8	3.5	0.6	78.6	42.3	7.5	0.3	20.0	9.0	0.5	19.0	90.6	0.8	1.9	2103.1	44.7	1595.8	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	7.7	0.4	0.0	3.1	2.1	1.4	89.3	0.0	1.1	109.8	0.0	23.2	0.1	1.2	0.0	0.5	6.3	0.9	0.0	0.7	0.0	0.0	21.7	17.8	1.9	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.1	0.1	0.2	103.7	189.9	0.0	1.0	0.0	21.9	0.4	0.0	0.0	15.7	2.1	0.1	0.0	0.0	0.0	0.8	1.0	10.9	0.3	0.9	0.3	1.8	0.4	14.3	0.7	0.1	0.3	0.4	1.7	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1763.3	0.0	0.1	0.1	0.1	0.6	0.2	0.5	0.2	12.0	0.2	0.4	0.3	0.3	7.3	0.3	19.0	0.3	0.1	0.0	8.6	0.0	7.4	0.1	4.7	5354.5	0.0	0.0	39.4	8.4	0.2	8.6	2170.2	18.4	0.0	0.2	0.5	375.4	0.0	46.6	0.1	3.7	0.7	3.0	16.6	0.0	0.0	317.3	0.0	0.8	2.6	6.9	4.5	0.0	0.0	0.0	0.1	0.0	0.0	31.8	197.4	0.0	0.4	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	231.8	219.6	0.0	0.2	29.1	33.9	0.2	152.9	0.0	0.0	0.0	50.5	0.0	0.0	36.2	3.8	0.0	2.5	0.1	154.1	150.4
PI4K2A	"DKFZP761G1923, PI4KII, PIK42A"	ENSG00000155252	"Phosphatidylinositol 4-kinase type 2 alpha"	Q9BTU6	10	97640686-97676434	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB030649, HPA076857"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB030649: , HPA076857: AB_2686817"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (4.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	12.0	25.7	15.5	10.0	15.1	24.1	9.3	15.1	18.9	12.6	13.4	10.7	9.8	12.7	13.0	20.7	9.6	14.0	14.2	15.5	17.8	12.6	15.0	14.2	11.2	20.2	18.8	10.0	8.4	16.6	15.8	18.0	22.0	10.9	8.7	12.9	10.5	10.4	12.7	17.4	10.8	13.0	15.8	14.6	9.4	10.8	17.3	9.8	9.5	13.0	10.6	14.5	12.7	15.2	28.7	21.3	17.2	30.7	36.0	25.8	13.8	28.0	61.5	43.3	45.7	19.4	27.7	10.4	16.2	35.8	31.8	27.1	19.3	55.9	35.8	12.6	16.4	9.3	14.6	17.7	34.5	8.4	12.7	27.3	46.9	45.4	80.1	47.4	22.4	19.9	14.7	16.5	30.4	14.6	18.4	6.4	11.1	14.7	19.8	8.6	17.8	10.3	29.7	26.6	5.8	18.9	23.9	5.9	35.5	24.0	16.4	13.2	25.0	20.6	15.2	24.6	22.1	14.6	18.4	16.9	38.1	5.0	6.8	0.0	1.2	0.0	1.3	0.8	1.0	1.4	0.5	1.1	1.3	0.6	0.4	0.9	0.4	0.7	0.6	0.6	1.2	0.6	15.5	15.1	15.1	18.9	15.5	17.8	20.2	18.8	22.0	15.8	17.3	15.2	4.9	3.2	5.4	9.8	12.0	13.4	4.5	6.5	8.0	14.7	10.7	8.9	10.4	10.0	4.3	5.5	12.5	14.0	12.5	8.6	3.9	4.9	2.4	6.8	15.4	6.9	3.0	8.2	10.9	4.9	6.4	12.0	7.1	7.6	1.3	5.7	3.6	9.9	38.1	11.8	10.9	4.0	6.1	15.0	24.7	2.2	4.4	19.0	10.6	12.2	15.0	8.0	18.6	5.5	6.0	7.2	0.8	9.1	9.4	5.8	9.0	7.3	4.8	15.1	6.6	11.9	8.0	11.0	6.1	6.3	14.3	27.1	9.7	12.4	3.6	7.8
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 209.1;Inhibitory neurons: 127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	18.8	21.6	45.2	19.2	61.0	24.1	16.8	2.1	74.4	20.4	9.6	23.7	15.8	24.2	9.9	14.3	19.5	13.5	21.5	65.3	9.0	21.3	25.2	19.1	20.5	14.6	4.8	21.4	18.7	34.5	25.2	17.9	14.5	19.5	14.9	27.7	16.5	16.9	23.6	15.1	22.9	21.9	0.0	21.0	26.0	25.7	8.6	34.3	18.0	15.9	18.0	22.2	16.9	43.3	24.5	20.2	17.4	26.3	48.7	29.1	24.9	21.6	32.6	31.3	30.4	15.9	10.2	45.6	12.6	43.9	30.7	21.1	33.4	20.9	19.0	38.9	50.9	47.1	27.1	18.3	24.3	47.0	36.1	26.2	12.9	26.7	14.7	20.4	25.8	13.8	130.2	37.6	24.6	33.8	41.6	16.0	13.8	43.4	20.6	41.1	38.1	8.5	17.3	38.3	42.6	31.0	28.4	32.6	22.6	24.3	27.6	21.3	26.2	56.4	29.1	21.1	18.5	28.6	31.3	35.8	37.4	33.2	24.1	2.1	3.7	5.3	3.2	3.8	3.1	3.4	3.6	3.9	2.5	3.4	3.6	5.0	5.1	7.0	3.3	8.5	4.3	2.2	45.2	61.0	2.1	74.4	65.3	9.0	14.6	4.8	14.5	0.0	8.6	43.3	13.0	12.8	30.4	65.6	14.7	10.1	6.5	7.6	9.6	35.8	17.2	14.4	30.2	20.0	10.5	7.3	47.9	17.8	21.5	19.7	1.9	9.7	36.5	10.3	17.9	15.5	19.2	12.4	209.1	6.3	19.6	15.6	38.7	15.8	12.0	13.8	11.4	19.7	20.1	37.0	127.4	16.7	10.2	21.0	12.6	25.3	19.9	20.2	10.6	39.4	10.9	23.1	16.5	50.3	88.4	8.9	9.7	24.0	15.5	10.1	23.8	10.3	9.6	25.4	26.3	14.5	19.3	35.3	29.6	14.1	9.8	20.0	15.3	26.1	14.3	8.9
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11149569	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 58.3"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BJ hTERT+ SV40 Large T+: 16.9;BJ hTERT+ SV40 Large T+ RasG12V: 23.1;HeLa: 38.1;U-266/70: 23.0;U-698: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015986, HPA031974, HPA040616"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	1.2	0.5	7.3	1.3	20.2	0.4	1.7	14.7	14.4	1.0	0.1	3.9	0.3	0.6	1.6	5.1	1.1	5.3	0.3	7.9	8.7	1.1	4.1	6.6	0.9	18.2	14.4	0.7	1.8	0.5	0.9	0.0	18.2	3.0	1.4	0.1	0.3	2.9	0.1	1.1	1.1	2.1	8.5	2.7	1.6	1.2	16.8	0.8	1.5	0.2	0.6	5.3	0.7	58.3	0.0	1.8	15.1	0.0	0.0	0.0	0.0	0.8	4.4	16.9	23.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	10.6	0.0	0.5	0.0	38.1	8.8	5.2	0.0	0.1	0.1	0.3	4.3	1.2	0.1	5.2	0.6	0.0	0.3	2.7	0.0	0.3	0.0	4.5	6.7	0.0	0.0	0.0	7.0	0.0	5.3	12.7	0.0	0.1	0.0	0.8	6.7	0.0	4.5	0.0	0.0	5.8	0.3	0.9	23.0	0.2	16.2	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	20.2	14.7	14.4	7.9	8.7	18.2	14.4	18.2	8.5	16.8	58.3	3.3	0.0	5.3	2.0	0.0	0.8	0.3	0.0	0.0	0.0	2.3	0.8	1.6	10.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	31.7	0.2	0.2	9.9	0.0	0.0	2.5	0.2	0.0	11.2	2.6	0.0	5.1	0.1	17.2	5.9	1.0	0.0	37.0	0.0	0.0	3.2	0.8	11.9	0.0	0.6	0.0	9.4	0.0	0.0	0.0	2.0	399.6	0.1	0.0	0.0	0.4	0.1	0.0	0.1	7.3	0.0	6.6	0.9	4.5	0.3	1.4	0.2	0.9	0.4	0.6	32.9	0.0	0.1
PIGW	"FLJ37433, Gwt1"	ENSG00000277161	"Phosphatidylinositol glycan anchor biosynthesis class W"	Q7Z7B1	17	36534987-36539310	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023499			Approved	"Plasma membrane"		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"		"HPA023499: "	"unprognostic (4.96e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.14e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.88e-1)"	4.5	3.8	1.0	3.9	1.1	2.7	3.9	1.4	1.5	3.2	1.8	4.3	2.6	4.2	2.0	7.4	3.4	1.9	3.7	1.0	1.5	6.5	6.5	3.7	3.8	1.5	1.2	2.5	4.7	2.6	4.0	2.0	1.5	3.3	3.6	1.8	5.0	1.3	8.2	5.8	4.3	2.6	1.1	4.4	4.5	2.8	1.4	2.1	4.1	3.4	3.5	3.6	4.3	1.3	10.8	15.2	9.0	9.2	4.9	4.2	15.0	11.6	6.2	12.2	9.3	11.7	12.2	19.9	3.8	7.9	14.9	15.7	16.5	8.0	16.1	11.3	23.3	14.7	7.3	11.0	3.8	32.2	17.2	5.2	9.6	12.5	5.4	2.5	7.9	6.3	26.9	9.5	8.9	10.1	16.4	11.2	16.5	7.5	13.0	15.3	24.0	18.8	7.6	11.6	20.7	16.7	21.0	8.6	9.3	8.4	27.8	4.7	10.4	21.7	29.1	20.8	26.1	8.8	32.8	22.0	5.2	18.0	19.6	0.8	1.7	0.3	2.0	2.7	2.8	1.5	2.6	2.1	3.5	2.9	3.2	3.1	0.4	2.6	3.5	2.1	1.6	2.2	1.0	1.1	1.4	1.5	1.0	1.5	1.5	1.2	1.5	1.1	1.4	1.3	3.6	3.2	3.1	1.6	4.6	3.4	9.5	4.6	12.5	2.2	4.3	2.9	1.6	10.0	4.2	0.0	0.0	6.1	5.4	2.9	7.9	6.8	0.2	2.4	3.6	4.7	1.2	12.6	2.0	6.4	6.7	3.8	5.1	2.7	0.0	2.3	1.1	6.0	4.5	3.3	2.6	4.0	0.0	3.3	2.2	0.6	2.8	3.5	0.0	0.0	3.1	4.2	1.0	1.5	2.5	7.1	3.6	2.2	4.9	10.2	1.0	4.9	2.8	3.1	0.0	3.7	3.6	3.4	7.4	9.4	6.8	4.1	3.1	3.5	5.6	5.3
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 87.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 87.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029409, HPA073301"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029409: AB_10610280, HPA073301: "	"unprognostic (8.83e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	10.5	10.3	14.4	10.4	15.6	9.0	9.9	14.7	16.7	7.5	19.5	10.8	9.1	8.3	12.4	10.3	7.9	8.3	9.6	15.2	16.7	12.2	8.2	7.2	7.1	15.1	15.8	6.8	9.0	19.6	12.7	8.3	14.8	12.8	10.1	17.4	9.9	10.5	17.1	10.4	9.1	11.2	16.0	6.8	7.6	6.0	16.2	11.6	9.2	14.1	10.9	8.7	7.6	16.7	39.4	18.7	21.4	18.1	22.7	15.3	12.6	18.1	20.7	19.3	20.5	13.7	25.6	20.3	63.6	15.4	25.1	22.2	19.5	16.6	23.1	18.6	19.6	21.0	12.8	12.6	19.2	20.6	34.6	15.1	25.7	17.1	15.7	16.3	12.7	36.5	11.7	38.6	21.0	30.1	59.2	32.1	12.8	30.7	18.3	31.1	27.6	29.5	24.6	11.5	24.4	29.2	31.8	23.9	29.7	16.9	71.8	20.3	8.2	18.1	9.2	25.6	29.5	57.0	70.4	41.1	20.7	26.9	21.5	39.6	7.5	87.5	3.3	10.8	3.0	4.6	3.1	4.6	7.7	5.5	3.7	3.2	18.8	8.7	11.6	3.3	4.4	4.1	14.4	15.6	14.7	16.7	15.2	16.7	15.1	15.8	14.8	16.0	16.2	16.7	14.2	19.2	16.3	13.7	16.4	17.1	30.1	5.5	31.9	34.9	28.3	19.2	12.6	21.5	8.4	29.5	47.9	21.4	31.6	20.8	35.2	7.9	30.5	17.2	23.5	16.9	15.7	15.8	17.7	5.6	20.9	22.0	9.2	17.9	12.0	19.3	17.5	16.6	20.1	33.7	23.7	17.0	8.2	21.4	25.4	22.7	28.0	18.1	21.4	15.9	25.0	50.0	32.0	12.1	14.5	5.2	12.5	35.0	20.1	33.8	27.1	32.5	10.2	39.1	26.3	23.6	28.1	27.1	36.0	29.3	15.9	11.6	21.2	22.7	25.7	23.0
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593315-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 83.2;lymphoid tissue: 62.3;salivary gland: 73.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;Hepatocytes: 70.7;Kupffer cells: 127.0;Macrophages: 89.8;Microglial cells: 60.9;monocytes: 57.4;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 44.7;memory B-cell: 48.3;naive B-cell: 44.5;non-classical monocyte: 123.0"	"Group enriched"	"Detected in all"	6	"B-cells: 48.3;monocytes: 123.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;NB-4: 62.1;REH: 183.5;THP-1: 92.9;U-698: 114.7;U-937: 95.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	8.1	4.5	2.1	51.1	2.0	47.5	4.7	2.4	3.2	2.8	2.7	7.3	6.8	2.1	1.7	2.4	2.2	24.8	2.5	1.9	2.9	11.8	83.2	16.7	61.2	6.5	4.6	6.0	22.8	2.0	1.4	14.1	5.3	2.8	8.6	3.1	73.6	2.4	0.7	1.0	7.7	8.3	4.7	62.3	6.9	3.0	5.7	8.7	4.1	3.1	57.8	15.2	0.6	7.6	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.2	2.8	1.5	85.3	8.5	0.0	1.3	0.1	17.7	0.0	0.6	48.0	3.0	13.0	0.0	1.7	0.1	36.1	6.7	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.9	0.1	0.1	0.4	1.1	62.1	0.8	24.3	1.0	183.5	4.3	20.0	0.2	0.1	3.6	2.0	0.2	0.2	1.1	0.3	0.2	92.9	0.0	0.0	2.8	0.1	0.7	0.7	0.2	114.7	0.0	95.2	0.0	6.1	16.0	10.5	13.3	44.7	4.7	48.3	0.3	4.1	12.9	44.5	0.1	3.3	13.5	14.0	123.0	11.3	0.5	14.4	2.1	2.0	2.4	3.2	1.9	2.9	6.5	4.6	5.3	4.7	5.7	7.6	0.5	3.2	3.9	1.3	53.7	1.5	0.1	0.1	0.6	0.6	2.2	2.3	2.6	32.9	2.2	1.8	2.1	0.5	41.5	8.1	1.9	40.0	4.3	0.3	0.1	1.8	1.8	10.3	0.8	29.1	0.9	0.7	0.0	0.2	14.0	0.2	5.7	70.7	47.7	0.0	0.8	2.8	4.1	127.0	32.5	1.0	1.2	89.8	5.4	60.9	57.4	0.2	58.7	1.0	0.3	16.4	21.2	2.2	9.4	0.4	1.6	18.3	1.1	3.4	0.0	0.6	0.8	0.8	0.2	0.3	1.1	2.3	18.3	0.4	3.8	0.3
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802722-8867677	"Metabolic proteins, Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 21.9;eosinophil: 75.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 75.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 148.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	0.4	0.0	1.1	1.8	1.6	2.2	0.4	0.9	1.1	0.6	0.8	0.8	1.5	0.9	0.1	0.5	0.2	1.2	1.3	1.0	1.1	0.0	0.3	1.2	2.1	1.4	1.5	0.0	0.4	0.1	0.0	0.6	1.6	0.3	0.6	0.0	0.2	0.3	0.5	0.8	2.2	0.7	1.1	2.9	1.0	0.4	1.9	2.1	0.0	0.3	1.5	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	19.4	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	2.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	21.9	7.2	75.8	0.5	9.6	0.4	2.7	0.1	0.3	10.8	0.3	0.1	0.2	1.1	1.5	7.8	0.0	0.0	3.3	1.1	1.6	0.9	1.1	1.0	1.1	1.4	1.5	1.6	1.1	1.9	1.6	0.2	0.0	1.3	0.3	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	11.5	0.0	0.1	2.6	0.0	0.4	0.6	0.0	0.1	0.2	0.5	0.0	47.4	0.0	0.4	0.0	7.6	0.0	0.5	0.0	0.0	4.4	1.6	20.6	0.0	3.9	1.8	7.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	1.6	0.1	0.0	0.0
PIP4K2C	"FLJ22055, PIP5K2C"	ENSG00000166908	"Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma"	Q8TBX8	12	57591174-57603418	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028658	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028658: AB_10601245"	"unprognostic (7.84e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (3.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.06e-6)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.42e-1)"	13.6	17.2	18.4	11.6	24.0	26.5	20.0	13.4	32.8	18.4	20.7	24.1	16.0	18.5	81.6	28.2	26.6	16.1	15.0	22.3	11.5	36.0	14.8	19.7	13.5	14.9	13.0	16.0	21.0	39.1	18.7	12.1	16.0	21.6	26.3	29.1	25.6	18.4	14.0	27.1	19.2	15.9	11.9	14.6	39.8	28.1	15.7	11.4	22.4	10.5	18.8	18.2	20.5	20.9	52.0	36.4	14.8	17.6	0.0	0.1	47.0	21.4	40.6	38.7	35.1	46.7	73.4	11.3	44.1	25.6	47.4	46.1	24.2	42.2	30.3	15.9	26.1	20.0	17.5	33.7	32.8	19.3	35.0	12.9	70.0	14.7	26.9	46.4	19.6	12.1	26.8	33.3	20.0	52.6	16.5	16.7	28.1	32.1	31.2	0.5	130.9	17.2	39.6	91.1	23.7	30.0	45.8	30.4	29.7	49.3	83.2	17.8	4.2	18.5	26.1	27.7	22.8	25.1	31.5	25.6	36.0	16.0	32.1	58.8	8.2	25.8	24.3	10.5	16.1	8.7	14.8	18.4	8.6	11.0	13.8	16.7	16.3	16.2	14.6	3.8	19.9	11.0	18.4	24.0	13.4	32.8	22.3	11.5	14.9	13.0	16.0	11.9	15.7	20.9	4.1	9.6	8.6	4.9	6.9	12.4	6.2	11.7	10.8	14.3	13.2	8.0	121.7	12.8	11.9	35.0	18.8	11.3	7.4	33.7	21.5	17.7	25.7	14.2	4.2	8.8	22.2	5.2	28.0	19.7	15.2	5.4	26.0	20.3	3.8	4.0	9.3	12.6	8.9	8.4	11.8	18.4	10.2	6.0	2.2	47.9	6.8	5.7	12.4	2.8	5.9	7.5	5.2	5.0	11.5	40.5	12.8	5.3	9.4	10.1	14.2	13.3	15.3	8.1	19.7	3.8	13.1	12.0	9.0	14.3	12.8	17.4	11.9	5.5	10.4	9.2
PITPNM3	"ACKR6, CORD5, NIR1, RDGBA3"	ENSG00000091622	"PITPNM family member 3"	Q9BZ71	17	6451263-6556555	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 20.5;Hepatic stellate cells: 27.8;Inhibitory neurons: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	23	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 17.7;HeLa: 14.8;hTCEpi: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022432, HPA059005"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA022432: AB_2670936, HPA059005: AB_2683876"	"unprognostic (2.97e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.63e-1)"	1.3	3.1	23.6	1.1	20.7	0.1	1.4	7.3	23.7	3.1	0.0	7.5	1.3	1.9	3.4	17.8	4.3	1.8	1.3	19.1	1.6	2.8	1.4	3.1	0.2	0.0	0.8	26.6	1.7	0.9	2.0	0.1	0.0	4.5	3.7	7.9	4.7	8.9	0.9	17.0	2.7	4.0	0.5	60.8	6.8	4.2	4.6	0.4	2.7	0.9	1.1	1.7	6.4	13.0	9.0	0.9	0.7	0.3	0.1	0.2	0.7	0.6	0.2	0.8	0.6	0.6	6.3	0.2	3.3	0.2	2.4	17.7	0.3	3.7	0.3	0.3	0.6	0.1	14.8	0.2	0.9	0.4	0.6	0.2	50.4	1.0	2.8	4.1	0.4	0.7	0.1	0.0	0.6	0.8	0.1	0.2	1.0	4.5	2.5	0.3	1.9	0.1	1.2	0.1	0.4	0.5	8.1	3.8	0.2	0.3	1.3	0.0	0.3	0.4	3.2	0.6	2.1	0.5	0.2	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	23.6	20.7	7.3	23.7	19.1	1.6	0.0	0.8	0.0	0.5	4.6	13.0	1.5	3.2	16.5	3.6	0.2	5.1	2.2	9.6	2.2	13.5	1.3	1.8	2.0	4.3	11.4	1.8	4.2	0.1	0.2	11.1	0.0	2.2	4.1	10.1	1.0	7.8	1.2	0.0	20.5	0.5	0.0	1.6	4.6	10.3	5.7	1.6	27.8	1.6	0.1	5.0	24.2	3.7	4.1	4.1	0.4	1.8	0.6	0.3	0.0	2.8	0.1	0.6	0.0	0.5	1.6	10.0	5.7	0.0	0.2	2.4	0.6	0.3	7.8	11.9	0.0	12.0	1.9	3.4	1.7	11.5	5.8	0.1	0.7	7.1	6.5	5.2
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 42.7;Spermatocytes: 52.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.2;Karpas-707: 2.6;U-266/70: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA041903: AB_2677734, HPA043634: AB_2678591"	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.4	0.9	1.5	0.5	1.7	1.5	0.2	3.2	1.1	0.2	0.3	0.1	0.3	0.3	0.7	0.4	0.3	0.4	1.1	0.8	1.2	0.2	0.1	0.2	0.9	0.7	0.5	0.3	0.8	0.1	0.3	0.2	0.8	0.4	0.2	1.1	0.5	0.0	2.3	0.5	0.2	0.1	0.1	0.7	0.4	8.2	1.1	0.1	0.7	0.8	0.2	0.1	0.2	3.1	0.7	0.5	0.1	0.0	0.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	1.4	1.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.6	2.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.2	1.4	0.7	2.6	0.0	0.2	0.5	1.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.4	0.4	0.6	0.1	0.4	0.3	0.2	0.2	0.2	0.4	0.7	0.2	0.5	2.0	1.6	0.1	1.0	0.2	0.8	5.3	0.9	1.8	1.0	0.6	0.5	1.5	0.8	0.7	0.5	1.9	1.0	0.9	4.1	1.0	0.6	2.0	0.6	0.6	1.5	1.7	3.2	1.1	0.8	1.2	0.7	0.5	0.8	0.1	1.1	3.1	0.6	3.2	2.2	4.6	4.7	2.2	1.8	0.6	7.4	2.4	0.5	0.4	1.7	0.0	0.9	0.0	0.0	0.4	1.6	0.6	0.0	0.1	42.7	1.5	1.3	1.3	0.0	0.8	5.0	0.0	0.2	1.5	0.5	1.8	1.3	0.5	1.4	0.4	0.3	3.3	5.6	0.0	2.0	0.6	1.9	8.2	0.6	1.3	3.6	1.9	0.1	0.9	1.0	3.5	6.1	0.1	0.0	0.4	1.7	1.5	0.1	0.3	0.0	4.1	0.0	3.2	1.1	52.3	3.1	2.6	1.1	0.1	3.1	0.8	0.2	0.8
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	"Protein kinase N1"	Q16512	19	14433053-14471867	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 102.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003982, CAB010278"	Approved		Approved	"Plasma membrane,Cytokinetic bridge"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Cytokinetic bridge"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	"unprognostic (3.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.24e-2)"	59.2	45.1	47.1	40.4	50.3	66.8	49.0	44.6	52.4	46.6	44.2	72.4	14.5	61.0	13.6	16.2	48.7	23.9	89.0	40.9	46.3	43.1	25.0	71.1	49.4	53.6	48.4	38.7	52.5	32.8	44.9	33.3	49.8	43.8	9.3	11.5	41.3	30.6	81.7	20.1	45.2	33.0	49.8	90.4	51.4	50.2	49.2	35.6	39.6	53.8	25.8	60.3	32.8	48.5	152.8	88.9	32.3	67.8	51.3	59.8	53.0	53.5	63.5	55.2	52.5	34.9	84.2	144.4	135.0	92.2	68.9	34.4	52.1	23.8	21.2	117.6	67.7	172.8	55.4	75.2	169.1	68.2	103.9	43.3	17.0	33.5	52.2	62.5	129.8	74.9	78.0	96.7	41.4	62.5	104.1	63.2	59.2	54.7	100.0	138.5	43.9	104.7	27.3	24.2	117.3	166.0	33.2	41.7	88.9	15.5	37.8	117.7	196.6	108.8	46.1	133.2	82.8	126.5	123.6	78.9	71.5	135.7	87.4	27.6	27.9	40.6	30.4	38.5	23.3	15.9	20.5	21.1	26.8	16.9	18.6	21.0	32.6	22.1	52.3	17.0	25.7	29.0	47.1	50.3	44.6	52.4	40.9	46.3	53.6	48.4	49.8	49.8	49.2	48.5	78.1	3.2	2.2	17.3	35.3	3.7	6.4	1.9	1.8	37.2	17.6	14.7	4.0	27.1	3.1	35.0	16.7	2.8	77.9	4.9	1.9	28.2	4.9	27.0	25.4	49.4	40.2	17.7	3.6	30.1	14.5	20.8	30.1	20.7	2.5	80.9	53.2	11.3	59.8	48.8	8.6	10.9	8.2	69.0	17.0	8.4	19.9	56.2	17.8	17.8	48.2	61.2	102.0	7.5	11.9	64.2	10.6	23.0	27.1	12.7	1.1	15.2	12.4	29.2	26.3	21.7	29.2	9.3	42.2	1.3	2.7	3.7	55.5	34.3	4.8	4.9
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 80.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 80.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	19.3	16.5	9.3	17.6	14.2	48.7	24.1	20.7	10.9	16.4	17.0	23.9	30.5	23.6	25.0	24.7	18.1	17.1	14.1	9.5	9.7	16.9	20.5	20.4	18.2	12.3	10.4	31.2	15.5	22.3	10.1	24.7	12.7	20.3	30.0	26.7	16.3	15.4	9.8	20.3	30.8	18.5	10.1	19.0	20.9	10.5	12.6	17.8	26.1	13.4	17.4	21.3	15.4	17.6	61.1	23.8	45.2	27.3	29.8	33.6	29.6	35.3	32.2	38.5	39.8	25.3	42.5	23.9	41.0	33.6	47.3	46.7	44.7	26.6	52.4	8.6	33.0	17.7	49.3	21.4	26.2	17.6	5.1	27.7	27.1	30.2	36.3	30.6	44.7	18.6	29.9	16.8	42.2	12.2	20.5	15.2	22.8	23.1	27.1	19.3	68.8	9.8	34.3	117.9	22.0	14.5	52.7	29.8	45.7	33.9	22.5	15.7	42.2	32.5	29.2	42.1	37.2	9.2	8.6	16.6	13.6	17.1	12.6	15.3	9.9	16.6	5.7	5.9	5.1	8.0	5.1	5.3	5.0	9.3	6.6	5.6	80.5	3.5	8.0	8.6	4.6	2.7	9.3	14.2	20.7	10.9	9.5	9.7	12.3	10.4	12.7	10.1	12.6	17.6	104.7	41.7	57.8	102.5	52.5	48.4	44.3	33.3	75.1	85.4	60.2	67.9	50.8	38.6	47.9	69.9	89.6	42.9	48.1	101.5	11.7	61.2	2.6	63.7	68.7	59.5	44.3	57.7	134.2	60.7	33.1	53.1	85.6	84.6	15.8	107.0	47.5	39.4	24.2	65.6	130.8	64.3	32.6	35.8	27.9	6.6	54.3	44.9	32.0	178.0	57.3	50.5	22.6	117.1	146.4	77.6	98.1	48.2	54.8	64.7	84.0	26.7	49.1	150.5	39.5	62.8	55.5	43.6	34.6	83.0	52.4	37.4	44.8	90.2	65.0	124.2
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 416.7;skin 1: 699.9;vagina: 200.4"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 139.7;Squamous epithelial cells: 234.5;Suprabasal keratinocytes: 409.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 125.5;head and neck cancer: 295.4;lung cancer: 79.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 234.6;HBEC3-KT: 144.2;hTCEpi: 501.4;hTERT-HME1: 132.5;PC-3: 192.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		2500000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	9.7	0.2	0.3	0.2	0.2	0.2	31.7	0.0	1.1	102.9	0.0	0.4	0.2	0.2	3.3	416.7	1.0	0.1	0.6	0.2	0.0	0.4	0.3	5.0	0.2	0.0	1.1	0.2	0.5	0.0	0.6	5.5	0.5	32.3	0.2	32.4	60.5	9.1	6.6	699.9	0.6	0.0	0.0	0.1	0.4	0.2	0.0	23.7	0.5	2.9	48.0	3.2	200.4	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	1.1	0.0	0.2	0.1	0.0	234.6	0.0	144.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	501.4	5.6	132.5	0.0	0.0	0.1	0.0	0.2	0.0	38.4	0.0	0.1	0.0	0.0	192.6	0.0	0.4	0.0	0.0	1.1	0.0	0.0	18.3	4.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.1	0.2	0.0	0.0	1.1	0.5	0.0	0.0	0.0	39.9	0.0	0.0	0.3	0.0	139.7	58.2	57.1	63.7	34.7	7.7	17.9	1.9	0.0	20.0	0.0	2.1	0.1	0.1	0.1	0.0	2.5	0.1	0.2	0.1	4.1	0.0	0.0	0.6	1.1	0.1	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.0	0.1	1.6	4.1	0.0	16.5	0.8	0.0	0.4	16.0	0.0	0.0	5.2	0.0	0.0	0.1	16.1	0.1	0.0	0.0	25.7	0.2	0.1	2.8	37.4	0.0	6.1	2.0	0.0	0.1	234.5	409.0	0.1	1.1	0.0	0.1	47.5
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094562	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 19.1;skin 1: 16.1;vagina: 22.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Glandular and luminal cells: 1.1;Ionocytes: 2.0;Prostatic glandular cells: 3.0;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 2.0;melanoma: 1.8;prostate cancer: 1.3;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RPMI-8226: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074206			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA074206: "	"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.3	5.2	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	19.1	0.0	0.2	0.8	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.4	22.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	15.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.4
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 563.5;Excitatory neurons: 2569.1;Inhibitory neurons: 1774.0;Oligodendrocyte precursor cells: 783.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 74.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 45.5;Hep G2: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		6600	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	9.3	8.9	11.7	5.7	52.3	4.8	7.6	0.0	74.3	8.2	0.0	18.1	7.2	9.3	3.5	5.4	9.6	8.5	11.7	17.4	0.0	13.2	4.3	5.0	1.8	0.0	0.1	3.7	14.7	44.3	4.3	19.6	0.0	13.4	4.1	7.1	29.0	18.8	14.4	2.6	5.7	8.1	0.0	3.6	8.0	3.0	9.8	6.8	3.8	11.0	0.9	15.9	6.7	23.8	0.2	1.2	4.8	0.3	8.7	16.1	6.3	20.2	13.1	5.2	3.1	45.5	5.0	2.2	8.2	3.9	0.3	0.0	3.7	0.0	3.8	0.0	4.4	1.0	3.5	68.7	2.2	1.1	0.7	1.1	0.8	7.1	0.0	6.5	10.6	13.0	7.1	26.0	0.1	6.2	1.0	3.3	15.0	10.6	6.6	14.7	0.0	12.1	4.0	16.8	16.9	7.2	0.1	4.1	0.9	17.1	19.9	6.6	1.9	16.8	7.5	1.3	12.7	19.4	24.5	33.9	8.6	12.6	29.5	0.3	1.3	1.2	1.4	0.3	2.0	0.1	0.4	0.5	0.1	0.2	0.2	0.4	0.8	1.1	0.1	0.3	0.1	0.2	11.7	52.3	0.0	74.3	17.4	0.0	0.0	0.1	0.0	0.0	9.8	23.8	74.8	0.0	3.4	563.5	1.1	1.9	20.8	2.3	8.0	7.6	8.1	23.2	26.9	7.2	2.6	16.5	0.0	2.4	16.8	1.3	33.2	1.2	9.9	42.1	5.1	54.6	0.0	6.5	2569.1	13.4	2.8	25.8	3.6	83.6	1.3	0.2	26.4	2.8	0.8	1.7	1774.0	2.1	0.0	8.2	1.2	4.3	3.4	9.1	7.2	211.7	12.2	18.2	15.5	783.1	34.8	1.8	0.5	3.8	6.1	20.2	0.1	9.4	9.9	4.1	0.0	7.4	13.3	4.7	5.6	2.5	1.7	1.8	15.4	1.1	1.2	18.9
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.4;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 22.6;granulocytes: 26.6;Hofbauer cells: 30.3;Kupffer cells: 46.6;Macrophages: 41.7;Microglial cells: 39.4;monocytes: 20.9;NK-cells: 26.8;T-cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 78.6;HMC-1: 93.4;THP-1: 28.1;U-937: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	5.9	4.0	3.8	29.2	3.9	52.4	2.5	3.8	5.4	3.3	3.4	5.1	6.1	2.7	1.4	3.0	4.5	9.7	3.0	4.0	5.6	1.9	6.3	16.8	28.7	8.4	7.1	1.5	1.3	1.3	2.1	7.0	7.3	2.6	8.0	0.5	5.4	4.0	1.2	1.9	10.4	7.3	6.2	40.7	5.5	1.3	7.7	20.5	2.2	1.7	22.2	7.3	1.8	9.6	0.4	0.0	0.6	0.0	0.0	0.0	10.5	0.0	0.1	0.0	0.0	0.1	19.1	1.5	17.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	78.6	0.0	0.0	0.0	16.9	93.4	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.7	4.3	0.0	0.0	4.7	9.2	0.9	0.0	0.2	13.7	2.0	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.2	5.1	0.0	28.1	10.1	0.0	9.1	0.0	0.0	0.0	0.0	3.7	0.0	53.2	0.0	1.7	2.6	5.3	1.8	2.7	1.2	0.4	0.9	0.9	2.7	0.5	0.9	1.0	4.2	1.2	2.7	1.0	1.9	1.5	3.8	3.9	3.8	5.4	4.0	5.6	8.4	7.1	7.3	6.2	7.7	9.6	0.9	6.4	16.8	0.3	9.6	0.9	0.1	0.1	0.6	0.1	1.9	2.5	3.3	1.5	3.2	1.8	0.0	0.5	22.6	0.2	0.0	0.1	2.2	0.2	0.5	1.7	0.0	8.0	1.8	0.0	0.5	1.9	0.0	0.2	26.6	0.1	1.1	0.4	30.3	0.0	0.8	1.7	0.0	46.6	15.5	0.6	0.3	41.7	3.6	39.4	20.9	0.0	26.8	0.5	0.2	0.4	0.3	0.0	5.7	0.0	0.0	0.9	4.4	0.2	0.0	0.4	0.7	0.5	2.3	0.3	0.6	0.4	20.8	0.3	2.0	0.0
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108959-45133354	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 195.8;Paneth cells: 104.7;Urothelial cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	13.5	34.3	42.2	5.1	49.7	2.0	11.7	50.5	36.0	12.4	27.9	34.2	2.5	13.2	1.5	14.7	10.1	6.4	34.1	33.8	42.5	9.6	1.4	7.7	1.0	69.8	50.5	18.9	2.7	1.3	7.6	5.8	46.4	13.0	15.3	14.4	10.8	5.4	85.7	20.6	6.5	5.1	62.8	2.0	21.0	10.8	59.4	0.9	5.3	56.5	1.5	30.4	11.9	54.0	23.1	56.2	4.1	8.1	5.9	12.8	28.0	12.3	27.3	11.2	10.5	13.7	40.9	0.8	43.5	29.0	9.2	51.9	6.3	53.1	4.4	11.6	21.0	0.9	62.6	18.1	30.3	1.3	3.2	13.7	21.0	10.4	13.7	28.5	7.0	2.5	5.0	1.7	12.1	36.2	3.7	5.4	4.9	109.9	55.0	8.1	9.2	1.5	35.8	45.1	1.1	7.2	13.3	22.1	12.5	8.5	47.0	2.5	14.3	6.9	37.9	9.3	14.8	2.1	2.6	1.8	11.4	1.5	5.7	0.7	0.3	0.5	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.2	0.0	0.1	0.1	0.1	42.2	49.7	50.5	36.0	33.8	42.5	69.8	50.5	46.4	62.8	59.4	54.0	8.7	12.8	1.3	22.9	1.0	7.6	16.3	12.2	21.1	29.8	6.8	9.3	26.9	14.3	4.9	7.3	25.0	3.9	0.9	195.8	1.9	6.7	15.8	3.3	12.7	9.0	4.9	0.0	1.3	3.5	13.1	10.6	29.6	9.6	1.3	6.5	10.4	0.7	1.6	6.7	3.7	15.1	4.1	1.4	1.9	5.5	19.9	1.6	3.6	1.0	1.2	8.9	0.0	0.0	0.1	30.0	104.7	33.1	1.1	28.7	4.2	2.0	2.7	40.0	6.6	16.8	4.9	2.3	7.6	3.8	5.7	7.3	1.1	7.0	46.2	88.6
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607855-218637184	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 166.0;skeletal muscle: 114.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 139.9;Cone photoreceptor cells: 246.0;Rod photoreceptor cells: 176.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009914, HPA038139, HPA038140"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Endoplasmic reticulum, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.5	2.7	4.5	0.2	4.4	0.0	1.3	4.5	7.2	1.4	3.5	15.6	0.6	0.6	0.3	4.8	0.6	0.4	1.1	4.5	4.6	10.7	0.6	0.6	0.1	5.6	5.1	0.7	0.5	1.7	9.6	0.2	4.9	4.4	1.7	166.0	2.3	0.3	114.0	1.0	3.3	1.3	4.2	0.3	6.9	9.8	5.0	0.1	1.6	30.4	0.1	20.5	2.0	4.7	0.0	0.9	1.2	0.0	0.3	1.2	1.1	0.0	2.5	0.4	1.3	0.0	0.1	0.0	1.5	0.4	0.4	0.1	0.0	1.5	0.3	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	2.8	0.1	1.9	0.5	4.2	2.8	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.1	4.3	0.0	1.8	20.2	0.3	0.1	0.1	0.2	2.1	0.0	4.5	0.1	0.0	0.2	0.2	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	4.4	4.5	7.2	4.5	4.6	5.6	5.1	4.9	4.2	5.0	4.7	0.3	0.0	1.1	7.8	0.1	0.5	0.3	0.9	3.4	139.9	1.5	0.9	1.0	0.0	0.1	0.0	246.0	0.1	0.1	0.0	0.0	0.1	21.4	0.6	0.4	1.5	0.0	0.0	6.7	0.0	13.5	0.7	0.0	1.0	0.0	0.1	0.7	0.0	0.6	8.4	4.9	0.1	0.0	0.0	0.4	33.8	0.3	0.2	0.0	0.0	0.1	9.1	0.0	2.0	2.3	0.7	0.0	0.0	0.0	0.1	0.0	2.2	0.2	176.9	0.0	6.1	1.8	3.6	1.2	0.6	0.1	0.8	0.1	0.0	0.1	0.2
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 53.4;Smooth muscle cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 63.4;BJ hTERT+ SV40 Large T+ RasG12V: 49.5;SK-MEL-30: 77.0"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"spinal cord: 45.0"	"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: AB_2678249, HPA048473: AB_2680409"	"prognostic favorable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	34.0	24.6	8.8	12.1	8.8	0.7	31.7	8.0	9.5	28.7	10.9	43.0	5.6	34.6	5.0	14.3	30.5	11.1	41.4	8.7	10.6	32.4	32.8	25.7	5.8	16.9	14.7	47.5	13.2	9.5	29.9	5.6	10.4	28.3	3.9	2.5	15.1	8.4	19.3	17.2	16.0	10.7	10.8	16.2	21.1	11.0	12.4	5.5	31.0	13.1	3.3	34.4	21.7	10.3	9.0	0.5	9.9	63.4	14.2	41.7	8.0	7.0	24.7	26.8	49.5	5.9	2.5	0.4	11.8	9.8	10.4	2.7	3.5	3.6	4.2	0.0	3.4	2.3	1.7	6.6	11.0	0.0	14.2	21.5	2.2	15.6	1.0	11.1	8.0	11.2	9.5	5.3	7.4	5.4	3.2	0.5	1.5	6.0	0.8	0.3	31.5	0.6	8.3	0.1	0.0	11.0	3.0	2.6	77.0	2.5	3.9	3.0	1.3	8.5	6.8	11.2	1.8	28.3	25.4	5.3	10.2	0.7	23.0	0.0	0.3	0.9	1.8	0.3	1.3	1.7	1.7	1.1	0.1	3.9	2.8	2.6	0.1	0.8	0.3	1.2	0.6	0.9	8.8	8.8	8.0	9.5	8.7	10.6	16.9	14.7	10.4	10.8	12.4	10.3	6.4	0.0	18.7	2.3	1.4	9.6	31.3	17.6	12.0	0.7	11.4	18.3	37.1	17.2	27.2	7.3	0.0	3.3	2.9	3.2	1.9	23.3	0.8	11.6	34.1	7.0	1.2	3.2	0.4	5.1	6.8	41.7	7.7	11.6	0.0	18.8	6.4	13.3	2.9	0.0	0.5	2.5	4.1	0.8	9.2	2.0	41.3	1.9	12.4	1.9	1.3	9.9	2.1	0.5	0.2	6.9	0.5	53.4	0.7	29.8	0.7	14.6	20.5	1.0	6.6	33.0	48.4	4.0	3.7	5.7	9.8	2.9	2.4	16.0	3.3	21.4
PLEKHH2	"KIAA2028, PLEKHH1L"	ENSG00000152527	"Pleckstrin homology, MyTH4 and FERM domain containing H2"	Q8IVE3	2	43637260-43767987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 66.2;Endometrial stromal cells: 150.5;Oligodendrocyte precursor cells: 191.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 7.4;RPTEC TERT1: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077225			Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA077225: AB_2686828"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.82e-2)"	13.1	3.0	2.8	1.7	2.7	0.1	8.9	3.6	2.8	20.9	8.8	11.8	3.7	19.8	4.4	4.6	15.9	7.3	4.8	2.3	2.8	15.9	1.7	27.6	2.9	3.0	3.4	23.0	2.9	5.4	2.0	3.8	3.1	5.1	4.3	1.7	4.8	5.0	1.8	8.4	6.5	9.8	2.7	5.4	5.0	3.9	2.7	0.4	5.5	2.5	1.8	6.2	8.5	2.5	0.5	4.0	1.6	0.0	3.1	7.4	0.3	0.5	2.0	0.8	2.0	0.0	1.3	1.0	0.2	0.6	3.3	2.6	0.5	0.6	1.5	0.0	1.1	0.1	0.6	0.1	0.5	0.0	0.5	2.2	0.6	1.9	0.1	1.1	1.7	1.6	3.9	0.1	0.7	1.1	0.8	0.1	0.9	0.6	3.9	0.0	4.6	0.0	6.3	0.2	1.2	0.6	0.4	0.0	3.9	1.1	0.5	0.1	0.2	4.5	1.3	0.2	1.4	0.9	0.2	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	2.7	3.6	2.8	2.3	2.8	3.0	3.4	3.1	2.7	2.7	2.5	4.6	38.5	8.7	19.2	0.9	8.7	17.5	5.8	6.8	1.0	5.3	8.3	2.9	11.5	12.9	66.2	6.2	0.3	1.3	0.1	5.9	6.2	1.6	5.9	150.5	3.8	0.0	0.0	15.6	1.4	0.3	57.4	3.1	8.8	1.3	42.6	2.2	0.0	0.8	0.0	4.3	0.3	2.0	0.3	8.6	3.3	35.8	1.2	12.4	15.9	0.2	5.8	0.0	191.0	52.7	7.2	0.0	50.4	0.4	9.2	0.3	4.1	7.3	4.1	46.0	40.7	24.6	10.8	5.9	2.6	8.4	0.5	3.6	13.1	0.6	8.7
PLEKHO2	"DKFZp761K2312, PLEKHQ1, PP1628, pp9099"	ENSG00000241839	"Pleckstrin homology domain containing O2"	Q8TD55	15	64841883-64868002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 103.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 63.2;Kupffer cells: 52.3;Macrophages: 46.5;Muller glia cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 27.1;granulocytes: 77.3;monocytes: 73.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 68.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040055	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		200000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA040055: AB_10793954"	"unprognostic (4.32e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.85e-3)"	37.9	31.8	23.1	30.5	26.9	52.0	22.7	25.0	25.0	17.0	16.7	23.6	10.0	19.8	5.7	13.9	22.4	26.0	16.5	21.7	24.4	14.2	11.8	42.2	34.3	31.8	26.2	14.9	8.2	7.4	10.3	25.4	26.6	17.4	7.8	14.4	9.9	13.9	5.8	10.6	17.8	22.9	27.6	103.2	16.3	8.3	28.0	16.0	29.9	8.2	21.1	25.8	16.7	25.5	6.5	4.2	7.9	7.8	68.0	38.8	18.4	18.5	27.4	19.2	19.6	5.1	4.0	17.1	9.5	37.7	19.5	2.2	9.0	7.4	11.2	26.6	2.7	17.2	1.9	6.0	52.2	19.4	24.7	28.3	6.5	24.0	7.8	16.6	27.0	3.5	5.2	59.5	25.9	1.9	4.1	20.9	15.0	3.2	3.7	14.9	19.0	12.2	3.1	4.4	0.6	6.7	7.7	2.6	25.4	12.9	2.7	26.1	35.3	14.8	13.4	14.1	7.8	22.0	37.1	5.8	16.0	24.8	8.8	22.2	43.2	25.6	13.2	52.3	11.9	9.8	7.4	12.2	27.1	6.8	3.1	6.5	77.3	7.0	73.0	3.1	10.7	36.0	23.1	26.9	25.0	25.0	21.7	24.4	31.8	26.2	26.6	27.6	28.0	25.5	24.9	0.0	5.6	17.3	9.1	5.6	2.3	2.3	0.6	0.6	6.4	8.3	3.6	2.8	2.4	9.2	0.0	4.2	15.9	0.5	3.9	2.4	5.0	1.4	5.9	26.1	0.0	2.1	0.2	1.5	5.9	8.6	0.5	2.3	18.4	2.5	34.2	2.1	63.2	0.0	0.2	0.3	4.1	52.3	24.3	2.9	18.3	46.5	14.2	8.4	18.9	56.8	16.5	2.5	2.7	2.0	0.0	25.6	2.7	3.5	0.0	2.2	2.1	3.8	13.1	10.2	5.9	0.9	2.3	1.9	4.4	6.0	10.5	4.6	0.4	3.4
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;retina: 1.6;testis: 2.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 8.5;Horizontal cells: 3.3;Spermatogonia: 6.9"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 11.9;SH-SY5Y: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: AB_2732631"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavorable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.0	0.4	5.2	0.0	5.8	0.0	0.0	0.1	6.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.5	0.0	0.0	0.0	0.0	1.3	3.9	0.0	0.4	0.0	0.2	0.0	2.8	0.0	0.1	1.6	0.0	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.0	7.1	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.9	0.0	0.0	0.0	0.5	0.1	0.4	21.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.8	0.1	6.6	6.1	4.5	1.3	3.9	2.8	2.0	7.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.3;Alveolar cells type 1: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 3.7;plasmacytoid DC: 12.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 12.2;NK-cells: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA020433: AB_2670440, HPA076083: AB_2686773"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.72e-4)"	"prognostic unfavorable (7.04e-4)"	120.8	32.4	33.2	36.3	40.6	1.4	71.4	44.3	43.6	83.7	22.1	46.4	21.8	120.5	76.2	117.8	68.3	83.1	57.9	30.7	34.9	113.2	202.0	139.8	24.2	43.5	40.1	101.5	31.4	12.7	11.7	78.4	42.2	43.6	31.8	11.9	46.8	103.2	31.4	119.5	25.0	119.4	38.4	99.8	37.7	22.3	39.5	27.2	175.0	48.8	41.9	75.4	88.5	47.9	206.2	207.1	176.8	51.5	174.3	161.7	269.3	208.2	233.1	194.5	233.9	225.0	167.2	0.8	590.0	171.9	140.6	256.7	190.5	339.1	314.2	2.9	235.8	19.4	234.6	95.0	157.5	0.1	9.6	103.1	159.5	302.7	211.1	315.3	429.5	16.8	0.5	0.3	188.9	59.7	0.4	2.3	234.6	88.0	243.2	0.4	117.8	4.9	233.1	109.1	0.6	36.9	436.8	107.9	89.7	253.7	60.2	3.0	474.3	314.5	53.9	324.6	422.8	7.8	30.5	4.2	137.6	0.8	133.4	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.1	0.0	0.1	3.7	0.0	12.2	1.4	0.2	33.2	40.6	44.3	43.6	30.7	34.9	43.5	40.1	42.2	38.4	39.5	47.9	209.3	211.5	88.6	26.8	2.0	124.9	121.4	79.6	48.9	0.2	5.6	25.4	17.9	24.3	79.4	99.3	0.0	4.0	1.6	3.5	13.7	59.0	8.4	33.0	39.4	130.5	13.2	4.4	12.3	53.8	105.3	74.3	31.1	64.1	0.0	60.5	64.2	92.1	3.9	0.0	47.6	6.9	38.7	5.0	21.7	8.0	51.9	3.0	56.9	40.3	0.6	26.4	0.0	1.5	97.9	68.6	6.5	82.8	1.6	80.7	2.2	22.0	31.2	1.5	52.6	19.8	132.3	1.2	17.7	65.5	134.1	4.5	3.6	131.1	11.1	100.6
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351450-17377342	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 436.2"	"Group enriched"	"Detected in many"	4	"Adipocytes: 439.2;Endothelial cells: 344.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 35.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 35.2"	"Cell line enriched"	"Detected in some"	27	"EFO-21: 549.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		53000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	283.0	51.1	2.7	54.6	3.1	1.7	210.5	2.9	4.2	102.7	18.2	95.7	86.7	90.0	5.1	48.9	83.3	139.2	92.5	3.3	3.1	153.0	6.9	31.0	50.5	3.7	3.5	16.7	96.1	98.6	64.3	48.8	3.6	68.4	22.3	0.0	77.9	38.0	32.7	58.9	103.3	50.5	3.6	166.7	116.6	4.4	3.5	18.9	436.2	12.9	16.2	104.4	80.8	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	549.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	9.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.1	20.0	0.0	2.3	0.1	0.3	0.5	2.2	2.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	35.2	0.0	0.6	2.7	3.1	2.9	4.2	3.3	3.1	3.7	3.5	3.6	3.6	3.5	4.1	439.2	6.4	0.0	0.3	0.7	22.9	1.0	0.0	8.0	0.0	2.7	3.3	3.7	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	3.6	0.4	0.3	344.9	0.0	0.4	0.4	2.5	0.1	48.9	0.0	0.3	0.0	0.4	79.6	0.2	1.8	0.0	0.3	0.0	0.0	3.5	28.8	0.8	0.0	5.5	23.2	6.5	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	7.6	1.5	0.0	0.0	0.0	0.1	0.0	1.4	6.1	0.5	0.7	2.9	16.8	0.1	1.4	0.7	0.0	2.3
PLXNA3	"6.3, Plxn3, PLXN4, SEX, XAP-6"	ENSG00000130827	"Plexin A3"	P51805	X	154458281-154477779	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058989			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		94000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA058989: AB_2683872"	"unprognostic (2.79e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	6.5	7.0	5.7	3.5	6.4	1.7	6.0	7.5	7.2	10.7	5.3	7.5	3.6	8.1	4.3	5.3	8.7	3.9	7.1	5.5	8.6	5.8	2.8	8.4	3.8	6.4	7.3	17.0	7.6	2.0	24.8	3.6	7.2	10.5	2.2	1.5	12.0	3.4	1.7	10.1	7.8	2.6	4.6	8.0	5.5	3.7	9.0	2.2	10.2	1.1	2.6	7.4	9.7	8.6	11.2	2.2	6.3	16.1	6.5	8.3	8.4	15.6	3.3	3.6	4.9	8.2	4.6	2.0	8.2	16.9	8.4	9.6	6.4	7.6	1.3	0.9	4.8	2.0	29.0	4.5	5.2	1.0	8.8	11.3	5.5	5.4	0.4	12.4	4.1	3.2	5.2	1.6	5.7	13.8	1.9	8.4	2.0	3.4	4.9	7.2	0.5	0.7	4.8	7.2	13.2	6.8	5.7	10.3	2.6	4.4	6.2	2.4	10.4	7.8	7.0	0.8	6.7	1.2	0.2	2.9	14.5	1.5	2.1	0.7	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.0	0.1	0.0	5.7	6.4	7.5	7.2	5.5	8.6	6.4	7.3	7.2	4.6	9.0	8.6	5.2	12.8	7.7	13.4	9.8	8.7	9.0	7.3	9.6	18.7	13.9	10.3	6.5	2.8	6.8	11.0	12.5	3.0	10.3	15.9	0.0	11.5	0.1	14.4	23.2	3.9	7.2	0.0	6.5	5.8	7.2	11.0	17.9	30.4	8.8	21.3	2.9	1.6	8.5	5.0	5.4	15.1	0.0	3.5	9.2	0.8	11.5	10.5	14.2	6.5	4.7	6.5	4.1	6.0	4.1	13.6	11.4	8.6	8.5	10.3	9.4	1.5	10.9	7.8	13.1	26.5	9.4	0.9	2.3	8.1	7.4	9.3	13.2	2.5	9.6	8.2
PLXNA4	"DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B"	ENSG00000221866	"Plexin A4"	Q9HCM2	7	132123332-132648688	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 13.8;brain: 29.1"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 235.3;Inhibitory neurons: 261.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.3"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 29.1;hippocampal formation: 26.0"	"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 25.2;HMC-1: 17.1;hTERT-RPE1: 22.1;RH-30: 18.5;TIME: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029919, HPA052141, HPA075592"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (5.76e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.42e-3)"	13.8	2.4	4.2	1.6	5.6	0.3	7.6	0.1	29.1	8.4	0.0	1.5	0.4	1.5	0.2	3.8	2.0	1.9	3.9	26.0	1.3	0.7	0.3	1.2	1.0	2.3	0.1	3.6	0.4	0.1	1.0	3.5	1.8	0.5	0.7	4.8	0.4	0.9	0.7	2.2	0.8	2.6	0.9	1.5	1.6	1.1	1.6	0.2	1.5	3.1	0.3	1.0	0.7	4.4	0.0	0.1	0.2	0.0	25.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	17.1	0.2	0.0	0.1	0.0	22.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	18.5	2.0	0.0	0.0	0.4	9.6	0.0	0.0	0.0	0.2	0.0	0.0	57.6	5.7	0.2	1.3	0.5	0.0	0.0	0.0	5.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.0	0.0	4.2	5.6	0.1	29.1	26.0	1.3	2.3	0.1	1.8	0.9	1.6	4.4	2.5	0.0	0.0	5.2	0.6	0.6	0.2	0.0	0.0	22.4	2.2	0.1	10.9	0.0	0.0	12.9	16.7	0.1	17.4	0.0	0.0	0.0	14.0	2.1	3.0	2.7	1.2	0.0	235.3	0.0	0.1	7.4	1.1	5.0	1.3	1.6	5.0	0.2	0.1	0.0	261.3	0.1	0.0	0.0	1.1	9.8	14.0	0.7	7.2	10.3	0.0	11.3	2.1	51.8	3.7	0.8	0.0	7.2	0.7	0.1	0.0	0.5	0.0	1.5	0.0	0.7	1.1	0.2	0.3	0.1	1.3	0.0	1.7	0.4	0.1	0.4
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669733-153689010	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.1;intestine: 81.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 40.9;Excitatory neurons: 29.0;Extravillous trophoblasts: 63.9;Granulosa cells: 46.9;Syncytiotrophoblasts: 49.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"AN3-CA: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.2	43.7	1.9	48.8	0.0	0.6	6.5	53.3	1.3	4.8	81.7	3.4	6.5	1.7	14.0	4.1	2.6	6.5	49.8	40.8	1.9	0.2	0.6	0.0	19.6	22.8	0.9	0.3	0.5	1.8	2.0	21.1	17.2	3.8	7.9	0.4	37.6	2.0	1.8	13.4	15.7	15.0	0.2	15.9	8.8	65.1	1.4	0.3	0.3	0.1	27.4	2.2	28.5	0.3	0.1	0.4	33.9	0.0	0.0	3.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.2	0.4	0.5	0.0	0.0	0.0	3.9	0.0	0.0	0.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.3	0.4	0.3	0.2	0.7	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.2	3.7	0.0	0.1	2.7	0.9	0.3	0.4	0.0	0.2	1.2	0.0	0.2	0.2	0.0	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	48.8	6.5	53.3	49.8	40.8	19.6	22.8	21.1	15.0	65.1	28.5	0.0	0.0	0.0	18.9	0.0	0.6	0.4	40.9	0.0	21.6	0.3	0.9	3.0	0.0	18.0	0.0	22.9	13.5	0.1	1.7	0.0	0.4	0.3	0.3	4.4	0.3	0.0	0.0	29.0	0.4	63.9	0.5	0.0	0.3	0.0	46.9	0.0	0.0	2.4	0.0	24.2	1.1	12.2	0.0	0.0	0.8	0.0	0.3	1.8	1.0	0.0	3.2	0.0	11.1	13.2	2.9	0.1	0.4	0.0	0.3	20.3	0.4	2.6	19.4	0.0	0.0	4.0	0.6	0.9	0.0	0.6	49.5	0.1	0.6	0.4	1.0
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99397629-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favorable (1.09e-4)"	68.2	68.8	56.9	52.0	55.4	106.8	75.3	78.4	89.8	103.1	67.5	114.5	51.4	79.7	93.6	51.8	93.2	38.2	84.6	54.3	56.4	67.1	62.2	74.4	78.7	56.7	54.7	123.0	66.0	38.4	112.0	36.4	52.9	91.2	49.4	102.1	76.6	48.1	89.4	64.1	94.1	49.4	49.3	90.6	77.1	39.4	56.9	51.4	114.5	31.2	54.9	81.6	80.3	60.1	26.7	19.5	98.8	72.0	35.3	46.8	45.8	44.1	22.8	25.6	29.9	33.3	49.2	85.8	26.6	25.3	28.7	41.9	49.3	33.3	45.2	75.0	48.8	52.6	105.0	30.6	22.2	73.0	67.9	51.8	50.0	27.4	37.5	95.7	34.2	44.8	59.3	52.5	31.3	25.2	31.8	71.2	55.2	24.5	15.3	62.1	29.6	32.4	47.1	47.1	43.4	51.9	21.7	23.6	35.3	75.4	32.8	58.6	45.0	25.2	28.9	25.7	37.2	35.9	24.3	70.5	37.5	68.3	27.0	12.3	10.8	11.9	12.5	6.4	13.0	19.3	12.0	10.4	5.0	25.8	17.9	16.6	30.0	23.5	7.7	19.6	12.4	3.7	56.9	55.4	78.4	89.8	54.3	56.4	56.7	54.7	52.9	49.3	56.9	60.1	175.8	185.9	237.6	356.2	375.8	195.3	357.3	250.5	165.6	546.2	143.9	192.5	121.2	137.2	215.7	178.4	446.2	158.3	336.4	152.4	74.3	130.8	17.0	132.2	185.7	210.7	247.8	194.4	241.5	104.5	102.1	240.1	100.9	140.5	190.5	344.5	135.7	109.4	99.7	498.0	257.4	129.6	199.4	128.0	236.8	47.9	593.3	152.1	167.2	193.9	261.6	223.6	375.9	270.4	252.6	133.1	176.2	441.2	209.8	293.6	205.8	58.6	179.6	419.9	249.8	288.7	236.3	342.6	181.3	115.5	173.6	180.9	283.8	363.3	151.3	352.4
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 48.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.1	0.1	0.2	0.1	0.1	0.2	2.0	0.3	0.4	0.8	0.0	0.6	0.9	0.0	1.7	1.3	0.5	0.7	0.1	0.1	0.1	0.3	0.1	1.0	0.2	0.1	0.1	0.1	0.2	6.3	0.4	0.3	0.1	0.6	0.2	0.1	1.1	2.0	0.2	48.0	0.7	0.3	0.0	0.2	0.7	0.1	0.1	0.2	0.7	0.0	0.5	0.4	2.1	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	3.6	0.1	1.3	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	2.5	0.0	0.3	3.9	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	8.2	0.3	0.0	20.9	10.6	5.0	1.8	0.0	3.0	1.5	0.8	0.0	3.9	11.0	0.0	1.5	0.1	0.9	0.0	5.3	2.2	1.3	0.7	0.3	3.0	0.0	0.4	1.3	0.4	0.6	10.2	4.8	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.2	8.2	0.0	2.2	5.5	0.0	0.1	5.4	0.0	0.0	0.4	0.0	0.0	0.5	20.8	1.1	0.0	0.0	5.0	0.4	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.1	7.0	37.6	7.9	0.5	0.2	0.6	14.2
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 446.2;Late spermatids: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		380000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Plasma membrane"	"HPA029209: AB_2672951"	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	22.7	19.2	14.0	22.2	16.5	142.9	23.5	27.0	22.4	22.4	3.3	36.6	36.8	28.0	19.3	25.7	17.3	20.1	36.8	16.7	24.4	42.5	51.2	20.3	24.4	18.2	16.3	16.2	25.5	36.8	14.3	22.1	20.0	29.9	36.0	51.0	31.5	23.0	78.9	21.9	37.3	26.5	15.3	20.4	23.2	54.5	16.4	31.1	24.3	76.6	26.2	21.4	17.8	23.1	129.7	28.6	24.4	20.9	36.5	33.6	31.1	34.8	40.7	25.3	23.8	16.3	37.2	77.1	32.4	39.6	18.7	28.1	25.5	35.9	44.0	70.1	14.4	47.6	19.5	25.7	30.6	54.7	32.6	28.6	42.1	29.7	40.4	29.5	25.1	38.7	26.9	59.6	31.3	56.5	71.5	12.8	23.0	25.8	23.9	25.3	56.5	25.0	30.4	61.2	41.2	31.0	36.1	41.7	30.1	22.2	42.0	23.5	35.1	52.4	52.0	23.3	25.0	46.1	28.1	89.9	24.0	21.2	27.1	5.4	1.0	3.0	1.8	1.0	1.9	0.9	1.4	1.6	1.5	3.0	1.1	1.0	4.4	2.9	1.2	0.9	2.6	0.9	14.0	16.5	27.0	22.4	16.7	24.4	18.2	16.3	20.0	15.3	16.4	23.1	25.9	16.0	22.6	43.8	34.2	77.4	41.3	17.6	34.7	42.2	41.6	22.7	95.0	44.3	20.0	38.6	64.6	31.9	49.1	111.2	33.2	24.6	446.2	31.3	34.6	31.5	60.9	93.5	77.8	24.4	24.0	36.6	25.5	38.8	26.6	20.7	22.9	73.3	28.2	58.9	71.6	60.2	22.4	33.5	51.0	565.6	42.3	58.6	60.5	25.3	26.8	40.1	45.3	66.4	53.4	34.6	87.8	52.3	45.4	86.5	128.5	90.0	17.8	66.8	39.5	36.2	35.9	69.8	25.3	32.9	82.3	73.5	40.8	19.4	42.1	69.6
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919425-21952848	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endothelial cells: 42.2;Hepatic stellate cells: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 28.6"	"Group enriched"	"Detected in all"	7	"dendritic cells: 8.9;granulocytes: 28.6;monocytes: 24.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 109.1;K-562: 173.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		510000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	24.1	18.1	14.9	21.6	13.9	26.8	17.6	11.6	15.7	18.5	11.8	17.1	8.9	19.9	3.8	22.1	15.0	12.2	16.8	14.5	19.4	18.4	8.0	26.1	15.2	16.8	16.4	12.5	12.3	6.4	8.5	26.6	17.3	15.8	4.2	3.7	10.9	14.3	17.0	14.8	13.8	12.1	15.3	35.8	12.0	6.3	17.1	7.8	12.4	10.5	7.8	22.0	15.9	15.4	28.9	30.1	19.0	18.6	10.4	18.1	23.9	32.1	18.9	27.7	19.0	13.8	11.3	17.3	39.0	22.7	11.8	33.9	8.3	19.9	9.8	24.7	27.1	66.8	14.5	13.2	17.1	25.0	17.4	17.1	5.9	27.1	12.6	19.6	109.1	16.9	173.4	7.2	35.9	26.2	15.0	19.3	8.0	9.2	32.7	21.9	49.0	5.2	9.4	12.1	7.7	29.6	30.4	10.0	25.7	7.4	12.5	17.2	93.1	33.1	33.4	30.5	31.1	14.1	12.2	19.6	33.5	46.7	64.7	0.0	12.8	5.9	1.7	21.0	1.0	1.1	1.1	0.9	8.9	0.9	1.0	1.3	28.6	3.1	24.4	2.2	2.4	5.4	14.9	13.9	11.6	15.7	14.5	19.4	16.8	16.4	17.3	15.3	17.1	15.4	32.1	6.4	6.0	11.8	5.5	8.2	5.2	4.9	8.6	8.3	7.4	9.9	11.9	8.6	4.1	1.8	2.1	16.6	5.1	1.4	3.9	5.2	2.0	3.0	9.4	42.2	6.0	5.5	11.6	5.1	10.0	8.4	3.1	3.8	3.8	10.4	56.4	6.5	20.6	8.4	12.7	4.2	6.1	37.0	22.0	1.5	7.2	23.4	7.2	18.7	30.9	4.1	6.2	12.5	6.8	7.4	1.1	6.8	5.0	7.4	2.6	4.4	4.0	6.5	6.6	17.2	8.2	14.2	13.1	8.5	5.7	3.0	6.4	7.1	4.5	6.6
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398181-67421183	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	70.0	102.4	61.2	102.6	70.8	127.8	63.5	64.0	70.7	62.1	61.2	110.8	95.9	50.5	66.8	184.0	61.1	51.2	122.0	63.5	63.6	121.8	128.2	78.9	147.8	68.3	62.4	33.1	105.1	64.2	59.8	83.5	63.8	81.1	89.6	21.6	100.4	51.0	123.2	105.8	107.1	56.1	63.9	148.7	102.7	34.6	65.8	113.7	88.7	81.3	155.6	74.9	80.6	68.2	283.1	305.6	181.1	270.3	88.4	108.9	185.6	136.1	158.4	267.4	202.3	445.8	328.5	237.2	227.3	208.1	198.4	238.7	213.9	280.2	169.6	256.3	139.9	227.5	129.3	232.7	195.2	295.2	281.1	123.3	181.1	225.7	130.7	125.4	272.2	226.0	217.4	191.1	220.5	619.4	378.2	562.2	303.5	526.7	241.1	262.7	254.0	209.8	262.2	220.7	142.5	236.7	159.2	283.0	439.8	135.3	338.5	201.2	196.4	208.5	208.9	245.3	179.0	190.1	193.2	271.8	244.6	199.9	224.3	921.6	735.9	1234.1	779.2	962.9	604.3	733.4	679.9	792.5	705.3	779.6	412.6	584.2	853.8	688.8	1186.1	500.4	1098.7	2042.5	61.2	70.8	64.0	70.7	63.5	63.6	68.3	62.4	63.8	63.9	65.8	68.2	49.2	76.9	92.2	8.8	165.8	99.9	143.5	305.9	64.3	35.5	81.7	79.1	8.4	102.9	157.8	86.5	10.4	360.4	151.2	377.5	213.2	265.6	2.5	63.1	67.2	101.6	96.9	108.8	8.8	311.1	507.0	68.8	132.0	107.1	109.6	87.1	89.3	113.9	377.1	43.7	7.7	241.3	181.0	219.8	138.5	7.7	49.0	186.5	136.9	9.4	353.0	53.8	408.8	6.0	13.1	318.4	308.4	28.6	206.5	139.0	341.3	297.4	70.5	30.5	98.6	67.1	100.7	13.6	94.6	142.0	121.6	427.3	176.3	100.1	231.7	205.4
PPP1R12B	"MGC131980, MGC87886, MYPT2, PP1bp55"	ENSG00000077157	"Protein phosphatase 1 regulatory subunit 12B"	O60237	1	202348699-202592706	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 356.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 836.8;Excitatory neurons: 225.7;Granulosa cells: 438.3;Oligodendrocytes: 647.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024171, HPA024640"	Enhanced		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Actin filaments"		"HPA024171: AB_1854266, HPA024640: AB_1854265"	"unprognostic (5.24e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.60e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	40.0	11.1	5.1	36.0	12.6	8.3	17.8	8.9	9.9	51.8	15.5	151.0	24.1	222.0	30.5	150.1	52.6	72.5	356.9	5.5	6.5	14.3	8.4	24.8	18.6	17.2	15.3	38.3	7.2	6.2	5.0	34.4	18.0	142.8	64.8	7.6	20.0	198.6	84.1	11.0	30.9	246.4	16.2	30.8	41.5	7.1	9.2	7.7	10.9	80.5	15.1	86.7	23.0	27.3	2.2	4.4	3.3	3.2	4.6	3.3	5.4	1.7	1.7	1.8	1.7	1.9	3.9	2.5	0.8	3.2	4.3	7.0	5.0	2.7	1.9	3.3	3.1	2.5	7.1	1.2	1.1	5.4	2.8	2.6	3.0	2.5	2.6	9.1	1.5	2.8	3.9	2.9	3.1	1.7	4.1	3.4	2.3	2.4	0.9	2.6	8.5	3.7	1.4	8.1	4.0	3.1	3.3	3.9	1.9	4.4	3.4	2.4	1.9	2.5	1.5	1.9	1.5	4.2	4.3	2.7	2.4	4.4	10.2	2.4	1.7	1.5	1.6	1.0	1.4	2.0	1.1	1.0	1.5	2.1	1.3	1.0	16.2	0.7	1.5	1.7	1.7	0.5	5.1	12.6	8.9	9.9	5.5	6.5	17.2	15.3	18.0	16.2	9.2	27.3	12.5	12.8	19.8	181.5	6.0	17.3	49.0	35.6	8.6	59.3	11.1	20.6	836.8	11.5	23.0	12.9	75.0	18.1	8.6	52.9	11.7	10.1	39.2	19.3	16.1	15.2	24.0	5.2	225.7	12.9	8.4	51.4	17.3	7.6	18.9	438.3	16.4	9.6	9.4	26.9	205.0	17.2	63.1	23.5	10.9	13.1	12.2	8.2	8.8	102.1	7.8	10.2	5.2	102.5	647.4	6.3	21.1	51.1	9.6	24.3	12.8	7.1	27.4	30.4	32.9	38.6	162.7	19.3	13.9	7.1	10.9	25.4	10.7	14.2	33.9	28.4
PPP1R16A	"MGC14333, MYPT3"	ENSG00000160972	"Protein phosphatase 1 regulatory subunit 16A"	Q96I34	8	144477969-144502121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 208.9;Proximal enterocytes: 440.8;Proximal tubular cells: 404.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MCF7: 49.9"	"Low region specificity"	"Detected in all"							HPA023755	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA023755: AB_1854268"	"unprognostic (9.63e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.45e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.79e-2)"	6.1	15.0	10.2	4.7	8.6	3.8	8.2	4.3	15.0	10.5	16.7	25.1	27.1	10.5	1.6	9.8	18.9	3.1	9.6	12.9	8.9	26.7	23.5	10.8	2.9	10.2	10.4	7.9	17.7	7.4	36.9	1.7	7.1	15.5	2.4	2.9	11.6	5.6	6.3	9.0	24.6	1.6	8.1	8.0	14.1	33.3	10.3	2.4	27.0	1.0	1.0	9.1	6.7	5.1	30.4	24.3	3.9	15.1	1.6	2.7	19.3	8.2	5.1	6.3	5.1	6.4	21.2	5.0	21.1	3.0	5.6	19.8	2.0	6.7	1.0	10.3	11.9	6.0	26.4	6.8	4.7	4.3	7.9	2.7	8.9	7.3	2.1	4.1	4.5	8.2	24.0	6.1	2.3	49.9	15.3	19.9	7.4	15.6	30.3	15.9	1.9	10.1	5.7	10.0	12.5	23.9	14.9	13.7	13.0	1.0	32.3	9.1	7.7	7.1	33.2	19.8	15.8	4.0	4.3	1.8	22.8	8.3	6.5	0.0	0.8	0.0	1.0	1.2	0.9	0.8	0.8	1.0	1.2	0.1	0.5	1.1	0.2	0.2	1.7	0.7	0.6	0.8	10.2	8.6	4.3	15.0	12.9	8.9	10.2	10.4	7.1	8.1	10.3	5.1	7.9	3.2	15.4	28.1	6.2	43.2	36.2	47.6	54.1	25.0	78.3	82.0	85.8	157.3	24.6	40.5	14.6	7.2	6.0	135.9	121.3	33.7	12.6	43.8	15.6	13.3	51.6	6.1	7.8	41.6	24.3	13.3	70.3	24.2	3.8	16.4	12.8	208.9	6.1	30.3	7.6	98.1	26.4	7.0	27.1	14.4	22.7	9.8	8.8	5.6	3.8	102.8	5.2	6.6	2.8	29.3	109.8	15.4	5.9	40.0	440.8	404.2	59.8	50.9	6.6	17.2	17.3	52.9	28.7	77.8	61.8	6.7	7.1	69.2	116.0	28.3
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 208.4;Kupffer cells: 164.4;Langerhans cells: 179.3;monocytes: 212.8;NK-cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 215.8;neutrophil: 169.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 215.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		11000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	35.4	16.7	9.5	42.5	9.1	56.0	25.9	9.9	12.8	30.2	7.0	38.0	8.8	36.8	3.5	18.1	28.6	25.6	23.2	9.4	12.1	14.2	16.8	51.5	75.5	17.8	12.6	26.8	10.1	2.7	7.0	21.4	15.5	19.7	7.7	2.6	15.4	11.5	10.8	21.6	33.7	17.3	13.7	80.4	19.5	5.9	15.6	53.5	17.6	9.0	38.2	36.1	24.4	13.9	63.2	9.4	34.4	37.3	28.0	80.4	1.7	48.4	63.6	43.3	29.9	6.6	11.2	64.7	25.0	77.3	73.7	35.8	21.6	44.7	29.6	74.8	2.2	79.3	20.7	6.6	59.1	28.6	116.3	44.0	44.0	97.9	89.8	64.5	60.0	53.3	27.2	58.2	57.8	6.9	40.8	43.5	3.2	1.6	13.8	162.8	28.8	33.9	18.0	3.4	3.8	19.2	30.1	10.9	65.9	18.8	9.4	26.8	90.8	139.4	29.2	29.4	103.3	11.6	57.3	77.3	40.7	131.9	155.9	43.0	16.4	215.8	43.4	21.8	31.8	20.9	23.1	42.5	9.5	22.0	16.7	32.5	169.6	37.8	25.2	14.9	39.7	22.6	9.5	9.1	9.9	12.8	9.4	12.1	17.8	12.6	15.5	13.7	15.6	13.9	39.1	3.2	15.7	1.6	89.7	109.0	29.6	15.7	79.6	2.3	14.2	14.6	3.1	8.6	4.6	9.2	0.0	3.1	116.5	0.8	0.0	25.1	24.2	4.4	24.4	67.8	1.8	35.4	0.8	8.2	20.4	34.1	7.1	6.7	53.2	5.9	32.9	8.2	208.4	3.3	1.3	0.8	8.2	164.4	179.3	19.9	27.7	123.3	39.2	19.7	212.8	1.0	332.7	11.1	0.1	20.8	0.0	23.3	52.9	23.8	0.4	2.5	4.4	3.1	26.3	28.6	53.5	1.2	1.3	38.3	59.7	4.0	141.6	6.8	0.7	22.5
PPP1R27	"DYSFIP1, toonin"	ENSG00000182676	"Protein phosphatase 1 regulatory subunit 27"	Q86WC6	17	81833492-81835050	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"skeletal muscle: 1205.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 56.5;Skeletal myocytes: 108.8"	"Cancer enriched"	"Detected in single"	10	"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"HL-60: 206.4;THP-1: 385.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042227, HPA048632"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA042227: , HPA048632: AB_2680469"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.98e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.30e-1)"	0.3	0.9	0.0	0.0	0.1	1.3	0.4	0.2	0.3	0.4	0.0	0.2	0.0	0.1	0.0	1.2	0.1	0.0	0.5	0.1	0.0	0.2	0.7	0.2	0.0	0.1	0.0	0.2	0.4	0.0	11.8	0.0	0.1	1.8	0.0	0.0	5.8	0.0	1205.9	2.1	0.2	0.0	0.0	0.2	0.1	0.5	0.1	0.1	0.4	47.6	0.0	0.1	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	206.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.2	0.0	0.0	385.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	1.2	2.9	1.3	2.4	0.6	0.0	0.2	0.0	0.0	3.0	0.3	1.6	0.0	0.0	56.5	0.9	0.7	0.9	1.2	0.0	0.0	0.5	2.7	0.6	0.0	1.5	0.0	0.7	1.1	1.2	0.6	0.0	0.0	1.1	0.0	0.0	0.4	5.7	0.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.3	4.7	0.2	0.2	0.2	0.0	108.8	0.5	1.7	0.6	1.2	0.1	1.4	0.2	0.2	1.6	0.5
PPP1R9A	"FLJ20068, KIAA1222, Neurabin-I"	ENSG00000158528	"Protein phosphatase 1 regulatory subunit 9A"	Q9ULJ8	7	94907202-95296415	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 294.1;Excitatory neurons: 262.8;Inhibitory neurons: 201.5;Oligodendrocyte precursor cells: 593.1;Oligodendrocytes: 308.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 6.8;NK-cell: 10.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.8;NK-cells: 10.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 12.2;RH-30: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027726, HPA075591"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA027726: AB_1855653, HPA075591: AB_2732296"	"unprognostic (1.05e-1)"	"unprognostic (6.59e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (8.63e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.79e-3)"	1.7	7.0	13.0	0.9	20.1	0.2	4.9	6.0	14.5	2.7	0.3	8.2	1.7	3.0	4.9	1.6	5.7	2.4	5.2	14.4	7.5	4.7	0.4	3.7	0.3	5.9	6.9	3.3	8.8	6.7	4.6	2.5	8.0	2.3	3.8	18.5	9.6	2.8	4.9	0.5	2.2	2.2	6.6	1.8	4.9	6.7	10.2	0.5	6.6	4.9	0.3	2.6	0.5	13.9	0.0	11.0	6.6	7.6	0.0	0.0	5.3	0.5	0.1	1.0	0.8	6.1	3.7	0.0	9.0	0.5	0.6	0.0	12.2	0.0	1.2	0.0	4.5	11.4	4.5	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.8	4.8	0.1	0.0	5.5	4.9	1.8	0.0	11.8	0.0	10.7	9.2	7.3	7.4	0.0	0.9	1.4	4.0	2.1	0.0	0.0	0.1	4.4	0.1	4.0	7.3	11.5	0.0	0.2	0.0	0.9	6.8	0.0	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	10.3	0.1	0.3	0.0	0.1	13.0	20.1	6.0	14.5	14.4	7.5	5.9	6.9	8.0	6.6	10.2	13.9	4.5	41.7	66.6	294.1	2.4	0.4	0.9	0.0	0.6	58.2	24.4	12.2	127.7	18.6	16.5	47.8	56.3	21.6	3.3	15.7	3.9	25.1	17.9	40.3	4.5	6.8	38.9	2.5	262.8	7.0	3.1	9.4	21.4	57.1	5.7	39.5	7.9	1.5	1.7	1.7	201.5	15.0	4.1	0.6	0.3	15.3	2.5	0.8	7.2	41.2	0.0	46.9	3.1	593.1	308.4	6.6	14.4	0.7	2.7	4.8	1.8	9.6	20.6	88.9	0.0	118.4	9.2	25.1	12.6	0.5	0.9	33.1	1.7	22.9	15.7	2.6
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766389	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 170.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 306.1;Late spermatids: 160.7;Spermatocytes: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 173.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	58.5	10.5	11.3	14.1	18.0	16.2	21.5	20.0	13.9	13.0	17.3	14.7	13.9	8.7	8.1	12.6	8.0	13.4	6.3	11.7	13.8	14.6	170.7	8.8	12.1	14.7	13.7	13.3	33.2	12.9	10.7	9.2	14.2	7.7	14.7	8.5	9.6	6.1	9.6	10.7	15.2	7.8	10.6	6.3	22.3	54.0	13.8	15.9	10.6	8.9	14.1	12.2	7.4	20.7	38.4	25.1	35.6	24.2	34.9	18.7	35.8	37.2	25.9	27.0	24.6	86.0	39.3	48.3	27.1	24.1	25.6	35.4	53.4	30.5	34.3	33.7	16.6	47.2	14.5	37.8	17.3	55.7	36.1	21.5	18.1	30.6	22.2	19.1	33.8	49.7	58.3	62.3	30.1	12.4	60.8	22.6	43.8	41.4	27.3	45.9	23.6	58.6	40.2	41.9	11.6	31.4	33.1	30.2	6.1	38.3	35.0	20.6	36.7	31.3	37.8	15.6	23.9	6.6	17.4	173.8	11.1	63.9	40.7	6.1	10.1	10.4	13.0	11.7	12.7	10.0	12.9	12.1	14.9	12.5	11.2	12.0	2.6	15.3	11.4	6.4	15.0	12.2	11.3	18.0	20.0	13.9	11.7	13.8	14.7	13.7	14.2	10.6	13.8	20.7	21.2	19.2	10.5	63.3	11.0	14.3	11.0	12.0	18.2	5.4	14.1	8.5	3.2	15.7	13.4	12.9	8.4	13.5	11.0	23.8	13.7	18.7	306.1	29.6	13.4	20.2	15.6	32.4	23.8	22.9	20.3	12.3	15.3	46.1	8.2	34.3	9.3	89.4	9.5	1.7	14.5	11.5	22.4	5.8	9.2	160.7	6.5	7.5	8.8	17.8	8.9	9.9	7.2	26.2	49.1	23.6	9.0	7.5	9.0	10.9	16.2	17.6	16.8	11.0	13.1	14.5	14.4	135.9	20.8	12.0	14.6	17.6	11.0	9.7	13.9	15.0
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591604-101595021	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	161	"testis: 80.8"	"Group enriched"	"Detected in some"	38	"Early spermatids: 399.2;Late spermatids: 198.3;Spermatocytes: 600.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA047157: AB_2679960"												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	80.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.1	0.0	0.4	0.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	399.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.3	10.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.2	600.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085376	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: AB_2678695"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	44.3	57.9	34.8	43.2	34.7	63.2	42.5	35.9	38.7	42.8	41.0	49.8	47.0	39.6	47.1	88.3	35.9	32.5	45.6	34.0	35.7	49.9	83.2	46.2	58.6	35.5	34.9	29.4	41.0	46.4	33.5	49.6	35.3	37.8	35.2	18.1	44.0	28.5	60.8	60.8	49.0	32.8	35.6	62.5	49.2	65.4	38.4	61.2	35.4	30.2	63.7	56.3	48.9	36.4	132.7	145.9	95.5	134.0	88.4	73.8	148.5	115.8	127.7	148.7	163.8	129.5	167.9	102.7	145.2	137.0	95.5	105.9	119.3	143.2	87.0	130.1	213.0	70.5	86.0	290.4	133.5	100.1	126.8	107.9	124.7	135.9	85.5	88.4	174.9	130.5	139.6	91.0	115.1	382.2	174.4	180.7	182.2	104.7	77.1	190.9	99.4	180.4	142.5	134.5	91.9	136.8	57.1	169.1	101.8	79.4	156.0	166.0	113.3	86.4	90.4	70.6	90.8	155.4	183.8	122.4	123.1	126.9	107.0	100.6	103.5	236.1	66.5	113.2	47.7	68.5	69.6	74.2	115.8	88.3	62.0	54.1	215.2	51.7	100.1	90.6	95.1	48.3	34.8	34.7	35.9	38.7	34.0	35.7	35.5	34.9	35.3	35.6	38.4	36.4	87.8	51.3	33.4	10.7	85.8	147.2	121.7	206.9	71.2	23.3	94.2	82.8	11.1	82.9	133.5	77.3	29.2	313.7	106.0	217.0	158.5	226.9	156.9	80.5	55.5	91.7	125.6	89.2	8.0	193.3	335.3	66.7	106.0	85.2	69.2	66.7	74.6	94.2	239.3	35.3	8.6	159.3	193.3	105.4	138.4	143.8	62.7	124.4	80.0	9.4	221.1	61.1	118.4	8.0	12.9	345.5	220.8	52.3	97.6	161.3	191.0	198.6	119.7	29.5	72.3	43.4	85.9	228.5	157.8	113.2	172.5	421.0	93.0	61.7	175.9	227.2
PPTC7	TA-PP2C	ENSG00000196850	"Protein phosphatase targeting COQ7"	Q8NI37	12	110533245-110583318	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 140.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	18.8	25.5	6.9	16.1	7.3	52.3	13.4	12.1	11.1	15.5	8.3	15.7	13.4	14.3	6.4	21.6	11.3	15.0	40.0	6.5	14.1	21.5	21.0	15.6	20.7	12.7	12.4	13.1	13.2	30.6	8.4	10.7	12.1	12.3	16.7	15.6	17.8	13.4	88.7	21.5	13.2	16.1	9.2	15.2	11.9	14.0	13.0	18.4	11.6	140.0	18.4	19.0	19.1	7.4	24.3	13.6	11.4	12.0	27.8	24.3	16.3	10.9	14.3	11.7	11.7	15.4	9.3	42.2	11.1	10.8	16.7	23.0	23.1	25.3	23.5	30.9	19.1	37.5	14.4	16.7	26.3	41.8	29.6	21.0	40.7	16.6	48.4	17.4	22.5	28.8	28.3	11.7	19.2	6.3	37.2	35.7	16.1	13.0	25.0	30.7	15.3	25.8	48.7	26.7	18.4	14.2	20.6	28.2	24.4	11.0	13.4	22.1	25.9	10.7	11.5	32.8	18.6	33.5	40.0	46.7	18.0	22.6	21.4	0.0	0.6	0.5	0.8	0.5	0.8	0.4	0.6	0.6	0.4	0.7	0.7	0.6	2.1	0.6	0.4	0.5	0.5	0.2	6.9	7.3	12.1	11.1	6.5	14.1	12.7	12.4	12.1	9.2	13.0	7.4	14.1	22.4	28.3	16.0	35.7	91.9	53.1	33.9	56.9	8.6	20.2	12.8	105.4	12.8	36.0	9.2	14.6	7.5	28.2	36.7	17.6	7.7	29.7	34.4	20.4	22.3	16.8	7.8	15.5	8.2	8.4	26.1	12.8	63.3	23.5	8.6	15.4	29.5	17.4	13.5	19.8	15.2	30.5	28.3	97.6	33.2	11.5	30.8	33.8	21.5	31.9	4.8	20.6	19.1	11.7	14.6	15.1	9.8	28.2	57.3	16.5	13.1	35.4	23.8	13.1	22.8	22.4	15.9	24.1	57.1	104.3	6.7	28.7	8.2	17.2	77.5
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966040-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.9;testis: 55.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 34.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 34.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	7.4	6.2	6.4	10.0	6.1	89.9	6.4	10.3	8.4	8.1	5.0	16.3	10.6	5.7	2.3	37.6	6.0	3.0	6.9	5.6	4.9	5.6	4.8	9.0	16.9	4.8	5.2	8.1	8.9	2.6	3.6	15.3	5.2	4.9	16.5	4.9	9.5	1.5	4.1	20.1	13.0	9.4	4.9	12.5	11.7	55.0	4.2	43.0	4.3	2.3	24.9	4.8	13.7	5.6	167.9	199.9	164.8	113.6	16.8	28.7	87.5	237.8	139.3	257.2	195.3	134.6	158.5	65.5	91.4	151.9	156.9	220.9	188.8	101.2	240.6	118.7	206.4	135.6	263.5	123.5	4.1	71.4	109.0	7.7	12.8	145.8	146.9	56.6	146.4	100.5	114.0	132.4	241.1	144.4	66.9	98.5	66.6	216.4	84.9	69.7	205.1	86.3	115.3	123.6	151.2	118.9	225.4	121.9	82.7	112.3	149.1	127.1	91.2	168.2	146.0	140.5	345.1	43.5	127.7	80.0	74.5	162.0	265.3	34.4	0.6	2.9	0.6	0.1	0.4	1.1	1.3	1.3	2.4	0.5	1.2	0.4	0.4	3.0	0.3	2.6	8.0	1.0	6.4	6.1	10.3	8.4	5.6	4.9	4.8	5.2	5.2	4.9	4.2	5.6	2.5	0.0	3.1	1.3	6.8	16.6	6.6	8.0	2.2	6.4	3.4	4.3	3.2	0.0	7.6	3.7	0.0	45.5	2.8	16.5	0.0	3.2	41.5	4.5	4.0	4.7	5.4	142.9	5.0	2.9	68.3	7.2	16.3	6.8	8.9	13.2	9.3	2.1	21.5	3.3	5.2	17.0	10.2	8.7	15.0	15.4	3.7	5.2	3.6	1.9	5.5	3.8	4.1	2.0	1.7	2.3	3.2	1.9	17.5	5.9	2.0	0.1	3.2	4.6	6.6	7.4	10.9	136.4	74.2	38.0	14.2	14.6	6.8	0.4	24.1	6.7
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477330-173488815	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	340.7	157.5	169.5	68.3	181.3	100.1	211.2	197.6	210.1	112.3	164.8	189.1	46.4	108.8	206.3	127.9	149.8	71.9	261.8	184.1	196.6	184.4	482.5	116.7	72.2	181.0	198.3	115.5	114.4	217.5	67.4	70.7	187.5	152.1	221.6	53.9	85.6	99.0	563.5	106.6	59.8	160.2	175.8	70.7	135.2	119.1	176.7	70.7	106.0	382.4	79.0	99.5	109.8	185.5	420.3	127.7	204.7	230.9	778.5	372.7	169.5	843.9	284.3	342.7	241.8	243.9	276.4	272.4	256.4	694.2	120.4	239.8	272.0	259.9	279.0	234.0	243.6	179.5	200.0	277.7	425.7	191.3	56.1	301.0	262.6	181.3	256.6	210.8	339.5	106.7	405.4	52.8	392.9	86.3	131.7	249.1	456.2	219.8	760.5	154.5	236.6	277.0	518.1	95.4	94.9	173.4	285.0	334.0	199.2	296.3	283.8	262.9	228.2	132.5	149.9	201.8	229.5	76.4	123.2	220.7	159.4	162.3	124.3	36.2	42.5	24.8	29.8	39.8	32.8	32.6	29.8	38.4	53.5	24.4	39.8	47.9	25.2	25.7	36.5	79.7	36.1	58.1	169.5	181.3	197.6	210.1	184.1	196.6	181.0	198.3	187.5	175.8	176.7	185.5	278.1	176.3	170.8	127.3	127.4	235.4	404.1	382.8	209.5	31.9	186.1	250.7	528.6	301.7	228.6	277.7	29.2	714.3	158.6	1315.9	860.8	178.6	237.5	206.9	226.8	191.8	142.1	449.5	13.8	202.3	939.1	307.0	111.6	200.0	348.6	216.6	214.2	1120.2	345.0	45.4	13.2	257.4	205.4	164.3	161.0	667.5	340.5	227.1	183.2	17.8	212.9	462.5	83.4	12.5	15.4	147.2	663.4	416.8	176.4	427.1	264.4	827.3	209.1	52.0	184.1	185.7	253.8	123.5	76.8	305.9	264.1	963.5	157.7	512.5	303.6	308.9
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788485	"Predicted membrane proteins"	"Neurotransmitter degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.7"	"Group enriched"	"Detected in some"	9	"Muller glia cells: 35.5;Oligodendrocytes: 54.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 5.2;Hep G2: 3.3;NTERA-2: 2.3;SCLC-21H: 8.3;SH-SY5Y: 8.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.1"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046671: AB_2679744, HPA060047: AB_2684194"	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	5.8	3.0	6.1	2.9	11.3	0.0	3.8	10.8	12.3	17.5	2.5	53.7	2.1	13.9	2.1	8.0	18.3	1.6	8.8	5.2	7.9	2.5	0.8	1.0	0.1	17.1	11.3	5.4	1.3	0.0	0.7	1.0	14.7	15.6	3.7	5.7	5.0	5.0	0.9	3.4	21.6	8.1	12.7	0.2	20.0	1.7	9.1	0.2	1.7	1.4	2.3	11.0	14.4	18.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.2	0.0	0.0	0.1	0.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.3	8.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	11.3	10.8	12.3	5.2	7.9	17.1	11.3	14.7	12.7	9.1	18.4	0.2	0.0	0.0	1.3	0.0	0.5	1.0	0.3	0.6	2.6	0.4	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.4	0.2	0.0	0.0	0.2	0.0	0.0	3.4	2.6	0.6	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	1.2	2.8	0.1	0.0	0.0	0.0	35.5	0.0	2.0	54.7	0.1	0.0	0.0	1.2	0.7	0.0	0.1	0.0	0.3	0.0	4.9	0.3	0.7	1.4	0.6	0.3	0.0	0.0	0.0	0.0	0.1
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 128.4;Microglial cells: 267.9;NK-cells: 229.6;T-cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdT-cell: 116.5;MAIT T-cell: 91.3;memory CD4 T-cell: 88.0;memory CD8 T-cell: 137.0;naive CD4 T-cell: 106.9;naive CD8 T-cell: 105.5;NK-cell: 117.1;T-reg: 79.8"	"Group enriched"	"Detected in all"	14	"NK-cells: 117.1;T-cells: 137.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 81.8;HUVEC TERT2: 108.7;MOLT-4: 75.8;RT4: 46.4;TIME: 72.0"	"Group enriched"	"Detected in all"	6	"basal ganglia: 28.0;thalamus: 17.9"	"Low region specificity"	"Detected in all"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	26.6	7.8	21.1	21.9	30.2	24.2	21.9	12.4	15.7	20.6	9.5	8.9	9.5	14.5	10.9	30.0	13.6	19.7	19.2	13.2	13.9	14.5	10.3	35.3	55.2	19.3	21.7	5.9	8.4	14.2	15.0	32.5	19.4	15.8	8.8	3.1	28.3	11.4	14.2	23.7	16.6	18.1	18.6	38.5	9.6	7.5	29.9	65.8	21.1	18.1	38.5	25.3	21.7	15.5	18.1	6.3	0.8	4.9	2.8	0.6	81.8	0.3	1.5	0.8	0.8	1.9	10.5	0.3	12.4	0.1	1.6	12.3	0.6	13.5	1.4	2.2	7.9	0.1	2.0	0.7	1.2	0.0	2.4	2.2	13.8	0.7	9.4	1.2	108.7	35.4	0.2	0.4	6.2	32.7	75.8	0.7	1.4	12.9	8.4	6.3	3.2	0.2	0.2	46.4	3.2	5.1	2.1	16.2	10.2	14.5	15.9	1.4	72.0	2.1	14.0	2.1	0.9	1.4	0.2	0.6	3.1	1.1	3.6	0.8	3.0	2.4	116.5	1.9	91.3	2.2	88.0	137.0	9.2	1.4	106.9	105.5	5.9	117.1	1.1	3.0	79.8	84.0	21.1	30.2	12.4	15.7	13.2	13.9	19.3	21.7	19.4	18.6	29.9	15.5	59.7	6.4	11.4	2.0	6.6	18.7	16.4	8.3	15.9	0.4	15.0	9.3	9.0	10.0	15.5	0.0	0.0	27.6	128.4	0.6	3.9	6.0	32.6	10.3	2.1	70.8	11.9	18.1	1.7	6.8	21.2	5.0	7.1	20.9	1.3	15.4	68.9	2.0	6.0	0.0	3.1	2.7	2.0	14.4	6.9	6.0	1.8	15.4	16.0	267.9	8.9	7.0	229.6	4.5	1.8	5.4	4.3	6.8	26.6	14.7	4.6	1.2	9.2	0.5	0.0	4.4	5.2	0.1	2.4	18.1	26.7	48.3	130.5	1.6	1.3	26.0
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050411-2185395	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 708.3;Syncytiotrophoblasts: 1107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 16.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.5;OE19: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.7	11.1	23.6	4.6	25.7	2.1	5.6	58.0	41.3	4.3	0.0	13.2	29.3	2.2	7.8	16.0	9.5	4.4	9.7	23.7	10.2	16.0	11.0	31.6	8.0	18.6	8.3	2.7	12.5	14.7	17.6	43.8	19.0	8.4	11.3	14.8	10.8	3.9	0.3	13.8	28.0	1.6	5.6	10.5	8.9	31.9	7.2	3.7	21.8	0.6	7.8	5.8	8.0	24.8	14.7	9.7	3.4	17.2	0.0	0.0	44.5	1.2	0.5	11.1	0.7	23.8	31.0	0.1	27.4	3.9	9.4	25.4	20.5	25.5	7.9	1.0	21.8	0.0	15.2	33.5	3.2	0.1	11.0	0.6	14.9	0.0	8.6	0.0	0.0	4.0	6.6	0.2	0.2	17.9	0.9	0.0	6.4	41.9	22.5	0.0	0.0	5.1	18.6	16.0	24.1	18.7	11.6	27.5	5.2	28.7	17.7	4.0	0.0	0.1	13.1	0.1	0.1	6.8	1.3	0.3	1.2	0.3	16.8	0.3	0.0	16.3	0.5	0.3	2.5	0.3	0.9	0.6	0.0	0.4	0.8	0.3	1.1	0.9	0.0	0.3	0.9	0.3	23.6	25.7	58.0	41.3	23.7	10.2	18.6	8.3	19.0	5.6	7.2	24.8	0.9	121.8	72.2	2.3	6.5	13.0	11.8	11.0	10.2	27.1	11.3	11.0	1.4	5.7	21.1	7.3	4.2	118.7	7.5	48.9	7.9	12.3	224.4	14.0	4.7	6.3	10.2	6.6	39.5	10.7	66.3	3.1	17.9	11.7	8.2	12.5	10.0	16.5	14.5	62.2	35.2	25.5	10.2	0.8	2.9	708.3	9.6	4.4	7.2	2.8	4.5	19.1	8.2	13.0	41.3	14.2	45.7	8.6	7.4	19.5	78.4	24.7	22.1	25.9	0.0	0.3	4.1	28.3	28.4	13.4	13.4	1107.9	9.8	2.6	31.3	14.3
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274449-95291308	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.1;skin 1: 60.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Club cells: 39.9;Collecting duct cells: 33.1;Squamous epithelial cells: 37.2;Urothelial cells: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 79.5;CAPAN-2: 135.9;HaCaT: 73.2;hTCEpi: 78.4;MCF7: 62.1;RT4: 83.8;SK-BR-3: 117.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: AB_2685104"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.7	0.3	1.1	1.5	1.3	0.3	10.3	1.0	2.1	16.6	0.2	11.4	10.5	1.9	27.9	88.1	5.5	27.0	1.1	0.9	0.6	32.4	0.8	1.7	0.1	1.4	0.7	1.1	10.2	25.5	1.5	4.5	1.2	24.7	9.8	0.4	35.2	27.7	0.7	60.0	4.8	0.8	0.3	0.6	26.3	0.6	1.4	2.0	11.9	0.2	7.9	25.7	37.9	2.1	79.5	0.1	0.2	0.8	0.3	0.1	38.5	0.1	0.2	0.3	0.4	0.8	135.9	0.0	0.0	0.1	0.1	73.2	0.0	42.4	0.4	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.0	78.4	0.1	0.4	1.9	0.0	0.1	0.0	0.1	0.0	62.1	0.4	0.5	0.1	3.7	0.5	0.2	0.0	0.1	0.2	83.8	0.6	0.2	0.0	117.7	0.1	0.9	37.2	0.1	0.0	0.2	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.0	2.1	0.9	0.6	1.4	0.7	1.2	0.3	1.4	2.1	0.4	3.2	4.2	1.3	0.1	6.6	25.2	27.6	14.2	0.4	29.1	14.9	1.7	37.1	39.9	33.1	4.2	19.0	0.1	8.0	11.7	15.6	0.5	2.7	0.6	0.9	3.6	0.0	0.6	11.0	3.5	0.6	25.5	5.5	0.0	0.7	0.0	0.0	2.4	0.0	1.2	10.4	12.2	0.0	0.8	1.4	0.3	0.2	7.2	0.0	0.6	0.1	0.0	1.5	3.2	17.5	12.4	0.7	0.0	14.1	0.7	0.1	12.3	1.1	0.0	0.4	2.2	0.6	0.1	37.2	12.8	11.2	0.2	0.8	17.4	37.5
PRR32	CXorf64	ENSG00000183631	"Proline rich 32"	B1ATL7	X	126819729-126821786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"tongue: 22.4"	"Cell type enriched"	"Detected in single"	13	"Cardiomyocytes: 1.3"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 10.7;pons and medulla: 13.5;thalamus: 8.2"	"Not detected"	"Not detected"			HPA048386	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centrosome"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear speckles, Centrosome"	"HPA048386: AB_2680380"					"unprognostic (7.10e-3)"	"unprognostic (7.97e-2)"				"unprognostic (3.79e-1)"						"unprognostic (2.98e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	4.1	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	22.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRRG1	PRGP1	ENSG00000130962	"Proline rich and Gla domain 1"	O14668	X	37349309-37457292	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.4"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078129			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA078129: AB_2686878"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (8.34e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (8.21e-2)"	"prognostic favorable (2.05e-7)"	"unprognostic (1.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.48e-1)"	8.6	3.7	12.3	2.1	24.9	0.2	5.2	21.6	19.7	4.4	4.7	4.0	2.9	4.3	1.5	4.1	2.6	8.8	6.4	12.9	15.9	10.5	7.9	5.5	1.7	26.7	21.3	4.2	1.6	1.2	1.4	8.1	25.3	3.4	4.1	1.5	2.9	7.8	15.9	2.2	3.0	5.4	18.4	2.9	2.4	1.5	18.4	1.5	8.3	7.8	1.0	5.6	3.8	39.4	32.3	7.2	5.6	5.6	18.7	15.4	2.4	14.1	17.6	4.7	8.2	17.1	20.2	0.0	21.8	10.4	8.9	10.7	15.6	10.0	8.3	0.1	5.2	5.2	7.7	5.7	22.6	0.0	7.2	23.2	8.1	9.1	7.7	9.4	24.8	0.0	2.6	0.1	16.5	2.4	0.1	0.1	6.8	5.1	13.4	0.0	13.1	0.0	79.2	1.7	0.0	0.1	9.7	15.6	6.1	15.3	0.1	3.5	17.6	7.5	4.2	14.2	4.1	0.0	0.1	0.0	7.3	0.0	7.3	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.3	24.9	21.6	19.7	12.9	15.9	26.7	21.3	25.3	18.4	18.4	39.4	29.7	6.4	4.2	15.7	0.0	11.3	4.8	7.6	5.2	2.2	5.3	5.3	8.1	15.7	2.7	33.1	0.0	7.0	0.2	7.6	7.9	6.8	0.7	3.3	12.9	18.4	3.0	0.0	23.3	3.1	14.9	9.6	4.6	9.2	1.3	3.9	17.9	16.3	4.8	18.5	10.8	5.7	14.2	4.1	5.3	0.4	4.7	1.4	3.6	31.9	0.8	2.2	0.0	12.5	229.8	18.7	7.5	2.6	0.0	9.1	4.3	9.4	2.9	0.5	6.6	8.3	8.4	2.5	4.2	5.2	6.3	10.4	0.4	3.5	4.8	8.1
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952408	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.6;fallopian tube: 7.6;parathyroid gland: 15.3;pituitary gland: 11.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.2;MCF7: 23.1;SK-BR-3: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		83000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	0.9	1.8	3.9	1.1	5.0	1.5	1.2	10.1	11.6	1.3	0.3	1.3	0.4	1.2	1.2	1.2	7.6	1.1	1.1	4.4	1.1	1.3	0.4	0.9	1.2	5.1	1.9	1.3	1.8	15.3	11.0	0.3	5.3	2.5	0.3	2.2	2.3	1.7	1.4	2.3	0.9	0.9	0.0	0.9	1.1	2.1	3.6	1.3	2.2	0.2	1.3	1.8	1.1	4.8	0.4	1.0	3.6	4.7	17.2	2.3	1.2	1.8	3.4	2.0	4.5	0.3	3.4	2.0	0.4	4.2	2.1	0.3	1.3	4.5	0.9	9.8	2.0	0.7	1.9	0.2	1.7	0.4	1.7	4.4	0.3	1.7	0.7	9.7	0.8	6.0	1.0	4.7	2.5	23.1	4.4	0.4	8.5	0.1	2.1	2.8	0.4	1.9	1.0	0.4	6.6	4.4	1.8	33.6	0.7	1.4	9.1	0.4	0.7	0.4	4.6	0.9	1.3	6.1	6.6	0.6	10.9	0.3	1.3	0.5	0.2	0.2	1.2	0.1	1.4	0.5	1.3	1.2	0.0	0.6	1.4	1.3	0.3	0.7	0.1	0.6	0.2	0.4	3.9	5.0	10.1	11.6	4.4	1.1	5.1	1.9	5.3	0.0	3.6	4.8	3.3	0.0	2.0	3.9	2.9	2.7	3.8	3.7	3.4	22.8	7.4	6.2	3.0	7.2	3.4	11.0	14.6	0.7	4.4	4.5	3.9	2.9	4.3	5.0	5.4	3.3	11.3	2.1	14.7	5.0	0.5	5.2	5.6	4.9	1.3	7.9	2.2	2.9	3.8	15.2	10.8	5.4	2.0	2.5	2.6	3.5	5.6	2.2	1.8	2.8	11.3	8.6	11.3	5.5	3.7	3.1	1.0	2.6	2.2	4.2	6.4	8.0	12.4	21.6	0.0	7.2	5.3	10.4	6.4	3.4	2.3	0.4	5.6	7.8	4.7	3.0
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 16.3;bone marrow: 57.7"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 4.8;Horizontal cells: 10.1;Inhibitory neurons: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 225.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Peroxisomes, Plasma membrane"	"HPA046373: AB_2679642, HPA052681: AB_2681912"	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	16.3	1.3	3.2	0.4	2.7	57.7	8.5	3.2	2.9	2.5	0.7	1.3	0.1	0.5	0.0	2.7	1.1	0.7	1.5	2.0	6.3	0.1	0.4	0.9	0.1	4.7	4.8	1.1	0.3	0.3	0.2	0.0	4.0	0.4	0.2	1.0	1.1	0.8	4.5	2.3	1.2	0.4	3.6	2.1	2.1	0.4	5.1	0.6	0.5	4.5	0.0	0.5	3.0	2.1	0.0	0.1	0.3	0.5	1.3	0.1	3.8	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.2	8.8	0.1	1.3	0.0	0.0	0.1	0.0	0.0	12.8	0.0	0.0	0.0	1.0	2.6	46.6	1.2	0.0	0.1	12.9	0.6	1.0	0.0	0.1	0.5	225.3	0.4	0.2	0.3	1.5	0.1	6.1	0.0	0.0	1.0	0.5	0.1	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.7	3.2	2.9	2.0	6.3	4.7	4.8	4.0	3.6	5.1	2.1	0.4	0.0	0.0	1.0	0.0	0.6	0.1	0.2	0.6	4.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.2	10.1	12.6	0.0	0.0	0.0	0.7	0.0	0.9	0.1	0.0	0.0	0.1	1.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.8	1.2	0.3	0.3	0.1	0.0	0.0	0.1
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611544-55743152	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 10.4;thyroid gland: 10.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 191.8;Oligodendrocyte precursor cells: 51.8;Rod photoreceptor cells: 62.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"AF22: 148.6;SuSa: 172.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Vesicles, Plasma membrane"	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	0.5	1.0	1.7	0.4	2.2	0.1	1.1	2.2	1.1	1.2	1.4	0.5	0.1	3.6	0.5	0.1	1.1	0.3	0.6	1.3	2.8	1.5	0.1	1.7	0.1	3.2	2.4	1.9	0.1	1.9	0.9	2.7	3.7	0.4	0.2	10.4	0.2	0.5	0.6	0.1	0.3	1.3	2.9	0.1	0.5	3.6	2.9	0.0	10.7	0.4	0.1	0.4	0.5	5.0	1.2	3.4	148.6	3.2	0.0	0.1	13.2	1.2	4.5	3.9	5.4	25.8	0.8	0.0	5.4	0.2	5.8	0.0	0.6	0.3	5.2	0.0	6.4	1.0	1.1	9.8	1.1	1.0	0.0	0.5	0.2	1.7	2.7	3.0	2.8	0.3	2.7	0.0	2.3	2.2	0.0	0.0	5.9	0.0	3.0	0.0	22.3	0.0	3.1	0.4	1.8	7.6	1.2	1.9	8.3	172.9	0.7	0.5	0.2	2.1	1.6	0.0	4.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	2.2	2.2	1.1	1.3	2.8	3.2	2.4	3.7	2.9	2.9	5.0	3.2	9.6	20.2	17.6	0.0	0.3	0.0	0.0	0.0	12.4	5.0	4.4	6.0	0.0	2.5	16.5	191.8	19.9	0.1	0.1	0.0	0.0	21.8	2.8	25.5	9.7	0.0	0.0	0.7	0.2	4.1	4.0	3.6	3.1	0.0	2.9	3.6	0.0	1.7	0.0	11.1	0.0	0.0	0.0	0.0	25.3	5.3	0.2	0.0	28.1	0.0	4.4	0.0	51.8	13.6	0.4	0.0	2.6	0.1	0.1	0.0	1.4	0.0	62.3	0.0	5.8	2.4	8.9	12.1	0.0	0.0	6.0	0.1	9.5	0.5	0.1
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393766-40414793	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 34.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.8;Breast myoepithelial cells: 23.2;Cardiomyocytes: 15.4;Skeletal myocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	8	"spinal cord: 114.2"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	4.5	4.7	6.2	1.3	6.8	1.6	3.9	5.2	6.5	4.8	2.9	3.6	1.1	4.4	1.0	2.0	4.2	1.8	3.1	4.7	4.4	6.7	1.0	34.6	1.3	5.4	4.9	6.2	3.8	5.9	1.5	5.1	6.7	4.6	0.7	0.8	3.8	3.5	4.9	3.2	2.2	2.0	4.9	2.0	3.7	1.6	5.7	0.7	9.6	5.5	0.8	4.3	3.1	4.1	1.6	2.6	2.1	2.7	1.3	4.4	2.6	1.4	1.5	1.9	1.4	1.0	1.7	0.5	1.6	1.3	1.2	0.9	1.0	0.6	0.7	0.8	0.9	0.3	0.3	0.5	2.1	0.1	2.3	3.3	3.2	1.2	1.1	1.7	1.6	2.9	2.0	0.5	1.0	2.2	1.0	0.6	0.6	3.8	1.7	3.2	1.8	1.5	0.4	1.8	0.2	1.0	2.7	2.3	2.0	0.9	3.2	1.2	1.4	3.8	2.9	1.6	0.8	5.3	5.0	0.7	1.1	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.2	6.8	5.2	6.5	4.7	4.4	5.4	4.9	6.7	4.9	5.7	4.1	17.8	3.2	5.9	0.7	1.4	6.2	2.3	0.3	5.7	0.1	8.1	23.2	15.4	2.8	0.9	1.8	0.0	1.1	1.7	1.0	0.0	0.3	0.1	1.3	1.7	9.2	0.0	0.4	0.6	0.6	0.7	7.0	0.0	3.0	0.0	2.0	6.8	1.3	1.1	0.0	0.5	0.7	2.0	1.6	2.5	0.1	3.4	2.5	3.6	7.5	0.3	3.3	0.0	0.0	0.5	0.5	1.4	4.5	0.9	1.7	1.2	1.9	0.2	0.1	0.0	30.3	6.1	0.3	0.7	5.0	4.1	2.7	1.1	1.3	1.5	1.0
PSD	"EFA6, EFA6A, KIAA2011, PSD1, TYL"	ENSG00000059915	"Pleckstrin and Sec7 domain containing"	A5PKW4	10	102402617-102421539	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 233.9;intestine: 261.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.7;Cone photoreceptor cells: 95.9;Endometrial stromal cells: 47.7;Excitatory neurons: 41.1;Inhibitory neurons: 29.9;Rod photoreceptor cells: 70.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 7.7;MOLT-4: 4.4;SCLC-21H: 7.4;SH-SY5Y: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059237	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA059237: AB_2683954"	"unprognostic (2.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	1.2	9.1	159.5	3.8	151.7	0.7	1.5	7.8	233.9	53.8	0.0	261.8	6.1	78.3	1.4	1.6	46.2	8.9	4.4	220.9	63.9	2.8	2.4	1.2	0.9	23.8	25.4	15.3	5.0	1.5	99.4	0.8	27.3	4.3	3.5	36.8	1.0	1.2	0.4	1.6	41.4	17.7	14.9	1.5	44.2	12.4	70.2	1.4	1.1	0.0	0.4	105.7	14.7	87.6	0.2	0.0	3.0	2.7	1.1	0.6	0.3	0.2	0.0	0.1	0.0	2.1	0.3	0.2	1.8	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.1	1.6	0.0	0.1	7.7	0.2	0.5	0.1	1.2	0.0	1.0	0.4	0.7	0.0	1.7	4.4	0.2	0.4	0.3	0.0	1.2	0.0	0.1	0.0	0.1	7.4	6.4	0.1	0.1	0.2	0.2	0.5	0.4	0.0	2.2	3.5	0.2	0.0	1.9	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	159.5	151.7	7.8	233.9	220.9	63.9	23.8	25.4	27.3	14.9	70.2	87.6	0.7	3.2	0.5	6.8	1.0	0.6	0.3	0.3	0.0	50.7	1.1	0.5	1.5	2.8	1.5	0.0	95.9	0.2	0.6	0.8	1.9	0.2	6.6	4.8	47.7	1.0	18.0	0.0	41.1	1.9	0.2	4.0	2.6	1.8	0.0	0.4	0.0	1.3	0.7	13.5	29.9	0.9	0.0	0.6	0.7	2.7	3.7	0.5	0.0	3.7	0.1	13.2	0.0	9.0	2.4	0.7	1.4	4.1	0.1	0.4	1.3	1.2	0.5	70.8	0.0	2.0	1.1	4.0	3.7	0.7	0.1	0.7	1.9	8.8	1.3	0.1
PSD2	"DKFZp761B0514, EFA6C"	ENSG00000146005	"Pleckstrin and Sec7 domain containing 2"	Q9BQI7	5	139795808-139844466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 106.3"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 229.9"	"Cancer enriched"	"Detected in single"	43	"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.1;U-2 OS: 1.1;U-698: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054625			Approved	"Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA054625: "	"unprognostic (3.76e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.12e-3)"	0.1	0.3	70.8	0.3	91.3	0.2	0.5	86.5	63.1	0.8	22.0	0.2	0.1	0.2	1.6	0.0	0.4	0.2	0.2	58.7	76.3	0.1	0.1	0.1	0.0	90.6	106.2	0.1	0.4	0.0	0.9	0.0	79.2	0.2	0.1	4.1	1.7	0.4	0.3	0.1	0.1	0.1	70.5	0.2	0.1	1.1	106.3	1.0	0.1	0.0	0.1	0.1	0.2	56.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.0	0.0	0.2	0.0	1.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	91.3	86.5	63.1	58.7	76.3	90.6	106.2	79.2	70.5	106.3	56.3	0.0	0.0	0.0	229.9	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	2.6	0.0	52.8	24.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSMC6	p42	ENSG00000100519	"Proteasome 26S subunit, ATPase 6"	P62333	14	52707178-52728590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042823	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042823: AB_2678188"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.14e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.67e-1)"	43.4	48.4	38.8	47.3	39.2	44.1	58.1	41.2	54.0	44.0	37.4	52.2	50.0	47.6	49.2	65.1	49.2	36.5	78.7	39.8	42.1	65.9	87.1	39.6	55.4	41.1	41.0	51.0	43.7	59.9	5.5	54.9	42.0	45.3	54.3	60.1	37.9	45.6	118.1	44.6	46.6	56.8	41.5	38.8	46.5	31.4	41.0	56.3	54.3	106.7	67.0	57.2	7.9	44.1	182.0	115.0	135.4	99.0	92.4	95.8	146.0	139.3	133.1	220.8	165.1	142.6	143.5	156.8	169.8	121.6	111.5	134.0	173.9	121.9	230.6	151.2	74.5	115.0	91.3	153.5	111.0	164.9	106.8	71.8	118.4	112.1	111.6	120.1	141.2	77.4	174.2	64.7	161.8	163.2	129.5	111.8	108.7	170.1	153.8	108.4	237.2	70.7	144.6	178.5	96.0	71.2	123.8	76.5	122.3	120.8	156.4	117.0	108.9	121.2	171.0	95.8	145.2	45.6	127.0	175.8	79.1	110.5	112.9	77.5	62.4	67.0	51.2	71.9	59.5	63.4	62.7	56.4	73.9	56.4	59.6	59.0	52.7	55.6	73.0	38.5	85.4	75.4	38.8	39.2	41.2	54.0	39.8	42.1	41.1	41.0	42.0	41.5	41.0	44.1	81.2	70.5	58.9	23.5	74.2	86.2	141.9	187.1	50.1	65.5	55.3	51.3	76.6	62.9	140.6	57.0	68.8	162.2	69.4	73.5	135.0	131.0	30.4	92.8	75.3	78.2	70.4	85.2	37.4	106.9	139.9	72.1	38.7	96.3	67.7	68.7	50.0	84.4	92.1	62.2	39.0	58.9	109.9	71.3	67.9	19.9	67.1	61.4	80.0	20.6	90.9	64.6	52.5	38.2	46.7	116.2	46.2	65.5	64.0	85.2	72.5	140.2	116.4	107.6	72.3	66.5	130.6	63.4	82.8	48.9	72.0	237.5	65.0	79.7	73.4	116.6
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888732-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	16.5	4.6	7.5	2.3	8.1	19.2	4.8	8.0	10.0	5.8	11.8	13.8	11.5	7.1	2.2	6.2	6.4	3.8	5.5	7.9	8.1	10.8	4.6	6.0	5.7	9.0	8.9	5.9	10.6	4.8	3.5	3.9	8.3	4.6	2.2	3.6	8.8	6.7	18.5	5.9	6.2	3.3	8.3	8.9	14.9	5.1	8.7	6.6	5.1	6.0	3.2	4.1	5.5	9.4	54.8	81.8	6.7	12.2	11.2	11.6	13.9	54.5	17.8	27.3	15.5	60.0	6.3	40.5	45.0	28.6	9.2	22.1	20.0	29.1	16.3	78.5	41.6	33.3	40.9	30.5	27.5	23.3	22.7	20.4	14.0	30.4	11.7	9.9	16.6	24.7	30.1	5.3	17.6	63.2	47.1	17.8	14.0	7.1	63.4	35.6	18.3	24.9	13.4	53.9	14.1	19.3	54.4	7.7	29.3	5.8	23.3	11.3	43.3	25.4	29.0	50.1	38.4	30.4	73.0	62.1	45.5	30.1	23.8	41.8	43.6	53.0	33.9	46.2	27.3	47.6	32.6	31.0	38.5	38.5	25.0	21.2	41.3	29.3	41.7	63.7	48.1	51.6	7.5	8.1	8.0	10.0	7.9	8.1	9.0	8.9	8.3	8.3	8.7	9.4	22.8	48.1	33.7	10.1	32.6	60.5	11.4	64.1	67.2	7.3	40.9	34.8	8.0	34.3	40.0	35.0	18.8	30.3	45.8	66.6	52.8	116.9	34.9	32.6	28.7	29.7	46.6	121.4	12.9	121.4	30.7	30.5	42.8	27.4	44.4	11.0	33.9	26.8	39.8	15.2	10.7	66.5	54.9	37.9	55.3	11.4	37.9	43.6	55.2	7.5	93.9	17.2	35.0	7.1	18.7	138.2	64.2	38.7	73.2	9.5	146.8	100.7	36.6	14.8	39.5	19.5	46.8	33.9	37.5	69.4	71.6	37.8	44.9	12.9	67.7	12.8
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 72.4;lymphoid tissue: 63.4;skeletal muscle: 33.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 44.6;Erythroid cells: 46.7;Macrophages: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 112.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 102.0;HMC-1: 108.3"	"Low region specificity"	"Detected in all"							"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.4	4.6	0.9	11.1	0.9	72.4	8.5	0.8	1.5	4.2	1.8	4.4	3.6	2.9	1.4	5.1	4.0	5.3	2.1	0.8	1.1	3.7	10.0	11.4	6.3	1.8	1.2	3.6	3.5	3.8	2.9	12.1	1.5	8.0	5.1	2.8	5.9	2.7	33.0	8.8	4.5	4.6	1.1	63.4	6.4	1.3	1.2	3.9	2.1	5.8	4.9	9.6	4.3	1.4	2.9	0.0	3.8	0.1	0.9	6.7	20.6	15.0	7.4	5.3	4.5	11.6	4.0	0.1	0.9	5.0	0.0	36.2	20.3	28.1	6.6	0.0	3.2	102.0	4.6	0.2	5.9	6.0	108.3	5.0	34.4	5.0	16.3	4.8	10.6	0.2	24.8	0.1	23.1	3.6	0.9	0.1	2.3	0.0	0.1	0.1	7.5	4.9	11.2	37.0	0.3	2.1	2.4	10.3	0.5	28.2	32.6	12.0	7.6	0.6	8.2	0.8	0.2	0.1	0.3	0.1	1.3	0.2	0.4	77.3	25.3	112.8	10.4	35.0	3.6	0.1	6.2	7.7	25.3	0.1	7.2	8.8	13.5	2.9	36.4	0.9	4.1	20.0	0.9	0.9	0.8	1.5	0.8	1.1	1.8	1.2	1.5	1.1	1.2	1.4	1.7	12.8	11.6	0.7	2.4	13.8	19.4	44.6	15.4	0.7	11.1	17.1	3.5	2.8	24.9	0.0	0.0	26.6	21.8	0.6	3.9	9.6	2.0	4.1	2.6	3.1	1.2	46.7	1.6	3.9	3.3	4.2	11.2	11.2	43.6	20.6	7.1	17.3	14.6	0.0	1.4	4.2	6.1	42.5	5.5	7.3	2.8	58.7	7.2	2.8	37.4	10.9	25.7	2.0	0.9	17.7	0.3	2.2	3.6	39.7	0.5	4.1	13.0	0.4	6.6	3.1	7.7	1.1	1.6	7.3	10.2	8.8	17.8	7.1	2.4	21.8
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47856673-48111197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 479.8"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BEWO: 12.4;Hep G2: 21.8;LHCN-M2: 9.6;SuSa: 20.1;TIME: 9.9;WM-115: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	0.5	0.1	0.6	0.0	0.6	0.0	0.3	0.0	1.5	0.6	0.1	0.3	0.1	0.3	0.6	0.3	0.5	0.2	0.5	0.8	0.5	0.4	0.3	0.5	0.0	0.2	1.0	0.2	0.2	0.0	0.9	0.3	0.0	0.5	0.1	0.8	0.5	1.0	0.1	0.0	0.1	0.3	0.5	0.0	0.1	0.2	0.3	0.0	0.8	0.1	0.0	0.3	0.3	0.4	0.0	0.0	9.4	0.0	1.3	3.9	12.4	1.2	2.8	0.0	0.4	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.2	21.8	0.5	0.0	0.0	6.2	5.4	0.0	0.1	4.4	1.8	2.5	0.0	0.0	9.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.5	0.1	0.0	0.0	20.1	0.0	0.0	9.9	2.3	1.9	0.0	0.2	0.0	0.0	0.0	3.3	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.5	0.8	0.5	0.2	1.0	0.0	0.5	0.3	0.4	0.5	0.0	1.1	6.5	0.0	0.1	0.0	1.0	0.0	1.0	0.4	0.3	0.2	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	90.6	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	479.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	89.9	0.0	0.6	0.0	2.5	2.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.9	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537376	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 109.4;skin 1: 53.9;vagina: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 132.1;Gastric mucus-secreting cells: 59.1;Intestinal goblet cells: 42.5;Paneth cells: 97.6;Proximal enterocytes: 80.2;Squamous epithelial cells: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 22.1;CAPAN-2: 41.4;HaCaT: 33.9;hTCEpi: 45.0;OE19: 57.0;RT4: 26.4;T-47d: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.5	0.1	0.6	3.6	1.7	0.8	3.8	2.9	1.7	19.8	0.0	26.5	28.9	0.4	0.1	109.4	0.4	3.5	0.2	0.6	0.9	0.8	5.2	2.6	0.6	1.6	1.0	0.3	3.6	0.0	0.2	0.3	1.7	3.1	15.7	0.8	19.1	0.6	0.6	53.9	22.2	0.8	0.6	0.8	26.2	0.3	1.1	0.3	0.2	0.0	6.4	9.8	43.2	5.4	22.1	2.6	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	41.4	0.1	7.2	0.0	0.1	33.9	0.0	0.1	0.0	5.4	0.4	0.0	10.2	0.1	0.1	0.0	6.7	0.0	45.0	0.0	0.2	0.2	0.0	0.1	0.2	2.5	0.2	12.5	0.0	0.2	0.2	57.0	15.5	0.1	1.2	0.5	0.0	26.4	0.3	2.2	2.6	8.1	0.0	0.1	25.2	1.6	0.2	0.3	0.4	0.8	0.3	0.5	0.1	0.1	0.4	0.5	1.1	0.4	0.7	0.1	0.1	0.5	0.5	0.3	0.1	0.0	1.3	0.3	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.3	0.6	1.7	2.9	1.7	0.6	0.9	1.6	1.0	1.7	0.6	1.1	5.4	0.3	12.8	25.6	0.3	1.4	5.9	2.6	7.7	5.2	2.2	7.0	4.3	0.4	12.8	14.9	0.0	2.1	0.2	0.2	132.1	0.0	1.4	0.2	0.4	0.5	3.2	5.4	0.0	0.1	1.6	0.2	1.4	59.1	1.3	9.5	0.2	0.4	1.7	0.6	0.0	0.1	42.5	2.0	2.2	2.0	0.0	0.3	2.6	0.0	0.0	1.0	1.6	1.0	0.0	0.8	17.6	97.6	0.0	0.1	1.5	80.2	0.2	8.9	3.7	0.0	2.3	1.1	0.2	0.3	48.0	15.5	0.1	2.0	0.2	32.1	15.9
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase non-receptor type 12"	Q05209	7	77537295-77640069	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		770000	"Cluster 40: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	60.5	30.1	24.2	43.9	26.6	69.9	50.3	29.2	31.6	40.9	25.9	48.9	18.9	38.6	18.6	38.5	39.6	40.2	39.0	25.1	27.3	36.1	30.9	65.0	27.5	28.5	27.8	34.6	20.1	21.0	21.9	74.7	30.5	26.4	27.7	30.9	23.8	33.2	24.6	36.9	29.7	40.2	26.7	52.7	27.1	30.1	32.7	33.9	31.0	44.5	27.5	46.7	39.6	30.2	72.4	43.5	100.6	51.8	69.1	71.7	54.2	73.3	93.0	56.6	80.0	21.6	109.9	8.6	23.2	86.3	123.6	50.2	34.2	73.4	113.3	21.2	19.2	44.9	44.2	88.4	67.7	25.8	28.8	59.0	80.3	123.2	157.6	101.0	121.6	2.1	54.9	12.2	182.6	49.4	3.6	71.9	81.7	97.6	49.2	15.1	80.6	4.5	97.6	38.5	12.5	66.6	90.4	81.5	73.4	172.2	39.5	93.9	89.3	121.4	73.1	45.0	141.3	12.6	7.4	22.2	71.6	65.9	215.7	3.6	4.1	6.8	3.1	2.8	1.3	2.3	1.1	2.6	3.8	1.0	0.6	3.3	9.5	13.3	5.3	0.3	1.6	2.7	24.2	26.6	29.2	31.6	25.1	27.3	28.5	27.8	30.5	26.7	32.7	30.2	139.3	70.5	56.2	30.0	18.2	68.8	60.0	55.9	23.9	16.7	40.9	26.3	41.3	28.6	46.4	20.2	8.4	40.0	89.0	31.2	3.9	42.1	3.5	43.9	62.4	114.4	12.1	16.6	65.8	39.6	58.7	54.6	21.4	87.2	14.5	21.7	119.2	24.6	50.1	35.3	58.0	21.7	28.5	82.0	121.3	6.7	46.6	96.1	35.6	93.7	54.9	66.9	163.7	70.4	67.3	75.0	21.4	47.0	17.6	62.0	10.9	19.2	23.2	15.2	65.7	127.9	66.8	51.2	71.4	29.8	101.4	72.1	27.3	24.4	23.3	104.8
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase non-receptor type 4"	P29074	2	119759922-119984899	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 224.3;Horizontal cells: 161.5;Inhibitory neurons: 187.5;NK-cells: 247.2;Oligodendrocyte precursor cells: 200.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 37.3"	"Group enriched"	"Detected in many"	4	"gdT-cell: 35.0;MAIT T-cell: 28.1;memory CD4 T-cell: 16.9;memory CD8 T-cell: 27.9;naive CD8 T-cell: 19.2;NK-cell: 24.4;T-reg: 11.0"	"Group enriched"	"Detected in many"	16	"NK-cells: 24.4;T-cells: 35.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	4.5	3.8	5.9	3.6	5.0	5.1	4.7	37.3	10.1	5.7	0.0	3.4	5.1	4.1	4.2	4.1	5.5	3.7	5.7	5.2	2.7	7.4	4.2	5.2	5.4	0.1	9.6	5.2	2.8	6.3	3.5	2.5	1.4	3.5	2.4	12.1	4.1	2.5	8.0	3.0	2.8	2.8	0.0	5.9	5.7	4.9	12.6	8.1	14.0	12.8	4.2	3.2	2.6	5.9	7.4	4.3	5.0	7.3	4.8	5.0	9.1	3.2	9.3	1.8	4.9	6.2	10.9	4.1	7.6	3.5	5.2	5.3	4.4	5.1	4.8	12.6	3.6	3.7	3.5	6.1	3.2	3.9	2.6	4.5	9.6	8.5	3.7	6.0	8.2	4.8	5.7	4.8	5.0	5.0	5.2	4.4	7.3	4.0	6.9	3.4	9.6	6.9	6.7	10.0	6.8	8.5	4.2	5.8	4.0	4.0	2.8	2.4	10.7	0.0	6.1	1.9	4.0	8.9	13.7	6.6	4.7	0.1	3.0	0.3	0.2	1.8	35.0	0.5	28.1	0.6	16.9	27.9	0.5	0.6	5.2	19.2	0.6	24.4	0.7	0.3	11.0	10.4	5.9	5.0	37.3	10.1	5.2	2.7	0.1	9.6	1.4	0.0	12.6	5.9	20.5	3.2	14.6	128.9	24.4	8.2	15.5	8.5	27.3	55.7	13.9	11.2	17.9	10.0	8.3	16.5	104.3	10.5	95.5	7.3	7.9	8.0	5.4	18.2	15.7	15.0	9.1	35.4	224.3	7.3	11.8	11.3	16.8	15.8	11.4	47.9	15.0	11.0	4.0	161.5	187.5	9.9	12.2	8.6	7.6	8.8	17.4	9.0	8.8	38.4	11.8	24.9	247.2	200.6	113.6	6.3	9.6	14.3	30.1	12.7	10.6	13.6	8.8	79.8	0.0	25.5	9.0	31.4	26.4	12.8	6.7	3.7	79.4	23.3	11.5	9.5
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase receptor type B"	P23467	12	70515870-70637440	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		14000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	26.7	9.4	16.0	4.7	14.1	0.1	18.8	12.3	12.1	12.8	7.1	10.9	7.5	12.3	4.4	6.8	10.8	14.7	23.2	10.1	12.4	22.5	16.7	35.7	3.2	15.9	14.2	4.0	6.2	7.8	4.7	32.6	18.1	6.3	11.1	1.4	3.3	8.0	17.1	4.1	9.3	18.1	12.4	30.0	6.2	2.5	19.0	3.0	14.8	38.8	3.4	7.7	5.3	11.9	4.4	0.3	1.9	0.2	0.0	0.1	0.9	0.9	4.2	2.2	5.2	0.1	3.4	1.7	24.3	0.6	0.4	15.2	0.2	0.7	7.8	1.3	0.7	0.4	1.7	1.1	0.2	0.7	0.0	0.1	0.7	6.1	0.0	19.7	61.4	0.0	3.6	1.0	1.3	0.0	0.1	0.0	2.3	4.4	0.9	0.1	1.6	0.9	11.3	1.8	0.0	0.8	1.6	0.0	3.5	0.4	0.0	1.5	90.3	0.9	0.9	0.4	5.4	1.1	0.9	0.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	14.1	12.3	12.1	10.1	12.4	15.9	14.2	18.1	12.4	19.0	11.9	215.9	0.0	13.2	2.0	3.1	3.7	0.8	1.0	0.0	7.1	0.9	0.9	12.3	11.5	1.3	3.7	0.0	0.0	2.0	12.8	0.0	1.5	4.6	2.2	0.7	211.5	0.0	16.0	52.5	0.9	0.0	7.3	1.5	4.0	25.2	0.5	504.0	4.7	0.4	5.0	68.8	6.4	0.0	20.0	4.6	3.0	1.2	1.2	5.4	164.9	0.0	0.4	0.0	2.5	2.9	12.2	11.1	0.0	0.1	0.8	3.2	0.1	0.2	0.9	0.0	6.4	5.2	0.7	0.7	0.9	1.6	0.0	1.0	1.8	6.8	0.7
PTPRCAP	"CD45-AP, LPAP"	ENSG00000213402	"Protein tyrosine phosphatase receptor type C associated protein"	Q14761	11	67435510-67437682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 79.7;lymphoid tissue: 174.1"	"Group enriched"	"Detected in some"	6	"B-cells: 203.3;Plasma cells: 283.5;T-cells: 233.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 351.1;HDLM-2: 242.3;HL-60: 140.6;MOLT-4: 206.8;NB-4: 996.9;U-698: 248.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Low region specificity"	"Detected in many"			HPA043734	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA043734: AB_10962214"																		7.1	2.9	3.0	73.0	2.9	27.0	5.3	2.6	4.9	7.0	3.1	14.3	14.0	4.6	0.0	7.9	7.9	3.0	3.5	2.5	2.5	9.9	8.9	14.4	126.5	3.9	2.8	5.0	3.8	0.3	4.2	0.6	3.4	10.6	2.4	0.0	10.2	0.6	2.2	4.2	79.7	0.9	3.4	174.1	24.7	1.5	3.0	109.2	13.0	0.2	51.3	7.5	7.0	3.5	0.4	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.2	351.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	242.3	0.5	0.2	0.9	0.0	0.0	140.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	95.5	1.1	33.3	0.1	3.7	206.8	996.9	0.0	0.0	0.3	65.8	0.2	0.6	0.0	1.1	0.2	0.4	0.2	0.0	1.1	0.0	0.6	0.3	1.4	0.0	1.5	0.0	0.3	0.3	0.3	248.9	0.0	0.3	0.1	23.6	6.7	75.0	1559.9	5.6	1322.2	1334.4	955.3	1380.5	12.7	1714.2	688.5	1083.9	33.4	826.7	8.0	848.7	1374.2	1237.9	3.0	2.9	2.6	4.9	2.5	2.5	3.9	2.8	3.4	3.4	3.0	3.5	0.0	0.0	0.0	7.2	203.3	12.7	0.0	0.9	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	15.1	0.2	0.0	0.0	4.4	17.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.3	20.6	0.0	0.0	5.0	39.2	7.5	0.5	0.0	1.0	0.5	3.1	0.0	0.0	0.0	283.5	0.0	0.0	0.1	1.4	0.0	0.0	0.0	3.5	0.0	0.0	1.6	9.7	0.0	233.3	0.0	0.0	0.0
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase receptor type G"	P23470	3	61561569-62297609	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 356.8;Excitatory neurons: 416.1;Inhibitory neurons: 684.3;Microglial cells: 771.0;Oligodendrocyte precursor cells: 920.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 81.7;HSkMC: 61.1"					"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"		NA	NA		520000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA000546: , HPA064237: AB_2685221"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	18.0	13.2	7.6	4.6	7.8	0.0	12.8	4.9	10.4	11.9	23.4	8.2	3.7	10.6	8.4	4.1	9.0	8.3	10.0	13.7	6.2	14.4	5.8	12.8	1.8	8.4	7.2	12.0	3.9	26.6	5.2	9.9	5.9	7.8	6.1	8.6	5.2	8.4	7.4	4.5	5.9	13.0	10.0	7.0	5.8	7.7	9.1	2.1	13.1	10.4	1.7	7.0	6.7	5.0	0.0	5.3	27.3	0.0	81.7	41.6	13.5	17.6	28.5	18.2	24.4	13.2	0.5	0.6	10.1	20.7	14.5	0.2	13.4	13.6	28.3	1.5	7.7	1.4	0.1	15.0	27.5	7.5	0.1	61.1	5.3	25.9	30.9	5.8	19.7	2.0	0.0	17.3	16.3	7.6	0.0	0.1	17.0	0.1	0.0	11.9	8.6	0.6	18.2	8.2	2.1	4.5	4.3	0.1	6.9	11.2	0.2	0.3	46.0	25.4	24.1	41.0	14.7	5.5	6.8	0.0	19.2	3.2	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.6	7.8	4.9	10.4	13.7	6.2	8.4	7.2	5.9	10.0	9.1	5.0	45.3	12.8	32.4	356.8	2.2	9.2	6.4	5.0	13.1	98.5	9.6	6.3	12.5	8.6	5.8	22.0	6.2	10.5	0.9	12.1	5.9	9.6	3.6	14.4	31.9	55.5	24.6	0.0	416.1	1.8	0.8	47.7	4.1	30.5	0.0	64.6	90.3	32.7	19.7	154.8	684.3	8.9	22.4	2.9	8.8	4.3	66.5	1.1	17.8	771.0	0.6	40.8	2.1	920.3	11.8	5.3	5.6	56.8	4.2	10.9	13.9	18.2	2.8	5.7	72.3	81.1	60.6	2.0	8.6	2.1	4.8	12.6	2.3	20.0	12.1	2.7
PTPRM	"hR-PTPu, PTPRL1, RPTPU"	ENSG00000173482	"Protein tyrosine phosphatase receptor type M"	P28827	18	7566782-8406861	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 142.0;Astrocytes: 188.1;Inhibitory neurons: 751.6;Microglial cells: 263.3;Oligodendrocyte precursor cells: 224.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 4.7"	"Group enriched"	"Detected in many"	33	"dendritic cells: 1.8;T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003891, CAB022442, CAB022443"	Supported		Approved	"Plasma membrane"		NA	Yes		130000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB022442: , CAB022443: , HPA003891: AB_2667073"	"unprognostic (2.59e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (1.07e-4)"	53.1	24.1	18.9	11.9	37.6	1.2	41.8	13.0	27.7	18.4	44.2	25.3	8.7	24.2	11.9	14.2	23.3	32.4	61.2	12.7	38.7	29.5	11.8	38.9	15.5	21.7	53.0	26.4	13.2	23.4	16.1	33.2	34.3	16.7	11.5	19.3	10.9	36.0	52.5	12.3	15.1	24.8	5.8	23.1	18.4	22.8	47.6	16.7	54.8	63.4	11.9	23.9	12.2	14.4	4.6	33.4	15.7	0.2	98.0	67.4	38.7	41.1	35.6	26.9	39.5	30.9	7.1	0.0	39.0	49.1	0.5	0.3	0.2	14.3	36.9	0.5	7.2	0.0	22.2	15.2	27.9	0.0	0.4	77.1	29.3	14.9	42.1	51.1	27.2	0.0	0.0	13.8	21.8	0.7	13.7	0.3	2.6	9.9	7.3	0.5	13.5	63.9	64.9	57.6	1.4	8.6	1.1	0.2	34.6	24.9	0.2	0.0	28.2	54.9	34.6	26.4	7.2	1.1	0.4	0.3	46.8	0.2	10.4	0.0	0.0	0.0	2.8	0.0	1.1	0.0	3.8	4.7	0.0	0.0	1.0	2.0	0.0	0.0	0.0	1.8	0.7	1.1	18.9	37.6	13.0	27.7	12.7	38.7	21.7	53.0	34.3	5.8	47.6	14.4	142.0	44.8	36.0	188.1	1.1	6.0	7.3	3.0	2.8	28.3	2.5	3.2	26.7	14.3	7.1	5.5	2.1	11.4	5.4	0.9	1.9	17.6	25.9	28.9	15.6	68.9	1.8	0.4	70.1	8.3	3.4	14.0	8.2	59.6	2.5	13.0	47.2	25.3	9.9	0.0	751.6	1.4	0.0	8.0	5.7	42.0	2.8	5.1	30.2	263.3	0.6	2.9	3.1	224.7	50.3	14.3	1.2	5.3	2.3	8.3	3.0	13.3	15.6	2.2	6.6	7.4	9.9	8.6	9.9	0.9	2.8	12.6	5.7	3.7	0.8	8.6
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436850-157443633	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 231.5;urinary bladder: 191.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 16.2;Fibroblasts: 44.7;Glandular and luminal cells: 24.0;Langerhans cells: 23.6;Macrophages: 27.0;Melanocytes: 14.2"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.9;thalamus: 4.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1219.3;ASC TERT1: 1751.7;BJ hTERT+: 1201.8;HHSteC: 2261.1;HSkMC: 2364.2;hTEC/SVTERT24-B: 1276.5;TIME: 1761.1;U-2197: 1605.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1090000	970000	"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	231.5	11.1	0.4	38.8	0.4	89.0	57.9	0.6	1.9	2.8	1.1	13.0	0.8	2.5	0.5	2.9	21.4	7.7	46.8	0.6	0.5	6.8	2.6	83.2	0.9	0.7	0.6	1.4	41.6	1.1	4.4	11.4	0.6	6.9	2.3	0.4	5.4	0.5	5.2	25.4	9.7	5.7	0.3	23.6	24.8	0.7	4.0	1.6	5.8	0.5	0.3	191.7	3.1	0.4	1.2	0.0	752.4	0.2	1219.3	1751.7	0.3	132.3	1201.8	56.2	60.9	0.7	7.9	0.2	460.6	157.4	87.6	0.0	0.3	1.1	110.5	0.8	0.3	2.0	0.1	0.0	2261.1	2.5	0.0	2364.2	0.8	1276.5	429.8	110.2	266.4	0.1	0.3	0.0	380.1	0.0	0.3	2.9	11.2	0.0	4.6	0.2	0.0	0.2	5.3	53.1	6.0	0.8	7.6	1.0	0.9	0.1	0.6	2.4	1761.1	252.2	12.2	1605.1	23.0	0.2	0.5	0.9	52.8	6.4	74.2	0.0	0.3	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.6	1.9	0.6	0.5	0.7	0.6	0.6	0.3	4.0	0.4	2.3	0.0	1.7	0.0	0.1	1.7	1.7	0.3	0.0	1.8	3.6	0.6	0.6	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	7.2	2.4	16.2	10.3	5.1	0.0	0.0	0.5	0.0	0.1	44.7	0.0	24.0	0.0	0.7	3.3	0.0	2.6	0.0	1.0	0.0	0.0	10.0	23.6	1.2	0.3	27.0	14.2	0.0	2.3	0.5	0.0	0.0	0.3	0.3	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.8	0.0	4.0	7.2	0.0	0.4	0.4	1.0	0.3	0.4	0.0	0.0	0.4
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;retina: 4.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 61.0;Excitatory neurons: 57.2;Inhibitory neurons: 69.5;Late spermatids: 22.0;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 27.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.1;JURKAT: 4.3;NTERA-2: 4.8;SH-SY5Y: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: AB_2680145"	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	0.3	0.4	7.7	0.2	8.3	0.0	0.2	10.5	9.0	1.3	0.5	0.3	0.1	2.0	0.6	0.2	0.4	0.8	0.4	8.7	7.7	0.4	0.0	0.2	0.2	6.6	6.7	0.5	0.0	0.0	3.0	0.2	7.4	0.5	0.1	4.1	0.3	0.6	0.1	0.0	0.2	1.3	6.1	0.6	0.2	2.6	7.3	0.1	0.2	0.2	0.1	0.2	0.8	6.5	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	2.0	0.0	0.7	0.0	3.1	1.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.9	0.0	0.7	3.0	4.3	0.3	0.4	0.1	0.0	0.6	0.0	4.8	0.0	0.2	1.6	0.8	0.0	0.0	0.0	0.8	5.7	0.0	0.0	0.0	2.2	0.0	0.0	1.9	2.0	2.5	0.0	0.3	0.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.3	10.5	9.0	8.7	7.7	6.6	6.7	7.4	6.1	7.3	6.5	0.5	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	13.3	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	17.3	0.2	3.2	0.5	0.0	0.0	57.2	0.0	0.0	1.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	20.2	69.5	0.0	0.0	0.0	0.3	22.0	0.6	0.1	0.0	12.2	0.0	10.8	0.0	49.3	27.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	1.3	4.2	1.5	0.0	0.0	0.0	0.1	1.8	0.0	0.0
PXDC1	C6orf145	ENSG00000168994	"PX domain containing 1"	Q5TGL8	6	3722614-3751713	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 103.6;Basal prostatic cells: 115.1;Extravillous trophoblasts: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 151.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019246			Approved	"Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA019246: AB_2670113"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (2.82e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.84e-1)"	68.0	14.9	33.7	14.7	34.6	1.4	50.5	35.1	36.5	30.3	49.3	37.2	29.9	31.4	15.6	25.5	28.3	48.3	36.0	33.0	35.2	25.9	168.7	47.6	13.0	39.5	36.1	19.2	26.7	14.2	13.9	61.8	36.4	29.8	7.7	3.1	39.3	19.8	16.9	38.7	26.5	26.7	36.9	19.0	28.5	5.6	35.7	7.4	44.6	15.6	6.7	46.3	28.7	36.0	44.5	17.5	28.6	19.9	87.9	66.4	99.4	75.6	57.7	62.6	48.2	30.6	8.8	0.0	49.0	123.9	48.0	34.4	5.7	20.8	29.3	43.2	6.6	0.0	14.7	26.8	151.4	0.1	0.2	59.0	67.2	38.8	83.2	52.7	70.2	3.0	0.1	5.9	49.7	2.7	0.1	0.5	1.3	9.0	27.3	2.5	16.0	2.1	24.4	35.7	3.1	1.6	51.7	52.4	115.5	38.3	4.6	2.7	77.8	56.9	24.7	22.2	54.4	0.1	0.1	0.2	13.6	0.1	40.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	33.7	34.6	35.1	36.5	33.0	35.2	39.5	36.1	36.4	36.9	35.7	36.0	103.6	48.1	8.6	8.1	8.1	48.3	115.1	11.8	40.9	0.6	28.0	27.7	8.1	18.6	11.7	7.3	0.0	32.8	1.5	0.6	11.7	33.2	0.5	4.7	18.3	39.6	0.0	5.3	0.1	51.6	131.0	62.1	14.8	5.6	3.8	1.6	45.7	68.7	25.1	0.0	2.6	1.4	8.2	9.7	80.8	0.9	22.7	31.6	24.9	9.4	22.0	16.0	0.0	11.1	2.5	77.6	0.1	18.0	4.4	55.8	25.7	20.4	9.6	0.8	0.0	38.7	33.4	0.6	4.5	17.5	33.1	78.4	3.2	0.4	1.2	47.4
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.2;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		6500000	"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	0.3	2.6	7.9	1.1	10.2	1.0	11.9	0.0	11.9	3.0	0.0	4.9	5.1	0.8	0.4	14.0	1.1	3.8	0.1	13.3	5.2	0.3	1.3	7.2	0.5	0.0	0.1	0.2	4.1	2.3	1.0	1.1	0.6	20.5	5.3	1.0	14.0	1.0	0.2	15.6	4.9	0.9	0.1	1.7	44.1	4.5	2.6	1.4	0.3	0.5	5.2	6.2	5.2	3.3	7.8	22.4	0.8	0.0	1.5	19.3	0.0	1.7	13.5	1.8	1.3	0.0	8.6	1.3	0.1	3.9	16.7	14.5	0.2	9.0	0.5	0.0	0.5	63.3	5.0	0.0	2.6	3.4	7.0	15.3	46.6	25.5	56.0	21.1	1.2	0.3	0.0	3.9	16.1	7.9	0.2	7.4	0.2	14.0	14.7	0.0	0.0	0.3	4.1	28.9	0.2	10.3	2.2	13.4	0.0	0.1	8.3	0.3	0.3	18.8	0.6	9.8	2.0	0.4	0.0	0.0	165.2	35.6	0.9	0.6	0.0	0.1	2.2	0.0	0.5	0.0	0.7	1.1	0.0	0.0	0.2	1.0	0.2	2.6	0.0	0.0	0.0	1.6	7.9	10.2	0.0	11.9	13.3	5.2	0.0	0.1	0.6	0.1	2.6	3.3	0.3	48.1	37.6	3.3	0.9	25.6	8.6	18.2	8.0	2.4	59.8	25.3	0.5	8.6	36.9	5.5	2.1	6.5	15.0	5.7	1.9	7.2	259.3	30.9	4.4	1.9	4.2	3.4	101.0	41.0	4.5	2.0	178.4	64.0	246.6	0.4	2.5	0.9	0.6	6.7	75.8	31.3	20.3	0.6	2.7	209.9	2.1	38.1	7.2	2.8	2.1	1.4	29.9	98.5	2.6	34.0	18.6	0.4	3.2	78.9	3.0	0.0	15.8	0.4	6.6	0.3	2.2	7.9	1.4	79.2	49.2	2.9	13.9	0.5	7.9	42.2
RAB43	"ISY1, RAB11B, RAB41"	ENSG00000172780	"RAB43, member RAS oncogene family"	Q86YS6	3	129087569-129122801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 46.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 12.0;Gastric mucus-secreting cells: 5.6;Plasma cells: 9.2;Squamous epithelial cells: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 11.2;T-cells: 2.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046840, HPA060085"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA046840: , HPA060085: AB_2684199"	"unprognostic (3.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	7.6	8.3	9.5	10.4	9.7	22.3	7.1	11.6	8.1	7.3	9.3	7.9	8.0	6.6	2.9	5.9	7.3	9.4	4.2	7.9	5.8	10.4	46.9	14.8	17.4	10.0	7.5	9.9	10.3	5.2	6.7	3.9	8.4	9.9	2.6	0.7	10.2	5.0	1.8	4.0	6.9	2.7	7.3	10.9	8.1	7.5	7.1	12.9	22.7	1.4	4.6	7.3	4.0	6.7	22.4	6.0	1.4	5.7	2.7	1.2	8.3	7.6	5.1	4.4	3.5	9.4	9.4	0.6	17.1	5.7	5.9	9.2	0.5	8.8	1.0	11.2	5.6	1.5	1.1	12.5	25.9	5.1	12.7	7.1	5.4	2.2	0.5	1.9	8.7	13.0	2.5	10.8	6.1	9.7	5.0	9.8	7.0	5.2	10.5	10.8	3.2	6.6	14.1	18.7	0.4	2.7	3.3	7.0	14.4	2.2	3.0	5.3	12.5	9.3	6.4	7.6	2.9	16.9	9.8	3.6	8.5	1.0	10.3	0.4	1.2	2.3	1.5	1.5	0.7	0.5	1.5	1.2	0.6	1.0	2.8	2.4	11.2	1.4	0.7	0.9	2.4	1.0	9.5	9.7	11.6	8.1	7.9	5.8	10.0	7.5	8.4	7.3	7.1	6.7	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	12.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.3	0.6	0.4	0.0	0.0	0.0	0.2	0.1	0.5	5.6	0.5	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	9.2	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	2.5	0.1	0.1	1.2	0.2	0.3	0.1
RAD52		ENSG00000002016	"RAD52 homolog, DNA repair protein"	P43351	12	911736-990053	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 34.9;Excitatory neurons: 38.0;Inhibitory neurons: 48.8;Microglial cells: 23.4;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028957			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	"Plasma membrane"	"HPA028957: AB_2672842"	"unprognostic (4.53e-1)"	"unprognostic (8.08e-3)"	"unprognostic (4.68e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-1)"	"prognostic unfavorable (2.22e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.74e-2)"	4.9	4.7	5.9	5.0	8.2	3.6	6.0	7.8	8.4	8.8	5.1	7.2	5.8	7.3	8.4	4.7	6.6	4.2	4.7	7.1	7.0	7.6	6.4	4.0	6.3	7.2	7.3	10.8	6.6	4.9	5.2	5.4	7.6	6.2	7.0	6.8	4.4	6.0	12.3	9.8	6.6	6.1	5.3	6.0	5.5	4.4	7.8	7.0	8.3	6.8	5.9	6.1	5.8	13.7	4.0	15.2	11.6	13.8	12.1	9.7	12.7	7.9	7.5	9.0	8.7	14.8	14.3	12.8	2.4	8.2	7.4	12.0	9.4	5.4	7.7	17.7	8.2	14.6	16.2	10.0	7.0	15.6	4.2	5.5	9.4	9.1	28.3	17.6	7.4	12.4	9.8	7.5	8.6	8.7	10.8	15.7	15.4	10.0	9.9	10.8	11.6	4.8	9.4	7.1	4.3	5.0	10.3	10.8	6.0	16.8	10.2	7.5	7.4	12.3	14.6	9.8	8.6	2.7	4.6	13.5	6.3	6.9	4.5	7.0	2.1	1.5	2.9	1.9	3.5	2.9	3.0	2.5	2.7	4.0	3.3	3.2	2.0	2.6	2.5	6.0	2.9	1.0	5.9	8.2	7.8	8.4	7.1	7.0	7.2	7.3	7.6	5.3	7.8	13.7	2.5	3.2	5.9	34.9	3.4	1.8	1.4	1.7	4.0	4.2	2.7	2.7	3.6	2.8	3.2	3.7	2.1	4.8	4.5	5.9	1.9	2.3	4.0	2.3	4.5	3.4	1.8	4.2	38.0	1.6	2.8	3.3	5.1	2.6	5.7	4.5	0.7	2.6	2.5	3.3	48.8	2.0	0.0	1.0	2.9	7.5	0.6	2.6	0.0	23.4	2.8	1.4	1.0	30.2	54.5	0.9	3.4	0.7	2.3	1.6	3.9	1.8	1.7	2.6	6.6	4.2	3.9	4.0	4.7	1.9	1.0	2.1	2.6	2.2	3.3	0.8
RAI2		ENSG00000131831	"Retinoic acid induced 2"	Q9Y5P3	X	17800049-17861337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 41.9;Leydig cells: 49.0;Peritubular cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.8"	"Cell line enriched"	"Detected in some"	10	"ASC diff: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051054	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA051054: AB_2681328"	"unprognostic (3.45e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (3.39e-14)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.80e-2)"	48.0	17.3	9.4	8.3	10.4	0.2	47.2	8.8	11.9	55.3	7.4	33.0	6.7	66.8	9.9	15.5	71.8	24.7	32.9	9.9	9.3	14.4	3.9	28.6	9.6	9.4	8.5	50.9	14.3	10.8	19.3	7.8	9.6	31.8	8.1	8.9	13.8	31.8	12.5	20.3	23.0	30.1	8.6	4.5	28.2	6.0	10.4	5.0	21.6	17.1	9.6	38.9	43.7	8.7	0.0	0.0	0.2	0.0	104.3	10.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.7	0.2	0.6	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.1	1.9	0.0	0.6	0.0	0.0	0.0	5.8	0.0	1.1	1.4	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.8	0.0	0.1	0.0	0.0	0.0	0.1	9.4	10.4	8.8	11.9	9.9	9.3	9.4	8.5	9.6	8.6	10.4	8.7	25.0	12.8	4.5	2.0	0.0	4.1	9.3	0.0	0.6	14.0	13.4	10.4	13.0	12.8	0.6	22.0	0.0	0.1	0.3	0.3	5.9	8.2	0.3	25.0	16.5	15.2	27.6	0.0	10.5	9.8	0.1	24.8	7.7	41.9	0.0	9.7	10.8	0.1	0.5	26.9	17.9	0.7	0.0	0.0	4.2	3.3	49.0	0.9	5.4	14.0	0.6	20.5	0.0	5.0	0.4	4.9	17.5	70.7	0.1	7.9	1.3	1.9	4.4	3.0	0.0	21.0	8.7	0.4	2.7	0.5	2.8	0.0	1.3	0.2	1.6	5.1
RALGAPA2	"AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2"	ENSG00000188559	"Ral GTPase activating protein catalytic subunit alpha 2"	Q2PPJ7	20	20389530-20712644	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 212.2;Microglial cells: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 91.5;SCLC-21H: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042707, HPA043622"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA042707: AB_2678124, HPA043622: AB_2678585"	"unprognostic (7.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (3.77e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.33e-2)"	16.7	6.5	4.6	6.1	6.2	20.6	15.0	10.8	7.6	9.6	5.7	12.2	10.3	8.7	3.7	8.8	10.8	11.3	7.9	4.3	4.8	10.2	27.3	25.2	6.4	6.9	8.0	7.4	17.0	13.1	14.5	17.6	7.5	13.1	12.6	13.4	15.1	5.5	34.4	16.9	10.5	7.0	2.8	7.5	18.3	10.1	13.1	8.0	21.1	21.0	5.4	12.6	8.4	9.5	7.0	4.4	9.2	4.7	5.1	3.6	10.1	1.8	2.0	2.1	3.0	3.8	9.5	3.2	6.1	3.0	10.6	7.1	9.4	8.6	4.0	16.1	4.6	11.1	2.5	6.7	1.8	14.0	6.4	3.1	6.4	3.5	1.7	3.9	13.1	14.9	2.2	6.0	3.8	4.9	5.6	18.5	3.8	22.8	3.9	7.6	6.2	4.5	7.4	91.5	51.4	4.5	6.9	5.2	6.1	8.9	3.6	13.7	3.3	3.7	3.6	2.7	2.6	3.5	2.6	1.8	3.1	9.1	5.4	4.4	1.1	3.6	0.8	0.4	1.2	1.1	0.5	0.8	0.5	0.8	1.0	1.1	4.4	2.7	1.0	1.2	1.0	0.3	4.6	6.2	10.8	7.6	4.3	4.8	6.9	8.0	7.5	2.8	13.1	9.5	90.7	6.4	42.5	212.2	9.7	10.6	10.1	25.9	6.8	47.8	13.5	7.7	9.1	41.5	27.0	14.7	27.1	10.6	14.6	24.7	1.9	23.9	28.9	61.0	16.4	80.1	24.6	10.7	87.3	24.9	4.9	7.6	51.5	123.0	8.2	97.3	67.1	47.4	12.8	52.2	122.0	20.7	40.7	18.3	10.3	7.3	1.8	13.0	8.8	145.2	18.2	8.8	10.3	122.2	111.1	19.5	21.0	6.8	4.8	20.5	20.6	12.5	43.1	13.5	13.1	16.4	9.7	12.3	11.1	15.3	16.6	11.2	14.3	19.7	30.6	25.0
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437764-47449143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 88.9;tongue: 33.1"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 63.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 238.7"	"Low region specificity"	"Detected in some"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	0.3	1.5	0.5	0.2	0.5	0.3	0.2	0.3	1.2	0.2	0.9	0.8	0.1	0.0	0.1	1.2	0.1	0.1	2.6	0.5	0.5	0.3	0.5	0.4	0.2	0.3	0.5	0.0	0.2	0.0	0.1	2.1	0.5	0.7	0.0	0.1	1.3	0.0	88.9	0.5	0.5	0.1	0.4	0.6	0.2	0.3	0.6	0.1	0.2	33.1	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.2	0.7	0.1	0.2	1.2	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	59.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	238.7	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.3	0.1	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	1.2	0.5	0.5	0.3	0.5	0.5	0.4	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.3	1.4	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	2.7	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.5	0.0	0.2	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.3	13.8	0.0	0.5	0.0	0.0	0.6	1.3	0.0	0.5	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	63.8	0.5	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.2	0.1
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 59.8;salivary gland: 28.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 36.8;Excitatory neurons: 14.0;Gastric mucus-secreting cells: 57.1;Oligodendrocytes: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.3;EFO-21: 19.3;REH: 22.3;RPMI-8226: 50.0;RPTEC TERT1: 19.0;U-698: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041650	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.0	15.4	10.9	1.2	13.8	0.5	1.0	0.5	19.1	3.5	1.1	1.7	0.4	0.1	0.1	22.6	1.6	0.3	0.0	23.6	4.0	17.2	0.1	0.2	1.1	1.7	4.3	0.0	1.1	59.8	5.0	0.2	1.8	0.2	1.1	0.5	28.5	3.9	0.0	11.4	0.5	0.0	0.6	0.2	10.6	0.7	7.7	0.2	10.1	0.0	2.7	0.2	5.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.9	15.3	19.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	4.3	0.0	0.0	0.6	5.5	0.0	22.3	0.0	50.0	19.0	0.0	0.5	0.0	0.0	7.2	0.0	0.1	2.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	13.8	0.5	19.1	23.6	4.0	1.7	4.3	1.8	0.6	7.7	12.1	0.0	0.0	0.0	1.3	0.8	0.5	0.0	0.4	0.0	0.5	2.4	2.0	4.3	2.8	1.0	36.8	0.0	1.1	0.0	1.9	0.0	1.4	0.1	1.8	0.6	0.3	1.2	0.0	14.0	0.0	0.2	0.3	57.1	4.6	2.5	0.0	0.0	0.0	0.4	0.0	1.0	4.8	0.0	0.0	5.5	0.2	0.0	1.2	1.8	0.0	1.0	2.7	0.0	0.0	46.5	5.2	3.3	0.0	0.6	0.0	0.1	5.2	0.5	0.0	0.0	0.0	0.2	0.1	0.7	4.6	1.1	1.2	0.4	0.1	3.3	0.6
RASAL2	nGAP	ENSG00000075391	"RAS protein activator like 2"	Q9UJF2	1	178094104-178484147	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 505.8;Inhibitory neurons: 398.4;Microglial cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 54.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018805, HPA020453"	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"		NA	Yes				"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Focal adhesion sites"		"HPA018805: AB_1856085, HPA020453: AB_1856086"	"unprognostic (5.55e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.05e-4)"	10.3	3.6	1.7	2.8	3.2	0.6	8.0	0.0	7.4	7.3	0.1	4.2	2.7	6.1	3.6	17.0	5.5	7.5	13.6	4.3	0.8	5.8	3.0	9.4	1.8	0.0	1.0	3.6	4.6	4.6	5.9	9.4	0.0	5.0	4.4	28.9	6.6	4.4	4.6	7.0	3.4	6.6	0.0	3.2	3.7	8.9	5.1	1.8	5.3	10.0	2.9	5.0	10.5	2.4	30.9	8.9	12.1	4.2	8.6	11.6	17.3	13.2	13.6	11.7	8.5	14.8	15.6	0.0	23.0	13.2	19.7	25.2	10.2	23.0	10.7	0.0	5.0	0.0	9.8	7.1	10.0	4.7	0.5	35.1	5.2	13.4	54.1	13.7	10.3	0.0	1.0	0.0	16.5	3.2	0.0	4.2	10.1	6.4	1.8	0.1	5.2	0.0	7.2	3.6	8.8	4.4	10.9	9.5	9.0	10.8	10.4	5.5	18.9	15.1	15.7	17.2	21.0	6.5	0.1	0.1	13.3	2.4	11.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.7	3.2	0.0	7.4	4.3	0.8	0.0	1.0	0.0	0.0	5.1	2.4	99.8	76.9	12.9	47.3	1.0	15.9	10.0	15.7	8.0	50.7	17.8	11.7	37.4	17.2	18.2	16.5	152.2	15.0	1.0	9.0	5.9	21.8	17.4	33.6	43.0	66.2	34.1	0.0	505.8	12.5	16.4	18.4	17.9	27.6	7.6	19.0	35.3	6.7	16.8	84.1	398.4	15.7	6.1	4.5	21.6	7.3	19.6	16.5	3.6	271.7	8.5	24.7	0.0	154.3	101.3	33.6	5.2	23.0	2.9	32.6	4.9	6.6	34.7	175.5	65.7	22.7	56.9	40.5	34.5	17.8	24.2	41.9	2.3	8.3	12.6	38.2
RASD1	"AGS1, DEXRAS1"	ENSG00000108551	"Ras related dexamethasone induced 1"	Q9Y272	17	17494437-17496395	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 371.9"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 425.1;Muller glia cells: 375.3;Peritubular cells: 469.8;Sertoli cells: 565.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	46	"plasmacytoid DC: 160.1"	"Lineage enriched"	"Detected in many"	46	"dendritic cells: 160.1"	"Group enriched"	"Detected in some"	4	"ASC diff: 70.2;REH: 71.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 75.6;hippocampal formation: 54.9;thalamus: 53.2"	"Low region specificity"	"Detected in all"			HPA047896	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"HPA047896: AB_10960535"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	244.7	53.5	48.7	5.9	63.7	9.3	153.3	31.1	83.6	69.2	13.4	16.1	5.4	22.8	11.9	11.7	32.7	12.6	91.0	60.8	61.9	181.7	271.3	25.4	3.0	71.6	49.8	53.7	30.1	4.2	371.9	1.3	39.4	32.7	6.5	47.7	97.8	55.7	183.1	44.1	12.2	3.4	45.7	18.6	42.2	47.7	40.4	13.1	88.4	103.0	1.2	16.6	26.3	53.6	0.0	0.3	0.3	0.0	70.2	3.8	0.3	0.9	1.4	0.1	0.2	3.0	0.0	0.0	8.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	0.9	0.3	0.3	8.3	0.5	0.1	0.3	17.1	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.2	7.5	13.8	1.3	1.4	1.3	4.5	71.0	0.1	0.1	1.5	0.0	12.9	0.4	1.1	0.9	16.3	2.1	0.1	0.1	4.1	0.1	0.7	0.5	0.2	14.5	0.6	0.2	0.4	0.0	0.5	0.0	0.4	0.0	0.4	3.5	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.8	160.1	0.1	1.0	48.7	63.7	31.1	83.6	60.8	61.9	71.6	49.8	39.4	45.7	40.4	53.6	172.2	28.9	36.8	21.2	11.0	17.2	96.2	46.6	27.3	51.4	106.9	147.2	71.2	20.0	33.5	149.0	4.2	3.3	45.8	42.9	13.7	93.5	2.7	150.9	264.2	31.1	222.4	0.4	15.0	1.3	2.2	191.1	86.6	425.1	8.8	40.3	9.7	21.6	3.6	6.7	5.2	262.7	260.4	3.1	22.2	8.1	109.6	27.3	30.2	1.9	2.2	375.3	0.0	17.1	1.6	9.0	21.8	469.8	56.1	73.3	16.8	13.8	7.2	23.8	565.4	228.1	191.7	1.7	3.0	54.8	13.2	6.7	27.0	73.7	32.9	20.0
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540831-35553999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 212.9"	"Group enriched"	"Detected in some"	4	"Intestinal goblet cells: 13.1;Sertoli cells: 46.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 212.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.1;hTERT-RPE1: 9.8;SK-BR-3: 5.6;U-2 OS: 3.1;U-87 MG: 4.0"	"Region enriched"	"Detected in all"	8	"basal ganglia: 589.6"	"Region enriched"	"Detected in all"	8	"basal ganglia: 429.3"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.8	7.3	30.8	2.5	212.9	3.8	2.3	0.0	30.7	3.1	0.0	28.2	2.3	4.7	15.0	1.9	5.6	2.2	8.6	12.5	9.9	1.5	0.4	3.2	0.4	4.6	12.5	1.2	1.6	1.2	2.1	0.2	6.4	15.2	4.0	0.5	4.0	22.7	15.0	1.6	6.2	7.3	1.8	0.2	3.8	0.7	48.4	0.7	1.2	4.5	1.2	4.3	2.5	9.0	0.1	2.2	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.8	0.6	0.1	0.4	0.0	0.1	1.9	3.1	0.1	0.1	0.0	0.7	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.1	2.5	1.6	0.2	9.8	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.2	1.0	0.0	0.7	0.0	0.0	1.5	0.2	1.6	5.6	0.0	0.1	0.4	0.1	0.0	1.3	3.1	0.1	0.7	1.4	0.5	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	212.9	0.0	30.7	12.5	9.9	4.6	12.5	6.4	1.8	48.4	9.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.6	1.7	2.9	3.3	1.9	0.0	0.2	0.0	0.0	0.0	0.7	3.0	0.0	0.2	0.1	0.1	0.2	2.9	0.0	0.0	3.2	0.2	0.0	3.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.6	13.1	2.0	0.0	0.8	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.0	0.7	0.0	2.3	0.7	0.0	0.5	0.1	0.0	0.1	0.2	46.0	0.4	6.9	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.5	0.3
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823608	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 217.0;retina: 162.8"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: AB_2681386"	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	16.4	9.7	76.1	47.1	135.2	91.2	6.9	155.5	113.5	27.9	40.0	8.4	5.3	25.4	22.5	10.0	22.1	15.6	4.2	68.9	94.7	4.0	5.9	25.4	58.6	217.0	148.8	7.0	3.1	1.5	5.0	9.1	186.4	7.3	9.6	162.8	3.0	9.3	1.2	4.2	14.5	38.7	135.8	32.7	7.0	20.6	120.0	19.5	4.7	5.0	73.6	20.7	4.9	197.0	0.1	14.5	34.9	56.8	0.4	0.0	59.2	3.5	10.0	0.6	0.2	3.4	0.1	62.7	5.6	3.1	1.4	0.2	5.1	0.0	0.8	22.7	2.1	41.1	0.0	0.7	0.0	74.7	40.1	0.1	0.0	1.3	0.0	1.3	23.4	7.0	0.2	24.0	0.0	0.1	11.0	96.3	7.8	0.0	1.1	17.1	3.9	23.8	0.0	29.0	0.4	2.8	0.0	1.0	1.7	7.4	0.0	47.0	0.7	1.5	7.4	0.7	4.6	0.3	5.9	37.8	0.3	116.8	0.4	85.6	61.5	101.3	7.7	50.1	14.6	24.3	12.0	10.4	46.8	16.4	7.8	6.5	139.5	8.5	59.9	30.7	11.8	42.1	76.1	135.2	155.5	113.5	68.9	94.7	217.0	148.8	186.4	135.8	120.0	197.0	5.5	0.0	8.7	7.5	49.3	4.7	0.0	0.1	0.0	39.2	4.1	1.7	1.9	1.5	1.9	0.0	27.1	3.0	43.0	0.1	1.9	1.2	6.0	3.2	19.6	18.6	0.0	6.1	1.5	0.9	5.1	10.9	1.1	1.0	54.3	4.5	11.4	1.2	27.1	6.7	1.3	0.7	0.0	87.1	75.8	25.1	33.2	64.6	8.8	26.2	148.5	19.3	7.2	33.7	106.7	0.6	0.0	149.7	14.3	1.2	0.0	0.3	0.1	160.3	0.0	9.4	3.5	0.7	1.0	0.3	2.6	1.4	20.8	0.8	0.0	2.3
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 124.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 124.1"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 145.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	33.1	22.9	13.8	43.3	9.3	17.3	14.9	7.1	9.5	19.4	33.0	106.6	21.1	23.9	15.1	36.8	13.2	29.3	44.3	7.6	9.2	6.9	10.9	32.5	37.0	11.4	20.5	19.6	13.1	3.3	4.6	39.6	13.6	33.0	42.0	1.5	35.6	48.7	45.0	6.8	26.3	60.1	11.4	47.6	34.5	13.5	22.1	15.4	6.5	13.1	33.2	50.3	14.1	13.4	28.1	30.9	9.6	18.6	10.2	14.7	58.3	11.9	61.8	15.8	18.6	22.3	28.9	43.6	24.8	8.6	19.0	12.1	29.6	12.5	19.0	35.5	11.3	28.6	13.0	25.5	27.9	30.5	19.3	10.0	10.7	36.2	26.7	46.1	68.0	20.7	15.4	21.0	18.7	26.5	20.2	19.9	21.4	65.8	18.8	32.5	30.9	18.4	20.8	33.6	21.7	22.7	20.0	3.8	145.5	23.0	17.3	19.0	98.7	12.8	15.6	13.5	13.1	19.5	22.0	28.0	15.4	26.2	37.8	19.6	16.6	12.5	13.2	17.7	11.1	14.1	19.4	14.9	9.1	10.1	19.1	20.3	124.1	12.0	17.7	8.4	22.1	2.8	13.8	9.3	7.1	9.5	7.6	9.2	11.4	20.5	13.6	11.4	22.1	13.4	30.7	3.2	15.4	4.2	32.7	16.3	15.0	5.5	2.8	0.0	12.4	13.7	56.5	30.0	8.9	5.5	0.0	35.5	39.0	67.4	0.0	12.4	0.3	14.4	4.1	31.2	26.4	16.4	8.7	21.2	19.1	14.5	20.9	28.3	6.3	4.7	20.7	4.6	24.1	0.0	16.2	15.8	2.0	69.9	149.3	0.8	2.5	55.7	48.0	49.6	72.7	2.8	32.0	3.5	4.8	24.0	14.5	14.3	9.8	25.5	13.3	1.7	3.9	0.2	13.1	9.2	27.0	0.6	19.3	5.9	11.9	19.7	30.7	1.6	20.7	21.1
RCSD1	"CapZIP, MGC21854, MK2S4"	ENSG00000198771	"RCSD domain containing 1"	Q6JBY9	1	167630093-167708696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 115.5;skeletal muscle: 147.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 258.0;Kupffer cells: 137.5;Macrophages: 80.7;Microglial cells: 78.7;monocytes: 121.6;NK-cells: 142.2;Sertoli cells: 78.9;T-cells: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 195.2;HDLM-2: 91.0;REH: 224.0;RPMI-8226: 139.7;THP-1: 103.4;U-266/70: 132.0;U-698: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016597, HPA073490"	Enhanced		Approved	"Plasma membrane"		NA	NA		200000	"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA016597: AB_2669397, HPA073490: "	"unprognostic (2.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.65e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.97e-2)"	14.2	5.8	5.5	42.9	6.1	55.7	11.6	5.8	6.3	5.6	5.9	12.0	8.8	4.6	2.5	8.6	4.0	11.7	25.6	5.2	6.3	5.2	8.0	16.8	88.7	9.9	7.3	2.8	1.5	2.4	2.0	17.5	8.4	3.7	11.9	0.6	4.7	3.9	147.9	2.8	29.3	8.6	6.8	52.4	12.4	3.7	7.7	115.5	6.1	50.6	73.7	14.0	3.4	10.0	0.3	0.0	0.2	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	195.2	0.6	0.2	0.0	0.2	0.0	0.0	0.0	91.0	0.3	1.6	0.1	0.1	0.2	34.4	3.7	0.5	0.3	0.4	0.0	0.0	0.0	76.0	67.8	56.7	25.4	0.0	69.3	49.8	1.7	0.0	0.0	224.0	0.8	139.7	0.0	0.1	0.1	0.1	0.2	0.6	0.1	2.7	0.1	103.4	0.5	0.2	0.6	0.2	0.4	132.0	42.5	132.0	0.1	64.6	0.0	249.3	170.3	271.3	63.5	119.8	76.9	216.4	81.7	80.0	103.4	201.7	68.1	64.7	165.7	130.0	122.7	54.3	129.4	148.9	5.5	6.1	5.8	6.3	5.2	6.3	9.9	7.3	8.4	6.8	7.7	10.0	18.7	3.2	6.7	0.3	258.0	1.1	1.2	0.0	3.4	0.7	6.2	10.7	46.8	0.0	3.1	1.8	0.0	0.5	73.9	0.1	0.0	0.2	0.8	0.4	2.1	18.8	0.0	30.1	4.2	0.0	0.5	12.4	4.1	0.3	13.9	0.2	19.2	1.5	44.2	0.0	0.7	0.0	0.0	137.5	26.9	1.7	0.9	80.7	5.4	78.7	121.6	0.2	142.2	2.0	0.6	0.1	0.0	0.4	55.1	0.8	0.0	0.5	0.0	0.8	78.9	5.8	39.7	0.0	0.3	1.0	1.7	1.2	97.2	0.6	0.1	0.3
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 207.3;Excitatory neurons: 114.3;Inhibitory neurons: 138.1;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: AB_2673269"	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	13.5	11.9	24.7	14.9	25.4	23.2	23.6	27.7	36.8	19.2	14.8	17.4	15.4	21.9	40.2	28.0	18.4	14.0	23.9	27.4	24.0	17.4	31.3	15.2	19.4	25.2	23.9	21.1	18.8	41.0	31.7	17.2	21.3	15.9	17.3	38.8	26.1	16.2	17.5	30.0	16.4	19.5	21.5	22.1	18.1	35.6	25.9	36.0	17.8	12.6	22.2	19.5	20.1	25.3	29.3	22.6	42.3	53.1	23.4	41.6	46.2	27.8	30.7	31.9	38.2	54.1	24.8	35.2	22.9	38.9	38.0	33.6	48.7	42.0	42.1	37.6	41.9	29.6	12.9	32.9	35.3	94.6	45.9	34.1	33.7	58.6	70.3	30.2	33.5	51.2	40.2	35.1	41.4	49.4	53.9	51.3	40.4	37.4	21.3	62.4	26.0	20.0	26.5	43.6	37.7	37.2	25.7	38.7	38.0	62.0	18.6	64.4	32.9	17.8	29.6	48.5	38.8	34.4	33.7	49.2	21.1	38.3	26.4	5.9	1.3	1.9	2.2	4.0	3.8	3.0	2.9	3.2	1.9	1.6	2.9	3.6	0.7	2.9	4.5	3.5	3.3	1.2	24.7	25.4	27.7	36.8	27.4	24.0	25.2	23.9	21.3	21.5	25.9	25.3	11.8	19.2	7.4	207.3	18.0	13.4	11.7	7.9	22.2	12.6	13.7	9.5	28.4	10.0	12.2	5.5	16.7	25.6	18.9	11.9	7.9	7.8	13.7	17.5	9.7	10.3	6.0	5.0	114.3	7.1	28.3	11.5	16.3	23.3	15.9	14.4	15.7	43.8	13.3	13.5	138.1	12.8	6.1	24.0	10.3	7.7	7.2	17.2	5.4	47.8	10.5	36.8	15.5	99.5	71.2	8.9	14.7	8.6	23.9	11.2	13.5	8.6	16.5	14.4	19.7	16.8	10.9	41.7	33.8	26.4	14.9	28.6	18.7	7.6	15.2	18.1
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.3;Endothelial cells: 51.1;Hofbauer cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 201.5"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 201.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 95.5;HMC-1: 222.1;NB-4: 74.8;U-937: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	19.8	5.9	2.4	7.4	2.5	77.9	15.6	2.3	2.8	8.7	10.1	13.7	3.2	10.1	3.5	3.1	7.1	4.6	12.8	3.3	2.2	8.6	3.5	13.3	5.4	2.5	2.4	5.7	3.5	3.9	4.3	10.4	2.2	9.5	1.9	1.5	4.1	2.8	7.9	6.3	9.6	6.1	2.7	10.5	8.6	3.7	2.4	16.7	8.2	3.9	4.8	11.8	5.4	2.1	30.5	8.0	4.0	18.9	13.0	9.4	20.8	48.8	21.4	15.8	7.7	0.5	1.1	0.0	1.2	95.5	7.0	3.0	11.2	1.1	14.5	0.2	6.5	1.3	1.5	2.2	19.0	11.4	222.1	5.2	0.3	5.0	1.9	6.1	16.0	4.8	4.7	0.3	18.1	0.4	0.6	74.8	8.6	0.8	0.3	3.2	8.6	0.0	2.9	0.1	0.3	43.6	19.8	0.0	17.6	14.9	0.4	34.7	3.2	12.4	11.0	7.5	0.1	7.1	7.7	0.0	0.2	64.1	19.5	201.5	6.9	80.7	6.1	5.4	6.2	0.1	6.1	5.2	2.1	0.1	9.7	8.7	35.5	2.2	7.3	9.1	4.3	3.8	2.4	2.5	2.3	2.8	3.3	2.2	2.5	2.4	2.2	2.7	2.4	2.1	101.3	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.1	7.4	0.0	0.0	1.8	1.8	0.0	0.8	16.5	0.0	0.0	1.1	0.0	2.3	1.9	51.1	0.0	0.0	0.0	0.9	1.2	9.2	0.0	6.0	1.3	12.5	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.9	0.0	0.0	0.5	1.5	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.5	10.7	4.2	0.0	0.0
RFPL1	RNF78	ENSG00000128250	"Ret finger protein like 1"	O75677	22	29438583-29442455	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3;retina: 3.0"	"Group enriched"	"Detected in some"	7	"Early spermatids: 9.1;Hepatic stellate cells: 8.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.5;HMC-1: 2.7;Karpas-707: 3.0;SH-SY5Y: 3.7;SiHa: 1.8;THP-1: 3.5"									"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"	"Plasma membrane"	"HPA048320: AB_2680356, HPA072380: AB_2686515"		"unprognostic (4.54e-1)"				"unprognostic (6.63e-8)"						"unprognostic (3.14e-3)"			"unprognostic (1.89e-1)"			0.1	2.9	2.5	0.2	2.3	0.0	0.0	0.0	10.3	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	1.1	0.0	0.2	0.0	0.0	2.5	0.1	0.2	0.3	0.1	0.0	1.3	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.5	0.5	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.1	0.0	3.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	2.5	2.3	0.0	10.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.4	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1
RFPL2	RNF79	ENSG00000128253	"Ret finger protein like 2"	O75678	22	32190435-32205001	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"brain: 10.2;prostate: 3.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 17.6;Inhibitory neurons: 8.6"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 5.6"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046608, HPA048320, HPA072380"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	"Plasma membrane"	"HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515"	"unprognostic (3.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.29e-2)"	"unprognostic (9.66e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.64e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.04e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.62e-7)"	"unprognostic (3.50e-2)"	0.0	0.5	1.5	0.0	1.9	0.4	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.1	0.0	0.1	1.7	0.7	0.3	0.0	0.0	0.1	0.0	1.7	3.8	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.9	0.0	10.2	2.3	0.9	1.7	0.7	1.7	0.0	1.0	1.6	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.7	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1
RFPL3	RNF120	ENSG00000128276	"Ret finger protein like 3"	O75679	22	32354885-32361161	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 24.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.6;Spermatocytes: 2.0;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;NB-4: 2.2;U-266/70: 2.5;U-266/84: 2.6"									"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	"Plasma membrane"	"HPA048320: AB_2680356, HPA072380: AB_2686515"	"unprognostic (1.63e-1)"				"unprognostic (9.90e-2)"			"unprognostic (1.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.32e-2)"		0.1	0.1	0.0	0.2	0.1	1.4	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.5	0.7	0.0	0.1	0.1	0.1	0.3	0.0	2.4	0.5	0.0	0.5	1.3	0.3	0.0	0.0	0.7	0.1	24.8	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	1.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.5	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.8	0.0	0.4	0.6	2.2	0.1	0.1	0.0	1.1	0.2	0.3	0.0	0.2	0.8	0.1	0.0	0.2	0.6	0.2	0.0	0.2	0.0	0.0	0.4	0.1	0.0	2.5	2.6	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RFTN2	"C2orf11, FLJ30574, Raftlin-2"	ENSG00000162944	"Raftlin family member 2"	Q52LD8	2	197568224-197676045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 70.9"	"Group enriched"	"Detected in many"	7	"Astrocytes: 152.8;Early spermatids: 125.0;Late spermatids: 351.7;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 320.6"	"Cancer enriched"	"Detected in many"	5	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.8;ASC diff: 15.5;ASC TERT1: 8.7;HSkMC: 10.7;TIME: 6.4;WM-115: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035232, HPA043190"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA035232: AB_10601495, HPA043190: "	"unprognostic (1.15e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.77e-2)"	10.8	4.7	30.0	1.9	48.9	0.3	3.2	39.2	32.6	4.4	3.7	1.8	0.7	4.6	1.2	2.5	2.2	4.4	3.4	28.3	29.4	2.0	1.0	2.4	2.5	42.5	36.6	9.9	1.9	0.6	0.7	6.2	49.5	1.7	1.9	4.3	3.3	1.6	1.5	2.3	1.3	3.3	40.2	1.9	1.5	3.0	33.7	0.8	1.9	5.8	1.5	2.7	2.4	70.9	0.2	0.0	19.8	0.4	15.5	8.7	0.7	0.2	1.3	0.0	1.1	0.3	0.4	0.4	0.5	1.8	0.4	0.6	0.0	0.0	0.0	0.8	0.1	0.1	1.0	0.0	2.2	0.3	0.3	10.7	0.4	0.1	0.0	0.1	2.3	0.6	0.0	0.2	0.4	0.9	0.1	0.1	0.8	0.8	0.6	0.1	0.5	0.2	0.0	0.2	0.5	0.2	0.0	0.0	3.0	3.4	0.1	0.0	6.4	1.7	0.3	0.1	0.3	0.5	1.1	0.2	1.6	0.0	9.6	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.1	0.1	0.0	30.0	48.9	39.2	32.6	28.3	29.4	42.5	36.6	49.5	40.2	33.7	70.9	14.8	0.0	0.6	152.8	0.2	2.4	0.2	0.1	0.0	1.3	1.3	1.4	2.2	2.8	0.1	0.0	0.0	0.2	0.5	0.1	0.0	1.0	125.0	0.9	9.7	13.0	0.0	0.0	1.2	0.0	0.1	16.3	0.0	0.4	0.0	8.6	19.6	0.3	0.4	3.3	1.5	0.0	0.0	0.6	3.3	351.7	15.8	0.7	16.0	32.8	0.0	23.5	0.0	198.5	320.6	0.1	0.0	22.2	1.6	0.3	0.0	0.1	0.2	1.5	6.6	16.2	8.3	4.5	2.8	0.5	2.3	0.0	0.6	3.3	0.0	0.1
RGR	RP44	ENSG00000148604	"Retinal G protein coupled receptor"	P47804	10	84230666-84259960	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 139.0"	"Cell type enriched"	"Detected in some"	29	"Muller glia cells: 1475.8"	"Cancer enriched"	"Detected in single"	4	"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"midbrain: 23.4;olfactory bulb: 49.7;thalamus: 27.3"	HPA059149			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Plasma membrane, Cytosol"	"HPA059149: "	"unprognostic (9.28e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.53e-2)"				"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"				"unprognostic (1.59e-1)"	"unprognostic (1.97e-1)"			0.2	0.0	11.9	0.0	11.9	0.0	0.1	4.4	14.6	0.0	14.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.5	7.4	8.5	0.0	0.0	0.2	0.0	5.2	8.2	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	139.0	0.1	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.9	4.4	14.6	7.4	8.5	5.2	8.2	5.4	3.1	10.1	6.2	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	20.6	0.1	0.1	0.4	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	10.6	0.3	0.0	0.0	0.0	0.0	1475.8	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	2.8	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357924-177372596	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 72.8;Proximal tubular cells: 113.7;Squamous epithelial cells: 95.8;Suprabasal keratinocytes: 115.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 110.4;cerebral cortex: 67.9;hippocampal formation: 56.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 112.5;HMC-1: 95.4;NB-4: 44.8;RPMI-8226: 57.9"	"Group enriched"	"Detected in many"	10	"amygdala: 66.0;basal ganglia: 57.9;cerebral cortex: 46.8;hippocampal formation: 93.6;white matter: 23.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 102.1"	"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: AB_2679836, HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	3.5	2.8	16.0	13.9	110.4	22.4	2.9	0.0	67.9	3.1	1.8	3.7	6.3	2.3	0.4	10.0	7.7	4.3	1.3	56.4	4.5	8.5	28.7	5.5	18.1	0.0	0.4	1.1	3.7	1.5	2.4	1.4	0.1	3.5	0.9	0.0	6.2	2.1	2.6	6.1	11.0	1.8	0.1	27.7	4.9	1.9	15.2	16.3	6.1	0.9	6.6	4.1	5.0	3.2	5.4	1.1	2.3	1.4	0.1	0.0	3.7	0.2	0.0	0.5	0.6	3.7	10.4	13.3	7.3	0.4	1.3	10.6	0.2	3.8	0.0	112.5	0.5	20.7	1.0	4.7	0.9	16.3	95.4	1.8	1.1	0.6	0.7	1.4	0.6	14.9	3.5	26.5	0.2	0.4	21.7	44.8	1.7	5.4	2.8	10.2	0.3	57.9	1.5	1.6	0.4	1.9	0.4	0.4	8.8	0.0	3.5	25.2	1.1	0.2	1.9	0.0	9.7	13.9	7.1	5.8	1.6	30.3	2.4	70.6	39.9	148.8	62.4	37.9	63.0	27.7	57.9	57.8	39.8	26.6	47.4	43.1	140.0	23.6	41.2	17.6	60.9	43.9	16.0	110.4	0.0	67.9	56.4	4.5	0.0	0.4	0.1	0.1	15.2	3.2	5.3	6.4	4.4	2.6	27.3	68.8	23.9	15.4	72.8	0.7	8.9	11.8	2.3	37.1	5.6	11.0	2.1	3.9	41.4	4.2	31.3	11.4	0.6	19.5	2.0	6.5	4.8	7.4	4.6	16.7	10.4	5.4	12.2	8.1	24.7	2.8	8.2	64.0	26.1	0.0	1.5	10.0	10.2	17.0	23.3	1.5	2.8	18.2	21.4	6.5	18.1	9.9	48.4	0.5	0.3	12.8	17.2	2.2	18.0	14.1	16.8	113.7	11.7	2.0	0.0	1.6	4.6	0.1	20.3	95.8	115.1	3.3	51.2	1.1	4.4	20.0
RGS7BP	R7BP	ENSG00000186479	"Regulator of G protein signaling 7 binding protein"	Q6MZT1	5	64506015-64612319	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 122.5;Inhibitory neurons: 170.6;Oligodendrocyte precursor cells: 67.8"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 26.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HUVEC TERT2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039600	Approved		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039600: AB_2676591"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.81e-3)"	"unprognostic (1.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.50e-3)"	1.9	3.2	3.2	0.5	12.2	0.0	0.5	1.0	26.0	4.0	0.0	0.6	0.9	2.3	3.7	1.7	7.8	1.7	2.6	7.2	1.2	2.0	1.0	1.4	0.3	0.2	3.3	2.4	0.2	0.1	0.8	0.0	0.0	5.3	0.7	4.8	1.8	7.4	0.1	0.3	1.0	1.4	0.0	0.7	0.8	0.8	10.2	0.0	0.3	1.0	0.1	0.9	0.5	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	12.2	1.0	26.0	7.2	1.2	0.2	3.3	0.0	0.0	10.2	5.0	0.4	0.0	0.0	5.5	0.1	0.0	0.1	0.1	0.6	6.5	0.7	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.1	5.1	4.6	0.0	2.7	122.5	0.0	0.0	0.8	0.0	4.7	0.0	0.1	23.2	0.1	0.0	0.0	170.6	0.0	0.0	0.3	0.0	1.9	7.2	0.1	0.0	12.2	0.0	3.6	0.0	67.8	6.4	0.0	0.0	13.9	0.0	0.1	0.0	0.2	2.2	2.1	6.6	0.1	13.2	0.3	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.2
RGS9BP	"FLJ45744, PERRS, R9AP"	ENSG00000186326	"Regulator of G protein signaling 9 binding protein"	Q6ZS82	19	32675848-32678300	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 28.9;retina: 17.4;skeletal muscle: 9.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 29.0;Cone photoreceptor cells: 56.3;Rod photoreceptor cells: 75.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.3;HMC-1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049791	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA049791: AB_2680884"	"unprognostic (2.82e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.20e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.34e-2)"	0.0	0.1	0.8	0.0	0.7	0.0	0.0	0.8	0.8	0.0	28.9	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.3	3.3	0.9	0.3	0.0	0.3	0.0	1.1	1.4	0.0	0.0	0.2	0.2	0.0	0.9	0.2	0.0	17.4	0.1	0.1	9.0	0.1	0.0	0.0	0.5	0.0	0.1	0.4	1.5	0.1	0.0	3.2	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.5	0.3	0.1	0.3	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.3	0.0	0.3	0.0	1.0	0.0	0.0	0.2	0.1	6.3	0.1	0.0	0.1	0.1	1.6	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.4	0.8	0.1	0.2	0.0	1.0	0.0	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.3	0.0	0.2	0.3	0.1	0.1	0.3	0.4	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.8	0.8	3.3	0.9	1.1	1.4	0.9	0.5	1.5	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	29.0	0.4	0.4	4.6	0.0	0.0	1.8	56.3	0.3	0.6	0.5	0.0	0.0	5.1	0.2	0.1	0.7	0.0	0.8	0.0	0.0	0.2	0.2	0.0	0.4	0.0	1.8	0.7	0.0	0.2	1.7	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.9	0.0	75.4	0.0	0.4	0.2	0.5	0.4	0.0	0.0	0.0	0.1	1.1	0.4	0.0
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 15.8"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 153.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.3"	"Group enriched"	"Detected in some"	7	"HEL: 43.0;K-562: 13.0"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.1	0.4	0.4	0.5	1.0	15.8	0.1	1.4	0.7	0.3	0.1	0.1	0.3	0.4	0.1	0.3	0.2	0.4	0.3	0.4	0.1	0.1	0.1	0.2	0.7	0.3	0.1	0.5	0.4	0.0	0.2	0.3	0.2	0.3	0.1	1.9	2.4	0.0	3.8	2.0	0.3	0.0	0.0	0.6	0.2	0.5	0.5	0.1	0.3	0.0	0.1	0.1	0.1	1.2	0.2	0.0	0.3	0.3	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.2	43.0	1.0	0.2	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.2	13.0	0.9	0.1	0.2	0.2	0.3	4.0	0.0	0.2	0.3	0.2	0.1	0.0	0.1	0.6	0.4	0.1	0.2	0.1	0.1	0.2	0.6	0.4	0.7	0.2	0.5	0.2	0.4	0.2	0.2	0.6	0.2	0.2	4.3	0.9	2.0	0.6	0.4	0.7	1.0	0.8	0.5	0.1	1.3	0.9	0.8	6.3	1.0	0.6	0.4	0.7	0.6	0.4	1.0	1.4	0.7	0.4	0.1	0.3	0.1	0.2	0.0	0.5	1.2	0.2	0.0	0.5	1.0	0.6	0.1	0.2	0.0	0.0	0.3	0.1	0.1	1.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.3	1.0	0.0	153.0	5.2	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.0	0.0	3.0	0.0	3.7	0.0	0.4	0.0	7.1	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	1.2	0.4	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.0	0.1
RHOBTB2	"DBC2, KIAA0717"	ENSG00000008853	"Rho related BTB domain containing 2"	Q9BYZ6	8	22987417-23020199	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 50.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 64.1;Alveolar cells type 2: 77.7;Excitatory neurons: 33.3;Proximal enterocytes: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 85.7;hTCEpi: 73.6;RT4: 126.9"	"Low region specificity"	"Detected in all"							HPA060938	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA060938: AB_2684391"	"unprognostic (2.67e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.43e-1)"	6.5	8.8	17.9	7.5	31.7	2.3	8.4	3.6	27.6	6.8	7.1	6.2	8.5	7.7	5.3	4.8	9.8	6.5	21.8	21.4	7.3	11.2	2.4	50.5	14.9	4.2	10.3	25.8	8.0	9.6	14.2	11.2	4.1	7.7	2.5	5.6	6.4	23.0	16.5	5.5	21.2	6.5	0.8	12.6	8.3	8.1	22.8	8.9	18.5	13.6	16.7	10.4	4.5	15.1	6.8	13.2	10.4	16.7	12.4	8.7	14.0	9.2	12.0	14.2	10.7	34.2	6.6	85.7	13.8	13.3	18.5	13.2	5.0	51.5	6.8	7.4	3.0	9.3	17.8	9.7	6.0	5.5	18.5	11.3	73.6	14.8	7.4	9.8	10.4	6.1	2.3	8.2	9.5	19.7	3.5	8.8	11.0	19.7	9.2	4.7	16.8	5.9	10.1	126.9	6.8	12.5	7.1	21.2	14.5	7.7	4.0	14.0	12.8	17.7	12.8	32.0	10.6	20.7	21.5	30.2	17.2	7.9	14.0	2.9	0.6	0.8	1.7	1.0	1.1	5.1	0.4	0.8	0.6	4.3	0.6	0.6	0.1	2.9	1.1	1.8	0.9	0.8	17.9	31.7	3.6	27.6	21.4	7.3	4.2	10.3	4.1	0.8	22.8	15.1	4.1	64.1	77.7	13.1	7.6	2.9	2.5	5.2	2.8	31.1	2.9	3.2	10.2	5.7	9.1	7.3	4.2	14.7	4.5	0.2	1.9	2.1	0.8	1.9	4.8	6.2	6.0	1.3	33.3	3.7	8.5	5.5	6.1	3.2	4.5	2.4	7.9	1.9	14.3	16.8	13.1	5.8	0.0	2.5	2.6	0.8	6.2	3.5	1.8	5.6	1.5	7.3	8.2	7.1	1.8	4.1	2.6	6.4	4.2	1.2	57.2	6.2	3.1	6.1	0.0	7.2	4.2	0.9	1.9	0.5	0.6	5.6	2.5	2.9	2.8	0.9
RHOJ	"ARHJ, FLJ14445, RASL7B, TCL"	ENSG00000126785	"Ras homolog family member J"	Q9H4E5	14	63204114-63293508	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.0;Astrocytes: 176.0;Endothelial cells: 72.5;Hepatic stellate cells: 41.4;Microglial cells: 35.6;Oligodendrocyte precursor cells: 43.2;Skeletal myocytes: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 63.8;HUVEC TERT2: 375.4;TIME: 100.9;WM-115: 106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003050	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003050: AB_1079812"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (3.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-3)"	19.6	3.3	12.5	8.5	14.6	0.1	17.4	10.8	16.9	12.9	8.5	14.2	7.5	27.9	17.3	15.5	18.5	25.3	17.9	14.0	11.1	11.7	4.2	21.5	9.6	10.9	11.0	14.2	4.4	3.5	6.4	9.3	11.0	11.8	10.7	5.5	8.4	13.8	7.9	7.6	9.8	31.4	8.3	12.6	9.3	2.8	14.5	3.1	13.8	13.4	4.9	19.7	9.4	13.0	0.0	0.0	63.8	0.0	0.0	0.0	0.0	10.6	42.6	3.6	6.2	0.0	0.0	0.0	5.9	0.8	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	0.1	8.0	35.8	375.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	5.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	14.6	1.1	0.1	0.0	100.9	0.1	1.1	0.8	6.1	0.0	0.0	0.0	0.0	0.0	106.5	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.5	14.6	10.8	16.9	14.0	11.1	10.9	11.0	11.0	8.3	14.5	13.0	41.0	0.0	1.3	176.0	0.3	5.9	0.3	0.1	0.0	0.3	1.2	5.2	3.8	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.5	0.3	6.7	72.5	0.0	0.0	11.1	0.9	0.0	31.0	0.0	0.3	0.0	0.5	41.4	0.5	0.1	0.0	2.2	0.0	0.0	1.9	7.7	1.6	11.8	1.0	3.6	35.6	0.0	11.1	0.0	43.2	0.4	0.1	0.0	16.1	2.5	0.6	0.0	0.0	0.0	0.4	6.6	34.6	17.0	0.1	0.4	0.9	4.8	0.1	0.6	6.9	0.0	1.4
RHOXF2	"CT107, PEPP-2, PEPP2, THG1"	ENSG00000131721	"Rhox homeobox family member 2"	Q9BQY4	X	120158613-120165630	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.0"	"Group enriched"	"Detected in some"	22	"Spermatocytes: 6.6;Spermatogonia: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"K-562: 100.5;NB-4: 69.9;THP-1: 27.9;U-266/84: 47.2"									"HPA003314, CAB020794"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB020794: , HPA003314: AB_1855193"					"unprognostic (1.60e-1)"										"unprognostic (5.04e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.0	11.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.5	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.5	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	2.1	0.5	0.1	0.7	0.9	0.7	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHOXF2B		ENSG00000203989	"Rhox homeobox family member 2B"	P0C7M4	X	120072264-120077690	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 21.2"	"Cell type enriched"	"Detected in single"	6	"Spermatogonia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HL-60: 596.6;K-562: 903.3;NB-4: 1129.0"									HPA003314	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA003314: AB_1855193"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	596.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	903.3	0.0	0.0	0.0	0.0	1129.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	94.3	3.0	0.0	0.0	0.6	0.2	0.0	156.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIC8A	"synembryn, synembryn-A"	ENSG00000177963	"RIC8 guanine nucleotide exchange factor A"	Q9NPQ8	11	207511-215113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041491, CAB046012"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		10000	"Cluster 44: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"CAB046012: AB_11129402, HPA041491: AB_2677510"	"unprognostic (3.93e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.13e-3)"	"unprognostic (8.70e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.63e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.60e-1)"	39.2	39.6	43.0	34.8	43.6	40.6	37.4	42.1	48.5	41.2	46.6	46.3	29.5	44.2	41.8	43.1	41.1	30.6	42.9	45.4	43.7	36.5	37.8	37.6	37.6	43.5	44.4	39.7	39.3	34.2	38.1	34.1	44.2	39.0	30.8	24.8	34.4	40.3	32.8	39.5	38.1	49.4	43.4	41.6	38.1	44.0	44.0	41.6	33.7	28.3	41.8	45.9	36.6	45.0	176.3	83.9	66.8	66.7	89.7	73.4	46.3	124.1	99.2	166.0	114.2	72.6	121.1	69.6	50.5	189.0	125.7	93.4	76.4	131.4	92.0	84.5	76.7	39.4	59.5	67.8	72.3	66.5	125.8	80.6	114.3	103.2	92.6	85.2	82.8	72.8	68.7	66.0	129.3	71.1	79.6	52.6	61.1	74.0	103.0	74.0	66.0	47.5	96.9	45.6	69.2	62.2	96.3	107.1	67.1	63.9	76.1	52.8	93.4	109.2	96.5	40.4	117.3	72.6	117.6	67.8	107.7	59.5	83.5	72.9	41.1	88.3	79.0	49.7	78.2	64.4	70.1	69.0	43.7	55.1	59.9	60.6	59.9	73.0	61.0	35.8	65.0	86.6	43.0	43.6	42.1	48.5	45.4	43.7	43.5	44.4	44.2	43.4	44.0	45.0	30.9	16.0	21.1	10.7	28.7	17.7	20.5	38.6	17.1	28.1	22.5	27.2	23.5	28.6	25.5	25.8	10.4	41.4	46.5	26.3	27.4	53.1	20.2	15.9	24.3	27.2	20.3	27.4	9.4	44.2	60.0	30.4	23.0	19.7	17.7	28.8	27.8	17.1	46.8	32.0	8.4	19.2	30.5	27.4	11.5	17.3	30.7	27.5	28.4	11.2	38.9	43.4	30.9	5.0	7.8	71.6	25.5	39.9	35.2	26.5	29.9	23.0	20.8	33.1	19.7	20.7	35.4	93.2	62.5	20.9	19.5	32.4	34.8	30.2	25.0	17.0
RILPL1	FLJ39378	ENSG00000188026	"Rab interacting lysosomal protein like 1"	Q5EBL4	12	123470054-123533719	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 62.4;skeletal muscle: 88.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Oligodendrocytes: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041314	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041314: AB_10795587"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.81e-1)"	7.8	9.0	17.1	3.1	21.1	2.6	7.5	18.6	18.3	10.7	17.9	10.5	1.3	12.0	4.1	5.1	9.5	3.4	62.4	15.2	16.7	6.8	4.2	6.8	1.8	19.0	19.7	8.5	3.7	6.6	6.4	7.3	18.6	9.1	1.4	3.0	6.8	7.4	88.9	6.8	4.2	6.3	15.9	4.4	5.5	4.1	18.0	1.5	13.3	41.1	1.0	9.5	7.5	27.1	8.3	11.4	10.1	7.9	11.1	10.4	10.6	14.6	8.1	7.8	6.9	7.1	1.9	0.3	7.1	14.3	5.6	8.9	7.5	7.0	3.1	8.4	13.8	1.1	8.1	10.6	19.4	0.4	3.0	11.9	13.6	8.7	12.5	19.5	8.0	1.5	6.6	0.4	8.0	13.8	0.9	2.7	7.4	2.4	11.9	1.3	5.5	0.4	5.6	8.5	1.6	9.3	7.8	6.7	17.9	5.5	9.0	0.2	16.0	10.2	5.1	14.8	9.4	1.7	0.9	0.2	10.4	0.0	6.5	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.5	0.4	1.1	0.3	0.3	0.3	0.2	0.2	17.1	21.1	18.6	18.3	15.2	16.7	19.0	19.7	18.6	15.9	18.0	27.1	13.0	38.5	11.7	32.3	0.7	4.6	5.1	3.4	6.2	14.1	4.6	14.7	9.8	4.3	7.2	11.0	6.2	9.1	0.7	0.2	1.9	2.2	1.8	6.3	18.0	8.5	0.0	0.0	28.8	2.2	6.2	9.4	1.1	7.4	1.3	18.9	9.7	1.6	5.7	23.5	16.4	1.3	0.0	1.3	2.4	1.6	15.5	3.3	5.4	18.7	0.9	21.4	0.0	13.6	64.9	2.2	0.5	8.2	0.3	5.1	0.1	2.6	4.1	6.4	6.6	14.4	9.9	0.9	2.9	2.3	3.8	9.3	2.0	21.5	0.7	3.3
RIMS2	"KIAA0751, OBOE, RAB3IP3, RIM2"	ENSG00000176406	"Regulating synaptic membrane exocytosis 2"	Q9UQ26	8	103500696-104256094	"Human disease related genes, Predicted intracellular proteins"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 50.6;brain: 48.2;retina: 102.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 383.6;Cone photoreceptor cells: 706.8;Excitatory neurons: 1589.3;Inhibitory neurons: 1234.9;Oligodendrocyte precursor cells: 577.0;Rod photoreceptor cells: 1088.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 9.2;RT4: 7.3;SCLC-21H: 16.5;SuSa: 8.8;U-2 OS: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046538, HPA066498, CAB079049"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"CAB079049: , HPA046538: , HPA066498: AB_2685678"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (8.01e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.67e-5)"	"unprognostic (8.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	0.2	50.6	22.4	0.2	27.1	0.4	0.7	35.5	48.2	7.5	0.0	0.1	0.4	0.6	0.9	0.3	5.9	0.9	0.1	18.4	16.4	0.3	0.1	0.1	0.3	5.5	9.7	2.0	0.7	0.0	15.0	0.4	6.4	1.7	0.1	102.3	0.8	1.0	0.2	0.3	0.5	1.3	3.5	0.1	0.6	2.8	16.7	0.8	1.3	0.1	0.2	1.7	2.4	29.4	4.6	0.0	4.8	0.0	0.0	0.1	0.0	0.4	0.3	1.0	1.3	0.1	0.3	9.2	0.1	0.1	1.4	0.3	1.9	0.8	2.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.0	1.5	0.0	1.2	0.0	0.5	0.0	0.4	0.9	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	7.3	16.5	3.3	0.0	0.1	0.7	8.8	0.4	0.2	0.0	0.0	6.5	0.1	0.1	1.2	0.0	0.1	0.4	0.3	0.3	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	22.4	27.1	35.5	48.2	18.4	16.4	5.5	9.7	6.4	3.5	16.7	29.4	0.4	28.9	22.5	38.5	0.2	0.3	1.8	2.8	1.8	383.6	0.7	0.6	0.9	1.5	16.9	0.0	706.8	0.5	0.1	0.2	1.9	0.1	34.2	2.1	0.4	4.9	8.4	0.0	1589.3	0.0	0.3	3.7	0.0	3.7	16.4	18.0	0.7	0.3	0.3	67.3	1234.9	0.9	0.0	0.6	0.8	20.1	72.1	2.5	1.8	63.7	0.6	86.6	1.0	577.0	27.0	0.3	1.2	29.3	0.3	4.1	2.0	0.2	10.6	1088.7	0.0	0.8	1.0	34.8	15.7	0.8	0.4	0.1	2.1	0.1	1.5	1.1
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183247	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	15.0	14.6	12.5	13.5	13.7	21.5	14.7	16.6	21.3	12.9	14.1	13.3	13.0	11.6	12.2	13.5	12.3	7.8	16.3	12.5	14.7	14.2	18.1	10.3	14.3	13.5	13.5	14.8	16.7	11.3	15.1	12.1	13.5	12.0	12.7	19.4	11.8	9.3	21.4	11.3	11.2	9.3	13.9	14.6	13.3	12.6	13.7	13.7	11.9	14.2	13.6	13.2	12.1	15.9	19.0	22.0	20.3	38.5	25.9	28.6	32.1	48.1	29.0	33.0	43.2	30.4	32.5	41.7	53.1	21.3	51.6	21.7	34.2	27.4	44.9	29.3	18.5	20.3	44.0	42.9	23.6	38.5	27.2	18.5	20.8	40.1	39.8	25.0	27.0	30.8	31.7	25.4	38.0	31.9	46.4	47.8	22.5	10.6	23.9	51.9	38.3	61.9	25.7	16.9	23.7	17.9	27.5	28.3	35.6	29.6	29.6	36.4	28.5	41.2	28.9	33.0	51.8	25.3	36.4	95.2	24.0	39.7	38.4	17.9	26.2	15.8	24.6	30.7	34.4	24.0	31.5	27.8	29.4	18.6	33.9	36.5	5.0	30.7	23.8	29.2	31.7	22.7	12.5	13.7	16.6	21.3	12.5	14.7	13.5	13.5	13.5	13.9	13.7	15.9	14.9	9.6	12.8	7.8	16.9	26.4	17.9	25.2	12.5	16.2	11.1	11.4	20.5	10.0	17.4	7.3	12.5	19.6	26.9	6.4	17.6	17.3	1.3	10.7	18.0	14.0	9.6	8.4	10.9	14.9	24.8	21.1	14.8	10.5	27.9	12.7	8.2	8.1	18.3	13.5	11.0	12.7	18.3	9.4	9.2	3.0	13.4	11.0	5.4	3.7	16.5	13.4	14.4	9.0	15.0	11.4	10.1	16.1	19.1	10.4	11.8	17.3	13.3	17.7	6.6	17.4	22.9	23.5	20.7	10.1	18.9	17.4	19.6	19.4	12.6	12.0
RIOK3	SUDD	ENSG00000101782	"RIO kinase 3"	O14730	18	23453287-23486603	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 174.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 338.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	"unprognostic (7.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.71e-2)"	23.1	18.5	5.5	20.4	7.1	174.3	19.2	7.9	10.2	17.4	8.3	47.5	51.6	16.7	12.4	65.5	14.8	24.3	32.7	5.9	6.7	29.6	55.6	22.7	22.8	9.3	7.3	15.7	27.6	22.8	5.4	34.9	8.9	20.1	43.5	19.6	23.2	14.5	52.9	33.3	62.5	19.7	7.5	21.5	38.5	36.6	6.9	21.5	22.2	48.8	30.2	25.8	27.0	10.6	41.9	15.7	17.8	25.0	31.8	37.7	28.5	38.9	29.8	27.6	28.4	17.3	47.5	27.6	52.3	43.7	26.9	57.6	25.9	45.4	38.9	29.5	12.0	25.9	26.9	22.2	71.7	74.7	25.8	39.0	91.2	44.1	66.7	36.7	38.4	19.2	39.8	34.7	45.0	19.4	25.8	15.6	17.6	59.0	31.3	31.3	33.2	41.2	39.3	50.0	39.5	28.9	50.1	28.4	37.4	41.0	21.9	45.0	63.7	48.4	10.9	21.2	28.9	66.1	56.0	38.2	31.0	36.7	38.2	50.1	24.5	14.8	15.0	34.6	10.8	14.0	12.3	12.6	19.1	18.5	9.8	11.2	17.2	15.0	39.0	8.6	19.4	20.7	5.5	7.1	7.9	10.2	5.9	6.7	9.3	7.3	8.9	7.5	6.9	10.6	49.7	80.1	57.7	23.2	46.4	120.4	92.4	78.6	113.8	44.1	49.3	35.6	69.1	51.5	81.5	25.8	56.3	43.0	74.6	338.1	25.4	51.0	271.5	130.1	85.5	44.1	62.8	259.8	35.5	52.7	64.6	48.8	93.8	267.2	63.3	40.0	29.6	88.5	41.1	28.6	34.2	119.9	50.8	59.9	51.2	305.8	22.4	85.7	42.7	15.9	80.6	18.3	53.5	34.2	49.5	148.4	210.7	30.1	63.4	118.5	199.5	52.5	72.3	46.4	6.6	43.9	51.6	28.4	10.1	164.2	143.6	88.4	57.3	71.1	77.2	244.4
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063824-3115187	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	18.5	12.0	1.9	9.3	1.9	0.5	16.2	1.8	3.8	12.8	2.4	17.5	12.3	14.5	5.3	17.6	12.8	10.6	11.8	1.8	1.9	13.7	23.6	13.5	10.1	2.2	1.9	8.5	17.4	12.2	12.3	10.9	2.0	13.7	13.0	2.4	16.4	8.9	11.7	20.7	19.9	11.9	2.0	19.4	16.5	5.3	2.0	11.9	14.4	5.0	13.0	15.5	13.7	1.9	14.4	9.8	12.9	12.4	27.6	19.2	5.5	21.4	30.8	22.8	26.7	12.4	8.0	13.8	20.9	30.1	23.2	14.3	17.9	17.2	24.3	27.8	9.4	16.7	4.5	6.9	17.2	15.6	20.1	24.8	15.1	20.4	15.3	17.6	20.6	6.2	19.4	4.6	22.0	17.8	10.7	7.7	8.8	17.4	12.7	11.8	10.9	14.5	17.3	27.2	11.3	12.2	14.7	7.8	22.4	26.0	15.2	8.7	25.1	20.6	12.1	8.2	16.4	9.8	15.3	13.5	8.9	7.0	27.7	0.1	0.4	0.9	0.6	0.9	1.0	0.3	0.9	1.7	1.0	1.2	0.7	0.7	0.0	1.5	0.5	0.5	1.7	0.8	1.9	1.9	1.8	3.8	1.8	1.9	2.2	1.9	2.0	2.0	2.0	1.9	28.6	6.4	12.0	17.3	14.7	11.0	10.3	6.6	16.5	4.4	14.7	17.8	8.6	17.2	16.7	9.2	12.5	8.9	21.9	27.1	5.9	9.4	2.0	10.5	14.0	16.7	6.6	7.2	23.1	12.9	7.7	18.3	27.0	13.4	10.8	8.7	10.0	14.6	11.6	5.0	26.7	17.7	4.1	6.7	11.1	0.8	6.8	15.3	3.6	11.2	13.8	6.6	12.3	14.6	16.2	13.8	11.7	6.0	22.3	11.3	12.7	8.7	17.4	21.4	19.7	32.5	17.9	1.2	2.8	20.5	9.9	11.9	20.8	10.6	11.3	14.5
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953885	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 1500.7;Late spermatids: 923.4;Spermatocytes: 558.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 561.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.36e-2)"	32.8	32.0	43.3	29.7	48.2	51.6	31.2	46.6	45.1	37.2	41.0	45.0	42.8	28.7	32.8	30.8	34.7	28.8	37.6	40.4	44.9	48.6	49.0	37.9	39.3	47.3	46.5	39.0	52.2	30.2	28.1	35.1	46.6	33.9	40.0	16.7	41.0	34.1	83.3	24.2	40.8	25.4	47.1	52.4	35.9	166.1	47.2	39.1	37.9	52.8	37.3	28.9	28.7	49.9	83.9	80.5	42.9	43.7	84.3	57.8	118.0	73.0	86.2	153.2	64.4	241.7	67.6	39.9	142.9	40.1	91.6	66.3	62.5	74.7	90.6	73.5	44.3	51.5	50.1	173.2	73.3	95.3	59.5	51.5	68.8	58.4	39.9	52.6	36.8	69.7	98.0	46.7	45.5	281.0	82.6	98.0	42.3	67.4	114.3	85.7	45.5	73.6	83.4	67.9	63.2	45.4	88.8	561.6	118.5	45.4	149.7	86.6	47.8	134.6	62.3	71.6	87.0	93.6	107.1	79.2	76.4	63.2	76.1	112.2	97.8	86.1	48.1	92.5	53.1	63.9	52.6	48.6	75.3	71.2	61.6	50.2	100.5	57.8	112.5	61.9	68.9	92.7	43.3	48.2	46.6	45.1	40.4	44.9	47.3	46.5	46.6	47.1	47.2	49.9	47.1	48.1	53.7	13.4	69.9	107.2	127.8	103.4	63.2	24.4	50.7	55.8	46.1	41.5	101.4	69.9	12.5	91.3	61.0	61.7	72.4	107.5	1500.7	72.2	36.3	55.3	60.4	45.4	22.8	101.1	77.4	61.9	41.3	71.4	45.0	31.9	46.1	63.7	110.6	40.4	24.4	79.5	42.7	76.6	146.5	923.4	70.5	66.0	71.2	27.2	96.3	38.0	56.7	10.6	26.2	92.1	77.9	59.8	81.9	122.5	96.4	120.9	75.8	22.6	39.5	45.5	59.2	558.0	138.4	45.8	87.1	124.8	69.2	46.5	80.4	113.3
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 11.4;granulocytes: 16.0;T-cells: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	27.4	39.3	13.7	39.4	15.9	20.4	28.2	16.2	16.1	24.7	18.6	26.4	12.2	21.0	30.9	53.1	16.9	48.3	18.8	15.6	19.8	19.5	15.3	73.6	38.7	11.1	13.1	29.0	12.3	47.7	19.4	52.4	11.6	25.9	29.3	33.8	25.6	32.7	9.0	22.3	16.6	27.4	14.3	29.2	26.7	12.1	20.3	26.5	33.8	13.7	48.4	68.1	24.4	14.7	65.5	63.5	95.2	115.1	98.5	43.6	18.6	51.3	88.9	46.3	74.6	22.2	52.9	22.4	89.7	45.3	87.9	83.1	75.9	67.3	80.9	92.7	27.2	47.2	68.5	18.4	42.1	31.4	43.2	27.0	118.8	43.2	63.0	64.7	46.2	53.6	47.7	83.6	44.1	1.9	36.1	9.8	41.3	20.5	32.0	47.3	41.6	44.8	61.4	22.3	34.5	63.9	51.8	54.7	86.5	64.7	38.5	28.4	49.7	51.6	47.0	41.9	92.1	18.4	27.6	20.6	60.3	38.4	113.1	3.5	2.5	16.0	3.0	2.6	3.5	11.4	4.4	3.6	1.9	5.1	5.8	4.0	9.5	2.3	2.3	2.7	6.3	1.3	13.7	15.9	16.2	16.1	15.6	19.8	11.1	13.1	11.6	14.3	20.3	14.7	34.1	112.2	244.1	25.1	62.9	122.7	102.0	90.0	73.4	106.7	97.2	77.3	12.7	65.8	114.0	36.8	58.4	2.8	55.1	98.4	19.6	75.0	28.9	27.5	37.1	75.7	54.1	67.5	89.2	114.4	24.3	45.7	52.0	36.7	69.1	30.2	127.8	19.5	45.5	114.4	74.2	41.8	32.6	115.0	240.8	39.5	46.3	69.4	65.8	52.5	153.9	56.1	47.4	40.2	38.9	108.6	53.7	51.9	38.1	123.8	16.9	10.6	65.6	53.4	46.0	25.4	46.5	19.2	34.8	81.9	99.4	10.9	69.3	19.0	72.0	163.1
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 278.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 619.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 619.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.91e-4)"	26.7	15.2	7.7	40.3	7.5	52.3	16.3	7.7	9.7	17.7	12.3	15.7	16.8	12.4	16.3	35.5	16.9	18.9	12.5	7.6	8.9	16.3	26.6	30.5	18.3	9.9	8.5	15.9	22.3	17.9	10.4	21.8	9.6	12.6	15.8	7.8	18.3	10.1	8.5	25.6	18.2	12.9	8.5	53.1	19.1	15.8	9.1	15.2	12.2	9.4	19.6	29.1	22.7	10.9	19.9	11.4	8.8	11.3	31.6	31.3	49.7	24.0	31.8	32.1	35.8	29.0	51.6	6.1	28.3	23.9	42.9	39.0	12.5	24.6	29.7	16.9	16.6	12.4	9.9	50.0	42.1	13.4	19.2	28.9	40.0	37.9	25.1	24.7	58.9	13.0	10.7	18.0	32.4	16.9	18.8	14.0	6.1	27.1	20.0	11.5	14.2	23.4	38.0	48.0	11.5	8.5	14.4	36.0	37.2	9.5	9.7	17.8	39.6	16.2	9.1	24.5	5.3	35.5	22.5	0.2	5.2	18.6	12.2	44.0	73.6	90.3	43.8	118.1	41.8	13.2	40.0	45.3	27.9	8.5	28.2	30.2	619.9	15.3	134.1	52.5	53.8	69.8	7.7	7.5	7.7	9.7	7.6	8.9	9.9	8.5	9.6	8.5	9.1	10.9	19.9	48.1	48.1	44.7	55.2	76.9	78.1	63.5	54.7	20.4	29.7	15.9	13.0	41.5	48.4	55.2	56.3	65.2	112.4	53.1	1.9	59.1	97.9	41.8	31.9	30.0	8.5	22.7	82.8	42.2	73.0	53.5	37.2	63.1	39.2	17.3	27.1	46.2	85.9	8.4	71.6	31.7	12.2	278.6	144.2	37.2	30.7	209.0	40.9	50.6	116.5	11.6	61.8	34.7	59.6	54.3	52.3	19.5	125.5	73.5	45.9	25.8	44.8	20.7	59.2	40.5	30.1	36.6	40.3	128.3	91.6	128.1	115.7	23.8	32.8	154.1
RNF165	"Ark2C, ARKL2, RNF111L2"	ENSG00000141622	"Ring finger protein 165"	Q6ZSG1	18	46326809-46463140	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.6;retina: 18.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 44.0;Cone photoreceptor cells: 100.1;Excitatory neurons: 47.4;Horizontal cells: 80.8;Inhibitory neurons: 34.4;NK-cells: 41.2;Oligodendrocyte precursor cells: 35.7;Rod photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 10.1;HaCaT: 7.3;HeLa: 7.5;RPMI-8226: 6.4;SCLC-21H: 13.9;SH-SY5Y: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041615, HPA047798"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"HPA041615: AB_2677582, HPA047798: AB_2680158"	"unprognostic (6.46e-3)"	"unprognostic (7.25e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-5)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-5)"	"unprognostic (3.53e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	0.6	0.5	3.1	0.3	3.7	0.3	0.7	7.6	6.4	0.6	0.0	0.4	0.0	0.2	1.9	1.2	1.2	0.3	1.0	4.7	0.2	1.6	5.2	0.3	0.2	0.0	0.3	0.0	0.3	2.4	4.1	0.2	0.0	2.2	0.1	18.2	0.8	1.3	1.5	1.2	0.3	0.1	0.1	2.0	0.2	0.5	1.3	0.9	4.0	0.8	0.4	0.3	0.5	1.9	1.6	0.1	10.1	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	7.3	0.5	1.0	0.0	0.0	1.1	0.1	7.5	0.0	0.0	3.4	0.0	0.0	0.8	0.0	0.0	0.4	0.0	2.3	0.0	0.2	0.0	0.0	2.6	0.9	1.7	0.4	1.3	2.7	0.6	6.4	0.7	2.2	13.9	13.2	2.0	0.0	0.0	0.9	0.3	0.5	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	3.1	3.7	7.6	6.4	4.7	0.2	0.0	0.3	0.0	0.1	1.3	1.9	9.1	3.2	1.7	1.6	0.3	2.7	9.5	12.9	28.5	44.0	2.9	7.2	8.4	1.5	2.8	0.0	100.1	0.2	10.0	0.2	3.9	0.0	3.8	1.5	9.3	5.0	0.0	0.0	47.4	0.0	0.3	2.4	0.0	0.6	0.0	0.0	1.8	8.9	0.1	80.8	34.4	0.0	2.0	1.9	1.3	5.1	2.5	0.4	1.8	1.9	0.3	5.0	41.2	35.7	1.8	0.1	0.0	4.1	0.4	5.0	0.1	0.1	0.6	49.1	0.0	4.5	0.7	0.4	0.9	3.7	2.0	0.3	3.2	3.2	0.0	2.4
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696499-88706408	"Enzymes, Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 91.2;lymphoid tissue: 101.6"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 132.3;NK-cells: 111.2;T-cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 108.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	22.7	18.4	16.1	28.8	16.2	91.2	16.0	14.4	24.5	18.3	13.9	18.3	14.1	16.6	3.2	11.8	20.0	14.0	21.3	15.5	15.0	20.7	23.4	48.3	40.4	19.4	16.8	17.8	19.5	5.4	17.6	8.2	17.6	19.7	4.9	3.4	14.8	5.8	21.3	11.8	37.2	6.3	16.9	101.6	17.8	12.8	20.9	18.0	18.8	8.2	21.1	18.1	14.4	20.0	10.3	15.9	12.5	18.4	5.8	5.0	23.3	10.3	6.5	11.8	5.3	11.1	6.4	12.4	13.0	6.0	6.8	11.1	7.2	6.8	4.7	6.4	21.7	16.7	12.4	18.7	15.9	16.7	20.4	6.0	6.4	9.4	8.2	6.9	12.4	20.6	28.6	8.8	5.0	20.3	38.9	108.0	20.3	4.4	21.5	36.3	7.8	32.2	5.3	4.5	11.8	12.3	23.9	4.8	12.1	5.9	13.4	53.3	18.6	8.7	13.4	13.5	12.5	19.9	13.5	31.6	7.8	62.8	12.4	7.0	25.6	61.3	31.6	19.1	27.7	4.2	19.3	27.6	23.8	3.9	15.7	22.9	40.4	11.3	22.7	14.8	21.8	21.6	16.1	16.2	14.4	24.5	15.5	15.0	19.4	16.8	17.6	16.9	20.9	20.0	15.2	9.6	3.6	7.8	23.5	4.8	4.6	2.4	6.2	10.1	6.0	7.1	2.8	4.3	3.1	7.3	6.2	8.8	132.3	2.3	9.8	6.5	1.4	5.2	7.4	11.0	4.9	13.7	6.5	9.2	9.6	8.8	8.2	4.9	21.0	12.3	8.6	4.8	38.8	8.4	4.8	3.1	2.0	46.7	32.4	2.5	9.3	52.4	10.6	15.0	41.5	11.7	111.2	3.5	4.5	5.5	1.0	7.9	55.1	4.5	1.8	7.0	4.7	9.6	6.6	8.9	10.0	9.1	9.9	4.8	5.8	3.7	73.1	12.2	3.7	1.9
RNF39	"FAP216, HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 24.5;skin 1: 63.3;vagina: 21.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 79.9;Basal respiratory cells: 96.2;Club cells: 55.7;Prostatic glandular cells: 57.2;Urothelial cells: 233.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 4.5;U-266/84: 3.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 8.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 9.0;cerebral cortex: 8.0;hippocampal formation: 4.4"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Plasma membrane, Centrosome"		"CAB019278: , HPA047115: AB_2679938"	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	1.1	0.8	0.0	0.0	0.1	0.0	8.6	0.1	0.3	16.8	0.0	0.6	0.2	0.6	0.0	24.5	1.4	0.1	0.3	0.1	0.1	0.4	0.2	1.9	0.0	0.2	0.0	1.3	1.7	0.1	1.4	0.0	0.2	7.2	0.0	0.5	15.8	0.1	0.4	63.3	0.5	0.0	0.0	0.2	8.3	1.6	0.1	0.0	0.4	0.0	0.4	3.9	21.6	0.1	1.2	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.2	1.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.7	0.0	0.9	0.3	0.2	0.0	0.4	0.0	0.5	0.0	4.5	0.0	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.8	3.6	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.3	3.2	2.7	0.0	0.0	17.8	79.9	96.2	42.1	0.5	23.7	28.6	0.3	7.2	55.7	0.0	0.0	0.0	0.8	1.8	0.0	6.4	0.6	3.6	2.4	1.1	0.0	0.0	0.0	3.3	0.0	1.2	17.3	20.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	14.2	0.0	2.1	0.0	1.2	0.4	3.6	0.0	0.6	0.0	0.0	0.0	0.0	24.2	2.2	1.2	0.0	57.2	0.1	0.0	13.0	0.4	0.0	0.0	3.0	0.1	0.4	11.3	23.9	0.7	0.6	0.0	0.9	233.1
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;retina: 15.4"	"Group enriched"	"Detected in many"	24	"Excitatory neurons: 3438.7;Inhibitory neurons: 4706.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 29.8;HEL: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013371, HPA013975"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA		1900000		"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA013371: AB_1856391, HPA013975: "	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	0.7	2.4	10.1	0.5	13.6	0.0	0.6	0.0	14.2	2.4	0.0	0.8	0.5	2.1	0.4	4.8	0.1	2.3	0.6	10.4	1.7	1.8	1.2	10.0	1.5	14.8	13.1	7.0	1.6	2.8	1.5	5.2	14.3	1.2	0.4	15.4	1.6	5.7	0.1	2.3	0.7	1.4	16.7	2.9	0.7	3.7	4.9	9.3	0.1	0.4	2.2	1.2	1.7	8.1	0.0	0.0	2.2	0.0	7.5	8.1	0.1	0.3	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	9.8	83.9	1.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.1	9.1	0.0	0.0	1.1	5.1	12.2	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	13.6	0.0	14.2	10.4	1.7	14.8	13.1	14.3	16.7	4.9	8.1	0.7	0.0	0.5	164.6	0.0	1.8	2.0	0.4	19.4	30.8	0.2	1.0	2.4	1.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	1.0	1.7	1.1	0.0	0.0	3438.7	0.0	0.1	10.6	0.0	3.2	0.0	2.3	3.3	0.7	0.1	52.2	4706.0	3.0	0.0	0.0	2.8	3.4	3.1	0.1	0.0	54.4	0.0	2.0	0.0	63.3	52.4	0.2	0.0	6.0	0.0	0.8	0.3	0.1	0.1	5.6	0.0	0.1	0.9	2.9	1.1	15.7	1.1	0.1	0.2	40.5	0.5	0.2
ROBO3	"FLJ21044, HGPPS, HGPS, RBIG1"	ENSG00000154134	"Roundabout guidance receptor 3"	Q96MS0	11	124865432-124881471	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 6.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.3;Muller glia cells: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 5.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"AF22: 18.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Low region specificity"	"Detected in many"			HPA071053			Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Vesicles	"HPA071053: "	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.95e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.75e-8)"	"unprognostic (7.27e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-3)"	2.8	1.8	0.5	0.0	0.3	0.2	1.9	0.0	3.2	0.7	0.0	1.3	0.3	0.8	0.0	0.7	2.0	0.0	1.8	0.7	0.2	1.6	0.4	1.1	0.1	0.9	0.9	6.4	0.7	0.0	0.8	0.2	0.2	1.4	0.0	0.2	1.2	0.0	0.5	0.7	0.9	0.8	0.2	1.6	0.6	1.2	1.7	0.0	1.4	0.0	0.0	0.7	1.2	0.9	0.0	0.0	18.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.1	0.0	0.0	1.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.6	0.9	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.0	3.2	0.7	0.2	0.9	0.9	0.2	0.2	1.7	0.9	13.2	0.0	7.3	32.3	0.4	2.9	14.5	16.2	4.0	1.9	5.9	10.9	2.7	1.5	5.9	12.9	0.0	0.2	8.5	2.1	0.0	9.3	0.4	0.4	0.5	11.4	3.5	2.1	6.9	0.8	0.2	19.0	0.5	0.7	8.9	19.0	7.5	0.3	1.6	0.0	2.3	2.4	10.2	1.6	20.1	0.6	13.4	8.0	3.6	11.2	1.6	45.3	8.2	4.5	9.2	1.2	2.5	8.2	0.7	8.2	1.0	0.8	0.6	2.1	0.0	14.3	4.4	10.1	10.8	2.3	1.0	0.1	3.6	3.5	2.7	6.5
ROBO4	"ECSM4, FLJ20798, MRB"	ENSG00000154133	"Roundabout guidance receptor 4"	Q8WZ75	11	124883691-124898500	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Adipocytes: 181.5;Endothelial cells: 119.7;Hepatic stellate cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 247.6;TIME: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065212			Approved	"Plasma membrane"		NA	NA		380000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA065212: AB_2685434"	"unprognostic (2.86e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.15e-2)"	41.4	7.2	11.4	6.6	9.6	0.2	31.8	9.0	9.4	10.0	5.8	6.5	2.9	10.9	2.1	5.5	10.3	9.7	25.8	7.9	9.2	18.5	5.3	34.8	7.8	11.3	10.7	4.1	4.3	4.7	4.6	28.6	11.2	7.0	1.7	0.2	4.1	4.6	13.9	6.9	7.3	9.9	9.5	43.5	6.3	1.4	13.2	1.8	16.7	11.9	2.0	9.4	7.0	8.6	0.4	0.0	0.4	0.0	0.0	1.1	0.1	0.2	3.1	0.7	1.5	0.0	0.0	0.0	23.6	0.1	1.0	0.0	0.0	0.4	1.2	0.0	0.0	0.9	0.0	0.1	0.6	0.0	0.0	0.1	0.0	8.9	3.0	0.4	247.6	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	224.8	1.2	0.6	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	9.6	9.0	9.4	7.9	9.2	11.3	10.7	11.2	9.5	13.2	8.6	181.5	0.0	4.2	2.3	1.6	2.2	1.0	0.2	0.6	0.2	0.6	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.5	0.2	0.3	119.7	0.0	4.0	0.0	0.2	0.0	5.2	0.0	0.3	2.5	0.6	148.9	1.5	0.1	0.0	0.0	0.0	0.0	8.1	3.7	1.7	4.4	2.8	1.8	20.6	0.1	1.1	0.0	0.5	0.1	0.1	0.0	1.2	2.6	0.3	0.0	0.0	0.0	5.2	0.0	4.5	2.1	0.0	0.1	0.6	1.3	0.0	0.9	2.0	0.1	0.2
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615116	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	18	"retina: 1186.9"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3239.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 2.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"HSkMC: 25.2;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028910, HPA073279"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA028910: AB_2672824, HPA073279: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	12.8	7.9	57.9	2.2	60.5	1.2	9.3	56.8	67.4	9.1	48.1	9.8	1.8	7.7	4.7	7.6	10.7	4.6	8.1	54.5	59.0	7.0	7.1	6.0	2.5	67.4	61.0	13.5	3.6	5.2	7.0	1.4	62.1	8.2	2.6	1186.9	4.2	5.0	3.3	5.4	5.3	5.4	60.0	7.5	7.0	6.2	63.1	1.6	6.0	3.7	2.5	9.6	7.3	62.1	3.2	1.9	3.1	6.6	4.5	22.0	0.6	2.1	3.7	4.3	2.8	0.9	5.3	3.0	15.9	12.2	2.0	4.1	1.5	4.2	1.1	5.3	3.0	3.1	8.6	4.0	13.0	1.1	0.9	25.2	5.9	4.5	9.1	15.1	7.0	1.2	4.0	6.5	9.1	8.3	1.7	2.3	0.8	1.7	5.9	1.6	2.6	19.1	5.0	1.8	3.3	5.1	5.0	5.8	2.5	0.5	8.1	1.4	8.3	7.2	2.7	8.3	2.5	2.9	31.9	2.4	14.2	3.1	1.5	0.0	0.4	0.3	0.3	0.1	0.9	0.2	1.2	0.3	0.2	0.3	0.5	0.6	0.1	2.7	0.4	0.3	0.4	0.5	57.9	60.5	56.8	67.4	54.5	59.0	67.4	61.0	62.1	60.0	63.1	62.1	19.9	0.0	4.4	4.9	0.6	3.7	5.7	5.0	7.4	356.6	3.8	7.2	2.5	2.8	2.3	5.5	594.2	1.0	0.6	2.4	1.9	1.6	2.0	1.0	4.1	31.3	4.2	0.0	0.2	3.1	0.2	4.1	1.1	1.0	1.3	1.2	21.8	1.7	1.1	171.6	0.5	2.8	0.0	1.9	0.8	7.9	19.0	1.2	3.6	1.9	1.3	516.9	1.0	1.0	6.5	2.1	2.5	5.7	0.6	3.1	3.1	4.7	2.7	3239.7	0.0	2.5	4.3	1.6	5.1	5.3	1.0	0.7	1.5	4.0	2.9	3.1
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022260	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	21.9	27.6	15.9	20.1	20.0	19.4	25.4	18.3	21.7	19.7	11.9	24.0	21.8	22.6	22.3	29.1	21.0	19.8	14.5	16.2	14.7	30.0	27.4	17.9	25.1	11.0	13.3	25.4	15.1	21.0	17.2	29.4	12.8	22.5	31.8	17.8	20.6	31.1	11.0	19.7	19.8	29.3	14.6	19.2	24.2	15.3	16.5	22.9	29.5	27.4	29.4	27.4	17.4	23.1	62.4	81.0	47.5	47.9	71.3	68.0	85.4	80.2	60.9	67.9	93.1	118.7	92.1	39.9	50.6	58.8	104.1	59.9	69.7	81.9	103.3	49.7	47.8	78.2	112.3	112.3	98.8	80.7	56.1	51.7	75.4	83.2	107.5	60.2	94.8	39.1	79.7	57.2	55.5	106.7	43.5	63.5	68.2	121.4	59.8	52.4	58.4	56.7	78.6	94.7	56.6	31.4	70.2	63.7	52.3	85.6	54.4	85.2	80.0	96.7	66.9	47.5	73.8	31.9	49.5	88.6	69.6	76.0	62.5	20.2	40.2	19.1	23.1	51.0	19.8	20.2	17.7	21.7	69.5	21.6	23.4	21.0	3.7	77.2	34.8	25.4	26.7	28.8	15.9	20.0	18.3	21.7	16.2	14.7	11.0	13.3	12.8	14.6	16.5	23.1	14.9	6.4	7.5	14.4	13.1	16.6	15.2	21.6	13.1	13.2	13.2	10.3	6.2	10.0	20.1	18.4	20.9	35.4	18.1	14.0	31.3	24.5	10.7	13.5	17.4	14.3	10.2	17.2	61.9	17.5	42.8	17.4	14.3	11.2	6.3	18.1	18.2	17.5	37.0	10.1	44.7	14.6	14.2	19.4	45.8	11.8	11.1	17.2	14.2	15.0	19.7	8.9	26.8	27.2	39.2	19.4	11.6	14.7	12.2	19.9	14.2	48.6	15.9	12.7	6.6	11.1	16.1	14.7	17.4	20.1	20.3	25.6	10.5	24.8	21.3	14.8
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.1;Cone photoreceptor cells: 8.4;Ionocytes: 2.0;Rod photoreceptor cells: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA						"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.0	3.1	0.0	0.0	1.9	0.0	0.7	0.0	8.4	0.3	1.3	0.5	0.0	0.5	0.1	0.1	0.0	0.3	1.8	0.0	0.6	0.2	0.5	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.5	2.0	0.0	1.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.5	0.1	0.2	4.4	0.0	0.0	0.4	0.1	0.3	0.0	0.3	0.4	0.1	0.0	0.7	0.0
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396155	"Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 3019.1;Undifferentiated cells: 3021.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 2852.7"	"Low region specificity"	"Detected in all"							"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: AB_2685164, HPA077586: AB_2686846"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	1674.1	1002.0	390.2	179.6	390.9	502.0	1779.0	387.0	608.7	1862.0	390.9	1384.5	163.9	1291.5	278.5	1823.7	1542.2	94.6	878.4	384.9	392.9	1127.4	829.5	1066.3	304.6	398.8	389.8	3553.5	2580.0	160.2	799.7	230.4	393.6	1347.0	290.4	94.6	1304.2	219.6	1546.0	2491.5	1369.6	209.8	398.2	1575.2	1319.0	266.3	391.9	430.4	981.5	224.1	502.0	1430.5	1751.0	405.9	508.3	1045.1	465.5	237.5	640.1	1232.0	273.6	198.9	532.7	642.1	1017.6	1196.0	360.1	571.6	367.5	318.1	399.5	350.5	727.8	641.2	651.0	309.1	1445.2	205.8	1919.5	1159.3	803.0	413.1	364.3	985.5	1395.8	436.6	895.6	931.0	576.9	563.1	486.8	660.7	546.2	2852.7	288.5	1285.4	583.8	1637.7	1118.7	367.7	384.8	863.5	633.5	811.3	314.8	508.8	116.8	506.3	608.3	459.4	238.4	806.3	187.0	206.4	369.8	477.2	350.9	330.0	475.0	470.0	223.6	749.5	240.3	130.7	562.7	109.4	608.3	591.8	1102.4	1242.0	1212.6	866.9	814.7	957.9	1322.5	1179.8	51.0	760.6	615.8	919.8	678.7	1804.2	390.2	390.9	387.0	608.7	384.9	392.9	398.8	389.8	393.6	398.2	391.9	405.9	309.5	439.1	987.0	0.0	1100.1	917.4	432.3	574.6	595.8	28.9	1600.3	970.8	16.1	885.0	946.8	174.7	14.6	762.3	615.9	641.2	434.3	1235.1	9.4	124.9	331.6	566.0	1100.8	1215.5	0.0	3019.1	1125.2	523.5	315.0	164.3	1272.4	137.9	1387.8	738.4	609.1	15.2	0.0	2744.0	183.1	2089.7	1144.3	49.3	1055.9	565.6	524.7	0.0	1620.0	187.9	710.6	0.0	0.0	2338.4	1805.5	418.6	559.4	350.6	1349.6	611.7	329.9	41.2	236.7	512.1	467.7	28.7	99.3	758.7	1122.1	751.4	875.8	153.1	3021.8	351.4
RPL36A-HNRNPH2		ENSG00000257529	"RPL36A-HNRNPH2 readthrough"		X	101391011-101412297	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 39.9;Club cells: 29.1;Fibroblasts: 8.8;granulocytes: 27.8;Respiratory ciliated cells: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (3.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"		"unprognostic (4.65e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.04e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-1)"	155.5	114.7	141.9	147.6	149.9	473.9	371.3	140.5	211.3	169.5	142.0	178.1	120.3	131.9	91.3	82.4	124.0	56.9	68.9	139.2	147.0	103.1	136.9	84.1	206.9	145.8	140.6	430.7	198.7	116.1	0.3	117.0	146.1	111.6	133.6	38.7	163.1	96.2	194.2	115.9	142.0	89.7	152.1	149.1	138.2	32.9	147.3	348.5	82.7	188.2	223.7	208.3	0.5	153.8	479.9	63.6	351.8	196.0	556.6	603.8	207.1	411.5	307.5	363.4	528.3	37.6	249.6	1272.3	379.1	379.3	282.1	312.4	692.9	639.6	308.0	494.4	334.8	589.7	99.9	58.4	726.0	839.5	372.7	837.9	498.0	458.3	744.0	628.2	359.2	413.5	590.6	507.6	266.5	119.0	364.7	535.8	425.9	1038.7	262.3	388.8	984.7	647.3	412.1	29.5	230.9	445.6	512.1	373.3	416.7	288.6	171.7	707.0	594.4	115.8	314.9	330.7	357.0	374.5	651.9	710.4	186.8	1188.4	141.9	97.1	324.6	105.0	284.3	334.8	348.1	373.2	363.3	332.4	450.1	354.6	364.2	357.9	57.5	277.5	292.2	306.2	274.4	605.1	141.9	149.9	140.5	211.3	139.2	147.0	145.8	140.6	146.1	152.1	147.3	153.8	0.0	12.8	39.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.5	0.0	0.0	8.8	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0
RPL36AL	RPL36A	ENSG00000165502	"Ribosomal protein L36a like"	Q969Q0	14	49618530-49620626	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (1.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.00e-1)"	279.7	310.9	234.2	246.4	241.7	404.2	328.6	232.1	349.8	381.8	221.4	331.8	260.5	280.7	492.7	277.4	315.9	162.6	273.2	225.1	244.6	255.3	372.3	240.5	311.9	244.4	237.3	501.3	628.8	220.0	252.9	176.7	240.6	250.8	248.8	102.0	327.5	253.2	378.6	247.6	284.9	197.9	242.0	294.2	360.3	137.6	240.5	283.4	211.2	206.5	377.1	297.8	285.9	246.2	635.8	473.9	330.1	192.6	471.3	649.8	194.9	508.9	569.9	475.4	534.7	499.0	426.1	833.4	474.5	430.3	327.9	443.5	287.6	441.3	554.8	288.1	331.1	521.6	527.5	652.8	595.1	838.8	426.0	667.8	668.2	362.7	485.9	553.7	614.6	367.3	339.5	714.4	372.8	831.7	496.5	752.6	186.0	452.1	482.0	308.6	519.5	449.5	730.7	964.2	290.3	178.1	448.5	350.8	544.1	313.0	762.2	460.1	468.2	291.3	463.0	382.3	399.8	427.6	487.0	842.7	210.5	376.9	283.7	1308.9	603.0	935.1	823.8	582.2	1113.2	959.3	1070.1	1040.5	614.8	729.1	984.7	937.6	654.0	806.3	542.2	1008.3	1096.2	1506.1	234.2	241.7	232.1	349.8	225.1	244.6	244.4	237.3	240.6	242.0	240.5	246.2	453.2	307.7	395.4	11.4	666.4	945.7	1352.2	1151.7	422.3	110.9	674.6	1022.1	662.4	652.0	643.5	312.6	25.0	690.0	778.0	871.5	995.9	739.8	614.3	490.0	431.4	515.5	366.2	535.9	14.1	1371.2	720.9	523.6	381.3	543.7	716.4	369.2	591.8	920.1	778.5	80.8	16.0	793.7	520.8	814.1	1020.0	236.4	725.7	585.0	843.1	22.5	1045.3	368.1	930.0	11.6	22.9	1311.2	1063.8	534.1	853.2	1279.2	1151.2	1194.4	579.1	127.7	486.4	693.6	898.3	364.7	150.2	390.6	839.3	516.3	888.1	355.4	620.5	1412.3
RRAD	"RAD, REM3"	ENSG00000166592	"RRAD, Ras related glycolysis inhibitor and calcium channel regulator"	P55042	16	66921679-66925536	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 305.8;skeletal muscle: 769.7"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 302.0;Endometrial ciliated cells: 477.6;Glandular and luminal cells: 245.5;Respiratory ciliated cells: 214.9;Skeletal myocytes: 179.2;Smooth muscle cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HDLM-2: 194.2;U-87 MG: 51.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041755	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA041755: AB_2677655"	"unprognostic (1.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-3)"	"unprognostic (3.46e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.80e-3)"	56.5	18.1	4.1	5.5	6.4	4.7	24.4	16.8	14.6	34.6	12.0	16.3	3.4	21.0	1.7	101.2	35.2	11.9	305.8	5.0	5.3	45.0	5.1	52.3	4.0	4.2	6.0	18.8	2.5	1.7	14.4	32.6	4.2	18.4	1.1	2.5	29.4	3.5	769.7	19.9	10.9	6.3	4.9	2.8	13.9	6.7	5.6	1.7	13.7	28.3	3.2	27.4	32.9	6.3	0.1	8.5	0.2	0.1	0.0	0.8	0.3	4.9	0.5	0.8	4.2	2.2	5.9	0.2	4.8	0.3	1.5	0.4	0.2	0.3	0.7	194.2	0.3	0.0	0.3	2.1	8.0	0.0	0.6	2.3	0.9	14.3	0.2	3.3	0.0	0.1	0.2	3.8	0.6	0.2	0.0	0.5	0.7	0.0	0.3	0.6	0.2	0.0	0.9	0.1	0.3	0.6	4.5	0.0	0.0	0.7	0.0	0.5	0.0	0.4	0.5	0.3	0.4	6.2	0.2	0.5	51.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	6.4	16.8	14.6	5.0	5.3	4.2	6.0	4.2	4.9	5.6	6.3	17.0	70.5	150.0	3.3	33.6	9.4	3.7	11.3	4.0	21.4	10.7	15.9	302.0	0.0	18.9	68.0	10.4	4.1	22.5	9.7	23.5	47.4	1.6	477.6	36.7	18.1	10.7	0.0	0.8	3.2	8.2	39.4	10.7	245.5	34.2	26.4	0.7	0.0	1.4	1.7	1.0	7.8	14.2	1.9	36.2	0.7	0.6	24.6	23.2	1.9	0.6	2.4	0.0	0.5	0.6	55.3	5.0	5.3	59.5	30.7	3.4	11.3	214.9	3.2	111.7	179.2	232.6	1.7	5.2	148.1	10.1	5.6	12.4	0.5	6.9	2.6
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696459-77783022	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 349.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 60.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	7.3	6.4	8.7	11.5	9.1	8.2	12.1	19.0	12.1	10.3	10.2	11.3	9.0	12.5	10.3	10.8	9.5	7.3	5.6	8.5	10.5	9.1	11.3	10.5	16.1	8.2	9.0	14.5	11.2	10.3	6.9	9.9	8.6	10.3	11.7	30.2	9.6	11.4	8.2	7.8	10.4	11.0	9.0	15.0	11.0	26.3	8.6	18.3	16.5	7.6	15.0	9.6	8.2	11.6	15.8	11.9	19.6	34.5	13.4	17.0	9.5	11.5	12.4	16.0	18.2	14.9	27.6	32.4	4.4	12.0	20.2	13.4	26.8	15.0	22.8	17.7	14.4	25.8	18.4	14.7	11.3	32.1	23.3	12.2	10.7	14.7	16.0	12.1	13.5	21.2	35.7	33.0	16.8	18.2	27.7	32.1	14.0	20.3	10.6	28.3	19.6	34.2	10.0	20.5	22.9	24.0	17.5	31.4	12.6	19.9	19.2	16.9	12.9	23.9	21.9	14.5	17.7	14.7	16.7	51.6	11.4	29.2	16.0	21.6	7.4	13.5	9.5	5.8	7.3	11.0	8.4	7.1	4.4	13.5	7.8	8.6	60.6	6.4	6.7	13.9	9.3	2.6	8.7	9.1	19.0	12.1	8.5	10.5	8.2	9.0	8.6	9.0	8.6	11.6	53.6	57.7	60.3	27.1	85.0	78.8	102.1	76.1	88.8	246.8	52.1	57.3	22.1	61.5	84.4	55.2	235.6	52.7	101.5	77.1	39.2	38.1	271.3	55.5	63.3	60.8	77.5	47.7	44.3	50.4	34.1	55.6	51.5	45.6	70.3	51.3	49.2	56.5	43.7	158.2	47.5	104.6	57.0	48.1	69.0	85.2	101.5	46.4	64.0	34.7	59.0	83.2	132.8	53.8	50.1	35.1	62.7	119.6	74.6	56.7	49.6	28.4	72.0	349.9	72.3	44.2	73.0	108.0	156.7	56.2	75.3	38.7	90.2	61.7	79.1	84.0
RSKR	"FLJ25006, SgK494"	ENSG00000167524	"Ribosomal protein S6 kinase related"		17	28601827-28614197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"retina: 5.8"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 7.1;Extravillous trophoblasts: 2.4;Hofbauer cells: 4.1;Syncytiotrophoblasts: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"							HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: AB_2679710"	"unprognostic (1.83e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.33e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.62e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.45e-5)"	"unprognostic (1.20e-7)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-3)"	0.2	0.5	1.2	0.8	1.2	1.6	0.2	1.4	1.7	0.4	1.2	0.2	0.3	0.3	0.1	0.1	0.4	0.0	0.2	1.1	1.2	0.9	0.2	0.2	0.3	1.3	1.2	0.5	0.1	0.1	0.4	0.3	1.4	0.3	0.3	5.8	0.1	0.1	0.5	0.7	0.3	0.1	1.1	0.4	0.2	1.1	1.3	0.4	0.3	0.1	0.3	0.3	0.2	1.5	0.4	0.5	0.6	0.8	0.2	0.1	0.2	0.0	0.0	0.6	0.2	0.9	0.1	1.2	0.1	0.0	0.4	0.6	0.8	0.1	0.6	0.3	0.6	1.0	0.4	0.4	0.0	0.2	0.8	0.0	0.4	0.3	0.4	0.1	0.2	1.2	0.6	0.2	0.1	1.3	0.4	1.0	1.2	1.2	0.1	0.8	2.2	0.7	0.5	1.3	0.4	0.4	0.4	0.1	0.9	0.9	0.5	0.5	0.4	0.3	0.8	0.7	0.5	0.6	0.4	0.6	0.4	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.4	1.7	1.1	1.2	1.3	1.2	1.4	1.1	1.3	1.5	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	24.8	0.2	0.0	0.0	0.0
RSPH3	"dJ111C20.1, RSHL2, RSP3"	ENSG00000130363	"Radial spoke head 3"		6	158972871-159000202	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 149.3;Respiratory ciliated cells: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039109	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"HPA039109: AB_10794423"	"unprognostic (6.18e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	2.9	4.7	0.8	2.2	1.0	1.6	3.7	0.2	4.7	3.9	14.5	4.2	5.9	3.4	4.6	5.7	6.1	3.3	3.8	2.0	1.0	6.3	2.7	4.6	1.4	1.9	2.6	3.4	4.3	13.2	3.5	3.1	1.5	5.2	3.7	6.7	4.4	4.1	1.5	3.8	5.6	3.7	1.6	2.3	4.1	9.9	1.1	1.8	7.6	2.2	2.0	2.9	3.0	1.6	8.5	3.7	2.1	4.9	4.8	6.3	2.2	6.2	7.0	1.9	2.8	1.2	4.6	1.7	4.8	7.2	6.3	6.1	1.4	5.6	2.8	4.4	2.9	2.2	3.9	2.6	4.6	2.4	1.6	7.1	9.5	3.8	6.9	10.0	2.5	2.5	2.8	2.6	4.5	4.3	1.5	2.7	1.2	3.8	2.7	2.2	0.3	1.6	8.6	2.6	2.8	4.0	11.6	3.8	2.2	2.4	4.7	5.3	5.4	2.0	5.5	4.8	3.0	2.9	6.1	1.2	10.1	2.9	3.9	0.9	4.0	0.6	0.6	3.0	1.2	0.9	0.9	1.2	4.0	2.4	0.7	1.1	10.5	1.7	7.0	4.6	1.3	1.5	0.8	1.0	0.2	4.7	2.0	1.0	1.9	2.6	1.5	1.6	1.1	1.6	2.3	25.6	17.9	15.0	4.0	7.4	17.2	19.1	6.2	14.2	12.2	7.6	17.5	17.2	25.1	22.0	35.5	10.3	5.7	25.6	13.7	15.8	149.3	67.0	6.9	6.0	13.1	2.1	32.8	10.2	11.4	7.6	10.2	12.7	2.5	9.2	7.9	8.4	10.1	3.3	18.5	17.6	16.2	9.5	16.5	62.9	14.0	12.6	7.2	4.7	8.3	14.4	4.1	6.0	3.5	13.1	21.1	17.7	5.7	18.4	33.1	19.7	120.4	32.5	6.6	5.9	10.2	57.3	10.9	18.6	8.8	5.9	6.1	12.2	13.1	23.1
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656068-78659328	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 1.8;GAMG: 1.4;HBF TERT88: 2.4;hTEC/SVTERT24-B: 1.7;RH-30: 2.1;U-251 MG: 1.6"	"Region enriched"	"Detected in single"	9	"hippocampal formation: 2.8"					"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA					"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737"	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.0	1.1	0.0	0.0	0.0	0.0	1.8	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 15: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	1.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.3	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 3084.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 28.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.9;NK-cells: 28.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 811.3;SuSa: 896.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		36000	"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	275.3	137.3	237.4	47.7	247.3	4.4	222.4	241.0	347.5	133.7	214.6	198.9	30.6	111.8	72.1	91.7	129.8	103.9	310.1	233.1	240.8	262.2	66.2	138.0	48.8	252.9	245.5	138.2	75.7	317.4	73.9	70.1	249.4	100.9	59.8	25.8	156.1	64.6	250.6	114.0	116.5	68.9	245.8	111.7	94.4	41.2	251.6	21.2	318.7	220.6	49.6	121.2	122.7	258.6	188.7	153.7	174.5	111.4	150.7	437.5	62.7	254.7	400.0	150.6	172.2	150.4	203.7	4.9	471.6	435.5	22.3	174.7	73.5	158.7	132.7	0.8	68.1	12.0	178.0	129.6	99.8	5.9	39.2	355.3	59.4	135.3	145.0	441.9	346.5	1.3	61.4	0.3	475.2	663.4	0.4	3.4	141.0	161.1	460.2	30.0	180.4	1.4	811.3	141.9	53.4	2.0	544.7	277.2	576.7	896.9	226.4	6.8	495.0	103.3	57.9	139.5	312.0	2.0	5.3	9.3	185.5	3.2	62.1	4.1	2.0	0.2	0.4	0.9	0.9	4.1	0.4	0.3	7.0	2.0	0.6	0.5	0.3	28.3	1.4	11.9	1.4	1.1	237.4	247.3	241.0	347.5	233.1	240.8	252.9	245.5	249.4	245.8	251.6	258.6	331.0	28.9	106.1	29.7	9.3	110.5	177.4	105.0	103.0	2.1	311.2	345.6	141.9	164.5	104.0	465.3	0.0	132.4	15.3	148.7	248.4	323.3	8.4	399.3	449.1	251.9	124.7	17.3	1.2	323.6	202.1	450.0	58.6	573.8	23.5	185.5	372.3	51.8	162.3	0.0	0.5	167.5	61.1	31.7	107.7	36.3	771.7	37.1	238.3	13.1	14.8	308.1	1.0	0.0	8.8	488.4	164.7	314.1	6.3	240.0	128.7	521.7	77.1	6.9	0.0	234.2	132.5	12.8	23.4	80.3	75.7	74.7	20.5	3084.7	100.6	244.3
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 3719.5;vagina: 1174.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 2340.8;Paneth cells: 1098.9;Proximal enterocytes: 1549.1;Squamous epithelial cells: 3205.8;Suprabasal keratinocytes: 3612.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 798.6;HaCaT: 1072.9;HBEC3-KT: 1527.6;hTCEpi: 2232.0;OE19: 1675.1;SK-BR-3: 1579.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		260000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	2.2	0.8	1.5	24.9	1.6	0.2	78.3	1.5	2.0	530.8	1.3	241.0	265.4	5.4	14.7	3719.5	20.4	18.5	4.2	1.5	1.5	70.1	16.3	82.7	0.6	1.5	1.5	1.4	17.7	125.2	5.1	1.1	1.5	19.6	240.0	0.0	550.3	39.0	2.2	608.0	209.0	13.1	1.4	1.3	119.2	0.7	1.7	149.0	98.6	0.0	449.7	32.9	1174.2	1.5	798.6	0.2	0.1	0.2	0.2	0.3	7.4	0.2	0.1	0.2	0.1	97.6	140.1	0.6	2.3	0.2	0.5	1072.9	0.0	1527.6	0.1	0.5	0.3	0.1	10.8	7.3	0.0	0.0	0.9	0.6	2232.0	0.5	20.7	0.3	0.3	0.1	0.6	1.1	0.2	140.0	0.7	1.1	0.4	1675.1	1.9	0.6	0.6	2.8	8.1	51.2	0.7	0.7	2.2	1579.1	2.1	36.5	3.9	1.7	0.0	0.7	0.8	1.1	2.0	0.4	0.8	0.9	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.5	2.0	1.5	1.5	1.5	1.5	1.5	1.4	1.7	1.5	2.7	60.9	162.6	2.3	4.2	2340.8	448.6	770.5	657.9	0.0	256.2	178.3	5.3	270.2	387.7	35.0	0.0	2.7	2.2	1058.2	49.0	197.5	0.0	37.3	6.4	21.5	153.4	0.0	0.0	65.8	1.5	22.8	85.6	80.3	28.0	0.2	1.1	9.5	0.3	0.0	0.0	660.1	126.1	0.3	213.7	0.0	0.0	3.0	241.9	0.0	2.0	0.0	0.0	0.0	0.1	343.0	1098.9	0.0	7.5	619.3	1549.1	4.9	56.2	0.0	0.0	1.3	27.1	0.0	0.0	3205.8	3612.0	0.3	8.7	13.6	580.9	824.9
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2477.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 995.4;Pancreatic endocrine cells: 1307.3;Prostatic glandular cells: 1141.1;Squamous epithelial cells: 1028.7;Suprabasal keratinocytes: 908.8;Theca cells: 1528.4;Urothelial cells: 1522.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 1369.9;SK-BR-3: 1618.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	166.8	79.1	81.3	61.9	79.8	0.8	159.7	78.6	98.0	333.0	70.8	139.7	121.5	78.4	19.8	2477.7	68.2	81.6	122.3	79.8	80.1	219.0	209.9	161.3	28.4	104.2	80.9	83.4	41.0	76.6	42.0	71.8	84.9	77.8	105.0	7.0	438.1	38.1	51.7	474.9	109.8	79.0	84.8	118.5	100.4	60.3	103.4	25.0	72.4	52.1	205.0	163.2	713.3	84.6	670.4	318.1	16.0	36.7	102.5	386.8	42.8	367.9	341.4	302.7	265.2	315.4	366.1	0.3	577.5	553.0	69.0	479.6	1.1	839.2	175.3	1.9	0.6	0.4	260.5	90.8	117.5	0.2	0.9	182.7	787.6	731.6	567.9	390.9	1369.9	0.0	8.5	0.8	677.3	918.7	0.9	1.4	69.0	1171.0	887.9	0.9	187.4	1.8	1150.3	236.1	0.8	1.9	267.6	1618.0	55.7	140.5	504.7	3.5	743.9	178.2	289.5	171.5	848.6	0.5	3.5	2.4	525.0	0.9	122.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	81.3	79.8	78.6	98.0	79.8	80.1	104.2	80.9	84.9	84.8	103.4	84.6	275.6	38.5	25.5	10.4	6.8	633.9	995.4	531.6	157.6	0.5	225.4	191.3	33.0	124.4	290.6	108.5	2.1	20.3	4.4	500.7	72.4	610.9	4.9	50.9	172.5	293.5	139.0	16.0	0.0	193.9	8.7	112.2	96.8	128.5	19.1	154.1	365.9	132.7	5.0	0.0	0.1	286.4	164.8	15.7	95.4	17.4	67.1	7.4	112.1	5.6	7.2	72.5	0.0	7.5	0.7	1307.3	610.0	61.3	5.6	1141.1	353.3	169.7	48.6	2.1	6.6	70.9	91.2	8.0	1.3	1028.7	908.8	8.2	12.9	1528.4	320.2	1522.5
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 3574.5;kidney: 1380.0;urinary bladder: 1097.4"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 11464.4;Basal prostatic cells: 4796.7;Basal respiratory cells: 10600.9;Basal squamous epithelial cells: 4741.9;Club cells: 3331.1;Prostatic glandular cells: 9446.4;Squamous epithelial cells: 9013.7;Suprabasal keratinocytes: 3626.5;Urothelial cells: 5382.7"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 848.8;head and neck cancer: 1229.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.1"	"Group enriched"	"Detected in many"	5	"HBEC3-KT: 21286.9;RT4: 8382.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	4.0	2.1	2.5	4.1	2.7	1.0	17.3	2.4	3.6	279.9	2.0	3.1	0.8	2.5	16.1	3574.5	5.6	1.8	3.9	2.3	3.2	1380.0	1.7	12.0	0.5	4.1	3.0	1.9	2.1	0.1	5.4	0.8	3.0	48.1	1.6	0.4	377.1	16.9	3.3	429.6	1.6	1.9	3.0	1.5	3.6	2.8	3.4	6.3	11.9	1.4	416.1	1097.4	747.3	3.5	827.0	9.3	1.1	0.9	10.8	4.2	1.2	10.4	11.5	9.0	7.8	2.1	26.8	1.2	418.3	17.8	18.3	2001.4	1.3	21286.9	9.9	5.4	3.7	3.8	56.2	5.0	4.5	0.7	1.9	8.8	2777.8	24.1	3135.5	21.7	13.2	0.0	0.8	1.5	47.7	3.4	0.2	0.2	2.2	22.3	155.4	1.3	497.9	2.1	502.4	8382.8	16.5	0.5	34.9	5.8	9.0	5.9	3.2	5.7	6.0	12.5	692.6	92.4	280.6	1.9	2.4	4.7	26.5	1.8	24.2	10.1	0.4	0.0	2.3	0.0	1.4	0.4	1.6	1.3	0.3	0.0	0.4	0.3	4.3	0.0	0.5	2.2	1.6	0.7	2.5	2.7	2.4	3.6	2.3	3.2	4.1	3.0	3.0	3.0	3.4	3.5	1.4	9.6	17.3	2.6	1.0	11464.4	4796.7	10600.9	4741.9	0.0	22.2	35.4	2.9	1.5	3331.1	218.8	0.0	0.7	0.8	3.2	1226.7	24.8	4.5	16.3	2.5	108.2	1.8	3.0	0.1	27.6	1.0	130.8	1.5	24.5	17.1	1.2	0.4	0.1	1.8	0.0	0.0	1.6	789.4	0.8	676.4	8.1	0.6	18.0	759.5	0.0	5.3	1.1	0.0	2.0	0.1	668.7	2.5	0.7	25.9	9446.4	0.8	11.8	560.8	0.1	0.0	5.5	207.0	0.6	3.0	9013.7	3626.5	0.3	37.8	8.9	2.0	5382.7
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36890229-36951843	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 214.2;Endometrial ciliated cells: 173.8;Kupffer cells: 280.2;Macrophages: 326.4;monocytes: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 510.8;BJ hTERT+ SV40 Large T+: 165.8;BJ hTERT+ SV40 Large T+ RasG12V: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		91000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane"	"HPA047072: AB_2679921"	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	79.5	39.9	11.9	94.3	12.4	11.5	65.7	11.6	12.2	39.1	33.2	58.4	29.4	33.0	9.1	45.8	81.8	40.2	60.5	11.4	16.6	12.2	26.1	68.0	78.0	16.8	15.0	38.0	42.2	14.0	21.7	36.0	17.9	26.3	28.8	5.5	32.6	18.1	23.8	27.8	55.2	44.1	17.6	94.2	45.0	12.6	18.0	29.3	31.7	20.7	51.2	55.3	39.9	26.4	29.9	10.9	3.7	15.6	510.8	101.8	5.5	10.8	37.7	165.8	187.8	39.1	11.2	64.4	19.9	14.4	94.9	21.2	34.7	27.8	30.9	17.4	20.6	5.3	18.8	30.9	39.3	28.2	5.1	96.4	1.0	45.3	1.9	13.3	26.4	0.0	13.7	18.8	5.4	12.0	0.0	19.2	7.9	18.3	25.9	2.8	21.7	35.3	15.7	8.2	23.0	4.2	20.2	10.2	28.2	4.7	20.5	125.4	13.9	11.5	13.5	25.1	28.5	7.3	20.3	21.7	14.5	3.2	7.1	1.4	147.7	4.8	52.2	174.4	47.0	4.5	55.7	53.3	278.6	3.1	55.5	47.6	18.5	56.2	167.0	96.4	95.8	144.3	11.9	12.4	11.6	12.2	11.4	16.6	16.8	15.0	17.9	17.6	18.0	26.4	48.7	28.9	25.5	4.2	19.4	6.4	2.3	7.8	5.7	5.5	6.9	5.8	17.3	14.3	35.3	1.8	4.2	2.6	214.2	2.6	0.0	10.3	3.3	173.8	12.7	44.3	6.0	30.7	8.6	10.2	3.3	71.4	13.3	40.6	12.6	10.5	42.5	20.1	137.2	6.7	8.5	5.7	8.2	280.2	52.3	4.8	82.3	326.4	5.4	36.5	257.9	25.1	116.4	14.1	3.5	7.5	31.3	96.3	54.8	1.9	1.1	1.9	104.4	2.9	59.2	9.6	31.9	10.2	4.9	12.1	5.8	2.9	102.6	9.7	5.5	4.9
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 1174.1;Langerhans cells: 317.9;Macrophages: 414.6;monocytes: 829.9;T-cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 273.7;K-562: 331.6;Karpas-707: 137.3"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 20.7"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	32.3	6.7	2.4	80.1	2.8	192.9	4.7	3.3	4.9	5.7	4.2	11.0	7.0	3.4	1.9	5.3	6.3	22.7	4.5	2.5	3.5	4.2	17.5	22.9	35.4	6.2	4.5	1.3	3.1	2.0	2.1	15.5	6.1	3.9	15.3	12.7	2.8	2.2	0.7	1.5	15.1	10.8	5.1	32.0	9.3	1.2	4.6	22.4	2.2	1.2	41.0	39.7	2.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	0.0	1.8	0.0	14.0	0.0	273.7	0.0	0.0	0.0	32.5	12.7	0.1	0.0	0.0	37.9	10.2	3.6	4.8	331.6	137.3	0.0	0.0	15.9	39.5	0.1	0.0	0.2	26.8	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	35.0	0.0	0.0	0.0	0.0	58.2	0.5	0.3	1.4	20.7	0.0	314.2	38.7	234.6	22.1	52.3	15.4	27.3	42.8	33.3	25.0	15.4	26.8	19.1	49.4	18.0	83.0	0.9	60.3	33.6	2.4	2.8	3.3	4.9	2.5	3.5	6.2	4.5	6.1	5.1	4.6	8.9	4.8	22.4	54.9	0.7	127.5	15.6	1.1	0.0	1.8	64.9	2.7	3.0	1.2	1.5	11.2	36.8	0.0	0.5	147.9	0.7	0.0	0.6	0.0	0.8	0.2	8.0	0.0	13.7	1.0	6.5	0.7	11.3	10.7	0.6	1174.1	0.1	4.6	1.8	62.0	0.0	0.8	0.8	0.0	183.7	317.9	0.4	0.6	414.6	21.4	131.2	829.9	1.6	24.7	2.5	0.6	0.7	1.1	0.0	119.3	0.5	0.0	0.5	8.0	4.7	0.0	2.2	3.7	0.1	0.2	1.2	13.2	0.5	332.8	0.1	0.9	0.9
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779949-129795201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 108.1;intestine: 36.5;lymphoid tissue: 120.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 69.5;dendritic cells: 66.3;Hofbauer cells: 51.3;Kupffer cells: 58.9;Macrophages: 40.0;monocytes: 45.3;NK-cells: 101.0;Plasma cells: 39.8;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 164.1;JURKAT: 119.4;MOLT-4: 120.6;NB-4: 89.1;REH: 88.5;U-698: 150.2;U-937: 117.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA		14000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	8.6	5.6	5.2	61.8	5.6	108.1	4.3	5.4	7.4	3.2	5.1	9.4	11.6	3.1	1.8	3.6	4.9	10.2	2.7	4.8	6.4	3.7	5.9	21.3	120.6	9.6	7.0	1.8	2.5	1.5	2.2	7.5	8.4	4.2	9.9	0.2	7.9	2.2	1.3	2.1	36.5	7.5	7.5	100.3	13.6	1.3	8.4	120.7	3.9	1.7	108.2	15.4	3.0	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	58.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	119.4	0.2	13.6	0.0	0.0	120.6	89.1	0.0	0.0	0.0	88.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	24.0	0.3	0.0	0.3	0.1	0.1	0.1	35.0	150.2	0.0	117.2	0.0	41.6	135.4	245.5	192.2	195.3	159.1	79.1	108.2	178.9	121.5	90.8	76.9	120.9	128.0	153.3	209.9	55.1	145.6	343.7	5.2	5.6	5.4	7.4	4.8	6.4	9.6	7.0	8.4	7.5	8.4	10.2	0.8	0.0	3.6	0.0	69.5	0.5	0.1	0.0	0.0	0.0	0.5	1.1	1.0	1.5	0.0	0.0	0.0	0.5	66.3	0.1	0.0	0.1	0.1	0.2	0.2	1.2	0.0	13.5	0.2	0.0	0.6	0.9	2.6	0.3	22.2	0.0	3.3	0.9	51.3	0.0	0.2	0.1	0.0	58.9	19.1	0.0	0.3	40.0	0.0	7.5	45.3	0.0	101.0	0.0	0.1	0.0	0.0	0.0	39.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.1	1.3	0.5	60.6	0.0	0.1	0.0
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292681-121313410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.6"	"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 141.0;Hepatocytes: 307.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	28.6	35.3	18.4	12.6	20.4	5.7	56.6	37.1	29.3	20.7	17.6	23.2	48.2	15.1	73.2	39.6	16.5	18.2	22.0	19.9	29.9	49.1	393.6	24.6	13.5	42.9	28.0	16.9	21.5	48.6	15.6	14.7	39.1	101.4	19.9	29.5	22.4	56.6	7.7	13.8	24.7	16.2	32.2	8.8	21.7	24.3	24.6	13.5	23.9	13.0	19.5	21.5	27.1	36.5	26.5	14.3	184.8	39.5	72.1	59.9	27.8	27.8	53.5	18.2	32.4	83.1	95.9	25.4	89.0	32.3	156.6	100.8	59.2	70.9	18.1	12.5	80.0	34.6	73.4	64.4	57.9	24.8	12.5	51.0	57.4	60.4	60.2	15.6	29.8	22.8	25.0	34.6	89.0	27.4	9.4	29.2	59.8	74.4	39.7	13.2	51.0	21.6	133.6	116.5	51.1	28.8	73.4	14.6	38.0	125.4	62.2	38.6	58.3	19.0	29.7	32.5	14.0	6.4	11.2	33.3	7.0	49.5	33.5	7.8	3.7	1.0	3.5	4.9	5.9	4.4	4.7	4.2	6.5	4.1	6.8	6.7	0.3	5.3	3.6	7.7	5.5	2.6	18.4	20.4	37.1	29.3	19.9	29.9	42.9	28.0	39.1	32.2	24.6	36.5	10.4	19.2	31.9	23.8	62.6	9.7	49.9	48.9	14.8	26.8	33.7	12.4	20.8	18.6	40.8	20.2	31.3	15.9	47.5	26.4	5.9	24.1	3.0	11.5	8.8	15.7	14.4	18.1	29.6	28.9	16.7	16.3	18.3	19.6	17.7	11.1	141.0	307.1	21.0	23.5	29.4	15.3	59.0	22.1	17.0	1.3	19.3	17.6	19.6	20.6	15.6	38.7	13.4	27.6	34.0	19.3	18.8	17.0	20.9	50.1	24.1	15.8	18.7	28.3	13.1	12.9	14.7	6.7	12.7	36.2	15.5	18.6	56.5	42.8	13.3	54.4
SCAMP4	FLJ33847	ENSG00000227500	"Secretory carrier membrane protein 4"	Q969E2	19	1905372-1926013	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043284	Approved		Approved	"Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles"	"Lipid droplets, Plasma membrane"	"HPA043284: AB_10806501"	"unprognostic (1.60e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (2.58e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.92e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.03e-1)"	23.2	27.4	31.1	15.5	39.9	11.4	25.4	41.3	33.3	28.1	33.6	23.3	19.8	26.0	17.5	39.9	38.3	19.5	15.5	28.9	33.1	34.4	28.3	25.5	15.6	51.5	42.9	27.1	36.5	15.8	31.8	18.8	47.7	31.7	9.8	7.4	43.9	20.4	13.9	36.3	20.3	12.3	39.7	25.1	26.4	22.0	40.6	8.3	32.7	5.8	9.4	22.0	25.0	53.5	53.6	53.9	25.7	56.8	50.7	31.7	29.6	35.5	33.1	39.3	46.7	44.9	51.1	22.5	32.1	30.7	23.1	63.7	24.7	38.2	14.5	34.8	21.7	15.8	19.0	44.3	65.6	16.9	23.2	48.8	24.2	34.8	21.2	32.9	27.2	25.2	35.7	25.3	23.3	67.8	21.5	31.6	38.8	31.1	18.6	25.9	18.1	34.6	49.8	47.5	33.8	45.0	23.9	49.9	31.4	18.1	50.6	41.5	29.6	44.8	30.5	81.1	35.7	57.8	62.6	21.0	59.1	26.9	30.1	1.7	4.4	1.9	3.9	4.9	2.0	5.1	2.7	2.6	4.8	3.4	1.5	2.9	2.1	5.8	4.5	12.0	2.3	3.7	31.1	39.9	41.3	33.3	28.9	33.1	51.5	42.9	47.7	39.7	40.6	53.5	16.9	9.6	7.3	12.1	22.9	17.1	25.0	20.8	33.0	19.7	40.0	23.5	3.0	21.5	14.1	49.7	75.0	40.0	59.6	53.0	7.9	20.8	0.8	63.2	23.2	17.8	18.7	11.6	8.3	12.5	38.1	18.2	43.3	42.1	17.2	27.8	15.7	13.4	38.0	21.9	8.0	36.1	20.3	20.1	24.9	1.9	21.8	24.2	21.4	5.6	21.0	29.6	33.0	16.6	18.9	16.1	25.3	17.3	16.0	30.0	47.6	10.1	33.2	52.2	0.0	15.8	15.7	19.0	26.1	30.8	20.2	59.0	20.4	26.9	31.1	28.1
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 81.0;choroid plexus: 28.9;heart muscle: 80.4;skeletal muscle: 101.3;tongue: 92.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 14.2;Horizontal cells: 15.2;Skeletal myocytes: 7.0"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	46	"dendritic cells: 6.9;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 27.0;AN3-CA: 49.2;HUVEC TERT2: 58.3;NTERA-2: 29.8;SH-SY5Y: 167.0"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	2.9	46.5	0.2	56.3	0.8	1.2	52.6	55.0	2.5	28.9	11.1	1.0	3.9	0.7	3.4	2.3	1.9	80.4	50.0	48.7	2.5	0.7	2.9	0.5	51.0	48.2	0.5	0.4	0.2	11.8	10.9	52.6	5.6	1.1	3.6	1.9	1.4	101.3	0.4	3.6	5.4	55.6	4.8	4.6	1.9	46.9	0.8	0.8	92.8	0.2	0.7	1.2	81.0	0.1	0.0	27.0	49.2	0.0	0.2	0.0	0.2	0.1	0.1	1.1	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	2.4	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.7	1.1	0.3	11.2	0.4	58.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	29.8	0.0	0.0	0.0	5.5	0.0	1.3	0.0	0.0	167.0	0.0	0.0	0.2	7.0	0.0	3.1	10.9	0.6	1.5	0.4	2.5	2.1	0.0	0.0	0.7	2.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	46.5	56.3	52.6	55.0	50.0	48.7	51.0	48.2	52.6	55.6	46.9	81.0	4.5	6.4	1.7	0.0	0.1	0.4	4.8	2.5	1.2	5.4	0.6	0.8	14.2	0.0	2.2	3.7	2.1	1.5	2.7	0.1	0.0	0.3	0.0	4.4	0.4	6.0	0.0	2.1	0.0	0.2	0.5	1.6	0.0	3.1	0.0	0.1	2.2	0.5	0.2	15.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	3.6	0.0	0.0	3.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.6	0.0	1.4	3.7	0.6	0.0	7.0	2.9	0.0	0.4	0.4	0.6	0.8	0.2	0.2	0.0	1.4
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660182	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.4;kidney: 47.1;placenta: 77.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 334.8;Distal enterocytes: 100.7;Early spermatids: 124.6;Hofbauer cells: 99.9;Paneth cells: 138.6;Proximal enterocytes: 318.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 94.3;SK-BR-3: 102.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020518, HPA024264"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		2300000	"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Cytosol	"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	2.9	1.0	3.6	1.3	4.5	1.3	0.9	4.6	5.3	1.3	2.9	18.3	26.7	1.3	0.5	17.9	4.1	2.8	0.3	3.8	4.8	47.1	0.3	4.1	0.6	9.4	6.8	0.7	0.9	1.1	2.6	77.6	9.7	3.2	16.0	2.4	10.7	1.1	0.5	3.6	46.4	1.1	7.1	0.5	19.6	7.1	5.7	0.6	1.1	1.7	4.3	3.5	1.3	12.3	0.2	0.2	0.2	0.8	0.0	0.0	0.3	0.3	0.1	0.1	0.5	0.1	0.5	0.3	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	10.4	0.1	1.3	0.2	0.1	0.4	0.3	0.2	1.4	0.4	0.0	0.2	0.1	0.2	0.4	20.8	0.5	0.5	0.2	1.4	0.2	5.7	3.2	0.3	0.5	0.1	94.3	3.6	4.1	0.2	1.0	102.8	0.1	0.7	10.8	0.6	0.1	0.3	0.8	2.0	0.2	3.4	0.2	0.2	0.1	0.4	0.1	1.2	0.2	0.2	0.3	0.2	0.3	1.1	0.3	0.3	0.2	0.5	0.3	0.3	0.6	0.4	0.3	0.3	0.2	0.1	3.6	4.5	4.6	5.3	3.8	4.8	9.4	6.8	9.7	7.1	5.7	12.3	3.5	0.0	23.6	0.0	0.7	2.8	1.5	1.6	0.6	3.2	3.3	1.7	1.2	4.3	8.5	334.8	0.0	23.8	0.2	100.7	82.2	0.6	124.6	25.5	1.0	6.7	9.1	0.0	0.1	0.2	4.7	2.7	55.5	11.3	39.9	0.0	0.4	0.1	99.9	0.0	0.2	62.9	46.8	3.0	0.5	87.8	0.3	2.8	10.6	15.0	1.7	0.4	0.0	0.0	0.3	8.6	138.6	1.2	1.4	4.7	318.4	3.2	17.2	3.0	0.0	0.9	1.0	3.8	5.5	26.6	6.5	65.8	2.2	0.1	21.4	23.1
SCN7A	"NaG, Nav2.1, Nav2.2, SCN6A"	ENSG00000136546	"Sodium voltage-gated channel alpha subunit 7"	Q01118	2	166403573-166611482	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 45.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 102.0;Leydig cells: 100.9;Peritubular cells: 159.9;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 7.9;HMC-1: 4.5;Karpas-707: 5.8;SK-BR-3: 15.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.6"	HPA072715	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA072715: "	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.84e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-4)"	4.6	8.6	3.4	3.4	3.0	0.3	10.2	0.1	1.8	7.8	0.0	35.8	3.4	9.0	6.3	10.1	10.9	3.8	20.6	1.1	7.1	1.8	1.2	27.6	0.5	4.0	7.1	45.4	4.9	0.7	1.0	12.3	5.4	11.0	8.5	10.6	6.1	10.1	7.2	2.4	6.8	7.6	2.9	3.2	7.8	5.6	9.8	3.2	1.2	15.0	0.4	4.7	7.1	1.2	0.1	0.1	0.7	0.9	0.2	0.0	0.8	0.7	0.0	1.3	0.0	0.6	0.2	0.4	0.1	0.0	0.3	0.3	0.1	0.1	0.0	7.9	0.5	0.2	1.5	0.6	0.0	0.2	4.5	0.0	0.0	0.4	0.1	0.4	0.0	0.4	1.2	5.8	0.0	1.0	0.8	0.5	1.1	0.3	0.3	0.0	0.5	0.0	0.1	0.8	0.2	0.4	0.3	15.4	0.0	0.3	0.4	0.1	0.4	0.2	1.0	0.7	0.4	1.0	0.3	1.1	0.2	0.2	0.4	1.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.8	3.4	3.0	0.1	1.8	1.1	7.1	4.0	7.1	5.4	2.9	9.8	1.2	1.4	0.0	1.1	1.0	0.0	0.3	0.2	0.0	5.7	21.5	0.2	0.3	16.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	2.4	0.0	0.3	4.1	0.0	0.0	7.7	0.0	0.0	102.0	0.0	0.0	15.9	0.1	9.3	0.0	0.2	0.0	20.9	0.0	0.0	0.0	1.2	4.1	100.9	1.8	5.4	14.0	0.0	4.9	0.0	14.1	0.3	0.1	0.0	159.9	1.2	0.5	0.0	0.5	0.0	1.8	151.2	16.7	26.1	0.5	1.2	1.7	1.1	0.0	0.2	0.3	0.0	0.3
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 21.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 43.2;Hofbauer cells: 67.5;Inhibitory neurons: 48.2;Langerhans cells: 42.8;Oligodendrocyte precursor cells: 133.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.6"	"Cell line enhanced"	"Detected in many"		"BJ: 23.0;BJ hTERT+: 16.8;HHSteC: 19.0;hTERT-RPE1: 15.6"	"Region enriched"	"Detected in many"	5	"hypothalamus: 9.3"	"Low region specificity"	"Detected in many"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	1.7	1.7	5.3	0.9	4.2	2.0	0.6	0.1	3.4	0.6	0.0	3.2	0.5	0.2	0.1	0.5	0.4	1.2	0.4	2.9	21.9	1.7	3.9	2.0	0.6	8.2	19.4	0.3	2.0	0.1	1.5	4.3	12.0	0.3	3.1	0.7	0.4	0.4	0.2	0.7	1.8	2.4	2.2	3.1	0.4	5.1	18.2	1.6	0.3	0.6	0.4	0.5	0.5	1.7	0.0	2.5	0.1	0.0	9.6	7.9	0.0	23.0	16.8	5.2	1.7	0.5	0.1	0.0	0.0	2.8	0.2	0.1	6.5	0.6	8.6	0.0	2.1	1.7	1.8	1.9	19.0	0.1	0.0	0.6	0.2	9.1	1.7	15.6	1.1	1.2	6.1	6.6	0.8	0.0	3.6	0.0	1.9	0.1	0.6	0.8	3.3	9.0	2.4	9.5	1.0	9.5	0.0	0.1	0.3	4.8	0.3	0.0	0.1	0.0	1.5	0.1	0.4	0.1	0.1	0.0	3.2	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.5	0.1	23.6	0.0	0.1	5.3	4.2	0.1	3.4	2.9	21.9	8.2	19.4	12.0	2.2	18.2	1.7	0.9	12.8	23.8	0.7	1.3	1.0	0.4	0.5	0.6	0.6	0.8	0.9	2.5	8.6	4.4	5.5	0.0	0.3	43.2	9.0	3.9	23.4	2.5	0.1	0.1	5.7	33.0	4.2	15.8	31.5	0.3	2.0	0.0	0.1	3.8	18.1	13.6	9.5	67.5	0.0	48.2	19.3	10.2	1.9	42.8	3.2	1.2	11.3	3.6	2.8	1.0	2.3	0.0	133.7	0.4	12.7	7.8	0.0	1.2	0.3	14.7	11.5	2.2	0.2	0.0	7.8	1.6	1.3	0.4	0.5	0.4	1.1	0.9	4.4	12.9	0.2
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35213956-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"thyroid gland: 28.9"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 10.8;Horizontal cells: 10.1;Rod photoreceptor cells: 7.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.0;ASC diff: 76.7;ASC TERT1: 102.2;HSkMC: 48.1;hTEC/SVTERT24-B: 30.1;U-138 MG: 29.1;WM-115: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1890000	490000		"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.06e-3)"	1.7	2.4	0.7	0.9	1.1	0.1	0.4	2.0	1.0	0.5	2.9	4.2	0.1	0.6	0.9	0.7	0.8	0.5	3.4	0.5	0.6	2.9	0.1	0.7	0.1	0.8	1.0	0.5	0.1	0.1	1.7	0.7	0.3	2.2	0.9	1.4	0.2	4.5	0.3	0.8	0.7	0.9	0.1	0.2	1.4	1.1	0.7	0.1	28.9	0.0	0.2	5.1	0.9	0.8	0.0	0.1	26.0	0.2	76.7	102.2	0.3	6.7	3.3	0.1	0.1	0.5	0.1	0.0	0.9	15.5	0.0	0.0	5.3	0.0	0.4	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	48.1	0.0	30.1	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	1.2	0.0	0.4	0.1	0.0	0.0	0.1	2.9	0.5	0.0	0.1	0.7	1.9	10.2	0.7	0.1	1.5	29.1	1.3	0.0	0.2	0.1	0.0	0.0	4.6	0.0	25.2	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.7	1.1	2.0	1.0	0.5	0.6	0.8	1.0	0.3	0.1	0.7	0.8	0.2	0.0	0.6	0.7	0.5	0.0	0.2	0.4	0.0	2.6	0.3	0.0	3.5	0.0	2.0	1.8	2.1	1.2	0.5	0.0	0.0	0.0	2.1	1.2	0.4	0.6	10.8	0.0	2.2	0.0	2.1	1.3	0.0	0.4	1.3	0.5	0.0	0.1	0.3	10.1	3.2	0.1	0.0	0.6	0.4	3.3	0.9	0.2	1.8	0.0	0.1	3.0	0.0	4.0	3.5	0.1	0.0	3.8	0.4	0.1	0.0	0.1	0.9	7.1	0.0	0.6	3.2	0.5	2.1	0.0	0.0	0.7	0.2	0.1	0.0	0.2
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493813-96611790	"CD markers, Predicted membrane proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 460.8;thyroid gland: 424.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 229.7;Hepatocytes: 235.5;Smooth muscle cells: 183.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in many"		"AF22: 643.1;EFO-21: 297.8;fHDF/TERT166: 288.4;RPTEC TERT1: 341.3;U-138 MG: 305.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA044416"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB025123: , HPA044416: AB_2678934"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.23e-1)"	109.5	36.3	35.2	35.9	41.0	10.2	66.6	37.6	49.9	157.0	26.4	77.9	21.8	76.0	15.2	50.1	84.6	44.5	68.9	32.1	51.8	88.9	460.8	56.8	18.9	41.1	46.6	170.5	61.2	30.2	61.5	124.4	37.5	63.4	40.1	29.7	25.0	104.4	19.9	25.3	39.8	90.9	38.5	25.8	41.9	25.5	49.6	5.3	424.5	58.5	8.0	84.0	58.1	33.7	0.5	0.3	643.1	0.3	230.2	214.1	0.6	94.8	113.4	54.3	60.5	19.8	0.2	0.2	297.8	288.4	8.0	0.5	114.3	1.8	47.1	0.3	44.4	0.6	56.7	250.2	7.4	1.9	2.9	83.1	2.8	123.5	3.1	210.2	1.9	0.1	64.3	0.3	23.1	6.0	0.3	16.9	68.1	0.0	0.7	0.7	101.5	2.4	341.3	57.2	19.1	49.5	0.2	0.3	4.9	217.8	27.6	73.0	51.3	305.1	91.5	1.5	53.2	6.0	0.3	1.1	96.9	0.4	97.5	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	13.6	0.0	0.1	0.0	0.0	0.6	35.2	41.0	37.6	49.9	32.1	51.8	41.1	46.6	37.5	38.5	49.6	33.7	11.9	57.7	38.1	93.7	1.7	53.8	78.9	29.6	15.9	36.6	41.4	30.2	32.7	37.1	5.1	57.0	12.5	1.9	0.5	0.1	29.4	14.4	31.6	29.3	65.1	10.7	3.5	10.7	4.6	15.3	2.5	229.7	9.7	76.4	1.3	44.3	17.5	235.5	109.8	5.0	22.0	1.5	138.4	20.5	154.7	18.6	52.5	62.9	62.2	21.5	68.2	17.4	0.0	7.1	1.7	8.9	1.2	104.9	2.5	41.7	0.8	56.4	4.0	12.5	32.9	100.0	183.1	5.5	57.6	1.3	39.2	3.8	4.2	33.3	5.7	17.6
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 410.9"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 515.9;Pancreatic endocrine cells: 476.4;Suprabasal keratinocytes: 472.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 512.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		320000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (7.42e-2)"	68.0	73.1	90.3	26.3	116.8	10.1	113.1	90.2	120.7	53.0	68.5	102.6	37.8	53.0	11.8	124.3	76.6	72.2	65.9	66.4	90.2	166.9	410.9	168.3	9.8	120.5	127.8	26.3	90.3	34.7	43.2	27.3	95.4	53.0	62.6	35.1	103.7	45.9	101.5	190.4	42.4	53.8	89.9	32.3	140.1	47.1	151.9	8.2	51.1	35.4	35.2	124.7	68.7	71.4	162.1	20.7	11.1	0.8	269.2	164.3	474.4	201.5	273.0	222.9	158.6	242.7	400.0	0.2	88.1	255.4	224.5	203.1	8.2	512.2	269.0	46.7	7.4	4.9	15.8	95.8	292.4	1.0	8.2	223.1	336.5	92.4	223.2	123.3	29.9	3.7	8.2	0.5	130.5	159.9	0.2	14.2	20.4	139.9	63.1	0.3	99.7	0.6	367.7	211.7	4.3	15.6	277.2	169.4	51.4	125.2	123.1	9.7	56.4	169.4	141.4	17.3	131.8	8.5	6.7	0.7	266.2	16.4	103.2	1.5	1.6	0.4	0.7	0.6	2.1	0.3	2.0	0.8	1.5	0.3	0.4	0.5	0.8	0.7	0.6	1.4	4.4	0.7	90.3	116.8	90.2	120.7	66.4	90.2	120.5	127.8	95.4	89.9	151.9	71.4	21.9	291.7	391.2	106.7	3.8	373.7	322.2	352.8	75.1	14.5	208.8	90.6	59.3	245.9	218.4	189.4	12.5	38.9	7.8	174.3	64.6	296.0	1.2	116.6	20.8	16.0	55.1	7.4	0.2	515.9	230.0	43.0	170.7	179.0	13.9	10.8	11.4	260.6	18.8	0.0	0.3	131.9	160.7	19.3	106.0	3.8	4.1	39.5	76.5	5.6	33.0	10.0	0.0	3.5	1.8	476.4	121.7	5.3	2.1	284.2	59.0	153.8	178.6	23.6	0.0	34.9	33.5	1.8	2.5	170.9	472.8	67.5	16.8	3.2	90.7	423.9
SEC16B	"LZTR2, PGPR-p117, RGPR, Sec16S"	ENSG00000120341	"SEC16 homolog B, endoplasmic reticulum export factor"	Q96JE7	1	177923956-177984303	"Predicted intracellular proteins"	"ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.4;liver: 36.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 66.3;Late spermatids: 50.4;Proximal enterocytes: 34.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.6;CAPAN-2: 7.2;EFO-21: 5.4;HDLM-2: 5.8;Karpas-707: 4.8;RPMI-8226: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054292, HPA072913"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Actin filaments"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum, Plasma membrane"	"Actin filaments"	"HPA054292: AB_2682439, HPA072913: AB_2732213"	"unprognostic (2.31e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.34e-4)"	"unprognostic (6.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	4.0	2.5	0.5	1.1	1.1	0.3	3.2	0.0	2.9	3.0	0.0	3.6	28.0	3.5	2.0	2.0	3.5	4.3	2.6	0.8	0.1	3.4	36.4	2.4	1.1	0.0	0.3	4.2	9.0	0.5	1.4	0.8	0.1	1.6	4.0	5.7	3.6	2.1	9.3	2.7	28.4	2.7	0.0	5.8	8.7	1.4	0.3	0.4	2.1	3.1	0.9	1.4	1.1	1.2	1.9	1.5	0.1	1.5	1.9	6.6	0.0	1.5	0.5	0.1	0.7	1.0	7.2	0.6	5.4	1.2	0.1	0.0	0.4	0.2	0.0	5.8	0.1	0.0	0.0	3.4	0.1	0.1	0.0	3.8	0.5	0.2	0.0	0.2	2.2	0.0	0.0	4.8	3.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	6.5	0.1	0.1	0.6	1.2	0.1	0.2	0.8	0.0	0.1	1.3	0.7	1.0	0.2	0.6	0.0	1.5	0.7	0.1	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	2.9	0.8	0.1	0.0	0.3	0.1	0.0	0.3	1.2	7.7	0.0	2.0	2.9	0.7	0.3	0.3	0.4	1.8	1.3	6.3	1.8	0.5	7.2	1.9	1.8	2.1	0.5	0.0	0.9	0.0	0.6	10.1	2.3	1.6	3.9	3.6	0.0	15.8	1.1	0.0	1.9	9.2	2.7	1.3	1.9	3.6	66.3	0.6	11.8	4.8	4.6	0.0	3.2	0.4	50.4	2.5	0.7	1.8	3.7	0.6	1.4	0.0	1.0	1.3	1.1	5.2	1.2	2.9	0.1	34.8	3.1	3.3	4.7	0.0	2.7	1.0	0.3	0.8	0.6	1.0	0.0	0.3	0.1	5.4	0.2
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 92.2;Breast myoepithelial cells: 93.5;Fibroblasts: 109.6;Ionocytes: 91.6;Oligodendrocytes: 223.7;Respiratory ciliated cells: 103.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 49.6"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 49.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 252.7;RT4: 238.3;T-47d: 267.0;U-2197: 349.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		13000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	53.8	9.5	4.9	12.7	8.1	0.8	57.3	9.1	5.5	53.0	2.6	38.4	10.6	42.7	23.1	20.5	15.4	30.0	22.1	11.0	12.7	10.0	1.3	18.4	1.0	15.0	8.0	48.5	2.6	0.8	3.7	6.0	17.5	66.6	31.3	1.0	27.3	42.3	19.3	17.9	14.1	44.4	10.0	22.2	20.6	12.9	8.4	1.4	1.8	34.3	1.1	69.8	14.4	12.8	6.6	77.0	156.4	0.6	35.2	82.5	0.3	51.8	59.7	25.9	32.5	12.4	144.7	0.0	2.1	17.7	252.7	31.2	0.7	47.0	42.4	0.1	15.8	9.9	63.6	0.7	41.3	0.7	0.2	36.1	32.3	63.6	62.0	220.2	0.5	0.0	0.5	0.1	46.4	113.7	0.2	0.3	1.4	22.2	12.2	0.1	75.5	1.2	142.9	238.3	0.8	82.4	145.7	38.9	9.5	66.3	267.0	0.2	125.2	140.1	64.2	349.2	93.9	1.2	0.0	0.1	52.8	0.0	142.3	49.6	5.7	0.9	0.0	2.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	2.6	0.0	1.9	3.3	0.0	1.7	4.9	8.1	9.1	5.5	11.0	12.7	15.0	8.0	17.5	10.0	8.4	12.8	7.4	9.6	8.9	3.3	0.3	26.4	41.8	92.2	10.8	0.3	15.8	93.5	38.2	1.5	39.8	7.3	6.2	0.5	1.7	56.1	1.9	3.8	0.5	20.3	11.9	7.7	6.0	4.6	41.7	6.6	1.3	109.6	17.9	34.4	5.1	13.2	1.1	0.0	8.8	0.0	16.7	15.7	91.6	3.1	14.9	2.3	7.8	9.0	55.2	20.6	8.3	1.5	1.0	3.0	223.7	68.2	12.4	52.3	0.0	53.7	12.5	0.4	103.0	0.6	0.0	38.8	17.3	0.7	2.7	3.0	18.9	0.3	1.5	9.9	30.4	70.0
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 47.8;thyroid gland: 45.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 157.4;Leydig cells: 52.5;Peritubular cells: 62.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 28.4;HaCaT: 28.7;TIME: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	NA	NA		120000		"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	3.2	2.9	5.9	1.0	1.9	0.0	5.9	0.8	4.6	5.6	0.0	2.8	1.8	2.4	2.6	1.7	5.1	1.7	2.2	6.2	4.7	3.8	1.0	3.6	3.3	2.3	8.9	1.9	0.7	0.2	0.5	0.7	2.2	8.3	3.4	2.2	4.3	1.9	0.0	2.4	3.3	1.4	3.0	47.8	3.3	3.8	3.2	0.3	45.4	0.9	1.4	3.1	0.7	3.2	0.0	0.0	12.1	0.0	0.0	0.0	0.5	7.6	8.2	8.8	4.2	0.0	0.0	0.0	2.2	28.4	0.2	28.7	3.1	0.0	5.8	0.0	5.8	0.0	3.1	0.0	0.1	0.0	0.0	0.1	0.0	1.5	7.2	10.1	13.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.6	7.5	2.1	8.9	6.8	2.8	0.0	0.1	1.1	0.0	0.0	0.4	13.8	0.4	0.0	44.2	0.0	2.7	0.4	0.0	5.4	3.4	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.9	0.8	4.6	6.2	4.7	2.3	8.9	2.2	3.0	3.2	3.2	2.8	0.0	3.3	18.3	1.8	3.6	2.4	0.1	0.0	2.6	0.8	8.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	157.4	1.6	0.3	14.8	26.5	0.0	12.3	0.2	0.0	15.3	0.0	4.3	2.5	0.2	2.9	0.0	1.3	1.7	5.1	0.7	2.0	0.0	5.7	23.3	52.5	0.5	12.4	19.7	0.0	1.9	0.0	3.0	0.9	0.0	0.0	62.4	0.0	5.8	1.9	4.7	0.8	4.1	0.0	0.7	2.0	0.7	0.8	0.1	2.4	0.0	0.5	11.2	1.0	0.4
SEMA4F	"SEMAM, SEMAW"	ENSG00000135622	"Ssemaphorin 4F"	O95754	2	74654228-74683853	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5;Inhibitory neurons: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064095, HPA065969"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane, Centrosome"	"HPA064095: AB_2732710, HPA065969: AB_2685590"	"unprognostic (9.69e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (5.94e-5)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.74e-6)"	"unprognostic (2.60e-2)"	"unprognostic (8.08e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (4.69e-2)"	3.2	2.3	5.4	0.9	7.0	0.4	3.2	3.2	8.2	4.1	0.1	2.5	0.5	3.6	1.7	1.3	3.3	0.8	2.7	8.0	6.3	3.5	1.0	2.5	1.5	4.2	2.1	5.3	2.6	3.0	7.2	0.9	3.9	3.1	1.0	4.7	2.7	1.4	1.4	1.9	2.1	1.6	1.5	2.6	2.2	4.1	8.1	1.2	3.1	1.3	1.4	2.6	3.2	3.8	6.1	3.4	3.7	5.5	5.8	3.3	2.6	3.9	8.9	7.4	6.5	1.4	3.3	2.3	5.0	6.2	14.4	1.9	6.7	5.7	7.5	5.3	7.0	4.4	1.4	3.8	2.3	1.0	5.4	2.6	6.0	4.9	2.4	14.1	2.9	4.4	0.2	0.2	4.8	2.1	3.3	0.8	2.6	2.7	4.0	0.0	5.4	0.0	6.0	2.6	2.9	5.8	7.0	1.8	6.5	5.0	2.6	0.7	4.9	11.5	5.8	2.9	7.1	5.2	5.6	0.3	13.4	0.3	5.6	0.3	0.1	0.7	1.9	0.0	1.2	1.1	1.1	1.7	0.0	0.8	1.1	1.3	0.3	1.0	0.2	0.0	0.9	0.8	5.4	7.0	3.2	8.2	8.0	6.3	4.2	2.1	3.9	1.5	8.1	3.8	2.2	0.0	6.5	4.9	2.7	0.4	1.8	1.8	2.2	8.8	1.8	2.5	2.4	5.7	4.8	5.5	12.5	0.8	1.4	0.7	1.9	2.1	3.2	0.6	0.6	2.2	7.2	0.8	44.5	1.6	2.4	3.3	1.5	1.0	2.5	3.0	3.3	0.6	0.8	11.8	22.7	0.6	2.0	0.0	0.7	3.7	0.9	0.7	0.0	4.7	1.5	3.3	4.1	4.5	5.8	2.7	1.4	1.5	0.7	1.3	0.4	0.3	1.3	6.7	6.6	3.1	1.4	5.6	11.2	0.5	0.4	0.4	3.5	0.5	1.0	1.6
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774228	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.5;placenta: 43.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Horizontal cells: 79.1;Inhibitory neurons: 319.5;Oligodendrocytes: 140.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 14.9;SCLC-21H: 13.3;SH-SY5Y: 12.1;SuSa: 14.2;U-266/70: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Golgi apparatus"	"HPA043109: AB_10793941"	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.5	1.5	11.3	3.9	27.9	0.4	5.0	11.1	21.3	5.8	0.0	10.6	21.8	1.6	2.5	1.7	4.9	4.0	9.4	9.8	16.3	15.1	3.1	8.9	2.1	17.2	31.1	26.7	16.1	10.6	5.5	43.1	23.1	4.5	12.7	15.8	4.5	8.4	20.9	3.0	38.5	3.3	12.0	2.5	3.0	2.6	20.5	2.7	5.8	6.0	0.6	3.1	10.0	28.8	0.0	0.0	2.5	0.0	1.5	1.2	0.2	0.6	14.9	0.4	0.0	0.3	0.1	2.2	0.0	4.0	0.0	7.6	3.4	1.1	0.1	1.1	1.7	0.0	5.0	0.0	4.0	0.0	0.2	1.1	8.3	0.0	0.5	0.0	1.0	5.7	0.1	3.4	0.4	0.8	2.8	0.7	4.6	0.0	0.0	1.6	0.1	2.4	1.1	1.1	13.3	12.1	0.1	1.0	4.3	14.2	0.5	0.0	0.0	6.9	0.3	0.2	0.0	10.0	0.0	2.3	1.8	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.3	27.9	11.1	21.3	9.8	16.3	17.2	31.1	23.1	12.0	20.5	28.8	13.9	51.3	1.5	72.8	0.2	2.0	4.0	1.4	1.2	6.2	0.5	10.7	10.0	4.3	2.1	11.0	114.7	19.7	0.1	40.6	5.9	1.0	0.2	0.5	2.3	10.1	17.4	0.0	120.7	0.2	1.8	10.8	0.0	0.3	3.8	71.0	5.0	0.9	2.6	79.1	319.5	5.4	0.0	0.0	1.9	1.2	23.3	1.0	8.8	15.9	0.0	9.3	0.0	43.2	140.1	0.3	8.5	13.5	0.0	1.2	53.5	0.2	0.1	2.3	0.0	9.3	13.9	0.8	6.3	0.3	1.1	4.7	0.2	3.4	15.1	1.6
SEPTIN2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	246.0	155.0	192.8	159.7	216.1	125.3	177.2	208.8	220.6	233.8	183.2	179.7	140.8	209.0	176.7	161.1	168.7	193.8	211.8	180.5	209.6	212.6	117.1	184.5	157.2	227.2	203.3	221.7	214.2	220.1	112.7	217.3	232.2	186.1	188.6	114.0	163.3	218.2	160.6	119.0	154.8	253.1	224.1	164.9	152.6	145.0	198.3	141.8	224.6	163.5	180.5	221.0	116.7	245.3	245.1	207.7	561.7	370.8	511.5	555.0	289.1	517.3	508.9	329.1	417.2	118.7	258.4	96.1	119.4	599.0	176.7	209.6	377.7	347.9	535.5	241.9	262.2	388.9	200.5	444.5	311.6	374.4	228.0	495.1	224.8	275.0	259.1	369.8	576.2	240.9	357.4	138.0	491.9	171.5	226.7	227.3	412.5	215.2	152.8	216.2	707.4	204.7	483.5	359.9	401.4	270.0	363.0	245.7	353.0	397.9	146.9	333.4	555.5	399.2	166.2	392.9	320.6	267.7	251.9	340.9	344.7	225.1	571.6	172.0	165.0	98.3	101.0	184.1	125.1	87.4	97.9	104.2	183.8	77.2	84.4	89.6	58.9	191.4	144.8	138.7	108.0	241.2	192.8	216.1	208.8	220.6	180.5	209.6	227.2	203.3	232.2	224.1	198.3	245.3	89.9	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	135.9	39.9	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	190.1	50.4	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	139.0	6.5	0.0	0.0	0.0
SEPTIN3	"SEP3, SEPT3"	ENSG00000100167	"Septin 3"	Q9UH03	22	41969475-41998221	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 233.7"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 27.9"	"Group enriched"	"Detected in many"	5	"glioma: 24.6;melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.6;Daudi: 22.3;SCLC-21H: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003548, CAB017633"	Supported	Supported	Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	"Actin filaments"	"CAB017633: AB_2301476, HPA003548: AB_1079908"	"unprognostic (2.10e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.67e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	0.2	4.6	134.7	0.4	160.5	0.1	1.3	82.4	233.7	0.2	30.5	0.8	0.3	0.2	1.4	0.2	0.1	0.4	0.2	167.0	89.5	0.3	0.1	0.7	0.5	86.2	73.4	0.2	1.2	18.6	7.8	5.7	83.8	1.3	0.5	28.4	0.4	0.0	0.1	1.6	0.4	0.3	56.9	0.2	0.7	2.1	91.4	0.9	0.8	0.2	0.5	0.3	0.4	150.7	1.5	1.7	26.6	20.1	0.3	0.0	13.3	0.3	0.3	1.8	0.8	0.4	3.1	22.3	0.7	0.2	11.4	0.1	14.0	0.1	0.7	9.2	4.6	0.1	0.5	0.0	0.2	0.0	0.9	0.2	1.0	0.1	0.0	0.0	0.0	12.1	0.0	3.4	0.0	2.4	3.7	0.2	18.2	0.2	0.7	17.9	0.0	1.3	0.0	2.7	71.4	14.8	10.9	0.1	18.2	2.5	2.6	6.7	0.0	0.0	9.2	0.9	1.0	14.1	13.1	0.2	0.3	9.0	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	134.7	160.5	82.4	233.7	167.0	89.5	86.2	73.4	83.8	56.9	91.4	150.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 235.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.3;Distal enterocytes: 530.1;Ductal cells: 735.4;Pancreatic endocrine cells: 457.4;Paneth cells: 465.1;Proximal enterocytes: 422.0;Syncytiotrophoblasts: 446.6;Urothelial cells: 432.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 10.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 10.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 305.6;HaCaT: 349.2;HBEC3-KT: 553.0;hTCEpi: 307.8;RT4: 381.9;SK-BR-3: 311.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favorable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (2.11e-4)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	6.5	23.8	1.2	15.0	1.4	8.1	33.8	1.5	1.2	68.9	2.9	111.0	118.7	15.3	21.4	120.7	18.9	59.1	3.2	1.0	1.7	114.1	235.5	20.9	3.5	1.8	2.2	0.9	37.7	45.8	9.7	44.5	1.9	56.6	56.2	0.1	151.0	62.1	76.8	53.5	105.6	2.6	1.6	3.4	90.7	4.9	5.8	8.8	28.4	24.5	9.5	116.5	39.3	1.8	87.3	20.5	17.7	57.0	37.3	50.4	48.2	162.8	119.5	10.6	13.1	31.1	305.6	57.0	209.5	154.6	12.9	349.2	2.3	553.0	2.1	5.5	13.2	0.0	17.2	16.6	42.0	0.5	64.1	46.0	307.8	66.5	144.2	45.5	6.7	6.9	2.6	0.5	18.2	14.2	2.1	2.0	18.3	172.1	42.4	0.4	34.8	19.5	57.9	381.9	7.6	42.4	41.7	311.0	6.5	8.5	182.8	9.9	40.7	2.8	13.0	1.8	3.4	2.9	2.1	2.6	1.4	1.6	13.7	0.0	2.4	2.2	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	10.4	0.0	0.6	1.2	1.4	1.5	1.2	1.0	1.7	1.8	2.2	1.9	1.6	5.8	1.8	2.2	16.0	8.9	0.0	2.7	12.4	108.7	374.7	37.0	0.0	162.9	72.9	0.7	138.7	173.3	117.7	0.0	466.3	4.2	530.1	72.4	735.4	6.4	61.6	18.2	8.8	116.6	3.6	0.4	326.3	91.2	5.4	80.0	140.7	0.0	1.6	5.7	54.5	47.5	0.0	0.4	195.0	183.1	5.1	5.0	12.9	2.1	13.1	40.9	1.0	48.4	0.6	0.0	0.0	0.2	457.4	465.1	0.0	0.1	192.2	422.0	71.0	54.3	0.0	0.0	23.5	19.3	0.7	9.5	30.8	21.2	446.6	3.5	0.1	145.7	432.5
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661893	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix: 418.5;esophagus: 809.7;vagina: 669.6"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 6903.4;Club cells: 6726.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 186.5;head and neck cancer: 69.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.9;HaCaT: 6.5;HBEC3-KT: 1.6;SiHa: 4.1;U-2197: 8.2"									"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		9100000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavorable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.1	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	418.5	0.0	0.1	0.0	3.2	0.0	809.7	0.2	0.2	0.4	0.0	0.0	0.1	0.2	3.1	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	7.6	0.0	0.0	100.0	0.0	0.1	42.9	0.1	0.0	0.0	0.1	0.5	1.9	0.0	4.8	0.1	0.0	19.6	73.8	669.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	6.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	35.2	6903.4	2.2	0.0	0.0	0.0	0.0	0.0	6726.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	31.4	0.1	0.2	0.5	0.0	0.0	0.0	8.9	0.0	3.0	0.0	0.9	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	986.7	0.0	0.0	55.4	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	60.2	0.0	0.2	447.6	0.0	0.0	0.0	178.1	1.0	0.3	413.5	0.0	0.3	0.8	0.0	0.0	265.9
SFSWAP	"SFRS8, SWAP"	ENSG00000061936	"Splicing factor SWAP"	Q12872	12	131711081-131799738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039362, HPA040063"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039362: AB_10794089, HPA040063: AB_10795413"	"unprognostic (1.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (7.50e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	26.9	18.3	18.5	10.1	20.8	28.1	26.3	18.5	24.8	27.1	13.7	25.9	10.1	24.6	4.0	23.2	24.5	4.8	20.2	18.2	19.0	24.9	19.4	20.3	11.3	20.4	19.3	29.0	21.9	7.4	21.7	8.1	19.8	21.8	4.3	9.3	20.2	6.8	29.5	32.6	24.6	5.6	16.9	28.4	20.8	16.3	21.2	12.6	24.5	6.7	7.6	22.3	24.3	25.1	26.1	23.0	16.0	17.0	12.6	10.3	35.8	19.7	13.6	22.9	15.6	22.6	12.3	31.9	18.0	14.8	11.9	23.9	22.7	18.1	13.2	9.9	36.0	29.0	12.9	27.0	13.4	37.8	27.4	11.7	20.4	20.8	24.9	18.2	14.3	24.3	40.9	12.3	10.4	32.7	31.9	57.1	41.9	14.0	38.0	36.7	16.2	25.2	13.3	18.8	25.1	28.3	18.7	15.6	25.1	12.5	22.5	29.1	18.6	19.0	24.8	14.8	22.3	35.0	41.2	31.7	18.7	25.5	25.9	2.0	4.1	1.9	3.0	2.7	3.0	2.1	2.8	2.6	2.9	3.7	3.0	3.4	5.6	5.4	3.4	7.2	2.4	1.8	18.5	20.8	18.5	24.8	18.2	19.0	20.4	19.3	19.8	16.9	21.2	25.1	46.4	73.7	44.5	48.6	37.9	38.9	41.5	19.0	42.1	49.7	25.4	25.9	19.3	21.5	38.6	14.7	66.7	30.4	52.6	22.1	0.0	23.1	21.4	27.0	48.8	39.3	21.6	38.7	55.1	26.6	31.8	39.2	37.8	39.7	38.0	47.1	21.4	16.7	22.1	42.1	43.2	24.9	14.2	27.4	21.4	12.9	30.1	30.3	23.2	36.5	35.4	33.7	50.4	58.3	85.1	28.6	24.1	29.7	43.6	44.7	20.8	11.8	30.7	62.4	46.0	52.1	38.1	39.5	42.8	39.7	46.9	43.6	45.9	48.4	22.9	48.2
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 116.6;Oligodendrocyte precursor cells: 133.2;Oligodendrocytes: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 2.1;memory B-cell: 4.4;naive B-cell: 6.6"	"Group enriched"	"Detected in many"	4	"B-cells: 6.6;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"		Yes	No		170000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: AB_2686713"	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	43.2	63.4	19.9	9.4	21.6	0.4	36.5	22.1	31.6	45.1	20.9	51.6	8.0	43.2	27.1	13.3	40.7	27.6	38.9	19.6	21.0	19.5	14.4	30.5	16.7	23.2	20.6	92.2	21.5	10.9	30.9	52.7	22.4	18.0	12.8	16.8	21.1	31.6	8.5	8.2	19.2	41.8	21.9	25.1	23.8	18.5	20.4	12.8	23.9	19.8	7.2	35.6	34.6	26.7	13.5	42.5	39.6	61.8	63.7	110.8	7.1	51.3	92.3	40.7	60.4	24.9	78.0	12.8	70.4	86.5	83.7	9.4	60.0	21.6	49.1	2.2	32.7	1.4	36.9	28.3	44.0	4.3	0.0	95.5	31.1	64.8	79.3	104.9	30.8	0.0	0.1	93.7	43.5	42.6	0.0	0.0	32.8	8.0	29.0	19.8	51.0	25.8	78.6	13.6	26.2	20.8	0.0	52.2	65.1	44.2	17.6	0.8	0.0	131.1	45.1	11.8	81.7	50.8	67.9	14.8	51.4	0.2	74.2	0.7	0.0	0.1	2.1	0.0	0.8	4.4	0.6	1.0	0.0	6.6	0.2	0.7	0.3	1.0	0.1	0.2	0.2	0.3	19.9	21.6	22.1	31.6	19.6	21.0	23.2	20.6	22.4	21.9	20.4	26.7	39.2	70.5	33.3	66.9	6.1	5.0	18.4	16.8	1.8	18.6	9.7	44.4	18.6	30.0	28.3	20.2	4.2	90.2	1.4	0.0	5.9	42.5	1.6	4.0	17.1	18.8	1.2	0.4	85.2	4.3	26.1	116.6	1.5	6.6	2.5	37.3	58.2	11.2	6.3	20.2	68.5	0.1	12.2	2.5	7.3	3.7	75.5	1.4	51.6	15.9	0.0	31.5	0.0	133.2	116.3	2.1	0.0	58.3	2.6	5.5	0.0	14.1	13.7	30.3	85.5	68.0	60.7	17.1	13.0	0.9	4.0	82.8	2.7	44.0	0.0	2.2
SH3BGR	21-GARP	ENSG00000185437	"SH3 domain binding glutamate rich protein"	P55822	21	39445855-39515506	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 1268.3;tongue: 578.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 180.2;Distal tubular cells: 46.9;Early spermatids: 151.2"	"Cancer enhanced"	"Detected in all"		"glioma: 21.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 101.0"					"Low region specificity"	"Detected in all"			CAB003685	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"CAB003685: AB_425682"	"unprognostic (3.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.68e-3)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.75e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.16e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-2)"	8.9	24.0	41.8	3.6	44.9	2.0	11.2	42.0	72.4	10.8	37.3	39.4	6.6	12.3	28.5	20.3	8.1	9.5	154.1	43.7	43.0	13.2	11.8	5.4	2.0	43.8	40.8	6.0	11.0	10.7	25.6	2.1	44.4	25.1	7.0	14.7	14.2	21.2	1268.3	4.8	8.5	11.0	41.0	3.3	16.9	20.1	42.4	3.2	16.3	578.1	2.1	20.8	8.1	50.5	2.0	2.9	3.7	4.2	5.5	9.2	1.0	2.7	0.6	1.9	1.5	1.6	3.9	6.6	8.9	10.9	14.5	0.3	1.2	3.1	2.9	3.9	7.6	7.6	0.9	3.1	15.1	2.8	1.3	7.6	13.5	7.0	12.1	3.4	1.8	13.9	5.0	7.7	7.8	9.4	3.7	4.2	3.2	6.2	6.2	6.5	13.1	4.5	8.3	1.8	10.0	4.0	5.8	4.9	5.4	2.3	19.8	0.5	1.6	5.0	0.6	3.1	7.9	26.3	5.7	6.7	101.0	5.0	6.9	0.0	0.2	0.0	0.2	0.9	0.9	1.4	0.4	0.9	0.9	0.6	1.6	1.2	0.2	1.2	0.9	3.7	0.1	0.4	41.8	44.9	42.0	72.4	43.7	43.0	43.8	40.8	44.4	41.0	42.4	50.5	2.4	3.2	3.9	15.3	1.4	2.7	12.8	5.9	1.8	2.1	11.4	25.0	180.2	5.7	4.4	5.5	4.2	3.7	3.2	2.3	46.9	5.1	151.2	11.3	5.0	3.1	1.2	0.8	6.4	21.3	1.7	5.6	3.6	10.6	4.5	5.3	2.2	9.2	2.4	5.0	6.5	1.7	4.1	1.6	2.0	35.4	2.1	1.5	12.4	5.6	1.2	21.2	0.0	3.0	14.6	4.8	3.2	5.7	1.0	3.3	2.3	14.4	6.7	6.2	6.6	22.7	16.9	32.4	23.6	1.1	1.7	1.9	1.4	4.7	2.7	4.6
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306368-36329340	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;thyroid gland: 27.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.3;Late spermatids: 53.6;Proximal enterocytes: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.4;HaCaT: 21.1;hTERT-RPE1: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042212, HPA042456, HPA066168"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favorable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.1	0.7	2.4	2.5	1.1	1.3	10.8	0.2	6.8	4.4	0.0	3.4	14.0	2.2	1.4	6.9	1.2	2.0	2.0	0.8	0.0	8.8	0.8	3.9	2.0	1.1	0.2	3.5	0.5	0.3	1.7	3.1	1.0	6.7	3.7	3.2	13.4	1.4	0.8	17.4	20.9	1.1	0.0	2.2	2.0	6.8	0.8	0.7	27.8	0.3	3.0	1.3	7.2	0.2	11.2	0.3	2.0	2.2	0.5	1.3	14.4	6.1	0.9	2.8	1.3	7.1	4.3	2.2	5.5	1.6	0.3	21.1	1.4	3.3	2.1	0.9	2.1	2.1	4.8	5.3	1.1	1.2	3.2	0.9	3.0	1.9	1.4	21.7	1.0	4.3	0.4	2.6	1.6	7.3	1.4	1.1	1.2	2.6	2.4	2.3	0.3	1.2	3.7	1.8	4.4	2.1	1.1	11.0	3.4	10.3	0.7	0.3	3.2	1.6	1.2	4.3	1.0	3.3	1.0	2.2	3.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	2.4	1.1	0.2	6.8	0.8	0.0	1.1	0.2	1.0	0.0	0.8	0.2	1.1	0.0	2.0	0.3	1.7	3.1	1.7	3.0	1.8	6.9	6.2	4.3	1.4	0.0	1.9	5.5	0.0	2.9	1.9	15.3	1.9	0.6	14.2	2.5	2.0	1.6	0.0	0.0	1.6	0.4	2.2	1.9	4.6	7.7	1.3	2.6	1.1	0.3	7.7	11.8	1.2	2.9	2.0	6.1	7.7	53.6	1.2	5.0	3.6	0.0	2.2	1.2	1.0	0.0	0.2	4.3	5.8	2.6	2.9	2.6	14.9	1.1	2.3	1.2	0.0	0.7	2.1	2.6	1.2	2.4	3.1	5.7	1.3	3.2	1.6	1.3
SHANK2	"CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3"	ENSG00000162105	"SH3 and multiple ankyrin repeat domains 2"	Q9UPX8	11	70467854-71252577	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.5;Horizontal cells: 136.3;Inhibitory neurons: 167.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"amygdala: 7.7;basal ganglia: 7.5;cerebral cortex: 9.3;hippocampal formation: 9.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.5;Karpas-707: 17.5;RT4: 15.9;T-47d: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008174, HPA017220"	Approved		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane"	"Nuclear speckles"	"HPA008174: AB_1856822, HPA017220: "	"unprognostic (3.08e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.23e-5)"	"unprognostic (1.24e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (1.94e-6)"	"unprognostic (3.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.80e-2)"	1.3	1.2	7.7	0.5	7.5	0.0	4.5	0.2	9.3	1.3	31.7	2.4	1.5	1.0	2.2	3.4	5.1	0.8	0.0	9.5	0.0	4.9	3.8	3.7	0.1	0.0	0.0	0.1	7.5	0.1	2.2	1.9	0.0	3.2	2.0	5.5	9.8	1.8	0.0	0.9	1.3	0.4	0.0	1.1	3.0	0.9	1.0	0.0	6.0	0.0	0.4	1.1	0.3	0.9	0.5	7.4	4.1	0.0	0.6	0.4	4.5	0.7	0.3	0.0	0.0	6.6	3.1	6.2	2.2	0.0	0.1	1.1	0.0	4.8	0.0	0.0	0.2	0.0	0.0	11.5	0.0	0.0	1.9	0.1	1.8	0.0	0.0	1.6	0.0	0.1	0.0	17.5	1.7	10.5	0.0	0.1	3.5	10.2	0.3	0.0	9.9	8.2	5.2	15.9	3.5	1.1	0.0	8.4	0.0	5.2	16.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	7.5	0.2	9.3	9.5	0.0	0.0	0.0	0.0	0.0	1.0	0.9	8.0	41.7	17.0	21.5	0.2	0.0	3.2	3.2	0.6	17.9	26.9	13.0	3.7	11.5	5.4	7.3	0.0	12.8	0.4	3.2	3.9	8.4	1.7	30.0	3.2	1.3	0.0	0.0	153.5	2.2	2.9	1.8	10.2	13.0	2.5	1.2	0.4	21.9	1.2	136.3	167.5	7.9	8.2	0.0	0.3	2.1	0.0	0.4	5.4	14.0	0.0	4.6	0.0	41.7	5.3	10.7	2.7	0.7	0.4	10.9	0.6	10.8	23.3	1.0	0.0	0.3	1.3	0.7	0.9	1.3	0.6	14.6	0.3	0.1	5.5	4.0
SHANK3	"KIAA1650, prosap2, PSAP2, SPANK-2"	ENSG00000251322	"SH3 and multiple ankyrin repeat domains 3"		22	50674415-50733298	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"brain: 73.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.3;Endothelial cells: 65.0;Hepatic stellate cells: 70.3;Microglial cells: 44.0;Oligodendrocytes: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 33.3;TIME: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003446	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA003446: AB_1079958"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.09e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-1)"	34.9	4.0	38.9	4.9	21.6	1.1	33.5	73.5	54.7	12.8	0.0	7.5	3.4	13.4	2.0	5.2	12.4	5.8	26.2	44.7	14.9	11.9	4.4	20.3	4.2	10.0	15.3	4.3	4.0	3.5	5.2	13.7	2.6	8.3	1.2	0.7	8.2	4.2	23.3	7.1	6.4	5.1	0.0	50.4	5.7	2.2	38.6	1.7	14.8	8.9	1.4	10.7	10.1	16.2	6.6	2.6	6.2	4.8	0.5	1.6	3.2	1.3	0.0	0.4	0.5	1.6	2.4	0.0	4.0	1.0	3.1	1.2	0.9	2.3	0.0	0.0	10.4	8.0	1.8	7.1	1.9	1.8	0.4	2.2	1.8	0.1	0.3	0.1	33.3	1.9	0.2	0.2	0.5	2.6	1.4	0.5	3.2	0.6	2.2	7.5	0.0	1.7	0.4	1.3	2.3	3.0	2.7	0.0	3.1	0.7	0.3	0.7	37.6	0.4	9.3	2.0	0.7	0.3	0.4	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	21.6	73.5	54.7	44.7	14.9	10.0	15.3	2.6	0.0	38.6	16.2	195.3	0.0	1.1	4.6	0.5	0.3	0.1	0.5	4.0	1.2	1.3	2.4	27.6	0.0	0.8	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.9	3.9	2.4	65.0	2.4	0.0	28.3	0.0	0.0	3.3	0.0	1.5	0.0	0.3	70.3	6.5	0.4	0.0	21.7	0.0	2.0	3.1	0.0	0.4	0.0	0.3	0.0	44.0	0.0	1.4	0.0	25.1	31.3	0.1	0.0	0.4	0.0	0.2	0.0	0.9	0.9	0.0	0.0	1.0	3.8	0.2	0.8	1.0	0.3	0.0	0.6	0.7	0.1	0.3
SHARPIN	"DKFZP434N1923, SIPL1"	ENSG00000179526	"SHANK associated RH domain interactor"	Q9H0F6	8	144098633-144108124	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 391.4;Late spermatids: 1255.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024825, HPA044453"	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA024825: , HPA044453: AB_10962490"	"unprognostic (4.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.00e-1)"	29.9	39.2	38.5	16.5	39.9	32.6	27.2	39.1	52.2	29.9	35.7	37.7	20.7	29.4	11.2	29.9	28.8	19.4	44.4	36.0	39.2	36.7	39.1	27.1	21.8	41.7	39.7	27.4	35.1	28.7	26.7	17.2	39.9	33.8	12.7	8.9	33.8	22.2	49.4	27.1	26.3	17.3	37.7	33.4	34.2	94.7	39.8	19.6	29.1	39.7	13.9	31.2	26.4	38.7	26.9	43.5	20.4	17.9	34.2	35.1	22.5	23.5	29.5	34.0	32.9	24.9	42.0	12.0	38.5	30.6	17.1	28.4	10.8	42.2	8.2	33.0	23.3	31.4	40.1	29.9	61.6	11.6	23.1	40.4	59.4	28.3	30.8	37.6	36.8	36.6	18.2	27.3	30.2	43.8	35.2	26.6	9.3	53.6	124.2	23.6	16.7	39.4	35.2	28.3	20.3	30.7	45.0	62.1	41.5	14.3	69.4	35.8	34.0	26.5	38.9	32.5	32.4	30.0	25.4	16.3	38.3	25.9	23.5	22.6	33.5	53.5	29.9	41.2	32.4	23.3	28.5	38.3	30.0	21.8	23.5	24.7	17.5	33.9	34.8	42.7	34.1	22.4	38.5	39.9	39.1	52.2	36.0	39.2	41.7	39.7	39.9	37.7	39.8	38.7	56.3	9.6	18.1	10.4	39.4	24.0	32.9	37.0	26.2	27.1	43.5	44.4	20.9	31.5	26.1	35.0	4.2	56.7	44.4	87.2	119.3	53.8	391.4	28.3	26.8	38.9	35.4	88.0	8.0	49.5	52.6	35.9	52.0	24.4	13.3	35.1	36.4	37.2	59.0	48.8	9.5	45.6	44.7	42.1	32.9	1255.3	49.0	33.0	46.2	15.0	57.7	45.4	59.8	9.0	14.3	95.2	81.3	43.6	31.2	36.1	83.1	86.4	20.6	28.9	52.6	26.8	44.2	181.7	67.9	33.5	32.4	43.1	38.8	37.4	59.0	33.9
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241213-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.2;cervix: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.3;Excitatory neurons: 27.4;Inhibitory neurons: 181.4;Oligodendrocyte precursor cells: 77.4;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"OE19: 52.0"	"Low region specificity"	"Detected in all"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	1.7	0.6	17.7	0.0	11.0	0.0	1.1	23.2	25.3	16.8	0.8	0.6	0.2	6.2	0.7	0.8	1.8	0.3	0.8	46.2	18.9	1.9	0.0	0.2	0.0	43.3	25.5	0.6	1.0	3.4	0.2	0.1	24.4	4.3	0.4	1.1	0.2	7.3	0.7	0.8	0.3	0.5	44.8	0.0	4.2	2.9	34.7	0.0	0.5	1.3	0.0	1.1	3.4	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	52.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	11.0	23.2	25.3	46.2	18.9	43.3	25.5	24.4	44.8	34.7	27.0	0.9	0.0	0.0	50.3	0.0	0.1	0.1	0.0	1.2	4.0	1.8	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.5	16.9	1.6	1.2	0.0	27.4	0.0	0.0	2.1	0.0	0.5	0.0	5.6	0.4	0.0	0.1	0.0	181.4	0.0	0.0	0.0	0.3	15.2	5.0	0.0	1.8	12.2	0.0	0.8	0.0	77.4	2.4	0.0	0.0	29.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.2	1.7	0.4	2.5	0.1	0.1	0.0	0.1	4.4	0.2	0.2
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786429-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Cone photoreceptor cells: 47.9;Microglial cells: 24.4;Peritubular cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 19.2;SK-MEL-30: 18.2;SuSa: 18.6;WM-115: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051646	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: AB_2681562"	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	0.7	1.8	4.3	0.4	6.0	0.0	1.0	3.6	10.1	2.4	5.4	1.5	0.7	1.5	2.7	5.0	1.6	3.1	0.7	5.9	4.0	3.7	4.0	4.1	0.3	4.8	5.0	6.9	3.7	2.4	4.4	7.6	4.3	5.3	1.3	20.8	3.2	2.6	0.1	4.1	0.5	0.8	4.3	0.7	1.5	3.4	4.7	3.6	1.4	0.1	1.3	2.4	3.1	5.2	6.2	0.7	11.0	1.5	0.6	1.7	6.2	0.6	2.0	2.4	3.8	7.5	0.1	0.0	2.0	1.6	0.4	4.8	5.7	15.9	2.8	0.0	4.3	0.0	0.0	1.2	3.5	0.0	7.4	0.3	10.9	18.0	0.7	3.9	13.7	0.0	0.0	0.0	3.9	6.5	0.0	0.1	9.7	0.0	0.0	0.0	12.1	0.0	10.2	19.2	1.6	0.9	0.5	0.1	18.2	18.6	6.5	0.4	6.4	17.3	2.2	0.1	0.6	0.0	0.0	0.0	11.4	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	6.0	3.6	10.1	5.9	4.0	4.8	5.0	4.3	4.3	4.7	5.2	1.1	0.0	1.5	26.4	0.0	1.9	3.3	2.8	10.8	9.5	3.4	1.7	4.1	4.3	3.1	3.7	47.9	8.9	0.0	2.0	3.9	3.0	0.5	4.8	2.5	7.2	1.2	2.7	9.5	0.0	1.3	1.5	3.1	5.9	0.0	5.4	10.0	5.7	0.7	1.7	9.5	0.3	4.1	0.8	0.0	1.0	3.7	0.2	0.0	24.4	0.0	2.4	0.0	9.5	4.6	1.6	0.1	83.1	0.0	5.4	0.1	1.0	2.8	18.0	0.0	0.6	1.8	0.1	1.1	10.8	2.0	2.1	0.5	5.5	0.9	5.3
SHTN1	"KIAA1598, shootin-1, shootin1"	ENSG00000187164	"Shootin 1"	A0MZ66	10	116881477-117126586	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 128.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 19.7;intermediate monocyte: 12.9;myeloid DC: 19.3;non-classical monocyte: 6.6;plasmacytoid DC: 12.9"	"Group enriched"	"Detected in many"	42	"dendritic cells: 19.3;monocytes: 19.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037942, HPA037943"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA037942: AB_2675748, HPA037943: AB_10671637"	"unprognostic (1.00e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.08e-6)"	1.9	4.0	63.2	4.5	94.5	0.7	4.9	42.7	54.1	2.9	10.0	4.3	4.1	2.4	4.6	3.1	2.9	3.8	1.6	46.9	73.9	4.7	7.6	6.2	2.9	77.5	70.1	3.9	12.2	8.0	6.2	3.1	69.5	4.2	5.2	10.6	6.7	1.4	0.3	5.6	4.8	2.0	48.6	4.5	5.7	6.4	79.5	2.7	7.5	0.8	2.3	2.1	2.1	128.1	24.2	13.4	1.3	2.8	0.0	0.0	12.8	2.0	5.3	4.0	7.6	15.1	15.5	0.0	4.0	7.4	11.8	12.2	10.6	8.9	4.1	0.0	11.0	0.0	14.5	8.9	1.7	4.3	3.7	0.5	7.5	4.0	7.5	10.3	9.7	6.4	6.7	0.1	2.8	9.6	0.0	0.1	5.0	4.8	8.9	0.0	17.5	5.4	10.3	3.3	14.5	5.7	16.0	23.3	13.8	15.7	18.4	3.8	17.0	1.4	9.4	0.1	11.7	2.4	0.1	0.0	7.1	0.0	7.2	0.0	19.7	0.2	0.0	12.9	0.0	0.0	0.1	0.0	19.3	0.0	0.1	0.0	0.4	0.0	6.6	12.9	0.4	5.6	63.2	94.5	42.7	54.1	46.9	73.9	77.5	70.1	69.5	48.6	79.5	128.1	1.4	76.9	35.7	0.0	2.0	0.0	18.9	0.0	15.4	92.3	31.8	15.9	4.9	35.8	23.5	23.9	62.6	42.1	24.7	10.6	21.5	46.4	7.5	43.4	10.6	5.1	17.0	1.7	0.0	53.2	30.9	11.2	36.7	81.1	2.5	23.6	1.8	50.5	37.3	48.8	0.0	15.5	0.0	83.6	0.0	11.7	11.1	77.2	0.0	0.0	90.3	13.8	1.0	0.0	0.0	46.2	42.5	5.3	0.8	25.2	21.2	58.4	18.2	59.4	13.1	18.2	5.0	22.0	39.6	20.5	0.0	20.0	3.1	28.4	15.7	15.4
SIGLEC6	"CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6"	ENSG00000105492	"Sialic acid binding Ig like lectin 6"	O43699	19	51517819-51531856	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"placenta: 106.7"	"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 76.0;granulocytes: 55.0;Syncytiotrophoblasts: 188.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.9;memory B-cell: 7.2;naive B-cell: 4.5;plasmacytoid DC: 11.0"	"Group enriched"	"Detected in many"	13	"B-cells: 7.2;dendritic cells: 11.0;granulocytes: 4.9"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 500.7"									"HPA008945, HPA009084, HPA018198"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"		"HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868"	"unprognostic (1.97e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (9.31e-3)"		"unprognostic (8.46e-4)"	"unprognostic (2.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.57e-3)"	0.6	0.1	0.2	3.0	0.3	0.5	0.7	0.4	0.3	1.6	0.1	2.2	2.2	1.5	1.0	2.5	0.3	2.5	0.4	0.2	0.0	0.1	0.1	4.3	3.8	0.1	0.1	0.1	0.3	0.1	0.0	106.7	0.2	1.0	3.1	0.4	0.5	0.7	0.5	0.5	3.3	1.3	0.0	1.7	2.6	0.3	0.2	0.7	0.0	0.6	4.2	1.8	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	15.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	1.2	500.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.3	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.9	0.2	4.9	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	1.6	4.5	0.0	0.0	0.2	0.6	0.0	11.0	0.0	0.4	0.2	0.3	0.4	0.3	0.2	0.0	0.1	0.1	0.2	0.0	0.2	0.5	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	5.2	0.7	0.0	0.0	55.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.7	0.5	0.0	0.0	0.0
SIGLEC7	"CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2"	ENSG00000168995	"Sialic acid binding Ig like lectin 7"	Q9Y286	19	51142299-51153526	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 31.3;Kupffer cells: 57.4;Macrophages: 33.1;monocytes: 15.5;NK-cells: 69.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 242.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Karpas-707: 55.4;RPMI-8226: 33.7;U-937: 35.0"									HPA075513			Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		2600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Vesicles	"HPA075513: "	"unprognostic (3.14e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.27e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.26e-2)"	3.7	2.9	0.9	10.6	1.0	4.6	1.0	1.0	1.9	0.6	1.2	1.9	1.6	0.5	0.4	0.4	1.2	2.6	1.3	0.8	1.3	1.6	7.4	5.0	7.7	2.1	1.5	0.4	0.5	0.7	0.6	6.2	1.9	0.7	2.4	0.2	0.7	0.4	0.2	0.2	2.2	3.8	1.4	19.2	0.9	0.9	2.2	1.5	0.5	0.3	2.4	3.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	33.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	1.2	1.1	0.0	0.2	35.0	0.0	3.2	140.2	242.1	10.6	105.8	18.9	3.8	0.2	4.8	65.5	0.2	0.3	4.4	116.7	96.8	44.0	2.9	0.0	80.9	0.9	1.0	1.0	1.9	0.8	1.3	2.1	1.5	1.9	1.4	2.2	2.4	0.4	0.0	2.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.8	0.0	0.2	8.3	0.1	0.0	0.0	0.4	0.0	0.2	0.6	0.0	8.8	0.0	0.0	0.2	0.3	0.0	0.0	1.3	0.0	6.1	0.8	31.3	0.0	0.0	0.0	0.0	57.4	3.5	0.0	1.5	33.1	0.0	0.0	15.5	0.0	69.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.5	0.4	0.0	0.0
SIN3B	KIAA0700	ENSG00000127511	"SIN3 transcription regulator family member B"	O75182	19	16829398-16880353	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050329	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA050329: AB_2681089"	"unprognostic (2.71e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (4.37e-4)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (1.18e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	38.6	31.7	30.1	21.7	28.4	12.6	42.0	8.6	33.3	57.2	12.7	35.9	15.0	59.3	24.1	25.9	49.9	20.4	27.3	30.1	22.7	31.6	19.8	43.6	26.8	19.8	21.8	58.0	25.5	37.8	32.3	29.0	27.0	43.9	12.3	10.0	30.9	35.2	24.7	32.9	36.4	30.6	10.3	43.0	27.2	51.7	24.8	13.2	42.8	14.9	18.1	34.0	43.7	24.5	28.1	14.7	24.4	31.5	19.7	18.1	76.8	23.3	19.2	31.6	27.9	36.4	25.7	25.0	25.5	27.2	26.7	23.6	20.4	20.9	29.1	26.2	36.8	27.0	35.6	16.7	25.9	15.8	20.8	29.9	26.9	21.3	18.2	25.1	29.1	19.7	22.2	15.0	22.4	33.7	21.7	25.5	30.4	14.6	46.6	28.4	22.4	16.6	18.0	23.5	18.0	22.5	29.6	22.5	18.4	32.5	15.9	14.7	38.6	30.5	18.5	44.6	26.5	21.3	16.8	25.0	21.1	20.6	23.1	0.1	4.2	3.9	1.0	3.8	0.6	3.5	0.9	1.1	1.3	2.7	1.1	0.8	2.0	1.2	3.4	1.5	0.3	1.5	30.1	28.4	8.6	33.3	30.1	22.7	19.8	21.8	27.0	10.3	24.8	24.5	45.4	22.4	11.9	30.7	18.9	7.9	11.6	7.4	14.2	20.3	14.4	18.4	8.3	1.5	8.6	3.7	14.6	21.9	9.5	7.0	3.9	10.6	11.4	16.3	34.6	18.8	4.9	6.9	29.9	8.6	29.2	16.0	13.7	36.2	5.1	29.9	10.8	7.0	17.6	10.1	29.8	8.4	0.0	14.6	5.5	24.2	50.7	13.9	5.4	19.7	14.6	8.0	10.3	21.6	26.3	14.5	4.0	66.5	22.0	14.2	4.2	7.5	6.9	14.5	6.6	17.5	13.7	9.7	9.2	14.4	8.1	124.9	11.7	34.5	7.3	17.9
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638101-65650918	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.5;NK-cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: AB_2676716"	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	21.6	17.2	16.4	48.7	15.5	53.8	16.2	14.1	16.8	20.6	10.3	24.0	12.5	20.9	3.4	14.3	19.5	16.0	25.7	15.8	13.2	17.0	15.0	37.0	60.7	22.3	16.0	13.1	8.4	3.5	7.5	19.4	19.5	17.1	6.0	0.9	14.1	10.0	10.0	8.1	37.8	12.0	19.5	95.6	15.9	4.7	24.5	21.3	14.9	6.4	32.5	18.8	15.3	21.0	1.6	13.3	9.1	20.1	5.4	11.1	21.7	14.9	12.7	11.7	11.3	3.9	14.5	21.3	33.2	7.6	0.4	7.8	3.4	5.1	3.9	22.7	8.1	52.6	20.7	7.4	9.6	21.5	21.5	11.4	2.3	16.2	2.1	11.5	34.4	21.8	30.3	9.2	5.8	5.8	8.6	36.1	6.4	5.4	12.3	38.8	5.1	19.3	4.4	0.8	3.4	20.9	7.5	12.6	31.7	8.5	9.6	32.5	49.2	14.2	28.7	15.2	3.0	14.1	12.2	48.4	19.5	33.0	42.0	3.2	3.3	9.3	5.8	3.9	4.1	4.1	2.8	3.7	2.3	4.7	2.0	3.1	11.1	4.7	4.8	2.1	3.0	3.0	16.4	15.5	14.1	16.8	15.8	13.2	22.3	16.0	19.5	19.5	24.5	21.0	22.5	6.4	5.2	7.5	59.0	6.8	24.7	23.2	17.6	2.1	24.8	26.5	7.2	21.5	19.2	23.9	0.0	10.1	82.5	16.5	37.2	19.8	3.0	8.3	6.8	26.8	21.0	31.6	0.1	14.5	19.6	12.2	11.2	14.9	7.0	37.1	42.8	22.0	38.4	5.0	0.2	12.8	30.5	44.4	11.4	9.8	8.1	40.2	10.6	14.0	23.7	7.6	88.6	0.5	4.0	27.2	12.7	13.2	29.6	29.0	39.0	20.7	6.0	1.8	13.1	7.4	20.9	0.8	13.8	14.4	11.1	13.5	50.4	30.9	14.3	31.9
SKAP1	"SCAP1, SKAP55"	ENSG00000141293	"Src kinase associated phosphoprotein 1"	Q86WV1	17	48133442-48430275	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.1;granulocytes: 120.1;Late spermatids: 156.1;NK-cells: 213.1;T-cells: 147.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 29.3;HDLM-2: 16.0;HMC-1: 13.0;JURKAT: 22.2;Karpas-707: 15.7;RPMI-8226: 19.8;RPTEC TERT1: 22.6;U-266/70: 14.8;U-266/84: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002969, CAB025882, CAB055513"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB025882: , CAB055513: , HPA002969: AB_1079870"	"prognostic favorable (5.07e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.14e-4)"	1.4	6.4	0.1	11.2	0.2	6.5	8.3	0.0	0.2	10.1	0.0	3.4	2.7	3.8	17.2	1.7	13.7	3.6	0.5	0.3	0.5	11.9	3.1	5.4	28.7	0.9	0.2	0.8	5.4	13.8	9.8	0.5	0.4	1.0	4.6	0.0	6.1	6.2	0.2	0.8	5.3	1.1	1.4	12.2	4.9	9.5	0.2	35.8	1.0	0.5	26.6	6.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	29.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.1	22.2	0.0	15.7	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	19.8	22.6	0.0	0.0	0.0	1.7	0.0	0.2	0.0	7.8	0.0	0.1	0.0	0.1	0.0	0.0	14.8	11.2	0.0	0.0	0.0	0.0	12.6	0.7	1.8	171.0	0.5	144.2	15.9	139.7	155.6	0.7	54.5	121.2	135.4	3.7	121.0	1.1	0.9	268.9	126.8	0.1	0.2	0.0	0.2	0.3	0.5	0.9	0.2	0.4	1.4	0.2	0.3	3.1	3.2	10.5	1.0	27.1	2.0	0.1	0.0	2.8	0.1	9.7	5.3	0.8	0.0	3.1	9.2	0.0	0.1	107.1	0.5	46.9	0.5	58.1	12.3	1.6	2.4	1.2	9.0	7.0	2.0	0.1	1.1	7.7	14.0	120.1	0.0	7.5	28.7	0.3	0.0	1.4	1.1	0.0	5.4	3.1	156.1	1.5	3.8	1.8	12.2	2.6	1.6	213.1	0.5	1.6	1.3	0.3	0.7	31.0	0.2	0.8	2.0	1.5	0.3	6.6	0.7	1.1	46.4	9.9	0.7	1.3	0.3	147.0	1.2	0.3	0.6
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 61.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 23.6;dendritic cells: 19.7;Late spermatids: 22.1;NK-cells: 45.3;Plasma cells: 21.4;T-cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Daudi: 88.2;U-698: 127.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA051363: AB_2681454, HPA051903: AB_2681658"	"prognostic favorable (9.42e-4)"	"prognostic favorable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favorable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favorable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"	1.7	1.1	0.2	20.6	0.2	3.2	2.2	0.8	0.4	2.0	0.3	3.8	2.7	1.3	1.4	2.1	1.3	4.6	1.0	0.2	0.1	0.9	4.0	4.4	61.7	0.3	0.1	1.2	0.9	0.2	0.2	1.8	0.3	1.3	3.5	0.1	2.2	0.5	0.4	0.6	13.8	1.4	0.1	32.2	5.5	1.2	0.4	19.3	1.7	0.5	48.6	5.7	1.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	6.7	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.8	0.1	0.0	0.0	21.8	1.3	0.1	0.7	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	14.2	127.4	0.0	0.6	0.0	11.2	0.3	23.1	56.1	1.0	38.9	36.2	35.6	71.4	0.3	35.4	19.5	39.5	2.5	41.3	3.1	1.0	45.6	22.2	0.2	0.2	0.8	0.4	0.2	0.1	0.3	0.1	0.3	0.1	0.4	0.3	0.1	0.0	1.3	0.0	23.6	0.4	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	19.7	0.1	0.0	0.1	9.4	0.1	0.1	0.3	0.0	3.2	0.0	0.2	0.0	0.4	0.5	0.1	1.3	0.0	3.3	1.1	1.1	0.0	0.0	0.0	0.0	4.3	0.8	22.1	0.0	1.1	0.0	0.0	1.6	0.0	45.3	0.0	0.0	0.1	0.1	0.0	21.4	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.3	0.0	26.1	0.0	0.0	0.0
SLC10A5		ENSG00000253598	"Solute carrier family 10 member 5"	Q5PT55	8	81693631-81695058	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.9;liver: 11.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 4.1;Enteroendocrine cells: 3.6;Gastric mucus-secreting cells: 6.1;Hepatocytes: 2.8;Proximal enterocytes: 7.2;Respiratory ciliated cells: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 3.6"	"Not detected"	"Not detected"							HPA025966	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA025966: AB_1856959"	"unprognostic (6.42e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.71e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.82e-7)"	0.1	0.2	0.9	0.3	0.9	0.0	0.2	1.8	1.4	0.3	0.0	2.8	3.2	0.3	0.7	0.3	0.3	1.7	0.2	0.8	0.9	1.8	11.3	0.2	0.0	0.6	0.7	0.3	1.0	0.2	1.0	0.0	0.7	0.6	3.7	0.5	0.3	0.2	0.2	0.4	3.9	0.2	0.2	0.3	3.4	0.1	1.0	0.1	0.5	0.3	0.2	0.3	0.2	0.8	0.2	0.2	0.2	0.3	0.2	0.5	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.4	0.5	0.0	0.0	0.2	0.3	0.1	0.2	0.2	0.8	0.6	1.3	0.5	0.1	0.0	0.1	0.1	0.6	0.2	0.8	0.6	0.1	0.2	0.5	0.3	0.3	0.2	0.2	0.4	0.0	3.6	0.2	0.0	0.1	0.2	0.2	1.4	0.5	0.3	0.1	0.2	0.1	0.1	0.5	0.1	0.3	0.3	0.5	0.4	0.5	0.3	0.9	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	1.8	1.4	0.8	0.9	0.6	0.7	0.7	0.2	1.0	0.8	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.3	0.3	0.3	0.6	0.0	0.5	0.0	0.0	0.0	0.0	4.1	1.9	0.4	0.0	0.4	0.3	0.2	3.6	0.0	0.9	1.1	0.1	0.1	6.1	0.3	0.0	0.3	0.7	2.8	0.0	0.0	0.8	1.5	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.5	1.9	0.0	0.0	0.4	7.2	1.7	4.1	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	2.4	0.5
SLC12A2	"BSC, BSC2, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189677	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 75.6"	"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 480.6;Oligodendrocytes: 566.6;Undifferentiated cells: 370.0"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 54.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 153.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Plasma membrane"	"HPA020130: AB_1854502, HPA063697: AB_2685094"	"unprognostic (4.61e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (8.60e-4)"	"unprognostic (3.99e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.95e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.88e-3)"	8.4	17.5	15.0	10.8	48.4	4.4	43.9	46.3	23.2	7.2	40.4	48.5	41.7	8.4	2.4	4.6	6.0	39.4	6.1	13.5	31.1	6.6	4.2	10.3	5.6	40.8	43.1	5.4	6.1	14.7	5.5	4.9	38.6	23.5	58.9	16.8	75.6	2.6	15.4	28.4	49.1	10.2	27.1	4.5	61.8	8.0	32.4	4.1	8.6	8.3	6.0	7.3	3.5	64.8	13.5	65.3	65.8	25.6	16.1	10.4	13.6	12.2	9.1	8.6	8.9	26.4	20.9	19.9	16.1	10.6	7.8	39.5	12.7	14.0	13.2	20.0	15.8	5.7	11.4	3.8	4.9	7.3	9.5	11.1	5.0	19.1	11.2	6.4	14.2	8.5	9.4	13.2	13.4	14.2	13.0	6.1	7.7	153.6	21.1	7.1	18.5	8.2	10.0	45.0	11.5	7.3	24.6	10.6	9.9	7.0	5.9	3.7	24.1	21.2	14.2	16.3	15.7	11.0	10.7	21.6	11.2	4.2	17.6	0.3	0.4	0.2	1.1	0.7	1.9	1.7	1.0	1.4	0.6	2.1	1.1	1.6	0.2	2.4	0.5	6.4	1.1	0.3	15.0	48.4	46.3	23.2	13.5	31.1	40.8	43.1	38.6	27.1	32.4	64.8	38.3	16.0	46.2	23.8	20.5	22.9	20.1	44.9	10.8	76.6	186.9	86.7	18.0	137.2	52.1	33.1	127.2	1.4	34.4	48.2	1.9	68.6	55.8	33.1	43.1	44.2	74.4	2.5	160.6	48.2	2.7	21.3	199.3	38.4	18.4	28.8	12.8	8.8	4.2	80.8	73.2	480.6	57.0	8.6	12.0	95.3	85.4	11.4	204.5	105.9	2.5	22.6	11.3	55.3	566.6	50.1	60.6	29.0	20.2	131.6	38.8	10.6	19.6	86.4	72.3	33.9	64.3	29.1	27.1	14.9	30.0	1.4	21.1	14.1	370.0	21.5
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421493-74533917	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Hepatocytes: 63.7;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 83.9;GAMG: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA072719: AB_2686552"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (3.16e-4)"	13.8	24.7	4.6	4.8	5.8	0.0	5.4	1.7	5.7	9.4	1.2	7.0	3.3	10.3	1.7	2.9	9.3	6.0	10.4	7.7	4.9	7.9	40.7	7.5	0.9	5.6	3.9	12.8	5.5	11.7	9.8	9.2	1.8	6.2	1.8	1.1	5.0	5.8	2.7	2.5	3.1	6.9	3.5	1.2	4.7	0.9	8.1	5.7	12.6	3.7	1.8	6.6	6.2	3.0	8.4	10.4	7.2	43.1	20.8	11.1	0.0	83.9	29.7	38.2	20.6	0.1	0.9	0.0	1.3	37.5	70.8	1.7	1.1	40.2	22.1	6.1	3.6	0.0	0.0	0.0	1.5	0.0	0.0	16.5	9.5	19.3	23.3	14.6	0.1	0.1	0.0	0.0	9.1	0.0	0.5	2.7	27.2	0.0	7.8	17.4	19.9	0.0	18.0	0.1	1.9	12.0	9.6	50.2	0.3	2.5	0.6	1.1	0.0	32.5	8.8	35.7	41.9	0.0	0.0	0.0	34.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.8	1.7	5.7	7.7	4.9	5.6	3.9	1.8	3.5	8.1	3.0	5.6	0.0	0.6	22.2	0.2	0.8	4.3	2.4	0.6	5.7	4.3	3.4	4.5	8.6	2.9	3.7	0.0	5.7	0.1	0.0	3.9	4.3	0.1	0.3	9.8	6.1	8.4	0.0	14.5	2.4	4.9	11.8	0.5	0.5	2.5	1.7	3.6	63.7	1.0	3.3	21.6	0.3	0.0	1.3	0.8	1.2	15.2	0.1	3.6	15.9	0.6	6.2	0.0	23.1	7.1	4.6	0.0	20.7	0.1	5.1	0.4	4.7	2.4	1.5	13.1	9.7	5.6	0.1	0.1	0.9	1.3	2.1	0.4	1.4	0.2	4.9
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45573365	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 82.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 158.0;Syncytiotrophoblasts: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 102.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 102.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	7.7	9.4	8.2	5.7	4.0	8.1	5.9	5.6	12.4	10.0	82.6	6.8	22.5	6.4	0.9	3.2	6.9	1.9	4.2	11.8	2.7	8.0	20.9	15.7	4.2	5.3	5.2	11.8	6.9	0.8	5.4	13.6	6.0	5.8	0.8	2.3	3.3	0.8	2.6	3.9	7.9	1.1	3.0	15.1	7.4	4.6	6.6	2.2	13.8	0.5	0.7	4.3	5.2	4.1	28.9	23.7	4.9	19.4	1.5	2.1	40.2	12.5	1.9	11.1	7.0	55.1	26.1	26.8	24.9	2.8	9.1	14.1	9.0	8.5	2.7	25.2	51.2	54.7	12.4	38.8	6.1	37.2	8.5	2.7	6.3	11.6	3.3	3.3	9.1	27.3	67.6	11.8	3.5	29.3	49.6	29.9	28.5	11.2	30.0	66.5	5.4	79.2	4.6	16.9	29.7	26.7	14.9	23.5	11.2	6.7	18.4	41.4	10.7	14.6	18.8	4.3	21.1	4.8	18.5	23.5	6.7	56.4	11.9	1.6	18.5	24.1	0.9	16.3	2.8	2.5	1.4	2.0	13.4	0.8	2.0	1.5	102.9	1.1	10.8	4.1	3.2	7.9	8.2	4.0	5.6	12.4	11.8	2.7	5.3	5.2	6.0	3.0	6.6	4.1	1.4	48.1	6.3	13.7	2.9	2.4	2.0	2.6	1.8	23.6	3.9	3.4	2.5	1.5	6.2	0.0	0.0	158.0	0.5	8.2	0.0	8.0	3.7	2.2	5.8	3.4	0.0	6.7	3.4	4.9	21.5	3.7	4.1	4.5	1.3	12.7	1.1	16.2	27.3	8.4	4.0	4.1	8.2	11.1	5.0	6.6	6.5	8.6	3.6	23.4	8.3	5.7	0.0	2.0	1.7	7.6	5.4	11.3	9.4	4.6	20.5	2.4	0.9	3.6	0.0	3.3	4.1	1.5	4.8	1.8	1.6	362.4	2.6	5.1	8.5	0.9
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718028	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.7;breast: 28.4;placenta: 24.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 65.4;Syncytiotrophoblasts: 160.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.9;BEWO: 6.2;CACO-2: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	46.7	0.6	5.0	1.9	3.3	1.2	28.4	4.7	4.3	0.5	1.0	2.6	9.1	0.5	0.1	0.7	0.5	5.7	0.7	3.4	4.4	2.2	13.8	4.1	0.8	5.2	4.2	0.9	1.7	0.1	0.1	24.1	5.4	0.3	1.8	2.2	1.1	0.1	0.9	1.6	5.6	0.4	4.4	0.5	0.5	0.5	5.7	0.2	0.4	0.8	0.4	1.0	0.4	4.0	0.3	0.9	0.2	0.8	13.9	0.3	6.2	0.1	0.2	0.2	0.6	20.2	0.4	0.2	0.1	0.1	4.6	0.4	0.6	0.5	0.8	0.0	1.0	0.1	1.1	0.8	1.8	0.2	0.1	3.4	0.4	0.1	0.8	0.3	0.0	0.3	0.1	0.6	0.0	1.6	0.1	0.5	3.0	0.7	0.1	0.3	0.1	0.2	0.2	0.2	0.9	0.1	0.3	1.9	0.5	2.6	0.2	0.2	0.6	0.4	0.4	4.1	0.4	0.1	0.1	0.6	1.4	0.2	0.5	6.8	0.8	1.0	0.4	0.6	0.3	0.8	0.4	0.4	0.2	1.3	0.5	0.5	3.3	2.2	0.7	1.0	0.2	0.3	5.0	3.3	4.7	4.3	3.4	4.4	5.2	4.2	5.4	4.4	5.7	4.0	0.2	9.6	5.1	2.3	0.0	0.0	0.5	0.0	0.6	5.3	0.2	0.1	0.4	5.7	0.0	1.8	0.0	65.4	0.1	5.7	1.9	4.4	0.3	0.1	0.0	2.6	1.2	0.0	0.4	0.0	7.4	3.2	0.0	0.1	0.0	0.3	0.0	13.1	5.1	0.0	0.9	1.6	0.0	0.6	0.0	0.7	0.3	0.9	0.0	25.3	0.0	0.8	0.0	4.5	0.3	0.4	1.0	0.0	0.1	0.4	9.3	3.0	0.0	0.2	0.0	1.7	1.6	0.0	0.3	0.0	0.0	160.6	0.2	0.1	6.5	0.4
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 20.5;testis: 21.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 34.9;Erythroid cells: 60.4;Late spermatids: 31.8;Spermatocytes: 43.1"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7;classical monocyte: 6.9"	"Group enriched"	"Detected in many"	56	"dendritic cells: 4.0;granulocytes: 5.7;monocytes: 6.9"	"Group enriched"	"Detected in some"	18	"NB-4: 16.9;REH: 14.6;THP-1: 53.1;U-937: 30.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036902	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"		"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	0.3	0.0	0.1	0.6	0.2	20.5	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.0	3.8	0.0	0.5	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.2	0.5	0.0	21.4	0.1	1.2	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	30.9	0.0	5.7	6.9	1.3	0.0	1.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.4	0.1	0.0	0.0	60.4	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	1.8	0.5	31.8	1.5	1.1	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	43.1	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0
SLC24A4	NCKX4	ENSG00000140090	"Solute carrier family 24 member 4"	Q8NFF2	14	92322581-92501481	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"choroid plexus: 92.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 251.6;Cone photoreceptor cells: 200.1"	"Group enriched"	"Detected in some"	5	"glioma: 0.5;melanoma: 0.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 11.1;intermediate monocyte: 14.7;non-classical monocyte: 11.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 14.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063206			Approved	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA063206: "	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.58e-2)"	0.5	0.2	7.1	1.4	10.3	3.5	0.1	17.5	8.1	0.2	92.6	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.2	7.2	5.3	0.0	0.1	0.8	1.2	22.7	14.1	0.2	0.1	0.0	1.4	0.3	19.1	0.2	0.2	12.3	0.1	0.3	0.8	0.1	0.3	0.4	14.7	2.7	0.1	1.1	16.5	0.4	0.1	1.0	0.4	0.3	0.2	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	0.0	0.0	14.7	0.2	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.5	0.1	11.6	0.5	0.0	2.7	7.1	10.3	17.5	8.1	7.2	5.3	22.7	14.1	19.1	14.7	16.5	12.9	0.8	0.0	1.9	47.0	0.4	0.0	0.1	0.0	0.0	251.6	0.3	0.1	1.8	0.0	0.0	0.0	200.1	0.0	0.1	0.0	0.0	0.0	4.0	0.5	0.1	0.9	0.0	0.8	19.9	0.0	0.1	0.5	0.0	0.8	0.0	0.0	1.1	0.0	4.0	0.0	28.5	0.0	0.0	22.2	1.8	5.6	0.3	16.6	0.0	2.8	44.3	4.1	1.0	10.1	1.3	0.1	0.0	0.4	0.1	0.2	0.0	0.2	0.7	10.6	0.0	9.9	0.2	0.1	1.6	0.0	0.0	0.3	0.3	0.0	0.0	0.1
SLC27A1	"ACSVL5, FATP, FATP1, FLJ00336, MGC71751"	ENSG00000130304	"Solute carrier family 27 member 1"	Q6PCB7	19	17468769-17506168	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Oligodendrocytes: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.7;SK-MEL-30: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076520			Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Mitochondria, Cytosol"	"HPA076520: AB_2732311"	"unprognostic (1.48e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	18.5	24.2	32.9	4.5	41.5	1.5	19.3	37.3	39.0	22.0	45.9	15.2	3.6	13.1	2.9	8.5	17.0	8.2	29.0	32.0	32.8	10.9	7.9	10.4	4.7	41.1	40.3	33.0	14.4	17.7	19.3	6.2	38.6	23.2	1.8	4.0	24.1	10.3	24.9	14.4	7.6	3.9	34.4	10.5	13.7	17.5	35.9	2.2	16.8	12.4	1.6	13.9	14.0	46.7	6.2	3.0	4.1	9.8	27.7	15.2	3.5	4.4	11.2	4.8	7.2	0.5	18.2	2.1	8.1	7.2	4.3	7.3	0.4	6.8	1.3	2.4	1.4	1.2	0.5	2.3	5.4	0.5	6.4	14.1	4.6	4.8	1.9	19.7	3.3	3.9	0.8	1.3	3.2	2.5	3.3	4.9	1.2	6.0	5.2	4.7	3.2	1.4	3.2	1.8	1.4	2.9	3.0	1.5	47.8	2.5	5.2	1.6	2.1	9.4	6.1	7.5	3.0	4.0	3.1	0.7	9.6	5.3	6.7	0.0	9.2	0.2	1.4	4.0	2.6	0.4	1.0	1.7	6.3	0.3	1.3	1.7	0.0	1.6	1.8	6.5	0.7	4.6	32.9	41.5	37.3	39.0	32.0	32.8	41.1	40.3	38.6	34.4	35.9	46.7	19.7	3.2	11.9	84.5	1.8	6.6	14.1	12.7	10.2	8.4	15.5	26.9	19.5	11.5	11.1	9.2	27.1	4.3	8.3	1.2	1.9	11.1	1.1	8.4	6.9	7.8	5.4	0.8	16.1	4.8	15.6	10.4	9.2	4.9	2.5	8.4	10.4	8.1	26.1	6.7	23.9	3.0	6.1	22.4	4.0	2.5	21.5	13.4	8.8	15.0	14.7	11.6	4.1	37.2	67.5	5.2	0.6	11.7	1.7	12.0	0.1	3.6	16.1	17.7	6.6	10.9	7.3	9.1	5.8	5.0	4.5	2.3	4.9	13.8	2.2	8.7
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 81.3"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 65.7"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Region enhanced"	"Detected in many"		"cerebellum: 4.7"	"Immune cell enhanced"	"Detected in some"		"basophil: 3.7;neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.4;CACO-2: 31.0;SuSa: 35.5"									HPA006539	Supported		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.8	5.7	0.7	0.3	0.9	6.2	0.9	4.7	1.0	0.2	1.8	0.9	0.2	0.2	0.2	1.5	0.4	0.9	0.7	1.5	0.9	0.6	3.0	0.5	0.5	0.2	0.1	2.7	6.6	0.0	0.4	1.1	0.5	1.2	0.5	1.4	0.1	0.1	0.5	0.7	0.5	0.5	0.0	0.3	0.2	81.3	1.3	0.2	0.2	0.1	0.2	1.0	0.3	0.5	0.4	1.5	0.7	0.4	0.3	0.8	18.4	0.2	0.0	0.0	0.5	31.0	0.2	0.1	0.8	0.0	0.3	0.2	0.1	0.0	0.0	0.7	0.2	3.3	1.2	8.1	0.1	2.0	4.5	0.0	0.2	0.2	0.0	0.1	0.0	1.1	3.6	0.8	0.0	0.7	0.4	1.6	3.6	0.1	0.0	0.2	0.1	1.1	0.0	0.5	0.6	0.2	0.5	0.7	0.1	35.5	0.1	2.7	0.5	0.1	3.0	0.5	0.5	3.0	1.3	0.6	0.9	0.1	0.6	3.7	0.4	1.0	0.6	0.1	0.6	0.3	0.5	0.4	0.2	0.3	0.3	0.4	3.4	0.6	0.1	0.2	1.0	0.2	0.7	0.9	4.7	1.0	1.5	0.9	0.2	0.1	0.5	0.0	1.3	0.5	2.1	0.0	1.1	0.0	0.9	0.6	0.0	0.0	0.0	0.1	0.1	0.3	2.4	0.0	0.0	0.0	4.2	0.4	0.5	0.1	0.0	0.0	8.9	0.1	1.3	3.2	0.0	6.9	1.9	1.5	1.5	1.9	0.0	0.2	9.5	6.4	5.3	0.5	0.2	0.0	2.2	0.0	0.0	2.5	12.2	5.4	0.3	1.4	1.8	1.9	0.0	0.1	0.0	0.5	0.4	0.3	5.7	2.6	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.2	2.7	65.7	3.1	0.0	0.1	0.4	3.6	4.2	0.1	0.0
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936187	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 427.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 362.1;Endothelial cells: 356.2;Extravillous trophoblasts: 382.4;granulocytes: 485.1;Langerhans cells: 710.4;Macrophages: 305.2;T-cells: 328.9"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 166.1;neutrophil: 223.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.4"	"Group enriched"	"Detected in many"	5	"BEWO: 1473.1;CACO-2: 1646.2;SuSa: 1119.9"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.36e-8)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	124.9	19.3	26.3	58.2	28.4	427.9	77.0	26.0	38.3	16.4	26.4	29.6	6.7	20.8	2.0	12.7	27.4	56.1	62.3	33.3	31.6	37.7	28.0	92.8	29.4	28.9	25.6	26.4	11.2	7.9	28.0	102.8	33.0	19.7	12.7	87.3	12.3	5.6	24.1	20.7	15.7	41.5	24.6	45.7	19.8	4.9	31.1	18.4	43.3	10.0	20.8	98.7	26.2	23.3	0.3	7.9	68.5	27.4	25.2	85.9	1473.1	24.7	26.7	23.9	55.9	1646.2	11.0	1.6	0.0	17.1	33.1	0.6	2.4	3.9	43.0	48.4	2.0	96.3	6.5	219.3	67.3	35.0	135.4	36.2	2.8	63.6	28.5	55.8	22.6	7.5	44.8	22.8	21.9	0.1	2.6	38.4	300.9	1.2	0.0	2.1	8.0	1.4	0.1	0.1	0.3	0.6	0.0	2.4	32.8	1119.9	0.0	4.9	23.1	29.7	15.6	57.4	2.5	0.2	68.8	5.2	86.9	15.9	16.6	166.1	19.3	29.7	25.3	2.3	20.2	7.4	16.9	19.5	10.0	7.0	10.8	14.8	223.4	15.6	1.0	0.8	24.9	17.4	26.3	28.4	26.0	38.3	33.3	31.6	28.9	25.6	33.0	24.6	31.1	23.3	362.1	144.2	98.8	5.5	301.0	129.5	3.5	1.7	8.6	33.0	5.1	7.6	21.0	7.2	26.8	3.7	62.6	69.6	112.1	0.2	0.0	0.2	3.1	5.0	84.3	356.2	1.2	13.7	24.4	0.0	382.4	188.9	12.2	4.3	485.1	6.5	96.4	2.4	113.4	5.0	20.8	0.3	0.0	76.4	710.4	3.1	10.2	305.2	183.2	34.7	43.4	28.5	41.2	6.6	5.0	0.7	1.3	7.9	93.2	5.3	0.1	1.4	10.3	70.2	118.3	21.5	187.1	2.4	1.2	4.9	82.0	111.4	328.9	41.7	0.1	4.0
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150976-113164140	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 571.4;salivary gland: 409.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.4;Kupffer cells: 145.6;Macrophages: 101.3;monocytes: 84.1;Oligodendrocytes: 113.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	12	"classical monocyte: 226.0;intermediate monocyte: 331.9;myeloid DC: 134.6;neutrophil: 355.8;non-classical monocyte: 423.3"	"Group enriched"	"Detected in all"	47	"dendritic cells: 134.6;granulocytes: 355.8;monocytes: 423.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.4;hTCEpi: 85.0;hTERT-HME1: 57.7;LHCN-M2: 68.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	48.2	16.7	45.0	18.4	72.6	20.1	24.4	68.2	77.8	7.3	34.2	11.3	10.8	4.4	16.7	9.3	6.9	8.6	10.3	45.1	54.0	27.8	33.4	27.4	16.1	76.6	65.8	5.1	19.2	571.4	2.5	23.6	71.4	4.4	12.1	0.8	409.1	42.6	16.7	48.2	17.2	10.8	61.5	32.7	11.8	13.8	61.7	12.1	6.3	14.6	17.6	13.3	10.7	108.2	7.8	3.1	1.3	1.7	54.4	22.3	6.5	4.0	13.9	12.8	12.3	2.4	1.5	0.3	0.5	9.1	7.9	37.7	5.1	31.0	12.0	2.2	1.3	0.1	1.2	3.3	20.7	1.9	0.8	25.3	85.0	30.0	57.7	1.8	6.9	3.0	1.4	2.6	68.9	6.5	1.6	0.7	0.4	1.8	2.6	0.2	39.3	0.0	4.5	4.2	0.9	2.5	6.9	36.4	1.4	0.8	8.6	2.5	2.4	2.0	1.9	13.7	3.2	2.1	5.0	0.1	12.5	3.2	2.0	5.1	226.0	24.0	4.3	331.9	6.5	1.2	4.9	5.2	134.6	1.0	3.8	3.9	355.8	1.0	423.3	2.1	3.0	104.9	45.0	72.6	68.2	77.8	45.1	54.0	76.6	65.8	71.4	61.5	61.7	108.2	13.8	9.6	9.2	2.3	7.0	37.1	6.4	37.7	13.6	7.0	15.3	10.8	0.6	4.3	10.9	1.8	35.5	96.4	3.6	12.8	3.9	13.5	4.1	23.5	4.9	6.4	3.5	0.4	2.1	7.7	9.0	14.4	3.6	8.4	0.0	2.7	12.8	18.1	57.2	6.7	1.8	4.5	10.2	145.6	65.6	4.6	15.8	101.3	0.0	4.7	84.1	6.9	3.1	0.5	113.7	18.5	11.0	9.4	9.1	10.2	51.3	18.2	14.8	9.1	19.7	8.7	7.8	31.0	5.2	3.3	38.4	43.1	7.9	4.6	5.7	7.6
SLC36A4	"FLJ38932, PAT4"	ENSG00000180773	"Solute carrier family 36 member 4"	Q6YBV0	11	93144174-93197991	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017887	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017887: AB_2190238"	"unprognostic (1.23e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.04e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.45e-3)"	"unprognostic (4.20e-2)"	5.8	7.4	4.2	9.3	4.6	19.4	4.6	8.1	5.8	5.1	6.2	5.4	2.0	7.1	2.1	5.3	4.8	5.7	6.0	4.0	8.5	9.4	7.8	6.0	5.3	7.2	6.9	5.7	5.7	6.5	7.7	6.2	7.7	4.9	6.4	15.3	3.7	5.9	2.4	4.1	3.1	8.1	5.5	4.1	4.3	4.3	6.1	7.3	8.8	2.3	6.7	6.9	3.6	7.0	10.4	18.2	36.5	7.3	12.7	25.6	20.5	17.6	29.2	25.6	31.0	14.6	33.1	12.5	9.9	16.5	13.3	12.5	11.4	6.5	23.4	21.1	13.3	14.5	35.3	9.8	10.0	36.6	20.6	12.4	20.0	14.9	9.2	12.0	14.0	17.6	1.3	0.2	26.5	2.6	16.3	27.4	14.8	4.0	18.4	7.2	21.7	5.1	8.7	15.1	33.6	43.8	25.7	9.9	6.4	26.4	18.0	10.6	15.7	48.0	14.8	28.6	26.0	5.1	10.9	0.0	10.9	15.0	25.4	0.1	4.9	5.3	0.8	2.6	1.0	0.9	0.6	1.0	1.9	1.0	1.5	1.0	1.5	0.5	1.7	0.7	0.5	1.1	4.2	4.6	8.1	5.8	4.0	8.5	7.2	6.9	7.7	5.5	6.1	7.0	11.9	12.8	11.5	35.9	29.5	30.7	43.2	9.7	25.6	21.2	10.3	8.0	11.5	20.0	7.1	20.2	22.9	10.7	13.6	3.1	35.2	24.4	9.9	15.5	19.2	18.5	27.6	5.5	66.8	43.6	25.8	21.9	18.8	5.7	4.5	29.0	13.2	9.1	13.6	26.9	71.0	19.6	10.2	52.3	47.1	4.2	18.0	50.1	21.4	27.2	42.8	20.7	13.4	45.2	59.4	33.2	6.3	15.4	22.1	70.4	0.4	16.2	20.8	24.2	6.6	18.0	18.1	7.3	3.3	11.8	32.0	16.3	15.7	20.6	4.3	30.6
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470260	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pancreas: 237.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 196.3;Erythroid cells: 74.3;Exocrine glandular cells: 80.8;Pancreatic endocrine cells: 129.4;Plasma cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 214.0;HBEC3-KT: 326.7;HeLa: 300.0;hTCEpi: 237.8;Karpas-707: 282.8;RPMI-8226: 539.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	4.2	1.9	29.9	13.0	21.8	55.7	2.5	22.6	26.3	9.4	10.6	13.2	13.3	4.2	2.7	10.2	4.9	3.7	6.1	21.6	22.5	1.8	0.9	25.3	8.8	30.4	23.1	6.7	237.2	0.4	0.9	1.1	28.0	5.6	16.2	3.4	9.3	8.6	0.6	21.3	9.2	7.0	22.0	13.8	15.9	0.7	30.4	8.5	20.3	1.3	9.1	9.4	8.7	21.1	143.0	0.3	0.1	1.6	2.8	11.6	0.3	9.4	0.0	0.3	0.1	0.4	0.3	147.8	0.2	61.7	0.3	214.0	164.4	326.7	0.0	47.4	0.2	80.7	300.0	102.4	23.2	166.7	0.2	22.0	237.8	2.9	0.6	0.2	2.8	35.5	150.7	282.8	32.2	0.2	36.3	57.9	74.2	0.0	0.7	131.5	0.7	539.6	0.0	0.1	13.1	0.7	0.1	0.9	0.2	1.1	0.5	6.9	4.7	0.6	0.4	0.4	0.4	0.4	1.0	53.0	1.6	0.8	0.7	0.1	0.4	0.4	17.3	0.6	24.2	11.4	18.6	16.4	2.3	8.9	8.7	11.3	0.5	9.6	0.1	13.1	21.7	9.1	29.9	21.8	22.6	26.3	21.6	22.5	30.4	23.1	28.0	22.0	30.4	21.1	2.3	0.0	0.6	0.3	15.4	26.6	2.7	196.3	17.1	3.2	0.2	0.3	0.4	0.0	33.6	5.5	18.8	0.2	6.7	9.9	0.0	5.5	0.4	1.1	9.1	11.8	0.0	74.3	0.3	80.8	0.6	8.9	3.6	2.7	4.5	1.0	0.4	0.4	2.4	0.0	0.5	17.5	4.1	0.3	3.9	1.3	2.5	2.1	8.8	32.8	1.8	0.3	8.2	0.5	0.2	129.4	5.5	1.2	62.3	4.5	1.2	0.0	4.2	0.3	0.0	0.7	4.6	0.1	0.4	6.4	8.5	0.0	9.5	4.6	21.4	1.9
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.2;Excitatory neurons: 98.8;Hofbauer cells: 100.3;Inhibitory neurons: 77.4;Late spermatids: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	7.6	9.1	6.0	4.7	6.6	2.9	7.4	6.1	9.5	7.3	8.9	4.8	3.1	5.1	13.2	3.3	5.6	9.9	3.7	6.9	6.5	12.0	6.3	8.6	7.8	5.4	6.0	5.8	3.4	21.3	7.2	9.6	6.0	5.1	6.6	7.5	5.9	3.9	2.1	2.9	3.5	5.3	5.0	6.6	3.8	5.0	7.4	5.0	6.3	3.0	4.8	7.0	5.0	6.7	16.2	21.5	6.8	12.3	68.7	25.3	4.9	11.6	34.5	10.7	10.2	5.4	41.0	4.0	19.2	10.6	22.5	13.5	6.8	11.9	9.8	6.0	3.2	6.7	8.6	14.2	22.7	3.7	12.1	19.9	4.9	10.5	12.2	43.2	14.3	6.8	9.3	8.4	37.5	9.2	6.6	8.4	4.0	9.5	14.3	1.6	20.1	11.9	30.7	8.5	3.3	3.0	9.9	7.0	19.1	9.3	10.4	5.8	15.6	16.4	7.1	20.0	6.5	1.6	4.9	1.6	34.0	3.0	13.1	0.0	6.6	0.1	1.7	7.1	2.2	2.2	3.1	2.4	3.6	2.0	2.7	3.4	0.2	0.8	4.5	4.4	4.5	2.8	6.0	6.6	6.1	9.5	6.9	6.5	5.4	6.0	6.0	5.0	7.4	6.7	6.8	22.4	6.7	31.6	6.0	5.2	11.4	14.6	8.0	19.7	7.2	7.5	4.3	7.2	10.0	5.5	22.9	5.6	4.9	2.6	1.9	5.3	178.2	13.0	11.0	7.2	4.2	3.4	98.8	2.8	9.4	11.2	5.1	6.2	6.3	7.3	4.2	4.6	100.3	5.0	77.4	3.1	6.1	24.8	10.0	124.4	10.8	26.2	5.4	20.6	6.4	11.7	2.1	54.3	30.8	7.4	1.9	6.0	5.8	6.6	3.3	23.1	40.4	24.9	0.0	12.3	9.1	16.6	11.5	6.4	2.8	6.7	7.8	5.0	2.8	6.9
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58684770	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Group enriched"	"Detected in all"	13	"Early spermatids: 271.8;Late spermatids: 753.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041777, HPA049428"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782, HPA049428: "	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	6.0	11.4	7.5	6.0	7.8	2.6	5.3	6.0	8.9	5.1	6.1	5.1	4.3	5.5	6.2	6.5	4.0	5.6	15.9	7.9	7.4	7.3	13.6	5.4	4.3	7.7	7.6	4.6	4.8	14.1	7.2	7.5	8.1	5.5	5.9	4.7	6.2	4.6	9.4	5.3	5.5	7.4	5.8	10.3	5.4	32.8	9.8	3.6	7.8	8.3	4.6	5.4	4.9	7.0	6.9	10.9	10.8	16.5	22.0	12.9	19.3	16.2	18.7	22.7	15.6	9.9	11.0	4.5	8.9	22.9	17.9	15.9	10.2	11.7	13.3	2.8	9.4	5.1	9.3	16.5	32.9	10.6	14.0	25.9	23.6	16.1	10.3	12.3	23.5	10.4	14.9	6.3	16.7	8.0	4.3	6.3	11.7	7.5	16.0	15.2	11.6	12.1	10.0	15.4	7.9	11.3	25.7	17.0	7.0	14.4	7.6	4.2	18.7	12.3	9.3	21.8	5.0	9.7	6.7	5.2	16.8	6.3	9.3	0.1	6.8	2.0	4.0	6.6	2.2	1.3	2.4	2.9	4.5	2.5	1.9	2.1	0.5	1.8	6.4	1.7	1.8	5.5	7.5	7.8	6.0	8.9	7.9	7.4	7.7	7.6	8.1	5.8	9.8	7.0	3.3	3.2	4.4	7.8	2.0	3.8	4.0	4.4	1.2	9.8	4.7	3.2	12.8	4.3	4.8	11.0	12.5	8.4	5.0	3.7	3.9	14.0	271.8	3.5	6.8	6.2	13.1	2.1	13.3	8.5	9.5	5.1	9.7	6.0	1.3	10.7	8.2	9.3	38.6	16.8	15.5	3.1	12.2	10.1	8.2	753.3	9.6	11.6	8.8	9.4	4.0	7.1	8.2	5.0	7.6	12.8	2.7	8.6	1.8	3.7	4.8	5.9	3.8	7.1	6.6	4.8	5.1	6.9	7.6	4.6	4.3	15.3	2.7	8.6	4.9	3.2
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 48.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.8;Microglial cells: 362.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	8.2	9.7	7.9	6.3	7.4	4.6	7.1	0.0	21.0	10.8	0.0	4.3	3.9	11.0	3.7	3.6	9.5	8.8	4.3	15.8	0.0	8.7	2.0	7.4	8.3	0.1	0.4	7.9	4.8	5.2	1.1	12.8	1.7	19.1	4.2	5.1	3.7	6.7	1.3	7.0	4.0	7.7	1.4	18.3	5.0	9.3	9.9	10.6	48.4	3.1	7.6	6.3	2.1	5.8	7.3	27.1	46.8	13.0	9.5	21.1	24.3	34.8	16.4	16.1	8.1	38.4	26.4	10.4	51.3	19.6	12.4	10.4	28.6	31.6	19.9	5.4	21.8	11.7	37.1	34.0	10.8	45.4	4.9	12.9	5.1	17.7	20.2	56.9	37.3	10.5	34.9	14.3	26.7	7.3	12.7	14.0	53.8	44.1	18.8	28.9	16.6	27.0	74.8	12.7	17.5	24.7	34.4	65.1	18.7	81.2	11.2	26.5	36.1	28.7	33.6	19.0	18.7	4.6	3.7	6.3	24.5	19.9	29.9	41.5	4.7	3.7	7.5	4.4	6.1	12.3	6.8	6.7	6.4	15.8	6.0	7.8	0.8	21.7	3.3	32.8	7.6	2.6	7.9	7.4	0.0	21.0	15.8	0.0	0.1	0.4	1.7	1.4	9.9	5.8	72.1	3.2	12.8	40.8	42.0	25.6	12.1	51.3	13.1	23.0	16.9	23.1	7.6	5.7	33.2	36.8	8.4	49.3	60.2	4.3	1.9	17.7	28.5	13.2	48.7	75.4	15.6	26.9	170.8	11.3	66.0	35.3	11.2	16.5	13.3	25.7	26.4	2.8	24.5	8.4	78.3	5.9	26.4	20.7	27.1	16.0	19.0	31.8	7.2	362.6	16.2	17.0	20.6	49.3	49.5	24.3	2.8	18.8	21.3	20.1	4.5	14.7	9.5	20.0	13.1	41.9	29.1	61.3	33.6	7.5	20.5	23.4	35.4	30.8	6.2	7.8
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367278-22434129	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 551.3;pancreas: 252.7"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 266.7;Hepatocytes: 611.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 321.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016508, HPA056732"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA		1100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"		"HPA016508: AB_1857148, HPA056732: "	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favorable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	63.5	72.4	13.0	35.5	11.0	1.4	39.8	11.9	13.1	17.3	39.7	48.2	142.2	30.2	6.2	11.6	25.9	32.0	76.7	14.5	22.9	30.8	551.3	23.9	7.6	43.0	30.4	27.7	252.7	12.9	21.5	19.0	25.7	22.3	50.3	18.6	21.8	18.7	43.0	20.0	84.9	33.0	13.3	8.1	80.5	26.5	25.3	6.0	87.7	17.4	6.9	56.0	14.5	14.8	51.8	68.3	18.4	37.6	65.1	54.7	40.1	72.8	321.0	111.3	173.5	226.9	47.9	51.1	39.9	86.1	288.9	55.6	92.8	91.1	181.9	53.1	49.2	40.8	51.0	230.7	154.3	28.5	43.2	58.4	72.6	198.0	136.9	56.3	50.5	36.5	36.2	51.2	57.3	24.0	43.4	18.2	113.4	81.9	49.8	60.1	34.9	110.8	40.8	22.3	31.3	48.7	74.3	31.3	151.4	39.7	25.1	39.4	28.0	137.3	69.2	87.4	75.7	29.2	28.7	66.9	194.3	37.7	81.9	0.0	0.4	2.1	6.7	0.1	7.2	4.0	3.8	5.0	1.5	1.9	4.3	5.9	0.1	2.7	0.1	0.7	3.4	3.4	13.0	11.0	11.9	13.1	14.5	22.9	43.0	30.4	25.7	13.3	25.3	14.8	12.4	3.2	7.7	11.4	9.1	33.3	11.5	10.8	18.8	7.8	20.3	16.6	66.6	41.5	3.8	7.3	2.1	0.4	3.6	91.6	1.9	47.6	0.5	136.1	58.3	32.2	33.4	10.5	26.2	74.7	2.7	58.8	47.9	266.7	0.0	20.8	29.6	611.4	1.8	48.8	24.6	60.6	6.1	15.4	25.8	3.2	23.9	2.9	44.4	6.5	2.7	5.2	2.1	9.0	3.9	47.3	39.1	41.8	13.5	26.5	75.6	24.6	1.1	8.2	0.0	47.1	32.2	0.7	3.0	4.1	21.0	0.5	7.4	14.7	43.5	9.4
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.8;seminal vesicle: 33.2;skin 1: 37.5"	"Cell type enhanced"	"Detected in some"		"Muller glia cells: 22.3;Squamous epithelial cells: 12.0;Suprabasal keratinocytes: 6.0;Urothelial cells: 4.4"	"Group enriched"	"Detected in many"	4	"cervical cancer: 5.1;colorectal cancer: 3.3;head and neck cancer: 6.1;melanoma: 1.9;urothelial cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	71	"HaCaT: 23.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"	"Cytoplasmic bodies"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.0	0.2	0.1	0.2	0.0	1.9	0.3	0.3	8.0	0.2	1.9	0.0	0.3	0.1	18.8	0.5	0.4	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	2.3	0.1	0.3	0.2	12.2	1.3	3.7	4.1	33.2	0.2	37.5	0.1	0.2	0.3	0.0	0.0	0.1	0.3	2.8	0.0	0.0	2.7	0.3	14.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.9	0.0	0.2	0.8	0.3	0.4	0.0	0.7	0.0	2.1	0.1	0.0	0.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	22.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.8	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	12.0	6.0	0.3	0.0	0.0	1.4	4.4
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515780	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 128.6;pancreas: 233.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;NB-4: 74.3;U-937: 70.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (7.30e-2)"	13.9	10.7	3.6	4.7	4.2	35.7	11.1	2.7	5.0	13.1	2.7	15.7	8.7	12.6	10.3	4.4	13.5	18.2	8.6	3.6	2.8	7.3	128.6	9.9	7.4	3.8	3.2	20.3	233.2	1.8	4.4	6.3	3.5	12.8	9.4	1.3	13.8	6.2	17.1	18.8	9.2	8.7	2.7	8.5	30.4	3.4	3.4	2.1	12.7	9.1	6.6	16.2	9.9	3.9	1.1	1.7	1.8	20.3	25.7	18.8	0.2	10.4	13.8	3.0	7.6	6.5	2.8	59.5	2.7	7.9	3.9	1.0	18.1	1.2	3.7	2.8	4.6	30.9	0.5	62.7	33.7	54.3	7.2	23.8	4.4	5.2	23.2	7.3	13.4	34.7	43.9	10.7	3.8	2.3	0.5	74.3	6.6	27.0	13.6	51.0	9.8	27.2	0.5	0.1	23.5	3.6	1.9	0.3	23.8	0.5	1.6	27.3	5.5	3.1	7.1	26.2	1.7	12.1	4.3	35.3	1.5	70.6	4.2	11.1	6.2	0.7	10.9	2.4	9.2	2.9	4.9	7.7	8.4	1.5	4.9	6.9	0.5	7.5	0.2	1.9	9.5	5.5	3.6	4.2	2.7	5.0	3.6	2.8	3.8	3.2	3.5	2.7	3.4	3.9	4.4	0.0	7.3	1.6	3.3	7.0	1.6	0.0	3.4	5.7	1.8	2.4	6.8	47.1	0.6	0.0	0.0	0.2	3.6	3.1	3.9	3.4	21.5	5.3	6.0	4.7	6.0	82.9	3.5	35.4	0.4	10.9	4.6	13.4	3.8	1.3	15.4	138.2	7.4	0.0	1.4	8.8	0.0	8.1	2.9	14.8	15.5	3.2	5.4	5.6	1.3	0.2	5.2	4.0	0.6	11.1	2.9	7.9	6.2	3.2	0.3	0.1	0.7	0.4	6.6	6.4	7.7	0.7	1.5	0.3	3.7	0.1	6.4	2.9	9.0	0.9
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 146.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 75.5;granulocytes: 67.0;Hofbauer cells: 73.7;Langerhans cells: 74.6;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 105.7;intermediate monocyte: 127.0;myeloid DC: 85.8;non-classical monocyte: 146.3;plasmacytoid DC: 85.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 85.8;monocytes: 146.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 513.8;HMC-1: 428.4;RPMI-8226: 570.9;WM-115: 532.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.3"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	61.4	16.8	5.2	34.8	5.9	58.0	50.3	5.9	7.3	40.2	6.8	23.7	8.3	28.1	4.5	34.8	30.0	28.5	34.8	5.5	7.1	15.9	146.9	46.9	26.5	6.7	6.4	24.3	13.7	3.9	4.9	14.3	7.3	14.4	11.8	0.9	35.2	7.5	15.6	34.6	20.6	25.5	6.3	20.8	20.1	4.7	11.1	23.2	76.3	13.3	28.9	30.7	28.2	8.5	289.2	0.0	16.0	0.4	52.9	76.9	0.7	22.0	93.0	31.6	54.1	0.0	61.4	165.0	9.8	52.0	16.3	161.8	47.0	28.8	63.3	1.0	0.2	257.3	93.0	0.0	106.6	513.8	428.4	231.7	0.9	306.5	3.5	22.9	89.7	75.0	299.8	154.4	123.7	0.6	108.6	328.2	24.3	0.0	5.3	221.8	3.3	570.9	76.1	0.0	38.0	0.0	62.2	1.4	263.5	1.5	24.1	77.3	48.1	1.5	81.4	209.2	62.5	0.3	0.9	41.3	187.3	183.2	532.1	15.2	105.7	23.4	19.6	127.0	22.2	9.6	13.5	26.8	85.8	7.1	10.4	10.5	9.0	3.9	146.3	85.7	26.5	60.7	5.2	5.9	5.9	7.3	5.5	7.1	6.7	6.4	7.3	6.3	11.1	8.5	19.8	16.0	49.1	1.6	6.1	46.8	7.4	30.8	48.3	0.5	8.0	14.2	3.7	28.6	26.1	1.8	0.0	0.6	11.9	0.3	0.0	75.5	1.0	1.0	3.1	33.0	0.0	38.3	0.1	6.4	5.0	33.4	2.0	3.0	67.0	2.9	14.3	61.7	73.7	0.0	0.2	0.6	16.2	21.0	74.6	1.7	9.9	47.0	30.2	8.4	10.2	0.6	3.1	8.5	0.8	9.4	0.5	12.4	22.5	14.5	0.0	0.1	4.9	0.1	65.7	15.5	22.0	0.7	1.1	13.6	17.6	0.8	11.8	12.3	1.2	3.0
SLC45A4	KIAA1126	ENSG00000022567	"Solute carrier family 45 member 4"	Q5BKX6	8	141207166-141308305	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 49.7;Cone photoreceptor cells: 54.2;Endometrial ciliated cells: 57.6;Glandular and luminal cells: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 8.3;neutrophil: 7.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 18.3;OE19: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023154	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA023154: AB_2191204"	"unprognostic (7.79e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.73e-6)"	"unprognostic (8.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.40e-2)"	3.5	2.5	3.8	3.7	4.8	5.8	2.9	1.2	16.6	7.1	14.7	4.4	2.3	4.3	1.5	3.3	7.1	2.7	6.6	5.1	1.5	10.2	0.9	6.7	2.7	6.6	1.0	3.1	7.9	2.5	14.9	5.0	6.6	6.6	1.6	5.4	7.8	5.3	4.6	5.7	4.1	1.7	0.7	4.8	12.5	13.7	2.2	2.3	5.8	1.4	2.0	3.4	2.8	6.1	4.6	9.8	3.7	5.9	0.3	0.3	16.1	2.5	1.5	2.2	1.7	6.4	12.2	0.9	11.8	1.0	3.1	3.7	2.1	1.2	1.0	7.2	3.3	2.7	3.1	0.0	1.7	1.1	18.3	0.8	1.9	1.6	0.9	0.5	1.5	5.0	5.6	0.7	0.8	11.9	11.0	2.5	4.7	30.8	4.1	3.3	0.2	3.1	8.9	7.9	5.5	4.6	2.7	0.8	4.5	2.6	1.9	7.2	0.8	0.0	2.4	3.8	4.9	3.9	12.7	1.3	2.1	4.3	4.0	1.1	0.1	8.3	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	7.0	0.2	0.1	0.3	0.2	0.1	3.8	4.8	1.2	16.6	5.1	1.5	6.6	1.0	6.6	0.7	2.2	6.1	3.3	9.6	12.7	6.5	3.0	2.7	6.6	3.6	5.2	33.1	6.4	5.8	13.5	15.7	8.9	49.7	54.2	8.7	7.5	14.7	0.0	9.3	12.5	57.6	10.8	3.4	2.4	0.0	29.0	2.7	0.8	2.9	37.2	97.1	1.3	1.8	1.1	0.0	6.7	3.3	21.7	7.7	8.2	2.5	3.3	5.9	2.1	8.6	3.6	7.5	1.8	4.3	5.2	6.6	0.9	7.8	4.5	2.2	5.3	6.0	3.7	3.2	22.3	9.2	0.0	1.5	3.2	5.7	2.6	4.4	2.4	16.3	4.6	4.0	5.1	11.3
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 76.0;liver: 96.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 53.2;Hepatocytes: 51.3;Proximal enterocytes: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.0;T-47d: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favorable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	13.8	11.7	5.1	10.2	5.7	2.9	10.0	7.7	5.2	14.7	10.0	19.8	46.7	5.6	11.1	4.0	7.5	23.8	12.3	4.7	5.7	18.2	96.0	11.5	16.3	5.9	6.0	3.9	6.7	23.9	10.2	9.5	6.1	6.5	18.8	15.9	9.0	9.9	8.5	4.2	76.0	8.2	6.6	18.2	7.8	11.0	6.6	11.6	12.5	8.6	11.1	7.0	2.2	5.6	0.0	2.8	0.0	7.6	6.0	2.3	0.2	2.7	15.7	3.0	4.4	0.1	6.6	5.2	4.7	4.0	11.5	0.6	3.5	1.4	4.5	3.9	6.2	3.6	0.0	0.0	11.4	0.0	4.3	9.8	2.9	4.5	7.3	3.0	5.6	15.7	3.9	0.0	14.5	3.0	8.6	0.6	0.3	8.0	2.2	3.5	13.3	0.2	27.0	0.9	1.2	0.4	0.0	14.1	5.7	3.1	20.6	4.6	2.0	1.4	2.7	0.4	16.0	4.0	2.0	0.8	0.9	0.0	2.8	33.1	8.9	3.8	10.3	13.1	8.6	7.4	8.0	10.1	11.7	9.7	11.4	10.8	9.8	7.0	19.4	11.0	10.6	8.7	5.1	5.7	7.7	5.2	4.7	5.7	5.9	6.0	6.1	6.6	6.6	5.6	6.2	0.0	5.4	16.0	14.5	1.9	0.1	7.4	1.8	33.7	15.1	3.3	9.6	17.2	15.6	9.2	8.4	0.6	16.4	49.0	1.9	15.5	4.6	2.1	1.7	12.2	3.6	4.6	11.6	5.6	0.3	6.2	0.0	2.1	25.9	53.2	17.5	51.3	10.8	21.9	13.0	6.8	2.0	32.1	36.6	1.8	1.5	22.5	7.2	16.9	9.3	14.2	12.3	14.6	15.6	3.5	5.3	2.2	6.5	0.6	125.0	10.1	15.4	9.8	0.0	2.8	7.2	2.6	0.9	4.9	1.7	0.7	11.4	16.8	13.9	0.2
SLC4A8	NBC3	ENSG00000050438	"Solute carrier family 4 member 8"	Q2Y0W8	12	51391317-51515763	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.1;pituitary gland: 17.9;retina: 11.1;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 92.6;Cone photoreceptor cells: 179.3;Excitatory neurons: 115.0;Horizontal cells: 116.1;Inhibitory neurons: 127.8;Oligodendrocytes: 248.9;Spermatocytes: 91.9"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 21.0;HMC-1: 14.8;SCLC-21H: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077895			Approved	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA077895: "	"unprognostic (4.01e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.72e-4)"	"unprognostic (3.13e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.60e-6)"	"unprognostic (1.35e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.47e-1)"	0.2	3.1	6.7	0.9	7.5	0.6	1.3	10.3	18.1	1.1	0.0	0.4	0.4	0.3	2.5	0.1	1.7	0.3	0.3	9.8	10.6	1.9	0.1	1.2	1.4	23.3	8.6	3.3	1.0	2.2	17.9	0.2	24.1	0.4	0.4	11.1	0.9	0.6	0.1	0.2	0.8	0.3	3.6	1.0	1.3	11.7	9.0	0.6	0.2	0.0	1.2	0.2	0.1	11.4	0.2	1.0	11.9	0.1	0.5	0.6	21.0	3.3	5.5	5.2	3.3	7.2	0.2	4.5	0.5	4.5	2.9	0.1	4.7	0.2	4.8	0.9	0.6	2.3	0.3	0.0	0.0	0.7	14.8	0.2	0.2	2.7	0.5	3.1	6.2	1.9	0.1	7.6	2.7	2.6	6.6	1.4	5.1	1.4	3.6	0.1	0.0	0.0	0.6	0.1	15.7	10.7	1.3	1.6	0.0	3.6	2.0	0.5	5.7	3.3	1.7	0.2	4.3	3.8	1.3	0.2	4.6	0.6	0.4	0.4	0.5	0.9	0.4	0.3	0.0	0.1	0.1	0.4	0.7	0.2	0.1	0.2	0.5	0.5	0.8	0.2	0.0	0.2	6.7	7.5	10.3	18.1	9.8	10.6	23.3	8.6	24.1	3.6	9.0	11.4	1.2	0.0	8.7	33.6	3.1	0.0	0.8	0.2	0.0	92.6	5.0	1.5	1.9	0.0	5.4	1.8	179.3	1.4	4.9	0.5	7.9	0.1	61.9	1.7	0.6	2.4	6.0	0.8	115.0	1.3	5.2	2.1	13.3	0.7	7.6	11.5	1.1	0.2	2.2	116.1	127.8	0.4	0.0	4.7	2.2	32.8	2.8	4.5	1.8	18.7	3.4	11.5	7.2	20.1	248.9	0.1	5.4	3.8	3.5	1.0	1.9	1.0	25.0	19.9	0.0	0.7	1.0	91.9	8.2	0.1	0.1	0.4	4.3	0.9	0.2	1.1
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360194-140375141	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	24	"kidney: 35.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 2.4;Inhibitory neurons: 2.4;Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 6.4;Spermatocytes: 1.7;Spermatogonia: 1.9"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051307	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Vesicles	"HPA051307: AB_2681434"	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.5	35.5	0.0	0.1	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.7	0.3	0.5	0.9	0.6	1.0	0.5	0.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.4	1.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	6.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.7	1.9	0.0	0.1	0.0	0.1	0.1	0.1	0.2
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 119.1;Extravillous trophoblasts: 111.7;Hepatocytes: 67.7;Syncytiotrophoblasts: 227.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 310.9;SK-BR-3: 337.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	42.4	8.6	27.5	14.2	25.2	18.1	31.5	24.0	30.6	9.4	46.2	13.0	20.9	14.3	67.4	10.9	11.5	7.5	7.7	23.4	23.9	8.5	104.0	7.9	13.8	24.0	24.4	10.2	11.6	9.8	8.0	39.1	25.9	9.3	12.7	6.4	12.5	11.1	17.0	10.0	15.3	9.7	23.9	9.1	10.1	23.4	30.6	11.6	8.0	8.8	26.5	11.3	8.8	21.9	78.9	79.6	49.9	66.1	45.4	16.5	310.9	28.1	19.1	41.8	28.7	118.8	27.0	54.2	41.3	15.4	44.7	42.8	108.3	32.4	29.1	42.2	63.5	96.6	34.9	184.4	53.8	125.1	47.8	57.1	27.1	51.4	39.7	11.1	38.2	43.3	143.6	21.1	27.0	161.0	42.7	60.4	144.8	90.1	29.0	70.7	58.7	78.2	24.0	74.5	42.0	61.7	30.3	337.1	40.1	48.6	74.9	26.0	17.5	45.3	62.5	27.9	76.1	35.7	88.6	84.7	24.5	86.1	65.2	0.1	5.9	1.8	7.4	6.6	8.9	5.8	7.0	7.0	8.7	5.3	7.1	8.6	0.3	6.3	8.9	8.9	7.6	5.8	27.5	25.2	24.0	30.6	23.4	23.9	24.0	24.4	25.9	23.9	30.6	21.9	2.5	0.0	4.4	7.8	13.4	8.0	8.6	3.8	7.4	5.3	41.9	31.9	6.8	8.6	3.1	7.3	4.2	119.1	12.5	6.7	1.9	9.8	15.1	3.9	7.4	6.2	5.4	12.6	7.2	8.2	111.7	6.0	5.6	6.9	0.0	18.1	7.1	67.7	21.8	11.8	9.0	9.2	4.1	9.1	6.0	32.0	7.2	6.6	0.0	29.0	47.9	2.5	6.2	6.6	5.0	7.0	4.3	13.9	10.0	14.1	11.7	3.9	2.9	3.1	13.1	5.5	5.2	35.1	21.5	7.6	6.3	227.9	8.6	9.4	15.2	7.8
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748628-74769353	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 352.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 295.8;Proximal enterocytes: 536.9;Proximal tubular cells: 433.0;Squamous epithelial cells: 303.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 572.4;SK-BR-3: 450.7;T-47d: 873.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		940000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	27.0	146.3	98.9	43.7	103.0	115.7	64.1	105.6	118.1	58.3	127.5	85.1	257.8	22.6	26.0	352.8	89.7	96.6	24.3	98.3	91.0	203.5	269.2	26.5	67.9	100.2	97.6	11.1	85.4	110.3	20.8	33.6	95.6	43.9	59.3	13.0	192.2	71.1	5.2	51.1	274.4	11.6	92.2	61.1	78.2	22.5	102.0	57.7	21.4	10.0	89.2	25.7	103.3	106.1	102.1	82.6	40.4	42.1	23.9	17.5	179.9	24.1	22.4	60.3	58.2	259.6	59.6	22.2	23.9	51.4	32.3	142.2	69.8	46.4	28.3	25.9	66.2	167.4	210.9	350.8	48.6	110.3	108.9	14.4	25.6	48.0	20.6	124.9	50.2	65.8	54.0	115.9	93.8	572.4	262.5	246.7	36.1	286.3	47.6	28.0	45.4	100.6	83.5	71.7	34.6	45.3	25.2	450.7	51.9	110.4	873.8	87.3	17.0	18.7	53.5	43.8	40.2	200.0	98.9	40.9	30.2	145.4	11.2	581.6	91.9	440.8	421.5	133.0	279.8	58.6	255.5	360.4	87.8	52.1	147.5	266.1	318.8	308.8	172.1	90.8	309.0	345.9	98.9	103.0	105.6	118.1	98.3	91.0	100.2	97.6	95.6	92.2	102.0	106.1	12.3	6.4	17.2	29.0	41.8	46.1	21.4	128.7	50.1	2.2	135.3	78.7	17.8	163.0	120.8	31.3	4.2	74.5	122.9	295.8	66.5	194.9	15.8	61.8	7.8	12.0	18.7	24.8	0.4	99.0	56.6	24.7	45.3	85.0	25.3	7.3	7.9	190.6	85.4	5.0	0.5	58.0	105.8	25.7	18.8	9.9	8.7	43.5	28.4	3.7	27.0	86.2	203.9	5.0	11.4	76.5	143.8	41.8	151.1	27.5	536.9	433.0	76.0	5.0	6.6	27.6	20.0	22.5	19.5	303.4	57.4	111.5	126.1	17.1	57.1	34.6
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473226-102533972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"stomach 1: 53.8"	"Group enriched"	"Detected in some"	12	"Collecting duct cells: 25.8;Gastric mucus-secreting cells: 54.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.3;OE19: 6.8;RT4: 4.1"	"Group enriched"	"Detected in some"	18	"hippocampal formation: 10.6;olfactory bulb: 6.8"	"Low region specificity"	"Detected in single"			HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.0	0.4	0.1	0.5	0.8	0.2	0.7	0.7	0.3	0.0	0.0	2.0	0.1	0.1	1.5	0.1	1.2	0.6	0.4	0.4	8.6	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	1.3	0.5	1.4	0.4	0.0	0.0	0.0	0.2	53.8	0.3	0.2	0.1	0.1	0.0	0.5	0.4	0.1	0.6	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.5	6.8	0.2	0.0	0.2	0.1	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.5	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.7	0.7	0.4	0.4	0.1	0.1	0.2	0.0	0.2	0.6	0.0	3.2	3.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.9	25.8	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	54.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.0	0.0	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.1	0.4	0.0	0.3	0.3
SLC9C2	"MGC43026, SLC9A11"	ENSG00000162753	"Solute carrier family 9 member C2 (putative)"	Q5TAH2	1	173500460-173603072	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;choroid plexus: 1.9;testis: 6.0"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 27.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA059122, HPA079529"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nuclear speckles"	"HPA059122: , HPA079529: "	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"		"unprognostic (8.52e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-6)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.81e-1)"	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.3	1.2	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.2	0.2	0.5	0.3	1.3	1.2	0.8	0.8	0.4	0.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	1.3	0.0	6.2	0.1	1.3	0.1	0.0	0.1	6.2	1.7	0.1	0.4	0.0	0.0	5.0	0.0	0.5	0.3	0.0	0.1	0.0	0.5	0.4	1.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	4.7	0.0	0.7	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.1	0.1	5.4	0.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296284	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 41.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 49.7;Early spermatids: 21.6;NK-cells: 26.8;Proximal tubular cells: 32.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5;neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.5;RPTEC TERT1: 98.8;U-937: 25.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.8	0.2	0.6	0.3	8.6	0.5	0.0	0.4	0.3	0.0	1.0	2.2	0.1	0.2	0.1	0.2	2.3	0.3	0.2	0.0	41.6	7.6	7.8	0.5	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.0	0.8	0.1	2.0	3.6	0.1	0.3	1.5	0.1	0.0	1.3	0.6	0.8	0.3	1.0	1.6	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	1.1	0.0	1.0	0.2	1.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	17.5	0.0	1.3	0.1	0.3	0.8	0.0	0.0	0.0	0.0	1.2	98.8	0.1	0.7	0.5	0.0	0.3	0.0	2.3	0.0	2.4	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	25.8	0.1	9.5	1.0	7.3	3.8	0.0	0.3	0.0	0.6	2.1	0.4	0.1	0.2	1.3	9.8	2.6	0.0	0.2	0.0	1.0	0.2	0.3	0.0	0.4	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.1	6.4	49.7	0.3	0.6	0.0	0.1	1.2	0.0	0.0	1.8	0.3	0.3	1.5	6.4	5.5	0.0	0.0	9.6	1.4	1.9	0.2	21.6	0.0	0.1	0.3	0.0	5.7	9.1	0.8	0.0	0.3	0.0	1.6	5.7	0.0	0.4	11.0	0.2	0.0	6.6	0.1	2.0	0.6	0.3	2.6	0.3	2.4	0.0	1.0	3.2	0.0	26.8	1.5	0.3	0.3	0.1	0.0	1.4	0.0	1.8	32.8	3.1	0.0	0.0	0.1	0.1	2.5	2.4	0.0	0.0	0.0	3.4	0.1	1.1	0.4
SLIT1	"MEGF4, SLIL1, Slit-1, SLIT3"	ENSG00000187122	"Slit guidance ligand 1"	O75093	10	96998038-97185959	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 32.5;pituitary gland: 13.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 27.0;Excitatory neurons: 96.2;Inhibitory neurons: 34.6;Late spermatids: 25.5;Oligodendrocyte precursor cells: 25.1"	"Group enriched"	"Detected in many"	4	"glioma: 9.2;thyroid cancer: 10.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"JURKAT: 23.2;MOLT-4: 81.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006879			Approved	"Plasma membrane"	"Secreted in brain"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA006879: AB_1078197"	"unprognostic (2.72e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.43e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.39e-3)"	0.4	0.1	28.6	0.2	32.5	0.2	0.1	0.0	29.8	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.2	0.0	0.1	28.7	5.2	0.1	0.1	0.2	0.1	0.0	2.1	0.1	0.6	0.1	13.5	0.0	0.0	0.3	0.1	0.8	0.1	0.0	0.1	0.0	0.2	0.1	1.6	0.3	0.3	1.8	14.1	2.4	2.5	0.0	0.1	0.1	0.1	7.4	0.0	0.1	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.3	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	23.2	0.0	0.6	0.0	0.2	81.0	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	4.9	2.1	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	1.7	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	28.6	32.5	0.0	29.8	28.7	5.2	0.0	2.1	0.0	1.6	14.1	7.4	0.2	0.0	0.0	6.5	0.5	0.0	0.1	0.0	0.0	3.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	27.0	0.5	0.1	0.1	1.8	0.0	96.2	0.0	0.0	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.5	0.0	34.6	0.0	0.0	0.3	0.0	25.5	0.0	0.3	0.0	2.8	0.2	0.1	0.0	25.1	3.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.1	0.2	3.4	2.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967140-104029233	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 201.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	20.5	15.1	10.9	15.2	19.9	28.9	21.7	20.9	13.7	19.9	15.3	20.4	13.3	21.3	16.2	56.4	14.1	21.3	22.4	11.7	10.0	20.6	17.8	24.0	11.8	11.5	11.1	24.0	16.7	26.3	9.6	25.8	11.7	17.6	20.8	15.1	21.9	17.7	23.1	26.3	14.7	20.6	10.3	14.9	24.1	15.2	12.3	15.2	22.4	25.1	17.5	30.5	28.6	18.5	50.5	28.9	33.7	24.3	36.6	50.1	14.2	30.6	40.7	22.5	20.9	18.4	53.7	26.6	18.6	31.8	19.1	53.7	18.0	39.5	33.5	21.3	24.7	27.0	23.5	15.6	26.6	32.7	22.4	25.5	49.5	30.9	87.6	31.7	40.9	16.9	34.6	17.9	29.8	18.6	23.0	18.0	8.4	32.4	18.2	22.2	41.4	13.8	29.0	60.3	8.0	13.8	26.6	25.7	25.8	17.2	13.8	23.4	63.4	16.6	16.9	30.6	36.3	21.6	28.0	16.7	24.2	43.1	10.7	0.6	0.5	1.7	1.4	0.5	1.5	0.4	0.8	1.0	0.5	0.6	0.6	1.0	2.7	0.5	0.4	0.9	0.8	0.3	10.9	19.9	20.9	13.7	11.7	10.0	11.5	11.1	11.7	10.3	12.3	18.5	73.5	179.5	129.5	38.5	19.9	57.0	87.1	30.9	26.7	32.2	32.0	35.1	110.4	30.0	100.9	44.1	25.0	37.4	40.1	70.0	3.9	34.0	8.4	43.3	77.1	80.2	18.5	25.5	35.3	54.0	13.6	52.6	44.9	90.3	35.3	54.6	50.7	25.3	19.9	25.2	39.3	37.2	18.3	24.5	36.9	16.6	46.6	37.5	8.8	34.7	43.9	25.7	27.8	34.2	63.9	85.5	81.6	63.2	22.3	67.8	21.9	11.5	57.9	25.4	6.6	68.1	49.3	46.3	35.3	61.4	68.5	52.4	44.2	71.7	37.4	201.0
SMAP1	"FLJ13159, SMAP-1"	ENSG00000112305	"Small ArfGAP 1"	Q8IYB5	6	70667776-70862011	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 325.7;Late spermatids: 281.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030574	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA030574: AB_10601589"	"unprognostic (1.55e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.22e-1)"	17.0	12.8	24.4	16.1	27.8	18.6	13.6	19.5	44.8	15.2	13.3	27.5	26.8	14.1	18.0	28.4	10.2	17.4	23.1	27.6	24.3	14.1	16.6	14.9	15.4	22.7	25.3	11.1	37.2	28.5	8.6	16.1	23.7	17.6	28.3	24.8	18.0	15.2	32.9	20.4	26.7	19.7	20.1	13.7	20.9	30.9	24.4	24.8	21.1	20.1	22.4	18.1	16.1	29.2	60.3	18.6	28.5	35.3	26.0	33.9	46.4	26.6	29.5	21.4	20.9	27.9	17.4	31.4	28.1	32.0	30.5	18.5	27.4	28.1	35.5	36.3	39.4	34.7	16.5	23.6	17.2	25.5	28.0	22.3	31.3	24.2	29.2	39.6	34.2	16.1	33.8	36.9	33.8	35.0	19.2	31.4	21.3	30.9	21.9	36.0	107.9	51.8	38.1	36.0	40.7	28.7	16.9	23.3	17.1	24.2	31.0	37.3	33.6	17.2	29.7	11.4	23.5	34.3	32.9	16.0	13.0	29.4	24.2	35.0	16.4	18.4	18.2	18.3	20.7	14.8	24.3	21.0	14.0	12.7	12.1	15.7	22.6	25.6	20.0	13.7	25.3	23.4	24.4	27.8	19.5	44.8	27.6	24.3	22.7	25.3	23.7	20.1	24.4	29.2	45.0	38.5	39.4	58.1	39.3	66.9	37.7	66.9	33.0	51.8	39.6	47.2	38.8	52.9	46.0	38.6	37.5	26.2	47.6	111.3	54.8	78.9	325.7	26.1	46.8	43.2	41.9	28.8	120.1	151.0	48.8	40.3	64.7	52.1	48.2	42.9	58.5	41.3	56.6	55.5	104.3	82.3	61.1	61.2	59.8	281.1	50.7	53.0	32.0	60.0	64.1	69.7	64.9	115.6	72.7	108.2	99.5	67.0	51.8	76.3	92.6	69.6	21.1	38.6	65.7	36.3	53.3	105.2	84.2	89.3	77.3	31.7	64.9	44.1	75.8	51.6
SMCO3	"C12orf69, LOC440087"	ENSG00000179256	"Single-pass membrane protein with coiled-coil domains 3"	A2RU48	12	14804650-14814182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.4;kidney: 3.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 5.9;Erythroid cells: 2.7;Hepatic stellate cells: 4.6;Proximal tubular cells: 7.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"spinal cord: 3.6"	"HPA040574, HPA047804"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"HPA040574: AB_2677026, HPA047804: AB_2680160"	"unprognostic (1.16e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.40e-4)"	"unprognostic (5.10e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.45e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-8)"	"unprognostic (2.85e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-1)"	0.5	0.4	0.0	0.1	0.2	0.3	0.2	0.1	0.1	3.4	0.3	0.2	0.0	0.3	0.1	0.0	0.3	1.8	0.9	0.1	0.2	3.0	1.5	1.1	0.5	0.1	0.2	0.2	0.2	0.5	0.2	1.1	0.1	0.8	0.1	1.3	0.1	1.6	0.1	0.1	0.1	0.1	0.1	1.8	0.1	0.2	0.1	0.0	0.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	1.9	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.5	2.8	0.0	1.8	0.0	0.1	0.0	0.0	5.9	0.2	0.0	0.0	0.2	0.3	0.0	2.7	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.0	4.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
SMG9	"C19orf61, FLJ12886"	ENSG00000105771	"SMG9 nonsense mediated mRNA decay factor"	Q9H0W8	19	43727983-43754962	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 103.2;Late spermatids: 329.5;Syncytiotrophoblasts: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041763, HPA042096"	Uncertain		Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"HPA041763: AB_2677659, HPA042096: AB_2677845"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.71e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.24e-3)"	"unprognostic (3.88e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (8.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (8.09e-4)"	9.0	11.7	10.3	10.9	10.8	8.4	8.7	10.9	13.5	10.6	5.9	9.0	8.0	9.0	7.7	9.2	7.7	6.8	7.7	10.2	10.6	7.7	6.6	10.0	13.0	13.1	11.6	7.8	5.8	8.8	9.4	10.1	13.6	11.5	6.2	5.9	12.0	6.9	7.5	10.7	10.0	8.1	9.5	13.5	8.7	33.8	11.6	11.8	8.3	7.1	12.0	10.0	9.9	14.9	25.3	27.2	19.5	12.5	13.4	18.9	13.1	35.1	20.8	38.4	28.7	19.4	32.5	27.4	16.9	24.1	13.2	10.7	22.9	19.7	24.9	21.1	13.2	49.2	20.5	12.9	15.6	37.4	25.9	10.1	16.6	27.9	29.6	32.1	15.8	25.0	37.7	23.6	18.0	17.9	39.9	10.6	9.4	48.0	18.2	21.2	16.1	12.3	20.4	20.4	32.4	15.9	36.7	27.4	21.3	15.4	16.6	20.5	19.2	59.7	35.4	22.3	27.1	11.5	26.8	33.4	17.9	28.4	49.7	1.0	5.3	3.3	5.1	7.7	4.5	7.4	5.1	4.3	6.9	5.3	6.7	4.5	1.3	4.2	11.7	6.1	4.1	11.3	10.3	10.8	10.9	13.5	10.2	10.6	13.1	11.6	13.6	9.5	11.6	14.9	7.7	32.1	8.3	20.9	13.7	9.3	15.0	16.8	11.4	13.2	10.0	11.0	4.4	4.3	9.0	9.2	4.2	49.5	11.3	9.5	1.9	12.2	103.2	5.5	7.0	12.0	4.2	7.8	19.5	8.7	15.8	11.4	15.8	8.9	9.5	12.1	11.0	3.3	21.4	13.5	23.0	11.3	8.2	10.3	9.2	329.5	13.1	12.1	10.6	11.2	16.2	6.0	4.1	16.1	29.6	13.6	9.2	12.0	11.2	15.9	8.5	6.8	8.4	9.2	6.6	11.2	8.5	42.6	16.2	8.4	7.1	95.4	9.3	11.8	12.2	11.1
SMOC1		ENSG00000198732	"SPARC related modular calcium binding 1"	Q9H4F8	14	69854131-70032366	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.2;liver: 67.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 104.4;Oligodendrocyte precursor cells: 372.4;Oligodendrocytes: 81.1;Peritubular cells: 133.2"	"Cancer enhanced"	"Detected in many"		"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 50.3;HeLa: 122.6;HSkMC: 38.3;SiHa: 72.1;SK-BR-3: 30.6;U-266/70: 42.3;U-87 MG: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004153, CAB034427"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		140000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"CAB034427: AB_2193382, HPA004153: AB_1080035"	"unprognostic (3.31e-1)"	"unprognostic (2.17e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.09e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	15.9	10.3	29.2	0.5	30.3	0.1	6.2	53.2	29.1	9.4	17.5	1.3	1.9	2.2	7.7	0.3	6.6	0.5	8.3	27.9	31.6	3.0	67.9	0.6	0.9	38.4	38.8	1.4	10.3	0.3	4.4	8.0	36.8	33.4	1.0	2.4	5.8	38.8	12.7	2.4	1.4	1.0	41.2	27.2	3.8	35.7	29.6	0.4	4.2	2.7	0.5	1.3	6.3	52.8	0.0	3.3	50.3	0.0	9.8	6.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	2.9	0.0	0.0	20.4	0.0	122.6	17.4	0.1	0.0	0.0	38.3	11.9	1.4	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.0	0.2	72.1	30.6	0.0	0.3	0.0	0.0	0.4	0.3	2.9	0.0	0.0	42.3	0.0	0.0	51.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	29.2	30.3	53.2	29.1	27.9	31.6	38.4	38.8	36.8	41.2	29.6	52.8	0.3	0.0	0.0	12.1	2.5	0.3	0.0	0.7	0.0	2.1	1.3	3.8	2.0	7.2	0.1	0.0	16.7	24.2	4.0	0.0	0.0	0.3	4.7	11.9	0.6	2.9	15.6	0.0	1.0	2.3	0.8	6.0	3.6	1.5	0.0	1.4	3.3	104.4	2.8	0.0	13.5	0.1	14.2	2.5	0.4	19.0	7.8	0.3	0.0	1.0	0.1	0.3	0.0	372.4	81.1	3.7	0.1	133.2	12.4	0.0	0.0	0.0	1.1	0.3	0.0	0.7	2.3	2.1	3.9	0.0	0.4	40.2	0.4	0.4	0.0	0.1
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440724-109443919	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 179.4;Late spermatids: 359.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.9	8.8	7.6	8.6	7.4	12.7	10.5	9.6	7.8	12.6	15.1	12.7	13.5	7.1	15.5	24.5	21.4	8.7	6.7	7.7	6.9	12.2	7.6	9.7	13.3	7.6	7.9	8.2	17.7	22.1	11.1	6.0	7.2	13.2	12.6	6.5	15.6	5.8	4.1	21.7	12.3	4.9	7.6	13.3	14.2	53.0	7.0	10.3	13.3	1.7	17.1	10.4	14.3	8.8	13.1	14.8	7.7	12.2	13.2	7.1	25.5	4.3	15.7	10.5	9.8	14.0	10.3	7.1	9.0	9.3	22.1	16.4	7.8	18.7	6.3	9.1	20.5	8.2	15.9	8.7	11.0	9.1	9.4	7.7	21.3	9.3	18.4	11.8	9.8	12.4	16.3	12.2	5.3	18.7	14.8	19.7	2.1	17.3	7.5	10.4	3.6	7.7	19.3	21.8	10.1	8.4	8.2	24.9	19.3	6.2	7.9	17.2	6.3	4.7	6.8	3.8	16.3	8.3	2.3	4.6	9.1	8.6	8.5	6.2	9.0	10.8	6.9	8.6	7.8	14.4	7.8	8.2	11.2	20.4	5.6	5.9	2.5	7.3	7.8	14.3	8.2	6.0	7.6	7.4	9.6	7.8	7.7	6.9	7.6	7.9	7.2	7.6	7.0	8.8	3.9	12.8	7.2	1.6	15.9	9.8	12.9	13.8	8.6	1.3	8.9	6.7	2.1	7.2	11.8	12.9	4.2	10.3	9.1	26.1	1.9	19.2	179.4	28.4	4.0	4.4	8.4	4.2	1.4	19.8	18.5	6.1	25.0	4.3	0.0	3.5	3.6	3.6	9.5	0.0	0.5	27.1	14.2	4.1	11.2	359.7	9.3	7.2	8.8	2.8	9.9	3.7	6.2	0.0	1.7	15.4	27.7	9.1	9.8	15.0	37.5	9.3	67.1	4.9	13.1	3.1	5.8	69.9	10.9	13.8	18.6	17.0	7.6	8.7	17.8	16.9
SMPX	"Chisel, Csl, DFN6, DFNX4"	ENSG00000091482	"Small muscle protein X-linked"	Q9UHP9	X	21705978-21758116	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"heart muscle: 757.5;skeletal muscle: 1183.4;tongue: 1097.5"	"Cell type enriched"	"Detected in some"	22	"Cardiomyocytes: 807.6"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 7.2;stomach cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"GAMG: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077360			Approved	"Plasma membrane"		NA	NA		62000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"		"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	0.2	0.1	2.6	0.5	2.4	0.1	1.1	3.6	3.8	0.3	0.9	25.6	0.7	0.4	0.0	20.0	0.7	0.5	757.5	1.6	4.1	0.1	1.2	0.5	0.2	1.7	3.3	1.1	0.2	0.0	0.2	0.0	1.5	11.1	3.4	1.7	17.8	0.7	1183.4	0.5	4.1	12.6	1.3	0.1	7.2	0.2	5.3	1.5	0.2	1097.5	0.1	3.2	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	3.6	3.8	1.6	4.1	1.7	3.3	1.5	1.3	5.3	2.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	807.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	0.0	16.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	35.6	9.5	0.1	0.3	0.0	0.0	0.3	0.1	2.1	0.1	0.0
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10218830-10307418	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	20	"brain: 1658.7;retina: 492.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 559.2;Excitatory neurons: 1015.8;Inhibitory neurons: 552.8;Rod photoreceptor cells: 254.4"	"Cancer enriched"	"Detected in many"	4	"glioma: 28.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.8;SCLC-21H: 78.2;SH-SY5Y: 46.6;U-87 MG: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		9000		"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.64e-3)"	"unprognostic (7.26e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-7)"	"unprognostic (6.86e-3)"	"unprognostic (5.87e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-2)"	1.5	43.6	251.0	4.1	383.5	0.2	4.4	598.0	1658.7	0.8	0.0	5.7	3.7	7.9	12.9	0.5	7.7	2.3	3.2	420.4	142.2	1.4	1.0	1.8	0.4	427.4	24.7	6.9	6.3	1.2	54.3	0.6	386.6	3.2	2.3	492.0	0.5	19.6	0.8	0.7	3.9	8.1	38.1	0.2	6.3	3.6	147.6	0.5	0.7	0.1	0.4	1.1	1.6	726.9	0.0	4.7	3.9	0.0	0.4	0.1	0.0	2.0	0.0	4.8	1.4	0.0	0.0	0.0	4.3	0.0	3.4	0.8	0.6	0.0	9.6	0.5	0.3	0.0	6.8	0.7	3.5	0.0	0.5	4.4	0.0	3.9	0.0	10.7	0.0	2.8	0.0	23.8	1.6	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.0	0.1	0.9	0.0	78.2	46.6	0.7	0.1	0.0	2.4	0.0	6.5	0.0	5.0	6.8	0.0	2.3	0.1	12.9	0.1	56.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	251.0	383.5	598.0	1658.7	420.4	142.2	427.4	24.7	386.6	38.1	147.6	726.9	0.5	0.0	0.0	117.2	0.0	0.8	1.4	0.1	0.0	559.2	0.2	1.3	0.5	8.6	0.0	0.0	106.3	0.0	0.2	0.0	0.0	0.2	16.3	0.1	0.7	5.2	43.5	0.0	1015.8	0.0	0.1	3.9	0.0	0.2	0.0	0.6	0.0	0.2	0.1	65.6	552.8	3.4	0.0	0.0	0.4	83.3	17.1	0.1	1.8	120.9	0.0	71.9	0.0	179.4	113.3	1.0	2.6	68.8	0.0	0.6	0.1	3.0	0.0	254.4	0.0	0.0	1.3	1.1	0.4	0.0	0.9	0.0	0.0	2.6	0.1	0.1
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 126.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	37.6	10.3	9.7	17.2	9.7	58.4	26.5	27.7	13.2	21.7	9.8	14.6	16.1	23.1	7.8	19.7	13.6	20.4	16.3	9.5	12.5	20.0	25.4	26.4	19.8	14.0	11.5	14.4	22.7	18.5	11.4	33.3	14.7	11.2	11.9	18.8	11.4	10.8	14.3	30.3	17.2	22.9	9.5	33.0	14.4	11.1	13.2	40.5	27.3	21.6	14.7	19.8	21.7	8.7	8.4	5.0	9.1	8.8	26.6	9.5	8.7	8.8	14.8	9.4	9.1	6.9	11.8	13.2	6.8	11.2	6.2	5.3	10.7	18.9	9.6	15.1	8.8	15.0	9.1	8.1	13.8	17.1	16.1	10.5	12.7	10.6	17.9	9.5	126.0	14.9	6.7	14.9	8.7	4.4	17.3	15.0	10.1	4.6	22.6	11.7	6.7	14.0	24.2	14.1	6.4	13.4	7.7	8.1	11.1	7.9	5.5	21.4	74.1	8.2	8.3	9.5	10.4	23.7	18.3	11.0	5.8	20.1	12.0	9.4	4.2	7.6	9.5	7.5	13.0	3.6	8.3	9.6	4.0	3.6	12.1	13.1	27.7	11.0	7.1	1.2	9.7	9.7	9.7	9.7	27.7	13.2	9.5	12.5	14.0	11.5	14.7	9.5	13.2	8.7	88.4	32.1	24.1	30.0	29.0	52.8	10.3	6.4	12.5	52.1	9.7	8.6	17.7	15.7	15.0	16.5	16.7	7.7	57.6	37.0	11.7	10.9	50.4	23.3	16.2	84.2	10.8	10.3	21.6	8.9	3.2	16.4	12.8	19.8	14.5	8.9	98.6	25.2	13.7	30.3	43.2	10.7	12.2	24.8	19.0	7.5	12.5	26.5	23.2	34.7	21.9	16.3	65.9	24.6	10.7	11.2	20.6	11.7	27.3	12.7	25.2	12.2	19.2	18.3	124.9	31.3	49.1	11.1	16.2	13.7	51.3	8.2	61.2	9.5	11.1	18.0
SOCS3	"CIS3, Cish3, SOCS-3, SSI-3"	ENSG00000184557	"Suppressor of cytokine signaling 3"	O14543	17	78356778-78360077	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 501.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 989.2;Endothelial cells: 635.9;Fibroblasts: 394.4;Langerhans cells: 381.5;Skeletal myocytes: 485.9;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.5;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 154.2;HSkMC: 73.3;U-266/70: 76.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 9.8"	"CAB012220, HPA068569"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane"	"CAB012220: AB_443287, HPA068569: AB_2686008"	"prognostic favorable (4.80e-4)"	"unprognostic (2.67e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (9.34e-9)"	"unprognostic (1.08e-2)"	"unprognostic (8.80e-2)"	"unprognostic (7.59e-3)"	"unprognostic (8.40e-2)"	501.5	50.3	19.1	99.0	20.2	126.4	114.1	18.8	27.5	35.1	21.7	119.0	19.4	53.4	1.9	72.7	306.5	190.4	76.8	16.8	21.2	72.1	84.2	234.8	46.9	43.1	22.1	55.5	46.2	23.6	55.7	77.5	24.6	61.8	27.2	4.2	36.3	17.1	26.1	55.3	64.2	125.2	23.7	52.0	123.9	5.9	32.2	115.9	54.1	37.1	11.8	187.9	31.6	19.6	6.4	10.2	7.3	3.8	2.8	44.3	19.1	31.4	28.3	32.1	13.6	6.6	4.4	0.2	6.7	7.5	20.4	2.0	1.5	3.1	12.7	154.2	0.9	5.8	24.1	1.4	14.5	0.1	2.7	73.3	2.6	24.9	9.3	19.4	14.0	0.5	17.4	58.2	15.1	3.3	3.3	1.0	5.2	1.2	12.8	0.2	36.9	1.1	51.4	6.3	0.3	4.6	9.5	2.5	1.3	26.8	2.9	1.4	8.4	62.7	17.6	22.2	18.4	76.0	46.9	0.1	51.6	0.8	4.1	0.0	1.0	0.2	0.8	0.1	1.9	0.0	2.1	0.9	1.1	0.0	3.1	0.6	9.5	0.3	0.0	1.0	1.3	0.5	19.1	20.2	18.8	27.5	16.8	21.2	43.1	22.1	24.6	23.7	32.2	19.6	989.2	48.1	125.6	0.7	64.7	164.3	120.7	75.0	125.2	1.0	176.3	136.4	23.1	18.6	51.7	38.6	2.1	14.9	42.1	20.5	5.9	44.4	0.8	106.7	207.6	635.9	33.0	11.6	0.0	38.6	46.0	394.4	125.4	166.8	36.0	5.8	307.3	20.2	94.6	0.0	0.1	25.0	30.5	78.4	381.5	1.7	78.3	231.0	85.4	1.0	33.6	7.7	1.0	0.0	1.0	43.0	28.1	2.2	115.5	72.0	24.3	11.5	38.1	2.7	13.1	485.9	381.7	0.4	1.0	36.3	133.0	62.1	88.7	5.3	41.0	90.5
SOCS5	"CIS6, Cish5, CISH6, KIAA0671, SOCS-5"	ENSG00000171150	"Suppressor of cytokine signaling 5"	O75159	2	46698952-46780245	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 121.0;fHDF/TERT166: 121.9;U-138 MG: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020884, CAB025510"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025510: , HPA020884: AB_1857356"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (4.52e-2)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	12.0	10.2	7.6	6.3	7.7	7.7	13.0	15.9	9.6	13.0	7.5	9.7	5.2	14.1	9.1	8.5	9.3	11.3	11.3	8.1	7.6	9.2	6.7	8.7	6.7	8.3	8.3	23.2	6.2	14.2	5.6	7.3	8.5	9.9	6.6	12.7	8.7	12.4	9.0	7.5	6.7	13.9	8.5	9.0	6.6	10.3	8.2	7.6	9.9	16.0	6.7	9.3	8.5	8.6	14.5	10.8	9.3	13.8	29.9	42.3	11.4	66.5	121.0	31.5	18.6	10.3	6.9	7.5	12.7	121.9	9.7	7.1	9.9	10.8	41.2	7.3	9.4	11.8	10.0	13.2	18.4	6.9	12.7	33.9	15.8	26.7	10.7	35.8	11.0	3.0	10.2	8.1	21.5	5.3	5.9	12.0	10.4	15.1	8.7	7.8	15.9	9.5	13.2	11.1	7.3	19.8	16.4	10.7	13.0	8.9	4.4	10.3	12.8	80.0	17.7	26.9	13.2	9.7	6.4	6.5	36.9	13.7	25.5	0.5	0.4	2.5	0.9	0.4	1.1	1.8	0.5	0.6	0.5	3.0	1.1	1.5	0.4	1.0	1.7	0.5	1.0	0.7	7.6	7.7	15.9	9.6	8.1	7.6	8.3	8.3	8.5	8.5	8.2	8.6	17.2	3.2	6.1	18.9	11.3	16.6	7.2	8.3	16.5	12.8	15.1	12.2	14.2	18.6	8.0	3.7	22.9	3.7	6.2	11.0	5.9	7.3	12.3	9.9	29.2	24.3	10.8	6.1	43.4	6.8	2.5	18.8	10.2	12.0	17.1	17.4	17.2	7.9	4.5	18.5	51.5	7.1	2.0	8.4	15.2	8.1	17.4	7.7	7.2	18.7	8.4	9.7	6.2	38.2	25.4	6.8	8.8	17.0	7.0	11.0	5.1	7.3	5.3	5.5	13.1	13.8	20.1	13.3	18.8	9.9	14.5	2.7	7.0	7.3	5.6	7.8
SORCS1		ENSG00000108018	"Sortilin related VPS10 domain containing receptor 1"	Q8WY21	10	106573663-107164534	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3;thyroid gland: 11.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 522.2;Inhibitory neurons: 179.7;Oligodendrocyte precursor cells: 381.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"RH-30: 80.8;SH-SY5Y: 104.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011948	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA011948: AB_1857366"	"unprognostic (5.86e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.82e-3)"	"unprognostic (5.81e-2)"	"unprognostic (6.48e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-4)"	0.6	3.1	3.0	1.9	6.2	0.0	1.3	0.0	10.3	2.5	0.0	9.4	0.7	1.1	0.3	0.9	1.6	1.1	3.1	5.4	5.8	4.7	0.1	0.1	1.0	0.6	4.5	0.7	1.6	0.0	0.9	0.0	2.7	2.2	1.9	9.6	1.1	2.5	0.3	1.5	3.6	1.4	0.5	0.8	2.5	1.2	5.8	1.0	11.0	1.7	1.5	3.6	2.8	6.6	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	80.8	0.1	0.0	0.0	0.0	104.9	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	6.2	0.0	10.3	5.4	5.8	0.6	4.5	2.7	0.5	5.8	6.6	0.0	0.0	0.5	7.2	0.0	0.6	0.0	0.0	1.2	2.0	0.1	0.5	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	16.6	0.1	4.9	0.2	0.0	0.0	522.2	0.0	0.0	3.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	1.7	179.7	0.0	0.0	0.3	0.3	5.2	0.0	0.2	1.8	26.2	0.0	49.1	0.0	381.5	10.0	0.1	0.0	0.4	0.0	0.0	0.0	2.2	0.0	2.1	0.0	1.0	0.3	0.2	1.9	0.2	0.1	0.0	0.3	0.0	0.0	0.0
SPAG16	"DKFZp666P1710, FLJ22724, PF20, WDR29"	ENSG00000144451	"Sperm associated antigen 16"	Q8N0X2	2	213284379-214410501	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.1;Inhibitory neurons: 273.7;Respiratory ciliated cells: 330.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037542	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA037542: AB_10672353"	"unprognostic (4.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.17e-1)"	16.3	16.8	36.6	6.4	37.4	2.4	20.8	35.1	45.9	21.0	39.0	16.5	18.8	18.2	31.6	26.1	46.5	22.0	22.2	34.2	37.8	30.4	18.8	10.8	11.5	38.8	39.6	25.8	15.5	24.4	29.7	9.8	37.8	22.1	17.2	21.5	15.7	20.5	10.3	24.9	10.9	12.1	40.9	8.0	26.1	46.3	38.4	13.0	26.4	10.8	13.8	18.9	19.4	40.6	26.8	9.9	29.4	0.0	19.3	35.0	0.2	14.3	17.1	18.3	19.3	20.8	28.8	11.1	16.7	16.0	29.3	18.5	13.4	17.4	38.6	0.0	10.5	5.8	28.0	24.6	21.9	6.3	0.1	30.1	23.5	16.3	9.5	25.0	7.6	11.6	18.8	12.3	18.4	0.0	21.4	0.1	16.3	0.0	8.7	22.6	30.9	0.5	29.4	25.8	21.4	25.1	16.3	15.1	21.3	24.2	70.3	2.7	7.8	17.2	9.2	9.3	15.1	20.0	9.7	0.4	28.6	0.0	8.0	2.0	0.3	0.9	8.1	1.3	11.7	9.3	9.1	10.4	3.1	8.5	12.0	10.4	0.5	15.4	0.9	5.1	9.4	3.4	36.6	37.4	35.1	45.9	34.2	37.8	38.8	39.6	37.8	40.9	38.4	40.6	17.7	16.0	19.5	89.5	10.7	42.3	46.6	82.8	22.8	47.6	38.0	45.6	67.5	74.4	73.6	40.5	95.9	50.6	7.5	17.1	76.3	44.0	243.1	207.0	31.3	18.5	38.2	9.0	205.9	24.9	20.8	30.8	32.1	30.3	10.1	34.0	12.8	16.9	11.7	40.4	273.7	37.8	101.7	4.6	9.6	86.2	41.3	5.9	23.2	42.2	29.2	82.7	8.2	92.0	74.9	27.3	18.8	44.8	9.4	25.4	9.4	94.9	330.0	69.0	13.1	30.8	36.1	167.9	31.0	64.6	56.4	23.5	12.9	55.3	39.8	53.8
SPANXN4	"CT11.9, SPANX-N4"	ENSG00000189326	"SPANX family member N4"	Q5MJ08	X	143025918-143034702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 25.9"	"Group enriched"	"Detected in some"	165	"Early spermatids: 97.7;Late spermatids: 298.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045730, HPA059094"	Uncertain		Approved	"Nuclear membrane,Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"	"Nuclear membrane"	"HPA045730: AB_10961036, HPA059094: "																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	298.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA12		ENSG00000186451	"Spermatogenesis associated 12"	Q7Z6I5	3	57060664-57075432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 20.5"	"Group enriched"	"Detected in some"	145	"Early spermatids: 464.2;Late spermatids: 1195.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;RH-30: 1.1"									"HPA043323, HPA075578"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA043323: AB_10796792, HPA075578: "	"unprognostic (2.31e-1)"	"unprognostic (2.18e-4)"	"unprognostic (3.47e-4)"	"unprognostic (2.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.71e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-3)"	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.2	0.2	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.2	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	20.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	1.1	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.7	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.2	0.6	2.0	0.8	0.7	0.5	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	464.2	1.0	0.1	0.6	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	1.3	0.0	1195.5	5.0	0.5	0.0	1.0	0.0	0.0	0.0	1.0	0.7	1.4	0.1	5.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	2.8	0.3	0.0	0.0	0.3	0.0	0.2	0.5
SPATC1L	C21orf56	ENSG00000160284	"Spermatogenesis and centriole associated 1 like"	Q9H0A9	21	46161148-46184476	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 48.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 208.9;Late spermatids: 472.3"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 3.7;cerebral cortex: 4.8;hippocampal formation: 2.9"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 36.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 37.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018979, HPA019165, HPA029394"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane, Cytosol"		"HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148"	"unprognostic (1.46e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.58e-1)"	7.6	23.4	4.2	1.0	3.7	1.3	8.5	0.0	4.8	11.4	0.0	9.7	1.3	9.8	0.6	7.7	6.8	1.4	11.5	2.9	0.6	7.3	1.3	5.9	1.6	0.4	0.1	13.9	11.3	1.6	14.2	1.1	0.1	32.5	0.7	0.3	6.7	2.5	5.6	10.5	6.9	0.8	0.0	8.4	8.3	48.9	0.9	1.0	6.3	0.8	1.0	9.8	11.7	0.1	2.9	0.0	3.6	6.7	2.0	4.7	1.9	4.1	2.2	2.2	1.7	0.0	1.8	9.0	8.0	5.0	2.6	0.5	0.0	3.2	0.6	8.3	6.6	21.6	1.3	5.0	0.1	0.0	8.5	5.0	1.5	0.0	0.0	4.2	7.2	10.1	37.8	13.2	3.1	5.7	7.0	2.5	15.0	4.0	18.0	15.4	4.9	10.0	3.4	0.8	1.1	6.9	3.2	1.7	8.6	2.5	5.6	8.3	0.4	6.5	8.0	9.3	6.3	21.9	12.6	6.6	8.6	11.9	6.1	1.5	5.7	36.1	4.3	6.8	5.6	7.6	6.2	5.9	8.6	7.6	9.7	9.2	0.3	6.6	4.7	7.2	7.0	3.6	4.2	3.7	0.0	4.8	2.9	0.6	0.4	0.1	0.1	0.0	0.9	0.1	20.5	0.0	0.0	3.6	13.5	23.6	11.6	21.4	18.2	6.8	11.9	14.6	1.9	12.8	6.9	3.7	0.0	3.4	10.1	7.7	15.6	16.8	208.9	6.3	14.6	15.4	60.4	12.8	2.6	20.5	17.7	18.1	13.7	8.8	0.0	18.8	14.6	0.6	13.7	3.3	2.0	16.4	8.2	8.8	24.4	472.3	32.3	9.9	28.4	1.0	5.9	5.8	6.2	3.0	3.1	17.8	6.6	31.6	28.0	24.1	6.8	13.4	2.8	3.1	19.7	12.0	14.0	17.8	14.7	17.0	40.1	3.1	11.7	4.0	18.3	8.1
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor Kazal type 13"	Q1W4C9	5	148268180-148286255	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"epididymis: 328.8"	"Group enriched"	"Detected in some"	6	"Leydig cells: 39.7;Peritubular cells: 26.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HeLa: 574.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036456	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.3	1.9	0.7	0.1	1.2	0.0	0.0	0.9	1.0	0.2	0.0	1.1	0.0	0.2	328.8	0.1	0.4	0.2	0.5	0.4	0.8	0.6	0.0	0.3	0.1	1.3	0.8	0.5	0.2	0.0	0.5	0.0	1.4	1.7	0.0	1.5	0.2	31.3	0.4	0.5	0.0	0.1	0.7	0.0	1.6	1.3	1.1	0.1	0.3	0.0	0.0	1.5	0.1	2.8	0.0	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	574.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.0	1.5	0.0	0.0	0.3	30.0	0.2	0.3	0.0	22.5	0.0	0.0	0.2	1.9	0.0	0.6	1.1	0.1	0.4	0.1	0.6	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.9	1.0	0.4	0.8	1.3	0.8	1.4	0.7	1.1	2.8	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.0	0.6	0.0	0.0	0.0	0.0	0.1	39.7	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.4	2.8	0.0	26.7	0.1	0.5	0.0	0.1	0.0	0.6	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 71.8;lung: 28.3;lymphoid tissue: 51.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 131.6;Erythroid cells: 125.9;Macrophages: 65.8;monocytes: 66.4;NK-cells: 352.2;Plasma cells: 60.3;T-cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 218.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 278.8;HL-60: 281.5;HMC-1: 158.3;MOLT-4: 122.2;REH: 98.4;THP-1: 164.1;U-937: 205.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"		NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB002666: , HPA055244: AB_2682756"	"prognostic favorable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	4.0	0.6	0.8	14.4	1.0	71.8	1.8	1.1	0.9	1.4	0.2	3.9	5.5	1.6	1.1	3.0	2.0	4.3	2.8	0.9	1.4	0.8	2.6	28.3	26.3	3.5	1.3	0.6	1.0	0.6	0.2	0.9	2.5	1.3	5.3	0.3	2.3	1.1	0.8	2.8	6.3	2.3	1.8	19.0	5.0	0.4	2.5	51.1	0.8	0.3	23.0	4.2	0.5	4.1	0.2	0.2	0.1	0.3	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.9	0.1	0.6	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	278.8	0.2	2.0	0.0	281.5	158.3	0.0	0.0	0.1	0.0	0.1	0.0	68.0	96.1	76.9	0.5	0.2	122.2	70.1	0.1	0.0	0.0	98.4	1.1	2.2	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.3	0.1	164.1	0.4	0.0	0.2	0.2	0.2	0.3	5.8	40.7	0.3	205.4	0.3	13.6	23.2	14.6	96.3	96.3	51.4	3.7	38.5	65.5	34.0	1.1	26.3	47.6	3.6	69.4	218.0	27.2	34.7	52.1	0.8	1.0	1.1	0.9	0.9	1.4	3.5	1.3	2.5	1.8	2.5	4.1	1.2	9.6	16.9	0.0	10.8	2.2	0.9	0.0	0.0	0.6	1.0	0.8	5.3	1.5	2.5	1.8	0.0	0.2	131.6	0.1	0.0	0.1	0.1	0.5	0.6	3.0	0.0	125.9	0.0	0.0	0.4	3.0	5.1	0.7	43.7	0.8	4.6	1.5	27.0	1.7	0.0	0.3	0.0	28.8	30.3	0.0	0.0	65.8	1.8	1.9	66.4	0.5	352.2	1.5	0.0	0.0	0.1	0.0	60.3	0.5	0.1	0.6	1.5	1.9	0.0	0.8	1.0	0.2	0.6	0.1	2.0	0.3	94.8	0.1	0.2	0.6
SPRED3		ENSG00000188766	"Sprouty related EVH1 domain containing 3"	Q2MJR0	19	38388421-38399587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.0;pituitary gland: 5.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.6;Enteroendocrine cells: 10.8;Excitatory neurons: 9.8;Inhibitory neurons: 10.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.9;TIME: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071521			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA071521: "	"unprognostic (1.09e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.71e-3)"	"unprognostic (3.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.09e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-11)"	"unprognostic (6.21e-4)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.45e-3)"	0.7	0.4	3.2	1.0	3.7	0.3	0.5	0.5	5.0	0.6	0.4	0.5	1.8	0.4	0.3	0.4	0.6	0.7	0.7	4.5	8.0	2.3	0.2	0.7	0.2	4.4	5.0	0.3	1.1	1.7	5.6	0.3	4.6	1.0	0.2	1.5	0.5	0.3	0.9	0.8	1.3	0.8	1.1	0.1	0.4	1.1	5.0	0.1	0.6	0.0	0.2	0.6	0.5	2.7	0.3	1.2	4.0	3.3	0.6	1.9	2.3	8.1	5.3	2.6	2.4	0.4	0.8	0.2	2.9	2.7	2.1	0.1	0.7	1.0	2.4	0.8	1.5	0.1	0.3	0.5	1.4	2.2	0.1	1.3	0.9	6.2	1.8	12.9	8.3	0.6	0.7	1.5	8.1	0.4	0.0	0.1	1.8	0.5	4.0	1.0	1.4	0.1	5.7	0.7	0.2	3.1	0.2	0.2	0.4	1.7	0.7	0.1	15.9	2.9	9.0	2.4	4.5	0.6	0.3	0.6	9.8	0.3	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	3.2	3.7	0.5	5.0	4.5	8.0	4.4	5.0	4.6	1.1	5.0	2.7	1.1	0.0	0.0	2.0	0.4	0.0	1.3	0.4	1.2	6.6	1.5	2.4	1.2	0.0	0.3	1.8	2.1	0.5	0.3	0.5	0.0	1.0	2.0	0.7	1.1	1.5	10.8	0.0	9.8	0.6	0.3	0.5	0.0	1.6	0.0	0.3	0.7	0.0	0.1	1.7	10.4	1.2	0.0	0.0	0.0	0.2	0.3	0.5	0.0	1.0	0.0	1.9	1.0	5.0	2.2	3.0	0.1	0.0	0.0	1.2	2.7	0.1	0.1	0.3	0.0	2.3	1.2	1.5	1.0	0.5	0.1	0.8	0.4	0.2	0.8	0.7
SPRYD3	FLJ14800	ENSG00000167778	"SPRY domain containing 3"	Q8NCJ5	12	53064316-53079404	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039426, HPA039685"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	"Vesicles, Plasma membrane, Actin filaments"	"HPA039426: AB_10673358, HPA039685: AB_2676623"	"unprognostic (7.73e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.27e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.78e-15)"	"unprognostic (9.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.41e-1)"	32.2	29.2	70.6	18.4	77.9	6.4	30.2	35.6	84.2	33.6	38.1	32.8	18.9	38.1	36.2	31.7	45.1	20.4	42.4	79.9	60.4	29.5	22.1	23.6	17.4	61.7	55.1	43.5	50.0	43.3	60.7	14.0	61.5	34.5	17.0	39.3	43.9	40.6	21.2	27.0	23.4	31.6	43.8	24.3	35.8	11.5	58.0	13.7	34.6	23.1	20.6	36.5	30.7	67.9	28.4	43.0	5.6	11.5	45.4	22.4	7.3	42.6	22.2	16.1	10.1	7.4	23.8	18.6	34.2	53.5	19.2	26.0	7.6	32.9	10.5	19.4	11.3	11.5	25.5	16.9	34.0	22.3	20.1	20.2	51.6	23.1	34.9	31.6	33.5	9.3	10.4	45.3	28.5	62.3	16.3	11.7	3.2	23.1	30.8	7.1	9.5	38.4	20.6	22.3	9.4	8.9	37.3	34.6	18.1	3.0	31.8	16.7	46.4	18.1	17.9	40.9	29.0	24.7	24.1	5.4	53.8	19.5	22.4	29.9	16.7	47.5	32.7	28.9	30.9	14.6	22.4	26.9	15.5	11.3	18.8	22.7	25.8	17.0	32.8	7.4	13.5	28.9	70.6	77.9	35.6	84.2	79.9	60.4	61.7	55.1	61.5	43.8	58.0	67.9	13.4	3.2	10.1	4.9	13.3	5.7	19.5	12.0	13.1	46.4	11.3	8.8	20.4	17.2	10.4	18.4	8.4	6.2	8.8	9.1	11.7	30.4	0.9	21.2	10.9	17.1	11.5	2.1	14.4	36.5	14.6	22.9	15.8	16.1	10.1	5.1	18.9	9.1	11.8	43.7	13.5	13.8	10.2	11.7	5.7	2.7	16.1	10.3	10.6	3.7	15.0	38.5	16.5	4.5	5.6	28.6	9.3	33.1	19.1	20.8	10.7	15.6	18.2	23.8	19.7	11.1	20.0	4.5	3.9	12.0	9.5	4.2	14.9	5.1	7.9	16.4
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66682497-66729226	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.6;skin 1: 85.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Vesicles	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	1.3	14.4	26.8	1.0	32.6	2.3	7.7	29.7	73.6	14.3	0.0	0.9	0.9	1.7	1.2	39.8	3.7	1.7	1.4	38.8	0.3	37.5	23.3	1.1	0.2	4.8	0.9	0.9	16.7	13.1	16.4	0.4	3.2	12.4	0.7	14.7	29.6	4.7	0.5	85.5	1.0	1.1	0.0	0.9	2.9	52.8	4.6	1.0	0.3	0.1	6.7	1.6	16.5	24.2	20.5	7.4	3.4	0.3	0.1	0.0	0.6	0.3	0.1	0.1	0.0	4.8	28.2	0.2	3.7	0.0	0.7	16.9	25.2	2.4	0.0	0.1	10.4	0.1	45.6	3.0	0.8	7.3	0.6	0.2	11.5	0.0	7.4	4.2	6.3	5.2	7.3	0.1	0.1	35.2	6.3	3.5	49.1	28.7	21.1	23.8	2.8	14.7	9.6	4.8	49.9	29.4	14.0	52.3	3.2	2.7	67.2	2.4	1.4	0.1	8.6	1.3	11.5	0.7	3.0	14.7	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	26.8	32.6	29.7	73.6	38.8	0.3	4.8	0.9	3.2	0.0	4.6	24.2	0.7	3.2	1.1	4.9	0.3	3.7	2.7	3.2	2.8	11.0	4.7	4.6	1.8	1.5	4.6	86.5	104.3	0.9	0.0	0.6	0.0	2.6	30.9	3.6	1.8	1.1	3.0	7.2	29.3	10.0	0.3	0.8	1.5	3.6	0.0	1.4	1.4	24.7	0.1	0.0	20.7	1.6	0.0	0.3	0.7	77.6	1.8	0.1	0.0	2.8	0.6	1.6	0.0	7.5	4.6	7.5	0.2	1.5	0.8	3.2	0.2	1.3	3.5	21.3	0.0	0.2	0.5	8.5	9.4	14.6	12.5	0.3	0.2	0.1	0.8	1.7
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346213-55373100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 245.5;Club cells: 245.2;Pancreatic endocrine cells: 155.5;Respiratory ciliated cells: 195.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 79.6"					"Low region specificity"	"Detected in all"			HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	12.5	12.0	10.4	2.5	11.5	3.7	12.2	11.0	12.4	12.9	9.2	7.3	3.8	6.8	4.2	26.1	5.6	10.3	9.3	10.7	10.1	9.6	14.5	10.5	2.5	11.0	11.2	3.1	20.2	7.0	5.9	4.0	10.8	7.4	4.1	1.5	16.4	2.9	6.3	15.4	7.0	2.6	10.9	6.8	9.7	3.3	10.9	6.0	7.6	5.4	6.0	10.0	14.7	12.7	9.7	4.3	10.3	10.1	29.4	20.4	5.6	10.4	9.3	2.4	5.4	6.5	19.5	21.2	11.7	11.0	11.1	7.0	5.3	7.9	3.9	6.6	17.1	12.3	5.2	15.8	9.2	23.7	6.1	17.6	14.5	5.4	5.3	7.8	14.4	38.5	21.2	47.7	21.1	10.8	36.0	10.3	13.0	53.2	9.3	11.4	3.3	14.0	12.8	7.9	16.0	9.1	10.7	79.6	8.3	9.0	9.4	17.9	8.3	25.0	4.7	2.0	8.1	28.6	15.8	7.9	34.1	29.5	25.9	25.6	35.8	11.7	16.1	56.5	18.6	12.5	12.0	15.2	30.2	12.7	10.2	14.4	1.8	8.6	59.5	61.7	12.5	23.1	10.4	11.5	11.0	12.4	10.7	10.1	11.0	11.2	10.8	10.9	10.9	12.7	25.4	9.6	15.9	4.6	7.8	13.6	13.3	245.5	5.2	4.9	43.8	29.3	5.3	34.3	245.2	5.5	4.2	27.0	21.2	12.2	3.9	93.4	3.2	51.2	31.0	19.6	12.0	14.9	11.1	105.4	106.0	16.2	13.3	105.9	14.0	6.7	17.5	18.6	63.4	10.1	17.1	22.6	57.0	32.4	34.1	0.5	1.8	27.6	24.9	4.7	31.3	21.9	18.6	8.5	23.4	155.5	10.0	5.7	16.8	17.5	9.4	18.4	195.0	3.9	13.1	13.3	28.2	3.5	20.1	32.7	29.7	7.5	7.2	15.4	23.3	108.6
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 379.9;Late spermatids: 599.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 61.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	8.7	6.0	6.4	18.1	8.2	41.7	14.5	10.0	14.8	12.5	6.8	31.2	25.2	12.7	9.3	23.9	8.6	11.9	8.3	8.9	3.7	16.7	16.0	12.9	19.7	4.0	4.1	8.7	23.3	14.5	9.0	14.5	4.3	9.6	35.6	25.8	16.1	10.9	20.0	26.7	23.6	14.2	2.4	17.8	18.0	44.7	5.2	19.9	8.7	12.6	24.3	31.0	16.2	11.6	104.1	39.2	54.9	82.4	30.2	39.3	69.0	62.1	60.1	57.3	60.2	109.0	34.1	139.0	51.8	39.1	65.5	51.3	110.3	74.2	100.6	96.2	79.9	73.5	42.6	93.8	26.7	111.3	34.0	25.6	39.3	66.0	84.7	44.6	72.3	76.4	157.7	55.6	48.2	36.8	111.1	80.8	45.9	62.9	42.7	77.8	67.3	84.1	56.8	169.5	117.5	42.9	65.4	59.3	42.5	55.2	33.3	70.3	54.8	52.4	41.3	37.2	78.6	33.1	78.6	128.5	20.9	124.3	48.1	61.0	4.4	30.6	8.5	5.3	12.1	8.6	11.2	11.5	5.9	6.9	9.2	10.0	50.9	11.2	7.6	3.3	14.9	6.3	6.4	8.2	10.0	14.8	8.9	3.7	4.0	4.1	4.3	2.4	5.2	11.6	26.6	9.6	25.8	18.6	40.0	42.3	119.3	91.0	67.7	36.8	25.8	22.7	28.7	14.3	51.4	22.0	37.5	54.3	33.1	51.6	29.4	55.4	379.9	29.9	40.2	29.2	46.2	46.7	74.2	68.2	53.2	25.1	46.9	54.0	7.6	44.1	13.2	41.8	21.6	10.1	50.0	50.8	32.6	16.3	19.9	599.1	22.1	20.0	16.0	24.4	31.5	16.8	32.0	30.2	29.7	100.4	47.9	24.8	68.0	117.9	50.8	59.4	33.8	92.9	6.6	17.8	48.9	197.3	100.4	126.8	41.8	39.7	43.6	33.7	90.7	162.6
SRPRB	"APMCF1, SR-beta"	ENSG00000144867	"SRP receptor subunit beta"	Q9Y5M8	3	133784023-133825772	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011173	Approved		Approved	"Plasma membrane"		NA	NA		12000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"HPA011173: AB_1857484"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (1.99e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.07e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.79e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.26e-2)"	20.4	26.8	21.1	18.4	23.3	14.1	24.7	23.2	24.6	26.6	26.4	23.1	19.0	14.4	47.9	29.9	17.9	13.3	16.9	21.1	23.7	26.6	52.9	14.8	15.3	24.5	24.4	13.8	83.2	27.6	25.4	16.0	24.5	18.2	26.1	6.8	49.9	23.7	19.0	15.4	15.4	21.0	22.4	15.5	24.4	26.8	23.1	10.7	26.1	16.5	28.9	23.7	13.8	28.9	44.8	37.5	22.6	72.7	91.8	62.3	45.6	97.4	49.4	50.2	44.3	73.7	34.6	90.4	131.5	72.4	51.2	64.8	69.8	50.9	47.7	57.8	59.6	80.6	34.9	65.2	110.8	124.5	56.7	57.3	83.3	46.2	135.9	28.1	43.5	43.6	68.1	96.9	55.5	65.6	40.9	55.5	43.8	120.3	63.8	49.1	43.5	190.8	61.9	32.1	74.7	32.7	77.3	66.6	28.3	17.0	76.9	55.1	46.0	51.9	29.0	82.8	54.0	118.8	131.5	131.4	45.3	82.9	56.9	13.1	30.5	3.9	54.3	41.1	73.0	38.9	45.4	47.9	36.3	36.7	43.3	51.9	2.2	41.5	27.5	53.8	29.1	50.3	21.1	23.3	23.2	24.6	21.1	23.7	24.5	24.4	24.5	22.4	23.1	28.9	16.8	16.0	20.6	15.3	43.4	37.7	32.0	38.2	11.4	6.5	36.4	22.0	26.6	37.1	32.8	36.8	12.5	65.4	29.1	14.2	11.7	46.0	68.9	18.7	51.2	26.3	32.2	21.7	16.0	67.4	71.2	40.6	28.5	30.1	32.4	19.8	18.9	88.4	49.4	6.7	15.7	58.8	36.7	19.7	23.1	35.9	32.0	20.6	35.6	8.4	16.4	17.2	20.6	17.6	92.6	36.0	17.7	27.8	146.0	52.3	20.0	33.0	24.3	9.4	13.1	38.2	30.2	60.1	40.6	52.1	31.5	51.7	26.1	52.9	43.9	28.5
SRRM3	FLJ37078	ENSG00000177679	"Serine/arginine repetitive matrix 3"		7	76201896-76287288	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"brain: 56.0;retina: 27.2"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 153.1;Cone photoreceptor cells: 479.6;Excitatory neurons: 139.1;Horizontal cells: 171.6;Inhibitory neurons: 144.4;Rod photoreceptor cells: 421.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 10.9;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019337			Approved	"Plasma membrane,Intermediate filaments,Microtubules"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Intermediate filaments, Microtubules"	"HPA019337: AB_1848909"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.15e-2)"	0.0	2.1	6.0	0.1	13.2	0.0	0.0	56.0	30.7	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.0	0.0	0.1	4.8	0.2	0.0	0.0	0.0	0.0	41.5	3.2	0.2	0.3	0.3	8.9	0.0	40.1	0.1	0.1	27.2	0.1	0.0	0.1	0.0	0.1	0.0	1.6	0.0	0.4	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	4.7	0.3	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	8.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	13.2	56.0	30.7	4.8	0.2	41.5	3.2	40.1	1.6	0.9	4.7	0.3	0.0	0.0	8.1	0.0	2.0	6.4	1.9	7.4	153.1	1.8	0.5	6.9	1.5	1.2	0.0	479.6	0.4	0.0	0.2	0.0	2.0	22.2	0.5	4.2	1.2	12.1	0.0	139.1	2.4	8.1	4.8	0.5	1.0	0.0	12.0	1.8	0.0	0.5	171.6	144.4	0.1	2.0	0.0	0.8	32.2	2.1	0.2	3.6	5.6	0.0	15.9	0.0	18.6	4.9	0.9	0.1	2.2	0.0	2.2	0.0	0.4	0.2	421.8	0.0	1.2	2.0	8.6	3.1	4.9	1.1	2.2	0.1	0.2	0.0	4.9
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303478-67312607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.6;eosinophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 64.9;MCF7: 64.1;RT4: 111.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	14.4	7.8	8.9	4.0	12.0	9.3	16.2	14.1	11.6	25.9	9.5	19.3	13.3	16.0	7.5	41.9	18.3	11.5	12.5	9.1	10.1	13.1	10.9	12.7	3.1	14.6	10.8	23.5	15.3	9.8	9.7	6.5	13.2	29.9	9.3	1.2	26.2	28.8	6.8	25.2	15.0	6.1	12.3	9.4	20.1	2.3	11.5	1.9	16.3	3.8	4.8	37.4	32.5	14.9	17.3	18.7	0.4	0.6	11.4	11.8	18.8	10.3	13.7	5.6	5.1	21.2	46.8	1.0	32.5	10.5	11.9	64.9	6.0	46.4	2.8	3.6	6.3	4.3	32.2	9.9	8.2	0.9	16.0	12.2	40.5	8.3	8.3	12.9	6.3	0.4	0.1	1.5	6.2	64.1	0.8	7.3	4.2	48.9	13.8	20.6	0.6	3.1	18.2	111.2	3.7	5.8	24.8	41.0	12.8	6.3	57.1	15.3	10.4	4.5	9.8	12.7	2.7	1.5	0.9	0.5	12.7	6.9	4.9	11.6	1.5	11.1	2.0	2.3	1.7	0.2	1.9	1.7	1.7	0.1	0.8	0.8	4.4	1.5	1.1	1.1	1.8	1.1	8.9	12.0	14.1	11.6	9.1	10.1	14.6	10.8	13.2	12.3	11.5	14.9	7.6	3.2	8.7	8.5	0.9	7.0	20.8	25.2	11.4	0.8	21.3	17.3	3.8	20.0	23.4	16.5	0.0	15.1	3.3	28.3	3.9	19.4	0.1	8.3	5.6	4.7	3.6	5.2	4.2	21.6	24.9	8.0	20.9	17.8	3.8	8.1	3.9	5.0	7.7	1.7	5.3	14.4	24.4	6.2	3.1	0.6	13.1	4.8	8.8	2.8	9.2	4.8	7.2	0.0	15.9	20.0	21.0	12.0	0.7	15.4	20.2	7.4	11.6	0.5	0.0	4.9	9.2	0.5	0.4	27.0	10.4	15.7	4.4	5.3	21.4	26.8
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.2;brain: 17.0;parathyroid gland: 6.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 106.1;Inhibitory neurons: 75.5;Oligodendrocyte precursor cells: 32.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"		Yes	NA		24000		"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Midbody"		"HPA043813: AB_2678683, HPA046771: AB_2679798"	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.1	12.2	4.0	0.0	12.9	0.2	0.0	17.0	11.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	6.2	0.0	1.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	6.2	0.5	0.0	1.4	0.1	0.0	0.7	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.2	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	87.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	12.9	17.0	11.4	6.2	0.0	0.4	0.1	1.4	0.0	0.0	7.7	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	7.8	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.9	0.0	3.1	0.0	0.1	0.2	0.0	0.0	106.1	0.0	0.0	0.2	0.0	0.0	0.0	12.9	0.0	0.0	0.1	0.0	75.5	0.2	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.7	0.0	1.1	0.0	32.2	9.1	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.6	0.0	0.6	0.2	0.8	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.1
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins, Transporters"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 439.5"	"Cell type enriched"	"Detected in many"	4	"Hepatic stellate cells: 745.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	59	"classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	60	"dendritic cells: 2.5;monocytes: 9.4"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		96000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	194.2	160.4	41.0	50.4	42.9	13.8	84.5	41.4	58.3	54.4	62.8	87.7	29.6	45.3	8.5	29.2	79.3	25.8	74.6	41.9	44.4	85.6	102.1	104.7	12.9	50.0	48.4	32.2	32.2	5.0	52.0	55.4	53.7	57.6	31.0	0.6	45.7	16.0	25.9	24.0	95.1	33.8	43.0	439.5	53.2	21.0	65.3	6.8	55.1	4.6	8.2	105.7	48.6	47.8	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.2	0.2	0.6	0.0	0.0	1.8	0.1	0.0	0.1	0.0	103.1	0.1	0.3	0.1	0.0	0.0	0.0	146.9	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.0	0.0	128.8	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	9.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	41.0	42.9	41.4	58.3	41.9	44.4	50.0	48.4	53.7	43.0	65.3	47.8	31.3	0.0	3.8	0.0	5.5	6.0	0.6	0.0	1.8	1.0	1.5	2.7	2.4	11.5	0.0	3.7	0.0	1.7	1.9	0.0	0.0	0.0	0.5	0.4	0.5	43.0	1.2	21.5	0.3	0.0	2.0	3.3	0.5	0.3	18.3	0.0	745.0	19.7	130.7	0.0	0.3	0.0	0.0	185.4	30.3	2.9	4.4	147.0	12.4	30.0	21.9	0.5	2.1	0.5	0.1	0.0	0.0	20.3	2.0	0.2	0.0	0.8	0.0	0.1	19.7	2.0	1.4	0.9	2.2	1.5	4.8	2.2	2.3	0.5	0.0	0.2
STAMBPL1	"ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373"	ENSG00000138134	"STAM binding protein like 1"	Q96FJ0	10	88879734-88975153	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.3;Excitatory neurons: 60.5;Microglial cells: 32.8;Spermatocytes: 40.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040202	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA040202: AB_10805708"	"unprognostic (2.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (4.41e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.40e-3)"	3.9	23.8	5.5	10.4	6.5	5.3	2.5	2.6	9.0	2.7	0.0	8.7	6.4	4.2	0.9	4.4	2.2	4.1	8.0	6.2	1.4	1.8	1.8	3.6	16.2	1.1	0.5	12.7	2.3	3.4	5.5	1.2	2.6	1.7	9.7	4.4	1.4	1.1	0.7	3.7	7.3	3.0	1.9	7.2	5.1	18.0	0.5	7.1	1.2	1.5	12.2	6.4	2.5	5.6	14.8	16.5	1.0	0.6	14.4	27.7	0.0	31.5	28.9	19.0	16.3	0.3	25.6	18.6	2.3	15.6	12.3	6.4	4.1	4.5	17.9	16.3	10.8	4.6	10.4	0.9	10.3	20.2	5.7	10.6	1.4	31.6	9.6	18.4	0.6	20.9	0.0	7.3	50.0	3.0	34.2	21.5	6.6	13.3	14.1	3.4	13.0	3.8	6.5	4.7	9.6	11.9	3.7	1.1	37.5	3.6	2.3	4.1	4.9	17.0	12.4	20.7	19.9	17.7	19.7	17.2	18.2	19.4	16.9	9.5	1.0	8.1	10.7	1.1	14.1	17.7	15.5	13.7	1.7	14.9	16.6	10.0	1.4	23.6	0.5	27.9	28.3	8.0	5.5	6.5	2.6	9.0	6.2	1.4	1.1	0.5	2.6	1.9	0.5	5.6	2.3	0.0	4.5	10.7	16.7	9.6	5.3	1.4	1.2	3.6	2.3	1.4	8.6	0.0	0.2	5.5	0.0	0.1	18.8	7.6	0.0	1.3	54.3	1.9	6.5	1.8	9.1	3.4	60.5	1.8	0.1	7.7	3.1	1.4	5.1	7.4	1.8	2.4	3.7	6.7	26.2	9.3	4.1	1.3	9.6	20.7	7.2	3.1	0.0	32.8	1.0	9.3	12.3	26.2	1.9	1.9	2.8	1.5	14.2	1.9	7.9	0.8	5.0	0.4	0.0	20.4	6.4	40.2	2.5	5.9	11.4	0.1	17.6	14.9	14.2	2.9
STARD4		ENSG00000164211	"StAR related lipid transfer domain containing 4"	Q96DR4	5	111496033-111512590	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046177, HPA048081"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"		"HPA046177: AB_2679570, HPA048081: AB_2680253"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (2.84e-4)"	6.2	15.8	8.3	15.9	15.8	19.4	3.9	25.2	12.6	10.2	11.5	14.7	40.8	7.7	16.2	8.5	5.0	9.7	15.0	9.5	10.6	8.5	34.1	20.9	12.6	16.0	16.7	6.5	6.1	14.4	8.2	27.3	13.8	20.7	16.9	12.0	6.6	9.9	1.5	2.5	35.7	6.9	10.1	12.1	17.9	6.8	14.8	7.2	9.0	1.7	10.1	7.7	9.2	11.3	20.6	10.0	48.2	29.4	42.4	84.0	16.3	21.0	46.6	29.8	89.1	37.7	59.9	24.5	8.4	13.4	89.0	9.1	24.8	71.8	28.8	23.7	10.4	19.1	33.3	22.8	46.4	9.5	11.7	44.6	48.3	64.1	47.6	35.6	56.6	23.5	10.7	46.5	20.8	3.9	23.7	17.3	16.6	0.6	5.5	5.4	53.3	22.5	44.6	6.7	27.2	105.6	0.0	12.3	19.0	32.1	16.0	30.4	84.4	25.6	22.9	17.2	8.9	15.9	15.8	21.6	24.3	34.8	13.2	7.1	1.4	0.9	2.5	2.1	1.3	1.7	1.2	1.9	1.8	1.7	1.2	1.9	0.0	2.1	1.5	1.3	0.8	1.4	8.3	15.8	25.2	12.6	9.5	10.6	16.0	16.7	13.8	10.1	14.8	11.3	8.2	25.6	34.8	16.0	13.1	1.0	1.4	35.0	1.2	10.8	1.6	0.4	17.8	8.6	18.1	9.2	8.4	15.6	24.8	37.3	1.9	7.8	9.4	6.7	3.5	20.2	21.4	3.6	38.8	9.2	6.0	6.0	15.8	11.5	32.3	6.5	5.0	39.9	20.3	6.7	20.8	32.5	22.4	19.6	26.7	8.3	7.2	27.8	3.6	20.6	5.7	7.1	9.2	20.1	23.6	10.0	30.0	7.9	17.6	3.3	30.1	5.7	9.5	7.6	19.7	2.4	15.2	8.7	9.4	6.8	2.6	14.1	14.5	38.2	23.0	5.2
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Glandular and luminal cells: 12.4;Spermatocytes: 17.8;Spermatogonia: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046543			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA046543: AB_2679692"	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.0	0.5	0.8	3.0	0.8	10.8	2.9	0.7	1.2	1.1	0.2	4.1	2.9	1.4	1.4	2.5	0.9	1.4	0.6	0.8	0.6	0.7	1.0	0.9	4.9	0.7	0.6	0.8	0.7	0.9	0.4	1.9	0.8	1.3	5.6	1.2	1.7	0.5	0.6	3.1	2.7	1.4	0.4	1.4	1.8	6.6	0.8	9.9	0.9	0.7	5.7	1.1	1.0	1.0	33.7	17.4	24.7	22.1	1.8	3.8	15.7	29.3	14.0	32.0	33.2	18.5	16.1	39.4	13.3	14.4	32.7	21.4	29.4	15.3	33.7	29.6	12.9	44.5	20.9	16.6	0.8	35.7	21.5	1.6	2.1	27.2	17.5	3.8	21.5	29.5	31.7	35.9	24.1	14.3	35.6	10.9	30.0	18.6	14.2	23.0	40.3	19.0	9.0	20.0	22.0	13.2	31.4	22.2	14.6	29.6	14.5	20.6	12.2	29.6	29.9	21.2	40.0	11.9	26.4	38.1	13.8	27.0	28.0	0.3	0.1	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.7	0.0	0.3	0.3	0.1	0.8	0.8	0.7	1.2	0.8	0.6	0.7	0.6	0.8	0.4	0.8	1.0	1.6	3.2	0.5	2.0	2.4	0.9	0.6	2.0	1.2	1.1	2.8	3.0	0.5	0.0	2.3	0.0	4.2	2.5	1.6	5.4	0.0	1.6	1.6	7.8	3.2	2.2	1.8	12.8	5.1	0.4	4.4	1.6	3.1	12.4	2.5	8.2	1.4	0.5	2.9	0.0	3.9	6.1	0.0	2.4	1.2	1.1	0.3	2.7	0.0	0.0	3.0	0.8	1.0	2.0	4.8	1.9	1.8	0.7	10.2	1.1	1.4	0.4	7.6	0.6	0.0	1.7	2.0	17.8	14.4	5.3	2.4	0.8	3.3	2.6	5.5	1.4
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 340.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.23e-4)"	"prognostic unfavorable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	68.0	128.0	114.5	70.2	119.9	61.3	49.7	124.6	340.6	69.5	122.1	72.9	40.4	74.1	49.0	79.5	72.4	43.5	98.5	120.2	133.4	86.7	68.9	70.8	72.9	124.0	131.3	87.6	53.3	61.4	71.7	77.5	139.2	60.7	56.0	62.9	56.1	56.1	140.3	60.5	53.9	66.7	123.6	69.0	66.1	126.3	134.2	66.2	57.6	92.2	88.2	81.2	63.8	159.4	321.0	486.3	298.1	251.7	161.8	108.1	271.5	277.2	150.1	393.9	228.1	361.3	265.2	371.1	322.9	220.3	475.4	329.7	745.4	280.3	427.6	302.1	311.7	521.5	302.6	336.7	142.8	278.7	325.1	109.4	174.5	327.1	242.7	162.4	284.2	276.1	537.2	209.5	232.1	468.8	432.0	388.6	366.4	306.0	407.2	418.3	279.1	385.6	282.8	271.8	242.7	217.3	314.4	338.9	266.7	310.3	357.1	194.0	253.8	252.0	310.9	333.1	389.0	189.8	434.0	388.0	328.8	282.6	374.1	61.0	66.8	57.4	87.6	95.1	88.2	85.9	65.5	79.5	69.9	68.5	72.7	81.6	20.0	108.2	114.6	58.1	66.1	119.1	114.5	119.9	124.6	340.6	120.2	133.4	124.0	131.3	139.2	123.6	134.2	159.4	31.3	44.8	32.9	7.8	40.0	80.4	184.1	61.5	40.9	37.5	32.5	29.8	46.1	31.5	59.1	20.2	41.7	124.8	39.8	38.3	49.0	76.3	31.0	65.8	48.6	45.9	67.3	69.0	9.5	55.2	146.1	49.6	24.5	51.1	79.3	47.8	14.3	27.4	91.5	63.9	14.9	39.9	97.6	21.9	90.3	77.5	27.4	46.7	62.2	12.2	51.8	36.9	53.5	11.1	17.2	69.5	32.7	39.9	56.4	75.7	22.3	39.6	85.8	36.7	26.3	36.1	65.4	96.3	118.6	47.6	72.0	211.0	67.0	62.8	48.6	95.3
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042079-172188224	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 107.7;Kupffer cells: 91.4;NK-cells: 171.0;T-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		16000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	14.9	5.7	3.1	37.1	3.6	76.5	11.4	18.4	5.6	4.5	3.5	8.5	8.4	4.9	1.7	5.6	4.7	13.2	7.6	3.1	4.0	5.9	6.2	18.4	44.1	6.2	4.4	2.5	7.2	3.1	4.1	17.2	5.8	4.4	6.9	1.2	4.7	3.5	5.0	14.2	16.0	7.8	5.4	45.2	11.1	14.0	6.4	20.6	5.3	5.5	25.0	14.9	5.2	7.0	22.2	20.2	12.7	18.8	14.7	18.1	31.5	28.4	24.0	20.2	18.9	10.6	28.6	26.8	14.6	35.6	42.3	25.4	5.7	35.1	13.5	35.0	9.3	32.1	8.2	6.1	20.2	32.7	36.4	17.4	7.5	27.4	23.1	7.5	18.3	10.4	3.0	36.2	14.7	35.7	23.5	73.4	5.0	11.3	16.1	38.2	9.9	17.7	8.2	27.6	8.3	10.2	16.4	22.5	77.9	15.6	8.2	68.7	24.8	22.3	11.3	15.8	15.5	30.2	48.4	17.1	29.4	49.8	143.3	16.7	26.5	23.4	36.5	46.3	26.9	10.0	19.3	26.3	22.5	8.1	11.0	20.0	48.9	16.9	71.8	7.1	26.7	44.0	3.1	3.6	18.4	5.6	3.1	4.0	6.2	4.4	5.8	5.4	6.4	7.0	35.8	3.2	11.2	1.6	40.5	6.6	8.4	7.2	5.7	4.3	3.3	3.7	3.8	5.7	6.1	1.8	6.2	4.1	107.7	11.8	1.9	4.5	2.5	3.5	4.6	23.9	12.0	11.8	8.5	6.2	27.2	9.3	20.9	7.1	28.4	3.6	18.2	2.3	36.3	47.1	7.9	19.9	2.0	91.4	43.8	3.2	2.8	61.3	8.8	32.8	49.8	2.1	171.0	10.1	14.4	10.7	11.8	1.5	42.8	11.7	6.5	2.0	6.1	2.2	13.1	5.1	10.2	5.3	7.8	2.6	4.1	5.1	81.4	11.4	5.3	10.7
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43650713	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 644.6;T-cells: 273.7;Urothelial cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	6.7	8.1	3.9	7.9	4.2	4.8	5.2	6.9	4.9	4.0	4.0	6.4	3.2	3.5	1.2	7.2	3.9	5.3	10.8	4.0	4.1	6.3	4.6	9.4	14.4	3.4	4.4	6.2	9.1	0.8	4.2	3.2	3.6	4.3	2.4	5.5	5.8	2.1	9.9	4.6	11.5	3.3	3.6	12.6	9.5	9.0	4.3	9.0	3.8	2.5	13.5	5.6	5.0	3.1	5.8	8.2	9.0	5.3	7.8	8.3	1.9	12.3	15.1	6.6	5.9	7.5	3.1	7.9	20.2	15.3	17.8	8.5	3.6	17.4	10.4	16.9	7.0	9.3	8.2	8.4	4.9	21.1	5.6	6.4	26.4	8.2	8.6	36.4	12.6	11.0	16.7	15.1	9.6	3.6	18.2	8.0	17.3	4.1	18.3	8.4	6.9	14.2	15.6	6.7	6.9	11.2	8.1	8.5	6.1	13.6	6.5	10.8	16.9	20.7	8.3	14.3	17.2	13.3	11.2	13.5	18.4	14.0	31.7	0.5	0.0	2.7	2.0	0.0	1.5	2.4	2.0	3.2	0.1	2.2	3.0	3.0	1.6	4.9	0.1	0.4	1.3	0.9	3.9	4.2	6.9	4.9	4.0	4.1	3.4	4.4	3.6	3.6	4.3	3.1	44.2	121.8	33.1	29.0	237.8	181.9	644.6	64.5	99.6	2.9	17.7	37.8	28.7	7.2	69.8	20.2	10.4	54.8	222.3	54.4	33.2	153.0	47.0	129.1	17.4	35.2	7.2	54.1	9.5	95.4	23.3	39.1	78.0	88.3	38.8	17.7	17.9	9.6	16.9	0.0	5.6	34.3	38.7	20.3	65.9	14.7	5.9	60.9	35.6	34.7	42.1	7.9	221.4	39.2	3.7	89.4	73.0	2.6	81.2	192.6	23.8	13.2	42.4	26.3	6.6	39.4	51.3	75.8	36.1	42.3	136.1	66.8	273.7	27.0	18.0	326.1
STXBP4	"MGC50337, Synip"	ENSG00000166263	"Syntaxin binding protein 4"	Q6ZWJ1	17	54968727-55173632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 41.7;Oligodendrocyte precursor cells: 84.4;Oligodendrocytes: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007760, HPA022138, HPA022888, HPA024227"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Cytosol	"CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630"	"unprognostic (5.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.00e-5)"	"unprognostic (4.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	1.4	2.0	2.3	1.7	2.3	1.4	1.8	2.2	1.7	2.2	7.8	1.7	2.5	2.8	1.7	1.9	2.8	2.6	1.8	1.5	3.1	4.3	0.9	2.1	1.2	3.2	3.9	2.9	1.5	6.0	2.0	1.8	2.8	3.0	1.7	4.5	1.4	3.5	1.1	1.0	1.4	2.7	3.0	1.1	1.6	2.1	3.2	1.8	3.1	1.0	1.2	1.9	1.3	3.7	5.0	7.3	6.6	5.9	5.5	5.4	2.7	3.8	3.6	4.8	4.7	4.3	2.6	3.4	7.9	3.8	4.2	2.9	8.6	3.8	8.9	5.1	4.9	4.4	4.8	8.9	2.3	2.8	1.3	6.1	1.1	7.0	1.6	2.2	4.9	2.9	7.2	2.6	5.8	2.2	9.3	1.8	4.8	4.2	5.2	3.9	7.7	2.0	8.6	3.0	6.3	4.8	5.8	0.9	3.2	3.5	8.4	1.9	3.8	6.8	5.2	4.2	4.0	2.3	2.3	5.8	4.4	3.6	4.1	1.7	0.4	0.0	0.9	0.3	1.0	0.7	0.8	0.6	0.5	1.1	0.7	0.9	0.1	2.2	0.5	1.1	0.8	0.3	2.3	2.3	2.2	1.7	1.5	3.1	3.2	3.9	2.8	3.0	3.2	3.7	6.6	0.0	9.1	39.5	3.9	0.9	2.4	3.3	4.6	5.6	4.4	3.3	9.6	2.8	5.4	9.2	41.7	1.6	2.1	2.0	9.8	6.0	6.7	16.6	14.4	4.3	6.0	5.2	29.0	2.7	1.9	7.5	6.1	5.8	7.6	6.1	6.1	5.1	2.3	8.4	25.5	1.4	0.0	2.4	1.4	5.3	17.7	2.4	7.2	20.6	2.1	5.9	1.0	84.4	39.3	3.3	2.1	11.7	1.6	2.2	4.9	7.2	17.4	21.6	32.9	8.8	11.4	11.1	7.3	2.8	3.0	0.3	4.8	5.1	3.1	1.2
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618923-10674318	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.1;stomach 1: 17.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Excitatory neurons: 20.6;Gastric mucus-secreting cells: 15.3;Paneth cells: 12.6;Proximal enterocytes: 10.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Immune cell enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.7;HDLM-2: 17.5;HMC-1: 18.3;HUVEC TERT2: 25.5;TIME: 23.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.4	0.3	1.2	1.8	3.0	1.1	3.9	0.0	5.2	1.9	0.0	15.9	2.4	0.5	1.2	7.3	2.2	3.5	0.1	3.6	0.0	0.6	0.3	1.3	1.4	0.0	0.0	0.3	0.3	0.0	2.4	0.7	0.0	11.6	17.1	0.9	6.7	0.9	0.1	2.8	11.2	0.6	0.0	0.9	17.5	0.2	0.0	0.2	0.4	0.0	2.5	5.1	3.3	0.3	4.8	0.2	0.0	0.6	0.0	0.0	1.3	7.3	0.7	3.5	3.4	2.6	28.7	0.3	4.7	1.8	4.5	1.4	1.6	8.0	7.4	17.5	0.4	1.0	2.4	0.2	0.0	2.2	18.3	0.4	0.4	5.1	0.3	0.5	25.5	0.2	0.3	0.3	8.1	3.1	0.2	1.3	4.2	11.8	2.0	0.1	2.0	0.3	2.5	14.6	0.9	0.1	4.5	4.9	0.0	6.7	3.5	0.6	23.8	1.0	3.8	0.5	0.8	0.0	1.0	0.2	3.5	0.2	5.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.1	12.5	0.0	0.0	0.0	0.3	1.2	3.0	0.0	5.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.2	0.0	0.0	0.3	0.8	3.1	1.2	0.6	3.3	2.0	0.7	1.5	3.3	0.0	0.0	0.1	1.8	19.6	0.0	0.5	0.2	7.3	0.5	0.4	4.2	0.8	20.6	0.2	0.6	0.2	15.3	4.5	1.3	6.3	0.0	0.0	0.0	0.0	1.6	8.9	2.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	6.2	0.0	0.5	5.9	12.6	0.0	0.9	4.7	10.6	0.0	8.8	0.4	0.0	1.2	0.2	0.2	0.8	3.1	1.0	0.3	1.9	0.0	6.9	5.5
SUCLG1		ENSG00000163541	"Succinate-CoA ligase GDP/ADP-forming subunit alpha"	P53597	2	84423528-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 554.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	118.7	73.3	70.6	43.1	73.2	48.2	80.0	76.2	92.5	49.9	91.1	156.9	231.1	42.4	78.8	86.9	54.6	41.9	258.1	71.1	74.5	554.0	193.0	41.6	47.8	71.7	70.2	45.7	93.6	244.2	46.8	48.8	72.9	54.3	165.9	38.4	120.6	66.6	274.1	55.4	195.4	63.5	73.8	39.6	81.1	36.9	73.3	61.7	97.6	368.1	63.1	66.4	58.5	76.9	90.2	94.9	73.8	91.1	137.8	91.2	127.7	98.4	85.2	126.0	91.2	224.5	72.0	122.4	67.0	119.8	100.2	126.8	156.7	118.4	149.8	119.3	141.4	105.9	75.4	129.2	116.0	110.6	82.7	109.1	95.6	106.3	143.7	76.7	115.1	97.9	110.1	98.1	117.5	137.4	158.2	101.1	39.4	334.1	170.0	98.3	172.6	134.5	172.2	106.4	89.8	49.3	78.9	163.7	162.3	69.0	99.8	85.4	93.1	96.6	94.6	119.9	124.9	84.2	131.0	107.8	113.9	150.4	88.0	101.6	91.0	80.8	79.0	110.2	88.5	70.2	72.0	88.4	115.4	55.4	79.1	84.3	49.7	102.3	114.3	63.2	107.7	142.7	70.6	73.2	76.2	92.5	71.1	74.5	71.7	70.2	72.9	73.8	73.3	76.9	52.7	64.1	96.5	32.7	61.0	35.4	108.9	129.6	44.3	33.3	105.0	109.1	408.6	131.5	115.2	141.6	22.9	232.3	49.9	218.1	935.2	131.8	49.2	67.1	56.9	57.0	106.3	68.4	45.8	113.2	129.3	69.8	79.5	80.8	91.3	46.0	57.5	210.0	131.7	45.4	43.5	202.1	105.8	71.3	46.0	35.9	54.7	82.2	119.2	16.9	89.8	68.2	58.7	28.1	46.2	67.1	215.4	74.1	57.1	64.2	647.5	2949.2	83.7	36.1	52.6	61.1	98.3	138.9	54.4	111.3	41.3	188.4	64.4	90.7	388.7	111.0
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming subunit beta"	Q96I99	3	67360460-67654612	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 278.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 402.3;Proximal tubular cells: 354.4;Undifferentiated cells: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		300000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	66.7	44.9	16.1	36.7	17.9	18.6	48.7	17.1	19.6	42.1	22.4	169.7	136.6	32.6	32.2	50.5	39.1	48.4	85.5	14.2	17.6	147.3	278.0	34.0	39.3	19.0	17.3	39.0	47.8	34.6	10.2	28.1	19.5	49.3	146.1	7.3	46.8	42.3	154.0	26.1	132.2	40.0	17.7	44.8	110.6	10.4	18.1	24.7	49.3	130.6	35.5	39.3	24.0	18.8	43.8	37.4	36.3	44.6	59.7	102.5	44.2	51.3	74.4	58.9	65.4	41.7	95.1	55.7	16.3	72.5	38.8	22.0	28.5	70.8	75.9	23.8	19.5	50.5	31.2	65.5	76.8	67.2	33.9	77.3	60.3	46.2	105.2	73.0	63.6	41.8	39.1	49.5	129.9	30.6	25.5	21.2	34.1	199.2	23.0	17.6	56.1	83.8	100.0	66.9	7.1	24.5	81.5	92.7	68.8	24.3	71.6	42.5	55.9	58.2	38.2	64.5	61.8	33.4	52.2	39.0	85.5	51.6	70.0	17.3	36.3	13.0	30.8	44.3	37.6	45.5	44.6	39.5	24.6	42.5	68.4	53.1	1.6	68.0	37.4	9.8	45.4	48.5	16.1	17.9	17.1	19.6	14.2	17.6	19.0	17.3	19.5	17.7	18.1	18.8	40.2	35.3	50.8	66.6	48.5	37.1	44.7	38.9	21.1	2.9	54.1	29.1	172.0	84.4	51.7	80.9	8.4	55.4	31.7	223.5	244.6	85.1	3.2	49.6	43.4	40.1	58.2	17.2	6.2	80.9	44.9	47.5	90.7	46.8	30.4	31.4	45.0	402.3	56.5	5.0	5.3	212.1	40.7	68.6	49.2	5.4	41.3	36.3	42.7	90.9	35.5	29.2	36.0	72.4	60.0	59.2	164.0	47.4	30.3	41.2	222.2	354.4	58.7	4.5	32.9	41.6	50.5	1.6	6.3	55.6	49.3	38.0	48.6	78.5	306.6	50.9
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: AB_2678745"	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	27.4	31.4	33.4	25.5	38.1	32.0	23.6	38.6	55.6	23.0	33.1	25.5	27.3	19.6	20.3	30.1	19.4	19.6	37.0	34.8	37.0	31.7	36.5	22.5	27.4	34.8	34.8	21.5	30.6	19.8	26.9	25.9	36.9	19.6	26.9	22.2	25.2	16.3	29.6	24.5	26.8	22.1	35.3	23.2	26.8	34.5	36.4	29.8	21.1	28.1	29.9	27.3	24.3	48.1	47.0	50.2	72.9	55.6	70.4	57.0	69.8	100.8	66.3	61.7	49.0	110.3	114.7	102.4	27.9	62.8	89.5	79.0	90.6	57.9	90.0	85.3	37.7	95.1	65.8	84.4	51.1	74.8	68.7	40.0	51.7	63.9	48.2	79.0	105.0	64.8	90.5	32.7	95.7	33.4	70.3	136.6	85.3	183.9	47.8	79.6	42.4	44.4	108.0	51.7	24.1	30.7	52.1	42.2	49.8	82.6	43.5	70.3	76.1	51.3	59.9	59.6	87.6	25.7	38.9	91.5	30.8	59.2	75.5	63.6	29.0	49.0	24.3	34.5	23.9	30.9	31.4	33.2	32.9	30.3	23.8	26.6	4.1	33.2	34.1	41.0	46.0	25.2	33.4	38.1	38.6	55.6	34.8	37.0	34.8	34.8	36.9	35.3	36.4	48.1	82.1	38.5	36.0	22.2	46.1	39.8	65.4	68.2	38.1	52.6	40.6	55.8	126.2	32.9	51.8	51.5	25.0	67.0	78.3	52.3	78.2	88.3	185.6	112.0	79.0	65.9	34.1	65.2	19.9	89.0	143.0	60.9	50.0	75.1	36.8	49.7	43.5	38.3	97.8	50.5	23.0	58.2	54.9	44.5	43.9	95.7	58.7	54.3	48.0	13.1	123.7	91.8	58.7	21.1	47.6	85.2	55.0	59.8	58.3	44.1	74.3	100.9	67.8	56.6	26.3	72.4	92.1	146.7	101.0	45.7	43.2	74.4	61.1	56.1	55.5	52.3
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone and transcription elongation factor"	Q7KZ85	17	28662198-28702679	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: AB_2675094"	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	31.2	33.5	24.6	25.4	25.8	65.3	28.3	25.0	26.8	27.0	26.8	36.6	20.0	30.6	26.8	26.5	26.6	24.7	28.8	24.0	29.0	25.6	35.8	28.9	28.4	24.0	25.2	31.2	31.4	30.8	34.3	27.8	24.3	28.7	20.9	29.2	29.1	25.6	54.5	39.2	32.2	27.3	21.6	34.4	31.3	21.4	28.7	34.0	28.9	32.6	30.3	32.1	25.6	25.6	49.4	101.3	49.8	57.1	59.1	39.3	38.2	66.2	70.3	76.3	67.8	94.7	21.5	52.1	33.6	66.5	58.7	57.5	73.6	48.1	78.4	97.6	65.4	72.9	83.2	59.4	49.4	77.2	77.9	54.6	28.4	81.2	53.6	50.3	50.8	50.3	72.9	59.7	55.1	59.1	76.9	33.4	38.7	43.2	32.4	38.7	91.2	42.7	37.6	95.9	37.8	49.9	77.6	120.5	41.6	67.9	74.2	54.2	80.6	59.8	49.4	57.5	85.3	75.4	62.2	74.4	67.5	34.4	50.5	14.7	4.5	4.4	3.7	2.9	3.9	4.5	3.1	4.1	3.7	4.5	3.1	2.8	6.8	4.3	5.0	6.2	3.1	3.1	24.6	25.8	25.0	26.8	24.0	29.0	24.0	25.2	24.3	21.6	28.7	25.6	33.9	38.5	51.0	24.2	36.5	22.4	19.2	16.8	43.3	29.5	27.4	26.0	51.6	22.8	28.4	20.2	56.3	24.4	38.4	29.5	5.9	22.1	5.4	31.0	45.3	32.6	31.0	33.0	21.6	21.3	21.3	32.7	46.4	49.1	50.5	36.6	22.9	33.9	23.7	30.3	19.7	23.1	8.2	23.0	22.4	17.8	25.7	41.8	8.8	16.9	29.9	22.0	30.9	17.6	19.4	31.9	18.7	26.7	55.7	20.0	23.4	10.5	25.7	44.4	32.9	32.4	32.0	19.8	19.1	40.1	24.3	49.8	38.3	42.0	22.9	25.7
SUSD2	"BK65A6.2, FLJ22778, W5C5"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181487-24189106	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 99.8"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 250.0;Alveolar cells type 2: 151.5;Proximal enterocytes: 154.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	29	"SK-BR-3: 898.7"	"Low region specificity"	"Detected in all"							HPA004117	Enhanced		Approved	"Plasma membrane"		NA	NA		6800000		"Cluster 19: Lung - Lung function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	12.1	9.6	4.9	1.9	2.8	0.2	9.5	1.7	5.8	13.6	2.2	4.8	12.8	9.8	0.5	2.8	15.0	1.8	12.5	1.6	5.3	32.6	2.9	99.8	2.2	22.9	6.9	5.4	4.3	1.5	7.1	3.6	26.5	5.6	1.0	0.1	4.7	5.6	2.2	28.2	34.6	3.4	6.8	3.6	6.3	3.2	13.2	0.8	17.8	1.4	1.3	5.4	11.0	10.0	5.1	10.4	0.1	0.0	18.8	24.3	0.8	2.4	0.1	0.1	0.0	7.8	0.6	1.4	21.5	0.5	0.4	1.4	0.1	0.5	0.0	0.6	0.3	0.0	0.4	30.6	8.0	0.0	0.3	21.5	0.4	0.1	6.2	0.0	0.1	0.0	0.5	0.3	0.0	9.1	0.3	0.4	0.7	2.5	0.3	0.3	0.0	2.5	0.1	0.2	1.7	13.5	0.7	898.7	0.2	3.6	3.0	0.0	0.0	0.1	0.9	0.7	0.1	1.1	1.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	2.8	1.7	5.8	1.6	5.3	22.9	6.9	26.5	6.8	13.2	10.0	1.7	250.0	151.5	0.3	0.6	0.3	0.3	2.6	0.0	0.0	3.4	3.4	6.8	0.0	20.9	1.8	0.0	13.8	0.3	0.7	5.9	0.1	0.0	1.3	0.7	1.1	1.8	0.0	0.2	0.0	0.7	6.7	0.5	1.3	3.8	0.1	2.9	0.5	1.1	0.0	0.1	5.5	2.0	0.0	0.3	0.4	0.6	0.8	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	154.9	27.8	3.6	0.0	0.0	0.6	22.1	1.7	1.3	0.7	2.7	26.4	1.1	0.0	1.6	0.6
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 73.8;parathyroid gland: 87.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 91.3;Hofbauer cells: 73.1;Kupffer cells: 96.7;Macrophages: 95.2;Microglial cells: 114.3;monocytes: 92.5;Plasma cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 77.3;eosinophil: 83.5;intermediate monocyte: 64.0;memory B-cell: 74.5;myeloid DC: 85.1;naive B-cell: 58.4;neutrophil: 112.1;NK-cell: 30.0;non-classical monocyte: 60.2;plasmacytoid DC: 63.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 125.8;HEL: 72.8;HL-60: 101.6;HMC-1: 64.1;REH: 84.4;THP-1: 76.8;U-698: 58.8;U-937: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		290000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.4	4.6	4.1	42.5	4.1	50.9	6.8	4.5	4.9	7.7	4.2	20.1	30.8	4.1	16.1	17.5	17.0	12.9	2.9	3.8	5.0	11.2	4.5	20.6	61.8	7.1	5.8	1.7	9.1	87.6	2.4	12.0	7.0	3.8	20.5	0.7	8.4	4.2	1.0	9.9	36.3	9.3	6.6	40.3	19.1	6.9	7.1	49.7	25.6	2.4	73.8	17.5	8.3	9.8	22.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.3	125.8	3.5	0.0	4.2	19.1	2.7	10.2	0.0	0.0	17.0	72.8	0.0	0.0	0.0	101.6	64.1	0.0	14.0	0.0	1.4	0.0	0.0	15.5	2.0	9.9	0.0	15.4	0.1	44.4	0.7	47.0	0.0	84.4	0.1	34.6	2.6	18.6	6.4	5.7	0.1	8.7	0.1	0.3	7.9	76.8	0.2	0.0	0.4	0.1	0.1	0.2	0.0	58.8	0.0	70.3	0.0	5.3	77.3	83.5	0.3	64.0	0.3	74.5	0.2	0.2	85.1	58.4	0.2	0.1	112.1	30.0	60.2	63.2	0.1	44.6	4.1	4.1	4.5	4.9	3.8	5.0	7.1	5.8	7.0	6.6	7.1	9.8	0.5	12.8	20.2	0.0	91.3	3.4	3.7	8.7	12.0	1.4	6.3	2.8	1.6	14.3	12.8	14.7	0.0	1.3	70.4	16.5	15.6	15.0	7.1	10.7	1.0	2.1	10.3	37.9	0.4	12.5	2.6	2.1	22.4	12.6	43.6	0.0	3.3	1.0	73.1	0.0	0.7	24.4	0.0	96.7	28.8	6.2	0.6	95.2	12.4	114.3	92.5	0.0	62.8	1.5	0.5	18.2	25.1	0.0	83.1	2.5	31.4	0.4	10.4	0.2	6.6	0.7	2.3	0.8	0.7	30.4	5.7	1.4	8.3	0.0	31.1	8.0
SYNC	"SYNC1, SYNCOILIN"	ENSG00000162520	"Syncoilin, intermediate filament protein"	Q9H7C4	1	32679906-32703596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 106.8;smooth muscle: 54.1;tongue: 73.4"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 74.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 121.0;U-138 MG: 113.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028311, HPA063549"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA028311: AB_2672554, HPA063549: "	"unprognostic (3.99e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.99e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.32e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-4)"	10.5	8.5	6.4	15.6	6.1	0.7	5.4	6.7	6.6	9.7	6.1	11.6	6.5	10.9	4.9	17.9	7.4	9.5	17.3	5.8	7.9	2.4	2.2	10.5	6.4	8.3	8.7	3.7	2.6	4.7	0.7	2.5	7.9	13.1	8.7	0.4	9.6	14.6	106.8	2.5	7.3	54.1	9.0	6.2	9.0	9.7	7.4	1.1	4.5	73.4	1.7	12.3	2.9	8.2	8.7	7.0	11.2	19.3	19.4	30.5	6.6	41.9	81.5	28.7	19.6	1.2	24.8	23.9	13.0	121.0	43.4	5.8	1.0	0.7	16.2	12.4	0.8	26.1	22.6	18.0	16.4	33.0	12.0	46.6	2.9	31.6	1.1	86.1	9.0	17.2	19.6	26.2	24.3	4.2	32.0	8.9	5.9	11.2	9.6	34.5	36.5	12.7	32.6	14.2	18.1	1.7	57.1	17.6	21.7	22.2	16.0	10.4	14.4	113.0	19.4	69.4	18.8	11.4	21.1	30.2	39.0	10.4	98.3	5.9	7.7	6.1	6.1	9.6	8.1	6.9	6.9	6.4	9.7	5.2	6.2	7.0	0.9	9.1	9.5	12.3	7.9	12.0	6.4	6.1	6.7	6.6	5.8	7.9	8.3	8.7	7.9	9.0	7.4	8.2	10.6	9.6	9.8	15.7	15.1	22.0	14.2	14.5	8.0	50.2	20.6	7.0	1.0	20.0	14.1	9.2	39.6	9.4	20.7	8.3	5.9	11.7	11.2	12.9	25.0	13.1	7.3	16.0	12.2	5.4	9.3	17.1	0.5	16.3	22.2	12.4	22.9	19.1	5.4	74.0	13.2	8.4	8.2	17.7	23.2	14.8	41.7	7.3	33.8	7.5	11.4	20.0	34.0	15.1	11.6	7.9	7.9	64.3	5.7	16.0	10.7	10.1	6.0	53.9	19.7	16.6	12.8	32.8	36.0	7.2	22.3	5.1	15.3	9.4	12.6	9.4
SYNGR3		ENSG00000127561	"Synaptogyrin 3"	O43761	16	1989660-1994275	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 122.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.2;Inhibitory neurons: 33.7;Spermatogonia: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.9;NK-cells: 2.0;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.9;HMC-1: 30.3;Karpas-707: 25.8;SK-BR-3: 32.1;U-266/70: 40.2"									"CAB034278, HPA042842"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB034278: AB_2200905, HPA042842: AB_2678198"	"unprognostic (8.89e-3)"	"prognostic favorable (6.92e-4)"	"unprognostic (6.07e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.92e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.12e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.78e-2)"	0.3	9.4	83.0	2.9	86.4	0.9	0.3	35.7	106.5	0.5	10.6	5.3	1.3	0.2	0.0	0.5	0.4	0.4	0.9	74.7	110.7	3.8	0.3	1.0	3.2	88.2	95.3	0.6	0.8	7.3	12.3	1.6	122.6	0.8	1.1	9.5	1.1	0.1	0.1	0.6	5.9	0.7	34.3	2.5	2.3	5.6	121.3	0.5	0.4	0.0	3.7	0.4	1.3	70.5	0.9	4.0	3.7	0.5	0.4	0.4	4.5	1.9	3.1	1.5	1.2	6.3	2.9	6.2	1.4	1.4	4.1	3.5	4.1	0.5	0.4	49.9	2.9	0.1	5.9	3.1	2.1	0.0	30.3	0.9	0.2	0.1	1.0	7.2	0.4	1.9	17.9	25.8	0.7	4.7	0.3	0.3	19.0	0.7	1.8	0.0	0.5	4.9	2.4	0.1	8.6	10.7	4.4	32.1	0.4	2.0	4.5	0.4	0.7	0.9	14.5	0.1	0.7	40.2	5.0	7.2	0.6	5.5	0.6	0.0	0.3	0.0	0.3	0.1	0.8	1.2	0.6	1.1	0.3	1.9	0.7	0.3	0.0	2.0	0.3	0.0	0.6	0.4	83.0	86.4	35.7	106.5	74.7	110.7	88.2	95.3	122.6	34.3	121.3	70.5	0.1	0.0	0.6	3.3	5.0	0.3	0.8	0.6	1.2	5.0	0.2	0.3	5.4	0.0	0.6	0.0	2.1	0.5	2.1	0.9	1.9	2.0	0.8	0.0	0.1	0.5	0.0	0.0	24.2	0.5	0.8	1.2	0.5	0.1	1.3	1.4	0.0	0.0	0.3	6.7	33.7	0.5	0.0	0.6	0.4	0.5	0.0	0.5	0.0	1.9	2.7	1.1	2.1	2.5	3.5	1.2	0.0	0.0	2.3	5.5	0.1	0.1	0.9	2.1	0.0	0.1	0.3	3.0	8.6	0.4	0.3	3.1	2.9	0.4	0.3	1.7
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659207	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 369.6;skeletal muscle: 1296.3;tongue: 502.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 264.7;Distal enterocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 88.4;EFO-21: 72.8;HUVEC TERT2: 72.7;TIME: 178.0;U-87 MG: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179"	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	91.8	112.1	103.5	21.3	60.7	0.3	48.6	0.0	88.9	23.2	0.8	37.4	31.4	38.7	20.9	31.0	30.8	32.2	369.6	91.2	5.2	60.6	38.5	72.1	10.6	18.2	8.5	34.6	32.9	17.1	21.6	23.8	5.2	46.0	17.5	10.0	21.6	29.1	1296.3	15.4	39.6	38.9	20.6	38.9	34.9	17.0	5.1	6.6	31.1	502.1	11.1	56.8	22.3	34.9	0.5	24.2	0.2	0.3	3.5	3.2	88.4	13.8	18.9	4.6	3.7	21.6	9.7	0.1	72.8	19.9	29.2	8.9	0.1	13.5	1.9	0.2	0.2	0.0	37.4	4.7	19.6	0.0	0.9	3.7	21.3	5.2	3.7	27.5	72.7	0.2	0.2	0.2	4.4	1.6	0.1	0.7	2.8	9.3	11.6	0.5	0.7	0.2	3.4	1.9	8.5	39.3	19.9	21.6	0.7	31.1	1.6	6.6	178.0	17.4	53.2	0.4	3.6	0.8	0.2	1.3	152.5	0.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.5	60.7	0.0	88.9	91.2	5.2	18.2	8.5	5.2	20.6	5.1	34.9	51.1	35.3	12.2	1.3	4.8	4.6	3.0	32.6	1.8	1.9	6.4	2.5	264.7	27.1	17.0	7.3	2.1	14.8	0.5	70.5	0.0	43.7	1.7	0.4	0.4	56.3	13.8	2.7	22.5	34.5	6.0	19.9	4.6	0.5	0.0	40.9	62.8	40.0	2.1	0.0	5.7	8.4	2.0	10.8	5.1	3.4	2.8	0.9	5.4	6.5	24.0	7.2	0.0	2.5	1.3	35.6	24.4	27.8	0.6	5.7	52.6	4.4	7.6	0.8	46.0	18.0	29.2	1.2	0.8	1.4	2.3	25.9	1.6	8.6	11.8	3.6
SYPL2	Mg29	ENSG00000143028	"Synaptophysin like 2"	Q5VXT5	1	109466546-109482134	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 363.5;tongue: 175.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.5;Cardiomyocytes: 10.6;Collecting duct cells: 3.7;Hepatocytes: 4.8;Late spermatids: 11.1;Proximal tubular cells: 5.1;Skeletal myocytes: 4.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 31.6;ASC TERT1: 13.2;BJ: 14.1;BJ hTERT+: 44.1;fHDF/TERT166: 23.1;HAP1: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076657			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"HPA076657: "	"unprognostic (1.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.90e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.05e-4)"	"unprognostic (2.54e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.39e-4)"	2.8	11.7	1.5	0.6	1.5	0.0	1.5	1.3	2.4	4.0	4.0	6.2	0.5	6.6	4.5	4.6	1.4	0.9	19.9	1.6	1.3	9.6	9.5	1.3	0.5	1.4	1.3	3.0	5.1	5.8	1.1	3.2	1.2	3.1	1.0	0.4	4.2	6.0	363.5	0.7	1.6	6.0	1.0	1.1	3.2	9.3	1.6	0.1	8.0	175.3	0.3	4.1	2.4	1.3	0.0	0.1	0.1	1.8	31.6	13.2	0.0	14.1	44.1	4.3	1.6	0.0	0.1	0.0	0.0	23.1	0.5	0.0	11.8	0.0	0.9	0.0	5.1	0.0	0.4	0.2	0.6	0.0	1.1	1.2	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.1	0.1	0.0	1.4	3.3	2.3	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	1.3	2.4	1.6	1.3	1.4	1.3	1.2	1.0	1.6	1.3	0.2	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	10.6	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.2	2.8	0.0	0.1	0.4	0.0	0.0	0.3	1.3	0.0	1.0	0.0	0.0	0.0	0.9	0.0	4.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.0	0.1	0.0	1.0	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.1	0.0	5.1	0.0	0.0	0.0	4.8	2.6	0.4	1.4	0.0	0.0	0.1	0.2	0.4	0.0	0.0
SYT4	"HsT1192, KIAA1342"	ENSG00000132872	"Synaptotagmin 4"	Q9H2B2	18	43267892-43277535	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.7;pituitary gland: 30.7;retina: 25.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 66.8;Cone photoreceptor cells: 22.9;Enteroendocrine cells: 28.7;Excitatory neurons: 50.9;Fibroblasts: 23.0;Inhibitory neurons: 34.1"	"Group enriched"	"Detected in some"	5	"glioma: 2.0;pancreatic cancer: 4.1;prostate cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 245.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010574	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"		"HPA010574: AB_2668309"			"unprognostic (2.91e-3)"		"unprognostic (2.03e-1)"			"unprognostic (2.37e-2)"		"unprognostic (2.87e-1)"	"unprognostic (7.67e-3)"	"unprognostic (5.30e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.80e-2)"		3.7	15.9	21.5	1.4	18.6	0.1	0.0	74.7	42.6	0.0	0.0	1.2	0.8	0.0	0.0	0.1	0.0	0.0	1.3	18.6	50.4	0.1	0.0	0.9	0.0	10.5	15.3	0.5	3.7	0.0	30.7	0.1	39.3	0.6	0.8	25.2	0.1	8.3	0.0	0.0	0.7	0.6	13.5	0.0	3.2	1.6	18.3	0.4	0.3	0.0	0.0	0.0	0.5	10.9	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	245.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	18.6	74.7	42.6	18.6	50.4	10.5	15.3	39.3	13.5	18.3	10.9	0.0	0.0	1.1	8.8	0.0	0.1	0.0	0.0	0.0	66.8	0.0	0.0	3.6	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	28.7	0.0	50.9	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.4	0.0	2.5	0.0	7.5	7.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.1
TACR2	"NK2R, NKNAR, SKR, TAC2R"	ENSG00000075073	"Tachykinin receptor 2"	P21452	10	69403903-69416918	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 184.0"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 6.7;Kupffer cells: 2.4;Leydig cells: 2.8"	"Cancer enriched"	"Detected in many"	4	"stomach cancer: 6.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 4.2;U-87 MG: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076573			Approved	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA076573: AB_2732313"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.88e-4)"	"unprognostic (5.59e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.32e-1)"	0.9	0.3	1.3	2.5	1.2	0.4	0.8	1.5	1.7	10.3	0.2	184.0	5.0	25.2	0.2	14.7	20.4	0.5	3.2	1.7	0.1	0.3	0.5	0.7	0.3	0.0	0.2	1.8	0.3	0.0	0.2	0.2	0.1	6.2	9.1	4.1	0.5	1.1	2.8	1.1	31.4	33.1	0.0	0.3	37.9	0.7	0.0	0.1	0.4	0.2	0.1	32.3	8.5	0.4	0.9	0.6	0.2	0.3	1.4	0.1	0.1	0.2	0.1	0.2	0.3	0.3	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.8	0.1	0.0	1.4	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.2	1.2	0.0	0.3	0.0	0.2	0.2	0.8	0.9	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.6	1.2	4.2	0.1	0.5	0.1	0.3	1.4	0.2	0.6	0.5	0.5	0.6	0.1	2.3	0.1	0.8	0.2	0.4	0.0	0.1	1.3	0.1	0.3	0.2	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	1.2	1.5	1.7	1.7	0.1	0.0	0.2	0.1	0.0	0.0	0.4	0.5	0.0	0.5	0.3	0.1	0.6	0.2	0.2	0.0	0.2	1.1	1.4	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.3	0.6	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.6	0.0	0.2	1.4	0.1	1.2	6.7	0.1	0.3	0.0	2.4	0.4	0.1	2.8	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.4	0.1	1.5	0.2	0.0	1.1	0.7	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.4
TAS2R10	"T2R10, TRB2"	ENSG00000121318	"Taste 2 receptor member 10"	Q9NYW0	12	10825317-10826358	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Astrocytes: 6.2;Excitatory neurons: 14.4;Inhibitory neurons: 14.4;Microglial cells: 4.7;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070201			Approved	"Vesicles,Plasma membrane,Actin filaments"		NA	NA						"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane"	"Actin filaments"	"HPA070201: "	"unprognostic (1.28e-1)"	"unprognostic (3.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.86e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.16e-5)"	"unprognostic (5.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.56e-3)"	0.2	0.6	0.1	0.0	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.0	0.4	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.3	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	14.1	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1
TASP1	"C20orf13, dJ585I14.2, FLJ20212"	ENSG00000089123	"Taspase 1"	Q9H6P5	20	13389392-13638932	"Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 136.1;Inhibitory neurons: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030824, HPA030825"	Uncertain		Approved	"Plasma membrane"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA030824: AB_10600327, HPA030825: AB_10601575"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.44e-3)"	"unprognostic (9.85e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.67e-2)"	7.0	4.5	1.0	4.3	1.7	4.9	6.8	1.5	2.9	6.5	3.9	5.2	3.7	6.8	6.0	4.8	8.1	4.5	5.7	1.2	2.7	5.4	4.5	6.0	5.7	1.3	1.7	5.6	5.9	8.7	7.4	6.5	1.0	5.2	5.7	6.4	6.0	4.6	2.9	5.5	4.6	5.1	0.5	5.6	5.6	6.1	2.3	12.5	7.8	4.3	5.2	5.6	6.2	2.9	13.1	7.7	3.1	3.7	3.6	5.6	6.0	5.3	7.6	6.1	7.1	16.0	13.3	5.9	3.6	7.0	6.7	17.2	4.9	18.4	7.1	3.5	5.8	11.8	4.7	20.3	7.4	16.0	4.1	6.3	12.1	6.2	15.0	3.7	6.1	10.4	10.7	0.2	5.4	15.8	30.7	8.7	4.2	11.7	3.5	4.8	12.7	9.1	8.5	9.8	8.3	5.7	8.2	15.8	10.2	4.4	8.3	5.8	5.9	5.7	4.0	5.9	7.6	11.3	16.7	4.2	3.2	3.6	5.5	2.3	4.5	4.9	12.7	6.5	9.0	12.1	12.8	10.0	5.0	9.8	18.6	14.4	2.5	14.8	6.5	19.5	13.3	7.1	1.0	1.7	1.5	2.9	1.2	2.7	1.3	1.7	1.0	0.5	2.3	2.9	10.7	6.4	7.7	31.3	19.6	14.1	13.2	11.1	24.5	14.9	10.0	8.8	6.4	17.2	8.8	5.5	10.4	12.0	13.8	3.9	7.9	12.1	20.1	15.7	10.6	6.6	3.6	7.8	136.1	6.0	12.3	15.9	13.3	9.5	15.2	5.2	3.6	6.4	4.7	11.8	131.0	9.9	4.1	3.0	4.7	4.8	3.4	5.8	10.6	35.6	2.9	6.6	11.3	50.3	49.6	8.6	11.4	3.4	13.3	8.0	5.3	12.2	23.5	17.0	6.6	23.7	17.0	29.3	9.3	18.0	12.1	7.0	12.7	10.2	7.7	8.9
TAZ	"BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2"	ENSG00000102125	Tafazzin	Q16635	X	154411524-154421726	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039557	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA039557: AB_10672899"	"unprognostic (1.14e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.29e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (4.00e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	19.0	13.8	37.2	8.5	38.1	41.4	17.2	38.1	44.4	18.1	37.0	18.3	9.7	15.1	7.6	21.7	16.6	8.7	43.5	37.0	37.0	22.3	21.9	21.4	17.9	39.3	37.6	18.5	21.3	12.1	14.5	6.6	38.5	17.9	11.7	8.4	13.6	10.2	47.0	18.7	22.9	12.3	37.7	39.2	17.4	4.5	37.9	14.1	18.5	65.6	16.0	18.4	18.4	39.4	24.5	28.6	9.3	11.7	18.3	13.4	18.4	6.9	21.0	15.3	17.1	8.5	29.6	28.2	43.6	16.4	36.6	28.4	17.2	16.6	12.3	25.5	19.6	5.5	20.0	16.4	25.8	12.3	11.8	15.4	35.6	11.7	31.7	12.9	25.6	30.9	12.1	34.9	18.1	17.6	29.0	33.2	2.4	24.9	27.9	21.4	16.2	40.1	24.2	9.0	11.8	17.9	5.3	17.9	26.6	11.1	10.5	16.0	15.5	10.4	11.9	25.5	15.2	55.9	30.6	66.2	13.7	36.6	13.3	5.8	11.1	17.5	12.4	10.4	11.5	12.5	16.6	15.5	14.5	18.7	14.1	12.0	9.9	12.7	7.8	7.9	15.4	9.4	37.2	38.1	38.1	44.4	37.0	37.0	39.3	37.6	38.5	37.7	37.9	39.4	36.2	6.4	11.8	37.2	29.3	10.8	7.9	10.5	14.8	21.6	11.1	15.6	21.1	14.3	13.0	9.2	18.8	5.0	29.7	13.6	5.9	14.7	1.1	6.5	9.6	18.5	6.1	9.7	22.4	16.5	10.1	12.4	23.4	9.6	18.4	19.2	15.0	7.9	24.4	10.1	28.4	15.9	12.2	19.9	16.5	2.0	11.5	20.4	14.2	14.0	21.7	14.2	15.5	23.1	39.7	13.4	12.2	9.1	17.2	8.3	19.6	5.9	8.0	25.6	13.1	12.4	11.3	10.4	3.8	16.8	11.2	2.9	25.6	9.2	15.8	6.7
TBC1D2	"Armus, PARIS1, TBC1D2A"	ENSG00000095383	"TBC1 domain family member 2"	Q9BYX2	9	98199011-98255649	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Oligodendrocytes: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 77.0;HaCaT: 98.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030871, HPA076521"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA030871: AB_10670046, HPA076521: "	"unprognostic (2.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.30e-1)"	8.8	5.3	11.1	5.7	16.0	13.1	7.8	12.3	26.0	10.8	8.5	8.6	12.6	4.4	1.5	37.4	5.5	4.0	3.7	10.6	12.9	6.4	19.8	32.0	3.8	14.9	14.9	2.9	3.0	3.5	4.4	7.2	16.4	12.0	4.4	3.4	14.7	6.1	4.3	24.3	10.1	2.8	11.4	9.4	7.0	3.4	23.3	3.0	8.1	1.4	4.9	11.7	17.3	23.9	77.0	10.8	0.5	2.5	8.2	15.9	24.3	33.2	18.4	23.8	19.6	6.9	32.8	1.3	24.7	19.6	5.2	98.1	0.7	36.8	8.3	2.6	1.4	0.7	38.0	5.4	37.6	1.7	2.9	21.7	59.8	23.6	58.7	41.5	8.6	2.1	2.4	1.0	19.0	9.9	0.4	4.6	1.6	7.4	6.2	1.2	4.8	0.2	36.0	46.7	0.9	1.4	11.3	24.4	3.4	1.7	8.1	2.6	51.7	28.8	8.6	4.8	13.6	1.6	1.5	0.6	29.0	2.9	3.2	2.1	27.5	8.4	2.5	15.3	1.8	1.2	3.8	2.2	10.0	0.8	1.6	1.9	11.9	1.2	12.3	1.3	5.5	10.8	11.1	16.0	12.3	26.0	10.6	12.9	14.9	14.9	16.4	11.4	23.3	23.9	2.9	57.7	12.5	5.2	2.4	8.3	18.5	30.4	21.6	3.3	2.7	5.6	0.7	4.3	23.3	3.7	0.0	21.5	0.9	16.2	3.9	3.3	1.8	4.6	3.7	5.0	7.7	0.4	4.6	3.2	10.9	2.4	6.1	10.3	0.0	0.6	1.1	6.1	32.0	1.7	5.4	12.6	18.3	16.2	1.8	1.2	1.8	18.3	3.6	4.7	7.5	4.4	3.1	12.1	64.9	14.4	10.7	0.7	1.7	9.2	16.4	3.2	10.8	2.4	0.0	1.8	3.4	2.1	3.0	29.8	10.9	17.4	2.4	0.7	5.7	17.1
TBC1D9B	"GRAMD9B, KIAA0676"	ENSG00000197226	"TBC1 domain family member 9B"	Q66K14	5	179862066-179907897	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038350	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038350: AB_10673170"	"unprognostic (5.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.53e-2)"	"unprognostic (9.45e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (8.22e-2)"	54.9	61.8	53.9	20.8	62.2	22.8	46.3	58.1	51.1	39.3	38.6	34.1	22.8	38.9	12.0	43.9	34.2	23.8	30.9	51.4	50.1	44.8	55.0	31.7	23.9	60.5	59.8	39.0	46.4	27.0	29.2	17.2	61.6	33.6	12.1	9.1	37.0	25.0	45.9	44.4	34.4	21.1	63.4	39.5	35.5	20.5	57.2	13.1	36.3	18.7	15.3	35.1	35.7	65.9	42.7	64.0	27.4	62.4	69.9	49.0	66.8	51.0	47.2	50.1	48.4	43.8	41.9	29.3	60.2	57.8	56.6	39.6	28.3	115.9	9.8	98.0	39.1	26.0	47.3	27.9	41.5	35.1	85.0	50.6	42.6	39.2	18.9	22.6	48.4	55.3	17.7	28.1	39.5	104.2	22.7	24.5	20.3	17.4	36.5	38.7	22.1	27.8	35.1	66.8	40.1	30.4	48.2	54.5	54.9	11.0	45.0	48.8	57.2	71.2	31.9	34.8	45.2	16.8	23.3	22.7	68.0	41.7	51.7	5.0	7.8	5.5	6.1	9.2	4.8	6.3	4.2	4.9	9.3	5.1	3.9	3.5	0.9	4.2	9.2	9.5	4.0	7.1	53.9	62.2	58.1	51.1	51.4	50.1	60.5	59.8	61.6	63.4	57.2	65.9	24.9	22.4	19.2	20.2	19.7	16.6	10.2	14.6	15.4	27.8	23.9	21.6	9.5	12.8	14.0	27.6	8.4	19.8	20.4	28.4	13.7	21.1	2.4	18.2	20.2	21.0	18.0	17.5	32.1	18.0	23.6	21.1	21.9	27.0	11.4	30.0	24.3	35.2	30.7	62.2	23.6	23.9	10.2	33.5	15.7	8.2	32.3	28.6	16.0	15.9	21.4	17.8	24.7	14.6	27.0	25.2	24.3	28.6	16.4	15.3	24.4	22.6	13.3	18.0	26.3	26.7	16.4	11.1	18.5	25.0	15.6	14.1	17.9	57.1	20.5	13.7
TCIM	"C8orf4, hTC-1, TC-1, TC1"	ENSG00000176907	"Transcriptional and immune response regulator"	Q9NR00	8	40153482-40155310	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.5;Alveolar cells type 2: 882.5;Collecting duct cells: 200.5;Distal tubular cells: 193.7;Ductal cells: 331.6;Glandular and luminal cells: 397.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 48.5;AF22: 134.4;BJ: 51.5;BJ hTERT+: 134.4;EFO-21: 87.5;HeLa: 94.8;RPTEC TERT1: 67.2;SuSa: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027188	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 12: NES - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027188: AB_10601150"	"unprognostic (8.88e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.48e-2)"	91.5	24.2	6.2	42.9	7.4	0.0	64.0	6.0	10.8	134.1	10.6	68.7	30.9	67.7	18.3	22.3	20.3	105.2	130.8	6.5	6.5	252.6	210.0	165.4	18.0	6.5	6.6	44.6	51.5	70.3	18.9	165.1	6.9	67.7	71.1	4.5	176.0	28.3	37.7	13.2	101.4	43.5	6.9	83.3	56.1	4.8	8.6	3.8	53.9	47.9	4.1	255.3	26.2	7.8	0.0	48.5	134.4	0.0	0.0	0.0	0.3	51.5	134.4	0.2	0.6	0.7	0.0	0.0	87.5	1.0	0.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	94.8	21.4	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.3	1.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.2	67.2	0.1	0.1	0.2	0.2	4.6	0.0	50.4	0.0	0.0	43.6	0.0	1.2	0.4	0.8	1.2	1.7	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.4	6.0	10.8	6.5	6.5	6.5	6.6	6.9	6.9	8.6	7.8	209.5	99.3	882.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	124.9	62.0	0.0	0.0	77.4	200.5	0.0	12.3	1.5	0.0	193.7	331.6	0.0	152.6	90.7	103.2	0.0	0.0	0.0	111.2	26.5	13.5	0.0	397.4	26.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	102.4	0.0	0.0	0.1	0.0	0.0	2.5	8.7	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	4.5	8.1	22.7	0.0	0.0
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044764	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Plasma membrane"	"HPA071317: AB_2686388"	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	3.9	4.8	11.8	4.5	13.9	8.9	6.6	4.9	6.6	7.1	7.8	6.5	5.9	5.8	8.2	9.2	6.6	2.6	4.1	5.3	7.0	6.5	4.7	19.0	3.8	3.6	6.4	4.8	5.1	4.6	8.2	3.9	5.0	10.1	4.9	5.5	4.3	2.1	6.4	7.0	6.3	2.8	10.6	7.9	22.3	4.6	28.3	4.9	1.7	23.7	8.1	5.0	4.2	33.8	18.6	40.9	37.5	10.1	14.0	32.7	31.7	25.9	38.4	34.6	13.6	35.5	42.9	23.3	21.7	12.9	33.9	18.2	29.5	55.2	44.1	19.6	43.9	16.7	16.6	8.7	73.2	24.1	10.1	12.9	26.9	24.9	21.9	49.5	57.3	30.6	43.5	45.9	35.0	56.3	39.2	10.0	39.8	43.7	42.3	77.3	34.0	24.6	27.3	30.7	20.9	26.9	77.6	10.1	27.0	31.0	30.8	39.9	16.5	15.7	23.0	28.7	31.8	60.4	52.3	35.5	32.3	24.6	28.7	8.9	15.1	18.8	14.6	18.3	21.1	19.8	20.8	14.2	20.0	21.7	23.1	5.7	23.8	14.1	15.0	32.2	14.8	4.8	4.5	6.6	4.9	4.1	5.3	3.8	3.6	3.9	2.8	4.6	4.2	2.9	0.0	1.1	4.2	15.2	4.7	4.9	7.4	4.0	3.0	6.4	7.1	1.4	1.5	5.0	14.7	8.4	11.4	14.6	3.8	5.9	9.2	123.5	13.2	6.1	3.6	3.6	12.8	13.4	5.6	14.9	4.3	7.7	9.2	2.5	8.9	3.9	4.2	8.8	3.3	13.9	4.9	0.0	6.8	10.2	36.7	2.8	7.8	1.8	1.9	8.0	1.5	8.2	8.0	24.2	6.4	4.8	3.0	16.9	5.7	2.9	7.8	11.0	2.7	0.0	3.4	5.4	33.7	22.8	8.7	4.5	10.1	15.0	10.3	7.9	4.0
TEKT3	FLJ32828	ENSG00000125409	"Tektin 3"	Q9BXF9	17	15303811-15341632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 31.0"	"Group enriched"	"Detected in some"	10	"Early spermatids: 413.1;Late spermatids: 408.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;SuSa: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027293, HPA044354, HPA073565"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA027293: , HPA044354: AB_10962623, HPA073565: "	"unprognostic (1.85e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.73e-2)"	"unprognostic (5.38e-4)"	"unprognostic (4.59e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (8.63e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.09e-4)"	"unprognostic (1.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.90e-3)"	"unprognostic (7.85e-2)"	0.3	0.2	0.7	0.3	0.6	0.1	0.5	1.4	0.9	1.2	0.6	0.3	0.3	0.5	0.6	0.1	4.9	0.4	0.2	0.4	0.4	0.3	0.2	0.8	0.1	0.9	1.0	0.9	0.7	0.2	1.0	0.3	0.5	0.4	0.2	0.6	0.5	0.1	0.1	0.7	0.4	0.2	0.5	0.2	0.2	31.0	0.4	0.1	0.7	0.0	0.1	0.2	0.4	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.1	0.1	1.5	0.0	0.2	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.7	0.3	0.0	0.1	0.0	0.0	0.7	0.6	1.4	0.9	0.4	0.4	0.9	1.0	0.5	0.5	0.4	1.1	0.7	3.2	0.5	0.7	0.1	0.3	0.1	0.7	0.0	0.7	0.5	0.5	0.7	1.5	4.7	0.0	0.0	0.3	0.2	0.5	0.0	0.1	413.1	16.3	1.7	0.7	1.8	0.0	1.2	0.0	0.5	3.9	0.0	0.5	0.0	0.7	0.4	0.1	3.8	0.0	1.1	0.0	0.0	0.0	1.4	408.9	11.1	0.3	0.0	1.0	0.0	1.7	0.0	2.0	0.8	0.0	0.1	6.4	0.0	0.2	0.7	0.1	39.1	0.2	6.6	3.2	1.4	25.9	2.6	0.0	0.1	0.0	0.1	3.4	0.0	0.2
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210506-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 197.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 386.6;Glandular and luminal cells: 283.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 230.0;hTCEpi: 263.6;SK-BR-3: 267.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA		34000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	29.3	7.2	2.7	54.4	2.7	44.1	32.2	3.4	3.6	29.0	10.0	134.7	41.1	105.9	21.7	58.2	45.2	37.4	14.7	2.3	2.9	19.3	10.1	41.0	49.6	6.4	3.5	7.3	20.8	15.3	5.7	25.6	3.4	55.2	69.0	13.4	34.2	197.1	5.1	23.2	47.5	147.6	3.2	30.0	52.1	39.9	4.3	33.5	66.4	8.9	51.3	87.1	41.1	3.0	115.9	24.0	27.0	0.2	11.7	29.7	62.3	58.9	28.9	10.9	10.6	60.4	126.2	0.0	230.0	41.7	1.3	116.9	14.4	87.3	26.4	57.3	46.0	11.5	53.1	30.5	69.9	53.6	0.2	66.4	263.6	37.7	95.0	74.9	31.1	0.0	11.9	39.5	3.0	24.4	0.2	0.7	17.8	134.0	67.4	0.2	0.4	46.0	110.9	44.0	12.4	113.4	85.5	267.1	68.2	77.6	0.3	21.5	52.3	0.6	1.5	86.2	0.7	92.6	48.9	1.3	7.4	27.2	89.3	274.7	79.2	221.5	150.2	132.1	144.7	104.6	113.4	137.6	86.9	95.5	111.0	127.6	41.6	205.1	170.5	20.7	130.4	162.8	2.7	2.7	3.4	3.6	2.3	2.9	6.4	3.5	3.4	3.2	4.3	3.0	40.8	243.6	47.0	0.0	60.4	200.4	196.2	64.8	60.3	2.2	62.2	57.0	16.1	47.1	81.7	36.8	12.5	23.2	121.3	140.8	21.5	110.7	386.6	176.7	29.9	49.0	50.6	17.7	0.1	112.3	78.1	23.6	84.1	283.9	18.9	54.1	25.7	11.9	15.4	1.7	0.1	100.7	34.6	58.0	119.0	112.5	1.8	78.0	28.4	10.3	77.6	24.7	201.8	0.0	0.3	196.8	112.1	0.4	76.3	102.4	65.3	13.6	68.1	13.9	6.6	9.0	42.3	19.1	10.6	55.9	122.7	29.1	79.2	8.8	79.7	135.9
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Vesicles, Plasma membrane"	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.5	0.1	0.6	1.7	0.2	1.1	0.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.5	0.4	0.2	0.2	0.1	0.5	0.5	0.3	0.1	0.0	0.2	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	27.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	6.3	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	7.9	0.0	3.3	0.3	0.0	0.4	0.1	0.1	0.3	0.2	1.2	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.1	0.6	0.4	0.5	0.5	0.5	0.5	0.5	0.5	0.8	4.4	0.0	0.0	2.9	5.7	0.9	1.8	0.7	2.8	0.6	4.7	7.2	1.3	5.7	1.5	1.8	0.0	1.6	0.7	0.1	0.0	0.0	23.3	0.4	0.2	1.5	0.0	0.0	2.2	0.0	1.0	0.7	0.5	1.8	1.3	0.2	1.4	0.8	3.7	0.0	2.2	0.5	2.0	0.6	2.3	6.4	0.3	4.6	3.6	2.8	0.0	0.6	1.0	1.0	3.0	0.1	0.0	0.4	4.3	0.7	0.0	0.1	0.2	1.3	0.0	1.2	1.5	56.4	16.2	1.7	0.1	1.1	0.7	0.0	0.0	0.4
TEX9		ENSG00000151575	"Testis expressed 9"	Q8N6V9	15	56244009-56445997	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.1;Endometrial ciliated cells: 86.2;Respiratory ciliated cells: 125.6;Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"basophil: 4.3;memory B-cell: 14.4;naive B-cell: 11.4"	"Group enriched"	"Detected in many"	12	"B-cells: 14.4;granulocytes: 4.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039415	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA039415: AB_10672775"	"unprognostic (3.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	1.8	6.1	4.1	4.6	3.9	3.4	10.1	7.4	3.9	8.8	17.0	3.6	11.6	5.2	8.4	4.4	28.0	5.2	1.1	3.2	4.2	10.8	1.5	4.4	6.0	9.4	8.6	5.4	5.4	14.2	9.9	1.6	4.5	4.5	4.8	18.0	10.5	3.4	1.2	5.6	8.0	2.2	5.3	3.2	12.2	16.4	6.6	3.7	17.4	1.5	10.6	2.7	1.6	5.7	7.8	7.1	15.3	13.7	3.7	10.8	2.0	1.7	6.3	4.8	5.7	1.7	6.9	15.5	7.0	1.2	8.2	6.6	6.6	7.4	5.5	1.7	7.8	9.1	6.7	5.2	1.1	3.3	1.3	5.9	13.3	5.4	4.1	6.9	0.2	11.1	5.2	1.4	2.6	4.5	6.5	1.2	7.2	13.2	3.0	2.6	7.1	5.5	15.9	4.4	24.3	9.8	8.7	4.9	5.5	11.2	14.6	3.0	0.7	20.3	5.8	6.5	6.4	2.1	16.5	11.7	8.0	1.7	3.9	4.3	0.1	0.1	0.4	0.6	0.1	14.4	0.4	0.3	0.2	11.4	0.2	0.8	0.3	0.4	0.4	0.4	0.6	0.7	4.1	3.9	7.4	3.9	3.2	4.2	9.4	8.6	4.5	5.3	6.6	5.7	1.5	6.4	7.5	38.8	21.0	4.2	7.3	13.2	20.5	6.4	11.3	11.7	0.8	5.7	23.5	11.0	12.5	1.8	0.3	2.3	21.5	15.6	89.1	86.2	5.1	3.2	7.7	5.9	14.3	7.0	0.5	5.0	17.3	4.8	1.3	5.1	1.8	0.4	1.3	1.7	20.4	3.7	16.2	0.0	2.1	40.9	4.7	2.7	3.6	4.7	1.2	6.8	1.0	14.6	15.1	4.5	5.4	3.8	15.8	3.7	12.3	21.7	125.6	37.5	0.0	4.6	6.0	74.6	36.6	6.9	2.3	0.3	1.0	6.2	6.7	4.9
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 713.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Basal respiratory cells: 63.6;Club cells: 18.8;Distal tubular cells: 29.4;Squamous epithelial cells: 34.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 30.8;head and neck cancer: 78.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.5;HaCaT: 24.2;HeLa: 16.2;MCF7: 17.5;SK-BR-3: 21.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171, HPA070372"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		530000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869, HPA070372: "	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	25.7	1.3	0.6	0.9	0.8	0.7	2.2	3.7	2.0	78.7	0.8	1.4	0.8	1.0	1.6	713.5	4.4	0.6	5.1	0.5	0.6	2.5	1.7	5.3	1.5	1.5	0.9	3.0	3.2	0.2	3.3	1.2	1.4	4.1	0.9	1.7	89.7	4.4	1.1	73.2	1.9	0.5	0.4	2.6	1.8	2.9	0.9	1.3	2.7	0.3	40.4	1.3	144.2	0.9	1.1	2.0	1.1	1.0	0.0	0.8	17.5	0.4	0.2	1.0	1.6	1.2	1.7	1.0	2.3	1.3	0.3	24.2	2.8	2.0	0.6	2.0	3.3	1.4	16.2	5.7	0.8	0.9	1.5	1.5	9.3	0.5	2.0	0.5	0.7	3.4	1.0	1.0	0.7	17.5	0.7	1.9	0.3	1.1	2.2	1.1	0.1	1.1	0.6	2.1	1.2	1.6	0.2	21.7	0.1	1.4	1.5	1.1	0.8	1.1	4.8	2.0	0.9	1.5	1.8	0.3	0.4	2.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	3.7	2.0	0.5	0.6	1.5	0.9	1.4	0.4	0.9	0.9	0.2	12.8	1.1	2.0	0.0	0.3	4.6	63.6	4.0	0.9	1.1	0.8	0.8	5.7	18.8	0.0	0.0	1.4	0.3	0.2	29.4	2.0	0.1	0.3	0.2	0.2	0.0	0.0	1.5	0.9	0.8	3.9	0.0	0.6	4.5	0.7	0.0	0.2	0.4	0.0	1.7	0.1	6.1	0.6	0.3	0.0	0.6	0.4	0.0	1.0	0.4	0.2	0.0	1.0	1.0	2.6	0.0	0.4	0.1	7.4	0.1	0.2	2.1	0.6	0.0	0.1	1.0	0.0	0.6	34.7	1.8	1.2	0.6	1.2	0.3	6.2
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127385-38166578	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 432.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 204.5;Cytotrophoblasts: 311.1;Ductal cells: 226.7;Endometrial stromal cells: 459.1;Hepatic stellate cells: 408.0;Hepatocytes: 205.7;Pancreatic endocrine cells: 326.5;Syncytiotrophoblasts: 374.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 1546.7;EFO-21: 505.5;hTERT-RPE1: 994.3;HUVEC TERT2: 695.3;TIME: 924.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	Yes	No		1700000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	105.9	45.1	23.0	68.4	22.3	3.2	30.3	22.9	29.5	432.0	53.0	30.6	29.8	266.3	28.3	37.3	217.7	127.7	394.9	21.4	23.0	76.7	244.1	288.5	18.0	25.4	22.5	40.6	25.6	19.3	95.9	234.3	26.0	88.7	20.8	2.1	9.8	56.6	63.9	4.0	63.7	159.0	24.4	32.7	62.3	3.9	30.6	15.4	36.3	33.4	10.3	154.2	87.8	24.8	65.0	47.5	0.2	1.8	47.3	5.1	24.0	95.5	45.2	0.7	1.8	78.4	1546.7	0.1	505.5	1.0	105.4	1.7	0.1	221.7	3.4	0.7	0.2	10.3	2.6	35.0	191.9	0.0	0.5	5.2	0.4	40.2	0.3	994.3	695.3	0.0	21.4	0.1	16.0	0.3	0.0	0.6	0.8	0.9	4.6	0.0	0.1	0.3	69.0	0.0	0.0	1.3	224.4	0.2	7.6	31.6	2.2	0.6	924.2	1.6	57.6	7.8	46.3	0.0	0.6	0.8	60.7	0.1	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	22.3	22.9	29.5	21.4	23.0	25.4	22.5	26.0	24.4	30.6	24.8	58.0	9.6	18.3	0.0	7.4	0.5	10.4	41.0	0.6	0.0	8.5	8.8	204.5	31.5	55.3	14.7	2.1	311.1	0.1	11.7	3.9	226.7	3.2	16.7	459.1	183.8	0.0	74.5	0.1	145.7	38.6	37.7	0.5	13.1	2.5	2.8	408.0	205.7	54.4	0.0	0.1	1.8	6.1	23.7	2.1	5.0	1.2	35.5	0.0	28.1	6.5	0.4	0.0	0.0	0.3	326.5	1.1	6.0	0.0	68.6	63.0	27.6	23.6	0.5	0.0	5.2	49.1	0.4	4.0	0.9	0.0	374.2	3.9	2.1	3.3	26.4
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 279.5;Granulosa cells: 228.3;Macrophages: 598.0;Smooth muscle cells: 283.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 2610.2;HUVEC TERT2: 2494.4;LHCN-M2: 1863.4;TIME: 3552.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 20.6"	"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA	16000000000	1400000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: AB_2684121"	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (8.47e-5)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	364.3	72.5	1.7	394.0	3.7	114.7	95.1	2.1	11.3	66.7	27.3	166.4	24.8	161.3	3.5	49.1	142.6	275.2	98.3	2.2	2.1	70.9	129.4	309.2	32.3	10.8	4.4	76.3	69.1	7.0	26.8	99.0	10.8	89.8	85.6	0.4	137.3	12.0	16.2	35.4	83.5	243.6	0.9	79.8	150.5	2.2	14.3	12.0	34.0	4.3	7.1	396.3	36.2	2.1	171.9	62.7	49.0	17.8	199.4	233.9	0.7	1025.7	861.6	283.6	185.5	185.0	135.7	1.0	348.4	2610.2	54.4	621.0	2.2	516.1	145.0	43.4	0.5	46.6	35.0	46.9	44.4	0.3	13.2	524.9	37.2	237.2	535.1	1123.6	2494.4	1.6	1.5	1.7	1863.4	14.7	0.8	3.6	8.9	17.7	20.3	0.7	125.7	1.3	430.6	472.6	0.6	0.4	300.7	16.4	18.5	60.8	178.6	3.3	3552.9	972.6	221.0	1141.1	1146.6	2.4	1.8	2.0	33.0	0.8	1064.4	0.3	8.7	15.7	0.7	0.8	2.7	0.0	0.4	0.5	0.5	0.1	0.1	0.1	1.5	7.8	0.1	0.4	0.0	10.5	1.7	3.7	2.1	11.3	2.2	2.1	10.8	4.4	10.8	0.9	14.3	2.1	19.0	25.6	19.6	0.7	4.9	95.7	131.2	37.6	181.6	0.1	66.8	69.8	48.7	18.6	19.9	69.9	6.2	1.9	8.2	144.5	0.0	52.1	0.2	64.9	127.7	79.2	3.6	0.0	0.9	127.5	2.5	279.5	15.8	38.2	162.7	228.3	44.6	7.4	6.3	0.0	1.3	46.4	48.8	105.9	97.9	0.3	1.8	598.0	39.2	13.1	5.9	0.1	3.1	0.0	0.1	183.9	55.1	0.4	5.9	79.2	8.5	48.3	11.9	1.5	6.6	59.0	283.8	0.2	0.3	51.8	51.0	2.1	19.5	10.8	67.8	42.1
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 86.8;Endometrial stromal cells: 71.1;Fibroblasts: 127.7;Langerhans cells: 69.8;Melanocytes: 56.9;Oligodendrocyte precursor cells: 40.7;Oligodendrocytes: 55.8;Smooth muscle cells: 33.7;Suprabasal keratinocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 250.2;ASC TERT1: 200.3;BJ hTERT+: 88.6;BJ hTERT+ SV40 Large T+: 96.3;BJ hTERT+ SV40 Large T+ RasG12V: 117.8;HSkMC: 113.2;hTEC/SVTERT24-B: 127.2;U-2197: 107.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		21000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	52.9	7.9	5.5	14.8	15.4	0.0	36.2	10.9	7.7	63.1	0.2	20.4	2.5	50.0	0.7	12.0	34.7	50.4	44.2	6.5	13.1	8.3	8.2	19.8	3.3	17.1	18.2	33.2	5.6	1.7	9.5	2.2	21.4	9.7	2.4	0.1	8.2	2.5	3.4	41.1	9.2	21.3	11.3	3.3	5.4	2.3	15.0	0.6	17.0	1.8	1.2	29.1	30.8	19.3	0.2	0.0	2.5	1.1	250.2	200.3	0.0	76.8	88.6	96.3	117.8	0.4	0.0	0.1	0.1	76.1	0.2	0.1	2.4	3.2	22.5	0.0	0.0	0.0	0.0	0.0	73.1	0.3	0.0	113.2	0.0	127.2	0.0	0.2	0.0	0.0	0.0	0.1	3.7	0.0	0.1	1.7	16.3	0.0	0.6	0.0	0.1	1.1	0.0	0.4	0.3	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.0	46.1	0.4	107.6	9.3	0.1	0.7	0.0	30.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	15.4	10.9	7.7	6.5	13.1	17.1	18.2	21.4	11.3	15.0	19.3	3.5	6.4	0.0	6.8	0.0	86.8	1.6	0.1	1.8	0.4	2.2	1.8	5.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.2	3.1	71.1	4.6	0.0	0.0	1.2	0.0	0.0	127.7	1.1	1.4	0.0	0.0	15.4	0.0	0.3	0.0	1.7	0.0	0.0	0.0	69.8	0.3	8.1	1.2	56.9	6.5	0.0	0.2	0.0	40.7	55.8	0.5	0.0	16.1	0.0	1.9	0.0	4.4	0.0	0.2	0.0	1.0	33.7	0.0	0.4	1.2	42.3	0.1	2.1	5.5	0.0	0.9
THEGL		ENSG00000249693	"Theg spermatid protein like"	P0DJG4	4	56530606-56603507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 27.3;Late spermatids: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA066627, HPA068093"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA066627: , HPA068093: AB_2685951"	"unprognostic (4.33e-2)"	"unprognostic (2.88e-3)"		"unprognostic (7.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.69e-2)"		"unprognostic (3.26e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.41e-2)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.5	0.0	0.1	0.1	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.3	0.0	0.0	0.1	0.0	1.3	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	20.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119415476-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 286.8;smooth muscle: 304.7;urinary bladder: 216.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.6;Excitatory neurons: 116.0;Fibroblasts: 201.9;Inhibitory neurons: 104.1;Muller glia cells: 108.1;Proximal tubular cells: 199.9;Smooth muscle cells: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 461.3;BJ: 738.4;BJ hTERT+: 832.5;fHDF/TERT166: 1330.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	90.6	16.4	97.9	78.6	114.8	0.2	25.6	12.9	286.8	78.9	0.0	35.4	10.2	58.6	27.8	29.4	23.1	101.0	12.9	135.4	73.3	142.2	7.4	21.6	40.4	83.6	37.0	9.2	14.8	39.4	18.1	62.0	60.8	15.5	41.8	25.3	8.5	47.0	3.4	13.9	14.5	304.7	35.4	21.9	17.4	11.4	43.6	73.2	37.9	8.3	35.6	216.7	21.7	108.7	0.7	3.9	108.5	0.1	461.3	331.5	0.3	738.4	832.5	263.6	289.3	0.2	0.2	0.4	0.1	1330.6	121.9	0.9	4.3	1.1	200.7	65.1	0.0	41.5	14.4	0.0	142.7	0.0	0.2	247.5	0.0	335.6	11.6	355.2	0.3	22.6	0.0	0.6	206.5	0.1	0.6	0.1	173.9	0.0	1.4	0.5	50.7	0.3	0.1	0.2	18.1	47.9	0.1	0.4	0.2	32.9	1.0	2.1	0.0	368.6	120.9	107.3	110.1	0.3	19.7	0.4	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.9	114.8	12.9	286.8	135.4	73.3	83.6	37.0	60.8	35.4	43.6	108.7	68.2	0.0	1.8	17.3	2.1	17.7	0.3	1.7	0.0	27.2	1.6	40.0	0.9	0.0	0.0	9.2	0.0	1.9	0.2	0.0	21.5	0.9	1.0	5.1	141.6	69.2	0.0	0.0	116.0	0.0	2.6	201.9	1.5	3.2	1.3	0.0	17.5	0.1	4.0	32.0	104.1	0.0	0.0	0.0	25.0	2.7	96.3	2.7	17.8	21.5	0.0	108.1	0.0	64.3	22.7	0.4	0.0	77.5	0.1	0.3	0.0	199.9	0.0	27.5	32.9	9.3	226.6	0.3	0.6	0.2	17.6	4.0	4.5	6.2	0.0	0.6
TIMD4	TIM4	ENSG00000145850	"T cell immunoglobulin and mucin domain containing 4"	Q96H15	5	156919292-156963226	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 55.3;testis: 144.0"	"Group enriched"	"Detected in some"	23	"Early spermatids: 1336.2;Late spermatids: 1946.7"	"Cancer enriched"	"Detected in some"	10	"renal cancer: 6.2"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.6;naive CD8 T-cell: 1.6;T-reg: 4.0"	"Lineage enriched"	"Detected in single"	18	"T-cells: 4.0"	"Group enriched"	"Detected in some"	18	"U-266/70: 96.7;U-266/84: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015625, CAB026027"	Approved		Approved	"Plasma membrane"		NA	NA		32000000	"Cluster 35: T-regs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"CAB026027: , HPA015625: AB_1858018"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.08e-2)"	14.9	0.4	0.4	6.9	0.3	16.1	0.4	0.3	1.4	0.1	1.8	1.1	0.4	0.0	1.3	0.1	0.1	1.3	0.7	0.5	0.4	3.4	16.3	1.6	55.3	0.5	0.4	0.0	0.2	0.1	0.0	5.0	0.5	0.3	0.8	0.0	0.2	0.0	0.1	0.3	1.7	1.0	0.3	8.0	0.2	144.0	0.5	22.4	1.1	0.0	17.4	4.8	0.1	0.5	0.1	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	96.7	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.3	2.4	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	4.0	0.7	0.4	0.3	0.3	1.4	0.5	0.4	0.5	0.4	0.5	0.3	0.5	0.5	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.4	5.9	0.1	1336.2	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.7	0.1	0.5	0.0	0.0	0.0	0.7	0.3	46.4	0.0	0.3	0.0	0.0	69.4	1.9	1946.7	14.9	1.9	0.0	2.8	0.0	0.0	1.0	0.0	0.3	0.0	0.0	10.9	6.5	0.0	0.0	0.8	0.0	0.0	13.1	0.0	0.1	16.6	8.1	0.0	0.0	0.3	1.7	0.1	0.1	0.0
TM2D2	BLP1	ENSG00000169490	"TM2 domain containing 2"	Q9BX73	8	38988808-38996824	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 218.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047152, HPA050547"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA047152: AB_2679957, HPA050547: AB_2681168"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (2.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-2)"	"unprognostic (8.61e-2)"	20.2	24.4	15.6	15.9	17.3	13.1	19.8	18.2	22.2	19.7	24.4	15.7	18.0	18.4	26.5	16.5	17.4	23.1	19.5	17.5	18.6	32.9	29.8	20.6	17.7	16.5	17.4	22.0	13.9	23.6	15.9	33.8	17.6	22.2	16.3	17.1	17.8	22.1	15.6	18.5	16.2	17.8	17.2	22.3	19.6	27.6	18.0	11.8	26.4	17.6	15.2	20.0	16.6	19.7	35.7	56.5	25.7	35.7	58.8	39.0	35.4	73.8	44.9	54.6	49.1	43.4	30.0	12.5	56.7	54.9	61.5	37.8	27.5	44.5	59.0	15.0	21.7	28.6	32.3	47.3	51.8	8.6	35.3	47.9	42.8	43.1	20.9	40.0	71.1	21.2	32.2	35.7	73.5	22.1	21.3	28.9	32.6	53.2	22.0	17.8	33.2	21.0	62.2	27.9	8.6	16.9	28.2	19.5	37.8	45.1	48.1	17.9	64.6	44.0	33.0	64.9	37.7	24.9	59.1	21.9	33.6	19.4	31.6	64.5	28.5	27.3	29.7	34.2	33.3	24.9	35.1	33.0	30.4	26.2	33.1	32.0	7.9	33.0	29.8	60.5	41.8	35.3	15.6	17.3	18.2	22.2	17.5	18.6	16.5	17.4	17.6	17.2	18.0	19.7	30.4	12.8	14.7	3.9	13.8	35.1	56.9	64.3	20.5	25.1	22.5	25.1	17.7	32.9	44.5	51.5	20.9	91.3	28.2	12.9	29.4	59.9	62.2	24.1	33.3	36.0	10.3	5.9	7.6	38.4	98.2	38.6	17.3	25.8	22.2	44.3	58.2	38.4	218.5	23.5	9.2	12.6	40.7	33.6	33.9	46.6	36.1	40.6	26.6	7.5	70.8	45.4	15.5	6.0	5.4	74.9	19.4	24.8	14.5	52.5	35.1	61.4	29.4	34.0	0.0	25.4	26.5	60.8	58.1	16.3	15.5	79.9	17.8	39.3	16.7	48.5
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149474697-149503394	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 945.8;intestine: 650.8;liver: 703.8"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 2070.3;Hepatocytes: 578.1"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	1.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.0	650.8	0.6	2.3	0.7	0.5	945.8	0.3	0.0	0.0	0.8	703.8	0.3	0.8	0.0	0.0	0.0	72.5	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	514.8	0.9	0.0	0.1	21.3	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.6	0.3	0.2	4.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.8	0.1	20.3	0.0	0.0	0.5	1.4	36.5	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.1	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	4.1	2070.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	25.9	1.1	3.1	0.3	0.6	3.0	13.5	0.1	2.0	0.2	0.1	10.7	3.3	0.0	0.0	7.1	578.1	0.1	0.0	0.1	41.6	0.0	11.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	8.2	17.5	0.0	0.3	0.0	76.6	4.8	0.1	0.0	0.0	0.0	0.7	4.1	0.3	0.0	0.0	0.1	0.5	5.6	2.0	0.2
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.4;stomach 1: 46.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 282.4;Pancreatic endocrine cells: 302.2;Proximal enterocytes: 374.3;Respiratory ciliated cells: 624.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 69.7;OE19: 41.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Nucleoplasm	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.6	0.1	0.2	3.1	0.4	1.5	12.7	0.5	0.3	8.9	5.6	21.6	45.4	2.1	17.5	1.2	5.1	25.5	0.1	0.3	0.0	0.3	0.6	18.9	0.2	0.2	0.2	0.1	2.3	6.0	0.1	3.2	0.2	12.2	22.7	0.2	22.8	0.2	0.1	1.8	53.4	1.1	0.0	0.1	46.0	3.8	0.2	0.1	0.7	0.0	1.1	3.2	0.5	0.2	6.9	10.8	0.0	0.3	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.1	69.7	0.0	0.3	0.0	0.2	4.4	1.1	0.0	0.0	0.1	0.1	0.0	1.8	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.1	0.0	0.2	2.5	41.5	3.1	0.0	0.0	2.6	0.1	0.3	0.7	0.2	0.1	2.1	0.0	1.1	0.9	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.1	157.0	162.5	0.0	1.8	0.8	22.9	46.6	2.8	0.3	57.4	17.9	0.9	102.9	282.4	22.0	2.1	39.0	1.0	173.7	0.0	121.1	32.8	107.0	6.9	2.9	38.9	8.0	1.9	166.3	3.4	3.3	188.1	88.4	5.7	11.0	0.7	0.6	2.7	3.3	2.0	101.5	26.4	0.0	1.1	32.6	0.3	1.8	1.8	0.0	1.0	0.2	0.0	0.5	0.9	302.2	180.9	0.7	0.5	103.1	374.3	2.0	624.7	1.9	0.0	0.4	9.5	1.3	1.1	2.2	1.7	16.3	1.3	1.5	125.1	55.9
TMED8	FAM15B	ENSG00000100580	"Transmembrane p24 trafficking protein family member 8"	Q6PL24	14	77335029-77377094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 62.7;Cone photoreceptor cells: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001205	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Vesicles	"HPA001205: AB_2204460"	"unprognostic (1.07e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.77e-1)"	5.5	8.3	8.2	8.6	9.6	7.7	5.7	4.7	8.4	5.9	4.1	4.4	3.3	6.7	5.1	3.6	5.4	4.1	3.4	7.5	16.6	10.4	3.4	4.6	17.5	7.9	10.5	7.3	5.6	11.1	9.2	4.4	11.2	5.9	4.8	24.2	4.4	5.9	2.3	4.9	5.5	5.6	6.9	8.0	6.2	6.8	12.8	9.8	10.9	2.4	19.5	4.7	3.5	5.9	14.7	12.0	13.9	12.4	8.5	7.6	11.8	9.2	6.0	9.4	10.1	7.5	8.1	58.7	7.5	7.5	7.7	10.0	10.4	10.5	14.6	18.6	6.3	19.6	9.5	7.9	5.9	9.6	51.8	8.0	7.4	12.3	11.0	9.5	13.5	47.7	10.1	15.4	9.5	14.4	15.2	14.2	6.9	10.7	12.0	12.2	12.7	4.7	9.9	9.0	17.2	10.4	15.9	9.4	11.8	10.6	15.2	15.9	9.7	9.7	6.2	17.5	10.7	12.3	25.2	28.9	11.1	17.7	14.3	2.3	0.7	2.2	0.3	0.9	0.4	2.1	0.5	0.4	0.6	2.1	0.3	0.5	1.0	0.5	0.8	1.0	0.7	0.5	8.2	9.6	4.7	8.4	7.5	16.6	7.9	10.5	11.2	6.9	12.8	5.9	6.6	3.2	7.8	62.7	33.9	6.6	4.9	7.7	2.8	33.4	12.5	8.3	16.8	8.6	5.3	22.0	108.4	10.5	7.9	6.5	5.9	6.4	4.8	9.8	15.5	10.4	44.3	15.4	44.7	4.7	10.0	8.4	7.1	9.0	0.0	9.1	8.9	9.8	7.8	28.6	40.7	6.3	10.2	24.8	7.7	6.9	14.6	19.8	5.4	21.5	16.8	14.9	6.2	39.7	24.2	6.8	3.3	14.3	19.9	7.5	3.2	22.2	20.9	39.3	13.1	7.1	8.4	6.8	15.7	8.2	8.9	4.1	10.3	19.8	6.7	4.3
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 237.2;Glandular and luminal cells: 507.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039739, HPA075651"			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA039739: AB_2676657, HPA075651: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	17.2	19.8	22.6	12.9	26.8	11.5	107.0	23.2	24.0	44.4	24.2	20.6	16.9	63.5	27.6	28.0	37.9	15.9	23.1	22.2	22.7	93.9	24.1	18.7	19.4	24.2	24.0	22.7	39.2	26.4	15.4	21.6	23.2	24.0	16.9	12.1	30.1	111.8	33.3	29.0	17.4	16.1	23.5	20.4	28.8	23.6	23.9	16.5	23.0	24.9	17.7	20.4	23.0	23.4	23.5	56.0	19.7	16.2	45.7	43.9	19.6	24.1	36.1	46.5	43.8	42.0	59.5	26.1	6.5	24.9	36.0	35.3	22.9	41.5	35.2	28.5	46.1	19.5	45.7	86.2	39.3	31.7	32.8	39.4	46.5	32.8	46.3	41.8	40.8	45.0	40.7	50.1	29.2	31.7	34.6	36.6	9.1	25.4	62.6	29.8	42.8	47.4	39.1	18.7	25.3	20.2	14.6	0.5	59.6	24.9	27.3	59.9	24.7	42.1	28.5	18.8	46.9	52.1	38.0	12.0	44.3	29.7	38.2	20.1	42.8	15.3	31.2	43.4	35.7	37.3	39.6	36.4	44.9	39.8	43.2	35.7	15.9	44.1	32.9	44.0	44.6	31.1	22.6	26.8	23.2	24.0	22.2	22.7	24.2	24.0	23.2	23.5	23.9	23.4	22.1	19.2	15.4	0.0	22.8	20.6	31.6	72.0	21.6	10.4	64.2	61.2	27.3	24.3	34.5	40.5	6.2	68.5	19.6	18.5	37.2	36.6	13.1	237.2	70.8	28.2	23.4	33.2	0.0	49.8	47.3	21.1	13.7	507.4	22.9	34.4	36.0	20.6	37.6	11.8	0.0	37.3	28.5	32.4	11.8	11.1	13.1	23.8	33.8	0.0	47.7	17.7	29.9	0.0	0.0	41.8	20.7	12.4	29.4	23.4	27.7	30.2	27.1	11.7	6.6	13.2	19.8	45.8	24.7	26.9	22.6	44.6	20.9	25.6	45.7	25.2
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397775	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.2;skeletal muscle: 23.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 209.9;Excitatory neurons: 357.3;Inhibitory neurons: 475.3;Oligodendrocyte precursor cells: 480.0"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 24.2;LHCN-M2: 13.8;SCLC-21H: 21.0;SH-SY5Y: 92.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		55000		"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: AB_2684993"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	1.4	11.3	6.3	1.5	9.6	0.2	1.5	3.4	10.0	2.0	3.2	1.5	0.4	2.4	0.6	9.6	1.7	0.8	6.8	9.6	2.9	0.4	0.1	11.0	1.7	0.0	4.1	0.3	0.3	3.0	2.2	2.4	4.0	1.0	1.3	35.2	1.3	2.0	23.1	1.4	1.6	5.5	0.0	1.3	1.3	13.9	7.9	1.3	3.1	7.0	2.3	8.3	0.8	0.8	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.7	1.0	1.8	8.5	0.0	0.0	0.0	0.0	24.2	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	13.8	0.7	0.1	0.3	3.8	0.0	0.0	0.0	4.8	0.1	1.1	0.0	21.0	92.6	0.0	0.1	0.3	5.5	0.2	0.0	0.0	0.1	0.1	0.0	3.4	1.3	0.0	0.7	1.8	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.6	3.4	10.0	9.6	2.9	0.0	4.1	4.0	0.0	7.9	0.8	0.6	3.2	4.6	209.9	0.0	2.4	0.5	0.2	0.0	10.4	1.3	2.8	1.7	1.5	5.0	0.0	102.2	1.8	0.0	0.0	0.0	0.0	80.6	1.0	0.6	1.3	0.0	0.0	357.3	0.4	8.6	4.6	4.1	0.2	1.3	5.5	0.4	0.0	0.3	1.7	475.3	0.0	0.0	0.0	0.8	38.2	0.9	0.1	0.0	33.7	0.0	5.7	0.0	480.0	22.2	0.3	0.0	0.7	1.2	0.2	0.0	0.0	0.0	57.6	0.0	6.8	3.3	17.2	11.2	0.0	1.6	1.1	1.0	4.9	0.0	0.4
TMEM121B	CECR6	ENSG00000183307	"Transmembrane protein 121B"	Q9BXQ6	22	17116297-17121367	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;prostate: 6.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hofbauer cells: 2.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 1.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;SCLC-21H: 14.2;THP-1: 11.9;U-937: 9.8"	"Low region specificity"	"Detected in all"							HPA068790	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA068790: AB_2686036"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.49e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.88e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.10e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.71e-1)"	0.3	0.6	6.4	0.9	7.5	1.0	0.7	3.5	7.6	0.2	1.5	0.2	0.2	0.3	0.9	0.3	0.3	0.2	1.2	8.7	3.9	0.3	0.1	0.3	0.1	3.8	3.3	0.2	1.1	0.1	1.6	0.7	3.3	6.6	0.2	1.3	0.4	0.2	1.3	0.5	0.2	0.3	3.6	0.7	0.2	1.9	4.9	0.1	0.1	0.4	0.1	0.3	0.2	5.1	0.0	0.0	6.0	0.8	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.1	0.3	0.0	0.8	3.2	2.1	0.0	0.1	0.2	3.0	0.0	0.3	0.1	14.2	2.1	0.0	0.0	0.3	0.8	0.0	11.9	0.6	0.6	0.2	0.2	0.0	0.2	0.4	0.9	0.0	9.8	0.3	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	6.4	7.5	3.5	7.6	8.7	3.9	3.8	3.3	3.3	3.6	4.9	5.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	1.3	0.9	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.8;kidney: 32.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 51.5;Ductal cells: 49.0;Proximal enterocytes: 90.7;Proximal tubular cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.4;CAPAN-2: 40.8;EFO-21: 27.9;RPTEC TERT1: 70.5;SK-BR-3: 25.0;T-47d: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.1	2.7	1.9	2.2	6.4	0.0	3.2	6.6	3.2	8.9	2.9	5.7	33.8	1.2	1.3	0.4	6.8	7.2	3.3	1.6	4.1	32.2	9.2	5.1	0.2	10.5	6.9	0.4	8.7	6.8	1.8	5.2	8.9	0.9	4.5	0.8	4.8	3.1	0.1	1.2	19.3	0.4	5.9	0.9	2.5	3.8	5.7	0.0	7.2	0.0	0.1	1.8	0.3	13.9	22.4	1.6	0.3	0.1	0.0	0.0	14.3	0.2	0.0	0.0	0.0	5.2	40.8	0.3	27.9	0.0	1.8	18.5	0.0	9.3	0.0	0.3	0.0	0.0	2.4	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	0.0	1.3	0.0	0.5	0.0	1.5	1.6	1.0	0.0	0.5	1.6	0.4	0.3	0.0	70.5	5.6	0.4	0.1	1.1	25.0	0.2	0.5	68.5	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.6	0.1	1.9	6.4	6.6	3.2	1.6	4.1	10.5	6.9	8.9	5.9	5.7	13.9	0.6	16.0	5.9	0.7	0.2	0.1	2.1	2.8	0.0	0.2	8.2	15.5	2.3	27.1	5.4	51.5	0.0	30.5	0.2	28.9	35.2	49.0	14.8	16.2	1.6	0.7	3.6	0.0	0.0	4.7	5.2	0.4	3.1	17.9	0.0	2.2	1.4	16.2	1.9	0.0	0.2	6.7	0.0	0.6	0.3	13.6	0.0	0.7	5.4	0.0	1.1	7.7	0.0	0.0	5.2	30.6	23.3	0.0	0.0	1.2	90.7	89.1	3.8	0.1	0.0	0.0	0.9	0.1	0.2	0.6	0.0	6.4	0.8	0.7	12.9	1.4
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 1656.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1171.9;monocytes: 502.3;Paneth cells: 762.4;Proximal enterocytes: 922.5;Proximal tubular cells: 976.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 865.5;intermediate monocyte: 586.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 865.5"	"Group enriched"	"Detected in some"	17	"HSkMC: 642.7;THP-1: 215.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA047509: AB_2680072"	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	120.9	49.5	48.5	190.8	50.1	13.5	77.8	50.7	65.8	74.5	43.0	251.8	167.7	25.9	25.7	50.4	81.5	197.3	208.5	45.4	58.0	356.5	1656.5	95.6	177.5	69.2	60.1	143.1	53.6	7.3	22.7	115.0	64.5	48.9	244.9	34.1	42.5	28.3	11.0	34.7	286.6	99.0	65.0	87.0	94.5	11.1	52.2	26.1	33.6	36.1	93.7	158.6	92.4	73.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	25.7	0.4	0.8	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.6	0.8	0.2	642.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.1	0.9	0.5	0.1	0.0	0.1	1.0	11.8	0.1	0.0	1.9	1.4	0.6	0.3	0.2	0.2	0.0	215.7	0.0	0.0	3.2	0.5	0.2	0.4	0.2	0.6	0.0	0.3	0.0	5.3	865.5	50.5	2.3	586.0	3.4	2.5	0.6	0.7	164.3	0.6	0.7	0.4	8.6	0.6	309.3	7.7	0.6	498.5	48.5	50.1	50.7	65.8	45.4	58.0	69.2	60.1	64.5	65.0	52.2	73.2	22.2	3.2	9.3	14.4	16.9	12.6	0.5	0.9	5.7	156.9	52.2	74.0	73.7	190.1	14.4	375.2	2.1	0.9	2.8	419.4	166.3	95.1	18.5	6.1	14.5	19.8	128.1	13.5	0.1	34.0	1.0	243.7	14.8	2.1	54.4	61.9	22.9	1171.9	92.5	6.7	0.6	252.1	46.8	98.5	44.4	12.2	43.5	190.0	16.0	8.4	502.3	87.3	1.0	7.5	0.1	65.4	762.4	3.4	1.5	2.5	922.5	976.5	11.3	17.9	0.0	6.7	34.0	4.0	3.8	1.8	15.6	2.7	9.1	0.4	263.7	2.8
TMEM183A	C1orf37	ENSG00000163444	"Transmembrane protein 183A"	Q8IXX5	1	203007374-203024848	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072607			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA072607: AB_2686539"	"unprognostic (2.94e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (6.46e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.28e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.01e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	21.6	19.1	27.6	17.0	28.8	76.6	22.1	28.2	35.1	22.9	23.8	30.9	26.6	19.8	18.8	30.3	19.4	14.1	17.0	30.1	30.1	22.8	23.9	21.0	21.7	26.7	25.8	20.1	28.7	17.8	12.2	14.4	27.7	21.2	30.2	21.8	25.4	16.4	14.8	27.5	26.1	19.9	23.7	22.2	25.2	34.1	26.7	30.0	22.2	12.7	24.1	23.4	22.9	27.0	32.7	31.2	39.2	64.6	50.6	37.7	64.4	32.2	31.7	36.4	31.7	38.1	33.6	81.1	22.6	41.7	14.6	40.4	53.1	45.1	30.1	26.6	64.5	40.2	33.8	42.3	36.6	72.6	33.9	37.3	49.3	30.1	60.2	36.8	46.6	64.4	83.8	28.7	34.5	73.3	59.7	74.4	107.7	44.0	49.2	45.4	66.7	65.7	57.0	31.6	50.2	62.7	48.0	79.0	48.1	61.9	56.6	56.6	34.8	24.4	34.2	42.3	35.7	28.8	49.7	62.4	27.0	55.7	26.3	33.3	33.6	51.2	23.5	29.2	23.1	23.8	26.3	26.6	37.4	26.2	29.8	24.7	28.7	36.6	27.8	26.8	30.6	37.4	27.6	28.8	28.2	35.1	30.1	30.1	26.7	25.8	27.7	23.7	26.7	27.0	39.7	16.0	20.5	3.6	40.4	73.4	61.5	62.2	41.5	22.8	62.2	48.6	14.9	54.3	52.1	35.0	10.4	53.2	57.3	70.4	70.5	88.6	161.1	31.1	34.9	36.2	52.7	103.7	13.2	76.1	86.0	34.8	42.3	34.4	17.7	34.6	40.7	53.6	60.4	18.5	11.8	87.5	63.1	63.1	52.0	113.7	27.1	49.7	39.2	6.5	71.1	26.6	50.4	3.5	7.2	52.7	57.6	29.3	62.1	100.2	102.3	100.4	44.5	28.0	19.7	38.3	46.7	95.0	80.9	72.9	82.1	51.6	48.3	39.6	88.6	105.2
TMEM218		ENSG00000150433	"Transmembrane protein 218"	A2RU14	11	125096545-125111763	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038489	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"HPA038489: AB_10672748"	"unprognostic (3.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.63e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.95e-2)"	"prognostic favorable (5.50e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.72e-2)"	17.7	18.1	4.8	9.5	5.5	5.3	14.0	5.3	6.5	15.5	5.3	13.5	8.4	16.6	6.9	11.6	14.8	7.4	10.2	4.6	5.4	12.7	12.9	12.0	10.5	6.0	5.5	15.0	14.5	10.3	15.2	5.9	5.8	13.0	6.0	6.5	10.9	6.8	9.2	8.9	11.8	8.3	5.7	16.6	13.2	5.6	5.1	8.4	10.9	5.7	7.0	13.8	13.2	6.3	12.5	24.0	14.9	18.2	13.5	18.6	9.0	12.2	9.2	9.3	12.0	2.5	35.9	15.6	29.9	7.5	14.2	14.2	9.4	11.6	12.2	22.0	13.5	35.1	6.1	10.0	13.3	11.1	12.6	14.7	15.2	16.5	19.6	14.9	13.7	19.1	14.4	19.4	16.2	6.4	2.9	23.3	12.2	34.0	22.6	16.3	18.0	12.0	8.3	12.3	12.9	19.4	16.6	6.6	9.1	8.7	31.3	15.7	17.6	11.4	10.3	13.4	13.5	11.1	10.1	12.9	9.1	22.9	20.3	43.7	40.1	17.4	21.6	31.6	18.7	29.6	20.5	20.5	47.4	23.9	17.2	20.4	15.7	32.5	30.9	41.1	20.5	27.0	4.8	5.5	5.3	6.5	4.6	5.4	6.0	5.5	5.8	5.7	5.1	6.3	21.0	19.2	13.4	7.8	17.8	12.1	19.6	34.6	19.4	7.0	22.1	24.6	8.1	15.7	16.6	14.7	0.0	28.0	18.1	5.7	27.4	20.5	3.4	23.1	22.4	15.8	10.8	14.5	4.4	16.2	18.4	21.1	8.6	10.6	3.8	22.2	18.5	15.1	42.2	23.5	7.4	11.7	20.3	21.0	17.5	1.9	10.2	21.9	17.8	14.0	26.0	26.0	18.6	9.5	11.2	13.1	3.9	16.6	15.8	9.4	8.5	19.7	29.4	12.4	26.3	16.7	18.3	16.6	13.8	18.0	14.2	9.7	14.5	27.0	13.7	16.6
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA016579: AB_2669392, HPA059374: AB_2683995"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	26.6	38.2	61.9	13.0	60.1	23.8	27.1	58.7	76.8	25.1	57.4	26.9	15.0	28.1	24.4	36.1	29.6	19.2	34.5	61.2	65.4	32.8	49.4	22.4	16.1	61.7	64.4	26.6	28.6	30.6	38.4	13.0	62.3	39.0	14.4	10.6	26.7	23.9	36.8	28.9	23.8	18.8	60.7	25.0	30.1	28.8	63.8	21.1	29.4	20.7	14.1	27.6	24.2	59.5	26.2	31.2	25.7	42.3	39.2	28.2	20.7	39.6	45.1	52.9	44.8	13.0	53.5	16.5	30.2	42.4	24.6	35.3	28.3	38.5	21.9	22.0	54.4	27.6	24.7	30.1	58.0	27.8	26.5	49.4	21.5	50.8	28.7	24.3	35.7	32.4	21.2	37.1	33.6	23.4	40.1	29.2	48.3	27.0	38.6	32.8	17.7	33.5	51.6	15.2	54.8	48.4	30.6	42.6	39.7	9.2	42.3	44.2	33.1	31.1	26.1	50.6	38.1	39.8	38.5	17.6	47.1	53.3	45.8	38.2	20.6	27.7	32.5	32.5	24.8	37.4	29.7	24.6	18.5	30.0	29.1	30.2	56.3	31.9	35.3	30.4	37.4	25.6	61.9	60.1	58.7	76.8	61.2	65.4	61.7	64.4	62.3	60.7	63.8	59.5	22.9	9.6	13.5	8.5	25.4	11.7	13.3	26.2	15.9	42.1	24.0	29.2	8.9	18.6	13.3	12.9	14.6	30.9	20.9	24.5	39.2	39.1	25.5	13.2	17.2	20.6	29.9	43.8	12.4	40.5	33.9	22.6	18.8	12.4	17.1	22.0	11.0	15.1	28.3	43.7	15.0	21.0	40.7	8.5	12.9	76.9	20.2	12.2	26.6	6.5	20.6	51.9	22.6	17.1	14.4	48.6	22.7	19.9	18.6	19.9	28.8	19.2	7.9	18.7	13.1	19.6	20.3	27.2	18.0	19.3	13.5	30.8	20.5	22.4	23.1	12.4
TMEM229A		ENSG00000234224	"Transmembrane protein 229A"	B2RXF0	7	124030921-124033067	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.6;intestine: 8.4;testis: 5.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Bipolar cells: 3.7;Oligodendrocytes: 11.4;Proximal enterocytes: 10.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"SH-SY5Y: 130.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056391	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA056391: AB_2683114"					"unprognostic (2.52e-2)"			"unprognostic (3.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.21e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.31e-1)"		"unprognostic (4.31e-3)"	0.0	1.0	7.5	0.0	11.0	0.0	0.0	9.8	9.0	0.1	2.5	0.1	8.4	0.1	0.4	0.0	0.6	0.0	0.2	7.7	9.6	0.0	0.0	0.0	0.0	9.1	12.6	0.2	0.0	0.8	0.9	0.1	9.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	3.9	0.1	7.9	0.1	1.8	5.3	10.2	0.0	0.0	0.0	0.0	0.3	0.0	11.7	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	130.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	11.0	9.8	9.0	7.7	9.6	9.1	12.6	9.0	7.9	10.2	11.7	0.0	0.0	0.0	9.4	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.2	0.0	2.0	11.4	0.0	2.5	0.0	0.0	0.1	10.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	1.2	0.7	0.2
TMEM245	"C9orf5, CG-2"	ENSG00000106771	"Transmembrane protein 245"	Q9H330	9	109015135-109119947	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023892	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA023892: AB_1845828"	"unprognostic (1.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.46e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-2)"	29.2	47.6	18.1	12.4	19.4	7.3	20.2	16.8	19.4	21.0	32.6	22.9	12.6	27.3	26.1	23.1	29.2	19.2	43.1	19.6	21.4	45.9	25.2	28.7	15.1	17.3	19.6	45.3	24.6	65.1	11.3	29.1	17.8	25.5	16.9	27.7	26.2	33.9	35.4	14.2	15.9	34.2	20.6	17.9	17.8	16.8	22.0	17.0	74.2	39.2	11.6	18.9	11.9	18.4	32.3	42.2	30.5	10.3	69.9	39.9	67.0	45.4	35.0	47.9	37.6	56.9	62.9	28.9	45.3	34.7	46.4	49.5	39.1	29.2	56.2	37.8	16.8	36.0	32.2	33.7	30.5	27.5	27.2	42.9	29.2	46.7	42.8	51.5	40.7	31.5	24.4	31.2	55.1	21.2	36.8	12.6	33.9	43.2	37.5	20.8	60.3	18.0	50.8	31.0	16.8	16.4	30.0	29.6	30.2	44.9	39.6	15.4	44.9	37.0	27.7	34.9	52.4	20.6	56.9	9.2	51.5	14.5	54.9	4.4	1.6	1.5	2.4	1.1	2.9	1.5	4.0	3.4	1.6	2.1	5.2	3.6	0.6	3.3	2.4	2.2	4.3	1.8	18.1	19.4	16.8	19.4	19.6	21.4	17.3	19.6	17.8	20.6	22.0	18.4	55.0	115.4	93.1	36.6	22.4	25.2	18.8	27.4	27.3	43.8	34.4	23.0	135.6	74.4	33.8	86.5	106.3	50.7	20.1	27.0	3.9	22.7	6.7	31.6	24.8	51.8	31.2	70.5	71.4	31.1	17.7	31.3	25.5	56.4	31.6	62.8	74.3	98.3	18.0	63.9	62.0	31.1	10.2	28.4	14.3	7.8	41.0	18.9	23.2	46.9	18.3	52.6	16.5	60.8	75.8	30.0	35.6	51.1	19.7	23.1	55.3	33.7	45.6	32.4	46.0	40.7	37.9	27.4	43.8	21.0	28.4	15.1	28.2	81.4	35.6	21.7
TMEM254	"bA369J21.6, C10orf57, FLJ13263"	ENSG00000133678	"Transmembrane protein 254"	Q8TBM7	10	80078646-80092557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029105, HPA072613"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Nucleoplasm	"HPA029105: AB_2672909, HPA072613: AB_2732205"	"unprognostic (9.40e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.39e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.96e-2)"	15.2	11.9	7.9	11.1	8.3	9.4	26.5	7.3	8.3	16.0	7.0	22.6	16.3	10.7	62.1	39.5	28.0	14.0	5.7	8.0	7.0	14.8	52.8	9.4	10.4	8.0	8.7	13.0	19.0	16.5	4.4	15.6	8.5	43.1	22.3	11.2	16.6	14.2	4.4	72.3	15.4	10.4	8.3	7.8	15.0	15.5	7.5	15.4	14.8	2.9	14.6	12.4	22.7	9.3	14.4	13.8	20.0	17.2	27.1	29.7	33.4	13.5	9.3	9.0	9.7	10.6	43.5	11.0	22.1	16.9	9.3	15.2	8.9	11.5	10.0	17.5	16.5	3.0	3.8	14.3	11.2	12.8	13.0	20.3	48.6	8.9	7.3	20.6	7.7	9.1	7.9	22.9	9.4	29.8	10.7	9.9	11.0	12.6	43.2	13.2	2.8	9.7	13.5	11.9	8.0	12.1	12.6	31.4	13.3	14.8	45.1	9.1	12.1	7.8	12.8	12.0	8.0	15.8	24.7	0.8	17.8	13.6	6.6	57.3	25.0	13.0	18.1	28.6	22.3	21.3	20.2	18.8	20.7	14.3	33.8	22.6	2.8	17.5	31.5	23.1	27.2	20.5	7.9	8.3	7.3	8.3	8.0	7.0	8.0	8.7	8.5	8.3	7.5	9.3	4.6	9.6	9.6	17.6	7.3	8.2	5.9	9.7	5.2	7.9	22.6	17.5	4.4	12.8	13.7	9.2	16.7	40.9	3.8	9.0	21.5	15.7	10.5	37.6	10.0	5.4	8.4	5.9	17.2	8.7	37.2	7.6	11.2	10.5	5.7	12.9	5.7	33.4	19.4	16.8	16.4	23.7	8.2	10.3	5.8	7.5	9.3	8.5	3.6	4.7	15.2	15.7	12.3	8.5	14.8	10.3	15.3	11.7	5.2	15.6	19.6	23.1	40.2	13.3	13.1	2.6	7.1	36.8	8.7	20.9	24.0	22.7	6.9	11.2	18.1	8.4
TMEM258	"C11orf10, Kud, Kuduk"	ENSG00000134825	"Transmembrane protein 258"	P61165	11	61768501-61792802	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044602	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"HPA044602: AB_10961423"	"unprognostic (6.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (1.34e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.58e-1)"	116.4	158.4	125.5	66.1	128.7	128.4	120.8	130.8	162.2	142.2	123.0	112.4	80.9	116.0	350.1	122.8	123.1	59.3	170.8	122.6	128.7	123.5	160.6	110.0	83.0	130.0	125.6	154.9	300.3	80.5	128.9	80.4	130.3	105.5	107.6	44.0	183.9	88.7	146.7	95.3	99.8	81.5	131.1	124.4	142.8	79.1	126.8	111.7	109.1	120.6	108.9	107.5	111.7	140.1	144.3	254.9	194.9	173.3	329.0	308.4	117.1	113.9	177.1	104.5	124.8	223.5	265.5	103.9	205.9	272.1	196.1	154.8	186.7	222.7	149.1	141.7	168.6	86.8	258.3	347.6	310.7	186.9	96.3	272.5	339.6	137.1	364.8	267.9	210.9	207.4	221.7	394.5	185.4	501.1	131.2	318.8	267.1	315.6	172.9	142.1	144.6	673.0	241.5	243.7	169.3	173.1	103.8	221.7	211.5	179.6	244.5	347.3	108.0	129.2	111.7	166.1	78.3	248.6	201.7	173.6	183.8	112.6	135.7	507.9	225.6	287.6	169.5	200.4	216.5	233.2	198.8	190.1	177.8	187.1	167.1	166.7	182.4	151.7	204.4	496.4	236.8	244.9	125.5	128.7	130.8	162.2	122.6	128.7	130.0	125.6	130.3	131.1	126.8	140.1	211.3	102.5	224.1	6.8	323.6	228.9	220.5	794.5	170.8	41.3	525.1	608.3	491.3	403.2	445.9	318.2	18.8	409.5	279.8	306.2	295.4	534.8	234.4	369.2	304.7	254.8	311.1	197.7	7.4	654.4	667.7	314.8	210.5	305.6	226.7	261.8	335.2	572.9	461.4	37.0	8.2	631.5	441.5	401.7	396.9	142.8	335.5	265.7	569.2	3.7	430.0	418.6	270.8	6.0	25.8	469.4	432.6	214.4	821.3	296.6	392.2	553.8	470.9	73.9	170.9	192.3	248.5	399.4	433.8	297.4	279.0	508.0	245.2	135.3	442.1	274.9
TMEM268	"C9orf91, DKFZp547P234, FLJ38045"	ENSG00000157693	"Transmembrane protein 268"	Q5VZI3	9	114611206-114646422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 10.3;Breast glandular cells: 8.8;Endometrial stromal cells: 8.9;Glandular and luminal cells: 8.8;Granulosa cells: 9.6;Hofbauer cells: 8.9;monocytes: 19.1;Syncytiotrophoblasts: 8.8;Theca cells: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017199	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA017199: AB_1845845"	"unprognostic (8.57e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (3.61e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	7.3	7.7	11.0	6.9	12.7	3.6	7.5	2.9	16.6	6.5	6.4	6.9	3.4	6.8	6.3	4.3	4.7	3.7	3.3	14.4	6.1	3.3	5.3	5.2	9.5	4.4	5.3	8.5	4.7	14.1	4.1	4.8	5.3	12.2	5.4	4.5	8.9	6.5	4.6	4.2	6.3	6.8	5.3	13.3	7.2	3.9	6.5	8.6	6.2	4.3	9.4	6.3	5.1	11.3	4.7	7.1	3.8	8.2	10.1	7.6	2.9	4.3	7.9	6.0	6.1	5.1	2.0	19.5	3.5	4.8	17.0	8.1	7.4	3.7	5.2	9.9	4.6	6.5	5.8	4.0	17.9	13.6	3.0	6.7	6.5	7.8	8.4	7.7	4.1	24.9	12.3	51.5	4.4	13.6	15.4	4.5	9.8	6.0	7.8	17.4	4.5	17.7	3.5	3.4	12.5	8.4	14.4	18.8	41.3	2.4	25.2	12.2	2.5	6.0	6.8	2.3	8.3	27.8	27.5	20.7	3.1	11.4	11.0	0.3	1.3	0.2	0.6	1.0	0.2	1.3	0.7	0.4	0.7	2.2	0.9	0.8	1.0	0.8	1.0	4.7	0.1	0.5	11.0	12.7	2.9	16.6	14.4	6.1	4.4	5.3	5.3	5.3	6.5	11.3	1.7	0.0	10.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	8.8	5.2	0.0	0.0	1.3	0.0	0.0	4.7	3.0	0.0	0.0	1.4	0.0	5.0	8.9	0.5	0.0	0.0	0.0	4.6	1.2	1.3	0.0	8.8	0.0	9.6	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	19.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.6	0.0	0.0	1.9	4.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.8	1.1	9.7	0.0	0.0
TMEM50A	SMP1	ENSG00000183726	"Transmembrane protein 50A"	O95807	1	25338317-25362361	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065192			Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA065192: AB_2685429"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-3)"	"prognostic favorable (8.64e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (7.39e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.39e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-3)"	"unprognostic (3.44e-2)"	47.2	63.0	43.9	44.5	47.8	41.8	55.5	45.3	55.8	47.0	43.7	58.5	49.6	35.7	53.0	36.5	38.4	45.7	44.2	45.0	44.4	55.0	33.4	58.1	52.2	46.5	44.4	26.2	32.6	49.5	14.6	57.7	46.4	54.4	65.7	45.4	81.5	52.7	16.9	41.1	55.4	46.0	47.2	46.9	49.5	16.1	45.5	47.1	47.0	26.5	47.3	55.1	29.8	50.4	43.3	44.6	74.3	42.3	132.9	119.8	28.1	89.0	123.6	143.4	159.5	36.5	110.9	50.2	47.9	274.6	55.7	62.6	56.3	61.9	161.2	126.1	81.4	104.7	47.5	55.2	96.5	82.4	80.3	128.0	91.4	106.1	60.5	69.7	107.0	50.8	73.1	79.5	140.9	30.6	53.2	90.2	90.6	73.7	37.1	45.7	85.3	88.9	148.8	30.9	64.5	42.3	89.0	64.2	72.2	69.3	32.7	52.0	171.0	86.5	36.6	144.9	36.8	52.3	61.5	45.0	117.1	117.2	50.3	275.5	76.9	109.8	87.9	94.7	91.9	49.6	77.2	91.1	55.9	40.9	55.1	76.6	159.2	80.5	117.3	51.9	95.4	106.3	43.9	47.8	45.3	55.8	45.0	44.4	46.5	44.4	46.4	47.2	45.5	50.4	244.8	144.2	84.2	21.2	107.9	253.4	184.5	392.3	146.8	43.9	162.0	164.8	105.6	102.9	212.7	169.2	27.1	108.9	191.0	175.6	50.9	300.3	25.4	136.4	119.3	203.3	83.0	93.6	31.6	215.6	312.5	198.1	91.3	180.8	126.6	58.2	152.0	68.3	227.1	25.2	27.3	170.7	309.3	162.4	245.1	12.7	151.9	223.8	199.3	16.9	253.8	102.0	154.5	28.1	48.8	315.3	164.8	98.9	168.2	340.6	120.0	113.1	205.1	41.7	210.4	71.6	200.6	94.7	47.0	166.8	317.7	181.6	180.9	116.9	106.9	274.3
TMEM52		ENSG00000178821	"Transmembrane protein 52"	Q8NDY8	1	1917590-1919279	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	5	"pancreas: 216.2;skeletal muscle: 298.9;tongue: 207.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 22.3;Hepatocytes: 25.9;Spermatocytes: 34.6;Spermatogonia: 39.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 20.5;OE19: 18.2;RPMI-8226: 37.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA079372			Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	Nucleoplasm	"HPA079372: "	"unprognostic (4.39e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.04e-5)"	"unprognostic (1.46e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.68e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	1.9	52.6	1.9	0.2	2.1	0.5	2.0	2.1	3.7	1.1	3.0	2.5	3.6	0.6	0.4	6.9	3.3	0.4	1.8	1.8	1.9	2.4	13.5	1.9	0.4	1.8	2.1	2.2	216.2	3.1	1.7	0.2	1.7	1.8	1.3	0.2	19.8	0.4	298.9	3.5	2.3	0.3	1.5	2.8	6.9	29.2	1.8	0.4	0.8	207.8	0.3	0.6	2.1	1.7	3.4	0.3	0.9	1.8	0.3	0.1	7.5	0.5	0.2	2.2	1.3	5.6	2.3	0.8	2.2	3.5	0.8	1.1	5.5	1.5	0.4	0.4	4.0	0.0	0.9	20.5	1.1	0.0	1.3	0.1	3.1	0.7	0.3	0.1	0.1	3.9	5.1	1.9	0.0	6.4	0.5	1.5	2.9	18.2	10.6	1.5	0.0	37.1	1.2	0.2	3.7	2.6	0.0	3.1	0.4	1.3	2.1	0.4	0.0	0.0	1.4	1.0	0.0	2.4	0.8	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	2.1	2.1	3.7	1.8	1.9	1.8	2.1	1.7	1.5	1.8	1.7	0.4	0.0	0.0	0.0	1.2	4.5	2.9	1.2	2.8	0.4	3.9	5.2	0.8	8.6	2.4	0.0	0.0	1.9	0.8	6.8	1.9	1.8	3.9	3.8	0.3	0.8	0.0	0.4	0.6	22.3	7.0	1.6	5.1	0.8	0.0	5.1	0.7	25.9	0.6	0.0	0.5	11.1	8.2	0.8	2.2	5.8	14.9	0.7	8.8	0.0	0.6	1.8	0.0	0.0	0.1	6.7	2.5	9.8	4.3	14.2	15.4	11.5	8.7	1.0	0.0	15.4	1.6	34.6	39.4	2.5	2.8	3.7	1.2	15.5	7.1	3.1
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	512	"intestine: 979.8"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 28.0"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"U-138 MG: 50.8;U-87 MG: 141.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.0;spinal cord: 1.8"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Plasma membrane"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.0	0.0	0.9	0.2	0.7	0.0	0.0	1.9	1.7	0.0	0.0	0.2	979.8	0.2	0.0	0.1	0.0	0.1	0.1	0.7	0.6	0.0	0.0	0.0	0.7	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	21.8	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	4.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.3	0.0	0.9	0.0	0.2	141.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.7	1.9	1.7	0.7	0.6	0.2	0.6	0.1	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0
TMTC2	DKFZp762A217	ENSG00000179104	"Transmembrane O-mannosyltransferase targeting cadherins 2"	Q8N394	12	82686880-83134870	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 60.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 2152.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.0;WM-115: 80.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026954, HPA026955"	Uncertain		Approved	"Plasma membrane,Actin filaments"		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	"Actin filaments"	"HPA026954: AB_2256025, HPA026955: AB_10602282"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.61e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.84e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.06e-2)"	3.7	0.8	11.4	4.7	39.8	2.1	4.6	21.4	25.1	4.8	0.0	11.7	2.8	5.4	4.4	9.8	10.0	7.8	2.0	11.2	19.1	6.6	1.2	6.4	1.8	28.3	29.9	1.9	4.5	2.8	3.5	3.4	26.7	6.1	5.7	5.5	6.9	11.2	1.2	5.2	4.7	6.8	11.7	1.3	10.2	3.0	26.8	1.5	6.4	1.7	2.2	7.5	7.3	60.8	1.7	6.4	32.0	0.2	4.3	3.9	2.9	2.1	0.7	1.7	0.3	0.3	3.4	0.0	0.5	11.9	1.2	2.8	9.7	4.9	0.5	7.5	5.8	0.0	5.2	0.2	0.4	2.2	1.0	1.1	4.3	0.2	1.6	3.4	2.7	3.5	0.0	4.2	0.4	3.4	1.6	8.8	1.1	6.0	5.3	0.0	1.3	0.6	2.9	14.1	8.3	15.1	2.9	4.6	21.0	5.4	4.9	0.5	1.7	5.3	1.8	7.2	2.7	7.8	5.7	1.2	1.2	3.8	80.2	0.0	0.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	11.4	39.8	21.4	25.1	11.2	19.1	28.3	29.9	26.7	11.7	26.8	60.8	10.7	9.6	8.9	333.3	2.0	14.4	15.5	12.0	18.2	38.1	8.9	5.5	1.8	11.5	18.4	14.7	8.4	13.6	3.1	3.6	0.0	5.4	12.9	13.5	7.5	10.3	2.4	0.8	117.1	8.2	1.7	9.8	12.8	13.1	0.0	0.2	2.5	1.4	1.9	8.4	377.0	9.8	2.0	6.6	9.6	5.0	5.9	6.2	32.0	86.2	9.3	13.9	1.0	38.7	2152.4	9.4	3.3	1.2	7.3	11.9	2.7	2.1	17.0	1.6	6.6	0.8	2.2	0.6	2.2	16.2	11.5	4.1	2.8	1.0	5.9	14.5
TNFRSF10D	"CD264, DcR2, TRAILR4, TRUNDD"	ENSG00000173530	"TNF receptor superfamily member 10d"	Q9UBN6	8	23135588-23164027	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 114.4;Endothelial cells: 52.3;Gastric mucus-secreting cells: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 99.5;LHCN-M2: 250.4;WM-115: 238.4"									HPA070971			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Actin filaments"		"HPA070971: AB_2686330"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.72e-1)"	10.6	2.3	4.8	5.3	4.8	9.0	4.8	4.5	6.1	3.7	6.1	6.1	4.4	4.7	3.7	2.6	5.9	7.9	6.2	4.4	4.6	12.1	17.6	10.0	3.5	4.9	4.7	7.1	3.5	1.9	2.8	2.9	5.1	4.6	7.3	0.5	2.2	2.9	1.4	2.1	6.9	7.7	5.2	5.0	5.5	3.0	6.1	1.8	3.8	1.0	4.1	3.9	3.1	5.0	15.1	12.7	16.3	9.4	12.2	47.7	0.3	78.2	29.5	5.8	7.9	24.4	12.2	0.0	16.1	47.1	0.0	5.0	13.7	68.6	50.3	0.1	12.1	4.2	7.7	21.2	52.7	2.7	5.3	60.1	75.0	20.6	14.0	71.4	99.5	0.6	0.0	0.1	250.4	0.0	0.0	8.2	13.2	44.1	0.1	3.0	0.1	3.8	19.0	6.8	0.3	0.1	8.4	0.0	0.0	36.1	0.1	9.9	59.4	0.1	0.0	4.7	0.1	0.0	0.0	0.0	63.3	4.0	238.4	2.5	2.1	0.9	0.0	0.8	0.1	1.3	1.9	0.6	2.9	0.4	5.2	2.1	1.4	0.2	1.4	0.0	0.6	1.5	4.8	4.8	4.5	6.1	4.4	4.6	4.9	4.7	5.1	5.2	6.1	5.0	114.4	0.0	9.8	0.3	7.0	5.0	4.1	11.3	14.8	0.0	6.0	12.8	3.5	1.5	10.2	1.8	0.0	0.1	1.2	6.8	0.0	5.7	0.4	6.4	5.8	52.3	1.8	0.0	0.1	2.2	0.3	19.2	83.6	9.5	7.6	1.5	16.1	8.2	2.9	0.0	0.1	5.6	6.1	6.1	9.8	0.1	0.3	13.0	8.8	19.7	3.5	0.3	0.0	0.5	0.1	12.3	3.1	0.4	6.8	4.9	6.8	2.8	6.4	0.2	0.0	11.9	14.3	0.8	2.3	4.5	2.4	0.1	5.9	2.1	6.9	3.7
TNFRSF12A	"CD266, FN14, TweakR"	ENSG00000006327	"TNF receptor superfamily member 12A"	Q9NP84	16	3018445-3022383	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 612.4;Basal prostatic cells: 1315.6;Basal respiratory cells: 622.2;Ductal cells: 938.2;Exocrine glandular cells: 698.4;Pancreatic endocrine cells: 1232.3;Prostatic glandular cells: 757.9;Urothelial cells: 695.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"eosinophil: 139.6;neutrophil: 102.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 139.6"	"Cell line enhanced"	"Detected in many"		"U-251 MG: 699.6"									HPA007853	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		370000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA007853: AB_1858463"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.06e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.04e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.98e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.17e-2)"	42.0	45.9	5.3	27.0	5.2	8.3	24.4	6.1	9.9	12.5	9.4	26.5	37.5	34.8	1.2	17.6	19.0	55.2	108.3	5.6	8.8	133.5	61.0	72.6	2.4	8.2	7.9	8.2	116.3	56.1	59.3	33.0	7.0	33.4	4.5	4.8	48.4	17.1	58.5	18.1	21.6	32.5	7.4	6.7	42.6	5.4	10.4	5.2	37.0	9.3	3.1	73.8	13.9	7.0	217.6	155.6	17.7	31.9	31.0	71.3	109.1	444.3	277.5	316.2	205.5	70.1	336.0	1.5	566.2	270.4	401.3	224.2	4.2	283.4	132.2	8.3	11.2	1.5	52.4	58.4	205.1	3.7	15.2	65.2	196.7	345.1	433.5	298.1	100.9	0.6	24.5	2.4	362.7	394.0	0.6	28.3	85.5	88.7	369.6	1.9	207.1	7.8	355.8	37.6	19.9	7.3	314.7	127.9	255.8	57.7	69.4	5.8	192.2	601.9	303.2	423.8	699.6	6.6	2.9	3.1	190.0	18.9	488.8	12.2	11.4	139.6	6.1	7.3	7.9	0.2	2.8	4.9	14.6	0.2	1.4	2.7	102.9	8.0	4.7	0.6	3.4	4.0	5.3	5.2	6.1	9.9	5.6	8.8	8.2	7.9	7.0	7.4	10.4	7.0	16.9	102.5	37.7	0.3	6.9	612.4	1315.6	622.2	113.3	1.5	139.0	46.7	63.9	195.9	238.7	182.1	2.1	134.6	10.0	74.2	64.6	938.2	1.3	170.5	29.4	47.5	27.3	1.3	0.2	698.4	169.5	155.1	33.1	173.1	59.1	3.0	24.3	20.7	39.7	0.0	0.5	19.9	152.5	5.6	121.4	0.8	6.2	23.0	112.1	1.9	10.8	23.3	4.1	0.0	0.1	1232.3	155.3	6.8	5.3	757.9	52.9	118.0	118.4	5.9	6.6	190.5	228.6	10.9	9.4	35.5	359.7	189.1	25.3	1.3	50.0	695.6
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6460786-6466175	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;pituitary gland: 29.9;skin 1: 25.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 34.1;Excitatory neurons: 37.5;T-cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"MAIT T-cell: 5.6;memory CD4 T-cell: 4.4;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.4;T-reg: 7.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.5;RPMI-8226: 25.7"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.4;hippocampal formation: 2.0"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"	NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	6.4	4.2	4.0	3.2	4.0	0.8	4.0	11.1	6.1	5.2	4.9	6.1	3.0	3.0	0.6	10.3	5.7	2.2	8.7	4.8	4.3	3.3	1.2	2.4	4.3	3.7	3.6	3.1	1.5	0.9	29.9	4.4	4.4	5.2	1.4	1.2	3.3	2.3	1.1	25.3	5.0	0.5	3.3	44.0	2.0	0.9	3.7	2.0	3.2	1.2	2.7	2.5	4.6	3.5	1.8	0.4	1.1	2.0	0.0	0.6	1.3	1.5	0.6	0.3	0.0	1.7	2.8	0.0	2.5	0.0	1.3	4.2	0.6	4.7	0.0	20.5	1.5	0.6	1.7	0.1	0.7	0.0	0.1	0.0	3.2	1.5	4.1	2.7	4.0	1.1	0.0	0.0	0.0	2.2	0.0	8.0	1.4	1.4	3.4	0.6	0.3	25.7	1.3	0.7	3.4	5.3	0.0	2.5	0.1	0.6	2.0	2.9	2.5	1.3	2.1	0.0	2.0	0.0	3.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.0	0.2	5.6	0.0	4.4	2.2	0.5	0.0	4.4	0.7	0.0	0.8	1.0	0.0	7.9	0.9	4.0	4.0	11.1	6.1	4.8	4.3	3.7	3.6	4.4	3.3	3.7	3.5	19.0	3.2	5.0	3.9	2.5	24.6	2.3	5.6	11.4	3.1	4.2	5.5	1.1	1.5	3.3	1.8	2.1	0.7	12.8	34.1	0.0	0.2	0.2	4.1	11.2	11.5	6.7	3.0	37.5	0.4	2.0	2.3	5.6	6.9	7.0	4.8	7.9	1.1	4.0	5.0	21.6	20.3	0.0	1.2	6.6	0.3	2.8	4.0	7.2	14.0	3.0	10.2	10.3	7.5	2.1	1.4	16.0	9.4	3.2	3.7	9.8	0.6	4.8	9.1	0.0	2.6	2.6	0.4	1.2	8.6	28.6	0.1	41.4	0.7	25.0	6.8
TNFRSF9	"4-1BB, CD137, ILA"	ENSG00000049249	"TNF receptor superfamily member 9"	Q07011	1	7915871-7943165	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 15.0;granulocytes: 63.4;Langerhans cells: 17.5;monocytes: 31.6;T-cells: 29.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"memory CD8 T-cell: 9.4;neutrophil: 7.8;NK-cell: 5.2;T-reg: 18.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.8;NK-cells: 5.2;T-cells: 18.5"	"Cell line enriched"	"Detected in some"	9	"HDLM-2: 111.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA071425			Approved	"Nucleoli,Plasma membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Nucleoli	"HPA071425: AB_2686394"	"unprognostic (7.23e-2)"	"unprognostic (1.72e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-4)"	"unprognostic (9.47e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (2.69e-8)"	"unprognostic (1.64e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.55e-2)"	0.5	0.2	0.4	3.9	0.4	2.2	0.2	1.1	0.5	0.2	0.3	0.5	0.5	0.3	0.2	0.6	0.1	1.6	0.2	0.4	0.1	0.2	0.7	0.8	9.0	0.3	0.1	0.2	0.7	0.0	0.0	0.2	0.3	0.3	1.1	0.5	0.3	0.2	0.2	0.5	0.8	0.2	0.0	4.1	0.8	0.2	0.3	3.7	0.2	0.2	9.9	1.9	0.0	1.1	2.5	0.9	0.2	0.2	0.0	0.1	0.1	0.1	0.4	0.5	0.5	3.1	0.5	0.1	1.2	0.1	1.8	0.4	0.0	0.4	1.9	111.5	0.2	0.6	0.5	0.1	1.8	0.0	0.9	0.3	0.7	0.5	0.2	0.4	0.1	0.1	0.4	0.3	0.1	0.2	0.0	0.3	0.1	0.1	0.2	0.1	0.7	0.2	0.3	0.1	0.2	0.2	0.4	0.2	0.0	1.3	0.1	0.3	0.3	0.3	3.2	0.1	0.5	0.2	0.2	0.2	13.0	0.8	0.1	1.5	1.9	0.2	1.7	0.6	0.3	0.3	1.1	9.4	1.4	0.4	0.2	1.7	7.8	5.2	0.1	0.3	18.5	1.4	0.4	0.4	1.1	0.5	0.4	0.1	0.3	0.1	0.3	0.0	0.3	1.1	0.6	0.0	1.7	0.0	1.6	0.3	0.9	0.3	0.6	0.0	0.3	0.5	0.4	0.0	1.9	0.0	0.0	0.0	15.0	0.1	0.0	1.3	0.0	0.6	1.0	0.8	0.0	0.0	0.2	1.1	0.0	1.0	3.6	1.4	63.4	0.0	0.0	0.0	0.8	0.0	0.3	0.2	0.0	0.3	17.5	0.0	0.0	3.6	5.4	0.0	31.6	0.0	1.0	0.0	0.1	2.0	0.1	0.0	9.4	0.5	0.0	0.1	0.0	0.0	0.0	7.7	1.0	0.4	0.1	0.1	0.4	0.0	29.2	0.0	0.5	0.3
TNNI2	"AMCD2B, DA2B, FSSV"	ENSG00000130598	"Troponin I2, fast skeletal type"	P48788	11	1838981-1841680	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	25	"skeletal muscle: 7969.8;tongue: 2622.3"	"Group enriched"	"Detected in many"	6	"Extravillous trophoblasts: 449.4;Skeletal myocytes: 598.7"	"Group enriched"	"Detected in many"	10	"cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 86.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 35.7;hTCEpi: 101.2"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 5.1"	"Not detected"	"Not detected"			"CAB018697, HPA055938"	Enhanced		Approved	"Plasma membrane,Intermediate filaments"		NA	NA		110000	"Cluster 52: Eosinophils - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Intermediate filaments"	"CAB018697: AB_628400, HPA055938: AB_2682976"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-2)"	3.0	1.8	0.3	1.1	0.3	6.1	7.9	0.3	0.6	1.0	0.4	1.2	0.3	0.8	0.3	66.9	0.9	5.6	1.7	0.3	0.4	0.7	1.6	7.8	1.6	0.4	0.4	0.7	8.8	0.0	0.9	3.0	0.4	14.0	0.2	0.0	216.1	3.2	7969.8	55.2	2.7	0.2	0.4	5.8	1.1	0.7	0.5	1.9	2.8	2622.3	1.0	27.4	3.2	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	35.7	1.0	0.2	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.1	8.1	101.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	3.1	0.0	0.1	1.2	2.4	0.0	1.0	0.0	1.0	0.0	0.7	0.0	0.0	12.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	13.8	5.8	53.3	0.1	12.5	0.1	3.8	0.0	0.0	8.0	4.8	0.0	0.0	39.7	0.4	17.6	86.4	0.0	2.5	0.3	0.3	0.3	0.6	0.3	0.4	0.4	0.4	0.4	0.4	0.5	0.6	1.2	3.2	4.4	0.0	9.1	25.1	2.6	1.8	15.4	0.0	0.5	23.7	5.6	21.5	3.0	0.0	0.0	33.8	15.7	0.1	0.0	1.4	0.0	1.4	0.2	2.0	0.0	0.0	0.0	0.6	449.4	2.4	1.1	0.1	10.8	0.4	0.4	0.3	39.6	0.0	0.0	0.0	2.0	18.8	10.7	0.0	0.3	25.9	0.0	0.0	16.0	0.0	1.0	0.0	0.0	1.4	0.0	0.0	4.2	0.1	0.0	0.2	13.2	0.0	0.0	598.7	2.4	0.0	0.6	2.7	6.5	87.2	1.9	4.3	0.0	0.9
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29052230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 34.9;choroid plexus: 25.2;fallopian tube: 20.1"	"Group enriched"	"Detected in some"	4	"dendritic cells: 20.1;Endometrial ciliated cells: 65.4;Respiratory ciliated cells: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;JURKAT: 1.2;NB-4: 1.3"	"Low region specificity"	"Detected in many"							"HPA037561, HPA037562, HPA075216"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Plasma membrane"		"HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: "	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.1	1.2	4.5	0.6	11.5	1.9	0.2	10.6	2.3	0.5	25.2	0.3	0.5	0.6	0.1	0.4	20.1	0.3	2.8	4.5	7.6	0.1	0.2	2.8	0.8	19.2	34.9	0.5	0.3	0.0	1.1	0.3	17.3	0.2	0.2	0.2	0.2	0.1	1.2	0.3	0.4	0.5	12.5	2.0	1.0	1.3	10.6	0.2	0.1	3.0	0.7	0.2	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.0	0.6	0.1	0.2	0.6	2.3	0.1	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.3	0.3	0.0	0.3	1.3	1.0	0.4	0.1	0.0	0.3	0.6	0.3	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.6	0.5	4.5	11.5	10.6	2.3	4.5	7.6	19.2	34.9	17.3	12.5	10.6	5.3	0.3	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	65.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.2	30.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	3.6	0.5	0.0	0.0
TOM1		ENSG00000100284	"Target of myb1 membrane trafficking protein"	O60784	22	35299275-35347992	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 213.8"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 170.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000818, HPA001749"	Approved		Approved	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		44000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA000818: AB_2666101, HPA001749: AB_1080323"	"unprognostic (3.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.20e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.16e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.31e-2)"	34.7	47.8	20.8	17.0	19.4	60.8	32.1	19.9	25.8	43.6	23.6	22.7	29.1	26.6	12.7	76.5	26.8	24.9	43.2	19.8	26.6	32.7	49.0	37.1	15.3	30.2	24.5	21.5	20.2	48.5	37.4	27.7	32.9	23.2	9.8	5.9	60.6	11.7	213.8	74.9	28.4	10.8	19.6	23.9	20.8	25.9	24.8	13.1	26.5	68.6	12.7	19.5	45.0	22.1	15.8	15.3	8.8	14.3	58.3	34.9	42.3	15.5	43.8	28.4	31.1	21.5	14.3	6.2	28.0	45.4	18.3	7.3	8.6	15.6	9.9	18.7	21.3	5.3	17.1	43.8	58.6	10.8	23.6	49.8	19.2	39.6	13.3	18.5	19.8	11.6	10.3	15.3	14.1	13.8	8.2	27.5	7.0	18.9	8.6	14.9	12.3	13.2	10.9	11.3	14.9	12.1	34.1	34.8	34.5	7.3	18.0	16.7	22.0	34.0	29.4	27.3	7.7	18.0	12.4	16.7	45.7	10.5	11.4	18.6	100.9	44.5	19.3	60.7	15.6	13.6	29.5	18.4	48.0	11.0	22.6	15.7	129.1	15.1	66.2	25.9	48.2	63.3	20.8	19.4	19.9	25.8	19.8	26.6	30.2	24.5	32.9	19.6	24.8	22.1	10.1	22.4	36.9	8.8	12.7	12.7	10.3	29.5	7.4	11.1	19.1	11.0	23.2	15.7	33.0	12.9	12.5	64.6	13.8	41.6	27.4	40.9	29.9	32.0	17.8	14.2	16.2	9.7	9.3	38.9	57.1	22.6	15.3	48.0	22.8	10.4	16.1	34.0	60.8	11.8	15.2	18.1	50.8	33.5	35.2	21.4	11.5	45.2	19.6	7.5	34.0	19.5	9.2	6.6	13.2	34.2	21.5	12.8	5.7	11.9	55.3	34.9	24.2	8.2	6.6	16.6	15.4	23.5	5.6	17.3	21.9	170.2	18.2	13.4	15.2	10.7
TPD52L1	"D53, hD53, TPD53"	ENSG00000111907	"TPD52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.3;salivary gland: 298.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 390.1;Squamous epithelial cells: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	44.7	258.3	83.9	10.1	96.2	0.8	67.0	72.6	97.4	35.8	103.4	36.2	9.7	15.2	68.8	152.4	34.6	27.3	71.4	78.4	81.3	40.6	58.4	10.9	6.6	81.4	76.8	20.7	47.1	67.3	24.8	8.9	78.8	41.0	13.0	1.9	298.3	79.1	111.9	47.9	10.6	12.3	68.5	2.0	43.1	5.1	81.5	3.4	60.7	126.2	12.3	59.6	60.8	76.6	37.7	42.0	0.5	269.1	2.4	0.6	63.3	6.2	5.9	0.0	0.7	67.3	46.9	0.1	136.2	31.2	9.1	83.8	8.4	58.2	0.2	0.8	58.0	0.8	58.0	0.5	5.7	0.2	0.1	7.4	234.3	0.1	30.7	82.5	0.0	0.0	30.5	0.6	4.7	365.5	0.0	0.7	4.4	36.8	22.7	0.4	0.1	0.0	271.4	9.8	9.1	0.2	70.5	189.4	4.6	9.6	162.3	0.8	0.2	1.8	5.9	0.5	2.0	0.1	0.1	0.2	1.0	0.3	0.7	1.8	0.5	0.3	0.3	0.2	0.3	0.3	0.6	0.2	0.2	0.4	0.7	0.5	2.7	2.6	0.1	0.4	0.2	0.4	83.9	96.2	72.6	97.4	78.4	81.3	81.4	76.8	78.8	68.5	81.5	76.6	141.6	0.0	28.3	390.1	2.2	19.6	44.6	70.2	128.1	3.8	164.4	154.9	45.8	25.8	51.7	125.0	4.2	32.7	3.2	3.9	176.1	30.7	6.9	71.7	21.1	87.2	16.2	0.0	16.4	110.8	140.2	18.8	13.7	184.5	2.5	29.5	15.4	59.9	10.9	0.0	48.2	11.3	83.4	2.1	5.2	4.9	17.4	3.4	131.6	28.1	0.6	3.9	1.0	11.6	2.9	35.3	2.3	36.5	2.6	37.1	10.9	45.4	15.7	1.3	0.0	177.1	10.1	5.7	9.2	272.2	37.2	14.4	3.5	53.8	17.8	19.2
TPRN	"C9orf75, DFNB79, FLJ90254"	ENSG00000176058	Taperin	Q4KMQ1	9	137191617-137204193	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;pancreas: 91.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 177.7;Proximal enterocytes: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 61.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 23.6"	"HPA020899, HPA076667"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA020899: AB_1845835, HPA076667: "	"unprognostic (5.41e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (2.94e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.77e-2)"	"prognostic favorable (5.16e-9)"	"unprognostic (1.96e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.44e-2)"	3.7	5.1	24.3	4.4	37.8	2.7	4.8	29.9	33.1	5.2	15.1	25.4	22.0	4.7	0.9	20.5	5.1	3.2	10.7	23.5	23.7	19.1	24.3	8.1	2.4	33.1	32.4	6.4	91.4	2.5	6.0	3.3	28.2	8.0	6.9	1.7	11.8	3.4	6.2	15.6	26.0	1.5	20.8	5.0	29.3	9.3	31.9	2.0	5.5	3.1	1.5	7.8	6.9	56.4	10.2	11.4	3.8	17.0	5.2	5.5	30.1	7.0	4.3	7.0	3.9	38.5	12.1	18.6	10.1	3.6	9.2	30.4	7.9	3.9	0.9	11.9	11.1	8.7	17.5	25.5	7.9	13.5	10.8	4.7	7.5	6.2	4.3	4.6	4.5	8.2	16.1	6.4	2.1	61.9	8.9	29.0	13.5	55.5	14.8	26.3	9.1	28.4	15.9	21.0	24.4	8.9	10.8	49.6	13.0	2.9	57.8	21.0	5.0	12.7	6.0	20.1	15.1	5.3	11.0	9.7	9.1	12.1	7.2	0.0	0.8	0.0	0.3	0.8	0.1	0.3	0.3	0.5	0.6	0.3	0.1	0.3	0.0	0.8	0.4	0.6	0.6	0.2	24.3	37.8	29.9	33.1	23.5	23.7	33.1	32.4	28.2	20.8	31.9	56.4	4.6	19.2	5.5	6.2	3.5	1.8	1.3	2.6	2.2	19.3	13.2	9.5	7.6	15.7	2.6	16.5	6.2	5.4	8.4	177.7	7.9	8.0	3.1	7.6	4.1	2.9	9.0	7.4	3.3	45.4	1.3	3.0	15.3	9.6	1.3	8.7	3.9	19.5	3.6	11.8	3.8	46.0	6.1	2.8	1.6	5.3	3.4	5.2	5.4	1.0	2.8	12.4	1.0	2.5	30.4	15.3	39.7	4.5	1.9	3.3	95.9	20.0	2.3	7.3	6.6	3.2	4.5	2.7	4.4	5.8	2.8	1.9	4.5	10.3	36.7	1.7
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	29.1	29.4	16.5	24.4	15.1	35.0	28.2	18.2	23.0	32.1	17.0	38.0	40.0	31.2	11.6	54.6	30.4	22.2	21.3	17.9	14.6	28.1	51.5	33.2	22.9	17.8	15.3	23.5	37.4	14.6	32.1	20.6	14.8	27.0	17.4	8.5	34.7	16.5	30.4	47.7	35.2	18.8	14.2	34.5	35.6	14.8	17.7	19.1	25.6	9.9	18.6	34.5	34.8	14.3	57.7	72.2	40.3	72.5	40.8	76.5	47.4	43.4	53.9	49.9	44.6	88.2	72.1	36.6	50.2	55.4	31.8	65.9	38.1	76.8	18.8	58.3	48.8	52.4	98.5	68.3	53.8	56.3	72.7	76.2	62.8	48.1	62.6	41.0	97.4	70.6	57.1	47.9	48.2	131.1	58.3	65.2	79.7	78.7	34.8	107.4	66.7	74.2	40.2	30.4	80.9	67.2	36.3	68.5	48.6	20.9	78.1	68.2	74.3	60.2	83.9	56.7	48.2	69.2	55.0	48.4	34.4	35.9	47.8	4.0	9.1	7.3	4.5	12.4	4.3	5.5	4.4	4.7	11.2	3.9	3.1	3.8	6.2	2.9	8.9	5.3	6.5	5.3	16.5	15.1	18.2	23.0	17.9	14.6	17.8	15.3	14.8	14.2	17.7	14.3	18.9	0.0	9.2	12.4	18.2	28.8	21.1	34.2	22.8	15.9	31.6	27.9	4.9	21.5	20.8	14.7	6.2	23.5	17.4	56.4	17.6	39.0	5.0	23.6	34.6	26.5	34.0	33.6	8.9	59.0	36.3	19.0	38.7	27.9	9.5	22.1	26.0	32.3	42.2	37.0	8.2	38.7	34.6	41.8	21.3	13.1	24.8	26.8	10.6	8.4	33.9	12.6	6.2	6.6	4.9	53.0	43.6	22.2	24.0	33.8	80.0	29.2	19.7	10.9	6.6	11.9	18.3	8.5	25.3	50.7	32.5	26.7	16.0	29.0	42.5	38.5
TRAPPC13	"C5orf44, FLJ13611, MGC48585"	ENSG00000113597	"Trafficking protein particle complex 13"	A5PLN9	5	65625004-65666233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037777	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"		"HPA037777: AB_10672464"	"unprognostic (3.66e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.25e-2)"	10.0	11.5	7.8	8.9	8.4	8.0	12.8	9.1	9.9	10.6	7.0	10.8	9.3	10.8	9.1	12.4	8.9	9.3	16.8	8.3	9.4	20.0	14.7	10.5	10.8	8.7	8.8	7.6	7.3	22.7	8.8	10.4	8.8	18.7	13.3	16.6	9.1	10.9	13.4	5.8	9.1	12.9	9.1	9.9	10.0	10.6	8.7	16.6	17.3	16.8	10.8	12.1	7.0	10.4	20.7	13.6	21.0	38.2	15.8	20.2	20.7	23.8	21.2	29.1	31.2	11.8	28.7	21.3	25.5	19.5	31.0	18.8	24.0	25.0	33.9	14.6	17.8	13.4	15.3	11.1	21.7	16.6	19.3	14.5	19.2	22.7	28.8	17.5	25.8	30.0	16.2	19.1	26.3	21.9	27.3	6.4	9.5	11.9	7.4	23.7	26.9	24.0	20.8	23.2	25.4	19.2	29.3	17.4	22.2	11.6	25.7	20.8	17.8	10.2	14.0	22.6	24.4	12.6	26.3	34.0	21.3	28.9	19.8	17.6	8.3	3.6	8.4	9.3	11.0	5.8	8.1	7.0	9.0	4.7	7.9	7.9	3.1	8.9	13.4	6.7	9.3	9.1	7.8	8.4	9.1	9.9	8.3	9.4	8.7	8.8	8.8	9.1	8.7	10.4	10.4	19.2	10.5	27.1	7.4	5.7	6.8	17.3	6.2	13.3	8.5	5.5	7.1	12.8	13.1	7.3	10.4	12.1	13.0	7.6	15.6	12.9	24.6	7.9	7.6	11.9	15.5	12.0	54.7	10.8	9.6	9.1	11.2	7.6	3.8	9.8	8.2	11.2	12.4	13.5	44.2	8.9	26.4	13.9	7.7	10.2	7.5	9.6	7.2	28.1	11.1	14.8	11.3	46.3	66.5	10.3	6.3	13.2	8.9	11.8	11.0	25.2	13.4	16.2	6.6	8.7	8.3	16.4	8.6	9.1	6.8	15.2	12.0	10.2	8.7	11.9
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228339-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 4.5;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	6	"HEL: 1.1"	"Not detected"	"Not detected"							HPA065044	Uncertain		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.9	0.0	0.0	8.1	0.0	0.4	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430358-125438403	"Enzymes, Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 365.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 242.7;Distal enterocytes: 281.6;Endometrial stromal cells: 240.1;Plasma cells: 283.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 9.9;neutrophil: 4.7;non-classical monocyte: 3.5;T-reg: 2.8"	"Group enriched"	"Detected in many"	12	"granulocytes: 9.9;monocytes: 3.5;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"HEL: 193.9;U-266/70: 114.2;U-266/84: 123.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA063982: AB_2685165"	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	82.5	25.5	7.5	40.9	9.0	365.5	28.0	12.1	16.2	35.9	7.0	45.1	20.4	25.5	13.6	33.5	15.7	80.2	18.3	8.2	10.1	23.9	139.6	53.7	17.2	9.0	8.4	4.1	43.0	78.9	12.0	28.9	8.7	45.4	51.9	16.3	19.2	7.1	44.0	20.4	32.0	43.2	7.5	22.3	38.0	6.9	11.9	36.0	107.5	19.2	18.0	99.1	5.4	7.6	14.7	16.4	2.2	4.6	4.6	8.8	25.4	9.4	13.2	6.8	2.3	22.1	18.9	26.5	8.5	6.9	40.6	11.0	7.0	9.1	5.8	11.8	34.3	193.9	7.3	43.6	11.6	98.3	17.0	8.5	13.5	27.8	62.8	33.0	20.0	0.3	17.5	81.6	0.9	15.8	9.2	15.3	15.8	35.1	31.6	18.5	3.3	29.2	54.6	55.1	13.7	5.0	22.9	24.6	93.1	14.0	6.4	4.6	10.4	7.3	9.5	7.3	11.7	114.2	123.2	36.6	13.1	0.7	17.7	0.0	0.7	9.9	0.0	1.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	4.7	0.0	3.5	0.3	2.8	0.1	7.5	9.0	12.1	16.2	8.2	10.1	9.0	8.4	8.7	7.5	11.9	7.6	69.6	134.6	168.5	13.7	19.8	100.1	242.7	68.6	77.4	25.5	100.8	71.9	16.6	31.5	67.9	16.5	0.0	12.3	2.8	281.6	11.7	45.3	0.4	96.6	240.1	62.0	112.0	5.3	2.1	24.7	19.1	54.6	58.6	222.5	29.9	0.5	8.2	131.7	35.3	21.9	0.7	129.6	32.6	72.0	59.7	1.7	0.3	85.9	56.9	4.7	27.5	20.1	0.0	4.5	0.2	45.5	130.9	0.4	283.6	139.0	117.4	24.9	39.7	3.8	0.0	36.6	45.1	0.3	2.2	88.2	64.2	30.6	14.8	1.5	106.9	128.7
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 145.9"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 153.4;Squamous epithelial cells: 95.5;Urothelial cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"T-reg: 45.1"	"Lineage enriched"	"Detected in many"	12	"T-cells: 45.1"	"Cell line enhanced"	"Detected in all"		"A549: 283.8;HaCaT: 229.0;HeLa: 203.8;OE19: 364.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (6.71e-4)"	18.3	32.7	14.1	7.8	16.2	17.4	13.4	17.7	21.5	44.9	10.3	14.1	22.8	6.1	4.9	145.9	8.8	16.3	23.1	13.5	15.8	8.5	5.9	14.5	9.7	16.9	16.0	7.3	6.0	3.6	4.4	34.5	17.2	10.2	11.2	3.6	38.0	11.7	28.1	44.9	12.5	9.0	15.8	6.0	31.7	12.7	17.2	10.1	18.7	27.2	37.3	35.7	70.2	22.1	91.5	283.8	8.6	19.4	40.4	46.1	9.6	14.8	51.9	17.9	25.0	17.2	115.6	9.8	54.7	64.7	106.9	229.0	25.6	65.7	12.0	120.0	16.4	4.5	203.8	9.5	67.1	5.4	9.6	25.7	40.9	39.3	22.3	49.6	38.8	11.4	5.7	45.8	49.2	32.2	20.2	11.7	13.1	364.2	17.0	8.7	71.8	6.9	92.4	116.0	6.4	17.7	64.7	72.2	22.1	49.7	10.9	12.6	61.0	22.5	26.3	10.9	51.3	11.1	12.9	1.0	34.6	12.6	58.3	0.4	3.8	1.0	1.2	1.1	0.8	0.5	4.9	1.5	2.6	0.6	1.3	2.6	0.6	0.9	0.5	0.4	45.1	2.3	14.1	16.2	17.7	21.5	13.5	15.8	16.9	16.0	17.2	15.8	17.2	22.1	34.9	38.5	2.6	14.0	5.3	30.8	59.0	55.6	10.2	7.2	11.8	5.7	12.5	10.0	73.5	11.0	18.8	13.6	2.8	9.9	0.0	49.1	1.1	16.5	9.9	28.7	4.2	9.0	9.6	17.3	8.4	9.6	34.7	25.7	4.5	12.4	3.6	3.2	4.0	3.3	14.0	21.7	28.5	2.9	8.6	3.9	7.2	2.9	7.2	11.2	13.0	6.6	4.1	18.6	19.2	153.4	26.9	4.5	3.7	29.5	4.3	6.2	33.5	8.4	6.6	5.8	14.0	10.3	12.1	95.5	77.6	4.7	5.9	60.9	18.4	111.9
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991231	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (8.20e-5)"	"prognostic favorable (4.94e-9)"	7.1	6.0	1.8	10.8	1.8	13.0	6.1	1.6	2.4	7.3	3.4	5.8	6.6	7.3	9.6	7.8	7.4	6.6	3.7	1.7	1.9	9.9	5.6	9.3	13.6	3.0	2.1	4.6	3.2	2.9	2.0	6.3	2.7	7.0	7.3	0.4	6.1	6.2	7.6	5.2	8.9	6.1	2.4	14.3	5.8	2.1	2.7	7.7	5.5	3.0	14.6	7.0	7.0	2.7	4.8	2.6	0.4	5.6	13.0	17.3	4.6	5.9	11.7	11.2	18.5	2.0	5.0	10.5	9.4	7.3	10.8	7.3	3.6	5.8	6.6	10.7	2.3	4.8	4.6	2.0	17.2	5.7	9.4	17.4	4.2	6.9	2.5	9.2	9.8	5.0	3.2	5.7	13.5	2.3	5.5	6.4	1.8	0.0	3.5	8.3	5.4	11.2	13.3	9.3	0.1	0.1	4.4	9.1	16.2	0.6	1.3	7.3	10.1	2.0	3.4	3.5	4.0	6.5	5.1	11.7	5.4	6.9	12.6	12.1	10.2	4.7	6.9	12.5	6.6	13.1	5.8	6.2	9.8	15.1	5.4	6.0	11.4	6.5	11.7	9.0	7.9	7.1	1.8	1.8	1.6	2.4	1.7	1.9	3.0	2.1	2.7	2.4	2.7	2.7	37.6	25.6	47.1	0.3	120.2	14.9	56.9	16.1	24.5	0.6	20.1	12.8	6.0	18.6	32.4	46.0	0.0	23.5	88.5	48.3	17.6	28.5	1.1	48.4	28.1	39.9	18.1	10.3	0.1	14.9	23.5	25.5	24.5	69.4	35.5	52.4	35.0	17.5	32.6	0.0	0.1	33.3	16.2	94.0	32.7	2.8	19.9	81.3	10.6	34.7	113.2	0.2	107.1	0.0	0.2	20.4	47.4	18.8	34.3	39.7	48.3	69.5	22.7	1.1	6.6	23.1	28.2	0.3	0.5	42.7	9.2	21.2	53.1	23.0	25.6	94.7
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919531	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	18.7	21.5	11.0	17.1	11.5	9.3	26.8	15.5	12.6	18.9	15.4	17.3	17.5	23.7	19.8	15.3	22.9	15.2	10.0	10.5	11.9	20.6	22.9	18.5	22.4	11.2	11.9	41.3	23.8	25.5	16.2	19.9	10.9	23.0	19.2	21.5	19.0	20.2	7.5	21.8	18.6	19.9	10.7	21.5	20.1	16.0	12.0	20.9	24.5	11.8	23.8	17.3	17.3	13.3	20.8	26.2	14.4	12.0	37.0	34.6	6.3	34.6	41.3	28.0	32.4	13.1	20.1	30.3	0.1	28.8	24.2	24.3	19.0	21.2	28.4	31.2	1.4	25.3	13.1	20.8	52.4	35.9	29.4	36.9	44.3	21.6	54.7	37.8	24.6	14.9	37.1	45.3	23.9	26.4	26.8	32.2	10.9	31.0	21.0	15.0	20.6	34.6	31.6	26.4	16.8	11.9	26.4	39.4	42.3	20.7	18.2	20.2	30.6	30.7	27.6	59.5	33.6	37.7	44.4	24.0	20.1	39.7	41.7	38.2	28.4	23.6	28.5	28.6	32.8	26.2	29.4	32.6	24.9	25.3	40.7	30.4	11.7	22.3	26.1	18.5	32.8	28.0	11.0	11.5	15.5	12.6	10.5	11.9	11.2	11.9	10.9	10.7	12.0	13.3	17.8	25.6	20.1	19.2	32.3	25.1	24.8	17.7	25.0	21.6	21.8	18.0	6.1	18.6	14.2	22.0	18.8	16.4	28.1	10.1	9.8	15.9	7.4	12.5	25.4	18.8	9.0	16.8	18.3	12.8	6.7	20.1	19.4	11.4	27.3	19.0	22.5	20.4	14.3	6.7	20.7	10.4	16.2	21.4	14.8	13.1	31.1	21.2	23.2	12.2	27.0	35.9	32.0	23.1	22.5	14.9	10.4	27.4	20.1	26.6	17.8	19.0	16.5	22.1	0.0	21.8	20.4	22.4	9.4	18.0	23.0	16.3	29.8	52.5	13.5	23.6
TRIM44	"DIPB, MC7"	ENSG00000166326	"Tripartite motif containing 44"	Q96DX7	11	35662775-35818007	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049053, HPA057633"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Plasma membrane"	"HPA049053: AB_2680613, HPA057633: AB_2683484"	"unprognostic (2.73e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-1)"	12.6	10.7	16.9	12.3	16.4	6.0	11.1	18.5	21.9	10.9	8.3	13.5	10.6	10.9	10.2	9.1	11.1	11.6	11.6	16.6	17.0	18.0	14.4	11.9	12.8	16.0	16.7	10.3	15.5	11.1	7.9	13.3	16.1	10.4	11.1	27.0	9.4	11.4	11.5	8.3	12.0	12.2	17.8	14.1	11.3	6.7	17.3	12.1	14.9	9.8	13.2	11.1	8.6	19.0	20.1	16.9	26.4	12.3	19.6	29.6	0.1	18.5	21.9	22.7	20.6	19.7	13.3	26.7	17.1	24.3	25.7	15.4	9.1	21.1	25.4	17.6	17.4	28.7	23.0	11.4	26.0	22.7	23.7	22.4	23.2	13.3	36.0	25.1	24.3	9.2	45.4	9.3	24.1	12.1	24.1	11.1	14.9	4.2	14.5	16.6	68.4	14.5	21.0	26.9	18.1	15.5	27.7	19.6	21.0	14.3	29.5	19.0	27.4	28.9	23.8	16.6	21.2	15.7	15.0	0.1	23.9	23.7	22.2	0.2	0.9	0.3	0.9	1.2	0.8	1.1	0.9	0.9	0.8	1.5	1.1	1.2	0.0	1.2	1.5	1.8	0.3	0.5	16.9	16.4	18.5	21.9	16.6	17.0	16.0	16.7	16.1	17.8	17.3	19.0	67.5	60.9	72.6	78.4	68.5	26.8	57.9	19.8	74.0	221.5	45.3	38.2	58.9	55.8	45.6	25.8	204.3	55.4	72.1	70.3	33.2	62.8	18.8	78.0	74.0	62.4	51.4	39.3	151.7	71.1	25.9	49.4	74.9	54.4	58.9	107.1	49.2	53.3	42.7	84.1	134.5	57.6	16.2	65.7	37.8	13.4	36.1	70.3	19.6	84.3	76.9	72.2	72.1	121.7	171.0	53.3	50.4	37.2	59.6	90.3	50.9	75.6	48.4	173.4	98.6	71.9	52.1	88.2	81.5	46.1	26.7	52.1	47.0	58.5	54.5	59.9
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282429-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 213.2;skeletal muscle: 580.7;tongue: 177.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 81.7;Ductal cells: 35.5;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 46.5;Skeletal myocytes: 17.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.1"	"Immune cell enriched"	"Detected in single"	17	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 3.6"	"Group enriched"	"Detected in some"	8	"HAP1: 7.3;NTERA-2: 15.6"	"Region enhanced"	"Detected in some"		"amygdala: 3.1"					HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	0.4	9.3	1.5	0.0	0.9	0.0	0.3	0.9	5.1	0.9	0.1	0.3	4.3	0.8	24.5	5.0	0.8	0.2	213.2	2.3	0.0	1.7	0.1	0.2	0.2	0.6	0.3	0.5	0.5	0.0	0.1	0.0	0.3	3.4	0.0	0.0	9.5	0.1	580.7	0.9	2.1	0.0	0.3	0.9	0.1	22.3	0.1	0.1	0.5	177.3	0.0	0.1	0.5	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	15.6	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	1.5	0.9	0.9	5.1	2.3	0.0	0.6	0.3	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.4	81.7	10.0	0.1	3.7	0.0	0.0	0.3	2.3	0.0	35.5	1.5	0.1	0.0	0.8	0.0	2.7	11.3	42.5	0.0	2.2	0.0	0.2	4.5	0.0	0.4	0.0	0.1	0.0	0.8	1.8	0.0	0.0	0.0	4.7	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.3	46.5	1.9	0.7	0.0	0.2	2.4	3.1	0.2	0.0	0.0	17.9	16.8	6.8	2.4	0.0	0.0	0.0	0.3	0.2	6.4	0.3
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32817997-32897824	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 4.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Extravillous trophoblasts: 15.6;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 4.5;Spermatogonia: 13.7"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 31.4;BEWO: 94.5;Hep G2: 63.8;NTERA-2: 84.3;SuSa: 76.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.0	0.0	1.0	0.0	1.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	0.9	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	31.4	0.0	0.0	0.0	94.5	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.6	0.0	63.8	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.0	0.0	0.6	6.9	84.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	76.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.8	0.9	0.8	0.1	0.1	0.1	0.0	0.8	0.2	0.0	9.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.7	0.0	1.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	3.1	0.0	15.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	4.5	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	3.6	0.7	0.5	0.0	0.0	0.1	0.3	13.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.1;testis: 2.6"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 16.5;Early spermatids: 17.3;Extravillous trophoblasts: 6.7;Late spermatids: 5.2;Spermatocytes: 6.4;Spermatogonia: 6.4;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	33.8	0.0	0.0	0.0	0.1	18.3	0.2	1.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	7.5	0.9	6.4	0.1	0.0	2.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	145.3	0.0	0.0	0.2	0.1	7.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.5	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	6.4	0.0	0.0	8.9	0.1	0.0	0.0	0.3
TRIP6	"MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1"	ENSG00000087077	"Thyroid hormone receptor interactor 6"	Q15654	7	100867387-100873454	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046454, CAB046460, HPA052813"	Approved		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		21000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Focal adhesion sites, Cytosol"		"CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961"	"unprognostic (7.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	42.2	43.0	34.3	15.7	39.5	15.7	42.6	36.2	41.6	59.4	40.4	45.2	9.7	74.6	16.2	63.7	49.5	37.0	39.1	32.6	36.2	55.8	41.1	33.8	14.6	40.6	36.9	50.6	39.8	46.4	16.8	27.4	35.9	42.9	8.4	5.4	46.8	56.7	10.2	55.1	21.5	27.5	36.9	20.0	27.6	18.4	38.4	16.6	50.5	5.8	12.1	47.2	52.5	37.0	128.1	63.4	26.8	126.1	37.8	44.9	131.2	82.3	79.8	101.2	94.8	55.8	143.9	5.5	81.3	87.7	128.3	94.2	38.0	149.2	27.3	19.1	58.5	0.5	117.9	0.8	99.3	66.5	7.1	81.1	94.0	67.8	108.2	64.2	52.8	19.1	83.3	1.0	90.5	286.9	1.3	99.5	92.4	52.3	50.4	47.9	27.0	12.7	65.5	42.8	9.7	1.7	67.5	192.3	78.1	43.8	20.3	77.5	86.5	149.5	145.8	167.5	186.7	1.0	2.1	0.8	92.9	7.8	230.5	0.0	1.2	0.2	0.1	2.1	0.4	2.5	0.9	0.7	1.9	2.4	1.1	0.6	0.0	0.0	3.8	5.2	0.9	0.4	34.3	39.5	36.2	41.6	32.6	36.2	40.6	36.9	35.9	36.9	38.4	37.0	24.5	48.1	38.8	14.4	8.0	131.9	151.5	144.1	78.0	0.9	48.3	55.8	13.9	38.6	87.0	60.7	0.0	113.0	12.0	9.5	80.3	106.9	1.1	22.7	46.1	26.3	4.9	6.7	0.3	84.3	90.4	54.6	40.8	44.8	8.2	55.3	23.9	28.8	44.0	1.7	0.4	12.8	34.6	8.0	59.3	2.8	65.9	17.5	37.4	5.6	20.3	94.8	0.0	4.0	6.5	95.0	13.1	72.6	16.0	72.9	3.6	130.0	34.3	4.6	72.3	50.9	104.0	4.7	4.5	68.2	98.3	132.8	7.1	58.3	18.8	155.6
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	22.0	19.8	16.5	16.2	15.3	21.1	21.0	14.7	22.1	24.3	14.8	20.0	11.8	22.9	6.3	22.3	23.6	8.9	17.3	15.5	14.7	18.0	22.1	17.3	23.2	16.0	14.8	28.7	25.4	10.0	17.2	11.3	16.8	23.0	10.9	6.5	17.0	11.4	28.8	23.4	21.7	12.5	14.2	30.6	18.9	16.8	16.2	11.6	19.2	10.5	15.9	22.3	22.2	17.6	38.6	25.3	26.9	46.0	26.7	34.1	38.7	42.1	20.9	45.3	39.1	27.4	30.8	47.7	53.6	22.9	23.7	34.8	45.2	37.3	20.9	31.3	62.8	38.0	68.7	46.5	48.7	77.2	43.1	48.4	48.4	47.3	44.1	28.9	33.8	35.2	83.7	14.9	28.6	42.6	31.7	83.3	64.0	24.2	57.5	52.5	34.6	65.8	28.3	38.2	63.5	28.9	26.2	53.7	44.8	19.4	21.0	42.8	38.2	65.1	25.5	39.8	75.1	25.6	53.4	44.1	30.3	80.7	34.7	1.8	18.9	0.6	8.9	15.0	8.6	12.4	9.6	8.6	18.2	12.9	11.1	8.5	3.7	5.6	9.9	10.6	6.9	10.7	16.5	15.3	14.7	22.1	15.5	14.7	16.0	14.8	16.8	14.2	16.2	17.6	15.5	12.8	13.1	8.5	47.5	24.0	27.0	16.8	22.8	8.9	16.6	20.2	8.3	11.5	9.6	12.9	2.1	21.7	19.6	16.6	5.9	17.3	22.4	7.9	11.7	17.6	7.2	13.0	12.0	14.9	22.6	14.3	17.9	9.8	29.8	19.7	6.1	10.8	47.7	8.4	9.1	14.1	4.1	80.0	51.0	47.9	14.0	57.4	17.8	10.3	64.8	6.1	12.3	2.5	7.5	12.8	6.8	12.8	24.2	29.0	7.8	14.2	9.2	12.6	13.1	17.5	16.1	21.1	20.0	20.7	20.6	15.5	24.4	14.6	22.5	20.3
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	5.6	6.9	7.3	5.7	8.1	6.0	6.2	10.7	8.0	8.3	5.8	8.3	4.4	7.1	4.4	5.5	7.6	4.1	4.9	6.8	7.3	6.9	6.4	4.9	7.4	7.9	7.6	9.5	7.9	3.9	6.7	3.8	7.1	8.3	3.5	7.3	6.1	4.2	4.4	10.7	7.1	4.0	6.6	8.1	6.7	3.4	7.6	4.0	7.6	2.1	4.2	7.6	7.1	9.8	4.7	5.6	7.0	6.2	4.2	3.3	3.1	4.4	3.3	4.5	3.9	3.3	4.1	8.7	3.3	3.4	2.7	5.3	3.3	5.5	4.1	3.7	5.6	7.8	14.8	3.5	7.6	8.0	5.2	3.8	5.5	4.3	7.4	5.3	4.7	10.4	6.2	3.6	3.4	3.3	8.1	6.2	6.2	5.0	6.7	8.1	2.4	4.6	4.3	4.2	9.4	9.0	3.7	4.7	4.1	4.4	5.0	5.7	4.8	3.6	5.1	5.9	4.0	4.2	6.1	6.9	2.1	6.1	7.3	3.4	2.7	1.5	3.1	2.4	3.8	3.3	2.8	3.1	1.2	4.3	3.3	3.0	2.8	2.4	1.7	2.3	1.9	1.5	7.3	8.1	10.7	8.0	6.8	7.3	7.9	7.6	7.1	6.6	7.6	9.8	13.2	3.2	8.9	30.3	20.3	7.4	11.4	8.9	15.9	16.2	13.5	16.5	7.4	14.3	8.4	3.7	6.2	16.1	11.0	7.9	11.7	11.3	2.1	7.1	14.1	12.8	13.8	13.7	25.4	12.5	8.6	14.0	13.7	9.1	14.5	17.3	13.6	8.1	8.2	16.8	27.5	14.0	8.2	10.4	9.5	0.9	14.6	12.2	10.6	19.7	15.5	15.9	25.7	37.2	45.7	10.0	6.7	23.7	9.1	14.2	11.4	9.0	7.8	13.5	26.3	13.0	11.1	4.2	5.3	9.7	7.5	12.2	16.4	12.3	10.9	9.4
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150498	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	8.8	8.7	6.9	12.2	9.8	5.2	14.5	9.6	9.6	11.2	6.7	9.3	11.2	13.9	11.8	8.5	9.2	7.2	8.0	6.5	9.7	8.8	8.7	7.8	18.2	8.5	9.0	13.5	11.5	12.9	6.8	10.7	8.7	10.4	11.3	21.7	9.1	8.1	13.1	14.7	10.7	10.1	7.0	14.1	10.0	9.4	8.5	11.3	12.0	6.2	14.6	9.5	10.3	14.9	17.5	10.0	16.5	11.5	8.7	16.9	18.0	18.0	7.1	13.4	11.1	11.9	7.0	28.7	21.8	14.4	8.9	15.4	30.6	14.0	23.1	29.0	24.2	17.2	23.1	11.6	15.7	30.0	15.4	11.9	15.5	25.5	33.3	8.4	12.4	21.0	36.6	17.9	13.6	6.7	24.6	15.6	23.0	16.7	19.9	26.0	25.0	15.7	11.1	13.6	10.7	17.9	16.6	15.8	21.6	16.1	9.3	26.1	13.0	17.8	11.9	15.1	24.3	22.8	20.0	34.0	20.1	23.5	7.0	0.2	5.8	3.1	10.5	6.1	13.0	19.9	11.3	10.6	7.0	18.7	16.8	14.0	2.5	7.9	5.1	12.8	8.6	5.6	6.9	9.8	9.6	9.6	6.5	9.7	8.5	9.0	8.7	7.0	8.5	14.9	13.1	25.6	17.0	34.0	29.0	9.7	14.2	14.2	19.9	38.9	10.7	7.9	11.1	12.8	22.2	14.7	29.2	14.2	18.9	8.0	13.7	10.5	20.9	14.3	21.0	15.7	20.4	11.3	23.1	6.1	10.2	13.7	11.7	8.0	21.5	18.7	17.9	11.4	7.6	28.6	32.1	9.9	18.3	10.1	7.0	6.0	24.8	10.3	10.6	25.3	14.7	16.6	41.2	33.7	97.4	8.5	9.6	18.4	9.0	12.6	13.0	10.7	20.4	44.7	19.7	16.0	13.4	47.6	21.9	12.2	11.9	7.3	21.5	15.8	13.6	10.0
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 9.4;Excitatory neurons: 14.6;Granulosa cells: 12.3;Inhibitory neurons: 20.0;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 37.1;SH-SY5Y: 33.8;SuSa: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071449			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles	"Plasma membrane, Cytosol"	"HPA071449: "	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	3.9	3.0	13.9	1.3	10.6	1.0	3.7	0.8	23.7	9.5	0.9	3.2	0.9	13.4	6.6	1.6	5.3	4.2	2.4	9.3	17.2	3.9	16.8	2.1	1.6	6.2	5.1	17.5	7.1	5.3	24.4	4.3	6.9	5.5	2.1	6.2	1.5	5.2	31.1	1.2	1.6	8.6	3.4	1.0	2.0	2.6	12.6	4.7	10.1	1.0	1.6	2.5	5.5	13.3	0.0	0.3	37.1	0.1	7.1	9.8	0.0	2.1	13.1	2.0	0.7	0.0	0.0	0.0	5.3	13.8	3.1	0.2	0.3	0.6	1.0	0.1	23.3	18.0	0.0	1.5	2.7	0.0	0.1	22.8	0.0	12.0	0.0	11.8	0.9	9.1	0.0	0.2	14.0	0.0	0.3	0.1	19.6	0.1	0.0	11.3	16.4	0.1	3.5	0.3	25.3	33.8	0.0	0.5	3.1	74.2	0.0	2.2	0.0	15.7	15.9	0.2	2.2	5.8	0.9	0.0	2.3	0.0	13.8	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	2.2	0.1	0.9	0.0	0.1	13.9	10.6	0.8	23.7	9.3	17.2	6.2	5.1	6.9	3.4	12.6	13.3	0.4	0.0	0.0	9.4	0.3	0.4	1.4	0.8	5.2	4.2	0.5	1.9	1.8	0.0	1.9	3.7	0.0	0.8	0.2	0.0	0.0	1.7	0.4	0.3	7.9	1.9	0.0	0.0	14.6	0.2	0.6	7.0	0.5	0.5	1.3	12.3	0.4	0.0	0.5	8.4	20.0	0.0	0.0	0.0	0.4	0.6	5.9	0.2	0.0	1.0	0.1	2.2	0.0	17.1	9.4	0.2	0.0	3.8	0.1	0.4	0.0	0.4	0.0	0.9	0.0	1.5	3.3	1.2	1.9	0.1	0.1	0.7	0.7	2.9	0.0	0.3
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 9.4;skin 1: 4.1"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 627.4;Melanocytes: 158.3"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	112	"SK-MEL-30: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: AB_2669090, HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.4	0.1	0.0	0.0	4.1	0.0	0.0	0.5	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.1	0.2	0.2	0.4	0.3	0.5	0.3	0.5	0.0	0.0	0.0	0.7	0.0	4.2	0.0	0.0	0.0	627.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	50.5	0.1	0.1	1.7	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	13.5	0.8	0.0	0.0	0.0	1.0	6.3	0.0	0.0	158.3	0.0	0.0	11.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	22.2	0.0	0.1	0.1	10.1	4.4	1.8	1.0	1.0	0.0	0.0	0.0	0.1
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 108.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.2;Oligodendrocytes: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	11.5	9.6	4.3	13.3	6.5	21.4	13.6	15.4	6.7	10.3	29.3	13.8	14.4	12.7	14.6	8.6	9.4	11.1	15.5	4.8	3.5	22.9	25.3	11.6	16.6	4.9	3.9	16.4	12.2	108.9	5.3	13.3	5.9	10.9	14.4	10.5	10.9	10.6	7.8	16.6	13.1	11.4	3.2	12.2	13.6	9.9	6.4	15.5	17.3	9.1	14.4	11.4	8.1	10.4	21.4	21.0	17.2	19.1	48.5	36.2	20.9	26.4	36.7	16.5	21.6	29.1	11.6	46.4	12.7	30.8	42.5	35.1	23.3	19.5	23.4	26.0	13.7	37.1	31.5	15.4	44.0	38.8	27.6	33.9	22.4	18.8	35.0	24.0	13.5	28.8	42.6	34.5	30.4	33.7	25.1	18.8	13.0	29.4	12.8	27.2	23.7	22.7	23.0	49.9	14.2	18.1	18.2	28.7	35.8	30.1	18.0	41.6	20.7	26.1	12.4	122.4	30.8	23.3	54.9	44.0	28.4	77.5	24.8	1.8	1.3	1.6	2.5	1.3	2.9	2.2	1.8	1.7	1.5	2.3	1.6	1.9	1.7	2.4	1.4	1.9	2.0	0.8	4.3	6.5	15.4	6.7	4.8	3.5	4.9	3.9	5.9	3.2	6.4	10.4	23.9	19.2	31.3	73.1	36.4	31.6	17.2	11.0	44.9	21.9	18.8	11.9	25.9	21.5	8.2	12.9	12.5	23.0	38.4	17.0	3.9	11.7	33.3	21.6	27.1	19.7	18.5	29.6	122.2	12.7	9.4	26.1	37.8	23.1	17.7	26.0	14.6	43.9	14.6	21.9	92.7	19.5	6.1	22.4	19.8	26.0	26.4	26.5	19.6	66.5	24.2	8.5	29.9	80.9	109.1	15.5	13.9	20.3	33.2	24.9	23.4	11.0	19.3	22.6	13.1	30.0	22.0	23.1	23.6	25.7	24.2	16.3	34.5	22.2	20.4	11.1
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557812	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.2;skin 1: 4.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.7;Plasma cells: 15.9;Proximal enterocytes: 26.1;Suprabasal keratinocytes: 24.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.3;BEWO: 5.0;CACO-2: 3.1;RH-30: 11.9;T-47d: 5.2;U-266/70: 3.1;U-266/84: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: AB_2686149"	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.1	0.0	1.1	0.5	1.1	0.5	0.2	0.1	1.1	0.3	0.0	0.9	2.0	0.0	0.1	0.2	0.0	0.1	0.0	0.6	0.3	0.0	0.6	0.1	0.3	0.4	0.3	0.2	0.0	0.1	0.3	0.2	0.4	0.1	1.7	0.2	0.1	0.0	1.5	4.8	5.2	0.1	0.1	0.2	0.9	0.4	0.9	0.0	0.0	0.5	0.5	0.2	0.3	1.8	3.3	0.0	0.3	0.0	0.2	0.3	5.0	0.1	0.0	0.0	0.0	3.1	0.8	0.1	1.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.1	0.5	0.2	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.2	0.4	0.1	11.9	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	5.2	0.1	0.0	0.0	0.1	0.1	0.0	3.1	2.7	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	1.1	0.1	1.1	0.6	0.3	0.4	0.3	0.4	0.1	0.9	1.8	0.2	0.0	2.5	2.9	5.8	18.7	3.9	0.2	10.2	1.2	0.9	0.5	3.5	1.5	0.2	0.0	0.0	0.3	2.6	8.9	1.9	0.0	0.3	0.7	0.9	1.6	0.0	0.0	1.6	0.0	0.9	3.7	6.1	0.9	0.0	1.1	0.0	0.3	0.3	5.0	0.6	2.7	0.0	0.0	3.8	0.4	3.1	0.8	7.2	0.0	0.1	2.2	3.1	0.5	2.3	1.2	2.5	3.4	15.9	5.9	26.1	2.3	0.2	1.0	0.0	6.9	1.8	0.0	1.5	2.9	24.6	0.5	1.8	2.8	0.9	3.7
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18526951	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	40.4	55.6	41.1	32.2	42.2	60.8	56.6	43.1	50.8	44.8	45.7	49.5	42.8	40.2	56.3	56.7	49.3	36.5	68.2	42.1	44.5	70.1	62.3	43.9	42.9	42.4	42.3	44.6	45.4	61.5	36.5	61.4	42.4	43.1	59.0	43.6	46.4	41.1	77.1	47.2	43.4	42.9	43.9	34.0	45.4	55.5	41.8	45.9	52.4	83.0	57.4	46.9	42.2	46.5	51.3	79.1	73.7	51.1	82.2	85.4	63.7	77.1	103.0	92.2	90.3	54.3	27.5	65.5	49.2	86.4	103.7	77.0	74.0	70.3	102.0	95.4	87.7	41.1	38.6	79.7	106.3	64.6	69.8	75.0	139.9	48.6	131.6	102.2	76.8	68.4	66.9	55.2	112.7	85.7	45.7	66.8	45.1	115.6	81.5	37.0	72.5	54.7	63.6	68.8	52.2	88.6	75.7	61.6	101.1	77.1	59.7	64.8	43.1	63.0	38.0	126.4	59.4	37.2	76.0	56.9	64.5	34.2	80.5	187.8	69.8	155.7	50.4	81.6	52.4	78.5	48.0	54.0	66.1	69.2	51.5	54.9	123.6	57.9	114.3	54.5	84.4	91.1	41.1	42.2	43.1	50.8	42.1	44.5	42.4	42.3	42.4	43.9	41.8	46.5	63.0	64.1	57.5	22.9	44.4	42.6	81.5	159.2	26.7	41.0	39.2	42.2	68.0	42.9	90.4	44.1	25.0	191.9	34.2	85.5	125.2	112.4	48.0	58.4	36.0	54.4	61.6	74.5	29.1	101.3	107.7	48.6	32.6	48.9	44.9	46.2	47.2	36.0	79.6	37.0	28.4	65.0	156.6	45.2	33.6	21.2	56.2	51.6	56.9	26.2	82.3	86.1	54.6	32.2	32.8	132.7	76.2	43.2	47.0	103.0	72.2	126.8	113.4	43.3	46.0	44.7	81.2	177.6	153.7	32.8	48.4	296.1	38.1	91.5	47.8	97.4
TSGA13		ENSG00000213265	"Testis specific 13"	Q96PP4	7	130668643-130687432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	103	"testis: 14.0"	"Group enriched"	"Detected in some"	18	"Early spermatids: 86.4;Late spermatids: 224.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022968	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA022968: AB_2671013"					"unprognostic (1.49e-1)"					"unprognostic (1.13e-2)"		"unprognostic (1.86e-1)"		"unprognostic (1.34e-1)"				0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.2	3.9	0.0	0.3	1.7	0.1	0.0	0.0	1.2	0.3	0.1	0.1	0.0	1.9	0.0	8.4	0.1	0.3	0.0	0.0	0.0	86.4	0.3	0.3	1.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.4	0.0	0.4	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.9	2.2	224.1	0.6	0.8	0.0	0.0	0.1	0.6	1.0	0.5	0.1	0.0	0.0	0.7	0.3	0.0	0.0	0.0	6.0	1.5	0.0	0.0	0.3	1.6	0.6	0.0	0.4	0.7	0.6	0.1	0.0	0.0
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31149979-31349436	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 32.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.0;Excitatory neurons: 34.4;Inhibitory neurons: 84.7;Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.2;RH-30: 46.4;U-138 MG: 32.8;U-87 MG: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	7.0	3.6	4.6	4.8	4.5	1.1	6.2	0.0	8.6	18.8	0.3	16.1	2.2	21.5	9.2	5.7	13.0	9.3	5.7	5.7	0.4	3.2	1.3	6.3	1.2	3.1	1.0	32.8	1.5	1.3	4.6	5.7	1.5	11.6	4.0	1.8	3.3	9.5	1.9	3.0	5.5	18.4	3.9	5.4	6.7	2.7	3.1	0.8	10.2	2.3	0.5	14.8	8.8	4.9	0.0	2.0	0.7	0.0	9.4	22.2	0.0	6.0	8.8	3.7	6.6	0.0	1.2	0.0	0.0	14.8	7.0	1.0	2.7	5.3	8.2	0.0	2.2	0.0	0.0	0.0	19.4	5.2	9.1	13.0	4.5	13.7	6.8	0.0	0.0	4.4	0.0	0.0	16.9	0.9	0.0	0.0	0.7	0.0	0.0	5.9	46.4	0.0	0.0	0.0	0.0	13.8	0.1	0.0	4.7	4.4	0.0	3.6	0.0	32.8	10.3	3.4	8.8	0.0	0.0	0.0	21.2	8.8	0.9	0.0	0.9	0.0	1.1	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.3	1.9	0.0	0.1	0.0	0.3	0.3	4.6	4.5	0.0	8.6	5.7	0.4	3.1	1.0	1.5	3.9	3.1	4.9	8.3	3.2	1.1	10.1	0.2	4.8	7.3	9.2	15.4	14.0	0.8	2.4	2.1	1.5	5.1	3.7	0.0	0.4	2.5	0.0	0.0	0.4	0.2	1.3	54.0	9.0	0.0	0.4	34.4	0.6	0.3	20.2	0.0	1.3	1.3	2.6	17.2	0.2	11.6	16.8	84.7	0.0	2.0	9.7	10.4	1.1	17.7	5.0	5.4	14.0	6.4	0.2	0.0	59.3	1.9	0.6	0.0	29.3	0.3	3.8	0.0	0.1	1.3	0.2	0.0	29.7	7.8	0.3	4.0	1.7	1.7	0.8	1.7	1.0	0.0	3.2
TSPAN16	"TM-8, TM4-B, TM4SF16"	ENSG00000130167	"Tetraspanin 16"	Q9UKR8	19	11296139-11326996	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 134.7"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 4868.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"basophil: 16.6;eosinophil: 19.1;neutrophil: 37.4"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 37.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA076551	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA076551: "	"unprognostic (1.06e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.06e-3)"		"unprognostic (1.37e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.69e-4)"	"unprognostic (8.81e-8)"	"unprognostic (1.98e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-3)"	"unprognostic (2.67e-1)"	0.0	0.0	0.2	0.2	0.1	5.1	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	134.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	16.6	2.2	19.1	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	37.4	0.0	0.4	0.0	0.0	0.3	0.2	0.1	0.3	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	892.5	0.0	0.1	1.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	4868.3	15.5	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.4	20.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TTC7B	TTC7L1	ENSG00000165914	"Tetratricopeptide repeat domain 7B"	Q86TV6	14	90524564-90816479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 88.8;Excitatory neurons: 116.7;Inhibitory neurons: 132.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 5.6;eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 72.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058363, HPA059577"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA058363: AB_2683692, HPA059577: AB_2684069"	"unprognostic (9.37e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.20e-6)"	"unprognostic (2.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.07e-2)"	23.7	11.6	42.9	9.1	43.4	10.2	18.1	47.1	57.2	20.1	0.7	37.9	5.0	24.2	6.1	15.5	18.0	9.2	33.2	51.0	18.7	16.9	17.6	18.5	4.1	35.7	32.2	15.8	24.7	15.7	18.2	18.4	38.7	16.1	4.4	14.4	12.8	13.9	60.9	9.3	11.0	17.6	14.6	15.4	22.4	4.2	45.2	3.5	9.5	27.9	2.7	25.4	13.1	39.6	19.4	17.2	20.0	14.8	18.2	21.5	65.5	15.5	13.2	20.2	21.7	4.5	5.1	0.2	23.6	17.4	23.9	0.4	13.1	10.8	19.6	35.3	14.1	43.6	8.9	4.1	18.3	1.0	72.8	16.1	7.1	10.9	13.2	18.5	29.4	16.9	24.7	35.3	19.7	20.5	0.5	17.2	11.4	1.1	14.8	37.8	33.0	6.6	6.6	14.4	30.5	20.9	15.4	6.3	33.3	12.7	9.0	13.3	33.7	20.6	16.1	15.2	25.4	12.0	6.3	0.2	29.6	4.1	20.6	5.6	0.2	8.0	0.1	0.5	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	1.0	0.3	0.1	0.5	0.9	0.5	42.9	43.4	47.1	57.2	51.0	18.7	35.7	32.2	38.7	14.6	45.2	39.6	13.1	3.2	1.1	88.8	0.5	2.8	2.1	1.1	0.6	13.4	2.7	2.8	21.6	2.8	0.4	5.5	16.7	13.1	0.6	0.1	1.9	2.3	5.9	1.3	5.2	7.9	1.2	2.5	116.7	2.4	7.4	7.3	0.5	2.0	7.6	20.0	10.8	9.9	8.1	30.3	132.8	0.1	4.1	5.6	4.3	3.2	6.8	7.2	12.4	36.5	2.7	6.0	0.0	69.9	70.7	0.8	0.1	7.2	0.4	3.0	0.3	4.0	5.5	17.8	26.3	9.9	9.2	1.7	1.6	0.7	2.0	30.1	1.1	2.1	0.0	1.2
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187134	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 104.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 56.3;Paneth cells: 56.9;Squamous epithelial cells: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: AB_2666770"	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	13.9	28.1	8.7	16.6	8.5	26.2	13.0	10.0	15.1	25.8	1.8	35.6	24.4	13.9	3.6	104.5	13.9	18.5	10.2	9.5	9.7	9.0	21.0	9.3	11.2	16.2	8.7	23.7	19.2	9.4	14.7	7.2	15.8	15.2	19.5	4.7	21.9	6.8	12.6	36.8	22.9	7.1	6.5	10.7	33.4	25.7	8.1	8.0	9.1	7.9	12.9	15.5	37.0	9.1	113.2	46.7	18.5	45.9	27.8	19.0	59.7	36.3	12.8	34.1	17.8	76.2	62.7	107.9	43.0	30.3	16.7	78.8	77.3	66.5	8.7	13.6	123.3	26.5	73.6	66.4	43.5	120.2	26.4	30.2	79.3	40.8	43.4	18.3	36.5	52.1	166.1	24.8	16.1	104.4	84.1	65.2	67.4	78.9	46.1	84.4	63.5	155.6	28.7	36.6	56.2	23.2	77.1	111.2	41.6	8.4	44.0	52.9	35.2	22.7	31.7	44.1	51.4	41.6	55.4	81.0	25.7	60.8	31.4	0.0	2.3	0.3	2.6	1.2	2.5	1.8	2.5	1.9	1.8	1.1	2.4	1.7	0.6	2.3	1.7	1.6	1.8	1.9	8.7	8.5	10.0	15.1	9.5	9.7	16.2	8.7	15.8	6.5	8.1	9.1	3.7	6.4	6.7	3.6	6.4	11.2	11.4	11.0	17.1	8.5	13.5	9.9	4.5	17.2	7.6	7.3	4.2	8.8	3.2	56.3	5.9	14.2	1.0	5.0	9.5	5.8	9.1	39.1	8.0	8.6	19.0	6.0	34.1	14.7	0.0	14.3	8.2	35.0	9.8	0.0	8.5	30.6	10.2	14.2	2.9	2.6	8.7	7.5	10.6	1.9	7.7	4.2	4.1	3.0	2.2	25.8	56.9	17.0	9.4	28.7	32.1	8.3	5.0	5.6	0.0	5.2	7.2	2.0	12.2	60.2	18.2	4.1	5.9	13.4	39.9	13.7
TTYH1		ENSG00000167614	"Tweety family member 1"	Q9H313	19	54415219-54436904	"Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 80.9;choroid plexus: 35.6;testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 257.6;Bipolar cells: 138.6;Muller glia cells: 653.4;Oligodendrocytes: 97.5;Rod photoreceptor cells: 155.3"	"Cancer enriched"	"Detected in many"	15	"glioma: 63.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;AN3-CA: 11.7;U-2 OS: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005725, HPA023617, HPA050655"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"HPA005725: , HPA023617: AB_10600836, HPA050655: AB_2681204"	"prognostic favorable (3.64e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.09e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.69e-1)"	0.9	0.9	64.3	0.0	67.9	0.0	3.5	64.0	80.9	4.0	35.6	10.0	0.2	1.6	0.0	1.1	10.4	0.2	3.6	57.6	59.7	1.2	0.7	0.2	0.0	69.4	66.5	1.5	19.4	0.0	17.7	0.0	63.5	3.5	0.0	3.2	3.6	0.4	3.3	5.9	2.6	0.0	67.6	1.4	2.5	53.4	69.3	0.0	0.3	0.0	0.0	1.7	4.2	66.8	0.1	0.0	7.9	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.3	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.3	67.9	64.0	80.9	57.6	59.7	69.4	66.5	63.5	67.6	69.3	66.8	0.4	3.2	0.6	257.6	0.4	0.8	1.2	0.6	0.0	138.6	44.3	42.2	1.3	4.3	3.0	0.0	20.9	0.9	1.3	0.2	0.0	30.4	3.9	0.3	0.9	2.8	1.2	0.0	26.4	0.6	0.7	1.5	0.0	0.7	0.0	13.7	0.7	0.1	0.3	10.1	3.3	0.0	0.0	0.0	1.5	4.8	1.8	0.3	23.2	19.7	0.3	653.4	0.0	48.2	97.5	2.2	0.0	0.7	0.1	1.9	0.4	0.7	2.8	155.3	6.6	2.3	7.8	2.2	5.1	0.0	0.9	4.2	0.6	0.5	0.3	1.9
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996579	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2550.5;NK-cells: 2028.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 951.8;HSkMC: 1276.5;hTCEpi: 664.0;hTERT-RPE1: 781.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	1542.7	466.8	130.3	566.5	159.9	404.7	1396.7	137.1	158.5	846.0	133.8	965.4	223.3	811.8	381.2	428.7	730.3	395.0	745.2	120.3	136.6	532.6	204.0	841.9	800.8	182.0	144.9	382.9	580.5	634.0	192.3	594.0	185.4	352.4	487.5	14.5	567.0	554.5	1446.1	1060.4	810.7	658.7	157.1	946.4	713.4	106.4	159.2	373.7	556.6	2306.2	1068.8	740.9	638.7	217.3	56.5	0.2	13.0	0.9	291.6	951.8	29.7	66.0	131.3	58.5	79.7	35.3	74.6	15.8	379.6	18.1	9.7	15.0	13.0	124.8	154.8	74.2	7.1	45.7	20.2	32.6	13.8	189.7	91.7	1276.5	664.0	119.0	206.7	781.9	23.2	61.8	184.8	121.2	30.2	76.5	31.9	180.2	36.3	112.5	48.5	28.5	107.8	498.3	151.6	122.8	61.7	99.9	283.1	80.5	239.0	26.2	29.1	266.6	56.5	160.1	10.0	304.2	108.7	169.3	170.7	13.8	39.3	86.6	86.3	1059.6	571.2	1219.2	792.2	551.3	729.8	519.3	668.8	710.4	334.4	542.4	650.2	708.5	1246.6	637.1	496.3	154.8	674.5	1684.4	130.3	159.9	137.1	158.5	120.3	136.6	182.0	144.9	185.4	157.1	159.2	217.3	2550.5	227.6	328.5	26.4	1360.4	70.7	236.9	129.8	413.8	6.5	167.4	111.2	526.0	185.8	184.4	272.2	29.2	5.0	1004.6	578.0	450.0	79.7	8.3	179.8	594.5	740.2	164.2	270.8	0.2	53.8	4.1	666.5	160.5	464.2	377.4	53.6	349.8	114.8	231.9	6.7	0.5	320.9	136.3	845.1	184.9	35.5	654.5	730.8	108.5	36.5	892.0	3.6	2028.9	45.2	55.8	225.7	459.4	447.2	639.6	370.7	79.0	169.3	155.8	3.7	1196.5	452.4	398.7	7.6	63.7	160.1	72.2	10.9	1142.8	303.9	186.9	516.2
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	12.9	15.4	10.8	11.7	11.8	13.1	17.0	11.3	12.7	13.4	10.2	15.2	8.9	16.0	12.2	11.6	14.7	9.2	20.3	10.5	12.5	17.4	13.8	10.6	14.6	11.2	12.1	26.6	11.7	21.5	11.7	12.7	11.8	15.1	11.1	14.6	14.0	13.6	10.6	9.9	8.9	17.9	11.5	11.0	11.5	11.9	11.6	12.7	19.2	14.4	16.4	15.2	11.1	13.2	19.6	16.1	27.3	19.5	30.3	32.9	41.4	32.9	30.0	30.7	26.9	34.3	16.2	51.0	29.4	28.6	45.1	15.6	31.5	37.9	38.3	31.9	27.1	40.2	49.4	67.0	19.9	81.2	24.9	25.1	37.7	39.2	37.6	24.7	27.7	34.8	70.8	38.0	39.9	16.6	39.8	27.1	72.8	29.2	37.2	37.2	56.8	23.0	26.6	25.2	21.1	18.0	15.7	42.4	53.7	29.5	23.2	29.3	18.2	13.6	37.0	37.0	40.2	21.9	42.7	35.4	30.3	29.0	39.9	9.1	6.4	1.8	10.6	8.8	10.0	10.7	9.2	9.7	9.9	9.8	13.2	14.2	0.5	15.4	6.9	9.6	9.4	5.8	10.8	11.8	11.3	12.7	10.5	12.5	11.2	12.1	11.8	11.5	11.6	13.2	30.6	16.0	23.9	17.6	34.1	25.6	40.5	32.7	58.1	34.5	32.4	42.3	29.9	20.0	28.6	16.5	4.2	44.5	21.2	7.4	78.2	36.2	19.8	28.9	38.8	31.7	13.8	18.5	28.0	59.4	51.1	34.7	15.8	29.0	21.0	32.8	21.8	29.2	33.1	50.5	22.7	19.5	22.4	30.9	22.6	19.6	43.5	26.2	21.4	14.0	39.5	27.6	37.0	30.2	24.5	32.5	8.4	61.3	35.6	45.7	12.2	64.4	18.4	22.5	13.1	44.2	36.0	34.3	45.3	44.1	22.7	22.3	29.2	55.7	25.9	31.2
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 678.4;U-251 MG: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	96.0	43.7	12.2	33.7	13.2	51.5	58.8	13.5	14.9	37.1	16.1	65.6	43.9	18.6	29.1	33.9	33.1	39.8	45.1	13.4	13.6	27.0	172.6	36.0	14.1	11.5	16.9	39.9	68.6	12.0	28.9	22.3	11.8	33.3	66.3	20.4	76.6	31.2	41.2	25.0	56.0	24.6	11.6	13.8	55.8	90.9	13.9	11.8	24.4	45.2	22.2	77.9	37.4	11.0	204.6	14.6	39.2	31.5	185.7	147.8	26.8	292.4	107.1	220.7	178.5	38.6	93.5	8.0	64.3	225.8	79.6	35.0	44.7	85.5	359.9	32.4	66.6	36.0	43.8	75.6	87.1	61.8	23.5	69.0	39.8	242.4	678.4	100.6	137.5	62.6	206.1	81.3	298.9	37.4	36.0	40.0	29.2	207.6	64.4	31.9	76.2	99.8	34.8	23.7	41.9	43.4	128.0	78.4	70.4	45.6	38.9	70.0	235.2	110.6	102.5	281.2	463.5	135.0	51.0	67.0	63.4	28.5	71.3	1.4	2.2	11.7	16.7	2.1	20.4	10.7	10.0	17.3	4.6	11.1	9.4	12.0	2.2	8.6	1.2	7.7	5.5	7.2	12.2	13.2	13.5	14.9	13.4	13.6	11.5	16.9	11.8	11.6	13.9	11.0	58.1	6.4	30.2	15.0	42.5	134.7	163.0	47.2	47.8	11.8	59.1	42.7	30.0	27.1	57.4	16.5	8.4	27.2	82.9	94.8	72.4	27.1	78.2	28.6	58.0	35.7	54.9	13.9	12.4	64.7	63.9	195.8	45.9	40.7	33.7	21.3	22.5	98.4	14.5	6.7	12.4	139.4	40.7	10.1	82.2	20.1	50.7	24.6	85.4	3.7	18.2	16.6	41.2	8.0	6.1	73.0	74.5	41.3	152.8	94.6	88.4	26.9	56.0	13.9	19.7	59.4	88.6	212.0	125.9	43.2	81.8	97.7	50.5	18.8	70.4	141.7
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 383.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473"	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	34.3	32.3	83.7	39.4	225.9	39.1	43.4	138.0	136.2	32.1	32.1	34.5	28.8	35.8	41.0	33.9	27.5	29.7	66.6	109.7	198.7	33.9	31.2	32.2	49.6	240.4	162.7	30.0	19.3	45.6	22.9	41.7	245.4	36.6	35.8	62.0	44.9	32.2	41.5	45.0	30.3	39.8	131.0	38.9	26.4	23.7	197.1	44.8	27.1	34.7	49.8	39.4	26.6	383.0	76.6	31.4	75.8	47.1	69.0	90.9	56.1	65.9	74.4	70.4	70.2	39.2	52.2	55.2	18.6	72.5	71.3	42.1	59.1	76.5	80.2	105.0	38.5	77.0	57.7	39.6	53.8	77.1	62.4	72.0	49.8	67.9	54.9	86.7	92.3	45.2	31.9	45.6	94.0	26.8	49.5	49.7	67.5	95.4	26.9	39.6	55.9	53.0	113.2	94.6	32.8	46.2	70.3	51.0	58.4	80.9	34.3	73.3	71.4	53.0	46.9	70.6	93.3	53.2	91.8	67.3	54.5	84.3	69.7	87.9	45.7	71.0	24.3	54.0	28.1	33.6	32.2	30.3	40.1	29.7	29.6	30.5	40.9	39.8	57.1	20.1	40.8	53.0	83.7	225.9	138.0	136.2	109.7	198.7	240.4	162.7	245.4	131.0	197.1	383.0	21.9	35.3	31.4	35.9	35.5	33.8	29.2	66.2	31.9	22.9	21.6	17.9	68.5	14.3	44.5	35.0	39.6	74.5	19.8	15.8	19.6	37.1	15.2	25.1	21.2	26.9	18.6	30.7	44.6	23.6	57.2	28.3	22.4	25.6	42.4	26.0	22.9	17.2	34.1	33.7	62.8	16.3	97.6	37.1	49.6	10.3	40.4	39.6	30.2	44.0	60.6	29.1	24.7	53.3	76.7	31.5	11.7	38.0	28.3	23.7	16.7	36.9	47.3	48.9	26.3	22.2	31.0	34.2	32.1	34.9	42.8	56.8	34.0	24.3	17.5	32.5
UBA52	"CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40"	ENSG00000221983	"Ubiquitin A-52 residue ribosomal protein fusion product 1"	P62987	19	18571730-18577550	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 11928.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041344, HPA049132, HPA056624"	Supported		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196"	"unprognostic (1.98e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	1161.5	955.0	823.8	793.2	845.7	2181.5	1115.4	815.0	1021.1	1262.7	808.6	984.4	531.1	938.2	966.2	1196.8	984.5	610.9	989.3	803.8	848.5	931.1	927.4	888.7	1469.5	861.9	825.6	1622.0	1664.8	844.0	758.0	720.8	858.2	917.0	789.6	235.6	1061.1	615.4	1629.9	1444.0	916.6	712.9	883.0	1239.2	989.5	755.3	853.4	1487.1	748.6	1196.7	1674.0	995.3	1107.5	875.5	1680.6	1304.1	961.2	1612.8	2437.7	2298.9	2376.3	1260.7	1738.5	2044.2	1618.9	2381.2	1521.6	2403.4	1268.0	2092.8	803.0	1103.3	1881.9	2242.7	1918.7	650.0	2938.0	1320.1	1942.1	2733.4	1770.8	2898.3	1616.2	2684.2	3008.4	1406.4	2024.7	1778.7	2083.2	1508.8	2131.5	3231.7	1769.8	2786.9	2336.4	2584.2	2162.6	3166.1	2800.9	1899.3	958.6	2769.6	2001.7	2497.0	1246.1	1505.9	914.3	2187.0	2300.9	1424.6	970.6	3681.4	1562.7	1017.6	850.0	2172.8	2271.9	1973.0	2863.7	2412.2	1386.0	3245.8	1412.8	962.6	2155.2	1163.1	1761.2	1764.2	2401.7	3126.7	2616.4	2119.8	2320.3	3025.4	2946.4	2445.0	1168.8	1864.5	1629.2	2469.2	2250.9	4829.5	823.8	845.7	815.0	1021.1	803.8	848.5	861.9	825.6	858.2	883.0	853.4	875.5	831.5	464.8	673.1	15.0	2198.0	1898.4	2027.9	1544.8	1365.8	117.9	1444.5	1279.9	332.3	1109.5	886.1	654.7	68.8	2020.5	1806.7	1264.6	1571.0	1437.7	3146.5	772.1	1337.9	1108.6	1106.6	2241.7	10.8	2271.5	2803.3	1060.1	672.2	1194.9	805.8	1061.9	1385.3	1919.9	2574.7	104.3	12.4	1812.7	710.1	3200.4	2894.6	11928.8	1875.2	2003.3	1250.4	8.4	3379.8	599.1	2276.1	11.1	23.1	1799.4	1853.6	1034.7	1202.4	2110.3	1645.1	2688.2	510.4	219.1	696.8	1483.1	2041.1	629.9	674.5	1939.2	2239.4	2282.9	1892.0	1285.6	1783.6	2426.6
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961373	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 301.3;tongue: 171.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 290.9;Late spermatids: 197.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 246.4;K-562: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		87000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favorable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	23.1	20.7	42.2	14.7	44.8	82.5	20.7	43.0	43.0	23.8	41.4	38.6	24.3	22.0	12.9	37.4	22.8	12.0	72.0	40.4	42.2	23.5	24.9	19.8	15.7	43.2	42.7	20.9	17.1	27.1	23.5	22.8	41.8	24.7	18.4	15.2	27.8	20.6	301.3	53.2	23.3	16.3	43.7	21.0	23.0	43.1	44.0	17.7	18.0	171.0	16.5	28.3	27.0	41.0	37.4	42.7	29.7	43.4	22.0	25.6	55.7	32.0	27.1	38.9	31.2	59.7	46.3	44.8	30.1	26.4	46.1	124.4	41.9	37.0	17.5	246.4	39.6	37.4	79.0	33.8	22.9	49.2	34.4	24.2	47.7	24.6	23.8	26.0	32.8	41.4	316.6	35.5	31.2	76.9	40.4	50.5	70.5	87.4	71.8	45.1	55.8	59.3	28.0	23.7	46.0	50.6	46.3	41.4	33.5	26.3	34.9	52.5	26.8	22.0	33.0	26.5	40.2	20.5	41.1	53.9	40.7	43.9	30.6	6.5	17.6	8.7	4.8	28.4	5.1	4.9	5.4	3.2	15.6	2.8	2.8	3.3	3.7	4.0	33.4	1.6	4.5	7.0	42.2	44.8	43.0	43.0	40.4	42.2	43.2	42.7	41.8	43.7	44.0	41.0	42.8	16.0	10.0	18.6	14.5	40.7	38.8	41.8	43.3	38.3	29.6	36.2	85.7	11.5	24.5	27.6	31.3	148.6	20.7	45.5	93.9	16.3	101.6	82.9	33.7	27.5	16.8	290.9	17.3	22.9	32.7	22.5	21.9	21.3	7.0	28.6	20.3	32.7	75.2	13.5	23.6	37.4	28.5	34.3	30.3	197.4	19.6	41.8	35.6	9.4	46.0	60.7	13.4	9.0	14.1	22.6	42.3	22.6	24.6	23.1	47.9	35.6	96.0	44.1	19.7	42.8	27.4	57.7	54.9	73.2	64.8	60.5	16.5	25.7	55.6	39.4
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	40.7	55.5	46.4	24.5	47.1	131.5	35.8	48.0	53.4	45.0	46.4	38.5	22.3	34.0	25.5	69.7	33.9	30.4	38.2	45.6	48.2	34.8	53.1	42.5	23.8	48.5	48.5	40.9	28.0	34.4	25.6	29.3	49.4	30.4	24.8	44.8	29.6	30.6	110.0	39.5	26.3	35.2	46.3	28.2	33.6	47.8	49.9	31.6	25.6	71.7	32.7	38.0	45.8	48.2	56.7	31.7	35.2	38.4	63.6	39.3	29.8	44.4	61.6	48.4	65.6	34.3	23.0	39.3	19.5	66.5	41.1	28.3	49.2	69.5	46.4	57.1	22.3	35.1	65.4	35.5	57.8	39.3	44.8	48.7	113.0	57.5	75.0	73.4	54.4	37.9	27.4	38.0	45.7	23.7	36.5	55.0	38.2	38.8	45.9	32.6	24.8	22.8	104.2	36.9	19.9	28.1	49.0	50.2	22.5	31.1	24.6	38.5	39.2	24.7	38.0	37.4	41.5	18.9	25.3	41.0	49.5	31.5	74.2	26.8	50.9	66.6	38.0	45.2	65.8	26.8	38.1	40.0	47.1	23.2	36.3	29.8	120.2	50.1	41.0	26.7	52.9	55.0	46.4	47.1	48.0	53.4	45.6	48.2	48.5	48.5	49.4	46.3	49.9	48.2	21.6	67.3	26.0	44.4	22.4	46.9	66.3	20.4	45.5	15.8	27.9	23.1	13.1	20.0	33.5	7.3	25.0	33.2	21.6	25.8	19.6	34.8	77.5	56.9	37.2	21.4	16.1	50.7	33.1	40.1	35.4	31.2	44.4	90.0	25.9	15.4	17.5	25.3	22.0	6.7	42.9	18.5	30.5	21.4	39.8	62.9	29.2	38.2	24.9	26.2	23.1	26.0	13.4	38.7	35.4	44.3	23.0	42.5	25.0	47.9	22.5	21.0	22.5	10.9	19.7	44.0	32.5	51.0	22.9	54.6	59.0	89.6	28.6	20.8	18.8	70.9
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.5;lymphoid tissue: 113.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Erythroid cells: 182.1;Extravillous trophoblasts: 449.1;Granulosa cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.1;T-cells: 8.2"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.3;white matter: 11.4"	"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Approved	"Plasma membrane,Cytosol"		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	2.6	2.9	0.3	21.5	0.3	78.5	4.3	0.9	0.6	6.1	0.7	26.7	21.4	5.7	0.6	37.2	1.9	2.7	1.4	0.2	0.3	1.9	2.9	5.4	45.3	0.3	0.7	1.3	1.0	0.4	0.4	20.4	0.7	1.5	30.9	0.2	5.0	0.9	0.9	18.5	20.6	10.5	0.2	15.8	13.0	16.4	1.6	113.5	1.1	0.2	69.5	6.9	12.3	0.4	312.8	223.9	390.9	188.3	10.4	24.0	225.2	238.5	121.6	390.7	278.4	743.8	345.4	327.6	233.2	115.5	475.6	294.9	2.2	260.5	395.8	141.7	213.7	101.5	168.5	196.0	3.0	145.4	241.6	7.6	27.8	265.7	257.3	57.4	193.4	206.4	1.8	261.6	325.4	516.2	243.5	41.1	237.1	350.8	529.4	256.0	354.8	1.4	134.9	105.9	226.1	188.7	378.3	271.7	154.4	196.2	276.6	209.4	70.1	341.2	298.4	236.2	473.4	84.3	2.9	369.4	208.0	103.4	328.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	1.7	0.6	0.1	0.1	0.1	2.1	2.1	0.5	0.3	8.2	3.2	0.3	0.3	0.9	0.6	0.2	0.3	0.3	0.7	0.7	0.2	1.6	0.4	0.9	0.0	3.7	0.0	17.9	17.3	7.8	39.0	5.7	0.0	8.6	14.6	0.0	1.5	9.3	0.0	0.0	129.6	3.6	27.4	0.0	1.3	12.0	5.8	5.9	9.5	1.2	182.1	0.0	0.5	449.1	28.5	25.5	9.6	5.7	119.0	18.2	3.6	92.6	0.0	0.1	41.1	50.8	20.8	18.1	6.4	0.9	24.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	7.2	0.0	37.0	12.6	6.2	0.6	1.8	0.0	0.0	0.5	19.2	52.2	50.7	83.2	11.6	31.2	13.7	2.5	68.4	18.4
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628434	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favorable (5.09e-5)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	78.4	59.9	75.8	66.9	82.0	106.9	72.6	79.3	84.2	84.2	63.0	106.8	46.5	72.8	102.6	89.0	95.0	49.8	93.7	77.9	85.8	80.1	82.6	77.0	83.5	78.7	80.4	64.3	66.5	72.8	62.3	65.5	80.0	57.0	92.8	77.2	61.0	72.3	190.3	77.9	70.4	74.3	81.9	79.3	70.2	135.6	80.1	128.0	61.3	127.3	140.2	79.7	72.8	86.4	175.9	113.9	194.3	137.0	127.9	161.7	125.4	179.6	165.5	204.7	238.6	292.0	160.6	247.8	229.1	185.7	254.0	108.8	192.6	300.2	272.5	162.4	113.7	140.1	115.0	172.1	249.9	136.9	119.7	129.9	152.0	204.9	301.8	177.4	221.8	159.5	125.0	203.1	192.9	175.5	215.3	197.2	108.1	60.4	124.0	162.7	198.1	179.6	220.4	202.0	177.5	117.0	157.1	198.7	309.4	413.4	125.2	121.6	148.9	156.4	87.6	132.5	223.5	146.0	260.0	343.8	112.3	223.2	128.0	44.1	57.0	115.9	57.7	53.7	62.1	89.2	82.1	80.9	63.3	90.7	102.5	90.3	90.7	65.1	66.2	106.1	110.8	58.0	75.8	82.0	79.3	84.2	77.9	85.8	78.7	80.4	80.0	81.9	80.1	86.4	137.1	32.1	69.8	35.9	215.4	171.8	182.3	204.8	112.7	76.3	124.8	146.9	96.4	124.4	96.5	68.0	81.3	181.4	205.8	158.0	215.2	208.4	637.0	457.2	94.2	131.0	123.4	148.8	62.0	178.4	228.0	104.8	77.5	230.9	138.8	119.4	109.9	80.6	178.0	94.2	54.4	120.8	142.4	136.4	203.4	550.0	104.4	150.8	152.9	49.6	189.5	170.7	234.8	38.2	65.7	228.7	127.1	93.6	237.3	234.8	123.8	200.9	63.9	105.1	118.3	102.2	171.2	459.7	152.5	149.4	203.7	249.6	217.1	111.7	160.4	247.1
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926436-43956136	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 32.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 30.2"					"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.86e-4)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	5.8	8.3	11.7	2.4	12.2	2.2	5.0	14.2	17.6	4.6	9.8	6.5	2.4	4.5	5.7	5.2	4.5	3.4	10.9	12.3	11.2	6.9	10.7	4.4	2.7	12.0	11.7	5.1	10.0	4.6	5.1	2.8	11.9	5.7	2.9	6.9	5.6	4.4	32.5	4.9	3.9	4.4	11.8	4.7	4.6	3.0	11.5	2.7	4.9	27.8	2.7	5.3	5.2	12.7	4.9	4.0	2.4	11.0	11.0	4.5	1.8	2.3	5.8	2.9	3.7	2.1	5.6	4.6	6.3	6.3	8.1	5.3	3.1	2.5	4.4	10.5	5.4	5.0	5.8	5.4	4.1	10.9	9.8	3.4	5.2	3.3	5.0	4.2	3.6	5.5	5.6	9.2	4.0	3.0	6.5	6.1	5.4	5.9	5.1	4.0	3.3	7.1	6.2	5.9	8.8	30.2	5.0	9.7	3.8	4.4	4.9	3.3	3.2	1.9	6.0	4.1	6.9	13.5	10.8	2.2	5.7	14.2	10.9	10.2	14.5	17.5	11.1	23.8	11.4	12.8	13.5	12.5	15.1	12.7	16.2	13.4	1.4	9.9	28.7	13.0	12.6	8.8	11.7	12.2	14.2	17.6	12.3	11.2	12.0	11.7	11.9	11.8	11.5	12.7	14.9	0.0	6.5	8.8	10.4	6.2	9.1	9.4	4.0	9.6	24.3	24.3	24.6	14.3	10.0	16.5	2.1	11.9	11.9	8.4	54.8	18.7	6.2	8.9	7.2	12.9	18.7	9.9	14.2	28.4	20.3	14.9	8.2	8.7	4.5	11.1	12.5	25.4	27.4	11.8	13.5	8.0	8.2	11.6	14.1	10.7	12.2	12.5	16.0	8.4	18.4	18.8	5.2	20.1	12.1	14.1	7.6	21.8	11.2	12.1	15.5	52.0	5.5	11.6	6.6	23.0	10.5	15.6	9.6	10.8	11.2	7.7	8.8	16.5	8.4	12.3
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698109-39782792	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		390000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	29.9	19.4	13.5	23.4	17.5	21.4	21.7	20.9	24.5	16.0	9.2	35.8	31.2	17.8	17.7	26.2	12.7	12.9	18.4	18.3	14.9	26.7	45.4	16.4	20.1	12.9	14.0	13.6	13.2	20.4	15.8	24.4	13.1	19.8	24.2	21.0	16.9	14.9	37.3	22.6	24.8	17.2	7.8	18.0	31.8	16.5	14.2	22.4	23.8	25.6	18.0	20.2	17.2	16.0	91.3	90.7	49.3	45.6	29.8	28.7	82.8	122.8	26.4	32.8	34.0	138.0	91.1	114.3	105.2	35.0	79.8	39.0	95.4	54.7	51.9	76.1	70.0	145.7	88.9	121.6	38.4	159.0	79.6	27.1	60.2	46.0	49.0	35.2	43.3	49.3	152.9	39.6	33.9	86.6	111.5	89.9	67.7	54.4	69.8	66.3	144.0	44.2	46.0	123.9	103.9	47.4	91.7	34.5	58.9	54.1	44.4	58.2	116.9	49.9	105.7	60.0	114.5	55.3	174.0	121.4	26.9	101.4	59.5	19.6	18.1	24.8	14.4	16.9	13.4	20.7	15.0	13.8	19.7	14.7	11.2	12.6	15.1	14.0	25.4	27.6	16.0	10.5	13.5	17.5	20.9	24.5	18.3	14.9	12.9	14.0	13.1	7.8	14.2	16.0	63.2	57.7	63.1	69.2	53.0	122.9	65.5	74.3	59.7	62.2	65.3	52.5	72.3	52.9	66.7	49.7	29.2	84.5	76.5	143.7	66.5	83.5	144.9	72.0	82.3	65.6	59.7	85.8	115.9	89.4	168.7	59.2	68.3	90.9	34.8	40.1	63.5	113.6	80.2	104.3	113.8	74.5	65.1	77.1	91.8	202.4	65.3	76.5	56.9	89.0	104.0	87.1	56.7	87.0	118.2	139.6	94.3	56.4	55.5	111.4	75.3	98.0	60.7	42.9	39.5	61.8	121.1	145.2	55.1	74.3	137.9	147.5	61.3	54.8	74.1	107.0
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407788	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 115.9;testis: 158.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 341.4;dendritic cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	16.3	17.6	17.1	21.8	17.3	115.9	11.0	15.7	23.7	16.8	10.9	18.5	11.4	17.2	5.5	37.1	15.1	13.1	24.8	25.2	23.8	13.0	11.5	16.2	35.7	17.0	16.5	14.8	7.7	6.8	28.8	13.6	22.2	15.1	9.3	9.4	12.0	6.2	15.5	12.0	16.2	15.0	16.7	25.7	17.6	158.3	18.9	47.8	10.3	5.7	30.9	16.2	17.8	21.3	532.9	279.4	241.3	193.8	15.3	21.6	42.9	419.3	126.1	253.2	229.1	191.1	183.6	508.6	169.5	106.4	304.5	152.9	243.6	109.5	111.4	402.0	810.5	305.8	162.8	62.5	45.1	370.0	286.0	23.8	30.2	186.7	179.1	55.0	100.6	272.7	310.0	347.0	161.3	139.5	503.2	191.3	605.3	147.2	470.6	437.4	185.5	185.8	69.2	111.5	609.3	330.0	534.5	131.2	248.6	72.6	93.8	198.1	155.9	151.9	432.8	130.7	1013.5	277.1	734.4	617.0	159.2	257.5	562.7	0.5	0.8	1.3	0.7	0.6	0.5	2.5	1.0	1.0	0.6	0.6	1.0	0.5	2.4	0.2	0.4	1.3	0.4	0.1	17.1	17.3	15.7	23.7	25.2	23.8	17.0	16.5	22.2	16.7	18.9	21.3	308.0	0.0	3.4	5.9	161.3	162.6	151.2	31.5	81.4	59.3	235.9	341.4	3.1	8.6	9.9	20.2	54.2	87.8	432.7	59.2	15.6	42.8	127.5	89.3	68.2	72.5	92.6	166.5	8.7	30.5	247.9	99.3	44.9	68.0	18.4	200.9	31.8	10.6	65.5	32.0	11.0	69.1	38.7	26.8	125.3	52.2	17.4	131.7	74.7	3.7	36.7	91.1	21.6	7.5	13.5	82.3	44.1	12.4	100.6	82.9	20.4	18.4	9.7	75.7	13.1	125.2	186.7	196.9	174.0	74.1	115.9	59.8	233.3	64.6	55.8	121.1
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138916-157269370	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favorable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	25.7	17.4	12.0	21.5	13.2	16.2	21.7	17.5	14.1	18.4	18.8	22.3	20.0	19.4	13.4	28.3	18.5	19.1	28.5	13.2	14.1	20.3	22.9	19.0	20.9	14.6	13.4	20.0	22.4	36.2	11.1	17.5	14.9	19.9	23.2	20.2	22.7	22.7	65.6	20.8	20.8	29.2	12.7	18.0	20.9	26.2	14.8	18.6	17.3	58.5	22.8	28.1	17.0	15.0	68.8	53.3	33.5	67.3	58.8	61.3	37.1	74.0	63.4	61.1	61.3	48.3	55.7	36.8	64.0	82.1	79.6	42.4	52.6	68.3	72.0	67.6	48.3	37.6	35.6	35.0	58.4	56.9	52.8	54.8	61.6	68.0	55.9	46.4	72.2	30.3	55.7	39.9	87.6	59.8	56.2	35.9	53.3	61.1	63.6	31.9	37.7	75.9	63.2	74.1	53.5	55.2	72.8	61.9	54.5	37.2	32.0	39.3	65.3	76.6	16.5	190.0	93.3	39.7	42.9	37.0	87.7	83.0	89.5	0.3	1.8	1.1	2.2	2.3	3.0	1.1	2.4	2.4	2.0	1.2	2.2	2.7	0.6	2.1	2.5	1.8	2.8	1.5	12.0	13.2	17.5	14.1	13.2	14.1	14.6	13.4	14.9	12.7	14.8	15.0	23.8	22.4	19.7	52.2	14.2	27.5	17.3	19.0	17.6	34.7	22.4	16.9	33.7	22.8	14.2	25.8	66.7	14.9	25.3	27.3	9.8	20.3	11.6	21.6	27.4	23.4	24.5	14.9	98.9	17.7	17.4	19.6	27.0	24.5	9.5	23.0	23.6	48.3	15.4	32.0	100.7	21.8	12.2	27.6	15.2	10.1	15.5	20.6	5.4	52.5	22.0	9.9	26.8	81.4	96.2	27.5	13.4	25.6	17.5	31.5	20.6	19.1	19.8	39.9	0.0	23.1	21.4	26.6	27.3	37.5	33.2	15.1	20.9	22.3	26.2	28.1
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563627-56567868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.8	20.2	24.9	14.9	26.8	11.1	12.1	19.7	30.6	15.9	12.7	15.7	11.2	16.6	15.9	18.7	17.5	14.5	21.6	27.4	25.5	13.5	19.4	13.8	18.4	20.2	20.4	25.7	10.5	23.6	16.3	15.8	22.1	20.2	12.1	22.2	14.4	20.0	28.0	13.6	12.4	18.4	21.3	14.9	13.1	4.4	22.6	18.9	20.7	22.8	18.6	18.6	11.1	25.5	36.3	26.5	25.9	30.6	58.3	37.0	16.3	28.6	33.9	21.0	23.2	14.9	16.6	27.6	30.5	34.0	32.9	20.7	50.0	31.9	25.3	43.0	30.1	11.2	34.2	15.9	30.6	22.1	23.7	34.7	39.6	28.3	24.6	30.3	18.7	17.6	13.3	29.5	33.6	16.9	28.5	19.2	21.7	11.6	31.1	25.3	33.7	26.3	42.8	27.9	31.9	29.9	41.3	18.1	17.4	45.2	30.4	16.1	21.2	22.2	22.5	32.4	17.5	11.1	14.8	18.9	24.9	23.1	19.3	50.0	23.6	24.1	15.1	31.1	17.1	7.8	22.9	17.7	17.8	8.6	30.3	18.9	20.4	20.9	34.2	6.5	23.5	20.3	24.9	26.8	19.7	30.6	27.4	25.5	20.2	20.4	22.1	21.3	22.6	25.5	13.9	22.4	17.2	0.0	30.5	31.2	41.6	27.4	20.5	42.3	14.5	11.3	37.6	15.7	25.0	18.4	18.8	28.8	15.4	12.1	17.6	20.0	0.1	11.8	22.7	18.9	34.2	18.3	0.0	16.6	26.7	27.9	13.7	15.7	12.7	14.2	18.2	20.3	24.7	42.1	0.0	20.3	18.3	30.7	25.3	1.6	24.8	21.1	17.8	0.0	35.9	22.3	42.2	0.0	0.0	18.9	12.7	36.5	23.5	32.0	20.7	16.4	27.5	35.8	13.1	25.4	29.8	0.3	1.5	32.7	30.4	40.0	28.7	12.2	19.3	35.6
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564029-42693505	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.5;Inhibitory neurons: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	11.0	10.7	8.5	12.7	10.1	17.9	12.9	14.1	11.1	10.3	11.3	12.7	14.4	10.9	11.2	9.5	9.4	8.6	11.2	9.0	8.8	12.1	17.2	11.9	12.7	9.0	8.7	12.2	15.6	15.0	8.8	11.7	9.3	10.5	13.8	29.7	12.0	10.0	22.8	12.2	13.8	10.6	8.6	15.3	12.2	6.2	9.1	13.5	13.3	22.3	11.5	10.8	10.4	14.2	18.5	9.0	10.4	16.4	20.9	20.0	14.0	13.8	14.9	12.0	12.4	13.2	7.4	12.5	10.7	15.0	13.9	18.1	15.1	11.8	15.2	17.1	10.6	20.0	13.3	17.3	17.0	19.6	13.1	14.1	12.7	12.0	12.9	14.8	13.7	17.9	23.7	15.4	11.7	14.9	15.4	17.1	9.5	36.2	8.7	13.6	15.5	19.0	13.8	15.7	12.4	9.8	14.0	13.3	13.9	15.7	13.0	18.7	19.8	10.8	8.4	13.5	10.1	14.1	13.4	18.9	5.7	14.5	6.8	17.7	7.1	15.2	6.5	7.3	5.4	5.2	4.2	5.1	5.5	5.2	4.3	4.8	38.5	5.9	9.8	4.1	5.3	3.4	8.5	10.1	14.1	11.1	9.0	8.8	9.0	8.7	9.3	8.6	9.1	14.2	33.5	16.0	24.6	82.6	33.9	16.6	18.1	14.9	28.5	43.0	20.4	15.9	39.3	30.0	22.1	20.2	60.5	17.4	46.6	51.6	17.6	18.5	12.4	27.5	30.8	24.8	12.6	75.1	138.5	15.3	13.4	26.5	34.1	32.9	20.3	31.3	21.8	35.0	13.2	63.9	142.7	22.5	14.2	26.7	28.6	3.9	25.4	26.1	19.6	87.1	43.0	23.5	32.0	123.1	131.4	15.0	29.1	24.0	50.6	22.8	37.2	11.7	27.9	53.5	39.5	30.0	27.2	11.2	10.9	28.1	16.2	17.2	44.0	24.0	21.5	22.7
UBTD1	FLJ11807	ENSG00000165886	"Ubiquitin domain containing 1"	Q9HAC8	10	97498924-97571206	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 6.4;neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034825	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA034825: AB_10602254"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.66e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.78e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.50e-3)"	18.8	11.1	14.9	5.7	15.2	8.8	14.7	16.8	17.0	16.5	12.6	10.3	1.8	13.5	4.0	9.5	13.6	7.0	35.1	13.5	15.8	29.2	18.6	29.8	3.1	17.7	17.1	8.7	9.6	3.6	15.9	3.8	16.2	13.4	0.6	6.0	11.2	7.5	34.2	49.5	5.5	3.6	16.1	11.0	9.4	60.3	18.9	1.6	14.6	11.2	1.1	12.4	16.3	14.6	18.1	17.7	4.6	23.0	18.9	17.8	5.4	20.3	29.4	21.3	16.3	12.0	15.4	2.2	24.1	13.8	13.4	21.4	4.6	27.2	3.0	5.6	9.1	2.2	5.5	15.2	27.2	2.0	5.9	24.6	9.0	23.3	5.7	32.8	34.3	4.7	1.2	3.3	13.9	8.6	0.9	18.5	7.5	3.4	32.1	1.8	8.1	2.1	16.7	6.7	1.5	4.8	9.2	5.6	27.1	4.0	20.8	13.6	37.5	26.9	16.4	28.4	26.8	4.2	5.1	0.9	22.7	12.3	14.3	1.0	2.6	6.4	0.1	0.7	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	6.6	0.0	0.7	0.9	0.3	0.5	14.9	15.2	16.8	17.0	13.5	15.8	17.7	17.1	16.2	16.1	18.9	14.6	5.0	41.7	28.6	13.1	1.1	26.0	8.8	32.2	19.4	3.8	10.0	4.8	15.5	8.6	21.2	7.3	4.2	3.5	0.6	1.5	11.7	18.9	53.5	8.2	8.7	23.8	0.0	0.4	5.6	12.8	12.8	11.6	2.6	4.0	0.0	0.8	7.9	7.0	25.8	6.7	5.9	0.2	10.2	10.1	18.9	33.8	12.8	10.3	10.6	12.2	8.4	16.5	2.1	2.0	14.5	22.1	0.1	9.4	3.0	14.0	0.0	10.4	19.1	18.6	13.1	8.5	10.3	7.5	7.9	8.2	29.7	2.9	1.9	1.5	0.4	7.6
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000277-74009085	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	80	"skeletal muscle: 393.2;tongue: 263.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Late spermatids: 14.0;NK-cells: 6.2;Skeletal myocytes: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	1.2	1.7	2.5	1.3	2.6	2.2	1.3	3.9	3.0	1.4	2.3	1.7	0.7	1.4	2.0	2.9	1.5	0.8	2.4	2.7	2.1	1.7	1.3	1.4	1.3	2.4	2.1	1.1	1.1	0.9	2.7	0.5	2.3	1.8	0.7	4.0	3.7	0.7	393.2	1.4	1.7	0.8	1.8	3.1	1.2	3.9	2.4	1.6	2.6	263.1	0.7	1.4	0.9	2.8	0.2	1.8	1.7	1.5	0.7	0.3	0.3	0.5	0.4	0.4	0.2	0.4	0.4	0.9	0.2	0.3	0.2	1.9	0.7	0.3	0.7	15.8	0.5	0.3	2.4	0.2	0.5	1.1	1.4	0.4	1.1	1.1	0.1	0.3	0.5	0.9	0.4	1.2	0.6	1.0	0.7	1.4	0.9	1.4	1.1	1.4	3.6	0.5	0.9	0.5	0.9	1.0	0.4	0.7	0.6	0.3	0.2	1.0	0.3	0.2	1.1	0.6	1.1	1.4	1.5	0.7	0.2	1.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.5	2.6	3.9	3.0	2.7	2.1	2.4	2.1	2.3	1.8	2.4	2.8	0.8	0.0	0.0	1.6	0.8	0.1	0.1	0.5	0.6	2.3	1.0	1.1	0.7	0.0	1.1	0.0	0.0	0.3	2.0	0.3	0.0	0.3	15.4	1.2	1.1	0.6	0.0	0.4	1.6	0.5	0.2	0.4	0.0	0.8	0.0	0.7	1.1	0.3	0.7	0.0	1.6	0.5	2.0	0.8	0.0	14.0	0.0	0.6	0.0	1.0	0.7	0.8	6.2	0.5	0.6	0.4	0.1	0.7	0.5	0.2	0.3	0.1	3.0	2.1	0.0	6.5	0.5	1.5	0.8	0.4	0.3	0.3	1.5	0.3	0.6	0.1
UNC5A	"KIAA1976, UNC5H1"	ENSG00000113763	"Unc-5 netrin receptor A"	Q6ZN44	5	176810519-176880898	"Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 30.4;pituitary gland: 14.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 54.4;Inhibitory neurons: 19.4;Muller glia cells: 13.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.5"	"Group enriched"	"Detected in many"	6	"amygdala: 10.5;basal ganglia: 15.1;cerebral cortex: 30.4;hippocampal formation: 16.3;white matter: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 86.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071450			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA071450: AB_2686397"	"unprognostic (5.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.66e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.07e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.77e-5)"	"unprognostic (6.39e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.17e-2)"	0.4	7.5	10.5	0.3	15.1	0.4	0.7	2.6	30.4	0.3	0.0	0.1	0.4	0.4	0.2	0.1	0.6	0.2	0.3	16.3	0.0	0.1	0.1	0.3	0.9	0.0	0.0	0.1	1.8	0.0	14.7	0.0	0.0	0.2	0.0	3.1	2.5	0.0	0.0	0.5	0.1	0.1	0.0	0.1	1.0	0.7	0.0	0.1	0.5	0.0	0.0	0.2	0.1	11.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.4	3.5	0.0	0.0	0.0	2.5	10.1	0.0	86.4	3.9	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.5	15.1	2.6	30.4	16.3	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	4.7	0.6	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.1	0.9	0.0	0.0	54.4	0.0	0.0	0.0	0.0	1.6	0.0	2.0	0.0	0.0	0.0	5.0	19.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	4.7	0.0	13.9	0.0	7.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNC79	KIAA1409	ENSG00000133958	"Unc-79 homolog, NALCN channel complex subunit"	Q9P2D8	14	93333219-93707876	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;pituitary gland: 11.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 524.0;Inhibitory neurons: 463.6;Oligodendrocyte precursor cells: 270.4;Oligodendrocytes: 202.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 4.3;SCLC-21H: 3.0;SH-SY5Y: 1.9;U-937: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071881			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA071881: AB_2732189"	"unprognostic (8.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.70e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.73e-3)"	"unprognostic (8.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.47e-2)"	0.0	0.7	2.2	0.0	2.8	0.0	0.0	5.1	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.1	1.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.2	11.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	2.5	0.4	0.0	0.1	0.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.3	0.0	0.0	0.1	0.1	3.0	1.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	5.1	4.7	2.1	1.9	0.0	0.1	0.0	0.0	0.4	2.3	0.3	0.0	0.0	89.8	0.4	0.3	0.3	0.5	0.0	41.9	0.3	0.3	2.8	0.0	0.1	0.0	10.4	0.1	0.3	0.7	0.0	0.3	36.9	4.8	0.9	0.6	0.0	0.4	524.0	0.2	0.1	0.6	1.1	0.8	0.0	0.3	0.4	0.2	0.3	40.4	463.6	0.3	0.0	0.6	0.4	16.4	0.6	0.4	0.0	23.4	0.1	2.1	0.0	270.4	202.6	0.4	0.1	0.4	0.0	0.3	0.6	1.9	0.9	5.7	0.0	0.5	0.8	3.4	2.5	0.2	0.3	0.7	0.2	0.5	0.2	0.3
UQCC1	"BFZB, C20orf44, CBP3, FLJ10850, UQCC"	ENSG00000101019	"Ubiquinol-cytochrome c reductase complex assembly factor 1"	Q9NVA1	20	35302566-35412031	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 64.6;Inhibitory neurons: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034875	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA034875: AB_10603226"	"unprognostic (9.66e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.45e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.34e-2)"	19.4	30.0	22.0	13.8	24.3	4.6	16.5	21.9	27.7	20.1	20.9	26.0	18.9	18.6	22.9	18.8	20.6	12.6	55.3	22.4	23.0	28.6	27.1	15.8	17.9	24.1	23.5	19.8	15.9	37.2	23.9	14.9	26.6	19.7	25.8	29.5	18.7	18.4	106.8	16.3	19.3	18.5	19.9	19.7	23.0	17.6	22.9	21.2	22.3	105.7	21.9	20.1	18.0	22.8	20.2	28.6	33.5	32.2	34.1	38.4	4.8	38.5	43.3	70.7	48.1	97.7	39.4	66.6	68.5	26.1	60.7	53.5	60.0	70.0	52.6	19.0	24.2	89.2	41.3	80.3	22.7	54.2	25.6	37.6	72.3	37.9	48.8	51.2	24.6	53.5	39.9	23.9	50.0	26.8	58.6	29.2	25.4	42.0	61.5	31.4	50.0	37.9	67.6	26.2	46.4	28.7	32.9	148.9	34.0	28.1	23.9	34.6	23.5	46.2	28.8	25.9	34.6	30.1	37.2	26.5	79.7	31.1	36.8	28.6	10.2	14.2	14.8	14.3	18.3	12.3	13.7	14.7	16.0	15.7	16.7	14.7	0.3	22.3	10.2	14.4	14.2	12.6	22.0	24.3	21.9	27.7	22.4	23.0	24.1	23.5	26.6	19.9	22.9	22.8	7.0	0.0	7.8	51.6	7.0	6.4	9.3	18.1	6.8	20.7	7.8	5.8	44.0	10.0	11.8	16.5	8.4	22.9	5.3	13.9	60.7	18.2	15.1	10.5	8.5	10.5	12.0	5.2	64.6	13.1	15.7	9.2	7.7	6.9	8.2	17.5	6.1	14.2	11.6	18.5	68.9	9.1	18.3	6.6	3.9	8.6	10.5	5.8	14.2	33.7	13.2	16.7	10.3	44.2	50.3	19.1	6.6	12.0	5.0	8.4	10.9	19.4	14.8	22.8	6.6	9.6	11.9	24.6	18.2	6.2	5.3	17.4	6.2	19.7	13.2	9.6
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381711	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 168.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 460.0;Late spermatids: 1094.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 14.5;U-266/70: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	7.0	13.4	11.9	1.6	22.6	1.9	4.1	18.8	19.0	6.0	32.7	10.2	13.9	5.2	5.7	9.8	11.6	2.3	73.5	18.6	9.4	53.4	18.9	3.4	0.1	12.0	13.1	6.2	18.1	24.2	18.9	1.3	7.7	4.1	6.0	76.2	7.6	3.0	168.3	12.8	17.4	6.8	8.2	0.6	6.2	86.5	15.1	0.6	3.8	62.8	0.6	4.5	4.8	17.5	6.0	0.5	0.9	3.2	0.1	0.2	1.3	0.7	0.4	0.0	0.6	6.1	0.8	10.2	1.8	1.1	1.4	1.0	7.9	2.9	0.2	7.2	1.0	2.8	4.4	12.5	2.7	0.0	2.8	0.9	0.6	0.7	2.0	1.3	0.6	7.6	14.5	0.8	1.7	4.1	0.0	0.6	1.6	2.0	1.3	0.1	2.1	1.5	4.6	0.3	11.9	3.6	3.4	2.6	0.7	1.7	8.8	6.2	0.0	0.0	1.5	0.8	1.0	56.9	13.5	0.2	0.1	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	22.6	18.8	19.0	18.6	9.4	12.0	13.1	7.7	8.2	15.1	17.5	0.6	3.2	2.7	10.7	0.6	2.4	5.3	1.5	1.2	75.2	3.3	2.4	85.2	7.2	6.1	5.5	95.9	0.5	1.6	25.5	113.5	3.1	460.0	39.0	3.0	3.6	0.0	0.4	15.7	1.6	0.9	7.4	2.0	8.4	0.0	2.0	2.2	23.0	17.2	10.1	11.6	2.0	0.0	1.3	2.9	1094.1	6.5	2.1	0.0	1.9	0.0	49.7	0.0	8.0	12.5	1.2	11.8	7.2	0.1	1.1	41.3	41.6	35.0	140.0	19.7	43.3	24.0	50.5	16.5	12.9	4.0	1.4	1.3	0.5	2.6	2.9
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881828	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 95.9;K-562: 60.2;MOLT-4: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	8.1	12.0	8.7	13.5	8.0	22.6	8.3	4.8	8.7	12.5	2.5	13.6	8.2	12.5	4.2	7.9	12.1	7.7	7.5	7.8	10.6	7.6	7.4	8.4	18.3	10.2	9.1	13.5	10.9	8.4	18.4	6.7	10.0	14.8	4.9	6.7	11.4	13.2	10.9	12.1	12.5	8.2	5.4	13.9	9.9	10.0	8.9	32.3	18.7	7.5	11.8	14.9	10.1	6.5	6.0	5.8	10.0	13.4	12.8	10.8	14.1	9.5	7.9	7.1	4.9	4.7	6.5	8.1	8.0	9.3	8.0	14.7	6.0	6.7	2.9	43.4	7.9	14.9	17.0	3.3	8.8	14.2	10.6	9.6	9.8	9.3	7.0	12.4	7.7	95.9	60.2	9.9	4.4	15.9	56.4	33.6	7.9	12.7	13.6	9.4	11.2	14.0	5.5	6.5	2.2	11.0	11.0	13.9	9.1	5.9	14.4	19.9	11.5	7.8	3.5	10.5	6.3	9.7	15.3	5.7	15.5	18.6	7.4	1.0	1.9	5.4	8.6	1.5	9.1	3.7	8.7	8.3	2.6	3.4	9.8	8.9	2.8	10.0	1.5	2.1	11.5	6.3	8.7	8.0	4.8	8.7	7.8	10.6	10.2	9.1	10.0	5.4	8.9	6.5	3.0	9.6	6.9	16.3	9.2	2.8	2.2	2.5	4.0	7.8	6.4	8.0	7.7	4.3	3.0	1.8	4.2	5.9	9.4	6.2	3.9	2.4	2.1	4.1	6.3	4.3	8.4	12.8	17.0	4.0	2.5	4.6	8.2	5.7	1.3	6.8	6.4	6.1	3.3	10.1	21.1	4.6	4.1	1.6	3.8	3.3	6.2	6.0	3.6	11.2	3.1	5.3	11.3	9.5	14.3	2.7	5.0	4.9	6.7	3.0	4.1	2.9	5.0	6.3	0.0	4.3	5.7	12.1	6.0	4.8	2.0	6.2	19.3	2.9	5.2	1.6
USP53	KIAA1350	ENSG00000145390	"Ubiquitin specific peptidase 53"	Q70EK8	4	119212587-119295517	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 586.8;Microglial cells: 269.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 327.9;SK-MEL-30: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035844, HPA035845"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA035844: AB_10669532, HPA035845: AB_2674817"	"unprognostic (9.33e-2)"	"unprognostic (1.49e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (4.37e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.54e-6)"	"prognostic favorable (3.58e-8)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	37.8	14.4	5.6	5.7	5.8	0.9	25.3	6.1	6.2	18.5	11.8	16.3	5.7	13.1	13.1	17.0	30.6	10.2	24.0	4.9	7.3	19.9	7.3	29.4	12.4	9.4	8.1	9.4	24.6	8.1	10.3	10.5	7.3	9.2	16.1	3.4	12.7	11.5	33.5	11.7	9.7	10.2	6.5	7.2	15.1	7.8	8.6	5.4	10.5	51.7	8.0	12.7	12.0	5.5	11.4	6.8	2.4	0.0	60.5	60.4	13.6	70.6	327.9	6.2	8.1	7.4	10.4	46.1	2.5	21.1	12.1	5.5	5.5	5.3	16.1	6.1	4.5	3.1	5.2	2.6	47.2	3.9	0.7	20.3	15.0	21.9	31.0	11.7	29.8	3.0	7.3	1.7	8.4	2.5	2.9	5.2	6.7	7.0	3.8	0.9	11.4	9.2	16.4	7.2	3.8	3.0	3.9	27.5	102.4	13.3	7.0	2.7	32.3	2.0	7.0	26.3	6.4	3.3	5.2	7.8	31.4	1.7	7.9	1.3	0.0	0.0	0.4	0.0	0.5	0.7	1.0	0.8	0.1	0.7	1.9	1.0	0.2	0.9	0.0	0.3	0.9	0.3	5.6	5.8	6.1	6.2	4.9	7.3	9.4	8.1	7.3	6.5	8.6	5.5	27.6	35.3	44.5	80.6	18.5	61.8	73.6	21.2	48.3	17.8	74.1	46.6	99.0	32.9	33.9	119.5	29.2	48.4	15.1	207.8	45.0	33.4	5.6	167.2	45.9	35.7	34.6	4.8	32.4	62.7	17.3	86.0	41.8	586.8	70.8	19.8	23.9	30.5	9.3	25.2	32.5	80.4	52.9	21.3	76.4	7.3	19.0	36.5	14.2	269.8	45.6	25.0	12.3	11.6	11.9	110.6	214.5	10.9	18.6	138.6	46.0	20.1	27.3	31.5	6.6	91.8	32.9	18.0	4.0	62.6	42.3	49.8	26.8	14.8	62.6	124.8
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20 small subunit processome component"	O75691	12	101280105-101386618	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	"Plasma membrane"	"HPA049341: AB_2680720"	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	4.3	4.2	2.2	5.0	3.7	4.2	5.7	2.9	2.7	5.7	2.5	3.2	2.1	4.6	2.6	4.0	3.8	2.4	3.0	2.3	2.5	3.3	3.0	3.0	5.0	2.8	2.8	6.4	4.8	5.3	2.2	4.3	2.9	3.5	4.2	3.5	5.6	3.3	5.2	4.6	3.1	4.0	2.4	3.6	3.2	5.6	3.3	4.3	4.2	3.9	4.8	5.1	3.5	5.0	8.1	19.9	14.8	6.9	13.0	15.1	18.2	13.8	10.8	21.5	11.8	23.1	5.7	21.6	7.1	15.4	16.2	16.6	33.0	14.2	27.8	9.8	13.4	22.8	10.0	17.3	7.3	38.4	10.2	9.9	7.3	29.9	10.3	8.2	15.0	10.9	36.7	4.3	15.8	10.6	16.8	10.9	38.9	11.3	20.6	18.8	24.2	16.8	9.1	24.4	17.0	11.5	25.8	16.1	15.7	12.2	17.0	8.5	17.1	25.3	12.5	17.8	27.1	7.8	12.6	35.1	13.8	17.2	39.6	0.0	0.2	0.0	0.5	0.3	0.5	0.9	0.5	0.7	0.4	0.6	0.6	0.7	0.0	0.6	0.2	0.8	0.5	0.2	2.2	3.7	2.9	2.7	2.3	2.5	2.8	2.8	2.9	2.4	3.3	5.0	14.3	9.6	9.9	16.0	16.7	10.1	9.7	7.7	11.4	9.9	8.7	8.4	10.3	7.2	13.6	3.7	10.4	7.8	4.4	3.4	5.9	7.6	1.5	11.4	24.5	12.6	6.6	14.9	17.0	11.6	8.8	13.0	7.7	10.1	13.3	18.6	7.1	7.6	5.8	21.9	17.0	6.3	4.1	6.3	3.5	1.2	9.6	8.6	3.6	8.4	3.3	3.3	4.1	16.1	34.2	5.9	1.9	8.2	13.2	14.5	1.1	3.0	9.0	9.4	6.6	24.9	11.0	22.6	22.3	17.3	11.1	2.9	10.0	23.7	9.8	7.2
VAMP5		ENSG00000168899	"Vesicle associated membrane protein 5"	O95183	2	85584431-85593406	"Predicted membrane proteins"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 487.9;Endothelial cells: 337.8;Hepatic stellate cells: 486.2;Kupffer cells: 340.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 364.7;LHCN-M2: 428.9;TIME: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035082	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA035082: AB_10610564"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (9.61e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.60e-1)"	134.0	117.4	71.0	59.9	74.1	41.2	118.4	72.9	89.1	78.6	66.8	76.4	23.3	79.4	33.2	45.3	84.3	58.0	114.7	69.4	76.1	90.0	79.3	134.6	92.7	79.1	71.4	52.8	29.0	14.7	31.9	74.1	74.2	72.8	20.5	2.9	36.9	36.7	217.3	44.5	54.1	77.2	73.8	97.5	54.0	11.4	78.0	50.9	63.8	199.6	41.2	87.1	69.7	71.7	0.8	0.2	2.4	0.0	89.3	155.8	2.4	98.5	155.9	95.5	104.5	39.5	15.1	0.3	2.3	172.2	50.7	1.1	0.0	2.4	42.2	142.9	2.8	1.9	2.5	56.1	187.2	4.5	0.9	108.4	9.6	40.1	1.1	138.9	364.7	61.7	0.4	0.3	428.9	14.5	63.1	13.8	0.1	27.2	0.6	92.4	0.4	2.7	2.7	3.6	0.2	3.4	0.6	27.4	0.5	2.2	3.2	5.1	250.0	2.3	6.7	7.5	0.2	0.1	3.1	2.4	110.5	5.4	65.9	59.1	222.6	176.5	180.5	503.8	171.7	60.7	136.1	135.2	79.0	54.5	102.4	125.1	70.2	94.4	424.9	86.4	248.7	283.0	71.0	74.1	72.9	89.1	69.4	76.1	79.1	71.4	74.2	73.8	78.0	71.7	487.9	19.2	21.2	3.6	43.9	60.8	39.8	104.1	39.3	0.8	14.9	27.3	84.4	71.4	70.1	44.1	0.0	22.9	64.5	38.8	29.4	29.9	1.8	7.7	64.7	337.8	12.6	35.6	0.1	49.1	7.2	148.0	9.7	7.9	44.4	22.2	486.2	198.6	80.3	3.3	0.2	20.5	36.7	340.8	91.5	10.2	192.6	147.8	275.7	4.7	136.0	17.5	112.3	0.5	1.6	44.2	51.9	165.1	68.4	64.7	126.5	91.2	50.6	1.0	59.2	152.2	83.9	5.5	6.6	19.8	45.3	21.6	88.5	19.2	7.8	49.4
VAMP8	EDB	ENSG00000118640	"Vesicle associated membrane protein 8"	Q9BV40	2	85561562-85582031	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 873.4;NB-4: 1362.5;U-937: 912.8"	"Low region specificity"	"Detected in all"							"HPA006882, HPA007215, CAB037132, CAB037147"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		220000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: "	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (8.07e-9)"	"prognostic favorable (1.59e-6)"	74.0	34.7	26.9	148.4	28.2	299.7	225.1	28.7	53.8	121.8	51.6	250.6	229.9	30.6	144.5	303.1	166.1	119.2	24.6	26.5	29.9	280.1	247.4	266.5	212.4	35.6	31.6	10.4	182.5	270.3	33.7	265.7	34.3	107.7	300.9	4.4	322.5	90.4	24.3	210.2	252.1	71.4	31.9	175.9	228.4	23.4	35.5	173.5	126.0	27.3	311.7	198.0	150.0	36.5	255.0	33.2	2.6	2.3	2.4	1.4	241.6	0.7	0.3	0.2	0.3	191.2	225.2	56.8	174.4	1.2	17.9	175.2	2.4	451.6	0.6	232.3	173.7	290.3	104.4	220.7	3.3	873.4	287.1	2.3	317.5	0.3	72.3	1.2	58.2	1.2	214.9	11.6	103.8	363.9	0.8	1362.5	3.2	315.9	26.0	5.2	8.9	381.7	516.9	384.3	8.4	2.9	120.9	628.3	19.4	126.3	231.4	665.4	113.9	0.3	15.3	2.9	2.7	3.0	151.1	340.0	2.6	912.8	1.1	601.3	868.6	328.4	469.3	740.3	455.6	519.3	537.0	463.3	787.3	508.3	423.2	442.0	52.4	556.3	460.0	2135.6	665.3	1536.0	26.9	28.2	28.7	53.8	26.5	29.9	35.6	31.6	34.3	31.9	35.5	36.5	39.4	371.8	283.2	1.3	147.7	259.1	303.3	800.9	164.4	1.2	289.7	251.7	6.3	356.0	662.1	366.0	0.0	980.8	447.1	832.3	765.0	630.7	28.0	231.3	22.8	46.1	129.1	147.4	0.1	730.0	460.4	35.6	188.6	212.9	269.4	3.3	163.1	314.8	1191.1	0.0	0.1	391.8	545.3	1000.4	488.7	49.1	9.3	537.2	352.2	2.8	686.1	7.9	375.9	0.0	0.5	865.5	843.2	7.5	103.0	302.7	1184.0	1046.8	600.5	2.0	46.0	21.4	56.5	48.0	8.3	239.8	329.7	877.8	219.5	13.8	299.4	602.0
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641970-115698224	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.3;NK-cells: 6.2;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB076375: AB_2665604, HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	4.9	3.9	2.1	3.8	1.2	2.5	3.2	0.8	1.1	9.1	3.0	6.8	3.8	5.5	4.9	10.4	12.0	3.8	5.4	1.3	1.3	5.3	3.0	4.1	2.1	1.2	3.0	4.4	5.0	5.2	0.5	3.6	1.7	4.4	6.4	1.6	6.4	4.5	0.9	6.8	3.9	7.3	1.2	2.2	5.5	5.0	6.5	7.3	7.6	2.4	2.5	6.4	4.4	1.0	49.6	20.7	6.6	8.9	24.1	21.5	13.1	18.8	13.5	24.1	19.1	12.0	24.1	0.0	31.5	21.9	22.7	60.9	11.2	33.3	15.8	57.9	13.7	27.4	18.4	9.8	8.8	8.2	11.4	11.4	23.1	17.2	18.2	12.8	24.1	45.9	16.8	14.8	24.5	65.7	41.0	3.4	16.7	28.8	19.5	0.1	19.1	14.3	11.0	32.8	5.9	8.0	33.9	22.2	15.4	12.4	11.3	8.8	26.2	16.5	25.7	36.3	34.6	2.1	2.3	0.2	22.3	14.3	41.1	0.0	0.5	0.0	1.9	0.3	0.5	0.2	1.2	1.9	2.3	0.0	0.4	2.0	0.0	6.2	0.5	2.0	3.0	1.0	2.1	1.2	0.8	1.1	1.3	1.3	1.2	3.0	1.7	1.2	6.5	1.0	9.2	3.2	3.2	5.5	0.5	7.4	7.4	16.8	11.4	5.2	4.6	4.6	7.9	2.8	9.6	9.2	39.6	5.0	3.4	11.2	0.0	15.7	6.1	25.1	7.7	10.5	6.7	13.2	0.9	13.8	7.3	10.1	8.2	17.0	0.0	5.1	28.9	2.5	4.3	0.0	0.7	8.6	10.2	1.9	1.4	3.0	5.9	2.9	0.0	4.7	11.1	4.7	9.2	2.0	0.1	20.8	6.1	8.2	1.8	8.3	2.6	5.6	12.8	0.9	6.6	4.3	8.5	5.5	7.0	20.0	6.5	0.4	3.1	3.2	10.3	6.5
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667231	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 20.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	Centrosome	"HPA023932: AB_2671373"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	4.6	3.6	3.2	6.0	3.6	20.2	4.8	4.1	5.1	3.7	1.8	4.4	3.8	3.0	4.5	3.5	2.9	3.7	2.9	4.1	4.7	4.4	7.0	4.1	8.6	4.0	3.6	3.9	4.0	5.6	1.6	4.4	4.4	3.6	4.1	4.5	4.2	3.1	5.3	3.3	3.6	3.3	3.4	8.8	4.5	5.7	5.0	5.3	4.2	5.3	7.7	4.1	2.4	4.3	8.5	7.6	3.8	5.1	11.5	8.1	3.7	6.7	6.7	5.0	5.8	4.5	7.8	11.5	1.9	9.0	6.2	7.4	6.2	5.6	7.2	8.6	4.5	12.8	7.5	5.6	6.9	4.3	13.2	8.7	8.1	5.5	9.9	6.1	5.5	6.1	8.8	10.8	7.5	4.1	9.4	7.4	7.3	7.1	5.2	5.9	6.0	5.8	7.3	6.6	2.2	4.3	5.2	7.8	6.0	4.8	8.0	7.0	11.1	6.6	4.9	5.9	4.5	9.5	5.0	11.9	6.6	6.0	5.1	10.0	2.7	5.9	3.4	4.3	2.8	1.7	2.1	2.5	2.9	2.2	1.7	2.2	9.7	2.4	8.3	1.1	2.8	1.7	3.2	3.6	4.1	5.1	4.1	4.7	4.0	3.6	4.4	3.4	5.0	4.3	18.6	19.2	15.2	9.8	18.5	17.0	9.3	10.3	12.5	11.0	12.6	9.4	20.3	11.5	12.8	7.3	22.9	10.4	38.9	18.4	3.9	10.2	7.5	16.7	17.1	14.2	6.0	23.4	17.6	13.6	5.5	15.0	15.3	16.4	19.0	12.4	17.2	22.9	14.9	11.8	18.1	15.5	8.2	47.3	20.4	5.2	8.1	25.6	10.6	14.0	28.6	11.9	39.1	13.6	21.1	13.0	16.6	15.8	21.8	14.2	14.7	12.8	18.6	12.1	6.6	21.7	20.2	32.9	16.6	16.3	20.6	9.9	28.6	11.8	13.2	16.9
VPS8	"FLJ32099, KIAA0804"	ENSG00000156931	"VPS8 subunit of CORVET complex"	Q8N3P4	3	184812143-185052614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 154.1;Granulosa cells: 124.3;Inhibitory neurons: 132.2;Oligodendrocytes: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036871	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA036871: AB_10672103"	"unprognostic (4.36e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.97e-2)"	10.9	9.6	18.7	10.0	22.1	23.2	10.6	24.2	24.0	12.7	29.1	11.4	8.3	12.3	16.3	10.1	9.0	11.1	19.6	20.4	23.6	10.6	8.5	10.7	10.5	25.1	21.4	14.3	8.9	15.8	16.3	12.1	26.3	10.9	14.7	16.4	7.9	10.1	28.6	12.9	9.3	12.9	17.1	13.3	13.0	16.9	26.1	11.6	14.9	15.3	10.7	10.4	10.3	36.4	18.0	10.7	15.9	15.9	32.5	28.8	10.6	17.7	18.8	12.3	17.0	13.6	9.0	19.1	29.3	26.9	50.4	20.8	17.3	21.0	23.6	34.8	15.4	20.4	13.0	8.1	20.0	14.3	27.0	20.6	19.4	17.6	17.5	22.6	31.4	17.7	10.9	13.5	22.7	12.8	11.6	8.5	10.5	18.4	10.1	14.1	30.6	15.0	12.2	30.8	16.2	10.6	19.9	20.8	15.6	23.6	33.2	7.5	27.9	18.8	10.5	19.6	15.3	16.5	21.5	25.9	21.6	17.7	15.5	19.0	6.6	22.9	5.0	5.2	4.9	4.4	5.4	5.2	8.1	5.5	8.0	5.4	23.9	5.7	6.6	2.3	4.8	4.3	18.7	22.1	24.2	24.0	20.4	23.6	25.1	21.4	26.3	17.1	26.1	36.4	11.8	12.8	11.5	66.3	17.9	10.5	9.2	8.3	11.4	24.5	8.7	8.3	24.6	11.5	9.7	9.2	18.8	12.8	10.8	17.3	7.9	7.7	22.2	11.0	17.5	12.8	18.0	11.6	154.1	4.6	6.7	14.7	21.9	14.3	2.5	124.3	12.5	7.7	20.2	11.8	132.2	16.6	12.2	19.1	16.7	16.5	10.5	21.2	10.6	89.9	32.0	10.1	32.0	86.5	149.2	6.4	12.7	12.8	14.4	9.4	9.2	8.8	14.4	17.3	6.6	13.0	10.0	94.3	27.8	15.8	16.1	7.7	17.8	11.8	13.2	13.0
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;choroid plexus: 19.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 10.9;Inhibitory neurons: 1.8;Late spermatids: 9.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"SCLC-21H: 1.2"	"Low region specificity"	"Detected in many"							"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	0.4	0.8	0.1	0.9	0.0	0.0	0.1	0.1	0.0	19.1	0.0	0.0	0.0	1.3	0.0	0.3	0.2	0.0	1.1	2.9	1.3	0.0	0.1	0.1	3.7	6.3	0.0	0.0	1.1	2.9	0.1	5.1	0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.2	3.0	0.0	0.2	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.1	0.1	1.1	2.9	3.7	6.3	5.1	1.5	3.0	0.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777328	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 21.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 4.2;Gastric mucus-secreting cells: 8.2;Proximal enterocytes: 5.0;Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 2.9;hypothalamus: 8.2;medulla oblongata: 5.9;pons: 5.5;thalamus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;HMC-1: 1.3;Karpas-707: 1.1;U-266/84: 1.6"	"Group enriched"	"Detected in some"	5	"cerebellum: 7.0;pons and medulla: 3.9"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		9200	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	0.4	0.3	0.5	0.1	0.3	0.0	0.7	0.1	2.9	0.8	0.0	1.3	1.0	4.6	0.0	0.4	7.2	0.7	5.2	0.8	8.2	5.7	1.4	1.4	0.1	5.9	1.0	0.5	2.6	1.7	21.3	0.0	5.5	0.8	0.4	0.2	1.4	1.3	6.6	0.8	2.3	0.0	0.0	0.5	3.0	0.7	7.5	0.0	1.8	0.0	0.1	0.6	0.7	1.0	0.8	1.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.1	0.0	0.9	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.1	2.9	0.8	8.2	5.9	1.0	5.5	0.0	7.5	1.0	0.0	0.0	1.1	0.0	0.6	0.1	0.4	0.5	1.2	0.5	0.1	0.3	0.8	0.0	0.3	1.8	0.0	0.0	0.2	1.4	1.9	0.6	0.0	1.5	0.1	0.1	4.2	0.0	1.5	0.5	0.0	0.1	8.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	0.4	0.3	5.0	2.4	1.6	0.8	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.5	0.4
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"WASP actin nucleation promoting factor"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.4;lymphoid tissue: 83.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 83.2;dendritic cells: 91.7;Hofbauer cells: 111.5;Kupffer cells: 110.7;Macrophages: 118.1;monocytes: 88.2;NK-cells: 84.5;Plasma cells: 57.8;T-cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 37.4"	"Group enriched"	"Detected in all"	4	"granulocytes: 37.4;monocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.5;HEL: 67.6;HMC-1: 157.0;MOLT-4: 70.8;NB-4: 75.7;RPMI-8226: 94.0;THP-1: 68.8;U-266/70: 83.1;U-937: 87.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	10.2	5.2	6.3	52.2	5.8	58.4	4.4	5.9	8.1	3.3	6.3	6.4	8.0	2.8	3.0	3.5	5.6	6.9	3.5	6.0	8.0	4.4	7.2	19.1	54.2	11.1	8.2	1.8	2.4	1.4	2.9	9.0	8.6	4.2	5.0	0.4	4.9	2.8	1.4	2.8	23.0	6.1	8.0	83.0	7.0	1.9	8.6	42.0	3.5	3.4	36.2	10.3	3.0	10.8	0.8	0.2	0.4	1.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.6	0.9	76.5	0.3	0.0	0.3	2.0	0.3	0.2	0.0	44.2	0.4	67.6	0.9	0.0	0.8	34.9	157.0	0.3	0.1	0.1	0.0	0.0	0.0	40.3	0.7	45.7	0.0	7.6	70.8	75.7	0.4	1.1	0.4	61.1	0.3	94.0	0.1	0.0	0.5	0.9	1.0	0.7	0.5	0.2	0.4	68.8	0.5	0.1	0.4	1.2	0.1	83.1	43.6	53.7	0.5	87.4	0.2	3.3	7.6	37.4	4.6	8.4	3.4	3.0	3.5	3.9	5.7	3.3	3.1	3.5	29.2	3.6	9.5	3.1	5.4	4.0	6.3	5.8	5.9	8.1	6.0	8.0	11.1	8.2	8.6	8.0	8.6	10.8	1.5	3.2	14.3	0.7	83.2	2.4	0.2	0.2	2.2	0.2	1.1	1.8	1.1	0.0	0.1	0.0	0.0	0.9	91.7	0.3	1.9	0.4	0.6	0.4	0.4	2.6	1.2	14.1	0.3	0.4	1.1	1.5	5.6	0.3	48.1	0.2	3.9	1.6	111.5	0.0	0.3	0.2	0.0	110.7	54.5	1.1	0.0	118.1	3.6	4.7	88.2	0.2	84.5	0.5	0.0	0.1	0.1	0.0	57.8	0.2	0.1	1.8	1.6	0.2	0.0	1.0	1.3	1.3	1.1	0.8	1.4	1.4	99.3	0.4	0.1	0.2
WASF2	"SCAR2, WAVE2"	ENSG00000158195	"WASP family member 2"	Q9Y6W5	1	27404230-27490167	"Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022632, HPA045288"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		84000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"	Cytosol	"CAB022632: , HPA045288: AB_2679287"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (5.29e-8)"	"unprognostic (3.94e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.26e-2)"	55.2	34.1	37.9	44.1	48.1	59.8	45.8	42.3	36.3	41.3	29.5	49.4	27.5	53.8	21.6	89.8	46.3	31.1	32.9	33.4	39.5	28.4	14.9	45.7	48.1	58.9	49.0	63.5	35.2	31.0	17.0	52.3	53.6	33.1	39.3	9.1	38.3	41.9	18.4	56.7	42.3	51.9	48.2	47.6	40.3	36.8	48.4	54.6	35.5	27.8	52.3	47.8	39.9	50.6	75.4	35.3	80.3	73.4	57.1	74.3	46.5	59.9	55.5	64.7	57.9	30.8	79.2	52.1	56.6	94.4	44.1	58.8	65.5	98.4	77.1	73.3	41.1	113.5	60.5	36.7	76.9	91.9	62.8	68.5	105.1	70.7	130.8	70.0	82.3	56.8	92.3	26.3	89.0	27.1	68.7	42.1	64.9	38.3	53.7	141.8	98.5	53.3	46.3	42.0	39.9	43.8	104.6	46.3	78.3	48.6	38.7	55.1	109.1	53.4	54.8	112.1	47.8	53.6	76.0	67.7	63.0	111.2	61.3	50.0	65.4	54.7	33.3	79.8	27.2	37.8	26.3	23.5	41.7	46.6	26.9	21.2	100.7	24.4	112.7	60.5	28.8	58.6	37.9	48.1	42.3	36.3	33.4	39.5	58.9	49.0	53.6	48.2	48.4	50.6	243.0	67.3	57.5	58.1	112.7	148.1	221.8	245.9	104.2	24.4	143.0	201.9	39.6	75.8	144.1	90.1	14.6	219.2	145.1	147.0	62.6	111.0	51.4	86.6	167.7	194.8	108.5	195.1	19.1	101.7	118.9	157.9	85.1	174.2	58.9	77.7	163.5	48.4	151.2	20.2	12.8	101.9	93.6	250.4	129.2	75.9	165.0	162.7	76.5	93.7	207.6	61.2	142.2	29.1	67.1	164.9	131.8	182.4	74.2	281.7	139.1	50.7	104.4	19.2	138.1	206.1	180.6	120.7	118.1	216.3	194.5	143.5	104.5	79.3	120.3	372.5
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874261-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	2.6	3.6	2.1	2.7	2.3	3.6	3.6	2.3	3.2	2.5	1.4	3.0	4.1	3.2	3.2	3.2	3.1	2.3	4.0	2.2	2.9	5.2	4.2	1.7	3.3	2.5	2.1	3.2	2.2	3.5	1.9	2.7	2.7	2.2	4.0	2.6	1.9	2.3	4.8	3.6	2.9	3.4	1.5	2.1	2.3	3.5	2.8	3.2	3.2	6.0	3.7	4.1	2.3	2.5	5.3	5.8	6.4	12.5	12.3	10.4	11.4	7.6	6.6	10.1	9.8	14.8	7.5	10.2	7.2	6.6	8.5	6.6	18.2	13.3	16.0	4.6	11.1	17.0	9.0	17.7	8.0	22.1	9.9	9.5	9.4	12.0	23.6	6.4	10.8	10.2	26.7	5.9	11.3	6.5	14.8	13.3	14.9	7.3	14.3	11.1	9.7	16.1	11.2	6.5	11.4	9.8	6.5	8.2	9.8	11.0	4.7	14.1	8.3	8.3	6.9	7.4	8.4	8.0	12.8	16.3	8.7	15.3	8.8	1.3	1.6	0.6	1.4	1.7	2.0	1.9	1.3	1.4	2.1	1.9	1.7	1.7	0.6	1.3	1.7	2.4	1.6	1.1	2.1	2.3	2.3	3.2	2.2	2.9	2.5	2.1	2.7	1.5	2.8	2.5	10.1	9.6	16.9	12.1	13.6	20.5	21.4	24.4	13.1	10.2	8.4	9.1	27.9	7.2	19.1	5.5	2.1	25.3	7.9	7.8	15.6	18.0	14.3	14.7	25.3	12.6	5.4	22.1	19.2	10.6	34.9	16.5	9.7	13.3	15.2	15.8	8.2	15.0	18.0	15.2	20.3	10.6	24.4	7.2	6.0	8.9	17.1	9.2	1.8	12.2	13.7	6.4	5.2	10.6	9.9	14.2	6.6	15.4	9.3	17.3	13.9	38.1	15.7	8.3	13.1	20.1	41.9	43.0	32.3	18.2	17.3	21.5	10.7	21.0	19.2	17.0
WDR13		ENSG00000101940	"WD repeat domain 13"	Q9H1Z4	X	48590042-48608869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000913	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA000913: AB_1858795"	"unprognostic (5.03e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.65e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.54e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.32e-2)"	67.2	76.7	84.2	27.7	81.1	34.6	63.8	68.2	95.2	71.6	85.0	71.6	43.8	71.5	73.7	54.6	67.1	33.4	150.3	85.7	70.4	91.9	106.3	60.8	23.4	73.0	70.2	93.1	189.2	36.9	80.1	29.5	70.5	67.5	26.3	28.2	75.7	45.3	105.2	56.9	54.4	37.5	69.4	58.6	76.6	22.9	74.5	18.7	64.8	83.0	19.6	59.5	56.3	78.5	41.6	59.4	29.3	90.8	39.3	57.4	22.4	28.1	50.7	31.9	29.0	35.5	64.8	28.7	26.3	57.8	25.7	35.0	14.6	61.6	11.3	34.2	26.2	19.7	72.2	65.3	89.3	17.1	51.4	54.7	86.4	45.3	82.7	55.6	44.4	16.3	19.8	35.5	44.9	59.4	23.7	29.9	21.2	18.0	46.6	22.4	31.0	52.3	56.7	32.6	33.9	41.9	31.8	65.2	66.9	20.4	41.9	32.6	74.0	33.0	48.8	52.8	27.5	41.0	16.6	11.0	48.9	25.3	46.5	75.5	42.4	24.7	20.9	47.4	16.7	32.7	21.8	19.9	39.1	25.0	17.4	19.6	29.9	33.0	57.2	24.6	27.0	31.1	84.2	81.1	68.2	95.2	85.7	70.4	73.0	70.2	70.5	69.4	74.5	78.5	61.1	44.8	41.7	19.9	22.3	35.1	72.8	69.1	37.5	45.5	39.2	35.8	79.7	68.6	49.9	20.2	54.2	44.2	19.9	75.5	103.7	89.0	6.1	75.9	36.1	54.0	50.4	31.2	7.8	119.2	34.5	50.5	62.2	53.0	30.4	46.2	65.3	50.2	42.6	33.7	6.6	58.3	50.8	35.4	30.6	20.8	51.6	34.9	58.7	15.0	42.1	68.9	22.6	7.1	14.0	96.8	75.0	43.2	28.3	48.3	90.2	140.7	74.3	55.6	46.0	51.2	59.6	11.2	21.0	29.7	29.8	70.7	21.4	56.2	59.8	65.8
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 74.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 313.9;Late spermatids: 118.8;Spermatocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	7.8	7.4	9.4	6.9	10.3	14.7	9.0	10.3	12.1	7.7	9.7	8.1	4.3	8.1	11.0	9.0	7.1	6.3	8.1	9.5	10.0	8.8	10.0	6.9	10.6	9.6	9.7	7.0	5.9	10.0	6.7	6.3	11.2	7.2	7.1	8.9	7.0	6.1	13.0	11.9	7.9	7.4	9.4	10.8	7.2	74.2	9.8	12.1	7.1	12.6	11.9	7.2	7.6	11.3	39.4	8.5	14.6	13.6	15.0	13.2	23.8	20.1	16.2	23.0	21.7	22.8	20.2	18.9	66.4	13.0	21.2	22.3	18.9	18.4	28.8	30.0	16.3	19.4	21.2	14.6	18.5	26.9	14.3	10.7	25.9	20.6	22.2	11.4	18.7	23.6	18.8	34.5	17.7	36.4	22.5	27.5	19.5	25.7	24.4	26.5	25.3	40.5	12.8	13.4	15.0	15.2	15.0	20.8	32.2	19.8	53.0	24.2	17.2	18.9	18.0	21.5	40.6	29.5	63.8	56.6	12.7	34.2	19.4	13.1	5.5	15.7	8.8	4.7	14.1	7.8	12.2	8.5	4.7	7.5	10.2	6.1	4.7	7.4	7.8	6.2	16.5	5.0	9.4	10.3	10.3	12.1	9.5	10.0	9.6	9.7	11.2	9.4	9.8	11.3	3.9	0.0	2.8	6.8	3.8	4.2	3.2	8.1	2.8	3.7	3.4	3.4	5.6	2.8	5.8	3.7	0.0	5.7	3.5	1.7	5.9	5.0	313.9	3.3	3.5	4.7	0.0	7.4	5.5	4.2	6.1	3.9	0.5	2.7	9.5	3.2	3.9	2.5	4.3	3.3	4.8	1.6	10.2	3.8	3.0	118.8	5.0	3.9	5.4	10.3	7.3	4.0	4.1	6.0	7.1	3.7	1.9	3.4	3.7	2.9	1.5	5.0	3.1	2.8	19.7	4.0	5.5	135.6	13.9	3.5	4.7	4.7	6.3	4.1	2.7	2.6
WDR6		ENSG00000178252	"WD repeat domain 6"	Q9NNW5	3	49007062-49015953	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042622	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA042622: AB_10966784"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.94e-2)"	"prognostic favorable (4.52e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	67.5	148.8	108.7	51.9	106.3	41.8	69.8	104.9	124.5	153.1	120.1	130.1	66.5	122.8	83.1	65.1	129.8	59.7	82.7	105.8	116.3	113.7	97.7	77.8	61.2	105.1	112.8	205.9	136.7	91.0	207.4	46.1	108.1	159.3	50.9	49.4	99.2	74.1	71.4	63.7	105.4	68.1	102.0	112.9	93.3	61.2	120.9	54.7	178.2	37.8	53.5	118.8	90.5	107.2	61.4	82.4	133.7	113.7	87.8	71.1	90.1	89.4	73.1	98.7	79.4	73.9	86.2	98.3	55.5	143.2	75.8	68.1	107.8	125.0	70.0	78.3	71.8	93.1	223.0	98.8	88.8	97.3	40.3	128.5	87.3	91.1	68.4	136.2	73.0	101.8	54.0	102.4	90.6	121.7	113.5	109.8	119.1	55.7	75.9	65.5	57.3	61.8	117.6	179.3	64.9	121.0	66.8	54.1	40.6	96.9	94.8	76.7	98.4	72.7	116.1	71.3	121.1	177.3	82.7	84.3	98.7	122.2	53.4	6.4	11.5	12.8	19.0	15.5	21.1	13.0	13.9	14.4	13.5	12.8	15.8	12.2	3.9	14.6	8.0	17.0	12.6	16.8	108.7	106.3	104.9	124.5	105.8	116.3	105.1	112.8	108.1	102.0	120.9	107.2	16.0	22.4	48.5	67.9	28.0	17.8	24.3	32.0	27.9	26.0	48.1	43.1	3.1	42.9	38.5	47.8	47.9	46.5	21.4	18.4	9.8	30.7	4.3	34.6	32.3	20.8	72.3	16.6	9.3	26.0	21.0	24.1	36.7	39.2	29.1	66.7	26.0	44.7	26.8	37.0	17.5	32.3	28.5	19.2	20.2	7.0	38.2	18.7	12.4	22.5	24.7	39.0	12.3	27.2	23.3	28.0	23.5	28.2	29.9	26.2	30.8	31.3	26.2	46.4	26.3	20.0	21.0	43.0	34.9	15.5	11.4	56.5	25.9	44.7	36.4	19.9
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 126.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 172.7;monocytes: 187.2;NK-cells: 245.1;Oligodendrocytes: 217.2;Plasma cells: 162.8;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.1;Karpas-707: 296.8;U-266/70: 233.0"	"Low region specificity"	"Detected in all"							"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		520000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300"	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	31.0	14.7	14.2	93.0	37.2	56.8	21.0	36.1	20.5	30.6	11.1	26.0	18.2	22.4	11.5	14.2	14.4	34.8	16.0	14.9	28.8	13.0	16.4	31.8	126.9	46.2	38.6	12.3	7.3	12.9	4.8	33.5	42.3	14.9	20.8	3.4	17.7	23.0	5.9	9.9	32.5	29.1	27.9	89.7	21.8	4.7	35.1	66.4	15.4	11.5	110.5	31.5	17.0	53.8	0.7	7.0	16.3	0.2	40.4	70.9	16.9	31.1	26.4	12.1	18.7	1.9	1.4	209.1	9.2	47.0	15.6	0.5	2.8	0.0	15.1	144.8	4.1	106.5	26.9	0.0	15.1	94.9	167.2	29.6	5.1	27.7	2.6	16.0	25.0	18.7	3.3	296.8	34.4	0.1	106.6	87.1	19.1	0.0	1.4	90.0	6.6	37.9	11.3	0.7	2.6	33.8	0.3	8.8	18.7	30.4	0.4	46.8	21.2	41.0	11.5	30.1	29.9	233.0	165.2	113.7	60.4	64.7	111.7	41.5	35.4	87.2	71.6	37.3	59.4	35.1	47.6	71.1	26.1	28.6	38.0	51.4	166.1	57.4	43.7	11.2	57.7	54.7	14.2	37.2	36.1	20.5	14.9	28.8	46.2	38.6	42.3	27.9	35.1	53.8	32.1	19.2	21.7	27.7	134.5	12.5	6.3	0.9	2.8	2.1	3.3	4.3	10.5	1.5	4.6	3.7	25.0	2.0	172.7	0.3	5.9	1.7	40.2	3.3	21.9	30.8	4.9	30.1	5.3	11.6	82.5	40.5	9.7	2.1	67.2	2.1	36.8	3.7	86.2	0.0	7.2	1.6	0.0	142.2	128.0	96.9	25.1	139.8	26.6	98.4	187.2	1.2	245.1	120.6	217.2	16.8	0.8	18.0	162.8	5.0	0.2	35.9	0.1	3.4	13.1	15.7	21.4	4.4	4.1	1.2	11.1	4.1	208.1	8.8	2.1	3.1
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342547-86478420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 171.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	33.6	22.1	16.3	25.8	21.5	18.2	40.6	19.6	16.3	23.6	24.3	26.9	26.3	23.0	24.6	33.1	18.5	45.3	50.8	14.3	20.7	40.9	111.7	27.2	39.0	18.3	19.0	24.7	28.0	116.3	9.8	36.9	19.7	33.4	33.1	43.2	25.9	25.6	171.4	40.8	28.1	24.6	18.1	45.7	34.3	29.5	19.5	22.7	32.6	122.2	30.6	33.7	15.8	23.1	59.8	27.1	18.3	13.1	23.0	22.4	16.3	21.0	22.5	16.5	19.5	18.9	35.3	24.9	14.0	36.5	22.9	49.3	26.4	34.1	28.5	31.6	21.0	28.7	24.4	44.7	16.8	11.7	14.0	20.5	42.5	18.2	33.3	25.3	74.1	29.0	14.3	28.7	28.4	29.6	27.7	8.1	11.2	82.6	30.0	18.0	21.4	22.5	37.3	44.5	5.5	12.9	21.2	104.7	23.0	39.8	31.3	10.8	84.4	23.9	28.7	26.3	10.7	33.9	22.0	25.7	29.9	1.6	19.0	6.2	2.1	3.9	5.2	1.9	4.6	2.7	6.4	5.3	1.5	2.4	7.5	4.7	1.3	2.4	2.2	1.9	6.5	2.0	16.3	21.5	19.6	16.3	14.3	20.7	18.3	19.0	19.7	18.1	19.5	23.1	51.2	25.6	22.6	29.0	13.0	35.8	26.9	15.4	26.7	28.8	41.7	23.5	82.7	44.3	19.2	29.5	58.4	28.3	19.5	23.7	43.0	20.5	42.1	22.6	20.1	32.3	23.6	3.0	55.3	37.6	3.3	27.6	35.2	35.5	3.8	18.0	62.4	88.8	55.9	40.4	134.6	25.3	14.2	95.2	28.1	12.7	32.3	43.0	30.2	61.8	18.6	23.3	18.6	60.3	103.8	45.1	16.0	36.5	18.5	45.1	15.8	45.7	17.2	52.6	6.6	18.8	16.6	12.4	21.2	28.8	39.5	23.0	32.0	25.1	19.7	38.3
XAGE2	"CT12.2, GAGED3, XAGE-2, XAGE2B"	ENSG00000155622	"X antigen family member 2"	Q96GT9	X	52369021-52375680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 199.5"	"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 1027.3;Extravillous trophoblasts: 1890.1;Syncytiotrophoblasts: 1367.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 96.3;SK-BR-3: 22.7;SuSa: 27.9;T-47d: 20.1"									"HPA052507, HPA060900"	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	"Plasma membrane"	"HPA052507: AB_2681855, HPA060900: AB_2684383"								"unprognostic (1.21e-1)"		"unprognostic (9.67e-2)"	"unprognostic (1.49e-1)"				"unprognostic (4.47e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	5.6	0.0	0.0	0.0	0.1	0.4	0.0	0.0	199.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	96.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	4.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	22.7	1.2	27.9	20.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	38.5	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1027.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1890.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	1367.6	0.0	0.0	0.0	0.0
XAGE3	"CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3"	ENSG00000171402	"X antigen family member 3"	Q8WTP9	X	52862525-52868083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	121	"placenta: 382.1"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 2223.5;Extravillous trophoblasts: 1309.1;Syncytiotrophoblasts: 2678.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;U-266/70: 2.2;U-266/84: 2.1"									"HPA052507, HPA060900"	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Plasma membrane"	"HPA052507: AB_2681855, HPA060900: AB_2684383"							"unprognostic (6.04e-2)"						"unprognostic (2.30e-1)"		"unprognostic (2.92e-1)"			3.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	382.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2223.5	0.0	0.1	0.0	0.2	0.3	0.1	0.0	4.5	0.0	0.0	0.0	0.4	1309.1	11.1	0.0	0.3	0.0	0.0	0.0	4.6	191.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	15.1	7.0	0.0	0.0	2678.1	0.0	0.0	0.1	0.0
XIAP	"API3, BIRC4, hILP, ILP-1"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913976	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: AB_2677993"	"prognostic unfavorable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	9.2	7.7	6.5	9.2	7.5	8.3	9.7	6.8	7.0	9.6	12.9	12.4	10.1	8.4	10.0	11.5	7.4	8.6	7.8	5.8	8.2	11.8	12.1	8.5	10.4	7.6	8.1	7.5	8.3	18.4	6.3	8.6	7.3	8.5	10.1	21.4	8.6	7.4	10.3	8.8	10.1	7.4	8.5	10.4	10.2	4.2	8.1	8.9	14.9	11.9	8.6	9.6	6.1	10.3	15.8	13.2	10.2	8.8	11.8	15.0	13.3	16.9	12.4	8.9	7.7	5.9	17.9	14.7	24.3	14.4	17.1	5.6	15.3	10.5	16.3	15.5	8.3	9.9	11.1	9.2	14.9	18.1	19.7	10.4	16.0	14.9	19.0	10.2	12.7	10.8	15.9	16.4	17.6	16.5	10.2	8.8	8.4	15.6	10.3	10.8	11.9	15.6	13.4	22.6	6.8	10.0	22.9	13.0	13.5	9.0	8.0	8.7	15.7	0.5	6.0	27.0	18.9	13.8	14.9	15.8	18.3	12.7	11.5	9.3	1.8	2.6	3.3	1.5	3.0	3.1	2.4	3.6	1.0	4.0	2.7	1.9	5.6	2.4	2.9	2.9	1.8	1.5	6.5	7.5	6.8	7.0	5.8	8.2	7.6	8.1	7.3	8.5	8.1	10.3	50.0	80.1	91.6	26.4	42.1	26.6	36.3	35.0	28.5	72.1	29.7	19.9	44.5	44.3	55.2	53.3	95.9	17.9	41.7	122.9	27.4	36.0	2.7	38.4	44.9	55.0	47.4	23.5	30.0	54.0	30.0	38.4	39.8	50.4	60.7	30.9	64.2	85.8	29.0	75.7	34.9	62.2	26.4	43.6	33.0	4.1	42.6	44.2	8.8	29.0	45.8	45.8	55.6	32.6	41.9	65.4	53.5	51.6	39.5	53.0	59.2	59.8	50.6	133.7	65.7	43.6	34.9	15.2	21.0	30.8	35.5	38.0	40.8	30.0	48.0	68.1
XIRP1	"CMYA1, DKFZp451D042, Xin"	ENSG00000168334	"Xin actin binding repeat containing 1"	Q702N8	3	39183210-39192596	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 682.0;skeletal muscle: 383.4"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 850.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Region enhanced"	"Detected in some"		"cerebellum: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;LHCN-M2: 1.1;RH-30: 3.0"	"Not detected"	"Not detected"							"HPA016750, HPA018458, CAB026391"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885"	"unprognostic (2.19e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-5)"	"unprognostic (2.08e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.12e-2)"	1.1	0.3	0.0	1.2	0.0	0.0	0.2	2.0	0.3	0.0	0.1	0.7	0.0	0.2	0.0	5.6	0.0	1.0	682.0	1.1	0.1	0.1	0.1	1.7	0.0	0.6	0.2	0.1	1.2	0.0	0.5	0.7	0.2	3.4	0.0	0.0	5.1	0.0	383.4	0.5	0.5	0.4	0.2	0.6	0.3	0.0	0.1	0.5	0.2	96.4	0.0	3.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	1.1	0.1	0.6	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	850.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888480-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 202.3;skeletal muscle: 1034.1;tongue: 543.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 1907.2"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HUVEC TERT2: 4.2;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	202.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	8.0	0.0	1034.1	1.2	0.1	0.0	0.0	0.5	0.1	3.0	0.0	0.1	0.3	543.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1907.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	10.1	0.0	0.0	1.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	23.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	5.8	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738949-129769536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 166.6;kidney: 156.0"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 475.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4"	"Group enriched"	"Detected in many"	7	"monocytes: 2.8;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	7.5	0.9	0.1	3.7	0.1	0.2	3.0	0.1	0.1	3.7	0.1	5.5	99.0	2.4	0.1	2.2	6.3	4.3	5.3	0.1	0.1	156.0	23.1	2.1	0.5	0.2	0.1	1.8	0.3	0.3	0.1	1.2	0.1	1.8	6.3	0.0	1.5	0.4	0.5	4.4	166.6	6.0	0.1	0.3	3.4	0.1	0.1	1.0	1.4	2.4	0.4	7.8	4.0	0.1	0.0	0.0	0.5	0.0	8.2	40.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.4	1.2	0.0	1.3	2.8	0.2	0.2	0.4	2.0	0.1	0.0	2.8	0.4	1.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.2	0.5	11.4	5.9	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.0	0.0	10.0	1.1	0.0	0.0	0.0	0.4	18.5	0.8	0.0	0.3	12.8	0.0	1.0	3.6	0.0	0.0	1.0	1.8	1.0	0.0	0.0	3.1	0.0	0.1	0.0	21.0	0.0	0.1	0.0	475.9	75.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.0	1.2	0.9	0.0	8.4	0.0
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097976-28211965	"Metabolic proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 202.1"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 202.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (8.80e-4)"	48.0	48.3	70.0	55.9	73.7	92.0	39.9	61.7	87.0	43.7	63.9	47.0	21.8	42.3	18.8	57.0	44.8	24.5	36.2	72.2	72.0	47.2	62.1	70.9	62.9	76.1	69.2	36.6	43.2	26.9	56.6	25.7	73.6	48.6	27.4	35.2	44.9	20.1	29.9	52.9	63.0	26.8	67.8	160.6	42.8	100.3	72.9	51.1	50.5	13.7	44.9	44.9	46.0	77.8	82.9	63.3	54.8	58.8	37.2	58.8	57.9	97.0	98.0	124.8	124.8	89.1	61.7	59.8	78.6	99.8	63.3	53.8	131.6	83.9	151.5	115.3	72.1	67.6	90.0	101.6	87.9	95.4	70.8	46.3	61.2	111.1	108.9	53.5	73.1	63.4	118.0	31.0	86.0	101.1	116.2	116.1	88.1	43.6	55.4	101.0	64.3	101.2	46.8	45.2	103.3	55.0	52.9	88.3	47.8	60.8	62.7	63.3	75.4	104.1	64.4	87.2	84.8	63.0	83.8	89.8	78.7	98.4	89.1	21.1	9.9	32.9	14.2	11.4	15.4	20.7	16.5	15.8	7.3	15.7	18.1	22.6	202.1	10.7	17.6	9.5	14.7	8.4	70.0	73.7	61.7	87.0	72.2	72.0	76.1	69.2	73.6	67.8	72.9	77.8	9.6	9.6	14.2	27.4	20.2	18.6	11.4	12.6	5.2	20.8	15.0	14.6	8.0	5.7	12.6	23.9	31.3	11.5	30.2	28.5	7.9	14.1	39.2	12.7	21.5	11.6	23.5	10.3	51.2	19.2	17.3	13.3	12.2	32.8	2.5	34.6	9.3	16.7	23.4	21.9	55.4	20.6	10.2	27.9	15.8	44.8	10.8	22.6	7.2	43.1	28.6	8.3	23.7	59.3	90.3	23.4	13.5	8.6	16.5	22.4	13.3	7.1	10.3	28.1	6.6	13.5	12.2	31.6	26.5	18.0	21.3	8.3	27.0	9.5	21.2	15.4
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470960	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Oligodendrocyte precursor cells: 1194.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.1;ASC TERT1: 34.0;U-2197: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA		150000	"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	6.4	6.2	6.2	4.9	8.0	7.2	4.5	2.3	6.3	7.8	8.5	8.8	4.3	7.9	1.0	5.1	3.7	2.3	4.2	8.8	3.6	1.0	0.3	3.5	5.1	3.7	4.3	5.3	2.8	0.9	0.6	6.0	4.2	2.7	5.2	8.3	2.5	4.5	1.1	5.0	5.3	5.7	1.6	5.4	3.4	2.3	3.6	4.1	2.2	1.2	4.3	4.3	4.6	4.6	0.0	0.3	8.0	0.1	55.1	34.0	9.6	25.6	12.9	2.7	1.0	0.3	0.6	6.1	0.0	31.3	0.9	0.6	0.0	5.1	4.5	12.1	0.6	8.0	0.0	0.0	0.6	11.5	10.2	12.6	0.7	15.0	2.4	4.6	0.0	0.3	0.0	23.8	2.8	0.8	0.1	12.4	8.5	4.4	0.0	3.5	0.0	1.2	0.0	11.5	2.0	15.2	1.9	7.9	1.4	5.9	1.9	7.2	0.0	24.6	2.9	57.2	0.0	26.4	1.4	11.6	28.9	12.8	22.4	0.3	0.2	0.4	0.2	1.2	0.3	0.1	0.1	0.1	0.4	0.3	0.2	0.1	0.1	0.4	2.0	0.1	0.3	0.2	6.2	8.0	2.3	6.3	8.8	3.6	3.7	4.3	4.2	1.6	3.6	4.6	1.0	3.2	2.5	45.4	9.2	7.9	1.6	0.0	1.2	12.9	3.8	3.7	3.4	0.0	0.7	0.0	98.0	12.7	12.4	9.1	0.0	1.5	0.5	0.5	24.7	2.9	12.6	7.4	172.8	1.6	20.1	12.2	2.6	0.8	2.5	6.4	1.4	0.2	3.5	0.0	72.8	4.3	4.1	9.7	27.6	0.8	12.8	8.5	3.6	29.0	6.1	1.9	11.3	1194.8	63.0	4.0	7.4	50.0	6.2	5.3	6.1	0.2	0.0	4.4	6.6	7.9	5.9	0.3	1.6	4.1	18.5	13.1	7.7	8.1	6.9	6.4
YIPF4	"FinGER4, MGC11061"	ENSG00000119820	"Yip1 domain family member 4"	Q9BSR8	2	32277904-32316594	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"brain: 129.1;choroid plexus: 65.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017884	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA017884: AB_1853855"	"unprognostic (5.61e-3)"	"unprognostic (8.50e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.11e-2)"	7.0	6.2	69.9	5.5	66.9	2.5	8.4	69.6	129.1	6.1	65.6	6.9	5.8	6.9	7.2	5.0	5.0	4.5	7.4	71.7	68.8	7.7	9.2	5.6	5.9	69.3	67.7	6.6	14.8	6.5	5.2	5.9	71.9	6.6	6.2	13.1	7.4	5.6	8.0	7.0	5.8	6.5	66.8	6.9	6.4	4.2	67.3	7.9	10.1	6.0	5.1	5.3	5.1	75.4	8.9	4.4	8.6	7.7	9.8	12.4	4.5	7.5	7.5	7.7	5.0	5.9	6.6	4.7	5.1	8.2	7.4	6.8	9.2	6.6	10.0	7.6	14.3	7.6	9.8	10.7	11.5	10.2	6.2	8.7	12.4	6.9	11.0	10.6	6.6	5.2	10.7	9.6	8.5	5.8	8.0	10.6	7.0	9.6	7.5	5.5	12.7	8.9	8.4	3.8	9.6	9.2	6.4	6.4	11.7	5.5	3.5	8.6	7.4	10.1	4.8	7.1	7.2	14.2	19.1	5.8	15.9	9.7	5.7	14.9	5.4	5.7	4.4	5.1	3.7	4.6	4.4	4.1	4.6	4.0	4.5	4.0	14.9	6.4	5.1	5.4	4.6	4.7	69.9	66.9	69.6	129.1	71.7	68.8	69.3	67.7	71.9	66.8	67.3	75.4	61.4	93.0	69.8	13.1	68.5	51.4	56.9	59.5	50.7	113.8	63.3	28.2	88.0	60.1	58.3	42.3	106.3	68.4	81.3	68.8	33.2	45.3	34.7	39.5	57.9	59.0	57.1	86.9	18.8	39.3	69.9	66.6	28.1	40.1	40.0	56.3	67.8	80.9	48.3	101.0	20.1	70.2	50.8	81.7	60.7	21.0	86.6	58.0	81.8	21.5	85.1	53.1	114.4	22.1	31.8	41.8	66.8	74.9	62.6	78.5	62.7	60.1	62.2	122.2	78.9	71.9	66.2	160.2	59.6	41.1	65.9	192.8	60.7	65.4	46.8	74.7
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350090	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (7.29e-5)"	43.0	27.0	22.4	19.5	26.5	116.6	43.8	31.9	25.0	52.6	18.6	40.0	15.6	43.6	22.7	48.0	42.3	15.3	34.1	20.9	26.0	38.2	33.1	40.6	28.4	23.6	23.6	68.6	44.5	20.3	41.2	23.8	24.8	37.9	19.6	38.5	42.1	17.6	47.2	51.3	40.5	17.2	23.2	41.9	36.3	31.3	23.1	30.3	42.1	16.7	26.7	37.3	50.5	32.7	31.8	18.4	37.1	22.2	21.7	18.8	30.4	33.8	21.3	20.6	21.5	22.9	27.9	50.8	27.0	17.2	16.7	23.3	35.1	29.4	33.1	38.2	21.3	38.8	27.3	25.6	22.1	41.5	29.0	17.8	31.3	18.5	44.0	26.6	22.6	24.7	37.5	29.0	30.7	23.9	48.9	37.1	27.6	30.4	18.0	42.4	41.6	22.8	32.6	35.6	31.9	24.8	29.5	31.5	25.9	34.3	24.6	28.8	24.1	23.5	24.9	16.4	22.5	30.1	21.8	53.7	15.9	26.6	22.0	69.3	20.3	40.4	24.1	12.7	19.0	36.1	19.6	19.8	12.2	44.8	26.9	22.9	105.4	20.8	27.0	39.3	20.3	9.7	22.4	26.5	31.9	25.0	20.9	26.0	23.6	23.6	24.8	23.2	23.1	32.7	104.6	112.2	129.5	54.9	104.7	119.9	103.6	76.2	88.8	105.8	112.8	107.2	92.6	85.8	125.1	73.5	70.9	73.6	136.8	58.1	52.8	70.2	98.5	131.9	135.3	92.2	85.8	74.7	43.8	57.2	124.8	81.3	54.0	254.8	94.7	86.2	63.5	85.6	43.2	90.9	49.4	77.9	63.1	61.0	75.9	22.0	74.6	84.5	64.0	56.2	67.0	99.2	96.8	59.3	110.1	81.6	56.0	67.7	103.2	121.6	42.0	44.0	113.2	138.4	52.6	122.0	98.8	139.2	95.9	127.1	134.5	119.0	122.0	59.5	66.9	119.8
ZBED3	MGC15435	ENSG00000132846	"Zinc finger BED-type containing 3"	Q96IU2	5	77072072-77087285	"Predicted intracellular proteins, Predicted secreted proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.7;JURKAT: 31.0;MOLT-4: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055995	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted to blood"	NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA055995: AB_2683000"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.82e-2)"	"unprognostic (8.64e-3)"	"unprognostic (3.63e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.08e-1)"	10.3	3.3	9.3	1.9	14.2	2.6	8.8	9.4	10.8	6.7	7.5	4.2	3.9	10.2	7.4	2.4	7.0	3.5	4.6	7.8	9.2	10.0	10.7	5.0	1.9	16.0	12.2	7.9	7.6	8.4	3.9	2.4	10.9	5.1	4.3	3.8	6.0	6.6	2.7	2.6	3.3	8.7	9.9	3.6	6.4	1.9	13.5	4.8	11.2	3.8	1.9	3.0	3.7	17.1	5.2	4.2	5.4	29.7	22.1	1.5	0.3	1.7	5.0	2.6	6.9	9.1	2.4	0.0	10.9	3.4	1.1	0.6	2.9	1.8	2.3	1.7	5.8	4.0	9.1	10.4	13.1	5.5	1.5	24.6	6.8	1.3	5.1	4.2	8.3	31.0	0.0	11.0	1.6	5.2	29.4	0.8	3.5	1.4	2.5	12.1	10.3	1.7	12.3	2.0	5.9	12.4	6.1	5.0	8.7	2.1	7.5	3.8	3.3	2.3	4.5	5.1	7.0	8.0	8.2	11.5	3.6	10.4	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	9.3	14.2	9.4	10.8	7.8	9.2	16.0	12.2	10.9	9.9	13.5	17.1	10.5	0.0	2.8	8.1	1.7	1.3	3.8	0.3	4.0	8.4	13.5	13.6	10.7	12.8	2.0	12.9	12.5	1.5	2.0	3.1	17.6	4.1	3.3	16.5	13.5	11.7	16.2	5.0	3.3	6.0	0.3	9.3	11.7	12.5	1.3	20.2	12.1	31.8	9.6	3.3	8.5	5.3	0.0	13.6	4.9	2.2	17.7	9.0	7.2	5.6	5.1	13.8	3.1	16.1	18.3	2.7	3.4	11.3	1.4	5.6	1.9	17.2	0.1	17.0	0.0	21.4	7.7	1.5	3.4	2.2	1.4	0.3	1.2	25.6	7.1	1.8
ZBTB8OS	ARCH	ENSG00000176261	"Zinc finger and BTB domain containing 8 opposite strand"	Q8IWT0	1	32600172-32650903	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046315	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"		"HPA046315: AB_2679623"	"unprognostic (3.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (5.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.11e-8)"	"unprognostic (1.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.42e-1)"	21.5	25.5	21.1	28.7	21.0	21.5	20.6	23.7	34.4	17.1	20.4	33.8	32.2	16.3	35.6	27.2	18.3	14.7	32.4	20.9	22.5	28.2	34.5	20.3	36.9	20.9	20.8	12.4	27.4	21.5	27.7	14.9	21.1	21.6	33.3	27.6	22.8	15.9	43.6	17.0	29.1	20.2	20.3	27.1	28.5	16.5	21.9	16.9	18.3	35.5	43.8	21.4	18.2	22.2	56.1	31.8	27.9	47.2	47.7	43.3	38.1	62.1	62.3	48.5	49.0	75.5	60.9	62.0	55.9	45.6	53.5	41.1	48.7	48.5	64.4	83.2	44.8	50.5	67.4	127.0	39.2	73.2	44.9	43.4	52.3	42.7	51.2	30.3	53.6	74.6	50.8	81.6	62.9	44.3	56.2	42.4	86.1	86.5	48.7	44.9	59.8	60.7	58.7	65.7	55.9	43.0	50.1	49.9	83.3	74.8	34.2	59.8	38.4	67.2	40.8	55.0	78.9	123.1	130.8	177.0	48.1	89.6	68.1	37.5	57.7	71.5	46.3	71.0	44.8	73.0	50.5	56.0	41.6	54.0	41.9	45.1	66.3	48.0	78.0	53.6	86.1	37.8	21.1	21.0	23.7	34.4	20.9	22.5	20.9	20.8	21.1	20.3	21.9	22.2	39.4	22.4	53.7	32.0	56.3	17.2	31.2	69.5	18.2	46.9	28.5	34.7	69.3	30.0	53.3	38.6	43.8	49.3	54.5	68.8	90.1	60.5	38.1	42.5	38.1	34.4	37.7	46.1	58.3	52.7	61.8	35.9	35.2	45.3	44.2	24.0	33.2	82.5	72.3	16.8	60.5	53.2	71.2	61.9	19.8	30.5	36.7	47.4	51.6	21.5	82.2	35.7	75.2	35.7	46.8	68.4	71.6	46.3	79.9	32.8	115.9	139.4	42.0	56.5	32.9	27.3	51.7	52.9	30.0	28.1	15.6	65.1	50.3	31.2	49.7	37.8
ZDHHC2	"DHHC2, ZNF372"	ENSG00000104219	"Zinc finger DHHC-type palmitoyltransferase 2"	Q9UIJ5	8	17156482-17224799	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 77.8"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023331, HPA023334"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA023331: AB_2671165, HPA023334: "	"unprognostic (8.92e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (5.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.10e-2)"	10.3	24.4	10.3	11.0	8.9	31.7	7.5	43.9	14.8	13.4	13.5	15.3	10.5	7.6	11.8	3.9	13.8	7.0	9.7	8.0	22.4	26.4	6.5	14.3	9.3	17.7	13.6	11.8	30.7	28.9	9.5	6.9	16.6	11.7	11.2	77.8	19.6	12.9	17.9	1.8	10.3	9.5	13.5	10.7	16.3	16.6	26.3	12.7	33.5	37.2	11.7	19.7	4.4	22.0	2.3	12.4	23.7	4.9	20.3	36.0	13.8	41.5	49.9	23.0	27.2	3.9	34.3	26.1	15.9	36.2	57.9	1.5	32.2	20.5	42.5	16.8	16.2	23.2	16.8	5.0	20.3	24.7	2.6	15.3	3.2	28.8	26.1	52.7	38.4	29.8	2.7	66.5	28.1	0.6	18.3	15.2	15.0	18.8	19.1	17.9	23.7	9.5	41.8	26.7	12.7	8.3	17.8	0.0	3.8	34.9	1.0	10.9	32.0	11.6	35.2	26.0	41.7	13.2	53.7	30.1	32.1	22.2	5.3	1.6	1.2	2.6	1.9	1.3	3.3	2.5	2.4	2.3	1.1	2.1	2.1	2.3	0.9	2.2	0.8	2.3	1.3	0.7	10.3	8.9	43.9	14.8	8.0	22.4	17.7	13.6	16.6	13.5	26.3	22.0	20.9	44.8	25.4	34.0	18.8	3.1	15.3	4.1	1.8	54.4	21.1	8.0	15.2	15.7	10.5	51.5	77.2	0.5	27.1	8.7	21.5	22.2	8.3	19.3	6.8	11.6	19.7	22.7	49.8	33.4	1.2	10.4	9.7	25.4	8.2	10.9	10.0	8.0	12.6	11.8	20.1	16.2	6.1	28.6	16.1	11.7	5.0	22.2	23.2	37.5	12.9	40.6	8.2	26.7	61.3	37.0	10.7	3.0	14.0	31.3	6.1	26.1	7.7	90.2	13.1	9.1	7.5	6.6	3.9	3.3	2.7	0.4	17.0	8.7	17.0	36.5
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type palmitoyltransferase 5"	Q9C0B5	11	57667747-57701182	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	29.0	21.7	8.3	27.2	7.8	29.2	25.8	8.3	9.5	27.0	11.0	36.4	29.6	22.3	24.1	60.9	25.0	27.9	27.9	7.5	9.2	28.2	36.7	29.0	24.4	8.5	8.9	20.7	31.6	45.3	12.6	36.7	8.7	28.0	34.4	35.9	35.0	26.7	40.9	45.2	31.0	29.0	6.9	25.5	30.2	36.2	10.9	30.6	36.9	45.5	35.0	42.3	28.7	8.9	80.3	86.2	33.7	34.7	74.9	57.4	64.9	72.8	89.8	61.8	46.3	52.3	97.0	53.4	91.9	89.5	53.1	110.1	53.6	88.9	55.4	66.5	24.4	45.8	40.1	49.3	81.5	85.9	73.7	81.3	79.3	88.8	92.9	51.1	71.0	45.6	61.5	66.2	79.7	48.4	49.1	29.3	41.1	61.0	52.2	47.8	66.6	67.1	74.8	115.2	25.3	30.7	67.6	77.0	78.5	45.4	81.9	52.6	80.7	76.5	40.7	82.9	52.2	48.2	63.0	45.9	59.1	44.4	68.0	11.6	5.2	7.1	6.9	6.8	8.3	5.8	6.7	6.0	5.4	5.7	6.7	6.9	6.9	5.0	8.1	9.0	7.0	6.8	8.3	7.8	8.3	9.5	7.5	9.2	8.5	8.9	8.7	6.9	10.9	8.9	28.8	16.0	10.5	14.7	13.4	16.2	12.7	13.7	16.5	21.4	20.4	15.2	21.6	12.8	19.8	12.9	37.5	10.1	20.3	41.3	3.9	14.4	21.3	19.9	22.1	17.1	11.5	10.8	16.4	18.2	9.9	15.5	15.8	35.5	19.7	24.9	16.1	15.1	13.0	13.5	17.9	17.5	18.3	16.3	10.2	9.8	11.8	18.4	1.8	14.0	16.0	14.0	17.5	17.6	14.7	26.0	20.8	7.5	12.4	15.1	22.9	11.4	17.4	47.7	0.0	18.4	18.5	13.3	7.1	31.5	19.9	18.6	15.9	16.8	19.7	20.5
ZFP41	"FLJ00028, FLJ38705, ZNF753"	ENSG00000181638	"ZFP41 zinc finger protein"	Q8N8Y5	8	143246821-143262705	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (4.92e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.20e-1)"	2.9	3.5	5.4	2.3	6.6	1.5	2.8	2.8	6.9	3.6	0.0	3.8	3.4	4.2	1.4	2.9	4.1	1.9	3.1	4.9	6.6	3.9	3.4	2.2	2.6	7.8	5.6	5.3	3.5	4.0	5.3	1.1	5.7	3.7	1.5	2.4	4.8	2.6	3.2	4.9	3.6	2.0	2.4	3.2	3.6	6.3	8.2	2.4	4.1	1.8	2.1	3.4	3.0	9.7	6.7	10.5	4.5	6.0	5.1	3.9	5.3	4.0	2.1	7.6	5.2	5.2	5.5	3.7	5.8	5.2	7.7	5.4	4.9	5.2	3.7	5.9	6.0	4.7	5.6	4.1	7.1	1.8	2.8	4.1	7.2	4.9	7.2	5.2	3.6	2.6	10.1	3.5	3.6	12.0	5.0	2.0	6.7	8.2	10.3	2.6	3.7	1.3	3.3	6.0	5.7	7.8	11.2	3.0	5.9	3.8	7.7	3.6	3.8	5.7	10.2	4.5	6.4	5.6	4.6	1.7	5.1	4.5	7.7	0.0	0.1	0.0	0.3	0.2	0.5	0.1	0.2	0.2	0.1	0.2	0.4	0.3	0.0	0.1	0.0	0.9	0.2	0.2	5.4	6.6	2.8	6.9	4.9	6.6	7.8	5.6	5.7	2.4	8.2	9.7	1.6	0.0	2.0	2.9	2.3	1.1	0.7	0.8	0.6	2.5	2.3	1.9	3.2	5.7	1.1	3.7	6.2	0.3	0.8	3.7	1.9	1.9	1.5	1.8	2.3	1.6	3.0	0.8	2.2	0.9	1.1	1.6	2.6	1.2	0.0	2.7	2.5	3.9	1.2	6.7	3.4	2.4	2.0	2.2	0.5	2.6	1.2	1.5	1.8	1.0	0.9	2.5	2.1	1.5	4.4	1.6	4.1	2.2	1.6	0.5	3.4	1.4	3.2	2.0	0.0	1.6	1.9	7.9	3.7	1.8	0.3	0.3	0.9	1.6	3.4	0.4
ZFP90	"KIAA1954, NK10, ZNF756"	ENSG00000184939	"ZFP90 zinc finger protein"	Q8TF47	16	68530090-68576072	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029017	Uncertain		Supported	"Vesicles,Plasma membrane,Centrosome"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Plasma membrane, Centrosome"		"HPA029017: AB_10669653"	"unprognostic (3.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.60e-2)"	7.0	6.3	19.4	7.2	18.6	6.1	11.1	27.0	31.1	11.7	9.9	8.2	2.9	10.8	12.2	5.9	9.5	6.5	8.0	18.2	18.1	8.6	5.4	6.7	9.5	15.2	14.6	12.7	7.4	15.7	13.5	5.8	15.3	9.2	6.2	12.7	6.3	8.8	8.2	9.3	7.3	9.3	11.0	10.5	8.1	9.7	18.2	13.4	8.2	9.0	11.3	7.5	8.0	20.3	10.6	11.4	20.9	19.9	18.1	19.2	9.7	9.7	11.0	13.2	15.2	8.0	7.0	11.5	12.7	12.6	11.1	9.7	12.9	12.5	15.0	10.1	4.7	3.0	2.2	13.4	14.0	0.0	10.3	17.2	20.2	12.1	16.8	23.5	10.7	21.2	5.8	4.1	16.3	18.8	11.6	10.7	7.8	6.3	8.5	21.0	6.5	7.6	9.0	7.2	23.5	17.9	28.1	2.1	10.5	15.4	16.8	14.9	8.4	12.2	7.2	10.4	5.8	8.1	15.9	14.0	4.1	4.0	9.9	7.9	1.5	2.5	5.2	1.6	6.7	4.5	4.9	6.0	2.0	3.3	6.7	5.9	0.3	4.3	1.0	2.3	5.8	2.7	19.4	18.6	27.0	31.1	18.2	18.1	15.2	14.6	15.3	11.0	18.2	20.3	13.1	19.2	8.9	18.6	15.1	3.4	6.4	10.5	14.8	21.1	8.5	9.4	10.5	10.0	9.0	20.2	14.6	3.4	11.8	1.5	7.9	10.2	20.6	9.8	14.4	10.9	16.1	13.2	34.0	6.1	1.7	14.7	5.1	6.5	12.0	30.3	11.0	5.2	6.9	18.5	41.4	4.7	4.1	7.9	5.7	13.2	16.4	8.3	3.6	11.2	6.4	13.0	19.6	31.2	35.5	6.5	3.2	17.7	7.2	5.9	1.3	8.1	24.2	17.3	0.0	12.4	11.0	12.1	19.1	8.6	4.5	1.4	18.7	13.7	4.5	4.0
ZFYVE28	"KIAA1643, lst-2"	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418651	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.9;Inhibitory neurons: 93.2;NK-cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.6;NB-4: 14.2;U-266/70: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: AB_2683477"	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	5.5	8.7	4.6	3.1	7.5	2.1	5.4	49.9	18.0	5.5	0.5	8.0	6.1	4.8	1.6	4.7	5.4	3.4	3.9	7.3	0.3	8.7	6.5	6.2	4.0	9.4	6.9	4.5	5.0	4.3	10.8	1.0	7.4	4.0	2.8	4.0	5.5	2.8	2.9	5.4	8.8	1.5	1.0	6.7	7.2	8.1	5.0	2.6	7.7	1.8	2.0	4.8	4.6	6.2	0.9	1.2	0.2	4.2	2.4	0.8	0.2	2.1	3.5	1.1	0.3	0.1	7.6	0.0	2.2	3.7	2.9	4.4	1.4	0.3	0.7	11.7	1.5	0.3	5.3	0.3	4.8	0.8	12.6	3.3	0.7	1.3	0.1	7.7	3.5	1.1	2.2	9.2	1.0	2.6	0.1	14.2	0.2	2.4	9.3	0.0	0.0	4.7	1.7	0.6	6.6	0.5	2.1	0.1	1.2	0.1	2.8	0.3	0.6	2.0	0.1	6.2	0.2	14.8	11.7	0.2	6.0	2.8	2.0	0.4	0.2	0.0	1.9	0.0	0.8	0.4	1.0	1.3	0.3	1.8	1.3	1.4	0.0	0.2	0.1	0.1	1.9	0.5	4.6	7.5	49.9	18.0	7.3	0.3	9.4	6.9	7.4	1.0	5.0	6.2	12.2	0.0	1.7	41.4	3.7	5.9	3.4	2.1	5.7	12.2	7.6	6.2	3.4	7.2	2.9	11.0	18.8	0.3	25.4	32.3	7.9	3.4	29.1	5.1	4.8	8.0	2.4	1.3	133.9	2.3	0.3	3.6	11.7	6.3	8.9	2.6	5.3	3.7	1.9	8.4	93.2	7.8	2.0	2.2	33.0	8.9	1.5	5.1	7.2	32.8	4.0	1.6	48.4	23.6	36.4	2.6	16.8	2.2	9.8	1.7	18.1	4.2	3.0	17.8	0.0	2.3	3.0	3.1	8.0	6.2	4.8	0.3	31.6	8.2	6.6	5.4
ZGPAT	"dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP"	ENSG00000197114	"Zinc finger CCCH-type and G-patch domain containing"	Q8N5A5	20	63707465-63736142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 123.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 14.2;Gastric mucus-secreting cells: 13.7;Plasma cells: 26.9;Squamous epithelial cells: 11.1;T-cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056705			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA056705: AB_2683213"	"unprognostic (4.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.58e-2)"	"prognostic favorable (6.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-3)"	14.5	17.0	5.3	8.8	5.8	14.8	14.6	5.4	8.9	15.7	7.5	18.0	10.0	16.1	3.4	16.6	14.2	5.5	16.0	5.6	4.7	22.2	123.5	13.0	11.5	7.6	5.4	11.9	14.0	8.4	14.4	6.5	5.9	14.9	3.0	1.4	13.7	6.7	16.7	19.0	14.8	4.9	4.1	20.3	15.3	20.2	5.7	9.5	13.8	4.3	4.1	15.9	15.0	7.4	15.3	19.3	7.4	12.0	6.0	4.2	17.1	15.5	10.1	24.0	10.0	41.6	20.4	15.6	28.9	8.8	23.3	27.4	5.0	18.3	3.0	10.7	13.3	14.8	16.9	43.3	11.7	9.4	25.2	10.7	15.3	9.9	3.9	6.5	13.2	18.5	16.5	13.9	8.0	15.3	22.6	22.1	12.1	22.3	24.0	23.9	5.7	15.7	13.5	14.0	14.0	17.4	22.1	24.7	14.2	3.7	16.9	26.0	15.2	37.2	13.3	14.3	20.1	13.9	24.3	22.2	23.5	9.3	17.0	8.6	21.0	26.5	28.3	21.5	28.1	19.2	24.6	26.3	19.7	16.2	23.9	24.7	21.8	26.4	18.4	28.2	26.2	18.6	5.3	5.8	5.4	8.9	5.6	4.7	7.6	5.4	5.9	4.1	5.7	7.4	0.3	3.2	3.4	4.6	8.0	0.0	0.0	0.1	14.2	1.0	0.2	0.3	0.3	0.0	1.3	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.1	0.4	1.1	2.1	1.8	6.3	7.4	0.2	0.3	3.3	13.7	0.6	2.5	0.5	0.4	2.3	0.2	0.0	5.8	0.2	0.0	1.3	0.0	0.0	0.0	5.4	1.8	8.4	0.0	0.2	0.0	5.5	4.6	0.4	0.1	0.0	26.9	0.2	0.3	0.5	0.1	1.1	0.0	0.5	1.4	0.3	0.1	11.1	0.3	0.3	8.9	0.5	0.2	0.1
ZMYND10	"BLU, CILD22, DNAAF7"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50345732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 120.2;testis: 258.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 309.4;Endometrial ciliated cells: 221.8;Late spermatids: 415.3;Respiratory ciliated cells: 390.8;Spermatocytes: 529.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"T-47d: 5.6;U-87 MG: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035255			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.3	0.1	5.0	0.2	5.0	0.7	1.1	3.5	2.8	4.3	29.2	0.2	0.2	1.7	1.6	0.2	120.2	0.5	0.2	4.3	6.7	2.1	0.9	11.1	0.2	12.5	15.6	0.6	1.1	3.7	5.9	0.1	9.4	0.7	0.1	3.2	0.3	0.4	0.4	0.5	0.4	0.5	10.4	0.6	0.3	258.5	7.3	0.5	1.9	0.2	0.1	0.2	0.3	9.2	1.6	0.6	0.2	0.5	0.6	0.9	0.3	0.2	0.9	1.6	0.5	0.0	1.0	0.7	0.6	1.0	0.2	0.2	1.5	0.0	0.1	0.4	0.6	1.5	1.2	0.0	0.0	0.5	0.8	0.0	0.1	2.0	0.1	1.5	0.1	1.3	0.5	0.1	0.2	1.0	0.3	2.7	0.0	0.2	0.7	0.7	0.0	0.5	2.0	0.0	1.8	0.5	0.1	0.5	0.0	0.0	5.6	0.6	0.0	0.3	0.4	0.9	0.1	1.0	0.4	0.1	3.9	2.2	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.1	5.0	5.0	3.5	2.8	4.3	6.7	12.5	15.6	9.4	10.4	7.3	9.2	0.5	3.2	5.1	1.3	0.7	0.5	0.4	24.2	1.2	1.2	2.3	1.7	0.8	0.0	33.1	1.8	4.2	0.1	1.7	0.2	0.0	1.1	309.4	221.8	2.4	1.2	0.0	3.2	0.5	0.0	0.2	1.1	0.0	3.6	0.0	0.3	0.7	0.4	0.6	0.0	0.3	0.7	22.4	0.0	0.4	415.3	9.0	1.3	1.8	1.0	0.9	1.2	2.1	0.5	1.3	0.1	0.0	5.7	0.9	0.6	0.0	1.0	390.8	7.6	0.0	0.9	9.8	529.7	9.1	1.1	0.4	0.1	1.7	0.2	0.3	0.1
ZNF10	KOX1	ENSG00000256223	"Zinc finger protein 10"	P21506	12	133130575-133159465	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 45.5;Excitatory neurons: 46.0;Inhibitory neurons: 48.4;Oligodendrocyte precursor cells: 54.3;Oligodendrocytes: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003204	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA003204: AB_1080663"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.13e-3)"	6.7	14.3	4.9	3.7	5.6	8.6	12.3	8.8	7.6	14.4	6.2	10.9	3.7	15.0	23.4	6.0	12.1	10.3	8.3	5.8	8.0	10.9	10.6	7.6	5.9	4.7	6.8	22.4	13.2	17.3	45.3	5.2	5.6	15.1	6.2	13.1	8.0	12.7	4.9	8.8	7.1	8.6	5.4	6.0	10.5	15.3	7.8	7.7	21.2	6.3	5.8	10.7	8.8	7.1	3.8	2.2	10.8	0.0	11.5	4.8	6.5	4.4	3.9	5.3	3.6	3.9	2.4	0.0	6.0	4.4	2.9	1.7	6.8	3.6	3.9	0.0	6.6	8.0	10.5	4.4	3.5	5.0	2.6	5.0	3.3	5.7	6.3	7.9	4.4	6.3	6.0	0.0	6.3	1.2	12.0	10.6	11.1	2.1	4.4	9.9	6.8	5.4	4.2	7.9	10.7	7.0	8.7	1.4	3.7	4.9	6.6	5.0	4.3	3.9	3.6	3.7	3.7	0.2	0.0	12.8	1.2	1.7	3.7	0.9	0.5	1.4	2.9	0.6	3.2	3.1	3.4	4.1	1.4	3.0	6.5	3.3	0.5	6.3	0.4	3.4	0.9	1.8	4.9	5.6	8.8	7.6	5.8	8.0	4.7	6.8	5.6	5.4	7.8	7.1	6.8	0.0	9.0	39.2	39.6	3.8	5.3	3.9	45.5	15.9	9.9	9.4	7.7	4.3	7.1	0.0	31.3	4.5	9.1	1.8	1.9	2.3	24.6	11.9	7.6	5.0	12.6	5.0	46.0	1.4	2.0	15.5	21.4	11.7	10.8	5.0	1.4	4.9	2.5	5.0	48.4	3.9	6.1	3.8	4.6	6.3	2.8	9.0	3.6	21.5	1.5	9.1	2.1	54.3	45.4	1.0	2.1	6.8	16.3	2.6	2.2	2.5	2.7	16.2	0.0	6.3	14.3	20.4	15.4	21.4	3.8	3.8	21.9	6.0	3.3	1.6
ZNF18	"HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38"	ENSG00000154957	"Zinc finger protein 18"	P17022	17	11977439-11997475	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.0;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006144	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA006144: AB_1080683"	"unprognostic (2.99e-3)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (5.12e-6)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (1.52e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.53e-3)"	7.2	5.7	7.9	5.8	8.6	13.7	6.1	7.7	11.2	6.7	7.4	6.0	5.0	5.3	6.3	7.5	5.7	5.5	5.9	7.9	8.3	5.8	12.4	5.1	8.8	8.4	8.0	5.7	6.0	4.3	7.7	4.0	8.8	8.4	6.7	4.9	5.2	5.1	7.3	9.7	6.6	5.8	7.6	10.2	5.3	14.1	8.1	8.5	6.2	4.6	8.0	6.3	6.6	9.8	3.0	6.1	6.4	9.7	11.9	10.5	3.4	4.3	7.5	5.5	5.9	2.9	5.0	10.3	6.3	4.7	4.8	6.1	5.4	6.8	5.9	7.8	4.5	6.1	6.9	4.0	8.4	3.4	7.8	8.7	10.8	4.2	7.6	6.3	8.4	12.0	3.6	4.7	7.6	3.1	11.5	6.9	4.8	10.9	2.8	9.4	6.5	4.6	8.0	3.6	2.5	5.4	7.3	3.6	5.9	37.2	5.1	3.2	6.7	6.5	3.2	2.9	3.3	5.2	4.1	5.1	7.5	7.9	7.8	10.5	5.9	6.9	10.3	5.9	9.6	9.0	9.3	9.7	5.8	7.2	10.0	10.3	19.1	7.7	8.2	8.6	11.1	6.1	7.9	8.6	7.7	11.2	7.9	8.3	8.4	8.0	8.8	7.6	8.1	9.8	2.5	0.0	2.0	10.1	3.8	2.0	1.7	4.2	4.6	2.0	2.0	1.4	1.6	2.8	2.1	1.8	2.1	2.4	3.5	2.5	1.9	3.1	23.0	1.8	2.8	1.9	1.2	5.2	7.4	0.9	2.2	2.7	2.0	1.8	2.5	5.1	2.5	3.7	4.3	1.7	8.4	4.2	6.1	3.8	1.8	27.3	3.4	3.2	1.8	8.4	3.4	2.0	5.2	7.5	9.3	2.1	5.0	3.4	2.3	1.6	3.9	3.1	2.5	1.2	0.0	2.5	2.3	9.6	4.9	5.0	2.3	1.5	4.7	2.8	3.1	1.1
ZNF2	"A1-5, Zfp661, ZNF661"	ENSG00000275111	"Zinc finger protein 2"	Q9BSG1	2	95165432-95184317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041358	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041358: AB_10795539"	"unprognostic (1.18e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	2.1	2.6	2.3	2.3	2.5	0.7	2.5	2.7	2.9	3.2	2.0	2.4	2.1	2.4	3.2	2.3	2.9	1.5	3.1	2.2	2.2	2.7	1.9	2.4	3.1	2.3	2.3	3.9	2.1	3.8	1.9	2.2	2.4	2.6	1.7	3.0	2.3	3.2	3.4	2.9	1.8	2.6	2.1	2.9	2.5	3.0	2.3	3.2	3.1	3.6	3.2	2.3	1.8	3.0	4.1	3.7	4.5	7.6	6.2	5.1	2.8	4.0	5.7	6.1	7.7	3.9	2.5	2.2	3.0	4.1	4.3	3.0	5.1	3.2	6.1	5.8	4.0	5.8	2.9	4.9	5.1	2.8	3.4	4.4	4.3	5.5	7.8	6.3	5.1	4.6	3.9	1.9	5.9	3.1	4.2	4.1	1.8	3.3	4.9	4.1	7.4	3.3	3.4	2.3	4.0	5.2	4.1	5.7	4.9	3.8	3.6	4.4	4.0	7.0	4.2	5.4	3.6	3.4	3.3	3.0	4.4	3.7	5.2	5.6	3.4	12.9	6.3	4.8	4.4	5.4	4.9	5.5	4.0	5.1	6.3	6.2	2.6	3.5	4.0	3.1	6.2	4.0	2.3	2.5	2.7	2.9	2.2	2.2	2.3	2.3	2.4	2.1	2.3	3.0	2.1	0.0	1.7	3.3	2.0	1.0	0.7	1.1	1.8	3.3	2.3	1.5	2.6	5.7	2.1	1.8	0.0	1.8	2.9	0.8	5.9	1.8	2.7	1.3	2.0	1.9	0.0	1.3	7.7	2.0	1.4	2.1	1.5	1.2	1.3	4.7	2.5	1.6	2.5	1.7	6.2	0.7	0.0	2.5	1.2	0.8	2.1	2.2	0.0	3.7	0.5	4.2	4.1	7.1	5.7	0.9	0.5	3.0	1.4	0.9	1.5	2.8	2.5	2.7	6.6	1.6	2.0	5.5	7.5	0.9	1.1	1.6	1.6	2.8	1.1	0.7
ZNF20	KOX13	ENSG00000132010	"Zinc finger protein 20"	P17024	19	12092843-12140355	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 42.1;Late spermatids: 66.3;Respiratory ciliated cells: 29.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 22.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 22.9;NK-cells: 6.8"	"Low cell line specificity"	"Detected in many"											HPA020887	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA020887: AB_2218842"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.08e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.21e-3)"	0.8	1.2	0.9	1.6	0.9	2.7	3.0	2.1	1.3	1.3	2.3	2.0	0.7	1.2	3.1	2.0	4.9	1.2	0.8	0.9	0.7	1.8	0.8	1.6	2.1	0.9	1.1	1.8	2.1	1.8	1.2	0.9	0.9	1.3	1.8	1.9	2.2	1.5	0.3	2.4	1.4	1.0	0.8	1.3	2.1	6.1	0.7	1.5	3.4	1.1	1.3	1.5	1.2	1.3	2.4	0.0	3.1	6.8	1.2	2.4	2.4	1.6	3.3	1.7	2.4	0.8	0.9	1.8	1.9	2.2	1.7	1.4	1.6	0.5	2.0	1.7	0.6	0.4	2.4	0.8	0.7	0.0	2.2	1.9	3.3	0.8	1.0	2.0	1.3	3.7	1.0	0.3	3.9	0.9	3.0	2.2	5.4	1.2	1.7	2.0	1.6	1.0	2.1	5.4	1.2	3.2	1.6	1.4	2.9	3.0	2.3	3.0	0.0	4.1	1.3	4.3	1.1	3.4	2.0	2.2	0.4	0.0	1.6	16.3	2.5	6.5	1.4	1.3	1.2	1.6	1.4	1.6	1.3	2.6	1.3	1.1	22.9	6.8	1.9	1.7	3.2	1.2	0.9	0.9	2.1	1.3	0.9	0.7	0.9	1.1	0.9	0.8	0.7	1.3	0.4	0.0	0.0	0.0	1.0	0.1	0.8	2.3	1.8	0.6	1.8	1.1	0.8	1.5	1.5	1.8	2.1	1.0	0.9	1.9	1.9	2.1	42.1	10.3	0.7	0.7	4.2	1.7	0.0	2.4	1.3	0.5	3.6	1.4	2.5	0.8	0.4	2.3	1.7	0.0	0.0	2.1	0.0	0.8	1.0	66.3	0.6	1.0	0.0	0.0	1.4	0.4	1.0	0.0	0.0	2.7	2.1	0.0	1.5	1.7	2.9	2.9	29.7	1.4	0.0	0.4	1.0	10.8	1.7	1.8	0.6	1.1	1.2	0.3	1.7	1.6
ZNF227		ENSG00000131115	"Zinc finger protein 227"	Q86WZ6	19	44207547-44237268	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA030573	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA030573: AB_10610702"	"unprognostic (3.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.64e-4)"	6.3	6.9	9.5	5.9	10.3	5.0	8.3	14.0	10.7	7.8	8.8	6.9	5.4	8.0	7.6	6.6	8.0	5.9	5.7	9.2	10.5	6.9	7.4	6.1	10.3	9.7	10.1	11.0	6.6	10.4	8.0	7.7	9.9	8.5	5.8	8.7	5.6	6.9	6.4	6.5	5.8	6.8	9.6	9.5	8.6	7.4	10.1	17.2	8.3	6.4	11.2	7.1	6.5	13.2	9.6	13.4	15.8	19.7	12.6	10.9	7.4	9.2	13.1	8.7	17.0	6.6	7.3	16.8	13.9	8.6	10.4	5.5	18.2	9.7	11.7	21.9	22.8	29.3	14.7	8.2	9.0	25.8	12.4	9.9	10.6	8.6	16.0	14.5	13.1	19.2	2.9	0.4	9.4	5.1	24.3	6.8	25.3	9.8	7.0	14.4	15.9	14.4	9.0	17.2	26.7	27.3	20.6	9.2	7.2	15.2	7.7	13.7	11.3	9.6	15.8	7.4	11.8	37.6	54.5	36.1	6.3	10.6	13.1	17.3	4.8	9.9	10.8	3.5	11.8	12.0	10.2	10.6	5.9	12.2	13.3	11.2	4.2	11.9	3.5	6.2	13.5	5.7	9.5	10.3	14.0	10.7	9.2	10.5	9.7	10.1	9.9	9.6	10.1	13.2	8.0	0.0	1.5	13.7	8.1	3.1	3.8	4.8	3.4	6.0	5.4	4.6	7.0	1.5	6.4	5.5	2.1	5.6	6.3	3.3	3.9	4.2	22.6	4.0	4.6	8.4	2.4	7.8	10.5	4.0	4.5	4.4	3.6	3.7	1.3	8.7	8.9	3.9	4.4	8.4	10.3	4.7	2.0	5.7	3.7	30.0	5.6	3.9	1.8	9.4	5.2	6.3	11.3	17.1	16.8	6.1	3.3	5.7	4.0	6.0	4.2	3.3	4.1	5.4	6.6	5.9	5.5	4.4	8.7	3.3	3.8	2.2	6.9	8.6	3.3	2.9
ZNF229		ENSG00000278318	"Zinc finger protein 229"	Q9UJW7	19	44417519-44448578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 6.9"									HPA001494	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA001494: AB_1080692"	"unprognostic (2.59e-1)"	"unprognostic (7.41e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.04e-3)"	"prognostic favorable (8.43e-5)"	"unprognostic (3.66e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.34e-1)"	0.5	1.7	1.3	0.1	1.4	0.1	1.0	1.3	1.6	1.0	1.7	0.9	0.7	1.1	1.1	0.7	1.9	0.5	1.4	1.4	1.4	0.8	0.7	0.6	0.3	1.3	1.3	2.3	0.8	2.7	1.3	1.1	1.3	1.2	0.1	4.5	0.7	0.8	0.8	0.3	0.4	0.8	1.2	0.6	0.6	0.7	1.5	1.1	2.0	1.2	0.3	0.8	0.5	1.6	0.0	3.7	2.7	0.0	2.9	2.4	0.0	4.4	1.4	2.1	2.8	0.0	0.6	0.0	1.7	2.5	3.4	1.3	0.0	2.8	1.4	0.0	1.4	0.4	1.2	0.3	5.0	0.0	0.0	3.4	0.0	1.7	6.9	2.9	2.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	3.4	0.0	1.0	0.0	0.0	1.3	2.1	5.5	0.7	1.0	1.9	0.3	0.0	2.0	0.0	0.0	1.9	1.3	0.1	0.5	0.1	3.1	2.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.0	1.5	0.0	0.0	0.0	0.1	1.3	1.4	1.3	1.6	1.4	1.4	1.3	1.3	1.3	1.2	1.5	1.6	1.4	0.0	0.0	5.9	0.4	0.1	0.7	2.0	1.8	5.8	2.1	2.2	3.7	0.0	1.3	0.0	4.2	0.9	0.0	0.2	3.9	1.7	0.7	1.6	1.7	1.3	0.0	2.1	3.1	1.2	0.6	1.0	2.6	1.0	0.0	3.4	1.4	0.2	0.7	1.7	4.5	0.3	0.0	0.6	0.0	0.5	0.9	0.3	0.0	1.0	0.1	4.7	0.0	7.5	2.2	2.0	0.3	1.9	0.0	1.6	0.3	1.6	4.5	6.9	0.0	1.0	1.5	1.8	2.4	1.4	0.0	0.8	0.2	3.4	0.5	0.9
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 63.5;NK-cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.9	12.5	13.3	11.0	14.2	21.0	10.4	13.5	15.9	12.5	9.3	13.0	10.7	10.0	3.5	19.1	14.5	5.3	10.0	12.4	11.8	13.5	14.3	12.0	16.9	15.2	13.2	16.0	13.6	4.4	14.6	4.8	14.0	13.4	5.7	3.8	11.7	4.2	10.6	17.6	19.6	4.5	11.0	26.8	12.0	9.3	14.4	8.1	12.8	4.6	10.6	10.8	14.4	19.7	6.6	5.5	4.8	11.8	3.7	5.4	7.9	5.2	3.0	4.6	1.7	7.4	7.4	8.4	4.6	5.2	2.1	12.1	6.0	5.6	3.1	5.4	25.8	7.9	12.0	3.1	6.8	7.7	9.7	7.3	7.2	6.2	4.7	4.5	5.9	7.7	13.9	7.8	1.9	9.9	9.1	19.3	3.2	7.1	10.6	14.4	5.5	6.0	5.5	3.9	11.5	10.0	9.4	8.8	6.0	2.8	11.8	11.0	7.6	6.3	9.1	5.2	4.3	24.4	8.5	4.7	6.2	14.5	7.2	3.8	1.2	1.5	6.6	1.1	3.3	1.2	3.7	5.4	0.7	1.7	3.7	4.9	3.1	3.8	1.0	1.2	2.7	2.0	13.3	14.2	13.5	15.9	12.4	11.8	15.2	13.2	14.0	11.0	14.4	19.7	17.1	9.6	13.3	15.7	20.8	11.5	8.3	11.2	14.8	15.8	13.9	11.7	2.6	12.8	10.7	11.0	20.9	4.6	63.5	16.8	1.9	7.6	1.9	11.5	14.7	13.6	7.2	13.5	17.6	6.6	3.9	9.5	15.8	14.4	12.6	14.3	20.0	11.5	9.0	6.7	14.6	14.5	2.0	9.8	9.8	2.3	11.5	19.7	8.8	18.7	13.5	9.7	89.6	25.1	30.6	9.2	13.2	10.5	25.4	12.9	19.8	3.4	10.1	21.6	13.1	12.3	8.7	17.0	9.7	15.5	16.1	4.0	39.0	24.0	15.7	11.0
ZNF277	"NRIF4, ZNF277P"	ENSG00000198839	"Zinc finger protein 277"	Q9NRM2	7	112206695-112343934	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027307	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Plasma membrane"	"HPA027307: AB_1859164"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (9.47e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	7.5	6.8	3.9	5.4	4.9	6.1	8.9	4.2	7.2	6.1	3.8	7.1	5.9	6.7	3.1	7.1	6.0	6.4	8.0	4.5	3.7	9.5	11.6	7.0	6.8	4.7	3.8	7.1	11.3	7.1	4.6	4.6	4.6	5.6	6.9	4.5	7.1	4.4	6.5	8.3	5.6	6.0	3.8	5.8	7.8	5.4	4.7	7.9	9.4	3.4	6.3	8.2	7.0	7.1	7.6	4.5	7.5	9.3	10.2	28.1	5.6	7.4	7.9	3.5	6.3	6.8	6.8	12.6	13.3	6.1	7.2	5.0	5.7	7.3	9.4	10.2	3.6	6.6	6.1	5.8	6.3	12.1	5.2	17.1	10.8	8.6	5.7	11.1	10.7	13.2	7.9	13.3	6.4	8.8	15.2	20.6	5.1	6.5	5.0	7.4	8.2	11.4	9.5	5.6	5.3	13.8	9.7	12.0	11.9	8.1	3.4	10.2	14.9	5.4	3.1	12.0	4.8	11.5	14.6	14.8	3.9	11.5	6.6	9.3	4.6	6.4	5.7	8.1	8.5	8.7	8.0	8.2	3.7	9.6	9.6	8.1	6.6	7.4	7.2	5.9	9.4	3.7	3.9	4.9	4.2	7.2	4.5	3.7	4.7	3.8	4.6	3.8	4.7	7.1	13.0	38.5	24.6	77.1	25.7	20.6	18.2	35.7	26.2	10.0	19.0	17.5	12.8	27.1	24.1	5.5	2.1	12.3	19.6	12.4	27.4	25.9	46.4	13.6	15.6	17.9	18.5	11.1	51.9	31.0	18.3	15.7	12.8	16.3	7.6	21.4	16.4	19.2	21.7	32.0	43.4	22.5	34.6	46.9	34.8	8.6	17.1	29.1	12.4	43.1	50.6	6.6	37.0	47.7	70.5	24.6	22.9	25.2	13.2	17.5	27.0	34.5	12.7	12.0	19.7	17.1	23.7	32.8	10.4	19.1	24.3	13.8	25.8	28.1	22.4	21.5
ZNF337	dJ694B14.1	ENSG00000130684	"Zinc finger protein 337"	Q9Y3M9	20	25673195-25696853	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Excitatory neurons: 30.4;Inhibitory neurons: 26.8;Oligodendrocyte precursor cells: 26.2;Oligodendrocytes: 29.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044303, HPA064219"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nuclear speckles"	"HPA044303: AB_2678890, HPA064219: AB_2685215"	"unprognostic (2.14e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.54e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.36e-4)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.82e-3)"	15.8	13.4	21.5	7.4	21.9	10.3	16.1	28.6	25.5	27.4	23.0	26.5	5.9	21.5	16.1	14.8	26.2	6.9	14.4	20.9	20.6	19.2	11.6	16.6	11.2	20.6	20.3	31.2	13.1	10.4	24.4	7.7	20.5	27.4	8.9	25.9	12.7	13.2	12.5	13.1	18.6	11.7	19.2	21.7	14.0	9.3	20.6	15.3	18.8	8.6	9.5	22.4	19.7	25.3	10.0	17.3	14.0	9.9	11.2	14.3	11.9	8.4	7.3	6.3	7.8	3.6	9.1	12.3	7.8	7.8	12.8	16.0	9.3	27.9	8.7	4.4	7.2	7.5	13.9	15.8	9.6	6.9	8.1	13.3	24.1	7.5	22.1	16.7	10.0	15.7	6.8	10.6	12.5	11.4	18.6	13.4	3.7	5.3	12.2	11.8	12.8	6.0	6.6	11.1	11.2	12.0	8.3	13.4	11.1	17.2	7.7	9.4	13.5	14.1	7.2	9.4	11.3	14.9	8.3	4.3	6.7	5.9	11.2	0.0	1.6	3.2	4.6	2.7	5.0	2.3	3.7	4.2	2.7	1.8	5.2	6.1	0.0	3.9	1.5	2.5	2.5	2.6	21.5	21.9	28.6	25.5	20.9	20.6	20.6	20.3	20.5	19.2	20.6	25.3	8.6	6.4	15.4	26.4	4.3	2.0	5.6	3.4	4.6	8.4	4.1	5.2	1.2	2.8	10.8	3.7	2.1	3.8	4.5	1.2	3.9	4.3	1.4	6.7	8.9	5.6	5.4	1.3	30.4	3.1	2.0	5.4	2.0	4.4	5.1	9.8	3.3	3.2	3.3	6.7	26.8	4.2	0.0	3.1	1.1	0.3	7.2	4.3	1.8	25.3	3.1	7.9	11.3	26.2	29.3	2.7	1.0	5.7	1.7	5.4	1.6	1.9	15.5	13.0	0.0	6.3	4.8	8.1	10.2	3.6	2.4	2.3	6.2	5.4	2.6	1.9
ZNF397	"MGC13250, ZNF47, ZSCAN15"	ENSG00000186812	"Zinc finger protein 397"	Q8NF99	18	35241030-35267133	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026087	Uncertain		Approved	"Nucleoli,Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Plasma membrane, Cytosol"	Microtubules	"HPA026087: AB_1859243"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.09e-3)"	12.9	13.4	17.6	14.4	23.4	5.0	16.1	19.1	20.0	13.5	14.9	12.8	10.6	15.7	12.4	9.8	11.7	10.1	10.5	16.4	20.7	11.3	10.6	10.4	16.2	20.5	20.9	17.8	12.4	14.8	12.0	11.9	20.1	13.9	13.9	25.0	12.4	12.1	11.7	13.6	12.6	11.5	15.4	16.1	13.3	9.9	20.3	13.1	15.7	11.0	15.8	11.9	11.8	34.4	4.2	7.9	18.7	17.1	20.3	17.0	8.9	8.4	8.3	4.1	5.4	3.0	5.7	21.2	7.4	6.7	5.6	11.1	12.2	9.2	5.7	13.5	7.5	0.9	11.7	8.6	6.7	10.3	7.4	7.7	12.1	4.9	14.1	14.6	2.6	16.1	12.7	14.4	10.7	9.1	17.4	7.8	16.1	3.2	3.2	18.2	5.4	15.1	8.4	11.0	20.2	17.4	13.7	7.2	8.2	16.2	12.5	7.6	4.2	13.6	7.6	4.6	3.8	23.2	9.3	11.9	12.0	7.1	13.1	10.1	4.6	8.3	5.7	7.5	4.1	10.6	5.3	4.7	3.3	11.3	7.8	5.4	11.0	4.7	9.4	7.5	3.0	2.2	17.6	23.4	19.1	20.0	16.4	20.7	20.5	20.9	20.1	15.4	20.3	34.4	15.5	35.3	21.0	24.5	35.3	4.1	19.4	8.0	10.2	51.0	11.8	10.4	16.4	15.7	17.3	14.7	35.5	22.6	15.8	14.1	13.7	18.7	66.0	10.8	20.4	17.6	31.0	20.4	17.4	10.9	13.4	18.4	12.8	8.9	11.4	31.7	31.1	12.6	10.8	33.7	19.5	11.5	12.2	20.5	5.4	49.6	18.6	11.8	8.8	23.4	20.3	24.6	15.5	30.2	94.1	10.7	18.3	22.6	6.1	15.8	24.3	11.4	16.4	46.1	32.9	25.3	16.6	29.7	23.4	7.8	4.5	14.6	13.9	22.1	16.1	11.1
ZNF407	"FLJ13839, FLJ20307, KIAA1703"	ENSG00000215421	"Zinc finger protein 407"	Q9C0G0	18	74597870-75065671	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 96.9;Excitatory neurons: 111.0;Inhibitory neurons: 100.2;Microglial cells: 113.4;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028255, HPA041673"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"		"HPA028255: AB_10603466, HPA041673: AB_2677610"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.04e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.79e-5)"	"unprognostic (8.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	2.4	1.9	2.9	3.1	3.5	5.3	2.9	8.0	2.8	2.7	8.6	2.8	2.2	3.7	1.9	2.5	2.7	2.1	3.2	2.3	2.9	2.4	2.2	2.4	3.3	3.6	3.0	4.8	2.2	3.9	1.5	2.7	4.1	2.8	2.2	2.9	2.4	2.8	3.9	2.3	2.4	3.1	2.9	3.4	2.3	4.0	3.2	5.5	3.6	3.6	3.0	2.4	2.0	4.1	3.9	4.0	4.4	4.1	3.2	4.7	3.2	5.1	4.4	3.7	4.0	1.7	2.2	5.6	1.5	7.1	2.5	4.5	4.2	5.5	5.4	9.3	2.6	7.1	5.5	3.2	2.9	10.9	6.0	4.3	2.4	5.9	5.1	3.5	5.6	3.9	4.1	8.0	5.7	3.1	5.3	1.5	2.6	1.4	3.6	5.4	5.8	4.4	2.6	7.2	4.2	4.0	4.7	2.9	3.6	3.2	3.4	4.6	7.9	8.3	3.5	2.3	4.1	2.8	6.2	5.7	3.0	4.6	5.0	1.6	0.7	0.9	1.0	0.9	1.0	0.8	0.8	0.6	0.3	0.8	0.9	1.1	2.2	1.1	0.6	1.3	0.2	0.4	2.9	3.5	8.0	2.8	2.3	2.9	3.6	3.0	4.1	2.9	3.2	4.1	16.5	6.4	6.3	96.9	10.6	3.2	5.0	3.0	2.8	11.2	6.3	6.0	19.4	2.8	4.9	5.5	6.2	4.2	11.4	6.9	0.0	4.3	4.6	8.6	15.3	10.0	4.2	3.4	111.0	2.9	2.7	7.6	17.3	14.4	1.3	10.2	3.3	5.5	3.2	5.0	100.2	5.7	2.0	5.3	2.8	3.3	5.3	7.6	5.4	113.4	6.1	6.2	8.2	122.6	130.5	4.8	6.0	4.5	11.1	4.4	4.3	2.6	6.2	13.2	6.6	10.8	8.1	9.0	12.8	5.6	4.1	5.2	10.1	12.1	6.0	3.9
ZNF474	"4933409D10Rik, FLJ32921"	ENSG00000164185	"Zinc finger protein 474"	Q6S9Z5	5	122129546-122153569	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.2;choroid plexus: 7.1;fallopian tube: 17.1;testis: 7.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 23.0;Endometrial ciliated cells: 23.2;Late spermatids: 12.4;Respiratory ciliated cells: 22.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.0;CAPAN-2: 1.1;GAMG: 1.3;TIME: 1.2"	"Low region specificity"	"Detected in many"							HPA036594			Approved	"Nuclear membrane,Plasma membrane"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane"	"Plasma membrane"	"HPA036594: "	"unprognostic (9.98e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.90e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-4)"	0.2	0.1	0.6	0.1	0.7	0.0	0.2	0.5	0.3	0.6	7.1	0.3	0.1	0.7	0.0	0.4	17.1	0.5	0.1	0.6	1.2	0.3	0.1	1.7	0.0	2.2	4.2	0.2	0.1	0.0	0.2	0.0	2.0	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	1.7	0.1	0.1	7.6	1.2	0.3	0.9	0.1	0.1	0.1	0.1	1.9	0.0	0.4	0.1	0.0	0.2	0.1	0.0	1.0	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.7	1.3	0.2	0.0	0.0	0.4	0.1	0.1	0.4	0.2	0.0	0.2	0.3	0.0	0.1	0.5	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.1	0.1	1.2	0.3	0.2	0.7	0.2	0.1	0.2	0.1	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.3	0.6	1.2	2.2	4.2	2.0	1.7	1.2	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.0	23.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.0	0.0	0.0	0.1	0.6	2.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ZNF503	"FLJ45745, MGC2555, Nlz2"	ENSG00000165655	"Zinc finger protein 503"	Q96F45	10	75397830-75401764	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 255.0;Squamous epithelial cells: 189.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 115.1;PC-3: 149.2;U-87 MG: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026848	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA026848: AB_10610704"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.63e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.63e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.97e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	14.5	39.9	6.1	3.1	10.1	2.0	9.2	3.8	5.2	34.5	1.0	17.7	8.1	44.1	10.3	20.1	23.8	2.4	9.0	7.4	5.5	25.6	7.1	14.2	1.5	12.0	9.2	46.3	25.4	4.6	4.8	3.3	7.6	17.5	1.8	1.4	9.5	17.6	3.6	5.3	8.5	7.7	10.0	8.0	16.3	2.4	8.1	1.1	7.8	2.1	1.0	13.8	18.2	6.5	5.2	4.9	1.1	6.3	10.6	7.1	1.6	4.6	2.8	1.9	1.7	7.5	20.4	0.0	13.4	4.6	1.1	9.4	0.7	4.9	1.4	0.0	115.1	0.0	12.4	24.8	8.5	6.1	12.9	19.1	4.8	3.5	2.0	16.6	0.5	0.5	0.1	0.2	2.6	2.7	0.2	18.8	0.1	3.8	149.2	0.0	5.6	0.1	2.8	4.1	4.1	5.2	8.5	0.6	27.1	1.0	1.0	4.2	3.9	14.6	16.3	30.7	13.0	0.0	0.0	0.0	44.9	27.2	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	10.1	3.8	5.2	7.4	5.5	12.0	9.2	7.6	10.0	8.1	6.5	27.2	38.5	11.6	2.3	1.7	27.1	35.6	15.0	255.0	23.7	7.7	42.3	20.4	10.0	10.1	40.5	20.9	0.5	2.1	0.8	58.7	45.9	0.1	53.2	72.2	41.0	3.6	5.3	12.6	34.7	0.3	60.1	18.3	48.1	6.3	2.7	44.6	10.3	13.5	6.7	3.2	6.7	10.2	27.4	30.5	2.0	59.7	30.7	24.9	13.1	8.2	7.7	0.0	4.0	0.7	33.2	1.5	49.2	3.9	19.7	13.4	32.5	1.7	26.3	39.5	10.2	78.1	0.2	6.0	189.3	13.9	0.3	4.0	24.5	9.7	14.3
ZNF510	KIAA0972	ENSG00000081386	"Zinc finger protein 510"	Q9Y2H8	9	96754553-96778129	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 21.5;Inhibitory neurons: 22.7;Oligodendrocytes: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049139	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA049139: AB_2680651"	"unprognostic (2.70e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.18e-2)"	3.6	3.8	4.8	3.3	4.7	2.3	4.8	8.3	6.1	5.2	2.4	3.9	2.6	4.7	3.5	2.7	4.0	2.7	3.6	4.9	5.2	3.8	3.8	3.3	4.3	3.6	4.2	5.7	5.1	5.0	4.6	3.1	3.7	4.3	3.3	11.7	3.3	4.3	4.3	3.4	2.9	4.1	4.0	4.2	3.4	3.3	5.2	5.5	4.7	4.8	4.7	3.7	3.2	5.2	4.2	4.3	8.1	7.2	6.7	6.3	4.0	3.7	6.5	6.1	6.4	3.7	2.7	5.7	2.2	3.7	5.8	8.7	3.2	3.3	5.8	6.5	3.7	6.0	7.0	2.5	3.5	3.5	5.2	4.3	5.8	4.5	6.9	6.5	5.3	8.2	6.8	4.5	7.8	3.9	9.3	5.2	6.6	5.9	3.6	5.6	14.4	2.4	4.3	3.2	9.9	7.8	7.0	3.9	3.8	5.4	3.1	6.2	4.1	4.4	4.5	5.6	5.9	8.8	9.8	3.5	2.7	2.0	4.6	0.4	0.2	0.6	0.7	0.3	1.2	0.9	1.2	0.9	0.2	1.0	1.3	0.9	0.1	1.4	0.8	0.3	0.8	0.4	4.8	4.7	8.3	6.1	4.9	5.2	3.6	4.2	3.7	4.0	5.2	5.2	5.5	3.2	3.2	13.4	4.5	1.7	1.6	1.7	0.6	11.0	2.6	2.5	5.1	1.5	2.9	3.7	2.1	2.2	3.2	1.4	1.9	2.2	5.7	3.5	6.3	4.2	1.2	4.0	21.5	2.6	1.4	5.7	2.0	4.0	1.3	5.7	3.6	1.3	2.0	16.8	22.7	2.1	2.0	2.5	0.5	6.9	5.9	2.2	5.4	10.3	2.0	4.5	8.2	18.1	20.5	1.8	2.8	4.1	3.1	2.0	1.0	1.9	3.2	6.5	6.6	4.6	3.3	3.6	5.6	1.8	1.4	0.8	4.6	4.3	1.5	1.1
ZNF571	HSPC059	ENSG00000180479	"Zinc finger protein 571"	Q7Z3V5	19	37554782-37594792	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 77.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.9;Oligodendrocytes: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA054762			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA054762: "	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.03e-4)"	"unprognostic (5.77e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-4)"	4.1	7.5	8.9	3.6	8.4	8.5	14.5	9.4	11.1	6.4	8.1	3.4	2.2	6.1	9.9	4.1	6.7	5.0	4.2	7.2	9.0	7.4	3.5	3.9	5.5	7.2	8.1	8.3	3.2	12.0	8.9	5.5	7.1	8.0	3.5	28.9	3.3	4.6	4.1	8.5	2.9	4.8	4.5	5.5	3.9	10.6	7.0	6.2	77.4	3.9	6.0	4.5	4.0	9.9	2.5	1.4	8.6	12.5	6.3	6.4	2.8	3.8	6.0	8.9	11.0	2.7	2.4	13.6	11.6	3.9	6.3	3.3	2.8	4.1	14.8	3.0	10.9	7.3	4.4	1.6	7.2	2.7	7.9	3.5	7.2	8.6	7.8	6.3	1.8	12.1	3.5	1.1	7.3	2.4	13.8	3.0	21.7	4.0	4.8	6.8	4.1	7.2	12.4	16.3	18.5	12.9	8.9	2.9	4.5	17.1	13.3	1.9	1.1	4.1	5.2	4.5	9.8	10.5	23.4	18.5	0.6	1.2	9.1	1.6	0.7	4.4	5.2	1.2	4.8	7.6	5.0	5.3	2.3	7.7	6.0	6.6	1.2	3.2	1.1	3.5	3.8	2.7	8.9	8.4	9.4	11.1	7.2	9.0	7.2	8.1	7.1	4.5	7.0	9.9	5.5	0.0	2.0	5.2	6.6	1.8	1.2	1.9	5.2	9.5	3.5	3.2	1.6	1.5	4.6	5.5	10.4	2.4	11.9	0.8	3.9	2.3	20.9	3.1	3.1	6.0	1.2	4.8	8.6	1.6	1.8	3.1	2.0	2.4	15.2	5.1	4.6	0.8	1.7	13.5	9.7	1.9	6.1	1.3	2.1	4.3	4.4	1.7	5.4	5.6	0.6	4.9	5.2	17.1	23.9	1.0	1.0	2.6	3.5	1.9	1.1	2.8	4.0	16.0	13.1	4.9	4.2	10.3	6.2	2.9	2.6	1.2	8.7	4.1	1.7	0.5
ZNF598	"FLJ00086, HEL2"	ENSG00000167962	"Zinc finger protein 598, E3 ubiquitin ligase"		16	1997654-2009821	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041760, HPA041896"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA041760: AB_10792490, HPA041896: AB_10796464"	"unprognostic (9.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.81e-2)"	15.0	10.1	2.3	6.8	2.2	11.8	13.9	2.3	5.3	15.4	0.9	14.7	7.0	15.4	0.0	19.4	13.1	2.6	11.6	2.5	2.1	13.1	21.0	15.3	5.5	2.9	2.4	12.4	32.3	2.2	16.3	5.0	2.3	16.2	1.4	0.4	18.7	4.4	26.7	30.0	14.8	2.1	1.7	18.6	14.9	17.6	2.6	5.1	10.8	3.8	2.9	15.8	15.3	2.0	22.8	30.1	7.0	17.5	4.9	6.6	22.0	17.3	7.4	10.5	8.3	31.9	12.4	23.4	20.0	6.7	7.7	27.0	9.3	17.3	1.7	31.2	69.9	18.6	33.5	18.3	22.3	29.3	20.0	7.9	23.2	16.6	18.9	1.1	11.6	27.2	41.3	31.5	4.0	40.5	25.2	45.0	21.6	8.9	35.4	62.4	14.2	52.9	4.0	8.7	33.5	28.9	17.4	20.4	28.3	1.3	14.5	46.6	20.6	23.0	27.6	21.0	32.4	39.2	36.3	29.6	9.7	27.6	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	2.3	2.2	2.3	5.3	2.5	2.1	2.9	2.4	2.3	1.7	2.6	2.0	11.7	6.4	11.5	6.2	7.5	29.7	12.9	9.0	10.2	12.8	13.9	12.4	1.0	10.0	8.8	1.8	16.7	9.1	11.1	21.2	0.0	8.1	5.6	10.1	11.6	12.7	11.4	10.8	5.4	26.5	12.8	10.5	36.2	13.7	12.7	11.9	6.8	20.1	9.5	16.8	5.3	36.2	12.2	8.4	10.3	9.7	13.4	8.8	1.8	5.6	8.2	7.8	9.2	1.0	6.7	19.6	9.5	8.2	9.3	23.9	13.5	3.3	12.7	10.7	0.0	11.2	9.1	9.0	11.9	14.0	34.8	9.3	9.8	13.1	20.8	19.7
ZNF599	FLJ30663	ENSG00000153896	"Zinc finger protein 599"	Q96NL3	19	34758073-34773229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 33.2;Early spermatids: 81.4;Late spermatids: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA014701	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA014701: AB_1859371"	"unprognostic (3.52e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.35e-3)"	"unprognostic (9.20e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.12e-3)"	4.4	5.9	5.8	2.3	6.7	1.2	5.6	6.8	6.0	8.1	8.1	6.3	2.5	7.6	11.9	3.9	8.6	2.4	4.7	5.5	6.4	9.5	4.7	4.7	3.3	6.4	6.6	7.4	4.8	9.8	11.0	3.1	6.3	9.5	2.8	4.7	5.9	4.8	3.6	4.4	4.3	3.6	6.2	5.0	4.8	14.0	6.6	4.2	11.1	5.0	2.7	6.0	6.1	7.3	4.8	2.4	4.6	3.4	5.2	6.9	2.6	1.7	4.5	4.1	4.7	2.0	3.1	0.5	4.3	3.1	3.8	2.3	3.4	2.3	4.9	0.5	4.2	3.6	4.9	5.7	4.1	0.8	3.5	6.5	3.1	1.9	2.0	6.7	4.7	8.3	6.2	0.4	6.0	1.9	9.1	3.8	2.0	6.5	0.1	4.6	4.5	3.0	5.1	1.1	5.8	8.4	5.6	1.0	3.2	3.0	2.8	0.4	2.6	3.2	4.4	3.0	1.9	5.1	5.6	0.4	2.5	0.1	3.8	1.9	0.6	3.5	3.4	1.4	2.3	1.0	3.5	1.9	1.0	2.2	3.5	3.2	0.3	3.5	3.2	2.2	2.8	1.6	5.8	6.7	6.8	6.0	5.5	6.4	6.4	6.6	6.3	6.2	6.6	7.3	5.8	0.0	3.7	5.2	2.5	3.1	7.6	5.5	6.8	4.2	10.2	11.2	4.4	1.5	8.3	18.4	2.1	7.9	5.2	1.1	33.2	4.6	81.4	25.4	6.4	5.3	1.2	3.8	0.7	2.3	4.5	8.3	1.5	4.1	0.0	6.6	5.0	4.0	3.8	0.0	3.5	3.3	4.1	1.0	1.9	30.8	10.2	1.2	5.4	0.0	0.9	14.4	4.1	9.5	8.1	3.1	0.9	4.9	4.8	5.5	2.9	15.3	22.7	2.7	6.6	5.7	5.7	26.2	7.5	4.8	1.6	1.9	3.9	7.2	3.2	6.0
ZNF646	KIAA0296	ENSG00000167395	"Zinc finger protein 646"	O15015	16	31074422-31084196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.8;Spermatocytes: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042364, HPA066468"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042364: AB_10794796, HPA066468: AB_2732746"	"unprognostic (1.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.66e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.23e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	5.6	4.1	4.4	6.7	4.9	9.2	5.0	6.9	5.9	5.8	1.6	5.0	6.4	6.5	2.5	5.2	5.5	3.5	4.8	3.7	2.9	4.9	4.3	4.7	7.1	6.2	4.7	6.2	5.6	4.4	5.0	4.0	4.9	5.4	2.8	1.6	6.2	4.0	7.9	8.0	6.4	3.2	3.5	8.0	5.5	25.7	5.8	8.6	5.1	3.7	5.1	5.4	4.9	6.3	7.8	15.8	10.2	8.0	7.1	5.5	13.7	8.3	8.8	9.8	9.0	11.6	7.1	15.0	13.0	7.1	6.5	10.2	8.5	9.2	3.7	17.2	8.1	11.1	15.6	9.7	7.4	14.4	16.7	7.1	8.1	10.6	6.0	7.6	5.9	12.5	18.2	8.5	7.5	12.2	16.0	9.9	13.8	3.5	8.1	25.5	20.2	15.3	3.1	7.3	14.7	14.9	9.5	10.0	4.9	4.4	8.4	12.5	12.1	12.3	7.0	8.2	7.8	14.2	14.1	14.9	11.2	15.5	9.8	9.8	4.5	13.2	5.1	4.2	2.6	3.9	2.4	2.1	4.6	4.4	2.7	3.0	25.1	4.8	2.8	6.6	2.6	2.1	4.4	4.9	6.9	5.9	3.7	2.9	6.2	4.7	4.9	3.5	5.8	6.3	4.7	3.2	1.3	3.6	4.2	3.3	1.0	2.6	2.8	3.6	3.4	3.4	1.7	1.5	2.2	1.8	4.2	1.9	6.6	6.6	1.9	4.1	24.8	3.0	3.7	3.4	6.0	2.1	2.2	3.5	2.1	2.5	5.6	4.9	1.3	5.1	1.8	1.9	4.9	1.7	2.1	3.4	4.1	4.7	2.8	6.6	2.8	6.4	0.0	7.5	3.7	3.6	4.1	2.0	3.1	4.4	7.6	4.5	2.3	2.4	5.8	2.2	2.7	1.1	0.0	3.5	2.3	16.2	7.0	2.9	4.0	2.5	4.9	2.8	3.7	1.9
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569672-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 180.3;Late spermatids: 576.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favorable (5.90e-4)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	8.7	8.4	17.6	9.8	17.5	11.4	5.1	20.5	19.1	6.7	16.4	9.7	14.6	7.8	5.6	5.6	10.4	4.2	7.0	16.5	15.8	8.2	8.3	7.5	9.5	17.5	16.9	9.1	12.3	9.7	8.4	3.3	17.2	7.5	6.4	5.6	10.1	6.9	25.6	9.0	11.6	5.8	16.2	12.0	10.1	13.6	18.1	8.2	5.1	9.7	5.4	6.6	5.7	20.2	10.4	9.5	7.3	8.1	13.3	5.2	3.1	6.7	8.2	5.0	4.0	2.5	15.1	6.2	12.8	6.9	6.0	8.6	2.2	3.6	4.7	16.7	6.4	3.8	3.7	2.7	6.3	4.3	17.9	8.7	8.2	5.3	6.0	7.7	4.7	7.7	3.9	12.0	5.3	13.5	14.9	9.9	3.3	8.6	4.9	13.3	3.8	9.2	8.2	3.2	12.1	13.2	2.4	14.1	15.3	2.0	15.6	7.8	5.4	5.5	4.0	5.2	4.7	20.5	13.2	5.7	12.2	4.3	9.7	12.0	4.6	11.0	6.2	4.2	5.4	6.5	6.6	6.8	4.2	7.6	5.7	5.0	5.3	20.4	6.5	7.4	11.2	3.3	17.6	17.5	20.5	19.1	16.5	15.8	17.5	16.9	17.2	16.2	18.1	20.2	16.3	6.4	3.1	5.9	22.8	6.4	10.5	12.6	16.5	19.8	20.3	22.7	11.2	22.8	10.2	16.5	18.8	7.5	26.0	38.6	49.0	24.8	180.3	25.4	9.5	14.0	20.4	11.2	5.1	31.2	9.6	15.6	17.9	9.0	5.1	12.1	20.7	22.6	24.4	21.9	5.1	27.7	12.2	33.1	12.0	576.6	19.9	17.4	17.8	1.9	28.3	31.2	30.9	9.0	10.3	21.8	37.2	19.9	16.7	10.1	59.2	54.1	38.4	27.4	6.6	17.2	20.2	34.5	8.5	11.2	7.1	4.7	23.2	15.1	23.6	8.5
ZNF706	HSPC038	ENSG00000120963	"Zinc finger protein 706"	Q9Y5V0	8	101177878-101206193	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1090.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042793			Approved	"Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA042793: AB_10795710"	"unprognostic (2.05e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-3)"	"unprognostic (5.22e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (5.90e-11)"	"unprognostic (9.65e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.17e-2)"	99.5	83.4	85.6	57.3	85.3	76.9	92.6	89.1	114.7	86.7	54.6	93.3	93.3	71.5	90.4	147.2	69.0	69.2	86.0	87.2	72.9	95.9	96.0	81.9	95.5	69.0	72.8	70.2	269.9	69.8	93.9	55.3	69.6	70.9	87.2	46.9	99.1	49.1	110.7	180.0	100.0	50.7	69.7	100.5	92.7	118.1	70.0	67.2	82.3	86.1	102.5	75.1	101.1	83.1	203.0	113.9	196.0	62.7	69.0	78.0	124.8	82.4	105.5	83.5	89.0	81.8	121.5	121.9	139.4	99.1	170.4	108.4	113.3	111.0	95.8	90.5	98.0	122.1	69.5	159.2	90.7	92.2	114.1	69.1	170.9	78.9	170.7	115.1	144.0	121.4	134.8	230.6	75.0	142.6	194.5	252.2	59.7	408.6	278.8	80.8	65.3	251.1	112.7	103.2	129.4	57.6	57.6	95.0	375.9	166.3	99.3	96.5	96.3	45.6	93.9	121.9	87.0	194.1	202.6	197.0	123.5	199.2	215.8	255.1	280.0	162.6	138.0	463.2	143.4	400.0	191.5	178.0	264.1	344.1	214.7	206.3	38.7	130.9	492.1	532.8	302.8	268.7	85.6	85.3	89.1	114.7	87.2	72.9	69.0	72.8	69.6	69.7	70.0	83.1	131.4	60.9	41.0	29.0	188.6	459.7	242.3	252.7	149.7	59.3	159.3	182.6	79.8	137.2	138.1	79.1	18.8	190.6	175.0	288.4	180.0	264.5	439.7	125.5	70.1	137.7	265.1	107.1	31.5	259.8	339.0	131.4	106.5	114.9	122.2	85.1	99.2	123.4	265.3	85.8	21.1	275.3	231.9	162.3	186.4	1090.7	86.9	214.8	206.3	16.9	298.4	131.3	114.4	14.6	57.6	401.5	265.4	86.9	329.4	326.5	339.2	195.1	110.8	55.9	105.2	111.6	169.8	84.3	82.7	224.8	518.0	193.3	112.7	72.7	153.5	311.7
ZNF717	"X17, ZNF838"	ENSG00000227124	"Zinc finger protein 717"		3	75678660-75785583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 47.7"									HPA044549	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA044549: AB_10964630"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.60e-6)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	5.1	5.7	7.6	3.3	9.6	2.8	7.3	7.7	9.5	5.7	4.4	5.1	5.7	5.9	15.4	5.4	7.2	4.5	5.9	7.2	8.1	9.9	7.9	4.6	4.8	9.0	8.5	7.9	8.9	8.3	9.3	5.0	9.2	6.7	6.6	7.8	7.2	4.7	4.2	9.9	5.2	4.2	8.5	7.1	7.4	8.2	8.7	4.7	9.3	4.4	7.1	5.8	5.4	12.3	11.4	5.8	5.2	3.6	6.1	8.5	3.9	3.5	5.2	5.1	5.9	9.4	9.8	5.2	4.6	6.0	5.0	6.3	6.8	4.5	4.2	0.5	7.0	8.6	9.4	0.9	15.9	0.5	8.6	10.4	4.8	12.8	17.4	4.3	0.7	0.5	47.7	11.6	5.7	1.8	0.6	17.1	5.2	8.9	6.3	7.7	4.5	27.0	7.6	3.8	4.2	17.4	3.5	6.6	14.6	5.1	16.8	4.6	1.6	9.3	10.9	6.4	1.4	12.0	19.9	5.2	4.7	1.3	6.0	1.3	2.6	5.1	2.1	3.8	1.2	5.1	3.3	2.0	2.7	6.1	6.3	3.7	0.7	3.0	3.8	4.1	1.1	2.0	7.6	9.6	7.7	9.5	7.2	8.1	9.0	8.5	9.2	8.5	8.7	12.3	6.6	3.2	3.1	28.1	6.0	3.2	4.2	3.4	5.2	8.5	9.1	8.3	5.6	8.6	4.2	7.3	2.1	5.2	5.8	2.2	11.7	4.6	5.0	3.4	4.8	5.1	5.3	7.4	21.7	4.4	1.8	5.7	4.6	2.6	8.9	11.4	7.9	8.2	7.3	10.1	27.2	7.0	4.1	5.7	4.1	2.1	2.5	4.5	1.8	16.9	5.0	5.2	5.2	25.6	35.4	3.9	2.0	3.0	0.7	5.1	6.3	17.5	6.3	8.1	0.0	5.1	5.3	11.1	8.6	7.0	4.4	3.4	3.1	7.9	5.0	3.9
ZNF720		ENSG00000197302	"Zinc finger protein 720"	Q7Z2F6	16	31713229-31794869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA041570	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041570: AB_10795126"	"unprognostic (5.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-3)"	"unprognostic (8.72e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.47e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-2)"	6.0	6.9	5.9	6.8	5.7	6.5	7.2	10.8	6.4	5.1	5.9	7.3	4.1	6.2	9.4	7.8	7.0	5.9	4.6	5.7	6.3	8.7	6.7	6.1	11.0	6.8	7.3	4.4	7.2	7.2	7.3	9.2	7.7	7.9	7.9	6.1	5.8	7.0	6.3	10.0	5.3	6.1	6.6	8.2	8.3	8.2	6.5	7.4	7.7	4.4	10.8	6.2	5.7	6.3	15.1	10.5	12.6	10.7	10.9	16.5	12.4	15.9	10.1	7.6	10.1	7.9	15.8	7.3	27.2	5.3	11.2	10.2	12.7	6.2	11.3	32.7	6.6	4.1	5.7	21.8	16.4	8.8	21.6	11.1	16.7	5.3	7.3	15.1	14.3	17.4	13.8	9.4	8.3	24.5	8.9	11.6	12.5	10.4	8.2	17.0	5.7	11.5	8.5	9.4	5.6	8.6	15.9	6.8	15.4	19.9	13.5	17.3	9.5	5.5	4.3	11.1	4.9	15.5	18.3	21.0	4.9	13.3	8.8	21.2	6.7	33.7	18.6	7.6	14.3	19.9	13.0	17.2	7.4	20.3	12.2	15.1	8.8	20.2	8.5	12.9	18.1	6.8	5.9	5.7	10.8	6.4	5.7	6.3	6.8	7.3	7.7	6.6	6.5	6.3	19.4	16.0	21.0	25.8	19.8	9.1	16.9	23.4	6.8	25.6	15.0	18.4	12.2	5.7	19.4	5.5	6.2	35.4	24.5	10.3	23.5	16.9	7.3	20.6	19.2	21.5	17.4	9.9	32.0	13.5	12.3	16.4	15.3	20.1	21.5	25.8	15.7	10.6	16.8	23.5	28.7	13.5	22.4	9.5	14.5	4.1	13.4	13.0	10.6	24.4	14.5	18.1	40.2	40.2	31.0	19.0	10.8	18.4	13.9	28.4	7.2	15.7	19.5	9.8	32.9	21.3	15.3	28.2	19.3	9.4	11.5	71.0	20.9	25.7	10.6	24.3
ZNF783	DKFZp667J212	ENSG00000204946	"Zinc finger family member 783"	Q6ZMS7	7	149262171-149297302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA020375	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA020375: AB_1859453"	"unprognostic (3.17e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (2.24e-7)"	"unprognostic (2.49e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.11e-4)"	7.1	5.4	6.6	5.3	6.5	3.0	7.4	6.6	7.4	10.8	5.0	7.7	4.0	8.9	3.6	6.0	10.1	3.0	5.4	6.2	6.6	9.9	3.4	6.2	7.3	7.1	6.6	11.7	7.1	2.9	7.1	2.9	6.7	9.4	3.8	2.9	5.8	4.0	6.4	7.0	9.2	4.5	6.1	12.8	6.6	6.6	6.8	4.0	8.3	3.3	6.4	8.1	7.8	8.0	3.5	3.5	5.7	4.1	3.7	6.9	5.3	2.1	1.1	5.0	2.2	5.6	6.5	11.9	5.5	3.5	1.1	2.3	4.0	4.3	2.2	3.3	3.5	7.6	8.7	1.1	8.5	5.1	9.2	7.4	8.7	4.5	5.5	3.1	3.4	4.2	6.2	6.0	4.2	7.6	7.6	7.8	12.8	8.1	4.7	1.6	0.5	10.6	5.6	5.8	4.5	9.5	8.5	4.0	6.0	3.0	4.4	10.1	5.0	4.0	0.9	2.1	4.9	9.1	6.2	0.1	5.6	1.8	8.7	0.1	0.4	0.1	1.0	0.7	0.8	0.7	0.6	0.6	0.4	1.3	0.8	0.7	0.1	0.5	1.7	0.9	0.4	0.4	6.6	6.5	6.6	7.4	6.2	6.6	7.1	6.6	6.7	6.1	6.8	8.0	6.7	3.2	2.7	5.5	6.1	2.5	2.5	4.6	1.8	13.3	7.5	7.6	2.2	7.2	3.2	0.0	10.4	3.0	6.1	3.4	3.9	2.1	5.3	3.2	7.9	4.3	3.6	1.7	5.7	2.7	2.0	7.0	7.1	6.2	0.0	6.4	5.0	6.6	4.2	6.7	6.3	4.7	4.1	7.9	4.6	5.0	8.7	3.9	5.4	11.2	5.2	3.8	8.2	4.0	8.5	3.0	1.6	5.7	3.9	4.0	3.0	1.1	5.5	8.8	13.1	7.4	5.0	16.3	6.9	3.6	3.0	1.1	5.0	6.9	4.3	2.4
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favorable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	2.6	3.6	2.1	3.3	2.7	3.4	3.6	5.6	2.5	3.1	2.6	3.6	2.6	3.5	4.4	2.9	4.0	2.0	3.2	2.0	2.7	2.9	3.3	2.9	4.1	2.8	2.3	3.8	2.9	4.9	2.6	3.0	2.2	3.5	3.5	3.1	3.4	3.4	4.7	3.6	2.8	3.7	1.6	3.7	3.0	6.2	2.4	5.5	3.8	5.2	4.7	4.3	2.2	2.9	2.5	5.0	6.5	3.9	7.1	4.2	18.2	6.1	7.4	7.2	8.2	5.3	2.3	5.4	2.4	4.6	9.5	7.7	4.9	7.5	5.7	5.4	3.2	3.7	8.4	6.0	8.4	8.9	5.7	4.2	8.3	8.9	7.2	4.6	7.5	6.1	6.4	7.9	6.9	5.5	7.0	3.3	5.2	6.2	6.4	5.7	9.0	7.7	3.1	3.6	7.4	5.0	11.7	5.9	3.5	5.6	7.9	5.0	5.3	4.6	4.2	4.6	4.8	10.5	24.1	6.8	5.9	2.7	7.8	2.2	3.3	5.1	6.0	4.1	6.7	5.1	3.9	7.6	4.7	5.8	5.2	5.7	4.5	7.2	2.8	4.9	5.5	3.6	2.1	2.7	5.6	2.5	2.0	2.7	2.8	2.3	2.2	1.6	2.4	2.9	0.8	0.0	0.5	2.6	2.4	1.5	1.2	0.8	1.8	0.8	1.0	0.9	2.5	2.8	1.7	0.0	0.0	2.0	0.9	0.9	1.9	2.0	4.5	0.4	1.9	1.1	0.0	4.8	3.1	0.6	0.6	1.2	2.6	0.5	0.0	1.1	1.1	1.2	2.1	1.7	3.2	0.5	0.0	0.8	1.2	4.7	0.6	0.6	0.0	1.0	0.1	0.9	2.1	4.0	2.9	0.5	0.3	1.9	3.0	0.7	0.9	1.0	0.7	1.2	0.0	0.4	1.3	5.8	1.6	2.3	1.0	2.6	1.5	1.3	1.1	0.9
ZNF839	C14orf131	ENSG00000022976	"Zinc finger protein 839"	A8K0R7	14	102317377-102342702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020434	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA020434: AB_10669862"	"unprognostic (7.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.10e-3)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.40e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	7.6	9.3	9.7	6.8	8.9	11.5	13.7	6.2	9.5	9.2	7.9	7.8	7.1	8.1	9.3	7.2	17.0	6.8	8.7	8.9	11.0	11.3	14.6	6.1	10.8	8.7	8.6	10.9	12.1	10.8	9.2	5.6	8.1	9.0	8.1	8.0	10.5	9.5	18.5	19.4	9.8	5.2	6.7	15.1	8.0	31.3	9.3	12.2	11.2	12.1	8.8	7.0	6.0	8.7	13.5	12.1	15.4	27.8	7.0	11.8	26.2	10.3	8.4	12.6	10.3	4.6	11.2	13.8	8.3	7.0	5.2	13.0	10.0	25.9	9.7	18.6	19.1	9.6	12.7	7.7	6.3	9.1	8.1	9.5	18.9	24.4	22.6	19.1	17.0	19.3	21.0	17.6	17.9	25.1	13.9	14.6	20.6	7.3	12.0	29.7	9.4	8.8	11.2	10.9	8.2	25.7	8.5	10.7	9.6	14.5	24.5	14.7	6.7	8.1	7.3	11.3	9.3	17.3	13.5	16.2	6.3	10.7	13.6	0.0	0.2	0.7	0.6	0.6	0.7	0.5	0.4	0.4	0.3	0.4	0.7	0.6	1.0	0.1	0.1	0.6	0.6	0.1	9.7	8.9	6.2	9.5	8.9	11.0	8.7	8.6	8.1	6.7	9.3	8.7	4.6	0.0	10.0	12.1	4.1	3.1	2.6	2.2	2.8	7.6	6.7	7.1	1.9	7.2	3.7	11.0	8.4	6.3	6.5	3.3	11.7	2.9	27.4	6.1	4.3	3.5	1.2	7.4	7.9	2.8	3.1	4.0	5.6	4.5	3.8	10.6	4.6	4.7	3.1	3.3	7.8	5.7	4.1	2.2	1.5	3.8	5.0	3.5	3.6	3.7	1.9	6.9	1.0	5.0	8.2	2.8	1.6	4.1	4.5	2.5	5.3	7.0	7.9	9.6	0.0	3.6	3.3	19.9	11.6	3.7	2.6	5.6	4.5	5.7	5.4	1.5
ZSCAN29	"FLJ35867, Zfp690, ZNF690"	ENSG00000140265	"Zinc finger and SCAN domain containing 29"	Q8IWY8	15	43358172-43371025	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007241, HPA011109"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Actin filaments"	"HPA007241: AB_10600420, HPA011109: AB_10611525"	"unprognostic (3.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.43e-2)"	6.3	5.6	7.9	8.6	10.1	5.6	6.8	8.1	7.4	7.2	8.1	7.6	8.8	8.9	5.2	7.2	6.4	6.0	5.5	6.6	7.4	5.7	6.9	6.9	10.7	9.3	9.7	7.4	11.4	7.7	5.5	8.1	8.9	6.8	7.6	13.6	8.5	6.5	9.7	5.8	9.9	6.4	7.7	9.0	8.8	17.3	8.5	10.7	7.2	8.5	10.4	6.6	6.0	10.3	11.7	12.5	28.9	17.9	10.0	10.5	15.6	9.0	13.9	15.6	16.2	19.7	8.1	11.4	14.7	11.1	12.6	33.7	21.5	11.0	13.9	29.6	11.8	25.1	20.5	15.5	11.1	17.3	21.2	9.3	19.0	10.6	14.9	11.0	8.0	17.3	23.7	13.5	12.7	7.4	16.7	14.2	14.5	17.1	9.6	25.7	16.1	14.0	9.1	13.9	20.6	22.2	13.9	22.5	10.4	14.5	15.8	26.6	9.1	18.3	14.4	14.0	16.4	25.8	38.4	21.6	10.7	16.9	14.1	0.4	0.3	3.1	0.4	0.4	0.3	0.8	0.4	0.3	0.4	0.5	0.2	0.6	0.7	1.0	0.3	0.3	0.8	0.3	7.9	10.1	8.1	7.4	6.6	7.4	9.3	9.7	8.9	7.7	8.5	10.3	3.5	6.4	7.9	6.8	5.8	3.6	2.6	3.7	4.6	10.8	4.8	4.8	7.8	4.3	7.8	7.3	27.1	5.1	7.1	11.0	0.0	5.4	81.7	5.0	8.2	4.9	6.1	1.3	6.4	7.1	4.4	5.8	9.7	7.8	0.0	6.5	3.9	7.2	5.8	13.5	5.2	8.1	4.1	10.6	3.7	20.7	6.8	4.8	5.4	9.4	6.7	5.5	10.3	10.1	10.2	8.7	5.0	6.0	3.3	3.9	7.7	2.6	5.2	18.0	0.0	4.9	3.8	12.0	6.7	4.4	3.1	3.8	4.2	2.8	7.0	2.4
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA041147: AB_2677329, HPA046751: AB_2679785"	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	3.0	4.1	2.7	3.7	2.6	6.0	3.5	4.6	2.9	3.1	2.7	4.1	4.6	3.4	3.5	3.5	4.2	3.2	4.9	2.7	2.5	3.6	1.9	3.3	5.0	2.6	2.7	5.8	4.2	4.9	1.1	4.0	2.5	4.1	3.5	8.2	4.9	3.4	15.9	6.5	4.4	3.5	1.9	4.6	4.3	3.8	2.9	3.9	4.5	5.1	4.9	3.4	1.4	3.1	7.2	8.6	6.4	7.8	11.2	6.3	6.5	4.8	5.9	10.2	9.3	19.5	8.4	8.4	13.9	6.7	11.2	17.0	10.1	12.9	7.7	3.4	6.1	10.7	11.5	14.0	6.8	9.2	10.9	9.2	10.6	8.6	8.2	7.8	7.9	7.3	9.8	6.7	6.0	20.8	10.0	7.9	3.6	8.1	9.7	7.8	9.1	6.0	6.7	10.1	8.6	5.5	16.2	24.0	5.8	5.7	14.6	7.2	7.0	11.5	7.3	6.4	7.0	6.6	5.0	8.2	9.2	6.8	6.0	2.4	1.4	3.6	0.5	1.8	0.3	2.4	1.7	0.7	0.7	2.2	2.3	2.1	1.6	0.6	1.8	2.2	1.4	0.8	2.7	2.6	4.6	2.9	2.7	2.5	2.6	2.7	2.5	1.9	2.9	3.1	0.8	3.2	2.7	0.7	1.4	1.1	2.4	2.4	2.2	3.0	0.8	0.5	5.7	4.3	1.2	0.0	0.0	2.9	0.3	4.2	3.9	2.4	0.6	1.1	1.7	1.7	2.4	4.4	0.8	3.8	2.8	1.9	4.1	1.5	3.8	2.5	2.5	2.1	1.7	6.7	0.9	2.8	2.0	1.4	1.9	0.7	3.4	0.7	0.0	0.0	1.8	1.6	1.0	0.0	0.8	3.3	3.7	1.5	0.5	1.6	2.4	1.2	0.4	3.8	0.0	2.0	1.8	1.0	2.0	1.4	1.6	2.3	1.8	3.6	3.0	2.0
ZSWIM8	"4832404P21Rik, KIAA0913"	ENSG00000214655	"Zinc finger SWIM-type containing 8"	A7E2V4	10	73785606-73801797	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041244	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA041244: AB_10794269"	"unprognostic (8.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-2)"	"prognostic favorable (5.61e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.52e-1)"	60.4	97.0	86.7	19.7	88.1	42.8	59.3	85.1	110.5	77.1	88.3	77.7	27.2	63.8	43.4	105.6	62.5	24.9	65.1	87.5	85.5	97.3	143.6	68.9	25.1	87.9	86.4	69.8	64.4	35.4	145.0	24.8	87.1	91.1	17.8	27.5	70.9	28.4	62.2	88.9	70.1	28.1	83.7	109.8	68.1	96.4	87.8	25.1	87.6	22.4	21.6	74.5	77.1	90.4	14.0	23.3	28.4	46.9	65.6	31.2	16.3	17.5	48.1	24.3	29.1	20.7	11.3	7.9	12.3	28.6	23.6	20.6	10.1	19.9	12.2	12.6	21.3	11.2	26.1	27.7	49.2	7.7	41.4	51.4	36.2	30.2	35.0	66.0	28.5	16.4	16.0	14.9	28.3	21.2	11.7	22.8	8.4	11.2	72.8	13.9	13.5	4.7	34.9	29.6	6.8	30.9	14.5	42.1	25.9	24.5	28.5	15.8	29.6	26.7	16.0	12.2	18.1	37.6	21.6	5.1	29.5	11.3	14.1	2.4	2.2	1.9	3.0	1.5	1.7	1.8	1.3	1.3	1.8	1.2	0.6	1.9	4.9	1.1	2.5	3.8	1.8	1.0	86.7	88.1	85.1	110.5	87.5	85.5	87.9	86.4	87.1	83.7	87.8	90.4	17.2	3.2	11.5	49.6	7.2	12.4	7.4	15.1	11.4	32.8	20.2	17.7	1.4	20.0	12.8	20.2	68.8	13.4	27.2	21.7	1.9	13.7	5.5	14.0	19.0	17.1	20.4	11.4	34.0	14.8	8.4	13.2	24.5	22.2	0.0	18.8	29.6	35.0	19.0	35.3	30.2	18.3	14.2	24.2	15.7	2.2	22.1	17.1	16.0	21.5	19.2	19.6	15.5	26.7	36.5	17.5	19.5	24.0	8.2	17.7	41.3	11.7	15.4	45.3	13.1	21.1	18.3	35.8	15.9	14.9	14.2	28.7	13.9	19.3	12.1	17.9
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381295-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 596.6"	"Cell type enhanced"	"Detected in many"		"Macrophages: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 163.3"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.4;granulocytes: 163.3;monocytes: 83.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		180000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites"	"Plasma membrane, Actin filaments"	"CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611"	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	211.5	75.4	21.6	82.5	24.3	106.3	191.0	24.4	33.5	275.7	24.8	382.6	28.1	596.6	16.5	136.7	294.9	57.0	152.0	21.9	21.9	99.4	89.9	316.8	53.9	27.5	24.7	168.7	78.5	84.3	52.4	38.4	27.5	171.9	20.2	5.2	108.1	75.3	113.3	130.7	148.7	127.7	23.8	213.6	154.0	98.9	28.8	27.6	89.0	19.1	31.1	301.6	185.9	26.8	73.9	39.3	50.6	70.5	93.9	208.2	63.4	152.1	158.9	146.5	122.7	135.4	42.6	4.6	57.5	168.5	84.1	55.8	31.7	138.0	67.8	81.6	18.7	105.9	45.7	46.9	163.8	86.4	162.6	222.9	60.5	160.1	54.0	90.5	187.9	9.1	28.0	42.8	159.6	73.4	1.3	165.9	110.0	25.4	273.1	16.3	28.0	6.4	112.2	34.6	2.8	39.5	112.3	99.2	57.0	45.9	12.1	80.5	343.7	176.5	74.1	187.9	152.4	15.6	20.4	11.7	154.6	87.4	119.8	18.9	70.8	48.2	20.2	70.4	16.2	3.1	19.4	23.3	58.4	2.0	11.7	13.8	163.3	14.7	83.6	14.5	19.1	44.1	21.6	24.3	24.4	33.5	21.9	21.9	27.5	24.7	27.5	23.8	28.8	26.8	51.6	6.4	6.4	8.1	26.7	33.8	174.0	78.4	26.7	3.7	40.2	85.3	11.6	25.8	45.4	35.0	0.0	40.6	51.7	40.1	7.9	100.3	1.5	23.4	172.6	58.2	38.2	19.3	36.9	94.1	95.8	66.6	44.9	42.0	36.8	13.7	55.3	32.0	164.6	0.0	18.3	26.7	24.4	195.7	95.1	6.8	28.6	207.1	14.2	7.5	171.9	15.1	40.2	7.5	5.2	169.8	48.2	55.3	20.3	61.3	19.8	19.6	9.9	3.0	85.5	48.7	103.9	7.3	9.9	46.3	20.2	28.0	91.9	8.8	28.6	106.4